{
 "cells": [
  {
   "cell_type": "code",
   "id": "8326350d-5e74-4325-8d48-12b75062c032",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:02:19.279732Z",
     "start_time": "2024-10-28T18:02:19.278220Z"
    }
   },
   "source": [
    "import requests\n",
    "import json"
   ],
   "outputs": [],
   "execution_count": 43
  },
  {
   "cell_type": "code",
   "id": "8ce22607-8e7a-4091-a9c8-475cbaee2686",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:02:19.371394Z",
     "start_time": "2024-10-28T18:02:19.369744Z"
    }
   },
   "source": [
    "#AC_URL = \"http://localhost:6380/query\"\n",
    "AC_URL = \"https://answercoalesce.renci.org/query\""
   ],
   "outputs": [],
   "execution_count": 44
  },
  {
   "cell_type": "code",
   "id": "3e93637c-9443-4744-99dd-adecdce06a9c",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:02:19.619803Z",
     "start_time": "2024-10-28T18:02:19.614260Z"
    }
   },
   "source": [
    "def generate_trapi_query(input_node_type,output_node_type,input_curies,predicate,input_is_subject=True):\n",
    "    envelope = {\"message\":{\"query_graph\": {\"nodes\":{\"input\":{},\"output\":{}}, \"edges\":{\"edge_0\":{}}}}}\n",
    "    input_node = envelope[\"message\"][\"query_graph\"][\"nodes\"][\"input\"]\n",
    "    input_node[\"categories\"] = [input_node_type]\n",
    "    input_node[\"ids\"] = [\"uuid:1\"]\n",
    "    input_node[\"member_ids\"] = input_curies\n",
    "    input_node[\"set_interpretation\"]=\"MANY\"\n",
    "    output_node = envelope[\"message\"][\"query_graph\"][\"nodes\"][\"output\"]\n",
    "    output_node[\"categories\"] = [output_node_type]\n",
    "    query_edge = envelope[\"message\"][\"query_graph\"][\"edges\"][\"edge_0\"]\n",
    "    if input_is_subject:\n",
    "        query_edge[\"subject\"] = \"input\"\n",
    "        query_edge[\"object\"] = \"output\"\n",
    "    else:\n",
    "        query_edge[\"subject\"] = \"output\"\n",
    "        query_edge[\"object\"] = \"input\"\n",
    "    query_edge[\"predicates\"]  = [ predicate ]\n",
    "    #query_edge[\"knowledge_type\"] = \"inferred\"\n",
    "    return envelope"
   ],
   "outputs": [],
   "execution_count": 45
  },
  {
   "cell_type": "code",
   "id": "39699889-ef49-44f9-a23f-6106c2ce6227",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:02:20.250011Z",
     "start_time": "2024-10-28T18:02:20.247277Z"
    }
   },
   "source": [
    "def phenotypes_to_disease(phenotypes, print_query=False):\n",
    "    #Phenotype to Disease\n",
    "    input_type = \"biolink:PhenotypicFeature\"\n",
    "    output_type = \"biolink:Disease\"\n",
    "    predicate = \"biolink:has_phenotype\"\n",
    "    input_is_subject = \"False\"\n",
    "    query = generate_trapi_query( input_type, output_type, phenotypes, predicate, input_is_subject)\n",
    "    if print_query:\n",
    "        print(json.dumps(query,indent=2))\n",
    "    response = requests.post( AC_URL, json = query )\n",
    "    print(response.status_code)\n",
    "    return response.json()"
   ],
   "outputs": [],
   "execution_count": 46
  },
  {
   "cell_type": "code",
   "id": "bb22f808-f399-40bb-b4a7-b26f2a2c8449",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:02:20.947606Z",
     "start_time": "2024-10-28T18:02:20.942521Z"
    }
   },
   "source": [
    "def genes_to_chemical(genes, print_query=False):\n",
    "    #Phenotype to Disease\n",
    "    input_type = \"biolink:Gene\"\n",
    "    output_type = \"biolink:ChemicalEntity\"\n",
    "    predicate = \"biolink:related_to\"\n",
    "    input_is_subject = \"False\"\n",
    "    query = generate_trapi_query( input_type, output_type, genes, predicate, input_is_subject)\n",
    "    if print_query:\n",
    "        print(json.dumps(query,indent=2))\n",
    "    response = requests.post( AC_URL, json = query )\n",
    "    print(response.status_code)\n",
    "    return response.json()"
   ],
   "outputs": [],
   "execution_count": 47
  },
  {
   "cell_type": "code",
   "id": "f44861fd-b83c-4bc0-a289-df6c6bf034bc",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:02:21.573364Z",
     "start_time": "2024-10-28T18:02:21.570375Z"
    }
   },
   "source": [
    "def phenotypes_to_gene(phenotypes):\n",
    "    #Phenotype to Gene\n",
    "    input_type = \"biolink:PhenotypicFeature\"\n",
    "    output_type = \"biolink:Gene\"\n",
    "    predicate = \"biolink:genetically_associated_with\"\n",
    "    input_is_subject = \"True\"\n",
    "    query = generate_trapi_query( input_type, output_type, phenotypes, predicate, input_is_subject)\n",
    "    response = requests.post( AC_URL, json = query )\n",
    "    print(response.status_code)\n",
    "    return response.json()"
   ],
   "outputs": [],
   "execution_count": 48
  },
  {
   "cell_type": "code",
   "id": "235d05ea-e5b2-4954-9075-3265c093edf5",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:02:21.781607Z",
     "start_time": "2024-10-28T18:02:21.777643Z"
    }
   },
   "source": [
    "def print_results(resp):\n",
    "    for result in resp[\"message\"][\"results\"]:\n",
    "        nb = result[\"node_bindings\"][\"output\"][0][\"id\"]\n",
    "        name = resp[\"message\"][\"knowledge_graph\"][\"nodes\"][nb][\"name\"]\n",
    "        edge_id=result[\"analyses\"][0][\"edge_bindings\"][\"edge_0\"][0][\"id\"]\n",
    "        edge_score=result[\"analyses\"][0][\"score\"]\n",
    "        edge = resp[\"message\"][\"knowledge_graph\"][\"edges\"][edge_id]\n",
    "        p=\"\"\n",
    "        edge_atts = edge[\"attributes\"]\n",
    "        for att in edge_atts:\n",
    "            if att[\"attribute_type_id\"] == \"biolink:p_value\":\n",
    "                p = att[\"value\"]\n",
    "        print(nb, name, p, edge_score) "
   ],
   "outputs": [],
   "execution_count": 49
  },
  {
   "cell_type": "code",
   "id": "2afa7510-db6c-4ad2-9896-4a13484000c2",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:02:47.799213Z",
     "start_time": "2024-10-28T18:02:23.977135Z"
    }
   },
   "source": [
    "genes = [\"NCBIGene:5297\", \"NCBIGene:5298\",\"NCBIGene:5290\"]\n",
    "r = genes_to_chemical(genes, print_query=False)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n"
     ]
    }
   ],
   "execution_count": 50
  },
  {
   "cell_type": "code",
   "id": "1e2cc170-4400-46c0-8ccb-8732e3f37dbe",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:04.095243Z",
     "start_time": "2024-10-28T18:03:03.932746Z"
    }
   },
   "source": [
    "print_results(r)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "PUBCHEM.COMPOUND:121452612 5-[2-[[(2R)-1-cyclohexylpropan-2-yl]amino]-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-piperidin-4-ylbenzenesulfonamide 1.3427467469050326e-14 0.988295\n",
      "PUBCHEM.COMPOUND:5109813 6-Phenylbenzo[d]thiazol-2-amine 1.3427467469050326e-14 0.988295\n",
      "PUBCHEM.COMPOUND:122184478 5-(2-amino-1,3-benzothiazol-6-yl)-N-methylpyridine-2-carboxamide 1.3427467469050326e-14 0.988295\n",
      "PUBCHEM.COMPOUND:121452677 5-[2-[[(1R)-1-cyclohexylethyl]amino]-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-piperidin-4-ylbenzenesulfonamide 1.3427467469050326e-14 0.988295\n",
      "PUBCHEM.COMPOUND:122184472 [5-(2-Amino-1,3-benzothiazol-6-yl)pyridin-2-yl]methanol 1.3427467469050326e-14 0.988295\n",
      "PUBCHEM.COMPOUND:89493897 5-[2-(cycloheptylamino)-4-methyl-1,3-thiazol-5-yl]-N-(2,6-dimethylphenyl)-2-methoxybenzenesulfonamide 1.3427467469050326e-14 0.988295\n",
      "PUBCHEM.COMPOUND:121467267 5-[2-[[(1R)-1-cyclohexylethyl]amino]-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-piperidin-3-ylbenzenesulfonamide 1.3427467469050326e-14 0.988295\n",
      "PUBCHEM.COMPOUND:121467269 3-[[2-Methoxy-5-[4-methyl-2-[[2-(oxan-4-yl)acetyl]amino]-1,3-thiazol-5-yl]pyridin-3-yl]sulfonylamino]benzoic acid 2.6225310022706397e-14 0.986489\n",
      "PUBCHEM.COMPOUND:121467248 N-[5-[5-[(4-hydroxycyclohexyl)sulfamoyl]-6-methoxypyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 2.6225310022706397e-14 0.986489\n",
      "PUBCHEM.COMPOUND:121452662 N-[5-[3-[(4-fluorophenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 2.6225310022706397e-14 0.986489\n",
      "PUBCHEM.COMPOUND:121452699 N-[5-[3-[(3-hydroxy-5-methylphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 2.6225310022706397e-14 0.986489\n",
      "PUBCHEM.COMPOUND:121467260 N-[5-[5-[(2,4-difluorophenyl)sulfamoyl]-6-methoxypyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 2.6225310022706397e-14 0.986489\n",
      "PUBCHEM.COMPOUND:72544842 6-Pyridin-3-yl-1,3-benzothiazol-2-amine 2.6225310022706397e-14 0.986489\n",
      "PUBCHEM.COMPOUND:121467246 N-[5-[5-[(4-hydroxyphenyl)sulfamoyl]-6-methoxypyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 2.6225310022706397e-14 0.986489\n",
      "PUBCHEM.COMPOUND:121467285 N-[5-[5-[(3-hydroxycyclohexyl)sulfamoyl]-6-methoxypyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 2.6225310022706397e-14 0.986489\n",
      "PUBCHEM.COMPOUND:121467247 N-[5-[5-[(3-hydroxyphenyl)sulfamoyl]-6-methoxypyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 2.6225310022706397e-14 0.986489\n",
      "PUBCHEM.COMPOUND:122184544 trans-4-(((6-(1-(Cyclopropylmethyl)-2-oxo-1,2-dihydropyridin-4-yl)benzo[d]thiazol-2-yl)amino)methyl)cyclohexane-1-carboxylic acid 4.5316968733598504e-14 0.984811\n",
      "PUBCHEM.COMPOUND:122184467 6-[6-(Methoxymethyl)pyridin-3-yl]-1,3-benzothiazol-2-amine 4.5316968733598504e-14 0.984811\n",
      "PUBCHEM.COMPOUND:122184482 6-Pyrimidin-2-yl-1,3-benzothiazol-2-amine 4.5316968733598504e-14 0.984811\n",
      "PUBCHEM.COMPOUND:122184533 6-(1-Propan-2-ylpyrazol-4-yl)-1,3-benzothiazol-2-amine 4.5316968733598504e-14 0.984811\n",
      "PUBCHEM.COMPOUND:122184481 6-Pyridin-2-yl-1,3-benzothiazol-2-amine 4.5316968733598504e-14 0.984811\n",
      "PUBCHEM.COMPOUND:122184535 6-[1-(Cyclopropylmethyl)pyrazol-4-yl]-1,3-benzothiazol-2-amine 4.5316968733598504e-14 0.984811\n",
      "PUBCHEM.COMPOUND:122184537 4-(2-Amino-1,3-benzothiazol-6-yl)-1-methylpyridin-2-one 4.5316968733598504e-14 0.984811\n",
      "PUBCHEM.COMPOUND:122184473 6-(6-Methylpyridin-3-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:141754964 Chmfl-PI4K-127 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184466 6-(6-Ethylsulfanylpyridin-3-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184479 5-(2-amino-1,3-benzothiazol-6-yl)-N,N-dimethylpyridine-2-carboxamide 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184470 6-[6-(Ethylamino)pyridin-3-yl]-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184468 6-[6-(Methylaminomethyl)pyridin-3-yl]-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184534 6-(1-Cyclopropylpyrazol-4-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184474 6-[6-(Trifluoromethyl)pyridin-3-yl]-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184538 4-(2-Amino-1,3-benzothiazol-6-yl)-1-ethylpyridin-2-one 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184529 6-(1-Methylpyrazol-3-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122362594 3-(2-amino-1,3-benzothiazol-6-yl)-3H-pyridin-6-one 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184536 6-(1-Benzylpyrazol-4-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184532 6-(1-Propylpyrazol-4-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:51003592 6-(6-Methoxypyridin-3-yl)benzo[d]thiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:39733146 6-(1-methyl-1H-pyrazol-4-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184475 6-(6-Methylsulfonylpyridin-3-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184542 1-(cyclopropylmethyl)-4-[2-[[(1S)-1-(oxan-4-yl)ethyl]amino]-1,3-benzothiazol-6-yl]pyridin-2-one 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184469 6-(6-Propan-2-yloxypyridin-3-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:134151667 5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-N-(2-hydroxyethyl)-2-methoxybenzenesulfonamide 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:53318615 6-(Pyridin-4-yl)benzo[d]thiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122362595 4-(2-Amino-1,3-benzothiazol-6-yl)piperidin-2-one 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184471 6-[6-[Ethyl(methyl)amino]pyridin-3-yl]-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184530 6-(2-Methylpyrazol-3-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184477 6-[6-(2-Methoxyethoxy)pyridin-3-yl]-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:87562294 6-(5-Methylsulfonylpyridin-3-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184531 6-(1-Ethylpyrazol-4-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184526 6-Pyrazin-2-yl-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184476 2-[5-(2-Amino-1,3-benzothiazol-6-yl)pyridin-2-yl]oxyethanol 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184539 4-(2-Amino-1,3-benzothiazol-6-yl)-1-(2-methoxyethoxy)pyridin-2-one 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184465 6-(6-Ethoxypyridin-3-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184480 6-(5-Propan-2-yloxypyridin-3-yl)-1,3-benzothiazol-2-amine 7.196108518813756e-14 0.983233\n",
      "PUBCHEM.COMPOUND:122184540 1-(Cyclopropylmethyl)-4-[2-(oxan-4-ylmethylamino)-1,3-benzothiazol-6-yl]pyridin-2-one 1.0741626019989746e-13 0.981737\n",
      "PUBCHEM.COMPOUND:122184541 1-(cyclopropylmethyl)-4-[2-[[(1R)-1-(oxan-4-yl)ethyl]amino]-1,3-benzothiazol-6-yl]pyridin-2-one 1.0741626019989746e-13 0.981737\n",
      "PUBCHEM.COMPOUND:78319187 4-(2-Amino-1,3-benzothiazol-6-yl)-1-(cyclopropylmethyl)pyridin-2-one 1.0741626019989746e-13 0.981737\n",
      "PUBCHEM.COMPOUND:122184543 1-(Cyclopropylmethyl)-4-[2-[(1,1-dioxothian-4-yl)methylamino]-1,3-benzothiazol-6-yl]pyridin-2-one 1.0741626019989746e-13 0.981737\n",
      "PUBCHEM.COMPOUND:166635768 24-[(1S)-1-cyclopropylethyl]-3-methyl-20,20-dioxo-16-oxa-20lambda6,30-dithia-4,6,13,19,24,29-hexazapentacyclo[19.6.1.12,5.17,11.022,26]triaconta-1(27),2,4,7,9,11(29),21(28),22(26)-octaene-12,23-dione 1.5294105381049963e-13 0.98031\n",
      "PUBCHEM.COMPOUND:141754143 US10961236, Example 31 2.097939852904869e-13 0.97894\n",
      "PUBCHEM.COMPOUND:145958690 (2S)-2-amino-N-[5-[6-chloro-5-[(2-methylphenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 2.097939852904869e-13 0.97894\n",
      "PUBCHEM.COMPOUND:168269160 N-[4-[3-anilino-5-(methylcarbamoyl)phenyl]pyridin-2-yl]oxane-4-carboxamide 2.7923353314021153e-13 0.977621\n",
      "PUBCHEM.COMPOUND:11774751 N-[4-(3-acetamido-5-anilinophenyl)pyridin-2-yl]oxane-4-carboxamide 2.7923353314021153e-13 0.977621\n",
      "PUBCHEM.COMPOUND:137333450 Chmfl-PI3KD-317 2.7923353314021153e-13 0.977621\n",
      "PUBCHEM.COMPOUND:145958063 (2S)-2-amino-N-[5-[6-chloro-5-[(4-methylphenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 2.7923353314021153e-13 0.977621\n",
      "PUBCHEM.COMPOUND:168296527 3-anilino-5-[2-(cyclopropanecarbonylamino)pyridin-4-yl]-N-(1,3-dioxolan-2-ylmethyl)-N-methylbenzamide 2.7923353314021153e-13 0.977621\n",
      "PUBCHEM.COMPOUND:6852167 N-(5-(4-Chloro-3-(N-(2-hydroxyethyl)sulfamoyl)phenyl)-4-methylthiazol-2-yl)acetamide 4.60906188104576e-13 0.975113\n",
      "PUBCHEM.COMPOUND:141754136 J5M3Tck9Y9 5.756560483768655e-13 0.973914\n",
      "CHEBI:52289 wortmannin 5.497219025222298e-11 0.932763\n",
      "PUBCHEM.COMPOUND:71597290 Tert-butyl 3-[[8-(2-chlorophenyl)-4,5-dihydrothiazolo[4,5-h]quinazolin-2-yl]carbamoylamino]propanoate 2.33172168716266e-10 0.910207\n",
      "PUBCHEM.COMPOUND:134150664 N-[2-[[6-chloro-3-[3-[2-(dimethylamino)ethylsulfamoyl]-4-methoxyphenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 2.33172168716266e-10 0.910207\n",
      "PUBCHEM.COMPOUND:134146889 N-[2-[[6-chloro-3-[4-methoxy-3-[2-(methylamino)ethylsulfamoyl]phenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 2.33172168716266e-10 0.910207\n",
      "PUBCHEM.COMPOUND:123131774 N-[2-[[3-[3-[(4-aminocyclohexyl)sulfamoyl]-4-methoxyphenyl]-6-chloro-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 5.246336030904975e-10 0.894737\n",
      "PUBCHEM.COMPOUND:121452653 N-cycloheptyl-5-[2-(cyclohexylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 5.246336030904975e-10 0.894737\n",
      "PUBCHEM.COMPOUND:123131773 N-[2-[[6-chloro-3-[3-[4-(hydroxymethyl)piperidin-1-yl]sulfonyl-4-methoxyphenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 5.246336030904975e-10 0.894737\n",
      "PUBCHEM.COMPOUND:134155918 5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-N-[2-(dimethylamino)ethyl]-2-methoxybenzenesulfonamide 5.246336030904975e-10 0.894737\n",
      "PUBCHEM.COMPOUND:134147646 N-(4-aminocyclohexyl)-5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-2-methoxybenzenesulfonamide 5.246336030904975e-10 0.894737\n",
      "PUBCHEM.COMPOUND:123131772 N-[2-[[6-chloro-3-(4-methoxy-3-morpholin-4-ylsulfonylphenyl)-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 5.246336030904975e-10 0.894737\n",
      "PUBCHEM.COMPOUND:134132647 N-[2-[[6-chloro-3-[3-(1-hydroxybutan-2-ylsulfamoyl)-4-methoxyphenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 5.246336030904975e-10 0.894737\n",
      "PUBCHEM.COMPOUND:44557921 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamide 7.955241522308678e-10 0.885915\n",
      "PUBCHEM.COMPOUND:121452684 N-(cyclohexylmethyl)-5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 9.326752472888513e-10 0.882377\n",
      "PUBCHEM.COMPOUND:121467272 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-N-cyclopropyl-2-methoxybenzenesulfonamide 9.326752472888513e-10 0.882377\n",
      "PUBCHEM.COMPOUND:89493966 2-cyclopentyl-N-[5-[4-methoxy-3-[(6-methylpyridin-3-yl)sulfamoyl]phenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 9.326752472888513e-10 0.882377\n",
      "PUBCHEM.COMPOUND:121452680 5-[2-(cyclohexylamino)-4-methyl-1,3-thiazol-5-yl]-N-cyclopentyl-2-methoxybenzenesulfonamide 9.326752472888513e-10 0.882377\n",
      "PUBCHEM.COMPOUND:121452730 5-[2-(2-cyclohexylethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(3-hydroxycyclopentyl)-2-methoxybenzenesulfonamide 9.326752472888513e-10 0.882377\n",
      "PUBCHEM.COMPOUND:24905152 1-(1-Methylethyl)-3-Quinolin-6-Yl-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine 9.326752472888513e-10 0.882377\n",
      "PUBCHEM.COMPOUND:121452691 N-(4-hydroxycyclohexyl)-2-methoxy-5-[4-methyl-2-(propan-2-ylamino)-1,3-thiazol-5-yl]benzenesulfonamide 1.457294583722347e-09 0.871941\n",
      "PUBCHEM.COMPOUND:71549092 2-cyclopentyl-N-[5-[3-[(4-hydroxyphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.457294583722347e-09 0.871941\n",
      "PUBCHEM.COMPOUND:67984037 4-[[4-[4-(Cyclopropylmethyl)-2-(methylamino)pyrimidin-5-yl]pyrimidin-2-yl]amino]cyclohexan-1-ol 1.457294583722347e-09 0.871941\n",
      "PUBCHEM.COMPOUND:23585510 Nvs-PI3-4 1.457294583722347e-09 0.871941\n",
      "PUBCHEM.COMPOUND:121452632 N-[5-[3-[(4-hydroxyphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 1.457294583722347e-09 0.871941\n",
      "PUBCHEM.COMPOUND:49854360 (2S)-1-N-(7-tert-butyl-4,5-dihydro-[1,3]thiazolo[5,4-e][1,3]benzothiazol-2-yl)pyrrolidine-1,2-dicarboxamide 2.098489094842777e-09 0.862836\n",
      "PUBCHEM.COMPOUND:49853953 (2R)-1-N-(8-tert-butyl-4,5-dihydro-[1,3]thiazolo[4,5-h]quinazolin-2-yl)-2-[(dimethylamino)methyl]pyrrolidine-1,2-dicarboxamide 2.098489094842777e-09 0.862836\n",
      "PUBCHEM.COMPOUND:23642173 N-(5-Methyl-isoxazol-3-yl)-3-{3-[4-methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-propionamide 2.098489094842777e-09 0.862836\n",
      "PUBCHEM.COMPOUND:118470198 US10112926, Example 4.4 2.098489094842777e-09 0.862836\n",
      "PUBCHEM.COMPOUND:49855193 CID 49855193 2.098489094842777e-09 0.862836\n",
      "PUBCHEM.COMPOUND:49854466 (2S,3R)-1-N-(7-tert-butyl-4,5-dihydro-[1,3]thiazolo[5,4-e][1,3]benzothiazol-2-yl)-3-methylpyrrolidine-1,2-dicarboxamide 2.8562562631426983e-09 0.854719\n",
      "PUBCHEM.COMPOUND:49854158 (2s,3r)-N~1~-(8-Tert-Butyl-4,5-Dihydro[1,3]thiazolo[4,5-H]quinazolin-2-Yl)-3-Methylpyrrolidine-1,2-Dicarboxamide 2.8562562631426983e-09 0.854719\n",
      "PUBCHEM.COMPOUND:118470391 US10112926, Example 61 2.8562562631426983e-09 0.854719\n",
      "PUBCHEM.COMPOUND:49854049 (2S)-1-N-(8-tert-butyl-4,5-dihydro-[1,3]thiazolo[4,5-h]quinazolin-2-yl)-2-methylpyrrolidine-1,2-dicarboxamide 2.8562562631426983e-09 0.854719\n",
      "PUBCHEM.COMPOUND:118470069 PI3K|A inhibitor 4 3.730593571155438e-09 0.847369\n",
      "PUBCHEM.COMPOUND:53322732 N6-(6-methoxypyridin-3-yl)-2-morpholino-[4,5'-bipyrimidine]-2',6-diamine 3.730593571155438e-09 0.847369\n",
      "PUBCHEM.COMPOUND:49854681 (2S,3S)-1-N-(7-tert-butyl-4,5-dihydro-[1,3]thiazolo[5,4-e][1,3]benzothiazol-2-yl)-3-[(dimethylamino)methyl]pyrrolidine-1,2-dicarboxamide 3.730593571155438e-09 0.847369\n",
      "PUBCHEM.COMPOUND:118470204 US10112926, Example 7 3.730593571155438e-09 0.847369\n",
      "PUBCHEM.COMPOUND:70686830 (2S)-1-N-[4-methyl-5-(4-pyrazol-1-ylphenyl)-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 4.7214985014551544e-09 0.840635\n",
      "PUBCHEM.COMPOUND:118470445 US10112926, Example 15 4.7214985014551544e-09 0.840635\n",
      "PUBCHEM.COMPOUND:137639139 5-(3-Amino-6-(imidazo[1,2-a]pyridin-3-yl)-5-methylpyrazin-2-yl)-N,1-dimethyl-1H-1,2,4-triazole-3-carboxamide 7.053001159415734e-09 0.828611\n",
      "PUBCHEM.COMPOUND:57466811 1-[2-(2-Ethyltetrazol-5-yl)ethyl]-3-[5-(3-fluoro-4-methylsulfonylphenyl)-4-methyl-1,3-thiazol-2-yl]urea 7.053001159415734e-09 0.828611\n",
      "PUBCHEM.COMPOUND:49784894 4-(2-[(6-Methoxypyridin-3-Yl)amino]-5-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}pyridin-3-Yl)-6-Methyl-1,3,5-Triazin-2-Amine 9.850744098432805e-09 0.818061\n",
      "PUBCHEM.COMPOUND:46202652 5-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyrimidin-2-amine 1.1424449380205976e-08 0.813222\n",
      "PUBCHEM.COMPOUND:58298316 Cc-223 1.888477052197634e-08 0.796075\n",
      "CHEBI:16708 adenine 4.2487981036425143e-08 0.766001\n",
      "CHEBI:84327 torin 1 4.901492131287287e-08 0.760393\n",
      "CHEBI:71954 BKM120 4.901492131287287e-08 0.760393\n",
      "PUBCHEM.COMPOUND:134957362 N-[6-[5-(methanesulfonamido)-6-methoxypyridin-3-yl]-1,3-dihydro-2-benzofuran-4-yl]-2-morpholin-4-ylacetamide 5.2453164858023484e-08 0.757701\n",
      "PUBCHEM.COMPOUND:58507717 Bimiralisib 5.2453164858023484e-08 0.757701\n",
      "CHEBI:90682 torin 2 8.864010600979221e-08 0.736176\n",
      "CHEBI:16761 ADP 1.1660373907224348e-07 0.72445\n",
      "CHEBI:90524 PI-103 2.7739935834072206e-07 0.685345\n",
      "CHEBI:15422 ATP 3.6716091557438977e-07 0.672072\n",
      "CHEBI:94691 3-[2,4-diamino-7-(3-hydroxyphenyl)-6-pteridinyl]phenol 4.20915681573026e-07 0.6655\n",
      "CHEBI:65326 pictrelisib 6.300348024809516e-07 0.645729\n",
      "CHEMBL.COMPOUND:CHEMBL3600785 CHEMBL3600785 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145973476 1-[4-(5-Amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)piperazin-1-yl]-2-(3,4-dimethoxyphenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122443909 (2R,5S)-4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)-2,5-dimethylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452638 5-[2-[[(1R)-1-cyclohexylethyl]amino]-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-[(3R)-pyrrolidin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452636 (2S)-2-cyclohexyl-N-[5-[3-[(4-hydroxyphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452695 2-cyclopentyl-N-[4-methyl-5-[4-methyl-3-(piperidin-4-ylsulfamoyl)phenyl]-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71572531 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(3-methylphenyl)piperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155519200 N-[5-[2-(2-hydroxyethylamino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:130383823 3-cyclopentyl-N-[5-[3-[[(3R)-3-hydroxycyclohexyl]sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121467271 N-[5-[3-[(3-aminocyclopentyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452722 N-[5-[4-methoxy-3-[(2-methylphenyl)sulfamoyl]phenyl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452661 N-(4-chloro-3-fluorophenyl)-5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155518838 4-[[4-[2-(2,2-Dimethylpropanoylamino)-4-methyl-1,3-thiazol-5-yl]-1,3-thiazol-2-yl]amino]butanoic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145976919 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-phenylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134141075 3-[6-chloro-2-methyl-8-(pyridin-2-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N,N-dimethylbenzenesulfonamide;hydrochloride 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134145381 6-chloro-N-[(2-ethylpyridin-4-yl)methyl]-3-(4-methoxyphenyl)-2-methylimidazo[1,2-b]pyridazin-8-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452605 2-cyclopentyl-N-[5-[4-methoxy-3-(piperidin-3-ylsulfamoyl)phenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:139330094 PI4KIIIbeta-IN-11 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71682209 N-[5-(6-aminopyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]-4-(trifluoromethyl)cyclohexane-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71549785 2-cyclohexyl-N-[5-[3-[(3-hydroxyphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:117894549 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-piperidin-3-ylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122444097 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452631 5-[2-[[(1S)-1-cyclohexylethyl]amino]-4-methyl-1,3-thiazol-5-yl]-N-(3-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121467251 2-cyclopentyl-N-[5-[3-[[(1S,3S)-3-hydroxycyclohexyl]sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155518122 tert-butyl N-[5-[2-(2-hydroxyethylamino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]carbamate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71550340 N-[5-[3-[(3-chloro-4-fluorophenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-2-cyclopentylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452733 5-[2-(tert-butylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-piperidin-4-ylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493816 N-(4-chloro-2-fluorophenyl)-5-[2-(cycloheptylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134138094 N-[2-[[6-chloro-3-[4-methoxy-3-(2-methoxyethylsulfamoyl)phenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452629 N-[5-[3-[(3-hydroxycyclohexyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452627 N-[5-[4-chloro-3-[(4-hydroxyphenyl)sulfamoyl]phenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452619 N-[5-[4-methoxy-3-[(3-methylphenyl)sulfamoyl]phenyl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155553069 N-[5-[2-[cyclohexyl(2-hydroxyethyl)amino]-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]-2,2-dimethylpropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145974410 (2S)-N-[4-[4-chloro-3-(2-hydroxyethylsulfamoyl)phenyl]-5-methyl-1H-imidazol-2-yl]-2-(4-chlorophenyl)propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452646 5-[2-(2-cyclohexylethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-piperidin-3-ylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452696 3-cyclopentyl-N-[5-[3-(4-hydroxybutylsulfamoyl)-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452737 5-[2-[[(2R)-1-cyclohexylpropan-2-yl]amino]-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-piperidin-3-ylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:15956160 {5-[4-(4-Morpholin-4-yl-phenylamino)-quinazolin-6-yl]-furan-2-yl}-methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452656 5-[2-(2-cyclohexylethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-[(3R)-pyrrolidin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493776 N-(3-chloro-4-methylphenyl)-5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493822 5-[2-(cycloheptylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-[4-(trifluoromethyl)phenyl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122443864 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)-2,3-dimethylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493782 N-(4-chloro-3-methylphenyl)-5-[2-(cyclohexylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452673 5-[2-(2-cyclohexylethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-piperidin-4-ylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452681 5-[2-(2-cyclohexylethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-[(3S)-pyrrolidin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:117653568 8-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)-3,8-diazabicyclo[3.2.1]octane-3-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493779 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-piperidin-4-ylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452732 5-[2-[[(2R)-1-cyclohexylpropan-2-yl]amino]-4-methyl-1,3-thiazol-5-yl]-N-(3-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71548660 1-[5-[3-[(4-Hydroxyphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-3-(2-methylpropyl)urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71573239 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(6-methoxypyridin-3-yl)piperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121467278 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(1-cyclopropylpiperidin-4-yl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452701 5-[2-[[(2R)-1-cyclohexylpropan-2-yl]amino]-4-methyl-1,3-thiazol-5-yl]-N-(4-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155567806 N-[4-(2-acetamido-4-methyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]-2-bromoacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71550633 N-[5-[3-[(2-fluorophenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452719 2-cyclopentyl-N-[4-methyl-5-[4-methyl-3-(piperidin-3-ylsulfamoyl)phenyl]-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76282315 (3R)-4-(6-Amino-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-N-(4-methoxy-2-methylphenyl)-3-methyl-1-piperazinecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11220250 N-[5-[2-(2-hydroxyethylamino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:117892879 2-cyclopentyl-N-[5-[3-[(3-hydroxyphenyl)sulfamoyl]-4-methylphenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452598 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(4-fluoro-3-methylphenyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452739 2-cyclopentyl-N-[5-[3-[(3-hydroxy-5-methylphenyl)sulfamoyl]-4-methylphenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493803 N-(3-chloro-4-fluorophenyl)-5-[2-(cyclohexylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452654 N-[5-[3-[(2-fluorophenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493919 N-(4-cyanophenyl)-5-[2-(cycloheptylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145970081 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-pyridin-3-ylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134133351 5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-N-cyclopropyl-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452609 5-[2-(2-cyclohexylethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(3-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155535344 3-[[4-[2-(2,2-Dimethylpropanoylamino)-4-methyl-1,3-thiazol-5-yl]-1,3-thiazol-2-yl]amino]benzoic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71572529 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(2-methylphenyl)piperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452617 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(1-cyclohexylpiperidin-4-yl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121467273 2-cyclopentyl-N-[5-[3-[(3R)-3-hydroxypyrrolidin-1-yl]sulfonyl-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155545077 (E)-N-[4-(2-acetamido-4-methyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]-4-methylpent-2-enamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134148636 6-chloro-N-[(2-ethylpyridin-4-yl)methyl]-3-(4-methoxy-3-piperidin-1-ylsulfonylphenyl)-2-methylimidazo[1,2-b]pyridazin-8-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156021093 N-[2-[[3-(3,4-dimethoxyphenyl)-2,6-dimethylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71572648 1-[4-(5-Amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)piperazin-1-yl]-2-(4-chlorophenoxy)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452687 2-cyclopentyl-N-[5-[3-[[(1S,3R)-3-hydroxycyclohexyl]sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493787 N-(3-chloro-4-methylphenyl)-5-[2-(cyclohexylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134153296 [1-[5-[6-Chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-2-methoxyphenyl]sulfonylpiperidin-4-yl]methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71682211 N-[5-(6-aminopyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]-4,4,4-trifluoro-2-methylbutanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452630 N-[5-[4-chloro-3-[(3-hydroxycyclohexyl)sulfamoyl]phenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121467266 N-[5-[3-[(3-chloro-5-methylphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-3-cyclopentylpropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452652 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(3-fluorophenyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91758319 N-(2-((6-chloro-3-(3-(N,N-dimethylsulfamoyl)phenyl)-2-methylimidazo[1,2-b]pyridazin-8-yl)amino)ethyl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452625 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(4-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71549513 N-[5-[3-[(4-hydroxycyclohexyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155561063 3-[[4-[2-(2,2-Dimethylpropanoylamino)-4-methyl-1,3-thiazol-5-yl]-1,3-thiazol-2-yl]amino]propanoic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121467279 3-cyclopentyl-N-[5-[3-[(4-hydroxycyclohexyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452740 N-(4-chloro-2-fluorophenyl)-5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122443986 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)-2-methylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155511230 N-[5-[2-[cyclohexyl(2-hydroxyethyl)amino]-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71549783 2-cyclopentyl-N-[5-[3-[(3-hydroxyphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452604 N-(4-hydroxycyclohexyl)-2-methoxy-5-[4-methyl-2-(2-methylpropylamino)-1,3-thiazol-5-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122444026 [4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)piperazin-1-yl]-(1H-benzimidazol-2-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452634 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(4-fluorophenyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71549510 N-[5-[3-[(3-hydroxyphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121467263 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-(1-propan-2-ylpiperidin-4-yl)benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145977751 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(6-methoxy-4-methylpyridin-3-yl)piperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452678 5-[2-[[(1S)-1-cyclohexylethyl]amino]-4-methyl-1,3-thiazol-5-yl]-N-(4-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11348293 N-[5-[2-(cyclohexylamino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452610 N-[5-[3-[(3-fluorophenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155561108 N-[4-(2-acetamido-4-methyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155565175 N-[5-[2-(2-hydroxyethylamino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]-2,2-dimethylpropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452637 5-[2-(tert-butylamino)-4-methyl-1,3-thiazol-5-yl]-N-(3-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134139703 N-[2-[[6-chloro-3-[3-(4-hydroxypiperidin-1-yl)sulfonyl-4-methoxyphenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493780 N-[5-[3-[(4-hydroxyphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-2-phenylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452671 5-[2-[[(1R)-1-cyclohexylethyl]amino]-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-[(3S)-pyrrolidin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134148851 N-[2-[[6-chloro-3-[3-(cyclopropylsulfamoyl)-4-methoxyphenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493982 N-[5-[3-[(2-chlorophenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452608 5-[2-(2-cyclohexylethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(4-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122443905 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methylphenyl)piperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493835 N-(2-chloro-4-fluorophenyl)-5-[2-(cycloheptylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452647 2-cyclopentyl-N-[5-[3-(4-hydroxybutylsulfamoyl)-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155521426 2-[[4-[2-(2,2-Dimethylpropanoylamino)-4-methyl-1,3-thiazol-5-yl]-1,3-thiazol-2-yl]amino]acetic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452682 N-(4-chloro-3,5-difluorophenyl)-5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71550339 N-[5-[3-[(4-chloro-2-fluorophenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-2-cyclopentylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168279711 5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-N-ethyl-2-hydroperoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145974197 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(6-methoxy-2-methylpyridin-3-yl)piperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452669 N-(3-hydroxycyclohexyl)-2-methoxy-5-[4-methyl-2-(2-methylpropylamino)-1,3-thiazol-5-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145974272 3-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)-3,8-diazabicyclo[3.2.1]octane-8-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134150788 N-[3-[4-[[[5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-2-methoxyphenyl]sulfonylamino]methyl]triazol-1-yl]propyl]-3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carboxamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL2397309 CHEMBL2397309 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134155860 N-[2-[[6-chloro-3-(4-methoxy-3-pyrazol-1-ylsulfonylphenyl)-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452710 5-[2-[[(1R)-1-cyclohexylethyl]amino]-4-methyl-1,3-thiazol-5-yl]-N-(3-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155545735 N-[4-methyl-5-[2-[(4-methylcyclohexyl)amino]-1,3-thiazol-4-yl]-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122444047 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-[(4-methoxyphenyl)methyl]piperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493894 N-(4-chlorophenyl)-5-[2-(cyclohexylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:117653382 (3R)-4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxy-2-methylphenyl)-3-methylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452657 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(3-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71550068 N-[5-[3-[[4-(hydroxymethyl)phenyl]sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155546020 N-[5-[2-[3-acetyl-N-(2-hydroxyethyl)anilino]-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71682058 N-[5-(6-aminopyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]-4-methoxycyclohexane-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89493773 N-(4-chloro-3-methylphenyl)-5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121467250 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(1-cyclopentylpiperidin-4-yl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134135057 3-[6-chloro-2-methyl-8-[(2-methylpyridin-4-yl)methylamino]imidazo[1,2-b]pyridazin-3-yl]-N,N-dimethylbenzenesulfonamide;hydrochloride 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452599 5-[2-(cyclohexylamino)-4-methyl-1,3-thiazol-5-yl]-N-(4-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452659 5-[2-(cyclohexylmethylamino)-4-methyl-1,3-thiazol-5-yl]-N-(2-fluorophenyl)-2-methoxybenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452607 3-cyclopentyl-N-[5-[4-methoxy-3-(piperidin-3-ylsulfamoyl)phenyl]-4-methyl-1,3-thiazol-2-yl]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134138026 3-[6-chloro-2-methyl-8-(pyridin-3-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N,N-dimethylbenzenesulfonamide;hydrochloride 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122443833 [4-(5-Amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)piperazin-1-yl]-imidazo[1,2-a]pyridin-2-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155528709 N-[4-(2-acetamido-4-methyl-1,3-thiazol-5-yl)-1,3-thiazol-2-yl]prop-2-enamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155526648 N-[5-[2-[cyclohexyl(methyl)amino]-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:134152630 N-[2-[[6-chloro-3-(4-methoxy-3-piperidin-1-ylsulfonylphenyl)-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452601 5-[2-(tert-butylamino)-4-methyl-1,3-thiazol-5-yl]-2-methoxy-N-piperidin-3-ylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:117653653 (3S,5R)-4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)-3,5-dimethylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:121452642 2-cyclopentyl-N-[5-[3-[(4-hydroxycyclohexyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71550338 N-[5-[3-[(2-chloro-4-fluorophenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-2-cyclopentylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436076 5-[7-(3-Methylsulfonyl-3-azabicyclo[3.1.0]hexan-1-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142315 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]propane-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259021 2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-(oxolan-2-ylmethyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580703 [1-(2-methoxyphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258923 2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-(oxolan-3-ylmethyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436440 5-[7-[(3S,4R)-4-fluoropyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168297494 (2S)-1-[2-(5-amino-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52947480 3-(2-Morpholino-6-(pyridin-3-yloxy)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444388 5-[7-(1-ethylsulfonyl-3-methylazetidin-3-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436201 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(1S,2R)-2-fluorocyclopropyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122179488 Methyl 3-iodo-5-[[4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]anilino]methyl]benzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939342 1-(5-fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-7-(4-morpholinyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]-thiazine 4,4-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258865 2-Amino-8-(2-fluoro-2-methylpropyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436071 5-[7-[(1R,5S)-3-azabicyclo[3.1.0]hexan-1-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785831 4-(5-((1,1-Dioxidohexahydro-5H-isothiazolo[2,3-A]pyrazin-5-YL)methyl)-2-((5-fluoro-6-methoxy-3-pyridinyl)amino)-3-pyridinyl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177574 5-(3-((1-Isopropylazetidin-3-yl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4776827 CHEMBL4776827 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:20877907 N-(2-Chlorophenyl)-N-Methyl-4h-Thieno[3,2-C]chromene-2-Carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581178 furan-3-yl-[(3S)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidin-1-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023760 Imidazo[1,2-a]pyridine derivative, 15 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:10336186 7-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580721 [1-[1-[2-(dimethylamino)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436017 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(azetidin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548195 2-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]amino]pyridin-3-yl]propan-2-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950390 1-Methyl-3-(morpholin-4-ylcarbonyl)-8-nitro-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436437 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1-methylimidazol-2-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581211 N-[2-[(3S)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidin-1-yl]ethyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436141 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-(dimethylamino)propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53321410 N-(6-(3H-imidazo[4,5-b]pyridin-6-yl)-2-morpholinopyrimidin-4-yl)quinolin-3-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60143105 N-[5-[2-[2-amino-4-ethyl-6-(4-methoxypiperidin-1-yl)pyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548313 4-[5-(1-Aminocyclopropyl)-2-[(5-fluoro-6-methoxypyridin-3-yl)amino]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403571 N-(5-(6-morpholino-4-(phenylsulfonyl)pyridin-2-yl)pyrimidin-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11349990 2-[[2-[4-[(3-Fluorophenyl)carbamoyl]naphthalen-1-yl]oxyacetyl]amino]acetic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785249 N-[5-bromo-3-(2-methyl-7H-purin-6-yl)pyridin-2-yl]-1H-indazol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145952943 6-[4-[[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]methyl]triazol-1-yl]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]hexanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168294744 (2S)-2-cyclobutyl-2-[[2-[(4S)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444341 5-[7-[1-(3-methoxypropylsulfonyl)azetidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436412 5-[7-[(3R)-1,3-dimethylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436340 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(3R)-oxolan-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44242425 N-(2-chlorophenyl)-N-methyl-8-(morpholine-4-carbonyl)-4,5-dihydrothieno[3,2-d][1]benzoxepine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76324912 N-[5-(7-amino-1-cyclopentyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]-2-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204847 2-[Methyl-[4-(2-propan-2-yl-1,2,4-triazol-3-yl)-9-oxa-3,6,13-triazatricyclo[8.4.0.02,6]tetradeca-1(14),2,4,10,12-pentaen-12-yl]amino]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371666 2,4-difluoro-N-[2-methoxy-5-(4-pyrrolidin-1-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122188267 N-[(E)-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-5-fluoro-N,2-dimethylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68267659 morpholin-4-yl-[3-[(3R)-1-(oxan-4-ylmethyl)piperidin-3-yl]-8,8-dioxo-8lambda6-thia-3,4,10-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876704 US11649227, Example 189 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142844 N-[5-[2-(4-ethyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548292 4-(2-(5-Fluoro-6-methoxypyridin-3-ylamino)-5-(4-(methylsulfonyl)benzyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436443 3-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-methylbutan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548358 4-(5-Fluoro-2-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436066 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71232963 2,4-difluoro-N-[5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]-2-oxo-1H-pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548249 6-(2-(6-Methoxypyridin-3-ylamino)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-3-yl)-2-methylpyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156597494 (e)-2-(2-(1-(Benzofuran-2-yl)ethylidene)hydrazineyl)-4-methylthiazole 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52948791 N,6-bis(3-methoxyphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436033 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(azetidin-2-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133354 [(3R)-1-methylpyrrolidin-3-yl] (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258946 2-Amino-8-(2-hydroxy-2-methylpropyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950386 (7-methoxy-1-methyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53320907 3-(6-Morpholino-2-(pyridin-4-ylmethylamino)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:137661615 1-[(4-Chlorophenyl)-(2-hydroxynaphthalen-1-yl)methyl]pyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66716893 5-[2-(1-Ethyl-1H-pyrazol-4-yl)-imidazo[2,1-b][1,3,4]thiadiazol-5-yl]-3-trifluoromethyl-pyridin-2-ylamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:127029085 (2S)-1-[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]piperidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:136068720 1-[4-(4-methylpiperazine-1-carbonyl)phenyl]-3-[4-(4-morpholin-4-yl-6-oxo-1H-1,3,5-triazin-2-yl)phenyl]urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53322730 4-(2-Morpholino-6-(quinolin-3-ylamino)pyrimidin-4-yl)pyridin-2-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548377 4-(2-(6-Methoxypyridin-3-Ylamino)-5-((3-(Methylsulfonyl)Azetidin-1-yl)Methyl)Pyridin-3-yl)-6-Methyl-1,3,5-Triazin-2-Amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46868948 8-Chloro-4-(3-methoxyphenyl)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142451 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]thiophene-2-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444382 5-[7-(1-Ethylsulfonyl-3-methylazetidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032304 2-Amino-6-bromo-8-(cis-4-(2-hydroxyethoxy)cyclohexyl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785440 4-(2-(6-Methoxypyridin-3-ylamino)-5-(1H-pyrazol-4-YL)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436108 5-[7-[(3S)-3-ethylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436188 5-[7-[(3S)-3-methylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258905 2-amino-6-bromo-8-[(1R,3S)-3-hydroxycyclopentyl]-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285098 1'-(7-fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6'-(1H-pyrazol-4-yl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52947717 3-(6-(4-Methoxyphenylamino)-2-morpholinopyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244276 5-[7-[2-Fluoro-4-(morpholin-4-ylmethyl)phenyl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580838 [1-[3-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258861 2-amino-8-[(1R,3R)-3-hydroxycyclopentyl]-4-methyl-6-(1-methylpyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876733 US11649227, Example 297 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032886 2-amino-8-(4-hydroxycyclohexyl)-4-methyl-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876594 US11649227, Example 194 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581090 [7-methoxy-1-[(3S)-1-(oxan-3-yl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52936736 N-(5-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyridin-3-yl)benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11176032 4-[2-(ethylamino)-2-oxoethoxy]-N-(3-fluorophenyl)naphthalene-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284734 1-(7-fluoro-3-methyl-4-(6'-(4-morpholinyl)-2,3,5,6-tetrahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridin]-1'(2'H)-yl)-2-quinolinyl)-2-pyrrolidinone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876641 US11649227, Example 319 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76317468 4-(2-Pyridin-3-ylpyrido[3,2-d]pyrimidin-4-yl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258900 2-amino-8-[(1R,3R)-3-hydroxycyclopentyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58379586 3-(2-Hydroxyethyl)-8-(6-methylpyridin-3-yl)-1-(oxan-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258892 3-[8-cyclopentyl-2-(ethylamino)-4-methyl-7-oxopyrido[2,3-d]pyrimidin-6-yl]-N-(1H-imidazol-2-yl)propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46941216 4-[2-(6-Amino-5-trifluoromethyl-pyridin-3-yl)-imidazo[2,1-b][1,3,4]thiadiazol-5-yl]-2-methoxy-benzoic acid methyl ester 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25171852 [3-[(E)-[methyl-(2-methyl-5-nitrophenyl)sulfonylhydrazinylidene]methyl]pyrazolo[1,5-a]pyridin-5-yl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548293 4-[amino-[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]methyl]-N,N-dimethylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66716849 5-[2-(3,4-Dimethoxy-phenyl)-imidazo[2,1-b][1,3,4]thiadiazol-5-yl]-pyridine-2-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548439 N-[5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(morpholin-4-ylmethyl)pyridin-2-yl]amino]-2-methoxypyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436053 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methoxyethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118712086 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]cyclopropanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548470 1-((5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-6-(6-methoxypyridin-3-ylamino)pyridin-3-YL)methyl)azetidin-3-OL 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444336 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N-methylazetidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177535 5-(4-((2,3-Dihydrobenzofuran-3-yl)sulfonyl)-6-morpholinopyridin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57400579 N-[(E)-1-(5-bromopyrazolo[1,5-a]pyridin-3-yl)ethylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142972 4-fluoro-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548472 4-(5-(3,6-dihydro-2H-pyran-4-yl)-2-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:124169052 CID 124169052 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876676 US11649227, Example 68 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436617 (2R)-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-(dimethylamino)propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182709 N-(6-(2-(2-Methylphenylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42644366 (2S)-2-methyl-1-N-[4-methyl-5-[2-(2-methylimidazol-1-yl)pyrimidin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58379579 1-(4-hydroxycyclohexyl)-3-methyl-8-(1H-pyrazol-5-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580919 (5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-(1,4-oxazepan-4-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548190 4-(2-(6-Methoxypyridin-3-ylamino)-5-(thiomorpholinomethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49817355 6-(1,1-Dioxidothiomorpholin-4-Yl)-N-(3-Methoxyphenyl)-1-Methyl-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168272443 5-[4-Morpholin-4-yl-6-(oxan-4-ylamino)-1,3,5-triazin-2-yl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285657 1-(7-Chloro-2-(2-fluorophenyl)-3-methyl-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548212 (S)-4-(2-(6-Chloropyridin-3-ylamino)-5-((2-methyl-4-(methylsulfonyl)piperazin-1-YL)methyl)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133327 tert-butyl (3S,4R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3,4-dimethylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580984 (5,5-dioxo-1-propyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168280655 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-N,N-dimethyl-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869167 4-(1H-indol-4-yl)-8-(methylamino)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580813 [1-[4-[(4,4-difluoropiperidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133351 azetidin-3-ylmethyl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580871 1-Ethyl-3-(morpholin-4-ylcarbonyl)-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436694 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(2-methylpyrazol-3-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950046 N-(3-(4-(3-methoxyphenylamino)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:14320027 (2-Oxo-1,2-diphenylethyl) 4-nitrobenzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58881874 1-Ethyl-3-[3-(3-hydroxy-4-methylanilino)pyrido[2,3-b]pyrazin-6-yl]urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581185 morpholin-4-yl-[3-[(3S)-1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-8,8-dioxo-8lambda6-thia-3,4,10-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184949 5-[7-[(4-Methylpiperazin-1-yl)methyl]-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436363 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-cyclobutylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939468 US8765940, 4-(5-chloro-3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133318 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-[(1R,4R,5R)-2-methylsulfonyl-2-azabicyclo[2.1.1]hexan-5-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76332159 2-[4-[2-Amino-6-(6-methoxypyridin-3-yl)-4-methylpyrrolo[2,3-d]pyrimidin-7-yl]cyclohexyl]oxyethanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:166035135 US11649227, Example 289 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141048 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580824 [1-[1-[2-(4-fluoropiperidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371662 2,4-difluoro-N-[2-methoxy-5-(7-pyrrolidin-1-yl-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:87057949 [1-[(3S)-1-(2-fluoroethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244842 4-(4,7-Dipyridin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-2-yl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53324888 3-(6-Morpholino-2-(pyridin-3-ylmethylamino)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60161770 2-[[4-(3-Hydroxyphenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]-methylamino]acetic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548167 2-((5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-6-(6-methoxypyridin-3-ylamino)pyridin-3-YL)methylamino)ethanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580417 [5,5-dioxo-1-[1-(2-pyrazol-1-ylethyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548330 6-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[(1R)-1-morpholin-4-ylethyl]pyridin-3-yl]-2-methylpyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145957011 4-[4-[[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]methyl]triazol-1-yl]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]butanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436675 {(3R)-4-[4-(2-aminopyrimidin-5-yl)-7-(3,3-difluorocyclobutyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-2-yl]morpholin-3-yl}methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580947 [1-[(3S)-1-[2-(3-methoxypyrrolidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68228408 [1-[1-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethyl]pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52943884 1-(4-(6-(3-Hydroxyphenyl)-2-morpholinopyrimidin-4-yl)piperazin-1-yl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580821 morpholin-4-yl-[1-[1-(2-morpholin-4-ylethyl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950309 3-(Morpholin-4-ylcarbonyl)-1-[3-(1,3-thiazol-2-yl)phenyl]-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950429 [1-(2-methyl-1,3-benzothiazol-6-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44242164 Methyl {2-[4-(2-Chlorophenyl)-4h-1,2,4-Triazol-3-Yl]-4,5-Dihydrothieno[3,2-D][1]benzoxepin-8-Yl}carbamate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580763 [5,5-dioxo-1-(pyrazin-2-ylmethyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578899 [1-(4-bromophenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70702027 4-(1-Methyl-4-propan-2-yloxypyrazolo[3,4-d]pyrimidin-6-yl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580633 [3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145989521 2-(3-Chloro-4-fluorophenyl)-1-(2,3,4-trihydroxyphenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940331 6-chloro-4-(4-methoxy-6-(1H-pyrazol-4-yl)-1H-indol-1-yl)-2,3-dimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204759 2-[[2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]oxy]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371697 2,4-difluoro-N-[2-methoxy-5-(7-piperidin-1-yl-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876197 US11649227, Example 300 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118712088 6-(5-Amino-6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939210 2-cyclopropyl-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-3-methyl-1,8-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436626 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2,2-dimethyl-3-oxopropanoic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548214 4-[2-[(6-chloropyridin-3-yl)amino]-5-[(1R)-1-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]ethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133332 5-[7-[(2S,3S,4S)-2,4-dimethylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:10271745 Imidazopyridine derivative, 8e 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939596 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]-pyridin-1-yl)-5,7-difluoro-2-(3-fluorobenzyl)-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53322917 N-(4-(6-morpholino-2-(pyridin-2-ylmethoxy)pyrimidin-4-yl)phenyl)methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950005 3-(4-(3-methoxyphenylamino)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579040 (1-butyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950396 (4-Methyl-5,5-dioxo-1-phenylpyrazolo[4,3-c][1,2]benzothiazin-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436369 2-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444368 5-[7-[(3R)-1-dimethylphosphorylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:136087060 1-[(E)-(4-hydroxy-3,5-dimethylphenyl)methylideneamino]-3-[4-(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenyl]urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285378 US8765940, tert-butyl 4-(5,7-difluoro-3-methyl-4-(6'-(4-morpholinyl)-2,3,5,6-tetrahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridin]-1'(2'H)-yl)-2-quinolinyl)-1-piperazinecarboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142043 N-[2-methoxy-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]-2-methylpyrazole-3-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940332 6-chloro-4-(4-methoxy-6-(4-pyridinyl)-1H-indol-1-yl)-2,3-dimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142041 4-Chloro-N-[2-methoxy-5-(4-methyl-6-morpholin-4-yl-pyrimidin-5-ylethynyl)-pyridin-3-yl]-benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46180607 4-[6-[(4-Methylsulfonylpiperazin-1-yl)methyl]-2-phenylthieno[3,2-d]pyrimidin-4-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142045 N-[2-methoxy-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]-1-methylpyrazole-4-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142449 2-bromo-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142977 N-[5-[2-[2-amino-4-ethyl-6-(4-hydroxypiperidin-1-yl)pyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133334 tert-butyl (1S,5R)-1-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748121 (2S)-1-N-[5-[2-(cyclopropylmethyl)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71041964 25-Methoxy-22,22-dioxo-3,12,22lambda6-trithia-6,8,15,23,26,30-hexazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,13(30),17(29),18,20,24,26-dodecaen-16-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548281 1-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-5-chloropyridin-2-ylamino)pyridin-2-yl)-3-(4-(2-methoxyethoxy)phenyl)urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581206 [1-[(3S)-1-[2-[bis(2-methoxyethyl)amino]ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939989 1-(7-Fluoro-2-(2-fluorophenyl)-3-methyl-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146263353 5-[2-amino-3-[(3S)-3-methylpiperazin-1-yl]quinolin-6-yl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:24888918 3-(2-morpholino-7-(pyridin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285285 1'-(2-(3-Fluorophenyl)-3-methyl-1,8-naphthyridin-4-yl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580545 [1-[1-(2-cyclohexylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70691729 4-(4-Chlorophenyl)-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-morpholin-4-ylthiophene-3-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581126 [1-[(3S)-1-[2-(2-methoxyethylamino)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876671 US11649227, Example 39 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168284506 5-(4-Morpholin-4-yl-6-piperazin-1-yl-1,3,5-triazin-2-yl)-1,3-benzoxazol-2-amine;hydrochloride 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436263 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2R)-oxolan-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44426434 4-(4-Phenyl-8-thia-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-6-yl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168273425 6-[4-Morpholin-4-yl-6-[4-(trifluoromethyl)piperidin-1-yl]-1,3,5-triazin-2-yl]-1,3-benzothiazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436557 2-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-N-methylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259010 2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-(oxolan-3-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68295019 N-[5-[2-(4-ethyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]-2-methoxypyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436610 Tert-butyl 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpiperidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580690 [6-methyl-1-[(3S)-1-(2-morpholin-4-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436245 2-amino-1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-ethylpyrrolidin-1-yl]-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:127030553 Methyl 2-[[4-(3-hydroxyphenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436027 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-cyclopropylethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141758 N-[5-[2-[4-[2-methoxyethyl(methyl)amino]-6-methylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580796 [1-[(3S)-1-(2-methoxyethyl)piperidin-3-yl]-6-methyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284623 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-(4-methyl-2-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950784 [1-(1-methylsulfonylpiperidin-3-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:127026223 N-[5-[4-[3-(dimethylamino)prop-1-ynyl]quinolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259017 8-(2-Cyclopropylethyl)-6-(6-methoxypyridin-3-yl)-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258836 2-amino-8-cyclopropyl-4-methyl-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940107 7-Chloro-9-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-3,3-dimethyl-2,3-dihydro-1H-cyclopenta[b]quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548361 4-(2-(6-methoxypyridin-3-ylamino)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-3-yl)-N,6-dimethyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580777 Morpholin-4-yl-[3-(oxan-4-yl)-8,8-dioxo-8lambda6,10-dithia-3,4-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,11-tetraen-5-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950782 1-[1-(Methylsulfonyl)piperidin-4-yl]-3-(morpholin-4-ylcarbonyl)-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581079 (4-methylpiperazin-1-yl)-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:153532125 2-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)anilino]-3H-benzimidazole-5-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162666109 1-Methyl-3-[5-[6-[(4-methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]-4-(trifluoromethyl)pyridin-2-yl]urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71813981 N-[6-[6-amino-5-(trifluoromethyl)pyridin-3-yl]imidazo[1,2-a]pyrazin-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:24889937 5-(2-Morpholin-4-yl-7-pyridin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939994 6-chloro-7-methoxy-2,3-dimethyl-4-(3,3,7-trimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939476 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-fluoro-3-methyl-2-(2-(methylsulfonyl)phenyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581117 [5,5-dioxo-1-[(3S)-1-(2-pyrrolidin-1-ylethyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876347 US11649227, Example 151 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284808 2-(2,2-dimethyl-4-morpholinyl)-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133345 propan-2-yl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258838 2-Amino-8-(4-hydroxycyclohexyl)-4-methyl-6-(6-propan-2-yloxypyridin-3-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141191 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]furan-3-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950700 (4-methylpiperazin-1-yl)-[3-(morpholine-4-carbonyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-8-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548385 5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-N-(5-fluoro-6-methoxypyridin-3-YL)-2,3'-bipyridin-6-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168271902 4-[[[5-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzoxazol-2-yl]amino]methyl]benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133338 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-(dimethylamino)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869241 4-(1H-indol-5-yl)-8-[2-methoxyethyl(methyl)amino]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581056 [6-methoxy-1-[(3S)-1-(2-methoxyethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168274816 1-[4-[4-(2-Amino-1,3-benzothiazol-6-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579152 [1-(5-fluoro-2-methylphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25170000 3-[(E)-[methyl-(2-methyl-5-nitrophenyl)sulfonylhydrazinylidene]methyl]pyrazolo[1,5-a]pyridine-5-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580655 morpholin-4-yl-[1-[4-[(oxan-4-ylamino)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141759 N-[2-methyl-5-[2-[4-methyl-6-[(3S)-3-methylmorpholin-4-yl]pyrimidin-5-yl]ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4756436 CHEMBL4756436 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548420 5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-[(4-methylsulfonylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-3-fluoro-1H-pyridin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436314 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-(methylamino)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145984149 4-[4-(4-chlorophenyl)-1H-pyrazol-5-yl]benzene-1,2,3-triol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876346 US11649227, Example 6 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44180511 N-[3-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)phenyl]pyridine-4-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60162301 3-[[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]-N,N-dimethylpropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:127029061 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950654 (5,5-dioxo-1-pyrrolidin-3-yl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939732 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]-pyridin-1-yl)-5,7-difluoro-2-(1H-indol-4-yl)-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258951 8-cyclopentyl-4-methyl-2-(methylamino)-6-(2-methyl-1H-imidazol-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784986 N-(6-methoxypyridin-3-yl)-3-(2-methyl-7H-purin-6-yl)-5-[(pyridin-4-ylamino)methyl]pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4795224 CHEMBL4795224 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141336 2-methyl-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]pyrazole-3-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:77390267 2-morpholin-4-yl-8-(1-phenyltriazol-4-yl)-2,3,4a,5,6,7,8,8a-octahydro-1H-quinolin-4-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580603 (3-Cyclohexyl-8,8-dioxo-8lambda6,12-dithia-3,4-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,10-tetraen-5-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436039 [3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidin-1-yl]-(1-methylcyclopropyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580431 (6-methyl-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876736 US11649227, Example 399 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444331 [2-(Methylamino)-2-oxoethyl] 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145986508 3-(3,4-Dichlorophenyl)-7,8-dihydroxychromen-4-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204890 2-[[4-(2-Propan-2-yl-1,2,4-triazol-3-yl)-9-oxa-3,6,13-triazatricyclo[8.4.0.02,6]tetradeca-1(14),2,4,10,12-pentaen-12-yl]oxy]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89646334 oxan-4-yl-[(3S)-3-[[4-[2-(trifluoromethyl)pyridin-4-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579071 (8-fluoro-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581217 [1-[4-[(3-methylsulfonylpyrrolidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876650 US11649227, Example 398 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285557 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-2-(5-fluoro-3-pyridinyl)-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:3602063 (2-Oxo-1,2-diphenylethyl) 4-chlorobenzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:16049526 3-(2-Morpholinopyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444393 3-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876357 US11649227, Example 65 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182427 N-(6-(2-(4-Fluorophenylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032644 Pfe-pkis 40 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:24889091 3-[7-(1-Methyl-1H-pyrazol-3-yl)-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168291557 N-[6-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzothiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177392 5-(3-(benzylsulfonyl)-5-morpholinophenyl)-N-cyclopropylpyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403559 1-((4-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)phenyl)amino)-2-methylpropan-2-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785438 5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(6-methoxypyridin-3-yl)-2,3'-bipyridin-6-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44426432 4-Morpholin-4-yl-pyrido[3'',2'':4,5]furo[3,2-d]pyrimidine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184942 4-[2-(1H-indazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580718 [1-[1-[2-(3,3-difluoropiperidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580631 morpholin-4-yl-[3-[(3S)-1-(oxan-3-yl)piperidin-3-yl]-8,8-dioxo-8lambda6-thia-3,4,10-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580590 [1-[4-[(3-methoxyazetidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258847 8-cyclopentyl-4-methyl-2-(methylamino)-N-(1,2-oxazol-3-yl)-7-oxopyrido[2,3-d]pyrimidine-6-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436691 tert-butyl 3-{4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl}azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258912 2-amino-4-methyl-8-(4-oxocyclohexyl)-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950869 1-Biphenyl-3-yl-3-(morpholin-4-ylcarbonyl)-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141755 N-[2-methyl-5-[2-[4-methyl-6-(1,4-oxazepan-4-yl)pyrimidin-5-yl]ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285490 1-(5,7-Difluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44609857 N-(2-chloro-5-(isoquinolin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436125 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-cyclopropyl-2-hydroxyethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580793 [1-[1-(2-methoxyethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44180629 4-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)-N-pyridin-3-ylbenzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580823 [1-[4-(methoxymethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581155 N-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]morpholine-4-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023757 Imidazo[1,2-a]pyridine derivative, 2e 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436387 tert-butyl 4-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-4-methylpiperidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122188260 N-[(E)-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-3,4-difluoro-N-methylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285118 1-[5,7-difluoro-3-methyl-4-(6-morpholin-4-ylspiro[2H-pyrrolo[3,2-b]pyridine-3,4'-oxane]-1-yl)quinolin-2-yl]-4,4-dimethylpyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578916 [1-(2-hydroxyethyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182282 N-(6-(2-(Pyridin-4-ylmethoxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548427 5-N-benzyl-2-N-(6-methoxypyridin-3-yl)-3-(2-methyl-7H-purin-6-yl)pyridine-2,5-diamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548262 (R)-2-((5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-6-(6-methoxypyridin-3-ylamino)pyridin-3-YL)methylamino)propan-1-OL 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436100 2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-ethylpyrrolidin-1-yl]-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436646 5-[7-[(3S,4R)-3,4-dimethylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548208 5-((isopropylamino)methyl)-N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70689600 4-(4-chlorophenyl)-2-morpholin-4-yl-5-(1H-pyrazol-4-yl)thiophene-3-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032719 2-Amino-8-(4-hydroxycyclohexyl)-4-methyl-6-(6-pyrrolidin-1-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436305 5-[7-(3-Methylpiperidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133335 tert-butyl (1R,5S)-1-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141338 N-[2-methyl-5-[2-[4-methyl-6-(4-methyl-3-oxopiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580748 [1-[4-[(2,6-dimethylmorpholin-4-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53326553 4-(1H-indazol-4-yl)-6-morpholino-N-(2-(pyridin-3-yl)ethyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436407 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-fluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581156 [7-ethoxy-1-[4-(morpholin-4-ylmethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876684 US11649227, Example 96 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168430257 US11649227, Example 244 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581019 [1-[(4-chlorothiophen-2-yl)methyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436684 5-[7-[(3S)-3-methyl-1-propan-2-ylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258828 Ethyl 3-[8-cyclopentyl-4-methyl-2-(methylamino)-7-oxopyrido[2,3-d]pyrimidin-6-yl]benzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580653 [7-(2-methoxyethylamino)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580724 morpholin-4-yl-[1-[1-(oxan-4-ylmethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939471 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-(3-(trifluoromethyl)benzyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436218 (3-aminooxolan-3-yl)-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876271 US11649227, Example 376 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:51357942 N-(6-(2-(Phenylamino)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258943 Tert-butyl 3-[2-amino-6-(6-methoxypyridin-3-yl)-4-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580937 morpholin-4-yl-[1-(oxan-3-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444383 5-[7-(1-Cyclopropylsulfonyl-3-methylazetidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168278126 (2S)-1-[2-[(4R)-4-(methoxymethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580802 1-Methyl-5-[5-(morpholine-4-carbonyl)-8,8-dioxo-8lambda6,10-dithia-3,4-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,11-tetraen-3-yl]pyridin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284965 2-(3,5-difluorophenyl)-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-3-methyl-1,8-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444386 ethyl 2-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-2-methylpropanoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11404154 2-[4-(Butylamino)pyrazolo[3,4-d]pyrimidin-1-yl]-1-phenylethanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133342 tert-butyl (2S)-2-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carbonyl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580753 [1-[4-[(2,2-dimethylmorpholin-4-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436183 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1H-imidazol-2-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182286 N-(6-(2-(Phenylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950565 [1-[(1-methylpiperidin-3-yl)methyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580664 [1-(3-chlorophenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579064 (6-fluoro-1-methyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436696 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-methyl-1,3'-bipyrrolidin-2'-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023754 Imidazo[1,2-a]pyridine derivative, 2b 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284855 1-(7-fluoro-3-methyl-2-pyridin-2-ylquinolin-4-yl)-6-morpholin-4-ylspiro[2H-pyrrolo[3,2-b]pyridine-3,4'-oxane]-5-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578717 [1-(4-methylpyridin-3-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53326636 N-[6-[2-(dimethylamino)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]quinolin-3-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52943947 3-(6-(1H-indazol-5-ylamino)-2-(piperazin-1-yl)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869635 4-(3-Hydroxyphenyl)-8-methyl-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118616985 2-fluoro-N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938827 4-(1-(7-fluoro-3-methyl-2-(2-(methylsulfonyl)phenyl)-4-quinolinyl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-6-yl)-2-pyrimidinamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023756 Imidazo[1,2-a]pyridine derivative, 2d 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580702 [1-[3-[(3-methoxypyrrolidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:72549107 1-(4-Fluorophenyl)-3-[4-[6-[(4-methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]phenyl]urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581190 [1-[(3S)-1-(2-aminoethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876660 US11649227, Example 274 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168280995 N-[5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzoxazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:5407855 3-(4-Fluorophenyl)-7,8-dihydroxychromen-4-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258917 8-Cyclopentyl-6-[1-(2,2-difluoroethyl)pyrazol-4-yl]-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76313939 4-[2-(4-Methoxyphenyl)pyrido[3,2-d]pyrimidin-4-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403581 Tert-butyl 4-(3-((3-(2-aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidin-1-yl)piperidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939345 2-(3,5-bis(trifluoromethyl)phenyl)-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-fluoro-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:77390259 US8841288, CL55b 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177397 5-(3-((4-Fluorobenzyl)sulfonyl)-5-morpholinophenyl)-6-methoxypyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258996 2-Amino-6-(6-chloropyridin-3-yl)-8-cyclopentyl-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436091 1-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidin-1-yl]-2-hydroxy-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436161 5-[7-[(3S)-1-cyclopentyl-3-methylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444409 5-[7-[1-(azetidin-3-ylsulfonyl)azetidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548228 4-(2-(6-Methoxypyridin-3-ylamino)-5-(1-(4-(methylsulfonyl)phenyl)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53320905 3-(4-(3,4-Dichlorophenyl)-6-morpholinopyrimidin-2-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578961 [4-(3-methoxypropyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580342 [7-methoxy-1-[(3S)-1-(2-morpholin-4-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133333 5-[7-[(2R,3R,4R)-2,4-dimethylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578983 3-(Morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444402 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylazetidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68267841 [1-[(3S)-1-[2-(3-fluoropyrrolidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785339 5-((3-methoxyphenylamino)methyl)-N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:9867340 17-Hydroxywortmannin 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44242493 N-(2,4-difluorophenyl)-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436297 [3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-(1-methylcyclopropyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580390 morpholin-4-yl-[1-[1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:1049534 4-[4-(Diphenylmethyl)piperazinyl]-1-phenylpyrazolo[5,4-d]pyrimidine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204557 2-Methyl-2-[[4-(2-propan-2-yl-1,2,4-triazol-3-yl)-9-oxa-3,6,13-triazatricyclo[8.4.0.02,6]tetradeca-1(14),2,4,10,12-pentaen-12-yl]oxy]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580730 [1-(4-methylsulfonylphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548239 1-(5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-6-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-YL)ethanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44457213 [(1S,3aR,6E,9S,9aR,10R,11aS)-6-[[tert-butyl-[3-(dimethylamino)propyl]amino]methylidene]-1,5-dihydroxy-9-(methoxymethyl)-9a,11a-dimethyl-4,7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-h]isochromen-10-yl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436692 5-[7-[(1S,5R)-3-methylsulfonyl-3-azabicyclo[3.1.0]hexan-1-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168279226 N-cyclopentyl-5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950431 morpholin-4-yl-[1-(oxan-4-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60148744 3-[2-((2S,6R)-2,6-dimethyl-morpholin-4-yl)-6-morpholin-4-yl-9H-purin-8-yl]-phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580670 [5,5-dioxo-1-[1-(oxolan-3-ylmethyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580602 [5,5-dioxo-1-[1-(3,3,3-trifluoropropyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581132 [1-[3-[(4-hydroxypiperidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142448 3-fluoro-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436226 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-cyclopropylethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876372 US11649227, Example 286 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177456 3'-((4-Fluorobenzyl)sulfonyl)-4-methoxy-5'-morpholino-[1,1'-biphenyl]-3-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548237 methyl N-[5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-chloropyridin-2-yl]amino]pyridin-2-yl]carbamate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436605 1-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-2-hydroxy-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:73345848 N-methyl-2-(2-propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[4,5-d][1,3]thiazole-8-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580949 [6-fluoro-1-[(3S)-1-(2-methoxyethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145950166 N-[5-[2-(dimethylamino)-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436498 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(2-methyloxolan-2-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436354 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(1R,2S)-2-fluorocyclopropyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403553 5-(3-morpholino-5-((1-(tetrahydro-2H-pyran-4-yl)azetidin-3-yl)sulfonyl)phenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46941130 5-[2-(6-Methyl-pyridin-3-yl)-imidazo[2,1-b][1,3,4]thiadiazol-5-yl]-3-trifluoromethyl-pyridin-2-ylamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444398 5-[7-[(3R)-3-methylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:87057946 N-[5-(morpholine-4-carbonyl)-3-(oxan-4-yl)-8,8-dioxo-8lambda6,10-dithia-3,4,12-triazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,11-tetraen-11-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:147330112 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)pyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869093 4-(3-Fluoro-5-hydroxyphenyl)-8-[2-methoxyethyl(methyl)amino]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785596 2-((5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-6-(6-methoxypyridin-3-ylamino)pyridin-3-YL)methyl)-2,5,7-triazaspiro[3.4]octane-6,8-dione 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548198 4-[2-[(5-Fluoro-6-methoxypyridin-3-yl)amino]-5-(oxan-4-yl)pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436120 [(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1-methylcyclopropyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141756 N-[5-[2-[4-(4-acetylpiperazin-1-yl)-6-ethylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]-4-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548233 4-[[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]methyl]-N,N-dimethylpiperazine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581196 [6-fluoro-1-[1-(2-morpholin-4-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49852675 2-Amino-8-(Trans-4-Methoxycyclohexyl)-4-Methyl-6-(1h-Pyrazol-3-Yl)pyrido[2,3-D]pyrimidin-7(8h)-One 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258891 tert-butyl 3-[2-amino-4-methyl-7-oxo-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-8-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68267661 [1-[(3S)-1-[2-[(2S,6R)-2,6-dimethylmorpholin-4-yl]ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:16456544 N-(3-chlorophenyl)-1-methyl-6-(4-methylpiperazin-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258850 6-(6-Methoxypyridin-3-yl)-4-methyl-2-(methylamino)-8-prop-2-enylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133347 tert-butyl (3R,4R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-4-fluoropyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548185 n-(5-Fluoro-6-methoxypyridin-3-yl)-5-((r)-1-((s)-2-methyl-4-(methylsulfonyl)piperazin-1-yl)ethyl)-3-(2-methyl-9h-purin-6-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285558 1-(7-Fluoro-3-methyl-4-(6'-(4-morpholinyl)-2,3,5,6-tetrahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridin]-1'(2'H)-yl)-2-quinolinyl)-2-piperidinone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133324 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N-ethyl-3-methylpyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580543 [5,5-dioxo-1-[1-(2-pyrazol-1-ylethyl)pyrrolidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548436 4-(1-(5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)ethyl)-N,N-dimethylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876355 US11649227, Example 77 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938718 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5-fluoro-3-methyl-2-(2-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71682807 (2S)-1-N-[4-methyl-5-(6-propan-2-ylpyrimidin-4-yl)-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580637 morpholin-4-yl-[1-[4-[1-(morpholin-4-ylmethyl)cyclopropyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436399 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2,2-dimethylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436538 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methoxy-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939993 US8765940, 6-(4-morpholinyl)-1-(2,3,8-trimethyl-4-quinolinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53320906 3-(2-Morpholino-6-(pyridin-4-ylmethylamino)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285088 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436160 (2R)-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxypropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748109 (2S)-2-methyl-1-N-[5-[2-(1-methylcyclopropyl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548183 N-(3-(9H-purin-6-yl)pyridin-2-yl)-1H-indol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950742 [1-[1-(2-hydroxyethyl)piperidin-4-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142974 N-[5-[2-[4-ethyl-6-(methylamino)pyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56834968 3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182714 N-(6-(2-(4-Fluorobenzyloxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:77390300 US8841288, CL 129A 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204894 (2R)-1-[4-(2-propan-2-yl-1,2,4-triazol-3-yl)-9-oxa-3,6,13-triazatricyclo[8.4.0.02,6]tetradeca-1(14),2,4,10,12-pentaen-12-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444371 [(2R)-2-hydroxypropyl] 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876206 US11649227, Example 63 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184947 3-[[2-(2-Aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]-1,1-dimethylurea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58527396 8-(2-Hydroxy-ethylamino)-4-(3-hydroxy-phenyl)-2-morpholin-4-yl-pyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141900 N-[5-[2-(4-ethyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]-2-methoxypyridin-3-yl]thiophene-2-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46913419 3-(5,6-Dimethoxypyridin-3-yl)imidazo[1,2-a]pyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44129270 (2S,4R)-4-(dimethylamino)-1-N-[4-methyl-5-[2-(1-methylcyclopropyl)-1,3-thiazol-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436464 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methyl-3-oxopropanoic acid 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL2058168 CHEMBL2058168 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436126 2-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-N,N-dimethylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581215 [1-[4-[(2-methoxyethylamino)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548373 4-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[[(3R)-3-methyl-4-methylsulfonylpiperazin-1-yl]methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52947519 N-[5-[3-[3-(methanesulfonamido)phenyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548473 5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-6-(5-fluoro-6-methoxypyridin-3-ylamino)nicotinaldehyde 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177534 (R)-5-(6-morpholino-4-((tetrahydrofuran-3-yl)sulfonyl)pyridin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580833 morpholin-4-yl-[1-[1-(2-morpholin-4-ylethyl)azetidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581148 [1-[(3R)-1-[2-(4-fluoropiperidin-1-yl)ethyl]pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023749 Imidazopyridine derivative, 8a 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444369 5-[7-[(3S)-1-dimethylphosphorylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950266 [1-[3-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259006 2-Amino-6-bromo-4-methyl-8-(oxolan-3-ylmethyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869245 8-(Dimethylamino)-4-[3-(methoxymethyl)phenyl]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581032 [1-[(3S)-1-[2-(3,3-difluoroazetidin-1-yl)ethyl]piperidin-3-yl]-6-fluoro-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548200 1-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-yl)pyridin-2-ylamino)pyridin-2-yl)-3-(3-fluorophenyl)urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145993856 4-[4-(3,4-dimethoxyphenyl)-1H-pyrazol-5-yl]benzene-1,2,3-triol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581004 morpholin-4-yl-[1-(4-morpholin-4-ylphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:127033886 3-[4-[(4-Methylsulfonylpiperazin-1-yl)methylamino]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142577 2,4-difluoro-N-[2-methyl-5-[2-(4-methyl-6-piperidin-1-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57395408 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2,5-trimethylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182142 N-(6-(2-(3-Morpholinopropoxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580493 [5,5-dioxo-1-[4-(piperidin-1-ylmethyl)phenyl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:124175050 (2S)-1-[2-(2-oxo-1,3-oxazolidin-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785597 3-(6-amino-2-methylpyrimidin-4-yl)-N-(1H-indazol-4-yl)quinoxalin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52945171 3-(6-(1H-indazol-5-ylamino)-2-(2-methoxyethylamino)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70702031 4-[6-(3-Methoxyphenyl)-1-methylpyrazolo[3,4-d]pyrimidin-4-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940457 US8765940, 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-methoxy-2,3,6-trimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581167 [6-methoxy-1-[(3S)-1-(2-morpholin-4-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60148865 4-[8-(2-methyl-1H-indol-4-yl)-2-morpholin-4-yl-7H-purin-6-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548193 (R)-N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-2-yl)-5-fluoroquinolin-7-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133346 propan-2-yl (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70702028 N-[3-(1-methyl-6-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-4-yl)phenyl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184765 [1,2-Bis(4-methoxyphenyl)-2-oxoethyl] 4-fluorobenzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580647 [4-(3-aminopropyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604376 [7-(3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-(2-bromo-4-methylsulfonylphenyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371657 N-[5-[4-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)thieno[2,3-d]pyrimidin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876744 US11649227, Example 371 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580625 2-cyclohexyl-1-[(3S)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444356 5-[7-[1-(2-Methoxyethylsulfonyl)azetidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44457191 [(1S,3aR,6E,9S,9aR,10R,11aS)-6-[[3-(dimethylamino)propyl-ethylamino]methylidene]-1,5-dihydroxy-9-(methoxymethyl)-9a,11a-dimethyl-4,7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-h]isochromen-10-yl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11281252 N-(3-fluorophenyl)-4-(2-morpholin-4-yl-2-oxoethoxy)naphthalene-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118712087 6-(5-Fluoro-6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59293648 (2S)-1-N-[5-[2-[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580632 morpholin-4-yl-[1-(2-morpholin-4-ylethyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168272042 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-N-[[4-(trifluoromethyl)phenyl]methyl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258829 2-amino-8-[(1R,3S)-3-hydroxycyclopentyl]-4-methyl-6-(1-methylpyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52937062 6-(6-Amino-5-morpholin-4-ylsulfonylpyridin-3-yl)imidazo[1,2-a]pyridine-3-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876179 US11649227, Example 171 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436173 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carbonyl]azetidine-3-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146173235 (S)-5-(6-morpholino-4-((tetrahydrofuran-3-yl)sulfonyl)pyridin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57398894 N-[(E)-1-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)propylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25183032 N-(6-(2-(Benzylamino)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284821 US8765940, 1'-(2-(3,5-dimethylphenyl)-7-fluoro-3-methyl-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950388 (5,5-dioxo-1-pyridin-2-yl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436510 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-fluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436410 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-hydroxy-2,2-dimethylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023758 Imidazo[1,2-a]pyridine derivative, 8 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133357 5-[7-(2-Methylsulfonyl-2-azabicyclo[2.1.1]hexan-4-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869303 8-(2-Hydroxyethylamino)-4-[3-(methoxymethyl)phenyl]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118630977 2,4-diamino-6-[[(1S)-1-[7-fluoro-3-(4-fluorophenyl)-4-oxoquinolizin-2-yl]ethyl]amino]pyrimidine-5-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:10405525 3-[2-Morpholin-4-yl-6-(pyridin-3-ylamino)pyrimidin-4-yl]phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162652786 ethyl 2-[2-[(2E)-2-[1-(1-benzofuran-2-yl)ethylidene]hydrazinyl]-1,3-thiazol-4-yl]acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71099997 2-Amino-8-cyclopentyl-6-(3-ethylphenyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146173039 5-(3-(Azetidin-3-ylsulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581066 [6-fluoro-5,5-dioxo-1-(oxolan-3-yl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436034 2-amino-1-[(3S)-3-{4-(2-aminopyrimidin-5-yl)-2[(3S)-3-methylmorpholin-4-yl]-5,6-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-3-methylpyrrolidin-1-yl]-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580510 [1-[1-[2-(4-fluoropiperidin-1-yl)ethyl]pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71600793 phenyl-(7-quinolin-3-yl-3,5-dihydro-2H-1,4-benzoxazepin-4-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285371 1'-(2-(3,5-Difluorophenyl)-3-methyl-1,7-naphthyridin-4-yl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]-pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580514 [7-methoxy-1-[(3S)-1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950349 [1-[[1-(2-methoxyethyl)piperidin-4-yl]methyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258882 2-amino-4-methyl-8-(oxan-4-yl)-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:16222214 4-(1H-indol-6-yl)-6-morpholino-N-(2-(pyridin-3-yl)ethyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184953 1-[2-(2-Aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]-3-methylbutan-2-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258949 2-amino-6-bromo-8-(trans-4-methoxycyclohexyl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52936957 N-(5-(3-(1H-Pyrazol-3-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)-benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436290 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidin-1-yl]-3-methylbutan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57390176 N,2-dimethyl-N-[(E)-(7-methylpyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-5-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869089 4-(3-Hydroxy-phenyl)-8-[(2-methoxy-ethyl)-methyl-amino]-2-morpholin-4-yl-pyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444385 5-[7-(3-Methylazetidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:21270203 2-(3-Chlorophenyl)-1-(2,3,4-trihydroxyphenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580643 2-cyclohexyl-1-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]pyrrolidin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:87057963 [1-[(3R)-1-(2-fluoroethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548255 2-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5-methylsulfonylpyridin-3-yl)amino]pyridin-3-yl]propan-2-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59605139 2,2,2-trifluoro-1-[4-[7-(1H-indazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl]phenyl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581136 [1-[4-[(3-fluoroazetidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869699 8-(4-Methylsulfonylpiperazin-1-yl)-2-morpholin-4-yl-4-phenylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53325281 4-(1H-indol-6-yl)-6-morpholino-N-(2-(pyridin-2-yl)ethyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25033538 2-Amino-6-(5-fluoro-6-methoxypyridin-3-yl)-8-[4-(2-hydroxyethoxy)cyclohexyl]-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784797 N-(3-(6-amino-2-methylpyrimidin-4-yl)pyridin-4-yl)-1H-indol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580706 [1-(4-hydroxycyclohexyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258979 8-Cyclopentyl-6-(2-methoxypyridin-3-yl)-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118712085 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]butane-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580999 [1-[3-[(3-methylsulfonylpyrrolidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876535 US11649227, Example 85 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580435 [1-(2-benzylindazol-5-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204592 (2S)-1-[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436283 (2S)-1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxypropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52949440 N-(3-methoxyphenyl)-1-methyl-6-(3-(methylsulfonyl)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548368 4-[2-[(5-Fluoro-6-methoxypyridin-3-yl)amino]-6-methylpyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580578 morpholin-4-yl-[1-[4-[(oxan-3-ylamino)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444375 [(2R)-2-hydroxypropyl] 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60162043 2-[[4-(3-Hydroxyphenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:166626608 (2S)-1-[2-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)anilino]pyrimidine-5-carbonyl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436637 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1H-pyrazol-5-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580502 (6-bromo-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876686 US11649227, Example 373 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578981 [1-(3-methylphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436613 Methyl 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548481 N-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-[(4-methylsulfonylpiperazin-1-yl)methyl]pyridin-2-yl]-1,3-benzoxazol-5-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876279 US11649227, Example 400 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258856 2-amino-8-[(1R,3R)-3-hydroxycyclopentyl]-4-methyl-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:10139567 Imidazo[1,2-a]pyridine derivative, 2g 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580771 [1-[1-(2-imidazol-1-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436085 5-[7-[(3R)-3-ethylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580621 [1-[(3S)-1-[2-(4-fluoropiperidin-1-yl)ethyl]piperidin-3-yl]-7-methoxy-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145989970 3-(3-Chloro-4-fluorophenyl)-7,8-dihydroxychromen-4-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444355 5-[7-[1-(Cyclopropylmethylsulfonyl)azetidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142450 1-methyl-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]imidazole-4-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4753286 CHEMBL4753286 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950434 [5,5-dioxo-1-(pyridin-2-ylmethyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580956 [1-(1-methylpiperidin-3-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436087 2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-fluoro-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548449 N-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)pyridin-2-ylamino)-2-methylpyridin-3-YL)methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023750 Imidazopyridine derivative, 8b 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142447 2,6-difluoro-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950480 [1-(cyclopentylmethyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67283910 5-{2-[3-Methoxy-4-(piperidin-4-yloxy)-phenyl]-imidazo[2,1-b][1,3,4]thiadiazol-5-yl}-pyrimidin-2-ylamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:586366 2-(4-Chlorophenyl)-1-(2,4-dihydroxyphenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580646 (7-methyl-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258940 2-amino-6-bromo-4-methyl-8-(tetrahydrofuran-3-yl)pyrido[2,3-d]pyrimidin-7(8H)-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444413 tert-butyl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3R)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436130 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1-hydroxycyclopropyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59251754 N-[6-[6-amino-4-(trifluoromethyl)pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403548 5-(3-(benzylsulfonyl)-5-morpholinophenyl)-N-methylpyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581063 [1-[(3S)-1-[2-(4-fluoropiperidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177518 5-(3-Morpholino-5-(phenylsulfonyl)phenyl)-4-(trifluoromethyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581138 [1-[4-[(3-hydroxypyrrolidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876633 US11649227, Example 55 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL2375959 CHEMBL2375959 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122179715 2-morpholin-4-yl-4-oxo-N-(pyridin-2-ylmethyl)pyrido[1,2-a]pyrimidine-9-carboxamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4794677 CHEMBL4794677 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177389 4-(3-(6-Methoxypyridin-3-yl)-5-(phenylsulfonyl)phenyl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436122 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444363 5-[7-[(3S)-3-methyl-1-methylsulfonylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258842 8-(2-Aminoethyl)-6-(6-methoxypyridin-3-yl)-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53326793 4-(4-(1H-indazol-4-yl)-6-(pyridin-2-ylmethoxy)pyrimidin-2-yl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580648 [1-[(3S)-1-[2-(4-hydroxypiperidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258902 3-[8-Cyclopentyl-2-(ethylamino)-4-methyl-7-oxopyrido[2,3-d]pyrimidin-6-yl]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244594 5-[2-Morpholin-4-yl-7-(4-morpholin-4-ylmethyl-phenyl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-pyrimidin-2-ylamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:137643612 1-[(2-Hydroxynaphthalen-1-yl)-(4-methylphenyl)methyl]pyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59507952 2-Amino-5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)pyridine-4-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950346 (6-methoxy-1-methyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940106 7-chloro-9-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-1,2,3,4-tetrahydroacridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:18766054 Imidazopyridine derivative, 8d 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580779 tert-butyl 3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]pyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142044 N-[5-[2-(4-ethyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]-2-methoxypyridin-3-yl]furan-2-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:20917060 2-(4-{4-[(3-methoxyphenyl)amino]-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl}piperazin-1-yl)ethanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258904 8-Cyclopentyl-6-(6-methoxypyridin-3-yl)-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:4160026 (2-Oxo-1,2-diphenylethyl) 2-fluorobenzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168293682 (2S)-1-[2-(4-oxo-6,7-dihydropyrazolo[1,5-a]pyrazin-5-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42645770 (2S)-2-methyl-1-N-[4-methyl-5-[2-[1-(trifluoromethyl)cyclopropyl]pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548364 4-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)pyridin-2-ylamino)pyridin-2(1H)-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141479 N-[5-[2-(4-ethyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]-2-methoxypyridin-3-yl]ethanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145992739 4-[4-(3-chlorophenyl)-1H-pyrazol-5-yl]benzene-1,2,3-triol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580830 morpholin-4-yl-[1-[(3S)-1-(oxan-4-yl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:13939416 2-(3,4-Dimethoxyphenyl)-1-(2,3,4-trihydroxyphenyl)ethan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118447157 N-[2-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-2-oxoethyl]-2-methylpropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141615 N-[5-[2-[4-ethyl-6-(4-hydroxypiperidin-1-yl)pyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]-4-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177499 5-(6-morpholino-4-((tetrahydro-2H-pyran-4-yl)sulfonyl)pyridin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68228419 3-[3-(morpholin-4-ylcarbonyl)-5,5-dioxidothiochromeno[4,3-c]pyrazol-1(4H)-yl]benzonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:126699967 US10065970, Example 258 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548395 N-(2-chloro-4-(3-(2-methyl-9H-purin-6-yl)pyridin-2-ylamino)phenyl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580683 (3-Cyclohexyl-8,8-dioxo-8lambda6,10-dithia-3,4-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,11-tetraen-5-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950026 3-[6-(1H-Indazol-5-ylamino)-2-(1-oxo-1lambda4-thiomorpholin-4-yl)-pyrimidin-4-yl]-phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436062 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:20877898 N-methyl-N-(2-methylphenyl)-4H-thieno[3,2-c]chromene-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436258 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1-fluorocyclopropyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:51357944 N-(6-(2-(3-Fluorophenylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285352 4-(6-Chloro-7-methoxy-2,3-dimethyl-4-quinolinyl)-6-(4-morpholinyl)-3,4-dihydro-2H-1,4-benzothiazine 1,1-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748100 (2S)-1-N-[5-[2-[2-(4-methoxyphenyl)propan-2-yl]pyridin-4-yl]-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950567 (1-cycloheptyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436123 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-cyclopropylethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:24888922 3-[7-(1h-Benzimidazol-5-Yl)-2-(Morpholin-4-Yl)-6,7-Dihydro-5h-Pyrrolo[2,3-D]pyrimidin-4-Yl]phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284605 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-3-methyl-2-(4-methyl-2-pyridinyl)-1,8-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53323984 4-(1H-indazol-4-yl)-6-morpholino-N-(2-(pyridin-2-yl)ethyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580636 (5,5-dioxo-1-pyridin-3-yl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580849 [5,5-dioxo-1-[6-(piperidin-1-ylmethyl)pyridin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142314 2-fluoro-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:72248494 1-N-[5-(2-tert-butylpyridin-4-yl)-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785921 4-[2-[(5-Fluoro-6-methoxypyridin-3-yl)amino]-5-[[4-methylsulfonyl-2-(trifluoromethyl)piperazin-1-yl]methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032976 2-Amino-8-cyclopentyl-4-methyl-6-(6-pyrrolidin-1-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876767 US11649227, Example 272 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581180 [1-[4-(methylaminomethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436652 tert-butyl(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436690 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-hydroxy-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76510694 8-(1-benzyltriazol-4-yl)-2-morpholin-4-yl-2,3,4a,5,6,7,8,8a-octahydro-1H-quinolin-4-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950430 [5,5-dioxo-1-(4-propan-2-ylphenyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145988761 2-[4-(Trifluoromethyl)phenyl]-1-(2,3,4-trihydroxyphenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "GTOPDB:12903 STX-478 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939467 1-(4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-quinolinyl)-2-piperidinone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580707 [1-[1-(2-methoxyethyl)piperidin-4-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53324887 3-(4-(4-Chlorophenyl)-6-morpholinopyrimidin-2-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580629 morpholin-4-yl-[1-[1-[2-(oxan-4-yl)ethyl]azetidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436058 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-cyclopropylethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548312 4-[2-(3,4-Difluoroanilino)pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580789 [4-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141194 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]furan-2-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938952 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-3-methyl-2-(2-methyl-3-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548189 4-(2-(5-Fluoro-6-methoxypyridin-3-ylamino)-5-(1-(isopropylamino)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141196 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]pyridine-3-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580669 [1-[3-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950607 (1-cyclopentyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4759861 CHEMBL4759861 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876464 US11649227, Example 88 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436067 3-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-oxopropanenitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56677061 3-[[3-(4-Bromophenyl)sulfonylquinoxalin-2-yl]amino]phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023761 Imidazo[1,2-a]pyridine derivative, 14b 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579007 (4-ethyl-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259011 2-amino-8-[(1R,3S)-3-hydroxycyclopentyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89664640 1-[(3S)-3-[[4-(4-methoxy-3-morpholin-4-ylsulfonylphenyl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869634 4-(3-Hydroxyphenyl)-8-[4-(methylsulfonyl)piperazin-1-yl]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876755 US11649227, Example 370 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784798 N-(6-Methoxypyridin-3-YL)-3-(2-methyl-9H-purin-6-YL)quinolin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141614 N-[5-[2-[4-ethyl-6-(4-methylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]-4-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950786 morpholin-4-yl-[1-[3-(morpholin-4-ylmethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436366 N-[2-[3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-2-oxoethyl]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548376 4-(2-(5-Fluoro-6-methoxypyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146263359 [6-(2-amino-1,3-benzoxazol-7-yl)imidazo[1,2-a]pyridin-3-yl]-[(3S)-3-methylmorpholin-4-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25172270 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-4-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581112 [7-methoxy-1-[(3S)-1-(2-methoxyethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581082 [1-[4-[[3-(3-methylbutoxy)pyrrolidin-1-yl]methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70681276 2-(Benzenesulfonyl)-3-pyrrolidin-1-ylquinoxaline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436139 5-[7-[1-(Azetidin-1-ylsulfonyl)azetidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436307 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(1S)-2,2-difluorocyclopropyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91934341 4-((1R,10R,Z)-4-((carboxymethylamino)methylene)-6-hydroxy-10-methyl-3,7,17-trioxo-2,3,4,7,10,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-1-yloxy)-4-oxobutanoic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168269690 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-N-[(4-nitrophenyl)methyl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436350 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methylpropan-2-ol 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4756299 CHEMBL4756299 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578982 [1-(3-methoxyphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444414 5-[7-[(3R)-3-methyl-1-methylsulfonylpyrrolidin-3-yl]-2-[(3R)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11508907 4-[6-ethylsulfanyl-1-[(E)-2-phenylethenyl]pyrazolo[3,4-d]pyrimidin-4-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:77360306 US8841288, CL 64a 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580971 tert-butyl 4-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578891 (8-amino-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876198 US11649227, Example 53 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53318739 3-(6-Morpholino-2-(pyridin-2-ylmethylamino)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44180738 4-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)-N-pyridin-4-ylbenzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950306 [1-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284698 US8765940, 1-(5,7-difluoro-3-methyl-4-(6'-(4-morpholinyl)-2,3,5,6-tetrahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridin]-1'(2'H)-yl)-2-quinolinyl)-5,5-dimethyl-2-piperidinone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133328 tert-butyl (3R,4S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3,4-dimethylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580723 [1-[1-(3-methoxypropyl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25033536 2-Amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(2-methoxy-5-pyrimidinyl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:77361592 2-[4-[4-(2-morpholin-4-yl-4-oxo-8H-quinolin-8-yl)triazol-1-yl]phenyl]acetonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42645530 (2S)-2-methyl-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748104 (2S)-1-N-[5-[2-[ethyl(2-methoxyethyl)amino]pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:72549551 1-[4-[4-(Dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-[6-[(4-methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]phenyl]urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258860 2-amino-4-methyl-8-(oxolan-2-ylmethyl)-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580663 [1-[(3S)-1-[2-(3,3-difluoroazetidin-1-yl)ethyl]piperidin-3-yl]-6-methoxy-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869092 4-(3-Hydroxyphenyl)-8-(2-methoxyphenyl)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581174 morpholin-4-yl-[3-[(3R)-1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-8,8-dioxo-8lambda6-thia-3,4,10-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168285796 (2S)-1-[2-(5-oxo-1,4-oxazepan-4-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032465 2-Amino-6-(5-fluoro-6-methoxypyridin-3-yl)-8-[3-(2-hydroxyethoxy)cyclobutyl]-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548465 4-(2-(3-(Difluoromethoxy)phenylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580509 morpholin-4-yl-[1-[(3S)-1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436064 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carbonyl]azetidine-3-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548248 N-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-((4-(methylsulfonyl)piperazin-1-YL)methyl)pyridin-2-YL)-3-methyl-3H-imidazo[4,5-B]pyridin-6-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142975 N-[5-[2-[4-(dimethylamino)-6-ethylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436050 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-cyclopropylethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939991 6-Chloro-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-3-ethyl-2-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:2762479 2-Morpholinoisonicotinic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53162191 N-[(2-Methoxyphenyl)methyl]-2-[5-(quinolin-6-YL)-1,3,4-oxadiazol-2-YL]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133356 Tert-butyl 4-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-2-azabicyclo[2.1.1]hexane-2-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580626 morpholin-4-yl-[3-[(3R)-1-(oxan-3-yl)piperidin-3-yl]-8,8-dioxo-8lambda6-thia-3,4,10-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436482 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(5-methyl-1H-pyrazol-4-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59252012 N-[6-(6-aminopyridin-3-yl)-1,3-benzothiazol-2-yl]-2-piperidin-1-ylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580638 [1-[1-(2-imidazol-1-ylethyl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168294917 1-(4-Fluorophenyl)-2-methyl-8-[4-(trifluoromethyl)phenyl]imidazo[4,5-c]quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023752 Imidazopyridine derivative, 8i 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436521 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3,3,3-trifluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259023 8-Cyclopentyl-6-(3-methoxyphenyl)-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548422 5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-4-N-(6-methoxypyridin-3-yl)pyrimidine-2,4-diamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141333 1,2-dimethyl-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]imidazole-4-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52947388 methyl 3-(6-(1H-indazol-5-ylamino)-2-morpholinopyrimidin-4-yl)benzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182867 N-(6-(2-(4-Methoxybenzyloxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145981748 4-[4-(2-chlorophenyl)-1H-pyrazol-5-yl]benzene-1,2,3-triol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:86766346 US8765940, 5'-chloro-1'-(7-fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133337 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-(dimethylamino)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403555 5-(3-(((2R,6S)-2,6-dimethyltetrahydro-2H-pyran-4-yl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284461 1'-(5,7-Difluoro-3-methyl-2-(1-piperazinyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258995 2-Amino-8-cyclopentyl-6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168281083 5-[4-Morpholin-4-yl-6-[[4-(trifluoromethyl)cyclohexyl]amino]-1,3,5-triazin-2-yl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950347 3-(Morpholin-4-ylcarbonyl)-2,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70702029 4-[1-Methyl-4-(3-methylphenoxy)pyrazolo[3,4-d]pyrimidin-6-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:2898075 2-Oxo-1,2-diphenylethyl 4-fluorobenzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581008 [7-(butylamino)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162664475 2,4-difluoro-N-[2-methoxy-5-(4-thiomorpholin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44129272 (2S,4S)-1-N-[5-(2-tert-butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]-4-(dimethylamino)pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145988716 4-[4-(4-fluorophenyl)-1H-pyrazol-5-yl]benzene-1,2,3-triol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:127026225 2,4-difluoro-N-[5-[4-[3-[2-hydroxyethyl(methyl)amino]prop-1-ynyl]quinolin-6-yl]-2-methoxypyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785439 5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5'-fluoro-N-(6-methoxypyridin-3-YL)-3,3'-bipyridin-6-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578828 3-(Morpholin-4-ylcarbonyl)-1-[piperidin-3-yl]-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604527 [7-(3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-(3-methyl-4-methylsulfonylphenyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258868 2-amino-4-methyl-6-(2-oxo-1H-pyrimidin-5-yl)-8-propan-2-ylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876539 US11649227, Example 1 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436081 5-[7-(4-Methylpiperidin-4-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258881 8-Cyclopentyl-2-(ethylamino)-6-(3-methoxyphenyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436286 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1-methylcyclopropyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578659 1-(3-Bromophenyl)-3-(morpholin-4-ylcarbonyl)-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580746 (5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-[2-(hydroxymethyl)morpholin-4-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53323983 3-(6-Morpholino-2-(2-(pyridin-4-yl)ethylamino)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142580 N-[5-[2-[4-(4-acetylpiperazin-1-yl)-6-methylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56834970 [3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] 2-propylpentanoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:24889765 3-(2-Morpholin-4-yl-7-thiazol-2-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:13939417 3-(3,4-Dimethoxyphenyl)-7,8-dihydroxy-4H-1-benzopyran-4-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142718 1-methyl-N-[5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]pyrazole-4-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133321 tert-butyl N-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]-N-methylcarbamate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371673 N-[5-[7-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284809 1-(7-fluoro-3-methyl-2-(4-methyl-2-pyridinyl)-4-quinolinyl)-7-(4-morpholinyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]thiazine 4,4-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371654 2,4-difluoro-N-[2-methoxy-5-[7-[(3S)-3-methylmorpholin-4-yl]-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950264 [1-[3-(2-aminopyrimidin-5-yl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938949 4-(3,3-Dimethyl-6-(9H-purin-6-yl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436295 5-[7-[(3R,4S)-4-fluoropyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68353647 2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1,2,4]triazolo[5,1-d][1,5]benzoxazepine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436434 tert-butyl 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581228 1-(4-methoxyphenyl)-2-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950520 3-(Morpholin-4-ylcarbonyl)-1-(piperidin-4-ylmethyl)-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177563 5-(4-(Chroman-4-yl)-6-morpholinopyridin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032721 2-Amino-6-(6-ethoxypyridin-3-yl)-8-(4-hydroxycyclohexyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89646241 2-methoxy-5-[6-[(3S)-1-(2-morpholin-4-ylacetyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876383 US11649227, Example 233 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258854 8-Cyclopentyl-4-methyl-2-(methylamino)-6-(1-methylpyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133323 tert-butyl 3-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carbonyl]-3-fluoroazetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259001 2-amino-8-(4-hydroxycyclohexyl)-4-methyl-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52947556 N-(2-amino-5-(3-(3-cyanophenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)pyridin-3-yl)morpholine-4-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284636 1-(7-Fluoro-3-methyl-2-(3-pyridinyl)-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950868 [5,5-dioxo-1-phenyl-7-(trifluoromethyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184952 5-[7-(Methoxymethyl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52948541 N-(6-(3-fluorophenyl)-2-morpholinopyrimidin-4-yl)-1H-indazol-5-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436319 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(1R,2R)-2-fluorocyclopropyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133355 [(3S)-1-methylpyrrolidin-3-yl] (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:136214093 (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]-inden-4-yl)oxy)propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950519 [1-(cyclohexylmethyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436172 5-[7-[(3S)-1,3-dimethylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57391047 [3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] furan-2-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436693 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-(dimethylamino)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436262 Tert-butyl 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182146 N-(6-(2-benzylpyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436182 2-amino-1-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidin-1-yl]-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939469 US8765940, 4-(5-chloro-3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-3-methyl-2-(4-methyl-2-pyridinyl)-1,8-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436061 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-[(3R)-3-methylpyrrolidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371664 N-[5-[7-(2,6-dimethylmorpholin-4-yl)-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66717262 5-(2-(3-Methanesulfonyl-phenyl)-imidazo[2,1-b][1,3,4]thiadiazol-5-yl]-3-trifluoromethyl-pyridin-2-ylamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46868949 4-(3-Methoxyphenyl)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141617 N-[5-[2-[4-ethyl-6-(4-methylsulfonylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]-4-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258932 2-Amino-8-[(4-fluorooxan-4-yl)methyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876765 US11649227, Example 177 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032641 2-amino-N-(2-ethylpyrazol-3-yl)-4-methyl-7-oxo-8-propan-2-ylpyrido[2,3-d]pyrimidine-6-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580568 [1-[4-[(4-fluoropiperidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4747503 CHEMBL4747503 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4789380 CHEMBL4789380 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168430262 US11649227, Example 348 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548430 4-(2-(4-Fluorophenyl)-4-(6-methoxypyridin-3-ylamino)pyrimidin-5-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950826 [1-(3-methylsulfonylphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182871 N-(6-(2-(3-(Pyridin-4-yl)propoxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876254 US11649227, Example 38 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580667 [6-Fluoro-1-[(3R)-1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548204 N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)pyridin-2-yl)-2-methylbenzo[d]oxazol-5-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403540 N-methyl-5-(3-morpholino-5-(phenylsulfonyl)phenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580515 [7-methoxy-1-[(3R)-1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:24890804 6-(2-Morpholin-4-yl-7-pyridin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyridin-3-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:137646194 1-[(2-Hydroxynaphthalen-1-yl)-naphthalen-1-ylmethyl]pyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444345 5-[7-tert-butyl-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876285 US11649227, Example 305 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204369 (2R)-2-[[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]oxy]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580483 morpholin-4-yl-[1-[1-(oxan-4-yl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444379 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182710 N-(6-(2-(3-Methylphenylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436664 1-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71600530 2,2,2-trifluoro-1-[4-(7-phenyl-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl)phenyl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133329 tert-butyl (1R,5S)-6-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-azabicyclo[3.1.0]hexane-3-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284682 3-((4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-quinolinyl)-methyl)benzonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258955 8-cyclopentyl-4-methyl-2-(methylamino)-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56659711 N-methyl-N-propan-2-yl-4H-thieno[3,2-c]chromene-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4779034 CHEMBL4779034 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950225 [1-(4,4-difluorocyclohexyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56680202 N-(3-chloropyridin-4-yl)-N-methyl-8-(1H-pyrazol-4-yl)-4,5-dihydrothieno[3,2-d][1]benzoxepine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581188 N-[3-(morpholine-4-carbonyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-6-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581214 Morpholin-4-yl-[3-[1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-8,8-dioxo-8lambda6-thia-3,4,10-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:165430683 1-{(4S,11aM)-2-[(4R)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-L-prolinamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284542 1-(5,7-difluoro-3-methyl-4-(6'-(4-morpholinyl)-2,3,5,6-tetrahydrospiro[pyran-4,3'-pyrrolo-[3,2-b]pyridin]-1'(2'H)-yl)-2-quinolinyl)-2-piperidinone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436075 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2S)-2-methylazetidin-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436339 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methyl-2-(methylamino)propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258921 2-amino-4-methyl-8-(oxan-4-yl)-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869242 4-[4-(Hydroxymethyl)phenyl]-8-[2-methoxyethyl(methyl)amino]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:72950095 4-[[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]-N,N-dimethylpiperidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142313 N-[2-methoxy-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142717 N-[5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]pyridine-3-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46205037 3-(1-Methyl-6-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11559805 1-(2-Chloro-2-phenylethyl)-6-methylsulfanyl-4-pyrrolidin-1-ylpyrazolo[3,4-d]pyrimidine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57403282 [3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] propanoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869697 4-(3,5-Difluorophenyl)-8-[2-methoxyethyl(methyl)amino]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60148891 [3-(2,6-dimorpholin-4-yl-7H-purin-8-yl)phenyl]methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285085 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-(5-(methylsulfonyl)-3-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436356 (5R)-5-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carbonyl]pyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032309 2-Amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-4-methyl-6-(1-methylpyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580747 morpholin-4-yl-[1-[(3S)-1-(oxan-4-yl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748168 (2S)-1-N-[4-chloro-5-[2-(1-methylcyclopropyl)pyridin-4-yl]-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:86766418 4-chloro-N,N-bis[(4-methoxyphenyl)methyl]-6-methyl-1,3,5-triazin-2-amine;4-chloro-N-[(4-methoxyphenyl)methyl]-6-methyl-1,3,5-triazin-2-amine;2,4-dichloro-6-methyl-1,3,5-triazine;2,4,6-trichloro-1,3,5-triazine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580997 3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]-N-(oxan-4-yl)benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548162 4-(2-(5-Fluoro-6-methoxypyridin-3-ylamino)-6-(2-methoxyethoxy)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436402 ethyl 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2,2-dimethyl-3-oxopropanoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548305 4-(4-(6-Methoxypyridin-3-ylamino)-2-morpholinopyrimidin-5-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436325 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(3-hydroxycyclobutyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49786099 N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91935421 WmC20-NMeHA, 4 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604770 4-[7-(3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940109 6-Chloro-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2,3,8-trimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68353609 2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-c]pyrazole 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162658189 N-[(E)-1-(1-benzofuran-2-yl)ethylideneamino]-4-phenyl-1,3-thiazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:127029063 2-(2-aminopyrimidin-5-yl)-4-morpholin-4-yl-N-(1-oxidopyridin-1-ium-3-yl)quinazolin-7-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950477 [1-[2-(dimethylamino)ethyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91801268 3-N-[5-(2-tert-butylpyrimidin-4-yl)-1,3-thiazol-2-yl]-3-azabicyclo[3.1.0]hexane-2,3-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:135911765 US10172858, Table 2.18 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142318 2,4-difluoro-N-[2-methyl-5-[2-[4-methyl-6-[methyl(oxan-4-yl)amino]pyrimidin-5-yl]ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548397 4-(5-Chloro-2-(tetrahydro-2H-pyran-4-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581042 [5,5-dioxo-1-[3-(pyrrolidin-1-ylmethyl)phenyl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436488 [1-(aminomethyl)cyclopropyl]-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:246708 Desyl benzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876257 US11649227, Example 46 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177536 5-[4-(Benzenesulfonyl)-6-morpholin-4-ylpyridin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032464 2-Amino-8-[3-(2-hydroxyethoxy)cyclobutyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444407 5-[2-[(3R)-3-methylmorpholin-4-yl]-7-[(3S)-3-methylpyrrolidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52946229 N-(5-(3-acetyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyridin-3-yl)benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285758 3-(4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-fluoro-3-methyl-2-quinolinyl)benzonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876603 US11649227, Example 50 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436114 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-fluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580856 [5,5-dioxo-1-[(3S)-1-pyridin-3-ylpiperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285151 1-(7-Fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-thiopyran]1',1'-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142181 N-[2-methoxy-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]-5-methylfuran-2-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580383 (4-benzyl-1-methyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57390137 N-[(E)-1-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)butylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580492 [1-(3-anilinophenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023746 Imidazopyridine derivative, 7a 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285276 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-3-methyl-2-phenyl-1,8-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "CHEBI:76288 2,6-diaminotoluene 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548326 4-(2-Methoxy-4-(6-methoxypyridin-3-ylamino)pyrimidin-5-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204821 4-(2-Propan-2-yl-1,2,4-triazol-3-yl)-12-pyrrolidin-1-yl-9-oxa-3,6,13-triazatricyclo[8.4.0.02,6]tetradeca-1(14),2,4,10,12-pentaene 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436083 5-[7-[(3S)-1-(2,2-difluoroethyl)-3-methylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436332 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2S)-3,3-dimethylazetidin-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444349 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylpyrrolidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:164627711 N-[2-methoxy-5-(7-methyl-4-thiophen-2-ylthieno[3,2-d]pyrimidin-6-yl)pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58379484 3-methyl-1-(oxan-4-yl)-8-(1H-pyrazol-5-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:2762944 Ethyl 2-morpholinoisonicotinate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444350 5-[7-[1-(cyclopropylmethylsulfonyl)azetidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785519 N-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-[(4-methylsulfonylpiperazin-1-yl)methyl]pyridin-2-yl]-1,3-benzothiazol-6-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58379494 1-[1-(2-Hydroxyacetyl)piperidin-4-yl]-8-(2-methoxyphenyl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258897 2-Amino-6-(5-fluoro-6-methoxypyridin-3-yl)-4-methyl-8-(oxan-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581101 [1-[4-[[2-methoxyethyl(methyl)amino]methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581201 [(3S)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidin-1-yl]-(oxan-4-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204871 12-Methoxy-4-(2-propan-2-yl-1,2,4-triazol-3-yl)-9-oxa-3,6,13-triazatricyclo[8.4.0.02,6]tetradeca-1(14),2,4,10,12-pentaene 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168430258 US11649227, Example 324 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258988 2-Amino-6-(4-fluorophenyl)-8-(2-hydroxy-2-methylpropyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53162188 N-(2-Phenylethyl)-2-[5-(quinolin-6-YL)-1,3,4-oxadiazol-2-YL]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284487 1'-(2-(3,5-Difluorophenyl)-3-methyl-1,8-naphthyridin-4-yl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581054 [6-fluoro-1-[(3S)-1-(oxan-4-yl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876637 US11649227, Example 343 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444391 tert-butyl 3-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]sulfonylazetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122179716 2-morpholin-4-yl-4-oxo-N-(pyridin-3-ylmethyl)pyrido[1,2-a]pyrimidine-9-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258820 2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-(2,2,2-trifluoroethyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70702030 Methyl 3-(1-methyl-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-6-yl)benzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032797 2-amino-8-(4-hydroxy-4-methylcyclohexyl)-4-methyl-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950351 [1-[3-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44457192 [(1S,3aR,6E,9S,9aR,10R,11aS)-6-[[2-(dimethylamino)ethyl-ethylamino]methylidene]-1,5-dihydroxy-9-(methoxymethyl)-9a,11a-dimethyl-4,7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-h]isochromen-10-yl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:127033266 2-[[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]-N,N-dimethylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032718 2-Amino-6-(2,3-dihydro-1,4-benzodioxin-6-yl)-8-(4-hydroxycyclohexyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177451 7-(3-((4-fluorobenzyl)sulfonyl)-5-morpholinophenyl)-2H-benzo[b][1,4]oxazin-3(4H)-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436677 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2S)-1-methylazetidin-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604658 1-(4-{[7-(1-methyl-1H-indazol-6-yl)-2,3-dihydro-1,4-benzoxazepin-4 (5H)-yl]carbonyl}phenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68774589 [7-(3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-(2-chloro-4-methylsulfonylphenyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71813983 N-[6-[6-amino-5-(trifluoromethyl)pyridin-3-yl]quinazolin-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548461 (6-(6-methoxypyridin-3-ylamino)-5-(2-methyl-9H-purin-6-yl)pyridin-3-yl)(4-(methylsulfonyl)phenyl)methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436308 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylazetidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444343 5-[7-[1-(2-methoxyethylsulfonyl)azetidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548219 N-(5-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580803 [6-fluoro-1-[(3S)-1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168278361 N-[5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzoxazol-2-yl]-2-methylpropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258922 2-amino-8-cyclobutyl-4-methyl-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436383 [(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(azetidin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403577 5-(3-(Benzylsulfonyl)-5-morpholinophenyl)-4-(trifluoromethyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436024 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1-hydroxycyclobutyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436725 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1-methylazetidin-3-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285064 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-3-methyl-2-(4-methyl-2-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444358 [(2S)-2-hydroxypropyl] 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184945 5-[7-(Aminomethyl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876409 US11649227, Example 237 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580650 [3-(hydroxymethyl)piperidin-1-yl]-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548199 4-(5-Chloro-2-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-YL)-N-(2-methoxyethyl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580418 [6-chloro-1-(oxan-4-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258916 3-[2-Amino-6-(6-methoxy-pyridin-3-yl)-4-methyl-7-oxo-7H-pyrido[2,3-d]pyrimidin-8-yl]pyrrolidine-1-carboxylic acid tert-butyl ester 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580485 (5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-(2-methylmorpholin-4-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141899 N-[2-methoxy-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]-2-(trifluoromethoxy)benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938826 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-3-methyl-2-(2-(methylsulfonyl)phenyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60163476 3-[[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]-N,N-dimethylbenzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42645771 (2S)-1-N-[5-[2-(1-cyanocyclopropyl)pyridin-4-yl]-4-methyl-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580854 [1-[3-[(4-fluoropiperidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579058 [1-(4-fluorophenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:166594437 5-[4-[[(4R)-3,4-dihydro-2H-chromen-4-yl]sulfonyl]-6-morpholin-4-ylpyridin-2-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436168 2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methylbutan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580921 [1-[(3S)-1-[2-(3-fluoroazetidin-1-yl)ethyl]piperidin-3-yl]-6-methoxy-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436124 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2S)-oxolan-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:124169215 CID 124169215 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578947 [1-(4-chlorophenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548269 4-(5-Fluoro-2-(5-fluoropyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57399764 [3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] butanoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578706 [1-(2-methoxyethyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604531 2,2,2-trifluoro-1-[4-[7-(1H-indazol-6-yl)-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl]phenyl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258993 2-Amino-8-cyclopentyl-6-(4-hydroxy-3-methoxyphenyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548257 2-(6-(6-Amino-2-methylpyrimidin-4-yl)-5-(5-fluoro-6-methoxypyridin-3-ylamino)pyrazin-2-yl)propan-2-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939208 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-8-fluoro-3-methyl-2-(2-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:73351941 N-methyl-2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydropyrazolo[1,5-d][1,4]benzoxazepine-9-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145991719 2-(3,4-Dichlorophenyl)-1-(2,3,4-trihydroxyphenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580798 [5,5-dioxo-1-[(3S)-1-pyridin-4-ylpiperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579022 8-Bromo-3-(morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258862 8-Cyclopentyl-2-(ethylamino)-6-(3-hydroxyphenyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869243 8-(Dimethylamino)-4-[3-(hydroxymethyl)phenyl]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4740055 CHEMBL4740055 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133344 ethyl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950521 [4-(cyclopropylmethyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162647972 N-[5-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]thieno[2,3-d]pyrimidin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258870 2-amino-8-cyclopentyl-4-methyl-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581011 [7-fluoro-1-[(3S)-1-(2-morpholin-4-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168292710 5-[4-Morpholin-4-yl-6-(4-propan-2-ylpiperazin-1-yl)-1,3,5-triazin-2-yl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118321319 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL1914740 CHEMBL1914740 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436271 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(3S)-3-fluoropyrrolidin-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44343745 4-[(4-Sulfamoylphenyl)methylsulfanylmethyl]benzoic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177546 5-(3-Morpholino-5-((4-morpholinophenyl)sulfonyl)phenyl) pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:72549793 CID 72549793 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258824 4-methyl-2-(methylamino)-8-(oxolan-3-ylmethyl)-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184939 5-(4-Morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122179489 Methyl 3-(6-methoxypyridin-3-yl)-5-[[4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]anilino]methyl]benzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580484 [6-fluoro-5,5-dioxo-1-[1-(oxolan-3-ylmethyl)pyrrolidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548477 5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N2-cyclopentyl-N4-(6-methoxypyridin-3-yl)pyrimidine-2,4-diamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436179 methyl 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168285521 1-(4-Fluorophenyl)-2-methyl-8-(1-methylpyrazol-4-yl)imidazo[4,5-c]quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:166035155 US11649227, Example 169 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436362 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methoxyethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876557 US11649227, Example 238 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436277 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2S)-pyrrolidin-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444348 5-[7-[1-(3-Methoxypropylsulfonyl)azetidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436252 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(3S)-oxolan-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:43845722 6-(2,6-dimethylmorpholin-4-yl)-N-(3-methoxyphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11460586 N-butyl-1-[(E)-styryl]pyrazolo[3,4-d]pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284589 1'-(5,7-Difluoro-3-methyl-2-(4-methyl-2-pyridinyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436164 5-[7-[(1S,5R)-3-azabicyclo[3.1.0]hexan-6-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548337 (S)-4-(2-(6-Chloro-5-methoxypyridin-3-ylamino)-5-((2-methyl-4-(methylsulfonyl)piperazin-1-YL)methyl)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940454 US8765940, 6-chloro-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2-(2-methoxyphenyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785919 4-(2-(5-Fluoro-6-Methoxypyridin-3-Ylamino)-5-(2,2,2-Trifluoro-1-(4-(Methylsulfonyl)Piperazin-1-yl)Ethyl)Pyridin-3-yl)-6-Methyl-1,3,5-Triazin-2-Amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52948997 3-(6-(1H-indazol-5-ylamino)-2-((2S,6R)-2,6-dimethylmorpholino)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91935423 WmC20-pro, 1 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:86664281 4-(5-bromo-3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444353 Methyl 2-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-2-methylpropanoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748171 (1S,5R)-2-N-[5-[2-(diethylamino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-yl]-2-azabicyclo[3.1.0]hexane-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4791961 CHEMBL4791961 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939597 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]-pyridin-1-yl)-5,7-difluoro-3-methyl-2-(2-phenylethyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258896 2-Amino-6-(2-aminopyridin-3-yl)-8-cyclopentyl-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444406 5-[2-[(3R)-3-methylmorpholin-4-yl]-7-(1-propan-2-ylsulfonylazetidin-3-yl)-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580673 [1-(4-methylcyclohexyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258877 2-amino-4-methyl-8-(oxolan-3-ylmethyl)-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436025 2-Amino-1-[3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidin-1-yl]-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142843 N-[5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44578074 (R)-2-(3-benzylmorpholino)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436459 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1,2-dimethylazetidin-2-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141898 N-[2-methyl-5-[2-[4-methyl-6-[methyl(oxolan-3-ylmethyl)amino]pyrimidin-5-yl]ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59251938 N-[6-(2-aminopyrimidin-5-yl)-1,3-benzothiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869633 8-(4-Acetylpiperazin-1-yl)-4-(3-hydroxyphenyl)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168293937 (2S)-1-[2-[(3S)-3-methoxy-2-oxopyrrolidin-1-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182024 N-(6-(2-(3-Methoxypropoxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168430260 US11649227, Example 328 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25172061 N-[(E)-(5-ethenylpyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939731 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-(1-methyl-1H-indol-5-yl)-quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548442 4-[2-[(5-Fluoro-6-methoxypyridin-3-yl)amino]-6-(morpholin-4-ylmethyl)pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53326551 3-(6-Morpholino-2-(pyridin-2-ylmethoxy)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580844 [6-fluoro-1-(oxan-4-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876747 US11649227, Example 251 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436273 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(3R)-3-fluoropyrrolidin-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258985 8-Cyclopentyl-6-(4-hydroxy-3-methoxyphenyl)-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162643012 2,4-difluoro-N-[2-methoxy-5-[4-(4-methyl-3-oxopiperazin-1-yl)thieno[2,3-d]pyrimidin-6-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580740 morpholin-4-yl-[1-[(4R)-1-(oxan-4-yl)azepan-4-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580742 morpholin-4-yl-[1-[(4S)-1-(oxan-4-yl)azepan-4-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436516 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950229 [1-[3-[(dimethylamino)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580627 [1-[(3S)-1-(1-methylpiperidin-3-yl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876348 US11649227, Example 299 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436275 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939593 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-((E)-2-phenylethenyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580680 [1-[4-(2-methyl-1-morpholin-4-ylpropan-2-yl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60143107 N-[5-[2-(2-amino-4-ethyl-6-piperidin-1-ylpyrimidin-5-yl)ethynyl]-2-methylpyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876754 US11649227, Example 51 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436104 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(3-hydroxy-3-methylazetidin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60148890 3-(2,6-dimorpholin-4-yl-7H-purin-8-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177466 (R)-4-methyl-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52941280 N-(6-(3-methoxyphenyl)-2-morpholinopyrimidin-4-yl)-1H-indazol-5-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244510 4-[4-(3-Methoxyphenyl)-7-pyridin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-2-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146263372 [6-(1H-indazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950387 (7-methoxy-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:24890272 4-[4-(3H-benzimidazol-5-yl)-7-pyridin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-2-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:72947195 N-[5-[2-amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-4-methyl-7-oxopyrido[2,3-d]pyrimidin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25183031 N-{6-[2-(Methylsulfanyl)pyrimidin-4-Yl]-1,3-Benzothiazol-2-Yl}acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580665 [1-[4-[(dimethylamino)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939340 4-(7-fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6-(4-morpholinyl)-3,4-dihydro-2H-1,4-benzoxazine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141053 1-methyl-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]pyrazole-4-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141477 N-[5-[2-[4-(4-acetylpiperazin-1-yl)-6-methylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580308 [1-[4-(2-methylphenyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142846 2,5-dimethyl-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]thiophene-3-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258999 2-Amino-6-bromo-4-methyl-8-(4-oxocyclohexyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548251 (R)-4-(2-(6-chloro-5-methoxypyridin-3-ylamino)-5-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032308 2-amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-4-methyl-6-(1H-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177403 (R)-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)-6-(trifluoromethyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258984 6-(6-Methoxypyridin-3-yl)-4-methyl-2-(methylamino)-8-(oxolan-3-ylmethyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581202 morpholin-4-yl-[1-[3-(1,2,4-oxadiazol-3-yl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403560 N-cyclopropyl-5-(6-morpholino-4-(phenylsulfonyl)pyridin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403566 5-(3-Morpholino-5-((4-(trifluoromethyl)phenyl)sulfonyl)phenyl) pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444403 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403545 Tert-butyl 3-((3-(5-aminopyrazin-2-yl)-5-morpholinophenyl)sulfonyl)azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580861 [1-[3-[(3,3-difluoropiperidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444342 5-[7-[1-(1-methylimidazol-4-yl)sulfonylazetidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869090 4-(3-Hydroxyphenyl)-8-(2-methoxyethoxy)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580618 3-(Morpholin-4-ylcarbonyl)-1-[1-(2-morpholin-4-ylethyl)piperidin-3-yl]-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548331 4-(4-(6-Methoxypyridin-3-ylamino)-2-(piperidin-1-yl)pyrimidin-5-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548309 4-(2-((5-Fluoro-6-methoxy-3-pyridinyl)amino)-5-((4-(methylsulfonyl)-1-piperazinyl)carbonyl)-3-pyridinyl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580349 [1-[4-[1-(dimethylamino)-2-methylpropan-2-yl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403583 5-(3-Morpholino-5-((3-(trifluoromethyl)phenyl)sulfonyl)phenyl) pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:51357945 N-(6-(2-(3-Methylbenzyloxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580902 morpholin-4-yl-[1-[(3S)-1-(oxan-4-ylmethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580807 [6-fluoro-1-[1-[2-(oxan-4-yl)ethyl]pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371656 2,4-difluoro-N-[2-methoxy-5-[7-(4-methoxypiperidin-1-yl)-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436159 2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-hydroxy-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580837 morpholin-4-yl-[3-[(3S)-1-(oxan-4-ylmethyl)piperidin-3-yl]-8,8-dioxo-8lambda6-thia-3,4,10-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177396 7-(3-((4-fluorobenzyl)sulfonyl)-5-morpholinophenyl)-3,4-dihydro-2H-benzo[b][1,4]oxazine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876223 US11649227, Example 349 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168276353 (2S)-1-[2-(2-oxo-1,3-oxazinan-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258878 2-Amino-6-(2-methoxypyrimidin-5-yl)-4-methyl-8-propan-2-ylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44608268 N-[2-chloro-5-(1,7-naphthyridin-6-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580828 morpholin-4-yl-[1-[1-[2-(oxan-4-yl)ethyl]piperidin-4-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258958 2-Amino-8-cyclopentyl-6-(3-fluoro-4-methoxyphenyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57900475 2-[2-[2-(Dimethylamino)ethyl]-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938717 2-(2,5-difluorophenyl)-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-fluoro-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950785 morpholin-4-yl-[1-[4-(morpholin-4-ylmethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204997 (2s)-2-({2-[1-(Propan-2-Yl)-1h-1,2,4-Triazol-5-Yl]-5,6-Dihydroimidazo[1,2-D][1,4]benzoxazepin-9-Yl}oxy)propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548375 N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)pyridin-2-yl)-2-methylquinolin-6-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580729 (7-bromo-1-cyclohexyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285584 1'-(7-Fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridin]-5'-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:45263535 2-[3-(6-Morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl)phenoxy]acetic acid;hydrochloride 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939475 1-(7-Fluoro-3-methyl-2-(2-(methylsulfonyl)phenyl)-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580565 [1-[3-(2-methylphenyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876395 US11649227, Example 301 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580598 [5,5-dioxo-1-(3-pyridin-3-ylphenyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168295037 Tert-butyl 4-[4-(2-amino-1,3-benzothiazol-6-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284411 1-(6-chloro-2,3-dimethyl-4-quinolinyl)-6-(1H-pyrazol-4-yl)-1H-indole-4-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258869 2-Amino-6-bromo-8-(2-hydroxy-2-methylpropyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46940004 2,2,2-trifluoro-1-[4-[7-(2-methyl-3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl]phenyl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436117 2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidin-1-yl]-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53318704 6-(1H-indazol-4-yl)-2-morpholino-N-(2-(pyridin-4-yl)ethyl)pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59251763 N-[6-(6-amino-5-methylpyridin-3-yl)-1,3-benzothiazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133322 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(2-fluoroazetidin-2-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436419 2-amino-1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548475 4-(2-(6-Methoxypyridin-3-ylamino)-5-(pyridazin-4-yl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548172 4-((5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)methyl)-N,N-dimethylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548451 6-(2-((5-fluoro-6-methoxy-3-pyridinyl)amino)-5-((1R)-1-(4-(methylsulfonyl)-1-piperazinyl)ethyl)-3-pyridinyl)-2-methyl-4-pyrimidinamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869636 4-(3-Hydroxyphenyl)-2-morpholin-4-yl-8-(1-naphthyl)pyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141475 N-[5-[2-(4-ethyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]-2-methoxypyridin-3-yl]cyclopropanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436344 [(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(3-hydroxyazetidin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285295 1'-(5-Fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444373 5-[7-(2-Methylpentan-2-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436398 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3,3,3-trifluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284692 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo-[3,2-b]pyridin-1-yl)-3-methyl-2-(2-pyridinyl)-1,8-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580613 (3-methoxypiperidin-1-yl)-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44592216 (2-((4-Fluoro-2-methylphenylamino)methyl)-6-morpholinopyridin-4-yl)methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403582 5-(3-Morpholino-5-(naphthalen-2-ylsulfonyl)phenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:126700983 (S)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]-inden-4-yl)amino)-2-cyclopropylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122185250 5-[7-(Methoxymethyl)-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)pyrrolo[2,1-f][1,2,4]triazin-2-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950866 (8,8-Dioxo-3-phenyl-8lambda6-thia-3,4,12-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70702026 4-[4-(4-Chlorophenoxy)-1-methylpyrazolo[3,4-d]pyrimidin-6-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71813982 N-[6-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-1,3-benzoxazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548445 4-(2-(3-Fluoro-4-methoxyphenylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258987 2-Amino-6-(6-chloropyridin-2-yl)-8-cyclopentyl-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244527 [3-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]phenyl]-(4-methylpiperazin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581240 [1-[3-[3-(methoxymethyl)-1,2,4-oxadiazol-5-yl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940455 US8765940, 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-6,8-dimethoxy-2,3-dimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44457183 [(1S,3aR,6E,9S,9aR,10R,11aS)-6-[[bis[3-(dimethylamino)propyl]amino]methylidene]-1,5-dihydroxy-9-(methoxymethyl)-9a,11a-dimethyl-4,7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-h]isochromen-10-yl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118321355 6-(6-Methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184940 5-(4-Morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869244 8-[2-Hydroxyethyl(methyl)amino]-4-[3-(hydroxymethyl)phenyl]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168293289 Methyl 4-[[[5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzoxazol-2-yl]amino]methyl]benzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578919 [1-(2-chlorophenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71042082 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,25,29-pentazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22(30),23,25,27-tetradecaen-14-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133343 ethyl (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032552 2-[3-[2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]cyclobutyl]oxyacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869696 8-Chloro-2-morpholin-4-yl-4-phenylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258926 2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-(2-methylpropyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145993781 4-[4-(3-chloro-4-fluorophenyl)-1H-pyrazol-5-yl]benzene-1,2,3-triol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580933 [1-[4-[(3,3-difluoropiperidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580920 [1-[4-[(3-methoxypyrrolidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581179 [1-[3-[[3-(3-methylbutoxy)pyrrolidin-1-yl]methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177502 (2-(2-Aminopyrimidin-5-yl)-6-morpholinopyridin-4-yl)(tetrahydrofuran-3-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177395 N,N-dimethyl-5-(3-morpholino-5-(phenylsulfonyl)phenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436508 (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N-ethyl-3-methylpyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580430 1-[3-(5-Ethyl-1,2,4-oxadiazol-3-yl)phenyl]-3-(morpholin-4-ylcarbonyl)-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581134 1-(3,3-difluoroazetidin-1-yl)-3-[(3S)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidin-1-yl]propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177527 6-(3-((2,4-Difluorobenzyl)sulfonyl)-5-morpholinophenyl)-5-methylpyridazin-3-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49786009 5-ethyl-N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581135 N-Methyl-3-(morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydrothiochromeno[4,3-c]pyrazol-6-amine 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876619 US11649227, Example 29 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258945 tert-butyl 3-[2-amino-4-methyl-7-oxo-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-8-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876339 US11649227, Example 4 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436097 5-[7-(3-aminocyclobutyl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548180 4-(4-(6-Methoxypyridin-3-ylamino)-2-(pyrrolidin-1-yl)pyrimidin-5-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436074 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2R)-2-methylazetidin-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258975 2-amino-8-(4-methoxycyclohexyl)-4-methyl-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444346 5-[7-(1-Bicyclo[1.1.1]pentanyl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950743 N-[3-(morpholine-4-carbonyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-8-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580931 [6-fluoro-1-[(3S)-1-[2-(oxan-4-yl)ethyl]pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032799 2-Amino-8-(4-hydroxycyclohexyl)-6-(2-methoxypyrimidin-5-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938951 1-(7-Fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-N-(2-methoxyethyl)-N,3,3-trimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-6-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444370 [(2S)-2-hydroxypropyl] 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581166 morpholin-4-yl-[1-[1-(oxetan-3-yl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76335666 3-(4-Thiomorpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444412 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3R)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2,2-dimethylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869169 8-[2-hydroxyethyl(methyl)amino]-4-(1H-indol-4-yl)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436029 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]butan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145990358 4-[4-(2-fluorophenyl)-1H-pyrazol-5-yl]benzene-1,2,3-triol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580347 [6-chloro-1-[(3R)-1-(2-morpholin-4-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258867 6-Bromo-4-methyl-2-(methylamino)-8-(oxolan-3-ylmethyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580704 N-cyclohexyl-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]pyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168287965 N-benzyl-5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578866 [1-(2-methylphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876533 US11649227, Example 288 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4799097 CHEMBL4799097 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284764 US8765940, methyl 4-(5,7-difluoro-3-methyl-4-(6'-(4-morpholinyl)-2,3,5,6-tetrahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridin]-1'(2'H)-yl)-2-quinolinyl)-1-piperazinecarboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436279 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]butan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548201 4-(2-((5-Fluoro-6-methoxypyridin-3-yl)amino)-5-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032800 8-(4-Hydroxycyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89896458 2-[[4-(3-hydroxyphenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]-N,N-dimethylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938603 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-5,7-difluoro-3-methyl-2-(1-piperidinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:72550013 (S)-5-(4-(3-methylmorpholino)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91801269 (2R)-2-methyl-1-N-[5-[2-(1-methylcyclopropyl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71600386 2,2,2-trifluoro-1-[4-(7-naphthalen-2-yl-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl)phenyl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168679611 US20230286960, Example 425 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950432 [1-[(4-methoxyphenyl)methyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876282 US11649227, Example 126 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52946248 3-(2-Morpholino-6-(pyridin-3-ylmethylamino)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032885 2-Amino-8-(4-hydroxycyclohexyl)-4-methyl-6-(1-methylpyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032305 2-Amino-6-[6-(dimethylamino)pyridin-3-yl]-8-[4-(2-hydroxyethoxy)cyclohexyl]-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580774 [1-[(3S)-1-[2-(2,2-dimethylmorpholin-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876280 US11649227, Example 296 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:77390362 US8841288, CL27e 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258893 2-amino-8-[(1R,3S)-3-hydroxycyclopentyl]-4-methyl-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876212 US11649227, Example 236 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258963 2-Amino-6-bromo-8-(trans-4-hydroxycyclohexyl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:87057956 [5,5-dioxo-1-[1-[4,4,4-trifluoro-3-(trifluoromethyl)butyl]piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436382 2-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-N-methylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548400 5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N4-(6-methoxypyridin-3-yl)-N2,N2-dimethylpyrimidine-2,4-diamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580508 [3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]cyclohexyl]-piperidin-1-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436432 (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylpyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876753 US11649227, Example 212 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444401 1-[3-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-3-methoxypropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578583 (1-benzyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52941331 3-(6-(Methylamino)-2-morpholinopyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:24889090 3-[7-(2-Methyl-pyridin-4-yl)-2-morpholin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580601 [1-[1-(3,3-dimethylbutyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:18766055 Imidazopyridine derivative, 8h 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580354 [5,5-dioxo-1-[3-(pyrazol-1-ylmethyl)phenyl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436149 5-[7-[(3S)-1-(5,5-dimethyl-4H-1,3-oxazol-2-yl)-3-methylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44436964 N''-(benzo[c]isoxazol-3-ylmethylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581181 [8-methoxy-1-[1-(2-morpholin-4-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70695401 N-[(E)-[1-[(3-fluorophenyl)methyl]indol-3-yl]methylideneamino]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436072 1-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70702032 4-[1-Methyl-6-(3-methylsulfanylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284979 1-(5,7-difluoro-3-methyl-4-(6-(4-morpholinyl)-2',3',5',6'-tetrahydrospiro[indole-3,4'-pyran]-1(2H)-yl)-2-quinolinyl)-2(1H)-pyridinone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869444 4-(3-Hydroxyphenyl)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785170 N-(5-((4-methoxybenzyloxy)methyl)-3-(2-methyl-9H-purin-6-yl)pyridin-2-yl)-1H-indol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436191 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(3R)-oxolan-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60161905 3-[[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122658900 4-[[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]-N,N-dimethylthiophene-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258989 2-Amino-8-cyclopentyl-6-(2-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876288 US11649227, Example 93 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436211 tert-butyl(3S)-3-{4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258826 8-cyclopentyl-2-(ethylamino)-4-methyl-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:22519935 (1-methyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:166035247 US11649227, Example 107 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578720 [1-[3-(2-methoxyethoxy)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581195 [1-[(3R)-1-(2-imidazol-1-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940453 6-chloro-4-(3,3-dimethyl-6-(4-pyridinyl)-2,3-dihydro-1H-indol-1-yl)-2,3-dimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436154 [3-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidin-1-yl]-(1-methylcyclopropyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580548 3-(Morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548178 5'-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(6-methoxypyridin-3-yl)-2,3'-bipyridin-6'-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285370 US8765940, 8-chloro-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2,3-dimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580581 morpholin-4-yl-[1-[4-(2-morpholin-4-ylpropan-2-yl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548381 5-chloro-N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876215 US11649227, Example 61 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155544033 N-[2-methoxy-5-[4-(2-piperidin-1-ylethylamino)quinazolin-6-yl]pyridin-3-yl]cyclopropanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:124169513 (2S)-1-[2-[(4R)-4-methyl-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581104 [1-[(3S)-1-(2-imidazol-1-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580859 [1-[3-(methoxymethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876434 US11649227, Example 105 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168290644 6-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzothiazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:166035089 US11649227, Example 222 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122658945 1-[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]-1,4-diazepan-5-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371676 2,4-difluoro-N-[2-methoxy-5-[4-(4-methoxypiperidin-1-yl)thieno[2,3-d]pyrimidin-6-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784793 1-[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]pyrrolidin-3-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122185249 5-[7-(methoxymethyl)-4-[(3R)-3-methylmorpholin-4-yl]pyrrolo[2,1-f][1,2,4]triazin-2-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940224 US8765940, 6-chloro-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-3-methyl-2-(trifluoromethyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50908576 3-(2,6-Dimorpholinopyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71814140 N-[6-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-1-methylbenzimidazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581232 morpholin-4-yl-[1-[6-(morpholin-4-ylmethyl)pyridin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:136214094 US10065970, Example 247 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548357 4-(5-(Difluoromethoxy)-2-(6-methoxypyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436700 5-[7-(3-methylazetidin-3-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436186 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2S)-azetidin-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876454 US11649227, Example 310 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42646254 (2S)-1-N-[5-(2-tert-butylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122185248 5-[7-(methoxymethyl)-4-[(3S)-3-methylmorpholin-4-yl]pyrrolo[2,1-f][1,2,4]triazin-2-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444376 5-[7-(1-Dimethylphosphorylazetidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4781697 CHEMBL4781697 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548469 4-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[[(3S)-3-methylmorpholin-4-yl]methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436367 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-(dimethylamino)-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950865 (1,1-dioxo-1,4-thiazinan-4-yl)-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436395 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxy-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52947387 3-(6-(1H-indazol-5-ylamino)-2-morpholinopyrimidin-4-yl)benzonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580666 (5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-(3-methylmorpholin-4-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76317570 N-[5-(7-amino-1-cyclopropyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580547 [7-fluoro-1-[(3S)-1-[2-(4-methoxypiperidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938719 1-(7-Fluoro-3-methyl-2-(3-(methylsulfonyl)phenyl)-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580832 [6-fluoro-5,5-dioxo-1-[1-(oxolan-3-ylmethyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142716 N-[5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]thiophene-2-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4760118 CHEMBL4760118 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:51357947 N-(6-(2-(4-Methylbenzyloxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91801267 1-N-[5-(2-tert-butylpyrimidin-4-yl)-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444394 5-[7-(3-Methyl-1-methylsulfonylazetidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46941036 2-(3,4-Dimethoxy-phenyl)-5-(6-methoxy-pyridin-3-yl)-6-methyl-imidazo[2,1-b][1,3,4]thiadiazole 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162645185 N-[5-[6-[(4-methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]-4-(trifluoromethyl)pyridin-2-yl]prop-2-enamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444337 5-[7-[(3R)-3-methyl-1-methylsulfonylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244873 3-(2-Morpholin-4-yl-7-pyridin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-phenylamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869088 8-Chloro-4-(3-hydroxyphenyl)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869513 8-(Dimethylamino)-4-[4-fluoro-3-(hydroxymethyl)phenyl]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259008 8-cyclopentyl-4-methyl-2-(methylamino)-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285241 1-(4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-quinolinyl)-2-pyrrolidinone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46337946 2-{[2-(1,3-Benzodioxol-5-YL)-7-oxo-6,7-dihydropyrazolo[1,5-A][1,3,5]triazin-4-YL]sulfanyl}-N-isopropylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784896 N-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-[(4-methylsulfonylpiperazin-1-yl)methyl]pyridin-2-yl]-1,3-benzoxazol-6-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68267665 [1-(1-azabicyclo[2.2.2]octan-3-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939990 1-(6-chloro-2,3-dimethylquinolin-4-yl)-6-(1H-pyrazol-4-yl)-1H-indole-3-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42646990 (2S)-4,4-difluoro-1-N-[4-methyl-5-[2-(1-methylcyclopropyl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:592738 2-(4-Chlorophenyl)-1-(2,4,6-trihydroxyphenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436052 tert-butyl 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpiperidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548325 N-((6-(6-methoxypyridin-3-ylamino)-5-(2-methyl-9H-purin-6-yl)pyridin-3-yl)methyl)pyridazin-3-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548354 1-(6-(6-Amino-2-methylpyrimidin-4-yl)-5-(6-methoxypyridin-3-ylamino)pyrazin-2-yl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436717 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-cyclopropylethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70702033 N-[3-(1-methyl-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-6-yl)phenyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284743 1-(7-fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-7-(4-morpholinyl)-2,3-dihydro-1H-pyrido[2,3-b][1,4]thiazine 4,4-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444344 oxetan-3-yl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548362 4-(4-(6-Methoxypyridin-3-ylamino)-2-(pyridin-4-yl)pyrimidin-5-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145990785 7,8-Dihydroxy-3-[4-(trifluoromethyl)phenyl]chromen-4-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133340 (1-aminocyclobutyl)-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52944867 N-(2-morpholino-6-phenylpyrimidin-4-yl)-1H-indazol-5-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52914958 6-fluoro-3-(morpholine-4-carbonyl)-1-[(3R)-1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-1H,4H-5lambda6-thiochromeno[4,3-c]pyrazole-5,5-dione 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244242 N-methyl-3-(2-morpholin-4-yl-7-pyridin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876373 US11649227, Example 335 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76332054 3-Chloro-5-(6-morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436055 5-[7-[1-(azetidin-1-ylsulfonyl)azetidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436073 (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N-tert-butyl-3-methylpyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162655468 N-[5-[4-(2,6-dimethylmorpholin-4-yl)thieno[2,3-d]pyrimidin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11202301 4-[2-(2,5-dimethoxyanilino)-2-oxoethoxy]-N-(3-fluorophenyl)naphthalene-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548345 4-(2-(6-Chloropyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580761 morpholin-4-yl-[1-[(3R)-1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950228 [1-(3-fluorophenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145949910 6-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]hexanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940458 US8765940, 6-chloro-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-methoxy-2,3-dimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580682 [1-[1-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436549 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(1R)-2,2-difluorocyclopropyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580795 [5,5-dioxo-1-[(3S)-1-(pyridin-3-ylmethyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42633904 [3-(5-Methyl-4-morpholin-4-yl-5H-pyrrolo[3,2-d]pyrimidin-2-yl)phenyl]methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60143108 N-[5-[2-(4-ethyl-6-piperidin-1-ylpyrimidin-5-yl)ethynyl]-2-methylpyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580640 [1-(4-tert-butylcyclohexyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258831 2-Amino-6-(5-fluoro-6-methoxypyridin-3-yl)-8-(4-methoxycyclohexyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869443 4-(3-Hydroxyphenyl)-8-(methylamino)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032716 2-Amino-6-[6-(dimethylamino)pyridin-3-yl]-8-(4-hydroxycyclohexyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436261 (2R)-2-amino-1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidin-1-yl]-3-methylbutan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581040 [1-[(1-methylpiperidin-4-yl)methyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44457189 [(1S,3aR,6E,9S,9aR,10R,11aS)-6-[[2-(diethylamino)ethyl-ethylamino]methylidene]-1,5-dihydroxy-9-(methoxymethyl)-9a,11a-dimethyl-4,7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-h]isochromen-10-yl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444384 5-[7-(3-Methyl-1-propan-2-ylsulfonylazetidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60143109 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]propane-2-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876239 US11649227, Example 57 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122178118 2,4-difluoro-N-[2-methoxy-5-(5-methyl-4-pyridin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258889 5-[2-Amino-8-(4-hydroxycyclohexyl)-4-methyl-7-oxopyrido[2,3-d]pyrimidin-6-yl]pyridine-2-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142317 2-chloro-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177522 4-(3-((4-Fluorobenzyl)sulfonyl)-5-(5-methoxypyridin-3-yl)phenyl)morpholine 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4783036 CHEMBL4783036 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66716981 2-(3,4-Dimethoxy-phenyl)-5-[6-(4-methyl-piperazin-1-yl)-5-trifluoromethyl-pyridin-3-yl]-imidazo[2,1-b][1,3,4]thiadiazole 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53321327 6-(1H-indazol-4-yl)-2-morpholino-N-(2-(pyridin-3-yl)ethyl)pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57900132 2-[4-(2-Chlorophenyl)-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244337 [4-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyridin-2-yl]-(4-methylpiperazin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259015 2-Amino-8-cyclopentyl-6-(2-methoxypyrimidin-5-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:2823822 4-Morpholin-4-yl-pyrido[3'',2'':4,5]thieno[3,2-d]pyrimidine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548323 N-[3-(2-methyl-7H-purin-6-yl)-5-[(4-methylsulfonylphenyl)methyl]pyridin-2-yl]-1H-indazol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155566417 6-(6-methoxy-5-nitropyridin-3-yl)-N-(2-piperidin-1-ylethyl)quinazolin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023748 Imidazopyridine derivative, 7c 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58881857 1-Ethyl-3-[3-(4-ethylanilino)pyrido[2,3-b]pyrazin-6-yl]urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52945072 1-(4-(3-methoxyphenylamino)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)piperidin-4-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548338 [(3S)-1-[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]pyrrolidin-3-yl]methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580710 [1-[1-[2-[(3R)-3-fluoropyrrolidin-1-yl]ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133319 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-[(1S,4S,5S)-2-methylsulfonyl-2-azabicyclo[2.1.1]hexan-5-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444354 5-[7-[(3S)-1-dimethylphosphorylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44600808 3-{7-[2-(dimethylamino)ethyl]-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436115 (5S)-5-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carbonyl]pyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162653557 N-[5-[4-(1,3,3a,4,6,6a-hexahydrofuro[3,4-c]pyrrol-5-yl)thieno[2,3-d]pyrimidin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940221 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2,3-dimethyl-8-(trifluoromethyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4759873 CHEMBL4759873 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177532 -(3-((2,4-Difluorobenzyl)sulfonyl)-5-morpholinophenyl)pyridin-3-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53326947 4-(6-(1H-indazol-4-yl)-2-(pyridin-2-ylmethoxy)pyrimidin-4-yl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436019 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2R)-2-methylazetidin-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:126700523 US10065970, Example 315 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548438 (5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)(4-hydroxypiperidin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548261 4-(2-(5-Fluoropyridin-3-ylamino)-6-methylpyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444327 [2-(methylamino)-2-oxoethyl] 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258863 2-amino-6-(2-methoxypyrimidin-5-yl)-4-methyl-8-(tetrahydro-2H-pyran-4-yl)pyrido-[2,3-d]pyrimidin-7(8H)-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876652 US11649227, Example 302 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142046 N-[2-Methoxy-5-(4-methyl-6-morpholin-4-yl-pyrimidin-5-ylethynyl)-pyridin-3-yl]-thiophene-2-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876670 US11649227, Example 76 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548295 N-(5-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-chloropyridin-2-ylamino)pyridin-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141474 N-[5-[2-(4-ethyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]-2-methoxypyridin-3-yl]-2-methoxyethanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71042059 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,24,25,28-hexazahexacyclo[20.5.2.12,6.19,13.117,21.025,29]dotriaconta-1(28),2(32),3,5,9,11,13(31),17(30),18,20,22(29),23,26-tridecaen-14-one 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4753136 CHEMBL4753136 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938830 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-2-(3,5-dimethylphenyl)-7-fluoro-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:136179636 4-(6-Morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl)phenol;hydrochloride 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581222 [1-[(3-methoxyphenyl)methyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938721 6-(4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-3-methyl-2-quinolinyl)-2(1H)-pyridinone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581143 N-(2-methoxyethyl)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285744 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-2-(3-fluorophenyl)-3-methyl-1,8-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436316 1-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444329 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3R)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N-methylpyrrolidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580622 [5,5-dioxo-1-[4-[(oxolan-3-ylamino)methyl]phenyl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:73052343 2,4-difluoro-N-[2-methoxy-5-[4-(3-morpholin-4-ylprop-1-ynyl)quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4874628 CHEMBL4874628 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182144 N-(6-(2-(2-Morpholinoethoxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4851911 CHEMBL4851911 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939214 US8765940, 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-3-methyl-2-(4-methyl-2-pyridinyl)-1,7-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950522 3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91801266 1-N-[5-[4-methylsulfonyl-3-(2-propyl-3H-pyrrol-3-yl)phenyl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284688 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-2-(3-methoxybenzyl)-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258959 2-Amino-8-(2-cyclopropylethyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436015 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxy-2-methylbutan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284939 1'-(5,7-Difluoro-3-methyl-2-(4-(methylsulfonyl)piperazin-1-yl)quinolin-4-yl)-6'-morpholino-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436638 (2R)-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxy-3-methylbutan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285595 1'-(5,7-Difluoro-2-(2-methoxy-4-pyridinyl)-3-methyl-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro-[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032801 2-(Ethylamino)-6-(5-fluoro-6-methoxypyridin-3-yl)-8-(4-hydroxycyclohexyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580801 1-[3-(5-Methyl-1H-1,2,4-triazol-3-yl)phenyl]-3-(morpholin-4-ylcarbonyl)-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876723 US11649227, Example 20 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548388 4-[[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5-fluoro-6-oxo-1H-pyridin-3-yl)amino]pyridin-3-yl]methyl]-N,N-dimethylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76328381 3-Bromo-5-(6-morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142713 2,4-difluoro-N-[2-methyl-5-[2-[4-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869574 4-(3-Fluoro-5-hydroxyphenyl)-8-methylsulfonyl-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25171644 N-[(E)-(5-methoxypyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548215 [1-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5-fluoro-6-methoxypyridin-3-yl)amino]pyridin-3-yl]-2-hydroxy-2-methylpropyl] 3-chlorobenzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133326 methyl (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950830 (4-methoxypiperidin-1-yl)-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244679 5-(2-Morpholin-4-yl-7-phenyl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548306 1-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5-fluoro-6-methoxypyridin-3-yl)amino]pyridin-3-yl]-2-methylpropane-1,2-diol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258894 2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-(oxan-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66610669 4-(2-(4-Fluoro-3-methoxyphenylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436352 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[1-(hydroxymethyl)cyclopropyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182023 N-(6-(2-(3-Phenylpropoxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579024 [5,5-dioxo-1-(2-phenylethyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939473 US8765940, 1-(6-chloro-2,3-dimethyl-4-quinolinyl)-6-(4-morpholinyl)-1H-indole-4-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:3100191 4-Morpholin-4-yl-2-phenylquinazolin-6-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436040 5-[7-[(1R,5S)-3-methylsulfonyl-3-azabicyclo[3.1.0]hexan-1-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11201062 Ethyl 2-[[2-[4-[(3-fluorophenyl)carbamoyl]naphthalen-1-yl]oxyacetyl]amino]acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177562 5-[3-[(4,4-Difluorocyclohexyl)methylsulfonyl]-5-morpholin-4-ylphenyl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784987 6-methoxy-N-(3-(2-methyl-9H-purin-6-yl)pyridin-4-yl)pyridin-3-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168296302 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-N-[(4-methoxyphenyl)methyl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60148889 [2-(2,6-dimorpholin-4-yl-7H-purin-8-yl)phenyl]methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436269 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2R)-1-methylazetidin-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876751 US11649227, Example 362 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950653 [1-(azepan-4-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59605041 [7-(3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-(4-ethylsulfonylphenyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548264 4-(2-(5-Chloro-6-methoxypyridin-3-ylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436233 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580412 tert-butyl 4-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]azepane-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581192 [5,5-dioxo-1-[(3R)-piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91897742 WmC20-cys, 3 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122178115 6-(2-Methoxypyrimidin-5-yl)-4-pyridin-4-ylthieno[2,3-d]pyrimidine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748115 (2S)-2-methyl-1-N-[5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58205017 (2S)-2-[[4-(2-propan-2-yl-1,2,4-triazol-3-yl)-9-oxa-3,6,13-triazatricyclo[8.4.0.02,6]tetradeca-1(14),2,4,10,12-pentaen-12-yl]oxy]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444378 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylazetidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46850921 4-[3-(Hydroxymethyl)phenyl]-8-[2-methoxyethyl(methyl)amino]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118617086 N-[2-chloro-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]-2-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258859 2-amino-4-methyl-6-(1H-pyrazol-4-yl)-8-(2,2,2-trifluoroethyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141051 N-[5-[2-[4-ethyl-6-(4-hydroxy-4-methylpiperidin-1-yl)pyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162672263 2,4-difluoro-N-[2-methoxy-5-[4-[(3R)-3-methylmorpholin-4-yl]thieno[2,3-d]pyrimidin-6-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66690290 N-[3-[5-[6-amino-5-(trifluoromethyl)pyridin-3-yl]imidazo[2,1-b][1,3,4]thiadiazol-2-yl]phenyl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91935422 6-(((11-hydroxy-4-(methoxymethyl)-4a,6a-dimethyl-5-(5-(methyl(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)pentanoyloxy)-2,7,10-trioxo-4,4a,6,6a,7,8,9,9a-octahydroindeno[4,5-h]isochromen-1(2H,5H,10H)-ylidene)methyl)(methyl)amino)hexanoic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580936 [1-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876654 US11649227, Example 117 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168430259 US11649227, Example 326 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44592261 2-((4-Fluoro-2-methylphenylamino)methyl)-6-(2-hydroxyethylamino)isonicotinic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580705 morpholin-4-yl-[1-[1-[2-(oxan-4-yl)ethyl]pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436302 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3,3,3-trifluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579065 morpholin-4-yl-(8-nitro-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182424 N-(6-(2-(2-Fluorophenylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548234 N-(5-fluoro-6-methoxypyridin-3-yl)-5-[(1S)-1-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]ethyl]-3-(2-methyl-7H-purin-6-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184944 5-(4-Morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl)-1,3-thiazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580811 [5,5-dioxo-1-[1-(oxolan-3-ylmethyl)pyrrolidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950740 N,N-dimethyl-3-(morpholine-4-carbonyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazole-8-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204405 4-(2-Propan-2-yl-1,2,4-triazol-3-yl)-9-oxa-3,6,13-triazatricyclo[8.4.0.02,6]tetradeca-1(14),2,4,10,12-pentaen-12-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032975 2-Amino-8-cyclopentyl-6-[6-(dimethylamino)-5-methylpyridin-3-yl]-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52936960 N-(5-(3-Phenylimidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91935419 11-Hydroxy-4-(methoxymethyl)-4a,6a-dimethyl-1-((methyl(pyridin-4-yl)amino)methylene)-2,7,10-trioxo-1,2,4,4a,5,6,6a,7,8,9,9a,10-dodecahydroindeno[4,5-h]isochromen-5-yl acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444339 [2-(Dimethylamino)-2-oxoethyl] 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950350 (8,8-Dioxo-3-phenyl-8lambda6,10-dithia-3,4-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,11-tetraen-5-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141476 N-[5-[2-[4-(4-acetyl-1,4-diazepan-1-yl)-6-methylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436127 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(3S)-oxolan-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68267651 2-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]pyrrolidin-1-yl]ethyl acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436078 2-amino-1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidin-1-yl]-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444362 (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylpyrrolidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444338 [2-(dimethylamino)-2-oxoethyl] 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580592 [1-(6-methoxypyridin-3-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258954 2-Amino-6-(5-aminopyrazin-2-yl)-8-cyclopentyl-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:90654214 8-[1-(2-hydroxyphenyl)triazol-4-yl]-2-morpholin-4-yl-2,3,4a,5,6,7,8,8a-octahydro-1H-quinolin-4-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142316 3-methoxy-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168297526 (2R,3R)-3-fluoro-1-[2-[(4S)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869164 4-(3-Fluoro-5-hydroxyphenyl)-8-(2-methoxyethoxy)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49786007 N-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-methylpyridine-2-YL)-1H-indazol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177500 5-(6-(2,6-Dimethylmorpholino)-4-(phenylsulfonyl)pyridin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023751 Imidazopyridine derivative, 8f 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876408 US11649227, Example 74 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168289451 5-[4-Morpholin-4-yl-6-[3-(trifluoromethyl)anilino]-1,3,5-triazin-2-yl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580645 [6-fluoro-1-[(3R)-1-[2-(oxan-4-yl)ethyl]pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444374 2-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-2-methylpropan-1-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939472 US8765940, 6-chloro-4-(4-methoxy-6-(4-morpholinyl)-1H-indol-1-yl)-2,3-dimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748113 (2S)-2-methyl-1-N-[4-methyl-5-(2-methylsulfanylpyrimidin-4-yl)-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91933687 (4aS,7R,12cS)-9-Bromo-7a,11-dihydroxy-4,4,7,12c-tetramethyl-1,2,3,4,4a,5,6,7,7a,12c-decahydro-8-oxa-dibenzo[a,h]azulen-10-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436207 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-methylbutan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133330 tert-butyl (2S,3S,4S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-2,4-dimethylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4750095 CHEMBL4750095 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580675 [1-[(3S)-1-[2-(3,3-difluoroazetidin-1-yl)ethyl]piperidin-3-yl]-7-methoxy-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580566 morpholin-4-yl-[8-(morpholin-4-ylmethyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436153 2-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-N,N-dimethylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42633906 {3-[5-methyl-4-morpholin-4-yl-7-(pyrrolidin-1-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidin-2-yl]phenyl}methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11653654 N-benzyl-6-methylsulfanyl-1-[(E)-styryl]pyrazolo[3,4-d]pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876295 US11649227, Example 19 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785254 4-Methyl-6-[5-methyl-2-(pyridin-3-ylamino)pyridin-3-yl]-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184943 4-[2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133349 tert-butyl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-ethylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581170 [5,5-dioxo-1-[3-(thiomorpholin-4-ylmethyl)phenyl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580534 [1-[(3S)-1-[2-(2-methylmorpholin-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940220 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2,3,8-trimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436051 2-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methylpropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42646003 (2S)-1-N-[5-[2-[1-(4-methoxyphenyl)cyclopropyl]pyridin-4-yl]-4-methyl-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141612 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]pyrrolidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950224 [8-(2-methoxyethylamino)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141335 N-[5-[2-[4-[4-(2-methoxyethyl)piperazin-1-yl]-6-methylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580982 (4-hydroxypiperidin-1-yl)-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436069 (2R)-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxy-3-methylbutan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436142 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N',3-dimethylpyrrolidine-1-carboximidamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436321 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2,2-dimethyl-3-(methylamino)propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581157 [7-fluoro-1-[4-(morpholin-4-ylmethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876214 US11649227, Example 298 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155528066 N-[2-methoxy-5-[4-(2-morpholin-4-ylethylamino)quinolin-6-yl]pyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42645769 (2S)-2-methyl-1-N-[4-methyl-5-[2-[1-(trifluoromethyl)cyclobutyl]pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784989 N-(6-methoxypyridin-3-yl)-3-(4-methyl-1,3,5-triazin-2-yl)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604899 [7-(6-aminopyridin-3-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-(4-methylsulfonylphenyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122185247 2-(2-aminopyrimidin-5-yl)-N,N-dimethyl-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazine-7-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444347 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-[1-(1-methylpyrazol-4-yl)sulfonylazetidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436530 3-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2,2-difluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436147 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580918 [5,5-dioxo-1-[(3S)-1-(pyridin-4-ylmethyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436388 Tert-butyl 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581069 [8-fluoro-1-[4-(morpholin-4-ylmethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258957 2-Amino-8-cyclopentyl-4-methyl-6-(1-methylpyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46941128 2-Amino-5-[2-(3,4-dimethoxy-phenyl)-imidazo[2,1-b][1,3,4]thiadiazol-5-yl]-nicotinonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436506 [(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-cyclobutylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950610 [5,5-dioxo-1-(oxolan-3-yl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580651 morpholin-4-yl-[1-[1-(oxan-4-yl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118321354 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548285 2-(5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)propan-1-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548391 4-(2-(2,2-Difluorobenzo[d][1,3]dioxol-5-ylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785168 N-(5-Chloro-3-(2-methyl-9H-purin-6-yl)pyridin-2-yl)-1H-indazol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580623 [1-[1-(2-methoxyethyl)azepan-4-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56683542 N-(3-chloropyridin-4-yl)-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:16456632 6-(2,6-dimethylmorpholin-4-yl)-1-methyl-N-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258839 2-Amino-6-[6-(dimethylamino)pyridin-3-yl]-8-(4-methoxycyclohexyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023747 Imidazopyridine derivative, 7b 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580848 [1-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285666 1-(5,7-difluoro-3-methyl-4-(6'-(4-morpholinyl)-2,3,5,6-tetrahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridin]-1'(2'H)-yl)-2-quinolinyl)-2-pyrrolidinone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53387575 N-[2-chloro-5-([1,2,4]triazolo[4,3-a]pyridin-6-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142579 2,4-difluoro-N-[2-methyl-5-[2-[4-methyl-6-[methyl(propan-2-yl)amino]pyrimidin-5-yl]ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60148769 [5-[2,6-bis[(3S)-3-methylmorpholin-4-yl]-7H-purin-8-yl]-2-methoxyphenyl]methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50908575 3-(6-(4-Hydroxycyclohexylamino)-2-morpholinopyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444395 N-[2-[3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-2-oxoethyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118616929 N-[2-chloro-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258947 2-Amino-6-bromo-4-methyl-8-(oxolan-2-ylmethyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580659 1-[2-[(3S)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidin-1-yl]ethyl]pyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580634 1-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]pyrrolidin-1-yl]-2-(oxan-4-yl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258933 2-Amino-6-(6-aminopyrazin-2-yl)-8-cyclopentyl-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580697 [1-[1-(2-hydroxyethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939861 4-(1-(5,7-difluoro-3-methyl-2-(1-phenylvinyl)quinolin-4-yl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-6-yl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244888 3-(2-Morpholin-4-yl-7-pyridin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142180 3,5-difluoro-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70685462 1-[3-(Benzenesulfonyl)quinoxalin-2-yl]piperidin-4-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869166 8-(dimethylamino)-4-(1H-indol-4-yl)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581183 [1-[(3S)-1-[2-(3-methoxyazetidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259020 6-(6-Chloropyridin-3-yl)-8-cyclopentyl-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548210 4-(2-(3,4-Dimethoxyphenylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:16222322 4-(6-(1H-indol-6-yl)-2-(pyridin-2-ylmethoxy)pyrimidin-4-yl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285125 1-(6-Chloro-7-methoxy-2,3-dimethyl-4-quinolinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran]-6-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436542 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-(azetidin-1-yl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444357 5-[7-(1-dimethylphosphorylazetidin-3-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436190 methyl 2-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methylpropanoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548389 2-(5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)-2-methylpropan-1-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580994 [5,5-dioxo-1-piperidin-3-yl-7-(trifluoromethoxy)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436327 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1-methylpyrazol-3-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436525 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-cyclopropylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436329 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-hydroxy-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580720 [5,5-dioxo-1-[1-(3-pyrrol-1-ylpropyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42644843 (2R)-1-N-[5-(2-tert-butylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]-2-(methoxymethyl)pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258998 4-methyl-2-(methylamino)-8-(oxolan-3-ylmethyl)-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:16645457 (2-Oxo-1,2-diphenylethyl) 3-fluorobenzoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11418543 4-(2-anilino-2-oxoethoxy)-N-(3-fluorophenyl)naphthalene-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950227 [1-(3,3-dimethylcyclohexyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44457195 [(1S,3aR,6E,9S,9aR,10R,11aS)-6-[[2-(dimethylamino)ethyl-methylamino]methylidene]-1,5-dihydroxy-9-(methoxymethyl)-9a,11a-dimethyl-4,7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-h]isochromen-10-yl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580749 morpholin-4-yl-[1-[(3R)-1-(oxan-4-yl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258990 2-Amino-8-[3-(2-hydroxyethoxy)cyclobutyl]-6-(2-methoxypyrimidin-5-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581152 1-[4-(morpholin-4-ylmethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazole-3-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436205 3-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2,2-dimethylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142042 5-Chloro-N-[2-methoxy-5-(4-methyl-6-morpholin-4-yl-pyrimidin-5-ylethynyl)-pyridin-3-yl]-thiophene-2-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141193 5-methyl-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]-1,2-oxazole-4-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436140 (2S)-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxypropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950265 [5,5-dioxo-1-(3-pyrrolidin-1-ylphenyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168280099 N-[5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzoxazol-2-yl]cyclohexanecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284771 1-(7-Fluoro-3-methyl-2-(4-pyridinyl)-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580353 [1-[3-(imidazol-1-ylmethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940456 8-chloro-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2,3,6-trimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4759620 CHEMBL4759620 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580964 [1-[3-(dimethylamino)propyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182711 N-(6-(2-(4-Methylphenylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939079 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-3-(1-methylethyl)-2-(2-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168295901 1-(4-Fluorophenyl)-8-(4-methoxyphenyl)-2-methylimidazo[4,5-c]quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581193 [1-[3-[3-[(dimethylamino)methyl]-1,2,4-oxadiazol-5-yl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141052 5-chloro-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]thiophene-2-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168281548 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-(2-hydroxyethyl)-2-methyl-4-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52948848 3-(4-(3-methoxyphenylamino)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)-N-methylbenzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869512 8-(2-Hydroxyethylamino)-4-[3-(hydroxymethyl)phenyl]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950481 morpholin-4-yl-[1-(oxan-4-ylmethyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11245521 4-[2-(dimethylamino)-2-oxoethoxy]-N-(3-fluorophenyl)naphthalene-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44436972 N,2-dimethyl-5-nitro-N''-(quinolin-4-ylmethylene)-benzenesulfonohydrazide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436253 [3-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-(1-methylcyclopropyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184948 N-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142973 2,4-difluoro-N-[2-methoxy-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133352 (3-methylazetidin-3-yl) (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581175 morpholin-4-yl-[1-[4-(morpholin-4-ylmethyl)cyclohexyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44180509 N-[3-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)phenyl]pyridine-3-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44457179 [(1S,3aR,6E,9S,9aR,10R,11aS)-1,5-dihydroxy-9-(methoxymethyl)-6-[[3-[4-(4-methoxyphenyl)piperazin-1-yl]propyl-methylamino]methylidene]-9a,11a-dimethyl-4,7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-h]isochromen-10-yl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876579 US11649227, Example 425 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580980 morpholin-4-yl-[1-[(3R)-1-(2-morpholin-4-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258974 2-Amino-8-cyclopentyl-6-[1-(2-hydroxy-2-methylpropyl)pyrazol-4-yl]-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548253 1-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-yl)pyridin-2-ylamino)pyridin-2-yl)-3-isopropylurea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580567 3-[3-(Morpholin-4-ylcarbonyl)-5,5-dioxidothiochromeno[4,3-c]pyrazol-1(4H)-yl]aniline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436360 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-hydroxy-2,2-dimethylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284766 1-(5,7-difluoro-3-methyl-4-(6'-(4-morpholinyl)-2,3,5,6-tetrahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridin]-1'(2'H)-yl)-2-quinolinyl)-2-azetidinone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869246 8-(2-Methoxyethylamino)-4-[3-(methoxymethyl)phenyl]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11609998 6-methylsulfanyl-1-[(E)-2-phenylethenyl]-4-piperidin-1-ylpyrazolo[3,4-d]pyrimidine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950394 (8,8-Dioxo-3-phenyl-8lambda6-thia-1,3,4,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),4,9,11-tetraen-5-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548380 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-[1-(4-methylsulfonylpiperazin-1-yl)cyclopropyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580840 [1-[1-[2-[(3R)-3-fluoropyrrolidin-1-yl]ethyl]pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371696 2,4-difluoro-N-[2-methoxy-5-[4-[(3S)-3-methylmorpholin-4-yl]thieno[2,3-d]pyrimidin-6-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444366 5-[7-[1-(1-Methylpyrazol-4-yl)sulfonylazetidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939346 6-(7-fluoro-3-methyl-4-(6-(4-morpholinyl)-2',3',5',6'-tetrahydrospiro[indole-3,4'-pyran]-1(2H)-yl)-2-quinolinyl)-2-pyridinol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950744 [3-(morpholine-4-carbonyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-8-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:72549326 N,N-dimethyl-4-[[4-[6-[(4-methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]phenyl]carbamoylamino]benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444410 tert-butyl (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3R)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950389 (1-cyclohexyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436701 N-[2-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-2-oxoethyl]propanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580662 [5,5-dioxo-1-[1-(2-phenylethyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142715 2,4-difluoro-N-[5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285077 1'-(3-Methyl-2-(2-pyridinyl)-1,7-naphthyridin-4-yl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]-pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118712010 6-(2-Methoxypyrimidin-5-yl)-4-methylpyrido[2,3-d]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785250 N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)-5-((pyridin-2-ylamino)methyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581103 [1-[(3S)-1-[2-(4-fluoropiperidin-1-yl)ethyl]pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580922 [1-[4-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950392 [1-(1H-indazol-5-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436192 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-oxopropanenitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145990081 4-[4-[4-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl]benzene-1,2,3-triol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118447156 N-[2-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-2-oxoethyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:24890625 3-(2-Morpholin-4-yl-7-phenyl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141757 N-[2-methyl-5-[2-[4-methyl-6-[(3R)-3-methylmorpholin-4-yl]pyrimidin-5-yl]ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940330 1-(6-chloro-2,3-dimethyl-4-quinolinyl)-6-(1H-pyrazol-4-yl)-1H-indol-4-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44426435 4-Morpholin-4-yl-2-phenyl-pyrido[3'',2'':4,5]furo[3,2-d]pyrimidine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59605039 1-(4-{[7-(1H-indazol-6-yl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl]carbonyl}-phenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876253 US11649227, Example 338 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58881819 1-Ethyl-3-[3-(4-methoxyanilino)pyrido[2,3-b]pyrazin-6-yl]urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580880 [5,5-dioxo-1-[3-(2-pyrazol-1-ylethoxy)phenyl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11405464 N-(3-fluorophenyl)-4-[2-(methylamino)-2-oxoethoxy]naphthalene-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436045 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3,3,3-trifluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168275240 5-(2-Aminopyrimidin-5-yl)-3-morpholin-4-yl-1-propylpyrazin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579020 (8-fluoro-1-methyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581005 [5,5-dioxo-1-[(3S)-1-(2-piperidin-1-ylethyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177506 Tert-butyl 4-(3-(2-aminopyrimidin-5-yl)-5-(phenylsulfonyl)phenyl)piperazine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258832 8-Cyclopentyl-6-(3-fluoropyridin-2-yl)-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436065 1-[3-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidin-1-yl]-2-hydroxy-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168282917 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-N-propan-2-yl-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939213 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-2-(5-fluoro-3-pyridinyl)-3-methyl-1,7-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939347 1'-(5,7-Difluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]-pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285405 4-(5-fluoro-2-(2-fluorophenyl)-3-methyl-4-quinolinyl)-6-(4-morpholinyl)-3,4-dihydro-2H-1,4-benzothiazine 1,1-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580743 [5,5-dioxo-1-(4-phenylphenyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580957 [5,5-dioxo-1-[(3S)-1-piperidin-3-ylpiperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56670031 N-methyl-N-(2-methylpropyl)-4H-thieno[3,2-c]chromene-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133339 (1-aminocyclopropyl)-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578873 3-(Morpholin-4-ylcarbonyl)-1-piperidin-4-yl-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436385 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444392 5-[7-(1-cyclopropylsulfonyl-3-methylazetidin-3-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581158 1-methyl-5-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]pyridin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168284942 (2S)-1-[2-(3-oxomorpholin-4-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66552348 N-[6-(2,4-dimethyl-1,3-thiazol-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950345 6-Methoxy-3-(morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580506 [6-fluoro-5,5-dioxo-1-[1-(2-pyrazol-1-ylethyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548343 2-(5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-6-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-YL)-2-methylpropanoic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71461427 N-[5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-chloropyridin-2-yl]amino]-2-chloropyridin-3-yl]-N-methylmethanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869165 4-(3-Fluoro-5-hydroxyphenyl)-8-(2-hydroxyethylamino)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177465 5-(3-((1-(4-Fluorobenzyl)azetidin-3-yl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145951752 6-(6-Methoxypyridin-3-yl)-4-methyl-8-(oxan-4-yloxy)quinazolin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581159 [1-[(3-ethyl-1,2,4-oxadiazol-5-yl)methyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436200 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methyl-2-(methylamino)propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580889 [1-[(3S)-1-(2-methoxyethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876344 US11649227, Example 111 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023745 Imidazopyridine derivative, 3 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939077 1-(7-Fluoro-3-methyl-2-(2-methyl-3-pyridinyl)-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032640 2-amino-4-methyl-7-oxo-8-propan-2-yl-N-(1H-pyrazol-5-yl)pyrido[2,3-d]pyrimidine-6-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876471 US11649227, Example 396 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122188274 N-[(E)-[5-(6-methoxypyridin-3-yl)pyrazolo[1,5-a]pyrimidin-3-yl]methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436043 (2R)-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxypropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950478 tert-butyl 4-{[3-(morpholin-4-ylcarbonyl)-5,5-dioxidothiochromeno[4,3-c]pyrazol-1(4H)-yl]methyl}piperidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869698 4-(3-Cyanophenyl)-8-(dimethylamino)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142714 N-[5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950352 [1-[3-(furan-3-yl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580878 [1-cyclohexyl-8-(2-methoxyethylamino)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436247 3-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2,2-dimethylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940105 7-chloro-9-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2,3-dihydro-1H-cyclopenta[b]quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177462 1-((4-(((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)methyl)phenyl) amino)-2-methylpropan-2-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938605 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5-fluoro-3,8-dimethyl-2-(2-pyridin-yl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168430256 US11649227, Example 45 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177454 1-Ethyl-3-(3'-((4-fluorobenzyl)sulfonyl)-3-methoxy-5'-morpholino-[1,1'-biphenyl]-4-yl)urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580944 [5,5-dioxo-1-[3-(piperidin-1-ylmethyl)phenyl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784796 N-(6-(4-(1H-indol-4-ylamino)pyridin-3-yl)-2-methylpyrimidin-4-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52943856 N-(5-(3-acetyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-2-aminopyridin-3-yl)morpholine-4-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403586 4-(3-(Benzylsulfonyl)-5-(2-methylimidazo[1,2-a]pyrimidin-6-yl)phenyl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581227 [4-fluoro-1-(oxan-4-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580352 morpholin-4-yl-[1-[1-(2-morpholin-4-ylethyl)piperidin-4-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548369 (R)-4-(2-(5-isopropyl-6-methoxypyridin-3-ylamino)-5-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52946467 2-(3-(6-(1H-indazol-5-ylamino)-2-morpholinopyrimidin-4-yl)phenoxy)ethanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548340 n-(5-Fluoro-6-methoxypyridin-3-yl)-3-(2-methyl-9h-purin-6-yl)-5-((r)-1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:2819874 3-(4-Chlorophenyl)-4-cyano-5-morpholin-4-ylthiophene-2-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581109 [5,5-dioxo-1-[(3S)-piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285432 1'-(2-(2,2-Dimethyl-4-morpholinyl)-5,7-difluoro-3-methyl-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:51357943 N-(6-(2-Phenethylpyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168272875 (2S)-1-[2-(3-oxo-1,4-oxazepan-4-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950741 [3-(morpholine-4-carbonyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-8-yl]-piperidin-1-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604689 [7-(3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-[4-(trifluoromethyl)phenyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53322641 6-(1H-indazol-4-yl)-2-morpholino-N-(2-(pyridin-2-yl)ethyl)pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60143106 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284649 1'-(3-Methyl-2-(pyridin-2-yl)-1,8-naphthyridin-4-yl)-6'-morpholino-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548370 N-(6-methoxypyridin-3-yl)-3-(2-methyl-7H-purin-6-yl)-5-morpholin-4-ylpyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548372 4-[2-[(6-methoxypyridin-3-yl)amino]-5-[[(3S)-3-methylmorpholin-4-yl]methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548425 N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-2-yl)isoquinolin-7-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168272706 Tert-butyl 4-[4-(2-amino-1,3-benzoxazol-5-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436449 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3,3,3-trifluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548387 N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)-5-(piperazin-1-ylmethyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133320 tert-butyl N-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]carbamate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436336 3-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2,2-difluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53326215 4-amino-N-(6-(dimethylamino)pyridin-3-yl)-2,7-dimethylquinazoline-8-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436456 5-[7-[3-(methylamino)cyclobutyl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:4583262 2-(4-Chlorophenyl)-1-(2,3,4-trihydroxyphenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580520 [1-[6-[(4-methylpiperazin-1-yl)methyl]pyridin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548455 N-(3-(6-amino-2-methylpyrimidin-4-yl)pyridin-4-yl)-1H-indazol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876292 US11649227, Example 82 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4745818 CHEMBL4745818 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938948 1-(7-fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-6-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578988 [1-(2-bromophenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168283841 (2S)-1-[2-[(5S)-2-oxo-5-(trifluoromethyl)pyrrolidin-1-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580757 [3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]cyclohexyl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580770 [1-[1-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581102 [1-[(3S)-1-[2-(3,3-difluoroazetidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580499 [1-(1-benzylpiperidin-3-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950307 [1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118712011 4-methyl-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579079 [1-(4-methylphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548401 4-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[(1R)-1-morpholin-4-ylethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71109676 2-amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-6-(1H-imidazol-5-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581034 Morpholin-4-yl-[3-[4-(morpholin-4-ylmethyl)phenyl]-8,8-dioxo-8lambda6-thia-3,4,10-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939595 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-(1-phenylcyclopropyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204549 (2S)-1-[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]azetidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436346 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-(3-methylpiperidin-3-yl)-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581204 methyl 5-[[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]methyl]furan-2-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604853 N-[3-[4-[4-(2,2,2-trifluoroacetyl)benzoyl]-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]phenyl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604870 2,2,2-trifluoro-1-[4-[7-(1H-pyrazol-4-yl)-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl]phenyl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:76321208 3-Fluoro-5-(6-morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444408 5-[2-[(3R)-3-methylmorpholin-4-yl]-7-[(3R)-3-methylpyrrolidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168296498 (3S)-4-[2-[(4S)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]morpholine-3-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436068 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2R)-oxolan-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444380 N-[2-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-2-methylpropyl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71037652 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(1-methylsulfonylpiperidin-4-yl)quinazolin-4-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580739 1-[(3S)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidin-1-yl]-2-(oxan-4-yl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285815 4-(5,7-difluoro-3-methyl-4-(6'-morpholino-2,3,5,6-tetrahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine]-1'(2'H)-yl)quinolin-2-yl)-N-methylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950828 (3-hydroxypiperidin-1-yl)-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:16456450 N-(3-methoxyphenyl)-1-methyl-6-morpholino-1H-pyrazolo[3,4-d]pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259003 2-amino-8-[(1R,3R)-3-hydroxycyclopentyl]-4-methyl-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548246 4-[2-[(5-Fluoro-6-methoxypyridin-3-yl)amino]-5-(morpholin-4-ylmethyl)pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168430261 US11649227, Example 342 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182565 N-(6-(2-Phenoxypyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548266 4-[5-(2-Aminopropan-2-yl)-2-[(5-fluoro-6-methoxypyridin-3-yl)amino]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177398 4-[3-[(4-Fluorophenyl)methylsulfonyl]-5-[3-(trifluoromethoxy)phenyl]phenyl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56680380 3-(benzenesulfonyl)-N-(3,5-dimethoxyphenyl)quinoxalin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939729 4-(6-(3,6-dihydro-2H-pyran-4-yl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:137641054 1-[(2,4-Dichlorophenyl)-(2-hydroxynaphthalen-1-yl)methyl]pyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580644 [6-fluoro-1-[(3S)-1-(oxan-4-yl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177463 5-(3-((1-Isopropylpiperidin-4-yl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444361 5-[7-[(3R)-3-methyl-1-methylsulfonylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580948 1-(3,3-difluoropyrrolidin-1-yl)-3-[(3S)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidin-1-yl]propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581197 [1-[1-[2-(3,3-difluoroazetidin-1-yl)ethyl]piperidin-3-yl]-6-fluoro-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177507 5-(3-(Phenylsulfonyl)-5-(piperidin-1-yl)phenyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548271 6-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[(1S)-1-morpholin-4-ylethyl]pyridin-3-yl]-2-methylpyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162659019 2,4-difluoro-N-[2-methoxy-5-[4-(4-methylpiperazin-1-yl)thieno[2,3-d]pyrimidin-6-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444389 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-(3-methyl-1-propan-2-ylsulfonylazetidin-3-yl)-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581169 [1-(3,5-dimethylcyclohexyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580577 [1-[(3S)-1-[2-(1-methylpiperidin-4-yl)oxyethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580800 [1-[4-(aminomethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578644 {4-[3-(morpholin-4-ylcarbonyl)-5,5-dioxidothiochromeno[4,3-c]pyrazol-1(4H)-yl]phenyl]methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:90664544 6-Morpholin-4-yl-4-[3-(2-morpholin-4-ylethoxy)phenyl]-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaene;dihydrochloride 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284684 1'-(3-Methyl-2-phenyl-1,8-naphthyridin-4-yl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53321743 2-morpholino-N-(4-(2-morpholino-4-oxo-4H-chromen-8-yl)-2-(2-(pyrrolidin-1-yl)ethoxy)phenyl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204388 (2S)-2-[[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]oxy]butanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177510 5-(3-(Benzylsulfonyl)-5-morpholinophenyl)pyrazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56676870 N-(2-methoxyphenyl)-N-methyl-4H-thieno[3,2-c]chromene-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436512 (3-aminooxolan-3-yl)-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578934 [1-(4-methoxyphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258853 2-amino-4-methyl-8-propan-2-yl-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141050 N-[5-[2-[2-amino-4-ethyl-6-(4-hydroxy-4-methylpiperidin-1-yl)pyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876522 US11649227, Example 245 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436758 ethyl 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methyl-3-oxopropanoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579030 4-(Methoxymethyl)-3-(morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydropyrazolo[4,3-c][1,2]benzothiazine 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580658 [1-[(3S)-1-[2-[2-methoxyethyl(methyl)amino]ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59251849 N-[6-(6-aminopyridin-3-yl)-1,3-benzothiazol-2-yl]-4-piperidin-1-ylbutanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89896555 3-[[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]-N,N-dimethylthiophene-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876695 US11649227, Example 265 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436317 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1H-pyrazol-4-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436640 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N-tert-butyl-3-methylpyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436532 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(3-fluoroazetidin-3-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258884 2-amino-8-[4-[(2S)-2,3-dihydroxypropoxy]cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122188258 N-[(E)-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-N-methyl-4-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876380 US11649227, Example 380 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:87057951 [1-[1-(2-fluoroethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141616 N-[5-[2-[4-(4-methoxypiperidin-1-yl)-6-methylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436309 5-[7-(1-cyclobutylsulfonylazetidin-3-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:68295238 2-[[4-(5-hydroxypyridin-3-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]-N,N-dimethylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44610008 N-(2-chloro-5-(1,8-naphthyridin-3-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436404 (1-aminocyclopropyl)-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938828 5-chloro-4-(1-(7-fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-pyrimidinamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581083 [1-[3-[(4-methoxypiperidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950566 [1-[2-(1-methylpyrrolidin-2-yl)ethyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580727 [5,5-dioxo-1-(2-pyridin-2-ylethyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:91935420 11-Hydroxy-4-(methoxymethyl)-4a,6a-dimethyl-1-((methyl(pyridin-4-yl)amino)methylene)-2,7,10-trioxo-1,2,4,4a,5,6,6a,7,8,9,9a,10-dodecahydroindeno[4,5-h]isochromen-5-yl 5-(methyl(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)pentanoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118796655 (5,5-Dioxo-1-phenyl-4,9b-dihydrothiochromeno[4,3-c]pyrazol-1-ium-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444334 2-(Methylsulfamoylamino)ethyl 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548413 4-Methyl-6-(2-(5-methylpyridin-3-ylamino)pyridin-3-yl)-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580616 [1-[1-(3-methoxypropyl)azepan-4-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71717423 N-cyclohexyl-N-methyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436156 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methylpropan-2-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141334 N-[2-methyl-5-[2-[4-methyl-6-(propan-2-ylamino)pyrimidin-5-yl]ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580676 8-Methyl-3-(morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436372 (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylpyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:14201550 (1S)-2-(3-phenylpropoxy)-1-[(2R)-piperidin-2-yl]ethanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444411 tert-butyl 3-[4-(2-aminopyrimidin-5-yl)-2-[(3R)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950267 [5,5-dioxo-1-(3-pyridin-4-ylphenyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44180851 3-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)-N-pyridin-2-ylbenzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:9934678 Imidazopyridine derivative, 4 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:127032676 3-N-[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]-1-N-methylbenzene-1,3-diamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580967 [1-[(3S)-1-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938604 4-(3,3-dimethyl-6-morpholino-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-2-(pyridin-2-yl)quinoline-3-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548405 4-(5-((3-Amino azetidin-1-yl)methyl)-2-(6-methoxypyridin-3-ylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244626 4-(4-Pyridin-3-yl-7-pyridin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-2-yl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118321328 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-2,4-difluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:45254976 2-[4-[8-(2-Methoxypyrimidin-5-yl)-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]phenyl]-2-methylpropanenitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436721 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(1S,2S)-2-fluorocyclopropyl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436169 tert-butyl 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carbonyl]-3-fluoroazetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284609 1'-(7-Fluoro-3-methyl-2-(4-methyl-2-pyridinyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo-[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244245 2-Morpholin-4-yl-7-pyridin-4-yl-4-pyrimidin-5-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548287 6-(3-(5-Fluoro-6-methoxypyridin-3-ylamino)-6-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyrazin-2-yl)-2-methylpyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57398107 [3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] pyridine-4-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:71813984 N-[6-[6-amino-5-(trifluoromethyl)pyridin-3-yl]imidazo[1,2-a]pyrimidin-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876719 US11649227, Example 163 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580544 [1-[4-[(4-methoxypiperidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580805 [6-fluoro-1-[1-(oxan-4-yl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436657 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:8547141 N-Benzyl-1-methyl-6-(morpholin-4-YL)-1H-pyrazolo[3,4-D]pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784897 n-(6-Methoxypyridin-3-yl)-3-(2-methyl-9h-purin-6-yl)-5-((phenylamino)methyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581199 [1-[4-[(2-methylmorpholin-4-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177501 5-(6-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-4-(phenylsulfonyl)pyridin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122658866 3-(4-Amino-6-morpholin-4-yl-1,3,5-triazin-2-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177508 5-(3-Morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)pyrazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580790 [4-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]-piperidin-1-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141195 3,5-dimethyl-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]-1,2-oxazole-4-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52946107 N-(6-(3-chlorophenyl)-2-morpholinopyrimidin-4-yl)-1H-indazol-5-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284909 5'-Ethenyl-1'-(7-fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581176 [7-methoxy-5,5-dioxo-1-[(3S)-1-(oxolan-3-ylmethyl)piperidin-3-yl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950310 1-[4-[[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]methyl]piperidin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:51354025 N-(4-(2-Acetamidobenzo[d]thiazol-6-yl)pyrimidin-2-yl)-4-methoxybenzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:166035087 US11649227, Example 203 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939474 1-(6-Chloro-2,3-dimethylquinolin-4-yl)-6-morpholino-2',3',5',6'-tetrahydrospiro[indoline-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:86664280 5'-Bromo-1'-(7-fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436178 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-(4-methylpiperidin-4-yl)-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57391915 N-[(E)-(5-cyclopropylpyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142976 N-[5-[2-[4-ethyl-6-(4-methoxypiperidin-1-yl)pyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604449 2,2,2-trifluoro-1-[4-(7-pyridin-3-yl-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl)phenyl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60143110 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]cyclohexanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444397 methyl (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:20877967 N-(4-fluorophenyl)-N-methyl-4H-thieno[3,2-c]chromene-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032642 8-cyclopentyl-N-[(1-ethylpyrazol-4-yl)methyl]-4-methyl-2-(methylamino)-7-oxopyrido[2,3-d]pyrimidine-6-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52942609 3-(2-Morpholino-6-(phenylamino)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56834971 [3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] prop-2-enoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580624 [1-[3-[(3-methoxyazetidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:137648413 1-(6-Methyl-3-phenylsulfanylpyrido[2,3-b]pyrazin-7-yl)-3-phenylurea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032720 2-Amino-6-(5-fluoro-6-methoxypyridin-3-yl)-8-(4-hydroxycyclohexyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580677 [1-[3-[(4,4-difluoropiperidin-1-yl)methyl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244213 5-[7-[4-[(4-Methylpiperazin-1-yl)methyl]phenyl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53321330 N-(3-(6-morpholino-2-(2-(pyridin-4-yl)ethylamino)pyrimidin-4-yl)phenyl)methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950479 [5,5-dioxo-1-(oxolan-2-ylmethyl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950482 4-Benzyl-3-(morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285013 6-Bromo-1-(6-chloro-7-methoxy-2,3-dimethylquinolin-4-yl)-2',3',5',6'-tetrahydrospiro[indoline-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258906 8-Cyclopentyl-2-(ethylamino)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869302 8-[2-Hydroxyethyl(methyl)amino]-4-[3-(methoxymethyl)phenyl]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032553 2-[3-[2-Amino-6-(5-fluoro-6-methoxypyridin-3-yl)-4-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]cyclobutyl]oxyacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580891 [1-[(3R)-1-(2-methoxyethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436016 1-[3-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-2-hydroxy-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168295341 5-[4-(4-Ethylpiperazin-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444333 5-[2-[(3R)-3-methylmorpholin-4-yl]-7-[(3S)-1-methylsulfonylpyrrolidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184941 5-(4-Morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122184951 [2-(2-Aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444404 1-[3-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]sulfonylazetidin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:72549795 phenyl N-[5-[6-[(4-methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]-4-(trifluoromethyl)pyridin-2-yl]carbamate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748125 (2S,4R)-1-N-[5-(2-tert-butylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]-4-hydroxy-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:10271535 Imidazopyridine derivative, 8g 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4754818 CHEMBL4754818 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580996 [6-fluoro-1-[(3R)-1-(oxan-4-yl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25171853 N,2-dimethyl-5-nitro-N'-[(Z)-(5-oxopyrazolo[1,5-a]pyridin-3-ylidene)methyl]benzenesulfonohydrazide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133353 azetidin-3-yl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950699 N-[3-(morpholine-4-carbonyl)-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-8-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436454 (2R)-1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxypropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:77360819 US8841288, CL29a 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436674 5-[7-[(3S)-1,3-dimethylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182022 N-(6-(2-(Benzyloxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258879 2-amino-8-(2-hydroxy-2-methylpropyl)-4-methyl-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869168 4-(1H-indol-4-yl)-8-(2-methoxyethylamino)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258986 6-(2-Aminopyridin-3-yl)-8-cyclopentyl-2-(ethylamino)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436274 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methyl-3-oxopropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938606 5-chloro-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2-(2-fluorophenyl)-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950608 (3-Cyclohexyl-8,8-dioxo-8lambda6-thia-3,4,10-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876317 US11649227, Example 309 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284578 US8765940, 1'-(5,7-difluoro-3-methyl-2-(5-methyl-2-(methylsulfonyl)phenyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141901 N-[2-methoxy-5-(4-methyl-6-morpholin-4-yl-pyrimidin-5-ylethynyl)-pyridin-3-yl]-methylsulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548396 4-[2-[(5-Fluoropyridin-3-yl)amino]-5-(1-methylpyrazol-4-yl)pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444377 5-[7-(1-Methoxy-2-methylpropan-2-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141478 N-[2-methyl-5-[2-(4-methyl-6-piperidin-1-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548310 5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(2-methoxyethyl)-6-((6-methoxy-3-pyridinyl)amino)-3-pyridinecarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785922 4-(5-(Ethylsulfonyl)-2-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:16801460 N-(3-methoxyphenyl)-1-methyl-6-(piperidin-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785340 N-(3-(6-amino-2-methylpyrimidin-4-yl)pyrazin-2-yl)-1H-indazol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580446 (8,8-Dioxo-3-phenyl-8lambda6,12-dithia-3,4-diazatricyclo[7.3.0.02,6]dodeca-1(9),2(6),4,10-tetraen-5-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444387 1-[3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-3-methoxypropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182285 N-(6-(2-(Benzylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168276785 5-[4-(4-Methylsulfonylpiperazin-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436195 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]propan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53317512 2-Morpholino-6-(quinolin-3-ylamino)-4,5''-bipyrimidin-2''-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56834969 [3-(10-Morpholin-4-yl-1,6,11,13-tetrazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-12-yl)phenyl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258876 2-amino-4-methyl-8-(oxolan-3-ylmethyl)-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580628 [1-[(3S)-1-[2-(4-methoxypiperidin-1-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436112 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylpyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133331 tert-butyl (2R,3R,4R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-2,4-dimethylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25169784 N,2-dimethyl-5-nitro-N-[(E)-[5-(trifluoromethyl)pyrazolo[1,5-a]pyridin-3-yl]methylideneamino]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548333 N-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-[(4-methylsulfonylpiperazin-1-yl)methyl]pyridin-2-yl]-6-fluoro-1H-indazol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49666528 2-({4-[(3,4-dimethylphenyl)sulfonyl]piperazin-1-yl}methyl)-3-(4-ethylphenyl)-3H-imidazo[4,5-b]pyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580521 [1-[1-(2-methoxyethyl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548192 N-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-chloropyridin-2-ylamino)-2-methylpyridin-3-YL)methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258937 2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-(4-oxocyclohexyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168282983 (2S)-1-[2-(5,5-dimethyl-2,4-dioxoimidazolidin-1-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177390 5-(3-Morpholino-5-(phenylsulfonyl)phenyl)-4-(trifluoromethyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436323 5-{7-[(3S)-1-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)-3-methylpyrrolidin-3-yl]-2-(morpholin-4-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl}pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258911 2-Amino-8-cyclopentyl-6-[1-(2,2-difluoroethyl)pyrazol-4-yl]-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580649 3-(Morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydrothiochromeno[4,3-c]pyrazole-6-carboxamide 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:23630332 N-(6-(2-aminopyrimidin-5-yl)-2-morpholinopyrimidin-4-yl)quinolin-3-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204531 (2S)-1-[4-(2-propan-2-yl-1,2,4-triazol-3-yl)-9-oxa-3,6,13-triazatricyclo[8.4.0.02,6]tetradeca-1(14),2,4,10,12-pentaen-12-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444360 [(3S)-4-[4-(2-aminopyrimidin-5-yl)-7-(3,3-difluorocyclobutyl)-5,6-dihydropyrrolo[2,3-d]pyrimidin-2-yl]morpholin-3-yl]methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89896459 2-[[4-(3-hydroxyphenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]-N-methylacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89647123 2-methoxy-5-[6-[(3S)-1-(1-methylpiperidine-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950433 [1-(3-methoxypropyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876691 US11649227, Example 130 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52936737 N-(5-(Imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580772 [6-chloro-1-[1-[2-(oxan-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436111 5-[7-[(1S,5R)-3-azabicyclo[3.1.0]hexan-1-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118612873 Gilmelisib 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436214 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methyl-N-propan-2-ylpyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4788408 CHEMBL4788408 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44457185 [(1S,3aR,6E,9S,9aR,10R,11aS)-1,5-dihydroxy-9-(methoxymethyl)-9a,11a-dimethyl-6-[[methyl(3-morpholin-4-ylpropyl)amino]methylidene]-4,7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-h]isochromen-10-yl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876740 US11649227, Example 308 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950391 [1-(2,3-dihydro-1,4-benzodioxin-6-yl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66717007 5-[2-(4-Methoxy-phenyl)-imidazo[2,1-b][1,3,4]thiadiazol-5-yl]-3-trifluoromethyl-pyridin-2-ylamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142578 N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]-2-(trifluoromethyl)benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436288 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-[(3S)-3-methylpyrrolidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133350 (2-amino-2-methylpropyl) (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70691801 4-[3-(Benzenesulfonyl)quinoxalin-2-yl]morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548426 n5-(3-Methoxyphenyl)-n2-(6-methoxypyridin-3-yl)-3-(2-methyl-9h-purin-6-yl)pyridine-2,5-diamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876330 US11649227, Example 392 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548336 6-(2-((5-fluoro-6-methoxy-3-pyridinyl)amino)-5-((1R)-1-((2S)-2-methyl-4-(methylsulfonyl)-1-piperazinyl)ethyl)-3-pyridinyl)-2-methyl-4-pyrimidinamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60162169 4-(1H-indazol-4-yl)-6-morpholin-4-yl-N-phenyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444352 5-[7-(3-methyl-1-methylsulfonylpyrrolidin-3-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59259018 2-Amino-8-(2-hydroxy-2-methylpropyl)-4-methyl-6-quinolin-3-ylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:56670030 N-(3-fluorophenyl)-N-methyl-4H-thieno[3,2-c]chromene-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168293727 (2S)-1-[2-[(5R)-5-methyl-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42644363 (2S)-1-N-[5-[2-[benzyl(ethyl)amino]pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580588 (8-bromo-1-methyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156403597 5-(3-((1-Isopropylpyrrolidin-3-yl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine hydrochloride 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581053 tert-butyl 3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604532 1-[4-[7-(3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl]phenyl]-2,2,2-trifluoroethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44347797 (3R,10R,13E)-10-[(3-chloro-4-methoxyphenyl)methyl]-3-(2-methylpropyl)-16-[(1S)-1-(3-phenyloxiran-2-yl)ethyl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579103 (6-fluoro-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25033537 2-amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-4-methyl-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436284 5-[7-(1-Cyclobutylsulfonylazetidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444365 5-[7-[(3R)-1-dimethylphosphorylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177528 5-(4-(4-Chloro-3-(trifluoromethyl)phenoxy)-6-morpholinopyridin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578966 (6-bromo-1-methyl-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604432 4-[7-(3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl]-N-methylbenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548452 5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(5-fluoro-6-methoxypyridin-3-yl)-2,4'-bipyridin-6-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133348 tert-butyl (3S,4R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-4-fluoropyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580719 [5,5-dioxo-1-(1-phenylpiperidin-3-yl)-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748112 (2R)-1-N-[5-(2-tert-butylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]-2-[(dimethylamino)methyl]pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57900240 2-[1-(2-Chlorophenyl)tetrazol-5-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548229 5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6'-methoxy-N-(6-methoxypyridin-3-yl)-3,3'-bipyridin-6-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444210 4-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]pyrrolidin-3-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580776 [1-[(3S)-1-[2-(3-methylmorpholin-4-yl)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436536 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3,3,3-trifluoro-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258873 8-Cyclopentyl-6-(3-hydroxyphenyl)-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436021 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-[(2S)-2-methylazetidin-2-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444367 5-[7-[1-(1-Methylimidazol-4-yl)sulfonylazetidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53325282 4-(1H-indazol-4-yl)-6-morpholino-N-(2-(pyridin-4-yl)ethyl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133336 tert-butyl N-[1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]carbamate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162674531 2,4-difluoro-N-[2-methoxy-5-[4-(3-methoxyazetidin-1-yl)thieno[2,3-d]pyrimidin-6-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939341 4-(3,3-dimethyl-6-morpholino-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-N-(pyridin-2-yl)quinolin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436702 2-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938607 2-(3,5-bis(trifluoromethyl)phenyl)-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-5-fluoro-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44242233 N-[4-(2-chlorophenyl)-5-(9-oxa-3-thia-14-azatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaen-4-yl)-1H-imidazol-2-yl]acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579055 [1-(3-hydroxypropyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581151 (5,5-dioxo-1,6-diphenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580892 [1-[1-(2-chloroethyl)pyrrolidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604871 [7-(3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-(3-fluoro-2-methyl-4-methylsulfonylphenyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:70702024 4-(1-Methyl-4-phenylmethoxypyrazolo[3,4-d]pyrimidin-6-yl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258885 2-Amino-8-(2-aminoethyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436470 tert-butyl 2-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carbonyl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:145950273 N-[6-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-6-oxohexyl]-N'-[4-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-4-oxobutyl]butanediamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42643633 (2S,4S)-1-N-[5-(2-tert-butylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]-4-fluoropyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4166142 CHEMBL4166142 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:11331051 (3R,10R,13E,16S)-10-[(3-chloro-4-methoxyphenyl)methyl]-3-(2-methylpropyl)-16-[(E,2R)-4-phenylbut-3-en-2-yl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436243 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581154 N,N-dimethyl-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580311 [1-[1-(3-methoxypropyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548339 2-(5-(6-Amino-2-methylpyrimidin-4-yl)-6-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)propan-2-ol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66578566 [1-(2-methylpropyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436534 (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methyl-N-propan-2-ylpyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168285939 8-(4-Chlorophenyl)-1-(4-fluorophenyl)-2-methylimidazo[4,5-c]quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580595 [1-[6-[(4-fluoropiperidin-1-yl)methyl]pyridin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580679 [6-chloro-1-[(3S)-1-(2-morpholin-4-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52937063 5-(3-Morpholinoimidazo[1,2-a]pyridin-6-yl)-3-(morpholinosulfonyl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122178117 N-[2-methoxy-5-(4-pyridin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444405 N-[2-[3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidin-1-yl]-2-oxoethyl]-2-methylpropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436229 [(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(1-hydroxycyclobutyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580573 [1-[1-(3-methylbutyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258942 8-Cyclopentyl-2-(ethylamino)-6-(4-hydroxy-3-methoxyphenyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141192 N-[5-[2-[4-ethyl-6-(4-hydroxypiperidin-1-yl)pyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436401 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-1-methylpyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258880 2-amino-4-methyl-8-(oxolan-2-ylmethyl)-6-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581057 [3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]-piperidin-1-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939339 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-fluoro-2-(2-fluorophenyl)-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155549676 5-[4-[2-(Dimethylamino)ethylamino]quinazolin-6-yl]-2-methoxypyridine-3-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581168 [6-fluoro-1-[(3S)-1-(oxan-3-yl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444390 5-[7-(3-methyl-1-methylsulfonylazetidin-3-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:45494812 N-(6-methylpyridin-2-yl)-5-((4-oxoquinazolin-3(4H)-yl)methyl)furan-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436417 (2R)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-fluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168276742 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-(2-hydroxyethyl)-2-[methyl-[3-(methylamino)propyl]amino]-4-nitrobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58881916 1-Ethyl-3-[3-(pyridin-3-ylamino)pyrido[2,3-b]pyrazin-6-yl]urea 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784990 N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-2-yl)-1H-indazol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580905 1-{4-[(3-Methylmorpholin-4-yl)methyl]phenyl}-3-(morpholin-4-ylcarbonyl)-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53322731 2-morpholino-N6-(6-phenoxypyridin-3-yl)-4,5''-bipyrimidine-2'',6-diamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168270582 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-N-[(4-propan-2-ylphenyl)methyl]-1,3-benzoxazol-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53323982 3-(6-Morpholino-2-(2-(pyridin-3-yl)ethylamino)pyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581124 [1-(1,3-benzothiazol-2-ylmethyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59604897 [7-(3H-benzimidazol-5-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-(4-methylsulfonylphenyl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:124169085 (2S)-1-[2-[(4S)-4-(fluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939470 1-(7-fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-5-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580686 morpholin-4-yl-[1-(3-morpholin-4-ylphenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580962 1-{3-[2-(1H-Imidazol-1-yl)ethoxy]phenyl}-3-(morpholin-4-ylcarbonyl)-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168679610 US20230286960, Example 244 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950308 morpholin-4-yl-[1-[3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785520 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(6-methoxypyridin-3-yl)quinolin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258971 2-Amino-8-cyclopentyl-6-(3-methoxyphenyl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89647180 2-Methoxy-5-{6-[(S)-1-(tetrahydro-pyran-4-carbonyl)-pyrrolidin-3-ylamino]-2,3-dihydro-benzo[1,4]oxazin-4-yl}-nicotinonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42644845 (2S)-1-N-[5-(2-tert-butylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]-2-(difluoromethyl)pyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436255 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3-methylbutan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258948 2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-(oxan-4-ylmethyl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50939733 2-benzyl-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436042 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(azetidin-3-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258851 2-amino-8-[(1R,3S)-3-hydroxycyclopentyl]-4-methyl-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869575 8-[2-(dimethylamino)ethyl-methylamino]-4-(1H-indol-4-yl)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57748173 (2S)-1-N-[5-[2-(diethylamino)pyridin-4-yl]-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146173541 5-(4-(Chroman-4-ylsulfonyl)-6-morpholinopyridin-2-yl)pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950268 N-[3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436729 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylazetidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580842 6-chloro-1-[(3R)-1-[2-(morpholin-4-yl)ethyl]piperidin-3-yl]-3-(morpholine-4-carbonyl)-1H,4H-5lambda6-thiochromeno[4,3-c]pyrazole-5,5-dione 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:57900198 4-[5-(2,4-difluorophenyl)-2H-triazol-4-yl]-9-oxa-3-thia-14-azatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaene-12-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89903188 4-[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:89996408 4-[[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]-N,N-dimethylcyclohexane-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938720 1-(7-Fluoro-2-(6-methoxy-2-pyridinyl)-3-methyl-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141902 N-[2-methoxy-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]-2-(trifluoromethyl)benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950867 N,N-Dimethyl-3-(morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydrothiochromeno[4,3-c]pyrazol-7-amine 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548447 4-[2-[(5-Fluoro-6-methoxypyridin-3-yl)amino]-6-(2,2,2-trifluoroethoxymethyl)pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4784118 CHEMBL4784118 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258823 6-[5-amino-6-[(2S)-2-aminopropoxy]pyrazin-2-yl]-8-cyclopentyl-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142452 2-methyl-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244739 4-[4-(3-hydroxyphenyl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-1H-pyridin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284882 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-(5-methyl-3-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436282 Tert-butyl 4-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-4-methylpiperidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371689 2,4-difluoro-N-[2-methoxy-5-(4-piperidin-1-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142848 N-[5-[2-[4-(dimethylamino)-6-ethylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]-4-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44180740 4-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)-N-pyridin-2-ylbenzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436162 (2S)-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxy-3-methylbutan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580426 (8,8-Dioxo-3-phenyl-8lambda6-thia-3,4,10-triazatricyclo[7.4.0.02,6]trideca-1(9),2(6),4,10,12-pentaen-5-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581189 [5,5-dioxo-1-[4-(pyrrolidin-1-ylmethyl)phenyl]-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950523 N-[[4-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]phenyl]methyl]methanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44600809 (3-{7-[2-(dimethylamino)ethyl]-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}phenyl)methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182868 N-(6-(2-(3-Methoxyphenylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284693 1'-(5,7-Difluoro-3-methyl-2-(2-(methylsulfonyl)phenyl)-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro-[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177517 4-(3-(2-Methoxypyrimidin-5-yl)-5-(phenylsulfonyl)phenyl)morpholine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49785081 N-(3-(2-methyl-9H-purin-6-yl)pyridin-4-yl)-1H-indazol-4-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182145 N-(6-(2-(3-Fluorobenzyloxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66579049 (7-amino-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "CHEMBL.COMPOUND:CHEMBL4757766 CHEMBL4757766 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244360 {4-[4-(2-Amino-pyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydro-pyrrolo[2,3-d]pyrimidin-7-yl]-3-fluoro-phenyl}-morpholin-4-yl-methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:42643892 (2S)-1-N-[5-[2-[2-(dimethylamino)ethyl-methylamino]pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168274763 (2S,3R)-3-methoxy-1-[2-[(4S)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581207 [1-[(3S)-1-(1-methylpiperidin-4-yl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548168 N5-(4-methoxybenzyl)-N2-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridine-2,5-diamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032554 2-[3-[2-Amino-6-(2-methoxypyrimidin-5-yl)-4-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]cyclobutyl]oxyacetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436059 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3,3,3-trifluoropropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444372 5-[7-(2-Methylbutan-2-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168283249 1-[4-[4-(2-Amino-1,3-benzoxazol-5-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436405 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2,2-dimethyl-3-oxopropanamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52937166 3,5-difluoro-N-[5-[3-(5-methyl-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950783 7-Bromo-3-(morpholin-4-ylcarbonyl)-1-phenyl-1,4-dihydrothiochromeno[4,3-c]pyrazole 5,5-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548386 4-(2-(5-Fluoro-6-methoxypyridin-3-ylamino)-5-(1-(4-(methylsulfonyl)phenyl)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436333 [(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(3-hydroxyazetidin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436166 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N',3-dimethylpyrrolidine-1-carboximidamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436203 (2S)-2-amino-1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-3,3,3-trifluoro-2-methylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444381 (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-sulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:58204526 9-Chloro-2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydro-[1,2,4]triazolo[1,5-d][1,4]benzoxazepine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122178114 6-(6-Methoxypyridin-3-yl)-4-pyridin-4-ylthieno[2,3-d]pyrimidine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548296 5-((tert-butylamino)methyl)-N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284883 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]-pyridin-1-yl)-5,7-difluoro-3-methyl-2-(1-naphthalenyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032643 8-cyclopentyl-4-methyl-2-(methylamino)-7-oxo-N-pyridin-2-ylpyrido[2,3-d]pyrimidine-6-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032556 2-amino-N-(2-ethylpyrazol-3-yl)-8-(4-hydroxycyclohexyl)-4-methyl-7-oxopyrido[2,3-d]pyrimidine-6-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66717247 5-[2-(5-Methoxy-pyridin-3-yl)-imidazo[2,1-b][1,3,4]thiadiazol-5-yl]-3-trifluoromethyl-pyridin-2-ylamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142847 N-[5-[2-[4-(4-cyclopropylpiperazin-1-yl)-6-ethylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]-4-fluorobenzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50938950 4-(3,3-dimethyl-6-(1H-pyrazol-4-yl)-2,3-dihydro-1H-pyrrolo-[3,2-b]pyridin-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133341 tert-butyl (2S)-2-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carbonyl]azetidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52942729 3-(6-(1H-indazol-5-ylamino)-2-thiomorpholinopyrimidin-4-yl)phenol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869511 4-[4-(Hydroxymethyl)phenyl]-8-(2-methoxyethylamino)-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436189 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]pyrrolidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032717 2-Amino-8-(4-hydroxycyclohexyl)-4-methyl-6-quinolin-3-ylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023753 Imidazopyridine derivative, 8j 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950829 3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]-N-pyridin-3-ylbenzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581200 methyl 3-[(3S)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidin-1-yl]propanoate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580402 [1-[1-[2-(2-methoxyethoxy)ethyl]piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285250 4-(3-methyl-2-(2-pyridinyl)-1,8-naphthyridin-4-yl)-6-(4-morpholinyl)-3,4-dihydro-2H-1,4-benzoxazine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548311 4-[[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5-fluoro-6-methoxypyridin-3-yl)amino]pyridin-3-yl]methyl]-N-methyl-N-propan-2-ylpiperazine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:122179717 2-morpholin-4-yl-4-oxo-N-(pyridin-4-ylmethyl)pyrido[1,2-a]pyrimidine-9-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168276463 (2S)-1-[2-[(5S)-5-methyl-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444364 5-[7-(2,3-Dimethylbutan-2-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:168281206 4-[[[5-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzoxazol-2-yl]amino]methyl]benzonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50925577 N-(5-(3-(3-cyanophenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)pyridin-3-yl)benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444325 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N-tert-butylpyrrolidine-1-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52936959 N-(5-(3-Morpholinoimidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)-benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:127031182 3-[[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]benzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548235 N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)-5-vinylpyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59507602 4-Chloro-5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)pyridin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444351 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-[1-(trifluoromethylsulfonyl)azetidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44457184 [(1S,3aR,6E,9S,9aR,10R,11aS)-1,5-dihydroxy-9-(methoxymethyl)-9a,11a-dimethyl-6-[[methyl-[3-(4-methylpiperazin-1-yl)propyl]amino]methylidene]-4,7-dioxo-2,3,3a,9,10,11-hexahydro-1H-indeno[4,5-h]isochromen-10-yl] acetate 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940335 6-chloro-4-(3,3-dimethyl-6-(1H-pyrazol-4-yl)-2,3-dihydro-1H-indol-1-yl)-2,3-dimethylquinoline 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46869514 4-[4-Fluoro-3-(hydroxymethyl)phenyl]-8-[2-hydroxyethyl(methyl)amino]-2-morpholin-4-ylpyrido[3,2-d]pyrimidine-6-carboxylic acid 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:3840028 7-ethoxy-N3-(furan-2-ylmethylene)acridine-3,9-diamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940225 1-(6-chloro-2,3-dimethyl-4-quinolinyl)-6-(4-pyridinyl)-1H-indole-4-carbonitrile 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25182562 N-(6-(2-(2-Methoxyphenylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60141337 N-[5-[2-[4-(4-cyclopropylpiperazin-1-yl)-6-methylpyrimidin-5-yl]ethynyl]-2-methylpyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:46941132 5-{2-[3-(Morpholine-4-sulfonyl)-phenyl]-imidazo[2,1-b][1,3,4]thiadiazol-5-yl}-3-trifluoromethyl-pyridin-2-ylamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950697 (8-methoxy-5,5-dioxo-1-phenyl-4H-thiochromeno[4,3-c]pyrazol-3-yl)-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258913 2-amino-4-methyl-8-(oxolan-3-yl)-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:44180743 3-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)-N-pyridin-4-ylbenzamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444400 N-[2-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-2-methylpropyl]-N-methylmethanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032977 2-Amino-6-[3-(hydroxymethyl)phenyl]-4-methyl-8-(oxan-4-yl)pyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285724 1'-(8-Chloro-2,3-dimethyl-4-quinolinyl)-6'-(4-morpholinyl)-1',2,2',3,5,6-hexahydrospiro[pyran-4,3'-pyrrolo[3,2-b]pyridine] 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548230 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-[(1-oxo-1,4-thiazinan-4-yl)methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436268 1-[3-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylazetidin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436134 5-[7-[(3R,4S)-3,4-dimethylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950226 [1-[3-(dimethylamino)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67285407 2-(3,5-difluorophenyl)-4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-3-methyl-1,7-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59244568 [5-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyridin-3-yl]-(4-methylpiperazin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25032884 2-(Ethylamino)-8-(4-hydroxycyclohexyl)-6-(2-methoxypyrimidin-5-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436088 [(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-(3-methoxyazetidin-1-yl)methanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580504 [1-(2-fluorophenyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:156876699 US11649227, Example 256 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:50940333 4-(6-chloro-2,3-dimethyl-4-quinolinyl)-6-(4-morpholinyl)-3,4-dihydro-2H-1,4-benzoxazine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142845 N-[5-[2-(4-ethyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]-2-methoxypyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118436264 3-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]piperidin-2-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580981 [6-fluoro-1-[(3S)-1-(2-morpholin-4-ylethyl)piperidin-3-yl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:141481226 6-(4-methoxyphenyl)-N-[4-(8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl)phenyl]pyrimidine-4-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:155544279 2-[(3R)-3-(3,4-dichlorophenyl)-5-(4-fluorophenyl)-3,4-dihydropyrazol-2-yl]-4-morpholin-4-yl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine 6,6-dioxide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:162371681 2,4-difluoro-N-[2-methoxy-5-[7-[(3R)-3-methylmorpholin-4-yl]-[1,3]thiazolo[5,4-d]pyrimidin-2-yl]pyridin-3-yl]benzenesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:796828 2-(4-Fluorophenyl)-1-(2,3,4-trihydroxyphenyl)ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:25023759 4-{6-Chloroimidazo[1,2-a]pyridin-3-yl}-2-[(2-methyl-5-nitrophenyl)sulfanyl]-1,3-thiazole 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548217 4-(5-Chloro-2-(5-fluoropyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:146177471 1-(3-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidin-1-yl)-2,2-dimethylpropan-1-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:166035180 US11649227, Example 306 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:52950827 {3-[3-(Morpholin-4-ylcarbonyl)-5,5-dioxidothiochromeno[4,3-c]pyrazol-1(4H)-yl]phenyl}methanol 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:77361436 US8841288, CL55a 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:49784895 4-Methyl-6-[5-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-(pyrimidin-5-ylamino)pyridin-3-yl]-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66581184 2-methoxy-1-[(3S)-3-[3-(morpholine-4-carbonyl)-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-1-yl]piperidin-1-yl]ethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59258887 2-Amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-4-methyl-6-quinolin-3-ylpyrido[2,3-d]pyrimidin-7-one 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:118444415 5-[7-[(3S)-3-methyl-1-methylsulfonylpyrrolidin-3-yl]-2-[(3R)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66717020 5-[2-(1H-Indol-5-yl)-imidazo[2,1-b][1,3,4]thiadiazol-5-yl]-3-trifluoromethyl-pyridin-2-ylamine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:67284884 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-2-(5-fluoro-3-pyridinyl)-3-methyl-1,8-naphthyridine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:53318294 4-amino-2,7-dimethyl-N-(1H-pyrazol-4-yl)quinazoline-8-carboxamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:66580983 [1-[3-(1-methylpyrazol-4-yl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:59548321 4-(2-(5-Fluoro-6-methoxypyridin-3-ylamino)-5-(2-morpholinopropan-2-yl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:60142576 2-methoxy-N-[2-methyl-5-[2-(4-methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-3-yl]ethanesulfonamide 1.0797523048107854e-05 0.495835\n",
      "PUBCHEM.COMPOUND:123133325 methyl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 1.0797523048107854e-05 0.495835\n",
      "CHEBI:91471 LSM-1231 1.2833634793031956e-05 0.48646\n",
      "CHEBI:91408 N-tert-butyl-3-[[5-methyl-2-[4-[2-(1-pyrrolidinyl)ethoxy]anilino]-4-pyrimidinyl]amino]benzenesulfonamide 1.9394213172340637e-05 0.464103\n",
      "PUBCHEM.COMPOUND:76325342 N-[5-(7-amino-6-phenyl-1,8-naphthyridin-3-yl)-2-methoxy-3-pyridyl]-2,4-difluoro-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57404800 N-[5-(2-amino-4-oxo-3-phenylquinazolin-6-yl)-2-methoxypyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67982639 5-[2-amino-4-oxo-3-[3-(trifluoromethyl)phenyl]quinazolin-6-yl]-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66800530 N-[5-(2-amino-3-phenyl-6-quinolyl)-2-methoxy-3-pyridyl]-2,4-difluoro-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76325343 N-[5-(6-amino-7-phenyl-1,5-naphthyridin-2-yl)-2-methoxy-3-pyridyl]-2,4-difluoro-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76336173 N-[5-(2-amino-3-phenyl-1,7-naphthyridin-6-yl)-2-methoxy-3-pyridyl]-2,4-difluoro-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67981475 5-[2-amino-4-oxo-3-(2-propan-2-ylphenyl)quinazolin-6-yl]-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76310805 N-[5-(2-amino-4-oxo-3-phenyl-quinazolin-6-yl)-2-methoxy-phenyl]-2,4-difluoro-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57407079 N-[2-amino-5-(2-amino-4-oxo-3-phenyl-quinazolin-6-yl)-3-pyridyl]-2,4-difluoro-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67982535 N-[5-(2-amino-4-oxo-3-phenylquinazolin-6-yl)-2-methoxypyridin-3-yl]-4-methylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:68095924 5-(2-amino-3-ethyl-4-oxoquinazolin-6-yl)-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67982543 N-[5-(2-amino-4-oxo-3-phenyl-quinazolin-6-yl)-2-methoxy-3-pyridyl]-2,4-difluoro-N-methyl-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66806967 N-[5-[2-amino-3-(4-morpholinophenyl)-6-quinolyl]-2-methoxy-3-pyridyl]-2,4-difluoro-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67982485 5-[2-amino-4-oxo-3-[4-(trifluoromethyl)phenyl]quinazolin-6-yl]-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57405315 N-[5-(2-amino-4-oxo-3-phenylquinazolin-6-yl)-2-methoxypyridin-3-yl]propane-2-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134136768 N-[2-[[6-chloro-3-[4-methoxy-3-(prop-2-enylsulfamoyl)phenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76282073 (S)-4-(6-amino-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-N-(4-methoxy-2-methylphenyl)-3-methylpiperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134137863 5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-2-methoxy-N-(2-methoxyethyl)benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:135742054 2-Fluoro-4-(2-methyl-8-((3-(methylsulfonyl)benzyl)amino)imidazo[1,2-a]pyrazin-3-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134142679 3-[6-chloro-2-methyl-8-(pyridin-4-ylmethylamino)imidazo[1,2-b]pyridazin-3-yl]-N,N-dimethylbenzenesulfonamide;hydrochloride 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122443951 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)-3-methylpiperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:129232085 CID 129232085 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134146987 6-chloro-N-[(2-ethylpyridin-4-yl)methyl]-3-(4-methoxy-3-pyrazol-1-ylsulfonylphenyl)-2-methylimidazo[1,2-b]pyridazin-8-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134155258 3-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-N,N-dimethylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:123131775 l]Ethanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134141276 5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-2-methoxy-N,N-dimethylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145965198 (3S)-4-(2-amino-9-methylpurin-6-yl)-N-(4-methoxy-2-methylphenyl)-3-methylpiperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71525653 (3S)-4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxy-2-methylphenyl)-3-methylpiperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76853139 N-[2-chloro-5-[2,5-dimethyl-7-[(2-methylpyridin-4-yl)methylamino]pyrazolo[1,5-a]pyrimidin-3-yl]phenyl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46894120 1-[4-(5-Amino-2-pyridin-3-yl-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)piperazin-1-yl]-2-(4-chlorophenoxy)ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134149528 5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-2-methoxy-N-prop-2-enylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71682210 N-[5-(6-aminopyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]-1-methylcyclohexane-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122443959 (3S)-4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(6-methoxy-2-methylpyridin-3-yl)-3-methylpiperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:137379517 CID 137379517 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:4904109 3-(3,4-dimethoxyphenyl)-2,5-dimethyl-N-(2-morpholin-4-ylethyl)pyrazolo[1,5-a]pyrimidin-7-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:91668195 4-[4-chloro-3-(methylcarbamoyl)phenyl]-N-[(3-pyrazol-1-ylphenyl)methyl]pyridine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71682212 N-[5-(6-aminopyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]-2-(5-methyl-4-phenyl-1,3-oxazol-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134140256 1-[5-[6-Chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-2-methoxyphenyl]sulfonylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71572646 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)piperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134137055 6-chloro-N-[(2-ethylpyridin-4-yl)methyl]-3-(4-methoxy-3-morpholin-4-ylsulfonylphenyl)-2-methylimidazo[1,2-b]pyridazin-8-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134155126 5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-N-(1-hydroxybutan-2-yl)-2-methoxybenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71572645 4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxy-2-methylphenyl)piperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:129232769 CID 129232769 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134137978 N-[2-[[6-chloro-3-[3-(dimethylsulfamoyl)-4-methoxyphenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168299253 4-amino-7-(3H-benzimidazol-5-yl)quinazoline-6-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155560887 N-[5-[2-[3-acetyl-N-(2-hydroxyethyl)anilino]-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]-2,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44180017 6-(2-Aminopyrimidin-5-yl)-n-(3-methoxyphenyl)-1-methyl-1h-pyrazolo[3,4-d]pyrimidin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168284786 cyclohexyl-[(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53318293 4-amino-N-(6-methoxypyridin-3-yl)-2,7-dimethylquinazoline-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155515353 2-(methylamino)-N-[4-[4-(2-methylsulfonylpropan-2-yl)-6-[(1R,6S)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884583 1-(4-(4,6-bis((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-4-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341440 5-[2-[4-(4-Methoxypiperidin-1-yl)-6-methylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86292820 (6-(1-((6-Methoxypyridin-3-yl)methyl)piperidin-4-yl)-1H-benzo[d]imidazol-2-yl)(4-(4-(trifluoromethyl)benzyl)piperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646313 2-methoxy-5-[6-[(3S)-1-(3-methylbutanoyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661401 [(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxolan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072622 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148816 [3-[2,6-bis[(3R)-3-methylmorpholin-4-yl]-7H-purin-8-yl]-4-fluorophenyl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811614 2-[1-[[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperidin-4-yl]propan-2-ol 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL2375953 CHEMBL2375953 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539109 N-[2-chloro-5-[4-[4-[[2-hydroxyethyl(methyl)amino]methyl]phenyl]quinolin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44242426 Methyl 2-((2-chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[b]thieno[2,3-d]oxepin-8-ylcarbamate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072728 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(2,2-dimethylmorpholin-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646320 (4,4-difluorocyclohexyl)-[(3S)-3-[[4-(5-methoxy-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677352 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1,3-oxazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709085 N-(2-hydroxyethyl)-N-methyl-9-[1-(3-methylphenoxy)ethyl]-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664860 [(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxolan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798543 5-[5-Methyl-3-(3-piperazin-1-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072934 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(3,3,4-trimethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073051 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-phenylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073026 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(cyclohexylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45482931 cis-1-(4-(4-(2,6-dimethylmorpholino)-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126752691 1-[4-[4-(Dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(2,6-dimorpholin-4-ylpyrimidin-4-yl)phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56653271 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-pyridin-3-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4861171 CHEMBL4861171 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145956818 4-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-N-[4-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]-4-oxobutyl]-4-oxobutanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700703 (S)-2-((1-(2-amino-7-methylbenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072791 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072951 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073655 N-[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699952 (S)-2-cyclopropyl-2-((1-(2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701013 US10065970, Example 250 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700977 (S)-2-((1-(2-aminobenzo[d]oxazol-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379491 3-Methyl-8-(6-methylpyridin-3-yl)-1-(oxan-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:165430682 (2S)-2-cyclopropyl-2-({(4S,11aM)-2-[(4S)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646036 2-methoxy-5-[6-[(3S)-1-(pyrazolo[1,5-a]pyrimidine-3-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353565 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(1-hydroxypropan-2-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700664 (S)-2-((1-(pyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25175568 (3S)-4-[2-(1H-indol-5-yl)-6-(methylsulfonylmethyl)pyrimidin-4-yl]-3-methylmorpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53323643 4-amino-2,7-dimethyl-N-(1H-pyrrolo[2,3-b]pyridin-5-yl)quinazoline-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:54581023 3-(1-(4-(phenylamino)-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539920 N-[5-[4-[4-[[bis(2-hydroxyethyl)amino]methyl]phenyl]quinolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072962 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444293 N-[3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49857479 (4aS,11cS)-9,10-dihydroxy-4,4,11c-trimethyl-1,2,3,4a,5,6-hexahydronaphtho[2,1-b][1]benzofuran-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:153532119 (2S)-1-[2-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)anilino]-3H-benzimidazole-5-carbonyl]pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354149 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(2-oxa-7-azaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:84972979 [(3S)-3-[[6-(5-isocyano-6-methoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1,3-thiazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162673569 4-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-6-[4-(2-nitrophenyl)sulfonylpiperazin-1-yl]-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930217 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798507 [6-(2-Amino-1,3-benzoxazol-5-yl)quinolin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884582 (R)-1-(4-(4-(3-methylmorpholino)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-3-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700667 (S)-2-((1-(pyridin-2-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900289 N-(2-chlorophenyl)-N-methyl-9-oxa-3-thia-14-azatricyclo[8.4.0.02,6]tetradeca-1(10),2(6),4,11,13-pentaene-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701238 2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)ethan-1-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548297 5-((4-methoxyphenylamino)methyl)-N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073003 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(1,5-dioxa-9-azaspiro[5.5]undecan-9-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25172066 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:4912089 2-(Pyridin-4-yl)benzo[d]oxazol-5-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168273298 4-[[5-(2-aminopyrimidin-5-yl)-3-morpholin-4-yl-2-oxopyrazin-1-yl]methyl]-N-hydroxybenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072550 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(oxan-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45109832 2-[4-[8-(6-Methoxypyridin-3-yl)-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]piperidin-1-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548350 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-[1-(3-methylsulfonylazetidin-1-yl)ethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072657 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-benzylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44181709 N-(3-methoxyphenyl)-1-methyl-6-(pyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:148306839 2-[[6-[5-[(2-Chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]methyl]butanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661351 5-[6-[(3S)-1-(1,1-dioxothiane-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59507597 5-[2-Morpholin-4-yl-6-(quinolin-3-ylamino)pyrimidin-4-yl]pyrimidine-2,4-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168287988 3-anilino-5-[2-(cyclopropanecarbonylamino)pyridin-4-yl]-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164617022 2-[4-[[2-(6-Aminopyridin-3-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913525 N-(2-Chloro-5-(6-(2-(trifluoromethyl)pyridin-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-3-yl)dimethylaminosulfonamid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52936848 N-(5-(3-Cyanoimidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073009 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(3-methyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664693 [(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxolan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145988008 [2-Amino-5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)pyridin-4-yl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072633 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-methyl-N-[(1-methylpiperidin-3-yl)methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379575 1-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(1-methylpyrazol-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444323 (1-acetylazetidin-3-yl) (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646302 2-methoxy-5-[6-[(3S)-1-(pyridine-3-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155556396 N-[2-methoxy-5-[4-[[1-(oxane-4-carbonyl)piperidin-4-yl]amino]quinazolin-6-yl]pyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700688 (S)-1-(1-(1H-benzo[d][1,2,3]triazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127047185 N-[3-(1-hydroxyethyl)phenyl]-1H-indole-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664694 [(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothiolan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701227 (S)-2-cyclopropyl-2-((1-(pyrimidin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:153532122 1-[2-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)anilino]-3H-benzimidazole-5-carbonyl]piperidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL2331659 CHEMBL2331659 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072921 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(9-methyl-3,9-diazaspiro[5.5]undecan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548273 4-methyl-6-[5-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-(1H-pyrazol-5-ylamino)pyridin-3-yl]-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353464 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-(1-hydroxypropan-2-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379542 8-[6-(Dimethylamino)pyridin-3-yl]-1-[1-(2,2-dimethylpropanoyl)piperidin-4-yl]-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709076 9-(1-Anilinoethyl)-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxylic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353278 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-(oxetan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072885 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155545624 1-Methyl-3-[4-(9-oxo-13-oxa-1,3,5,8-tetrazatricyclo[9.4.0.02,7]pentadeca-2,4,6-trien-4-yl)phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700508 US10065970, Example 263 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539922 2,4-difluoro-N-[2-methoxy-5-[4-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700777 (S)-2-cyclopropyl-2-((1-(pyridazin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677440 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548299 N-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-(2-methoxyethoxy)pyridin-2-ylamino)-2-methylpyridin-3-YL)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073087 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[(2S)-2,4-dimethylpiperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4875356 CHEMBL4875356 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70693329 3-[(8-bromo-1-methyl-4-oxo-3H-pyridazino[4,5-b]indol-5-yl)methyl]benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59251723 N-[6-[6-amino-5-(2-methoxyethoxy)pyridin-3-yl]imidazo[1,2-a]pyridin-2-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072663 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[(1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444297 5-[2-morpholin-4-yl-7-[(3R)-1-propan-2-ylsulfonylpyrrolidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76285477 5-(6-Morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-4-yl)benzene-1,3-diol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664743 (1,1-dioxothiolan-3-yl)-[(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700978 (S)-2-((1-(2-amino-7-chlorobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156017362 (2S)-1-N-[7-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxopyrido[1,2-a]pyrimidin-3-yl]pyrrolidine-1,2-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700968 (S)-2-((1-(2-aminoquinoxalin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:149379706 (2R)-3-[6-[5-[(2,4-dimethyl-1,3-thiazol-5-yl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168288843 7-[2-amino-6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxy-N-hydroxyheptanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073742 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-4-phenylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353374 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-(1-methoxypropan-2-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155511906 N-[5-[4-[[(3S)-1-(cyclopentanecarbonyl)pyrrolidin-3-yl]amino]quinazolin-6-yl]-2-methoxypyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072996 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-(2-hydroxyethyl)-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59507892 N-[6-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]quinolin-3-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700791 (S)-2-(4-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)-1H-pyrazol-1-yl)-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147143260 3-[6-[5-[(2-Chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-2,2-difluoropropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379593 1-[(2S)-1-hydroxypropan-2-yl]-8-(6-methoxypyridin-3-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709083 N-(2-hydroxyethyl)-N-methyl-2-morpholin-4-yl-4-oxo-9-(1-phenoxyethyl)pyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52937061 N-(5-(3-(Pyridin-4-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548238 N5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-methoxypyridin-2-YL)-2-chloropyridine-3,5-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072783 Ethyl 4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorobenzoyl]piperazine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353761 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-butylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46180664 1-(2-(1H-Indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)ethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379642 8-[1-(2-Hydroxyethyl)pyrazol-4-yl]-3-methyl-1-(oxan-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539042 N-[2-chloro-5-[4-[4-[[2-hydroxyethyl(methyl)amino]methyl]phenyl]quinolin-6-yl]pyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118987927 3-[(E)-[(4-morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl)hydrazinylidene]methyl]-4-oxo-4a,5,6,7,8,8a-hexahydrochromene-6-carboxylic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353960 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(oxan-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664800 5-[6-[(3S)-1-(2,2-dimethyl-4-oxo-3H-pyran-6-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:62706655 N-[2-methyl-6-[2-[(1-methylpyrazol-3-yl)amino]imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:24805152 1-Ethyl-3-[4-[4-(methylsulfonylmethyl)-6-morpholin-4-ylpyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647007 2-methoxy-5-[6-[(3S)-1-(5-methyl-1,3,4-oxadiazole-2-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:50925575 N-(5-(3-(pyridin-3-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl)pyridin-3-yl)benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677219 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1,3-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072770 3-[4-[4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorobenzoyl]piperazin-1-yl]propanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072920 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(3-pyrrolidin-1-ylcyclobutyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072571 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646921 2-methoxy-5-[6-[[(4R)-2-(oxane-4-carbonyl)-1,2-oxazolidin-4-yl]oxy]-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164617956 3-[6-amino-5-(1-methylpyrazol-4-yl)pyridin-3-yl]-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913423 (4R)-4-benzyl-3-[3-(5,6-dimethoxypyridin-3-yl)imidazo[1,2-a]pyridin-6-yl]-1,3-oxazolidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122184946 N-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379524 1-[1-(2-hydroxyacetyl)piperidin-4-yl]-3-methyl-8-(1H-pyrazolo[3,4-b]pyridin-5-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072592 5-[2-[4-Ethyl-6-(2-methoxypyridin-4-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53321409 n-(6-(6-Aminopyridin-3-yl)-2-morpholinopyrimidin-4-yl)quinolin-3-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:141471209 N-[5-(2-amino-4-methylthieno[2,3-d]pyrimidin-6-yl)-2-methylpyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168281282 6-[5-(2-aminopyrimidin-5-yl)-3-morpholin-4-yl-2-oxopyrazin-1-yl]-N-hydroxyhexanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701224 (S)-2-cyclopropyl-2-((1-(4-(methylsulfonyl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:141519563 (2R)-1-[4-[[4-(2,6-dimorpholin-4-ylpyrimidin-4-yl)phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70690535 6-(2-aminopyrimidin-5-yl)-N-[2-(dimethylamino)ethyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699991 US10065970, Example 280 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700506 (S)-1-(1-(2-oxo-3,4-dihydro-2H-benzo[4,5]oxazolo[3,2-a]pyrimidin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353857 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072859 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]phenyl]-(4-hydroxy-1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:10051792 [1-(3-Phenylpropyl)piperidin-3-yl]methyl 2-(3-cyclopentyl-2,5-dioxopyrrolidin-1-yl)benzoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145991982 5-[2,6-Bis(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798466 7-(2-Amino-1,3-benzoxazol-5-yl)-3-methyl-2-(4-methylpiperazin-1-yl)quinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379517 3-methyl-1-(oxan-4-yl)-8-(1H-pyrazol-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:148863997 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51353712 N-(6-(2-(3-Fluorophenylsulfonamido)pyrimidin-4-yl)benzo-[d]thiazol-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168295138 (2S)-2-[[2-[(4S)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900505 5-(2-Chlorophenyl)-4-(4,5-dihydrobenzo[b]thieno[2,3-d]oxepin-2-yl)thiazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072784 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[2-(2-oxopyrrolidin-1-yl)ethyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785517 4-(2-(6-Methoxypyridin-3-ylamino)-5-(1,2,3,6-tetrahydropyridin-4-YL)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118470524 3-[5-amino-6-(1,2,4-triazol-1-yl)pyrazin-2-yl]-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664768 3-[(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-3-oxopropanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168294385 2-methoxy-5-[4-[(3S)-1-propanoylpyrrolidin-3-yl]oxythieno[2,3-d]pyrimidin-6-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785435 N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-2-yl)benzo[d]thiazol-5-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700790 (R)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67347293 1-(1-Acetylpiperidin-4-yl)-8-(3-methoxyphenyl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45255194 N-methyl-4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-1-yl)piperidine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664719 [(3S)-3-[[4-(6-chloro-5-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothian-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71450646 N-[5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-chloropyridin-2-yl]amino]-2-chloropyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168292147 1-[(3S)-3-[[6-(2-methoxypyrimidin-5-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073649 5-[2-[4-Ethyl-6-[4-(methoxymethyl)piperidin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539919 2,4-difluoro-N-[5-[4-[4-[[4-(2-hydroxyethyl)piperazin-1-yl]methyl]phenyl]quinolin-6-yl]-2-methoxypyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700991 (S)-1-(1-(2-amino-7-ethylbenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646137 (5-amino-1-methylimidazol-4-yl)-[(3S)-3-[[1-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379660 2-[4-[8-(2-methoxypyrimidin-5-yl)-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]piperidin-1-yl]-N,N-dimethylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162675347 4-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-6-[4-(4-nitrophenyl)sulfonylpiperazin-1-yl]-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341521 5-[2-[4-Ethyl-6-(4-methylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:124193946 US9758538, Example 35 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073018 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(4-prop-2-ynylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073702 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-1,4-diazepan-5-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177399 5-(3-(Cyclohexylsulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379509 2-[4-[3-Methyl-8-(6-methylpyridin-3-yl)-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]piperidin-1-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:148454950 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-2-methyl-N-(2-methylpropyl)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51350808 1-(4-fluoro-3-(trifluoromethyl)phenyl)-9-(1H-pyrrolo[2,3-b]pyridin-5-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072827 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-benzylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379492 1-[4-(2-Hydroxyethoxy)cyclohexyl]-8-(2-methoxypyrimidin-5-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168276070 cyclopropyl-[(3S)-3-[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]oxypyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379563 4-[8-(2-Methoxypyrimidin-5-yl)-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]cyclohexane-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646472 cyclopropyl-[(3S)-3-[[1-[6-(difluoromethoxy)-5-methylpyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89589921 9-(2-aminopyrimidin-5-yl)-3-methyl-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700671 (S)-2-cyclopropyl-2-((1-(3-oxoisoindolin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881836 3-[6-(Ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664748 [(3S)-3-[[4-(5-chloro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothiolan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354350 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072819 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[3-(4-hydroxypiperazin-1-yl)cyclobutyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58137055 4-[6-(methylsulfonylmethyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yl)pyrimidin-4-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70693330 8-bromo-5-[(4-methoxyphenyl)methyl]-1-methyl-3H-pyridazino[4,5-b]indol-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45267273 4-[[(1R,18R)-1-methyl-6,11,16-trioxo-13-oxapentacyclo[10.6.1.02,10.05,9.015,19]nonadeca-2(10),3,5(9),12(19),14-pentaen-18-yl]oxy]-4-oxobutanoic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53308744 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-4-(trifluoromethyl)piperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11539769 1-Piperazineethanol, 4-[[2-(3-hydroxyphenyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]- 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71450647 N-[5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-chloropyridin-2-yl]amino]-2-chloropyridin-3-yl]pyridine-3-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341482 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-4-methylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59251984 N-[6-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-1,3-benzothiazol-2-yl]-4-piperidin-1-ylbutanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548327 N5-(2-methoxyethyl)-N2-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridine-2,5-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661402 2-methoxy-5-[6-[[(4R)-2-propanoyl-1,2-oxazolidin-4-yl]oxy]-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:88057843 [2-Chloro-4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]phenyl]-[4-(2,2-difluoroethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700494 (S)-2-cyclopropyl-2-((1-(2,4-difluorophenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884066 (Z)-N,N-diethyl-1-(1-methyl-3-((3-oxo-5-(3-pyridin-3-ylureido)benzofuran-2(3H)-ylidene)methyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)piperidine-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646373 2-methoxy-5-[6-[(3S)-1-(2-methoxyacetyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699962 (S)-1-(1-(3-oxo-2,3-dihydrobenzo[d]iso-xazol-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073659 2-[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]-N-[2-(dimethylamino)ethyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881852 1-Ethyl-3-(3-o-tolylamino-pyrido[2,3-b]-pyrazine-6-yl)-urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072746 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-pyridin-4-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53308739 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-cyclopropylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884592 (R)-1-(4-(4-(3-methylmorpholino)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646533 1-[(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-3-methoxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11373403 N-[4-[3-anilino-5-(methylcarbamoyl)phenyl]pyridin-2-yl]oxolane-3-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166630905 (2S,4S)-4-(dimethylamino)-1-[4-[[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646209 1-[(3S)-3-[[4-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688497 4-(6-Methanesulfonyl-5-methyl-pyridin-3-yl)-6-((S)-1-pyrimidin-2-yl-pyrrolidin-3-yloxy)-3,4-dihydro-2H-benzo[1,4]oxazine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11566902 5-[5-(2-Hydroxy-5-trifluoromethoxyphenyl)furan-2-ylmethylene]thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072614 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177461 5-(3-((4-Fluorophenethyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127048971 5-[8-(3-Methoxyoxetan-3-yl)-9-methyl-6-morpholin-4-ylpurin-2-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072589 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(3-hydroxypiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59507725 N-[6-[6-amino-4-(trifluoromethyl)pyridin-3-yl]-2-morpholin-4-ylpyrimidin-4-yl]quinolin-3-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49784991 4-(2-(6-Ethoxypyridin-3-ylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354353 [2-Chloro-4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]phenyl]-[4-(oxan-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072722 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[3-(4-methylpiperidin-1-yl)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646215 2-methoxy-5-[6-[(3S)-1-(1-methyl-6-oxopyridine-3-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661332 (1,1-Dioxothian-4-yl)-[3-[[1-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53320103 N-(2-morpholino-6-(pyrazin-2-yl)pyrimidin-4-yl)quinolin-3-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25170410 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-2-methyl-5-nitro-N-(2-piperidin-1-ylethyl)benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118321320 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700824 US10065970, Example 306 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379630 1-[1-(2-hydroxy-2-methylpropanoyl)piperidin-4-yl]-3-methyl-8-(1H-pyrazolo[3,4-b]pyridin-5-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134147904 2-Morpholin-4-yl-10-phenylbenzo[g]chromen-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354055 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(cyclopropylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155545182 3-[4-[(3S)-3-methylmorpholin-4-yl]-6-(2-methylsulfonylpropan-2-yl)pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379573 8-(2-Methoxypyrimidin-5-yl)-3-methyl-1-(1-methylpiperidin-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134136023 2,4-difluoro-N-[2-methoxy-5-[4-[4-[[methyl-[2-(methylamino)ethyl]amino]methyl]phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11645350 5-(5-Benzo[1,3]dioxol-5-yl-furan-2-ylmethylene)thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147033251 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-2-methyl-N-(2,2,2-trifluoroethyl)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664697 [(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072772 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173177 5-(6-Morpholino-4-(1-phenylvinyl)pyridin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71250848 7-[3-(Hydroxymethyl)-4-methoxyphenyl]-4-morpholin-4-ylpyrido[2,3-d]pyrimidine-2-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177391 N1-(5-(3-((4-fluorobenzyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-yl)ethane-1,2-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:78426693 17-Methoxy-14,14-dioxo-14lambda6-thia-2,7,15,18,25-pentazahexacyclo[19.6.2.22,5.19,13.116,20.024,28]tritriaconta-1(28),9(31),10,12,16,18,20(30),21(29),22,24,26-undecaen-8-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900255 2-(2-Cyclobutyl-1,2,4-triazol-3-yl)-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072846 5-[2-[4-Ethyl-6-(2-methylpyridin-4-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798857 5-[3-(2-Methylpyridin-3-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913526 N-(2-Chloro-5-(7-(pyridin-3-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-3-yl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155524748 N-[5-[4-[2-(dimethylamino)ethyl-methylamino]quinazolin-6-yl]-2-methoxypyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930503 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155533911 2-[[4-(3-Nitrophenyl)sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:121416203 N-[5-[4-(benzylamino)quinazolin-6-yl]pyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072748 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444284 4-[4-(2-Aminopyrimidin-5-yl)-7-[3-[methyl(methylsulfamoyl)amino]cyclobutyl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-2-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86581909 4-[[4-[6-[1-[(5-Ethoxypyrazin-2-yl)methyl]piperidin-4-yl]-1-methylindole-2-carbonyl]piperazin-1-yl]methyl]benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664772 [(3S)-3-[[4-[5-(difluoromethyl)-6-methoxypyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341441 1-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:129012345 9-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1-[3-(trifluoromethyl)phenyl]-4a,5,6,6a,7,8,9,10,10a,10b-decahydropyrimido[5,4-c][1,5]naphthyridine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:62706472 3-(6-amino-2-methylpyrimidin-4-yl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56650208 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-(1,3-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798554 5-(3-Morpholin-4-ylimidazo[1,2-a]pyridin-6-yl)-1,3-benzoxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548416 6-(3-(6-Methoxypyridin-3-ylamino)-6-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyrazin-2-yl)-2-methylpyrimidin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661335 [(3S)-3-[[1-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25023740 3-[7-Methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617473 [(3S)-3-[[4-(5-morpholin-4-ylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57398248 4-[4-[5-ethyl-3-(trifluoromethyl)pyrazol-1-yl]-6-(1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162658801 4-[4-(3-methylphenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646097 2-methoxy-5-[6-[(3S)-1-(pyrazine-2-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072977 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-[3-(dimethylamino)-2-hydroxypropyl]-2-fluorobenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072686 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-hydroxy-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379588 1-[1-[2-(Dimethylamino)acetyl]piperidin-4-yl]-8-(2-methoxypyrimidin-5-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072755 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(6-methyl-2,6-diazaspiro[3.3]heptan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798566 5-[3-(6-Morpholin-4-ylpyridin-3-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51353711 N-(6-(2-(2-Fluoro-N-methylphenylsulfonamido)pyrimidin-4-yl)benzo-[d]thiazol-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56683543 N2-(2-chloro-4-(methylcarbamoyl)phenyl)-N2,N8-dimethyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2,8-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379590 8-(6-Methoxypyridin-3-yl)-3-methyl-1-(1-propan-2-ylpiperidin-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162646646 4-[4-(benzenesulfonyl)piperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073731 5-[2-[4-Ethyl-6-[4-(3-methylsulfonylpropyl)piperazin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155129793 3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-(trifluoromethoxy)pyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155517424 1-ethyl-3-[4-[4-[(1S,6R)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548435 1-[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]-2,2-dimethylpropan-1-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700999 (S)-2-((1-(2-aminoquinoxalin-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]-inden-4-yl)oxy)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073701 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-3-methylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073040 Ethyl 4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]piperazine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89645889 1,4-dioxan-2-yl-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49857280 (4aS,11cS)-9,10-dihydroxy-4,4,11c-trimethyl-1,2,3,4a,5,6-hexahydronaphtho[2,1-b][1]benzofuran-8-carbaldehyde 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341611 5-[2-[4-Ethyl-6-(2-oxa-7-azaspiro[3.5]nonan-7-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444314 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N-methylazetidine-1-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:129012344 9-(2-Aminopyrimidin-5-yl)-1-[3-(trifluoromethyl)phenyl]-4a,5,6,6a,7,8,9,10,10a,10b-decahydropyrimido[5,4-c][1,5]naphthyridine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25109643 5-(7-Methyl-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147268726 (2R)-3-[6-[5-[(2,4-dichlorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45488021 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(2-(dimethylamino)ethyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379565 1-(1-Acetylpiperidin-4-yl)-3-methyl-8-(1-methylpyrazol-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700825 US10065970, Example 308 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71037651 3-(1-Acetylpiperidin-4-yl)-6-(2-amino-1,3-benzoxazol-5-yl)quinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072963 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(1-methylpiperidin-4-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44242299 n-(2-Chlorophenyl)-n-methyl-8-(1h-pyrazol-4-yl)-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70694722 6-(2-aminopyrimidin-5-yl)-N-(3-methoxypropyl)-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45254589 2-[4-[8-(6-methoxypyridin-3-yl)-2-oxo-3H-imidazo[4,5-c][1,5]naphthyridin-1-yl]phenyl]-2-methylpropanenitrile 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4749136 CHEMBL4749136 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155569362 2-(methylamino)-N-[4-[4-(2-methylsulfonylpropan-2-yl)-6-[(1S,6R)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811653 (2R)-1-[4-[[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072543 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(2,6-diazaspiro[3.4]octan-6-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884017 (Z)-1-(2-((4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-phenylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072741 2-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]phenyl]-2-methylpropanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:72549327 1-(4-(4-Methylpiperazine-carbonyl)phenyl)-3-(4-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166628907 (1S,3S,5S)-2-[4-[[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]-2-azabicyclo[3.1.0]hexane-3-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52937065 2,4-Difluoro-N-(5-(3-(5-methyl-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147298205 2-[[6-[5-[(2-Chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]methyl]-3-methylbutanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145993509 3,5-difluoro-N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:62706471 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(1-methylpyrazol-3-yl)-6-pyrimidin-5-ylimidazo[1,2-a]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:148417584 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N-ethyl-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:152946078 (2R)-3-[6-[5-[(4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145969494 N-[5-(2-amino-4-methylthieno[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-5-chlorothiophene-2-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072914 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(2,6-diazaspiro[3.3]heptan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379532 1-(1-Acetylpiperidin-4-yl)-3-methyl-8-(1,8-naphthyridin-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647168 1-[(3S)-3-[[4-(6-chloro-5-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548203 (1R)-1-[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]-2,2-dimethylpropan-1-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44606477 1-(4-(4-((1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-cyclopropylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52944935 N-(3-methoxyphenyl)-1-methyl-6-(3-methylbenzo[d]isoxazol-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155534617 Tert-butyl 4-[[6-[5-(methanesulfonamido)-6-methoxypyridin-3-yl]quinazolin-4-yl]amino]piperidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700008 US10065970, Example 298 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699939 (S)-2-cyclopropyl-2-((1-(2-methoxy-6-methylpyrimidin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930971 5-[2-[4-ethyl-6-(4-methoxypiperidin-1-yl)pyrimidin-5-yl]ethynyl]-N-methylpyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56651219 1-[4-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidine-1-carbonyl]piperidin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073663 [1-[6-Ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]piperidin-4-yl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:121289089 US9763952, Example B27 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44129353 (2S)-1-N-[4-methyl-5-(2-pentan-3-yl-1,3-thiazol-4-yl)-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44609702 N-(2-chloro-5-(cinnolin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495335 [(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(2-methyl-1,3-oxazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52941270 6-(3-amino-1H-indazol-4-yl)-N-(3-methoxyphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072716 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-cyclopentylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072788 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-piperidin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44138035 2-((4-Fluoro-2-methylphenoxy)methyl)-6-morpholinoisonicotinic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073024 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-hydroxy-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646162 1-[(3S)-3-[[4-(6-chloro-5-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-3-hydroxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072575 5-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073725 [1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperidin-3-yl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155517588 1-[4-(8,12-Dioxa-1,3,5-triazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-4-yl)phenyl]-3-methylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127049343 3-[2-(2-Aminopyrimidin-5-yl)-9-methyl-6-morpholin-4-ylpurin-8-yl]oxetan-3-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072699 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[(3S)-3-hydroxypyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148815 (3S)-4-[8-(1H-indol-4-yl)-2-[(3R)-3-methylmorpholin-4-yl]-7H-purin-6-yl]-3-methylmorpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677193 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(3-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072840 4-[4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorobenzoyl]-1-methylpiperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74538980 4-fluoro-N-[2-methoxy-5-[4-[4-(morpholin-4-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647115 1-[(3S)-3-[[4-(5-chloro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-3-hydroxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4754767 CHEMBL4754767 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148866 3-[2-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-6-morpholin-4-yl-7H-purin-8-yl]aniline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700986 (S)-1-(1-(4-(1H-1,2,4-triazol-3-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700781 (S)-2-cyclopropyl-2-((1-(4-(hydroxymethyl)-piperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118378672 [5-[1-[(5-Methoxypyrazin-2-yl)methyl]piperidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072942 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[2-(1-hydroxycyclopentyl)ethyl]-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:72549794 1-Ethyl-3-(5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholino pyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700804 US10065970, Example 283 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59244698 [4-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]phenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881868 1-Ethyl-3-[3-[(6-methoxypyridin-3-yl)amino]pyrido[2,3-b]pyrazin-6-yl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118987930 3-[(E)-[(4-morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl)hydrazinylidene]methyl]-6-nitro-4a,5,6,7,8,8a-hexahydrochromen-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156010977 4-[6-[5-[(2-Chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]butanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379555 1-[1-(2-Hydroxyethyl)piperidin-4-yl]-3-methyl-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51354021 N-(6-(2-(4-Fluorophenylsulfonamido)pyrimidin-4-yl)benzo-[d]thiazol-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53324021 4-amino-2,7-dimethyl-N-(6-methylpyridin-3-yl)quinazoline-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664706 [(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444280 tert-butyl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127029064 3-[[2-(2-Aminopyrimidin-5-yl)-4-morpholin-4-ylquinazolin-7-yl]amino]pyridine-2-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444277 (3R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N-methylpyrrolidine-1-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:121406011 N-[2-chloro-5-[4-[4-[(dimethylamino)methyl]phenyl]quinolin-6-yl]pyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53323078 N-(2-((1-methylcyclobutyl)methoxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072693 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-hydroxy-1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67347657 8-[1-(2-Hydroxyethyl)pyrazol-4-yl]-3-methyl-1-piperidin-4-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86581908 4-[[4-[5-[1-[(5-Ethoxypyrazin-2-yl)methyl]piperidin-4-yl]-1-methylindole-2-carbonyl]piperazin-1-yl]methyl]benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379539 1-[1-[2-(Dimethylamino)acetyl]piperidin-4-yl]-8-(6-methoxypyridin-3-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664727 [(3S)-3-[[4-[6-methylsulfonyl-5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44436951 N''-(imidazo[1,2-a]pyridin-3-ylmethylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56653270 4-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidine-1-carbonyl]pyrrolidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379559 1-[4-(2-Hydroxyethoxy)cyclohexyl]-8-(6-methoxypyridin-3-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811655 (2S)-1-[4-[[4-(2-amino-4-methylpyrimidin-5-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701250 (S)-2-cyclopropyl-2-((1-(3-(difluoromethoxy)-4-methoxyphenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49764911 1-Ethyl-3-[4-(4-morpholin-4-ylpyrimidin-2-yl)phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155515666 N-[2-methoxy-5-[4-(2-morpholin-4-ylethylamino)quinazolin-6-yl]pyridin-3-yl]cyclopropanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073728 5-[2-[4-(4-Ethoxypiperidin-1-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145967893 N-[5-(2-amino-4,8-dimethyl-7-oxopteridin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539108 N-[2-chloro-5-[4-[4-(1,2,4-triazol-1-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118378659 [6-[1-[(4-methoxyphenyl)methyl]piperidin-4-yl]-1H-benzimidazol-2-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155539520 N-[5-[4-[(1-acetylpiperidin-4-yl)amino]quinazolin-6-yl]-2-methoxypyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700507 US10065970, Example 259 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25023743 2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072780 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-methyl-N-[2-(2-oxopyrrolidin-1-yl)ethyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164809099 N-(2-chloro-5-(4-((1S-phenylethyl)amino)quinazolin-6-yl)pyridin-3-yl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072629 1-[4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]piperazin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118341852 2-[4-[[6-(1,3-Benzodioxol-5-yl)quinazolin-4-yl]amino]phenyl]acetonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072831 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353762 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(oxan-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:659595 N-[4-[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]phenyl]-2-(4-methylphenoxy)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700967 (S)-2-((1-(2-(methylamino)benzo-[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664663 (1,1-dioxothian-4-yl)-[(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89649178 N-methoxy-N-methyl-5-[6-[(3S)-1-propanoylpyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70694721 6-(2-aminopyrimidin-5-yl)-N-[3-(dimethylamino)propyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072549 [(8aR)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59244670 5-(2-Morpholin-4-yl-7-pyridin-4-yl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-pyrimidin-2-ylamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57391363 1-[(2-Chlorophenyl)methyl]-7-morpholin-4-ylimidazo[1,2-a]pyrimidin-5-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354249 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-prop-2-ynylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811656 (2R)-1-[4-[[4-(2-amino-4-methylpyrimidin-5-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118378655 [4-[[2-fluoro-4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-[6-[1-[(6-methoxypyridin-3-yl)methyl]piperidin-4-yl]-1H-benzimidazol-2-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700512 US10065970, Example 296 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700785 (S)-2-((1-(benzo[d]thiazol-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072930 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:62706654 3-[2-methyl-6-[[1-(oxolan-3-yl)pyrazol-4-yl]amino]pyrimidin-4-yl]-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118616923 N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073707 2-[1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperidin-4-yl]ethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072759 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-hydroxy-4-(trifluoromethyl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76314027 N-[5-(7-amino-5-methyl-2-oxo-1-propan-2-yl-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162669761 2,4-difluoro-N-[2-methoxy-5-[4-[(E)-4-oxo-4-pyrrolidin-1-ylbut-2-en-2-yl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44607002 6-(4-morpholino-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)pyridin-3-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341437 1-[6-Ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]-4-(trifluoromethyl)piperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798833 [6-(2-Amino-[1,3]oxazolo[4,5-b]pyridin-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647151 5-[6-[(3S)-1-(1-acetylpiperidine-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155550788 6-(6-methoxy-5-methylpyridin-3-yl)-4-[1-(oxan-4-yl)pyrazol-4-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155528005 N-[2-methoxy-5-[4-(2-piperidin-1-ylethylamino)quinazolin-6-yl]pyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072756 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-benzylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL3112730 CHEMBL3112730 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46215563 2-[2-methyl-6-(1H-1,2,4-triazol-5-yl)pyridin-3-yl]-8-[2-(oxan-4-yl)ethyl]-5,7-dihydropyrazino[2,3-b]pyrazin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072888 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798478 6-(2-Amino-1,3-benzoxazol-5-yl)-3-[2-(diethylamino)ethyl]quinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073706 5-[2-[4-(3,4-dihydro-1H-isoquinolin-2-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073717 5-[2-[4-(1,4-Dioxa-8-azaspiro[4.5]decan-8-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155561991 5-[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]-N-(oxan-4-ylmethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072847 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701011 US10065970, Example 253 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168288981 2-[2-(2,4-Difluorophenyl)-1,2,4-triazol-3-yl]-4-methyl-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazole-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379485 8-[6-(Dimethylamino)pyridin-3-yl]-1-[1-(2-hydroxy-2-methylpropanoyl)piperidin-4-yl]-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44601279 1-{4-[4-morpholin-4-yl-7-(2-piperidin-1-ylethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073712 5-[2-[4-Ethyl-6-[4-(2-methoxyethoxy)piperidin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11530037 3-[5-(2,4-Dioxothiazolidin-5-ylidenemethyl)furan-2-yl]-4-hydroxybenzoic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072574 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]phenyl]-[4-(oxan-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646361 1-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072600 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]phenyl]-[4-(1,1-dioxothiolan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700717 US10065970, Example 310 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147578457 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-(dimethylamino)pyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072954 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-methoxypiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146865035 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-ethylpyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539860 2,4-difluoro-N-[2-methoxy-5-[4-[4-(piperidin-1-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073729 1-[6-Ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]-4-methylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072822 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethyl)phenyl]-(4-propan-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:24809743 N''-(isoquinolin-4-ylmethylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56654312 [(3S)-3-[[6-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162676752 4-[4-(4-methoxyphenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52936847 N-(5-(3-Acetylimidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71615951 oxan-4-yl-[(3S)-3-[[4-[6-(trifluoromethyl)pyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354152 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(2,7-diazaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661356 [(3S)-3-[[5-fluoro-4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71455124 6-[2-hydroxypropyl(naphthalen-1-ylmethyl)amino]-4-morpholin-4-yl-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647086 2-methoxy-5-[6-[(3S)-1-(oxane-3-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539801 2,4-difluoro-N-[2-methoxy-5-[4-[4-(pyrrolidin-1-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51351031 1-(3-chloro-4-fluorophenyl)-9-(1H-pyrrolo[2,3-b]pyridin-5-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71250872 3-[2-tert-butyl-4-[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900523 2-[4-(2-chlorophenyl)-5-oxo-1H-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617584 5-[6-[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072564 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-[(dimethylamino)methyl]-4-hydroxypiperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073041 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(2-methyl-2,7-diazaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46891475 1-(2-((5-methoxy-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073744 5-[2-(4-Ethyl-6-pyrrolidin-1-ylpyrimidin-5-yl)ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379611 1-(1-Acetylpiperidin-4-yl)-3-methyl-8-(3-pyrazol-1-ylphenyl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930851 N-[[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]methyl]-2-cyclopentylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:141471204 N-[5-(2-amino-4-methylthieno[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073730 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-1-yl]-pyridin-2-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164610509 4-[[3-[4-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44577827 [(1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-6,11,16-trioxo-13,17-dioxapentacyclo[10.6.1.02,10.05,9.015,19]nonadeca-2(10),12(19),14-trien-3-yl] 5-[methyl-(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]pentanoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44543764 5-(9-methyl-6-morpholino-9H-purin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44181062 6-(2h-Indazol-4-Yl)-1-Methyl-N-[3-(Methylsulfonyl)propyl]-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709082 9-(1-anilinoethyl)-2-morpholin-4-yl-4-oxo-N-(2-piperazin-1-ylethyl)pyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072551 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71615952 {(S)-3-[4-(6-Methanesulfonyl-5-methyl-pyridin-3-yl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yloxy]-pyrrolidin-1-yl}-(tetrahydro-pyran-4-yl)-methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:148850817 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N-(2-hydroxyethyl)-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072745 3-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56653967 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1H-pyrazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379498 1-[1-[(2R)-2-hydroxypropanoyl]piperidin-4-yl]-3-methyl-8-(1H-pyrazolo[3,4-b]pyridin-5-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71472133 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,25-tetrazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22(30),23,25,27-tetradecaen-14-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072767 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(7-methyl-2,7-diazaspiro[4.4]nonan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930021 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-tert-butylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341486 5-[2-[4-(1,1-Dioxo-1,4-thiazinan-4-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168274202 1-(4-Fluorophenyl)-2-methyl-8-(4-methylphenyl)imidazo[4,5-c]quinoline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354568 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785251 N-[5-[[3-(2-methyl-7H-purin-6-yl)-5-[(4-methylsulfonylphenyl)methyl]pyridin-2-yl]amino]pyridin-2-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664642 [(3S)-3-[[4-(5-chloropyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57427669 1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-6-(2-methylsulfonylpropan-2-yl)pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072675 [4-(2-Aminoethyl)piperazin-1-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811578 5-[7-[(4-Methylsulfonylpiperazin-1-yl)methyl]-2-morpholin-4-ylthieno[3,2-d]pyrimidin-4-yl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617705 1-[(3S)-3-[[4-(5-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:129012343 9-(2-Methoxypyrimidin-5-yl)-1-[3-(trifluoromethyl)phenyl]-4a,5,6,6a,7,8,9,10,10a,10b-decahydropyrimido[5,4-c][1,5]naphthyridine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444266 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,N-dimethylpyrrolidine-1-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145981832 5-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-methoxypyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379632 8-(2-aminopyrimidin-5-yl)-1-[(2R)-1-hydroxypropan-2-yl]-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072627 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-methoxy-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661336 5-[7-[(3S)-1-(1,1-dioxothiane-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydropyrido[3,4-b][1,4]oxazin-1-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25169523 7-Methoxy-4-(4-nitrophenyl)sulfanylfuro[2,3-b]quinoline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118721839 1-[3-(Dimethylamino)propyl]-3-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44592217 2-((4-Fluoro-2-methylphenylamino)methyl)-6-morpholinoisonicotinaldehyde 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072647 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(1,4-oxazepan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548479 N-(2-chloro-5-(3-(2-methyl-9H-purin-6-yl)pyridin-2-ylamino)pyridin-3-yl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701242 (S)-2-cyclopropyl-2-((1-(2-(methylsulfonyl)-pyridin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341607 1-[9-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-3,9-diazaspiro[5.5]undecan-3-yl]-2-methoxyethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168283489 N-[4-[3-(3-fluoroanilino)-5-(methylcarbamoyl)phenyl]pyridin-2-yl]oxane-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341385 5-[2-[4-[4-(2-Methoxyethyl)piperazin-1-yl]-6-methylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930425 [(3S)-3-(dimethylamino)pyrrolidin-1-yl]-[4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664735 [(3S)-3-[[4-[5-(dimethylamino)-6-methylsulfonylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548282 N'-(2-chloro-5-((3-(2-methyl-9H-purin-6-yl)-5-(1-(4-morpholinyl)ethyl)-2-pyridinyl)amino)-3-pyridinyl)-N,N-dimethylsulfamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884590 1-(4-(4,6-bis((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341438 1-[6-Ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]-4-propan-2-ylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548191 4-[2-[(6-methoxypyridin-3-yl)amino]-5-[(1S)-1-(4-methylsulfonylpiperazin-1-yl)ethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:42632991 3-(4-Morpholin-4-yl-7-piperidin-4-yl-5H-pyrrolo[3,2-d]pyrimidin-2-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69929864 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52941692 N-(2-amino-5-(3-(3,4-dimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)pyridin-3-yl)morpholine-4-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701236 (S)-2-cyclopropyl-2-((1-(4-(difluoromethoxy)-phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661327 [(3S)-3-[[1-[6-(difluoromethoxy)-5-methylpyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168282559 1-[(3S)-3-[[6-(3-fluoro-4-methoxyphenyl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073059 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-methyl-N-(1-methylpiperidin-4-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145987359 4-(Dimethoxymethyl)-5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072641 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[(2S)-2,4-dimethylpiperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798859 1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-4-(cyclopropylmethyl)piperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155521099 6-Quinolin-3-ylquinazoline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646243 2-methoxy-5-[6-[(3S)-1-(morpholine-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44436979 N''-((6-bromoisoquinolin-4-yl)methylene)-N,2-dimethyl-5-nitrobenzenesulfonohydrazide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379523 8-(2-Aminopyrimidin-5-yl)-1-(4-hydroxycyclohexyl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072541 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-(1-methylpiperidin-3-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118616958 2,5-difluoro-N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072616 8-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorobenzoyl]-1-oxa-8-azaspiro[4.5]decan-3-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072637 8-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorobenzoyl]-1-oxa-8-azaspiro[4.5]decan-3-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44181707 6-(1H-indazol-4-yl)-N-(3-methoxyphenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699954 (S)-2-((1-(2-amino-7-ethylbenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072843 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(1,2,4-oxadiazol-3-ylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148794 (3R,3'R)-4,4'-(8-(1H-Indol-4-yl)-9H-purine-2,6-diyl)bis(3-methylmorpholine) 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072738 N-[2-[4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorobenzoyl]piperazin-1-yl]ethyl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930407 [(3R)-3-(dimethylamino)pyrrolidin-1-yl]-[4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539863 2,4-difluoro-N-[2-methoxy-5-[4-[4-[(4-propan-2-ylpiperazin-1-yl)methyl]phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881898 1-Ethyl-3-[3-(naphthalen-2-ylamino)pyrido[2,3-b]pyrazin-6-yl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495292 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-(1,3-oxazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354251 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]-[4-(oxan-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45255193 Methyl 4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-1-yl)piperidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:62706159 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(2-methoxypyridin-3-yl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688506 (S)-2-methoxy-5-(6-(1-((1-methylpiperidin-4-yl)methyl)pyrrolidin-3-yloxy)-2H-benzo[b][1,4]oxazin-4(3H)-yl)nicotinonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072588 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-[(dimethylamino)methyl]piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341522 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-4-propan-2-ylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:50991431 [6-(7-chloro-1H-pyrazolo[3,4-c]pyridin-4-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53322733 5,5''-(2-Morpholinopyrimidine-4,6-diyl)dipyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073720 5-[2-[4-(3-Azaspiro[5.5]undecan-3-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548417 4-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[(1S)-1-morpholin-4-ylethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56652245 (4,4-difluorocyclohexyl)-[(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177405 (R)-N-methyl-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700680 2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073082 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073016 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073029 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811704 (2S)-2-hydroxy-1-[4-[[4-(1H-indazol-4-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646341 1-[(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-3-hydroxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444211 5-[7-(3,3-Difluorocyclobutyl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884285 2-(3-((4-hydroxy-3-oxobenzofuran-2(3H)-ylidene)methyl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073056 [(8aS)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341608 5-[2-[4-Ethyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379570 1-[1-(2-hydroxyacetyl)piperidin-4-yl]-8-(1H-indazol-4-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89649556 [(3S)-3-[[4-(2-methylpyridin-4-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072981 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-cyclopentylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072918 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(1,1-dioxothiolan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:149380764 1-[[6-[5-[(2-Chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]methyl]cyclopropane-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548301 4-[2-[(6-methoxypyridin-3-yl)amino]-5-[(1R)-1-(4-methylsulfonylpiperazin-1-yl)ethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353856 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379487 8-[6-(Dimethylamino)-3-pyridinyl]-1,3-dihydro-1-[1-(2-hydroxyacetyl)-4-piperidinyl]-3-methyl-2H-imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53387572 N-[5-(3H-benzimidazol-5-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57395365 N-[(E)-1-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)butylideneamino]-2-methyl-5-nitrobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900418 2-[2-(2-Hydroxy-2-methylpropyl)-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688477 (S)-3-[1-(6-Methoxy-5-methyl-pyridin-3-yl)-2,3-dihydro-1H-pyrido[3,4-b][1,4]oxazin-7-yloxy]-pyrrolidine-1-carboxylic acid tert-butyl ester 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072697 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[(1-methylpiperidin-4-yl)methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379587 1-[4-(2-hydroxyethoxy)cyclohexyl]-8-(6-methoxypyridin-3-yl)-3H-imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072538 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-pyridin-4-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379577 1-[1-[2-(Dimethylamino)acetyl]piperidin-4-yl]-8-[6-(dimethylamino)pyridin-3-yl]-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44601112 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}phenyl)-3-ethylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548265 2-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5-fluoropyridin-3-yl)amino]pyridin-3-yl]propan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44413114 5-((5-(2-Hydroxy-5-nitrophenyl)furan-2-yl)methylene)-2-thioxothiazolidin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147772806 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-2-methyl-N-pentan-3-ylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66546792 N-[5-[3-(3-cyanophenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379619 1-(4-Hydroxycyclohexyl)-8-(6-methoxypyridin-3-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122179714 N-(4-methylphenyl)-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-9-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56650205 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-(1,3-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56655320 2-methoxy-5-[4-[[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]amino]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:131704412 [[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl-methylamino]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354052 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548421 N-(5-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-2-ylamino)pyridin-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145970821 N-[6-[5-[(5-chlorothiophen-2-yl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylthieno[2,3-d]pyrimidin-2-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71453425 6-[(3-hydroxy-2,2-dimethylpropyl)-(naphthalen-1-ylmethyl)amino]-4-morpholin-4-yl-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122179493 N-[2-(2-fluorophenyl)ethyl]-3-(6-methoxypyridin-3-yl)-5-[[4-[methyl-(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]anilino]methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118378631 [2-[1-[(5-Ethoxypyrazin-2-yl)methyl]piperidin-4-yl]indazol-5-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155559468 1-[4-[4-(3,6-dihydro-2H-pyran-4-yl)pyrimidin-2-yl]phenyl]-3-ethylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661314 [(3S)-3-[[4-[5-(difluoromethyl)-6-methylsulfonylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-[(3R)-oxolan-3-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072984 5-[2-(4-Ethyl-6-phenylpyrimidin-5-yl)ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709072 4-Chloro-2-[1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354148 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072651 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(9-methyl-3,9-diazaspiro[5.5]undecan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444298 5-[7-(1-Cyclopropylsulfonylazetidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646291 1-[(3R)-3-[(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168288534 1,2-dimethyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072904 5-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N,N-diethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:129012340 9-(6-Acetylpyridin-3-yl)-1-[3-(trifluoromethyl)phenyl]-4a,5,6,6a,7,8,9,10,10a,10b-decahydropyrimido[5,4-c][1,5]naphthyridine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353180 (4-Cyclobutylpiperazin-1-yl)-[4-[6-ethyl-5-[2-[6-(ethylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900462 4-(2-chlorophenyl)-3-(4,5-dihydrothieno[3,2-d][1]benzoxepin-2-yl)-1H-1,2,4-triazol-5-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379662 1-[1-[2-(Dimethylamino)acetyl]piperidin-4-yl]-3-methyl-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072577 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-hydroxy-4-methylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56652243 [(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(2,2-dimethyloxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073083 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-[4-(1-hydroxyethyl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073662 5-[2-[4-Ethyl-6-(4-methoxy-4-methylpiperidin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76317572 N-[5-(7-amino-1-cyclopentyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]-4-methoxybenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617588 1-[(3S)-3-[[4-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71452476 2-Amino-4-[5-chloro-2-[[6-chloro-5-[[2-methoxyethyl(methyl)sulfamoyl]amino]pyridin-3-yl]amino]pyridin-3-yl]-6-methyl-1,3,5-triazine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646880 US9763952, Example G1 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379545 1-[4-(2-Hydroxyethoxy)cyclohexyl]-3-methyl-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072986 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(1,1-dioxothiolan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353372 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(2-hydroxycyclopentyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700806 US10065970, Example 287 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073089 5-[2-[4-(6-Methoxypyridin-3-yl)-6-methylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168275168 1-cyclopropyl-2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118341923 2-[4-[[6-(4-Acetylphenyl)quinazolin-4-yl]amino]phenyl]acetonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042084 17-Methoxy-14,14-dioxo-14lambda6-thia-2,7,15,18,25,27-hexazahexacyclo[19.6.2.22,5.19,13.116,20.024,28]tritriaconta-1(27),9(31),10,12,16,18,20(30),21(29),22,24(28),25-undecaen-8-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700496 (S)-2-cyclopropyl-2-((1-(2-fluoro-4-methoxyphenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354569 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]-[4-(oxan-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44606999 4-(4-Morpholin-4-yl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)aniline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701264 (S)-5-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)picolinamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145968593 N-[5-(2-amino-4-methyl-7-oxo-8H-pyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127049342 5-(8-Cyclobutyl-9-methyl-6-morpholin-4-ylpurin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913310 4-Fluoro-N-(5-imidazo[1,2-a]pyridin-3-yl-3-pyridinyl)benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168270599 3-anilino-5-[2-(cyclopropanecarbonylamino)pyridin-4-yl]-N-[2-(dimethylamino)ethyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072679 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluoro-N-(piperidin-4-ylmethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072758 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(1,2,4-oxadiazol-3-ylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798683 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3,3-dimethylmorpholin-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44606820 2-[4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N-methylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168286487 N-[4-[3-anilino-5-(methylsulfamoyl)phenyl]pyridin-2-yl]oxane-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699982 US10065970, Example 266 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155543277 1-ethyl-3-[4-[4-(2-methylsulfonylpropan-2-yl)-6-[(1S,6R)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646175 5-[6-[(3S)-1-(1,3-dimethylpyrazole-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52936958 N-(5-(3-(2H-Tetrazol-5-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69931068 N-[[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]methyl]-3-methylbutanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:88979953 [6-(5-Amino-6-chloropyridin-3-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677222 [(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1,3-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44348080 [1-(3-Phenylpropyl)piperidin-3-yl]methyl 2-fluorobenzoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45255196 3-Methyl-1-[1-(2-methylpropanoyl)piperidin-4-yl]-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646761 5-[6-[(3S)-1-(2,4-dimethyl-1,3-oxazole-5-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56653621 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-pyridin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495298 (3S)-N-(2-hydroxyethyl)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]-N-methylpyrrolidine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798551 1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-4-ethylpiperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67348760 8-(6-Methoxypyridin-3-yl)-3-methyl-1-(2-piperazin-1-ylethyl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884549 1-(4-(4,6-bis((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-3-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701031 US10065970, Example 271 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403580 1-(3-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidin-1-yl)-2-methylpropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:124169471 CID 124169471 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162660172 4-[4-(2-chlorophenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58298333 7-(6-(2-Hydroxypropan-2-yl)pyridin-3-yl)-1-(2-methoxyethyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71037649 6-(2-Amino-1,3-benzoxazol-6-yl)-3-(oxan-4-yl)quinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49786097 (6-(6-methoxypyridin-3-ylamino)-5-(2-methyl-9H-purin-6-yl)pyridin-3-yl)methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664733 [(3S)-3-[[4-[5-(methylamino)-6-methylsulfonylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073741 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-1,4-diazepan-5-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353564 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(1-methoxypropan-2-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785918 4-[[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5-fluoro-6-methoxypyridin-3-yl)amino]pyridin-3-yl]methyl]-N-methyl-N-(2,2,2-trifluoroethyl)piperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798577 6-(2-Amino-1,3-benzoxazol-5-yl)-3-cyclobutylquinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56833539 4-[2-(1H-indazol-4-yl)thieno[2,3-d]pyrimidin-4-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354570 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:62706476 3-(2-methylpyrimidin-4-yl)-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL2375963 CHEMBL2375963 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134814186 3-[(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidine-1-carbonyl]-3H-pyridin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403584 3-((3-(2-aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)-N-(methoxymethyl)azetidine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444227 5-[7-[(1S)-3,3-difluorocyclopentyl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11652531 3-[5-(2,4-Dioxothiazolidin-5-ylidenemethyl)furan-2-yl]-4-hydroxybenzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:78426978 26-Methoxy-23,23-dioxo-23lambda6,32-dithia-6,8,12,16,24,27-hexazahexacyclo[23.3.1.12,5.110,14.118,22.04,9]dotriaconta-1(29),2,4(9),5,7,10,12,14(31),18(30),19,21,25,27-tridecaen-17-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072972 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-ethylsulfonylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44129511 (2S)-1-N-[4-methyl-5-(2-propan-2-yl-1,3-thiazol-4-yl)-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073031 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(2-methoxyethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072854 3-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-N,N-diethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072781 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-[(3-methyl-1,2-oxazol-5-yl)methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:68313479 2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrob enzo[f]imidazo[1,2-d][1,4]oxazepine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56655322 1-[4-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidine-1-carbonyl]piperidin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913523 N-[5-(6-benzyl-5-oxoimidazo[1,2-c]pyrimidin-3-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072594 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(2,7-diazaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913214 N-(2-Chloro-5-(2-methylimidazo[1,2-a]pyridin-3-yl)-3-pyridinyl)-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072928 [(9aS)-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072776 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-tert-butylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072668 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethyl)phenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58204851 2-[4-[2-(2,5-Dimethyl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]ethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539683 2,4-difluoro-N-[2-methoxy-5-(4-morpholin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53387571 N-[5-(2-amino-3H-benzimidazol-5-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539043 4-fluoro-N-[5-[4-[4-[[2-hydroxyethyl(methyl)amino]methyl]phenyl]quinolin-6-yl]-2-methoxypyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44348101 [1-(3-Phenylpropyl)piperidin-3-yl]methyl 2-(2,5-dioxo-3-prop-2-enylpyrrolidin-1-yl)benzoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59507663 N-[6-(6-amino-4-chloropyridin-3-yl)-2-morpholin-4-ylpyrimidin-4-yl]quinolin-3-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51351033 9-(6-aminopyridin-3-yl)-1-(3-chloro-4-fluorophenyl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677442 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-pyrazin-2-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25009673 5-(4,6-Dimorpholin-4-ylpyrimidin-2-yl)-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46215565 2-[6-(2-Hydroxypropan-2-yl)pyridin-3-yl]-8-[(4-methoxycyclohexyl)methyl]-5,7-dihydropyrazino[2,3-b]pyrazin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70686372 6-(2-aminopyrimidin-5-yl)-5-chloro-N-(2-methoxyethyl)-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798830 [6-[2-(Cyclopropylamino)-1,3-benzoxazol-5-yl]imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798777 N-methyl-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridine-3-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53320444 N-(2-hydroxy-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60142907 9-(6-methoxypyridin-3-yl)-3-methyl-1-[4-piperazin-1-yl-3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072991 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(3-methyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168272950 N-(2-amino-2-oxoethyl)-3-anilino-5-[2-(cyclopropanecarbonylamino)pyridin-4-yl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073666 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-4-cyclohexylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700987 (S)-1-(1-(3-chloro-4-(1H-1,2,4-triazol-3-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25260759 cis-1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(4-hydroxycyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072860 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(1-oxa-4,9-diazaspiro[5.5]undecan-9-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56652919 (2,2-dimethyloxan-4-yl)-[(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25070227 4-(2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-9H-purin-6-yl)morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073069 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-hydroxypiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798549 [6-(2-Amino-1,3-benzoxazol-6-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]-pyrrolidin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646413 2-methoxy-5-[6-[(3S)-1-(5-oxopyrrolidine-3-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495286 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(5-methyl-1,3,4-oxadiazol-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072809 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(3-morpholin-4-ylpyrrolidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930254 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-chloro-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495350 6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-4-((S)-1-pyridin-2-yl-pyrrolidin-3-yloxy)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072863 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072875 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[3-(methoxymethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072648 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]-[4-(1-hydroxyethyl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664716 [(3S)-3-[[4-(6-chloro-5-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:123332798 9-(6-isocyanopyridin-3-yl)-3-methyl-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073642 2-[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]-N-ethyl-N-methylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56652591 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(5-methyl-1,3-oxazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379601 1-[1-(2-hydroxyacetyl)piperidin-4-yl]-3-methyl-8-(1H-pyrazolo[3,4-b]pyridin-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072796 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]phenyl]-(oxazinan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073672 1-[6-Ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]piperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785521 4-(5-((5,6-Dihydro-[1,2,4]triazolo[1,5-A]pyrazin-7(8H)-YL)methyl)-2-(6-methoxypyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072626 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(4-propylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073004 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701243 methyl (S)-5-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)-2-methoxybenzoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548276 2-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5-methoxypyridin-3-yl)amino]pyridin-3-yl]propan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444290 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidine-1-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89589944 9-(2-methoxypyrimidin-5-yl)-3-methyl-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71458544 4-(Benzylamino)-6-morpholin-4-ylpyrimidine-2-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539744 N-[5-(4-chloroquinolin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:42632992 3-{7-[1-(4-fluorobenzyl)piperidin-4-yl]-4-morpholin-4-yl-5H-pyrrolo[3,2-d]pyrimidin-2-yl}phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164618439 N-[[5-[6-[5-(benzenesulfonamido)-6-methoxypyridin-3-yl]-7-methylthieno[3,2-d]pyrimidin-4-yl]thiophen-2-yl]methyl]formamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341484 5-[2-[4-(4-Cyclopropylpiperazin-1-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44156033 3-(1-phenyl-4-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168298549 N-[8-[6-(hydroxyamino)-6-oxohexoxy]-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073738 4-Ethyl-1-[6-ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]piperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548260 N'-(5-((3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(4-morpholinylmethyl)-2-pyridinyl)amino)-2-chloro-3-pyridinyl)-N,N-dimethylsulfamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:1018277 N-(3-chlorophenyl)-4-morpholin-4-yl-6-pyrazol-1-yl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379510 3-Methyl-1-(1-methylpiperidin-4-yl)-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354250 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379658 3-Methyl-8-quinolin-3-yl-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134148055 2,4-difluoro-N-[2-morpholin-4-yl-5-[4-[4-(morpholin-4-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44129198 (2S)-1-N-[5-[2-(dimethylamino)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072601 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155544916 1-ethyl-3-[4-[4-(methylsulfonylmethyl)-6-[(1R,6S)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072666 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-hydroxy-N,2-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46864999 (R)-1-(4-(4-(3-methylmorpholino)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072676 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-cyclopropylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:152818126 3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-(trifluoromethyl)pyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147583728 (2R)-3-[6-[5-[[3,5-bis(trifluoromethyl)phenyl]sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164622086 3-[6-amino-5-(5-methyl-1,3,4-oxadiazol-2-yl)pyridin-3-yl]-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701253 (S)-2-((1-(2-aminobenzo[d]thiazol-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073042 2-[4-[4-[5-[2-(6-amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]piperazin-1-yl]-N,N-dimethylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661342 (1,1-dioxothian-4-yl)-[(3S)-3-[[4-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66600035 N-[4-[[3-(2-methyl-7H-purin-6-yl)pyridin-2-yl]amino]phenyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46232682 cis-1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(4-methoxycyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073677 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688503 2-Methoxy-5-{2-methyl-6-[(S)-1-(tetrahydro-pyran-4-carbonyl)-pyrrolidin-3-yloxy]-2,3-dihydro-benzo[1,4]oxazin-4-yl}-nicotinonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647238 2-methoxy-5-[6-[(3S)-1-(5-oxopyrrolidine-2-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379489 1-[1-(2-Hydroxy-2-methylpropanoyl)piperidin-4-yl]-3-methyl-8-(1-methylpyrazol-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127029440 N-[4-chloro-3-(trifluoromethyl)phenyl]-4-(4-morpholin-4-yl-6,6-dioxo-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-yl)piperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71250882 7-[3-(Hydroxymethyl)-4-methoxyphenyl]-4-morpholin-4-ylpyrido[2,3-d]pyrimidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168292855 3-anilino-5-[2-(cyclopropanecarbonylamino)pyridin-4-yl]-N-[3-(dimethylamino)propyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700516 US10065970, Example 293 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155547524 5-[4,6-bis[(3S,5R)-3,5-dimethylmorpholin-4-yl]-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379616 1-[1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl]-3-methyl-8-(1H-pyrazolo[3,4-b]pyridin-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884064 (Z)-1-(2-((1-methyl-4-morpholino-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072887 4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorobenzoyl]piperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073080 [(8aS)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11601930 5-[5-(5-Fluoro-2-hydroxyphenyl)furan-2-ylmethylene]thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700962 (S)-2-((1-(3H-imidazo[4,5-b]pyridin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44180615 6-(1h-Indazol-4-yl)-1-methyl-n-(1-methylpiperidin-4-yl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646029 [(3S)-3-[[4-(6-chloro-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53387740 N-[5-(1,2-benzothiazol-5-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:24888752 3-(2-morpholino-7-(pyridin-4-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700665 (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44348411 [1-(3-Phenylpropyl)piperidin-3-yl]methyl 2-(3-benzyl-2,5-dioxopyrrolidin-1-yl)benzoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700963 (S)-2-cyclopropyl-2-((1-(2-methoxyquinoxalin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072775 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127047042 N-(4-benzoylphenyl)-1h-indole-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073643 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-1-yl]-(furan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127047188 N-[4-[hydroxy(phenyl)methyl]phenyl]-1H-indole-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072701 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646081 2-methoxy-5-[6-[[(4R)-2-(1-methylimidazole-4-carbonyl)-1,2-oxazolidin-4-yl]oxy]-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072646 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[4-(1,1-dioxothiolan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173831 US11236079, Example 6 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072546 [5-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-piperidin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118148657 2-methyl-2-[4-(3-methyl-2-oxo-9-quinolin-3-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-1-yl)phenyl]propanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379620 3-Methyl-1-(1-methylpiperidin-4-yl)-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072978 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[4-(dimethylamino)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913312 N-[2-chloro-5-(7-methylimidazo[1,2-a]pyridin-3-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:149127234 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-2-methyl-N-(oxetan-3-yl)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148841 (3S)-4-[8-(1H-indol-6-yl)-2-morpholin-4-yl-7H-purin-6-yl]-3-methylmorpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661310 [(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1-methylpyrazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379521 1-[1-[2-(Dimethylamino)acetyl]piperidin-4-yl]-3-methyl-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353953 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-(2-methoxyethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118616331 4-methoxy-N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646634 2-methoxy-5-[6-[(3S)-1-(1,3-thiazole-5-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661357 1-[(3S)-3-[[1-[5-(difluoromethyl)-6-methylsulfonylpyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-2-methoxyethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913422 3-(3-(5,6-Dimethoxy-3-pyridinyl)imidazo[1,2-a]pyridin-6-yl)-1,3-oxazolidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53323077 N-(2-(cyclobutylmethoxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:72549554 5-(6-((4-(Methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo [2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76335665 3-(2-Morpholin-4-ylpyrido[3,2-d]pyrimidin-4-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700010 US10065970, Example 297 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700985 (S)-2-cyclopropyl-2-((1-(6-methoxypyridin-3-yl)-1,7,8,9-tetrahydrooxepino-[4,3,2-cd]indazol-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86581758 [7-[1-[(6-Methoxypyridin-3-yl)methyl]piperidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646925 2-methoxy-1-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673808 4-bromo-1-(2-methyloxazolo[4,5-b]pyridin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulene 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699980 US10065970, Example 264 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148795 1-[8-(1H-indol-4-yl)-6-[(3S)-3-methylmorpholin-4-yl]-7H-purin-2-yl]piperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155566863 3-[4-(methylsulfonylmethyl)-6-[(1S,6R)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145968143 N-[5-[4-[2-(dimethylamino)ethylamino]quinazolin-6-yl]-2-methoxypyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403585 5-(3-((2-Fluorobenzyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072895 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-piperazin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699989 US10065970, Example 278 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148745 3-(2,4-Di-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)-phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072829 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-(2-methoxyethyl)-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072893 5-[2-[4-(6-Cyclopropylpyridin-3-yl)-6-methylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354252 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71472134 20-Fluoro-5-methoxy-8,8-dioxo-8lambda6-thia-4,7,15,25-tetrazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22(30),23,25,27-tetradecaen-14-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930166 [4-[6-ethyl-5-[2-[6-(ethylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]-(3-methyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072684 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073690 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperidin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699949 (S)-2-((1-((R)-3-(hydroxymethyl)-piperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444309 (3R,4R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-4-methoxy-N-methylpyrrolidine-1-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930771 N-[[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]methyl]-2-(dimethylamino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71037776 5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]-N-phenylpyridine-3-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155526193 3-[4-(Oxan-4-yl)pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59477194 (3R)-4-[2-(1H-indol-5-yl)-6-(methylsulfonylmethyl)pyrimidin-4-yl]-3-methylmorpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072832 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-[2-(dimethylamino)ethyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699956 (S)-2-cyclopropyl-2-((1-(pyrazolo[1,5-a]pyrimidin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173837 US11236079, Example 5 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881789 1-[3-(4-Chloroanilino)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:24970086 (2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76324910 N-[5-(7-amino-1-cyclopentyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699941 (S)-2-cyclopropyl-2-((1-(2-(hydroxymethyl)-6-methylpyrimidin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072707 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-hydroxypiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155555936 tert-butyl (3S)-3-[[6-[5-(methanesulfonamido)-6-methoxypyridin-3-yl]quinazolin-4-yl]amino]pyrrolidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155551907 2-(methylamino)-N-[4-[4-(methylsulfonylmethyl)-6-[(1R,6S)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699948 (S)-2-cyclopropyl-2-((1-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072871 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-ethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:91933688 (4aS,11cS)-6a,10-Dihydroxy-4,4,11c-trimethyl-1,3,4,4a,5,6,6a,11c-octahydro-2H-benzo[b]naphtho[1,2-d]furan-9-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74538916 2,4-difluoro-N-[2-methoxy-5-[4-[4-(pyrazol-1-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700687 (6-(4-bromo-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)quinoxalin-2-yl)methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46885495 4,6-dihydroxy-2-((2-methyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930772 N-[[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]methyl]-3-methoxypropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646872 1-[(3S)-3-[[4-(6-ethylsulfinylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56654309 {(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yloxy]-pyrrolidin-1-yl}-(1-methyl-1H-pyrazol-4-yl)-methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57427751 1-[2-(dimethylamino)ethyl]-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-6-(methylsulfonylmethyl)pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072878 [4-(Aminomethyl)piperidin-1-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073724 9-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-3,9-diazaspiro[5.5]undecane-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073654 5-[2-[4-(1,5-Dioxa-9-azaspiro[5.5]undecan-9-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709084 N-(2-hydroxyethyl)-N-methyl-9-[1-(2-methylphenoxy)ethyl]-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145955956 6-(5-Fluoro-6-methoxypyridin-3-yl)-4-methyl-8-(oxan-4-yloxy)quinazolin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072833 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-hydroxypiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548174 4-[(1S)-1-[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[[6-chloro-5-(dimethylsulfamoylamino)pyridin-3-yl]amino]pyridin-3-yl]ethyl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900394 2-[2-(2-Methylpropyl)-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147710307 2-Amino-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145961404 1-[4-[3-[6-(6-methoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]benzoyl]piperazin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168297563 N-[4-[3-(methylcarbamoyl)phenyl]pyridin-2-yl]oxolane-3-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072547 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(oxetan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146906937 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N-cyclopropyl-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701228 (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798755 [6-(2-Amino-6-chloro-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:153532124 PI3K/mTOR Inhibitor-5 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798573 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(3-morpholin-4-ylpropyl)quinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798434 5-[5-Methyl-3-(3-morpholin-4-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664675 [(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-pyridin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67346365 1-(1-Acetylpiperidin-4-yl)-8-(4-methoxyphenyl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700495 (S)-2-cyclopropyl-2-((1-(3-(difluoromethoxy)-phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042062 18-Methoxy-15,15-dioxo-15lambda6-thia-4,5,8,16,19,25,26,29-octazahexacyclo[20.5.2.12,5.110,14.117,21.025,28]dotriaconta-1(28),2(32),3,10(31),11,13,17,19,21(30),22(29),23,26-dodecaen-9-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073068 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-(4-hydroxy-4-methylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072842 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(1-methylpiperidin-3-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166628282 1-[4-[[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]piperidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:1839691 (6E)-5-imino-6-[(4-oxochromen-3-yl)methylidene]-2-(4-oxocyclohexa-2,5-dien-1-ylidene)-3H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46946049 6-(2-aminopyrimidin-5-yl)-N-(4-hydroxycyclohexyl)-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL3218579 CHEMBL3218579 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379525 1-(4-hydroxycyclohexyl)-3-methyl-8-(1H-pyrazol-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539045 4-fluoro-N-[2-methoxy-5-[4-[4-(1,2,4-triazol-1-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900428 2-[2-(2,4-Difluorophenyl)-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71528752 9-(6-aminopyridin-3-yl)-3-methyl-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042081 18-Methoxy-15,15-dioxo-15lambda6-thia-4,5,8,16,19,26,28-heptazahexacyclo[20.5.2.12,5.110,14.117,21.025,28]dotriaconta-1(27),2(32),3,10(31),11,13,17,19,21(30),22(29),23,25-dodecaen-9-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072553 5-[2-[4-[6-(Dimethylamino)pyridin-3-yl]-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785252 N-(6-methoxypyridin-3-yl)-3-(2-methyl-7H-purin-6-yl)-5-(4-methylsulfonylpiperazin-1-yl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664699 [2-[(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-2-oxoethyl] methanesulfonate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881888 1-[3-(3,4-Dimethoxyanilino)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89212428 (2S)-1-N-[5-(2-amino-1,3-benzoxazol-5-yl)-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145968320 N-[5-(2-amino-4-methylthieno[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646877 5-[6-[(3S)-1-(4-hydroxycyclohexanecarbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177400 (R)-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46865000 (R)-1-(4-(4-isopropylpiperazine-1-carbonyl)phenyl)-3-(4-(4-(3-methylmorpholino)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379544 1-(1-Acetylpiperidin-4-yl)-8-(2-methoxypyrimidin-5-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072995 2-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]phenyl]-2-methylpropanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073022 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-propan-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59453077 3-[6-(2-Hydroxypropan-2-yl)pyridin-3-yl]-5-[(4-methoxycyclohexyl)methyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930256 6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl-[4-[6-ethyl-5-[2-[6-(ethylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173835 US11236079, Example 2 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073070 3-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N,N-diethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173605 (E)-2-(2-((3-(2-aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)vinyl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646408 [(3S)-3-[[1-[5-(difluoromethyl)-6-methoxypyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49786096 2-(6-(6-methoxypyridin-3-ylamino)-5-(2-methyl-9H-purin-6-yl)pyridin-3-yl)ethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162653664 2-[4-[4-Morpholin-4-yl-6-(2-morpholin-4-ylethylamino)-1,3,5-triazin-2-yl]piperazin-1-yl]sulfonylphenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71748054 1-[4-[[4-(2-Aminopyrimidin-5-yl)-6-methyl-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]-2-hydroxyethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59251838 N-[6-(6-aminopyridin-3-yl)-1,3-benzothiazol-2-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4799656 CHEMBL4799656 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76335784 N-[5-[7-amino-1-[4-(2-hydroxyethoxy)cyclohexyl]-5-methyl-2-oxo-1,6-naphthyridin-3-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072877 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-(hydroxymethyl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46180665 N-((2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701001 (S)-2-((1-(2-amino-4-fluorobenzo[d]oxazol-5-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]-inden-4-yl)oxy)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072698 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(2-methoxyethyl)-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46225259 4-(6-morpholino-9H-purin-2-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617703 1-[(3S)-3-[[4-[5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166634213 1-[4-[[4-[4-[(3S)-3-methylmorpholin-4-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]carbamoylamino]benzoyl]piperidine-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073723 5-[2-[4-Methyl-6-(1,4-oxazepan-4-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444296 5-[7-(1-Ethylsulfonylazetidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354057 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-propan-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072935 [(3aS,6aS)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrol-5-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59507919 N-[6-(2-amino-4-methylpyrimidin-5-yl)-2-morpholin-4-ylpyrimidin-4-yl]quinolin-3-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072797 1-[4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylbenzoyl]piperazin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44181374 6-(1h-Indazol-4-yl)-1-methyl-4-(4-(methylsulfonyl)phenoxy)-1h-pyrazolo[3,4-d]pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913527 N'-(2-Chloro-5-(7-(4-pyridinyl)imidazo[1,2-a]pyridin-3-yl)-3-pyridinyl)-N,N-dimethylsulfamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162658235 2,4-difluoro-N-[2-methoxy-5-[4-[(E)-4-morpholin-4-yl-4-oxobut-2-en-2-yl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155560767 3-[4-[(1R,6S)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072802 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-fluoro-N-methoxy-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89649454 [(3S)-3-[[4-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072838 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647147 1-[(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700697 (S)-2-((1-(2-amino-7-(trifluoromethyl)-benzo[d]-oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71600385 2,2,2-trifluoro-1-[4-(7-quinolin-3-yl-3,5-dihydro-2H-1,4-benzoxazepine-4-carbonyl)phenyl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701235 (S)-2-((1-(2-amino-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56652592 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(3-methyl-1,2-oxazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:148408193 3-[6-[5-[(2-Chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353853 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-cyclopentylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072989 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]phenyl]-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700795 US10065970, Example 275 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701233 (S)-4-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)picolinamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155544961 5-[4,6-bis[(3S,5S)-3,5-dimethylmorpholin-4-yl]-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168296702 [(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-phenylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162662639 4-[4-(4-chlorophenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072828 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-(2-methoxyethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89589905 3-methyl-9-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073648 5-[2-[4-(2,2-Dimethylmorpholin-4-yl)-6-methylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353370 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(1-methoxypropan-2-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701226 (S)-2-cyclopropyl-2-((1-(thiazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881810 1-[3-(3-Chloro-4-methoxyanilino)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155175096 (2R)-3-[6-[6-amino-5-[(2-chloro-4-fluorophenyl)sulfonylamino]pyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353373 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(2-hydroxypropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127028516 1-(3-chloro-4-fluorophenyl)-3-[5-(4-morpholin-4-yl-6,6-dioxo-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-yl)pyridin-2-yl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11268375 N-[4-(3-anilinophenyl)pyridin-2-yl]oxolane-3-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118341870 2-[4-[(6-Pyridin-4-ylquinazolin-4-yl)amino]phenyl]acetonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155129768 (S)-PI3Kalpha-IN-4 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495360 1-(4-{(S)-3-[6-(6-Methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yloxy]-pyrrolidine-1-carbonyl}-piperazin-1-yl)-ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700684 (S)-2-((1-(2-chloro-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073013 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[1-(2-methoxyethyl)piperidin-4-yl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548197 N-[5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-[(1S)-1-morpholin-4-ylethyl]pyridin-2-yl]amino]-2-chloropyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073726 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-4-ethylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118321322 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-4-methoxybenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59507731 2-amino-5-[2-morpholin-4-yl-6-(quinolin-3-ylamino)pyrimidin-4-yl]-1H-pyrimidin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:84972981 [(3S)-3-[[6-(5-isocyano-6-methoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1-methylpyrazol-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353955 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-(cyclopropylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072884 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701007 US10065970, Example 246 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155558535 3-[4-[(1S,6R)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700672 (S)-2-((1-(benzo[d][1,3]dioxol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444270 5-[7-[(3R)-1-methylsulfonylpiperidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688495 2-Methoxy-5-{6-[(S)-1-((R)-1-methyl-pyrrolidine-3-carbonyl)-pyrrolidin-3-yloxy]-2,3-dihydro-benzo[1,4]oxazin-4-yl}-nicotinonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072958 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]-(4-ethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700796 US10065970, Example 274 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164809094 N-(2-chloro-5-(3-cyano-4-((1R-phenylethyl)amino)quinolin-6-yl)pyridin-3-yl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661359 [(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,4-dioxan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354352 [2-Chloro-4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]phenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147977206 (2R)-3-[6-[5-[(3,5-dimethyl-1,2-oxazol-4-yl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164809087 N-(2-chloro-5-(3-cyano-4-((1-(4-fluorophenyl)ethyl)amino)quinolin-6-yl)pyridin-3-yl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71615953 (1-methylimidazol-4-yl)-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379653 1-[1-(2-Hydroxy-2-methylpropanoyl)piperidin-4-yl]-3-methyl-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548314 (3R)-1-[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]pyrrolidin-3-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661378 [(3S)-3-[[4-[5-(fluoromethyl)-6-methylsulfonylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073665 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperazin-1-yl]-(1,2-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71037726 (2S)-1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072566 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49786101 1-(4-((6-(6-methoxypyridin-3-ylamino)-5-(2-methyl-9H-purin-6-yl)pyridin-3-yl)methyl)piperazin-1-yl)ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646190 5-[(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidine-1-carbonyl]-1-methylpyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072557 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(9-methyl-3,9-diazaspiro[5.5]undecan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700505 US10065970, Example 262 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072733 5-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53235449 N-methyl-2-(2-propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazole-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811654 1-[4-[[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]-2-hydroxy-2-methylpropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072992 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-[(1-methylpiperidin-3-yl)methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379609 4-[8-[6-(Dimethylamino)pyridin-3-yl]-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]piperidine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647110 1-[(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072723 [(8aR)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44592302 2-((4-Fluoro-2-methylphenylamino)methyl)-6-(3-hydroxyphenyl)isonicotinic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646600 [(3S)-3-[[1-[6-(difluoromethoxy)-5-methylpyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072869 4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]-N-cyano-N'-methylpiperazine-1-carboximidamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44181599 4-(5-Morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11680937 1-Phenyl-2-[4-(propylamino)pyrazolo[3,4-d]pyrimidin-1-yl]ethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168269985 N-[4-[3-(2-fluoroanilino)-5-(methylcarbamoyl)phenyl]pyridin-2-yl]oxane-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353463 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-(1-methoxypropan-2-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53325726 N-(2-(2-cyclopropylethoxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548275 N-[5-[[3-(6-amino-2-methylpyrimidin-4-yl)-5-ethenylpyridin-2-yl]amino]-2-chloropyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:158809507 US11236079, Example 4 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072750 [3-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]phenyl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072890 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[4-(cyclopropylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66656078 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1,2-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53326857 N-(2-((3-methyloxetan-3-yl)methoxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073700 5-[2-[4-(1,4-Dioxa-8-azaspiro[4.5]decan-8-yl)-6-methylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811702 (2R)-1-[4-[[4-(2-aminopyrimidin-5-yl)-6-methyl-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548224 N-(4-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-((4-(methylsulfonyl)piperazin-1-YL)methyl)pyridin-2-ylamino)-2-fluorophenyl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168277254 (2S)-2-[[2-(5-amino-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]oxy]propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661311 (1,1-dioxothiolan-3-yl)-[(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44348287 [1-(3-Phenylpropyl)piperidin-3-yl]methyl 2-(3-butyl-2,5-dioxopyrrolidin-1-yl)benzoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86581756 [6-[1-[(5-methoxypyrazin-2-yl)methyl]piperidin-4-yl]-1H-benzimidazol-2-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617587 2-methoxy-N,N-dimethyl-5-[6-[(3S)-1-propanoylpyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073061 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-[2-(dimethylamino)ethyl]-2,6-difluoro-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539921 N-[5-[4-[4-[[cyclohexyl(ethyl)amino]methyl]phenyl]quinolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072560 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluoro-N-methyl-N-(1-methylpiperidin-4-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073039 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353566 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(2-hydroxycyclopentyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073075 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-[(3-methyl-1,2-oxazol-5-yl)methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67348261 1-[1-(2-Hydroxyacetyl)piperidin-4-yl]-8-(4-methoxyphenyl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49857093 (2S,7S,10R)-2,6,6,10-tetramethyl-12-oxatetracyclo[9.7.0.02,7.013,18]octadeca-1(11),13(18),14,16-tetraen-16-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646484 5-[6-[(3S)-1-(3,3-dimethylbutanoyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072619 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(cyclopropylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4756561 CHEMBL4756561 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646903 2-methoxy-5-[6-[(3S)-1-(3-methylimidazole-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072773 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548428 4-(2-(6-Methoxypyridin-3-ylamino)-5-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147240257 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-ethoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072680 5-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156023086 US10851091, U.S. Pat. No. 8,242,104 No. 549 isomer 1 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646308 2-methoxy-5-[6-[(3S)-1-(piperidine-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073002 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-methyl-N-[2-(2-oxopyrrolidin-1-yl)ethyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177406 5-(3-(Benzofuran-6-ylsulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341480 5-[2-[4-(4,4-Difluoropiperidin-1-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168281234 2-[2-[2-amino-6-(6-methoxy-5-methylpyridin-3-yl)-4-methylquinazolin-8-yl]oxyethyl-methylamino]-N-hydroxypyrimidine-5-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44181481 6-(1h-Indazol-4-yl)-1-methyl-4-(4-(methylsulfonyl)phenyl)-1h-pyrazolo[3,4-d]pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072779 [5-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-chlorophenyl]-piperidin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073045 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[(1-methylpiperidin-3-yl)methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072812 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-fluoro-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073037 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(1,1-dioxothiolan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444332 5-[7-(3-Methyl-1-methylsulfonylpyrrolidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798532 [6-(2-Amino-1,3-benzoxazol-6-yl)-8-fluoroimidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699960 (S)-1-(1-(2-aminobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]inden-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25070229 4-(2-(3-(methylsulfonyl)phenyl)-9H-purin-6-yl)morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147496436 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methylpyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661404 [(3S)-3-[[4-(5-chloro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothian-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53324065 N-(2-morpholino-6-(pyridin-3-yl)pyrimidin-4-yl)quinolin-3-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45254980 1-(1-Ethylpiperidin-4-yl)-3-methyl-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379554 1-[1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl]-8-(2-methoxypyrimidin-5-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25129734 N-(6-thiophen-3-yl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71463157 2-Amino-4-[2-[[6-chloro-5-(dimethylsulfamoylamino)pyridin-3-yl]amino]pyridin-3-yl]-6-methyl-1,3,5-triazine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072865 [(9aS)-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444311 5-[7-(1-cyclopropylsulfonylazetidin-3-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166627323 (2S)-1-[4-[[4-[4-[(3R)-3-methylmorpholin-4-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76310353 N-[5-[7-amino-1-(4-hydroxycyclohexyl)-5-methyl-2-oxo-1,6-naphthyridin-3-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71041945 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,19,24,25,28-heptazahexacyclo[20.5.2.12,6.19,13.117,21.025,29]dotriaconta-1(28),2(32),3,5,9,11,13(31),17(30),18,20,22(29),23,26-tridecaen-14-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073048 3-[4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorobenzoyl]piperazin-1-yl]propanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677434 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(2-methyl-1,3-oxazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11529859 5-[5-(2-Hydroxy-5-chlorophenyl)furan-2-ylmethylene]thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173230 (3-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidin-1-yl)(cyclopropyl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164556421 N-(2-chloro-5-(4-((1S-(4-fluorophenyl)ethyl)amino)quinazolin-6-yl)pyridin-3-yl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072926 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-pyridin-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46885494 4,6-dihydroxy-2-((5-phenoxy-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145968302 N-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylthieno[2,3-d]pyrimidin-2-yl]butanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164625154 2-[4-[[2-(4-Aminophenyl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700964 2-((1-(3-cyanopiperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661374 [(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-pyrimidin-5-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073714 5-[2-[4-Ethyl-6-(4-phenylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073019 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[(2R)-2,4-dimethylpiperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145970354 N-[5-(2-amino-4,8-dimethyl-7-oxopyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072931 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(3-hydroxypiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44606475 1-(4-(4-((1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177509 5-(3-Morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)-4-(trifluoromethyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155528302 N-[2-methoxy-5-[4-(piperidin-4-ylamino)quinazolin-6-yl]pyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798820 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3,5-dimethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134814183 3-[(3S)-3-[[4-(6-chloro-5-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidine-1-carbonyl]-3H-pyridin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353958 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(4-ethylpiperazin-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148864 N-[3-(2,6-dimorpholin-4-yl-7H-purin-8-yl)phenyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701000 (S)-2-((1-(4-(1H-1,2,4-triazol-3-yl)phenyl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]-inden-4-yl)oxy)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:42635322 [3-(4-morpholin-4-yl-5H-pyrrolo[3,2-d]pyrimidin-2-yl)phenyl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168287905 (2S)-1-[2-[(3S)-3-hydroxy-2-oxopyrrolidin-1-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:68198078 (3S)-3-methyl-4-[2-morpholin-4-yl-8-(1H-pyrrolo[3,2-b]pyridin-6-yl)-7H-purin-6-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379576 3-Methyl-8-(6-methylpyridin-3-yl)-1-(1-pyrimidin-2-ylpiperidin-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699979 US10065970, Example 265 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122609016 26-Methoxy-23,23-dioxo-23lambda6-thia-6,8,12,16,24,27,32-heptazahexacyclo[23.3.1.12,5.110,14.118,22.04,9]dotriaconta-1(29),2,4(9),5,7,10,12,14(31),18(30),19,21,25,27-tridecaen-17-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118617093 N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]-4-(trifluoromethyl)benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444218 5-[7-[(3S)-1-methylsulfonylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646665 4-(5-methyl-6-methylsulfonylpyridin-3-yl)-6-[(3S)-1-propan-2-ylsulfonylpyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073064 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-hydroxy-1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354678 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-cyclobutylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122184950 5-[7-[(Dimethylamino)methyl]-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072975 5-[2-(4-Ethyl-6-quinolin-3-ylpyrimidin-5-yl)ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56654648 oxan-4-yl-[(3S)-3-[(6-quinolin-3-yl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl)oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70681202 4-(4-chlorophenyl)-2-morpholin-4-yl-5-(2H-triazol-4-yl)thiophene-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164809103 N-(2-chloro-5-(3-cyano-4-((1S-phenylethyl)amino)quinolin-6-yl)pyridin-3-yl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58137170 4-[6-[(4-Fluorophenyl)sulfonylmethyl]-2-pyridin-2-ylpyrimidin-4-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44129348 (2S,4R)-1-N-[5-(2-tert-butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]-4-(dimethylamino)pyrrolidine-1,2-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11645168 5-[5-(2-Fluoro-4-hydroxyphenyl)furan-2-ylmethylene]thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:21595422 (1S)-2-phenylmethoxy-1-[(2S)-piperidin-2-yl]ethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155545535 1-ethyl-3-[4-[4-[(1R,6S)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798680 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(oxan-4-yl)quinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699743 US10065970, Example 249 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072941 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(4,4-difluoropiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56833740 2-N-[2-chloro-5-(4-methylpiperazine-1-carbonyl)phenyl]-2-N,8-N-dimethyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2,8-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548398 N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-2-yl)benzo[d]thiazol-5-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53324923 4-amino-2,7-dimethyl-N-(1H-pyrazol-5-yl)quinazoline-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177467 5-(4-Benzyl-6-morpholinopyridin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798617 [6-(3-Amino-1,2-benzothiazol-7-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53235144 2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazole-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353567 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(2-hydroxypropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072792 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(3-methyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168270572 N-hydroxy-4-[[5-(3-hydroxyphenyl)-3-morpholin-4-yl-2-oxopyrazin-1-yl]methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354674 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(4-propan-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072620 [(8aS)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617702 1-[(3S)-3-[(4-quinolin-3-yl-2,3-dihydro-1,4-benzoxazin-6-yl)oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353179 [4-[6-Ethyl-5-[2-[6-(ethylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073006 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[4-(oxan-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379646 Benzyl 4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-1-yl)cyclohexane-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647106 N,2-dimethoxy-N-methyl-5-[6-[(3S)-1-propanoylpyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073049 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89649720 N,2-dimethoxy-5-[6-[(3S)-1-propanoylpyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073734 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperazin-1-yl]-cyclobutylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072929 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-ethylsulfonylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930229 [2-chloro-4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]phenyl]-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072816 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-[2-(dimethylamino)ethyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073027 [4-[6-Ethyl-5-[2-[6-(ethylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042040 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,19,25,29-hexazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22(30),23,25,27-tetradecaen-14-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709091 9-[1-(3-fluoro-2-methylphenoxy)ethyl]-N-(2-hydroxyethyl)-N-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664865 2-methoxy-5-[(2S)-2-methyl-6-[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072727 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluoro-N-(2-piperazin-1-ylethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353855 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-ethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701254 (5-(4-bromo-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)benzo[d]oxazol-2-yl)methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548222 N-(5-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-chloropyridin-2-ylamino)-2-methoxypyridin-3-yl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072894 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71453177 Methyl 2-(benzylamino)-6-morpholin-4-ylpyridine-4-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155537776 6-(6-methoxy-5-methylpyridin-3-yl)-4-[1-(oxan-4-ylmethyl)pyrazol-4-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:78135650 [3-[[4-(6-Methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44596118 4-[5-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]-6-ethylpyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:152999622 (2R)-3-[6-[5-[(3,4-dichlorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072652 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164609518 26-Methoxy-23,23-dioxo-23lambda6,32-dithia-3,4,6,12,16,24,27-heptazahexacyclo[23.3.1.12,5.110,14.118,22.04,8]dotriaconta-1(29),2,5,7,10(31),11,13,18(30),19,21,25,27-dodecaen-17-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134304562 (S)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-N-(4-methoxybenzyl)-pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118378634 [5-[1-[(6-Methoxypyridin-3-yl)methyl]piperidin-4-yl]pyrazolo[1,5-a]pyridin-2-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072807 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methyl-N-[(3-methyloxetan-3-yl)methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072667 [(8aS)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70693799 Pfe-pkis 2 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646758 1-[(3S)-3-[[4-(6-chloro-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-3-hydroxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168297808 1-[(3S)-3-[6-(5-fluoro-6-methoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]oxypyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646459 2-methoxy-5-[6-[(3S)-1-(1,2-oxazole-5-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881846 1-Ethyl-3-[3-(3-methoxy-4-methylanilino)pyrido[2,3-b]pyrazin-6-yl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073699 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-4-phenylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688493 5-{6-[(S)-1-((S)-1-Acetyl-pyrrolidine-3-carbonyl)-pyrrolidin-3-yloxy]-2,3-dihydro-benzo[1,4]-oxazin-4-yl}-2-methoxy-nicotinonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:148860040 (2R)-3-[6-[6-methoxy-5-[(3-methylthiophen-2-yl)sulfonylamino]pyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072811 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-[(3-methyl-1,2-oxazol-5-yl)methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58137137 [3-[4-(Methylsulfonylmethyl)-6-morpholin-4-ylpyrimidin-2-yl]phenyl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495278 5-[4-[(3S)-1-(2,2-dimethyloxane-4-carbonyl)pyrrolidin-3-yl]oxy-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072608 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[(3S)-3-hydroxypyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072610 5-[2-(4-Methyl-6-phenylpyrimidin-5-yl)ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072597 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145967732 N-[5-(2-amino-4-methylthieno[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]cyclopropanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353954 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-(oxan-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71041970 25-Methoxy-12-methyl-22,22-dioxo-3,22lambda6,30-trithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,12,17(29),18,20,24,26-dodecaen-16-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127047187 N-[3-[hydroxy(phenyl)methyl]phenyl]-1H-indole-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51350806 9-(2-aminopyrimidin-5-yl)-1-(4-fluoro-3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44539783 (Z)-1-(2-((4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073005 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89935635 4-[4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorobenzoyl]piperazine-1-carbaldehyde 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145970234 N-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylthieno[2,3-d]pyrimidin-2-yl]propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617704 N,N-dimethyl-5-[6-[(3S)-1-propanoylpyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45255192 3-Methyl-1-(1-propanoylpiperidin-4-yl)-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67348410 8-(2-Aminopyrimidin-5-yl)-3-methyl-1-piperidin-4-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548329 4-(2-(6-Methoxypyridin-3-ylamino)-5-(2-(4-(methylsulfonyl)piperazin-1-yl)propan-2-yl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86346018 3-[(E)-[(4-morpholin-4-yl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-yl)hydrazinylidene]methyl]-4-oxochromene-6-carboxylic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:42606080 3-(Pyridin-3-ylethynyl)-1h-indazole 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072660 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166632421 1-[4-[[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]piperidine-3-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155514046 1-(2-hydroxyethyl)-3-[4-[4-(2-methylsulfonylpropan-2-yl)-6-[(1S,6R)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]thiourea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709088 N-(2-hydroxyethyl)-9-[1-(2-methoxyphenoxy)ethyl]-N-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072607 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethyl)phenyl]-(4-ethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646338 1-[(3S)-3-[[4-(5-chloro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-3-methylsulfonylpropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354248 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(2,7-diazaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25182020 N-(6-(2-(3-(pyridin-3-yl)propoxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072949 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-benzylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45254781 2-[4-[8-(5-Fluoro-6-methoxypyridin-3-yl)-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]phenyl]-2-methylpropanenitrile 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4848869 CHEMBL4848869 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073703 2-[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]-N-[2-(dimethylamino)ethyl]-N-methylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118987929 3-[(E)-[(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)hydrazinylidene]methyl]-4-oxo-4a,5,6,7,8,8a-hexahydrochromene-6-carboxylic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379623 1-(4-Hydroxycyclohexyl)-3-methyl-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52937064 N-(5-(3-Cyanoimidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072771 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56652590 5-[4-[(3S)-1-(2,4-dimethyl-1,3-oxazole-5-carbonyl)pyrrolidin-3-yl]oxy-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673839 (S)-2-((1-(pyrimidin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379556 8-[6-(Dimethylamino)pyridin-3-yl]-1-[4-(2-hydroxyethoxy)cyclohexyl]-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073721 [1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperidin-4-yl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341483 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072897 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-methyl-1,4-diazepan-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67346846 1-piperidin-4-yl-8-quinolin-3-yl-3H-imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60155999 3-[3-(3-aminophenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46893484 3-(1-(2-methylpyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072937 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(7-methyl-2,7-diazaspiro[4.4]nonan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073676 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-1-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709090 9-[1-(4-fluoro-3-methylphenoxy)ethyl]-N-(2-hydroxyethyl)-N-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168283226 4-[5-[1-(4-Fluorophenyl)-2-methylimidazo[4,5-c]quinolin-8-yl]pyrimidin-2-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811742 5-(2-Morpholin-4-ylfuro[3,2-d]pyrimidin-4-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072683 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:87150169 1-(2-hydroxyethyl)-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-6-(2-methylsulfonylpropan-2-yl)pyrimidin-2-yl]phenyl]thiourea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168282419 (2S)-2-[[2-[(4S)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]butanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700685 (S)-1-(1-(1H-benzo[d]imidazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155543517 3-[4-(3,6-dihydro-2H-pyran-4-yl)pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118617097 4-chloro-N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59453060 2-[6-(2-Hydroxypropan-2-yl)pyridin-3-yl]-8-(4-methoxycyclohexyl)-5,7-dihydropyrazino[2,3-b]pyrazin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930321 [4-[6-Ethyl-5-[2-[6-(ethylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]-(2-oxa-7-azaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44242297 4-(6,7-Dihydropyrido[3,2-b]thieno[2,3-d]oxepin-9-yl)-(5-(2-chlorophenyl))-oxazole 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073067 [(8aS)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:72376504 3-Amino-5-[4-(Morpholin-4-Yl)pyrido[3',2':4,5]furo[3,2-D]pyrimidin-2-Yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156011759 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N-(2,2-difluorocyclopropyl)-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664856 (1,1-dioxothian-4-yl)-[(3S)-3-[[1-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646380 1-[(3S)-3-[[4-(5-propan-2-ylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811652 (2S)-1-[4-[[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646504 N-[2-methoxy-5-[6-[(3S)-1-(1-methylimidazole-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072915 [5-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-fluorophenyl]-piperidin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25069911 N-(3-(6-morpholino-9H-purin-2-yl)phenyl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162652701 4-[4-(3-fluorophenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811537 4-[4-(1H-indazol-4-yl)-7-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-2-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354567 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]-[4-(2-hydroxy-2-methylpropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:124193954 US9758538, Example 33 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548175 4-[5-(2-Aminopropan-2-yl)-2-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379571 8-[6-(Dimethylamino)pyridin-3-yl]-1-[1-(2-hydroxyethyl)piperidin-4-yl]-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89649085 [(3S)-3-[[4-(5-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548378 N-(2-Chloro-5-(3-(2-methyl-9H-purin-6-YL)-5-(1-morpholinoethyl)pyridin-2-ylamino)pyridin-3-YL)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072555 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072661 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxy-N-(2-morpholin-4-ylethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700009 US10065970, Example 299 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495358 (4-hydroxypiperidin-1-yl)-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56654646 [(3S)-3-[[6-(2-methoxypyrimidin-5-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44180282 3-[2-(4-Methoxyphenyl)ethynyl]-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353462 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-(2-hydroxycyclopentyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884593 (R)-1-(4-(4-(3-methylmorpholino)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(piperazin-1-yl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072650 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-[2-(dimethylamino)ethyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072700 Tert-butyl 2-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]-2,8-diazaspiro[4.5]decane-8-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58204320 2-[4-[2-(5-methyl-1H-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]ethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072761 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]phenyl]-(4-cyclopentylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646820 2-methoxy-5-[6-[(3S)-1-[2-(1-methylimidazol-4-yl)acetyl]pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913619 N-(2-chloro-5-(imidazo[1,2-a]pyrimidin-3-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:141471201 N-[5-(2-amino-4-methylthieno[2,3-d]pyrimidin-6-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798773 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(4-methylpiperazin-1-yl)quinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073660 N-[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperidin-4-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148863 3-(2,6-dimorpholin-4-yl-7H-purin-8-yl)aniline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:141471208 2,4-difluoro-N-[2-methoxy-5-[4-methyl-2-(methylamino)thieno[2,3-d]pyrimidin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164612621 2-[4-[[2-[6-Amino-4-(trifluoromethyl)pyridin-3-yl]-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148845 4-[8-(1H-indol-6-yl)-2-morpholin-4-yl-7H-purin-6-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664742 [(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,3-oxazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072806 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-pentan-3-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073704 5-[2-[4-Ethyl-6-[4-(2-methylprop-1-enyl)piperidin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25023742 3-(6-{[(2-Methoxyethyl)(methyl)amino]methyl}-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-2-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700784 (S)-2-((1-(1,4-oxazepan-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930884 1-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]piperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379589 1-[1-(2-methoxyacetyl)piperidin-4-yl]-3-methyl-8-(1H-pyrazolo[3,4-b]pyridin-5-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53320358 N-(2-(2-hydroxyethoxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884588 1-(4-(4,6-bis((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(2-(dimethylamino)ethoxy)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403570 5-(4-((2-Chlorophenyl)sulfonyl)-6-morpholinopyridin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072769 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-methyl-1,4-diazepan-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:54584949 3-(1-(4-(methylamino)-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162646906 4-[4-(4-fluorophenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166631590 1-[4-[[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxylic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661318 [(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxolan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072793 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-methoxy-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073682 N-[2-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-1-yl]ethyl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52936962 N-(5-(3-(Pyridin-3-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701256 (S)-2-((1-(1H-pyrazolo[3,4-b]pyridin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353280 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(6-methyl-2,6-diazaspiro[3.3]heptan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700792 (S)-2-cyclopropyl-2-((1-(7,8-dihydropyrido[3,4-b]pyrazin-6(5H)-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673766 1-(1-(2-methylbenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67348791 1-[4-[1-[1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl]-3-methyl-2-oxoimidazo[4,5-h][1,5]naphthyridin-8-yl]phenyl]-3-methylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52946207 3-(6-(1H-indazol-4-yl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamino)-2,2-dimethylpropan-1-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341386 5-[2-(4-Methyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353961 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(2-methoxyethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072790 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(3-pyrrolidin-1-ylpyrrolidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:68198076 [4-(2,6-dimorpholin-4-yl-7H-purin-8-yl)pyridin-2-yl]methanamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341481 5-[2-[4-Ethyl-6-(4-methoxypiperidin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495283 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(2-methylpyrazol-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072947 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(3,5-dimethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71461426 N-[5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-chloropyridin-2-yl]amino]-2-chloropyridin-3-yl]morpholine-4-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177497 5-(3-((1H-indol-3-yl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073740 5-[2-[4-Ethyl-6-(4-pyridin-2-ylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617706 2-methyl-5-[6-[(3S)-1-propanoylpyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379581 8-[6-(Dimethylamino)pyridin-3-yl]-3-(2-hydroxyethyl)-1-(oxan-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51350923 1-(3-chloro-4-fluorophenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798849 5-(3-Phenylquinoxalin-6-yl)-1,3-benzoxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700797 US10065970, Example 277 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44592299 6-(((4-Fluoro-2-methylphenyl)amino)methyl)-[2,4'-bipyridine]-4-carboxylic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072681 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-piperazin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072542 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(2,2-difluoroethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548315 4-[(1R)-1-[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[[6-chloro-5-(dimethylsulfamoylamino)pyridin-3-yl]amino]pyridin-3-yl]ethyl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700718 US10065970, Example 314 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700498 (S)-3-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073025 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(2,2-difluoroethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25172274 methyl 3-[[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-methylsulfamoyl]-4-methylbenzoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700674 (S)-2-cyclopropyl-2-((1-(quinoxalin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155562315 2-(methylamino)-N-[4-[4-(methylsulfonylmethyl)-6-[(1S,6R)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134814188 2-methoxy-5-[6-[(3S)-1-(2-oxopiperidine-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709071 3-[1-(7-Methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700816 US10065970, Example 304 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53317812 N-(2-(2-aminoethoxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072848 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-(1,1-dioxothiolan-3-yl)-2-fluoro-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341610 5-[2-[4-Ethyl-6-[4-(oxan-4-yl)piperazin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353759 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56653622 (1,3-dimethylpyrazol-4-yl)-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900315 1-(2,4-Difluorophenyl)-5-(4,5-dihydrothieno[3,2-d][1]benzoxepin-2-yl)-1,2,4-triazole 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646249 1-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-2-pyridin-4-ylethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164617093 2-[4-[[2-(4-Amino-3-fluorophenyl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072814 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(3-hydroxypropyl)-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379483 8-(2-Methoxypyrimidin-5-yl)-3-methyl-1-piperidin-4-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148814 [3-[2,6-bis[(3S)-3-methylmorpholin-4-yl]-7H-purin-8-yl]-5-methoxyphenyl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073697 5-[2-[4-Ethyl-6-[4-(2-morpholin-4-ylethyl)piperazin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166631011 1-[4-[[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168271293 1-[(3S)-3-[[6-(5-methylsulfonylpyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646938 2-methoxy-5-[6-[(3S)-1-(4-methyl-1,3-oxazole-5-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147316519 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N-(2-fluoroethyl)-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46227614 3-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "CHEBI:66578 liphagal 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700701 1-(2-aminobenzo[d]oxazol-5-yl)-N-((1r,3r)-3-fluorocyclobutyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073077 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(oxolan-2-ylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51350922 1-(4-fluoro-3-methylphenyl)-9-(1H-pyrrolo[2,3-b]pyridin-5-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495289 (4-hydroxycyclohexyl)-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548171 4-[1-[5-(6-Amino-2-methylpyrimidin-4-yl)-6-[[6-chloro-5-(dimethylsulfamoylamino)pyridin-3-yl]amino]pyridin-3-yl]ethyl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379526 3-methyl-1-(1-methylpiperidin-4-yl)-8-(1H-pyrazolo[3,4-b]pyridin-5-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122185879 N-[6-[6-chloro-5-[[cyano(phenyl)methyl]amino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700513 US10065970, Example 295 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647332 1-[(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-3-methylsulfonylpropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354566 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]-(4-ethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:42635502 3-(4-Morpholin-4-yl-5H-pyrrolo[3,2-d]pyrimidin-2-yl)aniline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072785 3-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-5-chloro-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661315 [(3S)-3-[[4-[5-(difluoromethyl)-6-methylsulfonylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-[(3S)-oxolan-3-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:68194826 1-methyl-3-[4-(6-oxo-6a,7,9,10-tetrahydro-5H-[1,4]oxazino[3,4-h]pteridin-2-yl)phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168292714 N-hydroxy-4-[[5-[2-(methylamino)pyrimidin-5-yl]-3-morpholin-4-yl-2-oxopyrazin-1-yl]methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341439 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-4-ethylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25023739 3-[6-Methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168272823 N-hydroxy-4-[[5-(1H-indazol-4-yl)-3-morpholin-4-yl-2-oxopyrazin-1-yl]methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46885425 2-((1H-indol-3-yl)methylene)-4,6-dihydroxybenzofuran-3(2H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072876 1-[4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorobenzoyl]piperazin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56651213 [(3S)-3-[[6-(5-fluoro-6-methoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072730 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[(3-methyloxetan-3-yl)methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52937066 N-(5-(3-(2H-Tetrazol-5-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495356 {(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yloxy]-pyrrolidin-1-yl}-(4-methyl-piperazin-1-yl)-methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53340937 Methyl 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403595 1-(3-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidin-1-yl)propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811701 (2S)-1-[4-[[4-(2-aminopyrimidin-5-yl)-6-methyl-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379488 4-[8-[6-(dimethylamino)pyridin-3-yl]-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]-N-methylpiperidine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:10125446 5-[5-(4-Hydroxyphenyl)furan-2-ylmethylene]thiazolidine-2, 4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072923 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-hydroxy-4-methylcyclohexyl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646368 1-[(3S)-3-[[4-(6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49857865 (2S,7S,10S)-2,6,6,10-tetramethyl-12-oxatetracyclo[9.7.0.02,7.013,18]octadeca-1(11),13(18),14,16-tetraen-15-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072545 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N,2-dimethyl-N-[2-(2-oxopyrrolidin-1-yl)ethyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073671 1-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-1,4-diazepan-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162670167 4-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-6-[4-(3-nitrophenyl)sulfonylpiperazin-1-yl]-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353279 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(6-methyl-2,6-diazaspiro[3.3]heptan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072940 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-fluorophenyl]-(4-hydroxy-1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072933 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethyl)phenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661352 (1,1-dioxothian-4-yl)-[(3S)-3-[[1-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072544 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(2-piperazin-1-ylethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379519 1-(4-hydroxycyclohexyl)-8-(1H-indol-4-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661339 [(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(3-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699964 US10065970, Example 257 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:131842331 Alpelisib acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072936 5-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-fluoro-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71472903 3-[[3-[(E)-[(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)hydrazinylidene]methyl]indol-1-yl]methyl]benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072787 [5-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-fluorophenyl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700789 (S)-1-(1-(4-(1H-pyrazol-3-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072798 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-(2-hydroxy-2-methylpropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811741 4-[4-(1H-indazol-4-yl)-6-methyl-7-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-2-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072658 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44607528 3-[4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-1,1-dimethylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072734 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(2,6-diazaspiro[3.3]heptan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072710 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-[4-(hydroxymethyl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072685 5-[2-[4-Ethyl-6-(4-methylsulfonylphenyl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46215564 8-(Cyclohexylmethyl)-2-[6-(2-hydroxypropan-2-yl)pyridin-3-yl]-5,7-dihydropyrazino[2,3-b]pyrazin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073050 5-[2-[4-Methyl-6-(4-methylsulfonylphenyl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073685 5-[2-[4-Ethyl-6-(4-pyridin-4-ylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073071 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798832 [6-[6-Amino-5-(trifluoromethyl)pyridin-3-yl]imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785082 N5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)pyridin-2-YL)pyridine-2,5-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646294 2-methoxy-5-[6-[(3S)-1-(1-methyl-2-oxopyridine-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156022115 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethyl-N-propan-2-ylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51350809 1-(4-fluoro-3-methylphenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341391 1-[1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperidin-4-yl]-2-methylpropan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661340 [(3S)-3-[[4-(6-ethoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646643 cyclopropyl-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072578 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:121334400 5-[4,6-Bis(3,7-dioxa-9-azabicyclo[3.3.1]nonan-9-yl)-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798836 [6-(5-Amino-6-methoxypyridin-3-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379504 2-[4-[3-Methyl-8-(1-methylpyrazol-4-yl)-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]piperidin-1-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646501 2-methoxy-5-[6-[(3S)-1-(pyrimidine-5-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53363439 N-[2-chloro-5-[4-(2-methoxyethylamino)quinolin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44607181 4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]aniline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148844 4-[8-(1H-indazol-4-yl)-2-morpholin-4-yl-7H-purin-6-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353959 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-butylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884591 (R)-1-(4-(4-(3-methylmorpholino)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44241764 2-(3-(2-((2-Chlorophenyl)(methyl)carbamoyl)-4,5-dihydrobenzo[b]thieno[2,3-d]oxepin-8-yl)phenyl)acetic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56650204 (2,2-dimethyloxan-4-yl)-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073722 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-4-benzylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74538981 N-[2-chloro-5-[4-[4-(morpholin-4-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072623 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379637 benzyl 4-(2-oxo-8-quinolin-3-yl-3H-imidazo[4,5-c][1,5]naphthyridin-1-yl)cyclohexane-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53316474 N-(2-isopropoxy-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89935536 [(8aS)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-[4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072912 N-[2-[4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorobenzoyl]piperazin-1-yl]ethyl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166625853 1-[4-[[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]piperidine-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89589902 9-(6-methoxypyridin-3-yl)-3-methyl-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173222 5-(3-(Benzofuran-3-ylsulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700990 (S)-2-cyclopropyl-2-((1-(8-fluoroquinoxalin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379518 8-[6-(dimethylamino)pyridin-3-yl]-1-[1-[(2R)-2-hydroxypropanoyl]piperidin-4-yl]-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072593 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(2-hydroxypropan-2-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900409 2-(4-(2-chlorophenyl)-1H-pyrazol-3-yl)-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073001 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluoro-N-(2-morpholin-4-ylethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701240 (S)-2-((1-(2-aminobenzo[cd]oxaol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)oxy)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072642 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[3-(4-methylpiperidin-1-yl)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930929 5-[2-(4-ethyl-6-piperidin-1-ylpyrimidin-5-yl)ethynyl]-N-methylpyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548258 4-[[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-hydroxymethyl]-N,N-dimethylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52936961 N-(5-(3-(3-Cyanophenyl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)-benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646386 methyl (3S)-3-[[4-(5-cyano-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701225 (S)-2-((1-(1H-indazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073673 5-[2-[4-Ethyl-6-(4-pyrimidin-2-ylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673722 (S)-2-cyclopropyl-2-((1-(2-methoxypyrimidin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072603 4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorobenzoyl]piperazine-1-carbaldehyde 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700805 US10065970, Example 285 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072726 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[3-(dimethylamino)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353182 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(oxetan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49835227 3-[2-methyl-6-[(6-morpholin-4-ylpyridazin-3-yl)amino]pyrimidin-4-yl]-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072794 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(3-hydroxypiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341525 1-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperazin-1-yl]-2-methylpropan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647067 2-methoxy-5-[6-[(3S)-1-(2-pyridin-4-ylacetyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168279992 1-[(3S)-3-[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]oxypyrrolidin-1-yl]-2-methylpropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073683 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-1-yl]-phenylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168292345 3-anilino-5-[2-(cyclopropanecarbonylamino)pyridin-4-yl]-N-(1,3-dioxolan-2-ylmethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44600650 [3-(4-Morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl)phenyl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58204717 2-(2-propan-2-yl-1,2,4-triazol-3-yl)-9-(1H-pyrazol-4-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168273246 N-[4-(3-acetamidophenyl)pyridin-2-yl]oxolane-3-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548412 4-(1-(5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-6-(benzo[D]thiazol-5-ylamino)pyridin-3-YL)ethyl)-N,N-dimethylpiperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155538979 N-[5-[4-[[(3S)-1-(2,2-dimethylpropanoyl)pyrrolidin-3-yl]amino]quinazolin-6-yl]-2-methoxypyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168274906 1-[(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]butan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71472135 31-Fluoro-5-methoxy-8,8-dioxo-8lambda6-thia-4,7,15,25-tetrazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22(30),23,25,27-tetradecaen-14-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699944 (S)-2-((1-(4-(hydroxymethyl)-piperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:129012342 9-(6-Aminopyridin-3-yl)-3-methyl-1-[3-(trifluoromethyl)phenyl]-4a,5,6,6a,7,8,9,10,10a,10b-decahydropyrimido[5,4-c][1,5]naphthyridine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072744 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(3-methoxypropyl)-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156023087 US10851091, U.S. Pat. No. 8,242,104 No. 549 isomer 2 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798533 [7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:9209612 N-(3-acetylphenyl)-1H-indole-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:16049456 3-(4-Morpholin-4-ylpyrimidin-2-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699963 US10065970, Example 256 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073718 2-[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]-N-(2-methoxyethyl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073679 5-[2-[4-Ethyl-6-(4-pyridin-3-ylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353276 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-(oxetan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072583 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-(1,1-dioxothiolan-3-yl)-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072712 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884122 4,6-dihydroxy-2-((1-methyl-4-phenyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166631318 1-[4-[[4-(2,6-Dimorpholin-4-ylpyrimidin-4-yl)phenyl]carbamoylamino]benzoyl]piperidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072905 5-[2-[4-Ethyl-6-(6-morpholin-4-ylpyridin-3-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617471 (S)-(3-((4-(6-methoxy-5-methylpyridin-3-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)oxy)pyrrolidin-1-yl)(tetrahydro-2H-pyran-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403587 1-(3-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidin-1-yl)-2-(4-fluorophenyl)ethan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44610484 N-[5-[3-(3-azabicyclo[3.2.2]nonan-3-yl)quinoxalin-6-yl]-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164628355 3-[5-amino-6-(3-methylpyrazol-1-yl)pyrazin-2-yl]-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59251739 N-[6-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-1,3-benzothiazol-2-yl]-4-morpholin-4-ylbutanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072768 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661348 [(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(4-hydroxycyclohexyl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661409 [(3S)-3-[[4-(5-chloro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,3-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379536 8-[6-(Dimethylamino)pyridin-3-yl]-3-methyl-1-(oxan-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072691 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-methyl-1,4-diazepan-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661328 [(3S)-3-[[1-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539746 2,4-difluoro-N-[2-methoxy-5-[4-(4-methylphenyl)quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072952 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-hydroxy-4-propan-2-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073058 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-ethylsulfonylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155569017 5-[4,6-Bis(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072704 Ethyl 4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxybenzoyl]piperazine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46227561 5-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548176 N-(5-((3-(6-amino-2-methyl-4-pyrimidinyl)-2-pyridinyl)amino)-2-chloro-3-pyridinyl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76324913 7-Amino-1-[4-(2-hydroxyethoxy)cyclohexyl]-3-(6-methoxypyridin-3-yl)-5-methyl-1,6-naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379597 Propan-2-yl 4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-1-yl)piperidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162650011 4-[4-(3-methoxyphenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677459 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1,3-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930226 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-pyridin-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073012 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-methyl-N-[(1-methylpiperidin-4-yl)methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072703 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-phenylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072548 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168292785 4-[1-(4-Fluorophenyl)-2-methylimidazo[4,5-c]quinolin-8-yl]benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177561 5-(3-(Benzylsulfonyl)-5-morpholinophenyl)-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444291 5-[7-[(3S)-1-ethylsulfonylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155535532 3-[4-(2-methylsulfonylpropan-2-yl)-6-[(1S,6R)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664670 [(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89645321 5-[6-[(3S)-1-(2-hydroxy-2-methylpropanoyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353758 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(oxan-4-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71458545 4-morpholin-4-yl-6-[[(1R)-1-naphthalen-1-ylethyl]amino]-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353178 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-cyclobutylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700493 (S)-2-((1-([1,2,4]triazolo[1,5-a]pyridin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155543736 3-[4-(2-methylsulfonylpropan-2-yl)-6-[(1R,6S)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:148470662 (2R)-3-[6-[5-[(2,3-dichlorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56652920 (2,4-dimethyl-1,3-oxazol-5-yl)-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4758904 CHEMBL4758904 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353854 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-propan-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66655821 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1,2-oxazol-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072711 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[3-(dimethylamino)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379596 Ethyl 4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-1-yl)piperidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073709 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperazin-1-yl]-(5-methylfuran-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177402 Cyclopropyl(3-((3-(2-(cyclopropylamino)pyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67347168 1-[4-[1-[1-(2-Hydroxyacetyl)piperidin-4-yl]-3-methyl-2-oxoimidazo[4,5-h][1,5]naphthyridin-8-yl]phenyl]-3-methylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072705 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(2-methyl-2,7-diazaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379643 1-[4-(2-Hydroxyethoxy)cyclohexyl]-3-methyl-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341388 5-[2-[4-Methyl-6-(4-methylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785522 N-(1-((5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(6-methoxypyridin-3-ylamino)pyridin-3-yl)methyl)azetidin-3-yl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495334 1-[4-[(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidine-1-carbonyl]piperidin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162669724 2,4-difluoro-N-[2-methoxy-5-[4-[(E)-3-(4-methylpiperazin-1-yl)-3-oxoprop-1-enyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59453133 3-[6-(2-Hydroxypropan-2-yl)pyridin-3-yl]-5-(oxan-4-ylmethyl)-7,8-dihydropyrazino[2,3-b]pyrazin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661410 2-methoxy-5-[6-[(3S)-1-(2-methylpropanoyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:148021419 (2R)-3-[6-[6-methoxy-5-[[3-(trifluoromethyl)phenyl]sulfonylamino]pyridin-3-yl]-4-oxoquinazolin-3-yl]-N,2-dimethylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699953 5-(4-bromo-3-fluoro-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)benzo[d]oxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072621 5-[2-[4-Methyl-6-[6-(trifluoromethyl)pyridin-3-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072763 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(2-hydroxyethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072990 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-(3-methoxypropyl)-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072662 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(dimethylamino)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072864 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-ethylsulfonylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709078 9-(1-anilinoethyl)-N-(2-hydroxyethyl)-N-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699997 US10065970, Example 290 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122178111 2,4-difluoro-N-[2-methoxy-5-(4-pyridin-4-ylpyrido[2,3-d]pyrimidin-6-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700794 US10065970, Example 273 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688486 imidazo[2,1-b][1,3]thiazol-6-yl-[(3S)-3-[[1-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073710 5-[2-[4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785341 [(2R)-1-[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]pyrrolidin-2-yl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11514586 5-(5-Pyridin-3-ylfuran-2-ylmethylene)thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072737 [4-(2-Aminoethyl)piperazin-1-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042492 N-[2-chloro-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]phenyl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072850 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]phenyl]-[4-(2-hydroxyethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072757 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]phenyl]-(1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072632 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[3-(4-methylpiperidin-1-yl)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072673 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(1-oxa-4,9-diazaspiro[5.5]undecan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44180268 6-(1h-Indazol-4-yl)-1-methyl-n-(4-(methylsulfonyl)phenyl)-1h-pyrazolo[3,4-d]pyrimidin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798707 7-(2-Amino-1,3-benzoxazol-5-yl)-3-methyl-2-morpholin-4-ylquinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072582 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-ethylsulfonylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072821 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]-(4-hydroxy-4-methylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072569 5-[2-[4-(2,6-Dimethylpyridin-4-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4859306 CHEMBL4859306 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072953 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[3-(diethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548165 (S)-4-(2-(2-Methoxypyrimidin-5-ylamino)-5-((2-methyl-4-(methylsulfonyl)piperazin-1-YL)methyl)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168282278 7-[5-(2-aminopyrimidin-5-yl)-3-morpholin-4-yl-2-oxopyrazin-1-yl]-N-hydroxyheptanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548406 4-((5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-((6-methoxy-3-pyridinyl)amino)-3-pyridinyl)methyl)-3-morpholinone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646225 1-[(3S)-3-[[4-(6-chloro-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177455 (R)-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168289952 N-[4-[3-(4-fluoroanilino)-5-(methylcarbamoyl)phenyl]pyridin-2-yl]oxane-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166629249 1-[4-[4-[(4aS,7aS)-2,3,4a,5,7,7a-hexahydro-[1,4]dioxino[2,3-c]pyrrol-6-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]-3-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073692 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-4-benzylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173838 5-(6-Morpholino-4-phenoxypyridin-2-yl)thiazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46225308 3-(6-morpholino-9H-purin-2-yl)benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073010 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4,4-difluoropiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156021947 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N,N-diethyl-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11551198 5-[5-(2-Hydroxy-5-methylphenyl)furan-2-ylmethylene]thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145949270 6-[4-(4-{4-[2-(difluoromethyl)-1H-1,3-benzodiazol-1-yl]-6-(morpholin-4-yl)-1,3,5-triazin-2-yl}piperazin-1-yl)-4-oxobutanamido]-N-[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]hexanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:42635321 3-(4-morpholino-5H-pyrrolo[3,2-d]pyrimidin-2-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56650541 oxan-4-yl-[(3S)-3-[[6-[5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89645758 1-[(3S)-3-[[4-(4-methyl-3-piperidin-1-ylsulfonylphenyl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072602 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[4-(cyclohexylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072968 5-[2-[4-Methyl-6-(6-methylpyridin-3-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073684 5-[2-[4-(2,2-Dimethylmorpholin-4-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072606 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701029 US10065970, Example 268 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56654997 2-methoxy-5-[4-[(3S)-1-propanoylpyrrolidin-3-yl]oxy-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664703 [(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothian-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89649504 2-methoxy-5-[6-[(3S)-1-(2-methylpyrazole-3-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66682582 5-[(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidine-1-carbonyl]-1H-pyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072834 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(2-methyl-2,7-diazaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072554 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-piperidin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44348293 [1-(3-Phenylpropyl)piperidin-3-yl]methyl 2-(2,5-dioxo-3-propan-2-ylpyrrolidin-1-yl)benzoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646712 2-methoxy-5-[7-[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydropyrido[3,4-b][1,4]oxazin-1-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548463 2-(5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)propan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122178119 N-[2-methoxy-5-(4-pyridin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]-4-(trifluoromethyl)benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646490 [3-[[5-Methyl-4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155511706 3-[4-[(3S)-3-methylmorpholin-4-yl]-6-(methylsulfonylmethyl)pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341389 2-[1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperidin-4-yl]propan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072747 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-pyridin-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403572 5-(3-((Cyclohexylmethyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25169786 methyl 3-[(E)-[methyl-(2-methyl-5-nitrophenyl)sulfonylhydrazinylidene]methyl]pyrazolo[1,5-a]pyridine-5-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67535447 N-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)imidazo[1,2-a]pyridin-2-yl]quinolin-6-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072988 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-butan-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072590 5-[2-[4-(6-Cyclopropylpyridin-3-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45254780 2-[4-[8-[6-(Dimethylamino)pyridin-3-yl]-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]phenyl]-2-methylpropanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072969 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(2-hydroxyethyl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56652246 2-methoxy-5-[4-[(3S)-1-[2-(oxan-4-yl)acetyl]pyrrolidin-3-yl]oxy-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073057 N-[2-[4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]piperazin-1-yl]ethyl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58204658 2-(1-isopropyl-1H-1,2,4-triazol-5-yl)-N-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-9-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353957 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-piperidin-1-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548359 N-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-(1-morpholinoethyl)pyridin-2-ylamino)-2-chloropyridin-3-YL)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700778 (S)-2-cyclopropyl-2-((1-(piperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148746 (3S)-3-methyl-4-[2-[(3S)-3-methylmorpholin-4-yl]-8-(1H-pyrrolo[2,3-b]pyridin-4-yl)-7H-purin-6-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072670 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-methoxypiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699943 (S)-2-cyclopropyl-2-((1-(4-methylpyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379649 3-Methyl-1-[1-(3-methyl-2-oxobutyl)piperidin-4-yl]-8-(1-methylpyrazol-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884548 1-(4-(4-((1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-3-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073021 4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]-1-methylpiperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072845 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-(2-morpholin-4-ylethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134304310 (S)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-3-fluoro-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811499 5-[7-[(4-Methylsulfonylpiperazin-1-yl)methyl]-2-morpholin-4-ylthieno[3,2-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53324425 N-(2-methoxy-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444316 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072674 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(2-morpholin-4-ylethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71451372 4-morpholin-4-yl-6-[[(1S)-1-naphthalen-1-ylethyl]amino]-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53320102 3-(2-Morpholino-6-(quinolin-3-ylamino)pyrimidin-4-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072944 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-phenylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072856 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45254779 2-[4-[8-[6-(dimethylamino)pyridin-3-yl]-2-oxo-3H-imidazo[4,5-c][1,5]naphthyridin-1-yl]phenyl]-2-methylpropanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646444 1-[(3S)-3-[[4-(5-chloro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59507937 5-(2,6-Dimorpholin-4-ylpyrimidin-4-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69929804 [2-Chloro-4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]phenyl]-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49857476 (4aS,11cS)-9-hydroxy-10-methoxy-4,4,11c-trimethyl-1,2,3,4a,5,6-hexahydronaphtho[2,1-b][1]benzofuran-8-carbaldehyde 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073072 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(2-hydroxyethyl)-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45254778 2-Methyl-2-[4-[3-methyl-8-(6-methylpyridin-3-yl)-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]phenyl]propanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53323076 N-(2-(2-methoxyethoxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073086 5-[2-[4-Ethyl-6-(2-ethylpyridin-4-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168297753 (2S)-2-[[2-[5-(hydroxymethyl)-2-(2,2,2-trifluoroethyl)-1,2,4-triazol-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]oxy]propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699996 US10065970, Example 288 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45254977 2-methyl-2-[4-[8-(1-methylpyrazol-4-yl)-2-oxo-3H-imidazo[4,5-c][1,5]naphthyridin-1-yl]phenyl]propanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701232 (S)-2-cyclopropyl-2-((1-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155535224 N-[5-[4-[[(3S)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]amino]quinazolin-6-yl]-2-methoxypyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89645326 2-methyl-1-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444310 ethyl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072782 4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorobenzoyl]-1-methylpiperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913424 (4S)-4-benzyl-3-[3-(5,6-dimethoxypyridin-3-yl)imidazo[1,2-a]pyridin-6-yl]-1,3-oxazolidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162669143 4-amino-1-[2-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)anilino]-3H-benzimidazole-5-carbonyl]piperidine-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:121334407 5-[4,6-Bis(2,2-dimethylmorpholin-4-yl)-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072708 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646384 2-methoxy-5-[6-[(3R)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148817 (3R)-4-[8-(1H-indol-4-yl)-2-morpholin-4-yl-7H-purin-6-yl]-3-methylmorpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118728811 5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-N-[(2S,3S)-3-(2H-tetrazol-5-yl)-2-bicyclo[2.2.2]octanyl]pyrimidin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354151 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(4-cyclobutylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177458 1-(4-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)piperidin-1-yl)ethan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072735 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(7,8-dihydro-5H-1,6-naphthyridin-6-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811612 4-[7-[(4-Methylsulfonylpiperazin-1-yl)methyl]-4-pyrimidin-5-ylthieno[3,2-d]pyrimidin-2-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177542 5-(4-(3,4-dihydroquinolin-1(2H)-yl)-6-morpholinopyridin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073030 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(azepan-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74538978 N-[2-chloro-5-[4-[4-(morpholin-4-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341523 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-4-propan-2-ylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:153212497 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N-(2-methoxyethyl)-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341564 1-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-1-yl]-2-methylpropan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354056 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-cyclopropylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89589923 3-methyl-9-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072625 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[3-(dimethylamino)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444254 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-[(3S)-1-methylsulfonylpyrrolidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700668 (S)-2-((1-(6-methoxypyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL2331658 CHEMBL2331658 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073035 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-chloro-N-methoxy-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042066 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,23,25-pentazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22,24,26(30),27-tetradecaen-14-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379644 8-[6-(Dimethylamino)pyridin-3-yl]-1-[1-(2-methoxyethyl)piperidin-4-yl]-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661350 [(3S)-3-[[4-[5-(difluoromethyl)-6-methoxypyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothian-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67348733 1-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(1H-pyrazolo[3,4-b]pyridin-5-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379499 4-[8-(6-methoxypyridin-3-yl)-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]-N-methylpiperidine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709087 9-[1-(3-cyanophenoxy)ethyl]-N-(2-hydroxyethyl)-N-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072916 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072956 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-pyrrolidin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072917 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-piperidin-1-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44607001 6-(4-morpholino-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)pyridin-2-amin 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51350919 1-(4-fluoro-3-methylphenyl)-9-(6-methoxypyridin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073669 2-[1-[6-Ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]piperidin-4-yl]ethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042057 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,18,25-pentazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17,19,21(31),22(30),23,25,27-tetradecaen-14-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56651214 2-methoxy-5-[4-[(3S)-1-(2-methoxyacetyl)pyrrolidin-3-yl]oxy-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4787768 CHEMBL4787768 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51351032 9-(2-aminopyrimidin-5-yl)-1-(3-chloro-4-fluorophenyl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74538982 N-[5-[4-[4-[(dimethylamino)methyl]phenyl]quinolin-6-yl]-2-methoxypyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379535 8-(2-Aminopyrimidin-5-yl)-3-methyl-1-(oxan-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072706 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118341835 2-[4-[[6-(1H-indol-5-yl)quinazolin-4-yl]amino]phenyl]acetonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913617 N'-(2-Chloro-5-(7-(3-pyridinyl)imidazo[1,2-a]pyridin-3-yl)-3-pyridinyl)-N,N-dimethylsulfamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:54584986 3-(1-(4-methoxy-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072638 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(3,4-dimethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699942 (S)-2-cyclopropyl-2-((1-(quinazolin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073023 5-[2-[4-Ethyl-6-(6-methylpyridin-3-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164628434 2-[4-[[2-(1H-indazol-6-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71458791 6-[2-hydroxyethyl(naphthalen-1-ylmethyl)amino]-4-[(2R)-2-methylmorpholin-4-yl]-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444246 Methyl 3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118352671 2,4-difluoro-N-[2-methoxy-5-[4-[4-[(2-methylimidazol-1-yl)methyl]phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548270 4-(2-((6-Methoxy-3-pyridinyl)amino)-5-(4-morpholinylcarbonyl)-3-pyridinyl)-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072617 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354054 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-cyclopentylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51350918 1-(4-fluoro-3-methylphenyl)-9-(1-methyl-1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699951 (S)-2-((1-([1,3]dioxolo[4,5-b]pyridin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46227632 5-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900447 2-[2-(2-Hydroxyethyl)-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59259002 2-Amino-8-cyclopropyl-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930848 N-[[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]methyl]cyclohexanecarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118711765 4-Pyrrolo[2,1-f][1,2,4]triazin-4-ylmorpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072965 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(2-oxa-7-azaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646441 5-[6-[(3S)-1-propanoylpyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700030 (S)-1-(1-(6-(1H-pyrazol-4-yl)pyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072911 1-[4-[4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]piperazin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699990 US10065970, Example 279 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072889 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(1,5-dioxa-9-azaspiro[5.5]undecan-9-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25023741 3-{6-[(Dimethylamino)methyl]-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-2-yl}phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072736 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-hydroxy-1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073043 1-[4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxybenzoyl]piperazin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168293832 1-[(3S)-3-[[6-(3-methylsulfonylphenyl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072786 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-methoxypiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709089 N-(2-hydroxyethyl)-9-[1-(3-methoxyphenoxy)ethyl]-N-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072692 5-[2-[4-Ethyl-6-(6-methoxypyridin-3-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646619 2-methoxy-5-[6-[(3S)-1-(1-methylpyrazole-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700669 (S)-2-cyclopropyl-2-((1-(2,2-difluorobenzo[d][1,3] dioxo1-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168282480 N-[(E)-[4-(hydroxycarbamoyl)phenyl]methylideneamino]-2-(1H-indazol-4-yl)-6-morpholin-4-ylpyrimidine-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49786008 2-methoxy-N-[3-(2-methyl-7H-purin-6-yl)pyridin-2-yl]pyrimidin-5-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701265 (S)-2-cyclopropyl-2-((1-(3-hydroxyquinolin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548384 N-(5-((3-(6-amino-2-methyl-4-pyrimidinyl)-2-pyrazinyl)amino)-2-chloro-3-pyridinyl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379627 1-(2-Methoxyethyl)-8-(6-methoxypyridin-3-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072777 4-[6-ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]-2-fluoro-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379482 1-(4-hydroxycyclohexyl)-8-(6-methoxypyridin-3-yl)-3H-imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661403 [(3S)-3-[[1-[5-(difluoromethyl)-6-methoxypyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothian-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:68198077 1-[4-[6-[(3S)-3-methylmorpholin-4-yl]-2-morpholin-4-yl-7H-purin-8-yl]pyridin-2-yl]ethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700511 US10065970, Example 294 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072715 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxy-N-methyl-N-[2-(2-oxopyrrolidin-1-yl)ethyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073727 4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155558737 1-ethyl-3-[4-[4-(2-methylsulfonylpropan-2-yl)-6-[(1R,6S)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379516 1-(4-Hydroxycyclohexyl)-3-methyl-8-(1-methylpyrazol-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072618 Tert-butyl 9-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]-1-oxa-4,9-diazaspiro[5.5]undecane-4-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379515 8-[6-(Dimethylamino)pyridin-3-yl]-3-methyl-1-piperidin-4-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700827 US10065970, Example 307 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89649608 oxan-4-yl-[(3S)-3-[[4-(5-propan-2-ylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444299 5-[7-[(3S)-1-ethylsulfonylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341570 N-[[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]methyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900530 2-[2-(2,4-Difluorophenyl)-1,2,4-triazol-3-yl]-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazole-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353658 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[(2S)-2,4-dimethylpiperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073000 3-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:54586917 3-(1-(4-amino-6-propyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699988 US10065970, Example 281 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379584 1-benzyl-8-(6-methoxypyridin-3-yl)-3H-imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444313 (3R,4R)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-4-hydroxy-N-methylpyrrolidine-1-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162660402 4-[4-(2-methylphenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341565 8-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2,8-diazaspiro[4.5]decan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71041788 18-Methoxy-15,15-dioxo-15lambda6-thia-4,5,8,16,19,26-hexazahexacyclo[20.6.2.12,5.110,14.117,21.025,29]tritriaconta-1(29),2(33),3,10(32),11,13,17,19,21(31),22(30),23,25,27-tridecaen-9-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548450 N-(4-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-chloropyridin-2-ylamino)-2-fluorophenyl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:88979788 [6-(2-Amino-1,3-benzothiazol-7-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89589901 N-(5-(3-methyl-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydropyrimido[5,4-c][1,5]naphthyridin-9-yl)pyridin-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548363 5-N-(4-methoxyphenyl)-2-N-(6-methoxypyridin-3-yl)-3-(2-methyl-7H-purin-6-yl)pyridine-2,5-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677194 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(4-methyl-1,3-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700815 US10065970, Example 303 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495336 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53324329 6-(2-aminopyrimidin-5-yl)-N-[6-(1-methylpiperidin-4-yl)oxypyridin-3-yl]-2-morpholin-4-ylpyrimidin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072973 [(9aR)-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:54582056 3-(1-(4-(2,2,2-trifluoroethylamino)-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444295 5-[2-morpholin-4-yl-7-[(3S)-1-propan-2-ylsulfonylpyrrolidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661388 (1,1-dioxothiolan-3-yl)-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379537 1-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661376 [(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(3-methylpyridin-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118341927 2-[4-[(6-Phenylquinazolin-4-yl)amino]phenyl]acetonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539861 2,4-difluoro-N-[5-[4-[4-(imidazol-1-ylmethyl)phenyl]quinolin-6-yl]-2-methoxypyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379614 1-[1-(2-Hydroxyethyl)piperidin-4-yl]-8-(2-methoxypyrimidin-5-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145969270 N-[6-[5-(methanesulfonamido)-6-methoxypyridin-3-yl]-4-methylthieno[2,3-d]pyrimidin-2-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073055 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-pyridin-4-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785342 N5-ethyl-N2-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridine-2,5-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930313 6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl-[4-[6-ethyl-5-[2-[6-(ethylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646187 2-methoxy-5-[6-[(3S)-1-(2-methylsulfonylacetyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353760 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701030 US10065970, Example 270 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646491 2-methoxy-5-[6-[(3S)-1-(1,3-oxazole-5-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073705 5-[2-[4-(7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072818 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(1,1-dioxothiolan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072644 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709086 9-[1-(2-fluorophenoxy)ethyl]-N-(2-hydroxyethyl)-N-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072740 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(dimethylamino)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664676 [(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,3-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86766423 4-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[[(2R)-4-methylsulfonyl-2-(trifluoromethyl)piperazin-1-yl]methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine;4-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[[(2S)-4-methylsulfonyl-2-(trifluoromethyl)piperazin-1-yl]methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548443 4-[[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5-fluoro-6-methoxypyridin-3-yl)amino]pyridin-3-yl]methyl]-N-cyclopropyl-N-methylpiperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664659 [(3S)-3-[[4-(6-ethylsulfinylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:24804168 3-ethyl-1-[4-[4-[(3S)-3-methylmorpholin-4-yl]-6-(methylsulfonylmethyl)pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67346771 Tert-butyl 4-[8-[4-(ethylcarbamoylamino)phenyl]-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]piperidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701012 US10065970, Example 252 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700510 US10065970, Example 261 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44606818 N-Methyl-N-[4-(4-morpholin-4-yl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155562639 1-(2-hydroxyethyl)-3-[4-[4-(2-methylsulfonylpropan-2-yl)-6-[(1R,6S)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]thiourea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072844 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-[2-(dimethylamino)ethyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:141471202 N-[5-(2-amino-4-methylthieno[2,3-d]pyrimidin-6-yl)-2-methylpyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379592 1-[1-(2-Aminoacetyl)piperidin-4-yl]-3-methyl-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:42635323 2-(3-Methylphenyl)-4-morpholin-4-yl-5H-pyrrolo[3,2-d]pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51351035 1-(3,4-difluorophenyl)-9-(1-methyl-1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71449565 6-[(2,3-dichlorophenyl)methylamino]-4-morpholin-4-yl-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073014 4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorobenzoyl]-1-methylpiperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072688 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-(6-methyl-2,6-diazaspiro[3.3]heptan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072764 [5-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]pyridin-2-yl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700988 (S)-2-cyclopropyl-2-((1-(1-(2-hydroxyethyl)-1H-pymzol-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548304 4-Amino-6-[2-[[6-chloro-5-(dimethylsulfamoylamino)pyridin-3-yl]amino]pyridin-3-yl]-2-methylpyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664859 (1,1-dioxothian-4-yl)-[(3R)-3-[[1-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168280469 1-[(3S)-3-[[6-(5-fluoro-6-methoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700501 (R)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072950 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(3-methyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444229 5-[7-[(1R)-3,3-difluorocyclopentyl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072567 [(3aS,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073737 5-[2-[4-Ethyl-6-(4-methylsulfonylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664661 [(3S)-3-[[4-(5-methoxy-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49850583 3-(Pyridin-2-ylethynyl)-1H-pyrazolo[3,4-b]pyridine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072925 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]phenyl]-[4-(2-methoxyethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155552080 5-[4-Morpholin-4-yl-6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661381 [(3S)-3-[[4-(6-ethylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168272198 1-[(3S)-3-[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]oxypyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072753 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-piperidin-1-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11669062 3-[6-[(4-Methylpiperazin-1-yl)methyl]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072664 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[(2R)-2,4-dimethylpiperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073034 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-(1,1-dioxothiolan-3-yl)-2-fluorobenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168271254 1-[(3S)-3-[[6-(3,4-dimethoxyphenyl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646487 1-[(3R)-3-[[4-(6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072919 [(3R)-3-(dimethylamino)pyrrolidin-1-yl]-[4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664722 [(3S)-3-[[4-(6-chloro-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothian-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701006 US10065970, Example 245 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379503 2-[4-[8-(5-fluoro-6-methoxypyridin-3-yl)-2-oxo-3H-imidazo[4,5-c][1,5]naphthyridin-1-yl]phenyl]-2-methylpropanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548242 4-[2-[(6-methoxypyridin-3-yl)amino]-5-[[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072774 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[3-(4-pyrrolidin-1-ylpiperidin-1-yl)cyclobutyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548166 N-[5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(2-methoxyethoxy)pyridin-2-yl]amino]-2-methoxypyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700976 (S)-2-cyclopropyl-2-((1-(1-oxetan-3-yl)-1H-pyrazol-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673816 (S)-2-((1-phenyl-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60142905 9-(6-methoxypyridin-3-yl)-3-methyl-1-piperidin-4-yl-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122178108 2,4-difluoro-N-[2-methoxy-5-(5-pyridin-4-yl-1,8-naphthyridin-3-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164625934 4-[[3-[4-[[2-[6-amino-4-(trifluoromethyl)pyridin-3-yl]-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073696 5-[2-[4-Ethyl-6-(4-propan-2-ylpiperazin-1-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379594 1-(1-acetylpiperidin-4-yl)-3-methyl-8-(1H-pyrazolo[3,4-b]pyridin-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072645 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(2-hydroxyethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699959 (S)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-3-fluoro-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)oxy)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:84972980 [(3S)-3-[[6-(5-isocyano-6-methoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1-methylpyrazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548423 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-[2,2,2-trifluoro-1-(4-methylsulfonylpiperazin-1-yl)ethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072765 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-hydroxypiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072795 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-piperazin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798461 5-[3-(Oxan-4-yl)benzimidazol-5-yl]-1,3-benzoxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168276243 cyclopropyl-[(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51350684 1-(4-fluoro-3-(trifluoromethyl)phenyl)-9-(1-methyl-1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700793 US10065970, Example 276 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444319 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-[(3S)-1-propan-2-ylsulfonylpyrrolidin-3-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56651216 (2,4-dimethyl-oxazol-5-yl)-{(S)-3-[6-(6-methoxy-5-methyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yloxy]-pyrrolidin-1-yl}-methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699994 US10065970, Example 292 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798526 6-(2-Amino-1,3-benzoxazol-5-yl)-3-[2-(4-methylpiperazin-1-yl)ethyl]quinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072839 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[3-(4-methylpiperazin-1-yl)cyclobutyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646415 2-methoxy-5-[6-[(3S)-1-(pyridine-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403551 3-((3-(2-aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)-N-(tert-butyl)azetidine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49857279 (4aS,11cS)-9,10-dimethoxy-4,4,11c-trimethyl-1,2,3,4a,5,6-hexahydronaphtho[2,1-b][1]benzofuran-8-carbaldehyde 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56650539 [(3S)-3-[[6-(5-chloro-6-methoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072852 5-[2-[4-Methyl-6-(6-piperidin-1-ylpyridin-3-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155529607 N-[5-[4-[[1-(cyclopentanecarbonyl)piperidin-4-yl]amino]quinazolin-6-yl]-2-methoxypyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073713 5-[2-[4-Methyl-6-(1-oxo-1,4-thiazinan-4-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71041619 26-Methoxy-23,23-dioxo-23lambda6,32-dithia-6,8,16,24,27-pentazahexacyclo[23.3.1.12,5.110,14.118,22.04,9]dotriaconta-1(29),2,4(9),5,7,10,12,14(31),18(30),19,21,25,27-tridecaen-17-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548231 2-(5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-6-(5-(phenylsulfonyl)pyridin-3-ylamino)pyridin-3-YL)propan-2-OL 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548348 1-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5-fluoro-6-methoxypyridin-3-yl)amino]pyridin-3-yl]-2,2,2-trifluoroethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168271774 cyclopentyl-[(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699958 (S)-1-(1-(4-(1,2,4-thiadiazol-3-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688498 4-(6-methanesulfonyl-5-methyl-pyridin-3-yl)-6-((S)-1-pyridin-2-yl-pyrrolidin-3-yloxy)-3,4-dihydro-2H-benzo[1,4]oxazine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072605 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-[(dimethylamino)methyl]piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073674 5-[2-[4-ethyl-6-[3-(methoxymethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688512 {(S)-3-[4-(5-Amino-6-methoxy-pyridin-3-yl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yloxy]-pyrrolidin-1-yl}-(1-methyl-1H-imidazol-4-yl)-methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646248 2-methoxy-5-[6-[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073736 5-[2-[4-ethyl-6-(3-methyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49784795 [(2S)-1-[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]pyrrolidin-2-yl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353465 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-(2-hydroxycyclopentyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353852 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(4-propan-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700780 2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072654 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-(2-methyl-2,7-diazaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:90394012 26-Methoxy-23,23-dioxo-3,23lambda6-dithia-6,8,12,16,24,27-hexazahexacyclo[23.3.1.12,5.110,14.118,22.04,9]dotriaconta-1(29),2(32),4,6,8,10,12,14(31),18(30),19,21,25,27-tridecaen-17-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701008 US10065970, Example 248 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073733 2-[1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]ethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701251 (S)-5-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)-2-methoxybenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073695 N-[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperidin-3-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664758 1-[(3S)-3-[[4-(5-chloro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-2-methylsulfonylethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70695335 5-[2-[(4-Ethylsulfonylpiperazin-1-yl)methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646330 [(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(4-hydroxycyclohexyl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341569 2-[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]-N,N-dimethylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:26699441 N-(4-acetylphenyl)-1H-indole-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664757 3-[(3S)-3-[[4-(5-chloro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-3-oxopropanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677362 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44481151 N-[6-(Pyridin-3-Yl)-1,3-Benzothiazol-2-Yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072576 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-hydroxy-1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353851 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664746 [(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-pyrimidin-5-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700973 (S)-1-(1-(2-(methylamino)benzo-[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495269 2-amino-5-[4-[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]oxy-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53319118 N-(2-isobutoxy-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072957 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-[(dimethylamino)methyl]piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76328475 N-[5-(7-amino-1-cyclopentyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]cyclopropanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798530 [7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67349024 1-[1-(2-Hydroxyacetyl)piperidin-4-yl]-8-(3-methoxyphenyl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155515279 1-methyl-3-[4-(4-methyl-8,9-dihydro-6H-purino[8,9-c][1,4]oxazin-2-yl)phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162661841 4-[4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58508043 5-[4-[(3R)-3-methylmorpholin-4-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71453424 4-morpholin-4-yl-6-[naphthalen-1-ylmethyl-(3,3,3-trifluoro-2-hydroxypropyl)amino]-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118616951 3-fluoro-N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127047186 N-[4-(1-hydroxyethyl)phenyl]-1H-indole-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:138961720 US9763952, Example B78 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072927 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[4-(azepan-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072939 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[(1R,3S)-4-methyl-2,4-diazabicyclo[1.1.1]pentan-2-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646325 [(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548181 (1S)-1-[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]-2,2-dimethylpropan-1-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379598 3-(2-Hydroxyethyl)-8-(6-methoxypyridin-3-yl)-1-(oxan-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617472 N,N-dimethyl-5-[6-[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379552 1-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(1-methylpyrazol-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072628 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(1-oxo-1,4-thiazinan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073735 2-[1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]-1-morpholin-4-ylethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127049341 5-(8-Ethyl-9-methyl-6-morpholin-4-ylpurin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072913 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(1,2,2,6,6-pentamethylpiperidin-4-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073020 Ethyl 4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylbenzoyl]piperazine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341566 8-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,8-diazaspiro[4.5]decan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688474 (S)-2-methoxy-5-(6-((1-(1-methyl-1H-imidazole-4-carbonyl)pyrrolidin-3-yl)oxy)-2H-benzo[b][1,4]oxazin-4(3H)-yl)nicotinonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073007 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-methyl-N-(oxan-4-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072967 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[3-(methoxymethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164609660 3-[6-amino-5-(1,3-dimethylpyrazol-4-yl)pyridin-3-yl]-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930398 N-[2-[4-[4-[6-ethyl-5-[2-[6-(ethylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorobenzoyl]piperazin-1-yl]ethyl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548300 4-methyl-6-[5-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-(1H-pyrazol-4-ylamino)pyridin-3-yl]-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71460604 6-[ethyl(naphthalen-1-ylmethyl)amino]-4-morpholin-4-yl-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700698 (S)-1-(1-(3H-[1,2,3]triazolo[4,5-b]pyridin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617701 1-[(3S)-3-[[4-(3,4-dimethoxyphenyl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548223 N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)-5-((pyridin-3-ylmethylamino)methyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646481 5-[6-[(3S)-1-[(3R)-1-acetylpyrrolidine-3-carbonyl]pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:54580063 2-(4-(2-(3-hydroxyphenylamino)-1H-benzo[d]imidazol-1-yl)-6-methoxy-1,3,5-triazin-2-ylamino)acetonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56650871 2-methoxy-5-[4-[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]oxy-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548379 (3S)-1-[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]pyrrolidin-3-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073647 N-[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-3-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072892 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(2,2-difluoroethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56653623 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1,3-thiazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646641 1-[(3S)-3-[[4-[4-methoxy-3-(trifluoromethyl)phenyl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71041625 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,19,23,25-hexazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22,24,26(30),27-tetradecaen-14-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25172662 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-[2-(diethylamino)ethyl]-2-methyl-5-nitrobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58508110 CID 58508110 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354351 [2-Chloro-4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]phenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548163 N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)-5-((pyridin-4-ylmethylamino)methyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072696 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(cyclohexylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539044 N-[2-chloro-5-[4-[4-(1,2,4-triazol-1-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073008 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46893618 3-(1-(6-amino-2-methylpyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072903 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(1,4-oxazepan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072789 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methyl-N-(1-methylpiperidin-3-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798544 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[4-(dimethylamino)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70689026 1-[4-[[6-(2-Aminopyrimidin-5-yl)-8-morpholin-4-ylimidazo[1,2-a]pyrazin-2-yl]methyl]piperazin-1-yl]-2-(dimethylamino)ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155555623 3-[4-(3-Oxabicyclo[4.1.0]heptan-6-yl)pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073084 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(dimethylamino)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548318 1-(5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)cyclopropanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44554910 2-((2-(4-fluorophenyl)-1H-indol-3-yl)methylene)-4,6-dihydroxybenzofuran-3(2H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700786 (R)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)-3-methoxy-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072725 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073052 Tert-butyl 7-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]-2,7-diazaspiro[3.4]octane-2-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:16757577 3-(4-Morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phenol;hydrochloride 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379599 1-(4-aminocyclohexyl)-8-quinolin-3-yl-3H-imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71454916 2-(benzylamino)-6-morpholin-4-yl-1H-pyridin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70682805 8-bromo-1-methyl-5-[(3-nitrophenyl)methyl]-3H-pyridazino[4,5-b]indol-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155549917 5-[4,6-Bis(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44601113 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}phenyl)-3-methylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173832 US11236079, Example 7 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11550986 5-[5-(3-Hydroxyphenyl)furan-2-ylmethylene]thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701266 (S)-2-((1-(4-(1H-1,2,4-triazol-3-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677363 [(3S)-3-[[6-(6-methoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51351030 1-(3-chloro-4-fluorophenyl)-9-(1-methyl-1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930427 Tert-butyl 7-[4-[6-ethyl-5-[2-[6-(ethylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorobenzoyl]-2,7-diazaspiro[3.5]nonane-2-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646572 4-(5-methyl-6-methylsulfonylpyridin-3-yl)-6-[(3S)-1-(oxan-4-ylsulfonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673803 5-(4-(1-methyl-1H-pymzol-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)benzo[d]oxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379635 8-(6-Methoxypyridin-3-yl)-3-methyl-1-(oxan-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44138128 2-((4-Fluoro-2-methylphenylamino)methyl)-6-morpholinoisonicotinic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709544 3-(3,4-dimethoxyphenyl)-5-pyridin-4-yl-1H-pyrrolo[2,3-b]pyridine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900437 4-(2-Chlorophenyl)-3-(4,5-dihydrothieno[3,2-d][1]benzoxepin-2-yl)-1,2,4-triazole 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548415 2-(5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-6-(6-chloro-5-methoxypyridin-3-ylamino)pyridin-3-YL)propan-2-OL 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89645823 1-[(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-2-methoxyethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:52948798 N-(2-amino-5-(3-(3,4-dimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)pyridin-3-yl)-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173828 US11236079, Example 1 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44348375 [1-(3-Phenylpropyl)piperidin-3-yl]methyl 2-(3-ethyl-2,5-dioxopyrrolidin-1-yl)benzoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700670 (S)-2-((1-(3-cyanophenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072743 N-[2-[4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorobenzoyl]piperazin-1-yl]ethyl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699961 (S)-2-(((R)-2-(2-aminobenzo[d]oxazol-5-yl)-4-methyl-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylen-7-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354051 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798476 5-[3-(2-Morpholin-4-ylpyridin-4-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072682 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]phenyl]-(4-phenylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072994 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-[[(2R)-1-ethylpyrrolidin-2-yl]methyl]-2-fluorobenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673780 (S)-1-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56650206 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700997 (S)-2-((1-(2-amino-4-fluorobenzo[d]thiazol-6-yl)-7,8,9,10-tetrahydro-6-oxa-2,10a-diazacycloocta[cd]-inden-4-yl)oxy)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073687 5-[2-[4-Ethyl-6-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495361 (S)-3-[6-(5-cyano-6-methoxy-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yloxy]-pyrrolidine-1-carboxylic acid methyl ester 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930164 [2-chloro-4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]phenyl]-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134135780 N-[2-(cyclopropyloxymethyl)-5-[3-(2-methoxyethyl)-4-oxoquinazolin-6-yl]pyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444300 5-[2-[(3S)-3-methylmorpholin-4-yl]-7-(1-methylsulfonylazetidin-3-yl)-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162670858 4-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379508 8-(6-Methoxypyridin-3-yl)-3-methyl-1-(2-morpholin-4-ylethyl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134814187 2-methoxy-5-[6-[(3S)-1-(6-oxo-3H-pyridine-3-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353660 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073664 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-4-(trifluoromethyl)piperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701241 (S)-2-cyclopropyl-2-((1-(5,6-dihydro-[1,2,4]triazolo[1,5-a]pyrazin-7(8H)-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072980 [5-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44600651 3-(4-Morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341524 4-Ethyl-6-(4-methoxypiperidin-1-yl)-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617586 1-[(3S)-3-[[4-(6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072581 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(2-oxa-7-azaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073063 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444320 5-(7-Tert-butyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168281404 1-[(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-2,2-dimethylpropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118523387 7-fluoro-3-methyl-1-[(3R)-oxan-3-yl]-8-[6-(3-pyrrolidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341526 5-[2-(4-Ethyl-6-morpholin-4-ylpyrimidin-5-yl)ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709079 9-(1-Anilinoethyl)-7-(morpholine-4-carbonyl)-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661317 [(3S)-3-[[4-(5-fluoro-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072997 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-phenylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646001 1-[(3S)-3-[[4-[5-(4-methylpiperazin-1-yl)sulfonylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164556550 6-(5,6-dimethoxypyridin-3-yl)-N-(1-phenylethyl)quinazolin-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134814184 3-[(3S)-3-[[4-(6-chloro-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidine-1-carbonyl]-3H-pyridin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646778 [(3S)-3-[[1-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072640 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-[(dimethylamino)methyl]piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:141519571 (2S)-1-[4-[[4-(2,6-dimorpholin-4-ylpyrimidin-4-yl)phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:24889936 5-(2-Morpholin-4-Yl-7-Pyridin-3-Yl-6,7-Dihydro-5h-Pyrrolo[2,3-D]pyrimidin-4-Yl)-Pyrimidin-2-Ylamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379618 1-[1-(2-Methoxyacetyl)piperidin-4-yl]-8-(2-methoxypyrimidin-5-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646842 1-[(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56650874 [(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072671 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(2-methyl-2,7-diazaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688494 2-methoxy-5-{6-[(S)-1-((S)-pyrrolidine-3-carbonyl)-pyrrolidin-3-yloxy]-2,3-dihydro-benzo[1,4]oxazin-4-yl}-nicotinonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548374 2-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-1,1,1-trifluoropropan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353659 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(2-hydroxy-2-methylpropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073079 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(oxazinan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072665 tert-butyl (3aR,6aS)-2-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884123 4,6-dihydroxy-2-((1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548213 2-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[(5,6-dimethoxypyridin-3-yl)amino]pyridin-3-yl]propan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646588 US9763952, Example B45 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341568 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-1-yl]-cyclopropylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884594 (R)-1-(4-(4-(dimethylamino)piperidin-1-yl)phenyl)-3-(4-(4-(3-methylmorpholino)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL3112712 CHEMBL3112712 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072694 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[3-(4-methylpiperidin-1-yl)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60142906 (R)-1-(1-(2-hydroxypropanoyl)piperidin-4-yl)-9-(6-methoxypyridin-3-yl)-3-methyl-3,4-dihydropyrimido[5,4-c][1,5]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548382 N-[5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-[(1R)-1-morpholin-4-ylethyl]pyridin-2-yl]amino]-2-chloropyridin-3-yl]methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700491 (S)-2-((1-(5-chloro-6-methoxypyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661383 1-[(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-2-methylsulfonylethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155516260 3-[4-[(3S)-3-methylmorpholin-4-yl]pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913524 N-(2-Chloro-5-(6-(pyridin-4-yl)imidazo[1,2-a]pyridin-3-yl)pyridin-3-yl)dimethylaminosulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71582894 {(S)-3-[1-(6-Methoxy-5-methyl-pyridin-3-yl)-2,3-dihydro-1H-pyrido[3,4-b][1,4]oxazin-7-yloxy]-pyrrolidin-1-yl}-(1-methyl-1H-imidazol-4-yl)-methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548459 4-[5-(1-Amino-2,2,2-trifluoroethyl)-2-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341567 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-methylpiperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661330 [(3S)-3-[[1-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118397117 [6-[1-[(6-Methoxypyridin-3-yl)methyl]piperidin-4-yl]imidazo[1,2-a]pyridin-2-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162658201 5-(6-Morpholin-4-yl-9-propan-2-ylpurin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354150 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(4-cyclobutylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46866605 4-(3-(4-(4,6-bis((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)ureido)-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56654311 [(3S)-3-[[6-(5-chloro-6-methoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164612094 2-[4-[[2-(1H-indol-4-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073066 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(4-tert-butylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56654994 1-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-3,3-dimethylbutan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354354 [2-Chloro-4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]phenyl]-(4-ethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700686 (S)-2-((1-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072689 5-[2-[4-Ethyl-6-[6-(trifluoromethyl)pyridin-3-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:62706814 N-[2-methyl-6-[2-[(1-methylpyrazol-3-yl)amino]imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495294 (2,2-dimethyloxan-4-yl)-[(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073085 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-[2-(2-hydroxyethoxy)ethyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700700 (S)-1-(1-(4-(2-oxoimidazolidin-1-yl)phenyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699966 US10065970, Example 254 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173118 5-(4-Morpholino-6-(phenylsulfonyl)pyridin-2-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177401 (R)-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)-3-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118341819 2-[4-[[6-(3-Nitrophenyl)quinazolin-4-yl]amino]phenyl]acetonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548334 4-[1-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[[6-chloro-5-(dimethylsulfamoylamino)pyridin-3-yl]amino]pyridin-3-yl]ethyl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71037775 2-methoxy-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]-N-phenylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548399 N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(morpholinomethyl)pyridin-2-yl)benzo[d]thiazol-5-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166635282 methyl (2S)-1-[4-[[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701267 (S)-4-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)-2-fluorobenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072678 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluoro-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44606998 3-(4-morpholino-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)aniline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646543 1-[(3S)-3-[[1-[5-(difluoromethyl)-6-methoxypyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-2-methoxyethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118617088 4-cyano-N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71462083 [2-(Benzylamino)-6-morpholin-4-ylpyridin-4-yl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700966 (S)-2-((1-(2-aminobenzo[d]thiazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148819 (3S)-4-[8-(1H-indol-4-yl)-2-[(3S)-3-methylmorpholin-4-yl]-7H-purin-6-yl]-3-methylmorpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646237 2-methoxy-5-[6-[(3S)-1-(oxolane-3-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403588 (3-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidin-1-yl)(4-fluorophenyl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148772 [4-chloro-3-[6-[(3S)-3-methylmorpholin-4-yl]-2-morpholin-4-yl-7H-purin-8-yl]phenyl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44129430 (2S)-1-N-[5-[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145986565 5-[4,6-Bis(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)pyrimidin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51350805 9-(6-aminopyridin-3-yl)-1-(4-fluoro-3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168284235 8-[5-(2-aminopyrimidin-5-yl)-3-morpholin-4-yl-2-oxopyrazin-1-yl]-N-hydroxyoctanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444318 methyl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyrrolidine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709080 2-[[9-(1-Anilinoethyl)-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carbonyl]-methylamino]acetic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073661 5-[2-[4-Ethyl-6-[4-(2-methoxyethyl)piperazin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341527 5-[2-[4-Methyl-6-(9-methyl-3,9-diazaspiro[5.5]undecan-3-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700011 US10065970, Example 300 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699993 US10065970, Example 291 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379647 N-methyl-4-[3-methyl-8-(1-methylpyrazol-4-yl)-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]piperidine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073652 5-[2-[4-(7,8-dihydro-5H-1,6-naphthyridin-6-yl)-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155568479 3-[4-(3,6-dihydro-2H-pyran-4-yl)-6-(methylsulfonylmethyl)pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118436165 5-{2-[(3S)-3-methylmorpholin-4-yl]-7-[1-(propan-2-ylsulfonyl)azetidin-3-yl]-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl}pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25195997 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-(1-methylpiperidin-4-yl)urea 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4746999 CHEMBL4746999 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661396 (1,1-dioxothian-4-yl)-[(3S)-3-[[4-(5-propan-2-ylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341387 5-[2-[4-(4-Cyclopropylpiperazin-1-yl)-6-methylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072539 4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxybenzoyl]piperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353952 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(4-ethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548211 (1R)-1-[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-2,2,2-trifluoroethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59244941 [5-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]pyridin-2-yl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700504 US10065970, Example 260 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164614010 2-[4-[[2-(3-Amino-4-fluorophenyl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664744 [(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,3-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118470495 3-[5-amino-6-(2-methyl-1,3-thiazol-5-yl)pyrazin-2-yl]-N-(4-hydroxycyclohexyl)-4-methylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177526 6-(3-((2,4-Difluorobenzyl)sulfonyl)-5-morpholinophenyl)pyridazin-3-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785830 N-[3-(2-methyl-7H-purin-6-yl)-5-(trifluoromethyl)pyridin-2-yl]-1H-indazol-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884071 (Z)-1-(2-((1-methyl-4-(4-(piperidine-1-carbonyl)piperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072861 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(trifluoromethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:122188257 N-[(E)-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-3-fluoro-N-methylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145981509 5-[4,6-Bis(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)pyrimidin-2-yl]-4-(difluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148747 [2-fluoro-5-[6-[(3S)-3-methylmorpholin-4-yl]-2-morpholin-4-yl-7H-purin-8-yl]phenyl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072924 Tert-butyl 4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]-1-oxa-4,9-diazaspiro[5.5]undecane-9-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:157652357 US11236079, Example 3 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118523375 1-Cyclobutyl-8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-3-methylimidazo[4,5-c]quinolin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072591 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072966 [4-(2,2-Difluoroethyl)piperazin-1-yl]-[4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072857 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]-(4-propan-2-ylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073091 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-(1,1-dioxothiolan-3-yl)-N,2-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67346053 1-[1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl]-8-(3-methoxyphenyl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168269446 1-[(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-2-methylpropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646590 5-[6-[(3S)-1-[2-(dimethylamino)acetyl]pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072855 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646397 6-[(3S)-1-cyclopropylsulfonylpyrrolidin-3-yl]oxy-4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072799 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-(1,1-dioxothiolan-3-yl)-2-methoxy-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073711 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-3-methylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354460 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379602 1-[1-(2-Aminoacetyl)piperidin-4-yl]-8-(2-methoxypyrimidin-5-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495274 (3-methoxycyclobutyl)-[(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4792033 CHEMBL4792033 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700012 US10065970, Example 301 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042083 26-Methoxy-23,23-dioxo-3,23lambda6-dithia-6,8,12,13,16,24,27-heptazahexacyclo[23.3.1.12,5.110,13.118,22.04,9]dotriaconta-1(29),2(32),4,6,8,10(31),11,18(30),19,21,25,27-dodecaen-17-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072987 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(2-hydroxy-2-methylpropyl)-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700807 US10065970, Example 286 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59453125 7-[6-(2-Hydroxypropan-2-yl)pyridin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177464 3-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661341 (1,1-Dioxo-hexahydro-1lambda*6*-thiopyran-4-yl)-{(S)-3-[5-fluoro-4-(6-methoxy-5-methyl-pyridin-3-yl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yloxy]-pyrrolidin-1-yl}-methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072612 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(3-hydroxypiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072609 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-(trifluoromethoxy)phenyl]-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44158569 3-[4-(2-Methylimidazol-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072635 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073686 5-[2-[4-Ethyl-6-(9-methyl-3,9-diazaspiro[5.5]undecan-3-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661316 [(3S)-3-[[4-(5-chloro-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700959 (S)-2-cyclopropyl-2-((1-(thieno[2,3-b]pyridin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56653272 1H-imidazol-5-yl-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884587 1-(4-(4,6-bis((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-((dimethylamino)methyl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71037724 6-(2-Amino-1,3-benzoxazol-5-yl)-3-cyclopentylquinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168270837 1-[4-[1-(4-Fluorophenyl)-2-methylimidazo[4,5-c]quinolin-8-yl]phenyl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71041623 13-Methoxy-16,16-dioxo-16lambda6-thia-5,12,15,23-tetrazaheptacyclo[21.5.3.26,9.110,14.117,21.02,7.026,30]pentatriaconta-1(29),2(7),3,5,8,10(33),11,13,17,19,21(32),26(30),27,34-tetradecaen-22-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700492 (S)-2-cyclopropyl-2-((1-(1-methyl-6-oxo-1,6-dihydropyridazin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646836 1-[(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-3-methoxypropan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785437 N-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-((4-(methylsulfonyl)piperazin-1-YL)methyl)pyridin-2-YL)-1H-benzo[D]imidazol-5-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072873 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444294 5-[7-[(3S)-1-cyclopropylsulfonylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379629 1-[(2R)-1-hydroxypropan-2-yl]-8-(1H-indol-4-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072709 3-[4-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorobenzoyl]piperazin-1-yl]propanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118378670 [5-[1-[(6-Methoxypyridin-3-yl)methyl]piperidin-4-yl]-1-methylpyrrolo[2,3-c]pyridin-2-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664695 [(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:95415 2-Hydroxy-1,2-bis(4-methoxyphenyl)ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072891 5-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-fluoro-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664673 (1,1-dioxothian-4-yl)-[(3S)-3-[[4-(5-ethyl-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701244 (S)-2-cyclopropyl-2-((1-(1,3-dimethyl-1H-pyrazol-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699950 1-(2-aminobenzo[d]oxazol-5-yl)-N-(3,3-difluorocyclobutyl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71037741 6-(2-Amino-1,3-benzoxazol-5-yl)-3-[2-(dimethylamino)ethyl]quinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072851 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(azepan-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072820 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-[2-(dimethylamino)ethyl]-2-fluoro-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073708 5-[2-[4-ethyl-6-(4-morpholin-4-yl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:117834533 4-amino-6-[(2S)-2-[5-(1-methylpyrazol-4-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379557 1-(4-hydroxycyclohexyl)-3-methyl-8-(1H-pyrazolo[3,4-b]pyridin-5-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67347798 1-[1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl]-8-(4-methoxyphenyl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664732 [(3S)-3-[[4-[5-(difluoromethyl)-6-methylsulfonylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166632045 methyl (2S,4R)-1-[4-[[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]-4-hydroxypyrrolidine-2-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354459 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-[4-(2-hydroxy-2-methylpropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646804 oxan-4-yl-[(3S)-3-[[4-[5-(trifluoromethyl)pyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661397 [(3S)-3-[[4-(6-chloro-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25070231 4-(2-(4-(methylsulfonyl)phenyl)-9H-purin-6-yl)morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072983 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-piperidin-1-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646310 1,4-dioxan-2-yl-[(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44348367 [1-(3-Phenylpropyl)piperidin-3-yl]methyl 2-(3-octyl-2,5-dioxopyrrolidin-1-yl)benzoate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53324426 N-(2-ethoxy-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700788 (S)-2-cyclopropyl-2-((1-(3-hydroxypiperidin-1-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646447 2-methoxy-5-[6-[(3S)-1-(1,3-oxazole-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664858 [(3S)-3-[[1-[5-(difluoromethyl)-6-methoxypyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118341884 2-[4-[[6-(2,3-Dihydro-1,4-benzodioxin-6-yl)quinazolin-4-yl]amino]phenyl]acetonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:153532123 1-[2-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)anilino]-3H-benzimidazole-5-carbonyl]piperidine-3-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646412 cyclohexyl-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354058 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042078 18-Methoxy-15,15-dioxo-15lambda6-thia-4,5,8,16,19,26,28-heptazahexacyclo[20.6.2.12,5.110,14.117,21.025,29]tritriaconta-1(28),2(33),3,10(32),11,13,17,19,21(31),22(30),23,25(29),26-tridecaen-9-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495352 6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-4-((S)-1-pyrimidin-2-yl-pyrrolidin-3-yloxy)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379640 3-Methyl-8-(1-methylpyrazol-4-yl)-1-(oxan-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL2375961 CHEMBL2375961 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353657 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[(2R)-2,4-dimethylpiperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646469 5-[6-[(3S)-1-(1,4-dioxane-2-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59453083 2-[6-(2-Hydroxypropan-2-yl)pyridin-3-yl]-8-(oxan-4-yl)-5,7-dihydropyrazino[2,3-b]pyrazin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177498 5-(3-((2,3-Dihydrobenzofuran-6-yl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661309 [(3S)-3-[[4-(6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548346 4-(5-(1-Aminoethyl)-2-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811610 3-[7-[(4-Methylsulfonylpiperazin-1-yl)methyl]-2-morpholin-4-ylthieno[3,2-d]pyrimidin-4-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59507839 5-(2,6-Dimorpholin-4-ylpyrimidin-4-yl)pyrimidine-2,4-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664739 [(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548308 N5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)pyridin-2-YL)-2-chloropyridine-3,5-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072672 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-butylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072760 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(piperidin-4-ylmethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548164 N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)-5-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073032 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-benzylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072817 5-[2-[4-Methyl-6-(2-methylpyridin-4-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073715 4-(4-Ethoxypiperidin-1-yl)-6-ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:42606431 3-(Pyridin-4-ylethynyl)-1H-pyrazolo[3,4-b]pyridine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646701 [(3S)-3-[[4-(6-chloro-5-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673750 (S)-2-cyclopropyl-2-((1-morpholino-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072562 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[(3S)-3-hydroxypyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042061 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,19,24,28,29-heptazahexacyclo[20.5.2.12,6.19,13.117,21.025,29]dotriaconta-1(28),2(32),3,5,9,11,13(31),17(30),18,20,22,24,26-tridecaen-14-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57403086 4-(3-(Cyclohexylmethyl)-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyrazin-5-yl)benzoic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073653 5-[2-[4-[4-[(4,5-Dimethyl-1,3-oxazol-2-yl)methyl]piperazin-1-yl]-6-ethylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673833 (S)-2-((2-(2-aminobenzo[d]oxazol-5-yl)-3,4-dihydro-5-oxa-1,2a-diazaacenaphthylen-7-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379546 1-(4-Hydroxycyclohexyl)-3-methyl-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57900125 2-[2-(2,2,2-Trifluoroethyl)-1,2,4-triazol-3-yl]-4,5-dihydrothieno[3,2-d][1]benzoxepine-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70697347 5-[2-[[(2S,6R)-2,6-dimethyl-4-methylsulfonylpiperazin-1-yl]methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379605 1-[(2R)-1-hydroxypropan-2-yl]-8-(6-methoxypyridin-3-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118397064 [5-[1-[(6-Methoxypyridin-3-yl)methyl]piperidin-4-yl]-1-methylbenzimidazol-2-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661375 [(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,3-oxazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072649 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]phenyl]-(4-butylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646524 6-[(3S)-1-ethylsulfonylpyrrolidin-3-yl]oxy-4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49786100 4-[[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]methyl]-N,N-dimethylpiperazine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881843 1-Ethyl-3-[3-(3-methylanilino)pyrido[2,3-b]pyrazin-6-yl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58137148 4-[6-(Propan-2-ylsulfonylmethyl)-2-pyridin-2-ylpyrimidin-4-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072902 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379549 1-[1-(2-Amino-2-methylpropanoyl)piperidin-4-yl]-3-methyl-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072909 4-[6-ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]-N,N-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70689122 8-bromo-5-[(3-methoxyphenyl)methyl]-1-methyl-3H-pyridazino[4,5-b]indol-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51351158 1-(4-fluoro-2-(trifluoromethyl)phenyl)-9-(1-methyl-1H-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785754 3-(3-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699987 US10065970, Example 282 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162670157 4-[4-(2-fluorophenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59507734 2-Amino-5-[2-morpholin-4-yl-6-(quinolin-3-ylamino)-pyrimidin-4-yl]-isonicotinonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:77014367 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(2,2-difluoroethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700500 (R)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)butanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646092 2-(dimethylamino)-1-[(3S)-3-[[4-(6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930379 N-[[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]methyl]hexanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881805 1-Ethyl-3-[3-(4-fluoroanilino)pyrido[2,3-b]pyrazin-6-yl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25165961 4-ethyl-6-[5-[1-(2-methylpropyl)pyrazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70695983 1-(3-(4-Bromophenylsulfonyl)quinoxalin-2-yl)piperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072898 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072580 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-methoxy-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617585 2-methoxy-5-[6-[(3S)-1-propanoylpyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162660548 4-[4-(2-methoxyphenyl)sulfonylpiperazin-1-yl]-6-morpholin-4-yl-N-(2-morpholin-4-ylethyl)-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699968 US10065970, Example 255 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042023 10,12-Difluoro-5-methoxy-8,8-dioxo-8lambda6-thia-4,7,15,25-tetrazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22(30),23,25,27-tetradecaen-14-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073747 4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-1-methylpiperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86766422 (1S)-1-[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-2,2,2-trifluoroethanol;(1R)-1-[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-2,2,2-trifluoroethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46885600 4,6-dihydroxy-2-((1-methyl-2-phenyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701252 (S)-2-cyclopropyl-2-((1-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:62706652 3-[2-methyl-6-(pyridin-3-ylamino)pyrimidin-4-yl]-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354457 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25133141 N-(6-(Pyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073667 5-[2-[4-Ethyl-6-[4-[2-(trifluoromethyl)phenyl]piperazin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548433 4-[(1S)-1-[5-(6-amino-2-methylpyrimidin-4-yl)-6-[[6-chloro-5-(dimethylsulfamoylamino)pyridin-3-yl]amino]pyridin-3-yl]ethyl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930207 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(2-hydroxyethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168279991 1-[(3S)-3-[[6-(6-methoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548352 N-(4-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-((4-(methylsulfonyl)piperazin-1-YL)methyl)pyridin-2-ylamino)phenyl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148843 4-[8-(1H-indol-4-yl)-2-morpholin-4-yl-7H-purin-6-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53323075 N-(2-(allyloxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56325569 N-[3-benzoylphenyl]-1h-indole-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403576 3-((3-(2-aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)-N,N-dimethylazetidine-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44129274 (2S)-1-N-[5-[2-(2-fluorophenyl)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884586 1-(4-(4,6-bis((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-(dimethylamino)piperidin-1-yl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709074 2-[1-(7-Methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzenesulfonic acid 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:121334382 5-[4,6-bis[(2S,6R)-2,6-dimethylmorpholin-4-yl]-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118378629 [2-[1-[(6-Methoxypyridin-3-yl)methyl]piperidin-4-yl]indazol-5-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884069 (Z)-1-(2-((1-methyl-4-(4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664844 [(3S)-3-[[1-[6-(difluoromethoxy)-5-methylpyridin-3-yl]-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothian-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884584 1-(4-(4,6-bis((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71037740 6-(2-Amino-1,3-benzoxazol-5-yl)-3-[3-(4-methylpiperazin-1-yl)propyl]quinazolin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56651215 5-[4-[(3S)-1-(cyclopentanecarbonyl)pyrrolidin-3-yl]oxy-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646094 1-[(3S)-3-[[4-(6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-2-morpholin-4-ylethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155556309 5-[4,6-bis[(3R)-3-methylmorpholin-4-yl]-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072948 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N,2-dimethoxy-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53340936 9-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-methyl-3,9-diazaspiro[5.5]undecane-3-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168281816 (2S)-3-methyl-2-[[2-[(4S)-2-oxo-4-(trifluoromethyl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]butanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700814 US10065970, Example 305 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156015377 2-chloro-4-fluoro-N-[2-methoxy-5-[3-[(2R)-2-methyl-3-morpholin-4-yl-3-oxopropyl]-4-oxoquinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53380858 1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548267 N-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-[(1R)-1-(4-methylsulfonylpiperazin-1-yl)ethyl]pyridin-2-yl]quinolin-7-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072830 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-chlorophenyl]-(1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444304 5-[7-(1-ethylsulfonylazetidin-3-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71449776 6-[3-hydroxypropyl(naphthalen-1-ylmethyl)amino]-4-morpholin-4-yl-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884589 1-(4-(4,6-bis((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146173006 5-(2-Morpholino-6-(phenylsulfonyl)pyridin-4-yl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646557 [(3S)-3-[[4-(5-fluoro-6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118378640 [4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]piperazin-1-yl]-[6-[1-[(6-methoxypyridin-3-yl)methyl]piperidin-4-yl]-1H-benzimidazol-2-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673879 US10065970, Example 302 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072813 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-(1-hydroxyethyl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177525 5-(3-Morpholino-5-((pyridin-4-ylmethyl)sulfonyl)phenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379558 1-(1-Acetylpiperidin-4-yl)-3-methyl-8-(4-methylsulfonylphenyl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072732 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-N-[(3-methyloxetan-3-yl)methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072901 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71460607 6-[2-hydroxybutyl(naphthalen-1-ylmethyl)amino]-4-morpholin-4-yl-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661414 [(3S)-3-[[4-[5-(difluoromethyl)-6-methoxypyridin-3-yl]-5-fluoro-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothian-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072946 tert-butyl N-[7-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]-7-azaspiro[3.5]nonan-2-yl]carbamate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646429 3-methoxy-1-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072985 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(oxolan-2-ylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:67347865 1-(4-Hydroxycyclohexyl)-8-(2-methoxypyrimidin-5-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073743 2-[1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]-1-(4-methylpiperazin-1-yl)ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11536358 5-(5-Pyridin-2-ylfuran-2-ylmethylene)thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168283244 1-[(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444271 [3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]cyclobutyl] N-methylsulfamate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785080 N2-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)-N5-phenylpyridine-2,5-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548202 5-N-[3-(2-methyl-7H-purin-6-yl)-5-[(4-methylsulfonylphenyl)methyl]pyridin-2-yl]pyridine-2,5-diamine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647064 (4-hydroxycyclohexyl)-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164809106 N-(2-chloro-5-(4-((1R-(4-fluorophenyl)ethyl)amino)quinazolin-6-yl)pyridin-3-yl)methanesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548186 (R)-4-(2-(6-chloropyridin-3-ylamino)-5-(1-(4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341485 5-[2-[4-Ethyl-6-(1-oxo-1,4-thiazinan-4-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341606 1-[9-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-3,9-diazaspiro[5.5]undecan-3-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11492951 5-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethylene)-thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25133144 N-(6-pyridin-4-yl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51357946 N-(6-(2-(3-Methoxybenzyloxy)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548467 4-(5-(3-Aminopentan-3-yl)-2-(5-fluoro-6-methoxypyridin-3-ylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70688479 6-(2-aminopyrimidin-5-yl)-8-morpholin-4-yl-N-(2-morpholin-4-ylethyl)imidazo[1,2-a]pyrazine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699955 (S)-1-(1-(5-(1H-1,2,4-triazol-3-yl)pyridin-2-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785343 N-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(piperazin-1-ylmethyl)pyridin-2-yl]-3H-benzimidazol-5-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71460605 6-[cyclopropyl(naphthalen-1-ylmethyl)amino]-4-morpholin-4-yl-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700679 (S)-2-cyclopropyl-2-((1-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56652244 [(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(2,4-dimethyl-1,3-oxazol-5-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:69930103 2-chloro-4-[6-ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146851665 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-2-methyl-N-propan-2-ylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798428 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyrazin-3-yl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444251 3-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]cyclobutane-1-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700666 (S)-2-((1-(5-cyanopyridin-2-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56654313 [3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]azetidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89589903 3-methyl-9-(6-methylsulfanylpyridin-3-yl)-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699936 5-(4-bromo-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)benzo[d]oxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700503 (S)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)butanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072729 5-[2-(4-Methyl-6-quinolin-3-ylpyrimidin-5-yl)ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444303 5-[7-[(3S)-1-cyclopropylsulfonylpyrrolidin-3-yl]-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699940 (S)-2-((1-(2-aminoquinazolin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53322283 4-amino-N-(6-(dimethylamino)pyridin-3-yl)-2-methylquinazoline-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126673768 (S)-2-cyclopropyl-2-((1-(1-methyl-1H-pyrazol-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444264 3-[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]azetidine-1-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379496 1-(1-Acetylpiperidin-4-yl)-8-[6-(dimethylamino)pyridin-3-yl]-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168292319 N-[5-chloro-4-[3-(4-fluoroanilino)-5-(methylcarbamoyl)phenyl]pyridin-2-yl]oxane-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:10432948 7-Methyl-2-(4-morpholinyl)-9-[1-[[2-(2H-tetrazol-5-yl)phenyl]amino]ethyl]-4H-pyrido[1,2-a]pyrimidin-4-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646111 5-[6-[(3S)-1-(cyclohexanecarbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:11515474 5-[5-(2-Hydroxy-3-nitrophenyl)furan-2-ylmethylene]thiazolidine-2,4-dione 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700695 (S)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)-3-methoxy-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661398 [(3S)-3-[[4-[5-(difluoromethyl)-6-methylsulfonylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798415 [6-(3-Amino-1,2-benzothiazol-6-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073681 5-[2-[4-methyl-6-(3-methyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44607529 N-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-2,2-dimethylhydrazinecarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072585 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methyl-N-(2-morpholin-4-ylethyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:76335780 CID 76335780 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4789813 CHEMBL4789813 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072906 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(1-oxo-1,4-thiazinan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53320445 N-(2-(2-amino-2-oxoethoxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354456 [2-Chloro-4-[6-ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]phenyl]-(4-methylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700663 (R)-2-((1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072599 [5-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-chlorophenyl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073739 [1-[6-Ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]pyrimidin-4-yl]piperidin-3-yl]methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379562 8-(2-Methoxypyrimidin-5-yl)-3-methyl-1-(oxan-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548170 2-((5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(6-methoxypyridin-3-ylamino)pyridin-3-yl)(hydroxy)methyl)-4-bromo-N,N-dimethylbenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700965 (S)-2-cyclopropyl-2-((1-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811703 2-hydroxy-1-[4-[[4-(1H-indazol-4-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811784 2-[4-[[4-(2-Aminopyrimidin-5-yl)-6-methyl-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]ethanol 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL2375956 CHEMBL2375956 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072961 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49786005 N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(1-morpholinoethyl)pyridin-2-yl)benzo[d]thiazol-5-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072653 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-[3-(dimethylamino)propyl]-2-fluoro-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59453076 5-(4-Hydroxycyclohexyl)-3-[6-(2-hydroxypropan-2-yl)pyridin-3-yl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341442 5-[2-[4-Ethyl-6-[4-(trifluoromethyl)piperidin-1-yl]pyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56653620 5-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidine-1-carbonyl]pyrrolidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646900 2-methoxy-5-[7-[(3S)-1-(1-methylimidazole-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydropyrido[3,4-b][1,4]oxazin-1-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155525333 3-[4-(methylsulfonylmethyl)-6-[(1R,6S)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89935540 Tert-butyl 6-[4-[6-ethyl-5-[2-[6-(ethylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2-fluorobenzoyl]-2,6-diazaspiro[3.3]heptane-2-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379631 4-[3-Methyl-8-(6-methylpyridin-3-yl)-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]piperidine-1-carbohydrazide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166628934 (2S)-1-[4-[[4-[4-[(4aS,7aS)-2,3,4a,5,7,7a-hexahydro-[1,4]dioxino[2,3-c]pyrrol-6-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53320104 N-(6-(5-aminopyrazin-2-yl)-2-morpholinopyrimidin-4-yl)quinolin-3-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168285085 N-[4-[3-anilino-5-(methanesulfonamido)phenyl]pyridin-2-yl]oxane-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798585 5-[3-(2-Aminopyrimidin-5-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56654310 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1,3-thiazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072721 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-chlorophenyl]-(4-hydroxy-1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155515425 2-(methylamino)-N-[4-[4-[(3S)-3-methylmorpholin-4-yl]-6-(methylsulfonylmethyl)pyrimidin-2-yl]phenyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168295930 1-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155510695 2-(methylamino)-N-[4-[4-[(3S)-3-methylmorpholin-4-yl]-6-(2-methylsulfonylpropan-2-yl)pyrimidin-2-yl]phenyl]acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51350807 1-(4-fluoro-3-(trifluoromethyl)phenyl)-9-(1H-indazol-5-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:54582091 3-(1-(6-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700984 (S)-2-((1-(1H-pyrazol-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073090 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-N-methoxy-N,2-dimethylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353661 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-cyclopropylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701010 US10065970, Example 251 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700673 (S)-2-cyclopropyl-2-((1-(quinazolin-7-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072879 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-chlorophenyl]-(oxazinan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700681 (S)-2-((1-([1,2,4]triazolo[1,5-a]pyrimidin-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)-2-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798531 [6-(2-Amino-1,3-benzoxazol-5-yl)-8-fluoroimidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661395 (1,1-dioxothian-4-yl)-[(3S)-3-[[4-(6-ethoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168273921 N-[4-[3-anilino-5-[(2-hydroxyacetyl)amino]phenyl]pyridin-2-yl]oxane-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379490 8-[6-(Dimethylamino)pyridin-3-yl]-3-methyl-1-(1-methylpiperidin-4-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162651895 1-Cyclopentyl-4-[[2-(2-ethylbenzimidazol-1-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700787 (S)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-cyclopropylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072587 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354676 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072570 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:134814185 4-[(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidine-1-carbonyl]piperidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49786006 N-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-5-methylpyridin-2-YL)-1H-indol-4-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700490 (S)-2-cyclopropyl-2-((1-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072766 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(7-methyl-2,7-diazaspiro[4.4]nonan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072874 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(1-methylpyrrolidin-3-yl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155542051 1-Ethyl-3-[4-[4-(3-oxabicyclo[4.1.0]heptan-6-yl)pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072810 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-[4-(2,2-difluoroethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072643 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-butylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072896 [4-[5-[2-(6-Amino-2-methylpyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(trifluoromethyl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59453087 2-[6-(2-Hydroxypropan-2-yl)pyridin-3-yl]-8-(2-methoxyethyl)-5,7-dihydropyrazino[2,3-b]pyrazin-6-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379548 1-(4-hydroxycyclohexyl)-8-(1H-indazol-5-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86688496 2-methoxy-5-{6-[(S)-1-((R)-pyrrolidine-3-carbonyl)-pyrrolidin-3-yloxy]-2,3-dihydro-benzo[1,4]oxazin-4-yl}-nicotinonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677236 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(3-methylimidazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548252 N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-((R)-1-((S)-2-methyl-4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-2-yl)benzo[d]thiazol-5-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168295771 N-[4-[3-anilino-5-(methylamino)phenyl]pyridin-2-yl]oxane-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072804 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(6-methyl-2,6-diazaspiro[3.3]heptan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168283857 1,8-Bis(4-fluorophenyl)-2-methylimidazo[4,5-c]quinoline 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072720 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-fluorophenyl]-(oxazinan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073688 5-[2-[4-(1,5-Dioxa-9-azaspiro[5.5]undecan-9-yl)-6-methylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785169 (6-(1H-indazol-4-ylamino)-5-(2-methyl-9H-purin-6-yl)pyridin-3-yl)methanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073053 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[1-(1-methylpiperidin-4-yl)piperidin-3-yl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:74539745 N-[5-[4-[4-(diethylaminomethyl)phenyl]quinolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072572 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164611873 2-[4-[[2-(1H-indazol-4-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162656814 2,4-difluoro-N-[2-methoxy-5-[4-[(Z)-4-morpholin-4-yl-4-oxobut-2-en-2-yl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379553 2-Methyl-2-[4-[3-methyl-8-(1-methylpyrazol-4-yl)-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]phenyl]propanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354675 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-(4-ethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155541609 1-ethyl-3-[4-[4-(methylsulfonylmethyl)-6-[(1S,6R)-3-oxabicyclo[4.1.0]heptan-6-yl]pyrimidin-2-yl]phenyl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71462308 6-[methyl(naphthalen-1-ylmethyl)amino]-4-morpholin-4-yl-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072630 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[(1-methylpyrrolidin-3-yl)methyl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:62706475 3-[2-methyl-6-(methylamino)pyrimidin-4-yl]-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354049 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-piperazin-1-ylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:85469442 [3-[[3-[3-[[6-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-6-oxohexyl]amino]propylsulfonyl-methylamino]phenyl]methyl]-4-methyl-2-oxochromen-7-yl] N,N-dimethylcarbamate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073036 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluoro-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617475 [(3S)-3-[[4-(6-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548353 2-Amino-4-[2-[[6-chloro-5-[[methyl(propan-2-yl)sulfamoyl]amino]pyridin-3-yl]amino]pyridin-3-yl]-6-methyl-1,3,5-triazine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66682557 (1,1-dioxothian-4-yl)-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:54584039 3-(1-(4-(pyridin-2-ylmethylamino)-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661399 (1,1-dioxothian-4-yl)-[(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664682 [(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxolan-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073062 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177565 5-(3-(((1H-benzo[d]imidazol-5-yl)methyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:141471203 N-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylthieno[2,3-d]pyrimidin-2-yl]cyclopropanecarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379495 1-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-quinolin-3-ylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073078 (2-Amino-7-azaspiro[3.5]nonan-7-yl)-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811700 (2R)-2-hydroxy-1-[4-[[4-(1H-indazol-4-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700808 US10065970, Example 284 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:121334511 CID 121334511 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145961403 1-[4-[3-[6-(6-methoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]phenoxy]piperidin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89647315 [(3S)-3-[[4-(6-methoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811577 4-Methyl-5-[7-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-morpholin-4-ylthieno[3,2-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71451587 6-[2-hydroxyethyl(naphthalen-1-ylmethyl)amino]-4-morpholin-4-yl-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162651496 2,4-difluoro-N-[5-[4-[(E)-4-(4-hydroxypiperidin-1-yl)-4-oxobut-2-en-2-yl]quinolin-6-yl]-2-methoxypyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56651217 furan-3-yl-[(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379574 8-[6-(Dimethylamino)pyridin-3-yl]-3-methyl-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]imidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700502 (S)-2-(4-(1-(2-aminobenzo[d]oxazol-5-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)-1H-pyrazol-1-yl)propanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073017 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-hydroxy-4-phenylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46932873 N-(6-methoxypyridin-3-yl)-3-(2-methyl-7H-purin-6-yl)-5-[(4-methylsulfonylphenyl)methyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57495362 {(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yloxy]-pyrrolidin-1-yl}-oxazol-4-yl-methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56650873 1-[(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548216 1-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-yl)pyridin-2-ylamino)pyridin-2-yl)-3-phenylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:70798856 6-Methyl-5-[3-(3-morpholin-4-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118378646 4-[[4-[6-[1-[(6-methoxypyridin-3-yl)methyl]piperidin-4-yl]-1H-benzimidazole-2-carbonyl]piperazin-1-yl]methyl]benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118397047 [6-[1-[(6-Methoxypyridin-3-yl)methyl]piperidin-4-yl]-1-methylbenzimidazol-2-yl]-[4-[[4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44540642 (Z)-1-methyl-3-(2-((1-methyl-4-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701249 (S)-2-cyclopropyl-2-((1-(pyridin-4-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:166630605 (2S)-1-[4-[[4-[4-[(3S)-3-methylmorpholin-4-yl]pyrimidin-2-yl]phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168294698 3-(2-acetamidopyridin-4-yl)-5-anilino-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126701032 US10065970, Example 272 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:147310606 (2R)-3-[6-[5-[(2-chloro-4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-oxoquinazolin-3-yl]-N-cyclobutyl-2-methylpropanamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379604 1-(1-Acetylpiperidin-4-yl)-8-(6-aminopyridin-3-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072976 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354053 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881818 1-Ethyl-3-[3-(3-propan-2-yloxyanilino)pyrido[2,3-b]pyrazin-6-yl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:51351034 1-(3,4-difluorophenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072573 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(cyclohexylmethyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700720 US10065970, Example 313 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145992083 5-[4,6-bis[(1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073645 8-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-methyl-2,8-diazaspiro[4.5]decan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:54581048 3-(1-(1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072974 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]-2-fluorophenyl]-(1,2-oxazolidin-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699999 US10065970, Example 289 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71617589 1-[(3S)-3-[[4-[6-methoxy-5-(4-methylpiperazin-1-yl)sulfonylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46883989 (Z)-1-(2-((4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-ethylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:56650538 [(3S)-3-[[6-(2,4-dimethoxypyrimidin-5-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913522 3-(5,6-Dimethoxy-3-pyridinyl)-6-(4-morpholinyl)imidazo[1,2-a]pyridine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:164628838 3-[[2-methoxy-5-(7-methyl-4-thiophen-2-ylthieno[3,2-d]pyrimidin-6-yl)pyridin-3-yl]sulfamoyl]-N-methylbenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71041635 25-Methoxy-22,22-dioxo-30-oxa-3,22lambda6-dithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,12,17(29),18,20,24,26-dodecaen-16-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073641 2-[1-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]-N-ethylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354458 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-dichlorophenyl]-(4-ethylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:45254782 2-[4-[8-(2-methoxypyrimidin-5-yl)-2-oxo-3H-imidazo[4,5-c][1,5]naphthyridin-1-yl]phenyl]-2-methylpropanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353461 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-[4-(1-hydroxypropan-2-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072849 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(1-oxo-1,4-thiazinan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072803 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(1,4-oxazepan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53317018 4-amino-6-((dimethylamino)methyl)-2-methyl-N-(1H-pyrazol-5-yl)quinazoline-8-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:127028515 1-(3-chloro-4-fluorophenyl)-3-[5-(4-morpholin-4-yl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-yl)pyridin-2-yl]urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25070228 4-(2-(furan-3-yl)-9H-purin-6-yl)morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:156403544 5-(3-(((1H-indol-3-yl)methyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072613 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-[3-(dimethylamino)pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072998 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-[1-(1-methylpiperidin-4-yl)pyrrolidin-3-yl]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58137176 5-[4-(Methylsulfonylmethyl)-6-morpholin-4-yl-pyrimidin-2-yl]-1H-benzoimidazole 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548342 4-[2-[(2-methoxypyrimidin-5-yl)amino]-5-[(1R)-1-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]ethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646083 2-methoxy-5-[6-[(3S)-1-(1H-pyrazole-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548279 methyl 4-[[6-[(6-methoxypyridin-3-yl)amino]-5-(2-methyl-7H-purin-6-yl)pyridin-3-yl]methyl]piperazine-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353371 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(1-hydroxypropan-2-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168283597 N-[4-[3-(methylsulfamoyl)phenyl]pyridin-2-yl]oxolane-3-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700930 US10065970, Example 269 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072561 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(2,7-diazaspiro[3.5]nonan-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46913618 N'-(2-Chloro-5-(7-methyl-6-(4-pyridinyl)imidazo[1,2-a]pyridin-3-yl)-3-pyridinyl)-N,N-dimethylsulfamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44129350 CID 44129350 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341609 1-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-1-yl]propan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073657 1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-4-cyclohexylpiperidin-4-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072899 [4-[6-Ethyl-5-[2-[6-(methylamino)pyridin-3-yl]ethynyl]pyrimidin-4-yl]-2,6-difluorophenyl]-[4-(hydroxymethyl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379608 4-[8-[1-(2-Hydroxyethyl)pyrazol-4-yl]-3-methyl-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]cyclohexane-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89589906 3-methyl-9-(6-pyrazol-1-ylpyridin-3-yl)-1-[3-(trifluoromethyl)phenyl]-4H-pyrimido[5,4-c][1,5]naphthyridin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89645996 2-methoxy-5-[6-[(3S)-1-(4-methoxycyclohexanecarbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444258 1-[(3S,4R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-4-fluoropyrrolidin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444261 5-[7-(1-Methylsulfonylazetidin-3-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661416 (1,1-Dioxothian-4-yl)-[3-[[4-(6-methoxy-5-methylpyridin-3-yl)-5-methyl-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:44129351 (1S,5R)-2-N-[5-(2-tert-butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]-2-azabicyclo[3.1.0]hexane-1,2-dicarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646583 1-[4-[(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidine-1-carbonyl]piperidin-1-yl]ethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072970 tert-butyl (3aS,6aS)-5-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole-1-carboxylate 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646031 2-methoxy-5-[3-methyl-6-[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydro-1,4-benzoxazin-4-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58379600 4-[3-Methyl-8-(1-methylpyrazol-4-yl)-2-oxoimidazo[4,5-c][1,5]naphthyridin-1-yl]cyclohexane-1-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353181 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(oxetan-3-yl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072979 [4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2,6-difluorophenyl]-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71460606 6-[4-hydroxybutyl(naphthalen-1-ylmethyl)amino]-4-morpholin-4-yl-1H-pyrimidin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148840 (3S)-4-[8-(1H-indol-4-yl)-2-morpholin-4-yl-7H-purin-6-yl]-3-methylmorpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072754 4-Ethyl-5-[2-(6-methylpyridin-3-yl)ethynyl]-6-(4-methylsulfonylphenyl)pyrimidine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072565 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methoxyphenyl]-[4-(azepan-1-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:54580062 3-(1-(4-amino-6-ethyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:46884585 1-(4-(4,6-bis((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073074 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(4-ethyl-4-hydroxypiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162665020 [2-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)anilino]-3H-benzimidazol-5-yl]-(4-methylsulfonylpiperazin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073678 5-[2-[4-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-6-methylpyrimidin-5-yl]ethynyl]pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118444302 3-[4-(2-aminopyrimidin-5-yl)-2-[(3S)-3-methylmorpholin-4-yl]-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,N-dimethylazetidine-1-sulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168289467 N-[(E)-[4-(hydroxycarbamoyl)phenyl]methylideneamino]-2-(3-hydroxyphenyl)-6-morpholin-4-ylpyrimidine-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072778 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methylphenyl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548307 N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)-5-((pyridin-2-ylmethylamino)methyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699978 US10065970, Example 267 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646256 (2,2-dimethyloxan-4-yl)-[(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168280037 N-[4-[3-anilino-5-(methylcarbamoyl)phenyl]pyridin-2-yl]-1-methylpiperidine-4-carboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700683 (S)-5-(4-((2-amino-1-cyclopropyl-2-oxoethyl)amino)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-1-yl)-2-fluorobenzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:24985365 3-(cyclohexylmethyl)-5-(1H-indazol-5-yl)-1H-imidazo[4,5-b]pyrazin-2-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58881831 1-[3-[(2-Chloropyridin-4-yl)amino]pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89646059 1-[(3S)-3-[[4-(5-morpholin-4-ylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]propan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548247 4-[(1R)-1-[5-(6-amino-2-methylpyrimidin-4-yl)-6-[[6-chloro-5-(dimethylsulfamoylamino)pyridin-3-yl]amino]pyridin-3-yl]ethyl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71520394 4-[4-(5-Methoxy-2-methylbenzimidazol-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53353563 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-(2-hydroxypropyl)piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073073 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chloro-6-fluorophenyl]-[4-[(3-methyl-1,2-oxazol-5-yl)methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:86581910 4-[[4-[5-[1-[(5-Methoxypyrazin-2-yl)methyl]piperidin-4-yl]-1-methylindole-2-carbonyl]piperazin-1-yl]methyl]benzonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073658 8-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-methyl-2,8-diazaspiro[4.5]decan-1-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072615 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:155561366 4-[[4-[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]pyridin-2-yl]amino]cyclohexan-1-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71811740 1-[4-[[4-(2-Aminopyrimidin-5-yl)-2-morpholin-4-ylthieno[3,2-d]pyrimidin-7-yl]methyl]piperazin-1-yl]-2-hydroxyethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664674 [(3S)-3-[[4-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1-methylpyrazol-3-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072656 4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluoro-N-(3-piperidin-1-ylcyclobutyl)benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:71042025 26-Methoxy-23,23-dioxo-3,23lambda6-dithia-6,8,13,16,24,27-hexazahexacyclo[23.3.1.12,5.110,14.118,22.04,9]dotriaconta-1(29),2(32),4,6,8,10(31),11,13,18(30),19,21,25,27-tridecaen-17-one 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072540 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-chlorophenyl]-(4-hydroxy-4-methylpiperidin-1-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:146177394 N-cyclopropyl-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)pyrimidin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25171642 N,2-dimethyl-N-[(E)-(5-methylpyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-5-nitrobenzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677232 (4-methoxycyclohexyl)-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072867 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-[(4,5-dimethyl-1,3-oxazol-2-yl)methyl]piperazin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118616927 4-fluoro-N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:168287113 2-methoxy-5-[4-[[(3S)-1-propanoylpyrrolidin-3-yl]amino]thieno[2,3-d]pyrimidin-6-yl]pyridine-3-carbonitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548393 2-[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxy-5-methylpyridin-3-yl)amino]pyridin-3-yl]propan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:42633175 3-[7-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-5H-pyrrolo[3,2-d]-pyrimidin-2-yl]phenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126699945 (S)-2-cyclopropyl-2-((1-(oxazol-2-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677195 [(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(1,3-oxazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:1471775 [6-Morpholino-2-(2-pyridinyl)-4-pyrimidinyl]methyl phenyl sulfone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:25171641 N,2-dimethyl-5-nitro-N-[(E)-pyrazolo[1,5-a]pyridin-3-ylmethylideneamino]benzenesulfonamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89649653 [(3S)-3-[[4-(5-methyl-6-methylsulfonylpyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-phenylmethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58073691 3-[4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]piperazin-1-yl]-3-oxopropanenitrile 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664731 [(3S)-3-[[4-[6-(difluoromethoxy)-5-methylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothian-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072882 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-(2,8-diazaspiro[4.5]decan-2-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:118709073 N-hydroxy-2-[[(1R)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:59548179 N-(4-(3-(2-methyl-9H-purin-6-yl)pyridin-2-ylamino)phenyl)cyclopropanecarboxamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:60148842 4-[8-(1H-indol-4-yl)-2-(4-methoxypiperidin-1-yl)-7H-purin-6-yl]morpholine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53341390 1-[1-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-methylpyrimidin-4-yl]piperidin-4-yl]-2-methylpropan-2-ol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:66677383 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(5-methyl-1,2-oxazol-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49857092 (2S,7S,10R)-14-bromo-2,6,6,10-tetramethyl-12-oxatetracyclo[9.7.0.02,7.013,18]octadeca-1(11),13(18),14,16-tetraen-15-ol 2.1594929509711707e-05 0.458303\n",
      "CHEMBL.COMPOUND:CHEMBL4750601 CHEMBL4750601 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49785920 (1S)-1-[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-2,2,2-trifluoroethanol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:53354153 [4-[5-[2-(6-Aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorophenyl]-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664698 1-[(3S)-3-[[4-(5,6-dimethoxypyridin-3-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-2-methoxyethanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:162655633 3-[4-[4-Morpholin-4-yl-6-(2-morpholin-4-ylethylamino)-1,3,5-triazin-2-yl]piperazin-1-yl]sulfonylphenol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89649346 [(3S)-3-[[4-(2-methoxypyridin-4-yl)-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:145979969 5-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(fluoromethyl)pyridin-2-amine 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700960 (S)-2-cyclopropyl-2-((1-(5-(methylsulfonyl)pyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:49857091 (3'R,6S)-4-bromo-1',1',3',6-tetramethylspiro[7,8-dihydro-6H-dibenzofuran-9,2'-cyclohexane]-2,3-diol 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89664730 [(3S)-3-[[4-[6-(difluoromethoxy)-5-methylpyridin-3-yl]-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:58072858 2-[4-[4-[5-[2-(6-aminopyridin-3-yl)ethynyl]-6-ethylpyrimidin-4-yl]-2-fluorobenzoyl]piperazin-1-yl]-N,N-dimethylacetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:126700497 (S)-2-cyclopropyl-2-((1-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-8,9-dihydro-7H-6-oxa-2,9a-diazabenzo[cd]azulen-4-yl)amino)acetamide 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:89661418 [3-[[4-[5-(Difluoromethyl)-6-methoxypyridin-3-yl]-5-methyl-2,3-dihydro-1,4-benzoxazin-6-yl]oxy]pyrrolidin-1-yl]-(1,1-dioxothian-4-yl)methanone 2.1594929509711707e-05 0.458303\n",
      "PUBCHEM.COMPOUND:57404801 N-[5-(2-amino-4-oxo-3-phenylquinazolin-6-yl)-2-methoxypyridin-3-yl]-2-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:67982080 5-[2-amino-3-(2-methylphenyl)-4-oxoquinazolin-6-yl]-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57405314 N-[5-(2-amino-4-oxo-3-phenylquinazolin-6-yl)-2-methoxypyridin-3-yl]methanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57406702 5-(2-amino-4-oxo-3-(2-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-6-yl)-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:67982712 5-(2-amino-4-oxo-3-phenylquinazolin-6-yl)-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57405149 N-[5-(2-amino-4-oxo-3-phenylquinazolin-6-yl)-2-methoxypyridin-3-yl]-4-cyanobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57404804 N-[5-(2-amino-4-oxo-3-phenylquinazolin-6-yl)-2-methoxypyridin-3-yl]-3-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:68096082 5-[2-amino-3-(oxan-4-yl)-4-oxoquinazolin-6-yl]-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:145762862 CID 145762862 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156021859 N-[3-(3-methyl-1,2,4-thiadiazol-5-yl)-3-azabicyclo[3.2.1]octan-8-yl]-8-(2,3,4-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:134152820 5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-N-[[1-(7-hydroxy-2-oxochromen-3-yl)triazol-4-yl]methyl]-2-methoxybenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71682214 (2R)-N-[5-(6-aminopyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]-4,4,4-trifluoro-2-methylbutanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117653759 (3S)-4-(5-amino-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)-3-methylpiperazine-1-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121452735 5-[2-[[(1R)-1-cyclohexylethyl]amino]-4-methyl-1,3-thiazol-5-yl]-N-(4-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:129232711 CID 129232711 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:134148697 N-[(1-benzyltriazol-4-yl)methyl]-5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-2-methoxybenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:73348992 N-[2-[[5-(4-aminophenyl)-1,3-thiazol-2-yl]amino]-2-oxoethyl]-N-benzylpyridine-4-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44605246 4-(4-morpholino-6-(4-(3-(4-(2-(pyrrolidin-1-yl)ethyl)phenyl)ureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:145992074 1-[4-[(3R)-3-methylmorpholin-4-yl]-6-(1-methylsulfonylcyclopropyl)pyrimidin-2-yl]benzimidazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53323642 4-amino-N-(6-(dimethylamino)pyridin-3-yl)-2,6-dimethylquinazoline-8-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:163408835 PI3K-IN-28 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173035 (R)-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57396627 1-[(3-Chloro-4-fluorophenyl)methyl]-7-morpholin-4-ylimidazo[1,2-a]pyrimidin-5-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155565775 N-hydroxy-5-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxypentanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:42635504 {3-[4-morpholin-4-yl-7-(pyrrolidin-1-ylmethyl)-5H-pyrrolo[3,2-d]pyrimidin-2-yl]phenyl}methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118523372 3-methyl-1-[(3R)-oxan-3-yl]-8-[6-(3-piperidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44609391 N-[2-chloro-5-[4-(4-hydroxypiperidin-1-yl)quinolin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25132806 N-[6-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122178123 2,4-difluoro-N-[2-methyl-5-(4-pyridin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44608430 N-(2-chloro-5-(3-((3-piperidinylmethyl)amino)-6-quinoxalinyl)-3-pyridinyl)-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155546205 4-[[4-fluoro-3-[2-(1H-indazol-4-yl)-4-morpholin-4-yl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidine-7-carbonyl]phenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403565 5-(3-(Benzylsulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179723 1-(2-Morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)-3-phenylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46190735 1-(4-(4-(3,6-dihydro-2H-pyran-4-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885534 4,6-dihydroxy-2-((2-(pyridin-2-yl)-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57411372 4-[2-(4-Chloro-2,3-dihydroindol-1-yl)-2-oxoethyl]-2-morpholin-4-yl-1,3-thiazole-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798538 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-hydroxypiperidin-1-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232721 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(4,4-dimethoxycyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:67285103 1-(2,3-Dimethyl-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:138667943 2-[4-[4-(6-Aminopyridin-3-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25074312 4-(2-(thiophen-3-yl)-9H-purin-6-yl)morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168271242 2-amino-N-(4-hydroxy-4-methylcyclohexyl)-5-[7-(methylsulfamoyl)-1-oxo-2-[(2S)-1,1,1-trifluoropropan-2-yl]-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197566 2,4-difluoro-N-[2-methoxy-5-[4-methyl-2-(methylamino)-8-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51003485 4-amino-N-(6-methoxypyridin-3-yl)-2,6-dimethylquinazoline-8-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56833540 5-(4-Morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179699 2-Morpholin-4-yl-9-(phenylsulfanylmethyl)pyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59548444 N-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)pyridin-2-ylamino)-2-chloropyridin-3-YL)morpholine-4-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58204974 CID 58204974 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44554913 2-((5-bromo-1H-indol-3-yl)methylene)-4,6-dihydroxybenzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:91755004 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-4-cyanobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197693 N-[5-(2-amino-4-methyl-8-propan-2-yloxyquinazolin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56833544 5-(6-((4-(Methylsulfonyl)piperidin-1-yl)methyl)-4-morpholinothieno[2,3-d]pyrimidin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44242168 N-(2-chlorophenyl)-9-cyano-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227578 Methyl 4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenylcarbamate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122188365 5-Chloro-3-[1-(2-methyl-5-nitrophenyl)sulfonylpyrrol-3-yl]pyrazolo[1,5-a]pyrimidine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53363611 N-(2-Chloro-5-(3-(pyridin-4-yl)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53318782 2-morpholino-N6-(tetrahydro-2H-pyran-4-yl)-4,5''-bipyrimidine-2'',6-diamine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51353708 N-(6-(2-(4-methoxy-N-methylphenylsulfonamido)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44181492 3-Benzyl-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118321327 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-4-(trifluoromethyl)benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44604824 1-[4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-3-(1H-imidazol-2-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121334438 4-(Difluoromethyl)-5-(4,6-dimorpholin-4-ylpyrimidin-2-yl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155526170 2-[3-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxypropyl-methylamino]-N-hydroxypyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884121 4,6-dihydroxy-2-((1-methyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:60155474 3-amino-6-[3-(benzenesulfonamido)phenyl]-N-methylpyrazine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197694 N-[6-[5-(methanesulfonamido)-6-methoxypyridin-3-yl]-4-methyl-8-(oxan-4-yloxy)quinazolin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25182281 N-(6-(2-(4-methoxyphenylthio)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:137636042 5-Imidazo[1,2-a]pyridin-3-yl-6-methyl-3-[2-(1-methylpiperidin-4-yl)triazol-4-yl]pyrazin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706317 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(1-cyclopropylpyrazol-4-yl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53363435 N-(2-chloro-5-quinazolin-6-ylpyridin-3-yl)-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177404 (R)-4-chloro-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25069592 (4-(6-morpholino-9H-purin-2-yl)phenyl)methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:162660791 5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]-1,3-thiazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44601278 1-{4-[4-Morpholin-4-yl-7-(2-pyrrolidin-1-ylethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59548437 N-(5-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-methoxypyridin-2-ylamino)-2-chloropyridin-3-yl)morpholine-4-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885273 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:24983903 3-(oxan-4-ylmethyl)-5-[4-(1H-1,2,4-triazol-5-yl)phenyl]-1H-imidazo[4,5-b]pyrazin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59548480 N-[3-[6-amino-2-(trifluoromethyl)pyrimidin-4-yl]pyridin-2-yl]-1H-indazol-4-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71526881 CID 71526881 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164617836 6-[1-(Cyclopropanecarbonyl)azetidin-3-yl]oxy-4-(1-methylpyrazolo[3,4-b]pyridin-5-yl)-2,3-dihydroisoindol-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227572 mTOR inhibitor-13 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227607 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-((4-methylpiperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-(pyridin-4-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56673546 2-N-(2-chlorophenyl)-2-N,8-N-dimethyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2,8-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57402386 N-[(E)-(5-cyano-6-fluoropyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44181719 5-Morpholin-4-yl-3-thiophen-2-ylthieno[3,2-b]pyran-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197700 N-[5-[2-(cyclopropylmethylamino)-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:163212515 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-7-(difluoromethoxy)-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488020 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(2-(dimethylamino)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "CHEBI:91364 1-[4-[1-(1,4-dioxaspiro[4.5]decan-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-pyrazolo[3,4-d]pyrimidinyl]phenyl]-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56966983 6-(2-aminopyrimidin-5-yl)-8-morpholin-4-yl-N-(oxan-4-yl)imidazo[1,2-a]pyrazine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403575 5-(3-morpholino-5-(((tetrahydro-2H-pyran-4-yl)methyl)sulfonyl)phenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71042418 N-[2-chloro-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]phenyl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:49853890 (8s)-9-[(2r)-2-Hydroxy-2-Phenylethyl]-2-(Morpholin-4-Yl)-8-(Trifluoromethyl)-6,7,8,9-Tetrahydro-4h-Pyrimido[1,2-A]pyrimidin-4-One 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155383531 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-1-oxo-7-(trifluoromethoxy)-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403539 2-((5-(3-(Benzylsulfonyl)-5-morpholinophenyl)pyrimidin-2-yl)amino)ethan-1-ol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53317513 N-[6-[2-(methylamino)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]quinolin-3-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884356 4-hydroxy-2-((1-methyl-4-morpholino-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177533 (2-(2-aminopyrimidin-5-yl)-6-morpholinopyridin-4-yl)(tetrahydro-2H-pyran-4-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168284098 1-(4-Fluorophenyl)-2-methyl-8-quinolin-3-ylimidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118444235 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-N-methylpyrrolidine-1-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:90232753 2-[(1S)-1-[[6-amino-5-[2-[6-(hydroxymethyl)pyridin-2-yl]ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:91864650 2-[4-[(6-Isoquinolin-4-ylquinazolin-4-yl)amino]phenyl]acetonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118617099 2,4-difluoro-N-[2-methoxy-5-(3-methyl-4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44621440 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-propylpyridine-3-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46913420 6-Bromo-3-(5,6-dimethoxy-3-pyridinyl)imidazo[1,2-a]pyridine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798405 5-[4-(Oxan-4-ylamino)quinolin-6-yl]-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25070552 1-(4-(2-(3-(hydroxymethyl)phenyl)-6-morpholino-9H-purin-9-yl)piperidin-1-yl)ethanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:137656872 5-(3-amino-6-imidazo[1,2-a]pyridin-3-ylpyrazin-2-yl)-N,1-dimethyl-1,2,4-triazole-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197599 N-[5-[8-cyclohexyloxy-4-methyl-2-(methylamino)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798700 1-[4-[6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridine-3-carbonyl]piperazin-1-yl]ethanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25261230 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197591 N-[5-[8-cyclobutyloxy-4-methyl-2-(methylamino)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798615 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3,3-difluoropyrrolidin-1-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58204873 2-(5-Methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-9-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173028 5-(3-((Difluoro(phenyl)methyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251975 N-[6-(5-amino-6-methoxypyrazin-2-yl)imidazo[1,2-a]pyridin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44539684 1-(3-((4-hydroxy-3-oxobenzofuran-2(3H)-ylidene)methyl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)-N,N-dimethylpiperidine-4-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44554240 4,6-dihydroxy-2-((2-phenyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179702 9-[(4-Methoxyphenoxy)methyl]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118499537 3-Methyl-1-(oxan-4-yl)-8-[6-(3-piperidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:11702204 5-[5-(2,5-Dihydroxyphenyl)furan-2-ylmethylene]thiazolidine-2,4-dione 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164610519 4-(3-Fluoro-5-hydroxyphenyl)-2,3-dihydroisoindol-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:66789609 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(6-ethoxypyridin-3-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155543524 4-[[4-fluoro-3-[4-[4-(1H-indazol-6-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]phenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45379224 1-(4-(4,6-Dimorpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea hydrochloride 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197630 N-[5-(2-amino-8-cyclohexyloxy-4-methylquinazolin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834570 2-amino-4-[(2S,4S)-4-methoxy-2-[5-(1-methylpyrazol-4-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384201 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-(methanesulfonamido)-1-oxo-3H-isoindol-5-yl]-N-[(1R)-1-cyclopropyl-2-hydroxyethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53318252 3-(4-Morpholino-6-(pyridin-4-yl)pyrimidin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:60155471 3-amino-6-[4-methoxy-3-(phenylsulfamoyl)phenyl]-N-methylpyrazine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168271992 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488056 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(2-(dimethylamino)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706650 N-(6-(2-(1H-pyrazol-3-ylamino)imidazo[1,2-b]pyridazin-3-yl)-2-methylpyrimidin-4-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164616554 4-[6-(methylamino)-5-(trifluoromethyl)pyridin-3-yl]-6-[1-[(2R)-2-methylcyclopropanecarbonyl]azetidin-3-yl]oxy-2,3-dihydroisoindol-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197596 N-[5-[2-amino-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]cyclopropanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227597 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44181493 5-morpholino-3-(pyridin-3-yl)-7H-thieno[3,2-b]pyran-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706315 N-[3-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-2-(1H-pyrazol-5-ylamino)imidazo[1,2-a]pyridin-6-yl]phenyl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:78320673 2-[(2S)-1-(2-amino-9-methylpurin-6-yl)pyrrolidin-2-yl]-5-chloro-3-phenylquinazolin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59548335 N-(5-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-methoxypyridin-2-ylamino)-2-chloropyridin-3-yl)methanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71042487 N-[2-methoxy-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]phenyl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71042166 N-[3-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]phenyl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25195571 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-isopropylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44818842 (3-(3-(1-benzylpiperidin-4-yl)-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76335781 7-Amino-1-cyclopentyl-3-(5-fluoro-6-methoxypyridin-3-yl)-5-methyl-1,6-naphthyridin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177412 1-(3-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidin-1-yl)ethan-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179719 2-methyl-N-(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)benzamide 3.2392219386070445e-05 0.436539\n",
      "CHEMBL.COMPOUND:CHEMBL2375958 CHEMBL2375958 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118500108 8-[6-[3-(Dimethylamino)propoxy]-2-fluoropyridin-3-yl]-1-(3-methoxycyclobutyl)-3-methylimidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122188270 N-[(E)-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-2-methoxy-N-methyl-5-nitrobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606643 (R)-ethyl 4-(6-(4-(3-(2-fluoroethyl)ureido)phenyl)-4-(3-methylmorpholino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118470801 3-[5-amino-6-(2-methyl-1,3-thiazol-5-yl)pyrazin-2-yl]-N-(3-hydroxypropyl)-4-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118728326 2-Bromo-11-chloro-6,7-dihydrobenzimidazolo[1,2-d][1,4]benzoxazepine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118471248 US9862711, Example 9 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57384862 5-(6,6-Dimethyl-4-morpholin-4-yl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)-4-methylpyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177521 (S)-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197598 2,4-difluoro-N-[2-methoxy-5-[4-methyl-2-(methylamino)-8-(oxan-4-ylmethoxy)quinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59477041 N-[6-[3-(butylsulfamoyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:52914097 US9227977, Example 50 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606640 1-(4-(4-((1R,4R)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884525 1-(4-(4,6-Di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(hydroxymethyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46913315 N-[2-chloro-5-(6-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57401867 1-(3-Fluorobenzyl)-7-morpholinoimidazo[1,2-a]pyrimidin-5(1H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488031 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-((dimethylamino)methyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25262617 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155535013 N-hydroxy-2-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyacetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70683291 3-(4-Chlorophenyl)-4-cyano-5-morpholin-4-ylthiophene-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56833738 N2-(2-chlorophenyl)-N2-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2,9-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834583 4-amino-6-[(2S)-2-[5-(3-hydroxyprop-1-ynyl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45482926 methyl 4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(4-(3-methylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:42623869 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-N-isopropylpyridine-3-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44610163 N-[2-chloro-5-[3-(4,4-difluoropiperidin-1-yl)quinoxalin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44609072 N-(2-chloro-5-quinoxalin-6-ylpyridin-3-yl)-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:49855192 CID 49855192 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51348054 2-[3-[4-[2-(5-Methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]azetidin-1-yl]ethanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197633 N-[5-[2-amino-4-methyl-8-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44129271 (2S)-1-N-[4-methyl-5-[2-(1-methylcyclopropyl)-1,3-thiazol-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:10017389 2-(2-Methyl-morpholin-4-yl)-benzo[h]chromen-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155567228 2-[ethyl-[2-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyethyl]amino]-N-hydroxypyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44609543 N-(2-chloro-5-(4-(1-piperidinyl)-6-quinolinyl)-3-pyridinyl)-4-fluorobenzenesulfonamid 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53363529 N-[2-chloro-5-[3-(dimethylamino)quinoxalin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:163212504 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-7-(methanesulfonamido)-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834555 4-amino-6-[(2S)-2-[3-(2-methylphenyl)-5-(1-methylpyrazol-4-yl)-4-oxoquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76324911 N-[5-(7-amino-1-cyclopentyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]-3-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884537 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885496 2-((5-bromo-2-methyl-1H-indol-3-yl)methylene)-4,6-dihydroxybenzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:145953272 2-amino-N-[5-[3-(benzenesulfonamido)-4-chlorophenyl]-4-methyl-1,3-thiazol-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71457607 3-[[5-(2-Acetamido-4-methyl-1,3-thiazol-5-yl)-1,3-oxazol-2-yl]amino]benzoic acid 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403541 5-(3-((4-Fluorobenzyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46830153 (Z)-1-(1-methyl-3-((3-oxo-5-(3-pyridin-3-ylureido)benzofuran-2(3H)-ylidene)methyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-N-(pyridin-3-ylmethyl)piperidine-4-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57396626 7-Morpholin-4-yl-1-[[3-(trifluoromethyl)phenyl]methyl]imidazo[1,2-a]pyrimidin-5-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25073388 3-(6-morpholino-9-(1-((6-morpholinopyridin-3-yl)methyl)piperidin-4-yl)-9H-purin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179694 9-[(4-Methylanilino)methyl]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881774 1-[3-(4-Cyanoanilino)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155383842 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-7-ethylsulfonyl-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118721838 1-Ethyl-3-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232802 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-phenylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834354 2-amino-4-[(2S,4S)-4-hydroxy-2-(4-oxo-3-phenyl-5-pyrimidin-5-ylquinazolin-2-yl)pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:68547896 7-Methyl-9-[(3-methylphenyl)methylamino]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881892 1-[3-(3,5-Dimethoxyanilino)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "CHEMBL.COMPOUND:CHEMBL4745332 CHEMBL4745332 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76328376 4-[2-(1H-indazol-4-yl)pyrido[3,2-d]pyrimidin-4-yl]morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403593 5-(3-((4-Fluorophenyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59453047 3-[2-methyl-6-(1H-1,2,4-triazol-5-yl)pyridin-3-yl]-5-[2-(oxan-4-yl)ethyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25195893 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-[2-(dimethylamino)ethyl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56833638 N2-(2-chlorophenyl)-N8-ethyl-N2-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2,8-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884242 4-hydroxy-2-((1-methyl-4-(4-(4-methylpiperazine-1-carbonyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:90331565 3-Anilino-1-[3-(cyanomethyl)-1-[(2,6-dimethylphenyl)carbamoyl]azetidin-3-yl]pyrazole-4-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197644 N-[5-[2-amino-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56833739 N2-(2-chlorophenyl)-N9-ethyl-N2-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2,9-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251964 N-[6-(5-amino-6-ethoxypyrazin-2-yl)imidazo[1,2-a]pyridin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798862 5-[3-[(3S)-3-methylpiperazin-1-yl]quinolin-6-yl]-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:137453801 5-[4,6-bis[(3S)-3-methylmorpholin-4-yl]-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25195682 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-pyridin-3-ylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884065 (Z)-N,N-dimethyl-1-(1-methyl-3-((3-oxo-5-(3-pyridin-3-ylureido)benzofuran-2(3H)-ylidene)methyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)piperidine-4-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155527271 2-[2-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyethylamino]-N-hydroxypyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71520395 4-[4-(6-Methoxy-2-methylbenzimidazol-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488070 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(6-morpholinopyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118470300 3-[5-amino-6-(2-methyltriazol-4-yl)pyrazin-2-yl]-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884406 4-hydroxy-2-((1-methyl-4-(4-methylpiperazin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197578 N-[5-[2-amino-4-methyl-8-(oxolan-3-ylmethoxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155518789 4-[[3-[4-[4-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:72549555 1-(4-Fluorophenyl)-3-(5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251850 N-[6-(6-amino-5-ethoxypyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884533 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(piperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155560338 2-[4-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxybutyl-methylamino]-N-hydroxypyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403598 5-(3-((3-Chloro-4-fluorophenyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155520064 N-hydroxy-2-[3-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxypropyl-methylamino]pyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798406 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(2R,6S)-2,6-dimethylmorpholin-4-yl]methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155569679 N-hydroxy-6-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyhexanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118470493 3-[5-amino-6-(2-methyl-1,3-thiazol-5-yl)pyrazin-2-yl]-N-(4,4-difluorocyclohexyl)-4-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251922 N-[6-(6-amino-5-methoxypyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227599 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57411135 4-[2-(3-Chloro-4-fluoroanilino)-2-oxoethyl]-2-morpholin-4-yl-1,3-thiazole-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44610482 N-[2-chloro-5-[3-(2-piperidin-1-ylethylamino)quinoxalin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44608115 N-[5-[3-[benzyl(methyl)amino]quinoxalin-6-yl]-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179693 9-[(3-Methylanilino)methyl]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46913314 N-[5-(6-bromoimidazo[1,2-a]pyridin-3-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:162652065 4-(difluoromethyl)-5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:42606078 4-((1H-Indazol-3-yl)ethynyl)aniline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155537194 2-[2-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyethyl-methylamino]-N-hydroxypyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57391917 N-[(E)-1-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)ethylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155513562 4-[[3-[4-[4-(4-aminophenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44609854 N-[2-chloro-5-(4-phenylquinolin-6-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118321317 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-5-chlorothiophene-2-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706312 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(2-methylpyridin-4-yl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44241762 8-[3-(aminomethyl)phenyl]-N-(2-chlorophenyl)-N-methyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177566 5-(6-Morpholino-4-(o-tolyloxy)pyridin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44242776 N~2~-{2-Chloro-4-[(4-Methylpiperazin-1-Yl)carbonyl]phenyl}-N~2~,N~8~-Dimethyl-4,5-Dihydrothieno[3,2-D][1]benzoxepine-2,8-Dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44242428 8-(Acetylamino)-N-(2-Chlorophenyl)-N-Methyl-4,5-Dihydrothieno[3,2-D][1]benzoxepine-2-Carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155547067 5-[4-[(3S,5S)-3,5-dimethylmorpholin-4-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57406937 (8s)-2-(Morpholin-4-Yl)-9-[2-(Propan-2-Yloxy)ethyl]-8-(Trifluoromethyl)-6,7,8,9-Tetrahydro-4h-Pyrimido[1,2-A]pyrimidin-4-One 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155383904 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-7-(methylsulfamoyl)-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606474 1-(4-(4-((1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71042024 26-Methoxy-23,23-dioxo-3,23lambda6-dithia-6,8,16,24,27-pentazahexacyclo[23.3.1.12,5.110,14.118,22.04,9]dotriaconta-1(29),2(32),4,6,8,10,12,14(31),18(30),19,21,25,27-tridecaen-17-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25109494 N-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)-N-methylacetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197593 N-[5-(2-amino-8-cyclobutyloxy-4-methylquinazolin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155531509 6-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxy-N-hydroxyhexanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:91799561 [4-[6-(Ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]-2-methoxyphenyl] 4-methylbenzenesulfonate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502812 8-[6-[3-(dimethylamino)propoxy]-2-fluoropyridin-3-yl]-3-methyl-1-[(3R)-oxan-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46830152 (Z)-1-(2-((4-(4-(3-oxa-8-azabicyclo[3.2.1]octane-8-carbonyl)piperidin-1-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56833637 N-(2-chlorophenyl)-N-methyl-8-(1H-pyrazol-5-yl)-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834574 2-amino-4-methyl-6-[(2S)-2-(4-oxo-3-phenyl-5-pyrimidin-5-ylquinazolin-2-yl)pyrrolidin-1-yl]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488082 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-((2-(dimethylamino)ethyl)(methyl)amino)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59548207 N-[3-(7H-purin-6-yl)pyridin-2-yl]-1H-indazol-4-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46913620 N-(2-Chloro-5-(6-chloroimidazo[1,2-b]pyridazin-3-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25260913 isopropyl 4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-(4-(3-methylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155383518 2-amino-N-[(1R)-1-cyclopropyl-2-hydroxyethyl]-5-[7-(difluoromethoxy)-1-oxo-2-[(2S)-1,1,1-trifluoropropan-2-yl]-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:24947414 4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno[2,3-d]pyrimidin-6-yl)methyl)-N,N-dimethylpiperazine-1-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57390136 N-[(E)-1-(5-bromopyrazolo[1,5-a]pyridin-3-yl)ethylideneamino]-2-methyl-5-nitrobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44555226 4,6-dihydroxy-2-((5-methoxy-1-(3-morpholinopropyl)-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44601448 1-{4-[7-(2-{[2-(Dimethylamino)ethyl]amino}ethyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:11522078 5-[5-(2-Hydroxyphenyl)furan-2-ylmethylene]thiazolidine-2, 4-dione 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179707 7-Methyl-9-(4-methylanilino)-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168293393 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]-N-[(3S)-oxolan-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885426 2-((5-chloro-1H-indol-3-yl)methylene)-4,6-dihydroxybenzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:50991340 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4,4-difluoropiperidin-1-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884544 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-(dimethylamino)piperidin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70224122 5-(9-isopropyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403543 4-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)benzonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798875 [6-(2-Amino-1,3-benzoxazol-5-yl)-8-methylimidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488033 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-((4-methylpiperazin-1-yl)methyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25070882 (3-(9-(1-benzylpiperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenyl)methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197607 N-[5-[2-amino-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]methanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58204339 2-(5-Methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-9-(1-methylpyrazol-4-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58169820 CID 58169820 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885624 [3-[7-[(dimethylamino)methyl]-4-morpholin-4-yl-5H-pyrrolo[3,2-d]pyrimidin-2-yl]phenyl]methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488052 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-(hydroxymethyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706157 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(2-methylphenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44608114 N-[2-chloro-5-[3-(cyclohexylmethylamino)quinoxalin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502871 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-7-fluoro-3-methyl-1-[(3R)-oxan-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62705990 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(2-fluorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:153111991 2,4-diamino-6-[[(1S)-1-(6-chloro-1-pyridin-3-ylindazol-3-yl)propyl]amino]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168270160 1-(6-fluoropyridin-3-yl)-2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:49855237 8-(4-Amino-2-fluoro-phenyl)-2-morpholin-4-yl-benzo[e][1,3]oxazin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197583 N-[5-[2-amino-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2-chloro-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44610162 N-[2-chloro-5-[3-[2-methoxyethyl(methyl)amino]quinoxalin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:137453918 5-[4-[(3S)-3-methylmorpholin-4-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502955 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-1-(3-methoxycyclobutyl)-3H-imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227603 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-((4-methylpiperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-cyclopropylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798769 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-(3,3-difluoroazetidin-1-yl)pyrrolidin-1-yl]methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232801 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-cyclopropylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177568 5-(3-Morpholino-5-((4-morpholinobenzyl)sulfonyl)phenyl) pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44607000 5-(4-Morpholino-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)-pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606642 (S)-ethyl 4-(6-(4-(3-(2-fluoroethyl)ureido)phenyl)-4-(3-methylmorpholino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177452 5-(3-Morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)-4-(trifluoromethyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45482923 methyl 4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(4-(3-pyridin-3-ylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168275289 4-[2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinolin-1-yl]benzonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118709075 2-[[(1R)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]-N-methylsulfonylbenzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197639 N-[5-[2-amino-4-methyl-8-(oxan-4-ylmethoxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173019 Tert-butyl 3-((3-(2-aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)azetidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884545 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-isopropylpiperazine-1-carbonyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118721842 1-[6-(5-Methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-3-[2-(1-methylimidazol-4-yl)ethyl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71527006 CID 71527006 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179709 7-Methyl-9-[(4-methylphenyl)methylamino]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798501 5-[3-(6-Methylpyridin-3-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44609858 N-[2-chloro-5-(1,5-naphthyridin-2-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232645 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(2-(dimethylamino)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179711 2-morpholin-4-yl-4-oxo-N-phenylpyrido[1,2-a]pyrimidine-9-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798506 6-(2-Amino-1,3-benzoxazol-5-yl)-3-cyclopropylquinazolin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168282600 2-[4-[2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinolin-1-yl]phenyl]acetonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403563 5-(3-Morpholino-5-tosylphenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197646 N-[5-[2-amino-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-5-chlorothiophene-2-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:137655854 5-Imidazo[1,2-a]pyridin-3-yl-6-methyl-3-[2-methyl-5-(1-methylpiperidin-4-yl)-1,2,4-triazol-3-yl]pyrazin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:66557964 8-[(2R)-1-(3,5-difluorophenyl)pyrrolidin-2-yl]-6-(morpholine-4-carbonyl)-2-morpholino-chromen-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25172063 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-methyl-3-nitrobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179724 phenyl N-(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)carbamate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118470474 3-[5-amino-6-(2,5-dimethyltriazol-4-yl)pyrazin-2-yl]-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44413107 5-[5-(3,5-Difluoro-2-hydroxyphenyl)furan-2-ylmethylene]thiazolidine-2,4-dione 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384058 CID 155384058 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197628 N-[5-[2-amino-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methylpyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798546 1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:88979879 6-(3-Morpholin-4-ylquinoxalin-6-yl)-1,3-benzothiazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502143 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-1-[(1R,3R)-3-methoxycyclopentyl]-3-methylimidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25071208 5-(9-(1-(4-methylbenzyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)pyridin-3-ol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:89473651 3-Anilino-1-[3-(cyanomethyl)-1-(2,4,4-trimethylpentan-2-ylcarbamoyl)azetidin-3-yl]pyrazole-4-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881893 1-Ethyl-3-[3-(3-hydroxy-phenyl)-pyrido[2,3-b]pyrazine-6-yl]-urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179695 9-[(4-Chloroanilino)methyl]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118503072 8-[6-[3-(dimethylamino)propoxy]-2-fluoropyridin-3-yl]-3-methyl-1-[(3R)-oxolan-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706313 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(1H-pyrazol-5-yl)-6-pyrimidin-5-ylimidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706815 N-[2-methyl-6-[2-[(1-methylpyrazol-3-yl)amino]-6-(2-methylpyridin-3-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:68405709 5-(4-pyridin-4-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:145987381 1-[4-(1-Methylsulfonylcyclopropyl)-6-morpholin-4-ylpyrimidin-2-yl]benzimidazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:138667945 2-[4-[4-[6-Amino-4-(trifluoromethyl)pyridin-3-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:11998563 (R)-2-(3-((1H-indol-3-yl)methyl)morpholino)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121334444 4-(Difluoromethyl)-5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44605790 methyl 4-(6-(4-(3-ethylureido)phenyl)-4-(2-methylmorpholino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71041963 (13S)-25-methoxy-31-methyl-22,22-dioxo-3,22lambda6-dithia-6,8,10,15,23,26-hexazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,17(29),18,20,24,26-decaen-16-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403554 5-(3-morpholino-5-((tetrahydro-2H-pyran-4-yl)sulfonyl)phenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177569 5-(4-(2-Methoxyphenoxy)-6-morpholinopyridin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:2816900 2-Morpholin-4-ylpyrimido[4,5-d]pyrimidin-5-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168289126 1-(4-Fluorophenyl)-2-methyl-8-naphthalen-2-ylimidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44608432 N-[2-chloro-5-[3-(2-methoxyethylamino)quinoxalin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53325374 3-(2-Morpholino-6-(2-(pyridin-2-yl)ethylamino)pyrimidin-4-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44605791 methyl 4-(4-(2-methylmorpholino)-6-(4-(3-pyridin-3-ylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251951 N-[6-(5-amino-6-propan-2-yloxypyrazin-2-yl)imidazo[1,2-a]pyridin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155558767 N-hydroxy-7-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyheptanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76313941 1-[4-(Hydroxymethyl)phenyl]-3-[3-(4-morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenyl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25261388 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(2-fluoroethyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71037730 (2R)-1-[6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridine-3-carbonyl]pyrrolidine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122181418 1-[4-[2-[5-Amino-6-(benzotriazol-1-yl)pyrazin-2-yl]-1-methylimidazol-4-yl]piperidin-1-yl]-2-(dimethylamino)ethanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251834 N-(6-(6-amino-5-(trifluoromethyl)pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57427752 1-(2-hydroxyethyl)-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-6-(methylsulfonylmethyl)pyrimidin-2-yl]phenyl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155564488 1-[4-[5-(Cyclopropylmethyl)-6-oxo-6a,7,9,10-tetrahydro-[1,4]oxazino[3,4-h]pteridin-2-yl]phenyl]-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76332051 4-[2-(1H-indazol-6-yl)pyrido[3,2-d]pyrimidin-4-yl]morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44608758 N-[2-chloro-5-[4-(dimethylamino)quinolin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71250891 [5-[2-tert-butyl-4-[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118730033 2,11-Dimethyl-6,7-dihydrobenzimidazolo[1,2-d][1,4]benzoxazepine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:90232871 2-[2-[4-amino-6-[[(1S)-1-(5-chloro-4-oxo-3-phenylquinazolin-2-yl)ethyl]amino]pyrimidin-5-yl]ethynyl]pyridine-4-carboxylic acid 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:54585940 3-(1-(4-amino-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:129262519 2,4-diamino-6-[[(1S)-1-(7-fluoro-4-oxo-1,3-diphenylquinolizin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121334370 4-(difluoromethyl)-5-[6-[(3S)-3-methylmorpholin-4-yl]-2-morpholin-4-ylpyrimidin-4-yl]pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706653 3-[2-methyl-6-(pyridazin-3-ylamino)pyrimidin-4-yl]-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155511904 4-[[3-[4-[4-(3-amino-4-fluorophenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44540644 (2z)-4,6-Dihydroxy-2-{[1-Methyl-4-(4-Methylpiperazin-1-Yl)-1h-Pyrrolo[2,3-B]pyridin-3-Yl]methylidene}-1-Benzofuran-3(2h)-One 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:10066542 7-Methyl-2-morpholin-4-yl-9-(pyridin-2-ylmethylamino)pyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44610316 N-[2-chloro-5-(3-piperidin-1-ylquinoxalin-6-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606302 1-(4-(4-((1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834552 2-amino-4-[(2S,4S)-4-methoxy-2-[5-(2-methoxypyrimidin-5-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "CHEMBL.COMPOUND:CHEMBL2375957 CHEMBL2375957 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884073 (Z)-N-methyl-1-(1-methyl-3-((3-oxo-5-(3-pyridin-3-ylureido)benzofuran-2(3H)-ylidene)methyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-N-(pyridin-3-ylmethyl)piperidine-4-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164614754 4-(3-Hydroxyphenyl)-6-(3-morpholin-4-ylpropylamino)-2,3-dihydroisoindol-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168270391 2-[4-[7-fluoro-2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinolin-1-yl]phenyl]-2-methylpropanenitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58204628 2-[4-[2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]ethanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155555707 4-[[3-[2-(6-aminopyridin-3-yl)-4-morpholin-4-yl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidine-7-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121416213 N-[2-chloro-5-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]pyridin-3-yl]methanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251852 N-(6-(6-amino-5-(trifluoromethyl)pyridin-3-yl)benzo[d]thiazol-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118550353 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-N-[4-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)phenyl]benzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168278580 1-(4-fluorophenyl)-8-(1H-indol-5-yl)-2-methylimidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118721843 1-[2-(1-Ethylimidazol-4-yl)ethyl]-3-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197680 N-[5-[2-amino-8-(4,4-difluorocyclohexyl)oxy-4-methylquinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884204 2-((4-(4-(8-oxa-3-azabicyclo[3.2.1]octane-3-carbonyl)piperidin-1-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-4-hydroxybenzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798705 (2S)-1-[6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridine-3-carbonyl]pyrrolidine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57411139 4-[2-(4-Fluoro-2,3-dihydroindol-1-yl)-2-oxoethyl]-2-morpholin-4-yl-1,3-thiazole-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44540925 (Z)-1-(2-((4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25073385 3-(9-(1-((6-methoxypyridin-3-yl)methyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25074311 4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76332160 7-Amino-1-cyclopentyl-5-methyl-3-(1-methylpyrrolo[2,3-b]pyridin-5-yl)-1,6-naphthyridin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118470060 US10112926, Example 60 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179691 9-[(N-methylanilino)methyl]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44610483 N-[2-chloro-5-[3-(2-phenylethylamino)quinoxalin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25261227 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44159380 4-[4-(2-ethylimidazol-1-yl)-6-(1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179690 9-(Anilinomethyl)-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44605789 methyl 4-(4-(2-methylmorpholino)-6-(4-(3-methylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155561330 N-hydroxy-4-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxybutanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834568 2-amino-4-[(2S)-2-[5-(2-methoxypyrimidin-5-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76321299 7-Amino-1-cyclopentyl-3-(2-methoxypyrimidin-5-yl)-5-methyl-1,6-naphthyridin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798616 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3,3-difluoroazetidin-1-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:162652947 5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]-1,3,4-thiadiazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45482947 methyl 4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-(4-(3-ethylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884543 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-isopropylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798763 5-[3-(4-Pyrazol-1-ylpiperidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227571 N-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:166635118 N-phenyl-5-[4-(2,2,2-trifluoroethoxy)phenyl]-1,3,4-thiadiazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179721 4-methyl-N-(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)benzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885566 4,6-dihydroxy-2-((5-methoxy-1-methyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177523 5-(3-(((1H-indol-5-yl)methyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44608118 N-[2-chloro-5-[3-(4-methoxypiperidin-1-yl)quinoxalin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384028 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]-N-(3-hydroxycyclobutyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155544561 N-(1-ethylpiperidin-4-yl)-4-[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155543234 4-[[4-fluoro-3-[4-[4-(1H-indol-5-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]phenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118523353 3-methyl-1-[(3R)-oxan-3-yl]-8-[6-(3-pyrrolidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44609547 N-[5-[4-(4-benzylpiperazin-1-yl)quinolin-6-yl]-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:42623632 5-(2-Amino[1,2,4]triazolo[1,5-a]pyridin-6-yl)-N-(cyclopropylmethyl)-3-pyridinesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51353709 n-(6-(2-(n-Ethyl-4-methoxyphenylsulfonamido)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706158 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(4-methylpyridin-3-yl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197556 N-[5-[2-amino-4-methyl-8-(1-methylpiperidin-4-yl)oxyquinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798504 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3S)-3-fluoropyrrolidin-1-yl]methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:129248622 4-[2-[(1S)-1-[(2,6-diamino-5-cyanopyrimidin-4-yl)amino]ethyl]-7-fluoro-4-oxo-3-phenylquinolizin-1-yl]benzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168273360 1-(4-fluorophenyl)-2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232644 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(2-hydroxyethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76072924 (1,1-dioxothian-4-yl)-[(3S)-3-[[1-(6-methoxy-5-methylpyridin-3-yl)-2,3-dihydropyrido[3,4-b][1,4]oxazin-7-yl]oxy]pyrrolidin-1-yl]methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76332161 N-[5-(7-amino-1-cyclopentyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51354595 N-(6-(3-(4-methoxyphenylsulfonamido)phenyl)benzo[d]thiazol-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488080 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-(piperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59548448 N-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)pyridin-2-ylamino)-2-chloropyridin-3-YL)-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44600954 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}phenyl)-3-pyridin-2-ylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834577 2-amino-4-[(2S,4S)-4-hydroxy-2-[5-(2-methoxypyrimidin-5-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25073081 3-(6-morpholino-9-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-9H-purin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164809124 N-(2-chloro-5-(4-((1R-phenylethyl)amino)quinazolin-6-yl)pyridin-3-yl)methanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:11581007 4-[5-(2,4-Dioxothiazolidin-5-ylidenemethyl)furan-2-yl]-3-hydroxybenzoic acid methyl ester 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:162674006 5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]-1,2,4-thiadiazol-3-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59548408 N-(5-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(morpholinomethyl)pyridin-2-ylamino)-2-chloropyridin-3-yl)methanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56950791 4-[4-(2-methylimidazol-1-yl)-6-(7-methyl-1H-indol-4-yl)-1,3,5-triazin-2-yl]morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:68295585 4-[[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]oxy]-N,N-dimethylbenzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179720 3-methyl-N-(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)benzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155556593 (4-Aminocyclohexyl)-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502060 8-[6-[3-(azetidin-1-yl)propoxy]pyridin-3-yl]-3-methyl-1-[(3R)-oxan-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44158465 5-[4-(2-Methylimidazol-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403589 5-(3-(((1H-imidazol-4-yl)methyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197560 N-[5-[2-amino-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834591 2-amino-4-[(2S,4S)-2-[6-fluoro-5-(1-methylimidazol-4-yl)-4-oxo-3-phenylquinazolin-2-yl]-4-hydroxypyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179700 2-Morpholin-4-yl-9-(phenoxymethyl)pyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155542658 N-hydroxy-2-[2-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyethyl-propan-2-ylamino]pyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76310354 N-[5-(7-amino-1-cyclopentyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]methanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53324066 N-(2-morpholino-4,5''-bipyrimidin-6-yl)quinolin-3-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884542 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-ethylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179701 9-[(4-Methylphenoxy)methyl]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:4416330 Methyl 2-(Acetylamino)-1,3-Benzothiazole-6-Carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173036 5-(3-Morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488069 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(6-(dimethylamino)pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46913418 N-[2-chloro-5-(6-morpholin-4-ylimidazo[1,2-a]pyridin-3-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71041954 10,12-Difluoro-5-methoxy-8,8-dioxo-8lambda6-thia-4,7,15,19,25-pentazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22(30),23,25,27-tetradecaen-14-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834404 2-amino-4-[(2S,4S)-2-[5-(2-ethoxypyrimidin-5-yl)-6-fluoro-4-oxo-3-phenylquinazolin-2-yl]-4-hydroxypyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251845 N-[6-[5-amino-6-(2-methoxyethoxy)pyrazin-2-yl]imidazo[1,2-a]pyridin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179697 4-methyl-N-[(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)methyl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177520 4-((3-(6-Amino-4-(trifluoromethyl)pyridin-3-yl)-5-morpholinophenyl)sulfonyl)benzonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:72549796 Ethyl (5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168295683 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]-N-[(2R)-1-hydroxypropan-2-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606641 (S)-ethyl 4-(6-(4-(3-ethylureido)phenyl)-4-(3-methylmorpholino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59252083 N-[6-[6-amino-5-(2-methoxyethoxy)pyridin-3-yl]imidazo[1,2-b]pyridazin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25262782 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-phenylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57397192 N-benzyl-N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-2-methyl-5-nitrobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168287758 4-[1-(4-Fluorophenyl)-2-methylimidazo[4,5-c]quinolin-8-yl]phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173124 5-(3-Morpholino-5-(((tetrahydrofuran-3-yl)methyl)sulfonyl)phenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121393679 2-amino-4-[(2S,4S)-4-hydroxy-2-[5-(6-methoxypyridin-3-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46886361 N-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)-N-methylacetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46225157 1-(4-(4-(3,6-dihydro-2H-pyran-4-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-(2-fluoroethyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884531 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(3,6-dihydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155523374 5-[4-Morpholin-4-yl-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76321298 N-[5-(2-Amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxy-3-pyridinyl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:129030297 8-[(2S)-1-(3,5-difluorophenyl)pyrrolidin-2-yl]-N,N-dimethyl-2-morpholin-4-ylquinoxaline-6-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884535 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-isopropylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164556410 N-[5-[4-(benzylamino)quinazolin-6-yl]-2-chloropyridin-3-yl]methanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46224808 (3-(9-(1-(2,4-difluorophenyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenyl)methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118503074 8-[6-[3-(Dimethylamino)propoxy]-2-fluoropyridin-3-yl]-3-methyl-1-(oxetan-3-yl)imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:16730437 1-[3-(4-Aminophenyl)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25071519 (3-(9-(1-(2-fluorobenzyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenyl)methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71037684 5-[3-(4-Methylimidazol-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44539683 4-hydroxy-2-((1-methyl-4-(4-(morpholine-4-carbonyl)piperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25071520 (3-(9-(1-(4-fluorobenzyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenyl)methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:90233185 2-[(1S)-1-[[6-amino-5-(2-phenylethynyl)pyrimidin-4-yl]amino]ethyl]-5-fluoro-3-pyridin-3-ylquinazolin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834523 2-amino-4-[(2S,4S)-2-[6-fluoro-5-(2-methoxy-1,3-thiazol-5-yl)-4-oxo-3-phenylquinazolin-2-yl]-4-hydroxypyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44555225 2-((1-(3-(dimethylamino)propyl)-5-methoxy-1H-indol-3-yl)methylene)-4,6-dihydroxybenzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25109014 5-(6-(2-Aminopropan-2-yl)-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25128667 N-(6-(3,4-Dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164556495 6-(5-(5-Oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)pyridin-3-yl)-4-((1-phenylethyl)amino)quinoline-3-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885280 1-(4-(4,6-Di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197595 N-[5-[8-(2,2-dimethyloxan-4-yl)oxy-4-methyl-2-(methylamino)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606644 (R)-ethyl 4-(4-(3-methylmorpholino)-6-(4-(3-pyridin-4-ylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56833458 5-[6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[2,3-d]pyrimidin-2-yl]-pyrimidin-2-ylamine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51347750 2-Methyl-1-[4-[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propan-2-ol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25070555 (3-(9-((1-benzylpiperidin-4-yl)methyl)-6-morpholino-9H-purin-2-yl)phenyl)methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118523397 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-1-(oxan-4-yl)-3H-imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118470672 3-[5-amino-6-(2-methyl-1,3-thiazol-5-yl)pyrazin-2-yl]-N-(2-hydroxyethyl)-4-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118523381 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-7-fluoro-1-[(1S,3S)-3-methoxycyclopentyl]-3-methylimidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118617094 N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]-2-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25260758 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(4-oxocyclohexyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706651 3-[2-Methyl-6-(Pyrazin-2-Ylamino)pyrimidin-4-Yl]-N-(1h-Pyrazol-3-Yl)imidazo[1,2-B]pyridazin-2-Amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179696 9-[(4-Methoxyanilino)methyl]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58204703 (2S)-2-hydroxy-1-[3-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]azetidin-1-yl]propan-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51346893 3-(4-Morpholino-6-(pyridin-2-yl)pyrimidin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44242362 2-N-(2-chlorophenyl)-2-N-methyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2,8-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227564 3-(2-(1H-indol-5-yl)thieno[3,2-d]pyrimidin-4-yl)-8-oxa-3-azabicyclo[3.2.1]octane 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164617445 26-Methoxy-23,23-dioxo-23lambda6,32-dithia-3,4,6,16,24,27-hexazahexacyclo[23.3.1.12,5.110,14.118,22.04,8]dotriaconta-1(29),2,5,7,10(31),11,13,18(30),19,21,25,27-dodecaen-17-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:134148445 1-[(3S)-3-[7-(3,4-dimethoxyphenyl)quinoxalin-2-yl]oxypyrrolidin-1-yl]propan-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173219 5-(3-((2,3-Dihydrobenzofuran-3-yl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168294307 1-benzyl-2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71520393 4-[4-[2-(Difluoromethyl)-6-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51357948 N-(6-(2-(2-phenylpropan-2-ylamino)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:50940334 4-(1-(6-Chloro-2,3-dimethylquinolin-4-yl)-3,3-dimethylindolin-6-yl)morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155569079 4-[[4-fluoro-3-[2-(1H-indol-4-yl)-4-morpholin-4-yl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidine-7-carbonyl]phenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122181417 1-[4-[5-[5-Amino-6-(benzotriazol-1-yl)pyrazin-2-yl]-2-methyl-1,2,4-triazol-3-yl]piperidin-1-yl]-2-(dimethylamino)ethanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168282084 5-[1-(4-Fluorophenyl)-2-methylimidazo[4,5-c]quinolin-8-yl]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168273903 2-amino-N-cyclopropyl-5-(2-ethyl-7-methyl-1-oxo-3H-isoindol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885278 1-(4-(4,6-Di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(2-(dimethylamino)ethoxy)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798436 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-fluoropiperidin-1-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71037735 6-(2-Amino-1,3-benzoxazol-5-yl)-3-[3-(diethylamino)propyl]quinazolin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155383829 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-7-methylsulfonyl-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44604825 1-methoxy-3-(4-{4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]-1Hpyrazolo[3,4-d]pyrimidin-6-yl}phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56833639 N-(2-chlorophenyl)-N-methyl-8-((methylamino)methyl)-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:10269329 9-(Benzylamino)-7-methyl-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53320018 3-(2-Morpholino-6-(pyridin-2-ylmethoxy)pyrimidin-4-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884538 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118523357 8-[6-[3-(Azetidin-1-yl)propoxy]pyridin-3-yl]-1-(3-methoxycyclobutyl)-3-methylimidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881811 1-Ethyl-3-[3-(1-methylpyrazol-4-yl)pyrido[2,3-b]pyrazin-6-yl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197602 N-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methyl-8-(oxan-4-yloxy)quinazolin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:162669113 6-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]pyridazin-3-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488060 4-(3-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)ureido)-N-(pyrrolidin-1-yl)benzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251848 N-[6-(6-amino-5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197555 N-[5-[2-amino-8-(2-methoxyethoxy)-4-methylquinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403564 N-cyclopropyl-5-(3-morpholino-5-(phenylsulfonyl)phenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884157 4-(3-((4-hydroxy-3-oxobenzofuran-2(3H)-ylidene)methyl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)-N,N-dimethylbenzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25070553 3-(9-((1-benzylpiperidin-4-yl)methyl)-6-morpholino-9H-purin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76314028 N-[5-(2-amino-4-pyridin-4-ylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798464 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-b]pyridazin-3-yl]-(4-methylpiperazin-1-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53317325 4-(1H-pyrazolo[3,4-b]pyridin-4-yl)morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70682114 6-(2-aminopyrimidin-5-yl)-N-(2-methoxyethyl)-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53325515 3-(2-Morpholino-6-(pyridin-2-ylmethylamino)pyrimidin-4-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44242777 8-N-(2-aminoethyl)-2-N-(2-chlorophenyl)-2-N-methyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2,8-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834571 2-amino-4-[(2S,4S)-4-hydroxy-2-(4-oxo-3-phenyl-5-pyridin-3-ylquinazolin-2-yl)pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884243 4-hydroxy-2-((4-(4-(4-(2-hydroxyethyl)piperazine-1-carbonyl)phenyl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798545 1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-4-methylpiperazin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168294625 2-methyl-1-[(1S)-1-phenylethyl]-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:11656338 2-[5-Cyclohexyl-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-1,2-dihydro-3H-1,3,4-benzotriazepin-3-yl]-N-(3-hydroxymethyl-phenyl)-acetamide 3.2392219386070445e-05 0.436539\n",
      "CHEBI:219513 Demethoxyviridin 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44156156 1-(4-(4-(3,6-dihydro-2H-pyran-4-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168279934 2-methyl-1-(oxolan-3-ylmethyl)-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:158459048 5-(3-((4-Methoxybenzyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227620 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-cyclopropylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25197239 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118321324 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]pyridine-3-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884203 (2Z)-4-hydroxy-2-({1-methyl-4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-ylcarbonyl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}methylidene)-1-benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164617629 4-[6-Amino-5-(trifluoromethyl)pyridin-3-yl]-6-[1-(cyclopropanecarbonyl)azetidin-3-yl]oxy-2,3-dihydroisoindol-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46225260 4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197604 N-[5-[8-cyclopentyloxy-4-methyl-2-(methylamino)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834537 2-[(2S,4S)-1-(2-amino-7H-purin-6-yl)-4-methoxypyrrolidin-2-yl]-5-(1-methylpyrazol-4-yl)-3-phenylquinazolin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197655 N-[5-[2-amino-4-methyl-8-(oxolan-2-ylmethoxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44554909 4,6-dihydroxy-2-((2-(naphthalen-2-yl)-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:129262526 2,4-diamino-6-[[(1S)-1-(7-fluoro-1-methyl-4-oxo-3-phenylquinolizin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177460 1-(3-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)pyrrolidin-1-yl)ethan-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25262174 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:50940110 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2-(2-fluorophenyl)-3-methylquinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251796 N-[6-(6-amino-5-ethoxypyridin-3-yl)imidazo[1,2-a]pyridin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:24992904 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinofuro[3,2-d]pyrimidine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44180035 5-Morpholin-4-yl-3-thiophen-3-ylthieno[3,2-b]pyran-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155562814 4-[[3-[4-[4-(4-amino-3-fluorophenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59453069 3-[2-methyl-4-(1H-1,2,4-triazol-5-yl)phenyl]-5-[2-(oxan-4-yl)ethyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71250929 [2-methoxy-5-[4-[(3S)-3-methylmorpholin-4-yl]-2-propan-2-ylpyrido[2,3-d]pyrimidin-7-yl]phenyl]methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118321318 N-[5-(2-amino-4-methylpyrido[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]thiophene-2-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76335783 7-amino-1-cyclopentyl-5-methyl-3-(1H-pyrazolo[3,4-b]pyridin-5-yl)-1,6-naphthyridin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606304 1-methyl-3-(4-(4-morpholino-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25070551 (3-(6-morpholino-9-(piperidin-4-yl)-9H-purin-2-yl)phenyl)methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44607003 N-[4-(4-Morpholin-4-yl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59548471 N-(5-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)pyridin-2-ylamino)-2-chloropyridin-3-YL)cyclopropanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118500097 1-(3-Methoxycyclobutyl)-3-methyl-8-[6-(3-pyrrolidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177453 3'-((4-Fluorobenzyl)sulfonyl)-5'-morpholino-[1,1'-biphenyl]-3-ol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884355 2-((4-(4-aminopiperidin-1-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-4-hydroxybenzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25262616 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25109782 N-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[2,3-d]pyrimidin-6-yl]methyl]-N-methylmethanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502142 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-1-[(1S,3S)-3-methoxycyclopentyl]-3-methylimidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173017 (3-((2-(2-Aminopyrimidin-5-yl)-6-morpholinopyridin-4-yl)oxy)azetidin-1-yl)(cyclopropyl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44544943 2-(2-(2-amino-4-methylpyrimidin-5-yl)-9-(2-hydroxyethyl)-6-morpholino-9H-purin-8-yl)propan-2-ol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155383776 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]-N-(4-hydroxy-4-methylcyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884539 4-(3-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)ureido)-N-(2-(dimethylamino)ethyl)benzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:11998564 5,5-dimethyl-2-(3-(naphthalen-2-ylmethyl)morpholino)-5,6-dihydrobenzo[d]thiazol-7(4H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798431 [5-(2-Amino-1,3-benzoxazol-5-yl)pyrazolo[1,5-a]pyridin-3-yl]-(4-methylpiperazin-1-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197609 N-[5-(2-amino-8-cyclopentyloxy-4-methylquinazolin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227600 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-(2-fluoroethyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25128663 N-[6-(5-Methylsulfonylpyridin-3-Yl)-[1,2,4]triazolo[1,5-A]pyridin-2-Yl]ethanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885276 1-(4-(4,6-Di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-((dimethylamino)methyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502938 1-(3-Hydroxycyclobutyl)-3-methyl-8-[6-(3-pyrrolidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118523362 3-methyl-1-[(3R)-oxolan-3-yl]-8-[6-(3-piperidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798488 5-(4-Pyridin-4-ylquinolin-6-yl)-1,2-benzoxazol-3-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56833636 5-[6-(3-Methylsulfonylphenyl)-4-morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl]pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227582 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-((4-methylpiperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76310352 N-[5-(7-amino-1-cyclopentyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]-5-chlorothiophene-2-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403592 4-((3-(2-Amino-4-(trifluoromethyl)pyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)benzonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798589 (2S)-1-[1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidine-3-carbonyl]pyrrolidine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:49785166 4-Methyl-6-[5-[(4-methylsulfonylpiperazin-1-yl)methyl]-2-[[6-(trifluoromethyl)pyridin-3-yl]amino]pyridin-3-yl]-1,3,5-triazin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232643 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173125 5-(6-Morpholino-4-(1-phenylcyclopropyl)pyridin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:11470740 7-methylsulfanyl-N-phenylheptanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44539685 (Z)-1-(2-((4-(2-oxa-5-azabicyclo[2.2.2]octan-5-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798494 6-(4-Pyridin-4-ylquinolin-6-yl)quinazolin-4-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197601 2,4-difluoro-N-[2-methoxy-5-[4-methyl-2-(methylamino)-8-(oxolan-3-ylmethoxy)quinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884075 (Z)-N-methyl-1-(1-methyl-3-((3-oxo-5-(3-pyridin-3-ylureido)benzofuran-2(3H)-ylidene)methyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-N-(pyridin-2-ylmethyl)piperidine-4-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403547 N-(5-(3-morpholino-5-(phenylsulfonyl)phenyl)pyrimidin-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122188283 5-Chloro-3-[1-(2-methyl-5-nitrophenyl)sulfonylpyrazol-3-yl]pyrazolo[1,5-a]pyrimidine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46225307 4-(2-(benzo[d][1,3]dioxol-5-yl)-9H-purin-6-yl)morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:16730347 1-[3-(4-Aminophenyl)pyrido[2,3-b]pyrazin-6-yl]-3-methylthiourea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834573 2-amino-4-[(2S)-2-[6-fluoro-5-(1-methylpyrazol-4-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834394 2-amino-4-methyl-6-[(2S)-2-[5-(1-methylpyrazol-4-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56955953 2-{4-[(4'-Methoxybiphenyl-3-Yl)sulfonyl]piperazin-1-Yl}-3-(4-Methoxyphenyl)pyrazine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179712 N-(2-methylphenyl)-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-9-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884534 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-ethylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232759 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,5-dioxaspiro[5.5]undecan-9-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251709 N-[6-(6-amino-5-methoxypyridin-3-yl)imidazo[1,2-a]pyridin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76310249 [3-(4-Morpholin-4-ylpyrido[2,3-d]pyrimidin-2-yl)phenyl]methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46225280 3-(6-morpholino-9-(piperidin-4-yl)-9H-purin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46913421 3-(5,6-Dimethoxypyridin-3-yl)-6-pyridin-4-ylimidazo[1,2-a]pyridine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:10021687 7-methyl-2-morpholin-4-yl-9-[[(1R)-1-phenylethyl]amino]pyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798598 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3R)-3-methoxypyrrolidin-1-yl]methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44180155 3-(Furan-3-yl)-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25195789 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-(2-methoxyethyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118721844 1-[6-(5-Methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-3-[2-(3-methylimidazol-4-yl)ethyl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122178122 5-chloro-N-[2-methoxy-5-(4-pyridin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]thiophene-2-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44609075 N-(2-chloro-5-quinolin-6-ylpyridin-3-yl)-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884528 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(isopropyl(methyl)amino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:16739368 PI-103 (Hydrochloride) 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155529500 2-[ethyl-[2-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyethyl]amino]-N-hydroxypyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122178125 N-[2-chloro-5-(4-pyridin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881915 1-Ethyl-3-[3-(pyrazin-2-ylamino)pyrido[2,3-b]pyrazin-6-yl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403542 5-(3-((2,4-Difluorobenzyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76332050 3-(4-Morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)aniline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45482935 ethyl 4-(6-(4-(3-ethylureido)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118470793 3-[5-amino-6-(3-methyl-1,2-oxazol-5-yl)pyrazin-2-yl]-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168276358 2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1-[6-(trifluoromethyl)pyridin-3-yl]imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834538 2-amino-4-[(2S,4S)-4-hydroxy-2-[5-(1-methylpyrazol-4-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168269416 Methyl 4-[1-(4-fluorophenyl)-2-methylimidazo[4,5-c]quinolin-8-yl]benzoate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25253230 4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[2,3-d]pyrimidin-4-yl)morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71526880 (2S,3S)-2-amino-1-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-3-methylpentan-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46913313 N-[5-(6-bromo-2-methylimidazo[1,2-a]pyridin-3-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146175459 3-((3-(2-aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)-N-ethylazetidine-1-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834589 2-amino-4-[(2S)-2-[5-(2-ethoxypyrimidin-5-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46239967 N-[(E)-1-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)propylideneamino]-2-methyl-5-nitrobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53320017 3-(6-Morpholino-2-(2-(pyridin-2-yl)ethylamino)pyrimidin-4-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57947021 [4-[6-(Ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]-2-methoxyphenyl] dihydrogen phosphate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44604823 1-{4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo-[3,4-d]pyrimidin-6-yl]phenyl}-3-cyclopropylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118500050 8-[6-[3-(Dimethylamino)propoxy]pyridin-3-yl]-1-(3-hydroxycyclobutyl)-3-methylimidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:50939344 1-(3-Methyl-2-phenyl-4-quinolinyl)-6-(4-morpholinyl)-1,2,2',3',5',6'-hexahydrospiro[indole-3,4'-pyran] 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885275 1-(4-(4,6-Di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-((4-methylpiperazin-1-yl)methyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71037675 5-[3-[(2S,6R)-2,6-dimethylmorpholin-4-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:54754350 N-{6-[(Z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]imidazo[1,2-a]pyridin-2-yl}acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57397894 3-(cyclohexylmethyl)-5-[4-(2-hydroxypropan-2-yl)phenyl]-1H-imidazo[4,5-b]pyrazin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155528423 4-[[3-[4-[4-(2-aminopyrimidin-5-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:136264452 4-(4-Morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706813 N-[2-methyl-6-[2-(1H-pyrazol-5-ylamino)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173013 5-(4-(Difluoro(phenyl)methyl)-6-morpholinopyridin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881877 3-[[6-(Ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]amino]-5-(trifluoromethyl)benzoic acid 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884077 (Z)-N-methyl-1-(1-methyl-3-((3-oxo-5-(3-pyridin-3-ylureido)benzofuran-2(3H)-ylidene)methyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-N-(pyridin-3-yl)piperidine-4-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25262783 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122178121 4-cyano-N-[2-methoxy-5-(4-pyridin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118728336 2-Methyl-11-(trifluoromethyl)-6,7-dihydrobenzimidazolo[1,2-d][1,4]benzoxazepine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44181598 3-(Furan-2-yl)-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44601449 1-(4-{7-[2-(4-Methylpiperazin-1-yl)ethyl]-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}phenyl)-3-pyridin-4-ylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884527 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(isopropylamino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44129043 (2S,4S)-1-N-[5-(2-tert-butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]-4-hydroxypyrrolidine-1,2-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798416 [6-[3-(Methylamino)-1,2-benzoxazol-6-yl]imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58169819 1-[4-[(6aS)-5-(cyclopropylmethyl)-6a-methyl-6-oxo-9,10-dihydro-7H-[1,4]oxazino[3,4-h]pteridin-2-yl]phenyl]-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173030 5-(6-Morpholino-4-(1-phenylethyl)pyridin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:89051931 8-[(2R)-1-(4-fluorophenyl)pyrrolidin-2-yl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46830277 4-hydroxy-2-((1-methyl-4-(4-(4-methylpiperazine-1-carbonyl)piperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76313940 [4-(4-Morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenyl]methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177393 (R)-4-fluoro-5-(3-morpholino-5-((tetrahydrofuran-3-yl)sulfonyl)phenyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384071 CID 155384071 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:86272388 (S)-2-(1-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)propyl)-5-fluoro-3-(3-(2,2,2-trifluoroethoxy)phenyl)quinazolin-4(3H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155528446 4-[[4-fluoro-3-[4-[4-(1H-indazol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]phenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:153279876 5-(3-phenyl-1H-benzimidazol-3-ium-5-yl)-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59251818 N-[6-[5-amino-6-(2,2,2-trifluoroethoxy)pyrazin-2-yl]imidazo[1,2-a]pyridin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881876 1-[3-(3,5-dimethyl-1H-pyrazol-4-yl)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884541 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(piperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:129262431 2,4-diamino-6-[[(1S)-1-(1-cyclopropyl-7-fluoro-4-oxo-3-phenylquinolizin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121334475 CID 121334475 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:68405246 5-(7-Pyridin-4-ylthieno[3,2-b]pyridin-2-yl)-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122188268 N-[(E)-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-N,2-dimethyl-5-methylsulfonylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884019 (Z)-1-(2-((4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(6-morpholinopyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706154 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(1H-pyrazol-5-yl)-6-pyridin-4-ylimidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:42606076 3-((1H-Indazol-3-yl)ethynyl)aniline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197651 N-[5-[2-amino-8-(cyclopropylmethoxy)-4-methylquinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118503071 8-[6-[3-(dimethylamino)propoxy]-2-fluoropyridin-3-yl]-3-methyl-1-[(3S)-oxolan-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232761 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(2-fluoroethyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59258944 2-amino-8-cyclopropyl-4-methyl-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118728817 5-[(2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-2-bicyclo[2.2.2]octanyl]-1,2-oxazol-3-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46898104 N-[2-chloro-5-(6-pyridin-3-ylimidazo[1,2-a]pyridin-3-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62705168 1-ethyl-3-[4-[4-[(3R)-3-methylmorpholin-4-yl]-6,6-dioxo-5,7-dihydrothieno[3,4-d]pyrimidin-2-yl]phenyl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:49854502 (8s)-9-[3,5-Bis(Fluoranyl)phenyl]-2-Morpholin-4-Yl-8-(Trifluoromethyl)-7,8-Dihydro-6h-Pyrimido[1,2-A]pyrimidin-4-One 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798783 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(1,4-dioxa-7-azaspiro[4.4]nonan-7-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227604 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-cyclopropylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44607183 Methyl{4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}carbamate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118630968 2-amino-4-[[(1S)-1-(7-fluoro-4-oxo-3-phenylquinolizin-2-yl)ethyl]amino]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706314 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(4-methylpyrimidin-5-yl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798607 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3S)-3-morpholin-4-ylpyrrolidin-1-yl]methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:87056190 2-amino-4-[(2S,4S)-4-hydroxy-2-[5-(5-methoxypyridin-3-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:49835286 3-[6-[(5-methoxypyridazin-3-yl)amino]-2-methylpyrimidin-4-yl]-N-(1H-pyrazol-5-yl)imidazo[1,2-b]pyridazin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:49788443 6-(2-Aminopyrimidin-5-yl)-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:16456451 N-(3-methoxyphenyl)-1-methyl-6-(4-methylpiperazin-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384097 CID 155384097 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59753763 7-methyl-2-morpholin-4-yl-9-[[(1S)-1-phenylethyl]amino]pyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25129386 N-[6-[3-(methanesulfonamido)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403556 2-((5-(3-Morpholino-5-(phenylsulfonyl)phenyl)pyrimidin-2-yl)amino)ethan-1-ol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53316967 3-(4-Morpholino-6-(pyridin-3-yl)pyrimidin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884546 4-(3-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)ureido)-N-(2-(dimethylamino)ethyl)benzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384208 2-amino-N-cyclopropyl-5-[7-cyclopropyl-2-[(1S)-1-cyclopropylethyl]-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197588 N-[5-(2-amino-8-methoxy-4-methylquinazolin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168286797 5-[1-(4-Fluorophenyl)-2-methylimidazo[4,5-c]quinolin-8-yl]pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118499887 8-[6-(3-Dimethylaminopropoxy)pyridin-3-yl]-1-(cis-3-methoxycyclobutyl)-3-methylimidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45379226 N-(2-(dimethylamino)ethyl)-4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)ureido)-N-methylbenzamide hydrochloride 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884283 2-((1-ethyl-4-(4-(4-(2-hydroxyethyl)piperazine-1-carbonyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-4-hydroxybenzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:66780835 4-[(2-Chlorophenyl)methyl]-2-morpholin-4-yl-[1,3]thiazolo[4,5-d]pyrimidin-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:126570059 3-[5-amino-6-(2-methyl-1,3-thiazol-5-yl)pyrazin-2-yl]-N-(3-hydroxy-3-methylbutyl)-4-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164615292 6-[1-(Cyclopropanecarbonyl)azetidin-3-yl]oxy-4-[6-(difluoromethoxy)pyridin-3-yl]-2,3-dihydroisoindol-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59258821 2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-pyrrolidin-1-ylpyrido[2,3-d]pyrimidin-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:145951131 1-[(3S)-3-[[6-(6-methoxypyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]propan-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884018 (Z)-1-(2-((4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488081 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-(2-(dimethylamino)ethylamino)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881861 3-[6-(Ethylcarbamoylamino)pyrido[2,3-b]pyrazin-3-yl]benzoic acid 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177529 5-(6-Morpholino-4-((tetrahydrofuran-3-yl)oxy)pyridin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76328474 7-Amino-1-cyclopentyl-3-(6-methoxypyridin-3-yl)-5-methyl-1,6-naphthyridin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179704 9-Anilino-7-methyl-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168272411 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-7-methoxy-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488061 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-morpholinophenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45482916 methyl 4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(4-(3-ethylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881938 1-Ethyl-3-[3-[(1-methylpyrazol-3-yl)amino]pyrido[2,3-b]pyrazin-6-yl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51003497 N-(2-(cyclopropylmethoxy)-4-(2-morpholino-4-oxo-4H-chromen-8-yl)phenyl)-2-morpholinoacetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:24804985 1-(4-Fluorophenyl)-3-[4-[4-(methylsulfonylmethyl)-6-morpholin-4-ylpyrimidin-2-yl]phenyl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118540006 1-(4-Chloro-3trifluoromethyl-phenyl)-3-[3-(5-morpholin-4-yl-7oxo-7H-thieno[3,2-b]pyran-3-yl)-phenyl]-urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:142506035 N-hydroxy-N-methyl-4-[[[4-oxo-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-5-yl]amino]methyl]benzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:137641383 4-[3-[4-Amino-5-[2-(2,2,2-trifluoroethyl)pyrazol-3-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]phenyl]-2,2-dimethylmorpholin-3-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384081 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-1-oxo-7-propan-2-yl-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173051 5-(6-Morpholino-4-(phenylsulfonyl)pyridin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834340 2-Amino-4-((2S,4S)-2-(6-fluoro-5-(1-methyl-1H-pyrazol-4-yl)-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)-4-hydroxypyrrolidin-1-yl)-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:162654516 5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]-4-(trifluoromethyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884529 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-thiomorpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798644 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[4-(3-methylpyrazol-1-yl)piperidin-1-yl]methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25172663 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-[2-(dimethylamino)ethyl]-2-methyl-5-nitrobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71041953 25-Methoxy-22,22-dioxo-3,12,22lambda6-trithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,13(30),17(29),18,20,24,26-dodecaen-16-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834524 2-amino-4-methyl-6-[(2S)-2-[5-(2-methylpyrimidin-5-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "CHEBI:95331 N-(7,8-dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-3-pyridinecarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884070 (Z)-1-(2-((1-methyl-4-(4-(pyrrolidine-1-carbonyl)piperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177531 5-[4-[Difluoro(oxan-4-yl)methyl]-6-morpholin-4-ylpyridin-2-yl]pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:49835107 3-(6-Amino-2-methylpyrimidin-4-yl)-N-(1H-pyrazol-3-yl)imidazo[1,2-b]pyridazin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884536 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-(dimethylamino)piperidin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168278844 1-(4-methoxyphenyl)-2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488059 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-(2,2-dimethylhydrazinecarbonyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46190736 (3-(9-(1-(4-(3-(dimethylamino)propoxy)benzyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenyl)methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44156032 3-(4-(3,6-dihydro-2H-pyran-4-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881858 1-[3-(3,4-Dimethoxyphenyl)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:90396359 (13R)-25-methoxy-31-methyl-22,22-dioxo-3,22lambda6-dithia-6,8,10,15,23,26-hexazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,17(29),18,20,24,26-decaen-16-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884158 (Z)-4-hydroxy-2-((1-methyl-4-(4-(morpholine-4-carbonyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:16049458 3-(6-morpholino-9H-purin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155512651 4-[[4-fluoro-3-[4-[4-(1H-indol-4-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]phenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168280252 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]-N-(4-hydroxycyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53387738 N-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzoxazol-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44555222 4,6-dihydroxy-2-((5-methoxy-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25262946 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25261389 methyl 4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-(4-(3-methylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179705 7-methyl-9-(N-methylanilino)-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44552663 4,6-dihydroxy-2-((1-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)-5-methoxy-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71682652 (2S)-1-N-[5-(2-tert-butylpyridin-4-yl)-4-methyl-1,3-thiazol-2-yl]-2-N-methylpyrrolidine-1,2-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403568 3-(((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)methyl) benzonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25071516 5-(9-(1-((6-fluoropyridin-3-yl)methyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)pyridin-3-ol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168286200 2-methyl-1-(oxan-4-ylmethyl)-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71520397 4-[4-(6-Methoxy-2-propan-2-ylbenzimidazol-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71527009 1-[4-[4-[2-(Difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-2-(dimethylamino)ethanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168272966 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-1-oxo-7-(trifluoromethyl)-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44605248 methyl 4-(4-morpholino-6-(4-(3-(4-(2-morpholinoethyl)phenyl)ureido)phenyl)-1Hpyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53363523 N-[2-chloro-5-[4-[4-(dimethylamino)phenyl]quinolin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488066 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(6-(methylamino)pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168270741 2-methyl-1-phenyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403574 5-(3-((2,3-Dihydrobenzofuran-7-yl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53326166 3-(2-Morpholino-6-(2-(pyridin-3-yl)ethylamino)pyrimidin-4-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834540 2-amino-4-[(2S,4S)-4-hydroxy-2-[5-[1-(2-hydroxyethyl)pyrazol-4-yl]-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227625 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-phenylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59606123 2-[4-[2-(2-Ethylbenzimidazol-1-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidine-6-carbonyl]piperazin-1-yl]-2-methylpropanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25172666 3-[(E)-[methyl-[(2-methyl-5-nitrophenyl)methyl]hydrazinylidene]methyl]pyrazolo[1,5-a]pyridine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46225281 3-(9-(1-((5-chloropyridin-3-yl)methyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44540543 4,6-dihydroxy-2-((1-methyl-4-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197590 N-[5-[2-(ethylamino)-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168288636 2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1-[4-(trifluoromethyl)phenyl]imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51354023 N-(6-(2-(N,4-dimethylphenylsulfonamido)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197682 N-[5-[2-amino-8-(2,2-dimethyloxan-4-yl)oxy-4-methylquinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58204711 2-[4-[2-(5-Methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]ethanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885279 1-(4-(4,6-Di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(2-(4-methylpiperazin-1-yl)ethoxy)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:6484194 4-Methyl-2-morpholin-4-yl-thiazole-5-carboxylic acid 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488078 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-(pyrrolidin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:53387574 N-(5-(benzo[d]oxazol-6-yl)-2-chloropyridin-3-yl)-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884354 2-((4-(4-(aminomethyl)piperidin-1-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-4-hydroxybenzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121334474 5-[4,6-bis[(3R,5S)-3,5-dimethylmorpholin-4-yl]-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384214 2-amino-5-[7-chloro-2-[(1S)-1-cyclopropylethyl]-1-oxo-3H-isoindol-5-yl]-N-cyclopropylpyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885277 1-(4-(4,6-Di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-((methylamino)methyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:23586721 7-Methyl-2-morpholin-4-yl-9-(pyridin-4-ylmethylamino)pyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25261390 tert-butyl 4-[6-{4-[(methylcarbamoyl)amino]phenyl}-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:16048654 Urea, N-ethyl-N'-(3-((4-methylphenyl)amino)pyrido(2,3-b)pyrazin-6-yl)- 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:66790311 N-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)imidazo[1,2-a]pyridin-2-yl]isoquinolin-7-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118523391 8-[6-[3-(dimethylamino)propoxy]-2-fluoropyridin-3-yl]-1-[(1R,3R)-3-methoxycyclopentyl]-3-methylimidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384020 2-amino-5-[7-cyclobutylsulfonyl-2-[(1S)-1-cyclopropylethyl]-1-oxo-3H-isoindol-5-yl]-N-cyclopropylpyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179708 9-(2,6-Dimethylanilino)-7-methyl-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59605730 2-(4-(2-(2-ethyl-1H-benzo[d]imidazol-1-yl)-9-methyl-6-morpholino-9H-purine-8-carbonyl)piperazin-1-yl)-2-methylpropanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:134138703 1-[(3S)-3-[6-(6-methoxypyridin-3-yl)cinnolin-4-yl]oxypyrrolidin-1-yl]propan-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25172271 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-5-fluoro-N,2-dimethylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121334481 5-[2,6-Bis(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)pyrimidin-4-yl]-4-(difluoromethyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834562 2-amino-4-[(2S)-2-[5-(6-methoxypyridin-3-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51354022 N-(6-(2-(4-Methylphenylsulfonamido)pyrimidin-4-yl)benzo-[d]thiazol-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403578 5-(3-(Benzofuran-7-ylsulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502818 8-[6-[3-(Dimethylamino)propoxy]-2-fluoropyridin-3-yl]-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168280184 2-amino-N-cyclobutyl-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177459 5-(3-((4,4-Difluorocyclohexyl)sulfonyl)-5-morpholinophenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881816 1-[3-(4-Chloro-2-methoxyphenyl)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168274073 2-amino-N-cyclopropyl-5-[2-(cyclopropylmethyl)-7-methyl-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606131 1-(2-fluoroethyl)-3-(4-(4-morpholino-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:166594436 N-(4-(((3-(2-aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)methyl)phenyl) methanesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71037704 5-[3-[4-(3-Methylpyrazol-1-yl)piperidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232804 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:90232865 2-[(1S)-1-[[6-amino-5-(2-phenylethynyl)pyrimidin-4-yl]amino]ethyl]-5-methylsulfonyl-3-phenylquinazolin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25196221 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-(2-fluoroethyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76335668 3-[4-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyrido[3,2-d]pyrimidin-2-yl]phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44609544 N-[2-chloro-5-[4-(4-propan-2-ylpiperazin-1-yl)quinolin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834561 4-amino-6-[(2S,4S)-2-[6-fluoro-5-(1-methylpyrazol-4-yl)-4-oxo-3-phenylquinazolin-2-yl]-4-hydroxypyrrolidin-1-yl]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:135197550 N-[5-[2-amino-4-methyl-8-(2-morpholin-4-ylethoxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44242423 N-(2-chlorophenyl)-8-cyano-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884284 3-(3-((4-hydroxy-3-oxobenzofuran-2(3H)-ylidene)methyl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)-N,N-dimethylbenzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25261555 methyl 4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-(4-(3-pyridin-3-ylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121334420 4-(difluoromethyl)-5-[6-[(3S)-3-methylmorpholin-4-yl]-2-morpholin-4-ylpyrimidin-4-yl]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155530465 2-[2-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyethyl-propan-2-ylamino]-N-hydroxypyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155735594 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]-N-[(1R,3R)-3-hydroxycyclopentyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46913311 N-(2-chloro-5-imidazo[1,2-a]pyridin-3-ylpyridin-3-yl)-4-fluorobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798411 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(1,1-dioxo-1,4-thiazinan-4-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502804 8-[6-[3-(Dimethylamino)propoxy]pyridin-3-yl]-7-fluoro-3-methyl-1-(4-methyloxan-4-yl)imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834373 2-amino-4-methyl-6-[(2S)-2-(4-oxo-3-phenyl-5-pyridin-3-ylquinazolin-2-yl)pyrrolidin-1-yl]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45482952 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25196219 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-methoxyurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118728325 2,11-Dichloro-6,7-dihydrobenzimidazolo[1,2-d][1,4]benzoxazepine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45482982 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502824 8-[6-[3-(dimethylamino)propoxy]-2-fluoropyridin-3-yl]-3-methyl-1-[(3S)-oxan-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384130 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropyl-2,2,2-trifluoroethyl]-7-(methanesulfonamido)-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51346892 3-(2-Morpholino-6-(2-(pyridin-4-yl)ethylamino)pyrimidin-4-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44129197 (2S)-1-N-[5-(2-tert-butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]-2-methylpyrrolidine-1,2-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173102 (2-(2-Aminopyrimidin-5-yl)-6-morpholinopyridin-4-yl)(phenyl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834586 2-amino-4-[(2S)-2-[5-(5-methoxypyridin-3-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118728320 11-Fluoro-2-methyl-6,7-dihydrobenzimidazolo[1,2-d][1,4]benzoxazepine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168297765 4-[1-(4-fluorophenyl)-2-methylimidazo[4,5-c]quinolin-8-yl]-N-methylbenzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177519 4-(3-(3-Methylpyridin-4-yl)-5-(phenylsulfonyl)phenyl)morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71037665 5-[3-(1,1-Dioxo-1,4-thiazinan-4-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76317471 1-[4-(4-Morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenyl]-3-pyridin-4-ylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168274619 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]-N-(oxetan-3-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881771 1-(4-Hydroxybutyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834398 2-amino-4-[(2S,4S)-4-fluoro-2-[5-(1-methylpyrazol-4-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403567 N-(4-((3-(2-aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)phenyl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70695189 (2S)-1-N-[4-methyl-5-(4-methylsulfonylphenyl)-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155384025 2-amino-N-(4-hydroxy-4-methylcyclohexyl)-5-[7-(methanesulfonamido)-1-oxo-2-[(2S)-1,1,1-trifluoropropan-2-yl]-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155555515 4-[[3-[4-[4-(6-aminopyridin-3-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118721841 3-[[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]carbamoylamino]-N-(2,2,2-trifluoroethyl)propanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:60155086 3-[[3-(2-Amino-6-methylpyrimidin-4-yl)pyridin-2-yl]amino]phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46215210 8-[2-(oxan-4-yl)ethyl]-2-[6-(1H-1,2,4-triazol-5-yl)pyridin-3-yl]-5,7-dihydropyrazino[2,3-b]pyrazin-6-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155516184 N-hydroxy-8-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxyoctanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44605792 (R)-ethyl 4-(6-(4-(3-ethylureido)phenyl)-4-(3-methylmorpholino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51352027 1-[4-[(6aS)-5-(cyclopropylmethyl)-6a-methyl-6-oxo-9,10-dihydro-7H-[1,4]oxazino[3,4-h]pteridin-2-yl]phenyl]-3-cyclopropylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168269892 2-amino-N-[(1R)-1-cyclopropyl-2-hydroxyethyl]-5-[7-(methylsulfamoyl)-1-oxo-2-[(2S)-1,1,1-trifluoropropan-2-yl]-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "CHEMBL.COMPOUND:CHEMBL2375964 CHEMBL2375964 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881946 1-(3-Hydroxypropyl)-3-(3-phenylpyrido[2,3-b]pyrazin-6-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25195788 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-(2-hydroxyethyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884072 (Z)-1-(2-((4-(4-(3-methoxypyrrolidine-1-carbonyl)piperidin-1-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:136245085 2-(4-Morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177530 5-(4-(2-Chlorophenoxy)-6-morpholinopyridin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155549895 2-[[4-(4-Bromophenyl)sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798578 6-(2-Amino-1,3-benzoxazol-5-yl)-3-propan-2-ylquinazolin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44554755 2-((2-(4-chlorophenyl)-1H-indol-3-yl)methylene)-4,6-dihydroxybenzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146177570 (2-(2-Aminopyrimidin-5-yl)-6-morpholinopyridin-4-yl)(2-chlorophenyl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:24970164 2-(2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)propan-2-ol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44607180 Methyl [4-(4-Morpholin-4-yl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl]carbamate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155512189 4-[[3-[4-[4-(4-amino-2-fluorophenyl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706470 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(3-methyl-1,2-oxazol-5-yl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118500144 8-[6-[3-(Azetidin-1-yl)propoxy]pyridin-3-yl]-1-(3-hydroxycyclobutyl)-3-methylimidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706817 N-[2-methyl-6-[2-[(1-methylpyrazol-3-yl)amino]-6-(1,3-oxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118502865 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-3-methyl-1-[(3R)-oxolan-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403591 5-(3-Morpholino-5-((4-(trifluoromethoxy)phenyl)sulfonyl)phenyl) pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168295787 4-[1-(4-Fluorophenyl)-2-methylimidazo[4,5-c]quinolin-8-yl]aniline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881823 1-[3-(5-Cyanothiophen-2-yl)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168296426 4-[[2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carbonyl]amino]cyclohexane-1-carboxylic acid 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:126577433 3-[5-amino-6-(1,3-dimethylpyrazol-4-yl)pyrazin-2-yl]-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885272 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168291635 2-methyl-2-[4-[2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinolin-1-yl]phenyl]propanenitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834406 4-amino-6-[(2S)-2-[6-fluoro-5-(1-methylpyrazol-4-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884547 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(2-(dimethylamino)ethoxy)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403550 3-((3-(2-Aminopyrimidin-5-yl)-5-morpholinophenyl)sulfonyl)benzonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:11601890 5-[5-(2,4-Dihydroxyphenyl)furan-2-ylmethylene]thiazolidine-2,4-dione 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:88979889 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(aziridin-1-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834527 2-Amino-4-((2S,4S)-2-(6-fluoro-5-(2-methoxypyrimidin-5-yl)-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)-4-hydroxypyrrolidin-1-yl)-6-methylpyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:11998444 rac-2-morpholino-5-phenyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:162648518 5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118728322 2-Bromo-11-fluoro-6,7-dihydrobenzimidazolo[1,2-d][1,4]benzoxazepine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706156 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(2-methylpyridin-3-yl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173115 5-(3-Morpholino-5-(phenylsulfonyl)phenyl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488077 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:67041250 4-butyl-6-[5-(1-piperidin-4-ylpyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179718 N-(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)benzamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44181494 5-Morpholin-4-yl-3-pyridin-4-ylthieno[3,2-b]pyran-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76335785 N-[5-(7-amino-1-cyclopentyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]benzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155519431 N-hydroxy-9-[6-(6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxynonanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884526 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((2S,5R)-2,5-bis(hydroxymethyl)pyrrolidin-1-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155523062 2-[3-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxypropylamino]-N-hydroxypyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155514838 9-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxy-N-hydroxynonanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155546042 2-methoxy-1-[4-[[4-[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]pyridin-2-yl]amino]piperidin-1-yl]ethanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57798309 7-Methyl-9-(2-methylanilino)-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168270549 2-amino-N-cyclopropyl-5-[7-(methanesulfonamido)-1-oxo-2-[(2S)-1,1,1-trifluoro-3-methylbutan-2-yl]-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:56932209 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-N-(4-chlorophenyl)pyridine-3-sulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25070554 3-(9-(1-benzylpiperidin-4-yl)-6-morpholino-9H-purin-2-yl)phenol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:67285093 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-5-fluoro-3-methyl-2-(2-pyridinyl)quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122188272 N-[(E)-[5-(3,4-dimethoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51353710 N-(6-(2-(2-Fluorophenylsulfonamido)pyrimidin-4-yl)benzo-[d]thiazol-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884530 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-((R)-3-methylmorpholino)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51353707 N-(6-(2-(4-Methoxyphenylsulfonamido)pyrimidin-4-yl)benzo[d]thiazol-2-yl)acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706316 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(3-methylimidazol-4-yl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885274 1-(4-(4,6-Di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(piperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798473 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[4-(2-hydroxyethyl)piperazin-1-yl]methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:122179713 N-(3-methylphenyl)-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-9-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:66558056 8-[(2R)-(1-(3-fluorophenyl)pyrrolidin-2-yl)]-6-(morpholine-4-carbonyl)-2-morpholino-4H-chromen-4-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227579 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-(pyridin-4-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232760 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488071 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(6-(2-morpholinoethoxy)pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168286870 4-[4-[2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinolin-1-yl]phenyl]morpholine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155531582 4-[[3-[4-[6-[6-amino-4-(trifluoromethyl)pyridin-3-yl]-2-morpholin-4-ylpyrimidin-4-yl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:88971162 N-[6-(4-pyridin-4-ylquinolin-6-yl)-1,3-benzothiazol-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:156403562 5-(6-Morpholino-4-(2-(trifluoromethoxy)phenoxy)pyridin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227605 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-((4-methylpiperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798746 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(2,2-dimethylmorpholin-4-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488057 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118470236 3-[5-amino-6-(2-methyl-1,3-thiazol-5-yl)pyrazin-2-yl]-N-(2-hydroxy-2-methylpropyl)-4-methylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44181720 3-(4-Methylphenyl)-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44138092 1-(4-(4-(3,6-dihydro-2H-pyran-4-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25172275 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-methylsulfonylbenzenesulfonamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606823 6-(1H-indol-5-yl)-4-morpholin-4-yl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884156 6-hydroxy-2-((1-methyl-4-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:121334494 5-[4,6-bis[(3R)-3-ethylmorpholin-4-yl]-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798402 5-(3-Piperidin-1-ylquinoxalin-6-yl)-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25071518 (3-(6-morpholino-9-(1-(pyridin-2-ylmethyl)piperidin-4-yl)-9H-purin-2-yl)phenyl)methanol 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46225156 1-(4-(4-(3,6-dihydro-2H-pyran-4-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:139486659 5-[4,6-bis[(3S,5S)-3,5-dimethylmorpholin-4-yl]-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118523378 1-Cyclobutyl-8-[6-[3-(dimethylamino)propoxy]-2-fluoropyridin-3-yl]-3-methylimidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:25197240 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881834 1-Ethyl-3-[3-[4-(3-morpholin-4-ylpropoxy)phenyl]pyrido[2,3-b]pyrazin-6-yl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:127035981 4-[4-(4-Acetylpiperazin-1-yl)-3-(trifluoromethyl)anilino]-6-quinolin-3-ylquinoline-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76321205 N-[5-(4-morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)pyrimidin-2-yl]acetamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884404 2-((4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-4-hydroxybenzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62707451 1-Ethyl-3-[4-(4-morpholin-4-yl-6,6-dioxo-5,7-dihydrothieno[3,4-d]pyrimidin-2-yl)phenyl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884074 (Z)-N-methyl-1-(1-methyl-3-((3-oxo-5-(3-pyridin-3-ylureido)benzofuran-2(3H)-ylidene)methyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-N-(pyridin-4-ylmethyl)piperidine-4-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:117834400 4-amino-6-[(2S)-2-[5-(2-methoxypyrimidin-5-yl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155537184 2-[4-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxybutylamino]-N-hydroxypyrimidine-5-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62706155 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(1H-pyrazol-5-yl)-6-pyridin-3-ylimidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155383718 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-methyl-1-oxo-3H-isoindol-5-yl]-N-[(3R)-5-oxopyrrolidin-3-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:162653971 4-Cyclopentyl-1-[[2-(2-ethylbenzimidazol-1-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46228569 1-(4-(4,6-Dimorpholino-1,3,5-triazin-2-yl)phenyl)-3-(piperidin-1-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155551208 4-[[3-[4-[4-[6-amino-4-(trifluoromethyl)pyridin-3-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227596 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-methylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62705991 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(3-fluorophenyl)-N-(1H-pyrazol-5-yl)imidazo[1,2-a]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:146173263 5-(6-Morpholino-4-phenoxypyridin-2-yl)pyrimidin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168291959 1-[(1R)-1-(4-fluorophenyl)ethyl]-2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:62705169 1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-6,6-dioxo-5,7-dihydrothieno[3,4-d]pyrimidin-2-yl]phenyl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168283845 2-methyl-1-[(1R)-1-phenylethyl]-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885281 1-(4-(4,6-Di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(2-hydroxyethoxy)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884532 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:118535500 1-[(1S,3S)-3-methoxycyclopentyl]-3-methyl-8-[6-(3-piperidin-1-ylpropylamino)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:78320671 4-amino-6-[(2S)-2-[5-chloro-3-(2-methylphenyl)-4-oxoquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164609873 4-[6-Chloro-5-(difluoromethoxy)pyridin-3-yl]-6-[1-(cyclopropanecarbonyl)azetidin-3-yl]oxy-2,3-dihydroisoindol-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798817 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-ethylpiperazin-1-yl)methanone 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44606476 1-(4-(4-((1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-cyclopropylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168282406 1-[(1S)-1-(4-fluorophenyl)ethyl]-2-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:162645758 4-(difluoromethyl)-5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59453111 5-[2-(oxan-4-yl)ethyl]-3-[4-(1H-1,2,4-triazol-5-yl)phenyl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:51355622 1-ethyl-3-[4-[8-(2-hydroxypropan-2-yl)-7-methyl-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46883991 4-hydroxy-2-((1-methyl-4-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884540 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(2-(dimethylamino)ethoxy)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:168277245 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-7-cyclopropylsulfonyl-1-oxo-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46227615 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-(2-hydroxyethyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881853 1-Ethyl-3-[3-[(5-methylpyridin-2-yl)amino]pyrido[2,3-b]pyrazin-6-yl]urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:137650083 5-(3-amino-5-methyl-6-pyrazolo[1,5-a]pyridin-3-ylpyrazin-2-yl)-N,1-dimethyl-1,2,4-triazole-3-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:58881940 1-[3-(4-Amino-3-methoxyphenyl)pyrido[2,3-b]pyrazin-6-yl]-3-ethylurea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46885601 4,6-dihydroxy-2-((1-(2-(4-(3-hydroxypropyl)piperazin-1-yl)ethyl)-5-methoxy-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884068 (Z)-1-(2-((4-(4-(8-oxa-3-azabicyclo[3.2.1]octane-3-carbonyl)piperidin-1-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:57391362 1-[(4-Fluorophenyl)methyl]-7-morpholin-4-ylimidazo[1,2-a]pyrimidin-5-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:71451228 3-amino-N-methyl-6-[3-(trifluoromethyl)phenyl]pyrazine-2-carboxamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155512340 8-[6-(5-fluoro-6-methoxypyridin-3-yl)-4-methylquinazolin-8-yl]oxy-N-hydroxyoctanamide 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:155541479 4-[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]-N-(1-methylsulfonylpiperidin-4-yl)pyridin-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46884067 (Z)-1-(2-((1-methyl-4-(4-(morpholine-4-carbonyl)piperidin-1-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:166632376 methyl (2Z)-2-[(2Z)-4-oxo-3-phenyl-2-[(E)-[4-(2,2,2-trifluoroethoxy)phenyl]methylidenehydrazinylidene]-1,3-thiazolidin-5-ylidene]acetate 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:70798861 5-[3-[4-(2,2,2-Trifluoroethyl)piperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:50939865 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-3-methyl-2-phenylquinoline 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:44156157 1-(4-(4-(3,6-dihydro-2H-pyran-4-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(2-fluoroethyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:45488058 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-(2-hydroxyethyl)phenyl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:164612865 6-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-4-yl]-4-(2-methylpyrimidin-5-yl)-2,3-dihydroisoindol-1-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:59453121 2-[2-methyl-4-(1H-1,2,4-triazol-5-yl)phenyl]-8-[2-(oxan-4-yl)ethyl]-5,7-dihydropyrazino[2,3-b]pyrazin-6-one 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:46232803 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1,4-dioxaspiro[4.5]decan-8-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(pyridin-4-yl)urea 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:50938829 4-(1-(7-Fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-6-methyl-2-pyrimidinamine 3.2392219386070445e-05 0.436539\n",
      "PUBCHEM.COMPOUND:76332568 N-[5-(2-amino-3-phenyl-quinoxalin-6-yl)-2-methoxy-3-pyridyl]-2,4-difluoro-benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57405485 N-[5-(2-amino-4-oxo-3-phenylquinazolin-6-yl)-2-methoxypyridin-3-yl]pyridine-3-sulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57545876 2,4-difluoro-N-[2-methoxy-5-[4-(4-morpholinyl)-6-quinazolinyl]-3-pyridinyl]Benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57406164 N-[5-(2-amino-4-oxo-3-phenyl-quinazolin-6-yl)-2-methoxy-3-pyridyl]-2,4-difluoro-benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470182 US10112926, Example 40 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118611725 (3S)-4-(2-aminothieno[2,3-d]pyrimidin-4-yl)-N-(4-methoxy-2-methylphenyl)-3-methylpiperazine-1-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145964752 4-(5-amino-2-phenyl-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)piperazine-1-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:134153378 5-[6-chloro-8-[(2-ethylpyridin-4-yl)methylamino]-2-methylimidazo[1,2-b]pyridazin-3-yl]-2-methoxy-N-prop-2-ynylbenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470015 US10112926, Example 19.18 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121452663 N-[5-[3-[(4-hydroxy-2-methylphenyl)sulfamoyl]-4-methoxyphenyl]-4-methyl-1,3-thiazol-2-yl]-2-(oxan-4-yl)acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118472770 US10112926, Example 19.8 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145978007 (3S)-4-(6-amino-[1,2]thiazolo[5,4-d]pyrimidin-4-yl)-N-(4-methoxy-2-methylphenyl)-3-methylpiperazine-1-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118469825 US10112926, Example 19.17 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470358 US10112926, Example 94b 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:126512348 US10112926, Example 19.11 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470290 US10112926, Example 19.20 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121452668 5-[2-(tert-butylamino)-4-methyl-1,3-thiazol-5-yl]-N-(4-hydroxycyclohexyl)-2-methoxybenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470189 US10112926, Example 73 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118469981 US10112926, Example 19.15 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470194 US10112926, Example 37.35 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470173 US10112926, Example 19.1 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470053 US10112926, Example 37.38 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470699 US10112926, Example 71 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470014 US10112926, Example 42 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121452711 3-cyclopentyl-N-[5-[4-methoxy-3-(piperidin-4-ylsulfamoyl)phenyl]-4-methyl-1,3-thiazol-2-yl]propanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470442 US10112926, Example 104.7 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118469844 US10112926, Example 37.32 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118472663 US10112926, Example 103b 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470497 US10112926, Example 62 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470009 US10112926, Example 43 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118470025 US10112926, Example 58 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53318295 4-amino-2,6-dimethyl-N-(1H-pyrazol-4-yl)quinazoline-8-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11998565 5,5-dimethyl-2-(3-(naphthalen-1-ylmethyl)morpholino)-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59293721 CID 59293721 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155556124 4-[[5-(1H-indazol-4-yl)-1,3,4-oxadiazol-2-yl]methyl]morpholine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:23642272 6,6-dimethyl-2-morpholino-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53316658 4-amino-2-methyl-N-(1H-pyrazol-4-yl)quinazoline-8-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46891472 N-(2-(dimethylamino)ethyl)-4-(3-(2-((5-methoxy-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)ureido)-N-methylbenzamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502921 8-[6-[3-(Dimethylamino)propoxy]pyridin-3-yl]-3-methyl-1-(4-methyloxan-4-yl)imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50992385 2-(1H-Indol-4-yl)-4-morpholin-4-yl-8-morpholin-4-ylmethyl-pyrido[3',2':4,5]furo[3,2-d]pyrimidine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003711 2-amino-N-[(1S)-1-[5-ethynyl-3-(4-fluorophenyl)-4-oxoquinazolin-2-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:139340129 N-[2-[[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]ethyl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118503217 3-methyl-8-[6-[3-(methylamino)propoxy]pyridin-3-yl]-1-[(3S)-oxan-3-yl]imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798562 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3-methylpiperazin-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548403 4-(3-(6-Methoxypyridin-3-ylamino)pyrazin-2-yl)-6-methyl-1,3,5-triazin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25172272 5-bromo-N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethylbenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164622772 N-[5-[6-(6-ethynylpyridin-3-yl)-1-oxo-2,3-dihydroisoindol-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71037639 5-[3-[2-(4-Methylpiperazin-1-yl)pyridin-4-yl]imidazo[1,2-a]pyridin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155513047 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-2-methoxy-N-methylacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164609860 4-(3-Hydroxyphenyl)-6-(3-phenylpropylamino)-2,3-dihydroisoindol-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53348185 2-[[4-Amino-3-(3-hydroxyprop-1-ynyl)indazol-1-yl]methyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164615772 4-(3-Fluoro-5-hydroxyphenyl)-6-(3-phenylpropylamino)-2,3-dihydroisoindol-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:149242889 2-(4-Methylphenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122181414 1-[4-[3-[5-Amino-6-(benzotriazol-1-yl)pyrazin-2-yl]pyrazol-1-yl]piperidin-1-yl]-2-(dimethylamino)ethanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44605247 methyl 4-(6-(4-(3-(4-(2-(4-methylpiperazin-1-yl)ethyl)phenyl)ureido)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44599203 1-{4-[7-(2,2,2-trifluoroethyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25171855 N-[(E)-(5-chloropyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51601993 9-[(1R)-1-anilinoethyl]-7-methyl-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71526877 (2R)-2-amino-1-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]propan-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49854572 (2S,3S)-1-N-(8-tert-butyl-4,5-dihydro-[1,3]thiazolo[4,5-h]quinazolin-2-yl)-3-[(dimethylamino)methyl]pyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53326637 2-(Morpholin-4-yl)[4,5'-bipyrimidin]-2'-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50991239 5-[3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003503 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-[(E)-prop-1-enyl]isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44125376 n-(5-(2-Aminoimidazo[1,2-a]pyridin-6-yl)-2-chloropyridin-3-yl)-4-fluorobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58205016 (2S)-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yloxy)propanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:142752517 US10961236, Example 61 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155513410 4-[[3-[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-yl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidine-7-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25266674 N-(2-chloro-5-phenyl-3-pyridinyl)benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577641 6,6-dimethyl-2-(6-(pyrimidin-2-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70693798 4-(4-chlorophenyl)-2-morpholin-4-yl-5-(1H-1,2,4-triazol-5-yl)thiophene-3-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71533728 PI4KIIIbeta-IN-9 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004207 N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]-1,6-naphthyridine-8-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004306 2-amino-N-[(1S)-1-[2-(3-methylphenyl)-8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76317571 7-amino-1-cyclopentyl-5-methyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1,6-naphthyridin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46225158 1-(4-(4-(3,6-dihydro-2H-pyran-4-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-phenylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155555 3-amino-6-[4-chloro-3-[(3-methoxyphenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49835108 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(5-fluoro-6-methoxypyridin-3-yl)imidazo[1,2-a]pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44180626 N-(4-(5-morpholino-7-oxo-7H-thieno[3,2-b]pyran-3-yl)phenyl)nicotinamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46227820 (3-(1-(1-benzylpiperidin-4-yl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)methanol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:137635072 4-[5-(4-Amino-5-chloropyrrolo[2,1-f][1,2,4]triazin-7-yl)-2-methoxyphenyl]-2,2-dimethylmorpholin-3-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122188252 N-[(E)-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-N-methyl-3-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57398391 1-(2-Methylbenzyl)-7-morpholinoimidazo[1,2-a]pyrimidin-5(1H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548226 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-methylpyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:149169124 2-(4-Chloro-3-nitrophenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46891468 1-(2-((7-fluoro-5-methoxy-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004067 N-[(1S)-1-[8-[2-(1-acetylpiperidin-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]-2-aminopyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798654 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-(4-methylpiperazin-1-yl)azetidin-1-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "CHEBI:186721 CAY10626 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:139340172 N'-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-N-methylethane-1,2-diamine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122178112 2,4-difluoro-N-[2-methoxy-5-(4-pyridin-4-ylcinnolin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46891423 1-(2-((5-methoxy-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11998448 rac-5-methyl-2-morpholino-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44600956 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}phenyl)-3-(4-fluorophenyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155526323 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-N-methylacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25032306 2-[4-[2-Amino-6-(5-fluoro-6-methoxypyridin-3-yl)-4-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]cyclohexyl]oxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:67285457 (1-(7-Fluoro-3-methyl-2-(pyridin-2-yl)quinolin-4-yl)-6-morpholinoindoline-3,3-diyl)dimethanol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25172065 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-(trifluoromethyl)benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:89819869 (9,10-Dihydroxy-4,4,11c-trimethyl-1,2,3,4a,5,6-hexahydronaphtho[2,1-b][1]benzofuran-8-yl)boronic acid 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:66788911 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(5-fluoro-6-methoxypyridin-3-yl)-6-(4-propan-2-ylpiperazin-1-yl)imidazo[1,2-a]pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:90232848 2-[(1S)-1-[[6-amino-5-[2-[4-(hydroxymethyl)pyridin-2-yl]ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70689027 5-[3-Bromo-2-[(4-methylsulfonylpiperazin-1-yl)methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46891473 1-(2-((7-fluoro-5-methoxy-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(4-(morpholine-4-carbonyl)phenyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798603 N-[5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155550309 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-2-methoxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44129275 (2S)-1-N-[5-(2-cyclobutyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:66788776 4-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-2-[(6-methoxypyridin-3-yl)amino]imidazo[1,2-a]pyridin-6-yl]-N,N-dimethylpiperazine-1-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50992384 US9580442, Example J 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44181601 3-(1,3-Benzodioxol-5-yl)-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25195572 1-{4-[1-(1-benzylpiperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl}-3-phenylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:16066756 Imidazo[1,2-a]pyridine derivative, 12 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46891470 1-(2-((5-methoxy-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(4-(morpholine-4-carbonyl)phenyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:162651382 4-(difluoromethyl)-5-[4-morpholin-4-yl-6-[(1S,5R)-3-oxa-8-azabicyclo[3.2.1]octan-8-yl]-1,3,5-triazin-2-yl]pyrimidin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003587 2-amino-N-[(1S)-1-[2-methyl-8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:149370890 2-[[4-(2,5-Dimethylphenyl)sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:66790335 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(5-fluoro-6-methoxypyridin-3-yl)-6-piperazin-1-ylimidazo[1,2-a]pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:67073110 4-(2,4-dichlorophenyl)-2-morpholin-4-yl-5-(2H-[1,2,4]triazol-3-yl)thiophene-3-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11998690 2-(2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141406399 2-(4-Nitrophenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51351159 1-[4-fluoranyl-2-(trifluoromethyl)phenyl]-9-(1~{H}-pyrazol-4-yl)benzo[h][1,6]naphthyridin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121259362 2-amino-N-[(1S)-1-[5-[2-(1-methylpyrazol-4-yl)ethynyl]-3-phenylquinolin-2-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71527005 [4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-[(2S)-pyrrolidin-2-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49853889 CID 49853889 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798521 5-[3-(3-Morpholin-4-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577951 5,5-dimethyl-2-(6-(1-methyl-1H-pyrazol-4-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003486 2-amino-N-[[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]methyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76287126 2-[(1S)-1-[[6-amino-5-(2-pyridin-2-ylethynyl)pyrimidin-4-yl]amino]ethyl]-5-methyl-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50991007 2-(1H-Indol-4-yl)-4,8-di-morpholin-4-yl-pyrido[3',2':4,5]furo[3,2-d]pyrimidine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71270948 3-(2-methyl-3-(trifluoromethyl)benzyl)-5-(tetrahydro-2H-pyran-4-yl)pyrazolo[1,5-a]pyrimidine-2,7-diol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:137649696 6-[2-[[4-amino-3-(3-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-3-[(2-chlorophenyl)methyl]-4-oxoquinazolin-5-yl]-N-[2-(2-methoxyethoxy)ethyl]hex-5-ynamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:67094333 1-ethyl-3-[4-[9-methyl-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155535273 2-[3-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxypropyl-methylamino]-N-hydroxypyrimidine-5-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003617 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-(2-pyridin-3-ylethynyl)isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:52940982 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(3,4-dimethoxyphenyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145955670 (2S)-2-amino-N-[5-[5-[(4-tert-butylphenyl)sulfonylamino]-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754230 US10961236, Example 58 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548460 4-(5-Chloro-2-(6-methoxypyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164626558 N-[2-chloro-5-(4-piperidin-1-ylcinnolin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46884282 4-hydroxy-2-((4-(4-(4-(2-hydroxyethyl)piperazine-1-carbonyl)piperidin-1-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)benzofuran-3(2H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155472 3-amino-6-[4-fluoro-3-(phenylsulfamoyl)phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:67284515 1-(7-fluoro-3-methyl-2-pyridin-2-ylquinolin-4-yl)-6-morpholin-4-ylspiro[2H-indole-3,4'-oxane] 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754134 (S)-N-(6-((5-(2-(1-Cyclopropylethyl)-7-(N-methylsulfamoyl)-1-oxoisoindolin-5-yl)-4-methylthiazol-2-yl)amino)pyridin-2-yl)-N-ethyl-2-methoxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155558262 N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-4-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754224 US10961236, Example 30 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71272765 3-(2,3-Dichlorobenzyl)-5-(pyridin-4-yl)-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-7-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71584055 4-[2-(1H-indol-4-yl)-6-(2-methylsulfonylpropan-2-yl)pyrimidin-4-yl]morpholine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44600010 N-[2-(Dimethylamino)ethyl]-4-({[4-(7-ethyl-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl)phenyl]carbamoyl}amino)benzamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:66780844 4-[(3-chloro-2-methylphenyl)methyl]-2-(4-morpholinyl)[1,3]thiazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11428504 7-Methyl-9-[(2-methylphenyl)methylamino]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577953 6,6-dimethyl-2-(6-methyl-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155560688 2-[[4-(4-Nitrophenyl)sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003485 2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]propyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:136088614 US10172858, Table 2.37 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59239165 Gdc-0349 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71251006 2,4-difluoro-N-[3-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]phenyl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118446704 2-amino-N-[(1S)-1-[8-[2-(1H-imidazol-5-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46884353 1-(3-((4-hydroxy-3-oxobenzofuran-2(3H)-ylidene)methyl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)piperidine-4-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44233389 Pyrazolo pyrimidine, 21 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155383503 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-1-oxo-7-(trifluoromethoxy)-3H-isoindol-5-yl]-N-(4-hydroxy-4-methylcyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76335786 N-[5-(7-amino-1-cyclopentyl-5-methyl-2-oxo-1,6-naphthyridin-3-yl)-2-methoxypyridin-3-yl]-4-cyanobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:162668873 4-(Cyclopropanecarbonyl)-1-[[2-(2-ethylbenzimidazol-1-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:134132909 tert-butyl (3R)-3-[6-(3,4-dimethoxyphenyl)quinazolin-4-yl]oxypyrrolidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164608868 N-[2-chloro-5-(4-pyrrolidin-1-ylcinnolin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44552844 2-((1-(3-(dimethylamino)propyl)-5-methoxy-2-methyl-1H-indol-3-yl)methylene)-4,6-dihydroxybenzofuran-3(2H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49785344 N-(5-{[3-(4-Amino-6-Methyl-1,3,5-Triazin-2-Yl)-5-(Tetrahydro-2h-Pyran-4-Yl)pyridin-2-Yl]amino}-2-Chloropyridin-3-Yl)methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122179689 7-methyl-9-[1-(N-methylanilino)ethyl]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:66580799 Roginolisib 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548196 4-(2-(6-Methoxypyridin-3-ylamino)-5-(pyrrolidin-1-ylmethyl)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155383522 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-(difluoromethoxy)-1-oxo-3H-isoindol-5-yl]-N-[(1R)-1-cyclopropyl-2-hydroxyethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155528904 5-(6-Amino-4-ethyl-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754177 US10961236, Example 26 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798747 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-(3,3-dimethylpiperazin-1-yl)azetidin-1-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44578108 2-(3-((1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)morpholino)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25052783 6,6-dimethyl-2-(6-(1-methyl-1H-pyrazol-4-yl)-2H-benzo[b][1,4]oxazin-4(3H)-yl)-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70682592 (2S)-1-N-[4-methyl-5-[4-methylsulfonyl-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141406400 2-(4-Bromophenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:78321635 4-amino-6-[(2S)-2-[5-chloro-3-(oxan-4-yl)-4-oxoquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:134140420 6-(3,4-dimethoxyphenyl)-4-[(3S)-1-methylpyrrolidin-3-yl]oxyquinazoline 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004007 2-amino-N-[(1S)-1-[8-(3-hydroxyprop-1-ynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577594 2-(6-Bromo-2H-benzo[b][1,4]oxazin-4(3H)-yl)-6,6-dimethyl-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798516 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3R)-3-fluoropyrrolidin-1-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:156767722 N-[2-chloro-5-[4-(4-methylpiperidin-1-yl)cinnolin-6-yl]pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798579 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-aminopiperidin-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11345433 Heptanamide, 7-mercapto-N-3-pyridinyl- 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57410062 4-[2-(4-Bromo-2,3-dihydroindol-1-yl)-2-oxoethyl]-2-morpholin-4-yl-1,3-thiazole-5-carboxylic acid 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754196 US10961236, Example 63 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004006 2-amino-N-[(1S)-1-[2-cyclopropyl-8-(2-cyclopropylethynyl)-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49854024 N-(3-bromo-4-fluorophenyl)-2-[1-methyl-4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49835172 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(5-fluoro-6-methoxypyridin-3-yl)-6-[4-(2-methoxyethyl)piperazin-1-yl]imidazo[1,2-a]pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53387410 N-(2-chloro-5-imidazo[1,2-b]pyridazin-6-ylpyridin-3-yl)-4-fluorobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53319932 5-(pyridin-4-yl)-1H-pyrrolo[2,3-b]pyridine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50992286 2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3',2':4,5]thieno[3,2-d]pyrimidine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57395409 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-methyl-5-nitro-2-propan-2-ylbenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46180663 4-[6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl]-phenylamine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46206784 1-{4-[7-(2,2-dimethoxyethyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798440 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(1-methylazetidin-3-yl)quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46865885 1-(4-(4,6-Di(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:142527967 O-[2-[2-[2-[2-[[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]ethoxy]ethoxy]ethoxy]ethyl]hydroxylamine 4.3189392678442804e-05 0.421239\n",
      "CHEBI:188618 1-Isopropyl-3-(3-pyridinylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25032391 2-[4-[2-Amino-6-(2-methoxypyrimidin-5-yl)-4-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]cyclohexyl]oxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71037751 6-methyl-5-[3-[(3S)-3-methylpiperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:139340126 3-[[4-[2-(Difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]propanoic acid 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71271910 3-(2,3-dichlorobenzyl)-5-(tetrahydro-2H-pyran-4-yl)-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-7-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44605038 methyl 4-(6-{4-[(anilinocarbonyl)amino]phenyl}-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155531296 9-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxy-N-hydroxynonanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:78320362 4-amino-6-[(2S,4S)-2-(5-chloro-4-oxo-3-phenylquinazolin-2-yl)-4-methoxypyrrolidin-1-yl]pyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121334509 4-(Difluoromethyl)-5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:56833542 5-[4-Morpholin-4-yl-6-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]thieno[2,3-d]pyrimidin-2-yl]pyrimidin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798397 5-(4-Morpholin-4-ylquinolin-6-yl)-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003584 (S)-2-amino-N-(1-(5-((1,5-dimethyl-1H-pyrazol-4-yl)ethynyl)-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798816 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-methyl-1,4-diazepan-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164619087 N-[2-chloro-5-[4-(6-morpholin-4-ylpyridin-3-yl)cinnolin-6-yl]pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:6852165 2-((9H-Purin-6-ylthio)methyl)-5-chloro-3-(2-methoxyphenyl)quinazolin-4(3H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:162371678 2,4-difluoro-N-[2-methoxy-5-(7-morpholin-4-yl-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155522042 2-[4-(Trifluoromethyl)phenyl]sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155565763 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-2-methoxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:52942879 1-[4-[4-Morpholin-4-yl-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]phenyl]-3-(6-pyridin-3-ylpyridin-3-yl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50992291 (E)-3-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-8-yl]-N,N-dimethylacrylamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53387411 N-(2-chloro-5-imidazo[1,2-a]pyridin-6-ylpyridin-3-yl)-4-fluorobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155383870 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-(methanesulfonamido)-1-oxo-3H-isoindol-5-yl]-N-[4-hydroxy-4-(trifluoromethyl)cyclohexyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76286976 5-chloro-2-[(1S)-1-[[2,6-diamino-5-(2-phenylethynyl)pyrimidin-4-yl]amino]ethyl]-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164615071 N-[2-chloro-5-[4-(4-morpholin-4-ylphenyl)cinnolin-6-yl]pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155548518 N-[(3S)-1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121259366 2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-2-phenylquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:56680186 N-(2-chlorophenyl)-N-methyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502485 8-(2-Aminopyrimidin-5-yl)-1-cyclopropyl-3-methylimidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:24955795 2-(7-bromo-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577919 2-(6-(1H-imidazol-5-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-6,6-dimethyl-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59606100 2-[4-[[2-(2-Ethylbenzimidazol-1-yl)-9-methyl-6-morpholin-4-ylpurin-8-yl]methyl]piperazin-1-yl]-2-methylpropanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118630853 6-methyl-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)ethyl]quinolizin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44181603 5-Morpholin-4-ylthieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4868231 CHEMBL4868231 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798399 5-[4-(2-Morpholin-4-ylethylamino)quinolin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141406390 2-(3-Nitrophenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44605426 isopropyl 4-[6-(4-{[(2-fluoroethyl)carbamoyl]amino}phenyl)-4-morpholin-4-yl-1Hpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:67050788 (2S)-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-ylamino)propanamide 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4871213 CHEMBL4871213 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44605039 Methyl 4-(6-(4-(3-(4-(2-hydroxyethyl)phenyl)ureido)phenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44232917 Pyrazolo pyrimidine, 12 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76328473 N-[5-(2-amino-4-methylquinazolin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:86272625 5-fluoro-2-[(1S)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)ethyl]-3-[4-(2,2,2-trifluoroethoxy)phenyl]quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44552846 4,6-dihydroxy-2-((1-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)-5-methoxy-2-methyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:146267141 Vulolisib 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50991237 5-[4-(1-Methylpiperidin-4-yl)oxyquinazolin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49854365 (2S)-1-N-[7-(cyclopropylmethyl)-4,5-dihydro-[1,3]thiazolo[5,4-e][1,3]benzothiazol-2-yl]pyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53348183 2-[[4-Amino-3-(4-fluoro-3-hydroxyphenyl)indazol-1-yl]methyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44233640 Pyrazolo pyrimidine, 25 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44600955 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}phenyl)-3-pyridin-4-ylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25171856 N-[(E)-(5-bromopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:137647765 4-[5-[4-Amino-5-(trifluoromethyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]-2-methoxyphenyl]-2,2-dimethylmorpholin-3-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164886635 6-(4,6-Dimorpholino-1,3,5-triazin-2-yl)benzo[d]oxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25032390 2-[4-[2-Amino-4-methyl-6-(1-methylpyrazol-4-yl)-7-oxopyrido[2,3-d]pyrimidin-8-yl]cyclohexyl]oxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164886637 PI3K|A/|A-IN-3 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145959196 2-amino-N-[5-[5-(benzenesulfonamido)-6-oxo-1H-pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:166633512 4-[2-(difluoromethyl)benzimidazol-1-yl]-N,N-bis(2-methoxyethyl)-6-morpholin-4-yl-1,3,5-triazin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118498727 1-(3-Methoxycyclobutyl)-3-methyl-8-[6-[3-(methylamino)propoxy]pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76335782 7-amino-1-cyclopentyl-3-(1H-imidazo[4,5-b]pyridin-6-yl)-5-methyl-1,6-naphthyridin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71041960 25-Methoxy-22,22-dioxo-3,11,22lambda6-trithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10(30),12,17(29),18,20,24,26-dodecaen-16-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155565845 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:146263441 N-[2-methoxy-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]phenyl]pyridine-3-sulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004302 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-(2-piperidin-4-ylethynyl)isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155515047 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-2-methoxy-N-methylacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:88979843 5-[3-[(3S)-3-methylpiperazin-1-yl]quinoxalin-6-yl]-1,3-benzothiazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155554 3-amino-6-[4-chloro-3-[(3-fluorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548220 1-[[5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]methyl]piperidin-4-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754238 US10961236, Example 14 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25170003 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-2-fluoro-N-methyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71450452 N-[4-methyl-5-(2-methylsulfonyl-1,3-oxazol-5-yl)-1,3-thiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:124194873 US9758538, Example 40 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59258852 2-Amino-8-cyclobutyl-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:166631371 2-[[4-[2-(Difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-[2-(methylamino)ethyl]amino]ethanol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118547302 Ethyl 4-(7-oxo-5-thiomorpholin-4-ylthieno[3,2-b]pyran-3-yl)benzoate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003719 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-[2-(1,3-thiazol-2-yl)ethynyl]isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003569 2-amino-N-[(1S)-1-[8-[2-(2-methyl-1,3-thiazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:134366712 US10961236, Example 38 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004027 2-amino-N-[(1S)-1-[1-oxo-8-[2-(oxolan-3-yl)ethynyl]-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122188249 N-[(E)-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155378 3-amino-6-[4-chloro-3-(phenylsulfamoyl)phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164609502 N-[2-methoxy-5-(6-methoxy-1-oxo-2,3-dihydroisoindol-4-yl)pyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:86727670 (3S)-1-[4-[5-[5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-methyl-1,2,4-triazol-3-yl]-1-piperidyl]-3-hydroxy-butan-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145980560 4-(Difluoromethyl)-5-[4-morpholin-4-yl-6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1,3,5-triazin-2-yl]pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44554915 4,6-dihydroxy-2-((5-methoxy-2-methyl-1-(3-(4-methylpiperazin-1-yl)propyl)-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59251991 (2S)-1-N-[6-[6-amino-5-(trifluoromethyl)pyridin-3-yl]-1,3-benzothiazol-2-yl]pyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003712 2-amino-N-[(1S)-1-[3-(3,4-difluorophenyl)-5-ethynyl-4-oxoquinazolin-2-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754207 US10961236, Example 50 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145960112 (2S)-2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylpentanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44129200 (2S)-1-N-[4-methyl-5-(2-pyridin-3-yl-1,3-thiazol-4-yl)-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164620024 N-[2-chloro-5-(4-pyridin-4-ylcinnolin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58507929 CID 58507929 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44514481 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-ethylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57400580 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-6-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:52942850 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-p-tolylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155536179 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-2-methoxy-N-methylacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:124193953 US9758538, Example 34 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798380 5-[3-(2-Cyclopropylethynyl)imidazo[1,2-a]pyridin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50991102 3-{4-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-8-ylmethyl]-piperazin-1-yl}-propionitrile 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4789747 CHEMBL4789747 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164613397 N-[5-[6-[(3R)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]oxy-1-oxo-2,3-dihydroisoindol-4-yl]-2-methylpyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155565715 7-(1H-indol-4-yl)isoquinoline 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548284 4-(5-((2-Methoxyethylamino)methyl)-2-(6-methoxypyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25109378 (3-(2-(2-Aminopyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798396 1-[6-(2-Amino-1,3-benzoxazol-5-yl)quinazolin-4-yl]piperidin-4-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003498 2-amino-N-[(1S)-1-[5-[2-(2-methyl-1,3-thiazol-4-yl)ethynyl]-4-oxo-3-phenylquinazolin-2-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:78321314 4-amino-6-[(2S)-2-(5-chloro-3-morpholin-4-yl-4-oxoquinazolin-2-yl)pyrrolidin-1-yl]pyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:86727663 1-(4-(5-(5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-methyl-1H-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25121551 4-[6-(3,4-Dimethoxyphenyl)imidazo[1,2-b]pyridazin-3-yl]benzamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754241 US10961236, Example 23 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:72163952 1-ethyl-3-[4-[8-(2-hydroxypropan-2-yl)-9-methyl-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71528725 CID 71528725 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:90232725 2-[(1S)-1-[[5-[2-(3-acetylphenyl)ethynyl]-6-aminopyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164623334 6-[5-[[(2S,6R)-2,6-dimethylmorpholin-4-yl]methyl]-1,3,4-oxadiazol-2-yl]-4-(3-fluoro-5-hydroxyphenyl)-2,3-dihydroisoindol-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58204651 3-methyl-2-(2-(1-(2,2,2-trifluoroethyl)-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yloxy)butanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122181415 1-[4-[4-[5-Amino-6-(benzotriazol-1-yl)pyrazin-2-yl]triazol-2-yl]piperidin-1-yl]-2-(dimethylamino)ethanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121334446 CID 121334446 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502490 1-cyclopropyl-3-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60151277 8-(6-Methoxypyridin-3-yl)-3-methyl-1-piperidin-4-ylimidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004300 2-amino-N-[(1S)-1-[1-oxo-8-(3-oxoprop-1-ynyl)-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:134366762 US10961236, Example 39 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004062 2-amino-N-[(1S)-1-(4-oxo-3-phenyl-5-prop-1-ynylquinazolin-2-yl)ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:56833541 5-[6-[(4-Methylpiperazin-1-yl)methyl]-4-morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl]pyrimidin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145956725 (2R)-2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:78323193 2-amino-4-[(2S)-2-[4-oxo-3-phenyl-5-(trifluoromethyl)quinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46886410 (3-(2-(2-Aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)phenyl)(4-methylpiperazin-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71549093 PI4KIIIbeta-IN-10 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44125256 N-(5-(2-aminoimidazo[1,2-b]pyridazin-6-yl)-2-chloropyridin-3-yl)-4-fluorobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44181718 3-(4-Methylsulfonylphenyl)-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57402387 5-cyano-N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethylbenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577922 6,6-dimethyl-2-(6-(2-methyl-1H-imidazol-4-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155561726 8-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxy-N-hydroxyoctanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155527176 N-hydroxy-9-[6-[5-(methanesulfonamido)-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxynonanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:134367002 US10961236, Example 25 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004019 2-amino-N-[(1S)-1-[8-[2-(2-methoxypyrimidin-5-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53326214 4-amino-2,6-dimethyl-N-(6-methylpyridin-3-yl)quinazoline-8-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004056 2-amino-N-[1-(2-phenyl-8-prop-1-ynylquinolin-3-yl)ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003814 2-amino-N-[(1S)-1-[2-cyclopropyl-8-[2-(3-methylimidazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44181724 3-(1H-indol-5-yl)-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754133 US10961236, Example 6 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118721840 2-[[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]carbamoylamino]-N-(2,2,2-trifluoroethyl)acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155538609 N-(2-amino-2-oxoethyl)-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-4-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:136627149 5-[3-(1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004028 2-amino-N-[(1S)-1-[8-[2-(4-methyl-1,3-thiazol-5-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155531257 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155532540 4-[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]-N-(oxan-4-ylmethyl)pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003832 2-amino-N-[(1S)-1-[8-[2-(5-methyl-1,3-thiazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798384 5-[3-[6-(4-Methylpiperazin-1-yl)pyridin-3-yl]imidazo[1,2-a]pyridin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:45488032 1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-ethyl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(4-(aminomethyl)phenyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:42630822 (2S,3S)-1-N-[5-(2-tert-butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]-3-methylpyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:52948007 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-cyanophenyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122181419 1-[4-[5-[5-Amino-6-(benzotriazol-1-yl)pyrazin-2-yl]-1-methylpyrazol-3-yl]piperidin-1-yl]-2-(dimethylamino)ethanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798404 5-[4-[2-(4-Methylpiperazin-1-yl)pyridin-4-yl]quinolin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155515734 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-2-methoxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118341844 2-[4-[[6-(3-Hydroxyphenyl)quinazolin-4-yl]amino]phenyl]acetonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754175 US10961236, Example 15 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76287127 2-[(1S)-1-[[6-amino-5-[2-(6-aminopyridin-2-yl)ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11998445 2-(morpholin-4-yl)-6,7-dihydro-4H-spiro[1,3-benzothiazole-5,1''-cyclohexane]-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754197 US10961236, Example 11 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44599206 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-{4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44600166 1-[4-(7-Ethyl-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl)phenyl]-3-[4-(piperazin-1-ylcarbonyl)phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004016 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-(2-pyridin-4-ylethynyl)isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502895 1-(3-Methoxycyclobutyl)-3-methyl-8-[6-(3-piperidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:89034380 1-[2-(1H-imidazol-5-yl)ethyl]-3-[6-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:138668243 2-[4-[4-(2-Aminopyrimidin-5-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71528727 (2S)-2-amino-1-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]propan-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141406394 2-(4-Tert-butylphenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754226 US10961236, Example 17 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:86272148 (S)-2-(1-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)propyl)-5-fluoro-3-(3-(2,2,2-trifluoroethyl)phenyl)quinazolin-4(3H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25109202 5-(4-Morpholino-thieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:42623219 6-(5-(Methylsulfonyl)pyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:166631882 N-[(4,5-dimethoxy-2-nitrophenyl)methyl]-2,4-difluoro-N-[2-methoxy-5-[4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155538990 2-[[4-(4-Fluorophenyl)sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118728330 2,11-Dibromo-6,7-dihydrobenzimidazolo[1,2-d][1,4]benzoxazepine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49835106 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(6-methoxypyridin-3-yl)imidazo[1,2-a]pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50992382 [2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-8-ylmethyl]-dimethyl-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155510913 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004023 2-amino-N-[(1S)-1-[8-[2-(oxan-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50992290 US9580442, Example F 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155567318 4-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxy-N-hydroxybutanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754144 US10961236, Example 44 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44621452 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-benzylpyridine-3-sulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76287718 2-[(1S)-1-[[6-amino-5-(2-pyridin-2-ylethynyl)pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44545849 1-{4-[4-Morpholin-4-yl-7-(2-oxoethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577592 5,5-dimethyl-2-(6-(pyridin-2-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:42623385 N-(5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)pyridin-3-yl)-4-chlorobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44475989 2-{[3-(2-Methoxyphenyl)-4-Oxo-3,4,5,6,7,8-Hexahydroquinazolin-2-Yl]sulfanyl}-N-Quinoxalin-6-Ylacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004012 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-(2-pyridin-2-ylethynyl)isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44129042 (2S,4R)-1-N-[5-(2-tert-butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]-4-hydroxypyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71272757 4-[2-methyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-7-oxo-1H-pyrazolo[1,5-a]pyrimidin-5-yl]morpholin-3-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71716799 2-[[2-Methyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-5-(oxan-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl]amino]ethanol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25071206 5-(9-(1-(4-chlorobenzyl)piperidin-4-yl)-6-morpholino-9H-purin-2-yl)pyridin-3-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003585 2-amino-N-[(1S)-1-[2-(3-fluorophenyl)-8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118720611 N,N-dimethyl-4-[6-(1H-pyrrolo[2,3-b]pyridin-4-yl)imidazo[1,2-b]pyridazin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:137654937 4-[4-Amino-5-(trifluoromethyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]-2-(2,2-dimethyl-3-oxomorpholin-4-yl)benzonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44129432 (2S)-1-N-[5-[2-(cyclopropylmethyl)-1,3-thiazol-4-yl]-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:162639275 N-[5-[6-[2-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-4-yl]-1-oxo-2,3-dihydroisoindol-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53323641 4-amino-2-methyl-N-(6-methylpyridin-3-yl)quinazoline-8-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155513084 N-(2-chloro-5-isoquinolin-7-ylpyridin-3-yl)methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:168282000 4-[(2S,3aS,7aS)-2-(5-fluoro-4-oxo-3-pyridin-3-ylquinazolin-2-yl)-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-2,6-diaminopyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53348181 2-[[4-Amino-3-(3-fluoro-5-hydroxyphenyl)indazol-1-yl]methyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798480 [4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004066 2-amino-N-[(1S)-1-[8-(3-methylbut-1-ynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44233639 Pyrazolo pyrimidine, 24 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44605427 isopropyl 4-(6-{4-[(cyclopropylcarbamoyl)amino]phenyl}-4-morpholin-4-yl-1Hpyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:24936051 5-(6-morpholino-9H-purin-2-yl)pyridin-3-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:134142931 1-[(3R)-3-[6-(3,4-dimethoxyphenyl)quinazolin-4-yl]oxypyrrolidin-1-yl]ethanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502493 8-[1-(3-Hydroxypropyl)pyrazol-4-yl]-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141406393 2-(2,5-Dimethylphenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118617158 2,4-difluoro-N-[2-methoxy-5-(4-oxopyrido[1,2-a]pyrimidin-7-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798518 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(2S)-2-methylpyrrolidin-1-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46884405 2-((4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-4-hydroxybenzofuran-3(2H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46227801 (3-(4-morpholino-7-(piperidin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)phenyl)methanol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754234 US10961236, Example 9 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:142752518 US10961236, Example 24 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122188280 N-[2-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)ethyl]-N,2-dimethyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003607 2-amino-N-[(1S)-1-[2-(4-methylphenyl)-8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:1627922 N-(3-(3,5-Dimethoxyphenylamino)quinoxalin-2-yl)-4-fluorobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164614311 N-[2-chloro-5-(4-ethoxycinnolin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122179490 4-[[3-(6-methoxypyridin-3-yl)phenyl]methylamino]-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798542 5-[3-(1-Methylpiperidin-4-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53162193 N-[2-(4-Chlorophenyl)ethyl]-2-[5-(quinolin-6-YL)-1,3,4-oxadiazol-2-YL]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122185870 N-[5-(2-acetamido-1,3-benzothiazol-6-yl)-2-chloropyridin-3-yl]-3-chlorobenzamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:89627788 2-[[4-[2-(Difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]ethanol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:52949940 2-Amino-8-isopropyl-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8h)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:162654812 4-(difluoromethyl)-5-[4-morpholin-4-yl-6-[(1S,5R)-8-oxa-3-azabicyclo[3.2.1]octan-3-yl]-1,3,5-triazin-2-yl]pyrimidin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46891471 1-(2-((5-methoxy-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:21595419 (1S)-2-naphthalen-2-yloxy-1-[(2S)-piperidin-2-yl]ethanol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:163196401 PI3K-IN-29 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:75593275 2-[(1S)-1-[[6-amino-5-[2-(5-aminopyridin-2-yl)ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118711367 1-(4-Chlorophenyl)-3-[4-[4-[3-(diethylamino)propylamino]thieno[3,2-d]pyrimidin-2-yl]phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122178126 5-chloro-N-[2-chloro-5-(4-pyridin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]thiophene-2-sulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49785167 N-[3-(6-amino-5-fluoro-2-methylpyrimidin-4-yl)pyridin-2-yl]-1H-indazol-4-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121334425 4-(difluoromethyl)-5-[2-[(3S)-3-methylmorpholin-4-yl]-6-morpholin-4-ylpyrimidin-4-yl]pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44578109 (S)-2-(3-(benzo[b]thiophen-3-ylmethyl)morpholino)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57403576 1-(2-Fluorobenzyl)-7-morpholinoimidazo[1,2-a]pyrimidin-5(1H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003512 2-amino-N-[(1S)-1-[8-[2-(4-methylpyridin-3-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51354883 N-(6-(6-chloro-5-(4-chlorophenylsulfonamido)pyridin-3-yl)benzo[d]thiazol-2-yl)acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577952 2-(7-methoxy-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-6,6-dimethyl-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:135151360 7-Methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(oxan-4-yl)purin-8-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:16081736 2-(morpholin-4-yl)-6,7-dihydro-4H-spiro[1,3-benzothiazole-5,1''-cyclopentane]-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76286826 2-[(1S)-1-[[6-amino-5-[2-[6-amino-4-(trifluoromethyl)pyridin-3-yl]ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003495 2-amino-N-[(1S)-1-[8-(2-cyclohexylethynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798737 [6-(7-methoxy-1H-pyrazolo[3,4-c]pyridin-4-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25171857 N-[(E)-(5-iodopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003603 2-amino-N-[(1S)-1-[1-oxo-8-[2-oxo-2-(1H-pyrazol-4-yl)ethyl]-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577638 5,5-dimethyl-2-(6-(pyridin-4-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11998803 (S)-2-(3-((1H-indol-3-yl)methyl)morpholino)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58204529 (2S)-2-[methyl-[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:66789704 2-[3-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-2-[(6-methoxypyridin-3-yl)amino]imidazo[1,2-a]pyridin-6-yl]propan-2-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118503281 1-[(1S,3S)-3-methoxycyclopentyl]-3-methyl-8-[6-(3-pyrrolidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145954195 (2S)-2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-phenylpropanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003707 3-amino-N-[(1S)-1-[5-ethynyl-3-(4-fluorophenyl)-4-oxoquinazolin-2-yl]ethyl]pyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:142506157 N-hydroxy-2-methyl-4-[[[4-oxo-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-5-yl]amino]methyl]benzamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51354878 N-[6-[6-chloro-5-[[2-(trifluoromethyl)phenyl]sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44606303 (S)-ethyl 4-(4-(3-methylmorpholino)-6-(4-(3-pyridin-4-ylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003862 2-amino-N-[(1S)-1-[8-[2-(6-methylpyridin-3-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155516982 2-[2-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxyethyl-methylamino]-N-hydroxypyrimidine-5-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:131989 2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164626051 4-(3-fluoro-5-hydroxyphenyl)-6-[(3R)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]oxy-2,3-dihydroisoindol-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122178109 2,4-difluoro-N-[2-methoxy-5-(4-pyridin-4-yl-1,7-naphthyridin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46886360 N-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)-N-methylmethanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548454 N-[3-(6-amino-2-methylpyrimidin-4-yl)pyridin-2-yl]-1H-indazol-4-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49854361 (2S)-1-N-(7-tert-butyl-4,5-dihydro-[1,3]thiazolo[5,4-e][1,3]benzothiazol-2-yl)-2-methylpyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58204675 (2S)-1-[2-[2-(2,2,2-trifluoroethyl)-1,2,4-triazol-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrrolidine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004293 2-amino-N-[(1S)-1-[5-[2-(1-methylpyrazol-4-yl)ethynyl]-4-oxo-3-phenylquinazolin-2-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122178113 N-[5-(2-amino-4-pyridin-4-ylquinazolin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548250 4-(3-(6-Methoxypyridin-3-ylamino)pyridin-4-yl)-6-methyl-1,3,5-triazin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:166630493 24-[(1S)-1-cyclopropylethyl]-3-methyl-20,20-dioxo-20lambda6,30-dithia-4,6,13,19,24,29-hexazapentacyclo[19.6.1.12,5.17,11.022,26]triaconta-1(27),2,4,7,9,11(29),21(28),22(26)-octaene-12,23-dione 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155528581 1-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-1,3-dimethylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57393644 N-[(E)-(5-ethynylpyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:52950013 N-(3-(3-(3,4-dimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl)benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:162676331 PI3K|A-IN-11 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118709579 9-[1-(4-fluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:168277511 2,4-diamino-6-[(2S,5S)-2-(6,8-difluoro-4-oxo-3-pyridin-3-ylquinazolin-2-yl)-5-methylpyrrolidin-1-yl]pyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44599029 1-{4-[7-(2-hydroxyethyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46244259 4-{4-[4-(Methylsulfonyl)piperidin-4-yl]-6-morpholin-4-ylpyrimidin-2-yl}-1H-indole 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50992386 [2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3',2':4,5]furo[3,2-d]pyrimidin-8-ylmethyl]-(2-methoxy-ethyl)-methyl-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71037772 2,4-difluoro-N-[5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155725 5-(5-aminopyrazin-2-yl)-2-chloro-N-(2,3-difluorophenyl)benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:33845371 4''-Chloro-7,8-dihydroxyisoflavone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003588 2-amino-N-[(1S)-1-[2-(3,4-difluorophenyl)-8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71042079 18,25-Dimethoxy-22,22-dioxo-3,22lambda6,30-trithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,12,17,19,21(29),24,26-dodecaen-16-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003574 2-amino-N-[(1S)-1-[8-[(1-methylpyrazole-4-carbonyl)amino]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58204681 (2S)-2-[[2-(2-methyl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]oxy]propanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118032519 7-methyl-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44621454 7-(5-Methylsulfonylpyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70695188 N-[5-(3-Cyano-4-methanesulfonyl-phenyl)-4-methyl-thiazol-2-yl]-acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004051 2-amino-N-[(1S)-1-[8-[(Z)-2-(1-methylpyrazol-4-yl)ethenyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:139207772 5-(6-Azanyl-4-methyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:45488079 Urea, N-[4-(4-methyl-1-piperazinyl)phenyl]-N'-[4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]- 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164627791 N-[2-methoxy-5-(1-oxo-2,3-dihydroisoindol-4-yl)pyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49854022 N-(3,4-difluorophenyl)-2-[1-methyl-4-(morpholin-4-yl)-6-oxo-1,6-dihydropyrimidin-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44601450 1-{4-[4-morpholin-4-yl-7-(2-piperazin-1-ylethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}-3-pyridin-4-ylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754180 US10961236, Example 2 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71452282 N-[4-methyl-5-(2-pyridin-3-ylsulfanyl-1,3-oxazol-5-yl)-1,3-thiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71003738 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3R)-3-pyrazol-1-ylpyrrolidin-1-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121259513 2-amino-N-[(1R)-1-[5-[2-(1-methylpyrazol-4-yl)ethynyl]-3-phenylquinolin-2-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:88979790 [6-(2-Amino-1,3-benzothiazol-6-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155555170 (3R)-N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164624192 N-[2-chloro-5-(5H-pyrrolo[2,3-b]pyrazin-2-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155533579 1-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44600952 1-(4-{7-[2-(Dimethylamino)ethyl]-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl}phenyl)-3-pyridin-3-ylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25172479 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-2-methyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:153532116 [2-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)anilino]-3H-benzimidazol-5-yl]-(4-methylpiperazin-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003729 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-(3,3,3-trifluoroprop-1-ynyl)isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155558167 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-2-methoxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548243 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-[(4-methylpiperazin-1-yl)methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4861979 CHEMBL4861979 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4871838 CHEMBL4871838 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003496 2-amino-N-[(1S)-1-[8-[2-(3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155518918 N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-4-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25071204 5-(6-morpholino-9-(piperidin-4-yl)-9H-purin-2-yl)pyridin-3-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76286676 2-[(1S)-1-[[6-amino-5-[2-[6-amino-4-(trifluoromethyl)pyridin-3-yl]ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-(3,5-difluorophenyl)quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76287570 2-[(1S)-1-[[6-amino-5-[2-(2-amino-1,3-benzothiazol-6-yl)ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004017 2-amino-N-[(1S)-1-[8-[2-(2-methoxypyridin-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:162652772 4-(Cyclobutanecarbonyl)-1-[[2-(2-ethylbenzimidazol-1-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155568356 2-(2,4,6-Trimethylphenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71042076 18-Chloro-25-methoxy-22,22-dioxo-3,22lambda6,30-trithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,12,17,19,21(29),24,26-dodecaen-16-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46891467 1-(2-((5-methoxy-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76321296 N-[5-[7-amino-5-methyl-1-(oxan-4-yl)-2-oxo-1,6-naphthyridin-3-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122188273 N,2-dimethyl-5-nitro-N-[(E)-(5-pyridin-3-ylpyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155569074 1-[1-[[2-(2-Aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004010 2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-3-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003844 2-amino-N-[(1S)-1-[8-[2-(2,4-dimethyl-1,3-thiazol-5-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46227608 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-(pyridin-4-yl)urea 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4850400 CHEMBL4850400 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58203724 3-{8-[1-(2-Hydroxy-2-methyl-propyl)-1H-pyrazol-4-yl]-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-2-yl}-4,4-dimethyl-oxazolidin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51355348 1-ethyl-3-[4-[7-[(3S)-3-ethylmorpholin-4-yl]-1,3-dimethylpyrazolo[4,3-d]pyrimidin-5-yl]phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58137106 4-[4-(methylsulfonylmethyl)-6-morpholin-4-yl-pyrimidin-2-yl]-1H-indole 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4853440 CHEMBL4853440 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155529706 N-[(2S)-1-amino-1-oxopropan-2-yl]-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-4-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754158 US10961236, Example 42 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155510865 N-hydroxy-6-[6-[5-(methanesulfonamido)-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxyhexanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155995 3-(3-pyridin-4-yl-1H-pyrrolo[2,3-b]pyridin-5-yl)aniline 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164619422 N-[2-chloro-5-(4-imidazol-1-ylcinnolin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118721837 3-[6-(5-Methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]-1,1-dimethylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502486 N-[5-(1-cyclopropyl-3-methyl-2-oxoimidazo[4,5-c]quinolin-8-yl)-2-methoxypyridin-3-yl]cyclopropanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:146263425 5-[3-(6-Morpholin-4-ylpyridin-3-yl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71527716 4-(7-Chloro-3-(2-methyl-3-(trifluoromethyl)benzyl)pyrazolo[1,5-a]pyrimidin-5-yl)morpholine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:139340238 3-[[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]-N-methylpropanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003723 2-amino-N-[(1S)-1-[3-methyl-5-[2-(1-methylpyrazol-4-yl)ethynyl]-4-oxoquinazolin-2-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502919 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-3-methyl-1-[(3R)-oxan-3-yl]imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71041957 (14R)-26-methoxy-32-methyl-23,23-dioxo-13-oxa-3,23lambda6-dithia-6,8,10,16,24,27-hexazahexacyclo[23.3.1.12,5.110,14.118,22.04,9]dotriaconta-1(29),2(32),4,6,8,18(30),19,21,25,27-decaen-17-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46244260 4-[2-(1H-indol-4-yl)-6-(4-methylsulfonyloxan-4-yl)pyrimidin-4-yl]morpholine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122178110 2,4-difluoro-N-[2-methoxy-5-(4-pyridin-4-ylquinazolin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44621451 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-phenylpyridine-3-sulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798731 1-[1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]piperidin-4-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164616225 6-[(3R)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]oxy-4-(3-fluoro-5-hydroxyphenyl)-2,3-dihydroisoindol-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50991339 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-(3,3-difluoropyrrolidin-1-yl)pyrrolidin-1-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003995 2-amino-N-[(1S)-1-[8-(3-morpholin-4-ylprop-1-ynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164628135 N-[5-[6-[1-(cyclopropanecarbonyl)azetidin-3-yl]oxy-1-oxo-2,3-dihydroisoindol-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70695469 4-[(3-chloro-2-methylphenyl)methyl]-2-(4-morpholinyl)-5-thioxo-5,6-dihydro[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:134147099 6-(3,4-dimethoxyphenyl)-4-[(3R)-1-methylpyrrolidin-3-yl]oxyquinazoline 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003811 2-amino-N-[(1S)-1-[8-(3-methoxybut-1-ynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003841 2-amino-N-[(1S)-1-[8-[2-(2-methyl-1,3-thiazol-5-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798723 6-Chloro-5-[3-(3-morpholin-4-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003708 2-amino-N-[(1S)-1-(5-ethynyl-3-methyl-4-oxoquinazolin-2-yl)ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:90233161 2-[(1S)-1-[[6-amino-5-(2-pyrazin-2-ylethynyl)pyrimidin-4-yl]amino]ethyl]-8-fluoro-5-methyl-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798511 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44578038 5,5-dimethyl-2-(pyridin-4-yl)-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46224766 (3-(6-morpholino-9-(1-(4-(pyridin-4-yl)benzyl)piperidin-4-yl)-9H-purin-2-yl)phenyl)methanol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:86272862 (S)-2-(1-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)ethyl)-5-chloro-3-(3-(2,2,2-trifluoroethoxy)phenyl)quinazolin-4(3H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155534594 1-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003917 2-amino-N-[(1S)-1-[8-[2-(1-methylsulfonylpiperidin-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60151412 1-(1-Acetylpiperidin-4-yl)-8-(6-methoxypyridin-3-yl)-3-methylimidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:24956159 2-(2,3-dihydropyrido[2,3-b][1,4]oxazin-1-yl)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46190734 1-(4-(4-(3,6-dihydro-2H-pyran-4-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-(pyridin-4-yl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:90284132 3-[4-[5-[5-Amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-methyl-1,2,4-triazol-3-yl]piperidin-1-yl]-3-oxopropanoic acid 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76287418 3-[2-[(1S)-1-[[6-amino-5-(2-pyridin-2-ylethynyl)pyrimidin-4-yl]amino]ethyl]-5-chloro-4-oxoquinazolin-3-yl]-N-ethylbenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121259298 2-amino-N-[(1R)-1-[5-[2-(1-methylpyrazol-4-yl)ethynyl]-4-oxo-3-phenylchromen-2-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121334436 4-(difluoromethyl)-5-[2-[(3S)-3-methylmorpholin-4-yl]-6-morpholin-4-ylpyrimidin-4-yl]pyrimidin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:136249373 1-(4-Hydroxyphenyl)-3-[4-(4-morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798871 N-[2-methoxy-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25129381 N-[6-(4-hydroxy-3,5-dimethylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155533335 N-[5-(1H-indazol-6-yl)-2-methoxypyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:91668225 3-amino-N-[(1S)-1-(5-ethynyl-4-oxo-3-phenylquinazolin-2-yl)ethyl]pyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46205562 2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3',2':4,5]furo[3,2-d]pyrimidine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004316 N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76286674 2-[(1S)-1-[[6-amino-5-[2-(6-aminopyridin-2-yl)ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-(3,5-difluorophenyl)quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44520812 3-[1-(1-Benzyl-piperidin-4-yl)-4-morpholin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl]-phenol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:124194522 US9758538, Example 72 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003600 2-amino-N-[(1S)-1-[1-oxo-8-[3-(2-oxopyrrolidin-1-yl)prop-1-ynyl]-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:124194932 US9758538, Example 79 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71042029 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,19,24,29-hexazahexacyclo[20.5.2.12,6.19,13.117,21.025,29]dotriaconta-1(28),2(32),3,5,9,11,13(31),17(30),18,20,22,24,26-tridecaen-14-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:139208204 2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-8aH-isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798495 [6-[2-(Methylamino)-1,3-benzoxazol-5-yl]imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59259014 2-Amino-6-(5-Fluoro-6-Methoxypyridin-3-Yl)-4-Methyl-8-(Pyrrolidin-1-Yl)pyrido[2,3-D]pyrimidin-7(8h)-One 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:124037284 2-[(1S)-1-[[6-amino-5-[2-(3-methoxypyridin-2-yl)ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4798343 CHEMBL4798343 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:66789238 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(6-methoxypyridin-3-yl)-6-piperazin-1-ylimidazo[1,2-a]pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53322563 2-(Pyridin-4-yl)thiazolo[5,4-d]pyrimidin-7-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118032511 2-amino-N-[(1S)-1-[8-(3-amino-3-methylbut-1-ynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:134366824 US10961236, Example 12 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76332052 1-[4-(4-Morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenyl]-3-pyridin-3-ylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60151411 Methyl 4-[8-(6-methoxypyridin-3-yl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-1-yl]piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:129029965 8-[(1S)-1-(3-fluoroanilino)ethyl]-N-(2-hydroxyethyl)-2-morpholin-4-ylquinoxaline-6-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:78324443 4-amino-6-[(4R)-4-(5-chloro-4-oxo-3-phenylquinazolin-2-yl)-1,3-thiazolidin-3-yl]pyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003866 2-amino-5,7-dimethyl-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:66790135 4-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-2-[(5-fluoro-6-methoxypyridin-3-yl)amino]imidazo[1,2-a]pyridin-6-yl]-N,N-dimethylpiperazine-1-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155562388 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-2-methoxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118720612 N,N-dimethyl-4-[5-(1H-pyrrolo[2,3-b]pyridin-4-yl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004025 2-amino-N-[(1S)-1-[8-[2-(1-methylimidazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76317470 1-(3-Hydroxyphenyl)-3-[4-(4-morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71272066 N-[2-methyl-3-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-5-(4-morpholinyl)pyrazolo[1,5-a]pyrimidin-7-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:72163951 1-ethyl-3-[4-[9-(2-hydroxyethyl)-8-(2-hydroxypropan-2-yl)-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754228 US10961236, Example 45 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44181605 3-(1H-indol-2-yl)-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798574 6-(2-amino-1,3-benzoxazol-5-yl)-N-(6-methylpyridin-3-yl)imidazo[1,2-a]pyridine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798510 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3-pyrazol-1-ylazetidin-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754154 US10961236, Example 62 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51355058 1-ethyl-3-[4-[7-methyl-6-[(3R)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155514764 1-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51354882 n-(6-(6-Chloro-5-(3-chlorophenylsulfonamido)pyridin-3-yl)benzo[d]thiazol-2-yl)acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:142752520 US10961236, Example 35 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:24956158 5,5-Dimethyl-2-(6-phenyl-2,3-dihydrobenzo[1,4]oxazin-4-yl)-5,6-dihydro-4H-benzothiazol-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141446054 6-(1H-indol-4-yl)-1H-indazole 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:56955955 5-{3-[(4-{3-[4-(1-Methylethyl)phenyl]pyrazin-2-yl}piperazin-1-yl)sulfonyl]phenyl}pyrimidin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71270906 2-methyl-3-(2-methyl-3-(trifluoromethyl)benzyl)-5-(tetrahydro-2H-pyran-4-yl)pyrazolo[1,5-a]pyrimidine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50992289 2,8-Bis-(1H-indol-4-yl)-4-morpholin-4-yl-pyrido[3',2':4,5]furo[3,2-d]pyrimidine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004029 2-amino-N-[(1S)-1-[8-[2-(5-methyl-1,3,4-thiadiazol-2-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57411369 4-[2-(4-Chloro-2,3-dihydroindol-1-yl)-2-oxoethyl]-2-morpholin-4-yl-1,3-thiazole-5-carboxylic acid 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155515135 2-[[4-(4-Chlorophenyl)sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:86272627 (5)-5-fluoro-2-(1-((5-fluoro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)ethyl)-3-(3-(2,2,2-trifluoroethoxy)phenyl)quinazolin-4(3H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754164 US10961236, Example 33 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:162670134 1-[[2-(2-Ethylbenzimidazol-1-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]-4-prop-2-enylpiperazin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:124173710 (alphaS)-alpha-[[5,6-Dihydro-2-[(4R)-4-methyl-2-oxo-3-oxazolidinyl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]cyclobutaneacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58881866 1-Ethyl-3-[3-(quinolin-3-ylamino)pyrido[2,3-b]pyrazin-6-yl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51003484 4-amino-2-methyl-6-(morpholinomethyl)-N-(1H-pyrazol-5-yl)quinazoline-8-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164621621 N-[2-chloro-5-(1H-imidazo[4,5-b]pyridin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155517457 5-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxy-N-hydroxypentanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:92042842 US9862711, Example 12 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:90232644 2-[(1S)-1-[[6-amino-5-(2-pyrazin-2-ylethynyl)pyrimidin-4-yl]amino]ethyl]-5-methyl-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155087 4-[3-[(6-Methoxypyridin-3-yl)amino]pyridin-2-yl]-6-methyl-1,3,5-triazin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145970017 2-[[4-(4-Methoxy-2-methylphenyl)triazol-1-yl]methyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004008 2-amino-N-[(1S)-1-[8-(3-hydroxy-3-methylbut-1-ynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122179692 9-[(2-Methylanilino)methyl]-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141406388 2-(4-Fluorophenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003784 2-amino-N-[(1S)-1-[8-(2-cyclopropylethynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003580 2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-propan-2-ylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50992383 US9580442, Example I 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004311 2-amino-N-[(1S)-1-[8-[2-(azetidin-3-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754215 US10961236, Example 37 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4864419 CHEMBL4864419 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164610297 6-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-4-yl]-4-(3-fluoro-5-hydroxyphenyl)-2,3-dihydroisoindol-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754217 US10961236, Example 43 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155525996 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-2-methoxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155512947 N-[2-chloro-5-(1H-indazol-6-yl)pyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164617201 N-[5-[6-[(3R)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]oxy-1-oxo-2,3-dihydroisoindol-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155519635 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754206 US10961236, Example 40 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49835055 3-(4-Amino-6-Methyl-1,3,5-Triazin-2-Yl)-N-(1h-Pyrazol-5-Yl)imidazo[1,2-A]pyridin-2-Amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:139208202 2-amino-N-[(1S)-1-[1-oxo-8-[2-(6-oxopiperidin-3-yl)ethynyl]-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155517071 N-[(3R)-1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798388 5-[4-(2-Morpholin-4-ylethyl)quinolin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:24768579 2-(6-bromo-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44600806 1-[4-(4-Morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl)phenyl]-3-pyridin-4-ylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155523124 1-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-1,3-dimethylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004315 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-[2-(1,3,5-trimethylpyrazol-4-yl)ethynyl]isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155556887 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-N-methylacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70690994 N-[5-(4-acetylphenyl)-4-methyl-1,3-thiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502066 1-(3-methoxycyclobutyl)-8-[6-(3-pyrrolidin-1-ylpropoxy)pyridin-3-yl]-3H-imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51355620 1-ethyl-3-[4-[7-[(3S)-3-ethylmorpholin-4-yl]-1-methylpyrazolo[4,3-d]pyrimidin-5-yl]phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155554125 2-Methoxy-5-[4-(2-morpholin-4-ylethylamino)quinazolin-6-yl]pyridine-3-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004319 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-[2-(1H-pyrazol-5-yl)ethynyl]isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155511261 7-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxy-N-hydroxyheptanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71682653 N-[5-(2-tert-butylpyridin-4-yl)-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003515 2-amino-N-[(1S)-1-[8-(2-cyclopentylethynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46946248 N-[3-(dimethylamino)propyl]-6-(1H-indazol-4-yl)-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145971490 (2S)-2-amino-N-[5-[6-chloro-5-[(4-phenylphenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:88979951 [6-(2-Amino-1,3-benzothiazol-6-yl)imidazo[1,2-a]pyridin-3-yl]-(4-methylpiperazin-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76310248 3-(4-Morpholin-4-ylpyrido[2,3-d]pyrimidin-2-yl)phenol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155561165 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49785829 N-(3-(6-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pyridin-2-yl)-1H-indazol-4-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:139208200 2-amino-N-[(1S)-1-[1-oxo-8-[2-(2-oxopiperidin-4-yl)ethynyl]-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164616115 N-[5-(6-cyclobutyloxy-1-oxo-2,3-dihydroisoindol-4-yl)-2-methoxypyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155470 3-amino-6-[4-chloro-3-(2,2,2-trifluoroethylsulfamoyl)phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003484 2-amino-5-methyl-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798503 6-(2-amino-1,3-benzoxazol-5-yl)-N-pyridin-3-ylimidazo[1,2-a]pyridine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:137658458 4-[3-[4-Amino-5-(trifluoromethyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]phenyl]morpholin-3-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003777 2-amino-N-[(1S)-1-[8-[2-(3-methylimidazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155556576 4-[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]-N-(oxan-4-yl)pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:117996244 (S)-2-amino-N-(1-(8-amino-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49831209 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-5,7-difluoro-3-methyl-2-(5-methyl-2-(methylsulfonyl)phenyl)quinoline 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155475 3-amino-6-[3-[(3-chlorophenyl)sulfonylamino]phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003602 2-amino-N-[(1S)-1-[8-[(3S)-3-hydroxybut-1-ynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:137636841 4-[3-[4-Amino-5-(trifluoromethyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]phenyl]-2,2-dimethylmorpholin-3-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164614151 3-amino-6-[4-chloro-3-[(3,4-difluorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155384121 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-1-oxo-7-(trifluoromethoxy)-3H-isoindol-5-yl]-N-[(1R)-1-cyclopropyl-2-hydroxyethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003721 2-amino-N-[(1S)-1-[8-[(E)-2-(1-methylpyrazol-4-yl)ethenyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798383 6-(2-amino-1,3-benzoxazol-5-yl)-N-(2-morpholin-4-ylethyl)imidazo[1,2-a]pyridine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003586 2-amino-N-[(1S)-1-[2-(2-methylphenyl)-8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003709 2-amino-N-[(1S)-1-(5-ethynyl-4-oxo-3-phenylquinazolin-2-yl)ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:153940692 2-[[4-[2,4,6-Tri(propan-2-yl)phenyl]sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44180029 5-Morpholin-4-yl-3-[4-(trifluoromethyl)phenyl]thieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122188279 N-[2-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)ethyl]-2-methyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4872728 CHEMBL4872728 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44600649 N-[2-(Dimethylamino)ethyl]-4-[({4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}carbamoyl)amino]benzamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:134146051 2-[4-[(6,7-Dimethoxyquinazolin-4-yl)amino]phenyl]acetonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:68405701 6-(2-Amino-1,3-benzoxazol-5-yl)quinoline-3-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122188282 5-Chloro-3-[1-(2-methyl-5-nitrophenyl)sulfonylpyrazol-4-yl]pyrazolo[1,5-a]pyrimidine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71041771 26-Methoxy-32-methyl-23,23-dioxo-3,23lambda6-dithia-6,8,12,13,16,24,27-heptazahexacyclo[23.3.1.12,5.110,13.118,22.04,9]dotriaconta-1(29),2(32),4,6,8,10(31),11,18(30),19,21,25,27-dodecaen-17-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502495 8-(2-Aminopyrimidin-5-yl)-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:24984058 5-(3H-benzimidazol-5-yl)-3-(cyclohexylmethyl)-1H-imidazo[4,5-b]pyrazin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:142527982 PI3K-IN-30 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:90283706 3-[4-[5-[5-Amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-ethyl-1,2,4-triazol-3-yl]piperidin-1-yl]-3-oxopropanoic acid 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122188266 N-[(E)-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-5-cyano-N,2-dimethylbenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164618272 6-[(3R)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]oxy-4-(5-hydroxypyridin-3-yl)-2,3-dihydroisoindol-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:24936050 Methyl 4-[6-[4-[[4-(hydroxymethyl)phenyl]carbamoylamino]phenyl]-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:153940691 2-[[4-(4-Tert-butylphenyl)sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46891469 1-(2-((7-fluoro-5-methoxy-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(pyridin-3-yl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155522149 N-[(2R)-1-amino-1-oxopropan-2-yl]-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-4-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754160 US10961236, Example 48 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155640 3-amino-6-[3-[(3-chlorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155527501 (3R)-N-(2-amino-2-oxoethyl)-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003509 2-amino-N-[(1S)-1-[8-[2-(4-methyl-1,3-thiazol-2-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:151426433 (E)-3-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]quinolin-4-yl]-N-(2-hydroxyethyl)-N-methylbut-2-enamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003726 2-amino-N-[(1S)-1-[8-[3-(dimethylamino)prop-1-ynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754178 US10961236, Example 53 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57402428 5-chloro-N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethylbenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:153532121 PI3K/mTOR Inhibitor-7 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44232918 1-methyl-3-(4-(4-morpholino-1-(piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754148 US10961236, Example 56 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46227606 1-(4-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-(pyridin-3-yl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:166630488 24-[(1S)-1-cyclopropylethyl]-3,16-dimethyl-20,20-dioxo-20lambda6,30-dithia-4,6,13,16,19,24,29-heptazapentacyclo[19.6.1.12,5.17,11.022,26]triaconta-1(27),2,4,7,9,11(29),21(28),22(26)-octaene-12,23-dione 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164610435 6-[(3R)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]oxy-4-(6-methoxypyridin-3-yl)-2,3-dihydroisoindol-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754157 US10961236, Example 46 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:52945142 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(pyrimidin-5-yl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141406387 2-(4-Chlorophenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003499 2-amino-N-[(1S)-1-[8-[2-(2-methylpyridin-3-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44181602 3-(4-Methoxyphenyl)-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4876806 CHEMBL4876806 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121259232 2-amino-N-[1-[5-[2-(1-methylpyrazol-4-yl)ethynyl]-4-oxo-3-phenylchromen-2-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46883920 (Z)-1-(2-((4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)-3-(2-(dimethylamino)ethyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44520808 3-(4-Morpholin-4-yl-1-piperidin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)-phenol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155544955 [4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-[(2R)-piperidin-2-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155384065 2-amino-5-[2-[(1S)-1-cyclopropylethyl]-7-(methanesulfonamido)-1-oxo-3H-isoindol-5-yl]-N-(4-hydroxy-4-methylcyclohexyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44181723 3-(3,4-Dichlorophenyl)-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:124193944 US9758538, Example 24 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58508283 5-[4-[(3S)-3-methylmorpholin-4-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004024 2-amino-N-[(1S)-1-[8-[2-(2-methylpyrazol-3-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004317 3-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003732 2-amino-N-[(1S)-1-[8-[2-(1,5-dimethylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121259289 2-amino-N-[(1S)-1-[5-[2-(1-methylpyrazol-4-yl)ethynyl]-4-oxo-3-phenylchromen-2-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57398392 1-[(3-Methylphenyl)methyl]-7-morpholin-4-ylimidazo[1,2-a]pyrimidin-5-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57495287 1-{(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-yloxy]-pyrrolidin-1-yl}-propan-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57391366 1-[(2,3-Dichlorophenyl)methyl]-7-(2,2-dimethylmorpholin-4-yl)imidazo[1,2-a]pyrimidin-5-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44599855 1-{4-[(4-Methylpiperazin-1-yl)carbonyl]phenyl}-3-{4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44605429 tert-butyl 4-[6-(4-{[(2-fluoroethyl)carbamoyl]amino}phenyl)-4-morpholin-4-yl-1Hpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155533591 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71682837 Nvp-clr457 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155544267 6-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxy-N-hydroxyhexanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44181721 3-(3-Methylphenyl)-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155726 5-(2-aminopyrimidin-5-yl)-2-chloro-N-(2,3-difluorophenyl)benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754153 US10961236, Example 59 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798653 6-(3-Pyridin-3-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44180157 3-(3-Methoxyphenyl)-5-(4-morpholinyl)-7H-thieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:146626007 2-[2-[2-[2-(2-Aminooxyethoxy)ethoxy]ethoxy]ethyl-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]ethanol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71041778 26-Methoxy-32-methyl-23,23-dioxo-3,23lambda6-dithia-6,8,12,16,24,27-hexazahexacyclo[23.3.1.12,5.110,14.118,22.04,9]dotriaconta-1(29),2(32),4,6,8,10,12,14(31),18(30),19,21,25,27-tridecaen-17-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118499562 8-[6-[3-(Azetidin-1-yl)propoxy]pyridin-3-yl]-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25261554 methyl 4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-6-(4-(3-cyclopropylureido)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121259510 2-amino-N-[(1R)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-2-phenylquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155152391 US10961236, Example 1 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155377 3-amino-N-methyl-6-[3-(phenylsulfamoyl)phenyl]pyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003501 2-amino-N-[(1S)-1-[8-[2-[1-methyl-5-(trifluoromethyl)pyrazol-4-yl]ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003579 2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)-2-oxoethyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155565269 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754220 US10961236, Example 60 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155533384 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:23585071 4-[2-(1H-indol-5-yl)-6-(methylsulfonylmethyl)pyrimidin-4-yl]morpholine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164624180 N-[2-methoxy-5-(1-oxo-6-propan-2-yloxy-2,3-dihydroisoindol-4-yl)pyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:73977439 2-Methyl-2-[4-(3-methyl-2-oxoimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798468 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(1-methylpiperidin-4-yl)quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548263 4-(2-(6-Methoxypyridin-3-ylamino)phenyl)-6-methyl-1,3,5-triazin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76287272 2-[(1S)-1-[[6-amino-5-[2-(2-aminopyrimidin-5-yl)ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44129044 (2S,3S)-1-N-[5-(2-tert-butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]-3-hydroxypyrrolidine-1,2-dicarboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577950 6,6-dimethyl-2-(6-(1-methyl-1H-imidazol-2-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71455818 N-[4-methyl-5-[2-(2,2,2-trifluoroethyl)-1,3-oxazol-5-yl]-1,3-thiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:127030212 (3E)-3-(2,3-dihydro-1-benzofuran-5-ylmethylidene)-5-methyloxolan-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:156021178 N-hydroxy-2-[[5-(6-methoxypyridin-3-yl)-7-morpholin-4-yl-1-benzothiophen-2-yl]methyl-methylamino]pyrimidine-5-carboxamide 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL5170522 CHEMBL5170522 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155723 3-amino-6-[3-[(2,3-difluorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118503042 3-Methyl-8-[6-[3-(methylamino)propoxy]pyridin-3-yl]-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58441681 2,4-difluoro-N-[2-methoxy-5-(4-pyridin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548232 N-(6-Methoxypyridin-3-yl)-3-(9H-purin-6-yl)pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:78321310 4-amino-6-[(2S)-2-(5-chloro-4-oxo-3-pyridin-3-ylquinazolin-2-yl)pyrrolidin-1-yl]pyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004013 2-amino-N-[(1S)-1-[8-(3-methoxyprop-1-ynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145972017 2-amino-N-[5-[5-(benzenesulfonamido)pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141406404 2-(2-Nitrophenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76287276 3-[2-[(1S)-1-[[6-amino-5-(2-pyridin-2-ylethynyl)pyrimidin-4-yl]amino]ethyl]-5-chloro-4-oxoquinazolin-3-yl]benzamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155531155 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:88979949 [6-(2-Amino-1,3-benzothiazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-methylpiperazin-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003605 2-amino-N-[(1S)-1-[2-(4-fluorophenyl)-8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003593 2-amino-N-[(1S)-1-[8-[(3R)-3-hydroxybut-1-ynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71270817 2-Methyl-3-(2-methyl-3-(trifluoromethyl)benzyl)-5-(2-methylmorpholino)pyrazolo[1,5-a]pyrimidin-7-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121334379 5-[4,6-bis[(3R)-3-methylmorpholin-4-yl]-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798410 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-methylsulfonylpiperazin-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11998447 rac-2-morpholino-5-propyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71271739 3-(2,3-dichlorobenzyl)-2-ethyl-5-(tetrahydro-2H-pyran-4-yl)pyrazolo[1,5-a]pyrimidin-7-ol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:86727672 1-[4-[5-[5-Amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-methyl-1,2,4-triazol-3-yl]-1-piperidyl]-2-hydroxy-2-methyl-propan-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71526878 CID 71526878 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155566279 N-[5-(1,3-dihydro-2-benzofuran-5-yl)-2-methoxypyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754155 US10961236, Example 3 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155524901 1-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155517534 (3S)-N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118499681 3-methyl-1-[(3S)-oxan-3-yl]-8-[6-(3-pyrrolidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57411134 4-[2-(2,3-Dihydroindol-1-yl)-2-oxoethyl]-2-morpholin-4-yl-1,3-thiazole-5-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155516445 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-2-methoxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71271625 4-(7-Methoxy-3-(2-methyl-3-(trifluoromethyl)benzyl)pyrazolo[1,5-a]pyrimidin-5-yl)morpholine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003715 2-amino-N-[(1S)-1-[8-[3-(4-methylpiperazin-1-yl)prop-1-ynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:139340216 N'-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]ethane-1,2-diamine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155517213 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155529643 N-[5-(2-aminopyrimidin-5-yl)-2-chloropyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44605430 tert-butyl 4-(6-{4-[(cyclopropylcarbamoyl)amino]phenyl}-4-morpholin-4-yl-1Hpyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50992288 4-Morpholin-4-yl-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)-pyrido[3',2':4,5]furo[3,2-d]pyrimidine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:49784893 N-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)pyridin-2-YL)-1H-indazol-4-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50991240 5-(3-Pyridin-3-ylimidazo[1,2-a]pyridin-6-yl)-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004294 2-amino-N-[(1S)-1-[2-cyclopropyl-8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4780201 CHEMBL4780201 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155996 3-(3-pyridin-3-yl-1~{H}-pyrrolo[2,3-b]pyridin-5-yl)aniline 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71527842 N,2-dimethyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-7-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141406392 2-(Benzenesulfonyl)chromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50940492 4-amino-2-methyl-N-(1H-pyrrolo[2,3-b]pyridin-5-yl)quinazoline-8-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71718034 4-[4-Morpholin-4-yl-6-(2-propan-2-ylbenzimidazol-1-yl)-1,3,5-triazin-2-yl]morpholine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155515394 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118499556 3-Methyl-1-(oxan-4-yl)-8-[6-(3-pyrrolidin-1-ylpropoxy)pyridin-3-yl]imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155473 3-amino-6-[6-amino-5-(phenylsulfamoyl)pyridin-3-yl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145996407 (Z)-4-[4-(1H-indol-4-yl)-6-morpholin-4-yl-8-oxa-3,5,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5,10,12-hexaen-12-yl]-1-(4-methylpiperazin-1-yl)but-3-en-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003788 2-amino-N-[(1S)-1-[8-[2-(6-methoxypyridin-3-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:142527981 N-[2-[[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]amino]ethyl]-N-methylacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46180606 6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-2-pyridin-4-yl-thieno[3,2-d]pyrimidine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754166 US10961236, Example 49 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003497 2-amino-N-[(1S)-1-[8-[2-(1,3-oxazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25165773 4-Ethyl-6-[5-(1h-Pyrazol-4-Yl)-1h-Pyrrolo[2,3-B]pyridin-3-Yl]pyrimidin-2-Amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53387573 N-[5-(2-amino-1,3-benzoxazol-6-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44593630 6,6-dimethyl-2-(6-(6-methylpyridazin-3-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004052 2-amino-N-[(1S)-1-[8-(3,3-dimethylbut-1-ynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25032389 2-[4-[2-amino-4-methyl-7-oxo-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-8-yl]cyclohexyl]oxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:78322567 4-amino-6-[(2S)-2-[4-oxo-3-phenyl-5-(trifluoromethyl)quinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57391916 N-[(E)-1-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)ethylideneamino]-2-methyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164618368 N-[5-[6-(cyclobutylmethoxy)-1-oxo-2,3-dihydroisoindol-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798675 [4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-[(2S)-pyrrolidin-2-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11599141 N-{1-[2-(1H-Indazol-4-yl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-6-ylmethyl]-piperidin-4-yl}-N-methyl-methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:67094257 1-ethyl-3-[4-[9-ethyl-6-[(3S)-3-methylmorpholin-4-yl]purin-2-yl]phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44180853 2-morpholino-8-phenyl-4H-chromene-4-thione 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003483 2-amino-N-[(1S)-1-[2-[2-(dimethylsulfamoyl)ethyl]-8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70689024 5-[2-[[(3S)-3-methyl-4-methylsulfonylpiperazin-1-yl]methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11998685 (S)-2-(3-benzylmorpholino)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004018 2-amino-N-[(1S)-1-[8-[2-(1,3-dimethylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46201895 1-[4-(7-Ethyl-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-2-yl)phenyl]-3-{4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118498627 8-[6-[3-(Dimethylamino)propoxy]pyridin-3-yl]-3-methyl-1-(oxetan-3-yl)imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118498683 8-[6-[3-(Dimethylamino)propoxy]pyridin-3-yl]-7-fluoro-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502901 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-3-methyl-1-[(3S)-oxolan-3-yl]imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:86273089 (S)-2-(1-((9H-purin-6-yl)amino)propyl)-5-fluoro-3-(3-(2,2,2-trifluoroethyl)phenyl)quinazolin-4(3H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51003380 5-(Pyridin-4-yl)benzo[d]thiazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798412 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-piperazin-1-ylmethanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:22135435 4-(Pyridin-4-yl)-1H-indole 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:168273579 4-[[[6-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)-1,3-benzoxazol-2-yl]amino]methyl]benzoic acid 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003575 2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-2-[2-(methylsulfamoyl)ethyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155569598 1-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44606133 1-(4-(4-morpholino-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)-3-(pyridin-3-yl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164616979 3-[5-amino-6-(cyclopropanecarbonyl)pyrazin-2-yl]-N-(4-hydroxycyclohexyl)-4-methylbenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:146263440 5-[3-(3,4-dihydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:121259897 2-amino-N-[1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-2-phenylquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155547573 N-hydroxy-8-[6-[5-(methanesulfonamido)-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxyoctanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155556 3-amino-6-[4-chloro-3-[[3-(trifluoromethyl)phenyl]sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:142752515 US10961236, Example 29 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155559192 (3R)-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-3-carboxylic acid 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71270957 2-Methyl-3-(2-methyl-3-(trifluoromethyl)benzyl)-5-morpholinopyrazolo[1,5-a]pyrimidine-7-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:168293147 2,4-diamino-6-[(2S,5S)-2-[5-chloro-3-(3-fluorophenyl)-4-oxoquinazolin-2-yl]-5-methylpyrrolidin-1-yl]pyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:45379222 1-(4-(4,6-Dimorpholino-1,3,5-triazin-2-yl)phenyl)-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44514205 (2,4-Difluorophenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70682591 N-[4-methyl-5-(4-methylsulfonylphenyl)-1,3-thiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59258834 2-amino-8-cyclobutyl-4-methyl-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59609976 N-[4-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)phenyl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548256 [(3R)-1-[[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]methyl]pyrrolidin-3-yl]methanol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004022 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-[2-(1,3-thiazol-5-yl)ethynyl]isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:89842161 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-[(E)-2-phenylethenyl]isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70693128 N-[5-(3-Chloro-4-methanesulfonyl-phenyl)-4-methyl-thiazol-2-yl]-acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155527559 CID 155527559 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:162663726 2,4-difluoro-N-[5-[4-[[1-(2-hydroxyethyl)pyrazol-4-yl]amino]quinazolin-6-yl]-2-methoxypyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4845684 CHEMBL4845684 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118728321 2-Chloro-11-fluoro-6,7-dihydrobenzimidazolo[1,2-d][1,4]benzoxazepine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004063 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-[2-(1H-pyrazol-4-yl)ethynyl]isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118523376 3-methyl-8-[6-[3-(methylamino)propoxy]pyridin-3-yl]-1-[(3R)-oxan-3-yl]imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:89627797 PI3K-IN-31 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155543139 5-(6-Amino-4-methoxy-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:11296261 (3R,10R,13E,16S)-10-[(4-methoxyphenyl)methyl]-3-(2-methylpropyl)-16-[(E,2R)-4-phenylbut-3-en-2-yl]-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155557123 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004318 2-amino-N-[(1S)-1-[8-[2-(2,3-dimethylimidazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76287419 3-[2-[(1S)-1-[[6-amino-5-(2-pyridin-2-ylethynyl)pyrimidin-4-yl]amino]ethyl]-5-chloro-4-oxoquinazolin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118502484 1-(azetidin-3-yl)-3-methyl-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)imidazo[4,5-c]quinolin-2-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:90232827 2-[(1S)-1-[[6-amino-5-[2-(4-methylpyridin-2-yl)ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:122188276 N-[(E)-(5-methoxypyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798652 5-(3-Pyridin-3-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51354881 N-[6-[6-chloro-5-[(2-chlorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798528 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-propan-2-ylpiperazin-1-yl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:78320672 5-Pyrimidinecarbonitrile, 4-amino-6-[(2S)-2-(5-chloro-3,4-dihydro-4-oxo-3-phenyl-2-quinazolinyl)-1-pyrrolidinyl]- 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003506 3-amino-5-methoxy-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:58204829 (2S)-2-[[2-(2-ethyl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]oxy]propanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754129 US10961236, Example 10 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:52945589 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-fluorophenyl)urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44577921 2-(6-(1H-pyrazol-5-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-6,6-dimethyl-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71459503 N-[4-methyl-5-[2-(pyridin-3-ylamino)-1,3-oxazol-5-yl]-1,3-thiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71037655 5-(3-Pyridin-3-ylquinoxalin-6-yl)-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754128 US10961236, Example 28 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155524976 N-hydroxy-7-[6-[5-(methanesulfonamido)-6-methoxypyridin-3-yl]-4-methylquinazolin-8-yl]oxyheptanamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754203 US10961236, Example 36 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:145986347 5-Methyl-3-(2-methylphenyl)-2-[(4-phenyltriazol-1-yl)methyl]quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:76287128 2-[(1S)-1-[[6-amino-5-[2-(2-aminopyrimidin-5-yl)ethynyl]pyrimidin-4-yl]amino]ethyl]-5-chloro-3-(3,5-difluorophenyl)quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003589 2-amino-N-[(1S)-1-[2-cyclohexyl-8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxoisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155533070 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-2-methoxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:66780027 4-Benzyl-2-morpholin-4-yl-[1,3]thiazolo[4,5-d]pyrimidin-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:162371682 2,4-difluoro-N-[2-methoxy-5-(4-morpholin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53319933 3-(2-Aminobenzo[d]thiazol-6-yl)phenol 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118728328 11-Bromo-2-methyl-6,7-dihydrobenzimidazolo[1,2-d][1,4]benzoxazepine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:137631388 4-[3-(4-Amino-5-chloropyrrolo[2,1-f][1,2,4]triazin-7-yl)phenyl]-2,2-dimethylmorpholin-3-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798382 5-Imidazo[1,2-a]pyridin-6-yl-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:60155553 3-amino-6-[4-chloro-3-[(3-methylphenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:81689713 5-fluoro-3-phenyl-2-[(1S)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)propyl]quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798444 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-(3,3-difluoropyrrolidin-1-yl)azetidin-1-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51354879 n-(6-(6-Chloro-5-(3-(trifluoromethyl)phenylsulfonamido)pyridin-3-yl)benzo[d]thiazol-2-yl)acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:51355344 1-Ethyl-3-[4-[7-methyl-6-(1,4-oxazepan-4-yl)purin-2-yl]phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25229450 methyl (4-(4-morpholino-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenyl)carbamate 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71037644 6-[6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141406396 2-(4-Methoxyphenyl)sulfonylchromeno[4,3-c]pyrazol-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754150 US10961236, Example 16 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754159 US10961236, Example 47 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71527008 (2S)-1-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-2-(methylamino)propan-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71716798 N-[2-methyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-5-(oxan-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl]hydroxylamine 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4878126 CHEMBL4878126 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754179 US10961236, Example 27 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:53162198 N-[(3,4-Dimethoxyphenyl)methyl]-2-[5-(quinolin-6-YL)-1,3,4-oxadiazol-2-YL]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:166636444 25-[(1S)-1-cyclopropylethyl]-3,17-dimethyl-21,21-dioxo-21lambda6,31-dithia-4,6,13,17,20,25,30-heptazapentacyclo[20.6.1.12,5.17,11.023,27]hentriaconta-1(28),2,4,7,9,11(30),22(29),23(27)-octaene-12,24-dione 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155539394 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-2-methoxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71527007 3-Amino-1-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]propan-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:617191 2-(morpholin-4-yl)-5,6-dihydro-1,3-benzothiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25032388 2-[4-[2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-7-oxopyrido[2,3-d]pyrimidin-8-yl]cyclohexyl]oxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754135 US10961236, Example 51 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798775 morpholin-4-yl-[6-(1H-pyrazolo[3,4-b]pyridin-5-yl)imidazo[1,2-a]pyridin-3-yl]methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:135397763 N-[2-chloro-5-(3,6-dihydro-2H-pyran-4-yl)pyridin-3-yl]methanesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:86727671 (2R)-1-[4-[5-[5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-methyl-1,2,4-triazol-3-yl]-1-piperidyl]-3-hydroxy-2-methyl-propan-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155563986 1-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004026 2-amino-N-[(1S)-1-[8-[2-(1-methylpiperidin-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004014 2-amino-N-[(1S)-1-[8-[2-(1-methyl-6-oxopyridin-3-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155560766 1-[1-[[2-(2-Aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-1,3-dimethylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155543659 (3S)-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-3-carboxylic acid 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003573 2-amino-N-[(1S)-1-(1-oxo-2-phenylbenzo[h]isoquinolin-3-yl)ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:168273207 2,4-diamino-6-[(2S,5S)-2-[3-(3-fluorophenyl)-5-(5-methoxypyridin-3-yl)-4-oxoquinazolin-2-yl]-5-methylpyrrolidin-1-yl]pyrimidine-5-carbonitrile 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164625366 6-[(3R)-1-(3,3-difluorocyclobutanecarbonyl)pyrrolidin-3-yl]oxy-4-(3-fluoro-5-hydroxyphenyl)-2,3-dihydroisoindol-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:62707599 1-ethyl-3-[4-[4-[(1R,5S)-8-oxa-3-azabicyclo[3.2.1]octan-3-yl]-6,6-dioxo-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-yl]phenyl]urea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:156767718 N-[2-chloro-5-(4-morpholin-4-ylcinnolin-6-yl)pyridin-3-yl]benzenesulfonamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:25032392 2-[4-(2-Amino-4-methyl-7-oxo-6-quinolin-3-ylpyrido[2,3-d]pyrimidin-8-yl)cyclohexyl]oxyacetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118004301 2-amino-N-[(1S)-1-[8-(3,3-diethoxyprop-1-ynyl)-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44137407 3-[4-(Dimethylamino)phenyl]-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71041787 18-Methoxy-15,15-dioxo-15lambda6-thia-4,5,8,16,19,26,28,29-octazahexacyclo[20.5.2.12,5.110,14.117,21.025,28]dotriaconta-1(27),2(32),3,10(31),11,13,17,19,21(30),22(29),23,25-dodecaen-9-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:57411256 4-[2-(5-Fluoro-2,3-dihydroindol-1-yl)-2-oxoethyl]-2-morpholin-4-yl-1,3-thiazole-5-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:90233096 2-[2-[4-amino-6-[[(1S)-1-(5-chloro-4-oxo-3-phenylquinazolin-2-yl)ethyl]amino]pyrimidin-5-yl]ethynyl]pyridine-4-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:66780034 4-[(2-Chlorothiophen-3-yl)methyl]-2-morpholin-4-yl-[1,3]thiazolo[4,5-d]pyrimidin-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:59548402 6-(3-(6-Methoxypyridin-3-ylamino)pyrazin-2-yl)-2-methylpyrimidin-4-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44181722 3-(4-chlorophenyl)-5-morpholino-7H-thieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:44181178 3-Bromo-5-(morpholin-4-yl)-7H-thieno[3,2-b]pyran-7-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:141754240 US10961236, Example 57 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798394 5-(4-Pyridin-3-ylquinolin-6-yl)-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "CHEMBL.COMPOUND:CHEMBL4860613 CHEMBL4860613 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:164626009 6-[(3R)-1-(cyclopropanecarbonyl)pyrrolidin-3-yl]oxy-4-(6-fluoro-5-hydroxypyridin-3-yl)-2,3-dihydroisoindol-1-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70798698 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(1-ethylpiperidin-4-yl)quinazolin-4-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:70688908 N-[4-methyl-5-(4-sulfamoyl-phenyl)-thiazol-2-yl]-acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:622262 5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:118003500 3-amino-5-methyl-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazine-2-carboxamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:46244173 4-{4-[1-(Methylsulfonyl)cyclopropyl]-6-morpholin-4-ylpyrimidin-2-yl}-1H-indole 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:71461240 N-[4-methyl-5-(2-pyridin-3-yl-1,3-oxazol-5-yl)-1,3-thiazol-2-yl]acetamide 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155530224 1-[1-[[2-(2-Aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-3-methylurea 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:50991241 [4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-(1-aminocyclopropyl)methanone 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:155549094 5-(6-Amino-1-butyl-4-methylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine 4.3189392678442804e-05 0.421239\n",
      "PUBCHEM.COMPOUND:90157166 N-(4-chlorophenyl)-N-methyl-3-[4-(methylcarbamoyl)phenyl]imidazo[1,2-a]pyrazine-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470519 US10112926, Example 37.3 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470361 US10112926, Example 88 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470042 US10112926, Example 37.27 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470166 US10112926, Example 37.1 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470106 US10112926, Example 5.5a 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469971 US10112926, Example 37.22 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469990 US10112926, Example 54 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470382 US10112926, Example 22 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470193 US10112926, Example 32 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470330 US10112926, Example 37.28 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470328 US10112926, Example 37.17 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470095 US10112926, Example 37.11 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470270 US10112926, Example 77 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469855 US10112926, Example 37 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470346 US10112926, Example 87 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118472695 US10112926, Example 23a 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470501 US10112926, Example 19.5 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470244 US10112926, Example 37.13 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470303 US10112926, Example 105 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512204 US10112926, Example 114.3 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512137 US10112926, Example 53 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470163 US10112926, Example 5.6 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470161 US10112926, Example 78 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470507 US10112926, Example 104.13 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470097 US10112926, Example 41 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512424 US10112926, Example 37.37a 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118472766 US10112926, Example 55 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470465 US10112926, Example 92 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470111 US10112926, Example 25 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470045 US10112926, Example 16 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126550886 US10112926, Example 101.2 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470137 US10112926, Example 29 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145975616 4-(5-amino-2-pyridin-3-yl-[1,3]thiazolo[5,4-d]pyrimidin-7-yl)-N-(4-methoxyphenyl)piperazine-1-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470121 US10112926, Example 84 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118472265 US10112926, Example 101.3 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470107 US10112926, Example 37.19 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118472762 US10112926, Example 103a 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512371 US10112926, Example 19.13 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470073 US10112926, Example 37.29 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470390 US10112926, Example 70 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512423 US10112926, Example 19.12 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126550883 US10112926, Example 96 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470028 US10112926, Example 37.30 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470386 US10112926, Example 47 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469823 US10112926, Example 37.39 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470153 US10112926, Example 35.1 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469977 US10112926, Example 100 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512330 US10112926, Example 19.4 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470135 US10112926, Example 86 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470118 US10112926, Example 5.2 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469999 US10112926, Example 102 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470231 US10112926, Example 19.10 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470277 US10112926, Example 31 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470108 US10112926, Example 19.19 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470020 US10112926, Example 48 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470071 US10112926, Example 80 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470131 US10112926, Example 12 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470186 US10112926, Example 36a 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469814 US10112926, Example 27 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470397 US10112926, Example 99 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512203 US10112926, Example 19.21 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470461 US10112926, Example 37.20 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470151 US10112926, Example 39 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470190 US10112926, Example 104.2 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512157 US10112926, Example 19.7 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470596 US10112926, Example 38 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118472655 US10112926, Example 19.3 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512219 US10112926, Example 4.8 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470459 US10112926, Example 83.3 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470187 US10112926, Example 34 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:92042839 US10112926, Example 19 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512230 US10112926, Example 19.2 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470293 US10112926, Example 37.9 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470249 US10112926, Example 5.3 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469972 US10112926, Example 35.4 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470089 US10112926, Example 104.15 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470336 US10112926, Example 91 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470468 US10112926, Example 64 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470096 US10112926, Example 89 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470547 US10112926, Example 107 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118472593 US10112926, Example 76a 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469974 US10112926, Example 11 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470479 US10112926, Example 19.16 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470565 US10112926, Example 50 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469778 US10112926, Example 14 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470123 US10112926, Example 19.9 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470048 US10112926, Example 21a 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470026 US10112926, Example 4.7 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470119 US10112926, Example 37.31 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470269 US10112926, Example 104.1 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118472316 US10112926, Example 108 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470428 US10112926, Example 37.7 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470398 US10112926, Example 104.5 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126550885 US10112926, Example 101.1 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470516 US10112926, Example 37.15 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470207 US10112926, Example 35.3 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470062 US10112926, Example 109 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469996 US10112926, Example 2 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512394 US10112926, Example 23b 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469864 US10112926, Example 21b 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469963 US10112926, Example 24 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470514 US10112926, Example 95 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118472286 US10112926, Example 35.2 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469936 US10112926, Example 90 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470230 US10112926, Example 35 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469872 US10112926, Example 37.16 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512409 US10112926, Example 37.6 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470115 US10112926, Example 113 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470340 US10112926, Example 35.5 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470149 US10112926, Example 111 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469816 US10112926, Example 65 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470090 US10112926, Example 19.6 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118472702 US10112926, Example 79 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469819 US10112926, Example 37.5 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118469998 US10112926, Example 93 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470100 US10112926, Example 44 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470065 US10112926, Example 37.4 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470373 US10112926, Example 4.5 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470195 US10112926, Example 104.11 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470087 US10112926, Example 104.6 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470046 US10112926, Example 37.24 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470006 US10112926, Example 37.12 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470224 US10112926, Example 37.23 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:126512285 US10112926, Example 19.22 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470120 US10112926, Example 37.14 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137639858 4-[6-[[(5aS,9aS)-1-methyl-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-2-(1H-indazol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:67284779 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:46196486 1-(4-(4-((6S)-6-hydroxy-3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-4-yl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:46892342 N-(3-(1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenyl)acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71270783 2-Methyl-3-(2-methyl-3-(trifluoromethyl)benzyl)-5-morpholinopyrazolo[1,5-a]pyrimidin-7-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57789333 AZD6482 (S-isomer) 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58204082 2-Hydroxy-1-{3-[2-(2-isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-azetidin-1-yl}-ethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:53350231 5-(6-(2-Methoxypropan-2-yl)-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58204007 2-{4-[2-(2-Isopropyl-5-methyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-pyrazol-1-yl}-ethanol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:50939992 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-2,3-dimethylquinoline 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798602 N-[6-(2-amino-1,3-benzoxazol-5-yl)-1H-indazol-3-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58204237 2-{3-[2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-azetidin-1-yl}-ethanol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57395410 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-2-(dimethylamino)-N-methyl-5-nitrobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548341 4-[5-Bromo-2-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118729947 4-amino-6-[[(1S)-1-[4-[2-(dimethylamino)ethylamino]-6-fluoro-3-phenylquinolin-2-yl]ethyl]amino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49843944 8-Methyl-2-morpholin-4-yl-7-(pyridin-3-ylmethoxy)-1,3-benzoxazin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:53363353 N-[5-(1,3-benzothiazol-6-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44187779 1-[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]-3-(2-methylpyridin-4-yl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58203785 1-{4-[2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-pyrazol-1-yl}-2-methyl-propan-2-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979839 5-(2-Amino-1,3-benzothiazol-5-yl)-7-fluoro-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118540010 1-(5-Tert-butyl-1,2-oxazol-3-yl)-3-[3-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)phenyl]urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:23582995 2-morpholino-8-phenyl-4H-benz[e]-1,3-oxazin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979831 7-(4-Pyridin-4-ylquinolin-6-yl)-1,3-benzothiazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51003483 4-amino-2,6-dimethyl-N-(1H-pyrazol-5-yl)quinazoline-8-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:68405693 5-[3-(Oxan-4-yloxy)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:67192973 8-[(1R)-1-(3,5-difluoro-N-methylanilino)ethyl]-6-(4-hydroxypiperidine-1-carbonyl)-2-morpholin-4-ylchromen-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58379533 1-[1-[(2S)-2-hydroxypropanoyl]piperidin-4-yl]-8-(1H-indazol-4-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:73977451 1-(4-Methoxyphenyl)-3-methyl-8-pyridin-4-ylimidazo[4,5-c]quinolin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49854461 (2S,3S)-1-N-(7-tert-butyl-4,5-dihydro-[1,3]thiazolo[5,4-e][1,3]benzothiazol-2-yl)-3-methylpyrrolidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798689 6-[3-(4-Methylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:121428416 PI3K/mTOR Inhibitor-1 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235033 8-[1-(3,5-difluoroanilino)ethyl]-N-ethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:72709284 (S)-1-(3-Methyl-2-oxobutyl)-8-((R)-3-methylmorpholino)-2-(trifluoromethyl)-3,4-dihydro-1H-pyrimido[1,2-a]pyrimidin-6(2H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:24905153 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137641405 4-[2-(1H-indazol-4-yl)-6-[[4-(3-methyl-1,2,4-triazol-4-yl)piperidin-1-yl]methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44552666 2-((1-(2-(dimethylamino)ethyl)-5-methoxy-2-methyl-1H-indol-3-yl)methylene)-4,6-dihydroxybenzofuran-3(2H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58379551 1-(1-Acetylpiperidin-4-yl)-3-methyl-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235041 8-(1-(3,5-dichlorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141519562 PI3Ka-IN-5 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44552664 4,6-dihydroxy-2-((5-methoxy-2-methyl-1-(2-(4-methylpiperazin-1-yl)ethyl)-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54585830 N-(1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-yl)-1H-indazol-3-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49854679 CID 49854679 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155639 3-amino-6-[4-chloro-3-[(4-chlorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44189010 1-[4-(3-Isopropyl-7-morpholin-4-yl-3H-[1,2,3]-triazolo[4,5-d]pyrimidin-5-yl)phenyl]-3-(4-morpholin-4-ylphenyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44516309 1-(4-(4,6-Dimorpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58203808 1-{3-[2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-azetidin-1-yl}-2-methyl-propan-2-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49854680 CID 49854680 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71270824 2-methyl-3-(2-methyl-3-(trifluoromethyl)benzyl)-5-(tetrahydro-2H-pyran-4-yl)pyrazolo[1,5-a]pyrimidin-7-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44621458 5-(2-amino-5-fluoro-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:53326216 4-amino-2,6-dimethyl-N-(1H-pyrrolo[2,3-b]pyridin-5-yl)quinazoline-8-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145951013 (2S)-2-amino-N-[5-[6-chloro-5-[(4-propan-2-ylphenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:25172661 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-ethyl-2-methyl-5-nitrobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44621447 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-methylpyridine-3-sulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798665 5-(3-Morpholin-4-ylimidazo[1,2-b]pyridazin-6-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54669876 2-N-[2-chloro-5-(dimethylcarbamoyl)phenyl]-2-N,8-N-dimethyl-4,5-dihydrothieno[3,2-d][1]benzoxepine-2,8-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51355621 1-ethyl-3-[4-[1-methyl-7-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrazolo[4,3-d]pyrimidin-5-yl]phenyl]urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54579941 1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(1-methyl-1H-pyrazol-3-yl)-1H-benzo[d]imidazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44515696 Methyl 4-[({4-[bis(morpholin-4-yl)-1,3,5-triazin-2-yl]phenyl}carbamoyl)amino]benzoate 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155535691 1-[1-[[2-(2-Aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-3-methylurea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58379543 1-(1-Acetylpiperidin-4-yl)-8-(6-methoxypyridin-3-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:127025628 2,4-Difluoro-N-[2-methoxy-5-[4-[3-(4-methylsulfonylpiperazin-1-yl)prop-1-ynyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798568 5-[3-(4-Aminopiperidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44180395 3-[4-(Methylamino)phenyl]-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44514201 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-(4-fluorophenyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70684690 N-[5-(4-Methanesulfonyl-3-trifluoromethyl-phenyl)-4-methyl-thiazol-2-yl]-acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52950102 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(2-hydroxyethyl)phenyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71042022 5-Methoxy-8,8-dioxo-8lambda6-thia-4,7,15,19,25-pentazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22(30),23,25,27-tetradecaen-14-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54581049 1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-phenyl-1H-benzo[d]imidazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118730715 8-[(3,5-difluoroanilino)methyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:166634836 (2S)-1-[4-[[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]-4-hydroxypyrrolidine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58204259 2-{3-[2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-azetidin-1-yl}-isobutyramide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57390138 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-2-methyl-N-(2-morpholin-4-ylethyl)-5-nitrobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137643598 CID 137643598 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155524467 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-2-methoxy-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:50939209 4-[3,3-Dimethyl-6-(Morpholin-4-Yl)-2,3-Dihydro-1h-Indol-1-Yl]-7-Fluoro-3-Methyl-2-(Pyridin-3-Yl)quinoline 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59259019 2-Amino-8-cyclopentyl-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235052 8-[1-(3-chloroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137639119 4-[4-Amino-5-[2-(2,2,2-trifluoroethyl)pyrazol-3-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]-2-(2,2-dimethyl-3-oxomorpholin-4-yl)benzonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52941322 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-((4-methylpiperazin-1-yl)methyl)phenyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:72550012 Unii-rca38L4HB5 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979884 6-(2-Amino-1,3-benzothiazol-6-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71042086 18-Fluoro-25-methoxy-22,22-dioxo-3,22lambda6,30-trithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,12,17,19,21(29),24,26-dodecaen-16-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52949869 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(hydroxymethyl)phenyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:168297519 5-chloro-3-(3-fluorophenyl)-2-[(2S,5S)-5-methyl-1-(7H-purin-6-yl)pyrrolidin-2-yl]quinazolin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44129118 (2S,4R)-1-N-[5-(2-tert-butyl-1,3-thiazol-4-yl)-4-methyl-1,3-thiazol-2-yl]-4-fluoropyrrolidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155531526 (3S)-N-(2-amino-2-oxoethyl)-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-3-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:139207773 5-(6-Azanyl-4-chloranyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798693 2-[4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979791 [6-(2-Amino-1,3-benzothiazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754200 US10961236, Example 20 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:6620134 Quinostatin 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49854462 (1S,5R)-2-N-(7-tert-butyl-4,5-dihydro-[1,3]thiazolo[5,4-e][1,3]benzothiazol-2-yl)-2-azabicyclo[3.1.0]hexane-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798381 5-[3-(1-Methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49872243 4-Amino-6-[1-[4-(dimethylamino)-6-fluoro-3-pyridin-2-ylquinolin-2-yl]ethylamino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145963117 (2S)-2-amino-N-[5-[6-chloro-5-[[4-(trifluoromethyl)phenyl]sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44125375 N-(5-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)-1H-benzo[d]imidazol-2-yl)acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754219 US10961236, Example 55 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:50925576 N-(5-(3-(3,4-dimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)pyridin-3-yl)benzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71270910 2-amino-3-[(2,3-dichlorophenyl)methyl]-5-(oxan-4-yl)-1H-pyrazolo[1,5-a]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:42606077 3-(Pyridin-4-ylethynyl)-1H-indazole 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137661095 4-[6-[[(5aS,9aS)-1-(trifluoromethyl)-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-2-(1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155383508 2-amino-N-cyclopropyl-5-[2-[(1S)-1-cyclopropylethyl]-1-oxo-7-propan-2-ylsulfonyl-3H-isoindol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52950001 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(2-chloropyridin-4-yl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155469 3-amino-6-(4-chloro-3-sulfamoylphenyl)-N-methylpyrazine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11254470 S-(7-anilino-7-oxoheptyl) ethanethioate 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:149556361 2-[[4-[4-(Trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155512775 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145969816 Methyl 3-[[6-[5-(ethylsulfonylamino)-6-methoxypyridin-3-yl]quinazolin-4-yl]amino]benzoate 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:46932297 (S)-N1-(5-(2-(Tert-butyl)pyridin-4-YL)-4-methylthiazol-2-YL)pyrrolidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:76325446 4-[2-(4-Bromo-2-methyl-2,3-dihydroindol-1-yl)-2-oxoethyl]-2-morpholin-4-yl-1,3-thiazole-5-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51354597 n-(6-(6-Cyano-5-(4-methoxyphenylsulfonamido)pyridin-3-yl)benzo[d]thiazol-2-yl)acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798610 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3-fluoroazetidin-1-yl)methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58204138 2-{4-[2-(5-Amino-2-isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-pyrazol-1-yl}-ethanol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49872924 4-Amino-6-[1-[6-fluoro-4-(2-hydroxyethylamino)-3-phenylquinolin-2-yl]ethylamino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145439085 N-(2-(2-(2-(3-(4-(4-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)piperazin-1-yl)-3-oxopropoxy)ethoxy)ethoxy)ethoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide 5.3986449388087826e-05 0.409473\n",
      "CHEMBL.COMPOUND:CHEMBL1234354 PF-04691502 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58203695 5-{8-[1-(2-Hydroxy-2-methyl-propyl)-1H-pyrazol-4-yl]-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-2-yl}-4-isopropyl-2,4-dihydro-[1,2,4]triazol-3-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59293755 CID 59293755 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:25057242 4-(3,4-Dimethoxyphenyl)-6-quinolin-3-ylquinazoline 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71270836 3-(2,3-Dichlorobenzyl)-2-ethyl-5-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:135391000 Puquitinib mesylate dihydrate 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:122188269 2-chloro-N-[(E)-(5-chloropyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-N-methyl-5-nitrobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:122188275 N-[(E)-(5-cyanopyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145959980 2-amino-N-[5-[5-(benzenesulfonamido)-6-methoxypyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137661301 3-[6-[[(5aR,9aS)-1-(trifluoromethyl)-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl]phenol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:132156028 4-(difluoromethyl)-5-[4-[(3R)-3-methylmorpholin-4-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]pyridin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155542800 4-Phenyl-6-quinolin-3-ylquinazoline 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155552 3-amino-6-[4-chloro-3-[(3-chlorophenyl)sulfonylamino]phenyl]-N-methylpyrazine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44513888 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-(4-methylphenyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59507757 2-amino-5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-1H-pyrimidin-6-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798754 5-[3-[3-(Dimethylamino)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49853846 (2S,4R)-1-N-(8-tert-butyl-4,5-dihydro-[1,3]thiazolo[4,5-h]quinazolin-2-yl)-4-(dimethylamino)pyrrolidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235018 8-[1-(3,5-difluoroanilino)ethyl]-N-ethyl-N-methyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:76287717 2-[(1s)-1-({6-Amino-5-[(1h-Pyrazol-4-Yl)ethynyl]pyrimidin-4-Yl}amino)ethyl]-5-Chloro-3-Phenylquinazolin-4(3h)-One 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52941479 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-3-yl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:67535551 3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(1H-indazol-4-yl)imidazo[1,2-a]pyridin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798751 5-[3-(4-Cyclopropylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798564 6-(2-amino-1,3-benzoxazol-5-yl)-N-methyl-N-(1-methylpiperidin-4-yl)imidazo[1,2-a]pyridine-3-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235073 8-[1-(3,5-difluoroanilino)ethyl]-N,N-diethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235088 8-[1-(3-fluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754210 US10961236, Example 13 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11154943 4-[2-(2,4-dimethylanilino)-2-oxoethoxy]-N-(3-fluorophenyl)naphthalene-1-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548245 4-(2-(5-fluoro-6-methoxypyridin-3-ylamino)-5-((S)-1-((S)-2-methyl-4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44516307 4-[({4-[Bis(morpholin-4-yl)-1,3,5-triazin-2-yl]phenyl}carbamoyl)amino]benzoic acid 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:46885648 4,6-dihydroxy-2-((1-(2-(4-(3-hydroxypropyl)piperazin-1-yl)ethyl)-5-methoxy-2-methyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59258855 2-amino-4-methyl-8-propan-2-yl-6-(1H-pyrazol-4-yl)pyrido[2,3-d]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44187951 methyl 4-(3-(4-(3-ethyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)ureido)benzoate 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71041627 10,12-Difluoro-5-methoxy-8,8-dioxo-8lambda6-thia-4,7,15,19,25,29-hexazahexacyclo[20.6.2.12,6.19,13.117,21.026,30]tritriaconta-1(29),2(33),3,5,9,11,13(32),17(31),18,20,22(30),23,25,27-tetradecaen-14-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118436386 1-[(3R)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]ethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44610317 N-[5-[3-(4-acetylpiperazin-1-yl)quinoxalin-6-yl]-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979793 N-[5-(2-amino-1,3-benzoxazol-5-yl)-1,3-thiazol-2-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58204017 2-[4-[2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazol-8-yl]pyrazol-1-yl]ethanamine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798839 2-Amino-1-[4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-2-methylpropan-1-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57401869 1-[(2,3-Dichlorophenyl)methyl]-2,3-dimethyl-7-morpholin-4-ylimidazo[1,2-a]pyrimidin-5-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44623107 N-(6-(6-Chloro-5-(phenylsulfonamido)pyridin-3-yl)benzo-[d]thiazol-2-yl)acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548283 4-(4-(6-Methoxypyridin-3-ylamino)pyrimidin-5-yl)-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71271965 3-(2-Methyl-3-(trifluoromethyl)benzyl)-5-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155556073 1-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-2-[(2S)-pyrrolidin-2-yl]ethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57404840 4-(cyclopropylmethyl)-N-methyl-5-[2-(pyridin-4-ylamino)pyrimidin-4-yl]pyrimidin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57411254 4-[2-(4-Bromo-2,3-dihydroindol-1-yl)-2-oxoethyl]-2-morpholin-4-yl-1,3-thiazole-5-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118444399 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylpyrrolidine-1-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:153532120 PI3K/mTOR Inhibitor-6 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145983808 2-[[4-amino-3-(1H-indol-5-yl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-3-(2,6-dimethylphenyl)-5-fluoroquinazolin-4-one 5.3986449388087826e-05 0.409473\n",
      "CHEBI:77276 1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol 4,5-biphosphate 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54579944 1-(4-methyl-6-(prop-2-ynylamino)-1,3,5-triazin-2-yl)-N-(1H-pyrazol-3-yl)-1H-benzo[d]imidazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70686829 N-[4-methyl-5-(4-pyrazol-1-ylphenyl)-1,3-thiazol-2-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:134156160 2-methoxy-5-[4-[(3S)-1-propanoylpyrrolidin-3-yl]oxyquinazolin-6-yl]pyridine-3-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:42623223 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-N-tert-butylpyridine-3-sulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49872344 2-[(1S)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]ethyl]-6-fluoro-3-phenylquinoline-4-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49785832 4-(2-(5-fluoro-6-methoxypyridin-3-ylamino)-5-((R)-1-((R)-2-methyl-4-(methylsulfonyl)piperazin-1-yl)ethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58203795 2-{4-[2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-pyrazol-1-yl}-isobutyramide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118709583 9-[(1R)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71037685 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(2-hydroxyethyl)quinazolin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137657006 4-[2-(1H-indol-4-yl)-6-[[4-(3-methyl-1,2,4-triazol-4-yl)piperidin-1-yl]methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49855001 CID 49855001 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:10475366 3-(6-(1H-indazol-5-ylamino)-2-morpholinopyrimidin-4-yl)phenol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155641 3-amino-6-[4-chloro-3-[(2-chloro-4-fluorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52949347 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-phenylurea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155561233 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-2-methoxy-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798414 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3S)-3-methylmorpholin-4-yl]methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:66780379 4-[(3-Chloro-2-methylphenyl)methyl]-2-morpholin-4-yl-[1,3]thiazolo[4,5-d]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548355 4-[2-[(5-Fluoropyridin-3-yl)amino]-5-[(4-methylsulfonylpiperazin-1-yl)methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58203898 2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-8-(1-methanesulfonylmethyl-1H-pyrazol-4-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798569 6-(2-amino-1,3-benzoxazol-5-yl)-N-(2-pyrrolidin-1-ylethyl)imidazo[1,2-a]pyridine-3-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57403580 1-[(2,3-Dichlorophenyl)methyl]-6-fluoro-7-morpholin-4-ylimidazo[1,2-a]pyrimidin-5-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548474 4-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[(1S)-1-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]ethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71528726 CID 71528726 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798741 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(5,8-dioxa-2-azaspiro[3.4]octan-2-yl)methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59634692 2-(1-(6-Amino-5-cyanopyrimidin-4-ylamino)ethyl)-6-fluoro-3-(pyridin-2-yl)quinoline-4-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:50991238 5-[4-[(1-Methylpiperidin-4-yl)amino]quinazolin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11955693 4-[4-(2-Methylbenzimidazol-1-yl)-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155532037 N-[2-chloro-5-(3,6-dihydro-2H-pyran-4-yl)pyridin-3-yl]benzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:66653673 [(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-(oxan-4-yl)methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57397253 2-chloro-N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-methyl-5-nitrobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754170 US10961236, Example 7 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44819024 1-[4-(3-methyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]-3-pyridin-3-ylurea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:122179492 3-(1,3-Benzodioxol-5-yl)-5-[[4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]anilino]methyl]benzoic acid 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155546361 2-[2,4,6-Tri(propan-2-yl)phenyl]sulfonylchromeno[4,3-c]pyrazol-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44577593 5,5-dimethyl-2-(6-(pyridin-3-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-5,6-dihydrobenzo[d]thiazol-7(4H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:76324823 5-(4-Morpholin-4-ylpyrido[2,3-d]pyrimidin-2-yl)pyrimidin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155548973 5-(6-Amino-4-fluoro-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145983168 2,4-difluoro-N-[2-methoxy-5-[4-(3-morpholin-4-ylpropyl)-3-oxo-1,4-benzoxazin-6-yl]pyridin-3-yl]benzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:67104052 8-[(1S)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-[(2S)-2-methylmorpholin-4-yl]-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57399042 4-[4-[2-(Difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11562853 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-2-methoxy-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51354600 N-[6-[6-Chloro-5-[[(4-methoxyphenyl)sulfonyl]amino]-3-pyridinyl]-1,3-benzothiazol-2-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548322 4-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[(1R)-1-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]ethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979789 5-[3-(4-Methylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzothiazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:146585699 4-[[[2-[(1S)-1-[(6-amino-5-cyanopyrimidin-4-yl)amino]propyl]-4-oxo-3-phenylquinazolin-5-yl]amino]methyl]-N-hydroxybenzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754229 US10961236, Example 22 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51354317 N-(6-(6-(4-Methoxyphenylsulfonamido)pyrazin-2-yl)benzo-[d]thiazol-2-yl)acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798744 [5-(2-Amino-1,3-benzoxazol-5-yl)pyrazolo[1,5-a]pyridin-3-yl]-pyrrolidin-1-ylmethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155565958 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:86647783 N-(2-isopropyl-4'-methyl-[4,5']bithiazolyl-2'-yl)-acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155643 3-amino-6-[4-chloro-3-[(2,4-dichlorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:66780016 5-Benzyl-4-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-2-morpholin-4-yl-[1,3]thiazolo[4,5-d]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:86727669 (3R)-1-[4-[5-[5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-methyl-1,2,4-triazol-3-yl]-1-piperidyl]-3-hydroxy-butan-1-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44545041 2-[2-(2-Aminopyrimidin-5-yl)-9-(2-hydroxyethyl)-6-morpholin-4-ylpurin-8-yl]propan-2-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:50940108 4-(3,3-Dimethyl-6-(4-pyridinyl)-2,3-dihydro-1H-indol-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70688455 1-[6-[5-(Tert-butylsulfamoyl)pyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44621448 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(2,2,2-trifluoroethyl)pyridine-3-sulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754149 US10961236, Example 34 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58379595 1-(1-acetylpiperidin-4-yl)-8-(1H-indazol-4-yl)-3-methylimidazo[4,5-c][1,5]naphthyridin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44347599 (2S)-2-[(4-chlorophenyl)methoxymethyl]-1-[2-(4-methoxyphenyl)ethyl]pyrrolidine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155557988 N-[3-(2-oxo-8-pyridin-3-yl-[1]benzofuro[3,2-b]pyridin-1-yl)phenyl]prop-2-enamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58379507 1-[1-(2-Hydroxyacetyl)piperidin-4-yl]-3-methyl-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52913931 8-(1-(3-chloro-4-fluorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798876 [6-(2-Amino-1,3-benzoxazol-6-yl)-8-methylimidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155535537 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-2-methoxy-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118498935 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-3-methyl-1-[(3S)-oxan-3-yl]imidazo[4,5-c]quinolin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145955279 (2S)-2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]butanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798738 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(2-methoxyethyl)quinazolin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44513885 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-pyridin-3-ylurea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44188843 1-[4-(3-isopropyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)-phenyl]-3-pyridin-3-yl-urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58203776 1-{4-[2-(5-Amino-2-isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-pyrazol-1-yl}-2-methyl-propan-2-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:45379223 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)-phenyl]-3-pyridazin-4-ylurea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798565 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(2-methylmorpholin-4-yl)methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70691776 3-[(2,3-Dichlorophenyl)methyl]-2-methylsulfanyl-5-morpholin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58234990 8-(1-(2,5-difluorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155722 3-amino-6-[4-chloro-3-[(2,3-dichlorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44514203 (4-Chlorophenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798673 6-(2-Amino-1,3-benzoxazol-5-yl)-3-piperidin-4-ylquinazolin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155557 3-amino-6-[4-chloro-3-[(3-chlorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548278 (S)-4-(2-(5-fluoro-6-methoxypyridin-3-ylamino)-5-((2-methyl-4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548236 4-[2-[(5-Fluoro-6-methoxypyridin-3-yl)amino]-5-[2-(4-methylsulfonylpiperazin-1-yl)propan-2-yl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:68405660 5-(2-Amino-1,3-benzoxazol-5-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:66780644 4-[(2-Methylphenyl)methyl]-2-morpholin-4-yl-[1,3]thiazolo[4,5-d]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155568452 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-N-methylmethanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235039 8-[1-(3,5-difluoroanilino)ethyl]-N-(2-methoxyethyl)-N-methyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798609 5-(3-amino-1H-indazol-6-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548221 4-(2-(5-Methoxypyridin-3-ylamino)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71041798 25-Methoxy-22,22-dioxo-3,22lambda6,30-trithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,12,17(29),18,20,24,26-dodecaen-16-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:66571003 Zandelisib 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54584860 1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(1-methyl-1H-pyrazol-5-yl)-1H-benzo[d]imidazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798391 5-[4-(1-Methylpyrazol-4-yl)quinolin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754205 US10961236, Example 41 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979883 N-[6-(2-amino-1,3-benzoxazol-6-yl)-1,3-benzothiazol-2-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:76335670 1-Methyl-3-[4-(4-morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenyl]urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44552667 4,6-dihydroxy-2-((5-methoxy-2-methyl-1-(2-morpholinoethyl)-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798556 6-(2-Amino-1,3-benzoxazol-5-yl)-4-pyridin-4-ylquinoline-3-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57400641 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-2-methoxy-N-methyl-5-nitrobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:162672741 N-[(2S)-1-amino-1-oxopropan-2-yl]-2-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)anilino]-3H-benzimidazole-5-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155540264 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:10217416 N-(benzenesulfonyl)-4-[5-[3-(trifluoromethyl)phenyl]-1H-imidazol-2-yl]cyclohexane-1-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145960272 (2S)-2-amino-N-[5-[6-chloro-5-[(3,4-dichlorophenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52943745 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(2-(dimethylamino)ethoxy)phenyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:10379373 N-quinolin-3-yl-7-sulfanylheptanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155561328 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-N-methylmethanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155530163 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]methanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44125377 N-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]imidazo[1,2-a]pyridin-2-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548390 4-[2-[(5-Fluoro-6-methoxypyridin-3-yl)amino]-5-[(4-methylsulfonylpiperazin-1-yl)methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11403978 1-[(E)-2-phenylethenyl]-4-piperidin-1-ylpyrazolo[3,4-d]pyrimidine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59453078 8-[2-(oxan-4-yl)ethyl]-2-[4-(1H-1,2,4-triazol-5-yl)phenyl]-5,7-dihydropyrazino[2,3-b]pyrazin-6-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:67103974 8-[(1R)-1-(3,5-difluoro-N-methylanilino)ethyl]-N-(2-hydroxyethyl)-N-methyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71270927 3-(2,3-Dichlorobenzyl)-5-morpholino-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-7-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52946289 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(dimethylamino)phenyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70688558 1-[6-[5-(Tert-butylsulfamoyl)pyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-morpholin-4-ylethyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44475987 2-{[4-Amino-3-(3-Hydroxyprop-1-Yn-1-Yl)-1h-Pyrazolo[3,4-D]pyrimidin-1-Yl]methyl}-5-Methyl-3-(2-Methylphenyl)quinazolin-4(3h)-One 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:166630960 N-[(2S)-1-amino-1-oxopropan-2-yl]-4-[[4-[4-[(3S)-3-methylmorpholin-4-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]carbamoylamino]benzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:162644684 2,4-difluoro-N-[2-methoxy-5-[4-[(E)-4-(4-methylpiperazin-1-yl)-4-oxobut-2-en-2-yl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54583916 3-(1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)benzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59293740 (2S)-1-N-[5-[2-(diethylamino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:132606879 3-[6-[[4-(3-Methyl-1,2,4-triazol-4-yl)piperidin-1-yl]methyl]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl]phenol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:53235062 2-(2-propan-2-yl-1,2,4-triazol-3-yl)-8-(1H-pyrazol-4-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazole 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:53378051 2-(1-{[2-(5-Fluoro-1h-Indol-4-Yl)-4-(Morpholin-4-Yl)pyrido[3,2-D]pyrimidin-6-Yl]methyl}piperidin-4-Yl)propan-2-Ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118547301 N-Hydroxy-4-[5-(Morpholin-4-Yl)-7-Oxo-7h-Thieno[3,2-B]pyran-3-Yl]benzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:153532118 1-[2-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)anilino]-3H-benzimidazole-5-carbonyl]piperidine-4-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11595536 4-[6-methylsulfanyl-1-[(E)-2-phenylethenyl]pyrazolo[3,4-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70676303 5-[6-(3-Methoxyoxetan-3-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl]pyrimidin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137655828 4-(4-Amino-5-chloropyrrolo[2,1-f][1,2,4]triazin-7-yl)-2-(2,2-dimethyl-3-oxomorpholin-4-yl)benzonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155512515 2-[[4-(2,4,6-Trimethylphenyl)sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155535520 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]-N-methylmethanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:163408818 Mek/PI3K-IN-2 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58203789 2-Amino-1-{3-[2-(2-isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-azetidin-1-yl}-2-methyl-propan-1-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11955695 2-(2-Difluoromethylbenzimidazol-1-yl)-4-morpholino-6-(piperazin-1-yl)-1,3,5-triazine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118444335 5-[7-[(3S)-3-methyl-1-methylsulfonylpyrrolidin-3-yl]-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl]pyrimidin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51354313 N-(6-(2-(4-Methoxyphenylsulfonamido)pyridin-4-yl)benzo-[d]thiazol-2-yl)acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44516311 N-(2-(dimethylamino)ethyl)-4-(3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)ureido)-N-methylbenzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:10357196 3-Amino-N-Methyl-6-[3-(1h-Tetrazol-5-Yl)phenyl]pyrazine-2-Carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70690496 1-[6-[5-(Tert-butylsulfamoyl)pyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-pyrazol-1-ylethyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798407 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-b]pyridazin-3-yl]-morpholin-4-ylmethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754151 US10961236, Example 19 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54579943 1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(1H-pyrazol-4-yl)-1H-benzo[d]imidazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145953653 (2S,3R)-2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-hydroxybutanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59293763 (2S)-1-N-[5-(2-cyclobutylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798594 5-[3-[3-[4-(Cyclopropylmethyl)piperazin-1-yl]azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71037738 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(2-morpholin-4-ylethyl)quinazolin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155805 5-(2-amino-4-methoxypyrimidin-5-yl)-2-chloro-N-(2,3-difluorophenyl)benzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44540130 N-(6-{6-Chloro-5-[(phenylsulfonyl)amino]-3-pyridinyl}-1H-indazol-4-yl)-2-methyl-1,3-thiazole-4-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58234995 8-[1-(3,5-Difluoroanilino)ethyl]-6-(4-hydroxypiperidine-1-carbonyl)-2-morpholin-4-ylchromen-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137636115 2,4-diamino-6-[[(1S)-1-[4-oxo-5-(6-oxo-6-pyrrolidin-1-ylhex-1-ynyl)-3-phenylquinazolin-2-yl]propyl]amino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798386 5-[4-(1H-pyrazol-4-yl)quinolin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:142752519 US10961236, Example 21 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44548482 4-(3-{4-[4-(8-Methyl-8-aza-bicyclo[3.2.1]oct-3-yloxy)-6-morpholin-4-yl-[1,3,5]triazin-2-yl]-phenyl}-ureido)-benzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:50939212 1-(7-Fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-6-(4-morpholinyl)-1,2-dihydrospiro[indole-3,3'-thietane]1',1'-dioxide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71037667 2-[4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]pyrazol-1-yl]ethanol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59293709 (2S)-1-N-[5-[2-(1-cyanocyclopropyl)pyridin-4-yl]-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:25172665 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-methyl-3-nitrobenzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44129429 CID 44129429 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:122188271 N,2-dimethyl-N-[(E)-(5-methylpyrazolo[1,5-a]pyrimidin-3-yl)methylideneamino]-5-nitrobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11414831 N-[4-(dimethylamino)phenyl]-7-sulfanylheptanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155806 5-[2-amino-4-(2,2,2-trifluoroethoxy)pyrimidin-5-yl]-2-chloro-N-(2,3-difluorophenyl)benzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58379501 1-(1-acetylpiperidin-4-yl)-3-methyl-8-(1H-pyrazolo[3,4-b]pyridin-5-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57391962 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-2-ethyl-N-methyl-5-nitrobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155379 3-amino-6-[4-chloro-3-(methylsulfamoyl)phenyl]-N-methylpyrazine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798441 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155538 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-[(4-methylsulfonyl-1,4-diazepan-1-yl)methyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44189011 1-(4-Dimethylaminophenyl)-3-[4-(3-isopropyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]-urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155565551 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548458 (R)-4-(2-(5-Fluoro-6-methoxypyridin-3-ylamino)-5-((2-methyl-4-(methylsulfonyl)piperazin-1-YL)methyl)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57400064 1-[(2,3-Dichlorophenyl)methyl]-7-[2-(hydroxymethyl)morpholin-4-yl]imidazo[1,2-a]pyrimidin-5-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137653565 3-[6-[[(5aS,9aS)-1-methyl-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl]phenol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155534269 N-[5-(3,6-dihydro-2H-pyran-4-yl)-2-methoxy-pyridin-3-yl]benzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:67535197 N-[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)imidazo[1,2-a]pyridin-2-yl]quinolin-7-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52943744 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-methylpiperazin-1-yl)phenyl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71270723 3-(2,3-Dichlorobenzyl)-2-methoxy-5-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:89216374 N-[2-chloro-5-[3-(1-methylpiperidin-4-yl)-4-oxoquinazolin-6-yl]pyridin-3-yl]methanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798745 [5-(2-Amino-1,3-benzoxazol-5-yl)pyrazolo[1,5-a]pyridin-3-yl]-morpholin-4-ylmethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:121334488 4-(Difluoromethyl)-5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)pyrimidin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:66780266 4-[(2,3-Dichlorophenyl)methyl]-2-morpholin-4-yl-[1,3]thiazolo[4,5-d]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71461243 N-[5-(2-tert-butyl-1,3-oxazol-5-yl)-4-methyl-1,3-thiazol-2-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:24855584 3-[[5-(3-fluoro-4-methylsulfonylphenyl)-4-methyl-1,3-thiazol-2-yl]carbamoylamino]-N-(5-methyl-1,2-oxazol-3-yl)propanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44819199 1-(4-(3-cyclopropyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)-3-(pyridin-3-yl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11418892 (2S)-1-N-[5-(3-fluoro-4-methylsulfonylphenyl)-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44552845 4,6-dihydroxy-2-((5-methoxy-2-methyl-1-(3-morpholinopropyl)-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51354315 N-(6-(5-(4-Methoxyphenylsulfonamido)pyridin-3-yl)benzo-[d]thiazol-2-yl)acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137648826 4-[6-[[(5aR,9aS)-1-methyl-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-2-(1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137658031 4-[2-(1H-indol-4-yl)-6-[[4-[3-(trifluoromethyl)-1,2,4-triazol-4-yl]piperidin-1-yl]methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118728332 2-Methyl-11-nitro-6,7-dihydrobenzimidazolo[1,2-d][1,4]benzoxazepine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44605249 Isopropyl 4-(6-(4-(3-Methylureido)phenyl)-4-morpholino-1Hpyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:67103709 N,N-dimethyl-2-morpholin-4-yl-4-oxo-8-[(1R)-1-(2,3,5-trifluoroanilino)ethyl]chromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:73977449 3-Methyl-1-(4-methylphenyl)-8-pyridin-4-ylimidazo[4,5-c]quinolin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52913592 8-(1-(3-fluoro-5-methylphenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44605428 4-{6-[4-(3-Methyl-ureido)-phenyl]-4-morpholin-4-yl-pyrazolo[3,4-d]pyrimidin-1-yl}-piperidine-1-carboxylic acid tert-butyl ester 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548320 4-(5-(Azetidin-1-ylmethyl)-2-(6-methoxypyridin-3-ylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235030 8-[1-(2,3-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44621449 CID 44621449 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11999032 (S)-2-(3-((1H-indol-3-yl)methyl)morpholino)-7,7-dimethyl-5,6,7,8-tetrahydrothiazolo[5,4-c]azepin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:166633789 N-[(2R)-1-amino-1-oxopropan-2-yl]-4-[[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235016 8-[1-(3,5-Difluoroanilino)ethyl]-2-morpholin-4-yl-6-(piperidine-1-carbonyl)chromen-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52946368 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(pyridazin-4-yl)urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137646667 CID 137646667 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155533564 2-[4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-1-[(2R)-pyrrolidin-2-yl]ethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:153411886 N-[5-[3-[4-[3-[2-[2-(2-aminooxyethoxy)ethoxy]ethoxy]propanoyl]piperazin-1-yl]quinoxalin-6-yl]-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70681248 2-Cyclopropyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-5-morpholin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798641 4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145982349 4-[4-(3,4-dichlorophenyl)-1H-pyrazol-5-yl]benzene-1,2,3-triol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235061 8-[1-(3,5-difluoroanilino)ethyl]-N-(2-methoxyethyl)-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58203922 (2S)-3-[3-[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazol-8-yl]azetidin-1-yl]propane-1,2-diol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44608429 N-(2-Chloro-5-(3-(piperazin-1-yl)quinoxalin-6-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:134152988 1-[(3S)-3-[[6-(6-methoxypyridin-3-yl)-1,5-naphthyridin-4-yl]oxy]pyrrolidin-1-yl]propan-1-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44188321 N-butyl-4-({[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]carbamoyl}amino)benzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71037727 (2R)-1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]pyrrolidine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71454160 7-[5-(2,2-Dimethylazetidin-1-yl)sulfonylpyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155376 5-[3-[4-[2-(4-Propan-2-ylphenyl)pyridin-3-yl]piperazin-1-yl]sulfonylphenyl]pyrimidin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:163409152 DNA-PK-IN-8 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979841 6-[3-[(3S)-3-methylpiperazin-1-yl]quinoxalin-6-yl]-1,3-benzothiazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59688563 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-N-methylmethanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49854156 (1S,5R)-2-N-(8-tert-butyl-4,5-dihydro-[1,3]thiazolo[4,5-h]quinazolin-2-yl)-2-azabicyclo[3.1.0]hexane-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57330208 4-amino-6-[[(1S)-1-(6-fluoro-3,4-dipyridin-2-ylquinolin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44577920 2-(6-(1H-pyrazol-4-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-5,5-dimethyl-5,6-dihydrobenzo[d]thiazol-7(4H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:127025346 Ethyl 4-[3-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]quinolin-4-yl]prop-2-ynyl]piperazine-1-carboxylate 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798514 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-piperidin-1-ylmethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:25229608 3-(4-Morpholino-1-methyl-1H-pyrazolo[3,4-d]pyrimidine-6-yl)phenol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118630925 2,4-diamino-6-[[(1S)-1-(7-fluoro-4-oxo-3-phenylquinolizin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:50908894 3-(6-(6-Methoxypyridin-3-ylamino)-2-morpholinopyrimidin-4-yl)phenol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118709582 9-[1-(3,4-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137655123 4-[6-[[(5aS,9aS)-1-(trifluoromethyl)-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-2-(1H-indazol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58379663 1-[1-(2-Methoxyacetyl)piperidin-4-yl]-3-methyl-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:73977461 2-Methyl-2-[4-[3-methyl-8-(1-methylpyrazol-4-yl)-2-oxoimidazo[4,5-c]quinolin-1-yl]phenyl]propanenitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:67103722 8-[(1R)-1-(3,4-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979880 6-[3-(4-Methylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzothiazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:56932240 N-tert-Butyl-5-(2-(3-(2-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)ethyl)ureido)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)pyridine-3-sulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145956886 (2S)-2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-4-methylpentanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137650579 4-[6-[[(5aR,9aS)-1-(trifluoromethyl)-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-2-(1H-indazol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155536473 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]methanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235020 8-(1-(3-fluoro-5-methoxyphenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:46885599 4,6-dihydroxy-2-((5-methoxy-1,2-dimethyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798776 [6-(2-Amino-1,3-benzoxazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235062 8-[1-(3,5-difluoroanilino)ethyl]-N-(2-hydroxyethyl)-N-methyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "CHEMBL.COMPOUND:CHEMBL4739883 CHEMBL4739883 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:142752521 US10961236, Example 8 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70685441 3-[(2,3-Dichlorophenyl)methyl]-2-methylsulfanyl-5-pyridin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798572 5-[3-[Methyl(2-morpholin-4-ylethyl)amino]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798722 5-[5-methyl-3-[(3S)-3-methylpiperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44540316 N-[6-(1H-Indol-6-yl)-1H-indazol-4-yl]-2-pyridinecarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235079 8-(1-(4-fluorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979836 N-[5-(2-amino-7-fluoro-1,3-benzoxazol-5-yl)-1,3-benzothiazol-2-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44580686 2-(6-(1-(2-hydroxy-3-methoxypropyl)-1H-pyrazol-4-yl)-2H-benzo[b][1,4]oxazin-4(3H)-yl)-6,6-dimethyl-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54583917 1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-benzo[d]imidazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70683337 2-Cyclopropyl-3-[(2,3-dichlorophenyl)methyl]-5-morpholin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798757 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3R)-3-methylmorpholin-4-yl]methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:46202808 2-(3-(6-(5-(N-tert-Butylsulfamoyl)pyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)ureido)-N,N-dimethylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118540004 3-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-thiomorpholin-4-ylthieno[3,2-b]pyran-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70693129 N-[5-(3-Bromo-4-methanesulfonyl-phenyl)-4-methyl-thiazol-2-yl]-acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798492 6-(4-Pyridin-4-ylquinolin-6-yl)quinolin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155516604 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:163408817 Mek/PI3K-IN-1 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118729949 4-amino-6-[[(1S)-1-[6-fluoro-4-(3-hydroxyazetidin-1-yl)-3-pyridin-2-ylquinolin-2-yl]ethyl]amino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51355172 N-(6-(6-Chloro-5-(4-tert-butylphenylsulfonamido)pyridin-3-yl)benzo[d]thiazol-2-yl)acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57748162 (2S)-1-N-[5-(2-tert-butylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]azetidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58379530 1-[1-(2-Hydroxy-2-methylpropanoyl)piperidin-4-yl]-3-methyl-8-(6-methylpyridin-3-yl)imidazo[4,5-c][1,5]naphthyridin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:87221041 6-(4-Pyridin-4-ylquinolin-6-yl)-1,3-benzothiazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:86723627 (S)-2-(1-(6-amino-5-(phenylethynyl)pyrimidin-4-ylamino)ethyl)-5-chloro-3-phenylquinazolin-4(3H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44233160 Pyrazolo pyrimidine, 13 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44577640 5,5-dimethyl-2-(6-(6-methylpyridin-3-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-5,6-dihydrobenzo[d]thiazol-7(4H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798489 6-(4-Pyridin-4-ylquinolin-6-yl)quinazolin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118709081 9-(1-anilinoethyl)-N-[2-(dimethylamino)ethyl]-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54579942 N-(1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-yl)isoxazol-3-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:52950012 5-(3-(3,4-dimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)pyridin-3-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70675846 6-[2-hydroxyethyl(naphthalen-1-ylmethyl)amino]-4-[(2S)-2-methylmorpholin-4-yl]-1H-pyrimidin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57495355 1-[(3S)-3-[[6-(6-methoxy-5-methylpyridin-3-yl)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979877 5-(3-Morpholin-4-ylquinoxalin-6-yl)-1,3-benzothiazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:134138053 tert-butyl (3S)-3-[6-(3,4-dimethoxyphenyl)quinazolin-4-yl]oxypyrrolidine-1-carboxylate 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118436453 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-hydroxy-2-methylpropan-1-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137642662 4-[3-[4-Amino-5-[2-(2,2,2-trifluoroethyl)pyrazol-3-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]phenyl]morpholin-3-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:57396625 7-Morpholino-1-(naphthalen-1-ylmethyl)imidazo[1,2-a]pyrimidin-5(1H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798766 [6-(2-Amino-7-methyl-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:25097993 2-{[4-Amino-3-(3-Fluoro-5-Hydroxyphenyl)-1h-Pyrazolo[3,4-D]pyrimidin-1-Yl]methyl}-5-Methyl-3-(2-Methylphenyl)quinazolin-4(3h)-One 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798756 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(6,8-dihydro-5H-imidazo[1,5-a]pyrazin-7-yl)methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44181604 3-(3-Amino-phenyl)-5-morpholin-4-yl-thieno[3,2-b]pyran-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798424 5-(3-Pyridin-4-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118729948 4-Amino-6-[1-(4-chloro-6-fluoro-3-pyridin-2-ylquinolin-2-yl)ethylamino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798717 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(3-pyrrolidin-1-ylpropyl)quinazolin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44621456 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyridine-3-sulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155521494 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]methanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59293715 (2S)-1-N-[4-methyl-5-(2-propan-2-ylpyrimidin-4-yl)-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798593 Methyl 4-[6-(2-amino-1,3-benzoxazol-5-yl)-4-morpholin-4-ylpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145955565 (2S)-2-amino-N-[5-[6-chloro-5-[(2,6-difluorophenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:46893754 2-(4-(2-(1H-pyrazol-3-ylamino)-1H-benzo[d]imidazol-1-yl)-6-methyl-1,3,5-triazin-2-ylamino)acetonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137660961 4-[6-[[(5aR,9aS)-1-methyl-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-2-(1H-indazol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71272453 2-Methyl-5-morpholino-3-(naphthalen-1-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:139207774 3-(2-Azanyl-1,3-benzoxazol-5-yl)-1-propan-2-yl-pyrazolo[3,4-d]pyrimidine-4,6-diamine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145951569 (2S)-2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798557 6-[3-[(3S)-3-methylpiperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145983624 2-[[4-Amino-3-(3,4-dimethoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-3-(2,6-dimethylphenyl)-5-fluoroquinazolin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155515384 6-amino-3-(2-amino-1,3-benzoxazol-5-yl)-1-propan-2-yl-5H-pyrazolo[3,4-d]pyrimidin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798420 [6-(2-Amino-1,3-benzoxazol-6-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:49872927 4-amino-6-[[(1S)-1-(6-fluoro-4-methylsulfonyl-3-phenylquinolin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:45378170 5-{8-[(3R)-4-Acetyl-3-methylpiperazin-1-yl]-6-morpholin-4-yl-9-(2,2,2-trifluoroethyl)-9H-purin-2-yl}pyrimidin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:134157534 [4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-[(2R)-pyrrolidin-2-yl]methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71270831 2-Methyl-3-(2-methyl-3-(trifluoromethyl)benzyl)-5-morpholinopyrazolo[1,5-a]pyrimidin-7-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:154734328 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-2-methoxy-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118471137 US9862711, Example 10 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:162644341 1-[3-[4-(Dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155525477 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-4-yl]methanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155642 3-amino-6-[4-chloro-3-[(2-chloro-3-fluorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754216 US10961236, Example 54 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44517288 1-[4-(4-Isopropoxy-6-morpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-{4-[(4-methylpiperazin-1-yl)carbonyl]phenyl}urea 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44621442 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N,N-diethylpyridine-3-sulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:25172664 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:46892208 3-(4-(2-(1H-pyrazol-3-ylamino)-1H-benzo[d]imidazol-1-yl)-6-methyl-1,3,5-triazin-2-ylamino)propanenitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:66779905 4-[[2-Methyl-3-(trifluoromethyl)phenyl]methyl]-2-morpholin-4-yl-[1,3]thiazolo[4,5-d]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118540009 3-Bromo-5-thiomorpholino-7H-thieno[3,2-b]pyran-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118729950 4-amino-6-[[(1S)-1-(6-fluoro-4-morpholin-4-yl-3-pyridin-2-ylquinolin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:88979794 N-[6-(2-amino-1,3-benzoxazol-5-yl)-1,3-benzothiazol-2-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:21270142 7,8-dihydroxy-3-(3-chlorophenyl)-4H-1-benzopyran-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:11751126 Nvp-bbd130 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798502 5-(3-Pyridin-2-ylquinoxalin-6-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235053 8-(1-(3,5-difluorophenylamino)ethyl)-6-(morpholine-4-carbonyl)-2-morpholino-4H-chromen-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798864 [6-(2-Amino-[1,3]oxazolo[5,4-b]pyridin-6-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798541 5-[3-[4-(2-Methoxyethyl)piperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798552 5-[3-(2-Morpholin-4-ylpyridin-4-yl)imidazo[1,2-a]pyridin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754195 US10961236, Example 5 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:76321204 [3-(4-Morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenyl]methanol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145974533 (2S)-2-amino-N-[5-[6-chloro-5-[(4-chlorophenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137633081 4-[6-[[(5aR,9aS)-1-(trifluoromethyl)-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-2-(1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137642801 4-[5-[4-Amino-5-[2-(2,2,2-trifluoroethyl)pyrazol-3-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]-2-methoxyphenyl]-2,2-dimethylmorpholin-3-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155554180 N-[1-[[2-(1H-indazol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-N-methylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155384203 PI3K|A inhibitor 5 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44233641 Pyrazolo pyrimidine, 27 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59293676 (2S)-1-N-[4-methyl-5-[2-(1-methylcyclopropyl)pyrimidin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137640453 2,4-diamino-6-[[(1S)-1-[5-(6-morpholin-4-yl-6-oxohex-1-ynyl)-4-oxo-3-phenylquinazolin-2-yl]propyl]amino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "CHEMBL.COMPOUND:CHEMBL4865059 CHEMBL4865059 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51355173 N-[6-[6-chloro-5-[(2-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145958571 1-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]cyclopropane-1-carboxamide 5.3986449388087826e-05 0.409473\n",
      "CHEMBL.COMPOUND:CHEMBL4858564 CHEMBL4858564 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118709077 9-(1-anilinoethyl)-N,N-dimethyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798642 5-[3-(4-Methyl-1,4-diazepan-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798761 6-(2-Amino-1,3-benzoxazol-5-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798743 5-[3-[3-[(3S)-3-methylpiperazin-1-yl]azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:66699750 3-[2-(oxan-4-yl)ethyl]-5-[4-(1H-1,2,4-triazol-5-yl)phenyl]-1H-imidazo[4,5-b]pyrazin-2-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145971948 (2R)-2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]butanamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:16757570 (E)-4-(3-chloro-4-fluorobenzyl)-6-((4-oxo-2-thioxothiazolidin-5-ylidene)methyl)-2H-benzo[b][1,4]oxazin-3(4H)-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235043 8-(1-((3,5-difluorophenyl)(methyl)amino)ethyl)-2-morpholino-6-(pyrrolidine-1-carbonyl)-4H-chromen-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:46871497 N-tert-Butyl-5-(2-(3-(2-oxo-2-(pyrrolidin-1-yl)ethyl)ureido)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)pyridine-3-sulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798668 6-(3-Morpholin-4-ylquinoxalin-6-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71037717 5-(2-Aminoimidazo[1,2-a]pyridin-6-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51355171 n-(6-(5-(3-Tert-butylphenylsulfonamido)-6-chloropyridin-3-yl)benzo[d]thiazol-2-yl)acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:162669051 4-[4-[4-Morpholin-4-yl-6-(2-morpholin-4-ylethylamino)-1,3,5-triazin-2-yl]piperazin-1-yl]sulfonylphenol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118004064 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-(2-phenylethynyl)isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:145955836 2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-2-cyclopropylacetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:89517226 [5-[6-(6-Methoxypyridin-3-yl)quinazolin-4-yl]pyridin-3-yl]-(4-methylpiperazin-1-yl)methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59548184 4-[2-[(5-fluoro-6-methoxypyridin-3-yl)amino]-5-[(1S)-1-(4-methylsulfonylpiperazin-1-yl)ethyl]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:58235077 8-[1-(3,5-Difluoroanilino)ethyl]-2-morpholin-4-yl-6-(pyrrolidine-1-carbonyl)chromen-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:168269547 N-[8-[6-(hydroxyamino)-6-oxohexoxy]-7-methoxy-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]benzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155563416 5-(6-Amino-1-butyl-4-chloropyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:134154582 1-[(3S)-3-[6-(3,4-dimethoxyphenyl)quinazolin-4-yl]oxypyrrolidin-1-yl]ethanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:142608579 5-(6-Amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44180397 3-[2-(4-Methylpiperazin-1-yl)pyrimidin-5-yl]-5-morpholin-4-ylthieno[3,2-b]pyran-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754172 US10961236, Example 32 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:76332666 4-[2-(4-Bromo-2-methyl-2,3-dihydroindol-1-yl)-2-oxoethyl]-2-morpholin-4-yl-1,3-thiazole-5-carboxylic acid 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155555483 N-[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]-1-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperidine-4-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:24936353 N-[1-[[2-(1H-indol-4-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-N-methylmethanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155375 5-[3-[4-[3-(4-Methoxyphenyl)pyrazin-2-yl]piperazin-1-yl]sulfonylphenyl]pyrimidin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118709578 9-[1-(3-chloro-2-fluoroanilino)ethyl]-N-[2-(dimethylamino)ethyl]-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidine-7-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137660883 2-amino-4-methyl-6-[(2S)-2-[4-oxo-5-(6-oxo-6-pyrrolidin-1-ylhex-1-ynyl)-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141519552 (2R)-1-[4-[[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137639099 3-[6-[[(5aS,9aS)-1-(trifluoromethyl)-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl]phenol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:71270807 3-(2-Methyl-3-(trifluoromethyl)benzyl)-5-morpholinopyrazolo[1,5-a]pyrimidin-7-ol 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:54584859 1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(1-(difluoromethyl)-1H-pyrazol-3-yl)-1H-benzo[d]imidazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:59507730 5-[2-Morpholin-4-yl-6-(2-phenylmorpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyrimidin-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118729946 4-amino-6-[[(1S)-1-[6-fluoro-4-(2-hydroxyethylsulfinyl)-3-phenylquinolin-2-yl]ethyl]amino]pyrimidine-5-carbonitrile 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:44621441 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-propan-2-ylpyridine-3-sulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:153496423 N-(2-(2-(2-(3-(4-(7-(6-Chloro-5-((4-fluorophenyl)sulfonamido)pyridin-3-yl)quinoxalin-2-yl)piperazin-1-yl)-3-oxopropoxy)ethoxy)ethoxy)ethoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118730717 8-[(1R)-1-(3,5-difluorophenoxy)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70685440 3-[(2,3-Dichlorophenyl)methyl]-2-methyl-5-morpholin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:146672979 N-[5-[6-[(dimethylamino)methyl]-2,3-dihydro-1,4-benzoxazin-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:60155638 3-amino-6-[4-chloro-3-[(2-chlorophenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:166628059 (2S,4R)-4-(dimethylamino)-1-[4-[[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzoyl]pyrrolidine-2-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798677 6-(2-amino-1,3-benzoxazol-5-yl)-N,N-bis(2-hydroxyethyl)imidazo[1,2-a]pyridine-3-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:53242225 1-(4-methyl-6-(methylamino)-1,3,5-triazin-2-yl)-N-(1H-pyrazol-3-yl)-1H-benzo[d]imidazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118003714 2-amino-N-[(1S)-1-[1-oxo-2-phenyl-8-[2-(1,3-thiazol-4-yl)ethynyl]isoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:141754193 US10961236, Example 4 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:56654649 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]oxy]pyrrolidin-1-yl]-(oxan-4-yl)methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:70798818 [6-(2-Amino-1,3-benzoxazol-6-yl)imidazo[1,2-a]pyridin-3-yl]-(4-methylpiperazin-1-yl)methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155512258 [4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]piperazin-1-yl]-[(2S)-piperidin-2-yl]methanone 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:50991337 5-(2-Amino-1,3-benzoxazol-5-yl)-7-fluoro-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:51354880 n-(6-(6-Chloro-5-(4-(trifluoromethyl)phenylsulfonamido)pyridin-3-yl)benzo[d]thiazol-2-yl)acetamide 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:155567232 5-(6-Amino-4-bromo-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:76287568 2-[(1S)-1-[[6-amino-5-(2-pyridin-3-ylethynyl)pyrimidin-4-yl]amino]ethyl]-5-chloro-3-phenylquinazolin-4-one 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:137635017 4-[6-[[(5aS,9aS)-1-methyl-5,5a,6,8,9,9a-hexahydro-4H-[1,2,4]triazolo[4,3-a][1,6]naphthyridin-7-yl]methyl]-2-(1H-indol-4-yl)thieno[3,2-d]pyrimidin-4-yl]morpholine 5.3986449388087826e-05 0.409473\n",
      "PUBCHEM.COMPOUND:118470537 US10112926, Example 114.1 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470197 US10112926, Example 104.3 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:126550882 US10112926, Example 83.1 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470104 US10112926, Example 104.9 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470549 US10112926, Example 35.6 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118469942 US10112926, Example 67 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470055 US10112926, Example 104.16 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118469997 US10112926, Example 112 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:46916382 4-(5-Amino-2-(pyridin-3-yl)thiazolo[5,4-d]pyrimidin-7-yl)-N-(p-tolyl)piperazine-1-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470132 US10112926, Example 104.10 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470587 US10112926, Example 83.4 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470129 US10112926, Example 83.2 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470040 US10112926, Example 49 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118469965 US10112926, Example 68 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470178 US10112926, Example 5.1 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155928388 4-amino-7-methyl-2-({5-methyl-1-[(3S)-oxolan-3-yl]-1H-pyrazol-4-yl}amino)-6-[(2R)-2-methylpyrrolidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155928387 4-amino-7-methyl-2-({5-methyl-1-[(3R)-oxolan-3-yl]-1H-pyrazol-4-yl}amino)-6-[(2R)-2-methylpyrrolidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470016 US10112926, Example 106 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470141 US10112926, Example 33 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470061 US10112926, Example 82a 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470022 US10112926, Example 83.5 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470408 US10112926, Example 4.6 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470611 US10112926, Example 9 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470304 US10112926, Example 4.2 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118469940 US10112926, Example 20 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:126512379 US10112926, Example 114.4 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470117 US10112926, Example 104.8 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470093 US10112926, Example 3 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470338 US10112926, Example 104.14 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470282 US10112926, Example 1 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470226 US10112926, Example 5 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470447 US10112926, Example 37.8 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71682213 N-[5-(6-aminopyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]-4,4,4-trifluoro-2,2-dimethylbutanamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470252 US10112926, Example 8 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118469967 US10112926, Example 74 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470392 US10112926, Example 45 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470356 US10112926, Example 63 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470247 US10112926, Example 4.3 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470592 US10112926, Example 94a 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:24905145 5-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-bromophenol 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470588 US10112926, Example 30 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470183 US10112926, Example 13 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118469954 US10112926, Example 5.4 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470064 US10112926, Example 26 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470098 US10112926, Example 69 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470084 US10112926, Example 115 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:126512398 US10112926, Example 114.2 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470280 US10112926, Example 104.12 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56833543 5-[6-[(1-Methylsulfonylpiperidin-4-yl)methyl]-4-morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl]pyrimidin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118436351 2-amino-1-{(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl}-2-methylpropan-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:91801158 3-(6-Methoxypyridin-3-Yl)-5-[({4-[(5-Methyl-1,3,4-Thiadiazol-2-Yl)sulfamoyl]phenyl}amino)methyl]benzoic Acid 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44188322 N-ethyl-4-[[4-(3-ethyl-7-morpholin-4-yltriazolo[4,5-d]pyrimidin-5-yl)phenyl]carbamoylamino]benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798841 5-[4-[(1-Methylpiperidin-4-yl)amino]pyrido[3,2-d]pyrimidin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798529 5-[4-[Methyl-(1-methylpiperidin-4-yl)amino]quinazolin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470054 US10112926, Example 10 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:5287855 (5E)-5-[(2,2-Difluoro-1,3-benzodioxol-5-YL)methylene]-1,3-thiazolidine-2,4-dione 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:57384863 Gdc-0084 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:49785078 N-(3-(2-methyl-9H-purin-6-yl)pyridin-2-yl)-1H-indol-4-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44188844 1-(4-Hydroxymethylphenyl)-3-[4-(3-isopropyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:54751698 8-[(1S)-1-anilinoethyl]-6-methyl-2-morpholin-4-ylchromen-4-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44187604 1-[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]-3-pyridin-4-ylurea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44516310 4-(3-(4-(4,6-Dimorpholino-1,3,5-triazin-2-yl)phenyl)ureido)-N-methylbenzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89404404 N-[2-chloro-5-[3-(1-methylpiperidin-4-yl)-4-oxoquinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44449088 3-[5-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoyl]-2-methylphenyl]-N-[(1S)-2-(dimethylamino)-1-phenylethyl]-1,2-dihydrotriazole-5-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470134 US10112926, Example 81 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44540030 N-[6-(3-hydroxyphenyl)-1H-indazol-4-yl]pyridine-2-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71270913 2-Methyl-3-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-5-(4-morpholinyl)pyrazolo[1,5-a]pyrimidine-7-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798537 5-(2-Amino-1,3-benzoxazol-6-yl)-7-fluoro-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798676 5-[3-(3-Pyrrolidin-1-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798498 6-(2-amino-1,3-benzoxazol-5-yl)-N-ethylimidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56660108 1-[4-(4-Methylpiperazine-1-carbonyl)phenyl]-3-[4-[4-morpholin-4-yl-6-(oxetan-3-yloxy)-1,3,5-triazin-2-yl]phenyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798575 6-(2-amino-1,3-benzoxazol-5-yl)-N-(3-pyrrolidin-1-ylpropyl)imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798567 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3-hydroxypyrrolidin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44620965 5-(6-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}-4-Morpholin-4-Ylthieno[3,2-D]pyrimidin-2-Yl)pyridin-2-Amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56667023 N-[2-(dimethylamino)ethyl]-4-[[4-(4-methoxy-6-morpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]-N-methylbenzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798863 5-(7-Methyl-3-pyridin-4-ylpyrazolo[1,5-a]pyridin-5-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798684 [4-[[6-(2-Amino-1,3-benzoxazol-5-yl)quinazolin-4-yl]amino]piperidin-1-yl]-cyclopropylmethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798868 N-[2-methoxy-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]methanesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:88979837 N-[6-(2-amino-7-fluoro-1,3-benzoxazol-5-yl)-1,3-benzothiazol-2-yl]acetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798582 1-[4-[[6-(2-Amino-1,3-benzoxazol-5-yl)pyrido[3,2-d]pyrimidin-4-yl]amino]piperidin-1-yl]ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:145952160 2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-2-methylpropanamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:136088603 US10172858, Table 2.65 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:57391367 7-(2-Methylmorpholin-4-yl)-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]imidazo[1,2-a]pyrimidin-5-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:168296167 1-[(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798651 5-[3-[3-(4-Methylsulfonylpiperazin-1-yl)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:50939081 4-(1-(7-Fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-3,3-dimethyl-2,3-dihydro-1h-indol-6-yl)-2-pyrimidinamine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798662 1-[4-[1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]piperazin-1-yl]ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798401 5-[3-(4-Morpholin-4-ylpiperidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:68405707 5-(3-Pyridin-4-ylimidazo[1,2-b]pyridazin-6-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44513886 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-phenylurea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118436056 tert-butyl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-(morpholin-4-yl)-5,6-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:121231532 2-[2-[(2R)-2-methyl-2,3-dihydroindol-1-yl]-2-oxoethyl]-6-morpholin-4-yl-1,3-diazinan-4-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:25168990 (S)-1-(4-(4-(1-(cyclopropylsulfonyl)cyclopropyl)-6-(3-methylmorpholino)pyrimidin-2-yl)phenyl)-3-(2-hydroxyethyl)thiourea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:142506238 4-[[[2-[(1S)-1-[(2,6-diamino-5-cyanopyrimidin-4-yl)amino]propyl]-4-oxo-3-phenylquinazolin-5-yl]amino]methyl]-N-hydroxybenzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:121445810 (2S)-2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-hydroxypropanamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56660109 4-[[4-[4-morpholin-4-yl-6-[(3S)-oxolan-3-yl]oxy-1,3,5-triazin-2-yl]phenyl]carbamoylamino]-N-(2-pyrrolidin-1-ylethyl)benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:122179491 3-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-[[4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]anilino]methyl]benzoic acid 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798648 2-Amino-1-[4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]propan-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798735 6-Fluoro-5-[3-(3-morpholin-4-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798536 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[4-(cyclopropylmethyl)piperazin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:134145670 1-[4-[3-[6-(3,4-Dimethoxyphenyl)quinazolin-4-yl]benzoyl]piperazin-1-yl]ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56683918 1-[4-(4-methylpiperazine-1-carbonyl)phenyl]-3-[4-[4-morpholin-4-yl-6-[(3S)-oxolan-3-yl]oxy-1,3,5-triazin-2-yl]phenyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:52936849 Ethyl 6-(5-(phenylsulfonamido)pyridin-3-yl)imidazo[1,2-a]pyridine-3-carboxylate 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44819375 4-({[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]carbamoyl}amino)-N-(2-pyridin-2-ylethyl)benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:146346677 4-(difluoromethyl)-5-[4-[(3R)-3-methylmorpholin-4-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]pyrimidin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:51355174 n-(6-(6-Chloro-5-(3-fluorophenylsulfonamido)pyridin-3-yl)benzo[d]thiazol-2-yl)acetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44188840 1-(4-(3-cyclopropyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)-3-(pyridin-4-yl)urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44516636 1-(4-(1,4'-Bipiperidine-1'-carbonyl)phenyl)-3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:46892845 1-(4-Amino-6-Methyl-1,3,5-Triazin-2-Yl)-N-(1h-Pyrazol-3-Yl)-1h-Benzimidazol-2-Amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:135397764 1-benzyl-N-[5-(3,6-dihydro-2H-pyran-4-yl)-2-methoxypyridin-3-yl]-2-methylimidazole-4-sulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:53235451 N-[[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazol-8-yl]methyl]acetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56682067 N-[5-(2-amino-1,3-benzothiazol-6-yl)-2-chloropyridin-3-yl]-4-fluorobenzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44819376 4-({[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]carbamoyl}amino)-N-[2-(4-methylpiperazin-1-yl)ethyl]benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798592 2-[4-[1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]piperazin-1-yl]ethanol 6.478338951626406e-05 0.399936\n",
      "CHEBI:91449 (2S)-N1-[5-(2-tert-butyl-4-thiazolyl)-4-methyl-2-thiazolyl]pyrrolidine-1,2-dicarboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:73659199 1-[6-(5-Methoxypyridin-3-Yl)-1,3-Benzothiazol-2-Yl]-3-[2-(1-Propyl-1h-Imidazol-4-Yl)ethyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037737 (2R)-1-[1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidine-3-carbonyl]pyrrolidine-2-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:59548316 4-(2-(2-Methoxypyrimidin-5-ylamino)-5-((4-(methylsulfonyl)piperazin-1-yl)methyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:121334504 4-(difluoromethyl)-5-[4-[(3S)-3-methylmorpholin-4-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]pyrimidin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798708 5-[3-[(1-Methylsulfonylpiperidin-4-yl)amino]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89216125 N-[2-chloro-5-[4-oxo-3-(1-propan-2-ylpiperidin-4-yl)quinazolin-6-yl]pyridin-3-yl]methanesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798595 5-[3-[(3S)-3,4-dimethylpiperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:59548177 4-(2-(6-Methoxypyridin-3-ylamino)-5-(piperidin-1-ylmethyl)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:11630874 AS-252424 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:145961004 (2S)-2-amino-N-[5-[6-chloro-5-[(2,3-dichlorophenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037769 [6-[5-Amino-6-(1,1,1-trifluoropropan-2-yloxy)pyrazin-2-yl]imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798527 1-[4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-2-(diethylamino)ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798748 7-Fluoro-5-[3-(3-morpholin-4-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71270848 [2-Methyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-5-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-7-yl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037744 (3S)-1-[1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]pyrrolidin-3-ol 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:57391365 1-[[2-Methyl-3-(trifluoromethyl)phenyl]methyl]-7-morpholin-4-ylimidazo[1,2-a]pyrimidin-5-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:66780515 5-(hydroxymethyl)-4-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-2-(4-morpholinyl)[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:145987142 N-methyl-1-[4-[(3R)-3-methylmorpholin-4-yl]-6-(1-methylsulfonylcyclopropyl)pyrimidin-2-yl]benzimidazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70684204 1-[6-[5-(Tert-butylsulfamoyl)pyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-[2-(5-cyclopropyltetrazol-2-yl)ethyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44181276 4-(5-Morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)benzoic acid 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798855 [6-(2-Amino-7-chloro-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:11234514 2-(4-(8-(2-(pyridin-3-yl)ethynyl)-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)acetonitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:11979157 1-[4-(3-Methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]cyclopropane-1-carbonitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70681262 5-(2-Methylmorpholin-4-yl)-2-methylsulfanyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798604 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3R)-3-morpholin-4-ylpyrrolidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798712 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-[(3S)-3-methylpiperazin-1-yl]azetidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:145955693 (2S)-2-amino-N-[5-[6-chloro-5-[(2,4-dichlorophenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798390 5-(3-Pyrrolidin-1-ylquinoxalin-6-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798847 7-Chloro-5-[3-(3-morpholin-4-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798596 5-[3-[3-(4-Propan-2-ylpiperazin-1-yl)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798840 1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-N-cyclopropylazetidine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798853 [5-(2-Amino-1,3-benzoxazol-5-yl)-7-methylpyrazolo[1,5-a]pyridin-3-yl]-morpholin-4-ylmethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44540492 N-[6-(1H-indol-4-yl)-1H-indazol-4-yl]cyclopropanecarboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:76324821 5-(4-Morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)pyridin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71548718 1-[4-[3-[6-(6-Methoxypyridin-3-yl)quinazolin-4-yl]benzoyl]piperazin-1-yl]ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89473644 3-Anilino-1-[3-(cyanomethyl)-1-[(2-ethoxyphenyl)carbamoyl]azetidin-3-yl]pyrazole-4-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:141419885 2-methoxy-5-[4-[[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]amino]quinazolin-6-yl]pyridine-3-carbonitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037661 5-[3-(1-Methylpyrazol-4-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:146731761 2-[[4-(4-Chloro-3-nitrophenyl)sulfonylpiperazin-1-yl]methyl]chromeno[4,3-c]pyrazol-4-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155533370 1-[4-[3-(6-Quinolin-3-ylquinazolin-4-yl)benzoyl]piperazin-1-yl]ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:46885565 4,6-dihydroxy-2-((5-methoxy-2-(pyridin-3-yl)-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798398 5-[3-(2-Methylmorpholin-4-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:25260915 1-Methyl-3-{4-[4-morpholin-4-yl-1-(1-pyridin-3-ylmethyl-piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]-phenyl}-urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:146273897 9-[(3~{R},4~{R})-4-fluoranylpyrrolidin-3-yl]-7-methyl-2-[(7-methylquinolin-6-yl)amino]purin-8-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44188841 1-(4-(3-cyclopropyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)-3-(thiophen-2-yl)urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798827 1-[4-[[6-(2-Amino-1,3-benzoxazol-5-yl)quinazolin-4-yl]amino]piperidin-1-yl]-2-(dimethylamino)ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798713 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-[(3R)-3-methylpiperazin-1-yl]azetidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44581248 7-(2-(1-(2-(dimethylamino)acetyl)-5-methoxyindolin-6-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)isoindolin-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:46865423 4,6-dihydroxy-2-((5-methoxy-2-methyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44514208 N-[2-(dimethylamino)ethyl]-N-methyl-4-[[4-(4-morpholin-4-yl-6-propan-2-yloxy-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:134134126 1-[(3S)-3-[6-(6-methoxypyridin-3-yl)quinazolin-4-yl]oxypyrrolidin-1-yl]propan-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118556943 [(3S)-3-{[8-(1-ethyl-5-methyl-1H-pyrazol-4-yl)-9-methyl-9H-purin-6-yl]oxy}pyrrolidin-1-yl](oxan-4-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44233390 Pyrazolo pyrimidine, 22 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44540126 N-[6-(3-hydroxyphenyl)-1H-indazol-4-yl]cyclopropanecarboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798500 6-(2-amino-1,3-benzoxazol-5-yl)-N-(2-hydroxyethyl)imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:11155871 N-[(3-amino-1,2-benzoxazol-6-yl)methyl]-2-[6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl]acetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44513884 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-pyridin-4-ylurea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56683916 4-[[4-(4-methoxy-6-morpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]-N-methyl-N-[2-(methylamino)ethyl]benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:168295564 PI3K/mTOR Inhibitor-11 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44577639 6,6-dimethyl-2-(6-(6-methylpyridin-3-yl)-2,3-dihydrobenzo[b][1,4]oxazin-4-yl)-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798709 (3S)-1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]pyrrolidin-3-ol 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798486 6-(4-Pyridin-4-ylquinolin-6-yl)-1,2-benzoxazol-3-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:124518210 (R)-Idelalisib 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798828 5-[4-[(1-Propan-2-ylpiperidin-4-yl)amino]quinazolin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118471440 US9862711, Example 8 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798590 [4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-(1-aminocyclobutyl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44819203 4-({[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]carbamoyl}amino)-N,N-dimethylbenzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798850 5-[3-[3-[(3R)-3-methylpiperazin-1-yl]azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44516635 1-(4-(4,6-Dimorpholino-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-(pyrrolidin-1-yl)piperidine-1-carbonyl)phenyl)urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44513887 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-thiophen-2-ylurea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798509 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(2-pyrrolidin-1-ylethyl)quinazolin-4-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798638 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-methylpiperazin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798729 [1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]-[(3S)-3-methylpiperazin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56663573 1-[4-(3,3-Dimethylpiperazine-1-carbonyl)phenyl]-3-[4-(4-methoxy-6-morpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:153289441 7-cyclopentyl-N,N-dimethyl-2-({4-[5-(morpholin-4-yl)-7-oxo-7H-thieno[3,2-b]pyran-3-yl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798442 5-[3-[(3S)-3-(4-methylpiperazin-1-yl)pyrrolidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118472628 US9862711, Example 2 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56595421 4-[4-[4-(Difluoromethoxy)-2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798393 5-[3-(2-Methylimidazol-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:75306001 2-[2-(4-Fluoro-2,3-dihydroindol-1-yl)-2-oxoethyl]-6-morpholin-4-yl-1,3-diazinan-4-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:53377727 5-(4-Morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:90331744 3-Anilino-1-[3-(cyanomethyl)-1-[(2,4-difluorophenyl)carbamoyl]azetidin-3-yl]pyrazole-4-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470908 US9862711, Example 11 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798387 5-[4-(4-Methylpiperazin-1-yl)quinazolin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:137321157 neolymphostin A 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44187955 N-[3-(Dimethylamino)propyl]-4-({[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]-carbamoyl}amino)benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118730712 N,N-dimethyl-2-morpholin-4-yl-4-oxo-8-[(1R)-1-(3,4,5-trifluoroanilino)ethyl]chromene-6-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798854 6-(2-amino-1,3-benzoxazol-5-yl)-N-cyclopropylimidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:168286987 cyclobutyl-[(3S)-3-[[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56670464 4-[[4-(4-methoxy-6-morpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]-N-(2-piperidin-1-ylethyl)benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:60155539 4-[5-[(1,1-Dioxo-1,4-thiazinan-4-yl)methyl]-2-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:134694318 3-Quinolinecarboxamide, 6-(6-(methoxymethyl)-3-pyridinyl)-4-(((1S)-1-(tetrahydro-2H-pyran-4-yl)ethyl)amino)- 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44540407 N-[6-(1H-Indol-4-yl)-1H-indazol-4-yl]-2-pyridinecarboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44189192 4-{3-[4-(3-isopropyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)-phenyl]-ureido}-benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798842 5-[3-(2-Pyrrolidin-1-ylethylamino)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70683338 3-[(2,3-Dichlorophenyl)methyl]-2-methyl-5-(2-methylmorpholin-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:50991335 [5-(2-Amino-1,3-benzoxazol-5-yl)-7-methylpyrazolo[1,5-a]pyridin-3-yl]-pyrrolidin-1-ylmethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798714 5-[3-[(3S)-3-morpholin-4-ylpyrrolidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:135927897 N-[6-(4-hydroxyphenyl)-1H-indazol-4-yl]pyridine-2-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798513 2-Amino-1-[4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798583 (2S)-2-amino-1-[4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]propan-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:49785828 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-(piperazin-1-ylmethyl)pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798571 6-(2-amino-1,3-benzoxazol-5-yl)-N-(1-methylpiperidin-4-yl)imidazo[1,2-b]pyridazine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56947516 4-(2-[(5-Fluoro-6-Methoxypyridin-3-Yl)amino]-5-{(1r)-1-[4-(Methylsulfonyl)piperazin-1-Yl]ethyl}pyridin-3-Yl)-6-Methyl-1,3,5-Triazin-2-Amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155535740 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-N-methylacetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798484 5-[3-(3-Morpholin-4-ylpropylamino)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798730 5-(5-Amino-6-methoxypyrazin-2-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798433 6-(3-Pyridin-4-yl-[1,2,4]triazolo[4,3-a]pyridin-6-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798535 [4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-(1-methylazetidin-3-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037734 5-[3-[2-(4-Methylpiperazin-1-yl)ethylamino]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:11328459 2-[6-cyano-3-[[2,2-difluoro-2-(3-fluorophenyl)ethyl]amino]-2-fluorophenyl]-N-[2-(diaminomethylideneamino)oxyethyl]acetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:49872835 4-amino-6-[[(1S)-1-[6-fluoro-4-(2-methoxyethylamino)-3-phenylquinolin-2-yl]ethyl]amino]pyrimidine-5-carbonitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798727 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:59548453 4-(5-Benzyl-2-(6-methoxypyridin-3-ylamino)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798512 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(2R)-2-methylpyrrolidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:23582824 (Z)-5-((4-(pyridin-4-yl)quinolin-6-yl)methylene)thiazolidine-2,4-dione 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:134150578 1-[(3R)-3-[7-(3,4-dimethoxyphenyl)quinoxalin-2-yl]oxypyrrolidin-1-yl]propan-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89473646 1-[1-[(3-Acetylphenyl)carbamoyl]-3-(cyanomethyl)azetidin-3-yl]-3-anilinopyrazole-4-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798563 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3-hydroxyazetidin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:50991338 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-[(3S)-3,4-dimethylpiperazin-1-yl]azetidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:137646413 4-[3-(4-Amino-5-chloropyrrolo[2,1-f][1,2,4]triazin-7-yl)phenyl]morpholin-3-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89473466 3-Anilino-1-[3-(cyanomethyl)-1-[(3,4-dimethylphenyl)carbamoyl]azetidin-3-yl]pyrazole-4-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798845 5-(3-Pyridin-4-ylpyrazolo[1,5-a]pyridin-5-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:145969580 cyclopropyl-[(3S)-3-[[6-(6-methoxypyridin-3-yl)quinazolin-4-yl]amino]pyrrolidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798829 2-[4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]ethanol 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:136088575 US10172858, Table 2.21 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037660 5-[3-[4-(2-Methylsulfonylethyl)piperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56683917 1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-[4-morpholin-4-yl-6-[(3S)-oxolan-3-yl]oxy-1,3,5-triazin-2-yl]phenyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89216439 N-[2-chloro-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]benzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798576 6-(2-amino-1,3-benzoxazol-5-yl)-N-[2-(diethylamino)ethyl]imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798379 5-[4-(4-Methylpiperazin-1-yl)quinolin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798848 5-[3-(4-Tert-butylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798470 5-[3-(3-Methylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798663 5-[3-[3-(Diethylamino)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798496 Methyl 4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazine-1-carboxylate 6.478338951626406e-05 0.399936\n",
      "CHEMBL.COMPOUND:CHEMBL4871210 CHEMBL4871210 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:49854052 (2S)-1-N-(8-tert-butyl-4,5-dihydro-[1,3]thiazolo[4,5-h]quinazolin-2-yl)pyrrolidine-1,2-dicarboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798661 4-[1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]piperazin-2-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44180158 N-[4-(5-morpholin-4-yl-7-oxothieno[3,2-b]pyran-3-yl)phenyl]pyridine-4-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798435 5-[3-[(3R)-3-morpholin-4-ylpyrrolidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798613 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3-methoxyazetidin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798852 6-(2-Amino-1,3-benzoxazol-5-yl)-3-ethylquinazolin-4-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44187952 N-[2-(dimethylamino)ethyl]-4-({[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]carbamoyl}amino)benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:54580925 1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5,6-difluoro-N-(1H-pyrazol-3-yl)-1H-benzo[d]imidazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798475 5-[3-[4-(Cyclopropylmethyl)piperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798702 1-[4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798679 5-[3-(3-Piperazin-1-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798477 5-[3-(4-Ethylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798389 5-[4-(Oxan-4-ylamino)quinazolin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44187783 1-[4-(3-Ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo-[4,5-d]pyrimidin-5-yl)phenyl]-3-pyridin-3-ylurea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:57403581 7-[(2R)-2-methylmorpholin-4-yl]-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]imidazo[1,2-a]pyrimidin-5-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44188842 1-[4-(3-isopropyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)-phenyl]-3-pyridin-4-yl-urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798752 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3S)-3-hydroxypyrrolidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798704 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-[(3R)-3,4-dimethylpiperazin-1-yl]azetidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470956 US9862711, Example 6 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798553 6-(2-amino-1,3-benzoxazol-5-yl)-N-[2-(4-methylpiperazin-1-yl)ethyl]imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:88979950 5-(4-Pyridin-4-ylquinolin-6-yl)-1,3-benzothiazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:76525183 2-[2-(3,3-dimethyl-2H-indol-1-yl)-2-oxoethyl]-6-morpholin-4-yl-1,3-diazinan-4-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71458574 hSMG-1 inhibitor 11e 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44605037 tert-Butyl 4-(6-(4-aminophenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798685 6-(2-Amino-1,3-benzoxazol-5-yl)-3-(1-propan-2-ylpiperidin-4-yl)quinazolin-4-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798591 [1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]-[4-(cyclopropylmethyl)piperazin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:57401865 1-(2,3-Dichlorobenzyl)-7-morpholinoimidazo[1,2-a]pyrimidin-5(1H)-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56673952 4-[[4-[4-morpholin-4-yl-6-[(3S)-oxolan-3-yl]oxy-1,3,5-triazin-2-yl]phenyl]carbamoylamino]-N-(2-piperidin-1-ylethyl)benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798483 6-(4-Pyridin-4-ylquinolin-6-yl)-1,2-benzothiazol-3-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:88979835 6-(2-Amino-1,3-benzothiazol-5-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:58204076 8-Azetidin-3-yl-2-(2-isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798715 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(3-morpholin-4-ylazetidin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798586 6-(2-amino-1,3-benzoxazol-5-yl)-N-(3-morpholin-4-ylpropyl)imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44819200 1-[4-(3-methyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]-3-(2-thienyl)urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:135927892 N-[6-(4-Hydroxyphenyl)-1H-indazol-4-yl]cyclopropanecarboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:124173704 (S)-2-((2-((S)-4-(fluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:67104025 8-[(1R)-1-(3,5-difluoro-N-methylanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:59548383 N-(6-methoxypyridin-3-yl)-3-(2-methyl-9H-purin-6-yl)pyridin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798426 5-(5-Amino-6-propan-2-yloxypyrazin-2-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798749 5-[3-(4-Propan-2-ylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:69489467 5-[3-Methyl-2-[(4-methylsulfonylpiperazin-1-yl)methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:57401868 2-Ethyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-7-morpholin-4-ylimidazo[1,2-a]pyrimidin-5-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:49785253 3-[[3-(6-Amino-2-methylpyrimidin-4-yl)pyridin-2-yl]amino]phenol 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798728 7-Methyl-5-[3-(3-morpholin-4-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037656 5-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56599298 (S)-(3-((6-(6-Methoxy-5-methylpyridin-3-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)oxy)pyrrolidin-1-yl)(tetrahydro-2H-pyran-4-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:168293540 cyclobutyl-[(3S)-3-[6-(5,6-dimethoxypyridin-3-yl)thieno[2,3-d]pyrimidin-4-yl]oxypyrrolidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798835 2-[4-[[6-(2-Amino-1,3-benzoxazol-5-yl)quinazolin-4-yl]amino]phenyl]-2-methylpropanenitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798482 5-[3-(3-Pyrrolidin-1-ylpropylamino)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70684794 5-[5-Chloro-2-[(4-methylsulfonylpiperazin-1-yl)methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118444359 (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-N,3-dimethylpyrrolidine-1-sulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56677282 N-[2-(dimethylamino)ethyl]-4-[[4-(4-methoxy-6-morpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89212429 N-[5-(2-amino-1,3-benzoxazol-5-yl)-4-methyl-1,3-thiazol-2-yl]acetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798767 5-[3-[3-(4-Methylimidazol-1-yl)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:24905149 2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798400 5-[3-[4-(Dimethylamino)piperidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798772 5-[3-(3-Aminoazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798826 1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperidin-4-ol 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:25261231 Pyrazolo pyrimidine, 18 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:77923770 7-(2-amino-1,3-benzoxazol-5-yl)-4aH-quinoxalin-2-one 6.478338951626406e-05 0.399936\n",
      "CHEBI:124914 2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)-7-pyrido[2,3-d]pyrimidinone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798643 [4-[[6-(2-Amino-1,3-benzoxazol-5-yl)quinazolin-4-yl]amino]piperidin-1-yl]-(1-methylazetidin-3-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798421 4-[[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]amino]cyclohexan-1-ol 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:124173721 (S)-2-cyclopropyl-2-((2-((R)-4-methyl-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)acetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155538256 5-[4-[[(3S)-1-[2-(dimethylamino)acetyl]piperidin-3-yl]amino]quinazolin-6-yl]-2-methoxypyridine-3-carbonitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798672 (2R)-2-amino-1-[4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-3-hydroxypropan-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:51354599 N-(6-(5-(4-Methoxyphenylsulfonamido)-6-methylpyridin-3-yl)benzo[d]thiazol-2-yl)acetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56677283 1-[4-(4-Methoxy-6-morpholin-4-yl-1,3,5-triazin-2-yl)phenyl]-3-[4-(4-methylpiperazine-1-carbonyl)phenyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798584 (2R)-2-amino-1-[4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]propan-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798580 1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]pyrrolidin-3-ol 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798671 5-[3-(3-Pyrazol-1-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798725 [6-(2-Amino-6-fluoro-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:66780118 {[4-[(3-Chloro-2-methylphenyl)methyl]-2-(4-morpholinyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-d]pyrimidin-5-yl]thio}acetic acid 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798395 5-[3-[(3R)-3-methylpiperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798614 6-(2-amino-1,3-benzoxazol-5-yl)-N-methyl-N-(oxan-4-yl)imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44473371 N-[2-(dimethylamino)ethyl]-4-[[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:88979838 5-(2-Amino-1,3-benzothiazol-6-yl)-7-fluoro-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44593631 2-(6-(1H-pyrazol-4-yl)-2H-benzo[b][1,4]oxazin-4(3H)-yl)-6,6-dimethyl-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:145976442 N-[5-[4-(3-chloro-4-fluoroanilino)quinazolin-6-yl]-2-methoxypyridin-3-yl]ethanesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037771 2-fluoro-N-[2-methoxy-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]benzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798858 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-pyrrolidin-1-ylmethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798534 6-(2-amino-1,3-benzoxazol-5-yl)-N-(1-methylpiperidin-4-yl)imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798697 5-(3-Morpholin-4-ylquinoxalin-6-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798581 [1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]-(4-propan-2-ylpiperazin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44819201 4-(3-(4-(3-ethyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)ureido)benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:132471103 2,4-difluoro-N-[5-[4-oxo-3-(1-propan-2-ylpiperidin-4-yl)-1,2,4a,5,6,7,8,8a-octahydroquinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:137647591 4-amino-6-[(2S)-2-[5-(6-morpholin-4-yl-6-oxohex-1-ynyl)-4-oxo-3-phenylquinazolin-2-yl]pyrrolidin-1-yl]pyrimidine-5-carbonitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:76317469 1-[3-(Hydroxymethyl)phenyl]-3-[4-(4-morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037658 5-[3-(4-Methylsulfonylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798711 5-(3-Piperazin-1-ylquinoxalin-6-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798762 5-[3-(3,3-Dimethylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:88979834 5-(2-Amino-1,3-benzothiazol-5-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:132220479 PI3Kdelta-IN-1 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:66677439 [(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]-(oxan-4-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798866 [5-(2-Amino-1,3-benzoxazol-5-yl)pyrazolo[1,5-a]pyridin-3-yl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71682651 (2S)-1-N-[5-(2-tert-butylpyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44233391 mTOR Inhibitor, WYE-23 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798499 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-tert-butylpiperazin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798701 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-cyclopropylpiperazin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155542898 1-[4-[3-[6-[6-Methoxy-5-(trifluoromethyl)pyridin-3-yl]quinazolin-4-yl]benzoyl]piperazin-1-yl]ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:46870269 1-[6-[5-(Tert-butylsulfamoyl)pyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70689639 2-Methyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-5-morpholin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798824 5-(3-Pyridin-4-ylimidazo[1,2-a]pyrazin-6-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798823 5-[3-(4-Methylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798753 1-[4-[[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]amino]piperidin-1-yl]ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:86732669 TC Khns 11 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037745 5-[3-[3-(1,1-Dioxo-1,4-thiazinan-4-yl)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798819 1-[4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-2-(dimethylamino)ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798724 5-[5-Amino-6-(1,1,1-trifluoropropan-2-yloxy)pyrazin-2-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155538266 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]methanesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:141419888 [(3S)-3-[[6-(6-methoxy-5-nitropyridin-3-yl)quinazolin-4-yl]amino]pyrrolidin-1-yl]-(oxan-4-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798524 1-[4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-2-pyrrolidin-1-ylethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:57345685 1-[(2,3-Dichlorophenyl)methyl]-2-methyl-7-morpholin-4-ylimidazo[1,2-a]pyrimidin-5-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470649 US9862711, Example 7 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798674 5-[3-(3-Imidazol-1-ylazetidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798639 5-(2-Methyl-3-pyridin-4-ylimidazo[1,2-b]pyridazin-6-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44187784 1-[4-(3-Ethyl-7-morpholin-4-yltriazolo[4,5-d]pyrimidin-5-yl)phenyl]-3-thiophen-2-ylurea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44454396 2-[4-[2-Methyl-8-(2-pyridin-3-ylethynyl)imidazo[4,5-c]quinolin-1-yl]phenyl]propanenitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037693 6-(2-amino-1,3-benzoxazol-5-yl)-N-[1-(2-methylsulfonylethyl)piperidin-4-yl]imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798834 5-[3-[3-(Difluoromethyl)piperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798851 5-[3-[[1-(2-Methylsulfonylethyl)piperidin-4-yl]amino]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:145953886 (2S)-2-amino-N-[5-[6-chloro-5-[(3-chlorophenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798437 5-[3-[(3R)-3-(4-methylpiperazin-1-yl)pyrrolidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798600 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3S)-3-methoxypyrrolidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798485 5-[3-[4-(4-Methylpiperazin-1-yl)piperidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798764 5-[3-[4-(2-Methylimidazol-1-yl)piperidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:129030078 8-[(1S)-1-(3,5-difluoroanilino)ethyl]-N-[2-(dimethylamino)ethyl]-2-morpholin-4-ylquinoxaline-6-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:145956683 (2S)-2-amino-N-[5-[6-chloro-5-[(2-chlorophenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118471117 US9862711, Example 4 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:57398393 1-[(2,3-Dichlorophenyl)methyl]-7-(2-methylmorpholin-4-yl)imidazo[1,2-a]pyrimidin-5-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:124173703 (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)butanamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:54582916 5-(1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)-N-methylfuran-2-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798588 5-[3-[3-(4-Ethylpiperazin-1-yl)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:46893088 N-(1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-yl)-1H-indazol-6-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798474 5-[3-[Methyl-(1-methylpiperidin-4-yl)amino]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798432 5-[3-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44514210 N-[2-(dimethylamino)ethyl]-4-[[4-(4-morpholin-4-yl-6-propan-2-yloxy-1,3,5-triazin-2-yl)phenyl]carbamoylamino]benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:90331793 3-Anilino-1-[3-(cyanomethyl)-1-[(4-ethoxyphenyl)carbamoyl]azetidin-3-yl]pyrazole-4-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:168298545 5-[[5-chloro-2-[(6S)-5-(2,6-diamino-5-cyanopyrimidin-4-yl)-5-azaspiro[2.4]heptan-6-yl]-4-oxoquinazolin-3-yl]methyl]-N-hydroxythiophene-2-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798670 5-[3-(2-Morpholin-4-ylethylamino)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44515083 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)-phenyl]-3-[4-(1-hydroxyethyl)phenyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798719 5-[3-[4-(4-Methylimidazol-1-yl)piperidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798560 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(azetidin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798736 [6-(2-Amino-7-fluoro-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:53258965 5-[2-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)-9-pentan-3-ylpurin-6-yl]pyrazin-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:134134680 1-[(3S)-3-[6-(6-methoxypyridin-3-yl)quinolin-4-yl]oxypyrrolidin-1-yl]propan-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798660 4-[1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]-1-methylpiperazin-2-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89216369 N-[2-chloro-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]-3-fluorobenzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118472589 US9862711, Example 3 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155512529 (4-Methylpiperazin-1-yl)-[3-(6-quinolin-3-ylquinazolin-4-yl)phenyl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798760 (2S)-2-amino-1-[4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-3-methylbutan-1-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:132210082 4-Acetyl-1-[3-[4-amino-5-[2-(oxan-4-yl)pyrazol-3-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]phenyl]-3,3-dimethylpiperazin-2-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798469 4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-N-methylpiperazine-1-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44515084 1-[4-(4,6-Dimorpholin-4-yl-1,3,5-triazin-2-yl)-phenyl]-3-[4-(hydroxymethyl)phenyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:44605035 methyl 4-(6-(4-aminophenyl)-4-morpholino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylate 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:129262531 2-amino-4-[[(1S)-1-[7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenylquinolizin-2-yl]ethyl]amino]-6-methylpyrimidine-5-carbonitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798508 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[(3S)-3-pyrazol-1-ylpyrrolidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037674 5-[3-(3,5-Dimethylpiperazin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70686341 1-[6-[5-(Tert-butylsulfamoyl)pyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-[2-(3,5-dimethyl-1,2-oxazol-4-yl)ethyl]urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:24905148 1-cyclopentyl-3-(H-imidazo[1,2-a]pyridin-7-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798837 1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-N-methylazetidine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155529479 N-[(3R)-1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-N-methylacetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798821 6-(2-amino-1,3-benzoxazol-5-yl)-N-(4-hydroxycyclohexyl)imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798681 5-(3-Pyridin-3-ylimidazo[1,2-b]pyridazin-6-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118471055 US9862711, Example 13 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798838 N-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-N',N'-diethylpropane-1,3-diamine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71042425 N-[2-methoxy-5-[3-(1-methylpiperidin-4-yl)-4-oxoquinazolin-6-yl]pyridin-3-yl]methanesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798822 5-[3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:53379513 N-[2-(dimethylamino)ethyl]-N-methyl-4-[[4-[4-morpholin-4-yl-6-[(3S)-oxolan-3-yl]oxy-1,3,5-triazin-2-yl]phenyl]carbamoylamino]benzamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798650 1-[4-[[6-(2-Amino-1,3-benzoxazol-5-yl)quinazolin-4-yl]-methylamino]piperidin-1-yl]ethanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470980 US9862711, Example 1 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:46865424 4,6-dihydroxy-2-((5-methoxy-2-phenyl-1H-indol-3-yl)methylene)benzofuran-3(2H)-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:60148924 PI3K/mTOR Inhibitor-9 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155525312 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperidin-3-yl]-N-methylmethanesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:54580924 1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-N-(1H-indol-6-yl)-1H-benzo[d]imidazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89473577 3-Anilino-1-[3-(cyanomethyl)-1-[(2-methylphenyl)carbamoyl]azetidin-3-yl]pyrazole-4-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:56927258 2-Methyl-3-(2-methyl-3-(trifluoromethyl)benzyl)-5-morpholinopyrazolo[1,5-a]pyrimidine-7-carboxylic acid 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:155536226 5-[4-[[(3S)-1-(2-aminopropanoyl)piperidin-3-yl]amino]quinazolin-6-yl]-2-methoxypyridine-3-carbonitrile 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798640 6-(2-amino-1,3-benzoxazol-5-yl)-N-[3-(diethylamino)propyl]imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798718 6-(2-amino-1,3-benzoxazol-5-yl)-N-(oxan-4-yl)imidazo[1,2-a]pyridine-3-carboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:118470639 US9862711, Example 5 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89216440 N-[2-chloro-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798716 5-[3-[(1-Methylpiperidin-4-yl)amino]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798695 5-[3-[3-(3-Methylpyrazol-1-yl)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798690 5-(3-Pyridin-4-ylquinoxalin-6-yl)-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798612 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-[(3S)-3-hydroxypyrrolidin-1-yl]azetidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89216371 N-[2-chloro-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]-2-fluorobenzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798611 [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[3-[(3R)-3-hydroxypyrrolidin-1-yl]azetidin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798869 3-fluoro-N-[2-methoxy-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]benzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037692 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-[4-(2-methylsulfonylethyl)piperazin-1-yl]methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70682086 1-[6-[5-(Tert-butylsulfamoyl)pyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-3-(2-pyrazin-2-ylethyl)urea 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71042542 N-[2-methoxy-5-[4-oxo-3-(1-propan-2-ylpiperidin-4-yl)quinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798843 1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-ol 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798561 [6-(2-Amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-(4-morpholin-4-ylpiperidin-1-yl)methanone 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:46853654 N-tert-Butyl-5-(2-(3-(2-morpholino-2-oxoethyl)ureido)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)pyridine-3-sulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:145952796 N-(6-phenyl-1H-indazol-4-yl)cyclopropanecarboxamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:9879653 3-(4-Morpholinopyrido[3,2-d]pyrimidin-2-yl)phenol 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:132471104 N-[2-chloro-5-[4-oxo-3-(1-propan-2-ylpiperidin-4-yl)-1,2,4a,5,6,7,8,8a-octahydroquinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:66780292 4-[(3-chloro-2-methylphenyl)methyl]-5-(methylthio)-2-(4-morpholinyl)[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798472 N-[1-[6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridine-3-carbonyl]piperidin-4-yl]acetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798403 5-[3-[(3S)-3-methylpiperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798710 5-[3-(Oxan-4-ylamino)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71037699 N-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-N',N'-diethylethane-1,2-diamine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71251007 N-[2-chloro-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]phenyl]-2,4-difluorobenzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:89212415 N-[5-(2-amino-1,3-benzoxazol-6-yl)-1,3-benzothiazol-2-yl]acetamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798750 5-[4-[(1-Methylsulfonylpiperidin-4-yl)amino]quinazolin-6-yl]-1,3-benzoxazol-2-amine 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:70798870 4-fluoro-N-[2-methoxy-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]benzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71042424 N-[2-methoxy-5-[3-(1-methylpiperidin-4-yl)-4-oxoquinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 6.478338951626406e-05 0.399936\n",
      "PUBCHEM.COMPOUND:71682057 (2S)-N-[5-(6-aminopyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]-4,4,4-trifluoro-2-methylbutanamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118470222 US10112926, Example 97 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118470255 US10112926, Example 4.1 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118470168 US10112926, Example 4 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118470233 US10112926, Example 98 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118470208 US10112926, Example 28 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118470005 US10112926, Example 17 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118730716 8-[(3,5-difluoro-N-methylanilino)methyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:164620063 2-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:122179487 3-(6-methoxypyridin-3-yl)-N-(3-methylbutyl)-5-[[4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]anilino]methyl]benzamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:156566147 N-(1,3-benzothiazol-5-yl)-1',1'-dioxospiro[1,3-dioxolane-2,3'-2H-thieno[2,3-g]quinoline]-8'-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:51033720 4-(4-cyano-2-fluorophenyl)-2-morpholino-5-(1H-1,2,4-triazol-5-yl)thiophene-3-carbonitrile 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:58204034 1-[2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-ethane-1,2-diol 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798570 [1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]-morpholin-4-ylmethanone 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798505 [1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]-(4-methylpiperazin-1-yl)methanone 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:67103909 8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-[(2S)-2-methylmorpholin-4-yl]-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:164610419 4-[[3-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798759 [1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]-[(3R)-3-methylpiperazin-1-yl]methanone 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:164619420 2-[4-[[2-(2-Aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:141461656 CID 141461656 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:127047685 8-[(3,5-difluoro-N-methylanilino)methyl]-N,N-dimethyl-2-[(2R)-2-methylmorpholin-4-yl]-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:122179486 N-[2-(2-fluorophenyl)ethyl]-3-(6-methoxypyridin-3-yl)-5-[[4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]anilino]methyl]benzamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798548 5-[3-[3-(3,3-Dimethylpiperazin-1-yl)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "CHEBI:124915 (3R)-4-[2-(1H-indol-4-yl)-6-(1-methylsulfonylcyclopropyl)-4-pyrimidinyl]-3-methylmorpholine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:155532820 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]methanesulfonamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:88971175 5-(2-Amino-1,3-benzothiazol-6-yl)-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:138961889 1-[6-[2-Amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]piperidin-4-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118730713 6-(azetidine-1-carbonyl)-8-[(1R)-1-(3,5-difluoroanilino)ethyl]-2-morpholin-4-ylchromen-4-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:49784892 4-(2-(6-Methoxypyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:59548371 4-(5-Methoxy-2-(6-methoxypyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:88979955 N-[2-chloro-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]-2,4-difluorobenzenesulfonamide 7.558021306423057e-05 0.391931\n",
      "CHEBI:94742 4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl ester 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:42623951 5-(2-Amino-8-fluoro-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-N-tert-butylpyridine-3-sulfonamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798523 4-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]-1-methylpiperazin-2-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:25172062 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118730711 8-[(1R)-1-(3-chloro-2-fluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:121426350 2-(Hydroxymethyl)-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazine-8-carboxylic acid 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:122179494 N-(1,3-dihydroxypropan-2-yl)-3-(6-methoxypyridin-3-yl)-5-[[4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]anilino]methyl]benzamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:49872831 4-amino-6-[[(1S)-1-(6-fluoro-4-methoxy-3-phenylquinolin-2-yl)ethyl]amino]pyrimidine-5-carbonitrile 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:127047140 8-[(8-fluoro-2,3-dihydro-1,4-benzoxazin-4-yl)methyl]-N,N-dimethyl-2-[(2R)-2-methylmorpholin-4-yl]-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:53235216 8-(1H-imidazol-2-yl)-2-(2-propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazole 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:49785083 4-(2-(6-Methoxypyridin-3-ylamino)-5-(morpholinomethyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:132209922 1-[(3S,5R)-4-[3-[4-amino-5-[2-(oxan-4-yl)pyrazol-3-yl]pyrrolo[2,1-f][1,2,4]triazin-7-yl]phenyl]-3,5-dimethylpiperazin-1-yl]ethanone 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:67103712 8-[(1R)-1-(3-chloro-5-fluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:49872925 4-amino-6-[[(1S)-1-[6-fluoro-4-(2-methylsulfonylethylamino)-3-phenylquinolin-2-yl]ethyl]amino]pyrimidine-5-carbonitrile 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:58441401 1-(4-{[2-(1H-indazol-4-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}piperazin-1-yl)-6-methylhept-5-ene-1,4-dione 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70693248 5-[2-[(4-Methylsulfonylpiperazin-1-yl)methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]-4-(trifluoromethyl)pyrimidin-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798739 (2R)-2-amino-1-[4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-3-methylbutan-1-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:129029978 8-[1-(3,5-difluoroanilino)ethyl]-N-[2-(dimethylamino)ethyl]-2-morpholin-4-ylquinoxaline-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:67050504 3-[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazol-8-yl]-1H-pyridin-2-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:135197621 2,4-difluoro-N-[2-methoxy-5-[4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:145952598 (2S)-2-amino-N-[5-[6-chloro-5-[(2,5-dichlorophenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:146585662 4-[[[2-[(1S)-1-[(2-amino-5-cyano-6-methylpyrimidin-4-yl)amino]propyl]-4-oxo-3-phenylquinazolin-5-yl]amino]methyl]-N-hydroxybenzamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:124173705 (S)-2-cyclopropyl-2-((2-((S)-4-(fluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)acetamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70694723 6-(2-aminopyrimidin-5-yl)-N-(2-methoxyethyl)-3-methyl-8-morpholin-4-ylimidazo[1,2-a]pyrazine-2-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798465 5-(3-Pyridin-4-ylpyrazolo[1,5-a]pyrimidin-5-yl)-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:136088593 US10172858, Table 2.63 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:46927938 5-(2-((4-(Methylsulfonyl)piperazin-1-yl)methyl)-8-morpholinoimidazo[1,2-a]pyrazin-6-yl)pyrimidin-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798522 [1-[7-(2-Amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]-(4-cyclopropylpiperazin-1-yl)methanone 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798430 5-[3-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:155552100 2-morpholin-4-yl-6-(9H-thioxanthen-4-yl)pyran-4-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:50905012 2-[4-[8-(2-Amino-1,3-benzoxazol-5-yl)-3-methyl-2-oxoimidazo[4,5-c]quinolin-1-yl]phenyl]-2-methylpropanenitrile 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:145955070 (2R)-2-amino-N-[5-[5-(benzenesulfonamido)pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]propanamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118728815 3-[(2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-2-bicyclo[2.2.2]octanyl]-2H-1,2-oxazol-5-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:155561152 [3-[6-(6-Methoxypyridin-3-yl)quinazolin-4-yl]phenyl]-(4-methylpiperazin-1-yl)methanone 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:44475985 3-{[4-Amino-1-(1-Methylethyl)-1h-Pyrazolo[3,4-D]pyrimidin-3-Yl]ethynyl}phenol 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:56595686 2-(Difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-5-methoxybenzimidazol-4-ol 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:58233988 5-(6-((4-(N-methyl,N-methylsulfonylamino)piperidin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118616775 PI3K/mTOR Inhibitor-2 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:155546999 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-N-methylmethanesulfonamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798669 Ethyl 4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazine-1-carboxylate 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:67061712 2-Methyl-1-(4-{2-[1-(2,2,2-Trifluoroethyl)-1h-1,2,4-Triazol-5-Yl]-4,5-Dihydro[1]benzoxepino[5,4-D][1,3]thiazol-8-Yl}-1h-Pyrazol-1-Yl)propan-2-Ol 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:129030298 8-[1-(3,5-difluorophenyl)pyrrolidin-2-yl]-N,N-dimethyl-2-morpholin-4-ylquinoxaline-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118730714 8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N-methyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:75201325 US10202371, Example 9 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118444396 methyl (3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidine-1-carboxylate 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118436155 1-[(3S)-3-[4-(2-aminopyrimidin-5-yl)-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-7-yl]-3-methylpyrrolidin-1-yl]-2-methylpropan-1-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:129029966 8-[(1R)-1-(3-fluoroanilino)ethyl]-N-(2-hydroxyethyl)-2-morpholin-4-ylquinoxaline-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:59548274 5-(4-Amino-6-methyl-1,3,5-triazin-2-YL)-N-(6-methoxypyridin-3-YL)-6'-methyl-3,3'-bipyridin-6-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798696 (3R)-1-[1-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]azetidin-3-yl]pyrrolidin-3-ol 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798540 5-[3-[3-(Trifluoromethyl)piperazin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:89212458 N-[2-chloro-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]methanesulfonamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:136088622 US10172858, Table 2.70 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:155525717 2-methoxy-5-[4-[[(3S)-1-(5-nitrofuran-3-carbonyl)piperidin-3-yl]amino]quinazolin-6-yl]pyridine-3-carbonitrile 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:129262522 PI3Kdelta-IN-8 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:127047797 8-[(6,8-difluoro-2,3-dihydro-1,4-benzoxazin-4-yl)methyl]-N,N-dimethyl-2-[(2R)-2-methylmorpholin-4-yl]-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:59548302 (5-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-6-(6-methoxypyridin-3-ylamino)pyridin-3-yl)methanol 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:124173719 (S)-2-cyclopropyl-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)acetamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798645 (2S)-2-amino-1-[4-[7-(2-amino-1,3-benzoxazol-5-yl)quinoxalin-2-yl]piperazin-1-yl]-3-hydroxypropan-1-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:136088584 US10172858, Table 2.68 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:127047138 8-[(6-fluoro-2,3-dihydro-1,4-benzoxazin-4-yl)methyl]-N,N-dimethyl-2-[(2R)-2-methylmorpholin-4-yl]-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:57345686 2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-7-morpholin-4-ylimidazo[1,2-a]pyrimidin-5-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:164625133 2-[4-[[2-(2-Aminopyrimidin-5-yl)-4-morpholin-4-ylfuro[3,2-d]pyrimidin-6-yl]methyl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798525 5-[3-[3-(4-Methylpiperazin-1-yl)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:58203995 2-{[2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-ylmethyl]-amino}-ethanol 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:155523599 [(3S)-1-[6-(6-methoxypyridin-3-yl)quinazolin-4-yl]piperidin-3-yl]-(4-methylpiperazin-1-yl)methanone 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:127047683 8-[(6,8-difluoro-2,3-dihydro-1,4-benzoxazin-4-yl)methyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:146680869 Methoxymethyloxathiatetraazatetracyclodocosahexaenedione 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:142506155 5-[[2-[(1S)-1-[(2-amino-5-cyano-6-methylpyrimidin-4-yl)amino]propyl]-4-oxo-3-phenylquinazolin-5-yl]amino]-N-hydroxypentanamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:58203976 2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-8-pyrrolidin-2-yl-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798487 7-(4-Pyridin-4-ylquinolin-6-yl)-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:155544583 4-[[(1R)-1-(4-chlorophenyl)ethyl]amino]-6-cyanoquinoline-3-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:145959429 (2S)-2-amino-N-[5-[5-(benzenesulfonamido)pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]propanamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798678 1-[4-[[6-(2-Amino-1,3-benzoxazol-5-yl)quinazolin-4-yl]amino]piperidin-1-yl]ethanone 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798490 6-(4-Pyridin-4-ylquinolin-6-yl)-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:44475990 3-(2-Amino-1,3-Benzothiazol-6-Yl)-1-{[2-(4-Methylpiperazin-1-Yl)quinolin-3-Yl]methyl}-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798844 5-[3-[3-(2-Methylimidazol-1-yl)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798427 N-[6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-2-yl]acetamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:71454944 1-[4-[4-[2-[3-(Diethylsulfamoyl)-4-methylanilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methylurea 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:105009 Prolinedithiocarbamate 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798694 5-[3-[3-(4-Cyclopropylpiperazin-1-yl)azetidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798867 2,4-difluoro-N-[2-methoxy-5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]benzenesulfonamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:58298318 Cc-115 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:11955205 4-(4-Acetylpiperazin-1-yl)-2-(2-difluoromethylbenzimidazol-1-yl)-6-morpholino-1,3,5-triazine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:155524238 N-[(3S)-1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-N-methylacetamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:71460422 1-[4-[4-[2-[4-Chloro-3-(dimethylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methylurea 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:11419728 Tert-butyl 3-[[5-(3-fluoro-4-methylsulfonylphenyl)-4-methyl-1,3-thiazol-2-yl]carbamoylamino]propanoate 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798765 5-(4-Morpholin-4-yl-1-piperidin-4-ylpyrazolo[3,4-d]pyrimidin-6-yl)-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:127046117 8-[(6-fluoro-2,3-dihydro-1,4-benzoxazin-4-yl)methyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798429 5-[3-[4-(4-Methylsulfonylpiperazin-1-yl)piperidin-1-yl]quinoxalin-6-yl]-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:49785079 N-[3-(2-methyl-7H-purin-6-yl)pyridin-2-yl]-1H-indazol-4-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:141509623 N-[4-(2-oxo-8-pyridin-3-yl-[1]benzofuro[3,2-b]pyridin-1-yl)phenyl]prop-2-enamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:60150509 2-Methyl-5-(2-methylmorpholin-4-yl)-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-one 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798720 5-[3-(4-Imidazol-1-ylpiperidin-1-yl)quinoxalin-6-yl]-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:71548719 2-Methoxy-5-[4-[3-(4-methylpiperazine-1-carbonyl)phenyl]quinazolin-6-yl]pyridine-3-carbonitrile 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:75201316 US10202371, Example 4 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:66972539 5-(3-Pyridin-4-ylimidazo[1,2-a]pyridin-6-yl)-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798392 5-(4-Morpholin-4-ylquinazolin-6-yl)-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:60155265 4-[5-(Methoxymethyl)-2-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:60155724 3-amino-6-[4-chloro-3-[(3-fluoro-2-methylphenyl)sulfamoyl]phenyl]-N-methylpyrazine-2-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:155549003 N-[1-[[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]pyrrolidin-3-yl]-2-methoxy-N-methylacetamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:162620908 2-[4-[4-Morpholin-4-yl-6-[6-[(2-morpholin-4-ylacetyl)amino]-4-(trifluoromethyl)pyridin-3-yl]-1,3,5-triazin-2-yl]piperazine-1-carbonyl]-1-benzofuran-7-carboxamide 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:118728813 2-[(2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-2-bicyclo[2.2.2]octanyl]ethylphosphonic acid 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:155533050 2-methoxy-5-[4-[[(3S)-1-(pyridine-3-carbonyl)piperidin-3-yl]amino]quinazolin-6-yl]pyridine-3-carbonitrile 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:71453206 1-Methyl-3-[4-[4-[2-[4-methyl-3-(methylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]urea 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:71037673 5-[6-[(4-Methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl]-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:70798550 5-[4-(Oxan-4-yloxy)quinazolin-6-yl]-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:50991236 5-(4-Pyridin-4-ylquinolin-6-yl)-1,3-benzoxazol-2-amine 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:49854573 CID 49854573 7.558021306423057e-05 0.391931\n",
      "PUBCHEM.COMPOUND:49784988 N-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)pyridin-2-yl)-1H-indol-4-amine 7.558021306423057e-05 0.391931\n",
      "CHEBI:15738 staurosporine 7.899495707574542e-05 0.389646\n",
      "PUBCHEM.COMPOUND:130421765 N-[5-[2-[(1S)-1-cyclopropylethyl]-7-(methanesulfonamido)-1-oxo-3H-isoindol-5-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:60155266 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-morpholin-4-ylpyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:132271619 2-[[Methyl(2-methylsulfonylethyl)amino]methyl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-8-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:58203712 8-(1-Methylimidazol-4-yl)-2-(2-propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazole 8.637692003324578e-05 0.385043\n",
      "CHEBI:71957 XL147 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:56589559 2-(Difluoromethyl)-3-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-7-methoxybenzimidazol-5-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:71458573 1-Methyl-3-[4-[4-[2-[3-(methylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]urea 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:57351276 N-{5-[3-Fluoro-4-(methanesulfonyl)phenyl]-4-methyl-1,3-thiazol-2-yl}acetamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:49847093 CID 49847093 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:59251679 N-{6-[6-Amino-5-(Trifluoromethyl)pyridin-3-Yl]imidazo[1,2-A]pyridin-2-Yl}acetamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:138961888 1-[6-[2-Amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]-3-phenylimidazolidin-2-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:122181416 1-[4-[5-[5-Amino-6-(benzotriazol-1-yl)pyrazin-2-yl]-1-methyl-1,2,4-triazol-3-yl]piperidin-1-yl]-2-(dimethylamino)ethanone 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:53235217 5-[2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazol-8-yl]pyridin-2-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:57900314 2-[1-(Propan-2-Yl)-1h-1,2,4-Triazol-5-Yl]-4,5-Dihydrothieno[3,2-D][1]benzoxepine-8-Carboxamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:155551961 N-[2-methoxy-5-[4-[[(3S)-1-(oxane-4-carbonyl)pyrrolidin-3-yl]amino]quinazolin-6-yl]pyridin-3-yl]methanesulfonamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:49785518 4-(2-(6-methoxypyridin-3-ylamino)-5-(1-methyl-1H-pyrazol-4-yl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:56648758 1-(4-((2-(2-Aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxyethanone 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:73774658 US10202371, Example 1 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:121445751 2-amino-N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:122185267 1-[2-(Diethylamino)ethyl]-3-[6-[5-[(4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]urea 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:155520373 N-[5-[4-[[(3S)-1-acetylpyrrolidin-3-yl]amino]quinazolin-6-yl]-2-methoxypyridin-3-yl]methanesulfonamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:71456728 1-[4-[4-[2-[3-(Diethylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methylurea 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:68947304 (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:155527651 4-[[[2-[(1S)-1-[(2,6-diamino-5-cyanopyrimidin-4-yl)amino]ethyl]-4-oxo-3-phenylquinazolin-5-yl]amino]methyl]-N-hydroxybenzamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:155513615 N-[2-methoxy-5-[4-(2-morpholin-4-ylethylamino)quinazolin-6-yl]pyridin-3-yl]methanesulfonamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:129030093 8-[1-(3-fluoroanilino)ethyl]-N-[2-(methylamino)ethyl]-2-morpholin-4-ylquinoxaline-6-carboxamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:44475986 N-[6-(4-Amino-1-{[2-(4-Methylpiperazin-1-Yl)quinolin-3-Yl]methyl}-1h-Pyrazolo[3,4-D]pyrimidin-3-Yl)-1,3-Benzothiazol-2-Yl]acetamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:54581983 N-(4-(1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenyl)acetamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:60155452 4-[[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]methyl]-N,N-dimethylpiperazine-1-carboxamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:49785436 4-(5-(3,6-Dihydro-2H-pyran-4-YL)-2-(6-methoxypyridin-3-ylamino)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:25070230 3-(6-(piperidin-1-yl)-9H-purin-2-yl)phenol 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:44180398 methyl 4-(5-morpholino-7-oxo-7H-thieno[3,2-b]pyran-3-yl)benzoate 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:59548431 4-((5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-(6-methoxypyridin-3-ylamino)pyridin-3-yl)methyl)-N,N-dimethylpiperazine-1-sulfonamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:59548462 4-(2-(6-Methoxypyridin-3-ylamino)-5-(4-(methylsulfonyl)benzyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:75201318 US10202371, Example 5 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:118728814 2-[[(2R,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-2-bicyclo[2.2.2]octanyl]methyl]-1,2,4-oxadiazolidine-3,5-dione 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:2769826 1-Naphthalen-2-yloxy-3-(propan-2-ylamino)propan-2-ol 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:49854023 2-[2-(2,3-dihydro-1H-indol-1-yl)-2-oxoethyl]-3-methyl-6-(morpholin-4-yl)pyrimidin-4(3H)-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:66779815 5-cyclopropyl-4-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-2-(4-morpholinyl)[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:66780337 4-[(3-chloro-2-methylphenyl)methyl]-5-(hydroxymethyl)-2-(4-morpholinyl)[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:66779813 4-[(3-chloro-2-methylphenyl)methyl]-5-methyl-2-(4-morpholinyl)[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:10247954 N-(4-(2-(phenylamino)pyridin-4-yl)pyridin-2-yl)-tetrahydrofuran-3-carboxamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:66779989 4-[(3-chloro-2-methylphenyl)methyl]-5-(methyloxy)-2-(4-morpholinyl)[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:86718541 US10202371, Example 3 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:132005220 N-[4-[[3-[(5,8,11-trimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]sulfonylamino]phenyl]prop-2-enamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:155566187 2-[[2-[(1S)-1-[(2,6-diamino-5-cyanopyrimidin-4-yl)amino]ethyl]-4-oxo-3-phenylquinazolin-5-yl]methylamino]-N-hydroxypyrimidine-5-carboxamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:145108300 N-[5-[5-(benzenesulfonamido)-6-chloropyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]propanamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:142506065 6-[2-[(1S)-1-[(2,6-diamino-5-cyanopyrimidin-4-yl)amino]propyl]-4-oxo-3-phenylquinazolin-5-yl]-N-hydroxyhexanamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:71449587 1-Methyl-3-[4-[4-[2-(3-sulfamoylanilino)pyrimidin-4-yl]pyridin-2-yl]phenyl]urea 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:75201323 US10202371, Example 12 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:59548356 4-(2-(6-Methoxypyridin-3-ylamino)-5-((4-(methylsulfonyl)piperidin-1-YL)methyl)pyridin-3-YL)-6-methyl-1,3,5-triazin-2-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:44620964 [3-(6-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}-4-Morpholin-4-Ylthieno[3,2-D]pyrimidin-2-Yl)phenyl]methanol 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:132271620 2-[(2-Methylsulfonylethylamino)methyl]-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-8-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:59548424 4-(2-(6-Methoxypyridin-3-ylamino)-5-((1-(methylsulfonyl)piperidin-4-yl)methyl)pyridin-3-yl)-6-methyl-1,3,5-triazin-2-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:58204242 2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-8-pyrrolidin-3-yl-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazole 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:50939338 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:75201317 US10202371, Example 10 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:53234281 2-(2-Propan-2-yl-1,2,4-triazol-3-yl)-4,5-dihydro-[1]benzoxepino[5,4-d][1,3]thiazole 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:44181600 5-morpholino-3-phenyl-7H-thieno[3,2-b]pyran-7-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:25032963 6,6-dimethyl-2-(6-(6-methylpyridazin-3-ylamino)-2H-benzo[b][1,4]oxazin-4(3H)-yl)-6,7-dihydrothiazolo[5,4-c]pyridin-4(5H)-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:71655831 5-chloro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)ethyl]quinazolin-4-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:60155451 Methyl 4-[[5-(4-amino-6-methyl-1,3,5-triazin-2-yl)-6-[(6-methoxypyridin-3-yl)amino]pyridin-3-yl]methyl]piperazine-1-carboxylate 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:11576772 3-[6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidin-2-yl]-phenol 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:66780007 5-amino-4-[(3-chloro-2-methylphenyl)methyl]-2-(4-morpholinyl)[1,3]thiazolo[4,5-d]pyrimidin-7(4H)-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:75201321 US10202371, Example 14 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:138961887 1-[6-[2-Amino-4-(trifluoromethyl)pyrimidin-5-yl]-2-morpholin-4-ylpyrimidin-4-yl]piperidin-2-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:129029979 8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N-[2-(dimethylamino)ethyl]-2-morpholin-4-ylquinoxaline-6-carboxamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:76310250 1-[4-(Hydroxymethyl)phenyl]-3-[4-(4-morpholin-4-ylpyrido[3,2-d]pyrimidin-2-yl)phenyl]urea 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:53234283 [2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]-methanol 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:168293075 (4S,5R)-3-[4-[2-amino-4-(trifluoromethyl)pyrimidin-5-yl]-6-morpholin-4-ylpyrimidin-2-yl]-4-(hydroxymethyl)-5-methyl-1,3-oxazolidin-2-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:11541283 N-[5-(5-benzenesulphonamido-6-chloropyridin-3-yl)-4-methylthiazol-2-yl]acetamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:154573770 PI3Kalpha-IN-4 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:58203779 2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-8-piperidin-4-yl-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:56599306 Pilaralisib 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:122185265 1-Cyclopropyl-3-[6-[5-[(4-fluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]urea 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:15983184 Puquitinib 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:130422161 N-[5-[2-[(1S)-1-cyclopropylethyl]-7-(methylsulfamoyl)-1-oxo-3H-isoindol-5-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:52936850 N-(5-(3-(5-Methyl-1,2,4-oxadiazol-3-yl)imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)benzenesulfonamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:135197617 Example 59 [WO2018121550] 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:24993871 6-(4-Methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-2-pyridin-3-yl-thieno[3,2-d]pyrimidine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:46220225 6-(1H-indazol-4-yl)-1-methyl-4-(4-(methylsulfonyl)phenoxy)-1H-pyrazolo[3,4-b]pyridine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:127045862 5-[4-Amino-1-(cyclopentylmethyl)pyrazolo[3,4-d]pyrimidin-3-yl]-1,3-benzoxazol-2-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:70685442 2-Methylsulfanyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-5-morpholin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-7-one 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:121426224 3-[(3-Fluoro-2-piperidin-4-ylphenyl)methyl]-2-methyl-6-morpholin-4-ylimidazo[1,2-b]pyridazin-8-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:60155268 4-[2-[(6-Methoxypyridin-3-yl)amino]-5-(4-methylpiperazin-1-yl)pyridin-3-yl]-6-methyl-1,3,5-triazin-2-amine 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:90134588 US10202371, Example 11 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:90124010 US10202371, Example 2 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:118366994 N-hydroxy-7-[2-(2-methoxypyrimidin-5-yl)-6-morpholin-4-ylpurin-9-yl]heptanamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:49778924 Thiazolo[4,5-d]pyrimidin-7(4H)-one, 5-methyl-4-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-2-(4-morpholinyl)- 8.637692003324578e-05 0.385043\n",
      "CHEBI:17682 benzoin 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:89517065 [3-[6-[6-Methoxy-5-(trifluoromethyl)pyridin-3-yl]quinazolin-4-yl]phenyl]-(4-methylpiperazin-1-yl)methanone 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:75201319 US10202371, Example 6 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:44180034 Ethyl 4-[5-(Morpholin-4-Yl)-7-Oxo-7h-Thieno[3,2-B]pyran-3-Yl]benzoate 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:129030181 N-[2-(dimethylamino)ethyl]-8-[(3-fluoro-2-methylanilino)methyl]-2-morpholin-4-ylquinoxaline-6-carboxamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:25172477 N-[(E)-(5-cyanopyrazolo[1,5-a]pyridin-3-yl)methylideneamino]-N-(2-hydroxyethyl)-2-methyl-5-nitrobenzenesulfonamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:75201324 US10202371, Example 8 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:155567372 [3-[6-(3,4-Dimethoxyphenyl)quinazolin-4-yl]phenyl]-(4-methylpiperazin-1-yl)methanone 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:75201320 US10202371, Example 7 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:75201322 US10202371, Example 13 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:142506036 4-[[[2-[(1S)-1-[(2-amino-5-cyano-6-methylpyrimidin-4-yl)amino]ethyl]-4-oxo-3-phenylquinazolin-5-yl]amino]methyl]-N-hydroxybenzamide 8.637692003324578e-05 0.385043\n",
      "PUBCHEM.COMPOUND:53308041 SureCN6875931 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:122181413 1-[4-[4-[5-Amino-6-(benzotriazol-1-yl)pyrazin-2-yl]pyrazol-1-yl]piperidin-1-yl]-2-(dimethylamino)ethanone 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:46947264 1-(4-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-3-(pyridin-4-yl)urea 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:121334433 (S)-4-(difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:22036885 2-(Difluoromethyl)-1-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)benzimidazol-4-ol 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:49785827 3-(3-(4-Amino-6-methyl-1,3,5-triazin-2-YL)pyridin-2-ylamino)phenol 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:121426376 2-Methyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazine-8-carboxylic acid 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:122178124 N-[2-chloro-5-(4-pyridin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]-2,4-difluorobenzenesulfonamide 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:59548407 N-(5-(3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-(2-methoxyethoxy)pyridin-2-ylamino)-2-chloropyridin-3-yl)methanesulfonamide 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:127046317 8-((8-Fluoro-2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)methyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:56648759 1-(4-((2-(2-Aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxy-2-methylpropan-1-one 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:155543588 1-N-[[2-[(1S)-1-[(2,6-diamino-5-cyanopyrimidin-4-yl)amino]ethyl]-4-oxo-3-phenylquinazolin-5-yl]methyl]-4-N-hydroxybenzene-1,4-dicarboxamide 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:122178120 2,4-difluoro-N-[2-methoxy-5-(4-pyridin-4-ylthieno[2,3-d]pyrimidin-6-yl)pyridin-3-yl]benzenesulfonamide 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:11538304 1-(2-Chloro-2-phenylethyl)-6-ethylsulfanyl-4-pyrrolidin-1-ylpyrazolo[3,4-d]pyrimidine 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:56648677 (S)-2-amino-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)propan-1-one 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:59507767 5-(2,6-Dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyrimidin-2-amine 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:24946706 4-Methyl-5-(6-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}-4-Morpholin-4-Ylthieno[3,2-D]pyrimidin-2-Yl)pyrimidin-2-Amine 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:59548349 (RAC)-4-(2-(6-Methoxypyridin-3-Ylamino)-5-((3-(Methylsulfonyl)Pyrrolidin-1-yl)Methyl)Pyridin-3-yl)-6-Methyl-1,3,5-Triazin-2-Amine 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:145960355 [8-[1-(3,5-difluorophenyl)pyrrolidin-2-yl]-2-morpholin-4-ylquinoxalin-6-yl]-[(3R,5S)-3,5-dimethylpiperazin-1-yl]methanone 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:25207689 5-(7-Methyl-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:56648757 2-Amino-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-methylpropan-1-one 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:121334440 4-(difluoromethyl)-5-[4-[(3S,5R)-3,5-dimethylmorpholin-4-yl]-6-[(3R)-3-methylmorpholin-4-yl]-1,3,5-triazin-2-yl]pyridin-2-amine 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:46866705 2H-Imidazo(4,5-C)(1,5)naphthyridin-2-one, 1,3-dihydro-1-(1-((2S)-2-hydroxy-1-oxopropyl)-4-piperidinyl)-3-methyl-8-(6-methyl-3-pyridinyl)- 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:129030296 8-[(2R)-1-(3,5-difluorophenyl)pyrrolidin-2-yl]-N,N-dimethyl-2-morpholin-4-ylquinoxaline-6-carboxamide 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:59548419 N'-(5-((3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-methoxy-2-pyridinyl)amino)-2-chloro-3-pyridinyl)-N,N-dimethylsulfamide 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:52913198 6-(2-((4-Amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5-ynamide 9.717351042456866e-05 0.379005\n",
      "CHEBI:92165 2-(4-morpholinyl)-4-benzo[h][1]benzopyranone 9.717351042456866e-05 0.379005\n",
      "CHEBI:85572 Ku-0063794 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:121231531 2-[2-[(2S)-2-methyl-2,3-dihydroindol-1-yl]-2-oxoethyl]-6-morpholin-4-yl-1,3-diazinan-4-one 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:46892971 2-(4-(2-(3-hydroxyphenylamino)-1H-benzo[d]imidazol-1-yl)-6-methyl-1,3,5-triazin-2-ylamino)acetonitrile 9.717351042456866e-05 0.379005\n",
      "CHEBI:91329 AZD-8055 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:132271625 [4-[8-Amino-2-(hydroxymethyl)-3-[2-methyl-3-(trifluoromethyl)anilino]imidazo[1,2-b]pyridazin-6-yl]morpholin-2-yl]methanol 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:46180666 2-(2-(2-Amino-4-methylpyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)propan-2-ol 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:130470684 7-Fluoro-6-[6-(methoxymethyl)-3-pyridinyl]-4-[[(1S)-1-(1-methyl-1H-pyrazol-3-yl)ethyl]amino]-3-quinolinecarboxamide 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:138504497 6-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-4-[[(1S)-1-(oxan-4-yl)ethyl]amino]cinnoline-3-carboxamide 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:121426321 2-Methyl-3-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazin-8-amine 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:124193915 Unii-75658jdg29 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:130453737 ATM Inhibitor-1 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:121426239 1-[[2-[(8-Amino-2-methyl-6-morpholin-4-ylimidazo[1,2-b]pyridazin-3-yl)amino]-6-(trifluoromethyl)phenyl]methyl]azetidin-3-ol 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:118374520 7-[2-(2-aminopyrimidin-5-yl)-6-morpholin-4-ylpurin-9-yl]-N-hydroxyheptanamide 9.717351042456866e-05 0.379005\n",
      "PUBCHEM.COMPOUND:132005225 PI3K|A/|A-IN-1 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:46891474 N-(2-(dimethylamino)ethyl)-4-(3-(2-((7-fluoro-5-methoxy-2-(1,3,5-trimethyl-1H-pyrazol-4-yl)-1H-indol-3-yl)methylene)-3-oxo-2,3-dihydrobenzofuran-5-yl)ureido)-N-methylbenzamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:141471198 N-[6-[5-[(2,4-difluorophenyl)sulfonylamino]-6-methoxypyridin-3-yl]-4-methylthieno[2,3-d]pyrimidin-2-yl]acetamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:121334501 CID 121334501 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:50939078 1'-[7-Fluoro-3-Methyl-2-(Pyridin-2-Yl)quinolin-4-Yl]-6'-(Morpholin-4-Yl)-1',2,2',3,5,6-Hexahydrospiro[pyran-4,3'-Pyrrolo[3,2-B]pyridine] 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:132005246 5,8,11-Trimethyl-2-[3-(4-propanoylpiperazin-1-yl)sulfonylanilino]pyrimido[4,5-b][1,4]benzodiazepin-6-one 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:46861592 5-(1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)benzene-1,3-diol 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:24946175 (2R)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:142506102 4-[2-[2-[(1S)-1-[(2,6-diamino-5-cyanopyrimidin-4-yl)amino]propyl]-4-oxo-3-phenylquinazolin-5-yl]ethyl]-N-hydroxybenzamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:54579940 1-(4-(1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenyl)-3-methylurea 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:50939080 4-(1-(7-Fluoro-3-methyl-2-(2-pyridinyl)-4-quinolinyl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-6-yl)-2-pyrimidinamine 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:74539862 2,4-difluoro-N-[5-[4-[4-[[2-hydroxyethyl(methyl)amino]methyl]phenyl]quinolin-6-yl]-2-methoxypyridin-3-yl]benzenesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:71454238 N-[5-[[3-(4-amino-6-methyl-1,3,5-triazin-2-yl)pyridin-2-yl]amino]-2-chloropyridin-3-yl]methanesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:66788835 2-[3-(4-Amino-6-methyl-1,3,5-triazin-2-yl)-2-[(5-fluoro-6-methoxypyridin-3-yl)amino]imidazo[1,2-a]pyridin-6-yl]propan-2-ol 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:59548288 N'-(5-((3-(4-amino-6-methyl-1,3,5-triazin-2-yl)-5-chloro-2-pyridinyl)amino)-2-chloro-3-pyridinyl)-N,N-dimethylsulfamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:56929824 N-[6-[5-amino-6-(1,1,1-trifluoropropan-2-yloxy)pyrazin-2-yl]imidazo[1,2-a]pyridin-2-yl]acetamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:135197594 2,4-difluoro-N-[2-methoxy-5-[4-methyl-2-(methylamino)-8-[(3R)-oxolan-3-yl]oxyquinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:86291103 Tenalisib 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:135197577 2,4-difluoro-N-[2-methoxy-5-[4-methyl-2-(methylamino)-8-(oxan-4-yloxy)quinazolin-6-yl]pyridin-3-yl]benzenesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:56832510 2-{4-[2-(2-Isopropyl-2H-[1,2,4]triazol-3-yl)-4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen-8-yl]pyrazol-1-yl}-ethanol 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:145996540 2,4-difluoro-N-[2-methoxy-5-[3-[5-[2-(4-methylpiperazin-1-yl)ethyl]-1,3,4-oxadiazol-2-yl]imidazo[1,2-a]pyridin-6-yl]pyridin-3-yl]benzenesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:46180604 5-(4-morpholino-6-((4-N-methylsulfonylpiperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-2-yl)pyrimidin-2-amine 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:74539799 2,4-difluoro-N-[2-methoxy-5-[4-[4-(1,2,4-triazol-1-ylmethyl)phenyl]quinolin-6-yl]pyridin-3-yl]benzenesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:44187953 1-(4-(3-ethyl-7-morpholino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl)-3-(4-(4-methylpiperazine-1-carbonyl)phenyl)urea 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:71453419 3-[[1-(4-Methyl-1,3,5-triazin-2-yl)benzimidazol-2-yl]amino]phenol 0.00010796998423945816 0.373636\n",
      "CHEBI:187241 PI3-Kinase alpha Inhibitor 2 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:56928390 Seletalisib 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:73673707 N-[5-[4-[4-[(dimethylamino)methyl]phenyl]quinolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:44180156 3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-morpholino-7H-thieno[3,2-b]pyran-7-one 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:118502708 2H-Imidazo[4,5-c]quinolin-2-one, 8-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]-1,3-dihydro-3-methyl-1-(tetrahydro-2H-pyran-4-yl)- 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:56648675 2-Amino-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)ethanone 0.00010796998423945816 0.373636\n",
      "CHEBI:90686 IC-87114 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:132005228 5,8,11-Trimethyl-2-[3-(4-prop-2-enoylpiperazin-1-yl)sulfonylanilino]pyrimido[4,5-b][1,4]benzodiazepin-6-one 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:46892970 3-(1-(4-amino-6-methyl-1,3,5-triazin-2-yl)-1H-benzo[d]imidazol-2-ylamino)phenol 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:57519748 Samotolisib 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:141471200 N-[5-(2-amino-4-methylthieno[2,3-d]pyrimidin-6-yl)-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:44609388 N-[2-chloro-5-[3-(4-propan-2-ylpiperazin-1-yl)quinoxalin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:155569607 5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]pyridin-2-amine 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:11398307 Benzamide, N-[6-[(6,7-dimethoxy-4-quinolinyl)oxy]-1-methyl-1H-indazol-3-yl]-3-(trifluoromethyl)- 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:146014481 Parp/PI3K-IN-1 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:142506192 6-[2-[(1S)-1-[(2-amino-5-cyano-6-methylpyrimidin-4-yl)amino]propyl]-4-oxo-3-phenylquinazolin-5-yl]-N-hydroxyhexanamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:129626595 N-[5-[7-[2-[4-(2-hydroxypropan-2-yl)piperidin-1-yl]ethoxy]-1,3-dihydro-2-benzofuran-5-yl]-2-methoxypyridin-3-yl]methanesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:44608757 N-[2-chloro-5-[3-(2-morpholin-4-ylethylamino)quinoxalin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 0.00010796998423945816 0.373636\n",
      "PUBCHEM.COMPOUND:52936347 4-quinolin-3-yl-1H-imidazo[4,5-c]pyridin-2-amine 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:142506220 4-N-hydroxy-1-N-[[4-oxo-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-5-yl]methyl]benzene-1,4-dicarboxamide 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:155550395 4-[[(1R)-1-(4-chlorophenyl)ethyl]amino]-6-pyridin-3-ylquinoline-3-carboxamide 0.00011876634147917262 0.368805\n",
      "CHEBI:95093 omipalisib 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:122163152 5-[4-Amino-1-(2,2-diethoxyethyl)pyrazolo[3,4-d]pyrimidin-3-yl]-1,3-benzoxazol-2-amine 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:155511557 5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]pyrimidin-2-amine 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:121426227 2-methyl-3-N-[2-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-6-morpholin-4-ylimidazo[1,2-b]pyridazine-3,8-diamine 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:44608754 N-[2-chloro-5-[4-[4-(pyridin-4-ylmethyl)piperazin-1-yl]quinolin-6-yl]pyridin-3-yl]-4-fluorobenzenesulfonamide 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:135197635 N-[5-[2-amino-4-methyl-8-[(3R)-oxolan-3-yl]oxyquinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:135565159 (S)-2-(2-(2-Methylindolin-1-yl)-2-oxoethyl)-6-morpholinopyrimidin-4(3H)-one 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:86268622 V929QJ7NQ8 0.00011876634147917262 0.368805\n",
      "CHEBI:228209 KU-55933 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:155568922 6-Cyano-4-(2-ethylbutylamino)quinoline-3-carboxamide 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:49783923 n-[5-[4-(5-{[(2r,6s)-2,6-Dimethyl-4-morpholinyl]methyl}-1,3-oxazol-2-yl)-1h-indazol-6-yl]-2-(methyloxy)-3-pyridinyl]methanesulfonamide 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:129012341 9-(6-Aminopyridin-3-yl)-1-[3-(trifluoromethyl)phenyl]-4a,5,6,6a,7,8,9,10,10a,10b-decahydropyrimido[5,4-c][1,5]naphthyridine-2,4-dione 0.00011876634147917262 0.368805\n",
      "PUBCHEM.COMPOUND:9929127 N-(6-chloro-7-methoxy-9H-pyrido[3,4-b]indol-8-yl)-2-methylnicotinamide 0.00012956258214497104 0.364418\n",
      "PUBCHEM.COMPOUND:56947515 Panulisib 0.00012956258214497104 0.364418\n",
      "PUBCHEM.COMPOUND:15887336 CID 15887336 0.00012956258214497104 0.364418\n",
      "PUBCHEM.COMPOUND:44124863 N-(6-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)imidazo[1,2-b]pyridazin-2-yl)acetamide 0.00012956258214497104 0.364418\n",
      "CHEBI:91428 9-(1-anilinoethyl)-7-methyl-2-(4-morpholinyl)-4-pyrido[1,2-a]pyrimidinone 0.00012956258214497104 0.364418\n",
      "PUBCHEM.COMPOUND:135197643 N-[5-[2-amino-4-methyl-8-(oxan-4-yloxy)quinazolin-6-yl]-2-methoxypyridin-3-yl]-2,4-difluorobenzenesulfonamide 0.00012956258214497104 0.364418\n",
      "CHEBI:91359 2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-9-pyrido[1,2-a]pyrimidinyl]ethyl]amino]benzoic acid 0.00012956258214497104 0.364418\n",
      "PUBCHEM.COMPOUND:25242324 Gne-493 0.00012956258214497104 0.364418\n",
      "PUBCHEM.COMPOUND:76685059 1-(4-(5-(5-Amino-6-(5-(tert-butyl)-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1H-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one 0.00012956258214497104 0.364418\n",
      "PUBCHEM.COMPOUND:58111426 Dezapelisib 0.00012956258214497104 0.364418\n",
      "CHEMBL.COMPOUND:CHEMBL4293970 CHEMBL4293970 0.00012956258214497104 0.364418\n",
      "PUBCHEM.COMPOUND:53361718 N-[2-chloro-5-(4-pyridin-3-ylquinolin-6-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 0.0001403587062381121 0.360402\n",
      "PUBCHEM.COMPOUND:53307606 N2-(2-chloro-4-(dimethylcarbamoyl)phenyl)-N2,N8-dimethyl-4,5-dihydrobenzo[b]thieno[2,3-d]oxepine-2,8-dicarboxamide 0.0001403587062381121 0.360402\n",
      "PUBCHEM.COMPOUND:145996536 (3R)-3-methyl-4-[5-[(3S)-3-methylmorpholin-4-yl]-2-(1H-pyrazol-5-yl)-[1,3]thiazolo[5,4-d]pyrimidin-7-yl]morpholine 0.0001403587062381121 0.360402\n",
      "PUBCHEM.COMPOUND:53361719 N-[2-chloro-5-(4-pyridin-4-ylquinolin-6-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 0.0001403587062381121 0.360402\n",
      "PUBCHEM.COMPOUND:127031435 (5Z)-5-(1,3-benzothiazol-6-ylmethylidene)-2-sulfanylidene-1,3-thiazolidin-4-one 0.0001403587062381121 0.360402\n",
      "CHEBI:71967 BGT226 free base 0.0001403587062381121 0.360402\n",
      "PUBCHEM.COMPOUND:71041613 25-Methoxy-31-methyl-22,22-dioxo-3,22lambda6,30-trithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,12,17(29),18,20,24,26-dodecaen-16-one 0.0001403587062381121 0.360402\n",
      "PUBCHEM.COMPOUND:72950888 Umbralisib 0.0001403587062381121 0.360402\n",
      "PUBCHEM.COMPOUND:56955954 3-Amino-6-{4-Chloro-3-[(2,3-Difluorophenyl)sulfamoyl]phenyl}-N-Methylpyrazine-2-Carboxamide 0.0001403587062381121 0.360402\n",
      "CHEBI:3237 butein 0.0001403587062381121 0.360402\n",
      "CHEBI:91890 6-(1,3-benzodioxol-5-yl)-N-(3-oxolanylmethyl)-4-quinazolinamine 0.00015115471375985398 0.356701\n",
      "CHEBI:94489 6-(N-carbamoyl-2,6-difluoroanilino)-2-(2,4-difluorophenyl)-3-pyridinecarboxamide 0.00015115471375985398 0.356701\n",
      "PUBCHEM.COMPOUND:49784002 Nemiralisib 0.00015115471375985398 0.356701\n",
      "PUBCHEM.COMPOUND:142506225 N-hydroxy-2-[[4-oxo-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-5-yl]methylamino]pyrimidine-5-carboxamide 0.00015115471375985398 0.356701\n",
      "PUBCHEM.COMPOUND:25262792 Vistusertib 0.00015115471375985398 0.356701\n",
      "PUBCHEM.COMPOUND:118728820 1-[(2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-2-bicyclo[2.2.2]octanyl]ethane-1,2-diol 0.00015115471375985398 0.356701\n",
      "PUBCHEM.COMPOUND:50990922 [(4-{2-[(3-Hydroxyphenyl)amino]-1h-Benzimidazol-1-Yl}-1,3,5-Triazin-2-Yl)amino]acetonitrile 0.00015115471375985398 0.356701\n",
      "PUBCHEM.COMPOUND:52913813 (R)-8-(1-((3,5-difluorophenyl)amino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide 0.00015115471375985398 0.356701\n",
      "PUBCHEM.COMPOUND:135565596 Copanlisib 0.00015115471375985398 0.356701\n",
      "PUBCHEM.COMPOUND:71041971 F7Wqk85U32 0.00015115471375985398 0.356701\n",
      "PUBCHEM.COMPOUND:44609387 N-[2-chloro-5-(3-morpholin-4-ylquinoxalin-6-yl)pyridin-3-yl]-4-fluorobenzenesulfonamide 0.00015115471375985398 0.356701\n",
      "PUBCHEM.COMPOUND:138454792 PI3K/Hdac-IN-1 0.00015115471375985398 0.356701\n",
      "CHEBI:75253 phenylarsine oxide 0.00016195060471145634 0.353271\n",
      "PUBCHEM.COMPOUND:137636872 4-[7-[1-[2-(Dimethylamino)ethyl]pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-2-[(3-fluorophenyl)methoxy]benzamide 0.00016195060471145634 0.353271\n",
      "PUBCHEM.COMPOUND:124173720 Inavolisib 0.00016195060471145634 0.353271\n",
      "CHEBI:131169 8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]-1-isoquinolinone 0.00016195060471145634 0.353271\n",
      "PUBCHEM.COMPOUND:139030535 5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]pyrazin-2-amine 0.00016195060471145634 0.353271\n",
      "PUBCHEM.COMPOUND:134163708 CID 134163708 0.00016195060471145634 0.353271\n",
      "PUBCHEM.COMPOUND:44608915 N-{2-Chloro-5-[4-(Morpholin-4-Yl)quinolin-6-Yl]pyridin-3-Yl}-4-Fluorobenzenesulfonamide 0.00016195060471145634 0.353271\n",
      "CHEBI:91361 8-(4-dibenzothiophenyl)-2-(4-morpholinyl)-1-benzopyran-4-one 0.00016195060471145634 0.353271\n",
      "CHEBI:34785 heptachlor 0.00017274637909417696 0.350076\n",
      "PUBCHEM.COMPOUND:137553174 4-(((5-Bromo-2-((3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)amino)methyl)benzenesulfonamide 0.00017274637909417696 0.350076\n",
      "PUBCHEM.COMPOUND:132471857 4-{6-[6-(propan-2-ylamino)-1H-indazol-1-yl]pyrazin-2-yl}benzoic acid 0.00017274637909417696 0.350076\n",
      "PUBCHEM.COMPOUND:11618268 Acalisib 0.00017274637909417696 0.350076\n",
      "PUBCHEM.COMPOUND:49784945 5-(7-(methylsulfonyl)-2-morpholino-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine 0.00017274637909417696 0.350076\n",
      "PUBCHEM.COMPOUND:145946093 2-methoxy-N-[2-methoxy-5-[7-[[(2R)-4-(oxetan-3-yl)morpholin-2-yl]methoxy]-1,3-dihydro-2-benzofuran-5-yl]pyridin-3-yl]ethanesulfonamide 0.00017274637909417696 0.350076\n",
      "PUBCHEM.COMPOUND:71458575 1-[4-[4-[2-[4-Chloro-3-(diethylsulfamoyl)anilino]pyrimidin-4-yl]pyridin-2-yl]phenyl]-3-methylurea 0.00017274637909417696 0.350076\n",
      "PUBCHEM.COMPOUND:155529247 PI3K/Hdac-IN-2 0.00017274637909417696 0.350076\n",
      "PUBCHEM.COMPOUND:121334520 5-[4,6-Bis(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine 0.00018354203690927528 0.347087\n",
      "PUBCHEM.COMPOUND:70798655 Serabelisib 0.00018354203690927528 0.347087\n",
      "CHEBI:94302 2-(4-ethyl-1-piperazinyl)-N-[4-[2-(4-morpholinyl)-4-oxo-1-benzopyran-8-yl]-1-dibenzothiophenyl]acetamide 0.00018354203690927528 0.347087\n",
      "PUBCHEM.COMPOUND:118366956 7-[2-(6-aminopyridin-3-yl)-6-morpholin-4-ylpurin-9-yl]-N-hydroxyheptanamide 0.00018354203690927528 0.347087\n",
      "PUBCHEM.COMPOUND:118107483 Remibrutinib 0.00019433757815800906 0.34428\n",
      "PUBCHEM.COMPOUND:46912230 5-(9-Isopropyl-8-methyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine 0.00019433757815800906 0.34428\n",
      "PUBCHEM.COMPOUND:142506210 N-hydroxy-6-[4-oxo-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-5-yl]hexanamide 0.00019433757815800906 0.34428\n",
      "PUBCHEM.COMPOUND:146585718 N-hydroxy-6-[[[4-oxo-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-5-yl]amino]methyl]pyridine-3-carboxamide 0.00019433757815800906 0.34428\n",
      "CHEBI:45302 (5Z)-5-(quinoxalin-6-ylmethylidene)-1,3-thiazolidine-2,4-dione 0.0002051330028416379 0.341635\n",
      "PUBCHEM.COMPOUND:11666231 5-[1-Quinolin-6-yl-meth-(z)-ylidene]-2-thioxo-thiazolidin-4-one 0.0002051330028416379 0.341635\n",
      "CHEBI:8717 quinethazone 0.0002051330028416379 0.341635\n",
      "PUBCHEM.COMPOUND:51001932 Taselisib 0.00021592831096141972 0.339134\n",
      "PUBCHEM.COMPOUND:134611894 N-[5-[2-[(1S)-1-cyclopropylethyl]-7-methylsulfonyl-1-oxo-3H-isoindol-5-yl]-4-methyl-1,3-thiazol-2-yl]acetamide 0.00021592831096141972 0.339134\n",
      "PUBCHEM.COMPOUND:25033539 PF-04691502 0.00021592831096141972 0.339134\n",
      "PUBCHEM.COMPOUND:155537016 N-(2-chloro-5-pyridin-4-ylpyridin-3-yl)methanesulfonamide 0.00021592831096141972 0.339134\n",
      "PUBCHEM.COMPOUND:57495353 Leniolisib 0.000226723502518613 0.336764\n",
      "PUBCHEM.COMPOUND:91933883 Eganelisib 0.000226723502518613 0.336764\n",
      "CHEBI:93752 (2S)-N1-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)-4-pyridinyl]-2-thiazolyl]pyrrolidine-1,2-dicarboxamide 0.00024831353595026963 0.332367\n",
      "CHEBI:90545 ZSTK-474 0.00025910837782725004 0.330319\n",
      "PUBCHEM.COMPOUND:44516953 Gedatolisib 0.00025910837782725004 0.330319\n",
      "PUBCHEM.COMPOUND:46866604 1-(4-(4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-6-(tetrahydro-2H-pyran-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-isopropylpiperazine-1-carbonyl)phenyl)urea 0.00025910837782725004 0.330319\n",
      "PUBCHEM.COMPOUND:54613583 Spiro[piperidine-4,3'-[3H]pyrido[3,4-b]indole]-4'-carbonitrile, 7',8'-dichloro-1',2',4',9'-tetrahydro-9'-methyl-1'-oxo- 0.0002699031031466762 0.328362\n",
      "PUBCHEM.COMPOUND:50990924 N-[6-[6-Chloro-5-[[(4-fluorophenyl)sulfonyl]amino]-3-pyridinyl]-1,3-benzothiazol-2-yl]acetamide 0.0002699031031466762 0.328362\n",
      "CHEBI:7443 nabumetone 0.0002699031031466762 0.328362\n",
      "CHEBI:91450 5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine 0.00028069771190980704 0.326487\n",
      "PUBCHEM.COMPOUND:118374514 7-[2-(2-aminopyrimidin-5-yl)-4-morpholin-4-ylpyrrolo[2,3-d]pyrimidin-7-yl]-N-hydroxyheptanamide 0.000313080838874012 0.321295\n",
      "CHEBI:82701 idelalisib 0.0003238749814245459 0.319692\n",
      "CHEBI:50915 PP121 0.00033466900742507743 0.318145\n",
      "PUBCHEM.COMPOUND:2690 9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine 0.00033466900742507743 0.318145\n",
      "CHEBI:39585 carbidopa (anhydrous) 0.00034546291687686425 0.316652\n",
      "PUBCHEM.COMPOUND:433294 Lithium Chloride 0.00034546291687686425 0.316652\n",
      "PUBCHEM.COMPOUND:138911334 CID 138911334 0.00034546291687686425 0.316652\n",
      "PUBCHEM.COMPOUND:155559898 5-(6-bromo-5-methoxy-1H-indol-3-yl)-2-(1H-pyrrol-2-yl)-1,3-oxazole 0.0003562567097811648 0.315208\n",
      "CHEBI:18135 catechol 0.0003562567097811648 0.315208\n",
      "PUBCHEM.COMPOUND:118366969 N-hydroxy-7-(2-(3-(hydroxymethyl)phenyl)-6-morpholino-9H-purin-9-yl)heptanamide 0.0003670503861392379 0.313811\n",
      "PUBCHEM.COMPOUND:67035086 cis-3-[4-amino-7-(3-azetidin-1-ylmethyl-cyclobutyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]-phenol 0.00039943071594867474 0.309871\n",
      "PUBCHEM.COMPOUND:10275789 N-[(E)-(6-Bromoimidazo[1,2-a]pyridin-3-yl)methylideneamino]-N,2-dimethyl-5-nitrobenzenesulfonamide 0.00043180999688736466 0.306264\n",
      "HMDB:HMDB0256910 Phosphatidylinositol 3,4,5-trisphosphate 0.00046418822898928276 0.302938\n",
      "CHEBI:71952 dactolisib 0.00047498073995428926 0.301885\n",
      "PUBCHEM.COMPOUND:54575456 Fimepinostat 0.0004965654122884033 0.299855\n",
      "CHEBI:94771 N-hydroxy-2-[4-[[(1-methyl-3-indolyl)methylamino]methyl]-1-piperidinyl]-5-pyrimidinecarboxamide 0.0005181496185030393 0.297919\n",
      "PUBCHEM.COMPOUND:25254071 Apitolisib 0.0005505250538729925 0.295173\n",
      "HMDB:HMDB0009874 PI(20:1(11Z)/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480254 Phosphatidylinositol Diphosphate(18:0/18:1n9) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480323 Pip2(20:4(5Z,8Z,11Z,14Z)/16:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:74947 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009855 PI(18:2(9Z,12Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009910 PI(22:3(10Z,13Z,16Z)/18:3(6Z,9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009931 PIP(16:0/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480241 Pip2(16:0/22:5(7Z,10Z,13Z,16Z,19Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480236 Pip2(16:0/22:2(13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480225 Pip2(16:0/16:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480336 Pip2(22:5(4Z,7Z,10Z,13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009819 PI(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:73209 1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-icosatetraenoyl)-sn-glycero-3-phospho-D-myo-inositol 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009798 PI(16:1(9Z)/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480197 Pip(20:2(11Z,14Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480140 Pip(16:2(9Z,12Z)/22:3(10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480247 Pip2(16:2(9Z,12Z)/16:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009875 PI(20:2(11Z,14Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480255 Pip2(18:0/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480250 Phosphatidylinositol Diphosphate(18:0/16:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:88557 PI(18:0/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009854 PI(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480212 Pip(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88418 PI(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750507 Pip(20:3(5Z,8Z,11Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009831 PI(18:1(11Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88561 PI(16:2(9Z,12Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480261 Pip2(18:0/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009828 PI(18:1(11Z)/18:3(9Z,12Z,15Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480249 Pip2(16:2(9Z,12Z)/22:3(10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480329 Pip2(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480201 Pip(20:3(5Z,8Z,11Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480298 Pip2(18:2(9Z,12Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88420 PI(16:0/22:3(10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480292 Pip2(18:2(9Z,12Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750514 Pip(22:4(10Z,13Z,16Z,19Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480313 Pip2(20:3(5Z,8Z,11Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480314 Pip2(20:3(5Z,8Z,11Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009887 PI(20:3(8Z,11Z,14Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009860 PI(18:3(6Z,9Z,12Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009840 PI(18:1(9Z)/18:3(9Z,12Z,15Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009853 PI(18:2(9Z,12Z)/20:2(11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750512 Pip(20:4(8Z,11Z,14Z,17Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009835 PI(18:1(9Z)/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:192104 PIP(16:0/22:2(13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750486 Pip(16:2(9Z,12Z)/16:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009880 PI(20:3(5Z,8Z,11Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480299 Pip2(18:3(6Z,9Z,12Z)/18:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:88574 PI(18:0/22:4(7Z,10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009907 PI(22:3(10Z,13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480208 Pip(20:3(8Z,11Z,14Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009845 PI(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750505 Pip(20:0/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:185927 PIP2(16:0/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480328 Pip2(20:4(8Z,11Z,14Z,17Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480149 Pip(18:0/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009897 PI(20:4(5Z,8Z,11Z,14Z)/20:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750508 Pip(20:3(8Z,11Z,14Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009904 PI(20:4(8Z,11Z,14Z,17Z)/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480234 Pip2(16:0/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:180835 PIP(16:1(9Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480267 Pip2(18:1(11Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480245 Pip2(16:1(9Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750498 Pip(18:1(9Z)/18:3(6Z,9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480207 Pip(20:3(8Z,11Z,14Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480311 Pip2(20:2(11Z,14Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009872 PI(20:1(11Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480277 Pip2(18:1(9Z)/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009889 PI(20:3(8Z,11Z,14Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480230 Phosphatidylinositol Diphosphate(16:0/20:1) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009881 PI(20:3(5Z,8Z,11Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480142 Phosphatidylinositol Phosphate(18:0/16:1) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009821 PI(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009884 PI(20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009823 PI(18:1(11Z)/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480334 Pip2(22:4(10Z,13Z,16Z,19Z)/16:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:192230 PIP(18:0/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480157 Pip(18:1(11Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480248 Pip2(16:2(9Z,12Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480302 Pip2(18:3(9Z,12Z,15Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480294 Pip2(18:2(9Z,12Z)/20:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750501 Pip(18:3(6Z,9Z,12Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480235 Pip2(16:0/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480272 Pip2(18:1(11Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:192191 PIP(18:0/18:3(9Z,12Z,15Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750491 Phosphatidylinositol Phosphate(18:0/20:4n6) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009841 PI(18:1(9Z)/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480195 Pip(20:1(11Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009902 PI(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009922 PIP(16:0/22:4(10Z,13Z,16Z,19Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88579 PI(18:0/18:3(9Z,12Z,15Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480285 Pip2(18:1(9Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009927 PIP(16:0/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009917 PI(22:5(4Z,7Z,10Z,13Z,16Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009873 PI(20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009903 PI(20:4(8Z,11Z,14Z,17Z)/20:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009905 PI(22:2(13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480132 Pip(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480306 Phosphatidylinositol Diphosphate(20:1/16:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009827 PI(18:1(11Z)/18:3(6Z,9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009852 PI(18:2(9Z,12Z)/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009882 PI(20:3(5Z,8Z,11Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009846 PI(18:2(9Z,12Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750513 Pip(22:2(13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009866 PI(20:0/16:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:145879 PIP2[3',4'](16:0/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480246 Pip2(16:1(9Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009780 PI(16:0/16:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009925 PIP[3'](16:0/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009862 PI(18:3(9Z,12Z,15Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480331 Pip2(22:2(13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480256 Pip2(18:0/18:3(6Z,9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480136 Pip(16:1(9Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480275 Pip2(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480263 Phosphatidylinositol Diphosphate(18:1n7/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480297 Pip2(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009820 PI(18:0/22:5(7Z,10Z,13Z,16Z,19Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480279 Pip2(18:1(9Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009867 PI(20:0/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480224 Phosphatidylinositol Diphosphate(16:0/16:1) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750506 Pip(20:1(11Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009896 PI(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:190205 PIP2(18:2/18:2) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009909 PI(22:3(10Z,13Z,16Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750500 Pip(18:2(9Z,12Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750510 Pip(20:4(5Z,8Z,11Z,14Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009876 PI(20:2(11Z,14Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750515 Pip(22:4(7Z,10Z,13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009843 PI(18:1(9Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480243 Pip2(16:1(9Z)/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009825 PI(18:1(11Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750496 Pip(18:1(9Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009830 PI(18:1(11Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88425 PI(16:1(9Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480215 Pip(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480178 Pip(18:2(9Z,12Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480316 Pip2(20:3(5Z,8Z,11Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480227 Phosphatidylinositol Diphosphate(16:0/18:1n7) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009833 PI(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480326 Pip2(20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480327 Pip2(20:4(8Z,11Z,14Z,17Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480216 Pip(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009895 PI(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009829 PI(18:1(11Z)/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009856 PI(18:2(9Z,12Z)/22:2(13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009859 PI(18:3(6Z,9Z,12Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88562 PI(16:1(9Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88558 PI(18:0/16:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009824 PI(18:1(11Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009926 PIP(16:0/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88572 PI(18:0/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88392 PI(16:0/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480165 1-Oleoyl-2-palmitoyl-sn-glycero-3-phosphoinositol-phosphate 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480169 Pip(18:1(9Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009847 PI(18:2(9Z,12Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750509 Pip(20:4(5Z,8Z,11Z,14Z)/16:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009915 PI(22:4(7Z,10Z,13Z,16Z)/18:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:142272 PIP(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88387 PI(16:0/20:2(11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480203 Pip(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480182 Pip(18:2(9Z,12Z)/20:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480199 Pip(20:3(5Z,8Z,11Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480268 Pip2(18:1(11Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88417 PI(16:0/22:4(7Z,10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:185425 {[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]-3-(octadecanoyloxy)propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750495 Pip(18:1(15Z)/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:185423 {[(1R,3S)-3-({[(2R)-2-(hexadecanoyloxy)-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480167 1-Oleoyl-2-stearoyl-sn-glycero-3-phosphoinositol-phosphate 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480240 Pip2(16:0/22:5(4Z,7Z,10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480289 Pip2(18:2(9Z,12Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480262 Pip2(18:0/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480290 Pip2(18:2(9Z,12Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009898 PI(20:4(5Z,8Z,11Z,14Z)/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009906 PI(22:2(13Z,16Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009900 PI(20:4(8Z,11Z,14Z,17Z)/18:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:84153 1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol 0.0008526452173095949 0.275801\n",
      "CHEBI:88559 PI(16:2(9Z,12Z)/22:3(10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88556 PI(18:0/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480260 Pip2(18:0/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480252 Pip2(18:0/16:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88415 PI(16:0/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88577 PI(18:0/18:3(6Z,9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009891 PI(20:3(8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480153 Phosphatidylinositol Phosphate(18:1n7/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480300 Pip2(18:3(6Z,9Z,12Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480163 Pip(18:1(11Z)/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88416 PI(16:0/22:2(13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009849 PI(18:2(9Z,12Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480312 Pip2(20:2(11Z,14Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009878 PI(20:2(11Z,14Z)/20:2(11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:185413 {[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-2-[(11Z)-icos-11-enoyloxy]-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750511 Pip(20:4(8Z,11Z,14Z,17Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480175 Pip(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480257 Pip2(18:0/18:3(9Z,12Z,15Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480273 Pip2(18:1(11Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480305 Pip2(20:0/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88563 PI(16:1(9Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750502 Pip(18:3(6Z,9Z,12Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480253 Phosphatidylinositol Diphosphate(18:0/18:1n7) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480133 Pip(16:0/22:5(7Z,10Z,13Z,16Z,19Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009842 PI(18:1(9Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009886 PI(20:3(8Z,11Z,14Z)/16:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009826 PI(18:1(11Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480337 Pip2(22:5(7Z,10Z,13Z,16Z,19Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480325 Pip2(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480269 Pip2(18:1(11Z)/18:3(6Z,9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480264 Pip2(18:1(11Z)/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480284 Pip2(18:1(9Z)/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480218 Pip(22:3(10Z,13Z,16Z)/16:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480317 Pip2(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480318 Pip2(20:3(8Z,11Z,14Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480283 Pip2(18:1(9Z)/18:3(9Z,12Z,15Z)) 0.0008526452173095949 0.275801\n",
      "GTOPDB:2353 PIP3 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009871 PI(20:1(11Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009911 PI(22:3(10Z,13Z,16Z)/18:3(9Z,12Z,15Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750499 Pip(18:2(9Z,12Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009832 PI(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480204 Pip(20:3(8Z,11Z,14Z)/16:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:88421 PI(16:0/22:4(10Z,13Z,16Z,19Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480296 Pip2(18:2(9Z,12Z)/20:2(11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009899 PI(20:4(8Z,11Z,14Z,17Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480324 Pip2(20:4(5Z,8Z,11Z,14Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750494 Pip(18:1(11Z)/18:3(6Z,9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480266 Pip2(18:1(11Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88580 PI(18:0/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009839 PI(18:1(9Z)/18:3(6Z,9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480139 Pip(16:2(9Z,12Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480244 Phosphatidylinositol Diphosphate(16:1/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480174 Pip(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009844 PI(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009908 PI(22:3(10Z,13Z,16Z)/16:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009923 PIP(16:0/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480229 Pip2(16:0/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480288 Pip2(18:1(9Z)/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009929 PIP(16:0/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480315 Pip2(20:3(5Z,8Z,11Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88560 PI(18:0/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480137 Pip(16:1(9Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480301 Pip2(18:3(6Z,9Z,12Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009924 PIP(16:0/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480198 Pip(20:2(11Z,14Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009868 PI(20:0/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009778 PI(16:0/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480330 Pip2(20:4(8Z,11Z,14Z,17Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009809 PI(18:0/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480274 Pip2(18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009858 PI(18:3(6Z,9Z,12Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009850 PI(18:2(9Z,12Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480233 Pip2(16:0/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480156 Pip(18:1(11Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88388 PI(16:0/20:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480242 Phosphatidylinositol Diphosphate(16:1/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480308 Pip2(20:1(11Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:73223 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-D-myo-inositol 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480231 Pip2(16:0/20:2(11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:192231 PIP(18:1(11Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750488 Pip(18:0/18:3(6Z,9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009802 PI(16:2(9Z,12Z)/16:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:88423 PI(16:1(9Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480270 Pip2(18:1(11Z)/18:3(9Z,12Z,15Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009865 PI(18:3(9Z,12Z,15Z)/22:3(10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009894 PI(20:4(5Z,8Z,11Z,14Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750493 Pip(18:1(11Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480310 Pip2(20:2(11Z,14Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480228 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol-3',4'-bisphosphate) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480161 Pip(18:1(11Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750497 Pip(18:1(9Z)/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009863 PI(18:3(9Z,12Z,15Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009901 PI(20:4(8Z,11Z,14Z,17Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009851 PI(18:2(9Z,12Z)/20:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480239 Pip2(16:0/22:4(7Z,10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009932 PIP(16:0/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480202 Pip(20:3(5Z,8Z,11Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:142271 PIP(18:0/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480333 Pip2(22:3(10Z,13Z,16Z)/16:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009822 PI(18:1(11Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480258 Pip2(18:0/20:2(11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009928 PIP(16:0/20:2(11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009890 PI(20:3(8Z,11Z,14Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750504 Pip(18:3(9Z,12Z,15Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750485 Pip(16:0/22:4(7Z,10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009893 PI(20:4(5Z,8Z,11Z,14Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480307 Pip2(20:1(11Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480286 Pip2(18:1(9Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009879 PI(20:3(5Z,8Z,11Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480222 Pip(22:5(7Z,10Z,13Z,16Z,19Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480168 Pip(18:1(9Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009916 PI(22:5(4Z,7Z,10Z,13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480278 Phosphatidylinositol Diphosphate(18:1n9/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009920 PI(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:88391 PI(16:0/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480238 Pip2(16:0/22:4(10Z,13Z,16Z,19Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480321 Pip2(20:3(8Z,11Z,14Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88581 PI(18:0/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009918 PI(22:5(7Z,10Z,13Z,16Z,19Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750503 Pip(18:3(6Z,9Z,12Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009869 PI(20:0/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480185 Pip(18:2(9Z,12Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:73212 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-D-myo-inositol 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480192 Phosphatidylinositol Phosphate(20:1/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480196 Pip(20:2(11Z,14Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480251 Phosphatidylinositol Diphosphate(18:0/16:1) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009888 PI(20:3(8Z,11Z,14Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480322 Pip2(20:3(8Z,11Z,14Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480154 Pip(18:1(11Z)/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750492 Pip(18:0/20:4(8Z,11Z,14Z,17Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009838 PI(18:1(9Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480271 Pip2(18:1(11Z)/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480303 Pip2(18:3(9Z,12Z,15Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480335 Pip2(22:4(7Z,10Z,13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009861 PI(18:3(6Z,9Z,12Z)/22:3(10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480259 Pip2(18:0/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480221 Pip(22:5(4Z,7Z,10Z,13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:191649 PIP(16:1(9Z)/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480180 Pip(18:2(9Z,12Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480166 Pip(18:1(9Z)/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480309 Pip2(20:1(11Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480280 Pip2(18:1(9Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009919 PI(22:5(7Z,10Z,13Z,16Z,19Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009870 PI(20:1(11Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:131750490 Pip(18:0/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480206 Pip(20:3(8Z,11Z,14Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009783 PI(16:0/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009834 PI(18:1(9Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480304 Pip2(18:3(9Z,12Z,15Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88389 PI(16:0/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480172 Pip(18:1(9Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480332 Pip2(22:3(10Z,13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:88424 PI(16:0/22:5(7Z,10Z,13Z,16Z,19Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009836 PI(18:1(9Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480319 Pip2(20:3(8Z,11Z,14Z)/18:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480237 Pip2(16:0/22:3(10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480281 Pip2(18:1(9Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480186 Pip(18:2(9Z,12Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:184328 {[(1R,5S)-2,3,4,6-tetrahydroxy-5-({hydroxy[(2R)-2-[(9Z)-octadec-9-enoyloxy]-3-(octadecanoyloxy)propoxy]phosphoryl}oxy)cyclohexyl]oxy}phosphonic acid 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480291 Pip2(18:2(9Z,12Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009914 PI(22:4(7Z,10Z,13Z,16Z)/16:0) 0.0008526452173095949 0.275801\n",
      "CHEBI:88578 PI(18:0/20:2(11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480265 Phosphatidylinositol Diphosphate(18:1n7/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009837 PI(18:1(9Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480173 Pip(18:1(9Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88573 PI(18:0/22:4(10Z,13Z,16Z,19Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480276 Phosphatidylinositol Diphosphate(18:1n9/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480193 Pip(20:1(11Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009913 PI(22:4(10Z,13Z,16Z,19Z)/18:0) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009864 PI(18:3(9Z,12Z,15Z)/18:1(9Z)) 0.0008526452173095949 0.275801\n",
      "CHEBI:88396 PI(16:0/16:1(9Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009877 PI(20:2(11Z,14Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480320 Pip2(20:3(8Z,11Z,14Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480282 Pip2(18:1(9Z)/18:3(6Z,9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480143 Pip(18:0/16:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009857 PI(18:2(9Z,12Z)/22:3(10Z,13Z,16Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009892 PI(20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009930 PIP(16:0/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480184 Pip(18:2(9Z,12Z)/20:2(11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009912 PI(22:4(10Z,13Z,16Z,19Z)/16:0) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480160 Pip(18:1(11Z)/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480287 Pip2(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480295 Pip2(18:2(9Z,12Z)/20:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009885 PI(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480232 Pip2(16:0/20:3(5Z,8Z,11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009848 PI(18:2(9Z,12Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0009883 PI(20:3(5Z,8Z,11Z)/18:2(9Z,12Z)) 0.0008526452173095949 0.275801\n",
      "PUBCHEM.COMPOUND:53480211 Pip(20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) 0.0008526452173095949 0.275801\n",
      "HMDB:HMDB0010154 PIP3(18:1(11Z)/18:1(11Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010160 PIP3(18:1(9Z)/20:3(5Z,8Z,11Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010147 PIP3(16:0/16:0) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010161 PIP3(18:1(9Z)/20:3(8Z,11Z,14Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010148 PIP3(16:0/16:1(9Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010159 PIP3(18:1(9Z)/18:1(9Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010151 PIP3(18:0/16:1(9Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010152 PIP3(18:0/18:1(11Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010158 PIP3(18:1(9Z)/18:1(11Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010149 PIP3(16:0/18:1(11Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010162 PIP3(18:2(9Z,12Z)/20:1(11Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010153 PIP3(18:0/18:1(9Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010157 PIP3(18:1(11Z)/20:3(8Z,11Z,14Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010150 PIP3(16:0/18:1(9Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010155 PIP3(18:1(11Z)/18:1(9Z)) 0.0008634335339013173 0.275256\n",
      "HMDB:HMDB0010156 PIP3(18:1(11Z)/20:3(5Z,8Z,11Z)) 0.0008634335339013173 0.275256\n",
      "CHEBI:18050 L-glutamine 0.0008742217340059419 0.274719\n",
      "PUBCHEM.COMPOUND:6918852 (4-Amino-2-((1-(methylsulfonyl)piperidin-4-yl)amino)pyrimidin-5-yl)(2,3-difluoro-6-methoxyphenyl)methanone 0.0008850098176247283 0.274189\n",
      "CHEBI:18358 methoxsalen 0.0009173733695786269 0.272639\n",
      "PUBCHEM.COMPOUND:24462 Cupric Sulfate 0.0009173733695786269 0.272639\n",
      "CHEBI:90295 PLX-4720 0.001036030757978924 0.267433\n",
      "CHEBI:65329 LY294002 0.001068389418029391 0.266127\n",
      "CHEBI:9774 tubocurarine 0.0011978135768826253 0.261305\n",
      "CHEBI:7601 nizatidine 0.0012733032589415042 0.258752\n",
      "CHEBI:49603 lapatinib 0.0013056542332090667 0.257708\n",
      "CHEBI:4806 (-)-epigallocatechin 3-gallate 0.0014997380736854814 0.251994\n",
      "PUBCHEM.COMPOUND:11314340 (2s)-1-{[5-(3-Methyl-1h-Indazol-5-Yl)pyridin-3-Yl]oxy}-3-Phenylpropan-2-Amine 0.001672225378457841 0.247564\n",
      "CHEBI:3112 biperiden 0.0017369004355460536 0.246032\n",
      "CHEBI:27732 caffeine 0.0020494374841746625 0.239428\n",
      "PUBCHEM.COMPOUND:11671467 Fostamatinib 0.0028357355774614175 0.226824\n",
      "CHEBI:91348 6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one 0.0036429308616863793 0.217427\n",
      "CHEBI:91338 5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine 0.004524716649733585 0.209524\n",
      "CHEBI:71219 pazopanib 0.004632198100387686 0.208681\n",
      "CHEBI:63452 midostaurin 0.00489010623687937 0.206745\n",
      "CHEBI:66919 ruxolitinib 0.0050297785741327036 0.205744\n",
      "CHEBI:78543 ponatinib 0.0053090644387053364 0.203833\n",
      "CHEBI:79699 Temsirolimus 0.005437939164752858 0.202989\n",
      "CHEBI:41977 daunorubicin 0.00652197329738835 0.196678\n",
      "CHEBI:45713 trans-resveratrol 0.006575607648595113 0.196397\n",
      "CHEBI:9168 sirolimus 0.006875906510421305 0.194871\n",
      "CHEBI:28869 menadione 0.006993856225639886 0.194292\n",
      "CHEBI:50729 mitoxantrone 0.007819112088552805 0.190529\n",
      "CHEBI:63632 topotecan 0.007979796383333211 0.189848\n",
      "CHEBI:38940 sunitinib 0.009595902792299282 0.183765\n",
      "CHEBI:49375 dasatinib (anhydrous) 0.010739496706196809 0.180126\n",
      "CHEBI:16469 17beta-estradiol 0.011988457251578304 0.176625\n",
      "CHEBI:29865 benzo[a]pyrene 0.022778598093591233 0.157259\n"
     ]
    }
   ],
   "execution_count": 51
  },
  {
   "cell_type": "code",
   "id": "25e83c2c-bcfa-4670-b4c0-72588a9e61a6",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:41.275718Z",
     "start_time": "2024-10-28T18:03:41.270374Z"
    }
   },
   "source": [
    "#Leigh Disease?\n",
    "leigh_phenotypes = [\"HP:0000739\", # | Anxiety, \n",
    "                    \"HP:0001288\", # | Gait disturbance, \n",
    "                    \"HP:0001252\", # | Hypotonia, \n",
    "                    \"HP:0001250\", # | Seizure, \n",
    "                    \"HP:0000750\", # | Delayed speech and language development, \n",
    "                    \"HP:0002378\", # | Hand tremor, \n",
    "                    \"HP:0002019\", # | Constipation, \n",
    "                    \"HP:0007146\"] # | Bilateral basal ganglia lesions"
   ],
   "outputs": [],
   "execution_count": 52
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:42.282991Z",
     "start_time": "2024-10-28T18:03:42.280572Z"
    }
   },
   "cell_type": "code",
   "source": [
    "input_type = \"biolink:PhenotypicFeature\"\n",
    "output_type = \"biolink:Disease\"\n",
    "predicate = \"biolink:has_phenotype\"\n",
    "input_is_subject = \"False\"\n",
    "query = generate_trapi_query( input_type, output_type, leigh_phenotypes, predicate, input_is_subject)\n",
    "print(json.dumps(query,indent=2))"
   ],
   "id": "d2ca144640d68e13",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\n",
      "  \"message\": {\n",
      "    \"query_graph\": {\n",
      "      \"nodes\": {\n",
      "        \"input\": {\n",
      "          \"categories\": [\n",
      "            \"biolink:PhenotypicFeature\"\n",
      "          ],\n",
      "          \"ids\": [\n",
      "            \"uuid:1\"\n",
      "          ],\n",
      "          \"member_ids\": [\n",
      "            \"HP:0000739\",\n",
      "            \"HP:0001288\",\n",
      "            \"HP:0001252\",\n",
      "            \"HP:0001250\",\n",
      "            \"HP:0000750\",\n",
      "            \"HP:0002378\",\n",
      "            \"HP:0002019\",\n",
      "            \"HP:0007146\"\n",
      "          ],\n",
      "          \"set_interpretation\": \"MANY\"\n",
      "        },\n",
      "        \"output\": {\n",
      "          \"categories\": [\n",
      "            \"biolink:Disease\"\n",
      "          ]\n",
      "        }\n",
      "      },\n",
      "      \"edges\": {\n",
      "        \"edge_0\": {\n",
      "          \"subject\": \"input\",\n",
      "          \"object\": \"output\",\n",
      "          \"predicates\": [\n",
      "            \"biolink:has_phenotype\"\n",
      "          ]\n",
      "        }\n",
      "      }\n",
      "    }\n",
      "  }\n",
      "}\n"
     ]
    }
   ],
   "execution_count": 53
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:47.537718Z",
     "start_time": "2024-10-28T18:03:42.865927Z"
    }
   },
   "cell_type": "code",
   "source": [
    "response = phenotypes_to_disease(leigh_phenotypes, print_query=False)\n",
    "print_results(response)"
   ],
   "id": "9ee644796d70069e",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "MONDO:0859085 neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked 3.676409906489578e-09 0.847779\n",
      "MONDO:0014553 Tenorio syndrome 1.547709027607439e-08 0.803001\n",
      "MONDO:0060761 neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum 1.547709027607439e-08 0.803001\n",
      "MONDO:0013761 childhood encephalopathy due to thiamine pyrophosphokinase deficiency 1.779218036784196e-08 0.798168\n",
      "MONDO:0010496 X-linked intellectual disability-short stature-overweight syndrome 2.0327049157737718e-08 0.793469\n",
      "MONDO:0012342 7q11.23 microduplication syndrome 3.664489074574276e-08 0.77171\n",
      "MONDO:0010305 creatine transporter deficiency 6.554722689681547e-08 0.748706\n",
      "MONDO:0008939 isolated cerebellar hypoplasia/agenesis 3.726313896403495e-07 0.671364\n",
      "MONDO:0012423 MORM syndrome 3.726313896403495e-07 0.671364\n",
      "MONDO:0014953 gnb5-related intellectual disability-cardiac arrhythmia syndrome 5.82152762230098e-07 0.649646\n",
      "MONDO:0030036 leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome 8.381793480638825e-07 0.631424\n",
      "MONDO:0007631 chromosome 16p12.1 deletion syndrome, 520kb 8.381793480638825e-07 0.631424\n",
      "MONDO:0014881 transketolase deficiency 1.140691060116855e-06 0.615719\n",
      "MONDO:0008774 2-aminoadipic 2-oxoadipic aciduria 1.140691060116855e-06 0.615719\n",
      "MONDO:0010452 intellectual disability, X-linked 90 1.489667817869212e-06 0.601916\n",
      "MONDO:0013491 megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without intellectual disability 1.489667817869212e-06 0.601916\n",
      "MONDO:0859152 neurodevelopmental disorder with cerebellar atrophy and motor dysfunction 1.489667817869212e-06 0.601916\n",
      "MONDO:0859207 neurodevelopmental disorder with hypotonia and gross motor and speech delay 1.489667817869212e-06 0.601916\n",
      "MONDO:0020741 pyridoxine-dependent epilepsy caused by ALDH7A1 mutant 1.8850895473043174e-06 0.589605\n",
      "MONDO:0859292 developmental delay, behavioral abnormalities, and neuropsychiatric disorders 1.8850895473043174e-06 0.589605\n",
      "MONDO:0009400 hyperprolinemia type 1 1.8850895473043174e-06 0.589605\n",
      "MONDO:0859280 developmental delay, hypotonia, and impaired language 1.8850895473043174e-06 0.589605\n",
      "MONDO:0014957 language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia 1.8850895473043174e-06 0.589605\n",
      "MONDO:0054764 neurodegeneration with brain iron accumulation 8 1.8850895473043174e-06 0.589605\n",
      "MONDO:0010393 intellectual disability, X-linked 93 1.8850895473043174e-06 0.589605\n",
      "MONDO:0032605 intellectual disability, autosomal recessive 66 2.32693618090683e-06 0.578497\n",
      "MONDO:0014210 intellectual disability-hypotonia-spasticity-sleep disorder syndrome 2.32693618090683e-06 0.578497\n",
      "MONDO:0013325 COG5-congenital disorder of glycosylation 2.32693618090683e-06 0.578497\n",
      "MONDO:0054776 epilepsy, familial focal, with variable foci 4 2.32693618090683e-06 0.578497\n",
      "MONDO:0030911 intellectual disability, autosomal dominant 46 2.8151876576608396e-06 0.56838\n",
      "MONDO:0009257 galactose epimerase deficiency 2.8151876576608396e-06 0.56838\n",
      "MONDO:0032729 intellectual developmental disorder, autosomal recessive 70 2.8151876576608396e-06 0.56838\n",
      "MONDO:0011950 infantile-onset autosomal recessive nonprogressive cerebellar ataxia 2.8151876576608396e-06 0.56838\n",
      "MONDO:0030988 developmental delay with dysmorphic facies and dental anomalies 2.8151876576608396e-06 0.56838\n",
      "MONDO:0010130 dihydropyrimidine dehydrogenase deficiency 2.8151876576608396e-06 0.56838\n",
      "MONDO:0033308 Joubert syndrome 30 2.8151876576608396e-06 0.56838\n",
      "MONDO:0013680 cognitive impairment with or without cerebellar ataxia 2.8151876576608396e-06 0.56838\n",
      "MONDO:0015004 dystonia 28, childhood-onset 3.3498239230479854e-06 0.559095\n",
      "MONDO:0054602 gaze palsy, familial horizontal, with progressive scoliosis, 2 3.3498239230479854e-06 0.559095\n",
      "MONDO:0032715 intellectual developmental disorder, autosomal recessive 69 3.3498239230479854e-06 0.559095\n",
      "MONDO:0859237 3-methylglutaconic aciduria, type VIIA 3.3498239230479854e-06 0.559095\n",
      "MONDO:0032662 intellectual developmental disorder, autosomal recessive 67 3.3498239230479854e-06 0.559095\n",
      "MONDO:0011449 Salla disease 3.3498239230479854e-06 0.559095\n",
      "MONDO:0060666 hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome 3.3498239230479854e-06 0.559095\n",
      "MONDO:0010447 intellectual disability, X-linked 19 3.3498239230479854e-06 0.559095\n",
      "MONDO:0014051 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2 3.3498239230479854e-06 0.559095\n",
      "MONDO:0013962 hereditary spastic paraplegia 53 3.9308249290456015e-06 0.550517\n",
      "MONDO:0024607 congenital muscular dystrophy with cataracts and intellectual disability 3.9308249290456015e-06 0.550517\n",
      "MONDO:0009609 methylcobalamin deficiency type cblG 3.9308249290456015e-06 0.550517\n",
      "MONDO:0014261 growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome 3.9308249290456015e-06 0.550517\n",
      "MONDO:0859231 macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin 3.9308249290456015e-06 0.550517\n",
      "MONDO:0859285 neurodevelopmental disorder with microcephaly, short stature, and speech delay 3.9308249290456015e-06 0.550517\n",
      "MONDO:0032665 intellectual developmental disorder, autosomal recessive 68 3.9308249290456015e-06 0.550517\n",
      "MONDO:0009509 Landau-Kleffner syndrome 3.9308249290456015e-06 0.550517\n",
      "MONDO:0014486 intellectual disability, autosomal dominant 30 3.9308249290456015e-06 0.550517\n",
      "MONDO:0032485 intellectual developmental disorder 61 3.9308249290456015e-06 0.550517\n",
      "MONDO:0014889 striatonigral degeneration, childhood-onset 3.9308249290456015e-06 0.550517\n",
      "MONDO:0030453 developmental and epileptic encephalopathy 97 3.9308249290456015e-06 0.550517\n",
      "MONDO:0030730 Tessadori-van Haaften neurodevelopmental syndrome 2 3.9308249290456015e-06 0.550517\n",
      "MONDO:0008722 short chain acyl-CoA dehydrogenase deficiency 3.9308249290456015e-06 0.550517\n",
      "MONDO:0033006 Galloway-Mowat syndrome 2, X-linked 3.9308249290456015e-06 0.550517\n",
      "MONDO:0014545 progressive myoclonic epilepsy type 8 4.5581706341248245e-06 0.542548\n",
      "MONDO:0032622 mitochondrial complex 1 deficiency, nuclear type 17 4.5581706341248245e-06 0.542548\n",
      "MONDO:0030930 neurodevelopmental disorder with or without early-onset generalized epilepsy 4.5581706341248245e-06 0.542548\n",
      "MONDO:0030995 global developmental delay with speech and behavioral abnormalities 4.5581706341248245e-06 0.542548\n",
      "MONDO:0033645 mitochondrial complex 4 deficiency, nuclear type 11 4.5581706341248245e-06 0.542548\n",
      "MONDO:0859196 Usmani-Riazuddin syndrome, autosomal recessive 4.5581706341248245e-06 0.542548\n",
      "MONDO:0859378 leukodystrophy, hypomyelinating, 25 4.5581706341248245e-06 0.542548\n",
      "MONDO:0008759 oxoglutaricaciduria 4.5581706341248245e-06 0.542548\n",
      "MONDO:0014805 Hao-Fountain syndrome 4.5581706341248245e-06 0.542548\n",
      "MONDO:0009354 methylcobalamin deficiency type cblE 5.2318410032487475e-06 0.53511\n",
      "MONDO:0014530 autosomal recessive spinocerebellar ataxia 18 5.2318410032487475e-06 0.53511\n",
      "MONDO:0032912 Coffin-Siris syndrome 11 5.2318410032487475e-06 0.53511\n",
      "MONDO:0859240 intellectual developmental disorder with or without peripheral neuropathy 5.2318410032487475e-06 0.53511\n",
      "MONDO:0012905 hypomyelinating leukodystrophy 6 5.951816007870529e-06 0.528139\n",
      "MONDO:0010327 HSD10 mitochondrial disease 5.951816007870529e-06 0.528139\n",
      "MONDO:0859176 neurodevelopmental disorder with motor and speech delay and behavioral abnormalities 5.951816007870529e-06 0.528139\n",
      "MONDO:0014874 pontocerebellar hypoplasia, type 2F 5.951816007870529e-06 0.528139\n",
      "MONDO:0033008 Galloway-Mowat syndrome 4 5.951816007870529e-06 0.528139\n",
      "MONDO:0009388 hyperlysinemia 5.951816007870529e-06 0.528139\n",
      "MONDO:0012020 chromosome 22q11.2 microduplication syndrome 5.951816007870529e-06 0.528139\n",
      "MONDO:0012789 dystonia 16 6.7180756259315415e-06 0.521581\n",
      "MONDO:0014859 developmental and epileptic encephalopathy, 37 6.7180756259315415e-06 0.521581\n",
      "MONDO:0032624 mitochondrial complex 1 deficiency, nuclear type 19 6.7180756259315415e-06 0.521581\n",
      "MONDO:0026720 mitochondrial complex 1 deficiency, nuclear type 12 6.7180756259315415e-06 0.521581\n",
      "MONDO:0014602 intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome 6.7180756259315415e-06 0.521581\n",
      "MONDO:0030835 developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy 6.7180756259315415e-06 0.521581\n",
      "MONDO:0859249 parenti-mignot neurodevelopmental syndrome 6.7180756259315415e-06 0.521581\n",
      "MONDO:0014354 intellectual disability, autosomal recessive 43 6.7180756259315415e-06 0.521581\n",
      "MONDO:0859174 Usmani-Riazuddin syndrome, autosomal dominant 6.7180756259315415e-06 0.521581\n",
      "MONDO:0026727 Shukla-Vernon syndrome 6.7180756259315415e-06 0.521581\n",
      "MONDO:0054763 neurodegeneration with brain iron accumulation 7 6.7180756259315415e-06 0.521581\n",
      "MONDO:0032680 global developmental delay with or without impaired intellectual development 6.7180756259315415e-06 0.521581\n",
      "MONDO:0032658 macrocephaly, acquired, with impaired intellectual development 6.7180756259315415e-06 0.521581\n",
      "MONDO:0044318 intellectual developmental disorder with gastrointestinal difficulties and high pain threshold 7.530599841859512e-06 0.515391\n",
      "MONDO:0014499 intellectual disability, autosomal recessive 46 7.530599841859512e-06 0.515391\n",
      "MONDO:0032866 cortical dysplasia, complex, with other brain malformations 10 7.530599841859512e-06 0.515391\n",
      "MONDO:0859142 Hiatt-Neu-Cooper neurodevelopmental syndrome 7.530599841859512e-06 0.515391\n",
      "MONDO:0032786 Noonan syndrome 11 7.530599841859512e-06 0.515391\n",
      "MONDO:0030979 endove syndrome, limb-brain type 7.530599841859512e-06 0.515391\n",
      "MONDO:0013005 EAST syndrome 7.530599841859512e-06 0.515391\n",
      "MONDO:0030910 intellectual disability, autosomal dominant 45 7.530599841859512e-06 0.515391\n",
      "MONDO:0029131 peripheral neuropathy, autosomal recessive, with or without impaired intellectual development 7.530599841859512e-06 0.515391\n",
      "MONDO:0024557 ataxia-telangiectasia-like disorder 1 8.389368646566588e-06 0.509533\n",
      "MONDO:0014185 chromosome 3q13.31 deletion syndrome 8.389368646566588e-06 0.509533\n",
      "MONDO:0060627 glycosylphosphatidylinositol biosynthesis defect 15 8.389368646566588e-06 0.509533\n",
      "MONDO:0859243 neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities 8.389368646566588e-06 0.509533\n",
      "MONDO:0014672 osteogenesis imperfecta type 17 8.389368646566588e-06 0.509533\n",
      "MONDO:0859202 developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities 8.389368646566588e-06 0.509533\n",
      "MONDO:0056797 neurodevelopmental disorder with midbrain and hindbrain malformations 8.389368646566588e-06 0.509533\n",
      "MONDO:0009281 glutaryl-CoA dehydrogenase deficiency 8.389368646566588e-06 0.509533\n",
      "MONDO:0008943 autosomal recessive spinocerebellar ataxia 2 8.389368646566588e-06 0.509533\n",
      "MONDO:0013674 neurodegeneration with brain iron accumulation 4 9.294362037447604e-06 0.503972\n",
      "MONDO:0957218 neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities 9.294362037447604e-06 0.503972\n",
      "MONDO:0030897 Lessel-Kreienkamp syndrome 9.294362037447604e-06 0.503972\n",
      "MONDO:0014503 autosomal recessive spinocerebellar ataxia 17 9.294362037447604e-06 0.503972\n",
      "MONDO:0100255 adenosine kinase deficiency 9.294362037447604e-06 0.503972\n",
      "MONDO:0014958 Harel-Yoon syndrome 9.294362037447604e-06 0.503972\n",
      "MONDO:0032702 Coffin-Siris syndrome 8 9.294362037447604e-06 0.503972\n",
      "MONDO:0020507 leukoencephalopathy with vanishing white matter 1 1.0245560018378075e-05 0.498683\n",
      "MONDO:0020632 epileptic encephalopathy, infantile or early childhood, 3 1.0245560018378075e-05 0.498683\n",
      "MONDO:0060763 intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities 1.0245560018378075e-05 0.498683\n",
      "MONDO:0014708 ring chromosome 14 1.0245560018378075e-05 0.498683\n",
      "MONDO:0007298 spinocerebellar ataxia type 29 1.0245560018378075e-05 0.498683\n",
      "MONDO:0030997 mitochondrial complex 1 deficiency, nuclear type 37 1.0245560018378075e-05 0.498683\n",
      "MONDO:0014219 alacrima, achalasia, and intellectual disability syndrome 1.0245560018378075e-05 0.498683\n",
      "MONDO:0032775 neurodevelopmental disorder with seizures and speech and walking impairment 1.0245560018378075e-05 0.498683\n",
      "MONDO:0054591 Stankiewicz-Isidor syndrome 1.0245560018378075e-05 0.498683\n",
      "MONDO:0013635 Adams-Oliver syndrome 2 1.0245560018378075e-05 0.498683\n",
      "MONDO:0013805 intellectual disability, autosomal dominant 13 1.1242942599712412e-05 0.49364\n",
      "MONDO:0012538 nemaline myopathy 7 1.1242942599712412e-05 0.49364\n",
      "MONDO:0009591 metachromatic leukodystrophy, juvenile form 1.1242942599712412e-05 0.49364\n",
      "MONDO:0014017 intellectual developmental disorder with autism and macrocephaly 1.1242942599712412e-05 0.49364\n",
      "MONDO:0859197 intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies 1.1242942599712412e-05 0.49364\n",
      "MONDO:0013885 Malan overgrowth syndrome 1.1242942599712412e-05 0.49364\n",
      "MONDO:0015022 intellectual developmental disorder with dysmorphic facies and ptosis 1.1242942599712412e-05 0.49364\n",
      "MONDO:0859198 short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies 1.1242942599712412e-05 0.49364\n",
      "MONDO:0030974 mitochondrial complex 2 deficiency, nuclear type 4 1.1242942599712412e-05 0.49364\n",
      "MONDO:0024542 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 1.1242942599712412e-05 0.49364\n",
      "MONDO:0035819 cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome 1.1242942599712412e-05 0.49364\n",
      "MONDO:0859155 chromosome 1p36 deletion syndrome, proximal 1.1242942599712412e-05 0.49364\n",
      "MONDO:0060640 neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy 1.1242942599712412e-05 0.49364\n",
      "MONDO:0010319 syndromic X-linked intellectual disability Hedera type 1.2286489798282047e-05 0.488823\n",
      "MONDO:0014949 developmental and epileptic encephalopathy, 47 1.2286489798282047e-05 0.488823\n",
      "MONDO:0026723 intellectual developmental disorder, X-linked 108 1.2286489798282047e-05 0.488823\n",
      "MONDO:0014289 macrocephaly-developmental delay syndrome 1.2286489798282047e-05 0.488823\n",
      "MONDO:0859531 neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures 1.2286489798282047e-05 0.488823\n",
      "MONDO:0011537 macrocephaly-autism syndrome 1.2286489798282047e-05 0.488823\n",
      "MONDO:0010083 succinic semialdehyde dehydrogenase deficiency 1.2286489798282047e-05 0.488823\n",
      "MONDO:0013882 hyperphosphatasia with intellectual disability syndrome 2 1.2286489798282047e-05 0.488823\n",
      "MONDO:0859375 developmental delay with hypotonia, myopathy, and brain abnormalities 1.2286489798282047e-05 0.488823\n",
      "MONDO:0015005 epilepsy, early-onset, vitamin B6-dependent 1.2286489798282047e-05 0.488823\n",
      "MONDO:0020738 multiple benign circumferential skin creases on limbs 1 1.2286489798282047e-05 0.488823\n",
      "MONDO:0957531 neurodevelopmental disorder with microcephaly and movement abnormalities 1.2286489798282047e-05 0.488823\n",
      "MONDO:0859230 Kury-Isidor syndrome 1.2286489798282047e-05 0.488823\n",
      "MONDO:0024457 neurodegeneration with brain iron accumulation 2A 1.3376181637393496e-05 0.484214\n",
      "MONDO:0032790 neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities 1.3376181637393496e-05 0.484214\n",
      "MONDO:0015003 dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 1.4511998146826618e-05 0.479795\n",
      "MONDO:0060707 Ververi-Brady syndrome 1.4511998146826618e-05 0.479795\n",
      "MONDO:0014541 motor developmental delay due to 14q32.2 paternally expressed gene defect 1.4511998146826618e-05 0.479795\n",
      "MONDO:0007800 chromosome 18p deletion syndrome 1.4511998146826618e-05 0.479795\n",
      "MONDO:0859137 neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia 1.4511998146826618e-05 0.479795\n",
      "MONDO:0014357 intellectual disability, autosomal dominant 24 1.5693919362832693e-05 0.475553\n",
      "MONDO:0044724 3-methylglutaconic aciduria type 9 1.5693919362832693e-05 0.475553\n",
      "MONDO:0032714 facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome 1.5693919362832693e-05 0.475553\n",
      "MONDO:0013357 chromosome 17q11.2 deletion syndrome, 1.4Mb 1.5693919362832693e-05 0.475553\n",
      "MONDO:0859232 neurodevelopmental disorder with central hypotonia and dysmorphic facies 1.5693919362832693e-05 0.475553\n",
      "MONDO:0859325 developmental and epileptic encephalopathy 109 1.5693919362832693e-05 0.475553\n",
      "MONDO:0010549 Charcot-Marie-Tooth disease X-linked dominant 1 1.692192532813248e-05 0.471475\n",
      "MONDO:0030770 congenital disorder of deglycosylation 2 1.692192532813248e-05 0.471475\n",
      "MONDO:0010428 chromosome Xp11.23-p11.22 duplication syndrome 1.692192532813248e-05 0.471475\n",
      "MONDO:0030356 short-rib thoracic dysplasia 21 without polydactyly 1.692192532813248e-05 0.471475\n",
      "MONDO:0859081 chromosome Xq13 duplication syndrome 1.692192532813248e-05 0.471475\n",
      "MONDO:0032817 neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies 1.819599609191449e-05 0.467549\n",
      "MONDO:0014298 chromosome 5q12 deletion syndrome 1.819599609191449e-05 0.467549\n",
      "MONDO:0054845 developmental and epileptic encephalopathy, 66 1.819599609191449e-05 0.467549\n",
      "MONDO:0033007 Galloway-Mowat syndrome 3 1.819599609191449e-05 0.467549\n",
      "MONDO:0014556 congenital contractures of the limbs and face, hypotonia, and developmental delay 1.819599609191449e-05 0.467549\n",
      "MONDO:0859347 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities 1.819599609191449e-05 0.467549\n",
      "MONDO:0013578 DYRK1A-related intellectual disability syndrome 1.9516111709833096e-05 0.463764\n",
      "MONDO:0014671 neuropathy, hereditary motor and sensory, type 6B 1.9516111709833096e-05 0.463764\n",
      "MONDO:0012613 intellectual disability, autosomal recessive 5 1.9516111709833096e-05 0.463764\n",
      "MONDO:0010306 X-linked intellectual disability, Cabezas type 1.9516111709833096e-05 0.463764\n",
      "MONDO:0013628 hyperphosphatasia with intellectual disability syndrome 3 1.9516111709833096e-05 0.463764\n",
      "MONDO:0007068 adenylosuccinate lyase deficiency 1.9516111709833096e-05 0.463764\n",
      "MONDO:0859199 developmental delay with or without intellectual impairment or behavioral abnormalities 1.9516111709833096e-05 0.463764\n",
      "MONDO:0859377 neurodevelopmental disorder with poor growth and behavioral abnormalities 1.9516111709833096e-05 0.463764\n",
      "MONDO:0054791 leukodystrophy, hypomyelinating, 16 1.9516111709833096e-05 0.463764\n",
      "MONDO:0030914 Clark-Baraitser syndrome 2.0882252244006536e-05 0.460113\n",
      "MONDO:0030934 intellectual developmental disorder, autosomal dominant 64 2.0882252244006536e-05 0.460113\n",
      "MONDO:0032600 Snijders Blok-Campeau syndrome 2.0882252244006536e-05 0.460113\n",
      "MONDO:0012869 intellectual disability, autosomal dominant 22 2.0882252244006536e-05 0.460113\n",
      "MONDO:0008830 aspartylglucosaminuria 2.0882252244006536e-05 0.460113\n",
      "MONDO:0014963 Shashi-Pena syndrome 2.0882252244006536e-05 0.460113\n",
      "MONDO:0010574 syndromic X-linked intellectual disability 5 2.2294397763015193e-05 0.456585\n",
      "MONDO:0032697 neurodevelopmental disorder and language delay with or without structural brain abnormalities 2.2294397763015193e-05 0.456585\n",
      "MONDO:0011866 pontocerebellar hypoplasia type 1A 2.2294397763015193e-05 0.456585\n",
      "MONDO:0030919 intellectual disability, autosomal dominant 53 2.3752528341899777e-05 0.453174\n",
      "MONDO:0030999 neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism 2.3752528341899777e-05 0.453174\n",
      "MONDO:0016862 Alagille syndrome due to a JAG1 point mutation 2.3752528341899777e-05 0.453174\n",
      "MONDO:0014699 intellectual disability, autosomal dominant 40 2.3752528341899777e-05 0.453174\n",
      "MONDO:0014601 autosomal recessive spinocerebellar ataxia 20 2.3752528341899777e-05 0.453174\n",
      "MONDO:0010361 intellectual disability, X-linked 30 2.3752528341899777e-05 0.453174\n",
      "MONDO:0014294 chromosome 15q11.2 deletion syndrome 2.3752528341899777e-05 0.453174\n",
      "MONDO:0010512 intellectual disability, X-linked, syndromic, Bain type 2.5256624062159242e-05 0.449872\n",
      "MONDO:0032745 developmental delay with variable intellectual impairment and behavioral abnormalities 2.5256624062159242e-05 0.449872\n",
      "MONDO:0032851 intellectual developmental disorder with impaired language and dysmorphic facies 2.5256624062159242e-05 0.449872\n",
      "MONDO:0014864 hypermanganesemia with dystonia 2 2.6806665011749075e-05 0.446673\n",
      "MONDO:0859228 combined oxidative phosphorylation deficiency 55 2.6806665011749075e-05 0.446673\n",
      "MONDO:0013819 intellectual disability, autosomal dominant 14 2.6806665011749075e-05 0.446673\n",
      "MONDO:0014893 Okur-Chung neurodevelopmental syndrome 2.6806665011749075e-05 0.446673\n",
      "MONDO:0023657 intellectual developmental disorder, autosomal dominant 65 2.6806665011749075e-05 0.446673\n",
      "MONDO:0020847 intellectual disability, autosomal dominant 58 2.6806665011749075e-05 0.446673\n",
      "MONDO:0859286 neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures 2.6806665011749075e-05 0.446673\n",
      "MONDO:0054831 Coffin-Siris syndrome 7 2.6806665011749075e-05 0.446673\n",
      "MONDO:0030047 microcephaly, developmental delay, and brittle hair syndrome 2.6806665011749075e-05 0.446673\n",
      "MONDO:0859298 neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-pelger-huet anomaly 2.6806665011749075e-05 0.446673\n",
      "MONDO:0008006 Mobius syndrome 2.8402631285079628e-05 0.443572\n",
      "MONDO:0060510 Cohen-Gibson syndrome 2.8402631285079628e-05 0.443572\n",
      "MONDO:0859365 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures 2.8402631285079628e-05 0.443572\n",
      "MONDO:0010758 Wieacker-Wolff syndrome 2.8402631285079628e-05 0.443572\n",
      "MONDO:0014755 skin creases, congenital symmetric circumferential, 2 3.004450298301388e-05 0.440562\n",
      "MONDO:0014300 proximal myopathy with extrapyramidal signs 3.004450298301388e-05 0.440562\n",
      "MONDO:0044738 Gabriele de Vries syndrome 3.004450298301388e-05 0.440562\n",
      "MONDO:0013308 CBL-related disorder 3.004450298301388e-05 0.440562\n",
      "MONDO:0014858 intellectual disability, autosomal dominant 43 3.004450298301388e-05 0.440562\n",
      "MONDO:0012948 chromosome 6pter-p24 deletion syndrome 3.004450298301388e-05 0.440562\n",
      "MONDO:0859312 neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities 3.004450298301388e-05 0.440562\n",
      "MONDO:0859306 developmental delay with variable intellectual disability and dysmorphic facies 3.173226021286567e-05 0.437639\n",
      "MONDO:0012176 Emanuel syndrome 3.173226021286567e-05 0.437639\n",
      "MONDO:0032855 neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies 3.173226021286567e-05 0.437639\n",
      "MONDO:0008944 Joubert syndrome 1 3.173226021286567e-05 0.437639\n",
      "MONDO:0014966 periventricular nodular heterotopia 7 3.173226021286567e-05 0.437639\n",
      "MONDO:0033005 Galloway-Mowat syndrome 1 3.173226021286567e-05 0.437639\n",
      "MONDO:0014482 intellectual disability, autosomal dominant 29 3.3465883088398216e-05 0.434798\n",
      "MONDO:0014343 Desbuquois dysplasia 2 3.3465883088398216e-05 0.434798\n",
      "MONDO:0044646 early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome 3.3465883088398216e-05 0.434798\n",
      "MONDO:0859209 Zaki syndrome 3.5245351729821686e-05 0.432036\n",
      "MONDO:0010477 blepharophimosis - intellectual disability syndrome, MKB type 3.5245351729821686e-05 0.432036\n",
      "MONDO:0859080 intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies 3.5245351729821686e-05 0.432036\n",
      "MONDO:0859201 neurodevelopmental disorder with impaired language and ataxia and with or without seizures 3.5245351729821686e-05 0.432036\n",
      "MONDO:0032572 cardiac, facial, and digital anomalies with developmental delay 3.5245351729821686e-05 0.432036\n",
      "MONDO:0010310 osteopathia striata with cranial sclerosis 3.707064626379172e-05 0.429347\n",
      "MONDO:0012095 intellectual disability-brachydactyly-Pierre Robin syndrome 3.707064626379172e-05 0.429347\n",
      "MONDO:0009124 Dubowitz syndrome 3.707064626379172e-05 0.429347\n",
      "MONDO:0100218 arthrogryposis multiplex congenita 5 3.707064626379172e-05 0.429347\n",
      "MONDO:0033561 deeah syndrome 3.894174682340754e-05 0.426729\n",
      "MONDO:0008907 PMM2-congenital disorder of glycosylation 3.894174682340754e-05 0.426729\n",
      "MONDO:0009341 Mowat-Wilson syndrome 3.894174682340754e-05 0.426729\n",
      "MONDO:0011213 Pierpont syndrome 3.894174682340754e-05 0.426729\n",
      "MONDO:0030918 intellectual disability, autosomal dominant 52 3.894174682340754e-05 0.426729\n",
      "MONDO:0044302 congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 4.282128658417969e-05 0.421692\n",
      "MONDO:0030920 intellectual disability, autosomal dominant 54 4.282128658417969e-05 0.421692\n",
      "MONDO:0014348 intellectual disability, autosomal recessive 42 4.282128658417969e-05 0.421692\n",
      "MONDO:0010208 wrinkly skin syndrome 4.282128658417969e-05 0.421692\n",
      "MONDO:0008013 chromosome 9p deletion syndrome 4.282128658417969e-05 0.421692\n",
      "MONDO:0030908 intellectual disability, X-linked, syndromic, 35 4.282128658417969e-05 0.421692\n",
      "MONDO:0859190 neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities 4.282128658417969e-05 0.421692\n",
      "MONDO:0060622 neurodevelopmental disorder with severe motor impairment and absent language 4.482968608373527e-05 0.419267\n",
      "MONDO:0012864 chromosome 2q32-q33 deletion syndrome 4.482968608373527e-05 0.419267\n",
      "MONDO:0030966 neurofacioskeletal syndrome with or without renal agenesis 4.482968608373527e-05 0.419267\n",
      "MONDO:0014944 short stature-brachydactyly-obesity-global developmental delay syndrome 4.688381220573145e-05 0.4169\n",
      "MONDO:0010501 syndromic X-linked intellectual disability 34 4.8983645115457136e-05 0.414589\n",
      "MONDO:0859139 blepharophimosis-impaired intellectual development syndrome 5.332035199141277e-05 0.410126\n",
      "MONDO:0013886 cerebellar dysfunction with variable cognitive and behavioral abnormalities 5.332035199141277e-05 0.410126\n",
      "MONDO:0800436 craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1 5.555718632037505e-05 0.407968\n",
      "MONDO:0010483 X-linked intellectual disability, Cantagrel type 5.555718632037505e-05 0.407968\n",
      "MONDO:0012315 distal 10q deletion syndrome 5.555718632037505e-05 0.407968\n",
      "MONDO:0010500 intellectual disability, X-linked, syndromic 33 5.7839648162528166e-05 0.405859\n",
      "MONDO:0032760 developmental delay with or without dysmorphic facies and autism 5.7839648162528166e-05 0.405859\n",
      "MONDO:0009069 congenital lactic acidosis, Saguenay-Lac-Saint-Jean type 6.016771771530428e-05 0.403794\n",
      "MONDO:8000008 Martsolf syndrome 1 6.016771771530428e-05 0.403794\n",
      "MONDO:0014892 micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome 6.016771771530428e-05 0.403794\n",
      "MONDO:0030606 Bryant-Li-Bhoj neurodevelopmental syndrome 1 6.496060077456897e-05 0.399794\n",
      "MONDO:0012637 COG1-congenital disorder of glycosylation 6.74253747080305e-05 0.397855\n",
      "MONDO:0957228 intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities 6.74253747080305e-05 0.397855\n",
      "MONDO:0054588 Noonan syndrome-like disorder with loose anagen hair 2 6.993567720605743e-05 0.395955\n",
      "MONDO:0014606 intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome 6.993567720605743e-05 0.395955\n",
      "MONDO:0014855 intellectual disability, autosomal dominant 42 7.249148849817927e-05 0.394092\n",
      "MONDO:0007874 trichorhinophalangeal syndrome type II 7.249148849817927e-05 0.394092\n",
      "MONDO:0859143 Radio-Tartaglia syndrome 7.249148849817927e-05 0.394092\n",
      "MONDO:0859187 neurodevelopmental disorder with hypotonia and brain abnormalities 7.509278882033923e-05 0.392266\n",
      "MONDO:0019349 Sotos syndrome 7.509278882033923e-05 0.392266\n",
      "MONDO:0011518 Wiedemann-Steiner syndrome 7.509278882033923e-05 0.392266\n",
      "MONDO:0020602 Simpson-Golabi-Behmel syndrome type 1 7.773955841489326e-05 0.390474\n",
      "MONDO:0008953 peroxisome biogenesis disorder 1A (Zellweger) 8.316942642265352e-05 0.38699\n",
      "MONDO:0859273 liver disease, severe congenital 8.316942642265352e-05 0.38699\n",
      "MONDO:0009798 Primrose syndrome 8.595248535261439e-05 0.385296\n",
      "MONDO:0014205 severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome 8.878093458847414e-05 0.383632\n",
      "MONDO:0010193 Weaver syndrome 9.165475440462125e-05 0.381998\n",
      "MONDO:0012914 chromosome 1q21.1 deletion syndrome 9.165475440462125e-05 0.381998\n",
      "MONDO:0030990 Kohlschutter-Tonz syndrome-like 0.00010054824017466732 0.377262\n",
      "MONDO:0007617 Coffin-Siris syndrome 1 0.0001130402137580136 0.371306\n",
      "MONDO:0011244 Marshall-Smith syndrome 0.00014743230692905888 0.357945\n",
      "MONDO:0030993 Tessadori-Van Haaften neurodevelopmental syndrome 3 0.00017022961700071613 0.350802\n",
      "MONDO:0008393 Rubinstein-Taybi syndrome due to CREBBP mutations 0.00017818812186499934 0.348545\n",
      "MONDO:0013256 chromosome 15q24 deletion syndrome 0.00018632606655853896 0.346347\n",
      "MONDO:0010413 intellectual disability, X-linked 95 0.00021586033752281006 0.33915\n",
      "MONDO:0859185 neurodevelopmental disorder with hypotonia and dysmorphic facies 0.00024830286965320296 0.332369\n",
      "MONDO:0859178 developmental delay, impaired speech, and behavioral abnormalities 0.00034080968472883263 0.31729\n",
      "MONDO:0012648 isobutyryl-CoA dehydrogenase deficiency 0.0004316740793603039 0.306278\n",
      "MONDO:0010488 intellectual disability, X-linked 100 0.0004316740793603039 0.306278\n",
      "MONDO:0013985 autosomal recessive nonsyndromic hearing loss 18B 0.0004316740793603039 0.306278\n",
      "MONDO:0044315 craniosynostosis 7 0.0004316740793603039 0.306278\n",
      "MONDO:0014825 chromosome 11p13 deletion syndrome, distal 0.0004316740793603039 0.306278\n",
      "MONDO:0013871 Seckel syndrome 6 0.0004316740793603039 0.306278\n",
      "MONDO:0014876 intellectual disability, autosomal recessive 54 0.0004316740793603039 0.306278\n",
      "MONDO:0030339 microcephaly 28, primary, autosomal recessive 0.0004316740793603039 0.306278\n",
      "MONDO:0010450 intellectual disability, X-linked 89 0.0004316740793603039 0.306278\n",
      "MONDO:0010406 chromosome Xp11.22 duplication syndrome 0.0004316740793603039 0.306278\n",
      "MONDO:0010157 Tryptophanuria with dwarfism 0.0006474412355706435 0.287901\n",
      "MONDO:0021011 hereditary progressive chorea without dementia 0.0006474412355706435 0.287901\n",
      "MONDO:0013345 d-2-hydroxyglutaric aciduria 2 0.0006474412355706435 0.287901\n",
      "MONDO:0009814 osteopenia-intellectual disability-sparse hair syndrome 0.0006474412355706435 0.287901\n",
      "MONDO:0024508 epilepsy, hot water, 1 0.0006474412355706435 0.287901\n",
      "MONDO:0012557 cardiomyopathy-hypotonia-lactic acidosis syndrome 0.0006474412355706435 0.287901\n",
      "MONDO:0014973 sudden cardiac failure, infantile 0.0006474412355706435 0.287901\n",
      "MONDO:0032592 cardiomyopathy, dilated, 2c 0.0006474412355706435 0.287901\n",
      "MONDO:0032628 mitochondrial complex 1 deficiency, nuclear type 24 0.0006474412355706435 0.287901\n",
      "MONDO:0013708 intellectual disability, autosomal recessive 25 0.0006474412355706435 0.287901\n",
      "MONDO:0010313 intellectual disability, X-linked 63 0.0006474412355706435 0.287901\n",
      "MONDO:0007952 maxillofacial dysostosis 0.0006474412355706435 0.287901\n",
      "MONDO:0032694 microcephaly 25, primary, autosomal recessive 0.0006474412355706435 0.287901\n",
      "MONDO:0013528 intellectual disability, autosomal recessive 14 0.0006474412355706435 0.287901\n",
      "MONDO:0014131 hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome 0.0006474412355706435 0.287901\n",
      "MONDO:0029465 intellectual developmental disorder, autosomal dominant 69 0.0006474412355706435 0.287901\n",
      "MONDO:0014184 specific language impairment 5 0.0006474412355706435 0.287901\n",
      "MONDO:0013705 intellectual disability, autosomal recessive 19 0.0006474412355706435 0.287901\n",
      "MONDO:0030434 epilepsy, idiopathic generalized, susceptibility to, 18 0.0006474412355706435 0.287901\n",
      "MONDO:0011710 specific language impairment 1 0.0006474412355706435 0.287901\n",
      "MONDO:0007325 choreoathetosis, familial inverted 0.0008631618162098167 0.27527\n",
      "MONDO:0010260 arthrogryposis, congenital, lower limb, X-linked 0.0008631618162098167 0.27527\n",
      "MONDO:0012732 tremor, hereditary essential, and idiopathic normal pressure hydrocephalus 0.0008631618162098167 0.27527\n",
      "MONDO:0009366 normal pressure hydrocephalus 0.0008631618162098167 0.27527\n",
      "MONDO:0008845 atonic-astatic syndrome of Foerster 0.0008631618162098167 0.27527\n",
      "MONDO:0013904 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 0.0008631618162098167 0.27527\n",
      "MONDO:0042979 hypokalemic periodic paralysis, type 1 0.0008631618162098167 0.27527\n",
      "MONDO:0013156 muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4 0.0008631618162098167 0.27527\n",
      "MONDO:0012382 hyperinsulinemic hypoglycemia, familial, 4 0.0008631618162098167 0.27527\n",
      "MONDO:0013493 acetyl-coa carboxylase deficiency 0.0008631618162098167 0.27527\n",
      "MONDO:0026733 intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type 0.0008631618162098167 0.27527\n",
      "MONDO:0013697 intellectual disability, autosomal recessive 29 0.0008631618162098167 0.27527\n",
      "MONDO:0030916 intellectual disability, autosomal dominant 50 0.0008631618162098167 0.27527\n",
      "MONDO:0011184 childhood apraxia of speech 0.0008631618162098167 0.27527\n",
      "MONDO:0014759 intellectual disability, autosomal recessive 51 0.0008631618162098167 0.27527\n",
      "MONDO:0013785 intellectual disability, autosomal recessive 34 0.0008631618162098167 0.27527\n",
      "MONDO:0013709 intellectual disability, autosomal recessive 28 0.0008631618162098167 0.27527\n",
      "MONDO:0014240 periventricular nodular heterotopia 6 0.0008631618162098167 0.27527\n",
      "MONDO:0032777 generalized epilepsy with febrile seizures plus, type 10 0.0008631618162098167 0.27527\n",
      "MONDO:0008569 thyroid hormone resistance, generalized, autosomal dominant 0.0008631618162098167 0.27527\n",
      "MONDO:0014524 intellectual disability, autosomal recessive 47 0.0008631618162098167 0.27527\n",
      "MONDO:0012204 familial pseudohyperkalemia 0.0008631618162098167 0.27527\n",
      "MONDO:0011200 torsion dystonia 7 0.0008631618162098167 0.27527\n",
      "MONDO:0008590 tremor, hereditary essential, 1 0.0008631618162098167 0.27527\n",
      "MONDO:0011951 amyotrophic lateral sclerosis type 6 0.0010788358313316428 0.265714\n",
      "MONDO:0014676 Emery-Dreifuss muscular dystrophy 3, autosomal recessive 0.0010788358313316428 0.265714\n",
      "MONDO:0011887 cataract, congenital, with mental impairment and dentate gyrus atrophy 0.0010788358313316428 0.265714\n",
      "MONDO:0013928 dystonia 23 0.0010788358313316428 0.265714\n",
      "MONDO:0013387 developmental and epileptic encephalopathy, 7 0.0010788358313316428 0.265714\n",
      "MONDO:0013548 acetyl-CoA acetyltransferase-2 deficiency 0.0010788358313316428 0.265714\n",
      "MONDO:0859158 ataxia, intention tremor, and hypotonia syndrome, childhood-onset 0.0010788358313316428 0.265714\n",
      "MONDO:0032631 mitochondrial complex 1 deficiency, nuclear type 27 0.0010788358313316428 0.265714\n",
      "MONDO:0012858 primary CD59 deficiency 0.0010788358313316428 0.265714\n",
      "MONDO:0004573 ariboflavinosis 0.0010788358313316428 0.265714\n",
      "MONDO:0013539 hypotonia-failure to thrive-microcephaly syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0013707 intellectual disability, autosomal recessive 24 0.0010788358313316428 0.265714\n",
      "MONDO:0012996 AGAT deficiency 0.0010788358313316428 0.265714\n",
      "MONDO:0010314 polymicrogyria, bilateral perisylvian, X-linked 0.0010788358313316428 0.265714\n",
      "MONDO:0859246 leukodystrophy, childhood-onset, remitting 0.001294463290987769 0.258066\n",
      "MONDO:0014724 Joubert syndrome 24 0.001294463290987769 0.258066\n",
      "MONDO:0011603 GNE myopathy 0.001294463290987769 0.258066\n",
      "MONDO:0024568 infantile liver failure syndrome 1 0.001294463290987769 0.258066\n",
      "MONDO:0011291 ALG6-congenital disorder of glycosylation 1C 0.001294463290987769 0.258066\n",
      "MONDO:0013950 peroxisome biogenesis disorder 11B 0.001294463290987769 0.258066\n",
      "MONDO:0010317 intellectual disability, X-linked, with or without seizures, arx-related 0.001294463290987769 0.258066\n",
      "MONDO:0030462 Joubert syndrome 40 0.001294463290987769 0.258066\n",
      "MONDO:0014190 combined oxidative phosphorylation defect type 17 0.001294463290987769 0.258066\n",
      "MONDO:0014270 STT3A-congenital disorder of glycosylation 0.001294463290987769 0.258066\n",
      "MONDO:0014851 hypercalcemia, infantile, 2 0.001294463290987769 0.258066\n",
      "MONDO:0011772 B4GALT1-congenital disorder of glycosylation 0.001294463290987769 0.258066\n",
      "MONDO:0014942 developmental and epileptic encephalopathy, 45 0.001294463290987769 0.258066\n",
      "MONDO:0013000 porphyria due to ALA dehydratase deficiency 0.001294463290987769 0.258066\n",
      "MONDO:0033310 Joubert syndrome 31 0.001294463290987769 0.258066\n",
      "MONDO:0012413 syndromic microphthalmia type 5 0.001294463290987769 0.258066\n",
      "MONDO:0032733 global developmental delay, progressive ataxia, and elevated glutamine 0.001294463290987769 0.258066\n",
      "MONDO:0012465 hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency 0.001294463290987769 0.258066\n",
      "MONDO:0030009 alopecia-intellectual disability syndrome 4 0.001294463290987769 0.258066\n",
      "MONDO:0010266 intellectual disability, X-linked 58 0.001294463290987769 0.258066\n",
      "MONDO:0010469 epsilon-trimethyllysine hydroxylase deficiency 0.001294463290987769 0.258066\n",
      "MONDO:0033543 cone-rod synaptic disorder syndrome, congenital nonprogressive 0.001294463290987769 0.258066\n",
      "MONDO:0060551 cerebellar atrophy, developmental delay, and seizures 0.001294463290987769 0.258066\n",
      "MONDO:0005260 autism 0.001294463290987769 0.258066\n",
      "MONDO:0032588 periventricular nodular heterotopia 8 0.001294463290987769 0.258066\n",
      "MONDO:0011824 autism, susceptibility to, 8 0.001294463290987769 0.258066\n",
      "MONDO:0013581 intellectual disability, autosomal dominant 2 0.001294463290987769 0.258066\n",
      "MONDO:0013058 cystic leukoencephalopathy without megalencephaly 0.001294463290987769 0.258066\n",
      "MONDO:0009673 spinal muscular atrophy, type II 0.001294463290987769 0.258066\n",
      "MONDO:0012787 hereditary spastic paraplegia 39 0.0015100442052276759 0.251713\n",
      "MONDO:0013877 mitochondrial pyruvate carrier deficiency 0.0015100442052276759 0.251713\n",
      "MONDO:0033311 Joubert syndrome 33 0.0015100442052276759 0.251713\n",
      "MONDO:0100105 brain small vessel disease 3 0.0015100442052276759 0.251713\n",
      "MONDO:0013883 congenital myasthenic syndrome 13 0.0015100442052276759 0.251713\n",
      "MONDO:0010380 cataract, ataxia, short stature, and intellectual disability 0.0015100442052276759 0.251713\n",
      "MONDO:0014220 myopathy due to myoadenylate deaminase deficiency 0.0015100442052276759 0.251713\n",
      "MONDO:0014080 osteosclerotic metaphyseal dysplasia 0.0015100442052276759 0.251713\n",
      "MONDO:0013763 Joubert syndrome 15 0.0015100442052276759 0.251713\n",
      "MONDO:0859271 glycosylphosphatidylinositol biosynthesis defect 25 0.0015100442052276759 0.251713\n",
      "MONDO:0012276 generalized epilepsy-paroxysmal dyskinesia syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0012624 acyl-CoA dehydrogenase 9 deficiency 0.0015100442052276759 0.251713\n",
      "MONDO:0014842 intellectual disability, autosomal dominant 41 0.0015100442052276759 0.251713\n",
      "MONDO:0032909 mitochondrial complex 3 deficiency, nuclear type 10 0.0015100442052276759 0.251713\n",
      "MONDO:0957255 mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 0.0015100442052276759 0.251713\n",
      "MONDO:0032629 mitochondrial complex 1 deficiency, nuclear type 25 0.0015100442052276759 0.251713\n",
      "MONDO:0020727 combined oxidative phosphorylation deficiency 22 0.0015100442052276759 0.251713\n",
      "MONDO:0009742 neuroectodermal melanolysosomal disease 0.0015100442052276759 0.251713\n",
      "MONDO:0014668 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4 0.0015100442052276759 0.251713\n",
      "MONDO:0024772 intellectual developmental disorder, X-linked, syndromic, Pilorge type 0.0015100442052276759 0.251713\n",
      "MONDO:0030849 intellectual developmental disorder with speech delay and axonal peripheral neuropathy 0.0015100442052276759 0.251713\n",
      "MONDO:0020787 hypomagnesemia, seizures, and intellectual disability 1 0.0015100442052276759 0.251713\n",
      "MONDO:0044326 developmental delay and seizures with or without movement abnormalities 0.0015100442052276759 0.251713\n",
      "MONDO:0010658 syndromic X-linked intellectual disability 12 0.0015100442052276759 0.251713\n",
      "MONDO:0011956 autism, susceptibility to, 3 0.0015100442052276759 0.251713\n",
      "MONDO:0029135 muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8 0.0015100442052276759 0.251713\n",
      "MONDO:0030625 dyskinesia with orofacial involvement, autosomal recessive 0.0015100442052276759 0.251713\n",
      "MONDO:0014517 generalized epilepsy with febrile seizures plus, type 9 0.0015100442052276759 0.251713\n",
      "MONDO:0008445 delayed speech-facial asymmetry-strabismus-ear lobe creases syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0010342 autism, susceptibility to, X-linked 3 0.0015100442052276759 0.251713\n",
      "MONDO:0010430 intellectual disability, X-linked 97 0.0015100442052276759 0.251713\n",
      "MONDO:0032699 epilepsy, idiopathic generalized, susceptibility to, 15 0.0015100442052276759 0.251713\n",
      "MONDO:0011627 autism, susceptibility to, 5 0.0015100442052276759 0.251713\n",
      "MONDO:0011970 rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0030538 dystonia 34, myoclonic 0.0015100442052276759 0.251713\n",
      "MONDO:0014742 Parkinson disease 22, autosomal dominant 0.001725578584098671 0.246296\n",
      "MONDO:0009353 homocystinuria due to methylene tetrahydrofolate reductase deficiency 0.001725578584098671 0.246296\n",
      "MONDO:0013645 autosomal recessive spinocerebellar ataxia 11 0.001725578584098671 0.246296\n",
      "MONDO:0013947 neuronopathy, distal hereditary motor, autosomal recessive 5 0.001725578584098671 0.246296\n",
      "MONDO:0012237 nemaline myopathy 6 0.001725578584098671 0.246296\n",
      "MONDO:0014714 progressive microcephaly-seizures-cortical blindness-developmental delay syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0032627 mitochondrial complex 1 deficiency, nuclear type 23 0.001725578584098671 0.246296\n",
      "MONDO:0054861 intellectual disability, autosomal recessive 63 0.001725578584098671 0.246296\n",
      "MONDO:0008962 Griscelli syndrome type 1 0.001725578584098671 0.246296\n",
      "MONDO:0859287 neurodevelopmental disorder with microcephaly, hypotonia, and absent language 0.001725578584098671 0.246296\n",
      "MONDO:0009562 beta-mannosidosis 0.001725578584098671 0.246296\n",
      "MONDO:0013690 Pitt-Hopkins-like syndrome 2 0.001725578584098671 0.246296\n",
      "MONDO:0032812 developmental and epileptic encephalopathy, 78 0.001725578584098671 0.246296\n",
      "MONDO:0009949 pyruvate carboxylase deficiency disease 0.001725578584098671 0.246296\n",
      "MONDO:0011203 Pierre Robin sequence with pectus excavatum and rib and scapular anomalies 0.001725578584098671 0.246296\n",
      "MONDO:0014271 STT3B-congenital disorder of glycosylation 0.001725578584098671 0.246296\n",
      "MONDO:0014633 myoclonic-atonic epilepsy 0.001725578584098671 0.246296\n",
      "MONDO:0032678 developmental and epileptic encephalopathy, 71 0.001725578584098671 0.246296\n",
      "MONDO:0032626 mitochondrial complex 1 deficiency, nuclear type 22 0.001725578584098671 0.246296\n",
      "MONDO:0014142 autosomal recessive limb-girdle muscular dystrophy type 2T 0.001725578584098671 0.246296\n",
      "MONDO:0014607 developmental and epileptic encephalopathy, 32 0.001725578584098671 0.246296\n",
      "MONDO:0012037 intellectual disability, autosomal recessive 3 0.001725578584098671 0.246296\n",
      "MONDO:0033652 mitochondrial complex 4 deficiency, nuclear type 17 0.001725578584098671 0.246296\n",
      "MONDO:0010654 Partington syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0011722 intellectual disability-obesity-prognathism-eye and skin anomalies syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0032906 spastic paraplegia 82, autosomal recessive 0.001725578584098671 0.246296\n",
      "MONDO:0010341 autism, susceptibility to, X-linked 2 0.001725578584098671 0.246296\n",
      "MONDO:0032883 intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures 0.001725578584098671 0.246296\n",
      "MONDO:0010297 FG syndrome 2 0.001725578584098671 0.246296\n",
      "MONDO:0011246 megaconial type congenital muscular dystrophy 0.001725578584098671 0.246296\n",
      "MONDO:0009324 Hartnup disease 0.001725578584098671 0.246296\n",
      "MONDO:0013620 congenital myasthenic syndrome 16 0.0019410664376458965 0.241583\n",
      "MONDO:0014768 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 0.0019410664376458965 0.241583\n",
      "MONDO:0014303 hereditary spastic paraplegia 64 0.0019410664376458965 0.241583\n",
      "MONDO:0014711 autosomal dominant Charcot-Marie-Tooth disease type 2W 0.0019410664376458965 0.241583\n",
      "MONDO:0859220 Ferguson-Bonni neurodevelopmental syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0009529 pyruvate dehydrogenase E3 deficiency 0.0019410664376458965 0.241583\n",
      "MONDO:0010192 Waardenburg syndrome type 4A 0.0019410664376458965 0.241583\n",
      "MONDO:0012251 MEDNIK syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0013772 Huppke-Brendel syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0013936 peroxisome biogenesis disorder 6A (Zellweger) 0.0019410664376458965 0.241583\n",
      "MONDO:0014525 combined oxidative phosphorylation defect type 23 0.0019410664376458965 0.241583\n",
      "MONDO:0013890 congenital myopathy with internal nuclei and atypical cores 0.0019410664376458965 0.241583\n",
      "MONDO:0008721 medium chain acyl-CoA dehydrogenase deficiency 0.0019410664376458965 0.241583\n",
      "MONDO:0044299 myasthenic syndrome, congenital, 22 0.0019410664376458965 0.241583\n",
      "MONDO:0009868 glycogen storage disease IXb 0.0019410664376458965 0.241583\n",
      "MONDO:0010598 glycogen storage disease IXa1 0.0019410664376458965 0.241583\n",
      "MONDO:0012392 2-methylbutyryl-CoA dehydrogenase deficiency 0.0019410664376458965 0.241583\n",
      "MONDO:0010494 linear skin defects with multiple congenital anomalies 3 0.0019410664376458965 0.241583\n",
      "MONDO:0013789 DDOST-congenital disorder of glycosylation 0.0019410664376458965 0.241583\n",
      "MONDO:0014764 spastic paraplegia-severe developmental delay-epilepsy syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0010508 intellectual disability, X-linked 103 0.0019410664376458965 0.241583\n",
      "MONDO:0859256 neurodevelopmental disorder with language delay and seizures 0.0019410664376458965 0.241583\n",
      "MONDO:0010656 intellectual disability, X-linked 1 0.0019410664376458965 0.241583\n",
      "MONDO:0859162 neurodevelopmental disorder with infantile epileptic spasms 0.0019410664376458965 0.241583\n",
      "MONDO:0010000 rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction 0.0019410664376458965 0.241583\n",
      "MONDO:0010830 neuronal ceroid lipofuscinosis 8 0.0019410664376458965 0.241583\n",
      "MONDO:0014798 brachydactyly type A1D 0.0019410664376458965 0.241583\n",
      "MONDO:0014956 Chitayat syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0032741 neurodevelopmental disorder with impaired speech and hyperkinetic movements 0.0019410664376458965 0.241583\n",
      "MONDO:0010665 Wilson-Turner syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0014437 Bardet-Biedl syndrome 9 0.0019410664376458965 0.241583\n",
      "MONDO:0013440 autosomal recessive limb-girdle muscular dystrophy type 2P 0.0019410664376458965 0.241583\n",
      "MONDO:0012588 neuronal ceroid lipofuscinosis 7 0.0019410664376458965 0.241583\n",
      "MONDO:0030909 intellectual disability, X-linked, syndromic, Houge type 0.0019410664376458965 0.241583\n",
      "MONDO:0030034 epilepsy, progressive myoclonic, 11 0.0019410664376458965 0.241583\n",
      "MONDO:0032927 triokinase and FMN cyclase deficiency syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0012756 proximal 16p11.2 microdeletion syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0014566 Charcot-Marie-Tooth disease axonal type 2U 0.002156507775912319 0.23742\n",
      "MONDO:0010699 Charcot-Marie-Tooth disease X-linked recessive 5 0.002156507775912319 0.23742\n",
      "MONDO:0014117 Charcot-Marie-Tooth disease type 4B3 0.002156507775912319 0.23742\n",
      "MONDO:0013803 leukoencephalopathy with calcifications and cysts 0.002156507775912319 0.23742\n",
      "MONDO:0007164 spastic ataxia 1 0.002156507775912319 0.23742\n",
      "MONDO:0014886 severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0030476 Galloway-Mowat syndrome 10 0.002156507775912319 0.23742\n",
      "MONDO:0859514 congenital myopathy 18 0.002156507775912319 0.23742\n",
      "MONDO:0032839 noonan syndrome 12 0.002156507775912319 0.23742\n",
      "MONDO:0013008 combined immunodeficiency due to STIM1 deficiency 0.002156507775912319 0.23742\n",
      "MONDO:0030311 combined oxidative phosphorylation deficiency 52 0.002156507775912319 0.23742\n",
      "MONDO:0032877 neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures 0.002156507775912319 0.23742\n",
      "MONDO:0054559 congenital disorder of glycosylation, type IIq 0.002156507775912319 0.23742\n",
      "MONDO:0010100 Tay-Sachs disease 0.002156507775912319 0.23742\n",
      "MONDO:0010487 intellectual disability, X-linked 99 0.002156507775912319 0.23742\n",
      "MONDO:0013793 encephalomyopathy, mitochondrial, due to voltage-dependent anion channel deficiency 0.002156507775912319 0.23742\n",
      "MONDO:0017715 3-hydroxyacyl-CoA dehydrogenase deficiency 0.002156507775912319 0.23742\n",
      "MONDO:0010366 FG syndrome 5 0.002156507775912319 0.23742\n",
      "MONDO:0020739 hypercalcemia, infantile, 1 0.002156507775912319 0.23742\n",
      "MONDO:0012245 developmental and epileptic encephalopathy, 3 0.002156507775912319 0.23742\n",
      "MONDO:0013702 intellectual disability, autosomal recessive 27 0.002156507775912319 0.23742\n",
      "MONDO:0859305 neurodevelopmental disorder with eye movement abnormalities and ataxia 0.002156507775912319 0.23742\n",
      "MONDO:0014585 congenital myasthenic syndrome 3C 0.002156507775912319 0.23742\n",
      "MONDO:0044304 hyperphenylalaninemia due to DNAJC12 deficiency 0.002156507775912319 0.23742\n",
      "MONDO:0014832 intellectual disability, autosomal recessive 53 0.002156507775912319 0.23742\n",
      "MONDO:0008769 neuronal ceroid lipofuscinosis 2 0.002156507775912319 0.23742\n",
      "MONDO:0013321 forsythe-wakeling syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0010392 glycogen storage disease due to phosphoglycerate kinase 1 deficiency 0.002156507775912319 0.23742\n",
      "MONDO:0014996 intellectual disability, autosomal recessive 58 0.002156507775912319 0.23742\n",
      "MONDO:0013353 intellectual disability, anterior maxillary protrusion, and strabismus 0.002156507775912319 0.23742\n",
      "MONDO:0011101 peroxisome biogenesis disorder 1B 0.002156507775912319 0.23742\n",
      "MONDO:0032882 Heyn-Sproul-Jackson syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0014447 Bardet-Biedl syndrome 19 0.002156507775912319 0.23742\n",
      "MONDO:0013385 Treacher Collins syndrome 2 0.002156507775912319 0.23742\n",
      "MONDO:0032656 microcephaly, cataracts, impaired intellectual development, and dystonia with abnormal striatum 0.002156507775912319 0.23742\n",
      "MONDO:0044308 bardet-biedl syndrome 21 0.002156507775912319 0.23742\n",
      "MONDO:0033667 Delpire-McNeill syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0013644 Charcot-Marie-Tooth disease axonal type 2O 0.002156507775912319 0.23742\n",
      "MONDO:0015015 congenital bile acid synthesis defect 6 0.002156507775912319 0.23742\n",
      "MONDO:0014419 ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0013003 isolated congenital hypoglossia/aglossia 0.002156507775912319 0.23742\n",
      "MONDO:0014159 autosomal recessive spinocerebellar ataxia 14 0.002156507775912319 0.23742\n",
      "MONDO:0012092 hereditary sensory and autonomic neuropathy type 5 0.002156507775912319 0.23742\n",
      "MONDO:0013605 brittle cornea syndrome 2 0.002371902608938751 0.233698\n",
      "MONDO:0029133 muscular dystrophy, limb-girdle, autosomal dominant 4 0.002371902608938751 0.233698\n",
      "MONDO:0014803 spasticity-ataxia-gait anomalies syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0032853 myopathy, distal, 6, adult-onset, autosomal dominant 0.002371902608938751 0.233698\n",
      "MONDO:0013679 sclerosteosis 2 0.002371902608938751 0.233698\n",
      "MONDO:0013091 glycogen storage disease IXc 0.002371902608938751 0.233698\n",
      "MONDO:0010547 X-linked progressive cerebellar ataxia 0.002371902608938751 0.233698\n",
      "MONDO:0032617 mitochondrial complex 1 deficiency, nuclear type 11 0.002371902608938751 0.233698\n",
      "MONDO:0012308 Joubert syndrome with renal defect 0.002371902608938751 0.233698\n",
      "MONDO:0016825 mitochondrial myopathy-lactic acidosis-deafness syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0014113 cardiofaciocutaneous syndrome 3 0.002371902608938751 0.233698\n",
      "MONDO:0031052 developmental and epileptic encephalopathy 106 0.002371902608938751 0.233698\n",
      "MONDO:0859289 intestinal dysmotility syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0014477 developmental and epileptic encephalopathy, 26 0.002371902608938751 0.233698\n",
      "MONDO:0012221 alpha-N-acetylgalactosaminidase deficiency type 1 0.002371902608938751 0.233698\n",
      "MONDO:0012635 COG8-congenital disorder of glycosylation 0.002371902608938751 0.233698\n",
      "MONDO:0014569 lethal congenital contracture syndrome 7 0.002371902608938751 0.233698\n",
      "MONDO:0009292 glycogen storage disease due to glycogen branching enzyme deficiency 0.002371902608938751 0.233698\n",
      "MONDO:0013166 GABA aminotransaminase deficiency 0.002371902608938751 0.233698\n",
      "MONDO:0014409 intellectual disability, autosomal recessive 44 0.002371902608938751 0.233698\n",
      "MONDO:0033365 developmental and epileptic encephalopathy, 56 0.002371902608938751 0.233698\n",
      "MONDO:0032634 mitochondrial complex 1 deficiency, nuclear type 31 0.002371902608938751 0.233698\n",
      "MONDO:0033566 combined oxidative phosphorylation deficiency 48 0.002371902608938751 0.233698\n",
      "MONDO:0011995 cataract - congenital heart disease - neural tube defect syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0014927 Joubert syndrome 27 0.002371902608938751 0.233698\n",
      "MONDO:0011966 periventricular heterotopia with microcephaly, autosomal recessive 0.002371902608938751 0.233698\n",
      "MONDO:0012774 chromosome 15q13.3 microdeletion syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0013164 beta-ureidopropionase deficiency 0.002371902608938751 0.233698\n",
      "MONDO:0030921 intellectual disability, autosomal dominant 55, with seizures 0.002371902608938751 0.233698\n",
      "MONDO:0060745 intellectual developmental disorder with or without epilepsy or cerebellar ataxia 0.002371902608938751 0.233698\n",
      "MONDO:0014059 microphthalmia, isolated, with coloboma 9 0.002371902608938751 0.233698\n",
      "MONDO:0013656 intellectual disability, autosomal dominant 9 0.002371902608938751 0.233698\n",
      "MONDO:0036212 spastic paraparesis-cataracts-speech delay syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0957274 spastic paraplegia 89, autosomal recessive 0.002371902608938751 0.233698\n",
      "MONDO:0054701 Kleefstra syndrome 2 0.002371902608938751 0.233698\n",
      "MONDO:0859319 dyskeratosis congenita, autosomal recessive 8 0.002371902608938751 0.233698\n",
      "MONDO:0030931 proteasome-associated autoinflammatory syndrome 4 0.002371902608938751 0.233698\n",
      "MONDO:0010660 intellectual disability, X-linked 9 0.002371902608938751 0.233698\n",
      "MONDO:0014341 complex cortical dysplasia with other brain malformations 6 0.002371902608938751 0.233698\n",
      "MONDO:0013541 complex cortical dysplasia with other brain malformations 1 0.002371902608938751 0.233698\n",
      "MONDO:0014784 severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0014862 cerebral palsy, spastic quadriplegic, 3 0.002371902608938751 0.233698\n",
      "MONDO:0011913 Alzheimer disease 3 0.002587250946763825 0.230335\n",
      "MONDO:0014511 Charcot-Marie-Tooth disease axonal type 2S 0.002587250946763825 0.230335\n",
      "MONDO:0032728 Charcot-Marie-Tooth disease, axonal, type 2EE 0.002587250946763825 0.230335\n",
      "MONDO:0012640 Charcot-Marie-Tooth disease type 4J 0.002587250946763825 0.230335\n",
      "MONDO:0014305 hereditary spastic paraplegia 63 0.002587250946763825 0.230335\n",
      "MONDO:0012205 autosomal dominant striatal neurodegeneration type 1 0.002587250946763825 0.230335\n",
      "MONDO:0011468 hereditary motor and sensory neuropathy, Okinawa type 0.002587250946763825 0.230335\n",
      "MONDO:0030963 Li-Campeau syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0031055 developmental and epileptic encephalopathy 107 0.002587250946763825 0.230335\n",
      "MONDO:0011336 familial hemophagocytic lymphohistiocytosis 4 0.002587250946763825 0.230335\n",
      "MONDO:0013867 brown-Vialetto-van Laere syndrome 2 0.002587250946763825 0.230335\n",
      "MONDO:0033366 developmental and epileptic encephalopathy, 57 0.002587250946763825 0.230335\n",
      "MONDO:0008816 Chiari malformation type II 0.002587250946763825 0.230335\n",
      "MONDO:0012539 Joubert syndrome 6 0.002587250946763825 0.230335\n",
      "MONDO:0030891 intellectual developmental disorder, autosomal dominant 66 0.002587250946763825 0.230335\n",
      "MONDO:0009123 orthostatic hypotension 1 0.002587250946763825 0.230335\n",
      "MONDO:0033655 mitochondrial complex 4 deficiency, nuclear type 20 0.002587250946763825 0.230335\n",
      "MONDO:0012784 autosomal recessive ataxia due to ubiquinone deficiency 0.002587250946763825 0.230335\n",
      "MONDO:0012960 intellectual disability, autosomal dominant 5 0.002587250946763825 0.230335\n",
      "MONDO:0859335 congenital myopathy 15 0.002587250946763825 0.230335\n",
      "MONDO:0014496 mitochondrial complex III deficiency nuclear type 9 0.002587250946763825 0.230335\n",
      "MONDO:0030727 developmental and epileptic encephalopathy 101 0.002587250946763825 0.230335\n",
      "MONDO:0012855 Joubert syndrome 8 0.002587250946763825 0.230335\n",
      "MONDO:0013918 distal tetrasomy 15q 0.002587250946763825 0.230335\n",
      "MONDO:0009556 malonic aciduria 0.002587250946763825 0.230335\n",
      "MONDO:0014487 congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0010657 methylmalonic acidemia with homocystinuria, type cblX 0.002587250946763825 0.230335\n",
      "MONDO:0012545 neutral lipid storage myopathy 0.002587250946763825 0.230335\n",
      "MONDO:0014140 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 0.002587250946763825 0.230335\n",
      "MONDO:0013658 intellectual disability, autosomal dominant 11 0.002587250946763825 0.230335\n",
      "MONDO:0100102 fetal akinesia deformation sequence 2 0.002587250946763825 0.230335\n",
      "MONDO:0013354 spastic ataxia 4 0.002587250946763825 0.230335\n",
      "MONDO:0014951 intellectual developmental disorder, autosomal recessive 74 0.002587250946763825 0.230335\n",
      "MONDO:0032759 intellectual developmental disorder with short stature and variable skeletal anomalies 0.002587250946763825 0.230335\n",
      "MONDO:0031019 spastic paraplegia 87, autosomal recessive 0.002587250946763825 0.230335\n",
      "MONDO:0033479 spinocerebellar ataxia 44 0.002587250946763825 0.230335\n",
      "MONDO:0012106 microcephaly 5, primary, autosomal recessive 0.002587250946763825 0.230335\n",
      "MONDO:0030912 intellectual disability, autosomal dominant 47 0.002587250946763825 0.230335\n",
      "MONDO:0032597 myasthenic syndrome, congenital, 24, presynaptic 0.002587250946763825 0.230335\n",
      "MONDO:0014311 autosomal recessive spinocerebellar ataxia 15 0.002587250946763825 0.230335\n",
      "MONDO:0859266 neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy 0.002587250946763825 0.230335\n",
      "MONDO:0014273 microcephaly-thin corpus callosum-intellectual disability syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0012081 15q11q13 microduplication syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0011166 lymphedema-atrial septal defects-facial changes syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0033618 Vissers-Bodmer syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0011551 TH-deficient dopa-responsive dystonia 0.002587250946763825 0.230335\n",
      "MONDO:0014387 leukoencephalopathy, progressive, with ovarian failure 0.002587250946763825 0.230335\n",
      "MONDO:0009897 adult polyglucosan body disease 0.0028025527994240108 0.227272\n",
      "MONDO:0013931 peroxisome biogenesis disorder 4B 0.0028025527994240108 0.227272\n",
      "MONDO:0009862 dihydropteridine reductase deficiency 0.0028025527994240108 0.227272\n",
      "MONDO:0013927 peroxisome biogenesis disorder 3A (Zellweger) 0.0028025527994240108 0.227272\n",
      "MONDO:0014119 intellectual disability-strabismus syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0009563 maple syrup urine disease 0.0028025527994240108 0.227272\n",
      "MONDO:0014397 combined oxidative phosphorylation defect type 20 0.0028025527994240108 0.227272\n",
      "MONDO:0013865 mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency 0.0028025527994240108 0.227272\n",
      "MONDO:0014570 lethal congenital contracture syndrome 8 0.0028025527994240108 0.227272\n",
      "MONDO:0014976 lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0012699 autosomal recessive limb-girdle muscular dystrophy type 2M 0.0028025527994240108 0.227272\n",
      "MONDO:0025353 developmental and epileptic encephalopathy, 90 0.0028025527994240108 0.227272\n",
      "MONDO:0010490 SSR4-congenital disorder of glycosylation 0.0028025527994240108 0.227272\n",
      "MONDO:0014746 SLC39A8-CDG 0.0028025527994240108 0.227272\n",
      "MONDO:0010139 isolated thyroid-stimulating hormone deficiency 0.0028025527994240108 0.227272\n",
      "MONDO:0032693 Galloway-Mowat syndrome 8 0.0028025527994240108 0.227272\n",
      "MONDO:0011964 DPAGT1-congenital disorder of glycosylation 0.0028025527994240108 0.227272\n",
      "MONDO:0030378 combined oxidative phosphorylation deficiency 53 0.0028025527994240108 0.227272\n",
      "MONDO:0010185 methylmalonic aciduria and homocystinuria type cblD 0.0028025527994240108 0.227272\n",
      "MONDO:0010798 proximal tubulopathy-diabetes mellitus-cerebellar ataxia syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0010265 Simpson-Golabi-Behmel syndrome type 2 0.0028025527994240108 0.227272\n",
      "MONDO:0014822 15q14 microdeletion syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0014077 cobblestone lissencephaly without muscular or ocular involvement 0.0028025527994240108 0.227272\n",
      "MONDO:0009238 hereditary folate malabsorption 0.0028025527994240108 0.227272\n",
      "MONDO:0009251 fructose-1,6-bisphosphatase deficiency 0.0028025527994240108 0.227272\n",
      "MONDO:0024506 Adams-Oliver syndrome 1 0.0028025527994240108 0.227272\n",
      "MONDO:0008056 myotonic dystrophy type 1 0.0028025527994240108 0.227272\n",
      "MONDO:0859264 congenital myopathy 11 0.0028025527994240108 0.227272\n",
      "MONDO:0012471 Aicardi-Goutieres syndrome 3 0.0028025527994240108 0.227272\n",
      "MONDO:0859313 neurodevelopmental disorder with speech impairment and with or without seizures 0.0028025527994240108 0.227272\n",
      "MONDO:0014072 D,L-2-hydroxyglutaric aciduria 0.0028025527994240108 0.227272\n",
      "MONDO:0014705 craniosynostosis 6 0.0028025527994240108 0.227272\n",
      "MONDO:0030861 osteogenesis imperfecta, type 21 0.0028025527994240108 0.227272\n",
      "MONDO:0958179 glycine encephalopathy 1 0.0028025527994240108 0.227272\n",
      "MONDO:0013292 chromosome 4q21 deletion syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0009569 Hennekam-Beemer syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0014856 combined oxidative phosphorylation defect type 30 0.0028025527994240108 0.227272\n",
      "MONDO:0014678 intellectual disability, autosomal dominant 39 0.0028025527994240108 0.227272\n",
      "MONDO:0010929 craniosynostosis 4 0.0028025527994240108 0.227272\n",
      "MONDO:0030263 leukodystrophy, hypomyelinating, 21 0.0028025527994240108 0.227272\n",
      "MONDO:0014928 Joubert syndrome 28 0.0028025527994240108 0.227272\n",
      "MONDO:0031021 developmental and epileptic encephalopathy 104 0.0028025527994240108 0.227272\n",
      "MONDO:0008603 trigonocephaly 1 0.0028025527994240108 0.227272\n",
      "MONDO:0060555 vertebral, cardiac, renal, and limb defects syndrome 2 0.0028025527994240108 0.227272\n",
      "MONDO:0033641 cleft palate, proliferative retinopathy, and developmental delay 0.0028025527994240108 0.227272\n",
      "MONDO:0014402 severe neurodegenerative syndrome with lipodystrophy 0.0028025527994240108 0.227272\n",
      "MONDO:0014625 developmental and epileptic encephalopathy, 33 0.0028025527994240108 0.227272\n",
      "MONDO:0011437 microcephaly 4, primary, autosomal recessive 0.0028025527994240108 0.227272\n",
      "MONDO:0032886 Liang-Wang syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0018764 microcephalic primordial dwarfism due to RTTN deficiency 0.0028025527994240108 0.227272\n",
      "MONDO:0009185 amelocerebrohypohidrotic syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0030964 intellectual developmental disorder, autosomal dominant 67 0.0028025527994240108 0.227272\n",
      "MONDO:0014204 basal ganglia calcification, idiopathic, 5 0.0028025527994240108 0.227272\n",
      "MONDO:0032901 Catifa syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0014940 neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset 0.003017808176953609 0.224463\n",
      "MONDO:0000914 cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 0.003017808176953609 0.224463\n",
      "MONDO:0012556 DK1-congenital disorder of glycosylation 0.003017808176953609 0.224463\n",
      "MONDO:0859519 neurodevelopmental disorder with absent speech and movement and behavioral abnormalities 0.003017808176953609 0.224463\n",
      "MONDO:0011257 MPI-congenital disorder of glycosylation 0.003017808176953609 0.224463\n",
      "MONDO:0013111 acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins 0.003017808176953609 0.224463\n",
      "MONDO:0011229 ethylmalonic encephalopathy 0.003017808176953609 0.224463\n",
      "MONDO:0015014 coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness 0.003017808176953609 0.224463\n",
      "MONDO:0013007 combined immunodeficiency due to ORAI1 deficiency 0.003017808176953609 0.224463\n",
      "MONDO:0014647 developmental and epileptic encephalopathy, 50 0.003017808176953609 0.224463\n",
      "MONDO:0859258 neurodevelopmental disorder with dystonia and seizures 0.003017808176953609 0.224463\n",
      "MONDO:0013349 ALG11-congenital disorder of glycosylation 0.003017808176953609 0.224463\n",
      "MONDO:0032616 mitochondrial complex 1 deficiency, nuclear type 10 0.003017808176953609 0.224463\n",
      "MONDO:0012432 Joubert syndrome 5 0.003017808176953609 0.224463\n",
      "MONDO:0014337 complex cortical dysplasia with other brain malformations 5 0.003017808176953609 0.224463\n",
      "MONDO:0010250 intellectual disability, X-linked 49 0.003017808176953609 0.224463\n",
      "MONDO:0014003 developmental and epileptic encephalopathy, 15 0.003017808176953609 0.224463\n",
      "MONDO:0032725 developmental and epileptic encephalopathy, 74 0.003017808176953609 0.224463\n",
      "MONDO:0030353 Joubert syndrome 38 0.003017808176953609 0.224463\n",
      "MONDO:0032663 developmental and epileptic encephalopathy, 70 0.003017808176953609 0.224463\n",
      "MONDO:0030487 spondylometaphyseal dysplasia, pagnamenta type 0.003017808176953609 0.224463\n",
      "MONDO:0007492 early-onset generalized limb-onset dystonia 0.003017808176953609 0.224463\n",
      "MONDO:0013840 encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0033362 developmental and epileptic encephalopathy, 53 0.003017808176953609 0.224463\n",
      "MONDO:0014683 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 0.003017808176953609 0.224463\n",
      "MONDO:0013762 lipoic acid synthetase deficiency 0.003017808176953609 0.224463\n",
      "MONDO:0013404 hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase 0.003017808176953609 0.224463\n",
      "MONDO:0033309 Joubert syndrome 32 0.003017808176953609 0.224463\n",
      "MONDO:0012719 combined PSAP deficiency 0.003017808176953609 0.224463\n",
      "MONDO:0957540 congenital disorder of glycosylation, type IIaa 0.003017808176953609 0.224463\n",
      "MONDO:0012052 ALG1-congenital disorder of glycosylation 0.003017808176953609 0.224463\n",
      "MONDO:0030537 central hypoventilation syndrome, congenital, 2, and autonomic dysfunction 0.003017808176953609 0.224463\n",
      "MONDO:0014752 nephrotic syndrome, type 11 0.003017808176953609 0.224463\n",
      "MONDO:0010507 Xq25 microduplication syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0054742 combined oxidative phosphorylation deficiency 35 0.003017808176953609 0.224463\n",
      "MONDO:0013336 chromosome 19p13.13 deletion syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0009544 macrocephaly/megalencephaly syndrome, autosomal recessive 0.003017808176953609 0.224463\n",
      "MONDO:0020858 mitochondrial complex 5 (ATP synthase) deficiency nuclear type 5 0.003017808176953609 0.224463\n",
      "MONDO:0030929 microcephaly 27, primary, autosomal dominant 0.003017808176953609 0.224463\n",
      "MONDO:0033656 mitochondrial complex 4 deficiency, nuclear type 21 0.003017808176953609 0.224463\n",
      "MONDO:0030028 neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline 0.003017808176953609 0.224463\n",
      "MONDO:0030060 neurodevelopmental disorder with language impairment and behavioral abnormalities 0.003017808176953609 0.224463\n",
      "MONDO:0030012 Diets-Jongmans syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0013490 megalencephalic leukoencephalopathy with subcortical cysts 2A 0.003017808176953609 0.224463\n",
      "MONDO:0008200 autosomal dominant Parkinson disease 1 0.0032330170893847643 0.22187\n",
      "MONDO:0010074 brachyolmia type 1, toledo type 0.0032330170893847643 0.22187\n",
      "MONDO:0032737 spastic paraplegia 80, autosomal dominant 0.0032330170893847643 0.22187\n",
      "MONDO:0029138 developmental and epileptic encephalopathy, 67 0.0032330170893847643 0.22187\n",
      "MONDO:0010188 familial isolated deficiency of vitamin E 0.0032330170893847643 0.22187\n",
      "MONDO:0859517 congenital myopathy 2b, severe infantile, autosomal recessive 0.0032330170893847643 0.22187\n",
      "MONDO:0060568 Pilarowski-Bjornsson syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0030312 spinocerebellar ataxia, autosomal recessive 29 0.0032330170893847643 0.22187\n",
      "MONDO:0010979 Timothy syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0009666 holocarboxylase synthetase deficiency 0.0032330170893847643 0.22187\n",
      "MONDO:0014905 encephalopathy due to defective mitochondrial and peroxisomal fission 2 0.0032330170893847643 0.22187\n",
      "MONDO:0011529 spinocerebellar ataxia type 13 0.0032330170893847643 0.22187\n",
      "MONDO:0014133 developmental and epileptic encephalopathy, 16 0.0032330170893847643 0.22187\n",
      "MONDO:0031028 developmental and epileptic encephalopathy 105 with hypopituitarism 0.0032330170893847643 0.22187\n",
      "MONDO:0010778 cyclic vomiting syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0014085 hydrocephalus, nonsyndromic, autosomal recessive 2 0.0032330170893847643 0.22187\n",
      "MONDO:0020777 congenital disorder of glycosylation with defective fucosylation 2 0.0032330170893847643 0.22187\n",
      "MONDO:0014848 TELO2-related intellectual disability-neurodevelopmental disorder 0.0032330170893847643 0.22187\n",
      "MONDO:0012368 aminoacylase 1 deficiency 0.0032330170893847643 0.22187\n",
      "MONDO:0009921 holoprosencephaly-postaxial polydactyly syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0013277 developmental and epileptic encephalopathy, 5 0.0032330170893847643 0.22187\n",
      "MONDO:0014141 muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14 0.0032330170893847643 0.22187\n",
      "MONDO:0014206 severe early-onset pulmonary alveolar proteinosis due to MARS deficiency 0.0032330170893847643 0.22187\n",
      "MONDO:0010149 transcobalamin II deficiency 0.0032330170893847643 0.22187\n",
      "MONDO:0010263 Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0014120 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 0.0032330170893847643 0.22187\n",
      "MONDO:0030472 developmental and epileptic encephalopathy 98 0.0032330170893847643 0.22187\n",
      "MONDO:0033043 spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy 0.0032330170893847643 0.22187\n",
      "MONDO:0859229 cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism 0.0032330170893847643 0.22187\n",
      "MONDO:0012856 Birk-Barel syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0012290 CEDNIK syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0012747 glycogen storage disease due to aldolase A deficiency 0.0032330170893847643 0.22187\n",
      "MONDO:0030937 mitochondrial complex 2 deficiency, nuclear type 3 0.0032330170893847643 0.22187\n",
      "MONDO:0014208 Charcot-Marie-Tooth disease type 2R 0.0032330170893847643 0.22187\n",
      "MONDO:0012792 mitochondrial DNA depletion syndrome 8a 0.0032330170893847643 0.22187\n",
      "MONDO:0009603 3-hydroxyisobutyryl-CoA hydrolase deficiency 0.0032330170893847643 0.22187\n",
      "MONDO:0032931 pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal 0.0032330170893847643 0.22187\n",
      "MONDO:0014983 congenital myasthenic syndrome 21 0.0032330170893847643 0.22187\n",
      "MONDO:0014288 Joubert syndrome 21 0.0032330170893847643 0.22187\n",
      "MONDO:0008918 carnitine-acylcarnitine translocase deficiency 0.0032330170893847643 0.22187\n",
      "MONDO:0859324 developmental delay, language impairment, and ocular abnormalities 0.0032330170893847643 0.22187\n",
      "MONDO:0032830 snijders blok-fisher syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0032880 developmental and epileptic encephalopathy, 82 0.0032330170893847643 0.22187\n",
      "MONDO:0012203 familial hyperthyroidism due to mutations in TSH receptor 0.0032330170893847643 0.22187\n",
      "MONDO:0025701 leukodystrophy, hypomyelinating, 22 0.0032330170893847643 0.22187\n",
      "MONDO:0011686 DNA ligase IV deficiency 0.0032330170893847643 0.22187\n",
      "MONDO:0044329 osteogenesis imperfecta, type 18 0.0032330170893847643 0.22187\n",
      "MONDO:0859262 ACCES syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0859144 Buratti-Harel syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0011325 Fanconi anemia complementation group F 0.0032330170893847643 0.22187\n",
      "MONDO:0859257 intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism 0.0032330170893847643 0.22187\n",
      "MONDO:0010659 FRAXE intellectual disability 0.0032330170893847643 0.22187\n",
      "MONDO:0014224 developmental delay with autism spectrum disorder and gait instability 0.0032330170893847643 0.22187\n",
      "MONDO:0030878 Kaya-Barakat-Masson syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0014778 Lamb-Shaffer syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0957203 intellectual developmental disorder, X-linked 111 0.0032330170893847643 0.22187\n",
      "MONDO:0859272 neurodevelopmental disorder with speech delay and variable ocular anomalies 0.0032330170893847643 0.22187\n",
      "MONDO:0013522 dyskeratosis congenita, autosomal dominant 3 0.0032330170893847643 0.22187\n",
      "MONDO:0859309 spastic paraplegia 88, autosomal dominant 0.0032330170893847643 0.22187\n",
      "MONDO:0030677 Charcot-Marie-Tooth disease, demyelinating, IIA 1I 0.0032330170893847643 0.22187\n",
      "MONDO:0010421 Bruton-type agammaglobulinemia 0.0032330170893847643 0.22187\n",
      "MONDO:0036484 Charcot-Marie-Tooth disease, dominant intermediate G 0.003448179546747442 0.219464\n",
      "MONDO:0012639 hereditary spastic paraplegia 18 0.003448179546747442 0.219464\n",
      "MONDO:0020750 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 0.003448179546747442 0.219464\n",
      "MONDO:0060659 neurodevelopmental disorder with poor language and loss of hand skills 0.003448179546747442 0.219464\n",
      "MONDO:0800028 dyskinesia with orofacial involvement, autosomal dominant 0.003448179546747442 0.219464\n",
      "MONDO:0033662 neurodevelopmental disorder with microcephaly, seizures, and brain atrophy 0.003448179546747442 0.219464\n",
      "MONDO:0009397 neonatal severe primary hyperparathyroidism 0.003448179546747442 0.219464\n",
      "MONDO:0030259 pontocerebellar hypoplasia, type 15 0.003448179546747442 0.219464\n",
      "MONDO:0010007 microbrachycephaly-ptosis-cleft lip syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0012885 SRD5A3-congenital disorder of glycosylation 0.003448179546747442 0.219464\n",
      "MONDO:0024309 neuropathy, hereditary sensory and autonomic, type 2A 0.003448179546747442 0.219464\n",
      "MONDO:0032609 mitochondrial complex 1 deficiency, nuclear type 4 0.003448179546747442 0.219464\n",
      "MONDO:0014201 developmental and epileptic encephalopathy, 18 0.003448179546747442 0.219464\n",
      "MONDO:0011022 Potocki-Shaffer syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0014505 developmental and epileptic encephalopathy, 27 0.003448179546747442 0.219464\n",
      "MONDO:0009678 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 0.003448179546747442 0.219464\n",
      "MONDO:0012703 lissencephaly due to TUBA1A mutation 0.003448179546747442 0.219464\n",
      "MONDO:0012824 hypomyelinating leukodystrophy 4 0.003448179546747442 0.219464\n",
      "MONDO:0014754 primary coenzyme Q10 deficiency 8 0.003448179546747442 0.219464\n",
      "MONDO:0010437 severe X-linked mitochondrial encephalomyopathy 0.003448179546747442 0.219464\n",
      "MONDO:0013458 hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0054785 multiple mitochondrial dysfunctions syndrome 6 0.003448179546747442 0.219464\n",
      "MONDO:0013989 developmental and epileptic encephalopathy, 14 0.003448179546747442 0.219464\n",
      "MONDO:0013875 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0014939 congenital myasthenic syndrome 20 0.003448179546747442 0.219464\n",
      "MONDO:0859250 neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures 0.003448179546747442 0.219464\n",
      "MONDO:0008082 multiple endocrine neoplasia type 2B 0.003448179546747442 0.219464\n",
      "MONDO:0011365 blepharophimosis - intellectual disability syndrome, SBBYS type 0.003448179546747442 0.219464\n",
      "MONDO:0010099 Tay-Sachs disease AB variant 0.003448179546747442 0.219464\n",
      "MONDO:0009953 leukocyte adhesion deficiency type II 0.003448179546747442 0.219464\n",
      "MONDO:0054781 combined oxidative phosphorylation deficiency 36 0.003448179546747442 0.219464\n",
      "MONDO:0030258 pontocerebellar hypoplasia, type 14 0.003448179546747442 0.219464\n",
      "MONDO:0014660 microcephaly 15, primary, autosomal recessive 0.003448179546747442 0.219464\n",
      "MONDO:0013255 arthrogryposis, renal dysfunction, and cholestasis 2 0.003448179546747442 0.219464\n",
      "MONDO:0013797 chromosome 17q12 deletion syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0032568 intellectual developmental disorder with macrocephaly, seizures, and speech delay 0.003448179546747442 0.219464\n",
      "MONDO:0032905 spastic paraplegia 81, autosomal recessive 0.003448179546747442 0.219464\n",
      "MONDO:0030024 neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities 0.003448179546747442 0.219464\n",
      "MONDO:0859211 neurodevelopmental disorder with hyperkinetic movements and dyskinesia 0.003448179546747442 0.219464\n",
      "MONDO:0010286 syndromic X-linked intellectual disability Siderius type 0.003448179546747442 0.219464\n",
      "MONDO:0031011 neurodevelopmental disorder with dysmorphic facies and variable seizures 0.003448179546747442 0.219464\n",
      "MONDO:0859225 neurodevelopmental disorder with or without variable movement or behavioral abnormalities 0.003448179546747442 0.219464\n",
      "MONDO:0030026 retinal dystrophy with leukodystrophy 0.003448179546747442 0.219464\n",
      "MONDO:0032730 leukodystrophy, hypomyelinating, 18 0.003448179546747442 0.219464\n",
      "MONDO:0030900 intellectual developmental disorder with paroxysmal dyskinesia or seizures 0.003448179546747442 0.219464\n",
      "MONDO:0033559 intellectual developmental disorder with seizures and language delay 0.003448179546747442 0.219464\n",
      "MONDO:0014648 Al-Raqad syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0009610 3-methylglutaconic aciduria type 1 0.003448179546747442 0.219464\n",
      "MONDO:0014992 lissencephaly 8 0.003448179546747442 0.219464\n",
      "MONDO:0010056 spinal muscular atrophy, type IV 0.003448179546747442 0.219464\n",
      "MONDO:0014702 autosomal recessive complex spastic paraplegia type 9B 0.0036632955590694496 0.217221\n",
      "MONDO:0010820 autosomal recessive juvenile Parkinson disease 2 0.0036632955590694496 0.217221\n",
      "MONDO:0054695 myopathy, centronuclear, 6, with fiber-type disproportion 0.0036632955590694496 0.217221\n",
      "MONDO:0060759 neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures 0.0036632955590694496 0.217221\n",
      "MONDO:0030261 pontocerebellar hypoplasia, type 1F 0.0036632955590694496 0.217221\n",
      "MONDO:0014543 congenital myasthenic syndrome 14 0.0036632955590694496 0.217221\n",
      "MONDO:0010773 mitochondrial myopathy with diabetes 0.0036632955590694496 0.217221\n",
      "MONDO:0012759 camptodactyly syndrome, Guadalajara type 3 0.0036632955590694496 0.217221\n",
      "MONDO:0014576 lipoyl transferase 1 deficiency 0.0036632955590694496 0.217221\n",
      "MONDO:0008861 3-methylcrotonyl-CoA carboxylase 1 deficiency 0.0036632955590694496 0.217221\n",
      "MONDO:0014563 mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency 0.0036632955590694496 0.217221\n",
      "MONDO:0014979 myoclonus, intractable, neonatal 0.0036632955590694496 0.217221\n",
      "MONDO:0060486 arthrogryposis multiplex congenita 1, neurogenic, with myelin defect 0.0036632955590694496 0.217221\n",
      "MONDO:0012099 AICA-ribosiduria 0.0036632955590694496 0.217221\n",
      "MONDO:0859360 spinocerebellar ataxia, autosomal recessive 33 0.0036632955590694496 0.217221\n",
      "MONDO:0010651 Menkes disease 0.0036632955590694496 0.217221\n",
      "MONDO:0859279 spinal muscular atrophy, distal, autosomal recessive, 6 0.0036632955590694496 0.217221\n",
      "MONDO:0032770 intellectual developmental disorder with severe speech and ambulation defects 0.0036632955590694496 0.217221\n",
      "MONDO:0007180 Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities 0.0036632955590694496 0.217221\n",
      "MONDO:0033045 orofaciodigital syndrome 16 0.0036632955590694496 0.217221\n",
      "MONDO:0014598 developmental and epileptic encephalopathy, 31 0.0036632955590694496 0.217221\n",
      "MONDO:0000909 Bartter disease type 4B 0.0036632955590694496 0.217221\n",
      "MONDO:0009665 biotinidase deficiency 0.0036632955590694496 0.217221\n",
      "MONDO:0060562 encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities 0.0036632955590694496 0.217221\n",
      "MONDO:0013456 constitutional megaloblastic anemia with severe neurologic disease 0.0036632955590694496 0.217221\n",
      "MONDO:0010532 infantile-onset X-linked spinal muscular atrophy 0.0036632955590694496 0.217221\n",
      "MONDO:0008425 omphalocele syndrome, Shprintzen-Goldberg type 0.0036632955590694496 0.217221\n",
      "MONDO:0014646 Zimmermann-Laband syndrome 2 0.0036632955590694496 0.217221\n",
      "MONDO:0013858 pontine tegmental cap dysplasia 0.0036632955590694496 0.217221\n",
      "MONDO:0012669 Legius syndrome 0.0036632955590694496 0.217221\n",
      "MONDO:0013252 Warsaw breakage syndrome 0.0036632955590694496 0.217221\n",
      "MONDO:0014510 fatty acyl-CoA reductase 1 deficiency 0.0036632955590694496 0.217221\n",
      "MONDO:0044205 Shwachman-Diamond syndrome 2 0.0036632955590694496 0.217221\n",
      "MONDO:0014895 developmental and epileptic encephalopathy, 40 0.0036632955590694496 0.217221\n",
      "MONDO:0010476 neurodegeneration with brain iron accumulation 5 0.0036632955590694496 0.217221\n",
      "MONDO:0032832 intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies 0.0036632955590694496 0.217221\n",
      "MONDO:0033547 Li-Ghorbani-Weisz-Hubshman syndrome 0.0036632955590694496 0.217221\n",
      "MONDO:0033482 spinocerebellar ataxia 47 0.0036632955590694496 0.217221\n",
      "MONDO:0009436 congenital hypothalamic hamartoma syndrome 0.0036632955590694496 0.217221\n",
      "MONDO:0030994 neurodevelopmental disorder with or without autism or seizures 0.0036632955590694496 0.217221\n",
      "MONDO:0013173 intellectual disability, autosomal recessive 13 0.0036632955590694496 0.217221\n",
      "MONDO:0032860 intellectual developmental disorder, autosomal recessive 72 0.0036632955590694496 0.217221\n",
      "MONDO:0011651 intellectual disability, short stature, facial anomalies, and joint dislocations 0.0036632955590694496 0.217221\n",
      "MONDO:0859223 congenital disorder of glycosylation, type Iw, autosomal dominant 0.0036632955590694496 0.217221\n",
      "MONDO:0032712 combined oxidative phosphorylation deficiency 38 0.0036632955590694496 0.217221\n",
      "MONDO:0009568 mast syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0014062 mitochondrial DNA deletion syndrome with progressive myopathy 0.0038783651363764366 0.215122\n",
      "MONDO:0014290 neurodegeneration with brain iron accumulation 6 0.0038783651363764366 0.215122\n",
      "MONDO:0014233 early-onset Parkinson disease 20 0.0038783651363764366 0.215122\n",
      "MONDO:0032706 spinocerebellar ataxia, autosomal recessive 27 0.0038783651363764366 0.215122\n",
      "MONDO:0024264 hypothyroidism, congenital, nongoitrous, 2 0.0038783651363764366 0.215122\n",
      "MONDO:0014356 mitochondrial complex III deficiency nuclear type 7 0.0038783651363764366 0.215122\n",
      "MONDO:0007999 holoprosencephaly 2 0.0038783651363764366 0.215122\n",
      "MONDO:0012211 MPDU1-congenital disorder of glycosylation 0.0038783651363764366 0.215122\n",
      "MONDO:0013306 combined oxidative phosphorylation defect type 7 0.0038783651363764366 0.215122\n",
      "MONDO:0011829 coenzyme Q10 deficiency, primary, 1 0.0038783651363764366 0.215122\n",
      "MONDO:0060704 neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures 0.0038783651363764366 0.215122\n",
      "MONDO:0012240 congenital myopathy 23 0.0038783651363764366 0.215122\n",
      "MONDO:0009723 Leigh syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0008799 anophthalmia/microphthalmia-esophageal atresia syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0013870 TMEM165-congenital disorder of glycosylation 0.0038783651363764366 0.215122\n",
      "MONDO:0013307 myopathy, lactic acidosis, and sideroblastic anemia 2 0.0038783651363764366 0.215122\n",
      "MONDO:0859575 Atelis syndrome 1 0.0038783651363764366 0.215122\n",
      "MONDO:0010667 Prieto syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0012393 congenital brain dysgenesis due to glutamine synthetase deficiency 0.0038783651363764366 0.215122\n",
      "MONDO:0009073 Ritscher-Schinzel syndrome 1 0.0038783651363764366 0.215122\n",
      "MONDO:0013178 congenital muscular dystrophy due to LMNA mutation 0.0038783651363764366 0.215122\n",
      "MONDO:0010398 syndromic X-linked intellectual disability 14 0.0038783651363764366 0.215122\n",
      "MONDO:0957217 cortical dysplasia, complex, with other brain malformations 12 0.0038783651363764366 0.215122\n",
      "MONDO:0010271 X-linked myotubular myopathy-abnormal genitalia syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0030977 neuronopathy, distal hereditary motor, autosomal recessive 7 0.0038783651363764366 0.215122\n",
      "MONDO:0958181 mitochondrial trifunctional protein deficiency 1 0.0038783651363764366 0.215122\n",
      "MONDO:0010079 Canavan disease 0.0038783651363764366 0.215122\n",
      "MONDO:0009612 methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency 0.0038783651363764366 0.215122\n",
      "MONDO:0008922 Sengers syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0010298 Lesch-Nyhan syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0009705 carnitine palmitoyl transferase 1A deficiency 0.0038783651363764366 0.215122\n",
      "MONDO:0859569 braddock-carey syndrome 1 0.0038783651363764366 0.215122\n",
      "MONDO:0008862 3-methylcrotonyl-CoA carboxylase 2 deficiency 0.0038783651363764366 0.215122\n",
      "MONDO:0009502 pyruvate dehydrogenase E2 deficiency 0.0038783651363764366 0.215122\n",
      "MONDO:0010814 chondrodysplasia-pseudohermaphroditism syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0060629 neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive 0.0038783651363764366 0.215122\n",
      "MONDO:0011240 megalencephaly-capillary malformation-polymicrogyria syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0014238 severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0032791 Coffin-Siris syndrome 10 0.0038783651363764366 0.215122\n",
      "MONDO:0957221 spastic paraplegia 70, autosomal recessive 0.0038783651363764366 0.215122\n",
      "MONDO:0015350 17q11.2 microduplication syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0013822 acrodysostosis 2 with or without hormone resistance 0.0038783651363764366 0.215122\n",
      "MONDO:0031002 Baralle-Macken syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0032691 Galloway-Mowat syndrome 6 0.0038783651363764366 0.215122\n",
      "MONDO:0011724 encephalopathy due to GLUT1 deficiency 0.0038783651363764366 0.215122\n",
      "MONDO:0014358 AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0030456 muscular dystrophy, limb-girdle, autosomal recessive 27 0.0038783651363764366 0.215122\n",
      "MONDO:0008086 neuropathy, hereditary sensory and autonomic, type 1A 0.0038783651363764366 0.215122\n",
      "MONDO:0009672 spinal muscular atrophy, type III 0.0038783651363764366 0.215122\n",
      "MONDO:0010936 frontotemporal dementia and/or amyotrophic lateral sclerosis 7 0.004093388288691872 0.21315\n",
      "MONDO:0007311 Charcot-Marie-Tooth disease type 1E 0.004093388288691872 0.21315\n",
      "MONDO:0024538 basal ganglia calcification, idiopathic, 1 0.004093388288691872 0.21315\n",
      "MONDO:0014213 intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0010395 phosphoribosylpyrophosphate synthetase superactivity 0.004093388288691872 0.21315\n",
      "MONDO:0044306 neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination 0.004093388288691872 0.21315\n",
      "MONDO:0009959 peroxisome biogenesis disorder type 3B 0.004093388288691872 0.21315\n",
      "MONDO:0009614 methylmalonic aciduria, cblB type 0.004093388288691872 0.21315\n",
      "MONDO:0013350 mitochondrial DNA depletion syndrome 4b 0.004093388288691872 0.21315\n",
      "MONDO:0014896 congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0012783 RFT1-congenital disorder of glycosylation 0.004093388288691872 0.21315\n",
      "MONDO:0014731 seizures-scoliosis-macrocephaly syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0010679 Duchenne muscular dystrophy 0.004093388288691872 0.21315\n",
      "MONDO:0054654 combined oxidative phosphorylation deficiency 32 0.004093388288691872 0.21315\n",
      "MONDO:0011873 Niemann-Pick disease, type C2 0.004093388288691872 0.21315\n",
      "MONDO:0020775 congenital disorder of glycosylation with defective fucosylation 1 0.004093388288691872 0.21315\n",
      "MONDO:0859356 congenital disorder of glycosylation, type IIy 0.004093388288691872 0.21315\n",
      "MONDO:0018274 GM3 synthase deficiency 0.004093388288691872 0.21315\n",
      "MONDO:0032661 neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia 0.004093388288691872 0.21315\n",
      "MONDO:0032675 myasthenic syndrome, congenital, 25, presynaptic 0.004093388288691872 0.21315\n",
      "MONDO:0859206 neurodevelopmental disorder with hearing loss and spasticity 0.004093388288691872 0.21315\n",
      "MONDO:0013594 spinocerebellar ataxia type 36 0.004093388288691872 0.21315\n",
      "MONDO:0060490 neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies 0.004093388288691872 0.21315\n",
      "MONDO:0011969 ALG8-congenital disorder of glycosylation 0.004093388288691872 0.21315\n",
      "MONDO:0013787 psychomotor retardation, epilepsy, and craniofacial dysmorphism 0.004093388288691872 0.21315\n",
      "MONDO:0013835 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 0.004093388288691872 0.21315\n",
      "MONDO:0957288 intellectual developmental disorder, autosomal recessive 79 0.004093388288691872 0.21315\n",
      "MONDO:0014732 hypomyelinating leukodystrophy 12 0.004093388288691872 0.21315\n",
      "MONDO:0014335 diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0010774 striatonigral degeneration, infantile, mitochondrial 0.004093388288691872 0.21315\n",
      "MONDO:0032807 neurodevelopmental disorder with visual defects and brain anomalies 0.004093388288691872 0.21315\n",
      "MONDO:0060591 immunodeficiency, developmental delay, and hypohomocysteinemia 0.004093388288691872 0.21315\n",
      "MONDO:0032692 Galloway-Mowat syndrome 7 0.004093388288691872 0.21315\n",
      "MONDO:0033135 Charcot-Marie-Tooth disease, demyelinating, type 1G 0.004093388288691872 0.21315\n",
      "MONDO:0008050 MYH7-related skeletal myopathy 0.004308365026037072 0.211292\n",
      "MONDO:0031006 neurodegeneration with ataxia and late-onset optic atrophy 0.004308365026037072 0.211292\n",
      "MONDO:0014726 Charcot-Marie-Tooth disease axonal type 2X 0.004308365026037072 0.211292\n",
      "MONDO:0020765 neuropathy, congenital hypomyelinating, 2 0.004308365026037072 0.211292\n",
      "MONDO:0009499 Krabbe disease 0.004308365026037072 0.211292\n",
      "MONDO:0009653 mucolipidosis type IV 0.004308365026037072 0.211292\n",
      "MONDO:0020714 mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy 0.004308365026037072 0.211292\n",
      "MONDO:0009567 Marinesco-Sjogren syndrome 0.004308365026037072 0.211292\n",
      "MONDO:0009260 GM1 gangliosidosis type 1 0.004308365026037072 0.211292\n",
      "MONDO:0032753 spastic ataxia 9, autosomal recessive 0.004308365026037072 0.211292\n",
      "MONDO:0014221 triosephosphate isomerase deficiency 0.004308365026037072 0.211292\n",
      "MONDO:0010848 spinocerebellar ataxia type 5 0.004308365026037072 0.211292\n",
      "MONDO:0014663 Silver-Russell syndrome 3 0.004308365026037072 0.211292\n",
      "MONDO:0032784 neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements 0.004308365026037072 0.211292\n",
      "MONDO:0012812 developmental and epileptic encephalopathy, 4 0.004308365026037072 0.211292\n",
      "MONDO:0100186 GTP cyclohydrolase I deficiency with hyperphenylalaninemia 0.004308365026037072 0.211292\n",
      "MONDO:0032778 arthrogryposis multiplex congenita 3, myogenic type 0.004308365026037072 0.211292\n",
      "MONDO:0014698 microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome 0.004308365026037072 0.211292\n",
      "MONDO:0009757 Niemann-Pick disease, type C1 0.004308365026037072 0.211292\n",
      "MONDO:0014981 immunodeficiency 49 0.004308365026037072 0.211292\n",
      "MONDO:0859337 combined oxidative phosphorylation deficiency 57 0.004308365026037072 0.211292\n",
      "MONDO:0012301 mitochondrial DNA depletion syndrome, myopathic form 0.004308365026037072 0.211292\n",
      "MONDO:0009712 congenital multicore myopathy with external ophthalmoplegia 0.004308365026037072 0.211292\n",
      "MONDO:0800103 COACH syndrome 1 0.004308365026037072 0.211292\n",
      "MONDO:0013905 autosomal recessive spinocerebellar ataxia 13 0.004308365026037072 0.211292\n",
      "MONDO:0026724 Paganini-Miozzo syndrome 0.004308365026037072 0.211292\n",
      "MONDO:0010495 trichothiodystrophy 5, nonphotosensitive 0.004308365026037072 0.211292\n",
      "MONDO:0014908 microcephaly 17, primary, autosomal recessive 0.004308365026037072 0.211292\n",
      "MONDO:0859274 neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomalies 0.004308365026037072 0.211292\n",
      "MONDO:0859212 neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus 0.004308365026037072 0.211292\n",
      "MONDO:0054748 Fanconi anemia, complementation group S 0.004308365026037072 0.211292\n",
      "MONDO:0100348 neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities 0.004308365026037072 0.211292\n",
      "MONDO:0032878 neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia 0.004308365026037072 0.211292\n",
      "MONDO:0010543 Barth syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0018820 recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0011327 neuronal intranuclear inclusion disease 0.0045232953584311885 0.209536\n",
      "MONDO:0100478 brain malformations with or without urinary tract defects 0.0045232953584311885 0.209536\n",
      "MONDO:0008822 arthrogryposis, renal dysfunction, and cholestasis 1 0.0045232953584311885 0.209536\n",
      "MONDO:0008723 very long chain acyl-CoA dehydrogenase deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0014144 autosomal recessive limb-girdle muscular dystrophy type R18 0.0045232953584311885 0.209536\n",
      "MONDO:0054636 Skraban-Deardorff syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0014946 Sifrim-Hitz-Weiss syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0011281 congenital myasthenic syndrome 5 0.0045232953584311885 0.209536\n",
      "MONDO:0011629 MOGS-congenital disorder of glycosylation 0.0045232953584311885 0.209536\n",
      "MONDO:0859304 neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction 0.0045232953584311885 0.209536\n",
      "MONDO:0013048 hereditary spastic paraplegia 50 0.0045232953584311885 0.209536\n",
      "MONDO:0013801 developmental and epileptic encephalopathy, 13 0.0045232953584311885 0.209536\n",
      "MONDO:0013754 cutis laxa, autosomal recessive, type 1B 0.0045232953584311885 0.209536\n",
      "MONDO:0013937 peroxisome biogenesis disorder 6B 0.0045232953584311885 0.209536\n",
      "MONDO:0014016 hereditary spastic paraplegia 49 0.0045232953584311885 0.209536\n",
      "MONDO:0012611 polyhydramnios, megalencephaly, and symptomatic epilepsy 0.0045232953584311885 0.209536\n",
      "MONDO:0030423 congenital disorder of glycosylation, type 2v 0.0045232953584311885 0.209536\n",
      "MONDO:0011038 cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0009706 hereditary myopathy with lactic acidosis due to ISCU deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0014567 glutamate pyruvate transaminase 2 deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0013053 microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type 0.0045232953584311885 0.209536\n",
      "MONDO:0012157 congenital myasthenic syndrome 4C 0.0045232953584311885 0.209536\n",
      "MONDO:0009590 metachromatic leukodystrophy due to saposin B deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0024554 D-2-hydroxyglutaric aciduria 1 0.0045232953584311885 0.209536\n",
      "MONDO:0010027 free sialic acid storage disease, infantile form 0.0045232953584311885 0.209536\n",
      "MONDO:0010268 X-linked lissencephaly with abnormal genitalia 0.0045232953584311885 0.209536\n",
      "MONDO:0013731 MEGF10-related myopathy 0.0045232953584311885 0.209536\n",
      "MONDO:0009394 juvenile Paget disease 0.0045232953584311885 0.209536\n",
      "MONDO:0014725 spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0014320 Bosch-Boonstra-Schaaf optic atrophy syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0014035 severe intellectual disability-progressive spastic diplegia syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0859327 developmental and epileptic encephalopathy 110 0.0045232953584311885 0.209536\n",
      "MONDO:0032611 mitochondrial complex 1 deficiency, nuclear type 6 0.0045232953584311885 0.209536\n",
      "MONDO:0013987 combined oxidative phosphorylation defect type 15 0.0045232953584311885 0.209536\n",
      "MONDO:0014811 cerebellar atrophy, visual impairment, and psychomotor retardation; 0.0045232953584311885 0.209536\n",
      "MONDO:0010516 midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis 0.0045232953584311885 0.209536\n",
      "MONDO:0030057 neurodevelopmental, jaw, eye, and digital syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0012516 mandibulofacial dysostosis-microcephaly syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0957397 intellectual developmental disorder, autosomal dominant 72 0.0045232953584311885 0.209536\n",
      "MONDO:0957229 hatipoglu immunodeficiency syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0013481 chromosome 13q14 deletion syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0032876 neurodevelopmental disorder with absent language and variable seizures 0.0045232953584311885 0.209536\n",
      "MONDO:0012444 neurodegeneration with brain iron accumulation 2B 0.0045232953584311885 0.209536\n",
      "MONDO:0011125 trichothiodystrophy 1, photosensitive 0.0045232953584311885 0.209536\n",
      "MONDO:0859218 developmental delay with variable neurologic and brain abnormalities 0.0045232953584311885 0.209536\n",
      "MONDO:0009262 GM1 gangliosidosis type 3 0.0045232953584311885 0.209536\n",
      "MONDO:0009111 dihydropyrimidinuria 0.0045232953584311885 0.209536\n",
      "MONDO:0010509 intellectual disability, X-linked 104 0.0045232953584311885 0.209536\n",
      "MONDO:0013737 hereditary spastic paraplegia 46 0.0045232953584311885 0.209536\n",
      "MONDO:0011894 Charcot-Marie-Tooth disease type 2E 0.004738179295891211 0.207871\n",
      "MONDO:0008858 Behr syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0010829 CARASIL syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0032821 myopathy, congenital, progressive, with scoliosis 0.004738179295891211 0.207871\n",
      "MONDO:0012519 Rubinstein-Taybi syndrome due to 16p13.3 microdeletion 0.004738179295891211 0.207871\n",
      "MONDO:0013986 combined oxidative phosphorylation defect type 14 0.004738179295891211 0.207871\n",
      "MONDO:0859520 Mitochondrial complex IV deficiency, nuclear type 23 0.004738179295891211 0.207871\n",
      "MONDO:0014573 Cole-Carpenter syndrome 2 0.004738179295891211 0.207871\n",
      "MONDO:0009470 Baraitser-Winter syndrome 1 0.004738179295891211 0.207871\n",
      "MONDO:0009070 D-glyceric aciduria 0.004738179295891211 0.207871\n",
      "MONDO:0010499 Ritscher-Schinzel syndrome 2 0.004738179295891211 0.207871\n",
      "MONDO:0859171 Luo-Schoch-Yamamoto syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0010537 Borjeson-Forssman-Lehmann syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0012718 hypotonia with lactic acidemia and hyperammonemia 0.004738179295891211 0.207871\n",
      "MONDO:0009033 temtamy syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0859350 neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies 0.004738179295891211 0.207871\n",
      "MONDO:0859252 neurodevelopmental disorder with poor growth and skeletal anomalies 0.004738179295891211 0.207871\n",
      "MONDO:0013655 intellectual disability, autosomal dominant 8 0.004738179295891211 0.207871\n",
      "MONDO:0859332 cortical dysplasia, complex, with other brain malformations 11 0.004738179295891211 0.207871\n",
      "MONDO:0012156 myasthenic syndrome, congenital, 1B, fast-channel 0.004738179295891211 0.207871\n",
      "MONDO:0030035 leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0012078 Joubert syndrome 3 0.004738179295891211 0.207871\n",
      "MONDO:0014318 hyperphosphatasia with intellectual disability syndrome 4 0.004738179295891211 0.207871\n",
      "MONDO:0013546 mitochondrial complex V (ATP synthase) deficiency nuclear type 2 0.004738179295891211 0.207871\n",
      "MONDO:0013881 pidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0030969 intellectual developmental disorder, autosomal dominant 68 0.004738179295891211 0.207871\n",
      "MONDO:0010183 methylmalonic aciduria and homocystinuria type cblF 0.004738179295891211 0.207871\n",
      "MONDO:0013552 hereditary spastic paraplegia 52 0.004738179295891211 0.207871\n",
      "MONDO:0009820 osteoporosis-pseudoglioma syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0012055 Larsen-like osseous dysplasia-short stature syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0009744 neuronal ceroid lipofuscinosis 1 0.004738179295891211 0.207871\n",
      "MONDO:0011242 Bartter disease type 4A 0.004738179295891211 0.207871\n",
      "MONDO:0007525 Ehlers-Danlos syndrome, arthrochalasis type 0.004738179295891211 0.207871\n",
      "MONDO:0009131 Riley-Day syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0859293 neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment 0.004738179295891211 0.207871\n",
      "MONDO:0032793 O'Donnell-Luria-Rodan syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0009623 Nijmegen breakage syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0013755 PYCR1-related de Barsy syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0010258 MEHMO syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0060758 spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits 0.004738179295891211 0.207871\n",
      "MONDO:0032779 neurodevelopmental disorder with microcephaly and structural brain anomalies 0.004738179295891211 0.207871\n",
      "MONDO:0054669 pontocerebellar hypoplasia, type 11 0.004738179295891211 0.207871\n",
      "MONDO:0013880 facial paresis, hereditary congenital, 3 0.004738179295891211 0.207871\n",
      "MONDO:0032795 intellectual developmental disorder 59 0.004738179295891211 0.207871\n",
      "MONDO:0044303 congenital heart defects and ectodermal dysplasia 0.004738179295891211 0.207871\n",
      "MONDO:0020769 Menke-Hennekam syndrome 2 0.004738179295891211 0.207871\n",
      "MONDO:0008178 inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 0.00495301684843197 0.20629\n",
      "MONDO:0859529 amyotrophic lateral sclerosis 27, juvenile 0.00495301684843197 0.20629\n",
      "MONDO:0014132 multiple mitochondrial dysfunctions syndrome 3 0.00495301684843197 0.20629\n",
      "MONDO:0010060 mitochondrial DNA depletion syndrome 7 (hepatocerebral type) 0.00495301684843197 0.20629\n",
      "MONDO:0030957 developmental and epileptic encephalopathy 103 0.00495301684843197 0.20629\n",
      "MONDO:0011049 Fine-Lubinsky syndrome 0.00495301684843197 0.20629\n",
      "MONDO:0013925 methylmalonic acidemia with homocystinuria, type cblJ 0.00495301684843197 0.20629\n",
      "MONDO:0032606 mitochondrial complex 1 deficiency, nuclear type 2 0.00495301684843197 0.20629\n",
      "MONDO:0033372 developmental and epileptic encephalopathy, 63 0.00495301684843197 0.20629\n",
      "MONDO:0014114 cardiofaciocutaneous syndrome 4 0.00495301684843197 0.20629\n",
      "MONDO:0032742 encephalopathy, acute, infection-induced, susceptibility to, 9 0.00495301684843197 0.20629\n",
      "MONDO:0032650 neurodegeneration, childhood-onset, with cerebellar atrophy 0.00495301684843197 0.20629\n",
      "MONDO:0014269 combined oxidative phosphorylation deficiency 19 0.00495301684843197 0.20629\n",
      "MONDO:0014745 congenital myasthenic syndrome 19 0.00495301684843197 0.20629\n",
      "MONDO:0009583 blepharophimosis - intellectual disability syndrome, Ohdo type 0.00495301684843197 0.20629\n",
      "MONDO:0060664 neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities 0.00495301684843197 0.20629\n",
      "MONDO:0032578 cortical dysplasia, complex, with other brain malformations 9 0.00495301684843197 0.20629\n",
      "MONDO:0012735 Temple-Baraitser syndrome 0.00495301684843197 0.20629\n",
      "MONDO:0012184 Pierson syndrome 0.00495301684843197 0.20629\n",
      "MONDO:0012890 pontocerebellar hypoplasia type 2B 0.00495301684843197 0.20629\n",
      "MONDO:0030669 gastrointestinal defects and immunodeficiency syndrome 2 0.00495301684843197 0.20629\n",
      "MONDO:0009598 metaphyseal chondrodysplasia-retinitis pigmentosa syndrome 0.00495301684843197 0.20629\n",
      "MONDO:0012999 guanidinoacetate methyltransferase deficiency 0.00495301684843197 0.20629\n",
      "MONDO:0859214 Marbach-Schaaf neurodevelopmental syndrome 0.00495301684843197 0.20629\n",
      "MONDO:0029143 intellectual developmental disorder with hypertelorism and distinctive facies 0.00495301684843197 0.20629\n",
      "MONDO:0032571 spondyloepimetaphyseal dysplasia, Krakow type 0.00495301684843197 0.20629\n",
      "MONDO:0015007 spastic paraplegia, intellectual disability, nystagmus, and obesity 0.00495301684843197 0.20629\n",
      "MONDO:0014791 Luscan-Lumish syndrome 0.00495301684843197 0.20629\n",
      "MONDO:0030061 periventricular nodular heterotopia 9 0.00495301684843197 0.20629\n",
      "MONDO:0800027 leukoencephalopathy, diffuse hereditary, with spheroids 1 0.005167808026066122 0.204785\n",
      "MONDO:0009261 GM1 gangliosidosis type 2 0.005167808026066122 0.204785\n",
      "MONDO:0011006 hereditary spastic paraplegia 9A 0.005167808026066122 0.204785\n",
      "MONDO:0030458 Charcot-Marie-Tooth disease, axonal, Type 2HH 0.005167808026066122 0.204785\n",
      "MONDO:0009109 lysinuric protein intolerance 0.005167808026066122 0.204785\n",
      "MONDO:0009974 familial hemophagocytic lymphohistiocytosis type 1 0.005167808026066122 0.204785\n",
      "MONDO:0013889 short stature-optic atrophy-Pelger-HuC+t anomaly syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0020495 PEHO-like syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0031481 microcephaly, epilepsy, and diabetes syndrome 1 0.005167808026066122 0.204785\n",
      "MONDO:0014353 immunodeficiency 23 0.005167808026066122 0.204785\n",
      "MONDO:0030953 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 0.005167808026066122 0.204785\n",
      "MONDO:0009613 methylmalonic aciduria, cblA type 0.005167808026066122 0.204785\n",
      "MONDO:0008644 velocardiofacial syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0009021 Toriello-Carey syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0008608 Down syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0012929 Compton-North congenital myopathy 0.005167808026066122 0.204785\n",
      "MONDO:0013845 auriculocondylar syndrome 2 0.005167808026066122 0.204785\n",
      "MONDO:0010396 developmental and epileptic encephalopathy, 2 0.005167808026066122 0.204785\n",
      "MONDO:0013952 peroxisome biogenesis disorder 13A (Zellweger) 0.005167808026066122 0.204785\n",
      "MONDO:0010822 Warburg micro syndrome 1 0.005167808026066122 0.204785\n",
      "MONDO:0014706 cutis laxa, autosomal dominant 3 0.005167808026066122 0.204785\n",
      "MONDO:0008471 spondyloepiphyseal dysplasia congenita 0.005167808026066122 0.204785\n",
      "MONDO:0044723 3-methylglutaconic aciduria type 8 0.005167808026066122 0.204785\n",
      "MONDO:0009636 mitochondrial DNA depletion syndrome 3 (hepatocerebral type) 0.005167808026066122 0.204785\n",
      "MONDO:0024464 pituitary hormone deficiency, combined, 1 0.005167808026066122 0.204785\n",
      "MONDO:0032921 neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation 0.005167808026066122 0.204785\n",
      "MONDO:0013171 purine nucleoside phosphorylase deficiency 0.005167808026066122 0.204785\n",
      "MONDO:0859224 intellectual disability and myopathy syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0014911 growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy 0.005167808026066122 0.204785\n",
      "MONDO:0011010 Matthew-Wood syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0020850 intellectual disability, autosomal recessive 65 0.005167808026066122 0.204785\n",
      "MONDO:0014741 DeSanto-Shinawi syndrome due to WAC point mutation 0.005167808026066122 0.204785\n",
      "MONDO:0032908 CEBALID syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0009271 geroderma osteodysplastica 0.005167808026066122 0.204785\n",
      "MONDO:0008693 ablepharon macrostomia syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0032816 neurodevelopmental disorder with ataxia, hypotonia, and microcephaly 0.005167808026066122 0.204785\n",
      "MONDO:0032939 intellectual developmental disorder, autosomal dominant 63, with macrocephaly 0.005167808026066122 0.204785\n",
      "MONDO:0013551 hereditary spastic paraplegia 47 0.005167808026066122 0.204785\n",
      "MONDO:0060549 congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay 0.005167808026066122 0.204785\n",
      "MONDO:0014006 Schuurs-Hoeijmakers syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0032922 Beck-Fahrner syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0033630 neurodevelopmental disorder with speech impairment and dysmorphic facies 0.005167808026066122 0.204785\n",
      "MONDO:0033642 neurodevelopmental disorder with alopecia and brain abnormalities 0.005167808026066122 0.204785\n",
      "MONDO:0013352 intellectual disability-severe speech delay-mild dysmorphism syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0011085 Charcot-Marie-Tooth disease type 4D 0.005382552838804166 0.203349\n",
      "MONDO:0030893 leukoencephalopathy, progressive, infantile-onset, with or without deafness 0.005382552838804166 0.203349\n",
      "MONDO:0030717 immunodeficiency 97 with autoinflammation 0.005382552838804166 0.203349\n",
      "MONDO:0030729 Tessadori-van Haaften neurodevelopmental syndrome 1 0.005382552838804166 0.203349\n",
      "MONDO:0015025 developmental and epileptic encephalopathy, 51 0.005382552838804166 0.203349\n",
      "MONDO:0009919 peroxisomal acyl-CoA oxidase deficiency 0.005382552838804166 0.203349\n",
      "MONDO:0014382 Tatton-Brown-Rahman overgrowth syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0030268 developmental and epileptic encephalopathy 6B 0.005382552838804166 0.203349\n",
      "MONDO:0034109 congenital myopathy with reduced type 2 muscle fibers 0.005382552838804166 0.203349\n",
      "MONDO:0032679 combined oxidative phosphorylation deficiency 37 0.005382552838804166 0.203349\n",
      "MONDO:0010006 Sandhoff disease 0.005382552838804166 0.203349\n",
      "MONDO:0859331 Rabin-Pappas syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0013745 Joubert syndrome 14 0.005382552838804166 0.203349\n",
      "MONDO:0012593 brain-lung-thyroid syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0011669 hypotonia-cystinuria syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0020789 pseudo-TORCH syndrome 1 0.005382552838804166 0.203349\n",
      "MONDO:0032698 neurodevelopmental disorder with central and peripheral motor dysfunction 0.005382552838804166 0.203349\n",
      "MONDO:0009738 sialidosis type 2 0.005382552838804166 0.203349\n",
      "MONDO:0011035 neurofibromatosis-Noonan syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0044726 psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0014529 cerebellar-facial-dental syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0060596 neurodevelopmental disorder with dysmorphic facies and distal limb anomalies 0.005382552838804166 0.203349\n",
      "MONDO:0013186 Noonan syndrome 6 0.005382552838804166 0.203349\n",
      "MONDO:0030323 spinocerebellar ataxia, autosomal recessive 31 0.005382552838804166 0.203349\n",
      "MONDO:0044634 retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0859186 Chopra-Amiel-Gordon syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0010717 pyruvate dehydrogenase E1-alpha deficiency 0.005597251296654461 0.201976\n",
      "MONDO:0014736 Charcot-Marie-Tooth disease axonal type 2Z 0.005597251296654461 0.201976\n",
      "MONDO:0013646 chromosome 8q21.11 deletion syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0859163 Faundes-Banka syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0013320 chromosome 16p12.2-p11.2 deletion syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0014605 microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0011271 rigid spine muscular dystrophy 1 0.005597251296654461 0.201976\n",
      "MONDO:0013951 peroxisome biogenesis disorder 12A (Zellweger) 0.005597251296654461 0.201976\n",
      "MONDO:0013641 Warburg micro syndrome 2 0.005597251296654461 0.201976\n",
      "MONDO:0009282 multiple acyl-CoA dehydrogenase deficiency 0.005597251296654461 0.201976\n",
      "MONDO:0009480 Joubert syndrome with oculorenal defect 0.005597251296654461 0.201976\n",
      "MONDO:0009068 cytochrome-c oxidase deficiency disease 0.005597251296654461 0.201976\n",
      "MONDO:0035133 PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0009564 Marden-Walker syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0013726 encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 0.005597251296654461 0.201976\n",
      "MONDO:0031071 Diamond-Blackfan anemia 21 0.005597251296654461 0.201976\n",
      "MONDO:0032610 mitochondrial complex 1 deficiency, nuclear type 5 0.005597251296654461 0.201976\n",
      "MONDO:0014995 neurodevelopmental disorder with hypotonia, seizures, and absent language 0.005597251296654461 0.201976\n",
      "MONDO:0013971 leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0008919 systemic primary carnitine deficiency disease 0.005597251296654461 0.201976\n",
      "MONDO:0010504 immunodeficiency 47 0.005597251296654461 0.201976\n",
      "MONDO:0013319 chromosome 4Q32.1-q32.2 triplication syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0014336 intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency 0.005597251296654461 0.201976\n",
      "MONDO:0020841 neurodevelopmental disorder with cerebellar atrophy and with or without seizures 0.005597251296654461 0.201976\n",
      "MONDO:0032836 weiss-kruszka syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0032726 combined oxidative phosphorylation deficiency 39 0.005597251296654461 0.201976\n",
      "MONDO:0010441 CK syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0032943 neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies 0.005597251296654461 0.201976\n",
      "MONDO:0032846 osteogenesis imperfecta, type 20 0.005597251296654461 0.201976\n",
      "MONDO:0014686 short stature, microcephaly, and endocrine dysfunction 0.005597251296654461 0.201976\n",
      "MONDO:0008963 Chediak-Higashi syndrome 0.005811903409623178 0.200662\n",
      "MONDO:0010478 SLC35A2-congenital disorder of glycosylation 0.005811903409623178 0.200662\n",
      "MONDO:0020630 epileptic encephalopathy, infantile or early childhood, 1 0.005811903409623178 0.200662\n",
      "MONDO:0011157 Gomez-Lopez-Hernandez syndrome 0.005811903409623178 0.200662\n",
      "MONDO:0030913 intellectual disability, autosomal dominant 48 0.005811903409623178 0.200662\n",
      "MONDO:0020781 encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 0.005811903409623178 0.200662\n",
      "MONDO:0054560 anauxetic dysplasia 1 0.005811903409623178 0.200662\n",
      "MONDO:0014371 developmental and epileptic encephalopathy, 23 0.005811903409623178 0.200662\n",
      "MONDO:0030992 short stature, oligodontia, dysmorphic facies, and motor delay 0.005811903409623178 0.200662\n",
      "MONDO:0013821 intellectual disability, autosomal dominant 16 0.005811903409623178 0.200662\n",
      "MONDO:0010711 TARP syndrome 0.005811903409623178 0.200662\n",
      "MONDO:0011730 fumaric aciduria 0.005811903409623178 0.200662\n",
      "MONDO:0014643 congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome 0.005811903409623178 0.200662\n",
      "MONDO:0012512 fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 0.005811903409623178 0.200662\n",
      "MONDO:0024553 myopathy, lactic acidosis, and sideroblastic anemia 1 0.005811903409623178 0.200662\n",
      "MONDO:0100297 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 0.005811903409623178 0.200662\n",
      "MONDO:0007113 Angelman syndrome 0.005811903409623178 0.200662\n",
      "MONDO:0015601 X-linked intellectual disability, van Esch type 0.005811903409623178 0.200662\n",
      "MONDO:0014547 combined oxidative phosphorylation defect type 24 0.005811903409623178 0.200662\n",
      "MONDO:0010865 pseudoaminopterin syndrome 0.005811903409623178 0.200662\n",
      "MONDO:0014464 progressive encephalopathy with leukodystrophy due to DECR deficiency 0.005811903409623178 0.200662\n",
      "MONDO:0013968 PGM1-congenital disorder of glycosylation 0.005811903409623178 0.200662\n",
      "MONDO:0009664 mulibrey nanism 0.005811903409623178 0.200662\n",
      "MONDO:0014728 combined oxidative phosphorylation defect type 27 0.005811903409623178 0.200662\n",
      "MONDO:0009722 Bailey-Bloch congenital myopathy 0.005811903409623178 0.200662\n",
      "MONDO:0032942 neurodevelopmental disorder with microcephaly and dysmorphic facies 0.005811903409623178 0.200662\n",
      "MONDO:0032800 robinow syndrome, autosomal recessive 2 0.005811903409623178 0.200662\n",
      "MONDO:0030917 intellectual disability, autosomal dominant 51 0.005811903409623178 0.200662\n",
      "MONDO:0012430 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 0.005811903409623178 0.200662\n",
      "MONDO:0027451 autosomal recessive cutis laxa type 2D 0.005811903409623178 0.200662\n",
      "MONDO:0008854 Bardet-Biedl syndrome 1 0.005811903409623178 0.200662\n",
      "MONDO:0032705 neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination 0.005811903409623178 0.200662\n",
      "MONDO:0013722 hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism 0.005811903409623178 0.200662\n",
      "MONDO:0013228 spondylo-megaepiphyseal-metaphyseal dysplasia 0.006026509187714335 0.199403\n",
      "MONDO:0020749 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 0.006026509187714335 0.199403\n",
      "MONDO:0013735 microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0859370 respiratory infections, recurrent, and failure to thrive with or without diarrhea 0.006026509187714335 0.199403\n",
      "MONDO:0018163 autosomal recessive cutis laxa type 2A 0.006026509187714335 0.199403\n",
      "MONDO:0009756 Niemann-Pick disease type A 0.006026509187714335 0.199403\n",
      "MONDO:0013266 intellectual disability, autosomal dominant 20 0.006026509187714335 0.199403\n",
      "MONDO:0013659 microcephaly-capillary malformation syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0012280 Goldberg-Shprintzen megacolon syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0010879 CODAS syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0030533 intellectual developmental disorder, autosomal recessive 73 0.006026509187714335 0.199403\n",
      "MONDO:0014139 Ehlers-Danlos syndrome, spondylodysplastic type, 2 0.006026509187714335 0.199403\n",
      "MONDO:0011337 familial hemophagocytic lymphohistiocytosis 2 0.006026509187714335 0.199403\n",
      "MONDO:0014198 mitochondrial DNA depletion syndrome 13 0.006026509187714335 0.199403\n",
      "MONDO:0031000 Tessadori-Van Haaften neurodevelopmental syndrome 4 0.006026509187714335 0.199403\n",
      "MONDO:0032677 lissencephaly 9 with complex brainstem malformation 0.006026509187714335 0.199403\n",
      "MONDO:0013169 chromosome 5p13 duplication syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0859336 muscular dystrophy, congenital, with or without seizures 0.006026509187714335 0.199403\n",
      "MONDO:0013299 chromosome 6q11-q14 deletion syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0010568 Aicardi syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0013820 intellectual disability, autosomal dominant 15 0.006026509187714335 0.199403\n",
      "MONDO:0859523 congenital myopathy 2c, severe infantile, autosomal dominant 0.006026509187714335 0.199403\n",
      "MONDO:0859241 neurodegeneration, childhood-onset, with progressive microcephaly 0.006026509187714335 0.199403\n",
      "MONDO:0859515 congenital myopathy 10b, mild variant 0.006026509187714335 0.199403\n",
      "MONDO:0013115 RIN2 syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0032864 intellectual developmental disorder with speech delay, autism, and dysmorphic facies 0.006026509187714335 0.199403\n",
      "MONDO:0009112 rhizomelic chondrodysplasia punctata type 2 0.006026509187714335 0.199403\n",
      "MONDO:0033492 Coffin-Siris syndrome 6 0.006026509187714335 0.199403\n",
      "MONDO:0019407 microcephalic osteodysplastic dysplasia, Saul-Wilson type 0.006026509187714335 0.199403\n",
      "MONDO:0859179 neurodevelopmental disorder with dysmorphic facies and thin corpus callosum 0.006026509187714335 0.199403\n",
      "MONDO:0030030 Nizon-Isidor syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0034121 NAD(P)HX dehydratase deficiency 0.006026509187714335 0.199403\n",
      "MONDO:0008853 Barber-Say syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0014748 progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0008840 ataxia telangiectasia 0.006026509187714335 0.199403\n",
      "MONDO:0014364 mitochondrial complex III deficiency nuclear type 8 0.006241068640929798 0.198193\n",
      "MONDO:0007987 Kniest dysplasia 0.006241068640929798 0.198193\n",
      "MONDO:0010278 Christianson syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0024537 Brown-Vialetto-van Laere syndrome 1 0.006241068640929798 0.198193\n",
      "MONDO:0009333 mullerian derivatives-lymphangiectasia-polydactyly syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0010176 orofaciodigital syndrome type 6 0.006241068640929798 0.198193\n",
      "MONDO:0009577 megalocornea-intellectual disability syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0013579 methylmalonate semialdehyde dehydrogenase deficiency 0.006241068640929798 0.198193\n",
      "MONDO:0013798 chromosome 16q22 deletion syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0009364 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 0.006241068640929798 0.198193\n",
      "MONDO:0011688 muscular dystrophy-dystroglycanopathy type B5 0.006241068640929798 0.198193\n",
      "MONDO:0859208 Hengel-Maroofian-Schols syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0859283 neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 0.006241068640929798 0.198193\n",
      "MONDO:0032764 Khan-Khan-Katsanis syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0012791 mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria 0.006241068640929798 0.198193\n",
      "MONDO:0010810 vitamin D hydroxylation-deficient rickets, type 1B 0.006241068640929798 0.198193\n",
      "MONDO:0008365 recombinant 8 syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0007790 Charcot-Marie-Tooth disease type 3 0.006241068640929798 0.198193\n",
      "MONDO:0011963 Joubert syndrome 2 0.006241068640929798 0.198193\n",
      "MONDO:0026730 Basilicata-Akhtar syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0014723 PMP22-RAI1 contiguous gene duplication syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0011652 Phelan-McDermid syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0044714 mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0014751 palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome 0.006241068640929798 0.198193\n",
      "MONDO:0011933 ALG2-congenital disorder of glycosylation 0.006241068640929798 0.198193\n",
      "MONDO:0014794 Meier-Gorlin syndrome 6 0.006241068640929798 0.198193\n",
      "MONDO:0014296 Warburg micro syndrome 4 0.006241068640929798 0.198193\n",
      "MONDO:0013060 autosomal recessive Parkinson disease 14 0.006241068640929798 0.198193\n",
      "MONDO:0011706 Kufor-Rakeb syndrome 0.006455581779269274 0.197029\n",
      "MONDO:0013582 mosaic variegated aneuploidy syndrome 2 0.006455581779269274 0.197029\n",
      "MONDO:0011451 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 0.006455581779269274 0.197029\n",
      "MONDO:0010671 microphthalmia, syndromic 1 0.006455581779269274 0.197029\n",
      "MONDO:0012123 congenital disorder of glycosylation type 1E 0.006455581779269274 0.197029\n",
      "MONDO:0014863 macrocephaly, dysmorphic facies, and psychomotor retardation 0.006455581779269274 0.197029\n",
      "MONDO:0008458 spinocerebellar ataxia type 2 0.006455581779269274 0.197029\n",
      "MONDO:0009290 glycogen storage disease II 0.006455581779269274 0.197029\n",
      "MONDO:0010184 methylmalonic aciduria and homocystinuria type cblC 0.006455581779269274 0.197029\n",
      "MONDO:0010465 Kabuki syndrome 2 0.006455581779269274 0.197029\n",
      "MONDO:0030837 neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities 0.006455581779269274 0.197029\n",
      "MONDO:0957215 congenital myopathy 20 0.006455581779269274 0.197029\n",
      "MONDO:0032591 hyperparathyroidism, transient neonatal 0.006455581779269274 0.197029\n",
      "MONDO:0010886 2q37 microdeletion syndrome 0.006455581779269274 0.197029\n",
      "MONDO:0013364 Rubinstein-Taybi syndrome due to EP300 haploinsufficiency 0.006455581779269274 0.197029\n",
      "MONDO:0009520 3-hydroxy-3-methylglutaric aciduria 0.006670048612730302 0.195909\n",
      "MONDO:0020485 King-Denborough syndrome 0.006670048612730302 0.195909\n",
      "MONDO:0859200 cerebellar ataxia, brain abnormalities, and cardiac conduction defects 0.006670048612730302 0.195909\n",
      "MONDO:0014722 Roifman syndrome 0.006670048612730302 0.195909\n",
      "MONDO:0100111 focal segmental glomerulosclerosis and neurodevelopmental syndrome 0.006670048612730302 0.195909\n",
      "MONDO:0010472 developmental and epileptic encephalopathy, 36 0.006670048612730302 0.195909\n",
      "MONDO:0060621 neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy 0.006670048612730302 0.195909\n",
      "MONDO:0033373 developmental and epileptic encephalopathy, 64 0.006670048612730302 0.195909\n",
      "MONDO:0013839 hereditary sensory and autonomic neuropathy type 6 0.006670048612730302 0.195909\n",
      "MONDO:0013894 short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome 0.006670048612730302 0.195909\n",
      "MONDO:0009079 DOORS syndrome 0.006670048612730302 0.195909\n",
      "MONDO:0859169 White-Kernohan syndrome 0.006670048612730302 0.195909\n",
      "MONDO:0030928 microcephaly 26, primary, autosomal dominant 0.006670048612730302 0.195909\n",
      "MONDO:0014243 Schaaf-Yang syndrome 0.006670048612730302 0.195909\n",
      "MONDO:0010461 syndromic X-linked intellectual disability Nascimento type 0.006670048612730302 0.195909\n",
      "MONDO:0054837 intellectual disability, autosomal dominant 57 0.006670048612730302 0.195909\n",
      "MONDO:0060760 intellectual developmental disorder with dysmorphic facies and behavioral abnormalities 0.006670048612730302 0.195909\n",
      "MONDO:0024528 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1 0.006670048612730302 0.195909\n",
      "MONDO:0010650 Melnick-Needles syndrome 0.006884469151308279 0.194829\n",
      "MONDO:0009319 pantothenate kinase-associated neurodegeneration 0.006884469151308279 0.194829\n",
      "MONDO:0014684 combined oxidative phosphorylation defect type 26 0.006884469151308279 0.194829\n",
      "MONDO:0014561 3-methylglutaconic aciduria, type VIIB 0.006884469151308279 0.194829\n",
      "MONDO:0957284 nemaline myopathy 5C, autosomal dominant 0.006884469151308279 0.194829\n",
      "MONDO:0009934 alveolar capillary dysplasia with misalignment of pulmonary veins 0.006884469151308279 0.194829\n",
      "MONDO:0008758 mitochondrial DNA depletion syndrome 4a 0.006884469151308279 0.194829\n",
      "MONDO:0011783 ALG12-congenital disorder of glycosylation 0.006884469151308279 0.194829\n",
      "MONDO:0014367 Aicardi-Goutieres syndrome 7 0.006884469151308279 0.194829\n",
      "MONDO:0015011 optic atrophy 11 0.006884469151308279 0.194829\n",
      "MONDO:0032838 neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies 0.006884469151308279 0.194829\n",
      "MONDO:0009393 ornithine translocase deficiency 0.006884469151308279 0.194829\n",
      "MONDO:0030922 intellectual disability, autosomal dominant 56 0.006884469151308279 0.194829\n",
      "MONDO:0008954 peroxisome biogenesis disorder 2A (Zellweger) 0.006884469151308279 0.194829\n",
      "MONDO:0957248 developmental and epileptic encephalopathy 31B 0.006884469151308279 0.194829\n",
      "MONDO:0008873 microcephalic osteodysplastic primordial dwarfism, type 3 0.006884469151308279 0.194829\n",
      "MONDO:0060624 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter 0.006884469151308279 0.194829\n",
      "MONDO:0008893 C syndrome 0.006884469151308279 0.194829\n",
      "MONDO:0031007 spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosis 0.006884469151308279 0.194829\n",
      "MONDO:0011435 microcephaly 2, primary, autosomal recessive, with or without cortical malformations 0.006884469151308279 0.194829\n",
      "MONDO:0010026 SHORT syndrome 0.006884469151308279 0.194829\n",
      "MONDO:0013624 Rafiq syndrome 0.00709884340499642 0.193786\n",
      "MONDO:0013245 syndromic multisystem autoimmune disease due to ITCH deficiency 0.00709884340499642 0.193786\n",
      "MONDO:0009431 hereditary hypophosphatemic rickets with hypercalciuria 0.00709884340499642 0.193786\n",
      "MONDO:0013990 pontocerebellar hypoplasia type 8 0.00709884340499642 0.193786\n",
      "MONDO:0008005 cardiospondylocarpofacial syndrome 0.00709884340499642 0.193786\n",
      "MONDO:0007415 mitochondrial complex III deficiency nuclear type 1 0.00709884340499642 0.193786\n",
      "MONDO:0009593 spondylometaphyseal dysplasia, Sedaghatian type 0.00709884340499642 0.193786\n",
      "MONDO:0024535 Singleton-Merten syndrome 1 0.00709884340499642 0.193786\n",
      "MONDO:0012683 pontocerebellar hypoplasia type 6 0.00709884340499642 0.193786\n",
      "MONDO:0011335 spondyloepimetaphyseal dysplasia with multiple dislocations 0.00709884340499642 0.193786\n",
      "MONDO:0013170 cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies 0.00709884340499642 0.193786\n",
      "MONDO:0007537 lateral meningocele syndrome 0.00709884340499642 0.193786\n",
      "MONDO:0859219 Rauch-Steindl syndrome 0.00709884340499642 0.193786\n",
      "MONDO:0011432 blepharophimosis - intellectual disability syndrome, Verloes type 0.00709884340499642 0.193786\n",
      "MONDO:0014165 multiple congenital anomalies-hypotonia-seizures syndrome 3 0.00709884340499642 0.193786\n",
      "MONDO:0010498 MEND syndrome 0.00709884340499642 0.193786\n",
      "MONDO:0009644 sulfite oxidase deficiency due to molybdenum cofactor deficiency type B 0.00709884340499642 0.193786\n",
      "MONDO:0859310 orofaciodigital syndrome 19 0.00709884340499642 0.193786\n",
      "MONDO:0010502 intellectual disability, X-linked 99, syndromic, female-restricted 0.00709884340499642 0.193786\n",
      "MONDO:0026722 Mullegama-Klein-Martinez syndrome 0.00709884340499642 0.193786\n",
      "MONDO:0010235 X-linked intellectual disability-psychosis-macroorchidism syndrome 0.00709884340499642 0.193786\n",
      "MONDO:0009998 Richieri Costa-Pereira syndrome 0.00709884340499642 0.193786\n",
      "MONDO:0016002 Ehlers-Danlos syndrome, kyphoscoliotic type 1 0.007313171383785802 0.192779\n",
      "MONDO:0859516 neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum 0.007313171383785802 0.192779\n",
      "MONDO:0011640 genitopatellar syndrome 0.007313171383785802 0.192779\n",
      "MONDO:0030331 Ritscher-Schinzel syndrome 4 0.007313171383785802 0.192779\n",
      "MONDO:0012481 mevalonic aciduria 0.007313171383785802 0.192779\n",
      "MONDO:0013563 multiple congenital anomalies-hypotonia-seizures syndrome 1 0.007313171383785802 0.192779\n",
      "MONDO:0012198 PCWH syndrome 0.007313171383785802 0.192779\n",
      "MONDO:0032824 glycosylphosphatidylinositol biosynthesis defect 21 0.007313171383785802 0.192779\n",
      "MONDO:0044324 Al Kaissi syndrome 0.007313171383785802 0.192779\n",
      "MONDO:0033562 neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia 0.007313171383785802 0.192779\n",
      "MONDO:0014823 hypotonia, infantile, with psychomotor retardation and characteristic facies 3 0.007313171383785802 0.192779\n",
      "MONDO:0014361 autism spectrum disorder due to AUTS2 deficiency 0.007313171383785802 0.192779\n",
      "MONDO:0014656 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 0.007527453097665351 0.191805\n",
      "MONDO:0859295 neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties 0.007527453097665351 0.191805\n",
      "MONDO:0025351 multiple congenital anomalies-neurodevelopmental syndrome, X-linked 0.007527453097665351 0.191805\n",
      "MONDO:0014376 intellectual disability, autosomal dominant 27 0.007527453097665351 0.191805\n",
      "MONDO:0008546 thanatophoric dysplasia type 1 0.007527453097665351 0.191805\n",
      "MONDO:0013993 pontocerebellar hypoplasia type 7 0.007527453097665351 0.191805\n",
      "MONDO:0800437 Carey-Fineman-Ziter syndrome 1 0.007527453097665351 0.191805\n",
      "MONDO:0008564 DiGeorge syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0008955 cerebrooculofacioskeletal syndrome 1 0.007741688556621809 0.190862\n",
      "MONDO:0030679 Noonan syndrome 14 0.007741688556621809 0.190862\n",
      "MONDO:0030437 congenital disorder of glycosylation, type IIw 0.007741688556621809 0.190862\n",
      "MONDO:0014831 progeroid and marfanoid aspect-lipodystrophy syndrome 0.007741688556621809 0.190862\n",
      "MONDO:0030896 chromosome 13q33-q34 deletion syndrome 0.007741688556621809 0.190862\n",
      "MONDO:0013379 Noonan syndrome 7 0.007741688556621809 0.190862\n",
      "MONDO:0100215 Rajab interstitial lung disease with brain calcifications 1 0.007741688556621809 0.190862\n",
      "MONDO:0010186 vitamin D-dependent rickets, type 2A 0.007741688556621809 0.190862\n",
      "MONDO:0010570 craniofrontonasal syndrome 0.007741688556621809 0.190862\n",
      "MONDO:0024526 Zimmermann-Laband syndrome 1 0.007741688556621809 0.190862\n",
      "MONDO:0044319 intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies 0.007741688556621809 0.190862\n",
      "MONDO:0030362 Aicardi-Goutieres syndrome 9 0.007741688556621809 0.190862\n",
      "MONDO:0010506 intellectual disability, X-linked 61 0.007741688556621809 0.190862\n",
      "MONDO:0009053 ALDH18A1-related de Barsy syndrome 0.007955877770639786 0.189949\n",
      "MONDO:0012495 spondyloepimetaphyseal dysplasia, Genevieve type 0.007955877770639786 0.189949\n",
      "MONDO:0014857 neurodevelopmental disorder with or without anomalies of the brain, eye, or heart 0.007955877770639786 0.189949\n",
      "MONDO:0011070 van Maldergem syndrome 1 0.007955877770639786 0.189949\n",
      "MONDO:0030375 neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2 0.007955877770639786 0.189949\n",
      "MONDO:0060711 Jaberi-Elahi syndrome 0.007955877770639786 0.189949\n",
      "MONDO:0020682 Ehlers-Danlos syndrome, spondylodysplastic type, 1 0.008170020749701742 0.189063\n",
      "MONDO:0000902 agenesis of the corpus callosum with peripheral neuropathy 0.008170020749701742 0.189063\n",
      "MONDO:0013056 developmental and epileptic encephalopathy, 39 0.008170020749701742 0.189063\n",
      "MONDO:0013025 chromosome 6q24-q25 deletion syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0010519 alpha thalassemia-X-linked intellectual disability syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0018346 ferro-cerebro-cutaneous syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0030553 acromesomelic dysplasia 4 0.008170020749701742 0.189063\n",
      "MONDO:0020723 vitamin D-dependent rickets, type 1A 0.008170020749701742 0.189063\n",
      "MONDO:0859236 neurodevelopmental disorder with neuromuscular and skeletal abnormalities 0.008170020749701742 0.189063\n",
      "MONDO:0007943 Nager acrofacial dysostosis 0.008170020749701742 0.189063\n",
      "MONDO:0032687 intellectual developmental disorder with abnormal behavior, microcephaly, and short stature 0.008170020749701742 0.189063\n",
      "MONDO:0060592 Sweeney-Cox syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0010038 growth delay due to insulin-like growth factor I resistance 0.008170020749701742 0.189063\n",
      "MONDO:0032672 intellectual developmental disorder with cardiac defects and dysmorphic facies 0.008170020749701742 0.189063\n",
      "MONDO:0008426 Shprintzen-Goldberg syndrome 0.00838411750378796 0.188203\n",
      "MONDO:0010664 syndromic X-linked intellectual disability Snyder type 0.00838411750378796 0.188203\n",
      "MONDO:0018663 regressive spondylometaphyseal dysplasia 0.00838411750378796 0.188203\n",
      "MONDO:0011946 diaphanospondylodysostosis 0.00838411750378796 0.188203\n",
      "MONDO:0013424 3p- syndrome 0.00838411750378796 0.188203\n",
      "MONDO:0010417 syndromic X-linked intellectual disability Najm type 0.00838411750378796 0.188203\n",
      "MONDO:0007404 Cri-du-chat syndrome 0.00838411750378796 0.188203\n",
      "MONDO:0030915 intellectual disability, autosomal recessive 61 0.00838411750378796 0.188203\n",
      "MONDO:0020681 Ehlers-Danlos syndrome, musculocontractural type 1 0.00859816804287656 0.187368\n",
      "MONDO:0008119 spinocerebellar ataxia type 1 0.00859816804287656 0.187368\n",
      "MONDO:0011936 microphthalmia with brain and digit anomalies 0.00859816804287656 0.187368\n",
      "MONDO:0007892 Lenz-Majewski hyperostotic dwarfism 0.00859816804287656 0.187368\n",
      "MONDO:0007621 Floating-Harbor syndrome 0.00859816804287656 0.187368\n",
      "MONDO:0012916 chromosome 2p16.1-p15 deletion syndrome 0.008812172376943555 0.186557\n",
      "MONDO:0014262 Rienhoff syndrome 0.008812172376943555 0.186557\n",
      "MONDO:0859301 neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects 0.008812172376943555 0.186557\n",
      "MONDO:0060502 neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 0.008812172376943555 0.186557\n",
      "MONDO:0851095 KINSSHIP syndrome 0.008812172376943555 0.186557\n",
      "MONDO:0859345 branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome 0.008812172376943555 0.186557\n",
      "MONDO:0009768 oculodentodigital dysplasia, autosomal recessive 0.008812172376943555 0.186557\n",
      "MONDO:0010200 Wilson disease 0.008812172376943555 0.186557\n",
      "MONDO:0009452 Vici syndrome 0.009026130515962775 0.185767\n",
      "MONDO:0011147 chromosome 18q deletion syndrome 0.009026130515962775 0.185767\n",
      "MONDO:0009561 alpha-mannosidosis 0.009026130515962775 0.185767\n",
      "MONDO:0012118 COG7-congenital disorder of glycosylation 0.009026130515962775 0.185767\n",
      "MONDO:0009855 d-bifunctional protein deficiency 0.009026130515962775 0.185767\n",
      "MONDO:0009629 Desbuquois dysplasia 1 0.009240042469905887 0.184999\n",
      "MONDO:0007843 Kabuki syndrome 1 0.009240042469905887 0.184999\n",
      "MONDO:0009747 mitochondrial DNA depletion syndrome 6 (hepatocerebral type) 0.009240042469905887 0.184999\n",
      "MONDO:0009785 opsismodysplasia 0.009240042469905887 0.184999\n",
      "MONDO:0014455 cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome 0.009240042469905887 0.184999\n",
      "MONDO:0009579 Frank-Ter Haar syndrome 0.009240042469905887 0.184999\n",
      "MONDO:0009926 autosomal recessive multiple pterygium syndrome 0.00945390824874241 0.184251\n",
      "MONDO:0010355 syndromic X-linked intellectual disability Claes-Jensen type 0.00945390824874241 0.184251\n",
      "MONDO:0012589 Pitt-Hopkins syndrome 0.009667727862439744 0.183522\n",
      "MONDO:0014700 Au-Kline syndrome 0.009667727862439744 0.183522\n",
      "MONDO:0010590 FG syndrome 1 0.009667727862439744 0.183522\n",
      "MONDO:0014242 van Maldergem syndrome 2 0.009667727862439744 0.183522\n",
      "MONDO:0015012 mucopolysaccharidosis-plus syndrome 0.009667727862439744 0.183522\n",
      "MONDO:0008150 osteoglophonic dwarfism 0.009667727862439744 0.183522\n",
      "MONDO:0859193 neuroocular syndrome 0.009667727862439744 0.183522\n",
      "MONDO:0009809 multicentric osteolysis, nodulosis, and arthropathy 0.009881501320963092 0.182812\n",
      "MONDO:0029140 glycosylphosphatidylinositol biosynthesis defect 18 0.009881501320963092 0.182812\n",
      "MONDO:0032755 neurodevelopmental disorder with or without variable brain abnormalities; NEDBA 0.009881501320963092 0.182812\n",
      "MONDO:0010561 Coffin-Lowry syndrome 0.009881501320963092 0.182812\n",
      "MONDO:0009511 Larsen-like syndrome, B3GAT3 type 0.009881501320963092 0.182812\n",
      "MONDO:0014258 congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome 0.009881501320963092 0.182812\n",
      "MONDO:0100224 mitochondrial complex I deficiency, nuclear type 1 0.009881501320963092 0.182812\n",
      "MONDO:0009479 Johanson-Blizzard syndrome 0.010095228634275527 0.182119\n",
      "MONDO:0013998 MEGF8-related Carpenter syndrome 0.010095228634275527 0.182119\n",
      "MONDO:0009485 oculocerebrofacial syndrome, Kaufman type 0.010095228634275527 0.182119\n",
      "MONDO:0013272 chromosome 14q11-q22 deletion syndrome 0.010095228634275527 0.182119\n",
      "MONDO:0009725 nemaline myopathy 2 0.010308909812337962 0.181442\n",
      "MONDO:0957247 congenital myopathy 22A, classic 0.01052254486510919 0.180782\n",
      "MONDO:0009254 fucosidosis 0.01052254486510919 0.180782\n",
      "MONDO:0012136 carnitine palmitoyl transferase II deficiency, neonatal form 0.010736133802545823 0.180136\n",
      "MONDO:0009571 Meckel syndrome, type 1 0.010736133802545823 0.180136\n",
      "MONDO:0011510 Bohring-Opitz syndrome 0.010736133802545823 0.180136\n",
      "MONDO:0033669 Noonan syndrome 13 0.010736133802545823 0.180136\n",
      "MONDO:0015021 hypotonia, ataxia, and delayed development syndrome 0.010736133802545823 0.180136\n",
      "MONDO:0019569 Cockayne syndrome type 1 0.01094967663460232 0.179506\n",
      "MONDO:0957265 congenital myopathy 22B, severe fetal 0.01094967663460232 0.179506\n",
      "MONDO:0010283 syndromic X-linked intellectual disability Lubs type 0.01094967663460232 0.179506\n",
      "MONDO:0030695 developmental and epileptic encephalopathy 100 0.01094967663460232 0.179506\n",
      "MONDO:0010407 intellectual disability, X-linked syndromic, Turner type 0.01094967663460232 0.179506\n",
      "MONDO:0013273 chromosome 16p13.3 duplication syndrome 0.011163173371231022 0.178889\n",
      "MONDO:0032645 trichohepatoneurodevelopmental syndrome 0.011163173371231022 0.178889\n",
      "MONDO:0010075 spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures 0.011163173371231022 0.178889\n",
      "MONDO:0859165 neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities 0.011163173371231022 0.178889\n",
      "MONDO:0009658 mucopolysaccharidosis type 3D 0.011163173371231022 0.178889\n",
      "MONDO:0026771 developmental and epileptic encephalopathy, 85, with or without midline brain defects 0.011163173371231022 0.178889\n",
      "MONDO:0013415 chromosome 17p13.1 deletion syndrome 0.011376624022382093 0.178286\n",
      "MONDO:0010077 spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome 0.011376624022382093 0.178286\n",
      "MONDO:0007387 Cornelia de Lange syndrome 1 0.011376624022382093 0.178286\n",
      "MONDO:0013932 peroxisome biogenesis disorder 5A (Zellweger) 0.011590028598003559 0.177695\n",
      "MONDO:0014936 ZTTK syndrome 0.012016699562439063 0.176551\n",
      "MONDO:0800044 congenital disorder of deglycosylation 1 0.012656360691197513 0.17492\n",
      "MONDO:0010466 multiple congenital anomalies-hypotonia-seizures syndrome 2 0.012656360691197513 0.17492\n",
      "MONDO:0032707 turnpenny-fry syndrome 0.01286948902242972 0.174397\n",
      "MONDO:0011929 chromosome 1p36 deletion syndrome 0.01286948902242972 0.174397\n",
      "MONDO:0010221 CHIME syndrome 0.013082571347708405 0.173884\n",
      "MONDO:0025699 Coffin-Siris syndrome 12 0.013082571347708405 0.173884\n",
      "MONDO:0007265 cardiofaciocutaneous syndrome 1 0.013295607676964425 0.173381\n",
      "MONDO:0800043 Stve-Wiedemann syndrome 1 0.013508598020126513 0.172887\n",
      "MONDO:0011053 intellectual disability-sparse hair-brachydactyly syndrome 0.013508598020126513 0.172887\n",
      "MONDO:0859191 biliary, renal, neurologic, and skeletal syndrome 0.013721542387121238 0.172402\n",
      "MONDO:0010035 Smith-Lemli-Opitz syndrome 0.01393444078787304 0.171925\n",
      "MONDO:0009964 short-rib thoracic dysplasia 9 with or without polydactyly 0.014360099730334832 0.170997\n",
      "MONDO:0859239 Chilton-Okur-Chung neurodevelopmental syndrome 0.014360099730334832 0.170997\n",
      "MONDO:0859181 DEGCAGS syndrome 0.014572860291882988 0.170545\n",
      "MONDO:0009650 mucolipidosis type II 0.01478557492686452 0.1701\n",
      "MONDO:0859177 VISS syndrome 0.014998243645193143 0.169663\n",
      "MONDO:0007251 campomelic dysplasia 0.014998243645193143 0.169663\n",
      "MONDO:0014558 autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome 0.0154234433715359 0.168809\n",
      "MONDO:0014379 ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 0.015848459550178218 0.167983\n",
      "MONDO:0009910 Wiedemann-Rautenstrauch syndrome 0.01712240759205958 0.165649\n",
      "MONDO:0008995 Yunis-Varon syndrome 0.017970789999834362 0.164203\n",
      "MONDO:0011146 tetrasomy 12p 0.019030238298996843 0.162503\n",
      "MONDO:0010457 Ogden syndrome 0.02051154600315702 0.1603\n"
     ]
    }
   ],
   "execution_count": 54
  },
  {
   "cell_type": "code",
   "id": "ba572bcf-889c-42c7-8b22-f9026cf07b6a",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:48.225249Z",
     "start_time": "2024-10-28T18:03:47.546707Z"
    }
   },
   "source": [
    "response = phenotypes_to_gene(leigh_phenotypes)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "NCBIGene:93986 FOXP2 0.0006474412355706435 0.287901\n",
      "NCBIGene:53335 BCL11A 0.0006474412355706435 0.287901\n",
      "NCBIGene:85358 SHANK3 0.0008631618162098167 0.27527\n",
      "NCBIGene:2077 ERF 0.0008631618162098167 0.27527\n",
      "NCBIGene:9378 NRXN1 0.0008631618162098167 0.27527\n",
      "NCBIGene:1806 DPYD 0.0010788358313316428 0.265714\n",
      "NCBIGene:26047 CNTNAP2 0.0015100442052276759 0.251713\n",
      "NCBIGene:26040 SETBP1 0.0015100442052276759 0.251713\n",
      "NCBIGene:284058 KANSL1 0.001725578584098671 0.246296\n",
      "NCBIGene:50484 RRM2B 0.0019410664376458965 0.241583\n",
      "NCBIGene:113189 CHST14 0.0019410664376458965 0.241583\n",
      "NCBIGene:2903 GRIN2A 0.002156507775912319 0.23742\n",
      "NCBIGene:5728 PTEN 0.003017808176953609 0.224463\n",
      "NCBIGene:3737 KCNA2 0.004093388288691872 0.21315\n",
      "NCBIGene:3954 LETM1 0.00495301684843197 0.20629\n",
      "NCBIGene:4204 MECP2 0.008170020749701742 0.189063\n",
      "NCBIGene:18 ABAT 0.011376624022382093 0.178286\n"
     ]
    }
   ],
   "execution_count": 55
  },
  {
   "cell_type": "code",
   "id": "fb42e799-db61-401e-b014-c43698a6f949",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:48.228068Z",
     "start_time": "2024-10-28T18:03:48.226035Z"
    }
   },
   "source": [
    "leigh_2 = [ \"HP:0001252\", #\t\"\"Hypotonia\"\"\"\n",
    "            \"HP:0002521\", #\t\"\"Hypsarrhythmia\"\"\"\n",
    "            \"HP:0001263\", #\t\"\"Global developmental delay\"\"\"\n",
    "            \"HP:0004305\", #\t\"\"Involuntary movements\"\"\"\n",
    "            \"HP:0002579\", #\t\"\"Gastrointestinal dysmotility\"\"\"\n",
    "            \"HP:0200147\", # \"Neuronal loss in basal ganglia\". \n",
    "            \"HP:0007183\" #\t\"\"Focal T2 hyperintense basal ganglia lesion\"\"\"\n",
    "          ]"
   ],
   "outputs": [],
   "execution_count": 56
  },
  {
   "cell_type": "code",
   "id": "a7d37a06-422a-48bd-afa3-3825550a14bc",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:53.431934Z",
     "start_time": "2024-10-28T18:03:48.230529Z"
    }
   },
   "source": [
    "response = phenotypes_to_disease(leigh_2)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "MONDO:0030919 intellectual disability, autosomal dominant 53 5.536048099918041e-11 0.932667\n",
      "MONDO:0014942 developmental and epileptic encephalopathy, 45 2.4244693060343317e-10 0.909512\n",
      "MONDO:0014842 intellectual disability, autosomal dominant 41 3.849422096046302e-10 0.900903\n",
      "MONDO:0014477 developmental and epileptic encephalopathy, 26 1.4929091468683857e-09 0.871354\n",
      "MONDO:0011966 periventricular heterotopia with microcephaly, autosomal recessive 1.4929091468683857e-09 0.871354\n",
      "MONDO:0013164 beta-ureidopropionase deficiency 1.4929091468683857e-09 0.871354\n",
      "MONDO:0030963 Li-Campeau syndrome 1.9379275651635485e-09 0.864869\n",
      "MONDO:0033366 developmental and epileptic encephalopathy, 57 1.9379275651635485e-09 0.864869\n",
      "MONDO:0010657 methylmalonic acidemia with homocystinuria, type cblX 1.9379275651635485e-09 0.864869\n",
      "MONDO:0011964 DPAGT1-congenital disorder of glycosylation 2.4635554288901497e-09 0.858662\n",
      "MONDO:0033362 developmental and epileptic encephalopathy, 53 3.076485468182307e-09 0.852705\n",
      "MONDO:0011229 ethylmalonic encephalopathy 3.076485468182307e-09 0.852705\n",
      "MONDO:0014905 encephalopathy due to defective mitochondrial and peroxisomal fission 2 3.783406612168245e-09 0.846974\n",
      "MONDO:0014505 developmental and epileptic encephalopathy, 27 4.591003990407202e-09 0.841449\n",
      "MONDO:0010437 severe X-linked mitochondrial encephalomyopathy 4.591003990407202e-09 0.841449\n",
      "MONDO:0014598 developmental and epileptic encephalopathy, 31 5.505958934325998e-09 0.836113\n",
      "MONDO:0032866 cortical dysplasia, complex, with other brain malformations 10 6.534948978654966e-09 0.830951\n",
      "MONDO:0957217 cortical dysplasia, complex, with other brain malformations 12 6.534948978654966e-09 0.830951\n",
      "MONDO:0010079 Canavan disease 6.534948978654966e-09 0.830951\n",
      "MONDO:0060629 neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive 6.534948978654966e-09 0.830951\n",
      "MONDO:0024554 D-2-hydroxyglutaric aciduria 1 1.0372848141105415e-08 0.816386\n",
      "MONDO:0020632 epileptic encephalopathy, infantile or early childhood, 3 1.0372848141105415e-08 0.816386\n",
      "MONDO:0009070 D-glyceric aciduria 1.1924678050687521e-08 0.811804\n",
      "MONDO:0014318 hyperphosphatasia with intellectual disability syndrome 4 1.1924678050687521e-08 0.811804\n",
      "MONDO:0859375 developmental delay with hypotonia, myopathy, and brain abnormalities 1.362387383411596e-08 0.807345\n",
      "MONDO:0031481 microcephaly, epilepsy, and diabetes syndrome 1 1.547709027607439e-08 0.803001\n",
      "MONDO:0010396 developmental and epileptic encephalopathy, 2 1.547709027607439e-08 0.803001\n",
      "MONDO:0044724 3-methylglutaconic aciduria type 9 1.967218534246531e-08 0.794632\n",
      "MONDO:0013357 chromosome 17q11.2 deletion syndrome, 1.4Mb 1.967218534246531e-08 0.794632\n",
      "MONDO:0032610 mitochondrial complex 1 deficiency, nuclear type 5 1.967218534246531e-08 0.794632\n",
      "MONDO:0010478 SLC35A2-congenital disorder of glycosylation 2.2027354608711227e-08 0.790596\n",
      "MONDO:0020630 epileptic encephalopathy, infantile or early childhood, 1 2.2027354608711227e-08 0.790596\n",
      "MONDO:0014371 developmental and epileptic encephalopathy, 23 2.2027354608711227e-08 0.790596\n",
      "MONDO:0859283 neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 2.7286134841983764e-08 0.782795\n",
      "MONDO:0011451 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 3.0203013760951864e-08 0.779022\n",
      "MONDO:0100111 focal segmental glomerulosclerosis and neurodevelopmental syndrome 3.332039088503381e-08 0.775328\n",
      "MONDO:0010472 developmental and epileptic encephalopathy, 36 3.332039088503381e-08 0.775328\n",
      "MONDO:0011866 pontocerebellar hypoplasia type 1A 3.332039088503381e-08 0.775328\n",
      "MONDO:0957248 developmental and epileptic encephalopathy 31B 3.664489074574276e-08 0.77171\n",
      "MONDO:0013990 pontocerebellar hypoplasia type 8 4.018313409938214e-08 0.768165\n",
      "MONDO:0014966 periventricular nodular heterotopia 7 5.660582551697144e-08 0.75465\n",
      "MONDO:0030920 intellectual disability, autosomal dominant 54 8.877532971785415e-08 0.736111\n",
      "MONDO:0014455 cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome 8.877532971785415e-08 0.736111\n",
      "MONDO:0060622 neurodevelopmental disorder with severe motor impairment and absent language 9.510064312910607e-08 0.733198\n",
      "MONDO:0014258 congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome 1.086365376255958e-07 0.727507\n",
      "MONDO:0100224 mitochondrial complex I deficiency, nuclear type 1 1.086365376255958e-07 0.727507\n",
      "MONDO:0010483 X-linked intellectual disability, Cantagrel type 1.312520693616589e-07 0.719291\n",
      "MONDO:0013345 d-2-hydroxyglutaric aciduria 2 1.605107070413724e-07 0.710384\n",
      "MONDO:0014855 intellectual disability, autosomal dominant 42 1.9572735060941756e-07 0.701442\n",
      "MONDO:0010466 multiple congenital anomalies-hypotonia-seizures syndrome 2 2.2880156330425105e-07 0.694294\n",
      "MONDO:0800044 congenital disorder of deglycosylation 1 2.2880156330425105e-07 0.694294\n",
      "MONDO:0013904 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 2.853164372864371e-07 0.684026\n",
      "MONDO:0008939 isolated cerebellar hypoplasia/agenesis 2.853164372864371e-07 0.684026\n",
      "MONDO:0013493 acetyl-coa carboxylase deficiency 2.853164372864371e-07 0.684026\n",
      "MONDO:0014839 chorea, childhood-onset, with psychomotor retardation 2.853164372864371e-07 0.684026\n",
      "MONDO:0010035 Smith-Lemli-Opitz syndrome 3.05684959199012e-07 0.680781\n",
      "MONDO:0030990 Kohlschutter-Tonz syndrome-like 3.1996635735317244e-07 0.678622\n",
      "MONDO:0013387 developmental and epileptic encephalopathy, 7 4.457507993581489e-07 0.662723\n",
      "MONDO:0014953 gnb5-related intellectual disability-cardiac arrhythmia syndrome 4.457507993581489e-07 0.662723\n",
      "MONDO:0013548 acetyl-CoA acetyltransferase-2 deficiency 4.457507993581489e-07 0.662723\n",
      "MONDO:0859158 ataxia, intention tremor, and hypotonia syndrome, childhood-onset 4.457507993581489e-07 0.662723\n",
      "MONDO:0032631 mitochondrial complex 1 deficiency, nuclear type 27 4.457507993581489e-07 0.662723\n",
      "MONDO:0013539 hypotonia-failure to thrive-microcephaly syndrome 4.457507993581489e-07 0.662723\n",
      "MONDO:0024568 infantile liver failure syndrome 1 6.418003297075121e-07 0.644809\n",
      "MONDO:0011291 ALG6-congenital disorder of glycosylation 1C 6.418003297075121e-07 0.644809\n",
      "MONDO:0030462 Joubert syndrome 40 6.418003297075121e-07 0.644809\n",
      "MONDO:0007631 chromosome 16p12.1 deletion syndrome, 520kb 6.418003297075121e-07 0.644809\n",
      "MONDO:0014190 combined oxidative phosphorylation defect type 17 6.418003297075121e-07 0.644809\n",
      "MONDO:0014270 STT3A-congenital disorder of glycosylation 6.418003297075121e-07 0.644809\n",
      "MONDO:0011772 B4GALT1-congenital disorder of glycosylation 6.418003297075121e-07 0.644809\n",
      "MONDO:0033310 Joubert syndrome 31 6.418003297075121e-07 0.644809\n",
      "MONDO:0012413 syndromic microphthalmia type 5 6.418003297075121e-07 0.644809\n",
      "MONDO:0013877 mitochondrial pyruvate carrier deficiency 8.734515686004526e-07 0.629339\n",
      "MONDO:0033311 Joubert syndrome 33 8.734515686004526e-07 0.629339\n",
      "MONDO:0100105 brain small vessel disease 3 8.734515686004526e-07 0.629339\n",
      "MONDO:0014881 transketolase deficiency 8.734515686004526e-07 0.629339\n",
      "MONDO:0014080 osteosclerotic metaphyseal dysplasia 8.734515686004526e-07 0.629339\n",
      "MONDO:0013763 Joubert syndrome 15 8.734515686004526e-07 0.629339\n",
      "MONDO:0012276 generalized epilepsy-paroxysmal dyskinesia syndrome 8.734515686004526e-07 0.629339\n",
      "MONDO:0957255 mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 8.734515686004526e-07 0.629339\n",
      "MONDO:0032629 mitochondrial complex 1 deficiency, nuclear type 25 8.734515686004526e-07 0.629339\n",
      "MONDO:0009742 neuroectodermal melanolysosomal disease 8.734515686004526e-07 0.629339\n",
      "MONDO:0008774 2-aminoadipic 2-oxoadipic aciduria 8.734515686004526e-07 0.629339\n",
      "MONDO:0014595 developmental and epileptic encephalopathy, 30 8.734515686004526e-07 0.629339\n",
      "MONDO:0012614 intellectual disability, autosomal recessive 6 8.734515686004526e-07 0.629339\n",
      "MONDO:0014714 progressive microcephaly-seizures-cortical blindness-developmental delay syndrome 1.140691060116855e-06 0.615719\n",
      "MONDO:0054861 intellectual disability, autosomal recessive 63 1.140691060116855e-06 0.615719\n",
      "MONDO:0008962 Griscelli syndrome type 1 1.140691060116855e-06 0.615719\n",
      "MONDO:0859287 neurodevelopmental disorder with microcephaly, hypotonia, and absent language 1.140691060116855e-06 0.615719\n",
      "MONDO:0010452 intellectual disability, X-linked 90 1.140691060116855e-06 0.615719\n",
      "MONDO:0032812 developmental and epileptic encephalopathy, 78 1.140691060116855e-06 0.615719\n",
      "MONDO:0009949 pyruvate carboxylase deficiency disease 1.140691060116855e-06 0.615719\n",
      "MONDO:0014271 STT3B-congenital disorder of glycosylation 1.140691060116855e-06 0.615719\n",
      "MONDO:0014633 myoclonic-atonic epilepsy 1.140691060116855e-06 0.615719\n",
      "MONDO:0859152 neurodevelopmental disorder with cerebellar atrophy and motor dysfunction 1.140691060116855e-06 0.615719\n",
      "MONDO:0032626 mitochondrial complex 1 deficiency, nuclear type 22 1.140691060116855e-06 0.615719\n",
      "MONDO:0014607 developmental and epileptic encephalopathy, 32 1.140691060116855e-06 0.615719\n",
      "MONDO:0859220 Ferguson-Bonni neurodevelopmental syndrome 1.4435053521496031e-06 0.603553\n",
      "MONDO:0020741 pyridoxine-dependent epilepsy caused by ALDH7A1 mutant 1.4435053521496031e-06 0.603553\n",
      "MONDO:0010192 Waardenburg syndrome type 4A 1.4435053521496031e-06 0.603553\n",
      "MONDO:0012251 MEDNIK syndrome 1.4435053521496031e-06 0.603553\n",
      "MONDO:0859292 developmental delay, behavioral abnormalities, and neuropsychiatric disorders 1.4435053521496031e-06 0.603553\n",
      "MONDO:0014525 combined oxidative phosphorylation defect type 23 1.4435053521496031e-06 0.603553\n",
      "MONDO:0009400 hyperprolinemia type 1 1.4435053521496031e-06 0.603553\n",
      "MONDO:0859280 developmental delay, hypotonia, and impaired language 1.4435053521496031e-06 0.603553\n",
      "MONDO:0014957 language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia 1.4435053521496031e-06 0.603553\n",
      "MONDO:0008721 medium chain acyl-CoA dehydrogenase deficiency 1.4435053521496031e-06 0.603553\n",
      "MONDO:0012392 2-methylbutyryl-CoA dehydrogenase deficiency 1.4435053521496031e-06 0.603553\n",
      "MONDO:0010494 linear skin defects with multiple congenital anomalies 3 1.4435053521496031e-06 0.603553\n",
      "MONDO:0013789 DDOST-congenital disorder of glycosylation 1.4435053521496031e-06 0.603553\n",
      "MONDO:0014764 spastic paraplegia-severe developmental delay-epilepsy syndrome 1.4435053521496031e-06 0.603553\n",
      "MONDO:0014886 severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome 1.781880996403615e-06 0.592561\n",
      "MONDO:0032605 intellectual disability, autosomal recessive 66 1.781880996403615e-06 0.592561\n",
      "MONDO:0032877 neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures 1.781880996403615e-06 0.592561\n",
      "MONDO:0054559 congenital disorder of glycosylation, type IIq 1.781880996403615e-06 0.592561\n",
      "MONDO:0010487 intellectual disability, X-linked 99 1.781880996403615e-06 0.592561\n",
      "MONDO:0014210 intellectual disability-hypotonia-spasticity-sleep disorder syndrome 1.781880996403615e-06 0.592561\n",
      "MONDO:0013702 intellectual disability, autosomal recessive 27 1.781880996403615e-06 0.592561\n",
      "MONDO:0859305 neurodevelopmental disorder with eye movement abnormalities and ataxia 1.781880996403615e-06 0.592561\n",
      "MONDO:0054776 epilepsy, familial focal, with variable foci 4 1.781880996403615e-06 0.592561\n",
      "MONDO:0859263 developmental delay, impaired speech, and behavioral abnormalities, with or without seizures 1.781880996403615e-06 0.592561\n",
      "MONDO:0859178 developmental delay, impaired speech, and behavioral abnormalities 2.0049774561372306e-06 0.586362\n",
      "MONDO:0032617 mitochondrial complex 1 deficiency, nuclear type 11 2.155804548394897e-06 0.582537\n",
      "MONDO:0012308 Joubert syndrome with renal defect 2.155804548394897e-06 0.582537\n",
      "MONDO:0014113 cardiofaciocutaneous syndrome 3 2.155804548394897e-06 0.582537\n",
      "MONDO:0030911 intellectual disability, autosomal dominant 46 2.155804548394897e-06 0.582537\n",
      "MONDO:0031052 developmental and epileptic encephalopathy 106 2.155804548394897e-06 0.582537\n",
      "MONDO:0009257 galactose epimerase deficiency 2.155804548394897e-06 0.582537\n",
      "MONDO:0012221 alpha-N-acetylgalactosaminidase deficiency type 1 2.155804548394897e-06 0.582537\n",
      "MONDO:0032729 intellectual developmental disorder, autosomal recessive 70 2.155804548394897e-06 0.582537\n",
      "MONDO:0013166 GABA aminotransaminase deficiency 2.155804548394897e-06 0.582537\n",
      "MONDO:0014409 intellectual disability, autosomal recessive 44 2.155804548394897e-06 0.582537\n",
      "MONDO:0030988 developmental delay with dysmorphic facies and dental anomalies 2.155804548394897e-06 0.582537\n",
      "MONDO:0033365 developmental and epileptic encephalopathy, 56 2.155804548394897e-06 0.582537\n",
      "MONDO:0032634 mitochondrial complex 1 deficiency, nuclear type 31 2.155804548394897e-06 0.582537\n",
      "MONDO:0033566 combined oxidative phosphorylation deficiency 48 2.155804548394897e-06 0.582537\n",
      "MONDO:0033308 Joubert syndrome 30 2.155804548394897e-06 0.582537\n",
      "MONDO:0011995 cataract - congenital heart disease - neural tube defect syndrome 2.155804548394897e-06 0.582537\n",
      "MONDO:0014927 Joubert syndrome 27 2.155804548394897e-06 0.582537\n",
      "MONDO:0013680 cognitive impairment with or without cerebellar ataxia 2.155804548394897e-06 0.582537\n",
      "MONDO:0030087 diabetes mellitus, permanent neonatal 2 2.155804548394897e-06 0.582537\n",
      "MONDO:0044330 hyperekplexia 4 2.155804548394897e-06 0.582537\n",
      "MONDO:0031055 developmental and epileptic encephalopathy 107 2.5652625674495586e-06 0.573326\n",
      "MONDO:0011336 familial hemophagocytic lymphohistiocytosis 4 2.5652625674495586e-06 0.573326\n",
      "MONDO:0054602 gaze palsy, familial horizontal, with progressive scoliosis, 2 2.5652625674495586e-06 0.573326\n",
      "MONDO:0032715 intellectual developmental disorder, autosomal recessive 69 2.5652625674495586e-06 0.573326\n",
      "MONDO:0012539 Joubert syndrome 6 2.5652625674495586e-06 0.573326\n",
      "MONDO:0030891 intellectual developmental disorder, autosomal dominant 66 2.5652625674495586e-06 0.573326\n",
      "MONDO:0859237 3-methylglutaconic aciduria, type VIIA 2.5652625674495586e-06 0.573326\n",
      "MONDO:0032662 intellectual developmental disorder, autosomal recessive 67 2.5652625674495586e-06 0.573326\n",
      "MONDO:0011449 Salla disease 2.5652625674495586e-06 0.573326\n",
      "MONDO:0012960 intellectual disability, autosomal dominant 5 2.5652625674495586e-06 0.573326\n",
      "MONDO:0014496 mitochondrial complex III deficiency nuclear type 9 2.5652625674495586e-06 0.573326\n",
      "MONDO:0060666 hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome 2.5652625674495586e-06 0.573326\n",
      "MONDO:0012855 Joubert syndrome 8 2.5652625674495586e-06 0.573326\n",
      "MONDO:0013918 distal tetrasomy 15q 2.5652625674495586e-06 0.573326\n",
      "MONDO:0009556 malonic aciduria 2.5652625674495586e-06 0.573326\n",
      "MONDO:0014487 congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome 2.5652625674495586e-06 0.573326\n",
      "MONDO:0014140 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 2.5652625674495586e-06 0.573326\n",
      "MONDO:0013658 intellectual disability, autosomal dominant 11 2.5652625674495586e-06 0.573326\n",
      "MONDO:0014199 developmental and epileptic encephalopathy, 17 2.5652625674495586e-06 0.573326\n",
      "MONDO:0033367 developmental and epileptic encephalopathy, 58 2.5652625674495586e-06 0.573326\n",
      "MONDO:0009625 diencephalic-mesencephalic junction dysplasia syndrome 1 2.5652625674495586e-06 0.573326\n",
      "MONDO:0014952 intellectual disability-epilepsy-extrapyramidal syndrome 2.5652625674495586e-06 0.573326\n",
      "MONDO:0009862 dihydropteridine reductase deficiency 3.0102416167028825e-06 0.564808\n",
      "MONDO:0859231 macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin 3.0102416167028825e-06 0.564808\n",
      "MONDO:0859285 neurodevelopmental disorder with microcephaly, short stature, and speech delay 3.0102416167028825e-06 0.564808\n",
      "MONDO:0032665 intellectual developmental disorder, autosomal recessive 68 3.0102416167028825e-06 0.564808\n",
      "MONDO:0013865 mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency 3.0102416167028825e-06 0.564808\n",
      "MONDO:0014976 lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome 3.0102416167028825e-06 0.564808\n",
      "MONDO:0859085 neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked 3.0102416167028825e-06 0.564808\n",
      "MONDO:0010490 SSR4-congenital disorder of glycosylation 3.0102416167028825e-06 0.564808\n",
      "MONDO:0009509 Landau-Kleffner syndrome 3.0102416167028825e-06 0.564808\n",
      "MONDO:0014746 SLC39A8-CDG 3.0102416167028825e-06 0.564808\n",
      "MONDO:0032693 Galloway-Mowat syndrome 8 3.0102416167028825e-06 0.564808\n",
      "MONDO:0030378 combined oxidative phosphorylation deficiency 53 3.0102416167028825e-06 0.564808\n",
      "MONDO:0010185 methylmalonic aciduria and homocystinuria type cblD 3.0102416167028825e-06 0.564808\n",
      "MONDO:0010265 Simpson-Golabi-Behmel syndrome type 2 3.0102416167028825e-06 0.564808\n",
      "MONDO:0014822 15q14 microdeletion syndrome 3.0102416167028825e-06 0.564808\n",
      "MONDO:0014077 cobblestone lissencephaly without muscular or ocular involvement 3.0102416167028825e-06 0.564808\n",
      "MONDO:0014486 intellectual disability, autosomal dominant 30 3.0102416167028825e-06 0.564808\n",
      "MONDO:0009238 hereditary folate malabsorption 3.0102416167028825e-06 0.564808\n",
      "MONDO:0024506 Adams-Oliver syndrome 1 3.0102416167028825e-06 0.564808\n",
      "MONDO:0024607 congenital muscular dystrophy with cataracts and intellectual disability 3.0102416167028825e-06 0.564808\n",
      "MONDO:0014072 D,L-2-hydroxyglutaric aciduria 3.0102416167028825e-06 0.564808\n",
      "MONDO:0014705 craniosynostosis 6 3.0102416167028825e-06 0.564808\n",
      "MONDO:0009609 methylcobalamin deficiency type cblG 3.0102416167028825e-06 0.564808\n",
      "MONDO:0030730 Tessadori-van Haaften neurodevelopmental syndrome 2 3.0102416167028825e-06 0.564808\n",
      "MONDO:0008722 short chain acyl-CoA dehydrogenase deficiency 3.0102416167028825e-06 0.564808\n",
      "MONDO:0013292 chromosome 4q21 deletion syndrome 3.0102416167028825e-06 0.564808\n",
      "MONDO:0033006 Galloway-Mowat syndrome 2, X-linked 3.0102416167028825e-06 0.564808\n",
      "MONDO:0025353 developmental and epileptic encephalopathy, 90 3.0102416167028825e-06 0.564808\n",
      "MONDO:0030453 developmental and epileptic encephalopathy 97 3.0102416167028825e-06 0.564808\n",
      "MONDO:0033371 developmental and epileptic encephalopathy, 62 3.0102416167028825e-06 0.564808\n",
      "MONDO:0031021 developmental and epileptic encephalopathy 104 3.0102416167028825e-06 0.564808\n",
      "MONDO:0014921 developmental and epileptic encephalopathy, 43 3.0102416167028825e-06 0.564808\n",
      "MONDO:0014625 developmental and epileptic encephalopathy, 33 3.0102416167028825e-06 0.564808\n",
      "MONDO:0030930 neurodevelopmental disorder with or without early-onset generalized epilepsy 3.490728263098343e-06 0.556888\n",
      "MONDO:0032622 mitochondrial complex 1 deficiency, nuclear type 17 3.490728263098343e-06 0.556888\n",
      "MONDO:0030995 global developmental delay with speech and behavioral abnormalities 3.490728263098343e-06 0.556888\n",
      "MONDO:0859519 neurodevelopmental disorder with absent speech and movement and behavioral abnormalities 3.490728263098343e-06 0.556888\n",
      "MONDO:0013007 combined immunodeficiency due to ORAI1 deficiency 3.490728263098343e-06 0.556888\n",
      "MONDO:0014647 developmental and epileptic encephalopathy, 50 3.490728263098343e-06 0.556888\n",
      "MONDO:0859258 neurodevelopmental disorder with dystonia and seizures 3.490728263098343e-06 0.556888\n",
      "MONDO:0013349 ALG11-congenital disorder of glycosylation 3.490728263098343e-06 0.556888\n",
      "MONDO:0032616 mitochondrial complex 1 deficiency, nuclear type 10 3.490728263098343e-06 0.556888\n",
      "MONDO:0012432 Joubert syndrome 5 3.490728263098343e-06 0.556888\n",
      "MONDO:0010250 intellectual disability, X-linked 49 3.490728263098343e-06 0.556888\n",
      "MONDO:0859196 Usmani-Riazuddin syndrome, autosomal recessive 3.490728263098343e-06 0.556888\n",
      "MONDO:0030353 Joubert syndrome 38 3.490728263098343e-06 0.556888\n",
      "MONDO:0859378 leukodystrophy, hypomyelinating, 25 3.490728263098343e-06 0.556888\n",
      "MONDO:0013840 encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome 3.490728263098343e-06 0.556888\n",
      "MONDO:0014683 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 3.490728263098343e-06 0.556888\n",
      "MONDO:0013762 lipoic acid synthetase deficiency 3.490728263098343e-06 0.556888\n",
      "MONDO:0013404 hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase 3.490728263098343e-06 0.556888\n",
      "MONDO:0033309 Joubert syndrome 32 3.490728263098343e-06 0.556888\n",
      "MONDO:0012052 ALG1-congenital disorder of glycosylation 3.490728263098343e-06 0.556888\n",
      "MONDO:0030537 central hypoventilation syndrome, congenital, 2, and autonomic dysfunction 3.490728263098343e-06 0.556888\n",
      "MONDO:0014805 Hao-Fountain syndrome 3.490728263098343e-06 0.556888\n",
      "MONDO:0012556 DK1-congenital disorder of glycosylation 3.490728263098343e-06 0.556888\n",
      "MONDO:0014337 complex cortical dysplasia with other brain malformations 5 3.490728263098343e-06 0.556888\n",
      "MONDO:0014003 developmental and epileptic encephalopathy, 15 3.490728263098343e-06 0.556888\n",
      "MONDO:0032663 developmental and epileptic encephalopathy, 70 3.490728263098343e-06 0.556888\n",
      "MONDO:0013351 infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly 3.490728263098343e-06 0.556888\n",
      "MONDO:0014392 developmental and epileptic encephalopathy, 25 3.490728263098343e-06 0.556888\n",
      "MONDO:0060568 Pilarowski-Bjornsson syndrome 4.006709077386659e-06 0.549489\n",
      "MONDO:0030312 spinocerebellar ataxia, autosomal recessive 29 4.006709077386659e-06 0.549489\n",
      "MONDO:0010979 Timothy syndrome 4.006709077386659e-06 0.549489\n",
      "MONDO:0009666 holocarboxylase synthetase deficiency 4.006709077386659e-06 0.549489\n",
      "MONDO:0014530 autosomal recessive spinocerebellar ataxia 18 4.006709077386659e-06 0.549489\n",
      "MONDO:0014133 developmental and epileptic encephalopathy, 16 4.006709077386659e-06 0.549489\n",
      "MONDO:0032912 Coffin-Siris syndrome 11 4.006709077386659e-06 0.549489\n",
      "MONDO:0020777 congenital disorder of glycosylation with defective fucosylation 2 4.006709077386659e-06 0.549489\n",
      "MONDO:0014848 TELO2-related intellectual disability-neurodevelopmental disorder 4.006709077386659e-06 0.549489\n",
      "MONDO:0859240 intellectual developmental disorder with or without peripheral neuropathy 4.006709077386659e-06 0.549489\n",
      "MONDO:0012368 aminoacylase 1 deficiency 4.006709077386659e-06 0.549489\n",
      "MONDO:0014141 muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14 4.006709077386659e-06 0.549489\n",
      "MONDO:0010263 Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome 4.006709077386659e-06 0.549489\n",
      "MONDO:0014120 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 4.006709077386659e-06 0.549489\n",
      "MONDO:0030472 developmental and epileptic encephalopathy 98 4.006709077386659e-06 0.549489\n",
      "MONDO:0859229 cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism 4.006709077386659e-06 0.549489\n",
      "MONDO:0012856 Birk-Barel syndrome 4.006709077386659e-06 0.549489\n",
      "MONDO:0012290 CEDNIK syndrome 4.006709077386659e-06 0.549489\n",
      "MONDO:0009354 methylcobalamin deficiency type cblE 4.006709077386659e-06 0.549489\n",
      "MONDO:0030937 mitochondrial complex 2 deficiency, nuclear type 3 4.006709077386659e-06 0.549489\n",
      "MONDO:0009603 3-hydroxyisobutyryl-CoA hydrolase deficiency 4.006709077386659e-06 0.549489\n",
      "MONDO:0032931 pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal 4.006709077386659e-06 0.549489\n",
      "MONDO:0014288 Joubert syndrome 21 4.006709077386659e-06 0.549489\n",
      "MONDO:0031028 developmental and epileptic encephalopathy 105 with hypopituitarism 4.006709077386659e-06 0.549489\n",
      "MONDO:0013277 developmental and epileptic encephalopathy, 5 4.006709077386659e-06 0.549489\n",
      "MONDO:0010778 cyclic vomiting syndrome 4.006709077386659e-06 0.549489\n",
      "MONDO:0014947 developmental and epileptic encephalopathy, 46 4.006709077386659e-06 0.549489\n",
      "MONDO:0030072 developmental and epileptic encephalopathy, 88 4.006709077386659e-06 0.549489\n",
      "MONDO:0014457 hyperphosphatasia with intellectual disability syndrome 5 4.006709077386659e-06 0.549489\n",
      "MONDO:0029138 developmental and epileptic encephalopathy, 67 4.006709077386659e-06 0.549489\n",
      "MONDO:0030059 developmental and epileptic encephalopathy, 87 4.006709077386659e-06 0.549489\n",
      "MONDO:0010327 HSD10 mitochondrial disease 4.5581706341248245e-06 0.542548\n",
      "MONDO:0012885 SRD5A3-congenital disorder of glycosylation 4.5581706341248245e-06 0.542548\n",
      "MONDO:0859176 neurodevelopmental disorder with motor and speech delay and behavioral abnormalities 4.5581706341248245e-06 0.542548\n",
      "MONDO:0014874 pontocerebellar hypoplasia, type 2F 4.5581706341248245e-06 0.542548\n",
      "MONDO:0032609 mitochondrial complex 1 deficiency, nuclear type 4 4.5581706341248245e-06 0.542548\n",
      "MONDO:0033008 Galloway-Mowat syndrome 4 4.5581706341248245e-06 0.542548\n",
      "MONDO:0012703 lissencephaly due to TUBA1A mutation 4.5581706341248245e-06 0.542548\n",
      "MONDO:0012824 hypomyelinating leukodystrophy 4 4.5581706341248245e-06 0.542548\n",
      "MONDO:0014754 primary coenzyme Q10 deficiency 8 4.5581706341248245e-06 0.542548\n",
      "MONDO:0013458 hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome 4.5581706341248245e-06 0.542548\n",
      "MONDO:0054785 multiple mitochondrial dysfunctions syndrome 6 4.5581706341248245e-06 0.542548\n",
      "MONDO:0013875 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 4.5581706341248245e-06 0.542548\n",
      "MONDO:0012020 chromosome 22q11.2 microduplication syndrome 4.5581706341248245e-06 0.542548\n",
      "MONDO:0859250 neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures 4.5581706341248245e-06 0.542548\n",
      "MONDO:0008082 multiple endocrine neoplasia type 2B 4.5581706341248245e-06 0.542548\n",
      "MONDO:0010099 Tay-Sachs disease AB variant 4.5581706341248245e-06 0.542548\n",
      "MONDO:0009953 leukocyte adhesion deficiency type II 4.5581706341248245e-06 0.542548\n",
      "MONDO:0054781 combined oxidative phosphorylation deficiency 36 4.5581706341248245e-06 0.542548\n",
      "MONDO:0014660 microcephaly 15, primary, autosomal recessive 4.5581706341248245e-06 0.542548\n",
      "MONDO:0013255 arthrogryposis, renal dysfunction, and cholestasis 2 4.5581706341248245e-06 0.542548\n",
      "MONDO:0800028 dyskinesia with orofacial involvement, autosomal dominant 4.5581706341248245e-06 0.542548\n",
      "MONDO:0033662 neurodevelopmental disorder with microcephaly, seizures, and brain atrophy 4.5581706341248245e-06 0.542548\n",
      "MONDO:0032710 developmental and epileptic encephalopathy, 72 4.5581706341248245e-06 0.542548\n",
      "MONDO:0026720 mitochondrial complex 1 deficiency, nuclear type 12 5.145099511675166e-06 0.536013\n",
      "MONDO:0014859 developmental and epileptic encephalopathy, 37 5.145099511675166e-06 0.536013\n",
      "MONDO:0060759 neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures 5.145099511675166e-06 0.536013\n",
      "MONDO:0030261 pontocerebellar hypoplasia, type 1F 5.145099511675166e-06 0.536013\n",
      "MONDO:0012759 camptodactyly syndrome, Guadalajara type 3 5.145099511675166e-06 0.536013\n",
      "MONDO:0014576 lipoyl transferase 1 deficiency 5.145099511675166e-06 0.536013\n",
      "MONDO:0008861 3-methylcrotonyl-CoA carboxylase 1 deficiency 5.145099511675166e-06 0.536013\n",
      "MONDO:0014563 mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency 5.145099511675166e-06 0.536013\n",
      "MONDO:0014979 myoclonus, intractable, neonatal 5.145099511675166e-06 0.536013\n",
      "MONDO:0014602 intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome 5.145099511675166e-06 0.536013\n",
      "MONDO:0859279 spinal muscular atrophy, distal, autosomal recessive, 6 5.145099511675166e-06 0.536013\n",
      "MONDO:0033045 orofaciodigital syndrome 16 5.145099511675166e-06 0.536013\n",
      "MONDO:0009665 biotinidase deficiency 5.145099511675166e-06 0.536013\n",
      "MONDO:0014354 intellectual disability, autosomal recessive 43 5.145099511675166e-06 0.536013\n",
      "MONDO:0859174 Usmani-Riazuddin syndrome, autosomal dominant 5.145099511675166e-06 0.536013\n",
      "MONDO:0013456 constitutional megaloblastic anemia with severe neurologic disease 5.145099511675166e-06 0.536013\n",
      "MONDO:0032624 mitochondrial complex 1 deficiency, nuclear type 19 5.145099511675166e-06 0.536013\n",
      "MONDO:0026727 Shukla-Vernon syndrome 5.145099511675166e-06 0.536013\n",
      "MONDO:0014646 Zimmermann-Laband syndrome 2 5.145099511675166e-06 0.536013\n",
      "MONDO:0013858 pontine tegmental cap dysplasia 5.145099511675166e-06 0.536013\n",
      "MONDO:0013252 Warsaw breakage syndrome 5.145099511675166e-06 0.536013\n",
      "MONDO:0014510 fatty acyl-CoA reductase 1 deficiency 5.145099511675166e-06 0.536013\n",
      "MONDO:0044205 Shwachman-Diamond syndrome 2 5.145099511675166e-06 0.536013\n",
      "MONDO:0032680 global developmental delay with or without impaired intellectual development 5.145099511675166e-06 0.536013\n",
      "MONDO:0010651 Menkes disease 5.145099511675166e-06 0.536013\n",
      "MONDO:0014895 developmental and epileptic encephalopathy, 40 5.145099511675166e-06 0.536013\n",
      "MONDO:0014356 mitochondrial complex III deficiency nuclear type 7 5.767482292204356e-06 0.529841\n",
      "MONDO:0007999 holoprosencephaly 2 5.767482292204356e-06 0.529841\n",
      "MONDO:0044318 intellectual developmental disorder with gastrointestinal difficulties and high pain threshold 5.767482292204356e-06 0.529841\n",
      "MONDO:0013306 combined oxidative phosphorylation defect type 7 5.767482292204356e-06 0.529841\n",
      "MONDO:0011829 coenzyme Q10 deficiency, primary, 1 5.767482292204356e-06 0.529841\n",
      "MONDO:0060704 neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures 5.767482292204356e-06 0.529841\n",
      "MONDO:0009723 Leigh syndrome 5.767482292204356e-06 0.529841\n",
      "MONDO:0008799 anophthalmia/microphthalmia-esophageal atresia syndrome 5.767482292204356e-06 0.529841\n",
      "MONDO:0013870 TMEM165-congenital disorder of glycosylation 5.767482292204356e-06 0.529841\n",
      "MONDO:0014499 intellectual disability, autosomal recessive 46 5.767482292204356e-06 0.529841\n",
      "MONDO:0859575 Atelis syndrome 1 5.767482292204356e-06 0.529841\n",
      "MONDO:0859142 Hiatt-Neu-Cooper neurodevelopmental syndrome 5.767482292204356e-06 0.529841\n",
      "MONDO:0032786 Noonan syndrome 11 5.767482292204356e-06 0.529841\n",
      "MONDO:0009073 Ritscher-Schinzel syndrome 1 5.767482292204356e-06 0.529841\n",
      "MONDO:0013005 EAST syndrome 5.767482292204356e-06 0.529841\n",
      "MONDO:0958181 mitochondrial trifunctional protein deficiency 1 5.767482292204356e-06 0.529841\n",
      "MONDO:0009612 methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency 5.767482292204356e-06 0.529841\n",
      "MONDO:0010298 Lesch-Nyhan syndrome 5.767482292204356e-06 0.529841\n",
      "MONDO:0030910 intellectual disability, autosomal dominant 45 5.767482292204356e-06 0.529841\n",
      "MONDO:0859569 braddock-carey syndrome 1 5.767482292204356e-06 0.529841\n",
      "MONDO:0008862 3-methylcrotonyl-CoA carboxylase 2 deficiency 5.767482292204356e-06 0.529841\n",
      "MONDO:0009502 pyruvate dehydrogenase E2 deficiency 5.767482292204356e-06 0.529841\n",
      "MONDO:0011240 megalencephaly-capillary malformation-polymicrogyria syndrome 5.767482292204356e-06 0.529841\n",
      "MONDO:0012211 MPDU1-congenital disorder of glycosylation 5.767482292204356e-06 0.529841\n",
      "MONDO:0032601 inflammatory bowel disease, immunodeficiency, and encephalopathy 5.767482292204356e-06 0.529841\n",
      "MONDO:0014213 intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome 6.425305561682488e-06 0.523995\n",
      "MONDO:0010395 phosphoribosylpyrophosphate synthetase superactivity 6.425305561682488e-06 0.523995\n",
      "MONDO:0044306 neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination 6.425305561682488e-06 0.523995\n",
      "MONDO:0009959 peroxisome biogenesis disorder type 3B 6.425305561682488e-06 0.523995\n",
      "MONDO:0009614 methylmalonic aciduria, cblB type 6.425305561682488e-06 0.523995\n",
      "MONDO:0012783 RFT1-congenital disorder of glycosylation 6.425305561682488e-06 0.523995\n",
      "MONDO:0014731 seizures-scoliosis-macrocephaly syndrome 6.425305561682488e-06 0.523995\n",
      "MONDO:0014185 chromosome 3q13.31 deletion syndrome 6.425305561682488e-06 0.523995\n",
      "MONDO:0060627 glycosylphosphatidylinositol biosynthesis defect 15 6.425305561682488e-06 0.523995\n",
      "MONDO:0054654 combined oxidative phosphorylation deficiency 32 6.425305561682488e-06 0.523995\n",
      "MONDO:0011873 Niemann-Pick disease, type C2 6.425305561682488e-06 0.523995\n",
      "MONDO:0859243 neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities 6.425305561682488e-06 0.523995\n",
      "MONDO:0859356 congenital disorder of glycosylation, type IIy 6.425305561682488e-06 0.523995\n",
      "MONDO:0018274 GM3 synthase deficiency 6.425305561682488e-06 0.523995\n",
      "MONDO:0032661 neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia 6.425305561682488e-06 0.523995\n",
      "MONDO:0859206 neurodevelopmental disorder with hearing loss and spasticity 6.425305561682488e-06 0.523995\n",
      "MONDO:0009281 glutaryl-CoA dehydrogenase deficiency 6.425305561682488e-06 0.523995\n",
      "MONDO:0957288 intellectual developmental disorder, autosomal recessive 79 6.425305561682488e-06 0.523995\n",
      "MONDO:0014732 hypomyelinating leukodystrophy 12 6.425305561682488e-06 0.523995\n",
      "MONDO:0008943 autosomal recessive spinocerebellar ataxia 2 6.425305561682488e-06 0.523995\n",
      "MONDO:0010774 striatonigral degeneration, infantile, mitochondrial 6.425305561682488e-06 0.523995\n",
      "MONDO:0013350 mitochondrial DNA depletion syndrome 4b 6.425305561682488e-06 0.523995\n",
      "MONDO:0015000 developmental and epileptic encephalopathy, 48 6.425305561682488e-06 0.523995\n",
      "MONDO:0859221 Yoon-Bellen neurodevelopmental syndrome 6.425305561682488e-06 0.523995\n",
      "MONDO:0009653 mucolipidosis type IV 7.118555909882093e-06 0.518443\n",
      "MONDO:0009567 Marinesco-Sjogren syndrome 7.118555909882093e-06 0.518443\n",
      "MONDO:0009260 GM1 gangliosidosis type 1 7.118555909882093e-06 0.518443\n",
      "MONDO:0014221 triosephosphate isomerase deficiency 7.118555909882093e-06 0.518443\n",
      "MONDO:0010848 spinocerebellar ataxia type 5 7.118555909882093e-06 0.518443\n",
      "MONDO:0957218 neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities 7.118555909882093e-06 0.518443\n",
      "MONDO:0014663 Silver-Russell syndrome 3 7.118555909882093e-06 0.518443\n",
      "MONDO:0032784 neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements 7.118555909882093e-06 0.518443\n",
      "MONDO:0100186 GTP cyclohydrolase I deficiency with hyperphenylalaninemia 7.118555909882093e-06 0.518443\n",
      "MONDO:0014503 autosomal recessive spinocerebellar ataxia 17 7.118555909882093e-06 0.518443\n",
      "MONDO:0014698 microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome 7.118555909882093e-06 0.518443\n",
      "MONDO:0014958 Harel-Yoon syndrome 7.118555909882093e-06 0.518443\n",
      "MONDO:0009757 Niemann-Pick disease, type C1 7.118555909882093e-06 0.518443\n",
      "MONDO:0014981 immunodeficiency 49 7.118555909882093e-06 0.518443\n",
      "MONDO:0859337 combined oxidative phosphorylation deficiency 57 7.118555909882093e-06 0.518443\n",
      "MONDO:0032702 Coffin-Siris syndrome 8 7.118555909882093e-06 0.518443\n",
      "MONDO:0800103 COACH syndrome 1 7.118555909882093e-06 0.518443\n",
      "MONDO:0012812 developmental and epileptic encephalopathy, 4 7.118555909882093e-06 0.518443\n",
      "MONDO:0060761 neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum 7.847219930377214e-06 0.513157\n",
      "MONDO:0100478 brain malformations with or without urinary tract defects 7.847219930377214e-06 0.513157\n",
      "MONDO:0008822 arthrogryposis, renal dysfunction, and cholestasis 1 7.847219930377214e-06 0.513157\n",
      "MONDO:0014144 autosomal recessive limb-girdle muscular dystrophy type R18 7.847219930377214e-06 0.513157\n",
      "MONDO:0014553 Tenorio syndrome 7.847219930377214e-06 0.513157\n",
      "MONDO:0060763 intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities 7.847219930377214e-06 0.513157\n",
      "MONDO:0054636 Skraban-Deardorff syndrome 7.847219930377214e-06 0.513157\n",
      "MONDO:0014708 ring chromosome 14 7.847219930377214e-06 0.513157\n",
      "MONDO:0014946 Sifrim-Hitz-Weiss syndrome 7.847219930377214e-06 0.513157\n",
      "MONDO:0007298 spinocerebellar ataxia type 29 7.847219930377214e-06 0.513157\n",
      "MONDO:0011629 MOGS-congenital disorder of glycosylation 7.847219930377214e-06 0.513157\n",
      "MONDO:0859304 neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction 7.847219930377214e-06 0.513157\n",
      "MONDO:0013048 hereditary spastic paraplegia 50 7.847219930377214e-06 0.513157\n",
      "MONDO:0013801 developmental and epileptic encephalopathy, 13 7.847219930377214e-06 0.513157\n",
      "MONDO:0013937 peroxisome biogenesis disorder 6B 7.847219930377214e-06 0.513157\n",
      "MONDO:0014016 hereditary spastic paraplegia 49 7.847219930377214e-06 0.513157\n",
      "MONDO:0012611 polyhydramnios, megalencephaly, and symptomatic epilepsy 7.847219930377214e-06 0.513157\n",
      "MONDO:0030423 congenital disorder of glycosylation, type 2v 7.847219930377214e-06 0.513157\n",
      "MONDO:0014567 glutamate pyruvate transaminase 2 deficiency 7.847219930377214e-06 0.513157\n",
      "MONDO:0013053 microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type 7.847219930377214e-06 0.513157\n",
      "MONDO:0009590 metachromatic leukodystrophy due to saposin B deficiency 7.847219930377214e-06 0.513157\n",
      "MONDO:0010027 free sialic acid storage disease, infantile form 7.847219930377214e-06 0.513157\n",
      "MONDO:0014219 alacrima, achalasia, and intellectual disability syndrome 7.847219930377214e-06 0.513157\n",
      "MONDO:0032775 neurodevelopmental disorder with seizures and speech and walking impairment 7.847219930377214e-06 0.513157\n",
      "MONDO:0054591 Stankiewicz-Isidor syndrome 7.847219930377214e-06 0.513157\n",
      "MONDO:0014725 spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome 7.847219930377214e-06 0.513157\n",
      "MONDO:0014320 Bosch-Boonstra-Schaaf optic atrophy syndrome 7.847219930377214e-06 0.513157\n",
      "MONDO:0014035 severe intellectual disability-progressive spastic diplegia syndrome 7.847219930377214e-06 0.513157\n",
      "MONDO:0013635 Adams-Oliver syndrome 2 7.847219930377214e-06 0.513157\n",
      "MONDO:0032611 mitochondrial complex 1 deficiency, nuclear type 6 7.847219930377214e-06 0.513157\n",
      "MONDO:0033364 developmental and epileptic encephalopathy, 55 7.847219930377214e-06 0.513157\n",
      "MONDO:0033864 infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome 7.847219930377214e-06 0.513157\n",
      "MONDO:0060491 neurodevelopmental disorder with involuntary movements 7.847219930377214e-06 0.513157\n",
      "MONDO:0012519 Rubinstein-Taybi syndrome due to 16p13.3 microdeletion 8.611284220542381e-06 0.508116\n",
      "MONDO:0014017 intellectual developmental disorder with autism and macrocephaly 8.611284220542381e-06 0.508116\n",
      "MONDO:0014573 Cole-Carpenter syndrome 2 8.611284220542381e-06 0.508116\n",
      "MONDO:0009470 Baraitser-Winter syndrome 1 8.611284220542381e-06 0.508116\n",
      "MONDO:0859197 intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies 8.611284220542381e-06 0.508116\n",
      "MONDO:0010499 Ritscher-Schinzel syndrome 2 8.611284220542381e-06 0.508116\n",
      "MONDO:0015022 intellectual developmental disorder with dysmorphic facies and ptosis 8.611284220542381e-06 0.508116\n",
      "MONDO:0012718 hypotonia with lactic acidemia and hyperammonemia 8.611284220542381e-06 0.508116\n",
      "MONDO:0009033 temtamy syndrome 8.611284220542381e-06 0.508116\n",
      "MONDO:0859350 neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies 8.611284220542381e-06 0.508116\n",
      "MONDO:0859198 short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies 8.611284220542381e-06 0.508116\n",
      "MONDO:0859332 cortical dysplasia, complex, with other brain malformations 11 8.611284220542381e-06 0.508116\n",
      "MONDO:0013546 mitochondrial complex V (ATP synthase) deficiency nuclear type 2 8.611284220542381e-06 0.508116\n",
      "MONDO:0030969 intellectual developmental disorder, autosomal dominant 68 8.611284220542381e-06 0.508116\n",
      "MONDO:0060640 neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy 8.611284220542381e-06 0.508116\n",
      "MONDO:0010183 methylmalonic aciduria and homocystinuria type cblF 8.611284220542381e-06 0.508116\n",
      "MONDO:0024542 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 8.611284220542381e-06 0.508116\n",
      "MONDO:0013552 hereditary spastic paraplegia 52 8.611284220542381e-06 0.508116\n",
      "MONDO:0013805 intellectual disability, autosomal dominant 13 8.611284220542381e-06 0.508116\n",
      "MONDO:0012055 Larsen-like osseous dysplasia-short stature syndrome 8.611284220542381e-06 0.508116\n",
      "MONDO:0009744 neuronal ceroid lipofuscinosis 1 8.611284220542381e-06 0.508116\n",
      "MONDO:0859155 chromosome 1p36 deletion syndrome, proximal 8.611284220542381e-06 0.508116\n",
      "MONDO:0013761 childhood encephalopathy due to thiamine pyrophosphokinase deficiency 8.611284220542381e-06 0.508116\n",
      "MONDO:0859293 neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment 8.611284220542381e-06 0.508116\n",
      "MONDO:0026723 intellectual developmental disorder, X-linked 108 9.410735381551768e-06 0.503297\n",
      "MONDO:0014289 macrocephaly-developmental delay syndrome 9.410735381551768e-06 0.503297\n",
      "MONDO:0011049 Fine-Lubinsky syndrome 9.410735381551768e-06 0.503297\n",
      "MONDO:0859531 neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures 9.410735381551768e-06 0.503297\n",
      "MONDO:0013925 methylmalonic acidemia with homocystinuria, type cblJ 9.410735381551768e-06 0.503297\n",
      "MONDO:0033372 developmental and epileptic encephalopathy, 63 9.410735381551768e-06 0.503297\n",
      "MONDO:0011537 macrocephaly-autism syndrome 9.410735381551768e-06 0.503297\n",
      "MONDO:0014114 cardiofaciocutaneous syndrome 4 9.410735381551768e-06 0.503297\n",
      "MONDO:0032742 encephalopathy, acute, infection-induced, susceptibility to, 9 9.410735381551768e-06 0.503297\n",
      "MONDO:0032650 neurodegeneration, childhood-onset, with cerebellar atrophy 9.410735381551768e-06 0.503297\n",
      "MONDO:0010083 succinic semialdehyde dehydrogenase deficiency 9.410735381551768e-06 0.503297\n",
      "MONDO:0013882 hyperphosphatasia with intellectual disability syndrome 2 9.410735381551768e-06 0.503297\n",
      "MONDO:0015005 epilepsy, early-onset, vitamin B6-dependent 9.410735381551768e-06 0.503297\n",
      "MONDO:0012735 Temple-Baraitser syndrome 9.410735381551768e-06 0.503297\n",
      "MONDO:0012184 Pierson syndrome 9.410735381551768e-06 0.503297\n",
      "MONDO:0957531 neurodevelopmental disorder with microcephaly and movement abnormalities 9.410735381551768e-06 0.503297\n",
      "MONDO:0859230 Kury-Isidor syndrome 9.410735381551768e-06 0.503297\n",
      "MONDO:0010060 mitochondrial DNA depletion syndrome 7 (hepatocerebral type) 9.410735381551768e-06 0.503297\n",
      "MONDO:0030957 developmental and epileptic encephalopathy 103 9.410735381551768e-06 0.503297\n",
      "MONDO:0014949 developmental and epileptic encephalopathy, 47 9.410735381551768e-06 0.503297\n",
      "MONDO:0032578 cortical dysplasia, complex, with other brain malformations 9 9.410735381551768e-06 0.503297\n",
      "MONDO:0009109 lysinuric protein intolerance 1.0245560018378075e-05 0.498683\n",
      "MONDO:0009974 familial hemophagocytic lymphohistiocytosis type 1 1.0245560018378075e-05 0.498683\n",
      "MONDO:0014353 immunodeficiency 23 1.0245560018378075e-05 0.498683\n",
      "MONDO:0030953 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 1.0245560018378075e-05 0.498683\n",
      "MONDO:0009613 methylmalonic aciduria, cblA type 1.0245560018378075e-05 0.498683\n",
      "MONDO:0012929 Compton-North congenital myopathy 1.0245560018378075e-05 0.498683\n",
      "MONDO:0014706 cutis laxa, autosomal dominant 3 1.0245560018378075e-05 0.498683\n",
      "MONDO:0024457 neurodegeneration with brain iron accumulation 2A 1.0245560018378075e-05 0.498683\n",
      "MONDO:0014911 growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy 1.0245560018378075e-05 0.498683\n",
      "MONDO:0032790 neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities 1.0245560018378075e-05 0.498683\n",
      "MONDO:0020495 PEHO-like syndrome 1.0245560018378075e-05 0.498683\n",
      "MONDO:0030893 leukoencephalopathy, progressive, infantile-onset, with or without deafness 1.1115744739791737e-05 0.494258\n",
      "MONDO:0015025 developmental and epileptic encephalopathy, 51 1.1115744739791737e-05 0.494258\n",
      "MONDO:0014382 Tatton-Brown-Rahman overgrowth syndrome 1.1115744739791737e-05 0.494258\n",
      "MONDO:0007800 chromosome 18p deletion syndrome 1.1115744739791737e-05 0.494258\n",
      "MONDO:0032679 combined oxidative phosphorylation deficiency 37 1.1115744739791737e-05 0.494258\n",
      "MONDO:0859331 Rabin-Pappas syndrome 1.1115744739791737e-05 0.494258\n",
      "MONDO:0013745 Joubert syndrome 14 1.1115744739791737e-05 0.494258\n",
      "MONDO:0012593 brain-lung-thyroid syndrome 1.1115744739791737e-05 0.494258\n",
      "MONDO:0011669 hypotonia-cystinuria syndrome 1.1115744739791737e-05 0.494258\n",
      "MONDO:0859137 neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia 1.1115744739791737e-05 0.494258\n",
      "MONDO:0020789 pseudo-TORCH syndrome 1 1.1115744739791737e-05 0.494258\n",
      "MONDO:0032698 neurodevelopmental disorder with central and peripheral motor dysfunction 1.1115744739791737e-05 0.494258\n",
      "MONDO:0015003 dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 1.1115744739791737e-05 0.494258\n",
      "MONDO:0010632 developmental and epileptic encephalopathy, 1 1.1115744739791737e-05 0.494258\n",
      "MONDO:0010717 pyruvate dehydrogenase E1-alpha deficiency 1.2021276158359883e-05 0.490008\n",
      "MONDO:0014357 intellectual disability, autosomal dominant 24 1.2021276158359883e-05 0.490008\n",
      "MONDO:0013320 chromosome 16p12.2-p11.2 deletion syndrome 1.2021276158359883e-05 0.490008\n",
      "MONDO:0014605 microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome 1.2021276158359883e-05 0.490008\n",
      "MONDO:0013951 peroxisome biogenesis disorder 12A (Zellweger) 1.2021276158359883e-05 0.490008\n",
      "MONDO:0032714 facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome 1.2021276158359883e-05 0.490008\n",
      "MONDO:0013641 Warburg micro syndrome 2 1.2021276158359883e-05 0.490008\n",
      "MONDO:0009480 Joubert syndrome with oculorenal defect 1.2021276158359883e-05 0.490008\n",
      "MONDO:0009068 cytochrome-c oxidase deficiency disease 1.2021276158359883e-05 0.490008\n",
      "MONDO:0035133 PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome 1.2021276158359883e-05 0.490008\n",
      "MONDO:0013726 encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 1.2021276158359883e-05 0.490008\n",
      "MONDO:0859232 neurodevelopmental disorder with central hypotonia and dysmorphic facies 1.2021276158359883e-05 0.490008\n",
      "MONDO:0014995 neurodevelopmental disorder with hypotonia, seizures, and absent language 1.2021276158359883e-05 0.490008\n",
      "MONDO:0013971 leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome 1.2021276158359883e-05 0.490008\n",
      "MONDO:0859325 developmental and epileptic encephalopathy 109 1.2021276158359883e-05 0.490008\n",
      "MONDO:0008919 systemic primary carnitine deficiency disease 1.2021276158359883e-05 0.490008\n",
      "MONDO:0010504 immunodeficiency 47 1.2021276158359883e-05 0.490008\n",
      "MONDO:0032726 combined oxidative phosphorylation deficiency 39 1.2021276158359883e-05 0.490008\n",
      "MONDO:0011157 Gomez-Lopez-Hernandez syndrome 1.2962140890445355e-05 0.485919\n",
      "MONDO:0020781 encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 1.2962140890445355e-05 0.485919\n",
      "MONDO:0054560 anauxetic dysplasia 1 1.2962140890445355e-05 0.485919\n",
      "MONDO:0013821 intellectual disability, autosomal dominant 16 1.2962140890445355e-05 0.485919\n",
      "MONDO:0010711 TARP syndrome 1.2962140890445355e-05 0.485919\n",
      "MONDO:0011730 fumaric aciduria 1.2962140890445355e-05 0.485919\n",
      "MONDO:0014643 congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome 1.2962140890445355e-05 0.485919\n",
      "MONDO:0012512 fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 1.2962140890445355e-05 0.485919\n",
      "MONDO:0007113 Angelman syndrome 1.2962140890445355e-05 0.485919\n",
      "MONDO:0015601 X-linked intellectual disability, van Esch type 1.2962140890445355e-05 0.485919\n",
      "MONDO:0014547 combined oxidative phosphorylation defect type 24 1.2962140890445355e-05 0.485919\n",
      "MONDO:0010865 pseudoaminopterin syndrome 1.2962140890445355e-05 0.485919\n",
      "MONDO:0014464 progressive encephalopathy with leukodystrophy due to DECR deficiency 1.2962140890445355e-05 0.485919\n",
      "MONDO:0013968 PGM1-congenital disorder of glycosylation 1.2962140890445355e-05 0.485919\n",
      "MONDO:0014728 combined oxidative phosphorylation defect type 27 1.2962140890445355e-05 0.485919\n",
      "MONDO:0010998 ALG3-congenital disorder of glycosylation 1.2962140890445355e-05 0.485919\n",
      "MONDO:0009841 PEHO syndrome 1.2962140890445355e-05 0.485919\n",
      "MONDO:0032817 neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies 1.3938325556205777e-05 0.481981\n",
      "MONDO:0012342 7q11.23 microduplication syndrome 1.3938325556205777e-05 0.481981\n",
      "MONDO:0014298 chromosome 5q12 deletion syndrome 1.3938325556205777e-05 0.481981\n",
      "MONDO:0859370 respiratory infections, recurrent, and failure to thrive with or without diarrhea 1.3938325556205777e-05 0.481981\n",
      "MONDO:0009756 Niemann-Pick disease type A 1.3938325556205777e-05 0.481981\n",
      "MONDO:0054845 developmental and epileptic encephalopathy, 66 1.3938325556205777e-05 0.481981\n",
      "MONDO:0013659 microcephaly-capillary malformation syndrome 1.3938325556205777e-05 0.481981\n",
      "MONDO:0012280 Goldberg-Shprintzen megacolon syndrome 1.3938325556205777e-05 0.481981\n",
      "MONDO:0033007 Galloway-Mowat syndrome 3 1.3938325556205777e-05 0.481981\n",
      "MONDO:0014556 congenital contractures of the limbs and face, hypotonia, and developmental delay 1.3938325556205777e-05 0.481981\n",
      "MONDO:0010879 CODAS syndrome 1.3938325556205777e-05 0.481981\n",
      "MONDO:0030533 intellectual developmental disorder, autosomal recessive 73 1.3938325556205777e-05 0.481981\n",
      "MONDO:0859347 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities 1.3938325556205777e-05 0.481981\n",
      "MONDO:0014139 Ehlers-Danlos syndrome, spondylodysplastic type, 2 1.3938325556205777e-05 0.481981\n",
      "MONDO:0011337 familial hemophagocytic lymphohistiocytosis 2 1.3938325556205777e-05 0.481981\n",
      "MONDO:0014198 mitochondrial DNA depletion syndrome 13 1.3938325556205777e-05 0.481981\n",
      "MONDO:0031000 Tessadori-Van Haaften neurodevelopmental syndrome 4 1.3938325556205777e-05 0.481981\n",
      "MONDO:0032677 lissencephaly 9 with complex brainstem malformation 1.3938325556205777e-05 0.481981\n",
      "MONDO:0013169 chromosome 5p13 duplication syndrome 1.3938325556205777e-05 0.481981\n",
      "MONDO:0013299 chromosome 6q11-q14 deletion syndrome 1.3938325556205777e-05 0.481981\n",
      "MONDO:0013820 intellectual disability, autosomal dominant 15 1.3938325556205777e-05 0.481981\n",
      "MONDO:0859241 neurodegeneration, childhood-onset, with progressive microcephaly 1.3938325556205777e-05 0.481981\n",
      "MONDO:0032864 intellectual developmental disorder with speech delay, autism, and dysmorphic facies 1.3938325556205777e-05 0.481981\n",
      "MONDO:0014916 developmental and epileptic encephalopathy, 41 1.3938325556205777e-05 0.481981\n",
      "MONDO:0034121 NAD(P)HX dehydratase deficiency 1.3938325556205777e-05 0.481981\n",
      "MONDO:0009504 mitochondrial DNA depletion syndrome 9 1.3938325556205777e-05 0.481981\n",
      "MONDO:0010176 orofaciodigital syndrome type 6 1.494981677959269e-05 0.478184\n",
      "MONDO:0014671 neuropathy, hereditary motor and sensory, type 6B 1.494981677959269e-05 0.478184\n",
      "MONDO:0013579 methylmalonate semialdehyde dehydrogenase deficiency 1.494981677959269e-05 0.478184\n",
      "MONDO:0012613 intellectual disability, autosomal recessive 5 1.494981677959269e-05 0.478184\n",
      "MONDO:0013798 chromosome 16q22 deletion syndrome 1.494981677959269e-05 0.478184\n",
      "MONDO:0013628 hyperphosphatasia with intellectual disability syndrome 3 1.494981677959269e-05 0.478184\n",
      "MONDO:0009364 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 1.494981677959269e-05 0.478184\n",
      "MONDO:0007068 adenylosuccinate lyase deficiency 1.494981677959269e-05 0.478184\n",
      "MONDO:0859208 Hengel-Maroofian-Schols syndrome 1.494981677959269e-05 0.478184\n",
      "MONDO:0859199 developmental delay with or without intellectual impairment or behavioral abnormalities 1.494981677959269e-05 0.478184\n",
      "MONDO:0032764 Khan-Khan-Katsanis syndrome 1.494981677959269e-05 0.478184\n",
      "MONDO:0008365 recombinant 8 syndrome 1.494981677959269e-05 0.478184\n",
      "MONDO:0054791 leukodystrophy, hypomyelinating, 16 1.494981677959269e-05 0.478184\n",
      "MONDO:0011963 Joubert syndrome 2 1.494981677959269e-05 0.478184\n",
      "MONDO:0011933 ALG2-congenital disorder of glycosylation 1.494981677959269e-05 0.478184\n",
      "MONDO:0030914 Clark-Baraitser syndrome 1.599660118835042e-05 0.474519\n",
      "MONDO:0030934 intellectual developmental disorder, autosomal dominant 64 1.599660118835042e-05 0.474519\n",
      "MONDO:0014863 macrocephaly, dysmorphic facies, and psychomotor retardation 1.599660118835042e-05 0.474519\n",
      "MONDO:0032600 Snijders Blok-Campeau syndrome 1.599660118835042e-05 0.474519\n",
      "MONDO:0012869 intellectual disability, autosomal dominant 22 1.599660118835042e-05 0.474519\n",
      "MONDO:0010184 methylmalonic aciduria and homocystinuria type cblC 1.599660118835042e-05 0.474519\n",
      "MONDO:0010465 Kabuki syndrome 2 1.599660118835042e-05 0.474519\n",
      "MONDO:0014963 Shashi-Pena syndrome 1.599660118835042e-05 0.474519\n",
      "MONDO:0032781 congenital hypotonia, epilepsy, developmental delay, and digital anomalies 1.599660118835042e-05 0.474519\n",
      "MONDO:0009520 3-hydroxy-3-methylglutaric aciduria 1.7078665414015282e-05 0.470976\n",
      "MONDO:0859200 cerebellar ataxia, brain abnormalities, and cardiac conduction defects 1.7078665414015282e-05 0.470976\n",
      "MONDO:0014722 Roifman syndrome 1.7078665414015282e-05 0.470976\n",
      "MONDO:0010574 syndromic X-linked intellectual disability 5 1.7078665414015282e-05 0.470976\n",
      "MONDO:0060621 neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy 1.7078665414015282e-05 0.470976\n",
      "MONDO:0033373 developmental and epileptic encephalopathy, 64 1.7078665414015282e-05 0.470976\n",
      "MONDO:0013894 short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome 1.7078665414015282e-05 0.470976\n",
      "MONDO:0032697 neurodevelopmental disorder and language delay with or without structural brain abnormalities 1.7078665414015282e-05 0.470976\n",
      "MONDO:0009079 DOORS syndrome 1.7078665414015282e-05 0.470976\n",
      "MONDO:0014684 combined oxidative phosphorylation defect type 26 1.819599609191449e-05 0.467549\n",
      "MONDO:0014561 3-methylglutaconic aciduria, type VIIB 1.819599609191449e-05 0.467549\n",
      "MONDO:0009934 alveolar capillary dysplasia with misalignment of pulmonary veins 1.819599609191449e-05 0.467549\n",
      "MONDO:0008758 mitochondrial DNA depletion syndrome 4a 1.819599609191449e-05 0.467549\n",
      "MONDO:0011783 ALG12-congenital disorder of glycosylation 1.819599609191449e-05 0.467549\n",
      "MONDO:0014367 Aicardi-Goutieres syndrome 7 1.819599609191449e-05 0.467549\n",
      "MONDO:0015011 optic atrophy 11 1.819599609191449e-05 0.467549\n",
      "MONDO:0014699 intellectual disability, autosomal dominant 40 1.819599609191449e-05 0.467549\n",
      "MONDO:0032838 neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies 1.819599609191449e-05 0.467549\n",
      "MONDO:0014601 autosomal recessive spinocerebellar ataxia 20 1.819599609191449e-05 0.467549\n",
      "MONDO:0009393 ornithine translocase deficiency 1.819599609191449e-05 0.467549\n",
      "MONDO:0030922 intellectual disability, autosomal dominant 56 1.819599609191449e-05 0.467549\n",
      "MONDO:0010361 intellectual disability, X-linked 30 1.819599609191449e-05 0.467549\n",
      "MONDO:0014294 chromosome 15q11.2 deletion syndrome 1.819599609191449e-05 0.467549\n",
      "MONDO:0060624 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter 1.819599609191449e-05 0.467549\n",
      "MONDO:0008893 C syndrome 1.819599609191449e-05 0.467549\n",
      "MONDO:0031007 spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosis 1.819599609191449e-05 0.467549\n",
      "MONDO:0013624 Rafiq syndrome 1.934857986116536e-05 0.46423\n",
      "MONDO:0013245 syndromic multisystem autoimmune disease due to ITCH deficiency 1.934857986116536e-05 0.46423\n",
      "MONDO:0032745 developmental delay with variable intellectual impairment and behavioral abnormalities 1.934857986116536e-05 0.46423\n",
      "MONDO:0007415 mitochondrial complex III deficiency nuclear type 1 1.934857986116536e-05 0.46423\n",
      "MONDO:0032851 intellectual developmental disorder with impaired language and dysmorphic facies 1.934857986116536e-05 0.46423\n",
      "MONDO:0007537 lateral meningocele syndrome 1.934857986116536e-05 0.46423\n",
      "MONDO:0859219 Rauch-Steindl syndrome 1.934857986116536e-05 0.46423\n",
      "MONDO:0014165 multiple congenital anomalies-hypotonia-seizures syndrome 3 1.934857986116536e-05 0.46423\n",
      "MONDO:0010498 MEND syndrome 1.934857986116536e-05 0.46423\n",
      "MONDO:0009644 sulfite oxidase deficiency due to molybdenum cofactor deficiency type B 1.934857986116536e-05 0.46423\n",
      "MONDO:0010512 intellectual disability, X-linked, syndromic, Bain type 1.934857986116536e-05 0.46423\n",
      "MONDO:0030856 developmental and epileptic encephalopathy 89 1.934857986116536e-05 0.46423\n",
      "MONDO:0014864 hypermanganesemia with dystonia 2 2.0536403364674227e-05 0.461014\n",
      "MONDO:0859228 combined oxidative phosphorylation deficiency 55 2.0536403364674227e-05 0.461014\n",
      "MONDO:0013819 intellectual disability, autosomal dominant 14 2.0536403364674227e-05 0.461014\n",
      "MONDO:0014893 Okur-Chung neurodevelopmental syndrome 2.0536403364674227e-05 0.461014\n",
      "MONDO:0023657 intellectual developmental disorder, autosomal dominant 65 2.0536403364674227e-05 0.461014\n",
      "MONDO:0859516 neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum 2.0536403364674227e-05 0.461014\n",
      "MONDO:0020847 intellectual disability, autosomal dominant 58 2.0536403364674227e-05 0.461014\n",
      "MONDO:0011640 genitopatellar syndrome 2.0536403364674227e-05 0.461014\n",
      "MONDO:0859286 neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures 2.0536403364674227e-05 0.461014\n",
      "MONDO:0054831 Coffin-Siris syndrome 7 2.0536403364674227e-05 0.461014\n",
      "MONDO:0012481 mevalonic aciduria 2.0536403364674227e-05 0.461014\n",
      "MONDO:0010305 creatine transporter deficiency 2.0536403364674227e-05 0.461014\n",
      "MONDO:0013563 multiple congenital anomalies-hypotonia-seizures syndrome 1 2.0536403364674227e-05 0.461014\n",
      "MONDO:0012198 PCWH syndrome 2.0536403364674227e-05 0.461014\n",
      "MONDO:0859295 neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties 2.175945324913542e-05 0.457894\n",
      "MONDO:0025351 multiple congenital anomalies-neurodevelopmental syndrome, X-linked 2.175945324913542e-05 0.457894\n",
      "MONDO:0859365 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures 2.175945324913542e-05 0.457894\n",
      "MONDO:0008546 thanatophoric dysplasia type 1 2.175945324913542e-05 0.457894\n",
      "MONDO:0013993 pontocerebellar hypoplasia type 7 2.175945324913542e-05 0.457894\n",
      "MONDO:0010758 Wieacker-Wolff syndrome 2.175945324913542e-05 0.457894\n",
      "MONDO:0008955 cerebrooculofacioskeletal syndrome 1 2.3017716165030653e-05 0.454865\n",
      "MONDO:0030679 Noonan syndrome 14 2.3017716165030653e-05 0.454865\n",
      "MONDO:0014300 proximal myopathy with extrapyramidal signs 2.3017716165030653e-05 0.454865\n",
      "MONDO:0044738 Gabriele de Vries syndrome 2.3017716165030653e-05 0.454865\n",
      "MONDO:0013308 CBL-related disorder 2.3017716165030653e-05 0.454865\n",
      "MONDO:0014858 intellectual disability, autosomal dominant 43 2.3017716165030653e-05 0.454865\n",
      "MONDO:0100215 Rajab interstitial lung disease with brain calcifications 1 2.3017716165030653e-05 0.454865\n",
      "MONDO:0012948 chromosome 6pter-p24 deletion syndrome 2.3017716165030653e-05 0.454865\n",
      "MONDO:0010570 craniofrontonasal syndrome 2.3017716165030653e-05 0.454865\n",
      "MONDO:0009053 ALDH18A1-related de Barsy syndrome 2.4311178766627605e-05 0.451923\n",
      "MONDO:0012176 Emanuel syndrome 2.4311178766627605e-05 0.451923\n",
      "MONDO:0014857 neurodevelopmental disorder with or without anomalies of the brain, eye, or heart 2.4311178766627605e-05 0.451923\n",
      "MONDO:0011070 van Maldergem syndrome 1 2.4311178766627605e-05 0.451923\n",
      "MONDO:0032855 neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies 2.4311178766627605e-05 0.451923\n",
      "MONDO:0008944 Joubert syndrome 1 2.4311178766627605e-05 0.451923\n",
      "MONDO:0859306 developmental delay with variable intellectual disability and dysmorphic facies 2.4311178766627605e-05 0.451923\n",
      "MONDO:0060711 Jaberi-Elahi syndrome 2.4311178766627605e-05 0.451923\n",
      "MONDO:0033005 Galloway-Mowat syndrome 1 2.4311178766627605e-05 0.451923\n",
      "MONDO:0014482 intellectual disability, autosomal dominant 29 2.5639827711979356e-05 0.449063\n",
      "MONDO:0000902 agenesis of the corpus callosum with peripheral neuropathy 2.5639827711979356e-05 0.449063\n",
      "MONDO:0013056 developmental and epileptic encephalopathy, 39 2.5639827711979356e-05 0.449063\n",
      "MONDO:0013025 chromosome 6q24-q25 deletion syndrome 2.5639827711979356e-05 0.449063\n",
      "MONDO:0010519 alpha thalassemia-X-linked intellectual disability syndrome 2.5639827711979356e-05 0.449063\n",
      "MONDO:0014343 Desbuquois dysplasia 2 2.5639827711979356e-05 0.449063\n",
      "MONDO:0044646 early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome 2.5639827711979356e-05 0.449063\n",
      "MONDO:0018346 ferro-cerebro-cutaneous syndrome 2.5639827711979356e-05 0.449063\n",
      "MONDO:0859236 neurodevelopmental disorder with neuromuscular and skeletal abnormalities 2.5639827711979356e-05 0.449063\n",
      "MONDO:0008426 Shprintzen-Goldberg syndrome 2.7003649662923154e-05 0.44628\n",
      "MONDO:0010664 syndromic X-linked intellectual disability Snyder type 2.7003649662923154e-05 0.44628\n",
      "MONDO:0011946 diaphanospondylodysostosis 2.7003649662923154e-05 0.44628\n",
      "MONDO:0013424 3p- syndrome 2.7003649662923154e-05 0.44628\n",
      "MONDO:0010417 syndromic X-linked intellectual disability Najm type 2.7003649662923154e-05 0.44628\n",
      "MONDO:0010477 blepharophimosis - intellectual disability syndrome, MKB type 2.7003649662923154e-05 0.44628\n",
      "MONDO:0859080 intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies 2.7003649662923154e-05 0.44628\n",
      "MONDO:0859201 neurodevelopmental disorder with impaired language and ataxia and with or without seizures 2.7003649662923154e-05 0.44628\n",
      "MONDO:0032572 cardiac, facial, and digital anomalies with developmental delay 2.7003649662923154e-05 0.44628\n",
      "MONDO:0030915 intellectual disability, autosomal recessive 61 2.7003649662923154e-05 0.44628\n",
      "MONDO:0020681 Ehlers-Danlos syndrome, musculocontractural type 1 2.8402631285079628e-05 0.443572\n",
      "MONDO:0012095 intellectual disability-brachydactyly-Pierre Robin syndrome 2.8402631285079628e-05 0.443572\n",
      "MONDO:0009124 Dubowitz syndrome 2.8402631285079628e-05 0.443572\n",
      "MONDO:0011936 microphthalmia with brain and digit anomalies 2.8402631285079628e-05 0.443572\n",
      "MONDO:0012916 chromosome 2p16.1-p15 deletion syndrome 2.983675924785188e-05 0.440933\n",
      "MONDO:0859301 neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects 2.983675924785188e-05 0.440933\n",
      "MONDO:0008907 PMM2-congenital disorder of glycosylation 2.983675924785188e-05 0.440933\n",
      "MONDO:0011213 Pierpont syndrome 2.983675924785188e-05 0.440933\n",
      "MONDO:0030918 intellectual disability, autosomal dominant 52 2.983675924785188e-05 0.440933\n",
      "MONDO:0060502 neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 2.983675924785188e-05 0.440933\n",
      "MONDO:0851095 KINSSHIP syndrome 2.983675924785188e-05 0.440933\n",
      "MONDO:0009452 Vici syndrome 3.130602022442422e-05 0.438362\n",
      "MONDO:0009561 alpha-mannosidosis 3.130602022442422e-05 0.438362\n",
      "MONDO:0009855 d-bifunctional protein deficiency 3.130602022442422e-05 0.438362\n",
      "MONDO:0044302 congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 3.281040089176165e-05 0.435854\n",
      "MONDO:0014348 intellectual disability, autosomal recessive 42 3.281040089176165e-05 0.435854\n",
      "MONDO:0008013 chromosome 9p deletion syndrome 3.281040089176165e-05 0.435854\n",
      "MONDO:0007843 Kabuki syndrome 1 3.281040089176165e-05 0.435854\n",
      "MONDO:0030908 intellectual disability, X-linked, syndromic, 35 3.281040089176165e-05 0.435854\n",
      "MONDO:0009747 mitochondrial DNA depletion syndrome 6 (hepatocerebral type) 3.281040089176165e-05 0.435854\n",
      "MONDO:0859190 neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities 3.281040089176165e-05 0.435854\n",
      "MONDO:0012864 chromosome 2q32-q33 deletion syndrome 3.4349887930608576e-05 0.433407\n",
      "MONDO:0030966 neurofacioskeletal syndrome with or without renal agenesis 3.4349887930608576e-05 0.433407\n",
      "MONDO:0014700 Au-Kline syndrome 3.592446802548804e-05 0.431019\n",
      "MONDO:0010590 FG syndrome 1 3.592446802548804e-05 0.431019\n",
      "MONDO:0014944 short stature-brachydactyly-obesity-global developmental delay syndrome 3.592446802548804e-05 0.431019\n",
      "MONDO:0014242 van Maldergem syndrome 2 3.592446802548804e-05 0.431019\n",
      "MONDO:0015012 mucopolysaccharidosis-plus syndrome 3.592446802548804e-05 0.431019\n",
      "MONDO:0032755 neurodevelopmental disorder with or without variable brain abnormalities; NEDBA 3.753412786470064e-05 0.428686\n",
      "MONDO:0010501 syndromic X-linked intellectual disability 34 3.753412786470064e-05 0.428686\n",
      "MONDO:0010561 Coffin-Lowry syndrome 3.753412786470064e-05 0.428686\n",
      "MONDO:0013998 MEGF8-related Carpenter syndrome 3.91788541403236e-05 0.426407\n",
      "MONDO:0013272 chromosome 14q11-q22 deletion syndrome 3.91788541403236e-05 0.426407\n",
      "MONDO:0859139 blepharophimosis-impaired intellectual development syndrome 4.0858633548209975e-05 0.424179\n",
      "MONDO:0009254 fucosidosis 4.257345278798748e-05 0.422\n",
      "MONDO:0012315 distal 10q deletion syndrome 4.257345278798748e-05 0.422\n",
      "MONDO:0032760 developmental delay with or without dysmorphic facies and autism 4.432329856305778e-05 0.419868\n",
      "MONDO:0009571 Meckel syndrome, type 1 4.432329856305778e-05 0.419868\n",
      "MONDO:0011510 Bohring-Opitz syndrome 4.432329856305778e-05 0.419868\n",
      "MONDO:0060752 neurodevelopmental disorder with spasticity and poor growth 4.432329856305778e-05 0.419868\n",
      "MONDO:0010283 syndromic X-linked intellectual disability Lubs type 4.610815758059522e-05 0.417781\n",
      "MONDO:0009069 congenital lactic acidosis, Saguenay-Lac-Saint-Jean type 4.610815758059522e-05 0.417781\n",
      "MONDO:0030695 developmental and epileptic encephalopathy 100 4.610815758059522e-05 0.417781\n",
      "MONDO:8000008 Martsolf syndrome 1 4.610815758059522e-05 0.417781\n",
      "MONDO:0013273 chromosome 16p13.3 duplication syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0859165 neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities 4.7928016551546164e-05 0.415738\n",
      "MONDO:0026771 developmental and epileptic encephalopathy, 85, with or without midline brain defects 4.7928016551546164e-05 0.415738\n",
      "MONDO:0013415 chromosome 17p13.1 deletion syndrome 4.97828621906279e-05 0.413737\n",
      "MONDO:0030606 Bryant-Li-Bhoj neurodevelopmental syndrome 1 4.97828621906279e-05 0.413737\n",
      "MONDO:0010077 spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome 4.97828621906279e-05 0.413737\n",
      "MONDO:0012637 COG1-congenital disorder of glycosylation 5.167268121632775e-05 0.411775\n",
      "MONDO:0013932 peroxisome biogenesis disorder 5A (Zellweger) 5.167268121632775e-05 0.411775\n",
      "MONDO:0054588 Noonan syndrome-like disorder with loose anagen hair 2 5.359746035090191e-05 0.409853\n",
      "MONDO:0014606 intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome 5.359746035090191e-05 0.409853\n",
      "MONDO:0007874 trichorhinophalangeal syndrome type II 5.555718632037505e-05 0.407968\n",
      "MONDO:0859143 Radio-Tartaglia syndrome 5.555718632037505e-05 0.407968\n",
      "MONDO:0014936 ZTTK syndrome 5.555718632037505e-05 0.407968\n",
      "MONDO:0859187 neurodevelopmental disorder with hypotonia and brain abnormalities 5.755184585453889e-05 0.40612\n",
      "MONDO:0019349 Sotos syndrome 5.755184585453889e-05 0.40612\n",
      "MONDO:0011518 Wiedemann-Steiner syndrome 5.755184585453889e-05 0.40612\n",
      "MONDO:0032707 turnpenny-fry syndrome 6.374529319957652e-05 0.400778\n",
      "MONDO:0008953 peroxisome biogenesis disorder 1A (Zellweger) 6.374529319957652e-05 0.400778\n",
      "MONDO:0011929 chromosome 1p36 deletion syndrome 6.374529319957652e-05 0.400778\n",
      "MONDO:0009798 Primrose syndrome 6.587955436572842e-05 0.399062\n",
      "MONDO:0010221 CHIME syndrome 6.587955436572842e-05 0.399062\n",
      "MONDO:0025699 Coffin-Siris syndrome 12 6.587955436572842e-05 0.399062\n",
      "MONDO:0014205 severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome 6.8048682802003e-05 0.397376\n",
      "MONDO:0010193 Weaver syndrome 7.025266526077488e-05 0.39572\n",
      "MONDO:0011053 intellectual disability-sparse hair-brachydactyly syndrome 7.025266526077488e-05 0.39572\n",
      "MONDO:0012914 chromosome 1q21.1 deletion syndrome 7.025266526077488e-05 0.39572\n",
      "MONDO:0859191 biliary, renal, neurologic, and skeletal syndrome 7.249148849817927e-05 0.394092\n",
      "MONDO:0009964 short-rib thoracic dysplasia 9 with or without polydactyly 7.941687049992678e-05 0.389371\n",
      "MONDO:0859239 Chilton-Okur-Chung neurodevelopmental syndrome 7.941687049992678e-05 0.389371\n",
      "MONDO:0859181 DEGCAGS syndrome 8.179492448838974e-05 0.387849\n",
      "MONDO:0009650 mucolipidosis type II 8.420775309253549e-05 0.386351\n",
      "MONDO:0859177 VISS syndrome 8.665534309104237e-05 0.384877\n",
      "MONDO:0007617 Coffin-Siris syndrome 1 8.665534309104237e-05 0.384877\n",
      "MONDO:0007251 campomelic dysplasia 8.665534309104237e-05 0.384877\n",
      "MONDO:0014558 autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome 9.165475440462125e-05 0.381998\n",
      "MONDO:0014379 ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 9.679305273361345e-05 0.379205\n",
      "MONDO:0011244 Marshall-Smith syndrome 0.0001130402137580136 0.371306\n",
      "MONDO:0009910 Wiedemann-Rautenstrauch syndrome 0.0001130402137580136 0.371306\n",
      "MONDO:0008995 Yunis-Varon syndrome 0.00012456415446630953 0.366399\n",
      "MONDO:0030993 Tessadori-Van Haaften neurodevelopmental syndrome 3 0.00013053355864083536 0.364043\n",
      "MONDO:0008393 Rubinstein-Taybi syndrome due to CREBBP mutations 0.00013664111164096067 0.361747\n",
      "MONDO:0011146 tetrasomy 12p 0.00013974666106821745 0.360621\n",
      "MONDO:0013256 chromosome 15q24 deletion syndrome 0.00014288670825046015 0.359509\n",
      "MONDO:0010457 Ogden syndrome 0.00016245070846939444 0.353118\n",
      "MONDO:0013076 attention deficit-hyperactivity disorder, susceptibility to, 7 0.0001888803437402939 0.345678\n",
      "MONDO:0033670 hearing loss, autosomal recessive 116 0.0001888803437402939 0.345678\n",
      "MONDO:0008563 thumb stiffness-brachydactyly-intellectual disability syndrome 0.0001888803437402939 0.345678\n",
      "MONDO:0014442 Bardet-Biedl syndrome 14 0.0001888803437402939 0.345678\n",
      "MONDO:0010454 intellectual disability, X-linked 88 0.0001888803437402939 0.345678\n",
      "MONDO:0030480 hearing loss, autosomal recessive 119 0.0001888803437402939 0.345678\n",
      "MONDO:0030958 dystonia 35, childhood-onset 0.0001888803437402939 0.345678\n",
      "MONDO:0859185 neurodevelopmental disorder with hypotonia and dysmorphic facies 0.00019046227996166924 0.345268\n",
      "MONDO:0012648 isobutyryl-CoA dehydrogenase deficiency 0.0003777250116963364 0.312472\n",
      "MONDO:0014438 Bardet-Biedl syndrome 10 0.0003777250116963364 0.312472\n",
      "MONDO:0009099 nephrogenic diabetes insipidus-intracranial calcification syndrome 0.0003777250116963364 0.312472\n",
      "MONDO:0014825 chromosome 11p13 deletion syndrome, distal 0.0003777250116963364 0.312472\n",
      "MONDO:0030005 epilepsy, early-onset, with or without developmental delay 0.0003777250116963364 0.312472\n",
      "MONDO:0014436 Bardet-Biedl syndrome 8 0.0003777250116963364 0.312472\n",
      "MONDO:0007366 seizures, benign familial neonatal, 2 0.0003777250116963364 0.312472\n",
      "MONDO:0030004 autism, susceptibility to, 20 0.0003777250116963364 0.312472\n",
      "MONDO:0033665 hearing loss, autosomal dominant 78 0.0003777250116963364 0.312472\n",
      "MONDO:0013917 nephronophthisis 15 0.0003777250116963364 0.312472\n",
      "MONDO:0010450 intellectual disability, X-linked 89 0.0003777250116963364 0.312472\n",
      "MONDO:0030105 galactosemia 4 0.0003777250116963364 0.312472\n",
      "MONDO:0859380 episodic kinesigenic dyskinesia 3 0.0003777250116963364 0.312472\n",
      "MONDO:0009814 osteopenia-intellectual disability-sparse hair syndrome 0.0005665340106065814 0.29388\n",
      "MONDO:0024508 epilepsy, hot water, 1 0.0005665340106065814 0.29388\n",
      "MONDO:0012557 cardiomyopathy-hypotonia-lactic acidosis syndrome 0.0005665340106065814 0.29388\n",
      "MONDO:0014973 sudden cardiac failure, infantile 0.0005665340106065814 0.29388\n",
      "MONDO:0032592 cardiomyopathy, dilated, 2c 0.0005665340106065814 0.29388\n",
      "MONDO:0032628 mitochondrial complex 1 deficiency, nuclear type 24 0.0005665340106065814 0.29388\n",
      "MONDO:0013734 microphthalmia, syndromic 11 0.0005665340106065814 0.29388\n",
      "MONDO:0014432 Bardet-Biedl syndrome 2 0.0005665340106065814 0.29388\n",
      "MONDO:0032694 microcephaly 25, primary, autosomal recessive 0.0005665340106065814 0.29388\n",
      "MONDO:0013116 congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome 0.0005665340106065814 0.29388\n",
      "MONDO:0014815 intellectual disability, autosomal recessive 52 0.0005665340106065814 0.29388\n",
      "MONDO:0009042 craniotelencephalic dysplasia 0.0005665340106065814 0.29388\n",
      "MONDO:0010252 intellectual disability, X-linked, with panhypopituitarism 0.0005665340106065814 0.29388\n",
      "MONDO:0012717 renal hypomagnesemia 4 0.0005665340106065814 0.29388\n",
      "MONDO:0010125 upper limb defect-eye and ear abnormalities syndrome 0.0005665340106065814 0.29388\n",
      "MONDO:0026729 congenital disorder of glycosylation, type ICC 0.0005665340106065814 0.29388\n",
      "MONDO:0859278 keratoderma-ichthyosis-deafness syndrome, autosomal recessive 0.0005665340106065814 0.29388\n",
      "MONDO:0014712 Senior-Loken syndrome 9 0.0005665340106065814 0.29388\n",
      "MONDO:0010451 intellectual disability, X-linked 41 0.0005665340106065814 0.29388\n",
      "MONDO:0014184 specific language impairment 5 0.0005665340106065814 0.29388\n",
      "MONDO:0032899 neutropenia, severe congenital, 8, autosomal dominant 0.0005665340106065814 0.29388\n",
      "MONDO:0012615 intellectual disability, autosomal recessive 7 0.0005665340106065814 0.29388\n",
      "MONDO:0014441 Bardet-Biedl syndrome 13 0.0005665340106065814 0.29388\n",
      "MONDO:0012286 myopathy, autophagic vacuolar, infantile-onset 0.0005665340106065814 0.29388\n",
      "MONDO:0029465 intellectual developmental disorder, autosomal dominant 69 0.0005665340106065814 0.29388\n",
      "MONDO:0030726 neutropenia, severe congenital, 9, autosomal dominant 0.0005665340106065814 0.29388\n",
      "MONDO:0012603 episodic kinesigenic dyskinesia 2 0.0005665340106065814 0.29388\n",
      "MONDO:0008845 atonic-astatic syndrome of Foerster 0.0007553073472082117 0.28109\n",
      "MONDO:0042979 hypokalemic periodic paralysis, type 1 0.0007553073472082117 0.28109\n",
      "MONDO:0013156 muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4 0.0007553073472082117 0.28109\n",
      "MONDO:0012382 hyperinsulinemic hypoglycemia, familial, 4 0.0007553073472082117 0.28109\n",
      "MONDO:0026733 intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type 0.0007553073472082117 0.28109\n",
      "MONDO:0012423 MORM syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0013697 intellectual disability, autosomal recessive 29 0.0007553073472082117 0.28109\n",
      "MONDO:0014240 periventricular nodular heterotopia 6 0.0007553073472082117 0.28109\n",
      "MONDO:0040500 glycosylphosphatidylinositol biosynthesis defect 16 0.0007553073472082117 0.28109\n",
      "MONDO:0025690 microcephaly, epilepsy, and diabetes syndrome 2 0.0007553073472082117 0.28109\n",
      "MONDO:0014524 intellectual disability, autosomal recessive 47 0.0007553073472082117 0.28109\n",
      "MONDO:0016581 conotruncal heart malformations 0.0007553073472082117 0.28109\n",
      "MONDO:0013939 peroxisome biogenesis disorder 7B 0.0007553073472082117 0.28109\n",
      "MONDO:0009366 normal pressure hydrocephalus 0.0007553073472082117 0.28109\n",
      "MONDO:0009844 pellagra-like syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0013606 Hermansky-Pudlak syndrome 9 0.0007553073472082117 0.28109\n",
      "MONDO:0859170 retinal dystrophy and microvillus inclusion disease 0.0007553073472082117 0.28109\n",
      "MONDO:0012860 thrombophilia due to protein C deficiency, autosomal recessive 0.0007553073472082117 0.28109\n",
      "MONDO:0007634 intellectual disability, FRA12A type 0.0007553073472082117 0.28109\n",
      "MONDO:0008428 septooptic dysplasia 0.0007553073472082117 0.28109\n",
      "MONDO:0014759 intellectual disability, autosomal recessive 51 0.0007553073472082117 0.28109\n",
      "MONDO:0010832 Bardet-Biedl syndrome 3 0.0007553073472082117 0.28109\n",
      "MONDO:0013580 pyruvate dehydrogenase E1-beta deficiency 0.0007553073472082117 0.28109\n",
      "MONDO:0014675 autosomal recessive nonsyndromic hearing loss 104 0.0007553073472082117 0.28109\n",
      "MONDO:0030916 intellectual disability, autosomal dominant 50 0.0007553073472082117 0.28109\n",
      "MONDO:0012548 Kostmann syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0012397 brachydactyly, coloboma, and anterior segment dysgenesis 0.0007553073472082117 0.28109\n",
      "MONDO:0010851 Lowry-MacLean syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0008859 berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification 0.0007553073472082117 0.28109\n",
      "MONDO:0014770 Joubert syndrome 25 0.0007553073472082117 0.28109\n",
      "MONDO:0012858 primary CD59 deficiency 0.0009440450282371355 0.271407\n",
      "MONDO:0004573 ariboflavinosis 0.0009440450282371355 0.271407\n",
      "MONDO:0014623 microcephaly 14, primary, autosomal recessive 0.0009440450282371355 0.271407\n",
      "MONDO:0010900 intrauterine growth retardation with increased mitomycin c sensitivity 0.0009440450282371355 0.271407\n",
      "MONDO:0014592 microcephaly and chorioretinopathy 3 0.0009440450282371355 0.271407\n",
      "MONDO:0010162 tyrosinemia type III 0.0009440450282371355 0.271407\n",
      "MONDO:0013774 trigonocephaly 2 0.0009440450282371355 0.271407\n",
      "MONDO:0014490 ketoacidosis due to monocarboxylate transporter-1 deficiency 0.0009440450282371355 0.271407\n",
      "MONDO:0014690 dyskeratosis congenita, autosomal dominant 6 0.0009440450282371355 0.271407\n",
      "MONDO:0012187 Fanconi anemia complementation group J 0.0009440450282371355 0.271407\n",
      "MONDO:0060577 neurodevelopmental disorder with microcephaly, ataxia, and seizures 0.0009440450282371355 0.271407\n",
      "MONDO:0010216 xeroderma pigmentosum group G 0.0009440450282371355 0.271407\n",
      "MONDO:0033044 Meckel syndrome 13 0.0009440450282371355 0.271407\n",
      "MONDO:0012996 AGAT deficiency 0.0009440450282371355 0.271407\n",
      "MONDO:0010794 NARP syndrome 0.0009440450282371355 0.271407\n",
      "MONDO:0010474 linear skin defects with multiple congenital anomalies 2 0.0009440450282371355 0.271407\n",
      "MONDO:0012623 intellectual disability, autosomal recessive 4 0.0009440450282371355 0.271407\n",
      "MONDO:0013950 peroxisome biogenesis disorder 11B 0.0011327470604279887 0.263653\n",
      "MONDO:0010317 intellectual disability, X-linked, with or without seizures, arx-related 0.0011327470604279887 0.263653\n",
      "MONDO:0030036 leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome 0.0011327470604279887 0.263653\n",
      "MONDO:0014851 hypercalcemia, infantile, 2 0.0011327470604279887 0.263653\n",
      "MONDO:0013000 porphyria due to ALA dehydratase deficiency 0.0011327470604279887 0.263653\n",
      "MONDO:0013389 developmental and epileptic encephalopathy, 12 0.0011327470604279887 0.263653\n",
      "MONDO:0010460 syndromic X-linked intellectual disability 17 0.0011327470604279887 0.263653\n",
      "MONDO:0013531 PSPH deficiency 0.0011327470604279887 0.263653\n",
      "MONDO:0060551 cerebellar atrophy, developmental delay, and seizures 0.0011327470604279887 0.263653\n",
      "MONDO:0014664 Joubert syndrome 23 0.0011327470604279887 0.263653\n",
      "MONDO:0013581 intellectual disability, autosomal dominant 2 0.0011327470604279887 0.263653\n",
      "MONDO:0014724 Joubert syndrome 24 0.0011327470604279887 0.263653\n",
      "MONDO:0011828 intellectual disability, autosomal recessive 2 0.0011327470604279887 0.263653\n",
      "MONDO:0013824 Joubert syndrome 17 0.0011327470604279887 0.263653\n",
      "MONDO:0032733 global developmental delay, progressive ataxia, and elevated glutamine 0.0011327470604279887 0.263653\n",
      "MONDO:0009008 heart defect - tongue hamartoma - polysyndactyly syndrome 0.0011327470604279887 0.263653\n",
      "MONDO:0013583 occipital pachygyria and polymicrogyria 0.0011327470604279887 0.263653\n",
      "MONDO:0012925 Diamond-Blackfan anemia 5 0.0011327470604279887 0.263653\n",
      "MONDO:0013058 cystic leukoencephalopathy without megalencephaly 0.0011327470604279887 0.263653\n",
      "MONDO:0014029 osteogenesis imperfecta type 14 0.0011327470604279887 0.263653\n",
      "MONDO:0011025 Cayman type cerebellar ataxia 0.0011327470604279887 0.263653\n",
      "MONDO:0014248 autism spectrum disorder - epilepsy - arthrogryposis syndrome 0.0011327470604279887 0.263653\n",
      "MONDO:0013900 alternating hemiplegia of childhood 2 0.0011327470604279887 0.263653\n",
      "MONDO:0012120 pyruvate dehydrogenase phosphatase deficiency 0.0011327470604279887 0.263653\n",
      "MONDO:0030033 seizures, early-onset, with neurodegeneration and brain calcifications 0.0011327470604279887 0.263653\n",
      "MONDO:0033543 cone-rod synaptic disorder syndrome, congenital nonprogressive 0.0011327470604279887 0.263653\n",
      "MONDO:0010318 FG syndrome 4 0.0011327470604279887 0.263653\n",
      "MONDO:0007210 Brachmann-de Lange-like facial changes with microcephaly, metatarsus adductus, and developmental delay 0.0011327470604279887 0.263653\n",
      "MONDO:0032588 periventricular nodular heterotopia 8 0.0011327470604279887 0.263653\n",
      "MONDO:0010289 intellectual disability, X-linked 72 0.0011327470604279887 0.263653\n",
      "MONDO:0010840 pachygyria-intellectual disability-epilepsy syndrome 0.0011327470604279887 0.263653\n",
      "MONDO:0014628 basal ganglia calcification, idiopathic, 6 0.0011327470604279887 0.263653\n",
      "MONDO:0013883 congenital myasthenic syndrome 13 0.0013214134505141377 0.25721\n",
      "MONDO:0010380 cataract, ataxia, short stature, and intellectual disability 0.0013214134505141377 0.25721\n",
      "MONDO:0014220 myopathy due to myoadenylate deaminase deficiency 0.0013214134505141377 0.25721\n",
      "MONDO:0859271 glycosylphosphatidylinositol biosynthesis defect 25 0.0013214134505141377 0.25721\n",
      "MONDO:0012624 acyl-CoA dehydrogenase 9 deficiency 0.0013214134505141377 0.25721\n",
      "MONDO:0032909 mitochondrial complex 3 deficiency, nuclear type 10 0.0013214134505141377 0.25721\n",
      "MONDO:0020727 combined oxidative phosphorylation deficiency 22 0.0013214134505141377 0.25721\n",
      "MONDO:0014668 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4 0.0013214134505141377 0.25721\n",
      "MONDO:0032910 mitochondrial complex 1 deficiency, nuclear type 34 0.0013214134505141377 0.25721\n",
      "MONDO:0044702 X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome 0.0013214134505141377 0.25721\n",
      "MONDO:0014766 leukodystrophy and acquired microcephaly with or without dystonia; 0.0013214134505141377 0.25721\n",
      "MONDO:0030859 COACH syndrome 2 0.0013214134505141377 0.25721\n",
      "MONDO:0032815 mitochondrial DNA depletion syndrome 17 0.0013214134505141377 0.25721\n",
      "MONDO:0012989 microcephaly 7, primary, autosomal recessive 0.0013214134505141377 0.25721\n",
      "MONDO:0014398 combined oxidative phosphorylation defect type 21 0.0013214134505141377 0.25721\n",
      "MONDO:0013642 holoprosencephaly 11 0.0013214134505141377 0.25721\n",
      "MONDO:0032699 epilepsy, idiopathic generalized, susceptibility to, 15 0.0013214134505141377 0.25721\n",
      "MONDO:0012029 microcephaly 6, primary, autosomal recessive 0.0013214134505141377 0.25721\n",
      "MONDO:0014071 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11 0.0013214134505141377 0.25721\n",
      "MONDO:0014168 severe combined immunodeficiency due to CORO1A deficiency 0.0013214134505141377 0.25721\n",
      "MONDO:0014444 Bardet-Biedl syndrome 16 0.0013214134505141377 0.25721\n",
      "MONDO:0010473 X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome 0.0013214134505141377 0.25721\n",
      "MONDO:0014408 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 0.0013214134505141377 0.25721\n",
      "MONDO:0014517 generalized epilepsy with febrile seizures plus, type 9 0.0013214134505141377 0.25721\n",
      "MONDO:0030849 intellectual developmental disorder with speech delay and axonal peripheral neuropathy 0.0013214134505141377 0.25721\n",
      "MONDO:0009952 radioulnar synostosis-developmental delay-hypotonia syndrome 0.0013214134505141377 0.25721\n",
      "MONDO:0014170 complex cortical dysplasia with other brain malformations 3 0.0013214134505141377 0.25721\n",
      "MONDO:0031031 intellectual developmental disorder, autosomal recessive 77 0.0013214134505141377 0.25721\n",
      "MONDO:0013773 porencephaly 2 0.0013214134505141377 0.25721\n",
      "MONDO:0012992 pancreatic insufficiency-anemia-hyperostosis syndrome 0.0013214134505141377 0.25721\n",
      "MONDO:0032827 epilepsy, idiopathic generalized, susceptibility to, 16 0.0013214134505141377 0.25721\n",
      "MONDO:0014600 dyskeratosis congenita, autosomal recessive 6 0.0013214134505141377 0.25721\n",
      "MONDO:0014171 complex cortical dysplasia with other brain malformations 4 0.0013214134505141377 0.25721\n",
      "MONDO:0030862 COACH syndrome 3 0.0013214134505141377 0.25721\n",
      "MONDO:0013661 combined malonic and methylmalonic acidemia 0.0013214134505141377 0.25721\n",
      "MONDO:0009475 isovaleric acidemia 0.0013214134505141377 0.25721\n",
      "MONDO:0014449 congenital analbuminemia 0.0013214134505141377 0.25721\n",
      "MONDO:0032894 neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy 0.0013214134505141377 0.25721\n",
      "MONDO:0012324 Frias syndrome 0.0013214134505141377 0.25721\n",
      "MONDO:0020787 hypomagnesemia, seizures, and intellectual disability 1 0.0013214134505141377 0.25721\n",
      "MONDO:0011627 autism, susceptibility to, 5 0.0013214134505141377 0.25721\n",
      "MONDO:0009760 Norman-Roberts syndrome 0.0013214134505141377 0.25721\n",
      "MONDO:0032789 intellectual developmental disorder, autosomal recessive 71 0.0013214134505141377 0.25721\n",
      "MONDO:0030454 Joubert syndrome 39 0.0013214134505141377 0.25721\n",
      "MONDO:0029135 muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8 0.0013214134505141377 0.25721\n",
      "MONDO:0032627 mitochondrial complex 1 deficiency, nuclear type 23 0.0015100442052276759 0.251713\n",
      "MONDO:0009562 beta-mannosidosis 0.0015100442052276759 0.251713\n",
      "MONDO:0013690 Pitt-Hopkins-like syndrome 2 0.0015100442052276759 0.251713\n",
      "MONDO:0011203 Pierre Robin sequence with pectus excavatum and rib and scapular anomalies 0.0015100442052276759 0.251713\n",
      "MONDO:0013491 megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without intellectual disability 0.0015100442052276759 0.251713\n",
      "MONDO:0032678 developmental and epileptic encephalopathy, 71 0.0015100442052276759 0.251713\n",
      "MONDO:0859207 neurodevelopmental disorder with hypotonia and gross motor and speech delay 0.0015100442052276759 0.251713\n",
      "MONDO:0014142 autosomal recessive limb-girdle muscular dystrophy type 2T 0.0015100442052276759 0.251713\n",
      "MONDO:0011152 PHGDH deficiency 0.0015100442052276759 0.251713\n",
      "MONDO:0010558 choroideremia-deafness-obesity syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0030513 dystonia 33 0.0015100442052276759 0.251713\n",
      "MONDO:0032619 mitochondrial complex 1 deficiency, nuclear type 14 0.0015100442052276759 0.251713\n",
      "MONDO:0014086 osteogenesis imperfecta type 15 0.0015100442052276759 0.251713\n",
      "MONDO:0010334 severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0032883 intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures 0.0015100442052276759 0.251713\n",
      "MONDO:0010489 intellectual disability, X-linked 101 0.0015100442052276759 0.251713\n",
      "MONDO:0859303 intellectual developmental disorder with ocular anomalies and distinctive facial features 0.0015100442052276759 0.251713\n",
      "MONDO:0009353 homocystinuria due to methylene tetrahydrofolate reductase deficiency 0.0015100442052276759 0.251713\n",
      "MONDO:0030518 trichothiodystrophy 9, nonphotosensitive 0.0015100442052276759 0.251713\n",
      "MONDO:0014118 congenital neutropenia-myelofibrosis-nephromegaly syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0030535 epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessive 0.0015100442052276759 0.251713\n",
      "MONDO:0010912 fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement 0.0015100442052276759 0.251713\n",
      "MONDO:0044313 intellectual disability, autosomal recessive 60 0.0015100442052276759 0.251713\n",
      "MONDO:0010485 X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0014696 cerebrooculofacioskeletal syndrome 3 0.0015100442052276759 0.251713\n",
      "MONDO:0013388 developmental and epileptic encephalopathy, 11 0.0015100442052276759 0.251713\n",
      "MONDO:0012849 Joubert syndrome 9 0.0015100442052276759 0.251713\n",
      "MONDO:0013302 nephronophthisis 11 0.0015100442052276759 0.251713\n",
      "MONDO:0033649 mitochondrial complex 4 deficiency, nuclear type 14 0.0015100442052276759 0.251713\n",
      "MONDO:0020788 hypomagnesemia, seizures, and intellectual disability 2 0.0015100442052276759 0.251713\n",
      "MONDO:0030045 Liberfarb syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0011676 PHACE syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0023670 Bardet-Biedl syndrome 20 0.0015100442052276759 0.251713\n",
      "MONDO:0033369 developmental and epileptic encephalopathy, 60 0.0015100442052276759 0.251713\n",
      "MONDO:0014350 Seckel syndrome 8 0.0015100442052276759 0.251713\n",
      "MONDO:0033115 spinocerebellar ataxia, autosomal recessive 25 0.0015100442052276759 0.251713\n",
      "MONDO:0014972 chromosome 19q13.11 deletion syndrome, proximal 0.0015100442052276759 0.251713\n",
      "MONDO:0009324 Hartnup disease 0.0015100442052276759 0.251713\n",
      "MONDO:0010555 X-linked chondrodysplasia punctata 1 0.0015100442052276759 0.251713\n",
      "MONDO:0859265 neurodevelopmental disorder with epilepsy and brain atrophy 0.0015100442052276759 0.251713\n",
      "MONDO:0012037 intellectual disability, autosomal recessive 3 0.0015100442052276759 0.251713\n",
      "MONDO:0012740 chromosome 22q11.2 deletion syndrome, distal 0.0015100442052276759 0.251713\n",
      "MONDO:0013645 autosomal recessive spinocerebellar ataxia 11 0.0015100442052276759 0.251713\n",
      "MONDO:0032843 oculopharyngeal myopathy with leukoencephalopathy 1 0.0015100442052276759 0.251713\n",
      "MONDO:0009529 pyruvate dehydrogenase E3 deficiency 0.0016986393312994233 0.246931\n",
      "MONDO:0013772 Huppke-Brendel syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0013936 peroxisome biogenesis disorder 6A (Zellweger) 0.0016986393312994233 0.246931\n",
      "MONDO:0013890 congenital myopathy with internal nuclei and atypical cores 0.0016986393312994233 0.246931\n",
      "MONDO:0044299 myasthenic syndrome, congenital, 22 0.0016986393312994233 0.246931\n",
      "MONDO:0009868 glycogen storage disease IXb 0.0016986393312994233 0.246931\n",
      "MONDO:0010598 glycogen storage disease IXa1 0.0016986393312994233 0.246931\n",
      "MONDO:0054764 neurodegeneration with brain iron accumulation 8 0.0016986393312994233 0.246931\n",
      "MONDO:0010393 intellectual disability, X-linked 93 0.0016986393312994233 0.246931\n",
      "MONDO:0013994 Joubert syndrome 20 0.0016986393312994233 0.246931\n",
      "MONDO:0859346 mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition 0.0016986393312994233 0.246931\n",
      "MONDO:0014771 Joubert syndrome 26 0.0016986393312994233 0.246931\n",
      "MONDO:0009560 oculotrichoanal syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0030034 epilepsy, progressive myoclonic, 11 0.0016986393312994233 0.246931\n",
      "MONDO:0014437 Bardet-Biedl syndrome 9 0.0016986393312994233 0.246931\n",
      "MONDO:0014666 hypomyelinating leukodystrophy 11 0.0016986393312994233 0.246931\n",
      "MONDO:0010665 Wilson-Turner syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0009285 gamma-glutamyl transpeptidase deficiency 0.0016986393312994233 0.246931\n",
      "MONDO:0032902 Joubert syndrome 36 0.0016986393312994233 0.246931\n",
      "MONDO:0013394 porencephaly-microcephaly-bilateral congenital cataract syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0012588 neuronal ceroid lipofuscinosis 7 0.0016986393312994233 0.246931\n",
      "MONDO:0032741 neurodevelopmental disorder with impaired speech and hyperkinetic movements 0.0016986393312994233 0.246931\n",
      "MONDO:0013687 autosomal recessive spinocerebellar ataxia 12 0.0016986393312994233 0.246931\n",
      "MONDO:0958185 mitochondrial trifunctional protein deficiency 2 0.0016986393312994233 0.246931\n",
      "MONDO:0013254 microcephaly, seizures, and developmental delay 0.0016986393312994233 0.246931\n",
      "MONDO:0014590 congenital myasthenic syndrome 18 0.0016986393312994233 0.246931\n",
      "MONDO:0013509 intellectual disability, autosomal dominant 6 0.0016986393312994233 0.246931\n",
      "MONDO:0032642 arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development 0.0016986393312994233 0.246931\n",
      "MONDO:0012756 proximal 16p11.2 microdeletion syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0032573 bone marrow failure syndrome 5 0.0016986393312994233 0.246931\n",
      "MONDO:0009611 3-methylglutaconic aciduria type 4 0.0016986393312994233 0.246931\n",
      "MONDO:0010508 intellectual disability, X-linked 103 0.0016986393312994233 0.246931\n",
      "MONDO:0859281 intellectual developmental disorder with autism and dysmorphic facies 0.0016986393312994233 0.246931\n",
      "MONDO:0013440 autosomal recessive limb-girdle muscular dystrophy type 2P 0.0016986393312994233 0.246931\n",
      "MONDO:0030909 intellectual disability, X-linked, syndromic, Houge type 0.0016986393312994233 0.246931\n",
      "MONDO:0032818 neurodevelopmental disorder with cerebellar hypoplasia and spasticity 0.0016986393312994233 0.246931\n",
      "MONDO:0054736 mosaic variegated aneuploidy syndrome 3 0.0016986393312994233 0.246931\n",
      "MONDO:0014328 developmental and epileptic encephalopathy, 19 0.0016986393312994233 0.246931\n",
      "MONDO:0957534 megalencephalic leukoencephalopathy with subcortical cysts 4, remitting 0.0016986393312994233 0.246931\n",
      "MONDO:0859256 neurodevelopmental disorder with language delay and seizures 0.0016986393312994233 0.246931\n",
      "MONDO:0032598 developmental and epileptic encephalopathy, 68 0.0016986393312994233 0.246931\n",
      "MONDO:0957543 auriculocondylar syndrome 4 0.0016986393312994233 0.246931\n",
      "MONDO:0011506 familial infantile myoclonic epilepsy 0.0016986393312994233 0.246931\n",
      "MONDO:0060554 vertebral, cardiac, renal, and limb defects syndrome 1 0.0016986393312994233 0.246931\n",
      "MONDO:0009622 Jawad syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0033203 nephrotic syndrome 14 0.0016986393312994233 0.246931\n",
      "MONDO:0013074 encephalocraniocutaneous lipomatosis 0.0016986393312994233 0.246931\n",
      "MONDO:0032927 triokinase and FMN cyclase deficiency syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0010890 acrocardiofacial syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0013338 Charcot-Marie-Tooth disease recessive intermediate B 0.0016986393312994233 0.246931\n",
      "MONDO:0032842 Siddiqi syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0012504 camptodactyly-tall stature-scoliosis-hearing loss syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0030476 Galloway-Mowat syndrome 10 0.0018871988354589298 0.242705\n",
      "MONDO:0859514 congenital myopathy 18 0.0018871988354589298 0.242705\n",
      "MONDO:0032839 noonan syndrome 12 0.0018871988354589298 0.242705\n",
      "MONDO:0013008 combined immunodeficiency due to STIM1 deficiency 0.0018871988354589298 0.242705\n",
      "MONDO:0030311 combined oxidative phosphorylation deficiency 52 0.0018871988354589298 0.242705\n",
      "MONDO:0010100 Tay-Sachs disease 0.0018871988354589298 0.242705\n",
      "MONDO:0013793 encephalomyopathy, mitochondrial, due to voltage-dependent anion channel deficiency 0.0018871988354589298 0.242705\n",
      "MONDO:0017715 3-hydroxyacyl-CoA dehydrogenase deficiency 0.0018871988354589298 0.242705\n",
      "MONDO:0010366 FG syndrome 5 0.0018871988354589298 0.242705\n",
      "MONDO:0020739 hypercalcemia, infantile, 1 0.0018871988354589298 0.242705\n",
      "MONDO:0013325 COG5-congenital disorder of glycosylation 0.0018871988354589298 0.242705\n",
      "MONDO:0012245 developmental and epileptic encephalopathy, 3 0.0018871988354589298 0.242705\n",
      "MONDO:0014585 congenital myasthenic syndrome 3C 0.0018871988354589298 0.242705\n",
      "MONDO:0030044 pseudo-TORCH syndrome 3 0.0018871988354589298 0.242705\n",
      "MONDO:0013274 retinitis pigmentosa 51 0.0018871988354589298 0.242705\n",
      "MONDO:0013644 Charcot-Marie-Tooth disease axonal type 2O 0.0018871988354589298 0.242705\n",
      "MONDO:0014112 cardiofaciocutaneous syndrome 2 0.0018871988354589298 0.242705\n",
      "MONDO:0010802 pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0032635 mitochondrial complex 1 deficiency, nuclear type 32 0.0018871988354589298 0.242705\n",
      "MONDO:0033282 multiple mitochondrial dysfunctions syndrome 5 0.0018871988354589298 0.242705\n",
      "MONDO:0014904 congenital disorder of glycosylation, type IAA 0.0018871988354589298 0.242705\n",
      "MONDO:0014116 complex cortical dysplasia with other brain malformations 2 0.0018871988354589298 0.242705\n",
      "MONDO:0014996 intellectual disability, autosomal recessive 58 0.0018871988354589298 0.242705\n",
      "MONDO:0014235 chromosome 22q13 duplication syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0957225 neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities 0.0018871988354589298 0.242705\n",
      "MONDO:0100119 Knobloch syndrome 2 0.0018871988354589298 0.242705\n",
      "MONDO:0010569 X-linked complicated corpus callosum dysgenesis 0.0018871988354589298 0.242705\n",
      "MONDO:0014297 Joubert syndrome 22 0.0018871988354589298 0.242705\n",
      "MONDO:0033667 Delpire-McNeill syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0010580 immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0011101 peroxisome biogenesis disorder 1B 0.0018871988354589298 0.242705\n",
      "MONDO:0033546 neurodegeneration, infantile-onset, biotin-responsive 0.0018871988354589298 0.242705\n",
      "MONDO:0009168 Fowler syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0014447 Bardet-Biedl syndrome 19 0.0018871988354589298 0.242705\n",
      "MONDO:0009488 keratoconus posticus circumscriptus 0.0018871988354589298 0.242705\n",
      "MONDO:0010815 spondyloepiphyseal dysplasia tarda with characteristic facies 0.0018871988354589298 0.242705\n",
      "MONDO:0054549 peroxisome biogenesis disorder 10B 0.0018871988354589298 0.242705\n",
      "MONDO:0032882 Heyn-Sproul-Jackson syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0010375 developmental and epileptic encephalopathy, 8 0.0018871988354589298 0.242705\n",
      "MONDO:0009606 methemoglobinemia due to deficiency of methemoglobin reductase 0.0018871988354589298 0.242705\n",
      "MONDO:0044304 hyperphenylalaninemia due to DNAJC12 deficiency 0.0018871988354589298 0.242705\n",
      "MONDO:0032621 mitochondrial complex 1 deficiency, nuclear type 16 0.0018871988354589298 0.242705\n",
      "MONDO:0014719 developmental and epileptic encephalopathy, 35 0.0018871988354589298 0.242705\n",
      "MONDO:0012964 chromosome 15q26-qter deletion syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0015015 congenital bile acid synthesis defect 6 0.0018871988354589298 0.242705\n",
      "MONDO:0013803 leukoencephalopathy with calcifications and cysts 0.0018871988354589298 0.242705\n",
      "MONDO:0013353 intellectual disability, anterior maxillary protrusion, and strabismus 0.0018871988354589298 0.242705\n",
      "MONDO:0014159 autosomal recessive spinocerebellar ataxia 14 0.0018871988354589298 0.242705\n",
      "MONDO:0010392 glycogen storage disease due to phosphoglycerate kinase 1 deficiency 0.0018871988354589298 0.242705\n",
      "MONDO:0013527 lissencephaly 4 0.0018871988354589298 0.242705\n",
      "MONDO:0013827 hyperekplexia 3 0.0018871988354589298 0.242705\n",
      "MONDO:0014200 aldosterone-producing adenoma with seizures and neurological abnormalities 0.0018871988354589298 0.242705\n",
      "MONDO:0013321 forsythe-wakeling syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0014260 immunodeficiency, common variable, 10 0.0018871988354589298 0.242705\n",
      "MONDO:0021013 trichothiodystrophy 4, nonphotosensitive 0.0018871988354589298 0.242705\n",
      "MONDO:0014832 intellectual disability, autosomal recessive 53 0.0018871988354589298 0.242705\n",
      "MONDO:0032900 neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements 0.0018871988354589298 0.242705\n",
      "MONDO:0014793 microcephaly-congenital cataract-psoriasiform dermatitis syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0013838 coenzyme Q10 deficiency, primary, 3 0.0018871988354589298 0.242705\n",
      "MONDO:0033638 mitochondrial complex 4 deficiency, nuclear type 8 0.0018871988354589298 0.242705\n",
      "MONDO:0013091 glycogen storage disease IXc 0.002075722724434478 0.238925\n",
      "MONDO:0010547 X-linked progressive cerebellar ataxia 0.002075722724434478 0.238925\n",
      "MONDO:0016825 mitochondrial myopathy-lactic acidosis-deafness syndrome 0.002075722724434478 0.238925\n",
      "MONDO:0859289 intestinal dysmotility syndrome 0.002075722724434478 0.238925\n",
      "MONDO:0012635 COG8-congenital disorder of glycosylation 0.002075722724434478 0.238925\n",
      "MONDO:0014569 lethal congenital contracture syndrome 7 0.002075722724434478 0.238925\n",
      "MONDO:0009292 glycogen storage disease due to glycogen branching enzyme deficiency 0.002075722724434478 0.238925\n",
      "MONDO:0011950 infantile-onset autosomal recessive nonprogressive cerebellar ataxia 0.002075722724434478 0.238925\n",
      "MONDO:0010130 dihydropyrimidine dehydrogenase deficiency 0.002075722724434478 0.238925\n",
      "MONDO:0012774 chromosome 15q13.3 microdeletion syndrome 0.002075722724434478 0.238925\n",
      "MONDO:0030046 neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity 0.002075722724434478 0.238925\n",
      "MONDO:0014862 cerebral palsy, spastic quadriplegic, 3 0.002075722724434478 0.238925\n",
      "MONDO:0859357 congenital disorder of glycosylation, type IIz 0.002075722724434478 0.238925\n",
      "MONDO:0032870 intellectual developmental disorder with short stature and behavioral abnormalities 0.002075722724434478 0.238925\n",
      "MONDO:0010660 intellectual disability, X-linked 9 0.002075722724434478 0.238925\n",
      "MONDO:0014784 severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome 0.002075722724434478 0.238925\n",
      "MONDO:0009781 Onychotrichodysplasia and neutropenia 0.002075722724434478 0.238925\n",
      "MONDO:0044323 Rahman syndrome 0.002075722724434478 0.238925\n",
      "MONDO:0014718 developmental and epileptic encephalopathy, 34 0.002075722724434478 0.238925\n",
      "MONDO:0011830 lissencephaly due to LIS1 mutation 0.002075722724434478 0.238925\n",
      "MONDO:0060745 intellectual developmental disorder with or without epilepsy or cerebellar ataxia 0.002075722724434478 0.238925\n",
      "MONDO:0030971 immunodeficiency 78 with autoimmunity and developmental delay 0.002075722724434478 0.238925\n",
      "MONDO:0011215 osteocraniostenosis 0.002075722724434478 0.238925\n",
      "MONDO:0859253 osteoporosis, childhood- or juvenile-onset, with developmental delay 0.002075722724434478 0.238925\n",
      "MONDO:0030528 immunodeficiency 93 and hypertrophic cardiomyopathy 0.002075722724434478 0.238925\n",
      "MONDO:0012830 chromosome 10q23 deletion syndrome 0.002075722724434478 0.238925\n",
      "MONDO:0012805 childhood onset GLUT1 deficiency syndrome 2 0.002075722724434478 0.238925\n",
      "MONDO:0014341 complex cortical dysplasia with other brain malformations 6 0.002075722724434478 0.238925\n",
      "MONDO:0031060 microcephaly 29, primary, autosomal recessive 0.002075722724434478 0.238925\n",
      "MONDO:0013656 intellectual disability, autosomal dominant 9 0.002075722724434478 0.238925\n",
      "MONDO:0033009 Galloway-Mowat syndrome 5 0.002075722724434478 0.238925\n",
      "MONDO:0859362 hyperinsulinemic hypoglycemia, familial, 8 0.002075722724434478 0.238925\n",
      "MONDO:0012553 cerebrooculofacioskeletal syndrome 2 0.002075722724434478 0.238925\n",
      "MONDO:0032685 infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development 0.002075722724434478 0.238925\n",
      "MONDO:0014685 progressive myoclonic epilepsy type 9 0.002075722724434478 0.238925\n",
      "MONDO:0014962 intellectual disability, autosomal recessive 57 0.002075722724434478 0.238925\n",
      "MONDO:0014691 Noonan syndrome 9 0.002075722724434478 0.238925\n",
      "MONDO:0032887 neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity 0.002075722724434478 0.238925\n",
      "MONDO:0016368 Rothmund-Thomson syndrome type 1 0.002075722724434478 0.238925\n",
      "MONDO:0030921 intellectual disability, autosomal dominant 55, with seizures 0.002075722724434478 0.238925\n",
      "MONDO:0014445 Bardet-Biedl syndrome 17 0.002075722724434478 0.238925\n",
      "MONDO:0033361 developmental and epileptic encephalopathy, 52 0.002075722724434478 0.238925\n",
      "MONDO:0014775 combined oxidative phosphorylation deficiency 28 0.002075722724434478 0.238925\n",
      "MONDO:0014059 microphthalmia, isolated, with coloboma 9 0.002075722724434478 0.238925\n",
      "MONDO:0014828 immunodeficiency-centromeric instability-facial anomalies syndrome 3 0.002075722724434478 0.238925\n",
      "MONDO:0010336 orofaciodigital syndrome VIII 0.002075722724434478 0.238925\n",
      "MONDO:0054701 Kleefstra syndrome 2 0.002075722724434478 0.238925\n",
      "MONDO:0013541 complex cortical dysplasia with other brain malformations 1 0.002075722724434478 0.238925\n",
      "MONDO:0020846 intellectual disability, autosomal recessive 64 0.002075722724434478 0.238925\n",
      "MONDO:0014495 retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome 0.002075722724434478 0.238925\n",
      "MONDO:0013811 combined oxidative phosphorylation defect type 9 0.002075722724434478 0.238925\n",
      "MONDO:0014254 otofaciocervical syndrome 2 0.002075722724434478 0.238925\n",
      "MONDO:0014051 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2 0.0022642110049530696 0.235509\n",
      "MONDO:0013867 brown-Vialetto-van Laere syndrome 2 0.0022642110049530696 0.235509\n",
      "MONDO:0008816 Chiari malformation type II 0.0022642110049530696 0.235509\n",
      "MONDO:0009123 orthostatic hypotension 1 0.0022642110049530696 0.235509\n",
      "MONDO:0033655 mitochondrial complex 4 deficiency, nuclear type 20 0.0022642110049530696 0.235509\n",
      "MONDO:0012784 autosomal recessive ataxia due to ubiquinone deficiency 0.0022642110049530696 0.235509\n",
      "MONDO:0859335 congenital myopathy 15 0.0022642110049530696 0.235509\n",
      "MONDO:0030727 developmental and epileptic encephalopathy 101 0.0022642110049530696 0.235509\n",
      "MONDO:0010447 intellectual disability, X-linked 19 0.0022642110049530696 0.235509\n",
      "MONDO:0012545 neutral lipid storage myopathy 0.0022642110049530696 0.235509\n",
      "MONDO:0100102 fetal akinesia deformation sequence 2 0.0022642110049530696 0.235509\n",
      "MONDO:0014868 developmental and epileptic encephalopathy, 38 0.0022642110049530696 0.235509\n",
      "MONDO:0010462 syndromic X-linked intellectual disability Chudley-Schwartz type 0.0022642110049530696 0.235509\n",
      "MONDO:0033570 combined oxidative phosphorylation deficiency 50 0.0022642110049530696 0.235509\n",
      "MONDO:0015004 dystonia 28, childhood-onset 0.0022642110049530696 0.235509\n",
      "MONDO:0020631 epileptic encephalopathy, infantile or early childhood, 2 0.0022642110049530696 0.235509\n",
      "MONDO:0010533 Arts syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0013634 neuropathy, hereditary sensory, type 2C 0.0022642110049530696 0.235509\n",
      "MONDO:0009349 holoprosencephaly 1 0.0022642110049530696 0.235509\n",
      "MONDO:0012407 pyridoxal phosphate-responsive seizures 0.0022642110049530696 0.235509\n",
      "MONDO:0010907 familial hypertryptophanemia 0.0022642110049530696 0.235509\n",
      "MONDO:0030912 intellectual disability, autosomal dominant 47 0.0022642110049530696 0.235509\n",
      "MONDO:0026763 holoprosencephaly 13, X-linked 0.0022642110049530696 0.235509\n",
      "MONDO:0014593 developmental and epileptic encephalopathy, 29 0.0022642110049530696 0.235509\n",
      "MONDO:0044322 intellectual developmental disorder with neuropsychiatric features 0.0022642110049530696 0.235509\n",
      "MONDO:0030318 spinocerebellar ataxia, autosomal recessive 30 0.0022642110049530696 0.235509\n",
      "MONDO:0011530 mesomelic dysplasia, Savarirayan type 0.0022642110049530696 0.235509\n",
      "MONDO:0014951 intellectual developmental disorder, autosomal recessive 74 0.0022642110049530696 0.235509\n",
      "MONDO:0012994 dopa-responsive dystonia due to sepiapterin reductase deficiency 0.0022642110049530696 0.235509\n",
      "MONDO:0030037 neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures 0.0022642110049530696 0.235509\n",
      "MONDO:0030907 intellectual disability, X-linked 106 0.0022642110049530696 0.235509\n",
      "MONDO:0033618 Vissers-Bodmer syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0011488 microcephaly 3, primary, autosomal recessive 0.0022642110049530696 0.235509\n",
      "MONDO:0859242 leukodystrophy, hypomyelinating, 24 0.0022642110049530696 0.235509\n",
      "MONDO:0012761 chromosome 3q29 microduplication syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0014730 microcephaly 16, primary, autosomal recessive 0.0022642110049530696 0.235509\n",
      "MONDO:0012694 Joubert syndrome 7 0.0022642110049530696 0.235509\n",
      "MONDO:0014065 mitochondrial complex III deficiency nuclear type 4 0.0022642110049530696 0.235509\n",
      "MONDO:0009543 prominent glabella-microcephaly-hypogenitalism syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0014311 autosomal recessive spinocerebellar ataxia 15 0.0022642110049530696 0.235509\n",
      "MONDO:0014273 microcephaly-thin corpus callosum-intellectual disability syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0012596 PSAT deficiency 0.0022642110049530696 0.235509\n",
      "MONDO:0032759 intellectual developmental disorder with short stature and variable skeletal anomalies 0.0022642110049530696 0.235509\n",
      "MONDO:0014789 CCDC115-CDG 0.0022642110049530696 0.235509\n",
      "MONDO:0009376 carbamoyl phosphate synthetase I deficiency disease 0.0022642110049530696 0.235509\n",
      "MONDO:0859266 neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy 0.0022642110049530696 0.235509\n",
      "MONDO:0020790 gaze palsy, familial horizontal, with progressive scoliosis 1 0.0022642110049530696 0.235509\n",
      "MONDO:0010873 band heterotopia of brain 0.0022642110049530696 0.235509\n",
      "MONDO:0013362 THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0009440 ichthyosiform erythroderma, corneal involvement, and hearing loss 0.0022642110049530696 0.235509\n",
      "MONDO:0014662 congenital insensitivity to pain-hypohidrosis syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0014261 growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0013927 peroxisome biogenesis disorder 3A (Zellweger) 0.002452663683740448 0.232398\n",
      "MONDO:0014119 intellectual disability-strabismus syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0009563 maple syrup urine disease 0.002452663683740448 0.232398\n",
      "MONDO:0014397 combined oxidative phosphorylation defect type 20 0.002452663683740448 0.232398\n",
      "MONDO:0014570 lethal congenital contracture syndrome 8 0.002452663683740448 0.232398\n",
      "MONDO:0012699 autosomal recessive limb-girdle muscular dystrophy type 2M 0.002452663683740448 0.232398\n",
      "MONDO:0010139 isolated thyroid-stimulating hormone deficiency 0.002452663683740448 0.232398\n",
      "MONDO:0010798 proximal tubulopathy-diabetes mellitus-cerebellar ataxia syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0032485 intellectual developmental disorder 61 0.002452663683740448 0.232398\n",
      "MONDO:0009251 fructose-1,6-bisphosphatase deficiency 0.002452663683740448 0.232398\n",
      "MONDO:0008056 myotonic dystrophy type 1 0.002452663683740448 0.232398\n",
      "MONDO:0859264 congenital myopathy 11 0.002452663683740448 0.232398\n",
      "MONDO:0012471 Aicardi-Goutieres syndrome 3 0.002452663683740448 0.232398\n",
      "MONDO:0859313 neurodevelopmental disorder with speech impairment and with or without seizures 0.002452663683740448 0.232398\n",
      "MONDO:0014889 striatonigral degeneration, childhood-onset 0.002452663683740448 0.232398\n",
      "MONDO:0030861 osteogenesis imperfecta, type 21 0.002452663683740448 0.232398\n",
      "MONDO:0958179 glycine encephalopathy 1 0.002452663683740448 0.232398\n",
      "MONDO:0009569 Hennekam-Beemer syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0014856 combined oxidative phosphorylation defect type 30 0.002452663683740448 0.232398\n",
      "MONDO:0033374 developmental and epileptic encephalopathy, 65 0.002452663683740448 0.232398\n",
      "MONDO:0009185 amelocerebrohypohidrotic syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0032657 developmental and epileptic encephalopathy, 69 0.002452663683740448 0.232398\n",
      "MONDO:0018975 neurofibromatosis type 1 0.002452663683740448 0.232398\n",
      "MONDO:0013931 peroxisome biogenesis disorder 4B 0.002452663683740448 0.232398\n",
      "MONDO:0009279 triple-A syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0033658 neurodevelopmental disorder with seizures and brain atrophy 0.002452663683740448 0.232398\n",
      "MONDO:0013281 COG4-congenital disorder of glycosylation 0.002452663683740448 0.232398\n",
      "MONDO:0014066 mitochondrial complex III deficiency nuclear type 5 0.002452663683740448 0.232398\n",
      "MONDO:0859260 Dworschak-Punetha neurodevelopmental syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0008287 Greig cephalopolysyndactyly syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0009866 phosphoenolpyruvate carboxykinase deficiency, cytosolic 0.002452663683740448 0.232398\n",
      "MONDO:0032875 short stature and microcephaly with genital anomalies 0.002452663683740448 0.232398\n",
      "MONDO:0010467 Xq27.3q28 duplication syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0030673 spastic paraplegia 86, autosomal recessive 0.002452663683740448 0.232398\n",
      "MONDO:0011736 Cree intellectual disability syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0024552 linear skin defects with multiple congenital anomalies 1 0.002452663683740448 0.232398\n",
      "MONDO:0007733 holoprosencephaly 3 0.002452663683740448 0.232398\n",
      "MONDO:0014678 intellectual disability, autosomal dominant 39 0.002452663683740448 0.232398\n",
      "MONDO:0013962 hereditary spastic paraplegia 53 0.002452663683740448 0.232398\n",
      "MONDO:0033641 cleft palate, proliferative retinopathy, and developmental delay 0.002452663683740448 0.232398\n",
      "MONDO:0014807 spinal muscular atrophy with congenital bone fractures 2 0.002452663683740448 0.232398\n",
      "MONDO:0011437 microcephaly 4, primary, autosomal recessive 0.002452663683740448 0.232398\n",
      "MONDO:0030902 mitochondrial complex 1 deficiency, nuclear type 36 0.002452663683740448 0.232398\n",
      "MONDO:0032596 myasthenic syndrome, congenital, 23, presynaptic 0.002452663683740448 0.232398\n",
      "MONDO:0013549 N-acetylaspartate deficiency 0.002452663683740448 0.232398\n",
      "MONDO:0009624 microcephaly and chorioretinopathy 1 0.002452663683740448 0.232398\n",
      "MONDO:0049222 intellectual disability, X-linked 107 0.002452663683740448 0.232398\n",
      "MONDO:0014150 developmental and epileptic encephalopathy 94 0.002452663683740448 0.232398\n",
      "MONDO:0859277 intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects 0.002452663683740448 0.232398\n",
      "MONDO:0014096 microcephaly-intellectual disability-phalangeal and neurological anomalies syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0009874 Rabson-Mendenhall syndrome 0.002452663683740448 0.232398\n",
      "MONDO:0032648 mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations 0.002452663683740448 0.232398\n",
      "MONDO:0011639 Diamond-Blackfan anemia 15 with mandibulofacial dysostosis 0.002452663683740448 0.232398\n",
      "MONDO:0014928 Joubert syndrome 28 0.002452663683740448 0.232398\n",
      "MONDO:0030964 intellectual developmental disorder, autosomal dominant 67 0.002452663683740448 0.232398\n",
      "MONDO:0032623 mitochondrial complex 1 deficiency, nuclear type 18 0.002452663683740448 0.232398\n",
      "MONDO:0030376 Martsolf syndrome 2 0.002452663683740448 0.232398\n",
      "MONDO:0100217 developmental delay with short stature, dysmorphic facial features, and sparse hair 2 0.002452663683740448 0.232398\n",
      "MONDO:0030696 mitochondrial DNA depletion syndrome 20 (mngie type) 0.002452663683740448 0.232398\n",
      "MONDO:0011257 MPI-congenital disorder of glycosylation 0.0026410807675210763 0.229543\n",
      "MONDO:0013111 acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins 0.0026410807675210763 0.229543\n",
      "MONDO:0033645 mitochondrial complex 4 deficiency, nuclear type 11 0.0026410807675210763 0.229543\n",
      "MONDO:0015014 coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness 0.0026410807675210763 0.229543\n",
      "MONDO:0032725 developmental and epileptic encephalopathy, 74 0.0026410807675210763 0.229543\n",
      "MONDO:0030487 spondylometaphyseal dysplasia, pagnamenta type 0.0026410807675210763 0.229543\n",
      "MONDO:0007492 early-onset generalized limb-onset dystonia 0.0026410807675210763 0.229543\n",
      "MONDO:0008759 oxoglutaricaciduria 0.0026410807675210763 0.229543\n",
      "MONDO:0012719 combined PSAP deficiency 0.0026410807675210763 0.229543\n",
      "MONDO:0957540 congenital disorder of glycosylation, type IIaa 0.0026410807675210763 0.229543\n",
      "MONDO:0014752 nephrotic syndrome, type 11 0.0026410807675210763 0.229543\n",
      "MONDO:0014917 developmental and epileptic encephalopathy, 42 0.0026410807675210763 0.229543\n",
      "MONDO:0011867 microphthalmia with cyst, bilateral facial clefts, and limb anomalies 0.0026410807675210763 0.229543\n",
      "MONDO:0020770 spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3 0.0026410807675210763 0.229543\n",
      "MONDO:0009544 macrocephaly/megalencephaly syndrome, autosomal recessive 0.0026410807675210763 0.229543\n",
      "MONDO:0030674 Teebi hypertelorism syndrome 2 0.0026410807675210763 0.229543\n",
      "MONDO:0012399 complex cortical dysplasia with other brain malformations 7 0.0026410807675210763 0.229543\n",
      "MONDO:0030471 Galloway-Mowat syndrome 9 0.0026410807675210763 0.229543\n",
      "MONDO:0011533 temtamy preaxial brachydactyly syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0007247 basal ganglia calcification, idiopathic, childhood-onset 0.0026410807675210763 0.229543\n",
      "MONDO:0014101 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 0.0026410807675210763 0.229543\n",
      "MONDO:0014473 microcephaly 13, primary, autosomal recessive 0.0026410807675210763 0.229543\n",
      "MONDO:0054742 combined oxidative phosphorylation deficiency 35 0.0026410807675210763 0.229543\n",
      "MONDO:0013438 pontocerebellar hypoplasia type 2D 0.0026410807675210763 0.229543\n",
      "MONDO:0859361 neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia 0.0026410807675210763 0.229543\n",
      "MONDO:0030060 neurodevelopmental disorder with language impairment and behavioral abnormalities 0.0026410807675210763 0.229543\n",
      "MONDO:0007204 Cole-Carpenter syndrome 1 0.0026410807675210763 0.229543\n",
      "MONDO:0010854 Toriello-Lacassie-Droste syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0010507 Xq25 microduplication syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0032901 Catifa syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0013336 chromosome 19p13.13 deletion syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0010364 X-linked intellectual disability-retinitis pigmentosa syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0014559 progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0032813 developmental and epileptic encephalopathy, 79 0.0026410807675210763 0.229543\n",
      "MONDO:0020858 mitochondrial complex 5 (ATP synthase) deficiency nuclear type 5 0.0026410807675210763 0.229543\n",
      "MONDO:0008305 Currarino triad 0.0026410807675210763 0.229543\n",
      "MONDO:0013521 dyskeratosis congenita, autosomal dominant 2 0.0026410807675210763 0.229543\n",
      "MONDO:0012178 intellectual disability with optic atrophy, facial dysmorphism, microcephaly, and short stature 0.0026410807675210763 0.229543\n",
      "MONDO:0012186 Fanconi anemia complementation group I 0.0026410807675210763 0.229543\n",
      "MONDO:0014781 combined oxidative phosphorylation deficiency 29 0.0026410807675210763 0.229543\n",
      "MONDO:0010397 severe neonatal-onset encephalopathy with microcephaly 0.0026410807675210763 0.229543\n",
      "MONDO:0030929 microcephaly 27, primary, autosomal dominant 0.0026410807675210763 0.229543\n",
      "MONDO:0007938 46,XY sex reversal 4 0.0026410807675210763 0.229543\n",
      "MONDO:0012436 neonatal diabetes mellitus with congenital hypothyroidism 0.0026410807675210763 0.229543\n",
      "MONDO:0014034 severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0008988 citrullinemia type I 0.0026410807675210763 0.229543\n",
      "MONDO:0013159 muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 0.0026410807675210763 0.229543\n",
      "MONDO:0009404 hypertelorism, microtia, facial clefting syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0010325 X-linked intellectual disability, Stocco dos Santos type 0.0026410807675210763 0.229543\n",
      "MONDO:0036189 oculogastrointestinal-neurodevelopmental syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0014545 progressive myoclonic epilepsy type 8 0.0026410807675210763 0.229543\n",
      "MONDO:0100220 Rajab interstitial lung disease with brain calcifications 2 0.0026410807675210763 0.229543\n",
      "MONDO:0957254 mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A 0.0026410807675210763 0.229543\n",
      "MONDO:0008209 Char syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0033615 coenzyme q10 deficiency, primary, 9 0.0026410807675210763 0.229543\n",
      "MONDO:0009735 Netherton syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0859517 congenital myopathy 2b, severe infantile, autosomal recessive 0.002829462263018155 0.226908\n",
      "MONDO:0011529 spinocerebellar ataxia type 13 0.002829462263018155 0.226908\n",
      "MONDO:0014085 hydrocephalus, nonsyndromic, autosomal recessive 2 0.002829462263018155 0.226908\n",
      "MONDO:0009921 holoprosencephaly-postaxial polydactyly syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0014206 severe early-onset pulmonary alveolar proteinosis due to MARS deficiency 0.002829462263018155 0.226908\n",
      "MONDO:0010149 transcobalamin II deficiency 0.002829462263018155 0.226908\n",
      "MONDO:0033043 spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy 0.002829462263018155 0.226908\n",
      "MONDO:0012747 glycogen storage disease due to aldolase A deficiency 0.002829462263018155 0.226908\n",
      "MONDO:0014208 Charcot-Marie-Tooth disease type 2R 0.002829462263018155 0.226908\n",
      "MONDO:0012792 mitochondrial DNA depletion syndrome 8a 0.002829462263018155 0.226908\n",
      "MONDO:0014983 congenital myasthenic syndrome 21 0.002829462263018155 0.226908\n",
      "MONDO:0008918 carnitine-acylcarnitine translocase deficiency 0.002829462263018155 0.226908\n",
      "MONDO:0033368 developmental and epileptic encephalopathy, 59 0.002829462263018155 0.226908\n",
      "MONDO:0014778 Lamb-Shaffer syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0859262 ACCES syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0859257 intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism 0.002829462263018155 0.226908\n",
      "MONDO:0030878 Kaya-Barakat-Masson syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0013760 congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0009503 pyruvate dehydrogenase E3-binding protein deficiency 0.002829462263018155 0.226908\n",
      "MONDO:0013933 peroxisome biogenesis disorder 5B 0.002829462263018155 0.226908\n",
      "MONDO:0000208 microcephaly, short stature, and impaired glucose metabolism 1 0.002829462263018155 0.226908\n",
      "MONDO:0009990 Revesz syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0032570 Joubert syndrome 35 0.002829462263018155 0.226908\n",
      "MONDO:0032830 snijders blok-fisher syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0032858 developmental and epileptic encephalopathy, 81 0.002829462263018155 0.226908\n",
      "MONDO:0030677 Charcot-Marie-Tooth disease, demyelinating, IIA 1I 0.002829462263018155 0.226908\n",
      "MONDO:0011686 DNA ligase IV deficiency 0.002829462263018155 0.226908\n",
      "MONDO:0011738 bilateral frontoparietal polymicrogyria 0.002829462263018155 0.226908\n",
      "MONDO:0012859 autosomal recessive osteopetrosis 7 0.002829462263018155 0.226908\n",
      "MONDO:0014044 dysmorphism-conductive hearing loss-heart defect syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0014031 microcephalic primordial dwarfism, Alazami type 0.002829462263018155 0.226908\n",
      "MONDO:0014516 microcephaly and chorioretinopathy 2 0.002829462263018155 0.226908\n",
      "MONDO:0010363 intellectual disability, X-linked 91 0.002829462263018155 0.226908\n",
      "MONDO:0032850 neurooculocardiogenitourinary syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0859272 neurodevelopmental disorder with speech delay and variable ocular anomalies 0.002829462263018155 0.226908\n",
      "MONDO:0032625 mitochondrial complex 1 deficiency, nuclear type 21 0.002829462263018155 0.226908\n",
      "MONDO:0010709 early-onset parkinsonism-intellectual disability syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0014224 developmental delay with autism spectrum disorder and gait instability 0.002829462263018155 0.226908\n",
      "MONDO:0033363 developmental and epileptic encephalopathy, 54 0.002829462263018155 0.226908\n",
      "MONDO:0013059 Aicardi-Goutieres syndrome 5 0.002829462263018155 0.226908\n",
      "MONDO:0014399 ataxia-telangiectasia-like disorder 2 0.002829462263018155 0.226908\n",
      "MONDO:0957203 intellectual developmental disorder, X-linked 111 0.002829462263018155 0.226908\n",
      "MONDO:0014485 pontocerebellar hypoplasia, type 1C 0.002829462263018155 0.226908\n",
      "MONDO:0013949 peroxisome biogenesis disorder 11A (Zellweger) 0.002829462263018155 0.226908\n",
      "MONDO:0009104 Donnai-Barrow syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0009397 neonatal severe primary hyperparathyroidism 0.003017808176953609 0.224463\n",
      "MONDO:0030259 pontocerebellar hypoplasia, type 15 0.003017808176953609 0.224463\n",
      "MONDO:0012905 hypomyelinating leukodystrophy 6 0.003017808176953609 0.224463\n",
      "MONDO:0010007 microbrachycephaly-ptosis-cleft lip syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0024309 neuropathy, hereditary sensory and autonomic, type 2A 0.003017808176953609 0.224463\n",
      "MONDO:0014201 developmental and epileptic encephalopathy, 18 0.003017808176953609 0.224463\n",
      "MONDO:0011022 Potocki-Shaffer syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0009678 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 0.003017808176953609 0.224463\n",
      "MONDO:0009388 hyperlysinemia 0.003017808176953609 0.224463\n",
      "MONDO:0013989 developmental and epileptic encephalopathy, 14 0.003017808176953609 0.224463\n",
      "MONDO:0014939 congenital myasthenic syndrome 20 0.003017808176953609 0.224463\n",
      "MONDO:0011365 blepharophimosis - intellectual disability syndrome, SBBYS type 0.003017808176953609 0.224463\n",
      "MONDO:0030258 pontocerebellar hypoplasia, type 14 0.003017808176953609 0.224463\n",
      "MONDO:0033619 myopathy, epilepsy, and progressive cerebral atrophy 0.003017808176953609 0.224463\n",
      "MONDO:0060533 microcephaly, short stature, and limb abnormalities 0.003017808176953609 0.224463\n",
      "MONDO:0014596 lissencephaly 7 with cerebellar hypoplasia 0.003017808176953609 0.224463\n",
      "MONDO:0012400 cortical dysplasia-focal epilepsy syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0030900 intellectual developmental disorder with paroxysmal dyskinesia or seizures 0.003017808176953609 0.224463\n",
      "MONDO:0011313 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 0.003017808176953609 0.224463\n",
      "MONDO:0030881 developmental and epileptic encephalopathy 102 0.003017808176953609 0.224463\n",
      "MONDO:0011902 Charcot-Marie-Tooth disease type 1F 0.003017808176953609 0.224463\n",
      "MONDO:0031011 neurodevelopmental disorder with dysmorphic facies and variable seizures 0.003017808176953609 0.224463\n",
      "MONDO:0032903 arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum 0.003017808176953609 0.224463\n",
      "MONDO:0014196 Hartsfield-Bixler-Demyer syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0033533 combined oxidative phosphorylation deficiency 45 0.003017808176953609 0.224463\n",
      "MONDO:0008021 Cowden syndrome 1 0.003017808176953609 0.224463\n",
      "MONDO:0014801 even-plus syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0013238 chromosome 17q23.1-q23.2 deletion syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0032568 intellectual developmental disorder with macrocephaly, seizures, and speech delay 0.003017808176953609 0.224463\n",
      "MONDO:0033559 intellectual developmental disorder with seizures and language delay 0.003017808176953609 0.224463\n",
      "MONDO:0013536 heme oxygenase 1 deficiency 0.003017808176953609 0.224463\n",
      "MONDO:0009554 3MC syndrome 3 0.003017808176953609 0.224463\n",
      "MONDO:0014218 severe dermatitis-multiple allergies-metabolic wasting syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0054835 classic dopamine transporter deficiency syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0009610 3-methylglutaconic aciduria type 1 0.003017808176953609 0.224463\n",
      "MONDO:0030987 vertebral, cardiac, tracheoesophageal, renal, and limb defects 0.003017808176953609 0.224463\n",
      "MONDO:0014648 Al-Raqad syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0859211 neurodevelopmental disorder with hyperkinetic movements and dyskinesia 0.003017808176953609 0.224463\n",
      "MONDO:0011538 frontoocular syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0859225 neurodevelopmental disorder with or without variable movement or behavioral abnormalities 0.003017808176953609 0.224463\n",
      "MONDO:0012772 Stevenson-Carey syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0100079 developmental and epileptic encephalopathy, 6 0.003017808176953609 0.224463\n",
      "MONDO:0032730 leukodystrophy, hypomyelinating, 18 0.003017808176953609 0.224463\n",
      "MONDO:0009746 hereditary sensory and autonomic neuropathy type 4 0.003017808176953609 0.224463\n",
      "MONDO:0013226 combined immunodeficiency with faciooculoskeletal anomalies 0.003017808176953609 0.224463\n",
      "MONDO:0012581 osteogenesis imperfecta type 8 0.003017808176953609 0.224463\n",
      "MONDO:0030873 cardiofacioneurodevelopmental syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0011342 SLC35A1-congenital disorder of glycosylation 0.003017808176953609 0.224463\n",
      "MONDO:0014992 lissencephaly 8 0.003017808176953609 0.224463\n",
      "MONDO:0054695 myopathy, centronuclear, 6, with fiber-type disproportion 0.0032061185160480996 0.222183\n",
      "MONDO:0014543 congenital myasthenic syndrome 14 0.0032061185160480996 0.222183\n",
      "MONDO:0010773 mitochondrial myopathy with diabetes 0.0032061185160480996 0.222183\n",
      "MONDO:0060486 arthrogryposis multiplex congenita 1, neurogenic, with myelin defect 0.0032061185160480996 0.222183\n",
      "MONDO:0012099 AICA-ribosiduria 0.0032061185160480996 0.222183\n",
      "MONDO:0859360 spinocerebellar ataxia, autosomal recessive 33 0.0032061185160480996 0.222183\n",
      "MONDO:0030835 developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy 0.0032061185160480996 0.222183\n",
      "MONDO:0032770 intellectual developmental disorder with severe speech and ambulation defects 0.0032061185160480996 0.222183\n",
      "MONDO:0007180 Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities 0.0032061185160480996 0.222183\n",
      "MONDO:0000909 Bartter disease type 4B 0.0032061185160480996 0.222183\n",
      "MONDO:0859249 parenti-mignot neurodevelopmental syndrome 0.0032061185160480996 0.222183\n",
      "MONDO:0060562 encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities 0.0032061185160480996 0.222183\n",
      "MONDO:0010532 infantile-onset X-linked spinal muscular atrophy 0.0032061185160480996 0.222183\n",
      "MONDO:0008425 omphalocele syndrome, Shprintzen-Goldberg type 0.0032061185160480996 0.222183\n",
      "MONDO:0012669 Legius syndrome 0.0032061185160480996 0.222183\n",
      "MONDO:0054763 neurodegeneration with brain iron accumulation 7 0.0032061185160480996 0.222183\n",
      "MONDO:0032658 macrocephaly, acquired, with impaired intellectual development 0.0032061185160480996 0.222183\n",
      "MONDO:0044696 early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome 0.0032061185160480996 0.222183\n",
      "MONDO:0030994 neurodevelopmental disorder with or without autism or seizures 0.0032061185160480996 0.222183\n",
      "MONDO:0010584 dyskeratosis congenita, X-linked 0.0032061185160480996 0.222183\n",
      "MONDO:0008763 Alstrom syndrome 0.0032061185160480996 0.222183\n",
      "MONDO:0011134 Curry-Jones syndrome 0.0032061185160480996 0.222183\n",
      "MONDO:0013342 hereditary spastic paraplegia 48 0.0032061185160480996 0.222183\n",
      "MONDO:0013173 intellectual disability, autosomal recessive 13 0.0032061185160480996 0.222183\n",
      "MONDO:0014702 autosomal recessive complex spastic paraplegia type 9B 0.0032061185160480996 0.222183\n",
      "MONDO:0859307 cleidocranial dysplasia 2 0.0032061185160480996 0.222183\n",
      "MONDO:0032884 ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies 0.0032061185160480996 0.222183\n",
      "MONDO:0013969 combined oxidative phosphorylation defect type 11 0.0032061185160480996 0.222183\n",
      "MONDO:0014619 trichothiodystrophy 3, photosensitive 0.0032061185160480996 0.222183\n",
      "MONDO:0010953 Fanconi anemia complementation group E 0.0032061185160480996 0.222183\n",
      "MONDO:0010476 neurodegeneration with brain iron accumulation 5 0.0032061185160480996 0.222183\n",
      "MONDO:0032632 mitochondrial complex 1 deficiency, nuclear type 28 0.0032061185160480996 0.222183\n",
      "MONDO:0018445 global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome 0.0032061185160480996 0.222183\n",
      "MONDO:0010431 Joubert syndrome 10 0.0032061185160480996 0.222183\n",
      "MONDO:0010749 trigonocephaly-short stature-developmental delay syndrome 0.0032061185160480996 0.222183\n",
      "MONDO:0010703 ornithine carbamoyltransferase deficiency 0.0032061185160480996 0.222183\n",
      "MONDO:0030785 intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly 0.0032061185160480996 0.222183\n",
      "MONDO:0032712 combined oxidative phosphorylation deficiency 38 0.0032061185160480996 0.222183\n",
      "MONDO:0011651 intellectual disability, short stature, facial anomalies, and joint dislocations 0.0032061185160480996 0.222183\n",
      "MONDO:0008814 hyperargininemia 0.0032061185160480996 0.222183\n",
      "MONDO:0014729 hereditary spastic paraplegia 75 0.0032061185160480996 0.222183\n",
      "MONDO:0033482 spinocerebellar ataxia 47 0.0032061185160480996 0.222183\n",
      "MONDO:0859213 congenital heart defects, multiple types, 8, with or without heterotaxy 0.0032061185160480996 0.222183\n",
      "MONDO:0030517 trichothiodystrophy 8, nonphotosensitive 0.0032061185160480996 0.222183\n",
      "MONDO:0957495 hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature 0.0032061185160480996 0.222183\n",
      "MONDO:0033547 Li-Ghorbani-Weisz-Hubshman syndrome 0.0032061185160480996 0.222183\n",
      "MONDO:0014512 PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation 0.0032061185160480996 0.222183\n",
      "MONDO:0800438 developmental delay with short stature, dysmorphic facial features, and sparse hair 1 0.0032061185160480996 0.222183\n",
      "MONDO:0014787 severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome 0.0032061185160480996 0.222183\n",
      "MONDO:0012789 dystonia 16 0.0032061185160480996 0.222183\n",
      "MONDO:0024264 hypothyroidism, congenital, nongoitrous, 2 0.0033943932870210093 0.220049\n",
      "MONDO:0012240 congenital myopathy 23 0.0033943932870210093 0.220049\n",
      "MONDO:0013307 myopathy, lactic acidosis, and sideroblastic anemia 2 0.0033943932870210093 0.220049\n",
      "MONDO:0010667 Prieto syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0012393 congenital brain dysgenesis due to glutamine synthetase deficiency 0.0033943932870210093 0.220049\n",
      "MONDO:0013178 congenital muscular dystrophy due to LMNA mutation 0.0033943932870210093 0.220049\n",
      "MONDO:0010398 syndromic X-linked intellectual disability 14 0.0033943932870210093 0.220049\n",
      "MONDO:0030979 endove syndrome, limb-brain type 0.0033943932870210093 0.220049\n",
      "MONDO:0010271 X-linked myotubular myopathy-abnormal genitalia syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0030977 neuronopathy, distal hereditary motor, autosomal recessive 7 0.0033943932870210093 0.220049\n",
      "MONDO:0008922 Sengers syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0009705 carnitine palmitoyl transferase 1A deficiency 0.0033943932870210093 0.220049\n",
      "MONDO:0010814 chondrodysplasia-pseudohermaphroditism syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0029131 peripheral neuropathy, autosomal recessive, with or without impaired intellectual development 0.0033943932870210093 0.220049\n",
      "MONDO:0054817 leukodystrophy, hypomyelinating, 17 0.0033943932870210093 0.220049\n",
      "MONDO:0015350 17q11.2 microduplication syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0011287 craniosynostosis-anal anomalies-porokeratosis syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0032691 Galloway-Mowat syndrome 6 0.0033943932870210093 0.220049\n",
      "MONDO:0014813 hypomyelinating leukodystrophy 13 0.0033943932870210093 0.220049\n",
      "MONDO:0014238 severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0012698 Waardenburg syndrome type 2E 0.0033943932870210093 0.220049\n",
      "MONDO:0014767 Seckel syndrome 9 0.0033943932870210093 0.220049\n",
      "MONDO:0014018 hereditary spastic paraplegia 54 0.0033943932870210093 0.220049\n",
      "MONDO:0012241 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3 0.0033943932870210093 0.220049\n",
      "MONDO:0044204 Shwachman-Diamond syndrome 1 0.0033943932870210093 0.220049\n",
      "MONDO:0011724 encephalopathy due to GLUT1 deficiency 0.0033943932870210093 0.220049\n",
      "MONDO:0032916 Imagawa-Matsumoto syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0030890 pontocerebellar hypoplasia, IIA 17 0.0033943932870210093 0.220049\n",
      "MONDO:0013566 Fanconi anemia complementation group L 0.0033943932870210093 0.220049\n",
      "MONDO:0013158 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 0.0033943932870210093 0.220049\n",
      "MONDO:0009655 mucopolysaccharidosis type 3A 0.0033943932870210093 0.220049\n",
      "MONDO:0044701 childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder 0.0033943932870210093 0.220049\n",
      "MONDO:0012322 holoprosencephaly 5 0.0033943932870210093 0.220049\n",
      "MONDO:0014358 AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0013822 acrodysostosis 2 with or without hormone resistance 0.0033943932870210093 0.220049\n",
      "MONDO:0014290 neurodegeneration with brain iron accumulation 6 0.0033943932870210093 0.220049\n",
      "MONDO:0009191 Lowry-Wood syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0032791 Coffin-Siris syndrome 10 0.0033943932870210093 0.220049\n",
      "MONDO:0009795 orofaciodigital syndrome IX 0.0033943932870210093 0.220049\n",
      "MONDO:0014023 congenital muscular dystrophy with intellectual disability and severe epilepsy 0.0033943932870210093 0.220049\n",
      "MONDO:0957221 spastic paraplegia 70, autosomal recessive 0.0033943932870210093 0.220049\n",
      "MONDO:0060641 neurodevelopmental disorder with or without seizures and gait abnormalities 0.0033943932870210093 0.220049\n",
      "MONDO:0010523 X-linked reticulate pigmentary disorder 0.0033943932870210093 0.220049\n",
      "MONDO:0044208 specific granule deficiency 2 0.0033943932870210093 0.220049\n",
      "MONDO:0020796 Silver-Russell syndrome 1 0.0033943932870210093 0.220049\n",
      "MONDO:0014888 MIRAGE syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0008434 Smith-Magenis syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0014797 lymphatic malformation 6 0.0033943932870210093 0.220049\n",
      "MONDO:0014933 developmental and epileptic encephalopathy, 44 0.0033943932870210093 0.220049\n",
      "MONDO:0014233 early-onset Parkinson disease 20 0.0033943932870210093 0.220049\n",
      "MONDO:0014896 congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome 0.00358263249659046 0.218044\n",
      "MONDO:0024557 ataxia-telangiectasia-like disorder 1 0.00358263249659046 0.218044\n",
      "MONDO:0010679 Duchenne muscular dystrophy 0.00358263249659046 0.218044\n",
      "MONDO:0020775 congenital disorder of glycosylation with defective fucosylation 1 0.00358263249659046 0.218044\n",
      "MONDO:0014672 osteogenesis imperfecta type 17 0.00358263249659046 0.218044\n",
      "MONDO:0859202 developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities 0.00358263249659046 0.218044\n",
      "MONDO:0032675 myasthenic syndrome, congenital, 25, presynaptic 0.00358263249659046 0.218044\n",
      "MONDO:0056797 neurodevelopmental disorder with midbrain and hindbrain malformations 0.00358263249659046 0.218044\n",
      "MONDO:0013594 spinocerebellar ataxia type 36 0.00358263249659046 0.218044\n",
      "MONDO:0060490 neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies 0.00358263249659046 0.218044\n",
      "MONDO:0011969 ALG8-congenital disorder of glycosylation 0.00358263249659046 0.218044\n",
      "MONDO:0013787 psychomotor retardation, epilepsy, and craniofacial dysmorphism 0.00358263249659046 0.218044\n",
      "MONDO:0013835 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 0.00358263249659046 0.218044\n",
      "MONDO:0014335 diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome 0.00358263249659046 0.218044\n",
      "MONDO:0018130 brain dopamine-serotonin vesicular transport disease 0.00358263249659046 0.218044\n",
      "MONDO:0032692 Galloway-Mowat syndrome 7 0.00358263249659046 0.218044\n",
      "MONDO:0024538 basal ganglia calcification, idiopathic, 1 0.00358263249659046 0.218044\n",
      "MONDO:0032618 mitochondrial complex 1 deficiency, nuclear type 13 0.00358263249659046 0.218044\n",
      "MONDO:0013553 immunodeficiency-centromeric instability-facial anomalies syndrome 2 0.00358263249659046 0.218044\n",
      "MONDO:0012073 ribose-5-P isomerase deficiency 0.00358263249659046 0.218044\n",
      "MONDO:0013853 pontocerebellar hypoplasia type 1B 0.00358263249659046 0.218044\n",
      "MONDO:0030031 lissencephaly 10 0.00358263249659046 0.218044\n",
      "MONDO:0010412 X-linked intellectual disability-craniofacioskeletal syndrome 0.00358263249659046 0.218044\n",
      "MONDO:0009352 classic homocystinuria 0.00358263249659046 0.218044\n",
      "MONDO:0014806 spinal muscular atrophy with congenital bone fractures 1 0.00358263249659046 0.218044\n",
      "MONDO:0012514 hypomyelinating leukodystrophy 5 0.00358263249659046 0.218044\n",
      "MONDO:0009843 hypomyelinating leukodystrophy 3 0.00358263249659046 0.218044\n",
      "MONDO:0030947 neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities 0.00358263249659046 0.218044\n",
      "MONDO:0859564 epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features 0.00358263249659046 0.218044\n",
      "MONDO:0032807 neurodevelopmental disorder with visual defects and brain anomalies 0.00358263249659046 0.218044\n",
      "MONDO:0024465 surfactant metabolism dysfunction, pulmonary, 2 0.00358263249659046 0.218044\n",
      "MONDO:0032888 neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies 0.00358263249659046 0.218044\n",
      "MONDO:0020765 neuropathy, congenital hypomyelinating, 2 0.0037708361514733027 0.216154\n",
      "MONDO:0009499 Krabbe disease 0.0037708361514733027 0.216154\n",
      "MONDO:0020714 mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy 0.0037708361514733027 0.216154\n",
      "MONDO:0032753 spastic ataxia 9, autosomal recessive 0.0037708361514733027 0.216154\n",
      "MONDO:0030897 Lessel-Kreienkamp syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0032778 arthrogryposis multiplex congenita 3, myogenic type 0.0037708361514733027 0.216154\n",
      "MONDO:0100255 adenosine kinase deficiency 0.0037708361514733027 0.216154\n",
      "MONDO:0012301 mitochondrial DNA depletion syndrome, myopathic form 0.0037708361514733027 0.216154\n",
      "MONDO:0009712 congenital multicore myopathy with external ophthalmoplegia 0.0037708361514733027 0.216154\n",
      "MONDO:0859251 Dentici-Novelli neurodevelopmental syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0033651 mitochondrial complex 4 deficiency, nuclear type 16 0.0037708361514733027 0.216154\n",
      "MONDO:0026724 Paganini-Miozzo syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0011504 NDE1-related microhydranencephaly 0.0037708361514733027 0.216154\n",
      "MONDO:0032878 neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia 0.0037708361514733027 0.216154\n",
      "MONDO:0054748 Fanconi anemia, complementation group S 0.0037708361514733027 0.216154\n",
      "MONDO:0012212 Loeys-Dietz syndrome 1 0.0037708361514733027 0.216154\n",
      "MONDO:0011628 propionic acidemia 0.0037708361514733027 0.216154\n",
      "MONDO:0011402 congenital cataracts-facial dysmorphism-neuropathy syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0032820 neurodevelopmental disorder with structural brain anomalies and dysmorphic facies 0.0037708361514733027 0.216154\n",
      "MONDO:0014067 short ulna-dysmorphism-hypotonia-intellectual disability syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0859212 neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus 0.0037708361514733027 0.216154\n",
      "MONDO:0014533 developmental and epileptic encephalopathy, 28 0.0037708361514733027 0.216154\n",
      "MONDO:0014599 intellectual disability, autosomal dominant 34 0.0037708361514733027 0.216154\n",
      "MONDO:0010224 corpus callosum agenesis-abnormal genitalia syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0008815 argininosuccinic aciduria 0.0037708361514733027 0.216154\n",
      "MONDO:0014908 microcephaly 17, primary, autosomal recessive 0.0037708361514733027 0.216154\n",
      "MONDO:0014506 hypomyelinating leukodystrophy 9 0.0037708361514733027 0.216154\n",
      "MONDO:0010613 inborn glycerol kinase deficiency 0.0037708361514733027 0.216154\n",
      "MONDO:0013905 autosomal recessive spinocerebellar ataxia 13 0.0037708361514733027 0.216154\n",
      "MONDO:0100348 neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities 0.0037708361514733027 0.216154\n",
      "MONDO:0011897 leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0100095 neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures 0.0037708361514733027 0.216154\n",
      "MONDO:0008723 very long chain acyl-CoA dehydrogenase deficiency 0.003959004258385117 0.214368\n",
      "MONDO:0011281 congenital myasthenic syndrome 5 0.003959004258385117 0.214368\n",
      "MONDO:0013754 cutis laxa, autosomal recessive, type 1B 0.003959004258385117 0.214368\n",
      "MONDO:0020507 leukoencephalopathy with vanishing white matter 1 0.003959004258385117 0.214368\n",
      "MONDO:0030997 mitochondrial complex 1 deficiency, nuclear type 37 0.003959004258385117 0.214368\n",
      "MONDO:0011038 cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome 0.003959004258385117 0.214368\n",
      "MONDO:0009706 hereditary myopathy with lactic acidosis due to ISCU deficiency 0.003959004258385117 0.214368\n",
      "MONDO:0012157 congenital myasthenic syndrome 4C 0.003959004258385117 0.214368\n",
      "MONDO:0010268 X-linked lissencephaly with abnormal genitalia 0.003959004258385117 0.214368\n",
      "MONDO:0013731 MEGF10-related myopathy 0.003959004258385117 0.214368\n",
      "MONDO:0009394 juvenile Paget disease 0.003959004258385117 0.214368\n",
      "MONDO:0859327 developmental and epileptic encephalopathy 110 0.003959004258385117 0.214368\n",
      "MONDO:0032787 holoprosencephaly 12 with or without pancreatic agenesis 0.003959004258385117 0.214368\n",
      "MONDO:0014617 intellectual disability, autosomal dominant 38 0.003959004258385117 0.214368\n",
      "MONDO:0014941 arthrogryposis, distal, with impaired proprioception and touch 0.003959004258385117 0.214368\n",
      "MONDO:0018820 recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome 0.003959004258385117 0.214368\n",
      "MONDO:0054782 leukodystrophy, hypomyelinating, 15 0.003959004258385117 0.214368\n",
      "MONDO:0859188 neurodevelopmental disorder with seizures and brain abnormalities 0.003959004258385117 0.214368\n",
      "MONDO:0032774 cerebellar, ocular, craniofacial, and genital syndrome 0.003959004258385117 0.214368\n",
      "MONDO:0013672 chromosome 15q25 deletion syndrome 0.003959004258385117 0.214368\n",
      "MONDO:0010543 Barth syndrome 0.003959004258385117 0.214368\n",
      "MONDO:0010714 Pelizeaus-Merzbacher spectrum disorder 0.003959004258385117 0.214368\n",
      "MONDO:0012125 hypomyelinating leukodystrophy 2 0.003959004258385117 0.214368\n",
      "MONDO:0012516 mandibulofacial dysostosis-microcephaly syndrome 0.003959004258385117 0.214368\n",
      "MONDO:0013987 combined oxidative phosphorylation defect type 15 0.003959004258385117 0.214368\n",
      "MONDO:0014811 cerebellar atrophy, visual impairment, and psychomotor retardation; 0.003959004258385117 0.214368\n",
      "MONDO:0012563 holoprosencephaly 9 0.003959004258385117 0.214368\n",
      "MONDO:0013675 multiple mitochondrial dysfunctions syndrome 2 0.003959004258385117 0.214368\n",
      "MONDO:0009266 Gaucher disease type II 0.003959004258385117 0.214368\n",
      "MONDO:0859164 osteootohepatoenteric syndrome 0.003959004258385117 0.214368\n",
      "MONDO:0957397 intellectual developmental disorder, autosomal dominant 72 0.003959004258385117 0.214368\n",
      "MONDO:0859218 developmental delay with variable neurologic and brain abnormalities 0.003959004258385117 0.214368\n",
      "MONDO:0010509 intellectual disability, X-linked 104 0.003959004258385117 0.214368\n",
      "MONDO:0014636 combined oxidative phosphorylation defect type 25 0.003959004258385117 0.214368\n",
      "MONDO:0012143 hereditary cryohydrocytosis with reduced stomatin 0.003959004258385117 0.214368\n",
      "MONDO:0032758 neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia 0.003959004258385117 0.214368\n",
      "MONDO:0009965 Perlman syndrome 0.003959004258385117 0.214368\n",
      "MONDO:0013986 combined oxidative phosphorylation defect type 14 0.004147136824040217 0.212675\n",
      "MONDO:0012538 nemaline myopathy 7 0.004147136824040217 0.212675\n",
      "MONDO:0859520 Mitochondrial complex IV deficiency, nuclear type 23 0.004147136824040217 0.212675\n",
      "MONDO:0013885 Malan overgrowth syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0859171 Luo-Schoch-Yamamoto syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0010537 Borjeson-Forssman-Lehmann syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0859252 neurodevelopmental disorder with poor growth and skeletal anomalies 0.004147136824040217 0.212675\n",
      "MONDO:0013655 intellectual disability, autosomal dominant 8 0.004147136824040217 0.212675\n",
      "MONDO:0012156 myasthenic syndrome, congenital, 1B, fast-channel 0.004147136824040217 0.212675\n",
      "MONDO:0030974 mitochondrial complex 2 deficiency, nuclear type 4 0.004147136824040217 0.212675\n",
      "MONDO:0030035 leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0012078 Joubert syndrome 3 0.004147136824040217 0.212675\n",
      "MONDO:0013881 pidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0035819 cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0009820 osteoporosis-pseudoglioma syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0011242 Bartter disease type 4A 0.004147136824040217 0.212675\n",
      "MONDO:0007525 Ehlers-Danlos syndrome, arthrochalasis type 0.004147136824040217 0.212675\n",
      "MONDO:0009591 metachromatic leukodystrophy, juvenile form 0.004147136824040217 0.212675\n",
      "MONDO:0009131 Riley-Day syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0008267 orofaciodigital syndrome V 0.004147136824040217 0.212675\n",
      "MONDO:0032779 neurodevelopmental disorder with microcephaly and structural brain anomalies 0.004147136824040217 0.212675\n",
      "MONDO:0060758 spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits 0.004147136824040217 0.212675\n",
      "MONDO:0013432 Meier-Gorlin syndrome 5 0.004147136824040217 0.212675\n",
      "MONDO:0032934 genitourinary and/or brain malformation syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0034145 oculocerebrodental syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0030473 developmental and epileptic encephalopathy 99 0.004147136824040217 0.212675\n",
      "MONDO:0010281 Danon disease 0.004147136824040217 0.212675\n",
      "MONDO:0012371 Noonan syndrome 3 0.004147136824040217 0.212675\n",
      "MONDO:0032795 intellectual developmental disorder 59 0.004147136824040217 0.212675\n",
      "MONDO:0044303 congenital heart defects and ectodermal dysplasia 0.004147136824040217 0.212675\n",
      "MONDO:0032793 O'Donnell-Luria-Rodan syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0014609 cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0008214 Pelger-Huet anomaly 0.004147136824040217 0.212675\n",
      "MONDO:0030933 Joubert syndrome 37 0.004147136824040217 0.212675\n",
      "MONDO:0011833 spinocerebellar ataxia type 21 0.004147136824040217 0.212675\n",
      "MONDO:0054669 pontocerebellar hypoplasia, type 11 0.004147136824040217 0.212675\n",
      "MONDO:0032636 mitochondrial complex 1 deficiency, nuclear type 33 0.004147136824040217 0.212675\n",
      "MONDO:0009863 BH4-deficient hyperphenylalaninemia A 0.004147136824040217 0.212675\n",
      "MONDO:0014132 multiple mitochondrial dysfunctions syndrome 3 0.004335233855151651 0.211067\n",
      "MONDO:0032606 mitochondrial complex 1 deficiency, nuclear type 2 0.004335233855151651 0.211067\n",
      "MONDO:0014269 combined oxidative phosphorylation deficiency 19 0.004335233855151651 0.211067\n",
      "MONDO:0014745 congenital myasthenic syndrome 19 0.004335233855151651 0.211067\n",
      "MONDO:0009583 blepharophimosis - intellectual disability syndrome, Ohdo type 0.004335233855151651 0.211067\n",
      "MONDO:0060664 neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities 0.004335233855151651 0.211067\n",
      "MONDO:0010496 X-linked intellectual disability-short stature-overweight syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0020738 multiple benign circumferential skin creases on limbs 1 0.004335233855151651 0.211067\n",
      "MONDO:0012890 pontocerebellar hypoplasia type 2B 0.004335233855151651 0.211067\n",
      "MONDO:0060578 neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures 0.004335233855151651 0.211067\n",
      "MONDO:0015010 atypical glycine encephalopathy 0.004335233855151651 0.211067\n",
      "MONDO:0012084 aromatic L-amino acid decarboxylase deficiency 0.004335233855151651 0.211067\n",
      "MONDO:0011778 multiple epiphyseal dysplasia, Al-Gazali type 0.004335233855151651 0.211067\n",
      "MONDO:0030669 gastrointestinal defects and immunodeficiency syndrome 2 0.004335233855151651 0.211067\n",
      "MONDO:0009598 metaphyseal chondrodysplasia-retinitis pigmentosa syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0014931 Alazami-Yuan syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0014838 Coffin-Siris syndrome 5 0.004335233855151651 0.211067\n",
      "MONDO:0030491 immunodeficiency 91 and hyperinflammation 0.004335233855151651 0.211067\n",
      "MONDO:0029143 intellectual developmental disorder with hypertelorism and distinctive facies 0.004335233855151651 0.211067\n",
      "MONDO:0011274 Muenke syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0012999 guanidinoacetate methyltransferase deficiency 0.004335233855151651 0.211067\n",
      "MONDO:0032571 spondyloepimetaphyseal dysplasia, Krakow type 0.004335233855151651 0.211067\n",
      "MONDO:0030886 holoprosencephaly 14 0.004335233855151651 0.211067\n",
      "MONDO:0014773 cardiac anomalies - developmental delay - facial dysmorphism syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0014693 Noonan syndrome 10 0.004335233855151651 0.211067\n",
      "MONDO:0859518 leukodystrophy, hypomyelinating, 26, with chondrodysplasia 0.004335233855151651 0.211067\n",
      "MONDO:0030061 periventricular nodular heterotopia 9 0.004335233855151651 0.211067\n",
      "MONDO:0010319 syndromic X-linked intellectual disability Hedera type 0.004335233855151651 0.211067\n",
      "MONDO:0012076 midface hypoplasia, obesity, developmental delay, and neonatal hypotonia 0.004335233855151651 0.211067\n",
      "MONDO:0009495 Keutel syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0015007 spastic paraplegia, intellectual disability, nystagmus, and obesity 0.004335233855151651 0.211067\n",
      "MONDO:0014534 lissencephaly 6 with microcephaly 0.004335233855151651 0.211067\n",
      "MONDO:0054573 Lopes-Maciel-Rodan syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0859214 Marbach-Schaaf neurodevelopmental syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0009821 lethal osteosclerotic bone dysplasia 0.004335233855151651 0.211067\n",
      "MONDO:0859136 Alzahrani-Kuwahara syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0009871 pili torti-developmental delay-neurological abnormalities syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0014791 Luscan-Lumish syndrome 0.004335233855151651 0.211067\n",
      "MONDO:0030458 Charcot-Marie-Tooth disease, axonal, Type 2HH 0.0045232953584311885 0.209536\n",
      "MONDO:0013889 short stature-optic atrophy-Pelger-HuC+t anomaly syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0008644 velocardiofacial syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0009021 Toriello-Carey syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0008608 Down syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0013845 auriculocondylar syndrome 2 0.0045232953584311885 0.209536\n",
      "MONDO:0013952 peroxisome biogenesis disorder 13A (Zellweger) 0.0045232953584311885 0.209536\n",
      "MONDO:0010822 Warburg micro syndrome 1 0.0045232953584311885 0.209536\n",
      "MONDO:0008471 spondyloepiphyseal dysplasia congenita 0.0045232953584311885 0.209536\n",
      "MONDO:0044723 3-methylglutaconic aciduria type 8 0.0045232953584311885 0.209536\n",
      "MONDO:0009636 mitochondrial DNA depletion syndrome 3 (hepatocerebral type) 0.0045232953584311885 0.209536\n",
      "MONDO:0024464 pituitary hormone deficiency, combined, 1 0.0045232953584311885 0.209536\n",
      "MONDO:0032921 neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation 0.0045232953584311885 0.209536\n",
      "MONDO:0013171 purine nucleoside phosphorylase deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0859224 intellectual disability and myopathy syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0011010 Matthew-Wood syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0032918 developmental and epileptic encephalopathy, 84 0.0045232953584311885 0.209536\n",
      "MONDO:0030852 neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities 0.0045232953584311885 0.209536\n",
      "MONDO:0024567 hypotonia, infantile, with psychomotor retardation and characteristic facies 1 0.0045232953584311885 0.209536\n",
      "MONDO:0859333 intellectual developmental disorder, autosomal dominant 70 0.0045232953584311885 0.209536\n",
      "MONDO:0010626 hyper-IgM syndrome type 1 0.0045232953584311885 0.209536\n",
      "MONDO:0032780 hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities 0.0045232953584311885 0.209536\n",
      "MONDO:0014918 tall stature-intellectual disability-renal anomalies syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0033642 neurodevelopmental disorder with alopecia and brain abnormalities 0.0045232953584311885 0.209536\n",
      "MONDO:0032939 intellectual developmental disorder, autosomal dominant 63, with macrocephaly 0.0045232953584311885 0.209536\n",
      "MONDO:0032854 zimmermann-laband syndrome 3 0.0045232953584311885 0.209536\n",
      "MONDO:0014743 rhizomelic chondrodysplasia punctata type 5 0.0045232953584311885 0.209536\n",
      "MONDO:0009216 glycogen storage disease due to GLUT2 deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0014006 Schuurs-Hoeijmakers syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0033630 neurodevelopmental disorder with speech impairment and dysmorphic facies 0.0045232953584311885 0.209536\n",
      "MONDO:0013551 hereditary spastic paraplegia 47 0.0045232953584311885 0.209536\n",
      "MONDO:0008221 prolidase deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0009927 3MC syndrome 2 0.0045232953584311885 0.209536\n",
      "MONDO:0032922 Beck-Fahrner syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0014351 pontocerebellar hypoplasia type 9 0.0045232953584311885 0.209536\n",
      "MONDO:0010088 mucosulfatidosis 0.0045232953584311885 0.209536\n",
      "MONDO:0014741 DeSanto-Shinawi syndrome due to WAC point mutation 0.0045232953584311885 0.209536\n",
      "MONDO:0030025 neurodevelopmental disorder with hypotonia, microcephaly, and seizures 0.0045232953584311885 0.209536\n",
      "MONDO:0020850 intellectual disability, autosomal recessive 65 0.0045232953584311885 0.209536\n",
      "MONDO:0100294 mitochondrial complex II deficiency, nuclear type 1 0.0045232953584311885 0.209536\n",
      "MONDO:0010089 isolated sulfite oxidase deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0013784 neonatal-onset encephalopathy with rigidity and seizures 0.0045232953584311885 0.209536\n",
      "MONDO:0013352 intellectual disability-severe speech delay-mild dysmorphism syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0060549 congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay 0.0045232953584311885 0.209536\n",
      "MONDO:0012278 supranuclear palsy, progressive, 2 0.0045232953584311885 0.209536\n",
      "MONDO:0030717 immunodeficiency 97 with autoinflammation 0.0047113213405893415 0.208074\n",
      "MONDO:0030729 Tessadori-van Haaften neurodevelopmental syndrome 1 0.0047113213405893415 0.208074\n",
      "MONDO:0060707 Ververi-Brady syndrome 0.0047113213405893415 0.208074\n",
      "MONDO:0009919 peroxisomal acyl-CoA oxidase deficiency 0.0047113213405893415 0.208074\n",
      "MONDO:0014541 motor developmental delay due to 14q32.2 paternally expressed gene defect 0.0047113213405893415 0.208074\n",
      "MONDO:0030268 developmental and epileptic encephalopathy 6B 0.0047113213405893415 0.208074\n",
      "MONDO:0034109 congenital myopathy with reduced type 2 muscle fibers 0.0047113213405893415 0.208074\n",
      "MONDO:0010006 Sandhoff disease 0.0047113213405893415 0.208074\n",
      "MONDO:0009738 sialidosis type 2 0.0047113213405893415 0.208074\n",
      "MONDO:0060596 neurodevelopmental disorder with dysmorphic facies and distal limb anomalies 0.0047113213405893415 0.208074\n",
      "MONDO:0044726 psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome 0.0047113213405893415 0.208074\n",
      "MONDO:0957210 neurooculorenal syndrome 0.0047113213405893415 0.208074\n",
      "MONDO:0010970 cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies 0.0047113213405893415 0.208074\n",
      "MONDO:0007804 Pallister-Hall syndrome 0.0047113213405893415 0.208074\n",
      "MONDO:0011035 neurofibromatosis-Noonan syndrome 0.0047113213405893415 0.208074\n",
      "MONDO:0014529 cerebellar-facial-dental syndrome 0.0047113213405893415 0.208074\n",
      "MONDO:0044634 retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome 0.0047113213405893415 0.208074\n",
      "MONDO:0010217 de Sanctis-Cacchione syndrome 0.0047113213405893415 0.208074\n",
      "MONDO:0859161 onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome 0.0047113213405893415 0.208074\n",
      "MONDO:0009657 mucopolysaccharidosis type 3C 0.0047113213405893415 0.208074\n",
      "MONDO:0014370 pontocerebellar hypoplasia type 2E 0.0047113213405893415 0.208074\n",
      "MONDO:0859186 Chopra-Amiel-Gordon syndrome 0.0047113213405893415 0.208074\n",
      "MONDO:0012690 Noonan syndrome 5 0.0047113213405893415 0.208074\n",
      "MONDO:0032752 developmental and epileptic encephalopathy, 75 0.0047113213405893415 0.208074\n",
      "MONDO:0011582 multiple mitochondrial dysfunctions syndrome 1 0.0047113213405893415 0.208074\n",
      "MONDO:0011948 pontocerebellar hypoplasia type 3 0.0047113213405893415 0.208074\n",
      "MONDO:0014736 Charcot-Marie-Tooth disease axonal type 2Z 0.004899311808335354 0.206678\n",
      "MONDO:0013646 chromosome 8q21.11 deletion syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0859163 Faundes-Banka syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0011271 rigid spine muscular dystrophy 1 0.004899311808335354 0.206678\n",
      "MONDO:0009282 multiple acyl-CoA dehydrogenase deficiency 0.004899311808335354 0.206678\n",
      "MONDO:0009564 Marden-Walker syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0031071 Diamond-Blackfan anemia 21 0.004899311808335354 0.206678\n",
      "MONDO:0060496 neurodevelopmental disorder with hypotonia, neuropathy, and deafness 0.004899311808335354 0.206678\n",
      "MONDO:0020841 neurodevelopmental disorder with cerebellar atrophy and with or without seizures 0.004899311808335354 0.206678\n",
      "MONDO:0060677 chromosome 1p35 deletion syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0012574 Potocki-Lupski syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0012117 ALG9-congenital disorder of glycosylation 0.004899311808335354 0.206678\n",
      "MONDO:0010441 CK syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0014686 short stature, microcephaly, and endocrine dysfunction 0.004899311808335354 0.206678\n",
      "MONDO:0007838 Jacobsen syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0011841 biotin-responsive basal ganglia disease 0.004899311808335354 0.206678\n",
      "MONDO:0014263 8q24.3 microdeletion syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0010881 mesomelia-synostoses syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0013319 chromosome 4Q32.1-q32.2 triplication syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0032846 osteogenesis imperfecta, type 20 0.004899311808335354 0.206678\n",
      "MONDO:0014894 Meier-Gorlin syndrome 7 0.004899311808335354 0.206678\n",
      "MONDO:0014994 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 0.004899311808335354 0.206678\n",
      "MONDO:0010222 X-linked Opitz G/BBB syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0009398 hyperphosphatasia with intellectual disability syndrome 1 0.004899311808335354 0.206678\n",
      "MONDO:0013810 COG6-ongenital disorder of glycosylation 0.004899311808335354 0.206678\n",
      "MONDO:0014336 intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency 0.004899311808335354 0.206678\n",
      "MONDO:0030913 intellectual disability, autosomal dominant 48 0.005087266768377201 0.205341\n",
      "MONDO:0030770 congenital disorder of deglycosylation 2 0.005087266768377201 0.205341\n",
      "MONDO:0010428 chromosome Xp11.23-p11.22 duplication syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0030992 short stature, oligodontia, dysmorphic facies, and motor delay 0.005087266768377201 0.205341\n",
      "MONDO:0030356 short-rib thoracic dysplasia 21 without polydactyly 0.005087266768377201 0.205341\n",
      "MONDO:0024553 myopathy, lactic acidosis, and sideroblastic anemia 1 0.005087266768377201 0.205341\n",
      "MONDO:0859081 chromosome Xq13 duplication syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0100297 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 0.005087266768377201 0.205341\n",
      "MONDO:0009664 mulibrey nanism 0.005087266768377201 0.205341\n",
      "MONDO:0009722 Bailey-Bloch congenital myopathy 0.005087266768377201 0.205341\n",
      "MONDO:0008854 Bardet-Biedl syndrome 1 0.005087266768377201 0.205341\n",
      "MONDO:8000012 neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1 0.005087266768377201 0.205341\n",
      "MONDO:0014914 Dias-Logan syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0032800 robinow syndrome, autosomal recessive 2 0.005087266768377201 0.205341\n",
      "MONDO:0011531 Noonan syndrome 2 0.005087266768377201 0.205341\n",
      "MONDO:0013572 Keppen-Lubinsky syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0008872 microcephalic osteodysplastic primordial dwarfism type II 0.005087266768377201 0.205341\n",
      "MONDO:0012427 Loeys-Dietz syndrome 2 0.005087266768377201 0.205341\n",
      "MONDO:0009269 geleophysic dysplasia 1 0.005087266768377201 0.205341\n",
      "MONDO:0032942 neurodevelopmental disorder with microcephaly and dysmorphic facies 0.005087266768377201 0.205341\n",
      "MONDO:0011217 desmosterolosis 0.005087266768377201 0.205341\n",
      "MONDO:0013722 hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism 0.005087266768377201 0.205341\n",
      "MONDO:0032890 neuromuscular disease and ocular or auditory anomalies with or without seizures 0.005087266768377201 0.205341\n",
      "MONDO:0014948 short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay 0.005087266768377201 0.205341\n",
      "MONDO:0012430 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 0.005087266768377201 0.205341\n",
      "MONDO:0032705 neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination 0.005087266768377201 0.205341\n",
      "MONDO:0030607 Bryant-Li-Bhoj neurodevelopmental syndrome 2 0.005087266768377201 0.205341\n",
      "MONDO:0014922 myofibrillar myopathy 7 0.005087266768377201 0.205341\n",
      "MONDO:0030917 intellectual disability, autosomal dominant 51 0.005087266768377201 0.205341\n",
      "MONDO:0009192 Wolcott-Rallison syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0013735 microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0018163 autosomal recessive cutis laxa type 2A 0.005275186227421581 0.204059\n",
      "MONDO:0013266 intellectual disability, autosomal dominant 20 0.005275186227421581 0.204059\n",
      "MONDO:0859336 muscular dystrophy, congenital, with or without seizures 0.005275186227421581 0.204059\n",
      "MONDO:0010568 Aicardi syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0859523 congenital myopathy 2c, severe infantile, autosomal dominant 0.005275186227421581 0.204059\n",
      "MONDO:0859515 congenital myopathy 10b, mild variant 0.005275186227421581 0.204059\n",
      "MONDO:0013115 RIN2 syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0009112 rhizomelic chondrodysplasia punctata type 2 0.005275186227421581 0.204059\n",
      "MONDO:0859179 neurodevelopmental disorder with dysmorphic facies and thin corpus callosum 0.005275186227421581 0.204059\n",
      "MONDO:0033492 Coffin-Siris syndrome 6 0.005275186227421581 0.204059\n",
      "MONDO:0010337 X-linked intellectual disability-cerebellar hypoplasia syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0033544 Tolchin-Le Caignec syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0100344 Bartter disease type 1 0.005275186227421581 0.204059\n",
      "MONDO:0019407 microcephalic osteodysplastic dysplasia, Saul-Wilson type 0.005275186227421581 0.204059\n",
      "MONDO:0012554 cerebrooculofacioskeletal syndrome 4 0.005275186227421581 0.204059\n",
      "MONDO:0859226 craniotubular dysplasia, Ikegawa type 0.005275186227421581 0.204059\n",
      "MONDO:0030543 combined oxidative phosphorylation deficiency 54 0.005275186227421581 0.204059\n",
      "MONDO:0013401 hereditary spastic paraplegia 51 0.005275186227421581 0.204059\n",
      "MONDO:0800025 Teebi hypertelorism syndrome 1 0.005275186227421581 0.204059\n",
      "MONDO:0010278 Christianson syndrome 0.005463070192173952 0.202827\n",
      "MONDO:0024537 Brown-Vialetto-van Laere syndrome 1 0.005463070192173952 0.202827\n",
      "MONDO:0009333 mullerian derivatives-lymphangiectasia-polydactyly syndrome 0.005463070192173952 0.202827\n",
      "MONDO:0009577 megalocornea-intellectual disability syndrome 0.005463070192173952 0.202827\n",
      "MONDO:0010306 X-linked intellectual disability, Cabezas type 0.005463070192173952 0.202827\n",
      "MONDO:0011688 muscular dystrophy-dystroglycanopathy type B5 0.005463070192173952 0.202827\n",
      "MONDO:0012791 mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria 0.005463070192173952 0.202827\n",
      "MONDO:0859377 neurodevelopmental disorder with poor growth and behavioral abnormalities 0.005463070192173952 0.202827\n",
      "MONDO:0010810 vitamin D hydroxylation-deficient rickets, type 1B 0.005463070192173952 0.202827\n",
      "MONDO:0007790 Charcot-Marie-Tooth disease type 3 0.005463070192173952 0.202827\n",
      "MONDO:0014413 orofaciodigital syndrome type 14 0.005463070192173952 0.202827\n",
      "MONDO:0030043 congenital disorder of glycosylation, type iit 0.005463070192173952 0.202827\n",
      "MONDO:0011652 Phelan-McDermid syndrome 0.005463070192173952 0.202827\n",
      "MONDO:0859275 neurodevelopmental disorder with spasticity, seizures, and brain abnormalities 0.005463070192173952 0.202827\n",
      "MONDO:0026730 Basilicata-Akhtar syndrome 0.005463070192173952 0.202827\n",
      "MONDO:0012892 bone fragility with contractures, arterial rupture, and deafness 0.005463070192173952 0.202827\n",
      "MONDO:0012927 chromosome 1q41-q42 deletion syndrome 0.005463070192173952 0.202827\n",
      "MONDO:0014723 PMP22-RAI1 contiguous gene duplication syndrome 0.005463070192173952 0.202827\n",
      "MONDO:0014751 palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome 0.005463070192173952 0.202827\n",
      "MONDO:0014364 mitochondrial complex III deficiency nuclear type 8 0.005463070192173952 0.202827\n",
      "MONDO:0014658 severe achondroplasia-developmental delay-acanthosis nigricans syndrome 0.005463070192173952 0.202827\n",
      "MONDO:0014507 Catel-Manzke syndrome 0.005463070192173952 0.202827\n",
      "MONDO:0013582 mosaic variegated aneuploidy syndrome 2 0.005650918669338471 0.201643\n",
      "MONDO:0010671 microphthalmia, syndromic 1 0.005650918669338471 0.201643\n",
      "MONDO:0012123 congenital disorder of glycosylation type 1E 0.005650918669338471 0.201643\n",
      "MONDO:0008830 aspartylglucosaminuria 0.005650918669338471 0.201643\n",
      "MONDO:0008458 spinocerebellar ataxia type 2 0.005650918669338471 0.201643\n",
      "MONDO:0009290 glycogen storage disease II 0.005650918669338471 0.201643\n",
      "MONDO:0013364 Rubinstein-Taybi syndrome due to EP300 haploinsufficiency 0.005650918669338471 0.201643\n",
      "MONDO:0030019 anauxetic dysplasia 3 0.005650918669338471 0.201643\n",
      "MONDO:0010028 sialuria 0.005650918669338471 0.201643\n",
      "MONDO:0030065 agenesis of corpus callosum, cardiac, ocular, and genital syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0010370 Cornelia de Lange syndrome 2 0.005650918669338471 0.201643\n",
      "MONDO:0014632 hypomyelinating leukodystrophy 10 0.005650918669338471 0.201643\n",
      "MONDO:0013051 autosomal recessive cutis laxa type 2B 0.005650918669338471 0.201643\n",
      "MONDO:0030837 neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities 0.005650918669338471 0.201643\n",
      "MONDO:0054581 Townes-Brocks syndrome 1 0.005650918669338471 0.201643\n",
      "MONDO:0957215 congenital myopathy 20 0.005650918669338471 0.201643\n",
      "MONDO:0010886 2q37 microdeletion syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0060532 congenital heart defects and skeletal malformations syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0010997 supranuclear palsy, progressive, 1 0.005650918669338471 0.201643\n",
      "MONDO:0020485 King-Denborough syndrome 0.005838731665618053 0.200502\n",
      "MONDO:0013839 hereditary sensory and autonomic neuropathy type 6 0.005838731665618053 0.200502\n",
      "MONDO:0859169 White-Kernohan syndrome 0.005838731665618053 0.200502\n",
      "MONDO:0009667 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 0.005838731665618053 0.200502\n",
      "MONDO:0013270 Rett syndrome, congenital variant 0.005838731665618053 0.200502\n",
      "MONDO:0014243 Schaaf-Yang syndrome 0.005838731665618053 0.200502\n",
      "MONDO:0014833 heart and brain malformation syndrome 0.005838731665618053 0.200502\n",
      "MONDO:0030928 microcephaly 26, primary, autosomal dominant 0.005838731665618053 0.200502\n",
      "MONDO:0054837 intellectual disability, autosomal dominant 57 0.005838731665618053 0.200502\n",
      "MONDO:0859297 neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities 0.005838731665618053 0.200502\n",
      "MONDO:0060760 intellectual developmental disorder with dysmorphic facies and behavioral abnormalities 0.005838731665618053 0.200502\n",
      "MONDO:0032772 brain abnormalities, neurodegeneration, and dysosteosclerosis 0.005838731665618053 0.200502\n",
      "MONDO:0032651 fibrosis, neurodegeneration, and cerebral angiomatosis 0.005838731665618053 0.200502\n",
      "MONDO:0030999 neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism 0.006026509187714335 0.199403\n",
      "MONDO:0016862 Alagille syndrome due to a JAG1 point mutation 0.006026509187714335 0.199403\n",
      "MONDO:0957284 nemaline myopathy 5C, autosomal dominant 0.006026509187714335 0.199403\n",
      "MONDO:0008954 peroxisome biogenesis disorder 2A (Zellweger) 0.006026509187714335 0.199403\n",
      "MONDO:0008873 microcephalic osteodysplastic primordial dwarfism, type 3 0.006026509187714335 0.199403\n",
      "MONDO:0013943 peroxisome biogenesis disorder 8B 0.006026509187714335 0.199403\n",
      "MONDO:0013864 Cornelia de Lange syndrome 4 0.006026509187714335 0.199403\n",
      "MONDO:0011575 cerebrooculonasal syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0007110 Diamond-Blackfan anemia 1 0.006026509187714335 0.199403\n",
      "MONDO:0007412 Beare-Stevenson cutis gyrata syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0010653 Renpenning syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0014887 bone marrow failure syndrome 3 0.006026509187714335 0.199403\n",
      "MONDO:0011939 Spondyloenchondrodysplasia with immune dysregulation 0.006026509187714335 0.199403\n",
      "MONDO:0011435 microcephaly 2, primary, autosomal recessive, with or without cortical malformations 0.006026509187714335 0.199403\n",
      "MONDO:0800167 Knobloch syndrome 1 0.006026509187714335 0.199403\n",
      "MONDO:0009319 pantothenate kinase-associated neurodegeneration 0.006026509187714335 0.199403\n",
      "MONDO:0011283 mitochondrial DNA depletion syndrome 1 0.006026509187714335 0.199403\n",
      "MONDO:0009431 hereditary hypophosphatemic rickets with hypercalciuria 0.0062142512423277 0.198341\n",
      "MONDO:0008005 cardiospondylocarpofacial syndrome 0.0062142512423277 0.198341\n",
      "MONDO:0009593 spondylometaphyseal dysplasia, Sedaghatian type 0.0062142512423277 0.198341\n",
      "MONDO:0024535 Singleton-Merten syndrome 1 0.0062142512423277 0.198341\n",
      "MONDO:0012683 pontocerebellar hypoplasia type 6 0.0062142512423277 0.198341\n",
      "MONDO:0011335 spondyloepimetaphyseal dysplasia with multiple dislocations 0.0062142512423277 0.198341\n",
      "MONDO:0013170 cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies 0.0062142512423277 0.198341\n",
      "MONDO:0011432 blepharophimosis - intellectual disability syndrome, Verloes type 0.0062142512423277 0.198341\n",
      "MONDO:0010572 occipital horn syndrome 0.0062142512423277 0.198341\n",
      "MONDO:0009165 Aicardi-Goutieres syndrome 1 0.0062142512423277 0.198341\n",
      "MONDO:0010502 intellectual disability, X-linked 99, syndromic, female-restricted 0.0062142512423277 0.198341\n",
      "MONDO:0015002 developmental and epileptic encephalopathy, 49 0.0062142512423277 0.198341\n",
      "MONDO:0012634 craniofacial dysplasia - osteopenia syndrome 0.0062142512423277 0.198341\n",
      "MONDO:0060642 neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features 0.0062142512423277 0.198341\n",
      "MONDO:0014780 hyperphosphatasia with intellectual disability syndrome 6 0.0062142512423277 0.198341\n",
      "MONDO:0009458 Schimke immuno-osseous dysplasia 0.0062142512423277 0.198341\n",
      "MONDO:0009998 Richieri Costa-Pereira syndrome 0.0062142512423277 0.198341\n",
      "MONDO:0060631 Alkuraya-Kucinskas syndrome 0.0062142512423277 0.198341\n",
      "MONDO:0010235 X-linked intellectual disability-psychosis-macroorchidism syndrome 0.0062142512423277 0.198341\n",
      "MONDO:0026722 Mullegama-Klein-Martinez syndrome 0.0062142512423277 0.198341\n",
      "MONDO:0016002 Ehlers-Danlos syndrome, kyphoscoliotic type 1 0.006401957836157258 0.197316\n",
      "MONDO:0030047 microcephaly, developmental delay, and brittle hair syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0030331 Ritscher-Schinzel syndrome 4 0.006401957836157258 0.197316\n",
      "MONDO:0859298 neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-pelger-huet anomaly 0.006401957836157258 0.197316\n",
      "MONDO:0032824 glycosylphosphatidylinositol biosynthesis defect 21 0.006401957836157258 0.197316\n",
      "MONDO:0044324 Al Kaissi syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0010156 Troyer syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0014823 hypotonia, infantile, with psychomotor retardation and characteristic facies 3 0.006401957836157258 0.197316\n",
      "MONDO:0014349 pontocerebellar hypoplasia type 10 0.006401957836157258 0.197316\n",
      "MONDO:0013268 frontonasal dysplasia with alopecia and genital anomaly 0.006401957836157258 0.197316\n",
      "MONDO:0014361 autism spectrum disorder due to AUTS2 deficiency 0.006401957836157258 0.197316\n",
      "MONDO:0014376 intellectual disability, autosomal dominant 27 0.006589628975900842 0.196324\n",
      "MONDO:0800437 Carey-Fineman-Ziter syndrome 1 0.006589628975900842 0.196324\n",
      "MONDO:0014757 macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome 0.006589628975900842 0.196324\n",
      "MONDO:0060510 Cohen-Gibson syndrome 0.006589628975900842 0.196324\n",
      "MONDO:0008564 DiGeorge syndrome 0.006589628975900842 0.196324\n",
      "MONDO:0013223 autosomal recessive spondylometaphyseal dysplasia, Megarbane type 0.006589628975900842 0.196324\n",
      "MONDO:0700107 chromosome 19q13.11 deletion syndrome, distal 0.006589628975900842 0.196324\n",
      "MONDO:0030437 congenital disorder of glycosylation, type IIw 0.006777264668255051 0.195364\n",
      "MONDO:0014831 progeroid and marfanoid aspect-lipodystrophy syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0014755 skin creases, congenital symmetric circumferential, 2 0.006777264668255051 0.195364\n",
      "MONDO:0030896 chromosome 13q33-q34 deletion syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0013379 Noonan syndrome 7 0.006777264668255051 0.195364\n",
      "MONDO:0010186 vitamin D-dependent rickets, type 2A 0.006777264668255051 0.195364\n",
      "MONDO:0859312 neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities 0.006777264668255051 0.195364\n",
      "MONDO:0024526 Zimmermann-Laband syndrome 1 0.006777264668255051 0.195364\n",
      "MONDO:0010506 intellectual disability, X-linked 61 0.006777264668255051 0.195364\n",
      "MONDO:0044319 intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies 0.006777264668255051 0.195364\n",
      "MONDO:0054844 pontocerebellar hypoplasia, type 1D 0.006777264668255051 0.195364\n",
      "MONDO:0054637 Noonan syndrome-like disorder with loose anagen hair 1 0.006777264668255051 0.195364\n",
      "MONDO:0030362 Aicardi-Goutieres syndrome 9 0.006777264668255051 0.195364\n",
      "MONDO:0009424 Bartter disease type 2 0.006777264668255051 0.195364\n",
      "MONDO:0012495 spondyloepimetaphyseal dysplasia, Genevieve type 0.006964864919915182 0.194433\n",
      "MONDO:0030375 neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2 0.006964864919915182 0.194433\n",
      "MONDO:0012562 holoprosencephaly 7 0.006964864919915182 0.194433\n",
      "MONDO:0010589 Aarskog-Scott syndrome, X-linked 0.006964864919915182 0.194433\n",
      "MONDO:0033532 Suleiman-El-Hattab syndrome 0.006964864919915182 0.194433\n",
      "MONDO:0013638 Warburg micro syndrome 3 0.006964864919915182 0.194433\n",
      "MONDO:0032822 developmental and epileptic encephalopathy, 80 0.006964864919915182 0.194433\n",
      "MONDO:0008800 microphthalmia with limb anomalies 0.006964864919915182 0.194433\n",
      "MONDO:0010471 Cornelia de Lange syndrome 5 0.006964864919915182 0.194433\n",
      "MONDO:0020682 Ehlers-Danlos syndrome, spondylodysplastic type, 1 0.0071524297375753 0.193531\n",
      "MONDO:0030553 acromesomelic dysplasia 4 0.0071524297375753 0.193531\n",
      "MONDO:0020723 vitamin D-dependent rickets, type 1A 0.0071524297375753 0.193531\n",
      "MONDO:0060592 Sweeney-Cox syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0010038 growth delay due to insulin-like growth factor I resistance 0.0071524297375753 0.193531\n",
      "MONDO:0007943 Nager acrofacial dysostosis 0.0071524297375753 0.193531\n",
      "MONDO:0026762 Wieacker-Wolff syndrome, female-restricted 0.0071524297375753 0.193531\n",
      "MONDO:0100151 nephropathic cystinosis 0.0071524297375753 0.193531\n",
      "MONDO:0032672 intellectual developmental disorder with cardiac defects and dysmorphic facies 0.0071524297375753 0.193531\n",
      "MONDO:0032687 intellectual developmental disorder with abnormal behavior, microcephaly, and short stature 0.0071524297375753 0.193531\n",
      "MONDO:0018663 regressive spondylometaphyseal dysplasia 0.007339959127928182 0.192656\n",
      "MONDO:0859209 Zaki syndrome 0.007339959127928182 0.192656\n",
      "MONDO:0007846 KBG syndrome 0.007339959127928182 0.192656\n",
      "MONDO:0008780 amyotrophic lateral sclerosis type 2, juvenile 0.007339959127928182 0.192656\n",
      "MONDO:0010310 osteopathia striata with cranial sclerosis 0.007527453097665351 0.191805\n",
      "MONDO:0008119 spinocerebellar ataxia type 1 0.007527453097665351 0.191805\n",
      "MONDO:0007892 Lenz-Majewski hyperostotic dwarfism 0.007527453097665351 0.191805\n",
      "MONDO:0009337 Hennekam lymphangiectasia-lymphedema syndrome 1 0.007527453097665351 0.191805\n",
      "MONDO:0008885 Elsahy-Waters syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0012496 Koolen-de Vries syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0100218 arthrogryposis multiplex congenita 5 0.007527453097665351 0.191805\n",
      "MONDO:0014262 Rienhoff syndrome 0.007714911653477074 0.190978\n",
      "MONDO:0033561 deeah syndrome 0.007714911653477074 0.190978\n",
      "MONDO:0009341 Mowat-Wilson syndrome 0.007714911653477074 0.190978\n",
      "MONDO:0009768 oculodentodigital dysplasia, autosomal recessive 0.007714911653477074 0.190978\n",
      "MONDO:0009026 Costello syndrome 0.007714911653477074 0.190978\n",
      "MONDO:0011147 chromosome 18q deletion syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0012118 COG7-congenital disorder of glycosylation 0.007902334802052331 0.190174\n",
      "MONDO:0012555 Cornelia de Lange syndrome 3 0.007902334802052331 0.190174\n",
      "MONDO:0009629 Desbuquois dysplasia 1 0.00808972255007886 0.189392\n",
      "MONDO:0010208 wrinkly skin syndrome 0.00808972255007886 0.189392\n",
      "MONDO:0009785 opsismodysplasia 0.00808972255007886 0.189392\n",
      "MONDO:0009579 Frank-Ter Haar syndrome 0.00808972255007886 0.189392\n",
      "MONDO:0007057 Acroosteolysis dominant type 0.00808972255007886 0.189392\n",
      "MONDO:0010355 syndromic X-linked intellectual disability Claes-Jensen type 0.008277074904243129 0.18863\n",
      "MONDO:0011977 8q22.1 microdeletion syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0012589 Pitt-Hopkins syndrome 0.008464391871230346 0.187887\n",
      "MONDO:0859193 neuroocular syndrome 0.008464391871230346 0.187887\n",
      "MONDO:0008965 CHARGE syndrome 0.008464391871230346 0.187887\n",
      "MONDO:0009511 Larsen-like syndrome, B3GAT3 type 0.008651673457724452 0.187163\n",
      "MONDO:0010010 Schinzel-Giedion syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0029140 glycosylphosphatidylinositol biosynthesis defect 18 0.008651673457724452 0.187163\n",
      "MONDO:0009479 Johanson-Blizzard syndrome 0.00883891967040812 0.186457\n",
      "MONDO:0009485 oculocerebrofacial syndrome, Kaufman type 0.00883891967040812 0.186457\n",
      "MONDO:0011150 acroosteolysis-keloid-like lesions-premature aging syndrome 0.00883891967040812 0.186457\n",
      "MONDO:0013886 cerebellar dysfunction with variable cognitive and behavioral abnormalities 0.009026130515962775 0.185767\n",
      "MONDO:0957247 congenital myopathy 22A, classic 0.009213306001068568 0.185094\n",
      "MONDO:0800436 craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1 0.009213306001068568 0.185094\n",
      "MONDO:0012136 carnitine palmitoyl transferase II deficiency, neonatal form 0.009400446132404395 0.184436\n",
      "MONDO:0033669 Noonan syndrome 13 0.009400446132404395 0.184436\n",
      "MONDO:0015021 hypotonia, ataxia, and delayed development syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0010500 intellectual disability, X-linked, syndromic 33 0.009400446132404395 0.184436\n",
      "MONDO:0957265 congenital myopathy 22B, severe fetal 0.00958755091664789 0.183794\n",
      "MONDO:0014892 micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome 0.00958755091664789 0.183794\n",
      "MONDO:0019569 Cockayne syndrome type 1 0.00958755091664789 0.183794\n",
      "MONDO:0010407 intellectual disability, X-linked syndromic, Turner type 0.00958755091664789 0.183794\n",
      "MONDO:0032645 trichohepatoneurodevelopmental syndrome 0.00977462036047542 0.183165\n",
      "MONDO:0010075 spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures 0.00977462036047542 0.183165\n",
      "MONDO:0012374 brachyphalangy, polydactyly, and tibial aplasia/hypoplasia 0.00977462036047542 0.183165\n",
      "MONDO:0009658 mucopolysaccharidosis type 3D 0.00977462036047542 0.183165\n",
      "MONDO:0957228 intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities 0.01014865325358177 0.181948\n",
      "MONDO:0024455 autosomal dominant Robinow syndrome 1 0.01052254486510919 0.180782\n",
      "MONDO:0007974 intellectual disability, autosomal dominant 1 0.010709437706958341 0.180216\n",
      "MONDO:0020602 Simpson-Golabi-Behmel syndrome type 1 0.010896295248423277 0.179662\n",
      "MONDO:0859273 liver disease, severe congenital 0.011269904456869458 0.178586\n",
      "MONDO:0007265 cardiofaciocutaneous syndrome 1 0.011643372543773012 0.177549\n",
      "MONDO:0800043 Stve-Wiedemann syndrome 1 0.01183005368330494 0.177046\n",
      "MONDO:0009999 autosomal recessive Robinow syndrome 0.01238988556615262 0.175587\n",
      "MONDO:0009856 Peters plus syndrome 0.01238988556615262 0.175587\n"
     ]
    }
   ],
   "execution_count": 57
  },
  {
   "cell_type": "code",
   "id": "1bc426cc-1ac4-44d8-a2ed-ab57ec20a552",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:53.604031Z",
     "start_time": "2024-10-28T18:03:53.433519Z"
    }
   },
   "source": [
    "response = phenotypes_to_gene(leigh_2)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "NCBIGene:51733 UPB1 0.0001888803437402939 0.345678\n",
      "NCBIGene:3295 HSD17B4 0.0003777250116963364 0.312472\n",
      "NCBIGene:84152 PPP1R1B 0.0009440450282371355 0.271407\n",
      "NCBIGene:284058 KANSL1 0.0015100442052276759 0.251713\n",
      "NCBIGene:50484 RRM2B 0.0016986393312994233 0.246931\n",
      "NCBIGene:113189 CHST14 0.0016986393312994233 0.246931\n",
      "NCBIGene:1356 CP 0.0033943932870210093 0.220049\n",
      "NCBIGene:3356 HTR2A 0.0033943932870210093 0.220049\n",
      "NCBIGene:7249 TSC2 0.0037708361514733027 0.216154\n",
      "NCBIGene:7248 TSC1 0.0037708361514733027 0.216154\n",
      "NCBIGene:3954 LETM1 0.004335233855151651 0.211067\n",
      "NCBIGene:4204 MECP2 0.0071524297375753 0.193531\n",
      "NCBIGene:4988 OPRM1 0.007339959127928182 0.192656\n",
      "NCBIGene:1813 DRD2 0.008277074904243129 0.18863\n",
      "NCBIGene:1392 CRH 0.008464391871230346 0.187887\n",
      "NCBIGene:5173 PDYN 0.008651673457724452 0.187163\n",
      "NCBIGene:18 ABAT 0.009961654470562097 0.18255\n",
      "NCBIGene:5443 POMC 0.013694926855229318 0.172462\n"
     ]
    }
   ],
   "execution_count": 58
  },
  {
   "cell_type": "code",
   "id": "954c7c16-6eb7-4dd7-918b-7001fb59cf9b",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:53.607403Z",
     "start_time": "2024-10-28T18:03:53.605090Z"
    }
   },
   "source": [
    "phenotypes_2 = [\n",
    "    \"HP:0000718\", # aggression         | 2 yrs - present\n",
    "    \"HP:0000739\", #anxiety                | 2 yrs - present\n",
    "    \"HP:0002616\", # Aortic root aneurysm HP:0002616 | 10 yrs - present\n",
    "    \"HP:0002019\", #constipation (occasional) HP:0002019 |        birth - present\n",
    "    #occasional bright lime-green stool | 5 yrs - present\n",
    "    \"HP:0000678\", #crowded teeth        HP:0000678         \n",
    "    \"HP:0000886\", # Deformed rib cage HP:0000886 | 6 months - present\n",
    "    \"HP:0002046\", #heat intolerance        HP:0002046 \n",
    "    \"HP:0002705\", #high arched palate        HP:0002705 \n",
    "    \"HP:0001290\", #hypotonia        HP:0001290 |        birth - present\n",
    "    \"HP:0000737\", # irritable        HP:0000737 |        2 yrs - present\n",
    "    \"HP:0001382\", # Joint hypermobility HP:0001382 | birth - present\n",
    "    \"HP:0000720\", # mood swings        HP:0000720 |        2 yrs - present\n",
    "    \"HP:0012801\", # narrow jaw        HP:0012801\n",
    "    \"HP:0010865\", # Oppositional defiant disorder HP:0010865 | 2 yrs - present\n",
    "    #Destructive tendencies | 3 yrs - present\n",
    "    \"HP:0002172\", # Postural instability HP:0002172 | birth - present\n",
    "    \"HP:0001250\", # seizures        HP:0001250 |        7 yrs - present\n",
    "    \"HP:0001649\", # Tachycardia HP:0001649 | 1 yr - present\n",
    "    \"HP:0001337\", # tremor        HP:0001337 | in hands 11 yrs - present\n",
    "    #Vascular skin abnormality (superficial blood vessels that rupture easily) HP:0011276 |  birth - present\n",
    "    \"HP:0001123\" # Visual field defect HP:0001123 | birth - present\n",
    "    # Seasonal allergies | birth - present\n",
    "    #Food allergy | 4 yrs - present\n",
    "]"
   ],
   "outputs": [],
   "execution_count": 59
  },
  {
   "cell_type": "code",
   "id": "ce04922a-36c7-4db8-b8c7-850152eaa54b",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:57.116751Z",
     "start_time": "2024-10-28T18:03:53.608972Z"
    }
   },
   "source": [
    "response = phenotypes_to_disease(phenotypes_2)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "MONDO:0010501 syndromic X-linked intellectual disability 34 2.342808145498639e-13 0.97844\n",
      "MONDO:0010441 CK syndrome 3.4695918945210576e-12 0.961943\n",
      "MONDO:0010306 X-linked intellectual disability, Cabezas type 2.012562565025918e-09 0.863907\n",
      "MONDO:0010671 microphthalmia, syndromic 1 2.303903948394455e-09 0.860418\n",
      "MONDO:0010655 X-linked intellectual disability with marfanoid habitus 4.259526562078124e-09 0.843608\n",
      "MONDO:0010500 intellectual disability, X-linked, syndromic 33 1.763189694158661e-08 0.798485\n",
      "MONDO:0032605 intellectual disability, autosomal recessive 66 2.237839556363733e-08 0.790027\n",
      "MONDO:0014606 intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome 2.576201852588367e-08 0.78491\n",
      "MONDO:0859143 Radio-Tartaglia syndrome 2.7675996639343947e-08 0.782271\n",
      "MONDO:0019349 Sotos syndrome 2.9694267590458545e-08 0.779656\n",
      "MONDO:0958179 glycine encephalopathy 1 4.9108665950578294e-08 0.760317\n",
      "MONDO:0013933 peroxisome biogenesis disorder 5B 7.538205405614794e-08 0.742952\n",
      "MONDO:0008082 multiple endocrine neoplasia type 2B 9.145073485559841e-08 0.734857\n",
      "MONDO:0100186 GTP cyclohydrolase I deficiency with hyperphenylalaninemia 1.7834031442323658e-07 0.705655\n",
      "MONDO:0033630 neurodevelopmental disorder with speech impairment and dysmorphic facies 3.0769867357839225e-07 0.680471\n",
      "MONDO:0013897 Loeys-Dietz syndrome 4 3.0769867357839225e-07 0.680471\n",
      "MONDO:0014353 immunodeficiency 23 3.0769867357839225e-07 0.680471\n",
      "MONDO:0030030 Nizon-Isidor syndrome 4.878636038640332e-07 0.658328\n",
      "MONDO:0034121 NAD(P)HX dehydratase deficiency 4.878636038640332e-07 0.658328\n",
      "MONDO:0011652 Phelan-McDermid syndrome 5.418155145890055e-07 0.653186\n",
      "MONDO:0013060 autosomal recessive Parkinson disease 14 5.418155145890055e-07 0.653186\n",
      "MONDO:0011706 Kufor-Rakeb syndrome 5.995899278607245e-07 0.648185\n",
      "MONDO:0060532 congenital heart defects and skeletal malformations syndrome 5.995899278607245e-07 0.648185\n",
      "MONDO:0012123 congenital disorder of glycosylation type 1E 5.995899278607245e-07 0.648185\n",
      "MONDO:0010997 supranuclear palsy, progressive, 1 5.995899278607245e-07 0.648185\n",
      "MONDO:0859178 developmental delay, impaired speech, and behavioral abnormalities 6.068080083354021e-07 0.647593\n",
      "MONDO:0008818 arterial tortuosity syndrome 6.613156069395213e-07 0.643318\n",
      "MONDO:0027462 autosomal recessive cutis laxa type 2C 6.613156069395213e-07 0.643318\n",
      "MONDO:0008999 Cohen syndrome 9.502992148480977e-07 0.625057\n",
      "MONDO:0010506 intellectual disability, X-linked 61 1.0337056430804927e-06 0.620766\n",
      "MONDO:0012948 chromosome 6pter-p24 deletion syndrome 1.0337056430804927e-06 0.620766\n",
      "MONDO:0010186 vitamin D-dependent rickets, type 2A 1.0337056430804927e-06 0.620766\n",
      "MONDO:0032687 intellectual developmental disorder with abnormal behavior, microcephaly, and short stature 1.214804752920903e-06 0.61248\n",
      "MONDO:0020723 vitamin D-dependent rickets, type 1A 1.214804752920903e-06 0.61248\n",
      "MONDO:0010664 syndromic X-linked intellectual disability Snyder type 1.3127519557401133e-06 0.608476\n",
      "MONDO:0007947 Marfan syndrome 1.5240764645646499e-06 0.600727\n",
      "MONDO:0011147 chromosome 18q deletion syndrome 1.6377070961332274e-06 0.596976\n",
      "MONDO:0030920 intellectual disability, autosomal dominant 54 1.7568185314431867e-06 0.593303\n",
      "MONDO:0026733 intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type 2.100211005050449e-06 0.583916\n",
      "MONDO:0014604 Parkinson disease 21 2.100211005050449e-06 0.583916\n",
      "MONDO:0009511 Larsen-like syndrome, B3GAT3 type 2.1482983280929006e-06 0.582721\n",
      "MONDO:0033669 Noonan syndrome 13 2.7546340594700205e-06 0.569538\n",
      "MONDO:0014892 micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome 2.92211726439384e-06 0.566393\n",
      "MONDO:0054588 Noonan syndrome-like disorder with loose anagen hair 2 3.659384724967949e-06 0.554358\n",
      "MONDO:0012413 syndromic microphthalmia type 5 4.722246071627631e-06 0.540642\n",
      "MONDO:0009908 pterin-4 alpha-carbinolamine dehydratase 1 deficiency 4.722246071627631e-06 0.540642\n",
      "MONDO:0030051 intellectual developmental disorder with autistic features and language delay, with or without seizures 6.425305561682488e-06 0.523995\n",
      "MONDO:0044326 developmental delay and seizures with or without movement abnormalities 6.425305561682488e-06 0.523995\n",
      "MONDO:0030849 intellectual developmental disorder with speech delay and axonal peripheral neuropathy 6.425305561682488e-06 0.523995\n",
      "MONDO:0013625 Parkinson disease 17 6.425305561682488e-06 0.523995\n",
      "MONDO:0859177 VISS syndrome 7.500894812071379e-06 0.515606\n",
      "MONDO:0009562 beta-mannosidosis 8.389368646566588e-06 0.509533\n",
      "MONDO:0030518 trichothiodystrophy 9, nonphotosensitive 8.389368646566588e-06 0.509533\n",
      "MONDO:0011203 Pierre Robin sequence with pectus excavatum and rib and scapular anomalies 8.389368646566588e-06 0.509533\n",
      "MONDO:0014379 ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 8.848045190061492e-06 0.506644\n",
      "MONDO:0009400 hyperprolinemia type 1 1.061416730197466e-05 0.496764\n",
      "MONDO:0010656 intellectual disability, X-linked 1 1.061416730197466e-05 0.496764\n",
      "MONDO:0008724 adducted thumbs-arthrogryposis syndrome, Christian type 1.061416730197466e-05 0.496764\n",
      "MONDO:0013193 thyrotoxic periodic paralysis, susceptibility to, 2 1.061416730197466e-05 0.496764\n",
      "MONDO:0014210 intellectual disability-hypotonia-spasticity-sleep disorder syndrome 1.3099433709796858e-05 0.485348\n",
      "MONDO:0010487 intellectual disability, X-linked 99 1.3099433709796858e-05 0.485348\n",
      "MONDO:0014950 aortic aneurysm, familial thoracic 10 1.3099433709796858e-05 0.485348\n",
      "MONDO:0013353 intellectual disability, anterior maxillary protrusion, and strabismus 1.3099433709796858e-05 0.485348\n",
      "MONDO:0007496 dystonia 12 1.3099433709796858e-05 0.485348\n",
      "MONDO:0008393 Rubinstein-Taybi syndrome due to CREBBP mutations 1.4800179894483303e-05 0.478729\n",
      "MONDO:0013256 chromosome 15q24 deletion syndrome 1.5820247061582707e-05 0.475119\n",
      "MONDO:0060724 glycosylphosphatidylinositol biosynthesis defect 17 1.584490025797781e-05 0.475035\n",
      "MONDO:0032870 intellectual developmental disorder with short stature and behavioral abnormalities 1.584490025797781e-05 0.475035\n",
      "MONDO:0030855 combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2 1.584490025797781e-05 0.475035\n",
      "MONDO:0012308 Joubert syndrome with renal defect 1.584490025797781e-05 0.475035\n",
      "MONDO:0032620 mitochondrial complex 1 deficiency, nuclear type 15 1.584490025797781e-05 0.475035\n",
      "MONDO:0060745 intellectual developmental disorder with or without epilepsy or cerebellar ataxia 1.584490025797781e-05 0.475035\n",
      "MONDO:0020715 multiple system atrophy 1, susceptibility to 1.584490025797781e-05 0.475035\n",
      "MONDO:0012994 dopa-responsive dystonia due to sepiapterin reductase deficiency 1.8850299540375845e-05 0.465639\n",
      "MONDO:0030037 neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures 1.8850299540375845e-05 0.465639\n",
      "MONDO:0011493 Stickler syndrome type 2 1.8850299540375845e-05 0.465639\n",
      "MONDO:0859168 myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy 1.8850299540375845e-05 0.465639\n",
      "MONDO:0032526 spinocerebellar ataxia 48 1.8850299540375845e-05 0.465639\n",
      "MONDO:0009830 parkinsonian-pyramidal syndrome 1.8850299540375845e-05 0.465639\n",
      "MONDO:0014928 Joubert syndrome 28 2.2115364356621945e-05 0.45702\n",
      "MONDO:0030854 combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 2.2115364356621945e-05 0.45702\n",
      "MONDO:0009238 hereditary folate malabsorption 2.2115364356621945e-05 0.45702\n",
      "MONDO:0009862 dihydropteridine reductase deficiency 2.2115364356621945e-05 0.45702\n",
      "MONDO:0009251 fructose-1,6-bisphosphatase deficiency 2.2115364356621945e-05 0.45702\n",
      "MONDO:0859185 neurodevelopmental disorder with hypotonia and dysmorphic facies 2.428027058522845e-05 0.451992\n",
      "MONDO:0010250 intellectual disability, X-linked 49 2.5639827711979356e-05 0.449063\n",
      "MONDO:0012432 Joubert syndrome 5 2.5639827711979356e-05 0.449063\n",
      "MONDO:0014805 Hao-Fountain syndrome 2.5639827711979356e-05 0.449063\n",
      "MONDO:0859196 Usmani-Riazuddin syndrome, autosomal recessive 2.5639827711979356e-05 0.449063\n",
      "MONDO:0030012 Diets-Jongmans syndrome 2.5639827711979356e-05 0.449063\n",
      "MONDO:0030676 parkinsonism-dystonia 3, childhood-onset 2.5639827711979356e-05 0.449063\n",
      "MONDO:0014559 progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome 2.5639827711979356e-05 0.449063\n",
      "MONDO:0859519 neurodevelopmental disorder with absent speech and movement and behavioral abnormalities 2.5639827711979356e-05 0.449063\n",
      "MONDO:0010256 intellectual disability, X-linked 21 2.5639827711979356e-05 0.449063\n",
      "MONDO:0011867 microphthalmia with cyst, bilateral facial clefts, and limb anomalies 2.5639827711979356e-05 0.449063\n",
      "MONDO:0100220 Rajab interstitial lung disease with brain calcifications 2 2.5639827711979356e-05 0.449063\n",
      "MONDO:0014917 developmental and epileptic encephalopathy, 42 2.5639827711979356e-05 0.449063\n",
      "MONDO:0032823 intellectual developmental disorder 60 with seizures 2.5639827711979356e-05 0.449063\n",
      "MONDO:0007492 early-onset generalized limb-onset dystonia 2.5639827711979356e-05 0.449063\n",
      "MONDO:0013208 cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome 2.5639827711979356e-05 0.449063\n",
      "MONDO:0008199 late-onset Parkinson disease 2.5639827711979356e-05 0.449063\n",
      "MONDO:0014224 developmental delay with autism spectrum disorder and gait instability 2.942342281720291e-05 0.44168\n",
      "MONDO:0009861 phenylketonuria 2.942342281720291e-05 0.44168\n",
      "MONDO:0014778 Lamb-Shaffer syndrome 2.942342281720291e-05 0.44168\n",
      "MONDO:0032830 snijders blok-fisher syndrome 2.942342281720291e-05 0.44168\n",
      "MONDO:0008918 carnitine-acylcarnitine translocase deficiency 2.942342281720291e-05 0.44168\n",
      "MONDO:0030878 Kaya-Barakat-Masson syndrome 2.942342281720291e-05 0.44168\n",
      "MONDO:0009666 holocarboxylase synthetase deficiency 2.942342281720291e-05 0.44168\n",
      "MONDO:0010327 HSD10 mitochondrial disease 3.3465883088398216e-05 0.434798\n",
      "MONDO:0012400 cortical dysplasia-focal epilepsy syndrome 3.3465883088398216e-05 0.434798\n",
      "MONDO:0859176 neurodevelopmental disorder with motor and speech delay and behavioral abnormalities 3.3465883088398216e-05 0.434798\n",
      "MONDO:0859194 Boudin-Mortier syndrome 3.3465883088398216e-05 0.434798\n",
      "MONDO:0014007 Aicardi-Goutieres syndrome 6 3.3465883088398216e-05 0.434798\n",
      "MONDO:0014867 spinocerebellar ataxia 43 3.3465883088398216e-05 0.434798\n",
      "MONDO:0032860 intellectual developmental disorder, autosomal recessive 72 3.776694214688169e-05 0.428357\n",
      "MONDO:0011651 intellectual disability, short stature, facial anomalies, and joint dislocations 3.776694214688169e-05 0.428357\n",
      "MONDO:0010476 neurodegeneration with brain iron accumulation 5 3.776694214688169e-05 0.428357\n",
      "MONDO:0010820 autosomal recessive juvenile Parkinson disease 2 3.776694214688169e-05 0.428357\n",
      "MONDO:0010271 X-linked myotubular myopathy-abnormal genitalia syndrome 4.232633381903997e-05 0.422308\n",
      "MONDO:0030979 endove syndrome, limb-brain type 4.232633381903997e-05 0.422308\n",
      "MONDO:0011240 megalencephaly-capillary malformation-polymicrogyria syndrome 4.232633381903997e-05 0.422308\n",
      "MONDO:0008713 acrodermatitis enteropathica 4.232633381903997e-05 0.422308\n",
      "MONDO:0014233 early-onset Parkinson disease 20 4.232633381903997e-05 0.422308\n",
      "MONDO:0011829 coenzyme Q10 deficiency, primary, 1 4.232633381903997e-05 0.422308\n",
      "MONDO:0007656 Gerstmann-Straussler-Scheinker syndrome 4.714379213618961e-05 0.416608\n",
      "MONDO:0012913 Wilms tumor, aniridia, genitourinary anomalies, intellectual disability, and obesity syndrome 4.714379213618961e-05 0.416608\n",
      "MONDO:0008943 autosomal recessive spinocerebellar ataxia 2 4.714379213618961e-05 0.416608\n",
      "MONDO:0024538 basal ganglia calcification, idiopathic, 1 4.714379213618961e-05 0.416608\n",
      "MONDO:0012212 Loeys-Dietz syndrome 1 5.2219051334437145e-05 0.411222\n",
      "MONDO:0012301 mitochondrial DNA depletion syndrome, myopathic form 5.2219051334437145e-05 0.411222\n",
      "MONDO:0014221 triosephosphate isomerase deficiency 5.2219051334437145e-05 0.411222\n",
      "MONDO:0033548 myopathy, congenital, with diaphragmatic defects, respiratory insufficiency, and dysmorphic facies 5.2219051334437145e-05 0.411222\n",
      "MONDO:0030057 neurodevelopmental, jaw, eye, and digital syndrome 5.755184585453889e-05 0.40612\n",
      "MONDO:0010509 intellectual disability, X-linked 104 5.755184585453889e-05 0.40612\n",
      "MONDO:0013754 cutis laxa, autosomal recessive, type 1B 5.755184585453889e-05 0.40612\n",
      "MONDO:0010516 midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis 5.755184585453889e-05 0.40612\n",
      "MONDO:0032876 neurodevelopmental disorder with absent language and variable seizures 5.755184585453889e-05 0.40612\n",
      "MONDO:0014144 autosomal recessive limb-girdle muscular dystrophy type R18 5.755184585453889e-05 0.40612\n",
      "MONDO:0032779 neurodevelopmental disorder with microcephaly and structural brain anomalies 6.31419103417607e-05 0.401274\n",
      "MONDO:0010258 MEHMO syndrome 6.31419103417607e-05 0.401274\n",
      "MONDO:0032793 O'Donnell-Luria-Rodan syndrome 6.31419103417607e-05 0.401274\n",
      "MONDO:0012055 Larsen-like osseous dysplasia-short stature syndrome 6.31419103417607e-05 0.401274\n",
      "MONDO:0007525 Ehlers-Danlos syndrome, arthrochalasis type 6.31419103417607e-05 0.401274\n",
      "MONDO:0030933 Joubert syndrome 37 6.31419103417607e-05 0.401274\n",
      "MONDO:0009744 neuronal ceroid lipofuscinosis 1 6.31419103417607e-05 0.401274\n",
      "MONDO:0030974 mitochondrial complex 2 deficiency, nuclear type 4 6.31419103417607e-05 0.401274\n",
      "MONDO:0032636 mitochondrial complex 1 deficiency, nuclear type 33 6.31419103417607e-05 0.401274\n",
      "MONDO:0013546 mitochondrial complex V (ATP synthase) deficiency nuclear type 2 6.31419103417607e-05 0.401274\n",
      "MONDO:0009131 Riley-Day syndrome 6.31419103417607e-05 0.401274\n",
      "MONDO:0009863 BH4-deficient hyperphenylalaninemia A 6.31419103417607e-05 0.401274\n",
      "MONDO:0010083 succinic semialdehyde dehydrogenase deficiency 6.898897964573881e-05 0.396663\n",
      "MONDO:0014791 Luscan-Lumish syndrome 6.898897964573881e-05 0.396663\n",
      "MONDO:0009871 pili torti-developmental delay-neurological abnormalities syndrome 6.898897964573881e-05 0.396663\n",
      "MONDO:0859214 Marbach-Schaaf neurodevelopmental syndrome 6.898897964573881e-05 0.396663\n",
      "MONDO:0012999 guanidinoacetate methyltransferase deficiency 6.898897964573881e-05 0.396663\n",
      "MONDO:0060578 neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures 6.898897964573881e-05 0.396663\n",
      "MONDO:0100292 Carey-Fineman-Ziter syndrome 2 6.898897964573881e-05 0.396663\n",
      "MONDO:0859151 fibromuscular dysplasia, multifocal 6.898897964573881e-05 0.396663\n",
      "MONDO:0014114 cardiofaciocutaneous syndrome 4 6.898897964573881e-05 0.396663\n",
      "MONDO:0009583 blepharophimosis - intellectual disability syndrome, Ohdo type 6.898897964573881e-05 0.396663\n",
      "MONDO:0010496 X-linked intellectual disability-short stature-overweight syndrome 6.898897964573881e-05 0.396663\n",
      "MONDO:0033642 neurodevelopmental disorder with alopecia and brain abnormalities 7.509278882033923e-05 0.392266\n",
      "MONDO:0013352 intellectual disability-severe speech delay-mild dysmorphism syndrome 7.509278882033923e-05 0.392266\n",
      "MONDO:0014006 Schuurs-Hoeijmakers syndrome 7.509278882033923e-05 0.392266\n",
      "MONDO:0014741 DeSanto-Shinawi syndrome due to WAC point mutation 7.509278882033923e-05 0.392266\n",
      "MONDO:0032939 intellectual developmental disorder, autosomal dominant 63, with macrocephaly 7.509278882033923e-05 0.392266\n",
      "MONDO:0010515 Meester-Loeys syndrome 7.509278882033923e-05 0.392266\n",
      "MONDO:0014236 Ehlers-Danlos syndrome, musculocontractural type 2 7.509278882033923e-05 0.392266\n",
      "MONDO:0030953 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 7.509278882033923e-05 0.392266\n",
      "MONDO:0032922 Beck-Fahrner syndrome 7.509278882033923e-05 0.392266\n",
      "MONDO:0009974 familial hemophagocytic lymphohistiocytosis type 1 7.509278882033923e-05 0.392266\n",
      "MONDO:0009613 methylmalonic aciduria, cblA type 7.509278882033923e-05 0.392266\n",
      "MONDO:0013171 purine nucleoside phosphorylase deficiency 7.509278882033923e-05 0.392266\n",
      "MONDO:0044723 3-methylglutaconic aciduria type 8 7.509278882033923e-05 0.392266\n",
      "MONDO:0014541 motor developmental delay due to 14q32.2 paternally expressed gene defect 8.1453073123519e-05 0.388065\n",
      "MONDO:0013745 Joubert syndrome 14 8.1453073123519e-05 0.388065\n",
      "MONDO:0044724 3-methylglutaconic aciduria type 9 8.806956801718505e-05 0.384045\n",
      "MONDO:0014357 intellectual disability, autosomal dominant 24 8.806956801718505e-05 0.384045\n",
      "MONDO:0035133 PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome 8.806956801718505e-05 0.384045\n",
      "MONDO:0010645 oculocerebrorenal syndrome 8.806956801718505e-05 0.384045\n",
      "MONDO:0014995 neurodevelopmental disorder with hypotonia, seizures, and absent language 8.806956801718505e-05 0.384045\n",
      "MONDO:0009564 Marden-Walker syndrome 8.806956801718505e-05 0.384045\n",
      "MONDO:0013357 chromosome 17q11.2 deletion syndrome, 1.4Mb 8.806956801718505e-05 0.384045\n",
      "MONDO:0032610 mitochondrial complex 1 deficiency, nuclear type 5 8.806956801718505e-05 0.384045\n",
      "MONDO:0010717 pyruvate dehydrogenase E1-alpha deficiency 8.806956801718505e-05 0.384045\n",
      "MONDO:0012427 Loeys-Dietz syndrome 2 9.494200916705618e-05 0.380193\n",
      "MONDO:0008854 Bardet-Biedl syndrome 1 9.494200916705618e-05 0.380193\n",
      "MONDO:0032688 polymicrogyria with or without vascular-type Ehlers-Danlos syndrome 9.494200916705618e-05 0.380193\n",
      "MONDO:0957266 RECON progeroid syndrome 9.494200916705618e-05 0.380193\n",
      "MONDO:0013924 osteogenesis imperfecta type 13 9.494200916705618e-05 0.380193\n",
      "MONDO:0024553 myopathy, lactic acidosis, and sideroblastic anemia 1 9.494200916705618e-05 0.380193\n",
      "MONDO:0012512 fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 9.494200916705618e-05 0.380193\n",
      "MONDO:0020781 encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 9.494200916705618e-05 0.380193\n",
      "MONDO:0859347 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities 0.00010207013244252334 0.376496\n",
      "MONDO:0014139 Ehlers-Danlos syndrome, spondylodysplastic type, 2 0.00010207013244252334 0.376496\n",
      "MONDO:0019567 Ehlers-Danlos syndrome, classic type, 1 0.00010207013244252334 0.376496\n",
      "MONDO:0800025 Teebi hypertelorism syndrome 1 0.00010207013244252334 0.376496\n",
      "MONDO:0033492 Coffin-Siris syndrome 6 0.00010207013244252334 0.376496\n",
      "MONDO:0018163 autosomal recessive cutis laxa type 2A 0.00010207013244252334 0.376496\n",
      "MONDO:0014916 developmental and epileptic encephalopathy, 41 0.00010207013244252334 0.376496\n",
      "MONDO:0030533 intellectual developmental disorder, autosomal recessive 73 0.00010207013244252334 0.376496\n",
      "MONDO:0011337 familial hemophagocytic lymphohistiocytosis 2 0.00010207013244252334 0.376496\n",
      "MONDO:0030543 combined oxidative phosphorylation deficiency 54 0.00010207013244252334 0.376496\n",
      "MONDO:0007068 adenylosuccinate lyase deficiency 0.00010945367391650902 0.372942\n",
      "MONDO:0014723 PMP22-RAI1 contiguous gene duplication syndrome 0.00010945367391650902 0.372942\n",
      "MONDO:0010810 vitamin D hydroxylation-deficient rickets, type 1B 0.00010945367391650902 0.372942\n",
      "MONDO:0859199 developmental delay with or without intellectual impairment or behavioral abnormalities 0.00010945367391650902 0.372942\n",
      "MONDO:0011933 ALG2-congenital disorder of glycosylation 0.00010945367391650902 0.372942\n",
      "MONDO:0014751 palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome 0.00010945367391650902 0.372942\n",
      "MONDO:0014671 neuropathy, hereditary motor and sensory, type 6B 0.00010945367391650902 0.372942\n",
      "MONDO:0044714 mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome 0.00010945367391650902 0.372942\n",
      "MONDO:0032781 congenital hypotonia, epilepsy, developmental delay, and digital anomalies 0.00011709236986533024 0.369523\n",
      "MONDO:0030019 anauxetic dysplasia 3 0.00011709236986533024 0.369523\n",
      "MONDO:0010465 Kabuki syndrome 2 0.00011709236986533024 0.369523\n",
      "MONDO:0008830 aspartylglucosaminuria 0.00011709236986533024 0.369523\n",
      "MONDO:0008458 spinocerebellar ataxia type 2 0.00011709236986533024 0.369523\n",
      "MONDO:0010184 methylmalonic aciduria and homocystinuria type cblC 0.00011709236986533024 0.369523\n",
      "MONDO:0030837 neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities 0.00011709236986533024 0.369523\n",
      "MONDO:0014063 mitochondrial complex III deficiency nuclear type 2 0.00012498595676855705 0.366229\n",
      "MONDO:0054813 Ehlers-Danlos syndrome, classic-like, 2 0.00012498595676855705 0.366229\n",
      "MONDO:0054837 intellectual disability, autosomal dominant 57 0.00012498595676855705 0.366229\n",
      "MONDO:0013270 Rett syndrome, congenital variant 0.00012498595676855705 0.366229\n",
      "MONDO:0013839 hereditary sensory and autonomic neuropathy type 6 0.00012498595676855705 0.366229\n",
      "MONDO:0957248 developmental and epileptic encephalopathy 31B 0.00013313417130887488 0.363051\n",
      "MONDO:0014684 combined oxidative phosphorylation defect type 26 0.00013313417130887488 0.363051\n",
      "MONDO:0030919 intellectual disability, autosomal dominant 53 0.00013313417130887488 0.363051\n",
      "MONDO:0010512 intellectual disability, X-linked, syndromic, Bain type 0.00014153675037194524 0.359984\n",
      "MONDO:0013624 Rafiq syndrome 0.00014153675037194524 0.359984\n",
      "MONDO:0007537 lateral meningocele syndrome 0.00014153675037194524 0.359984\n",
      "MONDO:0010502 intellectual disability, X-linked 99, syndromic, female-restricted 0.00014153675037194524 0.359984\n",
      "MONDO:0011335 spondyloepimetaphyseal dysplasia with multiple dislocations 0.00014153675037194524 0.359984\n",
      "MONDO:0010305 creatine transporter deficiency 0.00015019343104626687 0.357019\n",
      "MONDO:0030331 Ritscher-Schinzel syndrome 4 0.00015019343104626687 0.357019\n",
      "MONDO:0030047 microcephaly, developmental delay, and brittle hair syndrome 0.00015019343104626687 0.357019\n",
      "MONDO:0020847 intellectual disability, autosomal dominant 58 0.00015019343104626687 0.357019\n",
      "MONDO:0016002 Ehlers-Danlos syndrome, kyphoscoliotic type 1 0.00015019343104626687 0.357019\n",
      "MONDO:0009263 GAPO syndrome 0.00015019343104626687 0.357019\n",
      "MONDO:0044324 Al Kaissi syndrome 0.00015019343104626687 0.357019\n",
      "MONDO:0009817 autosomal recessive osteopetrosis 5 0.00015019343104626687 0.357019\n",
      "MONDO:0013563 multiple congenital anomalies-hypotonia-seizures syndrome 1 0.00015019343104626687 0.357019\n",
      "MONDO:0014864 hypermanganesemia with dystonia 2 0.00015019343104626687 0.357019\n",
      "MONDO:0013459 osteogenesis imperfecta type 10 0.00015910395062303635 0.354151\n",
      "MONDO:0060510 Cohen-Gibson syndrome 0.00015910395062303635 0.354151\n",
      "MONDO:0014831 progeroid and marfanoid aspect-lipodystrophy syndrome 0.00016826804659601018 0.351375\n",
      "MONDO:0013379 Noonan syndrome 7 0.00016826804659601018 0.351375\n",
      "MONDO:0054637 Noonan syndrome-like disorder with loose anagen hair 1 0.00016826804659601018 0.351375\n",
      "MONDO:0010570 craniofrontonasal syndrome 0.00016826804659601018 0.351375\n",
      "MONDO:0100215 Rajab interstitial lung disease with brain calcifications 1 0.00016826804659601018 0.351375\n",
      "MONDO:0014300 proximal myopathy with extrapyramidal signs 0.00016826804659601018 0.351375\n",
      "MONDO:0008944 Joubert syndrome 1 0.00017768545666136607 0.348685\n",
      "MONDO:0859306 developmental delay with variable intellectual disability and dysmorphic facies 0.00017768545666136607 0.348685\n",
      "MONDO:0032855 neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies 0.00017768545666136607 0.348685\n",
      "MONDO:0011070 van Maldergem syndrome 1 0.00017768545666136607 0.348685\n",
      "MONDO:0060711 Jaberi-Elahi syndrome 0.00017768545666136607 0.348685\n",
      "MONDO:0859236 neurodevelopmental disorder with neuromuscular and skeletal abnormalities 0.00018735591871756383 0.346076\n",
      "MONDO:0014482 intellectual disability, autosomal dominant 29 0.00018735591871756383 0.346076\n",
      "MONDO:0014343 Desbuquois dysplasia 2 0.00018735591871756383 0.346076\n",
      "MONDO:0020682 Ehlers-Danlos syndrome, spondylodysplastic type, 1 0.00018735591871756383 0.346076\n",
      "MONDO:0859201 neurodevelopmental disorder with impaired language and ataxia and with or without seizures 0.00019727917086520647 0.343544\n",
      "MONDO:0030915 intellectual disability, autosomal recessive 61 0.00019727917086520647 0.343544\n",
      "MONDO:0008426 Shprintzen-Goldberg syndrome 0.00019727917086520647 0.343544\n",
      "MONDO:0007621 Floating-Harbor syndrome 0.00020745495140690425 0.341085\n",
      "MONDO:0010310 osteopathia striata with cranial sclerosis 0.00020745495140690425 0.341085\n",
      "MONDO:0020681 Ehlers-Danlos syndrome, musculocontractural type 1 0.00020745495140690425 0.341085\n",
      "MONDO:0007892 Lenz-Majewski hyperostotic dwarfism 0.00020745495140690425 0.341085\n",
      "MONDO:0008908 MGAT2-congenital disorder of glycosylation 0.00021788299884713326 0.338696\n",
      "MONDO:0014262 Rienhoff syndrome 0.00021788299884713326 0.338696\n",
      "MONDO:0859301 neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects 0.00021788299884713326 0.338696\n",
      "MONDO:0010200 Wilson disease 0.00021788299884713326 0.338696\n",
      "MONDO:0008222 Andersen-Tawil syndrome 0.0002285630518920994 0.336372\n",
      "MONDO:0030908 intellectual disability, X-linked, syndromic, 35 0.0002394948494495994 0.334111\n",
      "MONDO:0009318 Hallermann-Streiff syndrome 0.0002394948494495994 0.334111\n",
      "MONDO:0009629 Desbuquois dysplasia 1 0.0002394948494495994 0.334111\n",
      "MONDO:0012864 chromosome 2q32-q33 deletion syndrome 0.00025067813062888266 0.33191\n",
      "MONDO:0021093 cranioectodermal dysplasia 1 0.00027379810129623703 0.327676\n",
      "MONDO:0029140 glycosylphosphatidylinositol biosynthesis defect 18 0.00027379810129623703 0.327676\n",
      "MONDO:0014258 congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome 0.00027379810129623703 0.327676\n",
      "MONDO:0010959 van den Ende-Gupta syndrome 0.00028573427000883126 0.325638\n",
      "MONDO:0009479 Johanson-Blizzard syndrome 0.00028573427000883126 0.325638\n",
      "MONDO:0012315 distal 10q deletion syndrome 0.0003103576737601333 0.321709\n",
      "MONDO:0957247 congenital myopathy 22A, classic 0.0003103576737601333 0.321709\n",
      "MONDO:0060752 neurodevelopmental disorder with spasticity and poor growth 0.0003230443892283633 0.319813\n",
      "MONDO:0032645 trichohepatoneurodevelopmental syndrome 0.00034916654992766155 0.316151\n",
      "MONDO:0026771 developmental and epileptic encephalopathy, 85, with or without midline brain defects 0.00034916654992766155 0.316151\n",
      "MONDO:0010075 spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures 0.00034916654992766155 0.316151\n",
      "MONDO:0013415 chromosome 17p13.1 deletion syndrome 0.00036260147679077705 0.314381\n",
      "MONDO:0957228 intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities 0.0003762852894177881 0.31265\n",
      "MONDO:0014855 intellectual disability, autosomal dominant 42 0.0004043985374278989 0.309298\n",
      "MONDO:0011518 Wiedemann-Steiner syndrome 0.0004188274560425709 0.307674\n",
      "MONDO:0012853 Fontaine progeroid syndrome 0.0004484285920667607 0.304524\n",
      "MONDO:0011929 chromosome 1p36 deletion syndrome 0.00046360029390462096 0.302996\n",
      "MONDO:0032707 turnpenny-fry syndrome 0.00046360029390462096 0.302996\n",
      "MONDO:0008953 peroxisome biogenesis disorder 1A (Zellweger) 0.00046360029390462096 0.302996\n",
      "MONDO:0859273 liver disease, severe congenital 0.00046360029390462096 0.302996\n",
      "MONDO:0009798 Primrose syndrome 0.00047901907491051254 0.301498\n",
      "MONDO:0014205 severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome 0.0004946846777963385 0.300028\n",
      "MONDO:0011053 intellectual disability-sparse hair-brachydactyly syndrome 0.0005105968454728517 0.298586\n",
      "MONDO:0010193 Weaver syndrome 0.0005105968454728517 0.298586\n",
      "MONDO:0012914 chromosome 1q21.1 deletion syndrome 0.0005105968454728517 0.298586\n",
      "MONDO:0010035 Smith-Lemli-Opitz syndrome 0.0005431598478343632 0.295782\n",
      "MONDO:0009999 autosomal recessive Robinow syndrome 0.0005598101693338767 0.294418\n",
      "MONDO:0030990 Kohlschutter-Tonz syndrome-like 0.0005598101693338767 0.294418\n",
      "MONDO:0859239 Chilton-Okur-Chung neurodevelopmental syndrome 0.000576706029252835 0.293079\n",
      "MONDO:0007617 Coffin-Siris syndrome 1 0.0006288642795458657 0.289199\n",
      "MONDO:0030993 Tessadori-Van Haaften neurodevelopmental syndrome 3 0.0009440402407871957 0.271407\n",
      "MONDO:0010339 epilepsy, X-linked 1, with variable learning disabilities and behavior disorders 0.0010249216925187008 0.267892\n",
      "MONDO:0015020 intellectual disability, autosomal recessive 59 0.0010249216925187008 0.267892\n",
      "MONDO:0032783 aortic valve disease 3 0.0010249216925187008 0.267892\n",
      "MONDO:0008208 patella, familial recurrent dislocation of 0.0010249216925187008 0.267892\n",
      "MONDO:0018767 severe primary trimethylaminuria 0.0010249216925187008 0.267892\n",
      "MONDO:0011376 ventricular fibrillation, paroxysmal familial, type 1 0.0010249216925187008 0.267892\n",
      "MONDO:0011886 torsion dystonia 13 0.0010249216925187008 0.267892\n",
      "MONDO:0008591 tremor-nystagmus-duodenal ulcer syndrome 0.0010249216925187008 0.267892\n",
      "MONDO:0012687 familial cavitary optic disk anomaly 0.0010249216925187008 0.267892\n",
      "MONDO:0014815 intellectual disability, autosomal recessive 52 0.0015369885472835136 0.250991\n",
      "MONDO:0010440 autism, susceptibility to, X-linked 4 0.0015369885472835136 0.250991\n",
      "MONDO:0009199 ethanolaminosis 0.0015369885472835136 0.250991\n",
      "MONDO:0024508 epilepsy, hot water, 1 0.0015369885472835136 0.250991\n",
      "MONDO:0009896 polymyoclonus, infantile 0.0015369885472835136 0.250991\n",
      "MONDO:0014422 vesicoureteral reflux 8 0.0015369885472835136 0.250991\n",
      "MONDO:0009814 osteopenia-intellectual disability-sparse hair syndrome 0.0015369885472835136 0.250991\n",
      "MONDO:0032814 microangiopathy and leukoencephalopathy, pontine, autosomal dominant 0.0015369885472835136 0.250991\n",
      "MONDO:0007435 dentatorubral-pallidoluysian atrophy 0.0015369885472835136 0.250991\n",
      "MONDO:0014626 spinocerebellar ataxia type 41 0.0015369885472835136 0.250991\n",
      "MONDO:0011309 familial gestational hyperthyroidism 0.0015369885472835136 0.250991\n",
      "MONDO:0013988 congenital heart defects, multiple types, 3 0.0015369885472835136 0.250991\n",
      "MONDO:0011163 malignant hyperthermia, susceptibility to, 5 0.0015369885472835136 0.250991\n",
      "MONDO:0012314 short QT syndrome type 3 0.0015369885472835136 0.250991\n",
      "MONDO:0009141 torsion dystonia 2 0.0015369885472835136 0.250991\n",
      "MONDO:0008044 myoclonic dystonia 11 0.0015369885472835136 0.250991\n",
      "MONDO:0012466 Parkinson disease 13, autosomal dominant, susceptibility to 0.0015369885472835136 0.250991\n",
      "MONDO:0010732 spastic paraparesis-deafness syndrome 0.0015369885472835136 0.250991\n",
      "MONDO:0010747 X-linked dystonia-parkinsonism 0.0015369885472835136 0.250991\n",
      "MONDO:0012498 congenital stationary night blindness autosomal dominant 1 0.0015369885472835136 0.250991\n",
      "MONDO:0007118 isolated anhidrosis with normal sweat glands 0.002048792920561606 0.239441\n",
      "MONDO:0014770 Joubert syndrome 25 0.002048792920561606 0.239441\n",
      "MONDO:0014846 spinocerebellar ataxia, autosomal recessive 23 0.002048792920561606 0.239441\n",
      "MONDO:0014524 intellectual disability, autosomal recessive 47 0.002048792920561606 0.239441\n",
      "MONDO:0008845 atonic-astatic syndrome of Foerster 0.002048792920561606 0.239441\n",
      "MONDO:0013580 pyruvate dehydrogenase E1-beta deficiency 0.002048792920561606 0.239441\n",
      "MONDO:0007518 edema, familial idiopathic, prepubertal 0.002048792920561606 0.239441\n",
      "MONDO:0014091 mitochondrial complex V (ATP synthase) deficiency nuclear type 4 0.002048792920561606 0.239441\n",
      "MONDO:0009363 hydrocephaly-tall stature-joint laxity syndrome 0.002048792920561606 0.239441\n",
      "MONDO:0013340 Parkinson disease 5, autosomal dominant, susceptibility to 0.002048792920561606 0.239441\n",
      "MONDO:0008939 isolated cerebellar hypoplasia/agenesis 0.002048792920561606 0.239441\n",
      "MONDO:0008133 optic atrophy 3 0.002048792920561606 0.239441\n",
      "MONDO:0012732 tremor, hereditary essential, and idiopathic normal pressure hydrocephalus 0.002048792920561606 0.239441\n",
      "MONDO:0030038 glaucoma, primary closed-angle 0.002048792920561606 0.239441\n",
      "MONDO:0044314 retinitis pigmentosa 78 0.002048792920561606 0.239441\n",
      "MONDO:0007661 Tourette syndrome 0.0025603349468989512 0.230738\n",
      "MONDO:0012986 bilateral parasagittal parieto-occipital polymicrogyria 0.0025603349468989512 0.230738\n",
      "MONDO:0014623 microcephaly 14, primary, autosomal recessive 0.0025603349468989512 0.230738\n",
      "MONDO:0010379 Brunner syndrome 0.0025603349468989512 0.230738\n",
      "MONDO:0060577 neurodevelopmental disorder with microcephaly, ataxia, and seizures 0.0025603349468989512 0.230738\n",
      "MONDO:0008059 Naegeli-Franceschetti-Jadassohn syndrome 0.0025603349468989512 0.230738\n",
      "MONDO:0011680 autosomal recessive congenital ichthyosis 3 0.0025603349468989512 0.230738\n",
      "MONDO:0024529 MVP1 0.0025603349468989512 0.230738\n",
      "MONDO:0009585 encephalopathy due to beta-mercaptolactate-cysteine disulfiduria 0.0025603349468989512 0.230738\n",
      "MONDO:0013548 acetyl-CoA acetyltransferase-2 deficiency 0.0025603349468989512 0.230738\n",
      "MONDO:0012858 primary CD59 deficiency 0.0025603349468989512 0.230738\n",
      "MONDO:0030935 mitochondrial complex 2 deficiency, nuclear type 2 0.0025603349468989512 0.230738\n",
      "MONDO:0013515 osteogenesis imperfecta type 6 0.0025603349468989512 0.230738\n",
      "MONDO:0007036 Achard syndrome 0.0025603349468989512 0.230738\n",
      "MONDO:0007244 Caffey disease 0.0025603349468989512 0.230738\n",
      "MONDO:0007523 Ehlers-Danlos syndrome, hypermobility type 0.0025603349468989512 0.230738\n",
      "MONDO:0011613 autosomal recessive early-onset Parkinson disease 6 0.0025603349468989512 0.230738\n",
      "MONDO:0011896 Parkinson disease 11, autosomal dominant, susceptibility to 0.0025603349468989512 0.230738\n",
      "MONDO:0008570 thyrotoxic periodic paralysis, susceptibility to, 1 0.0025603349468989512 0.230738\n",
      "MONDO:0009086 deafness-small bowel diverticulosis-neuropathy syndrome 0.0025603349468989512 0.230738\n",
      "MONDO:0007783 malignant hyperthermia, susceptibility to, 1 0.0025603349468989512 0.230738\n",
      "MONDO:0008306 ABri amyloidosis 0.0025603349468989512 0.230738\n",
      "MONDO:0013188 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 3 0.0025603349468989512 0.230738\n",
      "MONDO:0013436 retinitis pigmentosa 39 0.0025603349468989512 0.230738\n",
      "MONDO:0013613 Leber congenital amaurosis 16 0.0025603349468989512 0.230738\n",
      "MONDO:0013611 retinitis pigmentosa 62 0.0025603349468989512 0.230738\n",
      "MONDO:0013923 microcephaly 9, primary, autosomal recessive 0.003071614760772548 0.223795\n",
      "MONDO:0011703 spongiform encephalopathy with neuropsychiatric features 0.003071614760772548 0.223795\n",
      "MONDO:0032796 hyper-IgE recurrent infection syndrome 4, autosomal recessive 0.003071614760772548 0.223795\n",
      "MONDO:0024568 infantile liver failure syndrome 1 0.003071614760772548 0.223795\n",
      "MONDO:0030054 developmental and epileptic encephalopathy, 86 0.003071614760772548 0.223795\n",
      "MONDO:0060551 cerebellar atrophy, developmental delay, and seizures 0.003071614760772548 0.223795\n",
      "MONDO:0009009 hypoplasminogenemia 0.003071614760772548 0.223795\n",
      "MONDO:0032889 Poirier-Bienvenu neurodevelopmental syndrome 0.003071614760772548 0.223795\n",
      "MONDO:0014248 autism spectrum disorder - epilepsy - arthrogryposis syndrome 0.003071614760772548 0.223795\n",
      "MONDO:0012120 pyruvate dehydrogenase phosphatase deficiency 0.003071614760772548 0.223795\n",
      "MONDO:0009415 hypoglycemia, leucine-induced 0.003071614760772548 0.223795\n",
      "MONDO:0007191 Behcet disease 0.003071614760772548 0.223795\n",
      "MONDO:0859246 leukodystrophy, childhood-onset, remitting 0.003071614760772548 0.223795\n",
      "MONDO:0032919 intellectual developmental disorder 62 0.003071614760772548 0.223795\n",
      "MONDO:0004974 adrenal gland pheochromocytoma 0.003071614760772548 0.223795\n",
      "MONDO:0014521 progressive myoclonic epilepsy type 7 0.003071614760772548 0.223795\n",
      "MONDO:0009839 progressive supranuclear palsy-parkinsonism syndrome 0.003071614760772548 0.223795\n",
      "MONDO:0014167 epilepsy, familial adult myoclonic, 5 0.003071614760772548 0.223795\n",
      "MONDO:0014055 epilepsy, familial adult myoclonic, 4 0.003071614760772548 0.223795\n",
      "MONDO:0010698 optic atrophy 2 0.003071614760772548 0.223795\n",
      "MONDO:0007740 Wagner disease 0.003071614760772548 0.223795\n",
      "MONDO:0013395 retinitis pigmentosa 4 0.003071614760772548 0.223795\n",
      "MONDO:0032699 epilepsy, idiopathic generalized, susceptibility to, 15 0.00358263249659046 0.218044\n",
      "MONDO:0033572 intellectual developmental disorder with epilepsy, behavioral abnormalities, and coarse facies 0.00358263249659046 0.218044\n",
      "MONDO:0030731 aortic aneurysm, familial thoracic 12 0.00358263249659046 0.218044\n",
      "MONDO:0030539 central hypoventilation syndrome, congenital, 3 0.00358263249659046 0.218044\n",
      "MONDO:0010109 tetraamelia with ectodermal dysplasia and lacrimal duct abnormalities 0.00358263249659046 0.218044\n",
      "MONDO:0032871 leukodystrophy, hypomyelinating, 19, transient infantile 0.00358263249659046 0.218044\n",
      "MONDO:0010380 cataract, ataxia, short stature, and intellectual disability 0.00358263249659046 0.218044\n",
      "MONDO:0009952 radioulnar synostosis-developmental delay-hypotonia syndrome 0.00358263249659046 0.218044\n",
      "MONDO:0012624 acyl-CoA dehydrogenase 9 deficiency 0.00358263249659046 0.218044\n",
      "MONDO:0013877 mitochondrial pyruvate carrier deficiency 0.00358263249659046 0.218044\n",
      "MONDO:0011627 autism, susceptibility to, 5 0.00358263249659046 0.218044\n",
      "MONDO:0013763 Joubert syndrome 15 0.00358263249659046 0.218044\n",
      "MONDO:0030862 COACH syndrome 3 0.00358263249659046 0.218044\n",
      "MONDO:0009742 neuroectodermal melanolysosomal disease 0.00358263249659046 0.218044\n",
      "MONDO:0014766 leukodystrophy and acquired microcephaly with or without dystonia; 0.00358263249659046 0.218044\n",
      "MONDO:0030020 combined oxidative phosphorylation deficiency 44 0.00358263249659046 0.218044\n",
      "MONDO:0007796 hypoparathyroidism, familial isolated 1 0.00358263249659046 0.218044\n",
      "MONDO:0009158 Ehlers-Danlos syndrome, fibronectinemic type 0.00358263249659046 0.218044\n",
      "MONDO:0010535 Bazex-Dupre-Christol syndrome 0.00358263249659046 0.218044\n",
      "MONDO:0031031 intellectual developmental disorder, autosomal recessive 77 0.00358263249659046 0.218044\n",
      "MONDO:0012145 macular degeneration, age-related, 3 0.00358263249659046 0.218044\n",
      "MONDO:0011764 autosomal dominant Parkinson disease 8 0.00358263249659046 0.218044\n",
      "MONDO:0008235 pheochromocytoma-islet cell tumor syndrome 0.00358263249659046 0.218044\n",
      "MONDO:0008645 ventricular extrasystoles with syncopal episodes-perodactyly-robin sequence syndrome 0.00358263249659046 0.218044\n",
      "MONDO:0008233 pheochromocytoma 0.00358263249659046 0.218044\n",
      "MONDO:0008297 variegate porphyria 0.00358263249659046 0.218044\n",
      "MONDO:0013322 epilepsy, familial adult myoclonic, 3 0.00358263249659046 0.218044\n",
      "MONDO:0030625 dyskinesia with orofacial involvement, autosomal recessive 0.00358263249659046 0.218044\n",
      "MONDO:0010985 epilepsy, familial adult myoclonic, 1 0.00358263249659046 0.218044\n",
      "MONDO:0010662 paraplegia-intellectual disability-hyperkeratosis syndrome 0.00358263249659046 0.218044\n",
      "MONDO:0012904 epilepsy, progressive myoclonic, 1B 0.00358263249659046 0.218044\n",
      "MONDO:0014644 hereditary spastic paraplegia 74 0.00358263249659046 0.218044\n",
      "MONDO:0014292 leukoencephalopathy with mild cerebellar ataxia and white matter edema 0.00358263249659046 0.218044\n",
      "MONDO:0010167 urocanic aciduria 0.004093388288691872 0.21315\n",
      "MONDO:0859207 neurodevelopmental disorder with hypotonia and gross motor and speech delay 0.004093388288691872 0.21315\n",
      "MONDO:0859287 neurodevelopmental disorder with microcephaly, hypotonia, and absent language 0.004093388288691872 0.21315\n",
      "MONDO:0011722 intellectual disability-obesity-prognathism-eye and skin anomalies syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0010539 X-linked mandibulofacial dysostosis 0.004093388288691872 0.21315\n",
      "MONDO:0014972 chromosome 19q13.11 deletion syndrome, proximal 0.004093388288691872 0.21315\n",
      "MONDO:0032627 mitochondrial complex 1 deficiency, nuclear type 23 0.004093388288691872 0.21315\n",
      "MONDO:0013942 peroxisome biogenesis disorder 8A (Zellweger) 0.004093388288691872 0.21315\n",
      "MONDO:0013690 Pitt-Hopkins-like syndrome 2 0.004093388288691872 0.21315\n",
      "MONDO:0027407 Kleefstra syndrome 1 0.004093388288691872 0.21315\n",
      "MONDO:0032883 intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures 0.004093388288691872 0.21315\n",
      "MONDO:0032812 developmental and epileptic encephalopathy, 78 0.004093388288691872 0.21315\n",
      "MONDO:0033486 leukodystrophy, hypomyelinating, 14 0.004093388288691872 0.21315\n",
      "MONDO:0032619 mitochondrial complex 1 deficiency, nuclear type 14 0.004093388288691872 0.21315\n",
      "MONDO:0014968 encephalopathy, progressive, with amyotrophy and optic atrophy 0.004093388288691872 0.21315\n",
      "MONDO:0013584 hereditary sensory neuropathy-deafness-dementia syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0014654 Ullrich congenital muscular dystrophy 2 0.004093388288691872 0.21315\n",
      "MONDO:0014086 osteogenesis imperfecta type 15 0.004093388288691872 0.21315\n",
      "MONDO:0030534 hypogonadotropic hypogonadism 26 with or without anosmia 0.004093388288691872 0.21315\n",
      "MONDO:0009159 Ehlers-Danlos syndrome, cardiac valvular type 0.004093388288691872 0.21315\n",
      "MONDO:0014742 Parkinson disease 22, autosomal dominant 0.004093388288691872 0.21315\n",
      "MONDO:0007273 paragangliomas 4 0.004093388288691872 0.21315\n",
      "MONDO:0014500 atrial conduction disease 0.004093388288691872 0.21315\n",
      "MONDO:0014633 myoclonic-atonic epilepsy 0.004093388288691872 0.21315\n",
      "MONDO:0014607 developmental and epileptic encephalopathy, 32 0.004093388288691872 0.21315\n",
      "MONDO:0011930 epilepsy, familial adult myoclonic, 2 0.004093388288691872 0.21315\n",
      "MONDO:0032843 oculopharyngeal myopathy with leukoencephalopathy 1 0.004093388288691872 0.21315\n",
      "MONDO:0013314 retinitis pigmentosa 56 0.004093388288691872 0.21315\n",
      "MONDO:0025691 dystonia 30 0.0046038822713470855 0.208901\n",
      "MONDO:0014303 hereditary spastic paraplegia 64 0.0046038822713470855 0.208901\n",
      "MONDO:0009622 Jawad syndrome 0.0046038822713470855 0.208901\n",
      "MONDO:0013994 Joubert syndrome 20 0.0046038822713470855 0.208901\n",
      "MONDO:0012171 marfanoid habitus with situs inversus 0.0046038822713470855 0.208901\n",
      "MONDO:0060564 HELIX syndrome 0.0046038822713470855 0.208901\n",
      "MONDO:0007509 ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant 0.0046038822713470855 0.208901\n",
      "MONDO:0032897 intellectual developmental disorder with hypotonia and behavioral abnormalities 0.0046038822713470855 0.208901\n",
      "MONDO:0009669 spinal muscular atrophy, type 1 0.0046038822713470855 0.208901\n",
      "MONDO:0014764 spastic paraplegia-severe developmental delay-epilepsy syndrome 0.0046038822713470855 0.208901\n",
      "MONDO:0008721 medium chain acyl-CoA dehydrogenase deficiency 0.0046038822713470855 0.208901\n",
      "MONDO:0008795 aniridia-cerebellar ataxia-intellectual disability syndrome 0.0046038822713470855 0.208901\n",
      "MONDO:0032612 mitochondrial complex 1 deficiency, nuclear type 7 0.0046038822713470855 0.208901\n",
      "MONDO:0011486 congenital muscular dystrophy 1B 0.0046038822713470855 0.208901\n",
      "MONDO:0033653 mitochondrial complex 4 deficiency, nuclear type 18 0.0046038822713470855 0.208901\n",
      "MONDO:0033203 nephrotic syndrome 14 0.0046038822713470855 0.208901\n",
      "MONDO:0013509 intellectual disability, autosomal dominant 6 0.0046038822713470855 0.208901\n",
      "MONDO:0014771 Joubert syndrome 26 0.0046038822713470855 0.208901\n",
      "MONDO:0012391 neuronal ceroid lipofuscinosis 8 northern epilepsy variant 0.0046038822713470855 0.208901\n",
      "MONDO:0859292 developmental delay, behavioral abnormalities, and neuropsychiatric disorders 0.0046038822713470855 0.208901\n",
      "MONDO:0060556 joint laxity, short stature, and myopia 0.0046038822713470855 0.208901\n",
      "MONDO:0008179 paroxysmal extreme pain disorder 0.0046038822713470855 0.208901\n",
      "MONDO:0030887 cardiomyopathy, dilated, 2G 0.0046038822713470855 0.208901\n",
      "MONDO:0014417 spinocerebellar ataxia type 38 0.0046038822713470855 0.208901\n",
      "MONDO:0032741 neurodevelopmental disorder with impaired speech and hyperkinetic movements 0.0046038822713470855 0.208901\n",
      "MONDO:0012622 leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome 0.0046038822713470855 0.208901\n",
      "MONDO:0054764 neurodegeneration with brain iron accumulation 8 0.0046038822713470855 0.208901\n",
      "MONDO:0014666 hypomyelinating leukodystrophy 11 0.0046038822713470855 0.208901\n",
      "MONDO:0008453 adult-onset proximal spinal muscular atrophy, autosomal dominant 0.0046038822713470855 0.208901\n",
      "MONDO:0013702 intellectual disability, autosomal recessive 27 0.00511411457875759 0.205154\n",
      "MONDO:0014996 intellectual disability, autosomal recessive 58 0.00511411457875759 0.205154\n",
      "MONDO:0010691 Norrie disease 0.00511411457875759 0.205154\n",
      "MONDO:0032930 intellectual developmental disorder with poor growth and with or without seizures or ataxia 0.00511411457875759 0.205154\n",
      "MONDO:0009703 myopathy with abnormal lipid metabolism 0.00511411457875759 0.205154\n",
      "MONDO:0017715 3-hydroxyacyl-CoA dehydrogenase deficiency 0.00511411457875759 0.205154\n",
      "MONDO:0032621 mitochondrial complex 1 deficiency, nuclear type 16 0.00511411457875759 0.205154\n",
      "MONDO:0030088 diabetes mellitus, permanent neonatal 3 0.00511411457875759 0.205154\n",
      "MONDO:0013793 encephalomyopathy, mitochondrial, due to voltage-dependent anion channel deficiency 0.00511411457875759 0.205154\n",
      "MONDO:0032635 mitochondrial complex 1 deficiency, nuclear type 32 0.00511411457875759 0.205154\n",
      "MONDO:0014885 Hermansky-Pudlak syndrome 10 0.00511411457875759 0.205154\n",
      "MONDO:0014297 Joubert syndrome 22 0.00511411457875759 0.205154\n",
      "MONDO:0014611 multiple mitochondrial dysfunctions syndrome 4 0.00511411457875759 0.205154\n",
      "MONDO:0033667 Delpire-McNeill syndrome 0.00511411457875759 0.205154\n",
      "MONDO:0044304 hyperphenylalaninemia due to DNAJC12 deficiency 0.00511411457875759 0.205154\n",
      "MONDO:0011101 peroxisome biogenesis disorder 1B 0.00511411457875759 0.205154\n",
      "MONDO:0014959 mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant 0.00511411457875759 0.205154\n",
      "MONDO:0010100 Tay-Sachs disease 0.00511411457875759 0.205154\n",
      "MONDO:0013930 peroxisome biogenesis disorder 4A (Zellweger) 0.00511411457875759 0.205154\n",
      "MONDO:0010356 nephrogenic syndrome of inappropriate antidiuresis 0.00511411457875759 0.205154\n",
      "MONDO:0014719 developmental and epileptic encephalopathy, 35 0.00511411457875759 0.205154\n",
      "MONDO:0013896 Joubert syndrome 18 0.00511411457875759 0.205154\n",
      "MONDO:0009806 Bruck syndrome 1 0.00511411457875759 0.205154\n",
      "MONDO:0049223 osteogenesis imperfecta, type 19 0.00511411457875759 0.205154\n",
      "MONDO:0013473 Hirschsprung disease, cardiac defects, and autonomic dysfunction 0.00511411457875759 0.205154\n",
      "MONDO:0009606 methemoglobinemia due to deficiency of methemoglobin reductase 0.00511411457875759 0.205154\n",
      "MONDO:0013711 peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome 0.00511411457875759 0.205154\n",
      "MONDO:0010735 Kennedy disease 0.00511411457875759 0.205154\n",
      "MONDO:0013803 leukoencephalopathy with calcifications and cysts 0.00511411457875759 0.205154\n",
      "MONDO:0957225 neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities 0.00511411457875759 0.205154\n",
      "MONDO:0011834 spinocerebellar ataxia type 18 0.00511411457875759 0.205154\n",
      "MONDO:0010660 intellectual disability, X-linked 9 0.005624085345056082 0.201809\n",
      "MONDO:0020846 intellectual disability, autosomal recessive 64 0.005624085345056082 0.201809\n",
      "MONDO:0014113 cardiofaciocutaneous syndrome 3 0.005624085345056082 0.201809\n",
      "MONDO:0033361 developmental and epileptic encephalopathy, 52 0.005624085345056082 0.201809\n",
      "MONDO:0014569 lethal congenital contracture syndrome 7 0.005624085345056082 0.201809\n",
      "MONDO:0011950 infantile-onset autosomal recessive nonprogressive cerebellar ataxia 0.005624085345056082 0.201809\n",
      "MONDO:0009292 glycogen storage disease due to glycogen branching enzyme deficiency 0.005624085345056082 0.201809\n",
      "MONDO:0012221 alpha-N-acetylgalactosaminidase deficiency type 1 0.005624085345056082 0.201809\n",
      "MONDO:0011966 periventricular heterotopia with microcephaly, autosomal recessive 0.005624085345056082 0.201809\n",
      "MONDO:0009257 galactose epimerase deficiency 0.005624085345056082 0.201809\n",
      "MONDO:0032608 mitochondrial complex 1 deficiency, nuclear type 3 0.005624085345056082 0.201809\n",
      "MONDO:0032613 mitochondrial complex 1 deficiency, nuclear type 8 0.005624085345056082 0.201809\n",
      "MONDO:0010581 diabetes insipidus, nephrogenic, X-linked 0.005624085345056082 0.201809\n",
      "MONDO:0007451 diabetes insipidus, nephrogenic, autosomal 0.005624085345056082 0.201809\n",
      "MONDO:0011670 Ehlers-Danlos syndrome due to tenascin-X deficiency 0.005624085345056082 0.201809\n",
      "MONDO:0008146 osteogenesis imperfecta type 1 0.005624085345056082 0.201809\n",
      "MONDO:0013605 brittle cornea syndrome 2 0.005624085345056082 0.201809\n",
      "MONDO:0033365 developmental and epileptic encephalopathy, 56 0.005624085345056082 0.201809\n",
      "MONDO:0013464 episodic ataxia type 5 0.005624085345056082 0.201809\n",
      "MONDO:0011544 paragangliomas 3 0.005624085345056082 0.201809\n",
      "MONDO:0012805 childhood onset GLUT1 deficiency syndrome 2 0.005624085345056082 0.201809\n",
      "MONDO:0012116 spinocerebellar ataxia type 8 0.005624085345056082 0.201809\n",
      "MONDO:0009101 Wolfram syndrome 1 0.005624085345056082 0.201809\n",
      "MONDO:0030921 intellectual disability, autosomal dominant 55, with seizures 0.005624085345056082 0.201809\n",
      "MONDO:0013526 progressive myoclonic epilepsy type 6 0.005624085345056082 0.201809\n",
      "MONDO:0008793 angiomatosis, diffuse Corticomeningeal, of Divry and van Bogaert 0.005624085345056082 0.201809\n",
      "MONDO:0010246 developmental and epileptic encephalopathy, 9 0.006133794704306496 0.198792\n",
      "MONDO:0014952 intellectual disability-epilepsy-extrapyramidal syndrome 0.006133794704306496 0.198792\n",
      "MONDO:0011299 Huntington disease-like 1 0.006133794704306496 0.198792\n",
      "MONDO:0010907 familial hypertryptophanemia 0.006133794704306496 0.198792\n",
      "MONDO:0030891 intellectual developmental disorder, autosomal dominant 66 0.006133794704306496 0.198792\n",
      "MONDO:0010447 intellectual disability, X-linked 19 0.006133794704306496 0.198792\n",
      "MONDO:0008736 peroxisome biogenesis disorder 2B 0.006133794704306496 0.198792\n",
      "MONDO:0013867 brown-Vialetto-van Laere syndrome 2 0.006133794704306496 0.198792\n",
      "MONDO:0011449 Salla disease 0.006133794704306496 0.198792\n",
      "MONDO:0020790 gaze palsy, familial horizontal, with progressive scoliosis 1 0.006133794704306496 0.198792\n",
      "MONDO:0054761 microcephaly 20, primary, autosomal recessive 0.006133794704306496 0.198792\n",
      "MONDO:0014487 congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome 0.006133794704306496 0.198792\n",
      "MONDO:0009556 malonic aciduria 0.006133794704306496 0.198792\n",
      "MONDO:0033618 Vissers-Bodmer syndrome 0.006133794704306496 0.198792\n",
      "MONDO:0012855 Joubert syndrome 8 0.006133794704306496 0.198792\n",
      "MONDO:0008816 Chiari malformation type II 0.006133794704306496 0.198792\n",
      "MONDO:0012545 neutral lipid storage myopathy 0.006133794704306496 0.198792\n",
      "MONDO:0032716 leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate 0.006133794704306496 0.198792\n",
      "MONDO:0009349 holoprosencephaly 1 0.006133794704306496 0.198792\n",
      "MONDO:0008678 Williams syndrome 0.006133794704306496 0.198792\n",
      "MONDO:0033367 developmental and epileptic encephalopathy, 58 0.006133794704306496 0.198792\n",
      "MONDO:0014149 fetal akinesia-cerebral and retinal hemorrhage syndrome 0.006133794704306496 0.198792\n",
      "MONDO:0040501 ehlers-danlos syndrome, arthrochalasia type, 2 0.006133794704306496 0.198792\n",
      "MONDO:0044322 intellectual developmental disorder with neuropsychiatric features 0.006133794704306496 0.198792\n",
      "MONDO:0012694 Joubert syndrome 7 0.006133794704306496 0.198792\n",
      "MONDO:0014789 CCDC115-CDG 0.006133794704306496 0.198792\n",
      "MONDO:0010857 semantic dementia 0.006133794704306496 0.198792\n",
      "MONDO:0014868 developmental and epileptic encephalopathy, 38 0.006133794704306496 0.198792\n",
      "MONDO:0009376 carbamoyl phosphate synthetase I deficiency disease 0.006133794704306496 0.198792\n",
      "MONDO:0007051 acromegaloid facial appearance syndrome 0.006133794704306496 0.198792\n",
      "MONDO:0009123 orthostatic hypotension 1 0.006133794704306496 0.198792\n",
      "MONDO:0800131 hyper-IgE recurrent infection syndrome 4A, autosomal dominant 0.006133794704306496 0.198792\n",
      "MONDO:0030912 intellectual disability, autosomal dominant 47 0.006133794704306496 0.198792\n",
      "MONDO:0859335 congenital myopathy 15 0.006133794704306496 0.198792\n",
      "MONDO:0008294 acute intermittent porphyria 0.006133794704306496 0.198792\n",
      "MONDO:0008491 stiff-person syndrome 0.006133794704306496 0.198792\n",
      "MONDO:0008192 paragangliomas 1 0.006133794704306496 0.198792\n",
      "MONDO:0015004 dystonia 28, childhood-onset 0.006133794704306496 0.198792\n",
      "MONDO:0008047 episodic ataxia type 1 0.006133794704306496 0.198792\n",
      "MONDO:0030318 spinocerebellar ataxia, autosomal recessive 30 0.006133794704306496 0.198792\n",
      "MONDO:0011551 TH-deficient dopa-responsive dystonia 0.006133794704306496 0.198792\n",
      "MONDO:0012205 autosomal dominant striatal neurodegeneration type 1 0.006133794704306496 0.198792\n",
      "MONDO:0008436 Sneddon syndrome 0.006133794704306496 0.198792\n",
      "MONDO:0014678 intellectual disability, autosomal dominant 39 0.006643242790504057 0.196046\n",
      "MONDO:0049222 intellectual disability, X-linked 107 0.006643242790504057 0.196046\n",
      "MONDO:0014486 intellectual disability, autosomal dominant 30 0.006643242790504057 0.196046\n",
      "MONDO:0009530 lipoid proteinosis 0.006643242790504057 0.196046\n",
      "MONDO:0859285 neurodevelopmental disorder with microcephaly, short stature, and speech delay 0.006643242790504057 0.196046\n",
      "MONDO:0011437 microcephaly 4, primary, autosomal recessive 0.006643242790504057 0.196046\n",
      "MONDO:0014625 developmental and epileptic encephalopathy, 33 0.006643242790504057 0.196046\n",
      "MONDO:0859231 macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin 0.006643242790504057 0.196046\n",
      "MONDO:0012806 ectodermal dysplasia and immunodeficiency 2 0.006643242790504057 0.196046\n",
      "MONDO:0008603 trigonocephaly 1 0.006643242790504057 0.196046\n",
      "MONDO:0033371 developmental and epileptic encephalopathy, 62 0.006643242790504057 0.196046\n",
      "MONDO:0024506 Adams-Oliver syndrome 1 0.006643242790504057 0.196046\n",
      "MONDO:0008056 myotonic dystrophy type 1 0.006643242790504057 0.196046\n",
      "MONDO:0032648 mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations 0.006643242790504057 0.196046\n",
      "MONDO:0009563 maple syrup urine disease 0.006643242790504057 0.196046\n",
      "MONDO:0014513 nemaline myopathy 10 0.006643242790504057 0.196046\n",
      "MONDO:0033545 mitochondrial DNA depletion syndrome 19 0.006643242790504057 0.196046\n",
      "MONDO:0014807 spinal muscular atrophy with congenital bone fractures 2 0.006643242790504057 0.196046\n",
      "MONDO:0012471 Aicardi-Goutieres syndrome 3 0.006643242790504057 0.196046\n",
      "MONDO:0013931 peroxisome biogenesis disorder 4B 0.006643242790504057 0.196046\n",
      "MONDO:0013927 peroxisome biogenesis disorder 3A (Zellweger) 0.006643242790504057 0.196046\n",
      "MONDO:0033641 cleft palate, proliferative retinopathy, and developmental delay 0.006643242790504057 0.196046\n",
      "MONDO:0033635 mitochondrial complex 4 deficiency, nuclear type 3 0.006643242790504057 0.196046\n",
      "MONDO:0013549 N-acetylaspartate deficiency 0.006643242790504057 0.196046\n",
      "MONDO:0009609 methylcobalamin deficiency type cblG 0.006643242790504057 0.196046\n",
      "MONDO:0019917 maternal uniparental disomy of chromosome 20 0.006643242790504057 0.196046\n",
      "MONDO:0011964 DPAGT1-congenital disorder of glycosylation 0.006643242790504057 0.196046\n",
      "MONDO:0014921 developmental and epileptic encephalopathy, 43 0.006643242790504057 0.196046\n",
      "MONDO:0010185 methylmalonic aciduria and homocystinuria type cblD 0.006643242790504057 0.196046\n",
      "MONDO:0010490 SSR4-congenital disorder of glycosylation 0.006643242790504057 0.196046\n",
      "MONDO:0033374 developmental and epileptic encephalopathy, 65 0.006643242790504057 0.196046\n",
      "MONDO:0014115 hypomyelination with brain stem and spinal cord involvement and leg spasticity 0.006643242790504057 0.196046\n",
      "MONDO:0100489 Graves disease, susceptibility to, 1 0.006643242790504057 0.196046\n",
      "MONDO:0013281 COG4-congenital disorder of glycosylation 0.006643242790504057 0.196046\n",
      "MONDO:0014072 D,L-2-hydroxyglutaric aciduria 0.006643242790504057 0.196046\n",
      "MONDO:0008243 Pick disease 0.006643242790504057 0.196046\n",
      "MONDO:0011671 Huntington disease-like 2 0.006643242790504057 0.196046\n",
      "MONDO:0014746 SLC39A8-CDG 0.006643242790504057 0.196046\n",
      "MONDO:0013962 hereditary spastic paraplegia 53 0.006643242790504057 0.196046\n",
      "MONDO:0009601 metaphyseal dysplasia without hypotrichosis 0.006643242790504057 0.196046\n",
      "MONDO:0012592 osteogenesis imperfecta type 11 0.006643242790504057 0.196046\n",
      "MONDO:0030861 osteogenesis imperfecta, type 21 0.006643242790504057 0.196046\n",
      "MONDO:0014954 Ehlers-Danlos syndrome, periodontal type 2 0.006643242790504057 0.196046\n",
      "MONDO:0010122 congenital thrombotic thrombocytopenic purpura 0.006643242790504057 0.196046\n",
      "MONDO:0014402 severe neurodegenerative syndrome with lipodystrophy 0.006643242790504057 0.196046\n",
      "MONDO:0016163 autosomal dominant cerebellar ataxia type II 0.006643242790504057 0.196046\n",
      "MONDO:0014475 spinocerebellar ataxia type 40 0.006643242790504057 0.196046\n",
      "MONDO:0014261 growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome 0.006643242790504057 0.196046\n",
      "MONDO:0030453 developmental and epileptic encephalopathy 97 0.006643242790504057 0.196046\n",
      "MONDO:0014687 retinitis pigmentosa 73 0.006643242790504057 0.196046\n",
      "MONDO:0030930 neurodevelopmental disorder with or without early-onset generalized epilepsy 0.0071524297375753 0.193531\n",
      "MONDO:0007405 Crouzon syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0014157 mandibular hypoplasia-deafness-progeroid syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0009147 ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive 0.0071524297375753 0.193531\n",
      "MONDO:0013007 combined immunodeficiency due to ORAI1 deficiency 0.0071524297375753 0.193531\n",
      "MONDO:0032622 mitochondrial complex 1 deficiency, nuclear type 17 0.0071524297375753 0.193531\n",
      "MONDO:0032813 developmental and epileptic encephalopathy, 79 0.0071524297375753 0.193531\n",
      "MONDO:0013840 encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0012052 ALG1-congenital disorder of glycosylation 0.0071524297375753 0.193531\n",
      "MONDO:0014337 complex cortical dysplasia with other brain malformations 5 0.0071524297375753 0.193531\n",
      "MONDO:0014781 combined oxidative phosphorylation deficiency 29 0.0071524297375753 0.193531\n",
      "MONDO:0054742 combined oxidative phosphorylation deficiency 35 0.0071524297375753 0.193531\n",
      "MONDO:0013762 lipoic acid synthetase deficiency 0.0071524297375753 0.193531\n",
      "MONDO:0010507 Xq25 microduplication syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0011257 MPI-congenital disorder of glycosylation 0.0071524297375753 0.193531\n",
      "MONDO:0014683 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 0.0071524297375753 0.193531\n",
      "MONDO:0013111 acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins 0.0071524297375753 0.193531\n",
      "MONDO:0033657 leukodystrophy, hypomyelinating, 20 0.0071524297375753 0.193531\n",
      "MONDO:0007403 inherited Creutzfeldt-Jakob disease 0.0071524297375753 0.193531\n",
      "MONDO:0008988 citrullinemia type I 0.0071524297375753 0.193531\n",
      "MONDO:0013438 pontocerebellar hypoplasia type 2D 0.0071524297375753 0.193531\n",
      "MONDO:0009519 letterer-Siwe disease 0.0071524297375753 0.193531\n",
      "MONDO:0014003 developmental and epileptic encephalopathy, 15 0.0071524297375753 0.193531\n",
      "MONDO:0007818 hyper-IgE recurrent infection syndrome 1, autosomal dominant 0.0071524297375753 0.193531\n",
      "MONDO:0030995 global developmental delay with speech and behavioral abnormalities 0.0071524297375753 0.193531\n",
      "MONDO:0859300 neuronopathy, distal hereditary motor, autosomal dominant 10 0.0071524297375753 0.193531\n",
      "MONDO:0009052 cutis laxa, autosomal recessive, type 1A 0.0071524297375753 0.193531\n",
      "MONDO:0012558 epiphyseal dysplasia, Baumann type 0.0071524297375753 0.193531\n",
      "MONDO:0007352 renal coloboma syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0030929 microcephaly 27, primary, autosomal dominant 0.0071524297375753 0.193531\n",
      "MONDO:0024543 brittle cornea syndrome 1 0.0071524297375753 0.193531\n",
      "MONDO:0859361 neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia 0.0071524297375753 0.193531\n",
      "MONDO:0011091 Charcot-Marie-Tooth disease type 2D 0.0071524297375753 0.193531\n",
      "MONDO:0014231 juvenile onset Parkinson disease 19A 0.0071524297375753 0.193531\n",
      "MONDO:0007369 hereditary coproporphyria 0.0071524297375753 0.193531\n",
      "MONDO:0008045 spinal muscular atrophy-progressive myoclonic epilepsy syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0013681 alpha-methylacyl-CoA racemase deficiency 0.0071524297375753 0.193531\n",
      "MONDO:0014940 neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset 0.0071524297375753 0.193531\n",
      "MONDO:0011232 migraine, familial hemiplegic, 2 0.0071524297375753 0.193531\n",
      "MONDO:0020770 spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3 0.0071524297375753 0.193531\n",
      "MONDO:0033615 coenzyme q10 deficiency, primary, 9 0.0071524297375753 0.193531\n",
      "MONDO:0012449 spinocerebellar ataxia type 23 0.0071524297375753 0.193531\n",
      "MONDO:0957203 intellectual developmental disorder, X-linked 111 0.007661355679378102 0.191212\n",
      "MONDO:0859324 developmental delay, language impairment, and ocular abnormalities 0.007661355679378102 0.191212\n",
      "MONDO:0010659 FRAXE intellectual disability 0.007661355679378102 0.191212\n",
      "MONDO:0008438 hereditary spastic paraplegia 4 0.007661355679378102 0.191212\n",
      "MONDO:0008333 pseudoxanthoma elasticum, forme fruste 0.007661355679378102 0.191212\n",
      "MONDO:0014044 dysmorphism-conductive hearing loss-heart defect syndrome 0.007661355679378102 0.191212\n",
      "MONDO:0033368 developmental and epileptic encephalopathy, 59 0.007661355679378102 0.191212\n",
      "MONDO:0033636 mitochondrial complex 4 deficiency, nuclear type 4 0.007661355679378102 0.191212\n",
      "MONDO:0032570 Joubert syndrome 35 0.007661355679378102 0.191212\n",
      "MONDO:0009034 craniofacial dyssynostosis 0.007661355679378102 0.191212\n",
      "MONDO:0010778 cyclic vomiting syndrome 0.007661355679378102 0.191212\n",
      "MONDO:0033370 developmental and epileptic encephalopathy, 61 0.007661355679378102 0.191212\n",
      "MONDO:0012859 autosomal recessive osteopetrosis 7 0.007661355679378102 0.191212\n",
      "MONDO:0033363 developmental and epileptic encephalopathy, 54 0.007661355679378102 0.191212\n",
      "MONDO:0013277 developmental and epileptic encephalopathy, 5 0.007661355679378102 0.191212\n",
      "MONDO:0013948 peroxisome biogenesis disorder 10A (Zellweger) 0.007661355679378102 0.191212\n",
      "MONDO:0033637 mitochondrial complex 4 deficiency, nuclear type 7 0.007661355679378102 0.191212\n",
      "MONDO:0012792 mitochondrial DNA depletion syndrome 8a 0.007661355679378102 0.191212\n",
      "MONDO:0859517 congenital myopathy 2b, severe infantile, autosomal recessive 0.007661355679378102 0.191212\n",
      "MONDO:0012368 aminoacylase 1 deficiency 0.007661355679378102 0.191212\n",
      "MONDO:0859229 cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism 0.007661355679378102 0.191212\n",
      "MONDO:0033621 spinal muscular atrophy, infantile, James type 0.007661355679378102 0.191212\n",
      "MONDO:0009921 holoprosencephaly-postaxial polydactyly syndrome 0.007661355679378102 0.191212\n",
      "MONDO:0014485 pontocerebellar hypoplasia, type 1C 0.007661355679378102 0.191212\n",
      "MONDO:0010149 transcobalamin II deficiency 0.007661355679378102 0.191212\n",
      "MONDO:0009603 3-hydroxyisobutyryl-CoA hydrolase deficiency 0.007661355679378102 0.191212\n",
      "MONDO:0013059 Aicardi-Goutieres syndrome 5 0.007661355679378102 0.191212\n",
      "MONDO:0859216 neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis 0.007661355679378102 0.191212\n",
      "MONDO:0000208 microcephaly, short stature, and impaired glucose metabolism 1 0.007661355679378102 0.191212\n",
      "MONDO:0044329 osteogenesis imperfecta, type 18 0.007661355679378102 0.191212\n",
      "MONDO:0010263 Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome 0.007661355679378102 0.191212\n",
      "MONDO:0011892 epilepsy, idiopathic generalized, susceptibility to, 9 0.007661355679378102 0.191212\n",
      "MONDO:0010709 early-onset parkinsonism-intellectual disability syndrome 0.007661355679378102 0.191212\n",
      "MONDO:0008200 autosomal dominant Parkinson disease 1 0.007661355679378102 0.191212\n",
      "MONDO:0012203 familial hyperthyroidism due to mutations in TSH receptor 0.007661355679378102 0.191212\n",
      "MONDO:0032653 cardiac-urogenital syndrome 0.007661355679378102 0.191212\n",
      "MONDO:0014947 developmental and epileptic encephalopathy, 46 0.007661355679378102 0.191212\n",
      "MONDO:0008289 brain small vessel disease 1 with or without ocular anomalies 0.007661355679378102 0.191212\n",
      "MONDO:0100340 Friedreich ataxia 1 0.007661355679378102 0.191212\n",
      "MONDO:0013238 chromosome 17q23.1-q23.2 deletion syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0030900 intellectual developmental disorder with paroxysmal dyskinesia or seizures 0.008170020749701742 0.189063\n",
      "MONDO:0008695 chorea-acanthocytosis 0.008170020749701742 0.189063\n",
      "MONDO:0859571 diaphragmatic hernia 4, with cardiovascular defects 0.008170020749701742 0.189063\n",
      "MONDO:0014608 mandibulofacial dysostosis with alopecia 0.008170020749701742 0.189063\n",
      "MONDO:0007397 craniometaphyseal dysplasia, autosomal dominant 0.008170020749701742 0.189063\n",
      "MONDO:0031011 neurodevelopmental disorder with dysmorphic facies and variable seizures 0.008170020749701742 0.189063\n",
      "MONDO:0032852 myopathy, congenital, with structured cores and z-line abnormalities 0.008170020749701742 0.189063\n",
      "MONDO:0010007 microbrachycephaly-ptosis-cleft lip syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0014212 sulfite oxidase deficiency due to molybdenum cofactor deficiency type C 0.008170020749701742 0.189063\n",
      "MONDO:0032805 hypopigmentation, organomegaly, and delayed myelination and development 0.008170020749701742 0.189063\n",
      "MONDO:0013875 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0013989 developmental and epileptic encephalopathy, 14 0.008170020749701742 0.189063\n",
      "MONDO:0009678 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 0.008170020749701742 0.189063\n",
      "MONDO:0032736 metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression 0.008170020749701742 0.189063\n",
      "MONDO:0009397 neonatal severe primary hyperparathyroidism 0.008170020749701742 0.189063\n",
      "MONDO:0030024 neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities 0.008170020749701742 0.189063\n",
      "MONDO:0009953 leukocyte adhesion deficiency type II 0.008170020749701742 0.189063\n",
      "MONDO:0033537 combined oxidative phosphorylation deficiency 47 0.008170020749701742 0.189063\n",
      "MONDO:0014754 primary coenzyme Q10 deficiency 8 0.008170020749701742 0.189063\n",
      "MONDO:0011342 SLC35A1-congenital disorder of glycosylation 0.008170020749701742 0.189063\n",
      "MONDO:0024309 neuropathy, hereditary sensory and autonomic, type 2A 0.008170020749701742 0.189063\n",
      "MONDO:0013255 arthrogryposis, renal dysfunction, and cholestasis 2 0.008170020749701742 0.189063\n",
      "MONDO:0032568 intellectual developmental disorder with macrocephaly, seizures, and speech delay 0.008170020749701742 0.189063\n",
      "MONDO:0012703 lissencephaly due to TUBA1A mutation 0.008170020749701742 0.189063\n",
      "MONDO:0010099 Tay-Sachs disease AB variant 0.008170020749701742 0.189063\n",
      "MONDO:0033646 mitochondrial complex 4 deficiency, nuclear type 12 0.008170020749701742 0.189063\n",
      "MONDO:0012020 chromosome 22q11.2 microduplication syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0033662 neurodevelopmental disorder with microcephaly, seizures, and brain atrophy 0.008170020749701742 0.189063\n",
      "MONDO:0011790 Amish lethal microcephaly 0.008170020749701742 0.189063\n",
      "MONDO:0014874 pontocerebellar hypoplasia, type 2F 0.008170020749701742 0.189063\n",
      "MONDO:0010437 severe X-linked mitochondrial encephalomyopathy 0.008170020749701742 0.189063\n",
      "MONDO:0019568 Ehlers-Danlos syndrome, classic type, 2 0.008170020749701742 0.189063\n",
      "MONDO:0012581 osteogenesis imperfecta type 8 0.008170020749701742 0.189063\n",
      "MONDO:0014648 Al-Raqad syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0044720 cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0012905 hypomyelinating leukodystrophy 6 0.008170020749701742 0.189063\n",
      "MONDO:0859211 neurodevelopmental disorder with hyperkinetic movements and dyskinesia 0.008170020749701742 0.189063\n",
      "MONDO:0054835 classic dopamine transporter deficiency syndrome 0.008170020749701742 0.189063\n",
      "MONDO:0030712 oculopharyngodistal myopathy 4 0.008170020749701742 0.189063\n",
      "MONDO:0012651 spastic ataxia 2 0.008170020749701742 0.189063\n",
      "MONDO:0011902 Charcot-Marie-Tooth disease type 1F 0.008170020749701742 0.189063\n",
      "MONDO:0033533 combined oxidative phosphorylation deficiency 45 0.008170020749701742 0.189063\n",
      "MONDO:0030785 intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly 0.008678425082266912 0.187061\n",
      "MONDO:0859174 Usmani-Riazuddin syndrome, autosomal dominant 0.008678425082266912 0.187061\n",
      "MONDO:0009656 mucopolysaccharidosis type 3B 0.008678425082266912 0.187061\n",
      "MONDO:0859249 parenti-mignot neurodevelopmental syndrome 0.008678425082266912 0.187061\n",
      "MONDO:0032658 macrocephaly, acquired, with impaired intellectual development 0.008678425082266912 0.187061\n",
      "MONDO:0859223 congenital disorder of glycosylation, type Iw, autosomal dominant 0.008678425082266912 0.187061\n",
      "MONDO:0026727 Shukla-Vernon syndrome 0.008678425082266912 0.187061\n",
      "MONDO:0060486 arthrogryposis multiplex congenita 1, neurogenic, with myelin defect 0.008678425082266912 0.187061\n",
      "MONDO:0012669 Legius syndrome 0.008678425082266912 0.187061\n",
      "MONDO:0000909 Bartter disease type 4B 0.008678425082266912 0.187061\n",
      "MONDO:0007180 Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities 0.008678425082266912 0.187061\n",
      "MONDO:0014602 intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome 0.008678425082266912 0.187061\n",
      "MONDO:0032832 intellectual developmental disorder with nasal speech, dysmorphic facies, and variable skeletal anomalies 0.008678425082266912 0.187061\n",
      "MONDO:0013969 combined oxidative phosphorylation defect type 11 0.008678425082266912 0.187061\n",
      "MONDO:0014418 myopathy, centronuclear, 5 0.008678425082266912 0.187061\n",
      "MONDO:0013456 constitutional megaloblastic anemia with severe neurologic disease 0.008678425082266912 0.187061\n",
      "MONDO:0032712 combined oxidative phosphorylation deficiency 38 0.008678425082266912 0.187061\n",
      "MONDO:0013858 pontine tegmental cap dysplasia 0.008678425082266912 0.187061\n",
      "MONDO:0010505 intellectual disability-balding-patella luxation-acromicria syndrome 0.008678425082266912 0.187061\n",
      "MONDO:0011600 congenital myasthenic syndrome 4A 0.008678425082266912 0.187061\n",
      "MONDO:0033482 spinocerebellar ataxia 47 0.008678425082266912 0.187061\n",
      "MONDO:0026720 mitochondrial complex 1 deficiency, nuclear type 12 0.008678425082266912 0.187061\n",
      "MONDO:0010773 mitochondrial myopathy with diabetes 0.008678425082266912 0.187061\n",
      "MONDO:0014689 Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome 0.008678425082266912 0.187061\n",
      "MONDO:0033485 short-rib thoracic dysplasia 19 with or without polydactyly 0.008678425082266912 0.187061\n",
      "MONDO:0008425 omphalocele syndrome, Shprintzen-Goldberg type 0.008678425082266912 0.187061\n",
      "MONDO:0014563 mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency 0.008678425082266912 0.187061\n",
      "MONDO:0014646 Zimmermann-Laband syndrome 2 0.008678425082266912 0.187061\n",
      "MONDO:0008861 3-methylcrotonyl-CoA carboxylase 1 deficiency 0.008678425082266912 0.187061\n",
      "MONDO:0013252 Warsaw breakage syndrome 0.008678425082266912 0.187061\n",
      "MONDO:0014598 developmental and epileptic encephalopathy, 31 0.008678425082266912 0.187061\n",
      "MONDO:0012759 camptodactyly syndrome, Guadalajara type 3 0.008678425082266912 0.187061\n",
      "MONDO:0010703 ornithine carbamoyltransferase deficiency 0.008678425082266912 0.187061\n",
      "MONDO:0008814 hyperargininemia 0.008678425082266912 0.187061\n",
      "MONDO:0032624 mitochondrial complex 1 deficiency, nuclear type 19 0.008678425082266912 0.187061\n",
      "MONDO:0010651 Menkes disease 0.008678425082266912 0.187061\n",
      "MONDO:0030871 vertebral hypersegmentation and orofacial anomalies 0.008678425082266912 0.187061\n",
      "MONDO:0054695 myopathy, centronuclear, 6, with fiber-type disproportion 0.008678425082266912 0.187061\n",
      "MONDO:0010383 fragile X syndrome 0.008678425082266912 0.187061\n",
      "MONDO:0010902 spondyloepiphyseal dysplasia, Reardon type 0.008678425082266912 0.187061\n",
      "MONDO:0009720 Keipert syndrome 0.008678425082266912 0.187061\n",
      "MONDO:0032724 spondyloepimetaphyseal dysplasia with joint laxity, type 3 0.008678425082266912 0.187061\n",
      "MONDO:0014147 neuronal ceroid lipofuscinosis 13 0.008678425082266912 0.187061\n",
      "MONDO:0054763 neurodegeneration with brain iron accumulation 7 0.008678425082266912 0.187061\n",
      "MONDO:0012269 chromosome 3q29 microdeletion syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0009377 hyperammonemia due to N-acetylglutamate synthase deficiency 0.009186568810725743 0.185189\n",
      "MONDO:0032706 spinocerebellar ataxia, autosomal recessive 27 0.009186568810725743 0.185189\n",
      "MONDO:0014238 severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0010402 syndromic X-linked intellectual disability 94 0.009186568810725743 0.185189\n",
      "MONDO:0014356 mitochondrial complex III deficiency nuclear type 7 0.009186568810725743 0.185189\n",
      "MONDO:0014499 intellectual disability, autosomal recessive 46 0.009186568810725743 0.185189\n",
      "MONDO:0007043 Pfeiffer syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0031002 Baralle-Macken syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0029131 peripheral neuropathy, autosomal recessive, with or without impaired intellectual development 0.009186568810725743 0.185189\n",
      "MONDO:0009955 rapadilino syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0008799 anophthalmia/microphthalmia-esophageal atresia syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0009723 Leigh syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0010780 mitochondrial myopathy with reversible cytochrome C oxidase deficiency 0.009186568810725743 0.185189\n",
      "MONDO:0012240 congenital myopathy 23 0.009186568810725743 0.185189\n",
      "MONDO:0009705 carnitine palmitoyl transferase 1A deficiency 0.009186568810725743 0.185189\n",
      "MONDO:0012393 congenital brain dysgenesis due to glutamine synthetase deficiency 0.009186568810725743 0.185189\n",
      "MONDO:0008922 Sengers syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0032601 inflammatory bowel disease, immunodeficiency, and encephalopathy 0.009186568810725743 0.185189\n",
      "MONDO:0007999 holoprosencephaly 2 0.009186568810725743 0.185189\n",
      "MONDO:0014023 congenital muscular dystrophy with intellectual disability and severe epilepsy 0.009186568810725743 0.185189\n",
      "MONDO:0013158 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 0.009186568810725743 0.185189\n",
      "MONDO:0010667 Prieto syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0009612 methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency 0.009186568810725743 0.185189\n",
      "MONDO:0032916 Imagawa-Matsumoto syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0018828 pseudo-TORCH syndrome 2 0.009186568810725743 0.185189\n",
      "MONDO:0013005 EAST syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0032791 Coffin-Siris syndrome 10 0.009186568810725743 0.185189\n",
      "MONDO:0009073 Ritscher-Schinzel syndrome 1 0.009186568810725743 0.185189\n",
      "MONDO:0008862 3-methylcrotonyl-CoA carboxylase 2 deficiency 0.009186568810725743 0.185189\n",
      "MONDO:0014813 hypomyelinating leukodystrophy 13 0.009186568810725743 0.185189\n",
      "MONDO:0014933 developmental and epileptic encephalopathy, 44 0.009186568810725743 0.185189\n",
      "MONDO:0013870 TMEM165-congenital disorder of glycosylation 0.009186568810725743 0.185189\n",
      "MONDO:0011638 neuroferritinopathy 0.009186568810725743 0.185189\n",
      "MONDO:0010936 frontotemporal dementia and/or amyotrophic lateral sclerosis 7 0.009694452068661893 0.183433\n",
      "MONDO:0030031 lissencephaly 10 0.009694452068661893 0.183433\n",
      "MONDO:0008597 trichorhinophalangeal syndrome, type III 0.009694452068661893 0.183433\n",
      "MONDO:0008395 Ruvalcaba syndrome 0.009694452068661893 0.183433\n",
      "MONDO:0009352 classic homocystinuria 0.009694452068661893 0.183433\n",
      "MONDO:0009959 peroxisome biogenesis disorder type 3B 0.009694452068661893 0.183433\n",
      "MONDO:0008048 autosomal dominant centronuclear myopathy 0.009694452068661893 0.183433\n",
      "MONDO:0015000 developmental and epileptic encephalopathy, 48 0.009694452068661893 0.183433\n",
      "MONDO:0013350 mitochondrial DNA depletion syndrome 4b 0.009694452068661893 0.183433\n",
      "MONDO:0014806 spinal muscular atrophy with congenital bone fractures 1 0.009694452068661893 0.183433\n",
      "MONDO:0030947 neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities 0.009694452068661893 0.183433\n",
      "MONDO:0009281 glutaryl-CoA dehydrogenase deficiency 0.009694452068661893 0.183433\n",
      "MONDO:0009614 methylmalonic aciduria, cblB type 0.009694452068661893 0.183433\n",
      "MONDO:0013835 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 0.009694452068661893 0.183433\n",
      "MONDO:0013853 pontocerebellar hypoplasia type 1B 0.009694452068661893 0.183433\n",
      "MONDO:0032618 mitochondrial complex 1 deficiency, nuclear type 13 0.009694452068661893 0.183433\n",
      "MONDO:0018274 GM3 synthase deficiency 0.009694452068661893 0.183433\n",
      "MONDO:0034106 developmental and epileptic encephalopathy, 73 0.009694452068661893 0.183433\n",
      "MONDO:0009218 Farber lipogranulomatosis 0.009694452068661893 0.183433\n",
      "MONDO:0044306 neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination 0.009694452068661893 0.183433\n",
      "MONDO:0014896 congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome 0.009694452068661893 0.183433\n",
      "MONDO:0007160 Stickler syndrome type 1 0.009694452068661893 0.183433\n",
      "MONDO:0859202 developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities 0.009694452068661893 0.183433\n",
      "MONDO:0013014 spondyloepimetaphyseal dysplasia, aggrecan type 0.009694452068661893 0.183433\n",
      "MONDO:0013428 Meier-Gorlin syndrome 2 0.009694452068661893 0.183433\n",
      "MONDO:0013590 Stickler syndrome, type 4 0.009694452068661893 0.183433\n",
      "MONDO:0032675 myasthenic syndrome, congenital, 25, presynaptic 0.009694452068661893 0.183433\n",
      "MONDO:0014544 osteogenesis imperfecta type 16 0.009694452068661893 0.183433\n",
      "MONDO:0014672 osteogenesis imperfecta type 17 0.009694452068661893 0.183433\n",
      "MONDO:0010578 deafness dystonia syndrome 0.009694452068661893 0.183433\n",
      "MONDO:0014744 acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome 0.009694452068661893 0.183433\n",
      "MONDO:0060627 glycosylphosphatidylinositol biosynthesis defect 15 0.009694452068661893 0.183433\n",
      "MONDO:0018130 brain dopamine-serotonin vesicular transport disease 0.009694452068661893 0.183433\n",
      "MONDO:0060591 immunodeficiency, developmental delay, and hypohomocysteinemia 0.009694452068661893 0.183433\n",
      "MONDO:0023671 oculopharyngodistal myopathy 3 0.009694452068661893 0.183433\n",
      "MONDO:0054654 combined oxidative phosphorylation deficiency 32 0.009694452068661893 0.183433\n",
      "MONDO:0007311 Charcot-Marie-Tooth disease type 1E 0.009694452068661893 0.183433\n",
      "MONDO:0032702 Coffin-Siris syndrome 8 0.010202074989590517 0.181778\n",
      "MONDO:0030897 Lessel-Kreienkamp syndrome 0.010202074989590517 0.181778\n",
      "MONDO:0014975 autosomal recessive spastic paraplegia type 78 0.010202074989590517 0.181778\n",
      "MONDO:0032778 arthrogryposis multiplex congenita 3, myogenic type 0.010202074989590517 0.181778\n",
      "MONDO:0009653 mucolipidosis type IV 0.010202074989590517 0.181778\n",
      "MONDO:0100348 neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities 0.010202074989590517 0.181778\n",
      "MONDO:0033651 mitochondrial complex 4 deficiency, nuclear type 16 0.010202074989590517 0.181778\n",
      "MONDO:0800103 COACH syndrome 1 0.010202074989590517 0.181778\n",
      "MONDO:0009757 Niemann-Pick disease, type C1 0.010202074989590517 0.181778\n",
      "MONDO:0020714 mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy 0.010202074989590517 0.181778\n",
      "MONDO:0014067 short ulna-dysmorphism-hypotonia-intellectual disability syndrome 0.010202074989590517 0.181778\n",
      "MONDO:0014981 immunodeficiency 49 0.010202074989590517 0.181778\n",
      "MONDO:0008815 argininosuccinic aciduria 0.010202074989590517 0.181778\n",
      "MONDO:0013627 3M syndrome 3 0.010202074989590517 0.181778\n",
      "MONDO:0009712 congenital multicore myopathy with external ophthalmoplegia 0.010202074989590517 0.181778\n",
      "MONDO:0013719 cranioectodermal dysplasia 4 0.010202074989590517 0.181778\n",
      "MONDO:0013573 cranioectodermal dysplasia 3 0.010202074989590517 0.181778\n",
      "MONDO:0031006 neurodegeneration with ataxia and late-onset optic atrophy 0.010202074989590517 0.181778\n",
      "MONDO:0011266 myotonic dystrophy type 2 0.010202074989590517 0.181778\n",
      "MONDO:0011897 leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome 0.010202074989590517 0.181778\n",
      "MONDO:0013905 autosomal recessive spinocerebellar ataxia 13 0.010202074989590517 0.181778\n",
      "MONDO:0032878 neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia 0.010202074989590517 0.181778\n",
      "MONDO:0032798 ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features 0.010202074989590517 0.181778\n",
      "MONDO:0013674 neurodegeneration with brain iron accumulation 4 0.010202074989590517 0.181778\n",
      "MONDO:0012812 developmental and epileptic encephalopathy, 4 0.010202074989590517 0.181778\n",
      "MONDO:0008201 Perry syndrome 0.010202074989590517 0.181778\n",
      "MONDO:0014035 severe intellectual disability-progressive spastic diplegia syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0859282 neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures 0.010709437706958341 0.180216\n",
      "MONDO:0032774 cerebellar, ocular, craniofacial, and genital syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0014617 intellectual disability, autosomal dominant 38 0.010709437706958341 0.180216\n",
      "MONDO:0014016 hereditary spastic paraplegia 49 0.010709437706958341 0.180216\n",
      "MONDO:0008421 flat face-microstomia-ear anomaly syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0020647 microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0012138 muscular dystrophy-dystroglycanopathy type B6 0.010709437706958341 0.180216\n",
      "MONDO:0013053 microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type 0.010709437706958341 0.180216\n",
      "MONDO:0012157 congenital myasthenic syndrome 4C 0.010709437706958341 0.180216\n",
      "MONDO:0020507 leukoencephalopathy with vanishing white matter 1 0.010709437706958341 0.180216\n",
      "MONDO:0014941 arthrogryposis, distal, with impaired proprioception and touch 0.010709437706958341 0.180216\n",
      "MONDO:0014688 short-rib thoracic dysplasia 14 with polydactyly 0.010709437706958341 0.180216\n",
      "MONDO:0012611 polyhydramnios, megalencephaly, and symptomatic epilepsy 0.010709437706958341 0.180216\n",
      "MONDO:0008822 arthrogryposis, renal dysfunction, and cholestasis 1 0.010709437706958341 0.180216\n",
      "MONDO:0013675 multiple mitochondrial dysfunctions syndrome 2 0.010709437706958341 0.180216\n",
      "MONDO:0014636 combined oxidative phosphorylation defect type 25 0.010709437706958341 0.180216\n",
      "MONDO:0032787 holoprosencephaly 12 with or without pancreatic agenesis 0.010709437706958341 0.180216\n",
      "MONDO:0018820 recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0014708 ring chromosome 14 0.010709437706958341 0.180216\n",
      "MONDO:0014811 cerebellar atrophy, visual impairment, and psychomotor retardation; 0.010709437706958341 0.180216\n",
      "MONDO:0011281 congenital myasthenic syndrome 5 0.010709437706958341 0.180216\n",
      "MONDO:0010027 free sialic acid storage disease, infantile form 0.010709437706958341 0.180216\n",
      "MONDO:0014219 alacrima, achalasia, and intellectual disability syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0032611 mitochondrial complex 1 deficiency, nuclear type 6 0.010709437706958341 0.180216\n",
      "MONDO:0010268 X-linked lissencephaly with abnormal genitalia 0.010709437706958341 0.180216\n",
      "MONDO:0060491 neurodevelopmental disorder with involuntary movements 0.010709437706958341 0.180216\n",
      "MONDO:0014725 spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0033364 developmental and epileptic encephalopathy, 55 0.010709437706958341 0.180216\n",
      "MONDO:0014553 Tenorio syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0033864 infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0020684 Ehlers-Danlos syndrome, periodontal type 1 0.010709437706958341 0.180216\n",
      "MONDO:0011038 cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0011811 autosomal recessive cerebellar ataxia-saccadic intrusion syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0060761 neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum 0.010709437706958341 0.180216\n",
      "MONDO:0011327 neuronal intranuclear inclusion disease 0.010709437706958341 0.180216\n",
      "MONDO:0010714 Pelizeaus-Merzbacher spectrum disorder 0.010709437706958341 0.180216\n",
      "MONDO:0014320 Bosch-Boonstra-Schaaf optic atrophy syndrome 0.010709437706958341 0.180216\n",
      "MONDO:0011833 spinocerebellar ataxia type 21 0.011216540354143694 0.178737\n",
      "MONDO:0010014 craniometadiaphyseal dysplasia, wormian bone type 0.011216540354143694 0.178737\n",
      "MONDO:0009033 temtamy syndrome 0.011216540354143694 0.178737\n",
      "MONDO:0859252 neurodevelopmental disorder with poor growth and skeletal anomalies 0.011216540354143694 0.178737\n",
      "MONDO:0014609 cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome 0.011216540354143694 0.178737\n",
      "MONDO:0859332 cortical dysplasia, complex, with other brain malformations 11 0.011216540354143694 0.178737\n",
      "MONDO:0009470 Baraitser-Winter syndrome 1 0.011216540354143694 0.178737\n",
      "MONDO:0010183 methylmalonic aciduria and homocystinuria type cblF 0.011216540354143694 0.178737\n",
      "MONDO:0010537 Borjeson-Forssman-Lehmann syndrome 0.011216540354143694 0.178737\n",
      "MONDO:0032821 myopathy, congenital, progressive, with scoliosis 0.011216540354143694 0.178737\n",
      "MONDO:0009591 metachromatic leukodystrophy, juvenile form 0.011216540354143694 0.178737\n",
      "MONDO:0012718 hypotonia with lactic acidemia and hyperammonemia 0.011216540354143694 0.178737\n",
      "MONDO:0024542 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 0.011216540354143694 0.178737\n",
      "MONDO:0012750 lethal arthrogryposis-anterior horn cell disease syndrome 0.011216540354143694 0.178737\n",
      "MONDO:0011242 Bartter disease type 4A 0.011216540354143694 0.178737\n",
      "MONDO:0044303 congenital heart defects and ectodermal dysplasia 0.011216540354143694 0.178737\n",
      "MONDO:0054669 pontocerebellar hypoplasia, type 11 0.011216540354143694 0.178737\n",
      "MONDO:0032795 intellectual developmental disorder 59 0.011216540354143694 0.178737\n",
      "MONDO:0032566 squalene synthase deficiency 0.011216540354143694 0.178737\n",
      "MONDO:0009599 metaphyseal dysostosis-intellectual disability-conductive deafness syndrome 0.011216540354143694 0.178737\n",
      "MONDO:0015022 intellectual developmental disorder with dysmorphic facies and ptosis 0.011216540354143694 0.178737\n",
      "MONDO:0009820 osteoporosis-pseudoglioma syndrome 0.011216540354143694 0.178737\n",
      "MONDO:0020769 Menke-Hennekam syndrome 2 0.011216540354143694 0.178737\n",
      "MONDO:0008842 ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia 0.011216540354143694 0.178737\n",
      "MONDO:0859197 intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies 0.011216540354143694 0.178737\n",
      "MONDO:0030035 leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome 0.011216540354143694 0.178737\n",
      "MONDO:0008858 Behr syndrome 0.011216540354143694 0.178737\n",
      "MONDO:0859531 neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures 0.0117233830644565 0.177332\n",
      "MONDO:0012074 mandibuloacral dysplasia with type B lipodystrophy 0.0117233830644565 0.177332\n",
      "MONDO:0011234 auriculocondylar syndrome 1 0.0117233830644565 0.177332\n",
      "MONDO:0014931 Alazami-Yuan syndrome 0.0117233830644565 0.177332\n",
      "MONDO:0015007 spastic paraplegia, intellectual disability, nystagmus, and obesity 0.0117233830644565 0.177332\n",
      "MONDO:0044311 brachycephaly, trichomegaly, and developmental delay 0.0117233830644565 0.177332\n",
      "MONDO:0014773 cardiac anomalies - developmental delay - facial dysmorphism syndrome 0.0117233830644565 0.177332\n",
      "MONDO:0007157 arthrogryposis, distal, type 1A 0.0117233830644565 0.177332\n",
      "MONDO:0032742 encephalopathy, acute, infection-induced, susceptibility to, 9 0.0117233830644565 0.177332\n",
      "MONDO:0011049 Fine-Lubinsky syndrome 0.0117233830644565 0.177332\n",
      "MONDO:0012076 midface hypoplasia, obesity, developmental delay, and neonatal hypotonia 0.0117233830644565 0.177332\n",
      "MONDO:0026723 intellectual developmental disorder, X-linked 108 0.0117233830644565 0.177332\n",
      "MONDO:0030886 holoprosencephaly 14 0.0117233830644565 0.177332\n",
      "MONDO:0014745 congenital myasthenic syndrome 19 0.0117233830644565 0.177332\n",
      "MONDO:0032829 neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities 0.0117233830644565 0.177332\n",
      "MONDO:0015005 epilepsy, early-onset, vitamin B6-dependent 0.0117233830644565 0.177332\n",
      "MONDO:0012084 aromatic L-amino acid decarboxylase deficiency 0.0117233830644565 0.177332\n",
      "MONDO:0014132 multiple mitochondrial dysfunctions syndrome 3 0.0117233830644565 0.177332\n",
      "MONDO:0011537 macrocephaly-autism syndrome 0.0117233830644565 0.177332\n",
      "MONDO:0011252 spondyloepimetaphyseal dysplasia, Shohat type 0.0117233830644565 0.177332\n",
      "MONDO:0859518 leukodystrophy, hypomyelinating, 26, with chondrodysplasia 0.0117233830644565 0.177332\n",
      "MONDO:0032703 short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis 0.0117233830644565 0.177332\n",
      "MONDO:0015010 atypical glycine encephalopathy 0.0117233830644565 0.177332\n",
      "MONDO:0029143 intellectual developmental disorder with hypertelorism and distinctive facies 0.0117233830644565 0.177332\n",
      "MONDO:0054573 Lopes-Maciel-Rodan syndrome 0.0117233830644565 0.177332\n",
      "MONDO:0020850 intellectual disability, autosomal recessive 65 0.01222996597113841 0.175996\n",
      "MONDO:0008644 velocardiofacial syndrome 0.01222996597113841 0.175996\n",
      "MONDO:0011781 spinocerebellar ataxia type 17 0.01222996597113841 0.175996\n",
      "MONDO:0013845 auriculocondylar syndrome 2 0.01222996597113841 0.175996\n",
      "MONDO:0012929 Compton-North congenital myopathy 0.01222996597113841 0.175996\n",
      "MONDO:0008471 spondyloepiphyseal dysplasia congenita 0.01222996597113841 0.175996\n",
      "MONDO:0011010 Matthew-Wood syndrome 0.01222996597113841 0.175996\n",
      "MONDO:0032780 hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities 0.01222996597113841 0.175996\n",
      "MONDO:0010396 developmental and epileptic encephalopathy, 2 0.01222996597113841 0.175996\n",
      "MONDO:0030025 neurodevelopmental disorder with hypotonia, microcephaly, and seizures 0.01222996597113841 0.175996\n",
      "MONDO:0009261 GM1 gangliosidosis type 2 0.01222996597113841 0.175996\n",
      "MONDO:0032918 developmental and epileptic encephalopathy, 84 0.01222996597113841 0.175996\n",
      "MONDO:0060549 congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay 0.01222996597113841 0.175996\n",
      "MONDO:0032854 zimmermann-laband syndrome 3 0.01222996597113841 0.175996\n",
      "MONDO:0009021 Toriello-Carey syndrome 0.01222996597113841 0.175996\n",
      "MONDO:0032908 CEBALID syndrome 0.01222996597113841 0.175996\n",
      "MONDO:0010089 isolated sulfite oxidase deficiency 0.01222996597113841 0.175996\n",
      "MONDO:0024457 neurodegeneration with brain iron accumulation 2A 0.01222996597113841 0.175996\n",
      "MONDO:0013952 peroxisome biogenesis disorder 13A (Zellweger) 0.01222996597113841 0.175996\n",
      "MONDO:0014351 pontocerebellar hypoplasia type 9 0.01222996597113841 0.175996\n",
      "MONDO:0012278 supranuclear palsy, progressive, 2 0.01222996597113841 0.175996\n",
      "MONDO:0032790 neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities 0.01222996597113841 0.175996\n",
      "MONDO:0008608 Down syndrome 0.01222996597113841 0.175996\n",
      "MONDO:0014911 growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy 0.01222996597113841 0.175996\n",
      "MONDO:0030337 cutis laxa, autosomal recessive, type 2E 0.01222996597113841 0.175996\n",
      "MONDO:0014706 cutis laxa, autosomal dominant 3 0.01222996597113841 0.175996\n",
      "MONDO:0009927 3MC syndrome 2 0.01222996597113841 0.175996\n",
      "MONDO:0800027 leukoencephalopathy, diffuse hereditary, with spheroids 1 0.01222996597113841 0.175996\n",
      "MONDO:0859224 intellectual disability and myopathy syndrome 0.01222996597113841 0.175996\n",
      "MONDO:0030458 Charcot-Marie-Tooth disease, axonal, Type 2HH 0.01222996597113841 0.175996\n",
      "MONDO:0024564 cerebroretinal microangiopathy with calcifications and cysts 1 0.01222996597113841 0.175996\n",
      "MONDO:0018996 spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 0.01222996597113841 0.175996\n",
      "MONDO:0014529 cerebellar-facial-dental syndrome 0.012736289207362732 0.174722\n",
      "MONDO:0032698 neurodevelopmental disorder with central and peripheral motor dysfunction 0.012736289207362732 0.174722\n",
      "MONDO:0011948 pontocerebellar hypoplasia type 3 0.012736289207362732 0.174722\n",
      "MONDO:0011669 hypotonia-cystinuria syndrome 0.012736289207362732 0.174722\n",
      "MONDO:0060596 neurodevelopmental disorder with dysmorphic facies and distal limb anomalies 0.012736289207362732 0.174722\n",
      "MONDO:0009738 sialidosis type 2 0.012736289207362732 0.174722\n",
      "MONDO:0012593 brain-lung-thyroid syndrome 0.012736289207362732 0.174722\n",
      "MONDO:0032679 combined oxidative phosphorylation deficiency 37 0.012736289207362732 0.174722\n",
      "MONDO:0014370 pontocerebellar hypoplasia type 2E 0.012736289207362732 0.174722\n",
      "MONDO:0009919 peroxisomal acyl-CoA oxidase deficiency 0.012736289207362732 0.174722\n",
      "MONDO:0859186 Chopra-Amiel-Gordon syndrome 0.012736289207362732 0.174722\n",
      "MONDO:0011405 poikiloderma with neutropenia 0.012736289207362732 0.174722\n",
      "MONDO:0013225 congenital generalized lipodystrophy type 4 0.012736289207362732 0.174722\n",
      "MONDO:0030323 spinocerebellar ataxia, autosomal recessive 31 0.012736289207362732 0.174722\n",
      "MONDO:0014336 intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency 0.01324235290623453 0.173506\n",
      "MONDO:0032579 warburg-cinotti syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0012574 Potocki-Lupski syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0010101 Teebi-Shaltout syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0009480 Joubert syndrome with oculorenal defect 0.01324235290623453 0.173506\n",
      "MONDO:0009398 hyperphosphatasia with intellectual disability syndrome 1 0.01324235290623453 0.173506\n",
      "MONDO:0008919 systemic primary carnitine deficiency disease 0.01324235290623453 0.173506\n",
      "MONDO:0032836 weiss-kruszka syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0012117 ALG9-congenital disorder of glycosylation 0.01324235290623453 0.173506\n",
      "MONDO:0060496 neurodevelopmental disorder with hypotonia, neuropathy, and deafness 0.01324235290623453 0.173506\n",
      "MONDO:0007838 Jacobsen syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0013726 encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 0.01324235290623453 0.173506\n",
      "MONDO:0013810 COG6-ongenital disorder of glycosylation 0.01324235290623453 0.173506\n",
      "MONDO:0009068 cytochrome-c oxidase deficiency disease 0.01324235290623453 0.173506\n",
      "MONDO:0011271 rigid spine muscular dystrophy 1 0.01324235290623453 0.173506\n",
      "MONDO:0011841 biotin-responsive basal ganglia disease 0.01324235290623453 0.173506\n",
      "MONDO:0010354 Allan-Herndon-Dudley syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0014263 8q24.3 microdeletion syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0014894 Meier-Gorlin syndrome 7 0.01324235290623453 0.173506\n",
      "MONDO:0010504 immunodeficiency 47 0.01324235290623453 0.173506\n",
      "MONDO:0011106 facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0060677 chromosome 1p35 deletion syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0859163 Faundes-Banka syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0014605 microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome 0.01324235290623453 0.173506\n",
      "MONDO:0020841 neurodevelopmental disorder with cerebellar atrophy and with or without seizures 0.01324235290623453 0.173506\n",
      "MONDO:0030917 intellectual disability, autosomal dominant 51 0.013748157200790626 0.172342\n",
      "MONDO:0859081 chromosome Xq13 duplication syndrome 0.013748157200790626 0.172342\n",
      "MONDO:0009770 3MC syndrome 1 0.013748157200790626 0.172342\n",
      "MONDO:0009664 mulibrey nanism 0.013748157200790626 0.172342\n",
      "MONDO:0100297 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 0.013748157200790626 0.172342\n",
      "MONDO:0010711 TARP syndrome 0.013748157200790626 0.172342\n",
      "MONDO:0014547 combined oxidative phosphorylation defect type 24 0.013748157200790626 0.172342\n",
      "MONDO:0011730 fumaric aciduria 0.013748157200790626 0.172342\n",
      "MONDO:0009841 PEHO syndrome 0.013748157200790626 0.172342\n",
      "MONDO:0027451 autosomal recessive cutis laxa type 2D 0.013748157200790626 0.172342\n",
      "MONDO:0007113 Angelman syndrome 0.013748157200790626 0.172342\n",
      "MONDO:0032890 neuromuscular disease and ocular or auditory anomalies with or without seizures 0.013748157200790626 0.172342\n",
      "MONDO:0011157 Gomez-Lopez-Hernandez syndrome 0.013748157200790626 0.172342\n",
      "MONDO:0032705 neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination 0.013748157200790626 0.172342\n",
      "MONDO:0054560 anauxetic dysplasia 1 0.013748157200790626 0.172342\n",
      "MONDO:0009595 cartilage-hair hypoplasia 0.013748157200790626 0.172342\n",
      "MONDO:0030913 intellectual disability, autosomal dominant 48 0.013748157200790626 0.172342\n",
      "MONDO:0007875 Larsen syndrome 0.013748157200790626 0.172342\n",
      "MONDO:0014914 Dias-Logan syndrome 0.013748157200790626 0.172342\n",
      "MONDO:0030992 short stature, oligodontia, dysmorphic facies, and motor delay 0.013748157200790626 0.172342\n",
      "MONDO:0030607 Bryant-Li-Bhoj neurodevelopmental syndrome 2 0.013748157200790626 0.172342\n",
      "MONDO:0014948 short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay 0.013748157200790626 0.172342\n",
      "MONDO:0011803 hereditary spastic paraplegia 7 0.013748157200790626 0.172342\n",
      "MONDO:0013968 PGM1-congenital disorder of glycosylation 0.013748157200790626 0.172342\n",
      "MONDO:0010549 Charcot-Marie-Tooth disease X-linked dominant 1 0.013748157200790626 0.172342\n",
      "MONDO:0012430 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 0.013748157200790626 0.172342\n",
      "MONDO:0013722 hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism 0.013748157200790626 0.172342\n",
      "MONDO:0008963 Chediak-Higashi syndrome 0.013748157200790626 0.172342\n",
      "MONDO:0020749 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 0.014253702223999637 0.171226\n",
      "MONDO:0007363 congenital contractural arachnodactyly 0.014253702223999637 0.171226\n",
      "MONDO:0014591 autosomal dominant Robinow syndrome 2 0.014253702223999637 0.171226\n",
      "MONDO:0010568 Aicardi syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0009112 rhizomelic chondrodysplasia punctata type 2 0.014253702223999637 0.171226\n",
      "MONDO:0010879 CODAS syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0010337 X-linked intellectual disability-cerebellar hypoplasia syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0013659 microcephaly-capillary malformation syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0013735 microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0009756 Niemann-Pick disease type A 0.014253702223999637 0.171226\n",
      "MONDO:0013820 intellectual disability, autosomal dominant 15 0.014253702223999637 0.171226\n",
      "MONDO:0013115 RIN2 syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0010117 3M syndrome 1 0.014253702223999637 0.171226\n",
      "MONDO:0011911 craniolenticulosutural dysplasia 0.014253702223999637 0.171226\n",
      "MONDO:0031000 Tessadori-Van Haaften neurodevelopmental syndrome 4 0.014253702223999637 0.171226\n",
      "MONDO:0013299 chromosome 6q11-q14 deletion syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0007182 Machado-Joseph disease 0.014253702223999637 0.171226\n",
      "MONDO:0008840 ataxia telangiectasia 0.014253702223999637 0.171226\n",
      "MONDO:0859377 neurodevelopmental disorder with poor growth and behavioral abnormalities 0.01475898810876207 0.170155\n",
      "MONDO:0013615 craniosynostosis and dental anomalies 0.01475898810876207 0.170155\n",
      "MONDO:0014413 orofaciodigital syndrome type 14 0.01475898810876207 0.170155\n",
      "MONDO:0010278 Christianson syndrome 0.01475898810876207 0.170155\n",
      "MONDO:0009577 megalocornea-intellectual disability syndrome 0.01475898810876207 0.170155\n",
      "MONDO:0013578 DYRK1A-related intellectual disability syndrome 0.01475898810876207 0.170155\n",
      "MONDO:0014364 mitochondrial complex III deficiency nuclear type 8 0.01475898810876207 0.170155\n",
      "MONDO:0009333 mullerian derivatives-lymphangiectasia-polydactyly syndrome 0.01475898810876207 0.170155\n",
      "MONDO:0026730 Basilicata-Akhtar syndrome 0.01475898810876207 0.170155\n",
      "MONDO:0030043 congenital disorder of glycosylation, type iit 0.01475898810876207 0.170155\n",
      "MONDO:0014296 Warburg micro syndrome 4 0.01475898810876207 0.170155\n",
      "MONDO:0008365 recombinant 8 syndrome 0.01475898810876207 0.170155\n",
      "MONDO:0010176 orofaciodigital syndrome type 6 0.01475898810876207 0.170155\n",
      "MONDO:0012791 mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria 0.01475898810876207 0.170155\n",
      "MONDO:0010408 syndactyly-telecanthus-anogenital and renal malformations syndrome 0.01475898810876207 0.170155\n",
      "MONDO:0014507 Catel-Manzke syndrome 0.01475898810876207 0.170155\n",
      "MONDO:0030029 skeletal dysplasia, mild, with joint laxity and advanced bone age 0.01475898810876207 0.170155\n",
      "MONDO:0100325 odontochondrodysplasia 1 0.01475898810876207 0.170155\n",
      "MONDO:0011275 acromesomelic dysplasia 1, Maroteaux type 0.01475898810876207 0.170155\n",
      "MONDO:0030914 Clark-Baraitser syndrome 0.01526401498791028 0.169126\n",
      "MONDO:0010886 2q37 microdeletion syndrome 0.01526401498791028 0.169126\n",
      "MONDO:0030866 neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities 0.01526401498791028 0.169126\n",
      "MONDO:0012869 intellectual disability, autosomal dominant 22 0.01526401498791028 0.169126\n",
      "MONDO:0013364 Rubinstein-Taybi syndrome due to EP300 haploinsufficiency 0.01526401498791028 0.169126\n",
      "MONDO:0014716 macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome 0.01526401498791028 0.169126\n",
      "MONDO:0009681 Ullrich congenital muscular dystrophy 1 0.01526401498791028 0.169126\n",
      "MONDO:0032600 Snijders Blok-Campeau syndrome 0.01526401498791028 0.169126\n",
      "MONDO:0013051 autosomal recessive cutis laxa type 2B 0.01526401498791028 0.169126\n",
      "MONDO:0014863 macrocephaly, dysmorphic facies, and psychomotor retardation 0.01526401498791028 0.169126\n",
      "MONDO:0007100 familial amyloid neuropathy 0.01526401498791028 0.169126\n",
      "MONDO:0010574 syndromic X-linked intellectual disability 5 0.015768782994208475 0.168136\n",
      "MONDO:0010461 syndromic X-linked intellectual disability Nascimento type 0.015768782994208475 0.168136\n",
      "MONDO:0100101 fetal akinesia deformation sequence 1 0.015768782994208475 0.168136\n",
      "MONDO:0014833 heart and brain malformation syndrome 0.015768782994208475 0.168136\n",
      "MONDO:0009079 DOORS syndrome 0.015768782994208475 0.168136\n",
      "MONDO:0859200 cerebellar ataxia, brain abnormalities, and cardiac conduction defects 0.015768782994208475 0.168136\n",
      "MONDO:0060760 intellectual developmental disorder with dysmorphic facies and behavioral abnormalities 0.015768782994208475 0.168136\n",
      "MONDO:0060621 neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy 0.015768782994208475 0.168136\n",
      "MONDO:0014722 Roifman syndrome 0.015768782994208475 0.168136\n",
      "MONDO:0032651 fibrosis, neurodegeneration, and cerebral angiomatosis 0.015768782994208475 0.168136\n",
      "MONDO:0100111 focal segmental glomerulosclerosis and neurodevelopmental syndrome 0.015768782994208475 0.168136\n",
      "MONDO:0013426 aneurysm-osteoarthritis syndrome 0.015768782994208475 0.168136\n",
      "MONDO:0859169 White-Kernohan syndrome 0.015768782994208475 0.168136\n",
      "MONDO:0009660 mucopolysaccharidosis type 4B 0.015768782994208475 0.168136\n",
      "MONDO:0020485 King-Denborough syndrome 0.015768782994208475 0.168136\n",
      "MONDO:0020793 oculopharyngodistal myopathy 1 0.015768782994208475 0.168136\n",
      "MONDO:0011435 microcephaly 2, primary, autosomal recessive, with or without cortical malformations 0.01627329226035293 0.167181\n",
      "MONDO:0010361 intellectual disability, X-linked 30 0.01627329226035293 0.167181\n",
      "MONDO:0030999 neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism 0.01627329226035293 0.167181\n",
      "MONDO:0014601 autosomal recessive spinocerebellar ataxia 20 0.01627329226035293 0.167181\n",
      "MONDO:0008104 Noonan syndrome 1 0.01627329226035293 0.167181\n",
      "MONDO:0008873 microcephalic osteodysplastic primordial dwarfism, type 3 0.01627329226035293 0.167181\n",
      "MONDO:0008893 C syndrome 0.01627329226035293 0.167181\n",
      "MONDO:0014367 Aicardi-Goutieres syndrome 7 0.01627329226035293 0.167181\n",
      "MONDO:0009759 mosaic variegated aneuploidy syndrome 1 0.01627329226035293 0.167181\n",
      "MONDO:0008954 peroxisome biogenesis disorder 2A (Zellweger) 0.01627329226035293 0.167181\n",
      "MONDO:0032831 pontocerebellar hypoplasia, type 13 0.01627329226035293 0.167181\n",
      "MONDO:0008758 mitochondrial DNA depletion syndrome 4a 0.01627329226035293 0.167181\n",
      "MONDO:0014294 chromosome 15q11.2 deletion syndrome 0.01627329226035293 0.167181\n",
      "MONDO:0011783 ALG12-congenital disorder of glycosylation 0.01627329226035293 0.167181\n",
      "MONDO:0800167 Knobloch syndrome 1 0.01627329226035293 0.167181\n",
      "MONDO:0014699 intellectual disability, autosomal dominant 40 0.01627329226035293 0.167181\n",
      "MONDO:0014887 bone marrow failure syndrome 3 0.01627329226035293 0.167181\n",
      "MONDO:0010026 SHORT syndrome 0.01627329226035293 0.167181\n",
      "MONDO:0008322 pseudoachondroplasia 0.01627329226035293 0.167181\n",
      "MONDO:0009319 pantothenate kinase-associated neurodegeneration 0.01627329226035293 0.167181\n",
      "MONDO:0014561 3-methylglutaconic aciduria, type VIIB 0.01627329226035293 0.167181\n",
      "MONDO:0859219 Rauch-Steindl syndrome 0.016777542918971797 0.166261\n",
      "MONDO:0032745 developmental delay with variable intellectual impairment and behavioral abnormalities 0.016777542918971797 0.166261\n",
      "MONDO:0014780 hyperphosphatasia with intellectual disability syndrome 6 0.016777542918971797 0.166261\n",
      "MONDO:0009431 hereditary hypophosphatemic rickets with hypercalciuria 0.016777542918971797 0.166261\n",
      "MONDO:0007415 mitochondrial complex III deficiency nuclear type 1 0.016777542918971797 0.166261\n",
      "MONDO:0009593 spondylometaphyseal dysplasia, Sedaghatian type 0.016777542918971797 0.166261\n",
      "MONDO:0012683 pontocerebellar hypoplasia type 6 0.016777542918971797 0.166261\n",
      "MONDO:0024535 Singleton-Merten syndrome 1 0.016777542918971797 0.166261\n",
      "MONDO:0026722 Mullegama-Klein-Martinez syndrome 0.016777542918971797 0.166261\n",
      "MONDO:0013990 pontocerebellar hypoplasia type 8 0.016777542918971797 0.166261\n",
      "MONDO:0060631 Alkuraya-Kucinskas syndrome 0.016777542918971797 0.166261\n",
      "MONDO:0014165 multiple congenital anomalies-hypotonia-seizures syndrome 3 0.016777542918971797 0.166261\n",
      "MONDO:0011432 blepharophimosis - intellectual disability syndrome, Verloes type 0.016777542918971797 0.166261\n",
      "MONDO:0013245 syndromic multisystem autoimmune disease due to ITCH deficiency 0.016777542918971797 0.166261\n",
      "MONDO:0009644 sulfite oxidase deficiency due to molybdenum cofactor deficiency type B 0.016777542918971797 0.166261\n",
      "MONDO:0013170 cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies 0.016777542918971797 0.166261\n",
      "MONDO:0008005 cardiospondylocarpofacial syndrome 0.016777542918971797 0.166261\n",
      "MONDO:0010572 occipital horn syndrome 0.016777542918971797 0.166261\n",
      "MONDO:0010235 X-linked intellectual disability-psychosis-macroorchidism syndrome 0.016777542918971797 0.166261\n",
      "MONDO:0859516 neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum 0.017281535102625298 0.165372\n",
      "MONDO:0859298 neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-pelger-huet anomaly 0.017281535102625298 0.165372\n",
      "MONDO:0023657 intellectual developmental disorder, autosomal dominant 65 0.017281535102625298 0.165372\n",
      "MONDO:0009557 mandibuloacral dysplasia with type A lipodystrophy 0.017281535102625298 0.165372\n",
      "MONDO:0033562 neurodevelopmental disorder with dysmorphic facies, impaired speech, and hypotonia 0.017281535102625298 0.165372\n",
      "MONDO:0011640 genitopatellar syndrome 0.017281535102625298 0.165372\n",
      "MONDO:0014361 autism spectrum disorder due to AUTS2 deficiency 0.017281535102625298 0.165372\n",
      "MONDO:0012481 mevalonic aciduria 0.017281535102625298 0.165372\n",
      "MONDO:0012873 Ehlers-Danlos syndrome, spondylocheirodysplastic type 0.017281535102625298 0.165372\n",
      "MONDO:0014893 Okur-Chung neurodevelopmental syndrome 0.017281535102625298 0.165372\n",
      "MONDO:0009659 mucopolysaccharidosis type 4A 0.017281535102625298 0.165372\n",
      "MONDO:0009161 Ehlers-Danlos syndrome, dermatosparaxis type 0.017281535102625298 0.165372\n",
      "MONDO:0014993 myofibrillar myopathy 8 0.017281535102625298 0.165372\n",
      "MONDO:0032824 glycosylphosphatidylinositol biosynthesis defect 21 0.017281535102625298 0.165372\n",
      "MONDO:0859286 neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures 0.017281535102625298 0.165372\n",
      "MONDO:0010585 X-linked hypohidrotic ectodermal dysplasia 0.017785268943805686 0.164512\n",
      "MONDO:0008564 DiGeorge syndrome 0.017785268943805686 0.164512\n",
      "MONDO:0800437 Carey-Fineman-Ziter syndrome 1 0.017785268943805686 0.164512\n",
      "MONDO:0014757 macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome 0.017785268943805686 0.164512\n",
      "MONDO:0010758 Wieacker-Wolff syndrome 0.017785268943805686 0.164512\n",
      "MONDO:0014656 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 0.017785268943805686 0.164512\n",
      "MONDO:0030896 chromosome 13q33-q34 deletion syndrome 0.018288744574937277 0.163681\n",
      "MONDO:0014858 intellectual disability, autosomal dominant 43 0.018288744574937277 0.163681\n",
      "MONDO:0024526 Zimmermann-Laband syndrome 1 0.018288744574937277 0.163681\n",
      "MONDO:0008869 Seckel syndrome 1 0.018288744574937277 0.163681\n",
      "MONDO:0030679 Noonan syndrome 14 0.018288744574937277 0.163681\n",
      "MONDO:0054844 pontocerebellar hypoplasia, type 1D 0.018288744574937277 0.163681\n",
      "MONDO:0014755 skin creases, congenital symmetric circumferential, 2 0.018288744574937277 0.163681\n",
      "MONDO:0008596 trichorhinophalangeal syndrome type I 0.018288744574937277 0.163681\n",
      "MONDO:0044319 intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies 0.018288744574937277 0.163681\n",
      "MONDO:0030362 Aicardi-Goutieres syndrome 9 0.018288744574937277 0.163681\n",
      "MONDO:0013308 CBL-related disorder 0.018288744574937277 0.163681\n",
      "MONDO:0044738 Gabriele de Vries syndrome 0.018288744574937277 0.163681\n",
      "MONDO:0012176 Emanuel syndrome 0.018791962128376593 0.162876\n",
      "MONDO:0014966 periventricular nodular heterotopia 7 0.018791962128376593 0.162876\n",
      "MONDO:0013523 Nestor-Guillermo progeria syndrome 0.018791962128376593 0.162876\n",
      "MONDO:0032822 developmental and epileptic encephalopathy, 80 0.018791962128376593 0.162876\n",
      "MONDO:0033532 Suleiman-El-Hattab syndrome 0.018791962128376593 0.162876\n",
      "MONDO:0012495 spondyloepimetaphyseal dysplasia, Genevieve type 0.018791962128376593 0.162876\n",
      "MONDO:0014857 neurodevelopmental disorder with or without anomalies of the brain, eye, or heart 0.018791962128376593 0.162876\n",
      "MONDO:0010471 Cornelia de Lange syndrome 5 0.018791962128376593 0.162876\n",
      "MONDO:0014777 hypotonia, infantile, with psychomotor retardation and characteristic facies 2 0.018791962128376593 0.162876\n",
      "MONDO:0012997 cholestasis-pigmentary retinopathy-cleft palate syndrome 0.018791962128376593 0.162876\n",
      "MONDO:0010589 Aarskog-Scott syndrome, X-linked 0.018791962128376593 0.162876\n",
      "MONDO:0030375 neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2 0.018791962128376593 0.162876\n",
      "MONDO:0009053 ALDH18A1-related de Barsy syndrome 0.018791962128376593 0.162876\n",
      "MONDO:0013056 developmental and epileptic encephalopathy, 39 0.019294921736412216 0.162095\n",
      "MONDO:0013025 chromosome 6q24-q25 deletion syndrome 0.019294921736412216 0.162095\n",
      "MONDO:0026762 Wieacker-Wolff syndrome, female-restricted 0.019294921736412216 0.162095\n",
      "MONDO:0032672 intellectual developmental disorder with cardiac defects and dysmorphic facies 0.019294921736412216 0.162095\n",
      "MONDO:0007524 autosomal dominant Ehlers-Danlos syndrome, vascular type 0.019294921736412216 0.162095\n",
      "MONDO:0000902 agenesis of the corpus callosum with peripheral neuropathy 0.019294921736412216 0.162095\n",
      "MONDO:0859080 intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies 0.019797623531264928 0.161338\n",
      "MONDO:0007404 Cri-du-chat syndrome 0.019797623531264928 0.161338\n",
      "MONDO:0008708 acrocallosal syndrome 0.019797623531264928 0.161338\n",
      "MONDO:0011946 diaphanospondylodysostosis 0.019797623531264928 0.161338\n",
      "MONDO:0030880 mandibuloacral dysplasia progeroid syndrome 0.019797623531264928 0.161338\n",
      "MONDO:0010477 blepharophimosis - intellectual disability syndrome, MKB type 0.019797623531264928 0.161338\n",
      "MONDO:0032572 cardiac, facial, and digital anomalies with developmental delay 0.019797623531264928 0.161338\n",
      "MONDO:0010248 X-linked spondyloepimetaphyseal dysplasia 0.019797623531264928 0.161338\n",
      "MONDO:0018663 regressive spondylometaphyseal dysplasia 0.019797623531264928 0.161338\n",
      "MONDO:0012496 Koolen-de Vries syndrome 0.020300067645087804 0.160603\n",
      "MONDO:0007340 cleidocranial dysplasia 1 0.020300067645087804 0.160603\n",
      "MONDO:0008119 spinocerebellar ataxia type 1 0.020300067645087804 0.160603\n",
      "MONDO:0009124 Dubowitz syndrome 0.020300067645087804 0.160603\n",
      "MONDO:0100218 arthrogryposis multiplex congenita 5 0.020300067645087804 0.160603\n",
      "MONDO:0009768 oculodentodigital dysplasia, autosomal recessive 0.020802254209966124 0.159889\n",
      "MONDO:0012916 chromosome 2p16.1-p15 deletion syndrome 0.020802254209966124 0.159889\n",
      "MONDO:0009341 Mowat-Wilson syndrome 0.020802254209966124 0.159889\n",
      "MONDO:0030918 intellectual disability, autosomal dominant 52 0.020802254209966124 0.159889\n",
      "MONDO:0008907 PMM2-congenital disorder of glycosylation 0.020802254209966124 0.159889\n",
      "MONDO:0008675 Freeman-Sheldon syndrome 0.02130418335791746 0.159195\n",
      "MONDO:0012118 COG7-congenital disorder of glycosylation 0.02130418335791746 0.159195\n",
      "MONDO:0009561 alpha-mannosidosis 0.02130418335791746 0.159195\n",
      "MONDO:0008013 chromosome 9p deletion syndrome 0.021805855220891738 0.158519\n",
      "MONDO:0009785 opsismodysplasia 0.021805855220891738 0.158519\n",
      "MONDO:0007057 Acroosteolysis dominant type 0.021805855220891738 0.158519\n",
      "MONDO:0859190 neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities 0.021805855220891738 0.158519\n",
      "MONDO:0014455 cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome 0.021805855220891738 0.158519\n",
      "MONDO:0010208 wrinkly skin syndrome 0.021805855220891738 0.158519\n",
      "MONDO:0013323 cranioectodermal dysplasia 2 0.021805855220891738 0.158519\n",
      "MONDO:0044302 congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 0.021805855220891738 0.158519\n",
      "MONDO:0007843 Kabuki syndrome 1 0.021805855220891738 0.158519\n",
      "MONDO:0010355 syndromic X-linked intellectual disability Claes-Jensen type 0.022307269930771232 0.157862\n",
      "MONDO:0020763 Menke-Hennekam syndrome 1 0.022307269930771232 0.157862\n",
      "MONDO:0060622 neurodevelopmental disorder with severe motor impairment and absent language 0.022307269930771232 0.157862\n",
      "MONDO:0014700 Au-Kline syndrome 0.02280842761937063 0.157222\n",
      "MONDO:0014944 short stature-brachydactyly-obesity-global developmental delay syndrome 0.02280842761937063 0.157222\n",
      "MONDO:0010590 FG syndrome 1 0.02280842761937063 0.157222\n",
      "MONDO:0014242 van Maldergem syndrome 2 0.02280842761937063 0.157222\n",
      "MONDO:0054737 Fraser syndrome 1 0.02330932841843702 0.156598\n",
      "MONDO:0013998 MEGF8-related Carpenter syndrome 0.02380997245964999 0.155989\n",
      "MONDO:0009485 oculocerebrofacial syndrome, Kaufman type 0.02380997245964999 0.155989\n",
      "MONDO:0013886 cerebellar dysfunction with variable cognitive and behavioral abnormalities 0.02431035987462163 0.155395\n",
      "MONDO:0859139 blepharophimosis-impaired intellectual development syndrome 0.02431035987462163 0.155395\n",
      "MONDO:0010483 X-linked intellectual disability, Cantagrel type 0.02481049079489652 0.154816\n",
      "MONDO:0019570 Cockayne syndrome type 2 0.02481049079489652 0.154816\n",
      "MONDO:0015021 hypotonia, ataxia, and delayed development syndrome 0.0253103653519519 0.15425\n",
      "MONDO:0010592 focal dermal hypoplasia 0.0253103653519519 0.15425\n",
      "MONDO:0957265 congenital myopathy 22B, severe fetal 0.025809983677197505 0.153697\n",
      "MONDO:0010407 intellectual disability, X-linked syndromic, Turner type 0.025809983677197505 0.153697\n",
      "MONDO:8000008 Martsolf syndrome 1 0.025809983677197505 0.153697\n",
      "MONDO:0009069 congenital lactic acidosis, Saguenay-Lac-Saint-Jean type 0.025809983677197505 0.153697\n",
      "MONDO:0019569 Cockayne syndrome type 1 0.025809983677197505 0.153697\n",
      "MONDO:0009658 mucopolysaccharidosis type 3D 0.026309345901975804 0.153157\n",
      "MONDO:0009143 Meier-Gorlin syndrome 1 0.026309345901975804 0.153157\n",
      "MONDO:0007387 Cornelia de Lange syndrome 1 0.026808452157561898 0.152628\n",
      "MONDO:0030606 Bryant-Li-Bhoj neurodevelopmental syndrome 1 0.026808452157561898 0.152628\n",
      "MONDO:0024455 autosomal dominant Robinow syndrome 1 0.028304236420908836 0.151109\n",
      "MONDO:0014936 ZTTK syndrome 0.028304236420908836 0.151109\n",
      "MONDO:0007874 trichorhinophalangeal syndrome type II 0.028304236420908836 0.151109\n",
      "MONDO:0007974 intellectual disability, autosomal dominant 1 0.028802320111131884 0.150624\n",
      "MONDO:0025699 Coffin-Siris syndrome 12 0.03079210304215405 0.148778\n",
      "MONDO:0007265 cardiofaciocutaneous syndrome 1 0.03128891147129853 0.148338\n",
      "MONDO:0800043 Stve-Wiedemann syndrome 1 0.03178546524030658 0.147907\n",
      "MONDO:0859191 biliary, renal, neurologic, and skeletal syndrome 0.032281764479714994 0.147483\n",
      "MONDO:0009856 Peters plus syndrome 0.03327359989154565 0.146659\n",
      "MONDO:0859181 DEGCAGS syndrome 0.03426441874974732 0.145863\n",
      "MONDO:0009650 mucolipidosis type II 0.034759447296868966 0.145476\n",
      "MONDO:0007251 campomelic dysplasia 0.03525422209620786 0.145095\n",
      "MONDO:0014558 autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome 0.03624301097174728 0.144351\n",
      "MONDO:0009910 Wiedemann-Rautenstrauch syndrome 0.04018804254378047 0.141602\n",
      "MONDO:0008995 Yunis-Varon syndrome 0.042154498487287154 0.140346\n",
      "MONDO:0011146 tetrasomy 12p 0.044606903798540105 0.138871\n",
      "MONDO:0010457 Ogden syndrome 0.04802972615200964 0.136962\n"
     ]
    }
   ],
   "execution_count": 60
  },
  {
   "cell_type": "code",
   "id": "e4847942-1ae6-48cc-9355-edd1f4fbffeb",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:57.308149Z",
     "start_time": "2024-10-28T18:03:57.117833Z"
    }
   },
   "source": [
    "response = phenotypes_to_gene(phenotypes_2)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "NCBIGene:7200 TRH 0.00043350422688401063 0.306083\n",
      "NCBIGene:6262 RYR2 0.0010249216925187008 0.267892\n",
      "NCBIGene:6343 SCT 0.0010249216925187008 0.267892\n",
      "NCBIGene:10451 VAV3 0.002048792920561606 0.239441\n",
      "NCBIGene:3360 HTR4 0.0025603349468989512 0.230738\n",
      "NCBIGene:51083 GAL 0.005624085345056082 0.201809\n",
      "NCBIGene:3972 LHB 0.005624085345056082 0.201809\n",
      "NCBIGene:2778 GNAS 0.011216540354143694 0.178737\n",
      "NCBIGene:2796 GNRH1 0.011216540354143694 0.178737\n",
      "NCBIGene:1132 CHRM4 0.011216540354143694 0.178737\n",
      "NCBIGene:7432 VIP 0.012736289207362732 0.174722\n",
      "NCBIGene:196 AHR 0.01324235290623453 0.173506\n",
      "NCBIGene:2641 GCG 0.01324235290623453 0.173506\n",
      "NCBIGene:3827 KNG1 0.01475898810876207 0.170155\n",
      "NCBIGene:154 ADRB2 0.01475898810876207 0.170155\n",
      "NCBIGene:3952 LEP 0.017785268943805686 0.164512\n",
      "NCBIGene:43 ACHE 0.020300067645087804 0.160603\n",
      "NCBIGene:6334 SCN8A 0.020300067645087804 0.160603\n",
      "NCBIGene:1813 DRD2 0.022307269930771232 0.157862\n",
      "NCBIGene:1565 CYP2D6 0.022307269930771232 0.157862\n",
      "NCBIGene:590 BCHE 0.0253103653519519 0.15425\n",
      "NCBIGene:3630 INS 0.026808452157561898 0.152628\n",
      "NCBIGene:3350 HTR1A 0.026808452157561898 0.152628\n",
      "NCBIGene:135 ADORA2A 0.027307302575163592 0.152111\n",
      "NCBIGene:538 ATP7A 0.028304236420908836 0.151109\n",
      "NCBIGene:7124 TNF 0.033769136324707086 0.146258\n"
     ]
    }
   ],
   "execution_count": 61
  },
  {
   "cell_type": "code",
   "id": "050880bb-5140-4962-9a4c-d22c929c55a1",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:03:57.311468Z",
     "start_time": "2024-10-28T18:03:57.309468Z"
    }
   },
   "source": [
    "tbcd_phenotypes=[\n",
    "    \"HP:0002098\", # | Respiratory distress, \n",
    "    \"HP:0001252\", # | Hypotonia, \n",
    "    \"HP:0001250\" # | Seizure\n",
    "]"
   ],
   "outputs": [],
   "execution_count": 62
  },
  {
   "cell_type": "code",
   "id": "6b1f0e68-0811-4032-b5f0-022d84192745",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:00.073812Z",
     "start_time": "2024-10-28T18:03:57.313780Z"
    }
   },
   "source": [
    "response = phenotypes_to_disease(tbcd_phenotypes)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "MONDO:0014271 STT3B-congenital disorder of glycosylation 2.096353238263982e-07 0.698311\n",
      "MONDO:0014856 combined oxidative phosphorylation defect type 30 5.534189247952736e-07 0.652143\n",
      "MONDO:0010490 SSR4-congenital disorder of glycosylation 5.534189247952736e-07 0.652143\n",
      "MONDO:0008056 myotonic dystrophy type 1 5.534189247952736e-07 0.652143\n",
      "MONDO:0012792 mitochondrial DNA depletion syndrome 8a 7.367208238964271e-07 0.63792\n",
      "MONDO:0014754 primary coenzyme Q10 deficiency 8 8.381793480638825e-07 0.631424\n",
      "MONDO:0859279 spinal muscular atrophy, distal, autosomal recessive, 6 9.461748430404016e-07 0.625279\n",
      "MONDO:0013307 myopathy, lactic acidosis, and sideroblastic anemia 2 1.060706249785143e-06 0.619447\n",
      "MONDO:0060704 neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures 1.060706249785143e-06 0.619447\n",
      "MONDO:0009612 methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency 1.060706249785143e-06 0.619447\n",
      "MONDO:0010271 X-linked myotubular myopathy-abnormal genitalia syndrome 1.060706249785143e-06 0.619447\n",
      "MONDO:0009614 methylmalonic aciduria, cblB type 1.1817725093858931e-06 0.613899\n",
      "MONDO:0014221 triosephosphate isomerase deficiency 1.309372563059048e-06 0.608609\n",
      "MONDO:0013731 MEGF10-related myopathy 1.4435053521496031e-06 0.603553\n",
      "MONDO:0030997 mitochondrial complex 1 deficiency, nuclear type 37 1.4435053521496031e-06 0.603553\n",
      "MONDO:0014269 combined oxidative phosphorylation deficiency 19 1.73136490260581e-06 0.594067\n",
      "MONDO:0032742 encephalopathy, acute, infection-induced, susceptibility to, 9 1.73136490260581e-06 0.594067\n",
      "MONDO:0009613 methylmalonic aciduria, cblA type 1.8850895473043174e-06 0.589605\n",
      "MONDO:0008471 spondyloepiphyseal dysplasia congenita 1.8850895473043174e-06 0.589605\n",
      "MONDO:0013845 auriculocondylar syndrome 2 1.8850895473043174e-06 0.589605\n",
      "MONDO:0009068 cytochrome-c oxidase deficiency disease 2.2121232849383716e-06 0.581174\n",
      "MONDO:0009282 multiple acyl-CoA dehydrogenase deficiency 2.2121232849383716e-06 0.581174\n",
      "MONDO:0008919 systemic primary carnitine deficiency disease 2.2121232849383716e-06 0.581174\n",
      "MONDO:0859523 congenital myopathy 2c, severe infantile, autosomal dominant 2.5652625674495586e-06 0.573326\n",
      "MONDO:0859336 muscular dystrophy, congenital, with or without seizures 2.5652625674495586e-06 0.573326\n",
      "MONDO:0024537 Brown-Vialetto-van Laere syndrome 1 2.7516191437263643e-06 0.569597\n",
      "MONDO:0012123 congenital disorder of glycosylation type 1E 2.9444989333101498e-06 0.565986\n",
      "MONDO:0011451 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 2.9444989333101498e-06 0.565986\n",
      "MONDO:0014561 3-methylglutaconic aciduria, type VIIB 3.3498239230479854e-06 0.559095\n",
      "MONDO:0011783 ALG12-congenital disorder of glycosylation 3.3498239230479854e-06 0.559095\n",
      "MONDO:0013025 chromosome 6q24-q25 deletion syndrome 4.722246071627631e-06 0.540642\n",
      "MONDO:0011946 diaphanospondylodysostosis 4.973787214744436e-06 0.537842\n",
      "MONDO:0009747 mitochondrial DNA depletion syndrome 6 (hepatocerebral type) 6.045067680868649e-06 0.527298\n",
      "MONDO:0015012 mucopolysaccharidosis-plus syndrome 6.61976266806481e-06 0.52238\n",
      "MONDO:0957265 congenital myopathy 22B, severe fetal 8.499965323509392e-06 0.508822\n",
      "MONDO:0859165 neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities 8.836088518645015e-06 0.506717\n",
      "MONDO:0800044 congenital disorder of deglycosylation 1 1.1370861781769086e-05 0.493026\n",
      "MONDO:0007251 campomelic dysplasia 1.599660118835042e-05 0.474519\n",
      "MONDO:0010871 succinic acidemia 8.095308764147456e-05 0.388382\n",
      "MONDO:0700081 newborn respiratory distress syndrome 8.095308764147456e-05 0.388382\n",
      "MONDO:0007536 congenital lobar emphysema 0.00016189962188055022 0.353287\n",
      "MONDO:0007878 congenital laryngomalacia 0.00016189962188055022 0.353287\n",
      "MONDO:0013339 dilated cardiomyopathy 1GG 0.00016189962188055022 0.353287\n",
      "MONDO:0012648 isobutyryl-CoA dehydrogenase deficiency 0.00016189962188055022 0.353287\n",
      "MONDO:0013345 d-2-hydroxyglutaric aciduria 2 0.0002428396032477459 0.333442\n",
      "MONDO:0009814 osteopenia-intellectual disability-sparse hair syndrome 0.0002428396032477459 0.333442\n",
      "MONDO:0024508 epilepsy, hot water, 1 0.0002428396032477459 0.333442\n",
      "MONDO:0012557 cardiomyopathy-hypotonia-lactic acidosis syndrome 0.0002428396032477459 0.333442\n",
      "MONDO:0014973 sudden cardiac failure, infantile 0.0002428396032477459 0.333442\n",
      "MONDO:0032592 cardiomyopathy, dilated, 2c 0.0002428396032477459 0.333442\n",
      "MONDO:0032628 mitochondrial complex 1 deficiency, nuclear type 24 0.0002428396032477459 0.333442\n",
      "MONDO:0011014 pleuropulmonary blastoma 0.0003237730322735353 0.319707\n",
      "MONDO:0021067 mediastinal germ cell tumor 0.0003237730322735353 0.319707\n",
      "MONDO:0011718 primary ciliary dyskinesia 2 0.0003237730322735353 0.319707\n",
      "MONDO:0100211 growth hormone insensitivity with immune dysregulation 1, autosomal recessive 0.0003237730322735353 0.319707\n",
      "MONDO:0008845 atonic-astatic syndrome of Foerster 0.0003237730322735353 0.319707\n",
      "MONDO:0013904 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 0.0003237730322735353 0.319707\n",
      "MONDO:0042979 hypokalemic periodic paralysis, type 1 0.0003237730322735353 0.319707\n",
      "MONDO:0013156 muscular dystrophy-dystroglycanopathy (congenital without intellectual disability), type B4 0.0003237730322735353 0.319707\n",
      "MONDO:0012382 hyperinsulinemic hypoglycemia, familial, 4 0.0003237730322735353 0.319707\n",
      "MONDO:0008939 isolated cerebellar hypoplasia/agenesis 0.0003237730322735353 0.319707\n",
      "MONDO:0013493 acetyl-coa carboxylase deficiency 0.0003237730322735353 0.319707\n",
      "MONDO:0026733 intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type 0.0003237730322735353 0.319707\n",
      "MONDO:0012423 MORM syndrome 0.0003237730322735353 0.319707\n",
      "MONDO:0013697 intellectual disability, autosomal recessive 29 0.0003237730322735353 0.319707\n",
      "MONDO:0030346 ciliary dyskinesia, primary, 47, and lissencephaly 0.0004046999094883524 0.309263\n",
      "MONDO:0013387 developmental and epileptic encephalopathy, 7 0.0004046999094883524 0.309263\n",
      "MONDO:0014953 gnb5-related intellectual disability-cardiac arrhythmia syndrome 0.0004046999094883524 0.309263\n",
      "MONDO:0013548 acetyl-CoA acetyltransferase-2 deficiency 0.0004046999094883524 0.309263\n",
      "MONDO:0859158 ataxia, intention tremor, and hypotonia syndrome, childhood-onset 0.0004046999094883524 0.309263\n",
      "MONDO:0032631 mitochondrial complex 1 deficiency, nuclear type 27 0.0004046999094883524 0.309263\n",
      "MONDO:0012858 primary CD59 deficiency 0.0004046999094883524 0.309263\n",
      "MONDO:0004573 ariboflavinosis 0.0004046999094883524 0.309263\n",
      "MONDO:0013539 hypotonia-failure to thrive-microcephaly syndrome 0.0004046999094883524 0.309263\n",
      "MONDO:0009971 respiratory distress syndrome in premature infants 0.0004856202354225857 0.300872\n",
      "MONDO:0009684 muscular hypertonia, lethal 0.0004856202354225857 0.300872\n",
      "MONDO:0024568 infantile liver failure syndrome 1 0.0004856202354225857 0.300872\n",
      "MONDO:0011291 ALG6-congenital disorder of glycosylation 1C 0.0004856202354225857 0.300872\n",
      "MONDO:0013950 peroxisome biogenesis disorder 11B 0.0004856202354225857 0.300872\n",
      "MONDO:0010317 intellectual disability, X-linked, with or without seizures, arx-related 0.0004856202354225857 0.300872\n",
      "MONDO:0030462 Joubert syndrome 40 0.0004856202354225857 0.300872\n",
      "MONDO:0030036 leukoencephalopathy, motor delay, spasticity, and dysarthria syndrome 0.0004856202354225857 0.300872\n",
      "MONDO:0007631 chromosome 16p12.1 deletion syndrome, 520kb 0.0004856202354225857 0.300872\n",
      "MONDO:0014190 combined oxidative phosphorylation defect type 17 0.0004856202354225857 0.300872\n",
      "MONDO:0014270 STT3A-congenital disorder of glycosylation 0.0004856202354225857 0.300872\n",
      "MONDO:0014851 hypercalcemia, infantile, 2 0.0004856202354225857 0.300872\n",
      "MONDO:0011772 B4GALT1-congenital disorder of glycosylation 0.0004856202354225857 0.300872\n",
      "MONDO:0014942 developmental and epileptic encephalopathy, 45 0.0004856202354225857 0.300872\n",
      "MONDO:0013000 porphyria due to ALA dehydratase deficiency 0.0004856202354225857 0.300872\n",
      "MONDO:0033310 Joubert syndrome 31 0.0004856202354225857 0.300872\n",
      "MONDO:0012413 syndromic microphthalmia type 5 0.0004856202354225857 0.300872\n",
      "MONDO:0015009 lymphatic malformation 7 0.0005665340106065814 0.29388\n",
      "MONDO:0014444 Bardet-Biedl syndrome 16 0.0005665340106065814 0.29388\n",
      "MONDO:0030756 Stuve-Wiedemann syndrome 2 0.0005665340106065814 0.29388\n",
      "MONDO:0030849 intellectual developmental disorder with speech delay and axonal peripheral neuropathy 0.0005665340106065814 0.29388\n",
      "MONDO:0014595 developmental and epileptic encephalopathy, 30 0.0005665340106065814 0.29388\n",
      "MONDO:0013877 mitochondrial pyruvate carrier deficiency 0.0005665340106065814 0.29388\n",
      "MONDO:0033311 Joubert syndrome 33 0.0005665340106065814 0.29388\n",
      "MONDO:0100105 brain small vessel disease 3 0.0005665340106065814 0.29388\n",
      "MONDO:0014881 transketolase deficiency 0.0005665340106065814 0.29388\n",
      "MONDO:0013883 congenital myasthenic syndrome 13 0.0005665340106065814 0.29388\n",
      "MONDO:0010380 cataract, ataxia, short stature, and intellectual disability 0.0005665340106065814 0.29388\n",
      "MONDO:0014220 myopathy due to myoadenylate deaminase deficiency 0.0005665340106065814 0.29388\n",
      "MONDO:0014080 osteosclerotic metaphyseal dysplasia 0.0005665340106065814 0.29388\n",
      "MONDO:0013763 Joubert syndrome 15 0.0005665340106065814 0.29388\n",
      "MONDO:0859271 glycosylphosphatidylinositol biosynthesis defect 25 0.0005665340106065814 0.29388\n",
      "MONDO:0012276 generalized epilepsy-paroxysmal dyskinesia syndrome 0.0005665340106065814 0.29388\n",
      "MONDO:0012624 acyl-CoA dehydrogenase 9 deficiency 0.0005665340106065814 0.29388\n",
      "MONDO:0014842 intellectual disability, autosomal dominant 41 0.0005665340106065814 0.29388\n",
      "MONDO:0032909 mitochondrial complex 3 deficiency, nuclear type 10 0.0005665340106065814 0.29388\n",
      "MONDO:0957255 mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 0.0005665340106065814 0.29388\n",
      "MONDO:0032629 mitochondrial complex 1 deficiency, nuclear type 25 0.0005665340106065814 0.29388\n",
      "MONDO:0020727 combined oxidative phosphorylation deficiency 22 0.0005665340106065814 0.29388\n",
      "MONDO:0009742 neuroectodermal melanolysosomal disease 0.0005665340106065814 0.29388\n",
      "MONDO:0008774 2-aminoadipic 2-oxoadipic aciduria 0.0005665340106065814 0.29388\n",
      "MONDO:0014668 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4 0.0005665340106065814 0.29388\n",
      "MONDO:0030692 immunodeficiency 95 0.0006474412355706435 0.287901\n",
      "MONDO:0014714 progressive microcephaly-seizures-cortical blindness-developmental delay syndrome 0.0006474412355706435 0.287901\n",
      "MONDO:0032627 mitochondrial complex 1 deficiency, nuclear type 23 0.0006474412355706435 0.287901\n",
      "MONDO:0054861 intellectual disability, autosomal recessive 63 0.0006474412355706435 0.287901\n",
      "MONDO:0008962 Griscelli syndrome type 1 0.0006474412355706435 0.287901\n",
      "MONDO:0859287 neurodevelopmental disorder with microcephaly, hypotonia, and absent language 0.0006474412355706435 0.287901\n",
      "MONDO:0009562 beta-mannosidosis 0.0006474412355706435 0.287901\n",
      "MONDO:0010452 intellectual disability, X-linked 90 0.0006474412355706435 0.287901\n",
      "MONDO:0013690 Pitt-Hopkins-like syndrome 2 0.0006474412355706435 0.287901\n",
      "MONDO:0032812 developmental and epileptic encephalopathy, 78 0.0006474412355706435 0.287901\n",
      "MONDO:0009949 pyruvate carboxylase deficiency disease 0.0006474412355706435 0.287901\n",
      "MONDO:0011203 Pierre Robin sequence with pectus excavatum and rib and scapular anomalies 0.0006474412355706435 0.287901\n",
      "MONDO:0014633 myoclonic-atonic epilepsy 0.0006474412355706435 0.287901\n",
      "MONDO:0013491 megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without intellectual disability 0.0006474412355706435 0.287901\n",
      "MONDO:0859152 neurodevelopmental disorder with cerebellar atrophy and motor dysfunction 0.0006474412355706435 0.287901\n",
      "MONDO:0032678 developmental and epileptic encephalopathy, 71 0.0006474412355706435 0.287901\n",
      "MONDO:0032626 mitochondrial complex 1 deficiency, nuclear type 22 0.0006474412355706435 0.287901\n",
      "MONDO:0859207 neurodevelopmental disorder with hypotonia and gross motor and speech delay 0.0006474412355706435 0.287901\n",
      "MONDO:0014142 autosomal recessive limb-girdle muscular dystrophy type 2T 0.0006474412355706435 0.287901\n",
      "MONDO:0014607 developmental and epileptic encephalopathy, 32 0.0006474412355706435 0.287901\n",
      "MONDO:0009887 desquamative interstitial pneumonia 0.0007283419108450321 0.282688\n",
      "MONDO:0014956 Chitayat syndrome 0.0007283419108450321 0.282688\n",
      "MONDO:0010365 myopathy, congenital, with fiber-type disproportion, X-linked 0.0007283419108450321 0.282688\n",
      "MONDO:0859220 Ferguson-Bonni neurodevelopmental syndrome 0.0007283419108450321 0.282688\n",
      "MONDO:0009529 pyruvate dehydrogenase E3 deficiency 0.0007283419108450321 0.282688\n",
      "MONDO:0020741 pyridoxine-dependent epilepsy caused by ALDH7A1 mutant 0.0007283419108450321 0.282688\n",
      "MONDO:0010192 Waardenburg syndrome type 4A 0.0007283419108450321 0.282688\n",
      "MONDO:0012251 MEDNIK syndrome 0.0007283419108450321 0.282688\n",
      "MONDO:0013772 Huppke-Brendel syndrome 0.0007283419108450321 0.282688\n",
      "MONDO:0859292 developmental delay, behavioral abnormalities, and neuropsychiatric disorders 0.0007283419108450321 0.282688\n",
      "MONDO:0013936 peroxisome biogenesis disorder 6A (Zellweger) 0.0007283419108450321 0.282688\n",
      "MONDO:0014525 combined oxidative phosphorylation defect type 23 0.0007283419108450321 0.282688\n",
      "MONDO:0013890 congenital myopathy with internal nuclei and atypical cores 0.0007283419108450321 0.282688\n",
      "MONDO:0009400 hyperprolinemia type 1 0.0007283419108450321 0.282688\n",
      "MONDO:0859280 developmental delay, hypotonia, and impaired language 0.0007283419108450321 0.282688\n",
      "MONDO:0014957 language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia 0.0007283419108450321 0.282688\n",
      "MONDO:0008721 medium chain acyl-CoA dehydrogenase deficiency 0.0007283419108450321 0.282688\n",
      "MONDO:0044299 myasthenic syndrome, congenital, 22 0.0007283419108450321 0.282688\n",
      "MONDO:0009868 glycogen storage disease IXb 0.0007283419108450321 0.282688\n",
      "MONDO:0010598 glycogen storage disease IXa1 0.0007283419108450321 0.282688\n",
      "MONDO:0012392 2-methylbutyryl-CoA dehydrogenase deficiency 0.0007283419108450321 0.282688\n",
      "MONDO:0010494 linear skin defects with multiple congenital anomalies 3 0.0007283419108450321 0.282688\n",
      "MONDO:0054764 neurodegeneration with brain iron accumulation 8 0.0007283419108450321 0.282688\n",
      "MONDO:0010393 intellectual disability, X-linked 93 0.0007283419108450321 0.282688\n",
      "MONDO:0013789 DDOST-congenital disorder of glycosylation 0.0007283419108450321 0.282688\n",
      "MONDO:0014764 spastic paraplegia-severe developmental delay-epilepsy syndrome 0.0007283419108450321 0.282688\n",
      "MONDO:0014890 PERCHING syndrome 0.0008092360369599653 0.278074\n",
      "MONDO:0013003 isolated congenital hypoglossia/aglossia 0.0008092360369599653 0.278074\n",
      "MONDO:0014886 severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome 0.0008092360369599653 0.278074\n",
      "MONDO:0030476 Galloway-Mowat syndrome 10 0.0008092360369599653 0.278074\n",
      "MONDO:0859514 congenital myopathy 18 0.0008092360369599653 0.278074\n",
      "MONDO:0032839 noonan syndrome 12 0.0008092360369599653 0.278074\n",
      "MONDO:0032605 intellectual disability, autosomal recessive 66 0.0008092360369599653 0.278074\n",
      "MONDO:0013008 combined immunodeficiency due to STIM1 deficiency 0.0008092360369599653 0.278074\n",
      "MONDO:0030311 combined oxidative phosphorylation deficiency 52 0.0008092360369599653 0.278074\n",
      "MONDO:0032877 neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures 0.0008092360369599653 0.278074\n",
      "MONDO:0054559 congenital disorder of glycosylation, type IIq 0.0008092360369599653 0.278074\n",
      "MONDO:0010100 Tay-Sachs disease 0.0008092360369599653 0.278074\n",
      "MONDO:0010487 intellectual disability, X-linked 99 0.0008092360369599653 0.278074\n",
      "MONDO:0013793 encephalomyopathy, mitochondrial, due to voltage-dependent anion channel deficiency 0.0008092360369599653 0.278074\n",
      "MONDO:0014210 intellectual disability-hypotonia-spasticity-sleep disorder syndrome 0.0008092360369599653 0.278074\n",
      "MONDO:0017715 3-hydroxyacyl-CoA dehydrogenase deficiency 0.0008092360369599653 0.278074\n",
      "MONDO:0010366 FG syndrome 5 0.0008092360369599653 0.278074\n",
      "MONDO:0020739 hypercalcemia, infantile, 1 0.0008092360369599653 0.278074\n",
      "MONDO:0013325 COG5-congenital disorder of glycosylation 0.0008092360369599653 0.278074\n",
      "MONDO:0012245 developmental and epileptic encephalopathy, 3 0.0008092360369599653 0.278074\n",
      "MONDO:0013702 intellectual disability, autosomal recessive 27 0.0008092360369599653 0.278074\n",
      "MONDO:0859305 neurodevelopmental disorder with eye movement abnormalities and ataxia 0.0008092360369599653 0.278074\n",
      "MONDO:0014585 congenital myasthenic syndrome 3C 0.0008092360369599653 0.278074\n",
      "MONDO:0054776 epilepsy, familial focal, with variable foci 4 0.0008092360369599653 0.278074\n",
      "MONDO:0030781 restrictive dermopathy 2 0.0008901236144456169 0.27394\n",
      "MONDO:0013091 glycogen storage disease IXc 0.0008901236144456169 0.27394\n",
      "MONDO:0010547 X-linked progressive cerebellar ataxia 0.0008901236144456169 0.27394\n",
      "MONDO:0032617 mitochondrial complex 1 deficiency, nuclear type 11 0.0008901236144456169 0.27394\n",
      "MONDO:0012308 Joubert syndrome with renal defect 0.0008901236144456169 0.27394\n",
      "MONDO:0016825 mitochondrial myopathy-lactic acidosis-deafness syndrome 0.0008901236144456169 0.27394\n",
      "MONDO:0014113 cardiofaciocutaneous syndrome 3 0.0008901236144456169 0.27394\n",
      "MONDO:0030911 intellectual disability, autosomal dominant 46 0.0008901236144456169 0.27394\n",
      "MONDO:0031052 developmental and epileptic encephalopathy 106 0.0008901236144456169 0.27394\n",
      "MONDO:0009257 galactose epimerase deficiency 0.0008901236144456169 0.27394\n",
      "MONDO:0859289 intestinal dysmotility syndrome 0.0008901236144456169 0.27394\n",
      "MONDO:0014477 developmental and epileptic encephalopathy, 26 0.0008901236144456169 0.27394\n",
      "MONDO:0012221 alpha-N-acetylgalactosaminidase deficiency type 1 0.0008901236144456169 0.27394\n",
      "MONDO:0012635 COG8-congenital disorder of glycosylation 0.0008901236144456169 0.27394\n",
      "MONDO:0014569 lethal congenital contracture syndrome 7 0.0008901236144456169 0.27394\n",
      "MONDO:0032729 intellectual developmental disorder, autosomal recessive 70 0.0008901236144456169 0.27394\n",
      "MONDO:0009292 glycogen storage disease due to glycogen branching enzyme deficiency 0.0008901236144456169 0.27394\n",
      "MONDO:0013166 GABA aminotransaminase deficiency 0.0008901236144456169 0.27394\n",
      "MONDO:0014409 intellectual disability, autosomal recessive 44 0.0008901236144456169 0.27394\n",
      "MONDO:0011950 infantile-onset autosomal recessive nonprogressive cerebellar ataxia 0.0008901236144456169 0.27394\n",
      "MONDO:0030988 developmental delay with dysmorphic facies and dental anomalies 0.0008901236144456169 0.27394\n",
      "MONDO:0033365 developmental and epileptic encephalopathy, 56 0.0008901236144456169 0.27394\n",
      "MONDO:0032634 mitochondrial complex 1 deficiency, nuclear type 31 0.0008901236144456169 0.27394\n",
      "MONDO:0010130 dihydropyrimidine dehydrogenase deficiency 0.0008901236144456169 0.27394\n",
      "MONDO:0033566 combined oxidative phosphorylation deficiency 48 0.0008901236144456169 0.27394\n",
      "MONDO:0033308 Joubert syndrome 30 0.0008901236144456169 0.27394\n",
      "MONDO:0011995 cataract - congenital heart disease - neural tube defect syndrome 0.0008901236144456169 0.27394\n",
      "MONDO:0014927 Joubert syndrome 27 0.0008901236144456169 0.27394\n",
      "MONDO:0011966 periventricular heterotopia with microcephaly, autosomal recessive 0.0008901236144456169 0.27394\n",
      "MONDO:0012774 chromosome 15q13.3 microdeletion syndrome 0.0008901236144456169 0.27394\n",
      "MONDO:0013164 beta-ureidopropionase deficiency 0.0008901236144456169 0.27394\n",
      "MONDO:0013680 cognitive impairment with or without cerebellar ataxia 0.0008901236144456169 0.27394\n",
      "MONDO:0008740 agnathia-otocephaly complex 0.0009710046438321194 0.270199\n",
      "MONDO:0030963 Li-Campeau syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0014051 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2 0.0009710046438321194 0.270199\n",
      "MONDO:0031055 developmental and epileptic encephalopathy 107 0.0009710046438321194 0.270199\n",
      "MONDO:0011336 familial hemophagocytic lymphohistiocytosis 4 0.0009710046438321194 0.270199\n",
      "MONDO:0054602 gaze palsy, familial horizontal, with progressive scoliosis, 2 0.0009710046438321194 0.270199\n",
      "MONDO:0032715 intellectual developmental disorder, autosomal recessive 69 0.0009710046438321194 0.270199\n",
      "MONDO:0013867 brown-Vialetto-van Laere syndrome 2 0.0009710046438321194 0.270199\n",
      "MONDO:0033366 developmental and epileptic encephalopathy, 57 0.0009710046438321194 0.270199\n",
      "MONDO:0008816 Chiari malformation type II 0.0009710046438321194 0.270199\n",
      "MONDO:0012539 Joubert syndrome 6 0.0009710046438321194 0.270199\n",
      "MONDO:0030891 intellectual developmental disorder, autosomal dominant 66 0.0009710046438321194 0.270199\n",
      "MONDO:0859237 3-methylglutaconic aciduria, type VIIA 0.0009710046438321194 0.270199\n",
      "MONDO:0009123 orthostatic hypotension 1 0.0009710046438321194 0.270199\n",
      "MONDO:0033655 mitochondrial complex 4 deficiency, nuclear type 20 0.0009710046438321194 0.270199\n",
      "MONDO:0032662 intellectual developmental disorder, autosomal recessive 67 0.0009710046438321194 0.270199\n",
      "MONDO:0011449 Salla disease 0.0009710046438321194 0.270199\n",
      "MONDO:0012784 autosomal recessive ataxia due to ubiquinone deficiency 0.0009710046438321194 0.270199\n",
      "MONDO:0012960 intellectual disability, autosomal dominant 5 0.0009710046438321194 0.270199\n",
      "MONDO:0859335 congenital myopathy 15 0.0009710046438321194 0.270199\n",
      "MONDO:0014496 mitochondrial complex III deficiency nuclear type 9 0.0009710046438321194 0.270199\n",
      "MONDO:0060666 hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0030727 developmental and epileptic encephalopathy 101 0.0009710046438321194 0.270199\n",
      "MONDO:0012855 Joubert syndrome 8 0.0009710046438321194 0.270199\n",
      "MONDO:0013918 distal tetrasomy 15q 0.0009710046438321194 0.270199\n",
      "MONDO:0009556 malonic aciduria 0.0009710046438321194 0.270199\n",
      "MONDO:0014487 congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0010447 intellectual disability, X-linked 19 0.0009710046438321194 0.270199\n",
      "MONDO:0010657 methylmalonic acidemia with homocystinuria, type cblX 0.0009710046438321194 0.270199\n",
      "MONDO:0012545 neutral lipid storage myopathy 0.0009710046438321194 0.270199\n",
      "MONDO:0014140 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 0.0009710046438321194 0.270199\n",
      "MONDO:0013658 intellectual disability, autosomal dominant 11 0.0009710046438321194 0.270199\n",
      "MONDO:0100102 fetal akinesia deformation sequence 2 0.0009710046438321194 0.270199\n",
      "MONDO:0014943 mitochondrial DNA depletion syndrome 15 (hepatocerebral type) 0.0010518791256495616 0.266788\n",
      "MONDO:0011639 Diamond-Blackfan anemia 15 with mandibulofacial dysostosis 0.0010518791256495616 0.266788\n",
      "MONDO:0014261 growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome 0.0010518791256495616 0.266788\n",
      "MONDO:0009862 dihydropteridine reductase deficiency 0.0010518791256495616 0.266788\n",
      "MONDO:0859231 macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin 0.0010518791256495616 0.266788\n",
      "MONDO:0013927 peroxisome biogenesis disorder 3A (Zellweger) 0.0010518791256495616 0.266788\n",
      "MONDO:0014119 intellectual disability-strabismus syndrome 0.0010518791256495616 0.266788\n",
      "MONDO:0009563 maple syrup urine disease 0.0010518791256495616 0.266788\n",
      "MONDO:0859285 neurodevelopmental disorder with microcephaly, short stature, and speech delay 0.0010518791256495616 0.266788\n",
      "MONDO:0032665 intellectual developmental disorder, autosomal recessive 68 0.0010518791256495616 0.266788\n",
      "MONDO:0014397 combined oxidative phosphorylation defect type 20 0.0010518791256495616 0.266788\n",
      "MONDO:0013865 mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency 0.0010518791256495616 0.266788\n",
      "MONDO:0014570 lethal congenital contracture syndrome 8 0.0010518791256495616 0.266788\n",
      "MONDO:0014976 lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome 0.0010518791256495616 0.266788\n",
      "MONDO:0859085 neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked 0.0010518791256495616 0.266788\n",
      "MONDO:0012699 autosomal recessive limb-girdle muscular dystrophy type 2M 0.0010518791256495616 0.266788\n",
      "MONDO:0025353 developmental and epileptic encephalopathy, 90 0.0010518791256495616 0.266788\n",
      "MONDO:0009509 Landau-Kleffner syndrome 0.0010518791256495616 0.266788\n",
      "MONDO:0014746 SLC39A8-CDG 0.0010518791256495616 0.266788\n",
      "MONDO:0010139 isolated thyroid-stimulating hormone deficiency 0.0010518791256495616 0.266788\n",
      "MONDO:0032693 Galloway-Mowat syndrome 8 0.0010518791256495616 0.266788\n",
      "MONDO:0011964 DPAGT1-congenital disorder of glycosylation 0.0010518791256495616 0.266788\n",
      "MONDO:0030378 combined oxidative phosphorylation deficiency 53 0.0010518791256495616 0.266788\n",
      "MONDO:0010185 methylmalonic aciduria and homocystinuria type cblD 0.0010518791256495616 0.266788\n",
      "MONDO:0010798 proximal tubulopathy-diabetes mellitus-cerebellar ataxia syndrome 0.0010518791256495616 0.266788\n",
      "MONDO:0010265 Simpson-Golabi-Behmel syndrome type 2 0.0010518791256495616 0.266788\n",
      "MONDO:0014822 15q14 microdeletion syndrome 0.0010518791256495616 0.266788\n",
      "MONDO:0014077 cobblestone lissencephaly without muscular or ocular involvement 0.0010518791256495616 0.266788\n",
      "MONDO:0014486 intellectual disability, autosomal dominant 30 0.0010518791256495616 0.266788\n",
      "MONDO:0009238 hereditary folate malabsorption 0.0010518791256495616 0.266788\n",
      "MONDO:0032485 intellectual developmental disorder 61 0.0010518791256495616 0.266788\n",
      "MONDO:0009251 fructose-1,6-bisphosphatase deficiency 0.0010518791256495616 0.266788\n",
      "MONDO:0024506 Adams-Oliver syndrome 1 0.0010518791256495616 0.266788\n",
      "MONDO:0859264 congenital myopathy 11 0.0010518791256495616 0.266788\n",
      "MONDO:0024607 congenital muscular dystrophy with cataracts and intellectual disability 0.0010518791256495616 0.266788\n",
      "MONDO:0012471 Aicardi-Goutieres syndrome 3 0.0010518791256495616 0.266788\n",
      "MONDO:0859313 neurodevelopmental disorder with speech impairment and with or without seizures 0.0010518791256495616 0.266788\n",
      "MONDO:0014889 striatonigral degeneration, childhood-onset 0.0010518791256495616 0.266788\n",
      "MONDO:0014072 D,L-2-hydroxyglutaric aciduria 0.0010518791256495616 0.266788\n",
      "MONDO:0030453 developmental and epileptic encephalopathy 97 0.0010518791256495616 0.266788\n",
      "MONDO:0014705 craniosynostosis 6 0.0010518791256495616 0.266788\n",
      "MONDO:0030861 osteogenesis imperfecta, type 21 0.0010518791256495616 0.266788\n",
      "MONDO:0009609 methylcobalamin deficiency type cblG 0.0010518791256495616 0.266788\n",
      "MONDO:0958179 glycine encephalopathy 1 0.0010518791256495616 0.266788\n",
      "MONDO:0030730 Tessadori-van Haaften neurodevelopmental syndrome 2 0.0010518791256495616 0.266788\n",
      "MONDO:0008722 short chain acyl-CoA dehydrogenase deficiency 0.0010518791256495616 0.266788\n",
      "MONDO:0013292 chromosome 4q21 deletion syndrome 0.0010518791256495616 0.266788\n",
      "MONDO:0009569 Hennekam-Beemer syndrome 0.0010518791256495616 0.266788\n",
      "MONDO:0033006 Galloway-Mowat syndrome 2, X-linked 0.0010518791256495616 0.266788\n",
      "MONDO:0009689 congenital myasthenic syndrome 6 0.0011327470604279887 0.263653\n",
      "MONDO:0007268 hypertrophic cardiomyopathy 4 0.0011327470604279887 0.263653\n",
      "MONDO:0030930 neurodevelopmental disorder with or without early-onset generalized epilepsy 0.0011327470604279887 0.263653\n",
      "MONDO:0012556 DK1-congenital disorder of glycosylation 0.0011327470604279887 0.263653\n",
      "MONDO:0032622 mitochondrial complex 1 deficiency, nuclear type 17 0.0011327470604279887 0.263653\n",
      "MONDO:0030995 global developmental delay with speech and behavioral abnormalities 0.0011327470604279887 0.263653\n",
      "MONDO:0859519 neurodevelopmental disorder with absent speech and movement and behavioral abnormalities 0.0011327470604279887 0.263653\n",
      "MONDO:0011257 MPI-congenital disorder of glycosylation 0.0011327470604279887 0.263653\n",
      "MONDO:0013111 acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins 0.0011327470604279887 0.263653\n",
      "MONDO:0033645 mitochondrial complex 4 deficiency, nuclear type 11 0.0011327470604279887 0.263653\n",
      "MONDO:0011229 ethylmalonic encephalopathy 0.0011327470604279887 0.263653\n",
      "MONDO:0015014 coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness 0.0011327470604279887 0.263653\n",
      "MONDO:0013007 combined immunodeficiency due to ORAI1 deficiency 0.0011327470604279887 0.263653\n",
      "MONDO:0014647 developmental and epileptic encephalopathy, 50 0.0011327470604279887 0.263653\n",
      "MONDO:0859258 neurodevelopmental disorder with dystonia and seizures 0.0011327470604279887 0.263653\n",
      "MONDO:0013349 ALG11-congenital disorder of glycosylation 0.0011327470604279887 0.263653\n",
      "MONDO:0032616 mitochondrial complex 1 deficiency, nuclear type 10 0.0011327470604279887 0.263653\n",
      "MONDO:0012432 Joubert syndrome 5 0.0011327470604279887 0.263653\n",
      "MONDO:0014337 complex cortical dysplasia with other brain malformations 5 0.0011327470604279887 0.263653\n",
      "MONDO:0010250 intellectual disability, X-linked 49 0.0011327470604279887 0.263653\n",
      "MONDO:0014003 developmental and epileptic encephalopathy, 15 0.0011327470604279887 0.263653\n",
      "MONDO:0859196 Usmani-Riazuddin syndrome, autosomal recessive 0.0011327470604279887 0.263653\n",
      "MONDO:0032725 developmental and epileptic encephalopathy, 74 0.0011327470604279887 0.263653\n",
      "MONDO:0030353 Joubert syndrome 38 0.0011327470604279887 0.263653\n",
      "MONDO:0032663 developmental and epileptic encephalopathy, 70 0.0011327470604279887 0.263653\n",
      "MONDO:0030487 spondylometaphyseal dysplasia, pagnamenta type 0.0011327470604279887 0.263653\n",
      "MONDO:0859378 leukodystrophy, hypomyelinating, 25 0.0011327470604279887 0.263653\n",
      "MONDO:0007492 early-onset generalized limb-onset dystonia 0.0011327470604279887 0.263653\n",
      "MONDO:0013840 encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome 0.0011327470604279887 0.263653\n",
      "MONDO:0033362 developmental and epileptic encephalopathy, 53 0.0011327470604279887 0.263653\n",
      "MONDO:0014683 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 0.0011327470604279887 0.263653\n",
      "MONDO:0013762 lipoic acid synthetase deficiency 0.0011327470604279887 0.263653\n",
      "MONDO:0008759 oxoglutaricaciduria 0.0011327470604279887 0.263653\n",
      "MONDO:0013404 hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase 0.0011327470604279887 0.263653\n",
      "MONDO:0033309 Joubert syndrome 32 0.0011327470604279887 0.263653\n",
      "MONDO:0012719 combined PSAP deficiency 0.0011327470604279887 0.263653\n",
      "MONDO:0957540 congenital disorder of glycosylation, type IIaa 0.0011327470604279887 0.263653\n",
      "MONDO:0012052 ALG1-congenital disorder of glycosylation 0.0011327470604279887 0.263653\n",
      "MONDO:0030537 central hypoventilation syndrome, congenital, 2, and autonomic dysfunction 0.0011327470604279887 0.263653\n",
      "MONDO:0014805 Hao-Fountain syndrome 0.0011327470604279887 0.263653\n",
      "MONDO:0859517 congenital myopathy 2b, severe infantile, autosomal recessive 0.001213608448697405 0.260757\n",
      "MONDO:0060568 Pilarowski-Bjornsson syndrome 0.001213608448697405 0.260757\n",
      "MONDO:0030312 spinocerebellar ataxia, autosomal recessive 29 0.001213608448697405 0.260757\n",
      "MONDO:0010979 Timothy syndrome 0.001213608448697405 0.260757\n",
      "MONDO:0009666 holocarboxylase synthetase deficiency 0.001213608448697405 0.260757\n",
      "MONDO:0014905 encephalopathy due to defective mitochondrial and peroxisomal fission 2 0.001213608448697405 0.260757\n",
      "MONDO:0014530 autosomal recessive spinocerebellar ataxia 18 0.001213608448697405 0.260757\n",
      "MONDO:0011529 spinocerebellar ataxia type 13 0.001213608448697405 0.260757\n",
      "MONDO:0014133 developmental and epileptic encephalopathy, 16 0.001213608448697405 0.260757\n",
      "MONDO:0031028 developmental and epileptic encephalopathy 105 with hypopituitarism 0.001213608448697405 0.260757\n",
      "MONDO:0032912 Coffin-Siris syndrome 11 0.001213608448697405 0.260757\n",
      "MONDO:0010778 cyclic vomiting syndrome 0.001213608448697405 0.260757\n",
      "MONDO:0014085 hydrocephalus, nonsyndromic, autosomal recessive 2 0.001213608448697405 0.260757\n",
      "MONDO:0020777 congenital disorder of glycosylation with defective fucosylation 2 0.001213608448697405 0.260757\n",
      "MONDO:0014848 TELO2-related intellectual disability-neurodevelopmental disorder 0.001213608448697405 0.260757\n",
      "MONDO:0859240 intellectual developmental disorder with or without peripheral neuropathy 0.001213608448697405 0.260757\n",
      "MONDO:0012368 aminoacylase 1 deficiency 0.001213608448697405 0.260757\n",
      "MONDO:0009921 holoprosencephaly-postaxial polydactyly syndrome 0.001213608448697405 0.260757\n",
      "MONDO:0013277 developmental and epileptic encephalopathy, 5 0.001213608448697405 0.260757\n",
      "MONDO:0014141 muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14 0.001213608448697405 0.260757\n",
      "MONDO:0014206 severe early-onset pulmonary alveolar proteinosis due to MARS deficiency 0.001213608448697405 0.260757\n",
      "MONDO:0010149 transcobalamin II deficiency 0.001213608448697405 0.260757\n",
      "MONDO:0010263 Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome 0.001213608448697405 0.260757\n",
      "MONDO:0014120 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 0.001213608448697405 0.260757\n",
      "MONDO:0030472 developmental and epileptic encephalopathy 98 0.001213608448697405 0.260757\n",
      "MONDO:0033043 spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy 0.001213608448697405 0.260757\n",
      "MONDO:0859229 cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism 0.001213608448697405 0.260757\n",
      "MONDO:0012856 Birk-Barel syndrome 0.001213608448697405 0.260757\n",
      "MONDO:0012290 CEDNIK syndrome 0.001213608448697405 0.260757\n",
      "MONDO:0012747 glycogen storage disease due to aldolase A deficiency 0.001213608448697405 0.260757\n",
      "MONDO:0009354 methylcobalamin deficiency type cblE 0.001213608448697405 0.260757\n",
      "MONDO:0030937 mitochondrial complex 2 deficiency, nuclear type 3 0.001213608448697405 0.260757\n",
      "MONDO:0014208 Charcot-Marie-Tooth disease type 2R 0.001213608448697405 0.260757\n",
      "MONDO:0009603 3-hydroxyisobutyryl-CoA hydrolase deficiency 0.001213608448697405 0.260757\n",
      "MONDO:0032931 pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal 0.001213608448697405 0.260757\n",
      "MONDO:0014983 congenital myasthenic syndrome 21 0.001213608448697405 0.260757\n",
      "MONDO:0014288 Joubert syndrome 21 0.001213608448697405 0.260757\n",
      "MONDO:0008918 carnitine-acylcarnitine translocase deficiency 0.001213608448697405 0.260757\n",
      "MONDO:0800028 dyskinesia with orofacial involvement, autosomal dominant 0.001294463290987769 0.258066\n",
      "MONDO:0033662 neurodevelopmental disorder with microcephaly, seizures, and brain atrophy 0.001294463290987769 0.258066\n",
      "MONDO:0009397 neonatal severe primary hyperparathyroidism 0.001294463290987769 0.258066\n",
      "MONDO:0030259 pontocerebellar hypoplasia, type 15 0.001294463290987769 0.258066\n",
      "MONDO:0012905 hypomyelinating leukodystrophy 6 0.001294463290987769 0.258066\n",
      "MONDO:0010007 microbrachycephaly-ptosis-cleft lip syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0010327 HSD10 mitochondrial disease 0.001294463290987769 0.258066\n",
      "MONDO:0012885 SRD5A3-congenital disorder of glycosylation 0.001294463290987769 0.258066\n",
      "MONDO:0859176 neurodevelopmental disorder with motor and speech delay and behavioral abnormalities 0.001294463290987769 0.258066\n",
      "MONDO:0024309 neuropathy, hereditary sensory and autonomic, type 2A 0.001294463290987769 0.258066\n",
      "MONDO:0014874 pontocerebellar hypoplasia, type 2F 0.001294463290987769 0.258066\n",
      "MONDO:0032609 mitochondrial complex 1 deficiency, nuclear type 4 0.001294463290987769 0.258066\n",
      "MONDO:0014201 developmental and epileptic encephalopathy, 18 0.001294463290987769 0.258066\n",
      "MONDO:0011022 Potocki-Shaffer syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0014505 developmental and epileptic encephalopathy, 27 0.001294463290987769 0.258066\n",
      "MONDO:0009678 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4 0.001294463290987769 0.258066\n",
      "MONDO:0033008 Galloway-Mowat syndrome 4 0.001294463290987769 0.258066\n",
      "MONDO:0012703 lissencephaly due to TUBA1A mutation 0.001294463290987769 0.258066\n",
      "MONDO:0009388 hyperlysinemia 0.001294463290987769 0.258066\n",
      "MONDO:0012824 hypomyelinating leukodystrophy 4 0.001294463290987769 0.258066\n",
      "MONDO:0010437 severe X-linked mitochondrial encephalomyopathy 0.001294463290987769 0.258066\n",
      "MONDO:0013458 hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0054785 multiple mitochondrial dysfunctions syndrome 6 0.001294463290987769 0.258066\n",
      "MONDO:0013989 developmental and epileptic encephalopathy, 14 0.001294463290987769 0.258066\n",
      "MONDO:0013875 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0012020 chromosome 22q11.2 microduplication syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0014939 congenital myasthenic syndrome 20 0.001294463290987769 0.258066\n",
      "MONDO:0859250 neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures 0.001294463290987769 0.258066\n",
      "MONDO:0008082 multiple endocrine neoplasia type 2B 0.001294463290987769 0.258066\n",
      "MONDO:0011365 blepharophimosis - intellectual disability syndrome, SBBYS type 0.001294463290987769 0.258066\n",
      "MONDO:0010099 Tay-Sachs disease AB variant 0.001294463290987769 0.258066\n",
      "MONDO:0009953 leukocyte adhesion deficiency type II 0.001294463290987769 0.258066\n",
      "MONDO:0054781 combined oxidative phosphorylation deficiency 36 0.001294463290987769 0.258066\n",
      "MONDO:0030258 pontocerebellar hypoplasia, type 14 0.001294463290987769 0.258066\n",
      "MONDO:0014660 microcephaly 15, primary, autosomal recessive 0.001294463290987769 0.258066\n",
      "MONDO:0013255 arthrogryposis, renal dysfunction, and cholestasis 2 0.001294463290987769 0.258066\n",
      "MONDO:0011600 congenital myasthenic syndrome 4A 0.0013753115878290007 0.255555\n",
      "MONDO:0033485 short-rib thoracic dysplasia 19 with or without polydactyly 0.0013753115878290007 0.255555\n",
      "MONDO:0026720 mitochondrial complex 1 deficiency, nuclear type 12 0.0013753115878290007 0.255555\n",
      "MONDO:0054695 myopathy, centronuclear, 6, with fiber-type disproportion 0.0013753115878290007 0.255555\n",
      "MONDO:0014859 developmental and epileptic encephalopathy, 37 0.0013753115878290007 0.255555\n",
      "MONDO:0060759 neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures 0.0013753115878290007 0.255555\n",
      "MONDO:0030261 pontocerebellar hypoplasia, type 1F 0.0013753115878290007 0.255555\n",
      "MONDO:0014543 congenital myasthenic syndrome 14 0.0013753115878290007 0.255555\n",
      "MONDO:0010773 mitochondrial myopathy with diabetes 0.0013753115878290007 0.255555\n",
      "MONDO:0012759 camptodactyly syndrome, Guadalajara type 3 0.0013753115878290007 0.255555\n",
      "MONDO:0014576 lipoyl transferase 1 deficiency 0.0013753115878290007 0.255555\n",
      "MONDO:0008861 3-methylcrotonyl-CoA carboxylase 1 deficiency 0.0013753115878290007 0.255555\n",
      "MONDO:0014563 mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency 0.0013753115878290007 0.255555\n",
      "MONDO:0014979 myoclonus, intractable, neonatal 0.0013753115878290007 0.255555\n",
      "MONDO:0014602 intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome 0.0013753115878290007 0.255555\n",
      "MONDO:0060486 arthrogryposis multiplex congenita 1, neurogenic, with myelin defect 0.0013753115878290007 0.255555\n",
      "MONDO:0012099 AICA-ribosiduria 0.0013753115878290007 0.255555\n",
      "MONDO:0859360 spinocerebellar ataxia, autosomal recessive 33 0.0013753115878290007 0.255555\n",
      "MONDO:0010651 Menkes disease 0.0013753115878290007 0.255555\n",
      "MONDO:0030835 developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy 0.0013753115878290007 0.255555\n",
      "MONDO:0032770 intellectual developmental disorder with severe speech and ambulation defects 0.0013753115878290007 0.255555\n",
      "MONDO:0007180 Axenfeld-Rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities 0.0013753115878290007 0.255555\n",
      "MONDO:0033045 orofaciodigital syndrome 16 0.0013753115878290007 0.255555\n",
      "MONDO:0014598 developmental and epileptic encephalopathy, 31 0.0013753115878290007 0.255555\n",
      "MONDO:0000909 Bartter disease type 4B 0.0013753115878290007 0.255555\n",
      "MONDO:0009665 biotinidase deficiency 0.0013753115878290007 0.255555\n",
      "MONDO:0859249 parenti-mignot neurodevelopmental syndrome 0.0013753115878290007 0.255555\n",
      "MONDO:0014354 intellectual disability, autosomal recessive 43 0.0013753115878290007 0.255555\n",
      "MONDO:0859174 Usmani-Riazuddin syndrome, autosomal dominant 0.0013753115878290007 0.255555\n",
      "MONDO:0060562 encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities 0.0013753115878290007 0.255555\n",
      "MONDO:0013456 constitutional megaloblastic anemia with severe neurologic disease 0.0013753115878290007 0.255555\n",
      "MONDO:0010532 infantile-onset X-linked spinal muscular atrophy 0.0013753115878290007 0.255555\n",
      "MONDO:0032624 mitochondrial complex 1 deficiency, nuclear type 19 0.0013753115878290007 0.255555\n",
      "MONDO:0008425 omphalocele syndrome, Shprintzen-Goldberg type 0.0013753115878290007 0.255555\n",
      "MONDO:0026727 Shukla-Vernon syndrome 0.0013753115878290007 0.255555\n",
      "MONDO:0014646 Zimmermann-Laband syndrome 2 0.0013753115878290007 0.255555\n",
      "MONDO:0013858 pontine tegmental cap dysplasia 0.0013753115878290007 0.255555\n",
      "MONDO:0012669 Legius syndrome 0.0013753115878290007 0.255555\n",
      "MONDO:0013252 Warsaw breakage syndrome 0.0013753115878290007 0.255555\n",
      "MONDO:0014510 fatty acyl-CoA reductase 1 deficiency 0.0013753115878290007 0.255555\n",
      "MONDO:0044205 Shwachman-Diamond syndrome 2 0.0013753115878290007 0.255555\n",
      "MONDO:0054763 neurodegeneration with brain iron accumulation 7 0.0013753115878290007 0.255555\n",
      "MONDO:0032680 global developmental delay with or without impaired intellectual development 0.0013753115878290007 0.255555\n",
      "MONDO:0014895 developmental and epileptic encephalopathy, 40 0.0013753115878290007 0.255555\n",
      "MONDO:0032658 macrocephaly, acquired, with impaired intellectual development 0.0013753115878290007 0.255555\n",
      "MONDO:0014023 congenital muscular dystrophy with intellectual disability and severe epilepsy 0.001456153339750972 0.253203\n",
      "MONDO:0009377 hyperammonemia due to N-acetylglutamate synthase deficiency 0.001456153339750972 0.253203\n",
      "MONDO:0044204 Shwachman-Diamond syndrome 1 0.001456153339750972 0.253203\n",
      "MONDO:0024264 hypothyroidism, congenital, nongoitrous, 2 0.001456153339750972 0.253203\n",
      "MONDO:0014356 mitochondrial complex III deficiency nuclear type 7 0.001456153339750972 0.253203\n",
      "MONDO:0007999 holoprosencephaly 2 0.001456153339750972 0.253203\n",
      "MONDO:0012211 MPDU1-congenital disorder of glycosylation 0.001456153339750972 0.253203\n",
      "MONDO:0044318 intellectual developmental disorder with gastrointestinal difficulties and high pain threshold 0.001456153339750972 0.253203\n",
      "MONDO:0013306 combined oxidative phosphorylation defect type 7 0.001456153339750972 0.253203\n",
      "MONDO:0011829 coenzyme Q10 deficiency, primary, 1 0.001456153339750972 0.253203\n",
      "MONDO:0012240 congenital myopathy 23 0.001456153339750972 0.253203\n",
      "MONDO:0009723 Leigh syndrome 0.001456153339750972 0.253203\n",
      "MONDO:0008799 anophthalmia/microphthalmia-esophageal atresia syndrome 0.001456153339750972 0.253203\n",
      "MONDO:0013870 TMEM165-congenital disorder of glycosylation 0.001456153339750972 0.253203\n",
      "MONDO:0014499 intellectual disability, autosomal recessive 46 0.001456153339750972 0.253203\n",
      "MONDO:0859575 Atelis syndrome 1 0.001456153339750972 0.253203\n",
      "MONDO:0032866 cortical dysplasia, complex, with other brain malformations 10 0.001456153339750972 0.253203\n",
      "MONDO:0859142 Hiatt-Neu-Cooper neurodevelopmental syndrome 0.001456153339750972 0.253203\n",
      "MONDO:0010667 Prieto syndrome 0.001456153339750972 0.253203\n",
      "MONDO:0032786 Noonan syndrome 11 0.001456153339750972 0.253203\n",
      "MONDO:0012393 congenital brain dysgenesis due to glutamine synthetase deficiency 0.001456153339750972 0.253203\n",
      "MONDO:0009073 Ritscher-Schinzel syndrome 1 0.001456153339750972 0.253203\n",
      "MONDO:0013178 congenital muscular dystrophy due to LMNA mutation 0.001456153339750972 0.253203\n",
      "MONDO:0010398 syndromic X-linked intellectual disability 14 0.001456153339750972 0.253203\n",
      "MONDO:0957217 cortical dysplasia, complex, with other brain malformations 12 0.001456153339750972 0.253203\n",
      "MONDO:0030979 endove syndrome, limb-brain type 0.001456153339750972 0.253203\n",
      "MONDO:0030977 neuronopathy, distal hereditary motor, autosomal recessive 7 0.001456153339750972 0.253203\n",
      "MONDO:0013005 EAST syndrome 0.001456153339750972 0.253203\n",
      "MONDO:0958181 mitochondrial trifunctional protein deficiency 1 0.001456153339750972 0.253203\n",
      "MONDO:0010079 Canavan disease 0.001456153339750972 0.253203\n",
      "MONDO:0008922 Sengers syndrome 0.001456153339750972 0.253203\n",
      "MONDO:0010298 Lesch-Nyhan syndrome 0.001456153339750972 0.253203\n",
      "MONDO:0009705 carnitine palmitoyl transferase 1A deficiency 0.001456153339750972 0.253203\n",
      "MONDO:0030910 intellectual disability, autosomal dominant 45 0.001456153339750972 0.253203\n",
      "MONDO:0859569 braddock-carey syndrome 1 0.001456153339750972 0.253203\n",
      "MONDO:0008862 3-methylcrotonyl-CoA carboxylase 2 deficiency 0.001456153339750972 0.253203\n",
      "MONDO:0009502 pyruvate dehydrogenase E2 deficiency 0.001456153339750972 0.253203\n",
      "MONDO:0010814 chondrodysplasia-pseudohermaphroditism syndrome 0.001456153339750972 0.253203\n",
      "MONDO:0060629 neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive 0.001456153339750972 0.253203\n",
      "MONDO:0029131 peripheral neuropathy, autosomal recessive, with or without impaired intellectual development 0.001456153339750972 0.253203\n",
      "MONDO:0011240 megalencephaly-capillary malformation-polymicrogyria syndrome 0.001456153339750972 0.253203\n",
      "MONDO:0012582 interstitial lung disease due to ABCA3 deficiency 0.0015369885472835136 0.250991\n",
      "MONDO:0014213 intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome 0.0015369885472835136 0.250991\n",
      "MONDO:0010395 phosphoribosylpyrophosphate synthetase superactivity 0.0015369885472835136 0.250991\n",
      "MONDO:0044306 neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination 0.0015369885472835136 0.250991\n",
      "MONDO:0009959 peroxisome biogenesis disorder type 3B 0.0015369885472835136 0.250991\n",
      "MONDO:0013350 mitochondrial DNA depletion syndrome 4b 0.0015369885472835136 0.250991\n",
      "MONDO:0014896 congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome 0.0015369885472835136 0.250991\n",
      "MONDO:0012783 RFT1-congenital disorder of glycosylation 0.0015369885472835136 0.250991\n",
      "MONDO:0024557 ataxia-telangiectasia-like disorder 1 0.0015369885472835136 0.250991\n",
      "MONDO:0014731 seizures-scoliosis-macrocephaly syndrome 0.0015369885472835136 0.250991\n",
      "MONDO:0014185 chromosome 3q13.31 deletion syndrome 0.0015369885472835136 0.250991\n",
      "MONDO:0010679 Duchenne muscular dystrophy 0.0015369885472835136 0.250991\n",
      "MONDO:0060627 glycosylphosphatidylinositol biosynthesis defect 15 0.0015369885472835136 0.250991\n",
      "MONDO:0054654 combined oxidative phosphorylation deficiency 32 0.0015369885472835136 0.250991\n",
      "MONDO:0011873 Niemann-Pick disease, type C2 0.0015369885472835136 0.250991\n",
      "MONDO:0020775 congenital disorder of glycosylation with defective fucosylation 1 0.0015369885472835136 0.250991\n",
      "MONDO:0859243 neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities 0.0015369885472835136 0.250991\n",
      "MONDO:0859356 congenital disorder of glycosylation, type IIy 0.0015369885472835136 0.250991\n",
      "MONDO:0014672 osteogenesis imperfecta type 17 0.0015369885472835136 0.250991\n",
      "MONDO:0018274 GM3 synthase deficiency 0.0015369885472835136 0.250991\n",
      "MONDO:0032661 neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia 0.0015369885472835136 0.250991\n",
      "MONDO:0859202 developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities 0.0015369885472835136 0.250991\n",
      "MONDO:0032675 myasthenic syndrome, congenital, 25, presynaptic 0.0015369885472835136 0.250991\n",
      "MONDO:0859206 neurodevelopmental disorder with hearing loss and spasticity 0.0015369885472835136 0.250991\n",
      "MONDO:0056797 neurodevelopmental disorder with midbrain and hindbrain malformations 0.0015369885472835136 0.250991\n",
      "MONDO:0013594 spinocerebellar ataxia type 36 0.0015369885472835136 0.250991\n",
      "MONDO:0009281 glutaryl-CoA dehydrogenase deficiency 0.0015369885472835136 0.250991\n",
      "MONDO:0060490 neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies 0.0015369885472835136 0.250991\n",
      "MONDO:0011969 ALG8-congenital disorder of glycosylation 0.0015369885472835136 0.250991\n",
      "MONDO:0013787 psychomotor retardation, epilepsy, and craniofacial dysmorphism 0.0015369885472835136 0.250991\n",
      "MONDO:0013835 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 0.0015369885472835136 0.250991\n",
      "MONDO:0957288 intellectual developmental disorder, autosomal recessive 79 0.0015369885472835136 0.250991\n",
      "MONDO:0014732 hypomyelinating leukodystrophy 12 0.0015369885472835136 0.250991\n",
      "MONDO:0014335 diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome 0.0015369885472835136 0.250991\n",
      "MONDO:0008943 autosomal recessive spinocerebellar ataxia 2 0.0015369885472835136 0.250991\n",
      "MONDO:0010774 striatonigral degeneration, infantile, mitochondrial 0.0015369885472835136 0.250991\n",
      "MONDO:0020765 neuropathy, congenital hypomyelinating, 2 0.0016178172109564157 0.248904\n",
      "MONDO:0009499 Krabbe disease 0.0016178172109564157 0.248904\n",
      "MONDO:0009653 mucolipidosis type IV 0.0016178172109564157 0.248904\n",
      "MONDO:0020714 mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy 0.0016178172109564157 0.248904\n",
      "MONDO:0009567 Marinesco-Sjogren syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0009260 GM1 gangliosidosis type 1 0.0016178172109564157 0.248904\n",
      "MONDO:0032753 spastic ataxia 9, autosomal recessive 0.0016178172109564157 0.248904\n",
      "MONDO:0010848 spinocerebellar ataxia type 5 0.0016178172109564157 0.248904\n",
      "MONDO:0957218 neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities 0.0016178172109564157 0.248904\n",
      "MONDO:0014663 Silver-Russell syndrome 3 0.0016178172109564157 0.248904\n",
      "MONDO:0032784 neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements 0.0016178172109564157 0.248904\n",
      "MONDO:0012812 developmental and epileptic encephalopathy, 4 0.0016178172109564157 0.248904\n",
      "MONDO:0030897 Lessel-Kreienkamp syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0100186 GTP cyclohydrolase I deficiency with hyperphenylalaninemia 0.0016178172109564157 0.248904\n",
      "MONDO:0032778 arthrogryposis multiplex congenita 3, myogenic type 0.0016178172109564157 0.248904\n",
      "MONDO:0014503 autosomal recessive spinocerebellar ataxia 17 0.0016178172109564157 0.248904\n",
      "MONDO:0014698 microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0100255 adenosine kinase deficiency 0.0016178172109564157 0.248904\n",
      "MONDO:0014958 Harel-Yoon syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0009757 Niemann-Pick disease, type C1 0.0016178172109564157 0.248904\n",
      "MONDO:0014981 immunodeficiency 49 0.0016178172109564157 0.248904\n",
      "MONDO:0859337 combined oxidative phosphorylation deficiency 57 0.0016178172109564157 0.248904\n",
      "MONDO:0012301 mitochondrial DNA depletion syndrome, myopathic form 0.0016178172109564157 0.248904\n",
      "MONDO:0032702 Coffin-Siris syndrome 8 0.0016178172109564157 0.248904\n",
      "MONDO:0009712 congenital multicore myopathy with external ophthalmoplegia 0.0016178172109564157 0.248904\n",
      "MONDO:0800103 COACH syndrome 1 0.0016178172109564157 0.248904\n",
      "MONDO:0012516 mandibulofacial dysostosis-microcephaly syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0014907 short-rib thoracic dysplasia 15 with polydactyly 0.0016986393312994233 0.246931\n",
      "MONDO:0013675 multiple mitochondrial dysfunctions syndrome 2 0.0016986393312994233 0.246931\n",
      "MONDO:0957211 neurodegeneration and seizures due to copper transport defect 0.0016986393312994233 0.246931\n",
      "MONDO:0060761 neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum 0.0016986393312994233 0.246931\n",
      "MONDO:0100478 brain malformations with or without urinary tract defects 0.0016986393312994233 0.246931\n",
      "MONDO:0008822 arthrogryposis, renal dysfunction, and cholestasis 1 0.0016986393312994233 0.246931\n",
      "MONDO:0008723 very long chain acyl-CoA dehydrogenase deficiency 0.0016986393312994233 0.246931\n",
      "MONDO:0014144 autosomal recessive limb-girdle muscular dystrophy type R18 0.0016986393312994233 0.246931\n",
      "MONDO:0014553 Tenorio syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0060763 intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities 0.0016986393312994233 0.246931\n",
      "MONDO:0054636 Skraban-Deardorff syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0014708 ring chromosome 14 0.0016986393312994233 0.246931\n",
      "MONDO:0014946 Sifrim-Hitz-Weiss syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0011281 congenital myasthenic syndrome 5 0.0016986393312994233 0.246931\n",
      "MONDO:0007298 spinocerebellar ataxia type 29 0.0016986393312994233 0.246931\n",
      "MONDO:0011629 MOGS-congenital disorder of glycosylation 0.0016986393312994233 0.246931\n",
      "MONDO:0859304 neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction 0.0016986393312994233 0.246931\n",
      "MONDO:0013048 hereditary spastic paraplegia 50 0.0016986393312994233 0.246931\n",
      "MONDO:0013801 developmental and epileptic encephalopathy, 13 0.0016986393312994233 0.246931\n",
      "MONDO:0013754 cutis laxa, autosomal recessive, type 1B 0.0016986393312994233 0.246931\n",
      "MONDO:0013937 peroxisome biogenesis disorder 6B 0.0016986393312994233 0.246931\n",
      "MONDO:0020507 leukoencephalopathy with vanishing white matter 1 0.0016986393312994233 0.246931\n",
      "MONDO:0014016 hereditary spastic paraplegia 49 0.0016986393312994233 0.246931\n",
      "MONDO:0012611 polyhydramnios, megalencephaly, and symptomatic epilepsy 0.0016986393312994233 0.246931\n",
      "MONDO:0030423 congenital disorder of glycosylation, type 2v 0.0016986393312994233 0.246931\n",
      "MONDO:0011038 cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0009706 hereditary myopathy with lactic acidosis due to ISCU deficiency 0.0016986393312994233 0.246931\n",
      "MONDO:0014567 glutamate pyruvate transaminase 2 deficiency 0.0016986393312994233 0.246931\n",
      "MONDO:0013053 microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type 0.0016986393312994233 0.246931\n",
      "MONDO:0012157 congenital myasthenic syndrome 4C 0.0016986393312994233 0.246931\n",
      "MONDO:0009590 metachromatic leukodystrophy due to saposin B deficiency 0.0016986393312994233 0.246931\n",
      "MONDO:0024554 D-2-hydroxyglutaric aciduria 1 0.0016986393312994233 0.246931\n",
      "MONDO:0010027 free sialic acid storage disease, infantile form 0.0016986393312994233 0.246931\n",
      "MONDO:0014219 alacrima, achalasia, and intellectual disability syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0032775 neurodevelopmental disorder with seizures and speech and walking impairment 0.0016986393312994233 0.246931\n",
      "MONDO:0010268 X-linked lissencephaly with abnormal genitalia 0.0016986393312994233 0.246931\n",
      "MONDO:0054591 Stankiewicz-Isidor syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0009394 juvenile Paget disease 0.0016986393312994233 0.246931\n",
      "MONDO:0014725 spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0014320 Bosch-Boonstra-Schaaf optic atrophy syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0020632 epileptic encephalopathy, infantile or early childhood, 3 0.0016986393312994233 0.246931\n",
      "MONDO:0014035 severe intellectual disability-progressive spastic diplegia syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0859327 developmental and epileptic encephalopathy 110 0.0016986393312994233 0.246931\n",
      "MONDO:0013635 Adams-Oliver syndrome 2 0.0016986393312994233 0.246931\n",
      "MONDO:0032611 mitochondrial complex 1 deficiency, nuclear type 6 0.0016986393312994233 0.246931\n",
      "MONDO:0009867 lethal congenital glycogen storage disease of heart 0.0017794549088422389 0.245058\n",
      "MONDO:0012519 Rubinstein-Taybi syndrome due to 16p13.3 microdeletion 0.0017794549088422389 0.245058\n",
      "MONDO:0014017 intellectual developmental disorder with autism and macrocephaly 0.0017794549088422389 0.245058\n",
      "MONDO:0013986 combined oxidative phosphorylation defect type 14 0.0017794549088422389 0.245058\n",
      "MONDO:0012538 nemaline myopathy 7 0.0017794549088422389 0.245058\n",
      "MONDO:0859520 Mitochondrial complex IV deficiency, nuclear type 23 0.0017794549088422389 0.245058\n",
      "MONDO:0014573 Cole-Carpenter syndrome 2 0.0017794549088422389 0.245058\n",
      "MONDO:0009470 Baraitser-Winter syndrome 1 0.0017794549088422389 0.245058\n",
      "MONDO:0009070 D-glyceric aciduria 0.0017794549088422389 0.245058\n",
      "MONDO:0859197 intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies 0.0017794549088422389 0.245058\n",
      "MONDO:0013885 Malan overgrowth syndrome 0.0017794549088422389 0.245058\n",
      "MONDO:0010499 Ritscher-Schinzel syndrome 2 0.0017794549088422389 0.245058\n",
      "MONDO:0859171 Luo-Schoch-Yamamoto syndrome 0.0017794549088422389 0.245058\n",
      "MONDO:0015022 intellectual developmental disorder with dysmorphic facies and ptosis 0.0017794549088422389 0.245058\n",
      "MONDO:0010537 Borjeson-Forssman-Lehmann syndrome 0.0017794549088422389 0.245058\n",
      "MONDO:0012718 hypotonia with lactic acidemia and hyperammonemia 0.0017794549088422389 0.245058\n",
      "MONDO:0009033 temtamy syndrome 0.0017794549088422389 0.245058\n",
      "MONDO:0859350 neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies 0.0017794549088422389 0.245058\n",
      "MONDO:0859252 neurodevelopmental disorder with poor growth and skeletal anomalies 0.0017794549088422389 0.245058\n",
      "MONDO:0859198 short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies 0.0017794549088422389 0.245058\n",
      "MONDO:0013655 intellectual disability, autosomal dominant 8 0.0017794549088422389 0.245058\n",
      "MONDO:0859332 cortical dysplasia, complex, with other brain malformations 11 0.0017794549088422389 0.245058\n",
      "MONDO:0012156 myasthenic syndrome, congenital, 1B, fast-channel 0.0017794549088422389 0.245058\n",
      "MONDO:0030974 mitochondrial complex 2 deficiency, nuclear type 4 0.0017794549088422389 0.245058\n",
      "MONDO:0030035 leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome 0.0017794549088422389 0.245058\n",
      "MONDO:0012078 Joubert syndrome 3 0.0017794549088422389 0.245058\n",
      "MONDO:0014318 hyperphosphatasia with intellectual disability syndrome 4 0.0017794549088422389 0.245058\n",
      "MONDO:0013546 mitochondrial complex V (ATP synthase) deficiency nuclear type 2 0.0017794549088422389 0.245058\n",
      "MONDO:0013881 pidermolysis bullosa, junctional 7, with interstitial lung disease and nephrotic syndrome 0.0017794549088422389 0.245058\n",
      "MONDO:0030969 intellectual developmental disorder, autosomal dominant 68 0.0017794549088422389 0.245058\n",
      "MONDO:0060640 neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy 0.0017794549088422389 0.245058\n",
      "MONDO:0010183 methylmalonic aciduria and homocystinuria type cblF 0.0017794549088422389 0.245058\n",
      "MONDO:0024542 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 0.0017794549088422389 0.245058\n",
      "MONDO:0013552 hereditary spastic paraplegia 52 0.0017794549088422389 0.245058\n",
      "MONDO:0035819 cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome 0.0017794549088422389 0.245058\n",
      "MONDO:0009820 osteoporosis-pseudoglioma syndrome 0.0017794549088422389 0.245058\n",
      "MONDO:0013805 intellectual disability, autosomal dominant 13 0.0017794549088422389 0.245058\n",
      "MONDO:0012055 Larsen-like osseous dysplasia-short stature syndrome 0.0017794549088422389 0.245058\n",
      "MONDO:0009744 neuronal ceroid lipofuscinosis 1 0.0017794549088422389 0.245058\n",
      "MONDO:0011242 Bartter disease type 4A 0.0017794549088422389 0.245058\n",
      "MONDO:0007525 Ehlers-Danlos syndrome, arthrochalasis type 0.0017794549088422389 0.245058\n",
      "MONDO:0859155 chromosome 1p36 deletion syndrome, proximal 0.0017794549088422389 0.245058\n",
      "MONDO:0009591 metachromatic leukodystrophy, juvenile form 0.0017794549088422389 0.245058\n",
      "MONDO:0009131 Riley-Day syndrome 0.0017794549088422389 0.245058\n",
      "MONDO:0013761 childhood encephalopathy due to thiamine pyrophosphokinase deficiency 0.0017794549088422389 0.245058\n",
      "MONDO:0859293 neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment 0.0017794549088422389 0.245058\n",
      "MONDO:0014132 multiple mitochondrial dysfunctions syndrome 3 0.001860263944114525 0.243279\n",
      "MONDO:0010060 mitochondrial DNA depletion syndrome 7 (hepatocerebral type) 0.001860263944114525 0.243279\n",
      "MONDO:0026723 intellectual developmental disorder, X-linked 108 0.001860263944114525 0.243279\n",
      "MONDO:0030957 developmental and epileptic encephalopathy 103 0.001860263944114525 0.243279\n",
      "MONDO:0014289 macrocephaly-developmental delay syndrome 0.001860263944114525 0.243279\n",
      "MONDO:0011049 Fine-Lubinsky syndrome 0.001860263944114525 0.243279\n",
      "MONDO:0859531 neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures 0.001860263944114525 0.243279\n",
      "MONDO:0013925 methylmalonic acidemia with homocystinuria, type cblJ 0.001860263944114525 0.243279\n",
      "MONDO:0032606 mitochondrial complex 1 deficiency, nuclear type 2 0.001860263944114525 0.243279\n",
      "MONDO:0033372 developmental and epileptic encephalopathy, 63 0.001860263944114525 0.243279\n",
      "MONDO:0011537 macrocephaly-autism syndrome 0.001860263944114525 0.243279\n",
      "MONDO:0014114 cardiofaciocutaneous syndrome 4 0.001860263944114525 0.243279\n",
      "MONDO:0032650 neurodegeneration, childhood-onset, with cerebellar atrophy 0.001860263944114525 0.243279\n",
      "MONDO:0010083 succinic semialdehyde dehydrogenase deficiency 0.001860263944114525 0.243279\n",
      "MONDO:0014745 congenital myasthenic syndrome 19 0.001860263944114525 0.243279\n",
      "MONDO:0009583 blepharophimosis - intellectual disability syndrome, Ohdo type 0.001860263944114525 0.243279\n",
      "MONDO:0060664 neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities 0.001860263944114525 0.243279\n",
      "MONDO:0013882 hyperphosphatasia with intellectual disability syndrome 2 0.001860263944114525 0.243279\n",
      "MONDO:0859375 developmental delay with hypotonia, myopathy, and brain abnormalities 0.001860263944114525 0.243279\n",
      "MONDO:0015005 epilepsy, early-onset, vitamin B6-dependent 0.001860263944114525 0.243279\n",
      "MONDO:0010496 X-linked intellectual disability-short stature-overweight syndrome 0.001860263944114525 0.243279\n",
      "MONDO:0014949 developmental and epileptic encephalopathy, 47 0.001860263944114525 0.243279\n",
      "MONDO:0020738 multiple benign circumferential skin creases on limbs 1 0.001860263944114525 0.243279\n",
      "MONDO:0032578 cortical dysplasia, complex, with other brain malformations 9 0.001860263944114525 0.243279\n",
      "MONDO:0012735 Temple-Baraitser syndrome 0.001860263944114525 0.243279\n",
      "MONDO:0012184 Pierson syndrome 0.001860263944114525 0.243279\n",
      "MONDO:0012890 pontocerebellar hypoplasia type 2B 0.001860263944114525 0.243279\n",
      "MONDO:0957531 neurodevelopmental disorder with microcephaly and movement abnormalities 0.001860263944114525 0.243279\n",
      "MONDO:0859230 Kury-Isidor syndrome 0.001860263944114525 0.243279\n",
      "MONDO:0030458 Charcot-Marie-Tooth disease, axonal, Type 2HH 0.0019410664376458965 0.241583\n",
      "MONDO:0009109 lysinuric protein intolerance 0.0019410664376458965 0.241583\n",
      "MONDO:0009974 familial hemophagocytic lymphohistiocytosis type 1 0.0019410664376458965 0.241583\n",
      "MONDO:0013889 short stature-optic atrophy-Pelger-HuC+t anomaly syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0020495 PEHO-like syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0031481 microcephaly, epilepsy, and diabetes syndrome 1 0.0019410664376458965 0.241583\n",
      "MONDO:0014353 immunodeficiency 23 0.0019410664376458965 0.241583\n",
      "MONDO:0030953 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 0.0019410664376458965 0.241583\n",
      "MONDO:0008644 velocardiofacial syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0009021 Toriello-Carey syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0008608 Down syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0012929 Compton-North congenital myopathy 0.0019410664376458965 0.241583\n",
      "MONDO:0010396 developmental and epileptic encephalopathy, 2 0.0019410664376458965 0.241583\n",
      "MONDO:0013952 peroxisome biogenesis disorder 13A (Zellweger) 0.0019410664376458965 0.241583\n",
      "MONDO:0010822 Warburg micro syndrome 1 0.0019410664376458965 0.241583\n",
      "MONDO:0014706 cutis laxa, autosomal dominant 3 0.0019410664376458965 0.241583\n",
      "MONDO:0024457 neurodegeneration with brain iron accumulation 2A 0.0019410664376458965 0.241583\n",
      "MONDO:0044723 3-methylglutaconic aciduria type 8 0.0019410664376458965 0.241583\n",
      "MONDO:0009636 mitochondrial DNA depletion syndrome 3 (hepatocerebral type) 0.0019410664376458965 0.241583\n",
      "MONDO:0024464 pituitary hormone deficiency, combined, 1 0.0019410664376458965 0.241583\n",
      "MONDO:0032921 neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation 0.0019410664376458965 0.241583\n",
      "MONDO:0013171 purine nucleoside phosphorylase deficiency 0.0019410664376458965 0.241583\n",
      "MONDO:0859224 intellectual disability and myopathy syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0014911 growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy 0.0019410664376458965 0.241583\n",
      "MONDO:0032790 neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities 0.0019410664376458965 0.241583\n",
      "MONDO:0011010 Matthew-Wood syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0010607 heterotaxy, visceral, 1, X-linked 0.0020218623899659256 0.239964\n",
      "MONDO:0030893 leukoencephalopathy, progressive, infantile-onset, with or without deafness 0.0020218623899659256 0.239964\n",
      "MONDO:0030717 immunodeficiency 97 with autoinflammation 0.0020218623899659256 0.239964\n",
      "MONDO:0030729 Tessadori-van Haaften neurodevelopmental syndrome 1 0.0020218623899659256 0.239964\n",
      "MONDO:0060707 Ververi-Brady syndrome 0.0020218623899659256 0.239964\n",
      "MONDO:0015025 developmental and epileptic encephalopathy, 51 0.0020218623899659256 0.239964\n",
      "MONDO:0009919 peroxisomal acyl-CoA oxidase deficiency 0.0020218623899659256 0.239964\n",
      "MONDO:0014382 Tatton-Brown-Rahman overgrowth syndrome 0.0020218623899659256 0.239964\n",
      "MONDO:0014541 motor developmental delay due to 14q32.2 paternally expressed gene defect 0.0020218623899659256 0.239964\n",
      "MONDO:0030268 developmental and epileptic encephalopathy 6B 0.0020218623899659256 0.239964\n",
      "MONDO:0034109 congenital myopathy with reduced type 2 muscle fibers 0.0020218623899659256 0.239964\n",
      "MONDO:0007800 chromosome 18p deletion syndrome 0.0020218623899659256 0.239964\n",
      "MONDO:0032679 combined oxidative phosphorylation deficiency 37 0.0020218623899659256 0.239964\n",
      "MONDO:0010006 Sandhoff disease 0.0020218623899659256 0.239964\n",
      "MONDO:0859331 Rabin-Pappas syndrome 0.0020218623899659256 0.239964\n",
      "MONDO:0013745 Joubert syndrome 14 0.0020218623899659256 0.239964\n",
      "MONDO:0012593 brain-lung-thyroid syndrome 0.0020218623899659256 0.239964\n",
      "MONDO:0011669 hypotonia-cystinuria syndrome 0.0020218623899659256 0.239964\n",
      "MONDO:0859137 neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia 0.0020218623899659256 0.239964\n",
      "MONDO:0020789 pseudo-TORCH syndrome 1 0.0020218623899659256 0.239964\n",
      "MONDO:0032698 neurodevelopmental disorder with central and peripheral motor dysfunction 0.0020218623899659256 0.239964\n",
      "MONDO:0009738 sialidosis type 2 0.0020218623899659256 0.239964\n",
      "MONDO:0015003 dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 0.0020218623899659256 0.239964\n",
      "MONDO:0014915 short-rib thoracic dysplasia 16 with or without polydactyly 0.0021026518016041464 0.238416\n",
      "MONDO:0010717 pyruvate dehydrogenase E1-alpha deficiency 0.0021026518016041464 0.238416\n",
      "MONDO:0014736 Charcot-Marie-Tooth disease axonal type 2Z 0.0021026518016041464 0.238416\n",
      "MONDO:0013646 chromosome 8q21.11 deletion syndrome 0.0021026518016041464 0.238416\n",
      "MONDO:0859163 Faundes-Banka syndrome 0.0021026518016041464 0.238416\n",
      "MONDO:0014357 intellectual disability, autosomal dominant 24 0.0021026518016041464 0.238416\n",
      "MONDO:0013320 chromosome 16p12.2-p11.2 deletion syndrome 0.0021026518016041464 0.238416\n",
      "MONDO:0044724 3-methylglutaconic aciduria type 9 0.0021026518016041464 0.238416\n",
      "MONDO:0014605 microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome 0.0021026518016041464 0.238416\n",
      "MONDO:0011271 rigid spine muscular dystrophy 1 0.0021026518016041464 0.238416\n",
      "MONDO:0013951 peroxisome biogenesis disorder 12A (Zellweger) 0.0021026518016041464 0.238416\n",
      "MONDO:0032714 facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome 0.0021026518016041464 0.238416\n",
      "MONDO:0013641 Warburg micro syndrome 2 0.0021026518016041464 0.238416\n",
      "MONDO:0009480 Joubert syndrome with oculorenal defect 0.0021026518016041464 0.238416\n",
      "MONDO:0035133 PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome 0.0021026518016041464 0.238416\n",
      "MONDO:0009564 Marden-Walker syndrome 0.0021026518016041464 0.238416\n",
      "MONDO:0013726 encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 0.0021026518016041464 0.238416\n",
      "MONDO:0031071 Diamond-Blackfan anemia 21 0.0021026518016041464 0.238416\n",
      "MONDO:0013357 chromosome 17q11.2 deletion syndrome, 1.4Mb 0.0021026518016041464 0.238416\n",
      "MONDO:0032610 mitochondrial complex 1 deficiency, nuclear type 5 0.0021026518016041464 0.238416\n",
      "MONDO:0859232 neurodevelopmental disorder with central hypotonia and dysmorphic facies 0.0021026518016041464 0.238416\n",
      "MONDO:0014995 neurodevelopmental disorder with hypotonia, seizures, and absent language 0.0021026518016041464 0.238416\n",
      "MONDO:0013971 leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome 0.0021026518016041464 0.238416\n",
      "MONDO:0859325 developmental and epileptic encephalopathy 109 0.0021026518016041464 0.238416\n",
      "MONDO:0010504 immunodeficiency 47 0.0021026518016041464 0.238416\n",
      "MONDO:0032890 neuromuscular disease and ocular or auditory anomalies with or without seizures 0.002183434673090045 0.236933\n",
      "MONDO:0010478 SLC35A2-congenital disorder of glycosylation 0.002183434673090045 0.236933\n",
      "MONDO:0020630 epileptic encephalopathy, infantile or early childhood, 1 0.002183434673090045 0.236933\n",
      "MONDO:0011157 Gomez-Lopez-Hernandez syndrome 0.002183434673090045 0.236933\n",
      "MONDO:0030913 intellectual disability, autosomal dominant 48 0.002183434673090045 0.236933\n",
      "MONDO:0020781 encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 0.002183434673090045 0.236933\n",
      "MONDO:0054560 anauxetic dysplasia 1 0.002183434673090045 0.236933\n",
      "MONDO:0030770 congenital disorder of deglycosylation 2 0.002183434673090045 0.236933\n",
      "MONDO:0010428 chromosome Xp11.23-p11.22 duplication syndrome 0.002183434673090045 0.236933\n",
      "MONDO:0014371 developmental and epileptic encephalopathy, 23 0.002183434673090045 0.236933\n",
      "MONDO:0030992 short stature, oligodontia, dysmorphic facies, and motor delay 0.002183434673090045 0.236933\n",
      "MONDO:0013821 intellectual disability, autosomal dominant 16 0.002183434673090045 0.236933\n",
      "MONDO:0010711 TARP syndrome 0.002183434673090045 0.236933\n",
      "MONDO:0011730 fumaric aciduria 0.002183434673090045 0.236933\n",
      "MONDO:0014643 congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome 0.002183434673090045 0.236933\n",
      "MONDO:0012512 fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 0.002183434673090045 0.236933\n",
      "MONDO:0030356 short-rib thoracic dysplasia 21 without polydactyly 0.002183434673090045 0.236933\n",
      "MONDO:0024553 myopathy, lactic acidosis, and sideroblastic anemia 1 0.002183434673090045 0.236933\n",
      "MONDO:0859081 chromosome Xq13 duplication syndrome 0.002183434673090045 0.236933\n",
      "MONDO:0100297 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 0.002183434673090045 0.236933\n",
      "MONDO:0007113 Angelman syndrome 0.002183434673090045 0.236933\n",
      "MONDO:0015601 X-linked intellectual disability, van Esch type 0.002183434673090045 0.236933\n",
      "MONDO:0014547 combined oxidative phosphorylation defect type 24 0.002183434673090045 0.236933\n",
      "MONDO:0010865 pseudoaminopterin syndrome 0.002183434673090045 0.236933\n",
      "MONDO:0014464 progressive encephalopathy with leukodystrophy due to DECR deficiency 0.002183434673090045 0.236933\n",
      "MONDO:0013968 PGM1-congenital disorder of glycosylation 0.002183434673090045 0.236933\n",
      "MONDO:0009664 mulibrey nanism 0.002183434673090045 0.236933\n",
      "MONDO:0014728 combined oxidative phosphorylation defect type 27 0.002183434673090045 0.236933\n",
      "MONDO:0009722 Bailey-Bloch congenital myopathy 0.002183434673090045 0.236933\n",
      "MONDO:0032817 neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies 0.0022642110049530696 0.235509\n",
      "MONDO:0012342 7q11.23 microduplication syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0013735 microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0014298 chromosome 5q12 deletion syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0859370 respiratory infections, recurrent, and failure to thrive with or without diarrhea 0.0022642110049530696 0.235509\n",
      "MONDO:0018163 autosomal recessive cutis laxa type 2A 0.0022642110049530696 0.235509\n",
      "MONDO:0009756 Niemann-Pick disease type A 0.0022642110049530696 0.235509\n",
      "MONDO:0013266 intellectual disability, autosomal dominant 20 0.0022642110049530696 0.235509\n",
      "MONDO:0054845 developmental and epileptic encephalopathy, 66 0.0022642110049530696 0.235509\n",
      "MONDO:0013659 microcephaly-capillary malformation syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0012280 Goldberg-Shprintzen megacolon syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0033007 Galloway-Mowat syndrome 3 0.0022642110049530696 0.235509\n",
      "MONDO:0014556 congenital contractures of the limbs and face, hypotonia, and developmental delay 0.0022642110049530696 0.235509\n",
      "MONDO:0010879 CODAS syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0030533 intellectual developmental disorder, autosomal recessive 73 0.0022642110049530696 0.235509\n",
      "MONDO:0859347 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities 0.0022642110049530696 0.235509\n",
      "MONDO:0014139 Ehlers-Danlos syndrome, spondylodysplastic type, 2 0.0022642110049530696 0.235509\n",
      "MONDO:0011337 familial hemophagocytic lymphohistiocytosis 2 0.0022642110049530696 0.235509\n",
      "MONDO:0014198 mitochondrial DNA depletion syndrome 13 0.0022642110049530696 0.235509\n",
      "MONDO:0031000 Tessadori-Van Haaften neurodevelopmental syndrome 4 0.0022642110049530696 0.235509\n",
      "MONDO:0032677 lissencephaly 9 with complex brainstem malformation 0.0022642110049530696 0.235509\n",
      "MONDO:0013169 chromosome 5p13 duplication syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0013299 chromosome 6q11-q14 deletion syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0010568 Aicardi syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0013820 intellectual disability, autosomal dominant 15 0.0022642110049530696 0.235509\n",
      "MONDO:0859241 neurodegeneration, childhood-onset, with progressive microcephaly 0.0022642110049530696 0.235509\n",
      "MONDO:0859515 congenital myopathy 10b, mild variant 0.0022642110049530696 0.235509\n",
      "MONDO:0013115 RIN2 syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0032864 intellectual developmental disorder with speech delay, autism, and dysmorphic facies 0.0022642110049530696 0.235509\n",
      "MONDO:0009112 rhizomelic chondrodysplasia punctata type 2 0.0022642110049530696 0.235509\n",
      "MONDO:0007987 Kniest dysplasia 0.002344980797722621 0.234142\n",
      "MONDO:0014658 severe achondroplasia-developmental delay-acanthosis nigricans syndrome 0.002344980797722621 0.234142\n",
      "MONDO:0100325 odontochondrodysplasia 1 0.002344980797722621 0.234142\n",
      "MONDO:0010278 Christianson syndrome 0.002344980797722621 0.234142\n",
      "MONDO:0009333 mullerian derivatives-lymphangiectasia-polydactyly syndrome 0.002344980797722621 0.234142\n",
      "MONDO:0010176 orofaciodigital syndrome type 6 0.002344980797722621 0.234142\n",
      "MONDO:0009577 megalocornea-intellectual disability syndrome 0.002344980797722621 0.234142\n",
      "MONDO:0014671 neuropathy, hereditary motor and sensory, type 6B 0.002344980797722621 0.234142\n",
      "MONDO:0013579 methylmalonate semialdehyde dehydrogenase deficiency 0.002344980797722621 0.234142\n",
      "MONDO:0012613 intellectual disability, autosomal recessive 5 0.002344980797722621 0.234142\n",
      "MONDO:0010306 X-linked intellectual disability, Cabezas type 0.002344980797722621 0.234142\n",
      "MONDO:0013798 chromosome 16q22 deletion syndrome 0.002344980797722621 0.234142\n",
      "MONDO:0013628 hyperphosphatasia with intellectual disability syndrome 3 0.002344980797722621 0.234142\n",
      "MONDO:0009364 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 0.002344980797722621 0.234142\n",
      "MONDO:0011688 muscular dystrophy-dystroglycanopathy type B5 0.002344980797722621 0.234142\n",
      "MONDO:0007068 adenylosuccinate lyase deficiency 0.002344980797722621 0.234142\n",
      "MONDO:0859208 Hengel-Maroofian-Schols syndrome 0.002344980797722621 0.234142\n",
      "MONDO:0859283 neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 0.002344980797722621 0.234142\n",
      "MONDO:0859199 developmental delay with or without intellectual impairment or behavioral abnormalities 0.002344980797722621 0.234142\n",
      "MONDO:0032764 Khan-Khan-Katsanis syndrome 0.002344980797722621 0.234142\n",
      "MONDO:0012791 mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria 0.002344980797722621 0.234142\n",
      "MONDO:0859377 neurodevelopmental disorder with poor growth and behavioral abnormalities 0.002344980797722621 0.234142\n",
      "MONDO:0010810 vitamin D hydroxylation-deficient rickets, type 1B 0.002344980797722621 0.234142\n",
      "MONDO:0008365 recombinant 8 syndrome 0.002344980797722621 0.234142\n",
      "MONDO:0007790 Charcot-Marie-Tooth disease type 3 0.002344980797722621 0.234142\n",
      "MONDO:0054791 leukodystrophy, hypomyelinating, 16 0.002344980797722621 0.234142\n",
      "MONDO:0011963 Joubert syndrome 2 0.002344980797722621 0.234142\n",
      "MONDO:0032591 hyperparathyroidism, transient neonatal 0.002425744051928062 0.232826\n",
      "MONDO:0030914 Clark-Baraitser syndrome 0.002425744051928062 0.232826\n",
      "MONDO:0013582 mosaic variegated aneuploidy syndrome 2 0.002425744051928062 0.232826\n",
      "MONDO:0030934 intellectual developmental disorder, autosomal dominant 64 0.002425744051928062 0.232826\n",
      "MONDO:0010671 microphthalmia, syndromic 1 0.002425744051928062 0.232826\n",
      "MONDO:0014863 macrocephaly, dysmorphic facies, and psychomotor retardation 0.002425744051928062 0.232826\n",
      "MONDO:0032600 Snijders Blok-Campeau syndrome 0.002425744051928062 0.232826\n",
      "MONDO:0012869 intellectual disability, autosomal dominant 22 0.002425744051928062 0.232826\n",
      "MONDO:0008830 aspartylglucosaminuria 0.002425744051928062 0.232826\n",
      "MONDO:0008458 spinocerebellar ataxia type 2 0.002425744051928062 0.232826\n",
      "MONDO:0009290 glycogen storage disease II 0.002425744051928062 0.232826\n",
      "MONDO:0010184 methylmalonic aciduria and homocystinuria type cblC 0.002425744051928062 0.232826\n",
      "MONDO:0010465 Kabuki syndrome 2 0.002425744051928062 0.232826\n",
      "MONDO:0014963 Shashi-Pena syndrome 0.002425744051928062 0.232826\n",
      "MONDO:0020793 oculopharyngodistal myopathy 1 0.0025065007680987066 0.231558\n",
      "MONDO:0009520 3-hydroxy-3-methylglutaric aciduria 0.0025065007680987066 0.231558\n",
      "MONDO:0020485 King-Denborough syndrome 0.0025065007680987066 0.231558\n",
      "MONDO:0859200 cerebellar ataxia, brain abnormalities, and cardiac conduction defects 0.0025065007680987066 0.231558\n",
      "MONDO:0014722 Roifman syndrome 0.0025065007680987066 0.231558\n",
      "MONDO:0010574 syndromic X-linked intellectual disability 5 0.0025065007680987066 0.231558\n",
      "MONDO:0100111 focal segmental glomerulosclerosis and neurodevelopmental syndrome 0.0025065007680987066 0.231558\n",
      "MONDO:0010472 developmental and epileptic encephalopathy, 36 0.0025065007680987066 0.231558\n",
      "MONDO:0060621 neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy 0.0025065007680987066 0.231558\n",
      "MONDO:0033373 developmental and epileptic encephalopathy, 64 0.0025065007680987066 0.231558\n",
      "MONDO:0013839 hereditary sensory and autonomic neuropathy type 6 0.0025065007680987066 0.231558\n",
      "MONDO:0013894 short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome 0.0025065007680987066 0.231558\n",
      "MONDO:0011866 pontocerebellar hypoplasia type 1A 0.0025065007680987066 0.231558\n",
      "MONDO:0032697 neurodevelopmental disorder and language delay with or without structural brain abnormalities 0.0025065007680987066 0.231558\n",
      "MONDO:0009079 DOORS syndrome 0.0025065007680987066 0.231558\n",
      "MONDO:0859169 White-Kernohan syndrome 0.0025065007680987066 0.231558\n",
      "MONDO:0007412 Beare-Stevenson cutis gyrata syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0011945 Gaucher disease perinatal lethal 0.002587250946763825 0.230335\n",
      "MONDO:0014684 combined oxidative phosphorylation defect type 26 0.002587250946763825 0.230335\n",
      "MONDO:0030919 intellectual disability, autosomal dominant 53 0.002587250946763825 0.230335\n",
      "MONDO:0030999 neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism 0.002587250946763825 0.230335\n",
      "MONDO:0016862 Alagille syndrome due to a JAG1 point mutation 0.002587250946763825 0.230335\n",
      "MONDO:0957284 nemaline myopathy 5C, autosomal dominant 0.002587250946763825 0.230335\n",
      "MONDO:0009934 alveolar capillary dysplasia with misalignment of pulmonary veins 0.002587250946763825 0.230335\n",
      "MONDO:0008758 mitochondrial DNA depletion syndrome 4a 0.002587250946763825 0.230335\n",
      "MONDO:0014367 Aicardi-Goutieres syndrome 7 0.002587250946763825 0.230335\n",
      "MONDO:0015011 optic atrophy 11 0.002587250946763825 0.230335\n",
      "MONDO:0014699 intellectual disability, autosomal dominant 40 0.002587250946763825 0.230335\n",
      "MONDO:0032838 neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies 0.002587250946763825 0.230335\n",
      "MONDO:0014601 autosomal recessive spinocerebellar ataxia 20 0.002587250946763825 0.230335\n",
      "MONDO:0009393 ornithine translocase deficiency 0.002587250946763825 0.230335\n",
      "MONDO:0030922 intellectual disability, autosomal dominant 56 0.002587250946763825 0.230335\n",
      "MONDO:0008954 peroxisome biogenesis disorder 2A (Zellweger) 0.002587250946763825 0.230335\n",
      "MONDO:0010361 intellectual disability, X-linked 30 0.002587250946763825 0.230335\n",
      "MONDO:0014294 chromosome 15q11.2 deletion syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0957248 developmental and epileptic encephalopathy 31B 0.002587250946763825 0.230335\n",
      "MONDO:0008873 microcephalic osteodysplastic primordial dwarfism, type 3 0.002587250946763825 0.230335\n",
      "MONDO:0060624 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter 0.002587250946763825 0.230335\n",
      "MONDO:0008893 C syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0031007 spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosis 0.002587250946763825 0.230335\n",
      "MONDO:0013624 Rafiq syndrome 0.0026679945884526563 0.229154\n",
      "MONDO:0013245 syndromic multisystem autoimmune disease due to ITCH deficiency 0.0026679945884526563 0.229154\n",
      "MONDO:0032745 developmental delay with variable intellectual impairment and behavioral abnormalities 0.0026679945884526563 0.229154\n",
      "MONDO:0009431 hereditary hypophosphatemic rickets with hypercalciuria 0.0026679945884526563 0.229154\n",
      "MONDO:0013990 pontocerebellar hypoplasia type 8 0.0026679945884526563 0.229154\n",
      "MONDO:0008005 cardiospondylocarpofacial syndrome 0.0026679945884526563 0.229154\n",
      "MONDO:0007415 mitochondrial complex III deficiency nuclear type 1 0.0026679945884526563 0.229154\n",
      "MONDO:0032851 intellectual developmental disorder with impaired language and dysmorphic facies 0.0026679945884526563 0.229154\n",
      "MONDO:0009593 spondylometaphyseal dysplasia, Sedaghatian type 0.0026679945884526563 0.229154\n",
      "MONDO:0024535 Singleton-Merten syndrome 1 0.0026679945884526563 0.229154\n",
      "MONDO:0012683 pontocerebellar hypoplasia type 6 0.0026679945884526563 0.229154\n",
      "MONDO:0011335 spondyloepimetaphyseal dysplasia with multiple dislocations 0.0026679945884526563 0.229154\n",
      "MONDO:0013170 cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies 0.0026679945884526563 0.229154\n",
      "MONDO:0007537 lateral meningocele syndrome 0.0026679945884526563 0.229154\n",
      "MONDO:0859219 Rauch-Steindl syndrome 0.0026679945884526563 0.229154\n",
      "MONDO:0011432 blepharophimosis - intellectual disability syndrome, Verloes type 0.0026679945884526563 0.229154\n",
      "MONDO:0014165 multiple congenital anomalies-hypotonia-seizures syndrome 3 0.0026679945884526563 0.229154\n",
      "MONDO:0010498 MEND syndrome 0.0026679945884526563 0.229154\n",
      "MONDO:0009644 sulfite oxidase deficiency due to molybdenum cofactor deficiency type B 0.0026679945884526563 0.229154\n",
      "MONDO:0010512 intellectual disability, X-linked, syndromic, Bain type 0.0026679945884526563 0.229154\n",
      "MONDO:0014864 hypermanganesemia with dystonia 2 0.0027487316936943827 0.228013\n",
      "MONDO:0859228 combined oxidative phosphorylation deficiency 55 0.0027487316936943827 0.228013\n",
      "MONDO:0013819 intellectual disability, autosomal dominant 14 0.0027487316936943827 0.228013\n",
      "MONDO:0014893 Okur-Chung neurodevelopmental syndrome 0.0027487316936943827 0.228013\n",
      "MONDO:0016002 Ehlers-Danlos syndrome, kyphoscoliotic type 1 0.0027487316936943827 0.228013\n",
      "MONDO:0023657 intellectual developmental disorder, autosomal dominant 65 0.0027487316936943827 0.228013\n",
      "MONDO:0859516 neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum 0.0027487316936943827 0.228013\n",
      "MONDO:0020847 intellectual disability, autosomal dominant 58 0.0027487316936943827 0.228013\n",
      "MONDO:0011640 genitopatellar syndrome 0.0027487316936943827 0.228013\n",
      "MONDO:0859286 neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures 0.0027487316936943827 0.228013\n",
      "MONDO:0054831 Coffin-Siris syndrome 7 0.0027487316936943827 0.228013\n",
      "MONDO:0030047 microcephaly, developmental delay, and brittle hair syndrome 0.0027487316936943827 0.228013\n",
      "MONDO:0030331 Ritscher-Schinzel syndrome 4 0.0027487316936943827 0.228013\n",
      "MONDO:0012481 mevalonic aciduria 0.0027487316936943827 0.228013\n",
      "MONDO:0010305 creatine transporter deficiency 0.0027487316936943827 0.228013\n",
      "MONDO:0013563 multiple congenital anomalies-hypotonia-seizures syndrome 1 0.0027487316936943827 0.228013\n",
      "MONDO:0859298 neurodevelopmental disorder with facial dysmorphism, absent language, and pseudo-pelger-huet anomaly 0.0027487316936943827 0.228013\n",
      "MONDO:0012198 PCWH syndrome 0.0027487316936943827 0.228013\n",
      "MONDO:0032824 glycosylphosphatidylinositol biosynthesis defect 21 0.0027487316936943827 0.228013\n",
      "MONDO:0010585 X-linked hypohidrotic ectodermal dysplasia 0.002829462263018155 0.226908\n",
      "MONDO:0007037 Achondroplasia 0.002829462263018155 0.226908\n",
      "MONDO:0008006 Mobius syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0007895 platyspondylic dysplasia, Torrance type 0.002829462263018155 0.226908\n",
      "MONDO:0013459 osteogenesis imperfecta type 10 0.002829462263018155 0.226908\n",
      "MONDO:0859295 neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties 0.002829462263018155 0.226908\n",
      "MONDO:0025351 multiple congenital anomalies-neurodevelopmental syndrome, X-linked 0.002829462263018155 0.226908\n",
      "MONDO:0859365 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures 0.002829462263018155 0.226908\n",
      "MONDO:0014376 intellectual disability, autosomal dominant 27 0.002829462263018155 0.226908\n",
      "MONDO:0008546 thanatophoric dysplasia type 1 0.002829462263018155 0.226908\n",
      "MONDO:0013993 pontocerebellar hypoplasia type 7 0.002829462263018155 0.226908\n",
      "MONDO:0800437 Carey-Fineman-Ziter syndrome 1 0.002829462263018155 0.226908\n",
      "MONDO:0010758 Wieacker-Wolff syndrome 0.002829462263018155 0.226908\n",
      "MONDO:0008955 cerebrooculofacioskeletal syndrome 1 0.0029101862969530736 0.225838\n",
      "MONDO:0030679 Noonan syndrome 14 0.0029101862969530736 0.225838\n",
      "MONDO:0030437 congenital disorder of glycosylation, type IIw 0.0029101862969530736 0.225838\n",
      "MONDO:0014831 progeroid and marfanoid aspect-lipodystrophy syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0014755 skin creases, congenital symmetric circumferential, 2 0.0029101862969530736 0.225838\n",
      "MONDO:0030896 chromosome 13q33-q34 deletion syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0014300 proximal myopathy with extrapyramidal signs 0.0029101862969530736 0.225838\n",
      "MONDO:0013379 Noonan syndrome 7 0.0029101862969530736 0.225838\n",
      "MONDO:0044738 Gabriele de Vries syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0013308 CBL-related disorder 0.0029101862969530736 0.225838\n",
      "MONDO:0014858 intellectual disability, autosomal dominant 43 0.0029101862969530736 0.225838\n",
      "MONDO:0100215 Rajab interstitial lung disease with brain calcifications 1 0.0029101862969530736 0.225838\n",
      "MONDO:0012948 chromosome 6pter-p24 deletion syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0010186 vitamin D-dependent rickets, type 2A 0.0029101862969530736 0.225838\n",
      "MONDO:0859312 neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities 0.0029101862969530736 0.225838\n",
      "MONDO:0010570 craniofrontonasal syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0024526 Zimmermann-Laband syndrome 1 0.0029101862969530736 0.225838\n",
      "MONDO:0009053 ALDH18A1-related de Barsy syndrome 0.0029909037960281996 0.224802\n",
      "MONDO:0012495 spondyloepimetaphyseal dysplasia, Genevieve type 0.0029909037960281996 0.224802\n",
      "MONDO:0012176 Emanuel syndrome 0.0029909037960281996 0.224802\n",
      "MONDO:0014857 neurodevelopmental disorder with or without anomalies of the brain, eye, or heart 0.0029909037960281996 0.224802\n",
      "MONDO:0011070 van Maldergem syndrome 1 0.0029909037960281996 0.224802\n",
      "MONDO:0030375 neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2 0.0029909037960281996 0.224802\n",
      "MONDO:0032855 neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies 0.0029909037960281996 0.224802\n",
      "MONDO:0008944 Joubert syndrome 1 0.0029909037960281996 0.224802\n",
      "MONDO:0859306 developmental delay with variable intellectual disability and dysmorphic facies 0.0029909037960281996 0.224802\n",
      "MONDO:0014966 periventricular nodular heterotopia 7 0.0029909037960281996 0.224802\n",
      "MONDO:0060711 Jaberi-Elahi syndrome 0.0029909037960281996 0.224802\n",
      "MONDO:0033005 Galloway-Mowat syndrome 1 0.0029909037960281996 0.224802\n",
      "MONDO:0014482 intellectual disability, autosomal dominant 29 0.003071614760772548 0.223795\n",
      "MONDO:0020682 Ehlers-Danlos syndrome, spondylodysplastic type, 1 0.003071614760772548 0.223795\n",
      "MONDO:0000902 agenesis of the corpus callosum with peripheral neuropathy 0.003071614760772548 0.223795\n",
      "MONDO:0013056 developmental and epileptic encephalopathy, 39 0.003071614760772548 0.223795\n",
      "MONDO:0010519 alpha thalassemia-X-linked intellectual disability syndrome 0.003071614760772548 0.223795\n",
      "MONDO:0014343 Desbuquois dysplasia 2 0.003071614760772548 0.223795\n",
      "MONDO:0044646 early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome 0.003071614760772548 0.223795\n",
      "MONDO:0018346 ferro-cerebro-cutaneous syndrome 0.003071614760772548 0.223795\n",
      "MONDO:0030553 acromesomelic dysplasia 4 0.003071614760772548 0.223795\n",
      "MONDO:0020723 vitamin D-dependent rickets, type 1A 0.003071614760772548 0.223795\n",
      "MONDO:0859236 neurodevelopmental disorder with neuromuscular and skeletal abnormalities 0.003071614760772548 0.223795\n",
      "MONDO:0008426 Shprintzen-Goldberg syndrome 0.0031523191917150915 0.222819\n",
      "MONDO:0010664 syndromic X-linked intellectual disability Snyder type 0.0031523191917150915 0.222819\n",
      "MONDO:0018663 regressive spondylometaphyseal dysplasia 0.0031523191917150915 0.222819\n",
      "MONDO:0013424 3p- syndrome 0.0031523191917150915 0.222819\n",
      "MONDO:0010417 syndromic X-linked intellectual disability Najm type 0.0031523191917150915 0.222819\n",
      "MONDO:0859209 Zaki syndrome 0.0031523191917150915 0.222819\n",
      "MONDO:0010477 blepharophimosis - intellectual disability syndrome, MKB type 0.0031523191917150915 0.222819\n",
      "MONDO:0859080 intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies 0.0031523191917150915 0.222819\n",
      "MONDO:0859201 neurodevelopmental disorder with impaired language and ataxia and with or without seizures 0.0031523191917150915 0.222819\n",
      "MONDO:0032572 cardiac, facial, and digital anomalies with developmental delay 0.0031523191917150915 0.222819\n",
      "MONDO:0007340 cleidocranial dysplasia 1 0.0032330170893847643 0.22187\n",
      "MONDO:0020681 Ehlers-Danlos syndrome, musculocontractural type 1 0.0032330170893847643 0.22187\n",
      "MONDO:0010310 osteopathia striata with cranial sclerosis 0.0032330170893847643 0.22187\n",
      "MONDO:0012095 intellectual disability-brachydactyly-Pierre Robin syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0009124 Dubowitz syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0008119 spinocerebellar ataxia type 1 0.0032330170893847643 0.22187\n",
      "MONDO:0011936 microphthalmia with brain and digit anomalies 0.0032330170893847643 0.22187\n",
      "MONDO:0007892 Lenz-Majewski hyperostotic dwarfism 0.0032330170893847643 0.22187\n",
      "MONDO:0012916 chromosome 2p16.1-p15 deletion syndrome 0.003313708454310455 0.220947\n",
      "MONDO:0014262 Rienhoff syndrome 0.003313708454310455 0.220947\n",
      "MONDO:0033561 deeah syndrome 0.003313708454310455 0.220947\n",
      "MONDO:0859301 neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects 0.003313708454310455 0.220947\n",
      "MONDO:0008907 PMM2-congenital disorder of glycosylation 0.003313708454310455 0.220947\n",
      "MONDO:0009341 Mowat-Wilson syndrome 0.003313708454310455 0.220947\n",
      "MONDO:0011213 Pierpont syndrome 0.003313708454310455 0.220947\n",
      "MONDO:0030918 intellectual disability, autosomal dominant 52 0.003313708454310455 0.220947\n",
      "MONDO:0060502 neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 0.003313708454310455 0.220947\n",
      "MONDO:0851095 KINSSHIP syndrome 0.003313708454310455 0.220947\n",
      "MONDO:0009452 Vici syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0011147 chromosome 18q deletion syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0009561 alpha-mannosidosis 0.0033943932870210093 0.220049\n",
      "MONDO:0012118 COG7-congenital disorder of glycosylation 0.0033943932870210093 0.220049\n",
      "MONDO:0009855 d-bifunctional protein deficiency 0.0033943932870210093 0.220049\n",
      "MONDO:0044302 congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 0.003475071588045229 0.219175\n",
      "MONDO:0030920 intellectual disability, autosomal dominant 54 0.003475071588045229 0.219175\n",
      "MONDO:0009629 Desbuquois dysplasia 1 0.003475071588045229 0.219175\n",
      "MONDO:0014348 intellectual disability, autosomal recessive 42 0.003475071588045229 0.219175\n",
      "MONDO:0010208 wrinkly skin syndrome 0.003475071588045229 0.219175\n",
      "MONDO:0008013 chromosome 9p deletion syndrome 0.003475071588045229 0.219175\n",
      "MONDO:0007843 Kabuki syndrome 1 0.003475071588045229 0.219175\n",
      "MONDO:0030908 intellectual disability, X-linked, syndromic, 35 0.003475071588045229 0.219175\n",
      "MONDO:0009785 opsismodysplasia 0.003475071588045229 0.219175\n",
      "MONDO:0859190 neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities 0.003475071588045229 0.219175\n",
      "MONDO:0014455 cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome 0.003475071588045229 0.219175\n",
      "MONDO:0009579 Frank-Ter Haar syndrome 0.003475071588045229 0.219175\n",
      "MONDO:0060622 neurodevelopmental disorder with severe motor impairment and absent language 0.003555743357911879 0.218323\n",
      "MONDO:0012864 chromosome 2q32-q33 deletion syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0030966 neurofacioskeletal syndrome with or without renal agenesis 0.003555743357911879 0.218323\n",
      "MONDO:0008150 osteoglophonic dwarfism 0.0036364085971496707 0.217493\n",
      "MONDO:0012589 Pitt-Hopkins syndrome 0.0036364085971496707 0.217493\n",
      "MONDO:0014700 Au-Kline syndrome 0.0036364085971496707 0.217493\n",
      "MONDO:0010590 FG syndrome 1 0.0036364085971496707 0.217493\n",
      "MONDO:0014944 short stature-brachydactyly-obesity-global developmental delay syndrome 0.0036364085971496707 0.217493\n",
      "MONDO:0014242 van Maldergem syndrome 2 0.0036364085971496707 0.217493\n",
      "MONDO:0032755 neurodevelopmental disorder with or without variable brain abnormalities; NEDBA 0.003717067306287276 0.216683\n",
      "MONDO:0010501 syndromic X-linked intellectual disability 34 0.003717067306287276 0.216683\n",
      "MONDO:0010561 Coffin-Lowry syndrome 0.003717067306287276 0.216683\n",
      "MONDO:0009511 Larsen-like syndrome, B3GAT3 type 0.003717067306287276 0.216683\n",
      "MONDO:0014258 congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome 0.003717067306287276 0.216683\n",
      "MONDO:0100224 mitochondrial complex I deficiency, nuclear type 1 0.003717067306287276 0.216683\n",
      "MONDO:0009479 Johanson-Blizzard syndrome 0.003797719485853338 0.215893\n",
      "MONDO:0013998 MEGF8-related Carpenter syndrome 0.003797719485853338 0.215893\n",
      "MONDO:0009485 oculocerebrofacial syndrome, Kaufman type 0.003797719485853338 0.215893\n",
      "MONDO:0013272 chromosome 14q11-q22 deletion syndrome 0.003797719485853338 0.215893\n",
      "MONDO:0859139 blepharophimosis-impaired intellectual development syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0957247 congenital myopathy 22A, classic 0.003959004258385117 0.214368\n",
      "MONDO:0010483 X-linked intellectual disability, Cantagrel type 0.003959004258385117 0.214368\n",
      "MONDO:0009254 fucosidosis 0.003959004258385117 0.214368\n",
      "MONDO:0800436 craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1 0.003959004258385117 0.214368\n",
      "MONDO:0012315 distal 10q deletion syndrome 0.003959004258385117 0.214368\n",
      "MONDO:0012136 carnitine palmitoyl transferase II deficiency, neonatal form 0.0040396368524078935 0.213632\n",
      "MONDO:0032760 developmental delay with or without dysmorphic facies and autism 0.0040396368524078935 0.213632\n",
      "MONDO:0009571 Meckel syndrome, type 1 0.0040396368524078935 0.213632\n",
      "MONDO:0011510 Bohring-Opitz syndrome 0.0040396368524078935 0.213632\n",
      "MONDO:0010283 syndromic X-linked intellectual disability Lubs type 0.004120262918973215 0.212912\n",
      "MONDO:0009069 congenital lactic acidosis, Saguenay-Lac-Saint-Jean type 0.004120262918973215 0.212912\n",
      "MONDO:0030695 developmental and epileptic encephalopathy 100 0.004120262918973215 0.212912\n",
      "MONDO:8000008 Martsolf syndrome 1 0.004120262918973215 0.212912\n",
      "MONDO:0014892 micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome 0.004120262918973215 0.212912\n",
      "MONDO:0009143 Meier-Gorlin syndrome 1 0.004200882458609504 0.212207\n",
      "MONDO:0013273 chromosome 16p13.3 duplication syndrome 0.004200882458609504 0.212207\n",
      "MONDO:0032645 trichohepatoneurodevelopmental syndrome 0.004200882458609504 0.212207\n",
      "MONDO:0010075 spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures 0.004200882458609504 0.212207\n",
      "MONDO:0013415 chromosome 17p13.1 deletion syndrome 0.004281495471845135 0.211518\n",
      "MONDO:0030606 Bryant-Li-Bhoj neurodevelopmental syndrome 1 0.004281495471845135 0.211518\n",
      "MONDO:0010077 spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome 0.004281495471845135 0.211518\n",
      "MONDO:0012637 COG1-congenital disorder of glycosylation 0.004362101959208437 0.210844\n",
      "MONDO:0013932 peroxisome biogenesis disorder 5A (Zellweger) 0.004362101959208437 0.210844\n",
      "MONDO:0957228 intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities 0.004362101959208437 0.210844\n",
      "MONDO:0054588 Noonan syndrome-like disorder with loose anagen hair 2 0.004442701921227706 0.210183\n",
      "MONDO:0014606 intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome 0.004442701921227706 0.210183\n",
      "MONDO:0014855 intellectual disability, autosomal dominant 42 0.0045232953584311885 0.209536\n",
      "MONDO:0007874 trichorhinophalangeal syndrome type II 0.0045232953584311885 0.209536\n",
      "MONDO:0859143 Radio-Tartaglia syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0014936 ZTTK syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0859187 neurodevelopmental disorder with hypotonia and brain abnormalities 0.0046038822713470855 0.208901\n",
      "MONDO:0019349 Sotos syndrome 0.0046038822713470855 0.208901\n",
      "MONDO:0011518 Wiedemann-Steiner syndrome 0.0046038822713470855 0.208901\n",
      "MONDO:0020602 Simpson-Golabi-Behmel syndrome type 1 0.004684462660503559 0.208279\n",
      "MONDO:0010466 multiple congenital anomalies-hypotonia-seizures syndrome 2 0.004765036526428722 0.207669\n",
      "MONDO:0032707 turnpenny-fry syndrome 0.004845603869650658 0.207071\n",
      "MONDO:0008953 peroxisome biogenesis disorder 1A (Zellweger) 0.004845603869650658 0.207071\n",
      "MONDO:0859273 liver disease, severe congenital 0.004845603869650658 0.207071\n",
      "MONDO:0009798 Primrose syndrome 0.004926164690697393 0.206483\n",
      "MONDO:0010221 CHIME syndrome 0.004926164690697393 0.206483\n",
      "MONDO:0025699 Coffin-Siris syndrome 12 0.004926164690697393 0.206483\n",
      "MONDO:0007265 cardiofaciocutaneous syndrome 1 0.005006718990096924 0.205907\n",
      "MONDO:0014205 severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome 0.005006718990096924 0.205907\n",
      "MONDO:0010193 Weaver syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0800043 Stve-Wiedemann syndrome 1 0.005087266768377201 0.205341\n",
      "MONDO:0011053 intellectual disability-sparse hair-brachydactyly syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0012914 chromosome 1q21.1 deletion syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0859191 biliary, renal, neurologic, and skeletal syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0010035 Smith-Lemli-Opitz syndrome 0.005248342763691545 0.204238\n",
      "MONDO:0030990 Kohlschutter-Tonz syndrome-like 0.005328870981781299 0.203702\n",
      "MONDO:0009964 short-rib thoracic dysplasia 9 with or without polydactyly 0.005409392680863154 0.203174\n",
      "MONDO:0859239 Chilton-Okur-Chung neurodevelopmental syndrome 0.005409392680863154 0.203174\n",
      "MONDO:0859181 DEGCAGS syndrome 0.005489907861464847 0.202655\n",
      "MONDO:0009650 mucolipidosis type II 0.005570416524114067 0.202145\n",
      "MONDO:0859177 VISS syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0007617 Coffin-Siris syndrome 1 0.005650918669338471 0.201643\n",
      "MONDO:0014558 autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome 0.005811903409623178 0.200662\n",
      "MONDO:0014379 ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 0.005972862086539299 0.199713\n",
      "MONDO:0011244 Marshall-Smith syndrome 0.006455581779269274 0.197029\n",
      "MONDO:0009910 Wiedemann-Rautenstrauch syndrome 0.006455581779269274 0.197029\n",
      "MONDO:0008995 Yunis-Varon syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0030993 Tessadori-Van Haaften neurodevelopmental syndrome 3 0.006938067053548422 0.194565\n",
      "MONDO:0008393 Rubinstein-Taybi syndrome due to CREBBP mutations 0.00709884340499642 0.193786\n",
      "MONDO:0011146 tetrasomy 12p 0.007179221819345575 0.193404\n",
      "MONDO:0013256 chromosome 15q24 deletion syndrome 0.007259593726813918 0.193028\n",
      "MONDO:0010457 Ogden syndrome 0.007741688556621809 0.190862\n",
      "MONDO:0859185 neurodevelopmental disorder with hypotonia and dysmorphic facies 0.00838411750378796 0.188203\n",
      "MONDO:0859178 developmental delay, impaired speech, and behavioral abnormalities 0.009828062282834912 0.182988\n"
     ]
    }
   ],
   "execution_count": 63
  },
  {
   "cell_type": "code",
   "id": "1e2dc7e2-219d-4a61-9d05-2f518022dfcf",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:00.190956Z",
     "start_time": "2024-10-28T18:04:00.074634Z"
    }
   },
   "source": [
    "response = phenotypes_to_gene(tbcd_phenotypes)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "NCBIGene:284058 KANSL1 0.0006474412355706435 0.287901\n",
      "NCBIGene:50484 RRM2B 0.0007283419108450321 0.282688\n",
      "NCBIGene:113189 CHST14 0.0007283419108450321 0.282688\n",
      "NCBIGene:3954 LETM1 0.001860263944114525 0.243279\n",
      "NCBIGene:4204 MECP2 0.003071614760772548 0.223795\n",
      "NCBIGene:18 ABAT 0.004281495471845135 0.211518\n"
     ]
    }
   ],
   "execution_count": 64
  },
  {
   "cell_type": "code",
   "id": "c7230bc3-4dd1-4bec-9ad5-a40346ce06aa",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:00.193936Z",
     "start_time": "2024-10-28T18:04:00.191766Z"
    }
   },
   "source": [
    "wdyf_phenotypes = [\n",
    "    #Global developmental delay \n",
    "    \"HP:0001263\",\n",
    "    #Seizure \n",
    "    \"HP:0001250\",\n",
    "    #Neurodevelopmental delay \n",
    "    \"HP:0012758\",\n",
    "    #Delayed social development \n",
    "    \"HP:0012434\"\n",
    "]"
   ],
   "outputs": [],
   "execution_count": 65
  },
  {
   "cell_type": "code",
   "id": "c0e79e06-e9f7-4aec-9ae0-e03fc7c6faa1",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:04.262909Z",
     "start_time": "2024-10-28T18:04:00.194841Z"
    }
   },
   "source": [
    "response = phenotypes_to_disease(wdyf_phenotypes)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "MONDO:0012830 chromosome 10q23 deletion syndrome 7.043541590830241e-07 0.640171\n",
      "MONDO:0014992 lissencephaly 8 1.489667817869212e-06 0.601916\n",
      "MONDO:0032866 cortical dysplasia, complex, with other brain malformations 10 1.8850895473043174e-06 0.589605\n",
      "MONDO:0014908 microcephaly 17, primary, autosomal recessive 2.32693618090683e-06 0.578497\n",
      "MONDO:0060761 neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum 2.5652625674495586e-06 0.573326\n",
      "MONDO:0060758 spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits 2.8151876576608396e-06 0.56838\n",
      "MONDO:0029143 intellectual developmental disorder with hypertelorism and distinctive facies 3.076708944928911e-06 0.563642\n",
      "MONDO:0014351 pontocerebellar hypoplasia type 9 3.3498239230479854e-06 0.559095\n",
      "MONDO:0033492 Coffin-Siris syndrome 6 4.5581706341248245e-06 0.542548\n",
      "MONDO:0014601 autosomal recessive spinocerebellar ataxia 20 5.951816007870529e-06 0.528139\n",
      "MONDO:0013076 attention deficit-hyperactivity disorder, susceptibility to, 7 0.00010793599385078916 0.373652\n",
      "MONDO:0033670 hearing loss, autosomal recessive 116 0.00010793599385078916 0.373652\n",
      "MONDO:0008563 thumb stiffness-brachydactyly-intellectual disability syndrome 0.00010793599385078916 0.373652\n",
      "MONDO:0014442 Bardet-Biedl syndrome 14 0.00010793599385078916 0.373652\n",
      "MONDO:0010454 intellectual disability, X-linked 88 0.00010793599385078916 0.373652\n",
      "MONDO:0030480 hearing loss, autosomal recessive 119 0.00010793599385078916 0.373652\n",
      "MONDO:0030958 dystonia 35, childhood-onset 0.00010793599385078916 0.373652\n",
      "MONDO:0014438 Bardet-Biedl syndrome 10 0.00021586033752281006 0.33915\n",
      "MONDO:0009099 nephrogenic diabetes insipidus-intracranial calcification syndrome 0.00021586033752281006 0.33915\n",
      "MONDO:0014825 chromosome 11p13 deletion syndrome, distal 0.00021586033752281006 0.33915\n",
      "MONDO:0030005 epilepsy, early-onset, with or without developmental delay 0.00021586033752281006 0.33915\n",
      "MONDO:0014436 Bardet-Biedl syndrome 8 0.00021586033752281006 0.33915\n",
      "MONDO:0007366 seizures, benign familial neonatal, 2 0.00021586033752281006 0.33915\n",
      "MONDO:0030004 autism, susceptibility to, 20 0.00021586033752281006 0.33915\n",
      "MONDO:0033665 hearing loss, autosomal dominant 78 0.00021586033752281006 0.33915\n",
      "MONDO:0013917 nephronophthisis 15 0.00021586033752281006 0.33915\n",
      "MONDO:0010450 intellectual disability, X-linked 89 0.00021586033752281006 0.33915\n",
      "MONDO:0030105 galactosemia 4 0.00021586033752281006 0.33915\n",
      "MONDO:0032862 hydrocephalus, congenital communicating, 1 0.00021586033752281006 0.33915\n",
      "MONDO:0044315 craniosynostosis 7 0.00021586033752281006 0.33915\n",
      "MONDO:0013734 microphthalmia, syndromic 11 0.0003237730322735353 0.319707\n",
      "MONDO:0014432 Bardet-Biedl syndrome 2 0.0003237730322735353 0.319707\n",
      "MONDO:0032694 microcephaly 25, primary, autosomal recessive 0.0003237730322735353 0.319707\n",
      "MONDO:0013116 congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome 0.0003237730322735353 0.319707\n",
      "MONDO:0014815 intellectual disability, autosomal recessive 52 0.0003237730322735353 0.319707\n",
      "MONDO:0009042 craniotelencephalic dysplasia 0.0003237730322735353 0.319707\n",
      "MONDO:0010252 intellectual disability, X-linked, with panhypopituitarism 0.0003237730322735353 0.319707\n",
      "MONDO:0012717 renal hypomagnesemia 4 0.0003237730322735353 0.319707\n",
      "MONDO:0010125 upper limb defect-eye and ear abnormalities syndrome 0.0003237730322735353 0.319707\n",
      "MONDO:0026729 congenital disorder of glycosylation, type ICC 0.0003237730322735353 0.319707\n",
      "MONDO:0859278 keratoderma-ichthyosis-deafness syndrome, autosomal recessive 0.0003237730322735353 0.319707\n",
      "MONDO:0014712 Senior-Loken syndrome 9 0.0003237730322735353 0.319707\n",
      "MONDO:0010451 intellectual disability, X-linked 41 0.0003237730322735353 0.319707\n",
      "MONDO:0014184 specific language impairment 5 0.0003237730322735353 0.319707\n",
      "MONDO:0032899 neutropenia, severe congenital, 8, autosomal dominant 0.0003237730322735353 0.319707\n",
      "MONDO:0012615 intellectual disability, autosomal recessive 7 0.0003237730322735353 0.319707\n",
      "MONDO:0013345 d-2-hydroxyglutaric aciduria 2 0.0003237730322735353 0.319707\n",
      "MONDO:0014441 Bardet-Biedl syndrome 13 0.0003237730322735353 0.319707\n",
      "MONDO:0012286 myopathy, autophagic vacuolar, infantile-onset 0.0003237730322735353 0.319707\n",
      "MONDO:0029465 intellectual developmental disorder, autosomal dominant 69 0.0003237730322735353 0.319707\n",
      "MONDO:0030726 neutropenia, severe congenital, 9, autosomal dominant 0.0003237730322735353 0.319707\n",
      "MONDO:0040500 glycosylphosphatidylinositol biosynthesis defect 16 0.0004316740793603039 0.306278\n",
      "MONDO:0025690 microcephaly, epilepsy, and diabetes syndrome 2 0.0004316740793603039 0.306278\n",
      "MONDO:0013904 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 0.0004316740793603039 0.306278\n",
      "MONDO:0014524 intellectual disability, autosomal recessive 47 0.0004316740793603039 0.306278\n",
      "MONDO:0016581 conotruncal heart malformations 0.0004316740793603039 0.306278\n",
      "MONDO:0013939 peroxisome biogenesis disorder 7B 0.0004316740793603039 0.306278\n",
      "MONDO:0009366 normal pressure hydrocephalus 0.0004316740793603039 0.306278\n",
      "MONDO:0009844 pellagra-like syndrome 0.0004316740793603039 0.306278\n",
      "MONDO:0013606 Hermansky-Pudlak syndrome 9 0.0004316740793603039 0.306278\n",
      "MONDO:0859170 retinal dystrophy and microvillus inclusion disease 0.0004316740793603039 0.306278\n",
      "MONDO:0012860 thrombophilia due to protein C deficiency, autosomal recessive 0.0004316740793603039 0.306278\n",
      "MONDO:0007634 intellectual disability, FRA12A type 0.0004316740793603039 0.306278\n",
      "MONDO:0008428 septooptic dysplasia 0.0004316740793603039 0.306278\n",
      "MONDO:0014759 intellectual disability, autosomal recessive 51 0.0004316740793603039 0.306278\n",
      "MONDO:0014839 chorea, childhood-onset, with psychomotor retardation 0.0004316740793603039 0.306278\n",
      "MONDO:0010832 Bardet-Biedl syndrome 3 0.0004316740793603039 0.306278\n",
      "MONDO:0013580 pyruvate dehydrogenase E1-beta deficiency 0.0004316740793603039 0.306278\n",
      "MONDO:0014675 autosomal recessive nonsyndromic hearing loss 104 0.0004316740793603039 0.306278\n",
      "MONDO:0030916 intellectual disability, autosomal dominant 50 0.0004316740793603039 0.306278\n",
      "MONDO:0008939 isolated cerebellar hypoplasia/agenesis 0.0004316740793603039 0.306278\n",
      "MONDO:0012548 Kostmann syndrome 0.0004316740793603039 0.306278\n",
      "MONDO:0012397 brachydactyly, coloboma, and anterior segment dysgenesis 0.0004316740793603039 0.306278\n",
      "MONDO:0010851 Lowry-MacLean syndrome 0.0004316740793603039 0.306278\n",
      "MONDO:0013493 acetyl-coa carboxylase deficiency 0.0004316740793603039 0.306278\n",
      "MONDO:0008859 berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification 0.0004316740793603039 0.306278\n",
      "MONDO:0014770 Joubert syndrome 25 0.0004316740793603039 0.306278\n",
      "MONDO:0014623 microcephaly 14, primary, autosomal recessive 0.000539563480040318 0.296083\n",
      "MONDO:0010900 intrauterine growth retardation with increased mitomycin c sensitivity 0.000539563480040318 0.296083\n",
      "MONDO:0013387 developmental and epileptic encephalopathy, 7 0.000539563480040318 0.296083\n",
      "MONDO:0032631 mitochondrial complex 1 deficiency, nuclear type 27 0.000539563480040318 0.296083\n",
      "MONDO:0014592 microcephaly and chorioretinopathy 3 0.000539563480040318 0.296083\n",
      "MONDO:0010162 tyrosinemia type III 0.000539563480040318 0.296083\n",
      "MONDO:0013539 hypotonia-failure to thrive-microcephaly syndrome 0.000539563480040318 0.296083\n",
      "MONDO:0013774 trigonocephaly 2 0.000539563480040318 0.296083\n",
      "MONDO:0014490 ketoacidosis due to monocarboxylate transporter-1 deficiency 0.000539563480040318 0.296083\n",
      "MONDO:0014953 gnb5-related intellectual disability-cardiac arrhythmia syndrome 0.000539563480040318 0.296083\n",
      "MONDO:0014690 dyskeratosis congenita, autosomal dominant 6 0.000539563480040318 0.296083\n",
      "MONDO:0012187 Fanconi anemia complementation group J 0.000539563480040318 0.296083\n",
      "MONDO:0013548 acetyl-CoA acetyltransferase-2 deficiency 0.000539563480040318 0.296083\n",
      "MONDO:0060577 neurodevelopmental disorder with microcephaly, ataxia, and seizures 0.000539563480040318 0.296083\n",
      "MONDO:0010216 xeroderma pigmentosum group G 0.000539563480040318 0.296083\n",
      "MONDO:0033044 Meckel syndrome 13 0.000539563480040318 0.296083\n",
      "MONDO:0012996 AGAT deficiency 0.000539563480040318 0.296083\n",
      "MONDO:0859158 ataxia, intention tremor, and hypotonia syndrome, childhood-onset 0.000539563480040318 0.296083\n",
      "MONDO:0010794 NARP syndrome 0.000539563480040318 0.296083\n",
      "MONDO:0010474 linear skin defects with multiple congenital anomalies 2 0.000539563480040318 0.296083\n",
      "MONDO:0012623 intellectual disability, autosomal recessive 4 0.000539563480040318 0.296083\n",
      "MONDO:0010460 syndromic X-linked intellectual disability 17 0.0006474412355706435 0.287901\n",
      "MONDO:0013531 PSPH deficiency 0.0006474412355706435 0.287901\n",
      "MONDO:0030462 Joubert syndrome 40 0.0006474412355706435 0.287901\n",
      "MONDO:0060551 cerebellar atrophy, developmental delay, and seizures 0.0006474412355706435 0.287901\n",
      "MONDO:0014664 Joubert syndrome 23 0.0006474412355706435 0.287901\n",
      "MONDO:0013581 intellectual disability, autosomal dominant 2 0.0006474412355706435 0.287901\n",
      "MONDO:0014724 Joubert syndrome 24 0.0006474412355706435 0.287901\n",
      "MONDO:0011291 ALG6-congenital disorder of glycosylation 1C 0.0006474412355706435 0.287901\n",
      "MONDO:0024568 infantile liver failure syndrome 1 0.0006474412355706435 0.287901\n",
      "MONDO:0033310 Joubert syndrome 31 0.0006474412355706435 0.287901\n",
      "MONDO:0011772 B4GALT1-congenital disorder of glycosylation 0.0006474412355706435 0.287901\n",
      "MONDO:0011828 intellectual disability, autosomal recessive 2 0.0006474412355706435 0.287901\n",
      "MONDO:0013824 Joubert syndrome 17 0.0006474412355706435 0.287901\n",
      "MONDO:0032733 global developmental delay, progressive ataxia, and elevated glutamine 0.0006474412355706435 0.287901\n",
      "MONDO:0009008 heart defect - tongue hamartoma - polysyndactyly syndrome 0.0006474412355706435 0.287901\n",
      "MONDO:0013583 occipital pachygyria and polymicrogyria 0.0006474412355706435 0.287901\n",
      "MONDO:0012413 syndromic microphthalmia type 5 0.0006474412355706435 0.287901\n",
      "MONDO:0012925 Diamond-Blackfan anemia 5 0.0006474412355706435 0.287901\n",
      "MONDO:0013058 cystic leukoencephalopathy without megalencephaly 0.0006474412355706435 0.287901\n",
      "MONDO:0014942 developmental and epileptic encephalopathy, 45 0.0006474412355706435 0.287901\n",
      "MONDO:0014029 osteogenesis imperfecta type 14 0.0006474412355706435 0.287901\n",
      "MONDO:0011025 Cayman type cerebellar ataxia 0.0006474412355706435 0.287901\n",
      "MONDO:0014248 autism spectrum disorder - epilepsy - arthrogryposis syndrome 0.0006474412355706435 0.287901\n",
      "MONDO:0013900 alternating hemiplegia of childhood 2 0.0006474412355706435 0.287901\n",
      "MONDO:0012120 pyruvate dehydrogenase phosphatase deficiency 0.0006474412355706435 0.287901\n",
      "MONDO:0030033 seizures, early-onset, with neurodegeneration and brain calcifications 0.0006474412355706435 0.287901\n",
      "MONDO:0014270 STT3A-congenital disorder of glycosylation 0.0006474412355706435 0.287901\n",
      "MONDO:0033543 cone-rod synaptic disorder syndrome, congenital nonprogressive 0.0006474412355706435 0.287901\n",
      "MONDO:0010318 FG syndrome 4 0.0006474412355706435 0.287901\n",
      "MONDO:0007210 Brachmann-de Lange-like facial changes with microcephaly, metatarsus adductus, and developmental delay 0.0006474412355706435 0.287901\n",
      "MONDO:0014190 combined oxidative phosphorylation defect type 17 0.0006474412355706435 0.287901\n",
      "MONDO:0032588 periventricular nodular heterotopia 8 0.0006474412355706435 0.287901\n",
      "MONDO:0007631 chromosome 16p12.1 deletion syndrome, 520kb 0.0006474412355706435 0.287901\n",
      "MONDO:0010289 intellectual disability, X-linked 72 0.0006474412355706435 0.287901\n",
      "MONDO:0010840 pachygyria-intellectual disability-epilepsy syndrome 0.0006474412355706435 0.287901\n",
      "MONDO:0008774 2-aminoadipic 2-oxoadipic aciduria 0.0007553073472082117 0.28109\n",
      "MONDO:0033311 Joubert syndrome 33 0.0007553073472082117 0.28109\n",
      "MONDO:0044702 X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0014766 leukodystrophy and acquired microcephaly with or without dystonia; 0.0007553073472082117 0.28109\n",
      "MONDO:0030859 COACH syndrome 2 0.0007553073472082117 0.28109\n",
      "MONDO:0032815 mitochondrial DNA depletion syndrome 17 0.0007553073472082117 0.28109\n",
      "MONDO:0012989 microcephaly 7, primary, autosomal recessive 0.0007553073472082117 0.28109\n",
      "MONDO:0014398 combined oxidative phosphorylation defect type 21 0.0007553073472082117 0.28109\n",
      "MONDO:0013642 holoprosencephaly 11 0.0007553073472082117 0.28109\n",
      "MONDO:0032699 epilepsy, idiopathic generalized, susceptibility to, 15 0.0007553073472082117 0.28109\n",
      "MONDO:0100105 brain small vessel disease 3 0.0007553073472082117 0.28109\n",
      "MONDO:0012029 microcephaly 6, primary, autosomal recessive 0.0007553073472082117 0.28109\n",
      "MONDO:0014842 intellectual disability, autosomal dominant 41 0.0007553073472082117 0.28109\n",
      "MONDO:0014071 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11 0.0007553073472082117 0.28109\n",
      "MONDO:0013763 Joubert syndrome 15 0.0007553073472082117 0.28109\n",
      "MONDO:0014881 transketolase deficiency 0.0007553073472082117 0.28109\n",
      "MONDO:0012614 intellectual disability, autosomal recessive 6 0.0007553073472082117 0.28109\n",
      "MONDO:0032629 mitochondrial complex 1 deficiency, nuclear type 25 0.0007553073472082117 0.28109\n",
      "MONDO:0014168 severe combined immunodeficiency due to CORO1A deficiency 0.0007553073472082117 0.28109\n",
      "MONDO:0014444 Bardet-Biedl syndrome 16 0.0007553073472082117 0.28109\n",
      "MONDO:0010473 X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0014408 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 0.0007553073472082117 0.28109\n",
      "MONDO:0014517 generalized epilepsy with febrile seizures plus, type 9 0.0007553073472082117 0.28109\n",
      "MONDO:0030849 intellectual developmental disorder with speech delay and axonal peripheral neuropathy 0.0007553073472082117 0.28109\n",
      "MONDO:0009952 radioulnar synostosis-developmental delay-hypotonia syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0014170 complex cortical dysplasia with other brain malformations 3 0.0007553073472082117 0.28109\n",
      "MONDO:0031031 intellectual developmental disorder, autosomal recessive 77 0.0007553073472082117 0.28109\n",
      "MONDO:0013773 porencephaly 2 0.0007553073472082117 0.28109\n",
      "MONDO:0014595 developmental and epileptic encephalopathy, 30 0.0007553073472082117 0.28109\n",
      "MONDO:0012992 pancreatic insufficiency-anemia-hyperostosis syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0032827 epilepsy, idiopathic generalized, susceptibility to, 16 0.0007553073472082117 0.28109\n",
      "MONDO:0014600 dyskeratosis congenita, autosomal recessive 6 0.0007553073472082117 0.28109\n",
      "MONDO:0014171 complex cortical dysplasia with other brain malformations 4 0.0007553073472082117 0.28109\n",
      "MONDO:0030862 COACH syndrome 3 0.0007553073472082117 0.28109\n",
      "MONDO:0014080 osteosclerotic metaphyseal dysplasia 0.0007553073472082117 0.28109\n",
      "MONDO:0013661 combined malonic and methylmalonic acidemia 0.0007553073472082117 0.28109\n",
      "MONDO:0009475 isovaleric acidemia 0.0007553073472082117 0.28109\n",
      "MONDO:0014449 congenital analbuminemia 0.0007553073472082117 0.28109\n",
      "MONDO:0032894 neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy 0.0007553073472082117 0.28109\n",
      "MONDO:0012324 Frias syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0020787 hypomagnesemia, seizures, and intellectual disability 1 0.0007553073472082117 0.28109\n",
      "MONDO:0011627 autism, susceptibility to, 5 0.0007553073472082117 0.28109\n",
      "MONDO:0013877 mitochondrial pyruvate carrier deficiency 0.0007553073472082117 0.28109\n",
      "MONDO:0012276 generalized epilepsy-paroxysmal dyskinesia syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0009742 neuroectodermal melanolysosomal disease 0.0007553073472082117 0.28109\n",
      "MONDO:0957255 mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 0.0007553073472082117 0.28109\n",
      "MONDO:0009760 Norman-Roberts syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0032789 intellectual developmental disorder, autosomal recessive 71 0.0007553073472082117 0.28109\n",
      "MONDO:0030454 Joubert syndrome 39 0.0007553073472082117 0.28109\n",
      "MONDO:0029135 muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8 0.0007553073472082117 0.28109\n",
      "MONDO:0859287 neurodevelopmental disorder with microcephaly, hypotonia, and absent language 0.0008631618162098167 0.27527\n",
      "MONDO:0010558 choroideremia-deafness-obesity syndrome 0.0008631618162098167 0.27527\n",
      "MONDO:0030513 dystonia 33 0.0008631618162098167 0.27527\n",
      "MONDO:0032619 mitochondrial complex 1 deficiency, nuclear type 14 0.0008631618162098167 0.27527\n",
      "MONDO:0014607 developmental and epileptic encephalopathy, 32 0.0008631618162098167 0.27527\n",
      "MONDO:0014086 osteogenesis imperfecta type 15 0.0008631618162098167 0.27527\n",
      "MONDO:0010334 severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome 0.0008631618162098167 0.27527\n",
      "MONDO:0032883 intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures 0.0008631618162098167 0.27527\n",
      "MONDO:0032812 developmental and epileptic encephalopathy, 78 0.0008631618162098167 0.27527\n",
      "MONDO:0010489 intellectual disability, X-linked 101 0.0008631618162098167 0.27527\n",
      "MONDO:0859303 intellectual developmental disorder with ocular anomalies and distinctive facial features 0.0008631618162098167 0.27527\n",
      "MONDO:0009353 homocystinuria due to methylene tetrahydrofolate reductase deficiency 0.0008631618162098167 0.27527\n",
      "MONDO:0030518 trichothiodystrophy 9, nonphotosensitive 0.0008631618162098167 0.27527\n",
      "MONDO:0014118 congenital neutropenia-myelofibrosis-nephromegaly syndrome 0.0008631618162098167 0.27527\n",
      "MONDO:0030535 epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessive 0.0008631618162098167 0.27527\n",
      "MONDO:0010912 fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement 0.0008631618162098167 0.27527\n",
      "MONDO:0044313 intellectual disability, autosomal recessive 60 0.0008631618162098167 0.27527\n",
      "MONDO:0009949 pyruvate carboxylase deficiency disease 0.0008631618162098167 0.27527\n",
      "MONDO:0014714 progressive microcephaly-seizures-cortical blindness-developmental delay syndrome 0.0008631618162098167 0.27527\n",
      "MONDO:0054861 intellectual disability, autosomal recessive 63 0.0008631618162098167 0.27527\n",
      "MONDO:0010485 X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome 0.0008631618162098167 0.27527\n",
      "MONDO:0032626 mitochondrial complex 1 deficiency, nuclear type 22 0.0008631618162098167 0.27527\n",
      "MONDO:0014696 cerebrooculofacioskeletal syndrome 3 0.0008631618162098167 0.27527\n",
      "MONDO:0014633 myoclonic-atonic epilepsy 0.0008631618162098167 0.27527\n",
      "MONDO:0013388 developmental and epileptic encephalopathy, 11 0.0008631618162098167 0.27527\n",
      "MONDO:0012849 Joubert syndrome 9 0.0008631618162098167 0.27527\n",
      "MONDO:0859152 neurodevelopmental disorder with cerebellar atrophy and motor dysfunction 0.0008631618162098167 0.27527\n",
      "MONDO:0013302 nephronophthisis 11 0.0008631618162098167 0.27527\n",
      "MONDO:0033649 mitochondrial complex 4 deficiency, nuclear type 14 0.0008631618162098167 0.27527\n",
      "MONDO:0020788 hypomagnesemia, seizures, and intellectual disability 2 0.0008631618162098167 0.27527\n",
      "MONDO:0030045 Liberfarb syndrome 0.0008631618162098167 0.27527\n",
      "MONDO:0011676 PHACE syndrome 0.0008631618162098167 0.27527\n",
      "MONDO:0023670 Bardet-Biedl syndrome 20 0.0008631618162098167 0.27527\n",
      "MONDO:0033369 developmental and epileptic encephalopathy, 60 0.0008631618162098167 0.27527\n",
      "MONDO:0014350 Seckel syndrome 8 0.0008631618162098167 0.27527\n",
      "MONDO:0010452 intellectual disability, X-linked 90 0.0008631618162098167 0.27527\n",
      "MONDO:0033115 spinocerebellar ataxia, autosomal recessive 25 0.0008631618162098167 0.27527\n",
      "MONDO:0014972 chromosome 19q13.11 deletion syndrome, proximal 0.0008631618162098167 0.27527\n",
      "MONDO:0014271 STT3B-congenital disorder of glycosylation 0.0008631618162098167 0.27527\n",
      "MONDO:0008962 Griscelli syndrome type 1 0.0008631618162098167 0.27527\n",
      "MONDO:0009324 Hartnup disease 0.0008631618162098167 0.27527\n",
      "MONDO:0010555 X-linked chondrodysplasia punctata 1 0.0008631618162098167 0.27527\n",
      "MONDO:0859265 neurodevelopmental disorder with epilepsy and brain atrophy 0.0008631618162098167 0.27527\n",
      "MONDO:0012037 intellectual disability, autosomal recessive 3 0.0008631618162098167 0.27527\n",
      "MONDO:0012740 chromosome 22q11.2 deletion syndrome, distal 0.0008631618162098167 0.27527\n",
      "MONDO:0013645 autosomal recessive spinocerebellar ataxia 11 0.0008631618162098167 0.27527\n",
      "MONDO:0013994 Joubert syndrome 20 0.0009710046438321194 0.270199\n",
      "MONDO:0859346 mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition 0.0009710046438321194 0.270199\n",
      "MONDO:0014771 Joubert syndrome 26 0.0009710046438321194 0.270199\n",
      "MONDO:0009560 oculotrichoanal syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0030034 epilepsy, progressive myoclonic, 11 0.0009710046438321194 0.270199\n",
      "MONDO:0020741 pyridoxine-dependent epilepsy caused by ALDH7A1 mutant 0.0009710046438321194 0.270199\n",
      "MONDO:0010494 linear skin defects with multiple congenital anomalies 3 0.0009710046438321194 0.270199\n",
      "MONDO:0014437 Bardet-Biedl syndrome 9 0.0009710046438321194 0.270199\n",
      "MONDO:0014666 hypomyelinating leukodystrophy 11 0.0009710046438321194 0.270199\n",
      "MONDO:0014957 language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia 0.0009710046438321194 0.270199\n",
      "MONDO:0859280 developmental delay, hypotonia, and impaired language 0.0009710046438321194 0.270199\n",
      "MONDO:0010665 Wilson-Turner syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0009285 gamma-glutamyl transpeptidase deficiency 0.0009710046438321194 0.270199\n",
      "MONDO:0032902 Joubert syndrome 36 0.0009710046438321194 0.270199\n",
      "MONDO:0013394 porencephaly-microcephaly-bilateral congenital cataract syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0012588 neuronal ceroid lipofuscinosis 7 0.0009710046438321194 0.270199\n",
      "MONDO:0032741 neurodevelopmental disorder with impaired speech and hyperkinetic movements 0.0009710046438321194 0.270199\n",
      "MONDO:0013687 autosomal recessive spinocerebellar ataxia 12 0.0009710046438321194 0.270199\n",
      "MONDO:0958185 mitochondrial trifunctional protein deficiency 2 0.0009710046438321194 0.270199\n",
      "MONDO:0013254 microcephaly, seizures, and developmental delay 0.0009710046438321194 0.270199\n",
      "MONDO:0014590 congenital myasthenic syndrome 18 0.0009710046438321194 0.270199\n",
      "MONDO:0013509 intellectual disability, autosomal dominant 6 0.0009710046438321194 0.270199\n",
      "MONDO:0032642 arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development 0.0009710046438321194 0.270199\n",
      "MONDO:0012756 proximal 16p11.2 microdeletion syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0032573 bone marrow failure syndrome 5 0.0009710046438321194 0.270199\n",
      "MONDO:0009611 3-methylglutaconic aciduria type 4 0.0009710046438321194 0.270199\n",
      "MONDO:0010508 intellectual disability, X-linked 103 0.0009710046438321194 0.270199\n",
      "MONDO:0012251 MEDNIK syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0859281 intellectual developmental disorder with autism and dysmorphic facies 0.0009710046438321194 0.270199\n",
      "MONDO:0009400 hyperprolinemia type 1 0.0009710046438321194 0.270199\n",
      "MONDO:0013440 autosomal recessive limb-girdle muscular dystrophy type 2P 0.0009710046438321194 0.270199\n",
      "MONDO:0030909 intellectual disability, X-linked, syndromic, Houge type 0.0009710046438321194 0.270199\n",
      "MONDO:0032818 neurodevelopmental disorder with cerebellar hypoplasia and spasticity 0.0009710046438321194 0.270199\n",
      "MONDO:0054736 mosaic variegated aneuploidy syndrome 3 0.0009710046438321194 0.270199\n",
      "MONDO:0859292 developmental delay, behavioral abnormalities, and neuropsychiatric disorders 0.0009710046438321194 0.270199\n",
      "MONDO:0014328 developmental and epileptic encephalopathy, 19 0.0009710046438321194 0.270199\n",
      "MONDO:0008721 medium chain acyl-CoA dehydrogenase deficiency 0.0009710046438321194 0.270199\n",
      "MONDO:0957534 megalencephalic leukoencephalopathy with subcortical cysts 4, remitting 0.0009710046438321194 0.270199\n",
      "MONDO:0859256 neurodevelopmental disorder with language delay and seizures 0.0009710046438321194 0.270199\n",
      "MONDO:0014525 combined oxidative phosphorylation defect type 23 0.0009710046438321194 0.270199\n",
      "MONDO:0032598 developmental and epileptic encephalopathy, 68 0.0009710046438321194 0.270199\n",
      "MONDO:0013789 DDOST-congenital disorder of glycosylation 0.0009710046438321194 0.270199\n",
      "MONDO:0957543 auriculocondylar syndrome 4 0.0009710046438321194 0.270199\n",
      "MONDO:0011506 familial infantile myoclonic epilepsy 0.0009710046438321194 0.270199\n",
      "MONDO:0012392 2-methylbutyryl-CoA dehydrogenase deficiency 0.0009710046438321194 0.270199\n",
      "MONDO:0060554 vertebral, cardiac, renal, and limb defects syndrome 1 0.0009710046438321194 0.270199\n",
      "MONDO:0009622 Jawad syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0014764 spastic paraplegia-severe developmental delay-epilepsy syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0033203 nephrotic syndrome 14 0.0009710046438321194 0.270199\n",
      "MONDO:0010192 Waardenburg syndrome type 4A 0.0009710046438321194 0.270199\n",
      "MONDO:0013074 encephalocraniocutaneous lipomatosis 0.0009710046438321194 0.270199\n",
      "MONDO:0859220 Ferguson-Bonni neurodevelopmental syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0032927 triokinase and FMN cyclase deficiency syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0010890 acrocardiofacial syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0013338 Charcot-Marie-Tooth disease recessive intermediate B 0.0009710046438321194 0.270199\n",
      "MONDO:0032842 Siddiqi syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0012504 camptodactyly-tall stature-scoliosis-hearing loss syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0030044 pseudo-TORCH syndrome 3 0.0010788358313316428 0.265714\n",
      "MONDO:0013274 retinitis pigmentosa 51 0.0010788358313316428 0.265714\n",
      "MONDO:0013644 Charcot-Marie-Tooth disease axonal type 2O 0.0010788358313316428 0.265714\n",
      "MONDO:0014112 cardiofaciocutaneous syndrome 2 0.0010788358313316428 0.265714\n",
      "MONDO:0010802 pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0032635 mitochondrial complex 1 deficiency, nuclear type 32 0.0010788358313316428 0.265714\n",
      "MONDO:0033282 multiple mitochondrial dysfunctions syndrome 5 0.0010788358313316428 0.265714\n",
      "MONDO:0014904 congenital disorder of glycosylation, type IAA 0.0010788358313316428 0.265714\n",
      "MONDO:0014116 complex cortical dysplasia with other brain malformations 2 0.0010788358313316428 0.265714\n",
      "MONDO:0014996 intellectual disability, autosomal recessive 58 0.0010788358313316428 0.265714\n",
      "MONDO:0014235 chromosome 22q13 duplication syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0013702 intellectual disability, autosomal recessive 27 0.0010788358313316428 0.265714\n",
      "MONDO:0957225 neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities 0.0010788358313316428 0.265714\n",
      "MONDO:0100119 Knobloch syndrome 2 0.0010788358313316428 0.265714\n",
      "MONDO:0010569 X-linked complicated corpus callosum dysgenesis 0.0010788358313316428 0.265714\n",
      "MONDO:0010487 intellectual disability, X-linked 99 0.0010788358313316428 0.265714\n",
      "MONDO:0014210 intellectual disability-hypotonia-spasticity-sleep disorder syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0014297 Joubert syndrome 22 0.0010788358313316428 0.265714\n",
      "MONDO:0033667 Delpire-McNeill syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0010580 immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0011101 peroxisome biogenesis disorder 1B 0.0010788358313316428 0.265714\n",
      "MONDO:0033546 neurodegeneration, infantile-onset, biotin-responsive 0.0010788358313316428 0.265714\n",
      "MONDO:0009168 Fowler syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0014447 Bardet-Biedl syndrome 19 0.0010788358313316428 0.265714\n",
      "MONDO:0054776 epilepsy, familial focal, with variable foci 4 0.0010788358313316428 0.265714\n",
      "MONDO:0009488 keratoconus posticus circumscriptus 0.0010788358313316428 0.265714\n",
      "MONDO:0032877 neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures 0.0010788358313316428 0.265714\n",
      "MONDO:0010815 spondyloepiphyseal dysplasia tarda with characteristic facies 0.0010788358313316428 0.265714\n",
      "MONDO:0054549 peroxisome biogenesis disorder 10B 0.0010788358313316428 0.265714\n",
      "MONDO:0054559 congenital disorder of glycosylation, type IIq 0.0010788358313316428 0.265714\n",
      "MONDO:0032605 intellectual disability, autosomal recessive 66 0.0010788358313316428 0.265714\n",
      "MONDO:0032882 Heyn-Sproul-Jackson syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0010375 developmental and epileptic encephalopathy, 8 0.0010788358313316428 0.265714\n",
      "MONDO:0009606 methemoglobinemia due to deficiency of methemoglobin reductase 0.0010788358313316428 0.265714\n",
      "MONDO:0014886 severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0044304 hyperphenylalaninemia due to DNAJC12 deficiency 0.0010788358313316428 0.265714\n",
      "MONDO:0032621 mitochondrial complex 1 deficiency, nuclear type 16 0.0010788358313316428 0.265714\n",
      "MONDO:0014719 developmental and epileptic encephalopathy, 35 0.0010788358313316428 0.265714\n",
      "MONDO:0012964 chromosome 15q26-qter deletion syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0015015 congenital bile acid synthesis defect 6 0.0010788358313316428 0.265714\n",
      "MONDO:0013803 leukoencephalopathy with calcifications and cysts 0.0010788358313316428 0.265714\n",
      "MONDO:0013353 intellectual disability, anterior maxillary protrusion, and strabismus 0.0010788358313316428 0.265714\n",
      "MONDO:0014159 autosomal recessive spinocerebellar ataxia 14 0.0010788358313316428 0.265714\n",
      "MONDO:0010392 glycogen storage disease due to phosphoglycerate kinase 1 deficiency 0.0010788358313316428 0.265714\n",
      "MONDO:0013527 lissencephaly 4 0.0010788358313316428 0.265714\n",
      "MONDO:0859305 neurodevelopmental disorder with eye movement abnormalities and ataxia 0.0010788358313316428 0.265714\n",
      "MONDO:0013827 hyperekplexia 3 0.0010788358313316428 0.265714\n",
      "MONDO:0014200 aldosterone-producing adenoma with seizures and neurological abnormalities 0.0010788358313316428 0.265714\n",
      "MONDO:0013321 forsythe-wakeling syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0014260 immunodeficiency, common variable, 10 0.0010788358313316428 0.265714\n",
      "MONDO:0021013 trichothiodystrophy 4, nonphotosensitive 0.0010788358313316428 0.265714\n",
      "MONDO:0014832 intellectual disability, autosomal recessive 53 0.0010788358313316428 0.265714\n",
      "MONDO:0032900 neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements 0.0010788358313316428 0.265714\n",
      "MONDO:0014793 microcephaly-congenital cataract-psoriasiform dermatitis syndrome 0.0010788358313316428 0.265714\n",
      "MONDO:0859263 developmental delay, impaired speech, and behavioral abnormalities, with or without seizures 0.0010788358313316428 0.265714\n",
      "MONDO:0014820 mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type) 0.0010788358313316428 0.265714\n",
      "MONDO:0030088 diabetes mellitus, permanent neonatal 3 0.0010788358313316428 0.265714\n",
      "MONDO:0014862 cerebral palsy, spastic quadriplegic, 3 0.0011866553799647767 0.261698\n",
      "MONDO:0859357 congenital disorder of glycosylation, type IIz 0.0011866553799647767 0.261698\n",
      "MONDO:0012308 Joubert syndrome with renal defect 0.0011866553799647767 0.261698\n",
      "MONDO:0031052 developmental and epileptic encephalopathy 106 0.0011866553799647767 0.261698\n",
      "MONDO:0030988 developmental delay with dysmorphic facies and dental anomalies 0.0011866553799647767 0.261698\n",
      "MONDO:0032870 intellectual developmental disorder with short stature and behavioral abnormalities 0.0011866553799647767 0.261698\n",
      "MONDO:0010660 intellectual disability, X-linked 9 0.0011866553799647767 0.261698\n",
      "MONDO:0014784 severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome 0.0011866553799647767 0.261698\n",
      "MONDO:0044330 hyperekplexia 4 0.0011866553799647767 0.261698\n",
      "MONDO:0009781 Onychotrichodysplasia and neutropenia 0.0011866553799647767 0.261698\n",
      "MONDO:0044323 Rahman syndrome 0.0011866553799647767 0.261698\n",
      "MONDO:0009257 galactose epimerase deficiency 0.0011866553799647767 0.261698\n",
      "MONDO:0013164 beta-ureidopropionase deficiency 0.0011866553799647767 0.261698\n",
      "MONDO:0014718 developmental and epileptic encephalopathy, 34 0.0011866553799647767 0.261698\n",
      "MONDO:0011830 lissencephaly due to LIS1 mutation 0.0011866553799647767 0.261698\n",
      "MONDO:0060745 intellectual developmental disorder with or without epilepsy or cerebellar ataxia 0.0011866553799647767 0.261698\n",
      "MONDO:0030087 diabetes mellitus, permanent neonatal 2 0.0011866553799647767 0.261698\n",
      "MONDO:0033365 developmental and epileptic encephalopathy, 56 0.0011866553799647767 0.261698\n",
      "MONDO:0030971 immunodeficiency 78 with autoimmunity and developmental delay 0.0011866553799647767 0.261698\n",
      "MONDO:0012221 alpha-N-acetylgalactosaminidase deficiency type 1 0.0011866553799647767 0.261698\n",
      "MONDO:0011215 osteocraniostenosis 0.0011866553799647767 0.261698\n",
      "MONDO:0859253 osteoporosis, childhood- or juvenile-onset, with developmental delay 0.0011866553799647767 0.261698\n",
      "MONDO:0014113 cardiofaciocutaneous syndrome 3 0.0011866553799647767 0.261698\n",
      "MONDO:0030528 immunodeficiency 93 and hypertrophic cardiomyopathy 0.0011866553799647767 0.261698\n",
      "MONDO:0012805 childhood onset GLUT1 deficiency syndrome 2 0.0011866553799647767 0.261698\n",
      "MONDO:0014341 complex cortical dysplasia with other brain malformations 6 0.0011866553799647767 0.261698\n",
      "MONDO:0033308 Joubert syndrome 30 0.0011866553799647767 0.261698\n",
      "MONDO:0031060 microcephaly 29, primary, autosomal recessive 0.0011866553799647767 0.261698\n",
      "MONDO:0011966 periventricular heterotopia with microcephaly, autosomal recessive 0.0011866553799647767 0.261698\n",
      "MONDO:0014477 developmental and epileptic encephalopathy, 26 0.0011866553799647767 0.261698\n",
      "MONDO:0013656 intellectual disability, autosomal dominant 9 0.0011866553799647767 0.261698\n",
      "MONDO:0032634 mitochondrial complex 1 deficiency, nuclear type 31 0.0011866553799647767 0.261698\n",
      "MONDO:0033009 Galloway-Mowat syndrome 5 0.0011866553799647767 0.261698\n",
      "MONDO:0859362 hyperinsulinemic hypoglycemia, familial, 8 0.0011866553799647767 0.261698\n",
      "MONDO:0011995 cataract - congenital heart disease - neural tube defect syndrome 0.0011866553799647767 0.261698\n",
      "MONDO:0014927 Joubert syndrome 27 0.0011866553799647767 0.261698\n",
      "MONDO:0012553 cerebrooculofacioskeletal syndrome 2 0.0011866553799647767 0.261698\n",
      "MONDO:0030911 intellectual disability, autosomal dominant 46 0.0011866553799647767 0.261698\n",
      "MONDO:0032685 infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development 0.0011866553799647767 0.261698\n",
      "MONDO:0014685 progressive myoclonic epilepsy type 9 0.0011866553799647767 0.261698\n",
      "MONDO:0014962 intellectual disability, autosomal recessive 57 0.0011866553799647767 0.261698\n",
      "MONDO:0013166 GABA aminotransaminase deficiency 0.0011866553799647767 0.261698\n",
      "MONDO:0032617 mitochondrial complex 1 deficiency, nuclear type 11 0.0011866553799647767 0.261698\n",
      "MONDO:0014691 Noonan syndrome 9 0.0011866553799647767 0.261698\n",
      "MONDO:0032887 neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity 0.0011866553799647767 0.261698\n",
      "MONDO:0033566 combined oxidative phosphorylation deficiency 48 0.0011866553799647767 0.261698\n",
      "MONDO:0016368 Rothmund-Thomson syndrome type 1 0.0011866553799647767 0.261698\n",
      "MONDO:0030921 intellectual disability, autosomal dominant 55, with seizures 0.0011866553799647767 0.261698\n",
      "MONDO:0014445 Bardet-Biedl syndrome 17 0.0011866553799647767 0.261698\n",
      "MONDO:0033361 developmental and epileptic encephalopathy, 52 0.0011866553799647767 0.261698\n",
      "MONDO:0014775 combined oxidative phosphorylation deficiency 28 0.0011866553799647767 0.261698\n",
      "MONDO:0013680 cognitive impairment with or without cerebellar ataxia 0.0011866553799647767 0.261698\n",
      "MONDO:0014059 microphthalmia, isolated, with coloboma 9 0.0011866553799647767 0.261698\n",
      "MONDO:0014828 immunodeficiency-centromeric instability-facial anomalies syndrome 3 0.0011866553799647767 0.261698\n",
      "MONDO:0010336 orofaciodigital syndrome VIII 0.0011866553799647767 0.261698\n",
      "MONDO:0054701 Kleefstra syndrome 2 0.0011866553799647767 0.261698\n",
      "MONDO:0013541 complex cortical dysplasia with other brain malformations 1 0.0011866553799647767 0.261698\n",
      "MONDO:0032729 intellectual developmental disorder, autosomal recessive 70 0.0011866553799647767 0.261698\n",
      "MONDO:0020846 intellectual disability, autosomal recessive 64 0.0011866553799647767 0.261698\n",
      "MONDO:0014409 intellectual disability, autosomal recessive 44 0.0011866553799647767 0.261698\n",
      "MONDO:0014495 retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome 0.0011866553799647767 0.261698\n",
      "MONDO:0013811 combined oxidative phosphorylation defect type 9 0.0011866553799647767 0.261698\n",
      "MONDO:0014254 otofaciocervical syndrome 2 0.0011866553799647767 0.261698\n",
      "MONDO:0032662 intellectual developmental disorder, autosomal recessive 67 0.001294463290987769 0.258066\n",
      "MONDO:0010462 syndromic X-linked intellectual disability Chudley-Schwartz type 0.001294463290987769 0.258066\n",
      "MONDO:0009625 diencephalic-mesencephalic junction dysplasia syndrome 1 0.001294463290987769 0.258066\n",
      "MONDO:0033570 combined oxidative phosphorylation deficiency 50 0.001294463290987769 0.258066\n",
      "MONDO:0013658 intellectual disability, autosomal dominant 11 0.001294463290987769 0.258066\n",
      "MONDO:0031055 developmental and epileptic encephalopathy 107 0.001294463290987769 0.258066\n",
      "MONDO:0015004 dystonia 28, childhood-onset 0.001294463290987769 0.258066\n",
      "MONDO:0014496 mitochondrial complex III deficiency nuclear type 9 0.001294463290987769 0.258066\n",
      "MONDO:0033367 developmental and epileptic encephalopathy, 58 0.001294463290987769 0.258066\n",
      "MONDO:0060666 hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0033366 developmental and epileptic encephalopathy, 57 0.001294463290987769 0.258066\n",
      "MONDO:0020631 epileptic encephalopathy, infantile or early childhood, 2 0.001294463290987769 0.258066\n",
      "MONDO:0010533 Arts syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0013634 neuropathy, hereditary sensory, type 2C 0.001294463290987769 0.258066\n",
      "MONDO:0009556 malonic aciduria 0.001294463290987769 0.258066\n",
      "MONDO:0009349 holoprosencephaly 1 0.001294463290987769 0.258066\n",
      "MONDO:0054602 gaze palsy, familial horizontal, with progressive scoliosis, 2 0.001294463290987769 0.258066\n",
      "MONDO:0014952 intellectual disability-epilepsy-extrapyramidal syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0012407 pyridoxal phosphate-responsive seizures 0.001294463290987769 0.258066\n",
      "MONDO:0010907 familial hypertryptophanemia 0.001294463290987769 0.258066\n",
      "MONDO:0014199 developmental and epileptic encephalopathy, 17 0.001294463290987769 0.258066\n",
      "MONDO:0030912 intellectual disability, autosomal dominant 47 0.001294463290987769 0.258066\n",
      "MONDO:0026763 holoprosencephaly 13, X-linked 0.001294463290987769 0.258066\n",
      "MONDO:0014593 developmental and epileptic encephalopathy, 29 0.001294463290987769 0.258066\n",
      "MONDO:0044322 intellectual developmental disorder with neuropsychiatric features 0.001294463290987769 0.258066\n",
      "MONDO:0030318 spinocerebellar ataxia, autosomal recessive 30 0.001294463290987769 0.258066\n",
      "MONDO:0012539 Joubert syndrome 6 0.001294463290987769 0.258066\n",
      "MONDO:0032715 intellectual developmental disorder, autosomal recessive 69 0.001294463290987769 0.258066\n",
      "MONDO:0012960 intellectual disability, autosomal dominant 5 0.001294463290987769 0.258066\n",
      "MONDO:0030963 Li-Campeau syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0014487 congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0011530 mesomelic dysplasia, Savarirayan type 0.001294463290987769 0.258066\n",
      "MONDO:0013918 distal tetrasomy 15q 0.001294463290987769 0.258066\n",
      "MONDO:0014140 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 0.001294463290987769 0.258066\n",
      "MONDO:0014951 intellectual developmental disorder, autosomal recessive 74 0.001294463290987769 0.258066\n",
      "MONDO:0012994 dopa-responsive dystonia due to sepiapterin reductase deficiency 0.001294463290987769 0.258066\n",
      "MONDO:0010657 methylmalonic acidemia with homocystinuria, type cblX 0.001294463290987769 0.258066\n",
      "MONDO:0030037 neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures 0.001294463290987769 0.258066\n",
      "MONDO:0030907 intellectual disability, X-linked 106 0.001294463290987769 0.258066\n",
      "MONDO:0033618 Vissers-Bodmer syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0011488 microcephaly 3, primary, autosomal recessive 0.001294463290987769 0.258066\n",
      "MONDO:0030891 intellectual developmental disorder, autosomal dominant 66 0.001294463290987769 0.258066\n",
      "MONDO:0859242 leukodystrophy, hypomyelinating, 24 0.001294463290987769 0.258066\n",
      "MONDO:0012761 chromosome 3q29 microduplication syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0014730 microcephaly 16, primary, autosomal recessive 0.001294463290987769 0.258066\n",
      "MONDO:0012694 Joubert syndrome 7 0.001294463290987769 0.258066\n",
      "MONDO:0014065 mitochondrial complex III deficiency nuclear type 4 0.001294463290987769 0.258066\n",
      "MONDO:0009543 prominent glabella-microcephaly-hypogenitalism syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0014311 autosomal recessive spinocerebellar ataxia 15 0.001294463290987769 0.258066\n",
      "MONDO:0014273 microcephaly-thin corpus callosum-intellectual disability syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0012596 PSAT deficiency 0.001294463290987769 0.258066\n",
      "MONDO:0032759 intellectual developmental disorder with short stature and variable skeletal anomalies 0.001294463290987769 0.258066\n",
      "MONDO:0014789 CCDC115-CDG 0.001294463290987769 0.258066\n",
      "MONDO:0009376 carbamoyl phosphate synthetase I deficiency disease 0.001294463290987769 0.258066\n",
      "MONDO:0859266 neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy 0.001294463290987769 0.258066\n",
      "MONDO:0859237 3-methylglutaconic aciduria, type VIIA 0.001294463290987769 0.258066\n",
      "MONDO:0020790 gaze palsy, familial horizontal, with progressive scoliosis 1 0.001294463290987769 0.258066\n",
      "MONDO:0010873 band heterotopia of brain 0.001294463290987769 0.258066\n",
      "MONDO:0013362 THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome 0.001294463290987769 0.258066\n",
      "MONDO:0011449 Salla disease 0.001294463290987769 0.258066\n",
      "MONDO:0009440 ichthyosiform erythroderma, corneal involvement, and hearing loss 0.001294463290987769 0.258066\n",
      "MONDO:0011336 familial hemophagocytic lymphohistiocytosis 4 0.001294463290987769 0.258066\n",
      "MONDO:0012855 Joubert syndrome 8 0.001294463290987769 0.258066\n",
      "MONDO:0024607 congenital muscular dystrophy with cataracts and intellectual disability 0.0014022595656567425 0.254754\n",
      "MONDO:0013931 peroxisome biogenesis disorder 4B 0.0014022595656567425 0.254754\n",
      "MONDO:0859231 macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin 0.0014022595656567425 0.254754\n",
      "MONDO:0009862 dihydropteridine reductase deficiency 0.0014022595656567425 0.254754\n",
      "MONDO:0009279 triple-A syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0014921 developmental and epileptic encephalopathy, 43 0.0014022595656567425 0.254754\n",
      "MONDO:0033658 neurodevelopmental disorder with seizures and brain atrophy 0.0014022595656567425 0.254754\n",
      "MONDO:0013281 COG4-congenital disorder of glycosylation 0.0014022595656567425 0.254754\n",
      "MONDO:0014066 mitochondrial complex III deficiency nuclear type 5 0.0014022595656567425 0.254754\n",
      "MONDO:0859260 Dworschak-Punetha neurodevelopmental syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0008287 Greig cephalopolysyndactyly syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0859285 neurodevelopmental disorder with microcephaly, short stature, and speech delay 0.0014022595656567425 0.254754\n",
      "MONDO:0009866 phosphoenolpyruvate carboxykinase deficiency, cytosolic 0.0014022595656567425 0.254754\n",
      "MONDO:0009238 hereditary folate malabsorption 0.0014022595656567425 0.254754\n",
      "MONDO:0032875 short stature and microcephaly with genital anomalies 0.0014022595656567425 0.254754\n",
      "MONDO:0030378 combined oxidative phosphorylation deficiency 53 0.0014022595656567425 0.254754\n",
      "MONDO:0013865 mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency 0.0014022595656567425 0.254754\n",
      "MONDO:0010467 Xq27.3q28 duplication syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0030673 spastic paraplegia 86, autosomal recessive 0.0014022595656567425 0.254754\n",
      "MONDO:0011736 Cree intellectual disability syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0014705 craniosynostosis 6 0.0014022595656567425 0.254754\n",
      "MONDO:0030730 Tessadori-van Haaften neurodevelopmental syndrome 2 0.0014022595656567425 0.254754\n",
      "MONDO:0024552 linear skin defects with multiple congenital anomalies 1 0.0014022595656567425 0.254754\n",
      "MONDO:0007733 holoprosencephaly 3 0.0014022595656567425 0.254754\n",
      "MONDO:0014678 intellectual disability, autosomal dominant 39 0.0014022595656567425 0.254754\n",
      "MONDO:0014746 SLC39A8-CDG 0.0014022595656567425 0.254754\n",
      "MONDO:0009509 Landau-Kleffner syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0013962 hereditary spastic paraplegia 53 0.0014022595656567425 0.254754\n",
      "MONDO:0033641 cleft palate, proliferative retinopathy, and developmental delay 0.0014022595656567425 0.254754\n",
      "MONDO:0014807 spinal muscular atrophy with congenital bone fractures 2 0.0014022595656567425 0.254754\n",
      "MONDO:0011437 microcephaly 4, primary, autosomal recessive 0.0014022595656567425 0.254754\n",
      "MONDO:0011964 DPAGT1-congenital disorder of glycosylation 0.0014022595656567425 0.254754\n",
      "MONDO:0030902 mitochondrial complex 1 deficiency, nuclear type 36 0.0014022595656567425 0.254754\n",
      "MONDO:0032596 myasthenic syndrome, congenital, 23, presynaptic 0.0014022595656567425 0.254754\n",
      "MONDO:0013549 N-acetylaspartate deficiency 0.0014022595656567425 0.254754\n",
      "MONDO:0009624 microcephaly and chorioretinopathy 1 0.0014022595656567425 0.254754\n",
      "MONDO:0049222 intellectual disability, X-linked 107 0.0014022595656567425 0.254754\n",
      "MONDO:0859085 neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked 0.0014022595656567425 0.254754\n",
      "MONDO:0014976 lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0014150 developmental and epileptic encephalopathy 94 0.0014022595656567425 0.254754\n",
      "MONDO:0032665 intellectual developmental disorder, autosomal recessive 68 0.0014022595656567425 0.254754\n",
      "MONDO:0010185 methylmalonic aciduria and homocystinuria type cblD 0.0014022595656567425 0.254754\n",
      "MONDO:0859277 intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects 0.0014022595656567425 0.254754\n",
      "MONDO:0014096 microcephaly-intellectual disability-phalangeal and neurological anomalies syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0009874 Rabson-Mendenhall syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0032648 mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations 0.0014022595656567425 0.254754\n",
      "MONDO:0014486 intellectual disability, autosomal dominant 30 0.0014022595656567425 0.254754\n",
      "MONDO:0011639 Diamond-Blackfan anemia 15 with mandibulofacial dysostosis 0.0014022595656567425 0.254754\n",
      "MONDO:0014077 cobblestone lissencephaly without muscular or ocular involvement 0.0014022595656567425 0.254754\n",
      "MONDO:0014928 Joubert syndrome 28 0.0014022595656567425 0.254754\n",
      "MONDO:0010265 Simpson-Golabi-Behmel syndrome type 2 0.0014022595656567425 0.254754\n",
      "MONDO:0030964 intellectual developmental disorder, autosomal dominant 67 0.0014022595656567425 0.254754\n",
      "MONDO:0013292 chromosome 4q21 deletion syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0031021 developmental and epileptic encephalopathy 104 0.0014022595656567425 0.254754\n",
      "MONDO:0009609 methylcobalamin deficiency type cblG 0.0014022595656567425 0.254754\n",
      "MONDO:0032623 mitochondrial complex 1 deficiency, nuclear type 18 0.0014022595656567425 0.254754\n",
      "MONDO:0033006 Galloway-Mowat syndrome 2, X-linked 0.0014022595656567425 0.254754\n",
      "MONDO:0008722 short chain acyl-CoA dehydrogenase deficiency 0.0014022595656567425 0.254754\n",
      "MONDO:0010490 SSR4-congenital disorder of glycosylation 0.0014022595656567425 0.254754\n",
      "MONDO:0014072 D,L-2-hydroxyglutaric aciduria 0.0014022595656567425 0.254754\n",
      "MONDO:0033371 developmental and epileptic encephalopathy, 62 0.0014022595656567425 0.254754\n",
      "MONDO:0024506 Adams-Oliver syndrome 1 0.0014022595656567425 0.254754\n",
      "MONDO:0030376 Martsolf syndrome 2 0.0014022595656567425 0.254754\n",
      "MONDO:0032693 Galloway-Mowat syndrome 8 0.0014022595656567425 0.254754\n",
      "MONDO:0100217 developmental delay with short stature, dysmorphic facial features, and sparse hair 2 0.0014022595656567425 0.254754\n",
      "MONDO:0014822 15q14 microdeletion syndrome 0.0014022595656567425 0.254754\n",
      "MONDO:0014625 developmental and epileptic encephalopathy, 33 0.0014022595656567425 0.254754\n",
      "MONDO:0013404 hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase 0.0015100442052276759 0.251713\n",
      "MONDO:0014752 nephrotic syndrome, type 11 0.0015100442052276759 0.251713\n",
      "MONDO:0014917 developmental and epileptic encephalopathy, 42 0.0015100442052276759 0.251713\n",
      "MONDO:0011867 microphthalmia with cyst, bilateral facial clefts, and limb anomalies 0.0015100442052276759 0.251713\n",
      "MONDO:0020770 spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3 0.0015100442052276759 0.251713\n",
      "MONDO:0013840 encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0859519 neurodevelopmental disorder with absent speech and movement and behavioral abnormalities 0.0015100442052276759 0.251713\n",
      "MONDO:0009544 macrocephaly/megalencephaly syndrome, autosomal recessive 0.0015100442052276759 0.251713\n",
      "MONDO:0030674 Teebi hypertelorism syndrome 2 0.0015100442052276759 0.251713\n",
      "MONDO:0012399 complex cortical dysplasia with other brain malformations 7 0.0015100442052276759 0.251713\n",
      "MONDO:0030471 Galloway-Mowat syndrome 9 0.0015100442052276759 0.251713\n",
      "MONDO:0011533 temtamy preaxial brachydactyly syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0007247 basal ganglia calcification, idiopathic, childhood-onset 0.0015100442052276759 0.251713\n",
      "MONDO:0014647 developmental and epileptic encephalopathy, 50 0.0015100442052276759 0.251713\n",
      "MONDO:0014101 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 0.0015100442052276759 0.251713\n",
      "MONDO:0014392 developmental and epileptic encephalopathy, 25 0.0015100442052276759 0.251713\n",
      "MONDO:0014473 microcephaly 13, primary, autosomal recessive 0.0015100442052276759 0.251713\n",
      "MONDO:0054742 combined oxidative phosphorylation deficiency 35 0.0015100442052276759 0.251713\n",
      "MONDO:0013762 lipoic acid synthetase deficiency 0.0015100442052276759 0.251713\n",
      "MONDO:0013438 pontocerebellar hypoplasia type 2D 0.0015100442052276759 0.251713\n",
      "MONDO:0859361 neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia 0.0015100442052276759 0.251713\n",
      "MONDO:0013007 combined immunodeficiency due to ORAI1 deficiency 0.0015100442052276759 0.251713\n",
      "MONDO:0013351 infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly 0.0015100442052276759 0.251713\n",
      "MONDO:0030060 neurodevelopmental disorder with language impairment and behavioral abnormalities 0.0015100442052276759 0.251713\n",
      "MONDO:0007204 Cole-Carpenter syndrome 1 0.0015100442052276759 0.251713\n",
      "MONDO:0014683 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 0.0015100442052276759 0.251713\n",
      "MONDO:0010250 intellectual disability, X-linked 49 0.0015100442052276759 0.251713\n",
      "MONDO:0030353 Joubert syndrome 38 0.0015100442052276759 0.251713\n",
      "MONDO:0030537 central hypoventilation syndrome, congenital, 2, and autonomic dysfunction 0.0015100442052276759 0.251713\n",
      "MONDO:0010854 Toriello-Lacassie-Droste syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0010507 Xq25 microduplication syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0032901 Catifa syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0033362 developmental and epileptic encephalopathy, 53 0.0015100442052276759 0.251713\n",
      "MONDO:0013349 ALG11-congenital disorder of glycosylation 0.0015100442052276759 0.251713\n",
      "MONDO:0013336 chromosome 19p13.13 deletion syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0010364 X-linked intellectual disability-retinitis pigmentosa syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0014805 Hao-Fountain syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0014559 progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0012052 ALG1-congenital disorder of glycosylation 0.0015100442052276759 0.251713\n",
      "MONDO:0030930 neurodevelopmental disorder with or without early-onset generalized epilepsy 0.0015100442052276759 0.251713\n",
      "MONDO:0011229 ethylmalonic encephalopathy 0.0015100442052276759 0.251713\n",
      "MONDO:0032813 developmental and epileptic encephalopathy, 79 0.0015100442052276759 0.251713\n",
      "MONDO:0020858 mitochondrial complex 5 (ATP synthase) deficiency nuclear type 5 0.0015100442052276759 0.251713\n",
      "MONDO:0008305 Currarino triad 0.0015100442052276759 0.251713\n",
      "MONDO:0032622 mitochondrial complex 1 deficiency, nuclear type 17 0.0015100442052276759 0.251713\n",
      "MONDO:0013521 dyskeratosis congenita, autosomal dominant 2 0.0015100442052276759 0.251713\n",
      "MONDO:0859258 neurodevelopmental disorder with dystonia and seizures 0.0015100442052276759 0.251713\n",
      "MONDO:0012178 intellectual disability with optic atrophy, facial dysmorphism, microcephaly, and short stature 0.0015100442052276759 0.251713\n",
      "MONDO:0012186 Fanconi anemia complementation group I 0.0015100442052276759 0.251713\n",
      "MONDO:0014781 combined oxidative phosphorylation deficiency 29 0.0015100442052276759 0.251713\n",
      "MONDO:0010397 severe neonatal-onset encephalopathy with microcephaly 0.0015100442052276759 0.251713\n",
      "MONDO:0030929 microcephaly 27, primary, autosomal dominant 0.0015100442052276759 0.251713\n",
      "MONDO:0007938 46,XY sex reversal 4 0.0015100442052276759 0.251713\n",
      "MONDO:0859378 leukodystrophy, hypomyelinating, 25 0.0015100442052276759 0.251713\n",
      "MONDO:0012436 neonatal diabetes mellitus with congenital hypothyroidism 0.0015100442052276759 0.251713\n",
      "MONDO:0014034 severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0030995 global developmental delay with speech and behavioral abnormalities 0.0015100442052276759 0.251713\n",
      "MONDO:0012432 Joubert syndrome 5 0.0015100442052276759 0.251713\n",
      "MONDO:0008988 citrullinemia type I 0.0015100442052276759 0.251713\n",
      "MONDO:0859196 Usmani-Riazuddin syndrome, autosomal recessive 0.0015100442052276759 0.251713\n",
      "MONDO:0013159 muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 0.0015100442052276759 0.251713\n",
      "MONDO:0009404 hypertelorism, microtia, facial clefting syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0032616 mitochondrial complex 1 deficiency, nuclear type 10 0.0015100442052276759 0.251713\n",
      "MONDO:0010325 X-linked intellectual disability, Stocco dos Santos type 0.0015100442052276759 0.251713\n",
      "MONDO:0036189 oculogastrointestinal-neurodevelopmental syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0014545 progressive myoclonic epilepsy type 8 0.0015100442052276759 0.251713\n",
      "MONDO:0100220 Rajab interstitial lung disease with brain calcifications 2 0.0015100442052276759 0.251713\n",
      "MONDO:0957254 mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A 0.0015100442052276759 0.251713\n",
      "MONDO:0008209 Char syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0033615 coenzyme q10 deficiency, primary, 9 0.0015100442052276759 0.251713\n",
      "MONDO:0033309 Joubert syndrome 32 0.0015100442052276759 0.251713\n",
      "MONDO:0009735 Netherton syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0014778 Lamb-Shaffer syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0859240 intellectual developmental disorder with or without peripheral neuropathy 0.0016178172109564157 0.248904\n",
      "MONDO:0859262 ACCES syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0859257 intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism 0.0016178172109564157 0.248904\n",
      "MONDO:0012368 aminoacylase 1 deficiency 0.0016178172109564157 0.248904\n",
      "MONDO:0014905 encephalopathy due to defective mitochondrial and peroxisomal fission 2 0.0016178172109564157 0.248904\n",
      "MONDO:0030937 mitochondrial complex 2 deficiency, nuclear type 3 0.0016178172109564157 0.248904\n",
      "MONDO:0012856 Birk-Barel syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0030878 Kaya-Barakat-Masson syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0010979 Timothy syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0013760 congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0009503 pyruvate dehydrogenase E3-binding protein deficiency 0.0016178172109564157 0.248904\n",
      "MONDO:0013933 peroxisome biogenesis disorder 5B 0.0016178172109564157 0.248904\n",
      "MONDO:0014457 hyperphosphatasia with intellectual disability syndrome 5 0.0016178172109564157 0.248904\n",
      "MONDO:0010263 Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0012290 CEDNIK syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0014947 developmental and epileptic encephalopathy, 46 0.0016178172109564157 0.248904\n",
      "MONDO:0000208 microcephaly, short stature, and impaired glucose metabolism 1 0.0016178172109564157 0.248904\n",
      "MONDO:0020777 congenital disorder of glycosylation with defective fucosylation 2 0.0016178172109564157 0.248904\n",
      "MONDO:0859229 cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism 0.0016178172109564157 0.248904\n",
      "MONDO:0030472 developmental and epileptic encephalopathy 98 0.0016178172109564157 0.248904\n",
      "MONDO:0009990 Revesz syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0032570 Joubert syndrome 35 0.0016178172109564157 0.248904\n",
      "MONDO:0032830 snijders blok-fisher syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0032858 developmental and epileptic encephalopathy, 81 0.0016178172109564157 0.248904\n",
      "MONDO:0030677 Charcot-Marie-Tooth disease, demyelinating, IIA 1I 0.0016178172109564157 0.248904\n",
      "MONDO:0011686 DNA ligase IV deficiency 0.0016178172109564157 0.248904\n",
      "MONDO:0060568 Pilarowski-Bjornsson syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0030059 developmental and epileptic encephalopathy, 87 0.0016178172109564157 0.248904\n",
      "MONDO:0009354 methylcobalamin deficiency type cblE 0.0016178172109564157 0.248904\n",
      "MONDO:0029138 developmental and epileptic encephalopathy, 67 0.0016178172109564157 0.248904\n",
      "MONDO:0011738 bilateral frontoparietal polymicrogyria 0.0016178172109564157 0.248904\n",
      "MONDO:0014133 developmental and epileptic encephalopathy, 16 0.0016178172109564157 0.248904\n",
      "MONDO:0012859 autosomal recessive osteopetrosis 7 0.0016178172109564157 0.248904\n",
      "MONDO:0014044 dysmorphism-conductive hearing loss-heart defect syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0014031 microcephalic primordial dwarfism, Alazami type 0.0016178172109564157 0.248904\n",
      "MONDO:0014516 microcephaly and chorioretinopathy 2 0.0016178172109564157 0.248904\n",
      "MONDO:0010363 intellectual disability, X-linked 91 0.0016178172109564157 0.248904\n",
      "MONDO:0032912 Coffin-Siris syndrome 11 0.0016178172109564157 0.248904\n",
      "MONDO:0032850 neurooculocardiogenitourinary syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0030072 developmental and epileptic encephalopathy, 88 0.0016178172109564157 0.248904\n",
      "MONDO:0014848 TELO2-related intellectual disability-neurodevelopmental disorder 0.0016178172109564157 0.248904\n",
      "MONDO:0859272 neurodevelopmental disorder with speech delay and variable ocular anomalies 0.0016178172109564157 0.248904\n",
      "MONDO:0014530 autosomal recessive spinocerebellar ataxia 18 0.0016178172109564157 0.248904\n",
      "MONDO:0032625 mitochondrial complex 1 deficiency, nuclear type 21 0.0016178172109564157 0.248904\n",
      "MONDO:0032931 pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal 0.0016178172109564157 0.248904\n",
      "MONDO:0010709 early-onset parkinsonism-intellectual disability syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0014224 developmental delay with autism spectrum disorder and gait instability 0.0016178172109564157 0.248904\n",
      "MONDO:0033363 developmental and epileptic encephalopathy, 54 0.0016178172109564157 0.248904\n",
      "MONDO:0013059 Aicardi-Goutieres syndrome 5 0.0016178172109564157 0.248904\n",
      "MONDO:0014399 ataxia-telangiectasia-like disorder 2 0.0016178172109564157 0.248904\n",
      "MONDO:0030312 spinocerebellar ataxia, autosomal recessive 29 0.0016178172109564157 0.248904\n",
      "MONDO:0009603 3-hydroxyisobutyryl-CoA hydrolase deficiency 0.0016178172109564157 0.248904\n",
      "MONDO:0957203 intellectual developmental disorder, X-linked 111 0.0016178172109564157 0.248904\n",
      "MONDO:0014120 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 0.0016178172109564157 0.248904\n",
      "MONDO:0014485 pontocerebellar hypoplasia, type 1C 0.0016178172109564157 0.248904\n",
      "MONDO:0014288 Joubert syndrome 21 0.0016178172109564157 0.248904\n",
      "MONDO:0014141 muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14 0.0016178172109564157 0.248904\n",
      "MONDO:0013949 peroxisome biogenesis disorder 11A (Zellweger) 0.0016178172109564157 0.248904\n",
      "MONDO:0009104 Donnai-Barrow syndrome 0.0016178172109564157 0.248904\n",
      "MONDO:0009666 holocarboxylase synthetase deficiency 0.0016178172109564157 0.248904\n",
      "MONDO:0060533 microcephaly, short stature, and limb abnormalities 0.001725578584098671 0.246296\n",
      "MONDO:0013255 arthrogryposis, renal dysfunction, and cholestasis 2 0.001725578584098671 0.246296\n",
      "MONDO:0014596 lissencephaly 7 with cerebellar hypoplasia 0.001725578584098671 0.246296\n",
      "MONDO:0012400 cortical dysplasia-focal epilepsy syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0030900 intellectual developmental disorder with paroxysmal dyskinesia or seizures 0.001725578584098671 0.246296\n",
      "MONDO:0011313 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 0.001725578584098671 0.246296\n",
      "MONDO:0032609 mitochondrial complex 1 deficiency, nuclear type 4 0.001725578584098671 0.246296\n",
      "MONDO:0054781 combined oxidative phosphorylation deficiency 36 0.001725578584098671 0.246296\n",
      "MONDO:0012824 hypomyelinating leukodystrophy 4 0.001725578584098671 0.246296\n",
      "MONDO:0032710 developmental and epileptic encephalopathy, 72 0.001725578584098671 0.246296\n",
      "MONDO:0030881 developmental and epileptic encephalopathy 102 0.001725578584098671 0.246296\n",
      "MONDO:0011902 Charcot-Marie-Tooth disease type 1F 0.001725578584098671 0.246296\n",
      "MONDO:0859250 neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures 0.001725578584098671 0.246296\n",
      "MONDO:0010437 severe X-linked mitochondrial encephalomyopathy 0.001725578584098671 0.246296\n",
      "MONDO:0859176 neurodevelopmental disorder with motor and speech delay and behavioral abnormalities 0.001725578584098671 0.246296\n",
      "MONDO:0010327 HSD10 mitochondrial disease 0.001725578584098671 0.246296\n",
      "MONDO:0054785 multiple mitochondrial dysfunctions syndrome 6 0.001725578584098671 0.246296\n",
      "MONDO:0031011 neurodevelopmental disorder with dysmorphic facies and variable seizures 0.001725578584098671 0.246296\n",
      "MONDO:0032903 arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum 0.001725578584098671 0.246296\n",
      "MONDO:0014196 Hartsfield-Bixler-Demyer syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0008082 multiple endocrine neoplasia type 2B 0.001725578584098671 0.246296\n",
      "MONDO:0014505 developmental and epileptic encephalopathy, 27 0.001725578584098671 0.246296\n",
      "MONDO:0033533 combined oxidative phosphorylation deficiency 45 0.001725578584098671 0.246296\n",
      "MONDO:0012885 SRD5A3-congenital disorder of glycosylation 0.001725578584098671 0.246296\n",
      "MONDO:0008021 Cowden syndrome 1 0.001725578584098671 0.246296\n",
      "MONDO:0014801 even-plus syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0014874 pontocerebellar hypoplasia, type 2F 0.001725578584098671 0.246296\n",
      "MONDO:0013238 chromosome 17q23.1-q23.2 deletion syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0009953 leukocyte adhesion deficiency type II 0.001725578584098671 0.246296\n",
      "MONDO:0032568 intellectual developmental disorder with macrocephaly, seizures, and speech delay 0.001725578584098671 0.246296\n",
      "MONDO:0033559 intellectual developmental disorder with seizures and language delay 0.001725578584098671 0.246296\n",
      "MONDO:0013536 heme oxygenase 1 deficiency 0.001725578584098671 0.246296\n",
      "MONDO:0009554 3MC syndrome 3 0.001725578584098671 0.246296\n",
      "MONDO:0013458 hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0010099 Tay-Sachs disease AB variant 0.001725578584098671 0.246296\n",
      "MONDO:0014218 severe dermatitis-multiple allergies-metabolic wasting syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0054835 classic dopamine transporter deficiency syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0009610 3-methylglutaconic aciduria type 1 0.001725578584098671 0.246296\n",
      "MONDO:0030987 vertebral, cardiac, tracheoesophageal, renal, and limb defects 0.001725578584098671 0.246296\n",
      "MONDO:0014648 Al-Raqad syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0859211 neurodevelopmental disorder with hyperkinetic movements and dyskinesia 0.001725578584098671 0.246296\n",
      "MONDO:0011538 frontoocular syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0013875 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0859225 neurodevelopmental disorder with or without variable movement or behavioral abnormalities 0.001725578584098671 0.246296\n",
      "MONDO:0012703 lissencephaly due to TUBA1A mutation 0.001725578584098671 0.246296\n",
      "MONDO:0012772 Stevenson-Carey syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0012020 chromosome 22q11.2 microduplication syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0100079 developmental and epileptic encephalopathy, 6 0.001725578584098671 0.246296\n",
      "MONDO:0014660 microcephaly 15, primary, autosomal recessive 0.001725578584098671 0.246296\n",
      "MONDO:0032730 leukodystrophy, hypomyelinating, 18 0.001725578584098671 0.246296\n",
      "MONDO:0009746 hereditary sensory and autonomic neuropathy type 4 0.001725578584098671 0.246296\n",
      "MONDO:0013226 combined immunodeficiency with faciooculoskeletal anomalies 0.001725578584098671 0.246296\n",
      "MONDO:0014754 primary coenzyme Q10 deficiency 8 0.001725578584098671 0.246296\n",
      "MONDO:0012581 osteogenesis imperfecta type 8 0.001725578584098671 0.246296\n",
      "MONDO:0030873 cardiofacioneurodevelopmental syndrome 0.001725578584098671 0.246296\n",
      "MONDO:0011342 SLC35A1-congenital disorder of glycosylation 0.001725578584098671 0.246296\n",
      "MONDO:0033008 Galloway-Mowat syndrome 4 0.001725578584098671 0.246296\n",
      "MONDO:0030258 pontocerebellar hypoplasia, type 14 0.001725578584098671 0.246296\n",
      "MONDO:0030259 pontocerebellar hypoplasia, type 15 0.001725578584098671 0.246296\n",
      "MONDO:0014354 intellectual disability, autosomal recessive 43 0.0018333283259100194 0.243862\n",
      "MONDO:0010584 dyskeratosis congenita, X-linked 0.0018333283259100194 0.243862\n",
      "MONDO:0008763 Alstrom syndrome 0.0018333283259100194 0.243862\n",
      "MONDO:0011134 Curry-Jones syndrome 0.0018333283259100194 0.243862\n",
      "MONDO:0060759 neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures 0.0018333283259100194 0.243862\n",
      "MONDO:0013342 hereditary spastic paraplegia 48 0.0018333283259100194 0.243862\n",
      "MONDO:0013173 intellectual disability, autosomal recessive 13 0.0018333283259100194 0.243862\n",
      "MONDO:0032624 mitochondrial complex 1 deficiency, nuclear type 19 0.0018333283259100194 0.243862\n",
      "MONDO:0014602 intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome 0.0018333283259100194 0.243862\n",
      "MONDO:0044205 Shwachman-Diamond syndrome 2 0.0018333283259100194 0.243862\n",
      "MONDO:0014702 autosomal recessive complex spastic paraplegia type 9B 0.0018333283259100194 0.243862\n",
      "MONDO:0859307 cleidocranial dysplasia 2 0.0018333283259100194 0.243862\n",
      "MONDO:0859279 spinal muscular atrophy, distal, autosomal recessive, 6 0.0018333283259100194 0.243862\n",
      "MONDO:0032884 ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies 0.0018333283259100194 0.243862\n",
      "MONDO:0013969 combined oxidative phosphorylation defect type 11 0.0018333283259100194 0.243862\n",
      "MONDO:0014619 trichothiodystrophy 3, photosensitive 0.0018333283259100194 0.243862\n",
      "MONDO:0026720 mitochondrial complex 1 deficiency, nuclear type 12 0.0018333283259100194 0.243862\n",
      "MONDO:0033045 orofaciodigital syndrome 16 0.0018333283259100194 0.243862\n",
      "MONDO:0010953 Fanconi anemia complementation group E 0.0018333283259100194 0.243862\n",
      "MONDO:0010476 neurodegeneration with brain iron accumulation 5 0.0018333283259100194 0.243862\n",
      "MONDO:0012759 camptodactyly syndrome, Guadalajara type 3 0.0018333283259100194 0.243862\n",
      "MONDO:0032680 global developmental delay with or without impaired intellectual development 0.0018333283259100194 0.243862\n",
      "MONDO:0026727 Shukla-Vernon syndrome 0.0018333283259100194 0.243862\n",
      "MONDO:0859174 Usmani-Riazuddin syndrome, autosomal dominant 0.0018333283259100194 0.243862\n",
      "MONDO:0032632 mitochondrial complex 1 deficiency, nuclear type 28 0.0018333283259100194 0.243862\n",
      "MONDO:0018445 global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome 0.0018333283259100194 0.243862\n",
      "MONDO:0010431 Joubert syndrome 10 0.0018333283259100194 0.243862\n",
      "MONDO:0010749 trigonocephaly-short stature-developmental delay syndrome 0.0018333283259100194 0.243862\n",
      "MONDO:0010703 ornithine carbamoyltransferase deficiency 0.0018333283259100194 0.243862\n",
      "MONDO:0030785 intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly 0.0018333283259100194 0.243862\n",
      "MONDO:0032712 combined oxidative phosphorylation deficiency 38 0.0018333283259100194 0.243862\n",
      "MONDO:0014510 fatty acyl-CoA reductase 1 deficiency 0.0018333283259100194 0.243862\n",
      "MONDO:0014598 developmental and epileptic encephalopathy, 31 0.0018333283259100194 0.243862\n",
      "MONDO:0030261 pontocerebellar hypoplasia, type 1F 0.0018333283259100194 0.243862\n",
      "MONDO:0011651 intellectual disability, short stature, facial anomalies, and joint dislocations 0.0018333283259100194 0.243862\n",
      "MONDO:0008814 hyperargininemia 0.0018333283259100194 0.243862\n",
      "MONDO:0014563 mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency 0.0018333283259100194 0.243862\n",
      "MONDO:0014859 developmental and epileptic encephalopathy, 37 0.0018333283259100194 0.243862\n",
      "MONDO:0014729 hereditary spastic paraplegia 75 0.0018333283259100194 0.243862\n",
      "MONDO:0033482 spinocerebellar ataxia 47 0.0018333283259100194 0.243862\n",
      "MONDO:0859213 congenital heart defects, multiple types, 8, with or without heterotaxy 0.0018333283259100194 0.243862\n",
      "MONDO:0030517 trichothiodystrophy 8, nonphotosensitive 0.0018333283259100194 0.243862\n",
      "MONDO:0957495 hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature 0.0018333283259100194 0.243862\n",
      "MONDO:0008861 3-methylcrotonyl-CoA carboxylase 1 deficiency 0.0018333283259100194 0.243862\n",
      "MONDO:0033547 Li-Ghorbani-Weisz-Hubshman syndrome 0.0018333283259100194 0.243862\n",
      "MONDO:0013456 constitutional megaloblastic anemia with severe neurologic disease 0.0018333283259100194 0.243862\n",
      "MONDO:0014576 lipoyl transferase 1 deficiency 0.0018333283259100194 0.243862\n",
      "MONDO:0014512 PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation 0.0018333283259100194 0.243862\n",
      "MONDO:0013858 pontine tegmental cap dysplasia 0.0018333283259100194 0.243862\n",
      "MONDO:0800438 developmental delay with short stature, dysmorphic facial features, and sparse hair 1 0.0018333283259100194 0.243862\n",
      "MONDO:0014646 Zimmermann-Laband syndrome 2 0.0018333283259100194 0.243862\n",
      "MONDO:0014787 severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome 0.0018333283259100194 0.243862\n",
      "MONDO:0013252 Warsaw breakage syndrome 0.0018333283259100194 0.243862\n",
      "MONDO:0009665 biotinidase deficiency 0.0018333283259100194 0.243862\n",
      "MONDO:0014979 myoclonus, intractable, neonatal 0.0018333283259100194 0.243862\n",
      "MONDO:0957217 cortical dysplasia, complex, with other brain malformations 12 0.0019410664376458965 0.241583\n",
      "MONDO:0015350 17q11.2 microduplication syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0011287 craniosynostosis-anal anomalies-porokeratosis syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0032691 Galloway-Mowat syndrome 6 0.0019410664376458965 0.241583\n",
      "MONDO:0859569 braddock-carey syndrome 1 0.0019410664376458965 0.241583\n",
      "MONDO:0014813 hypomyelinating leukodystrophy 13 0.0019410664376458965 0.241583\n",
      "MONDO:0014238 severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0012698 Waardenburg syndrome type 2E 0.0019410664376458965 0.241583\n",
      "MONDO:0014767 Seckel syndrome 9 0.0019410664376458965 0.241583\n",
      "MONDO:0013005 EAST syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0013870 TMEM165-congenital disorder of glycosylation 0.0019410664376458965 0.241583\n",
      "MONDO:0007999 holoprosencephaly 2 0.0019410664376458965 0.241583\n",
      "MONDO:0014356 mitochondrial complex III deficiency nuclear type 7 0.0019410664376458965 0.241583\n",
      "MONDO:0014018 hereditary spastic paraplegia 54 0.0019410664376458965 0.241583\n",
      "MONDO:0011829 coenzyme Q10 deficiency, primary, 1 0.0019410664376458965 0.241583\n",
      "MONDO:0012241 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3 0.0019410664376458965 0.241583\n",
      "MONDO:0009073 Ritscher-Schinzel syndrome 1 0.0019410664376458965 0.241583\n",
      "MONDO:0044204 Shwachman-Diamond syndrome 1 0.0019410664376458965 0.241583\n",
      "MONDO:0009723 Leigh syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0032786 Noonan syndrome 11 0.0019410664376458965 0.241583\n",
      "MONDO:0009612 methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency 0.0019410664376458965 0.241583\n",
      "MONDO:0011724 encephalopathy due to GLUT1 deficiency 0.0019410664376458965 0.241583\n",
      "MONDO:0044318 intellectual developmental disorder with gastrointestinal difficulties and high pain threshold 0.0019410664376458965 0.241583\n",
      "MONDO:0009502 pyruvate dehydrogenase E2 deficiency 0.0019410664376458965 0.241583\n",
      "MONDO:0032916 Imagawa-Matsumoto syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0008862 3-methylcrotonyl-CoA carboxylase 2 deficiency 0.0019410664376458965 0.241583\n",
      "MONDO:0030890 pontocerebellar hypoplasia, IIA 17 0.0019410664376458965 0.241583\n",
      "MONDO:0013566 Fanconi anemia complementation group L 0.0019410664376458965 0.241583\n",
      "MONDO:0013158 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 0.0019410664376458965 0.241583\n",
      "MONDO:0013306 combined oxidative phosphorylation defect type 7 0.0019410664376458965 0.241583\n",
      "MONDO:0009655 mucopolysaccharidosis type 3A 0.0019410664376458965 0.241583\n",
      "MONDO:0044701 childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder 0.0019410664376458965 0.241583\n",
      "MONDO:0012322 holoprosencephaly 5 0.0019410664376458965 0.241583\n",
      "MONDO:0859142 Hiatt-Neu-Cooper neurodevelopmental syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0008799 anophthalmia/microphthalmia-esophageal atresia syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0014358 AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0010079 Canavan disease 0.0019410664376458965 0.241583\n",
      "MONDO:0014499 intellectual disability, autosomal recessive 46 0.0019410664376458965 0.241583\n",
      "MONDO:0060629 neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive 0.0019410664376458965 0.241583\n",
      "MONDO:0013822 acrodysostosis 2 with or without hormone resistance 0.0019410664376458965 0.241583\n",
      "MONDO:0014290 neurodegeneration with brain iron accumulation 6 0.0019410664376458965 0.241583\n",
      "MONDO:0009191 Lowry-Wood syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0032791 Coffin-Siris syndrome 10 0.0019410664376458965 0.241583\n",
      "MONDO:0060704 neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures 0.0019410664376458965 0.241583\n",
      "MONDO:0009795 orofaciodigital syndrome IX 0.0019410664376458965 0.241583\n",
      "MONDO:0014023 congenital muscular dystrophy with intellectual disability and severe epilepsy 0.0019410664376458965 0.241583\n",
      "MONDO:0010298 Lesch-Nyhan syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0957221 spastic paraplegia 70, autosomal recessive 0.0019410664376458965 0.241583\n",
      "MONDO:0859575 Atelis syndrome 1 0.0019410664376458965 0.241583\n",
      "MONDO:0060641 neurodevelopmental disorder with or without seizures and gait abnormalities 0.0019410664376458965 0.241583\n",
      "MONDO:0011240 megalencephaly-capillary malformation-polymicrogyria syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0030910 intellectual disability, autosomal dominant 45 0.0019410664376458965 0.241583\n",
      "MONDO:0010523 X-linked reticulate pigmentary disorder 0.0019410664376458965 0.241583\n",
      "MONDO:0044208 specific granule deficiency 2 0.0019410664376458965 0.241583\n",
      "MONDO:0020796 Silver-Russell syndrome 1 0.0019410664376458965 0.241583\n",
      "MONDO:0958181 mitochondrial trifunctional protein deficiency 1 0.0019410664376458965 0.241583\n",
      "MONDO:0014888 MIRAGE syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0008434 Smith-Magenis syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0014797 lymphatic malformation 6 0.0019410664376458965 0.241583\n",
      "MONDO:0014933 developmental and epileptic encephalopathy, 44 0.0019410664376458965 0.241583\n",
      "MONDO:0032601 inflammatory bowel disease, immunodeficiency, and encephalopathy 0.0019410664376458965 0.241583\n",
      "MONDO:0015000 developmental and epileptic encephalopathy, 48 0.002048792920561606 0.239441\n",
      "MONDO:0010395 phosphoribosylpyrophosphate synthetase superactivity 0.002048792920561606 0.239441\n",
      "MONDO:0032661 neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia 0.002048792920561606 0.239441\n",
      "MONDO:0018130 brain dopamine-serotonin vesicular transport disease 0.002048792920561606 0.239441\n",
      "MONDO:0032692 Galloway-Mowat syndrome 7 0.002048792920561606 0.239441\n",
      "MONDO:0024538 basal ganglia calcification, idiopathic, 1 0.002048792920561606 0.239441\n",
      "MONDO:0032618 mitochondrial complex 1 deficiency, nuclear type 13 0.002048792920561606 0.239441\n",
      "MONDO:0009959 peroxisome biogenesis disorder type 3B 0.002048792920561606 0.239441\n",
      "MONDO:0008943 autosomal recessive spinocerebellar ataxia 2 0.002048792920561606 0.239441\n",
      "MONDO:0011873 Niemann-Pick disease, type C2 0.002048792920561606 0.239441\n",
      "MONDO:0060627 glycosylphosphatidylinositol biosynthesis defect 15 0.002048792920561606 0.239441\n",
      "MONDO:0009614 methylmalonic aciduria, cblB type 0.002048792920561606 0.239441\n",
      "MONDO:0013553 immunodeficiency-centromeric instability-facial anomalies syndrome 2 0.002048792920561606 0.239441\n",
      "MONDO:0054654 combined oxidative phosphorylation deficiency 32 0.002048792920561606 0.239441\n",
      "MONDO:0014731 seizures-scoliosis-macrocephaly syndrome 0.002048792920561606 0.239441\n",
      "MONDO:0957288 intellectual developmental disorder, autosomal recessive 79 0.002048792920561606 0.239441\n",
      "MONDO:0012073 ribose-5-P isomerase deficiency 0.002048792920561606 0.239441\n",
      "MONDO:0859356 congenital disorder of glycosylation, type IIy 0.002048792920561606 0.239441\n",
      "MONDO:0012783 RFT1-congenital disorder of glycosylation 0.002048792920561606 0.239441\n",
      "MONDO:0013853 pontocerebellar hypoplasia type 1B 0.002048792920561606 0.239441\n",
      "MONDO:0010774 striatonigral degeneration, infantile, mitochondrial 0.002048792920561606 0.239441\n",
      "MONDO:0009281 glutaryl-CoA dehydrogenase deficiency 0.002048792920561606 0.239441\n",
      "MONDO:0859206 neurodevelopmental disorder with hearing loss and spasticity 0.002048792920561606 0.239441\n",
      "MONDO:0030031 lissencephaly 10 0.002048792920561606 0.239441\n",
      "MONDO:0018274 GM3 synthase deficiency 0.002048792920561606 0.239441\n",
      "MONDO:0010412 X-linked intellectual disability-craniofacioskeletal syndrome 0.002048792920561606 0.239441\n",
      "MONDO:0014732 hypomyelinating leukodystrophy 12 0.002048792920561606 0.239441\n",
      "MONDO:0009352 classic homocystinuria 0.002048792920561606 0.239441\n",
      "MONDO:0044306 neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination 0.002048792920561606 0.239441\n",
      "MONDO:0014806 spinal muscular atrophy with congenital bone fractures 1 0.002048792920561606 0.239441\n",
      "MONDO:0012514 hypomyelinating leukodystrophy 5 0.002048792920561606 0.239441\n",
      "MONDO:0009843 hypomyelinating leukodystrophy 3 0.002048792920561606 0.239441\n",
      "MONDO:0030947 neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities 0.002048792920561606 0.239441\n",
      "MONDO:0859564 epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features 0.002048792920561606 0.239441\n",
      "MONDO:0859221 Yoon-Bellen neurodevelopmental syndrome 0.002048792920561606 0.239441\n",
      "MONDO:0032807 neurodevelopmental disorder with visual defects and brain anomalies 0.002048792920561606 0.239441\n",
      "MONDO:0024465 surfactant metabolism dysfunction, pulmonary, 2 0.002048792920561606 0.239441\n",
      "MONDO:0014185 chromosome 3q13.31 deletion syndrome 0.002048792920561606 0.239441\n",
      "MONDO:0859243 neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities 0.002048792920561606 0.239441\n",
      "MONDO:0032888 neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies 0.002048792920561606 0.239441\n",
      "MONDO:0014213 intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome 0.002048792920561606 0.239441\n",
      "MONDO:0800103 COACH syndrome 1 0.002156507775912319 0.23742\n",
      "MONDO:0026724 Paganini-Miozzo syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0011504 NDE1-related microhydranencephaly 0.002156507775912319 0.23742\n",
      "MONDO:0014958 Harel-Yoon syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0009260 GM1 gangliosidosis type 1 0.002156507775912319 0.23742\n",
      "MONDO:0957218 neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities 0.002156507775912319 0.23742\n",
      "MONDO:0032878 neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia 0.002156507775912319 0.23742\n",
      "MONDO:0009757 Niemann-Pick disease, type C1 0.002156507775912319 0.23742\n",
      "MONDO:0054748 Fanconi anemia, complementation group S 0.002156507775912319 0.23742\n",
      "MONDO:0012212 Loeys-Dietz syndrome 1 0.002156507775912319 0.23742\n",
      "MONDO:0011628 propionic acidemia 0.002156507775912319 0.23742\n",
      "MONDO:0011402 congenital cataracts-facial dysmorphism-neuropathy syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0032820 neurodevelopmental disorder with structural brain anomalies and dysmorphic facies 0.002156507775912319 0.23742\n",
      "MONDO:0014067 short ulna-dysmorphism-hypotonia-intellectual disability syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0859212 neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus 0.002156507775912319 0.23742\n",
      "MONDO:0014533 developmental and epileptic encephalopathy, 28 0.002156507775912319 0.23742\n",
      "MONDO:0014221 triosephosphate isomerase deficiency 0.002156507775912319 0.23742\n",
      "MONDO:0032784 neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements 0.002156507775912319 0.23742\n",
      "MONDO:0014599 intellectual disability, autosomal dominant 34 0.002156507775912319 0.23742\n",
      "MONDO:0010224 corpus callosum agenesis-abnormal genitalia syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0008815 argininosuccinic aciduria 0.002156507775912319 0.23742\n",
      "MONDO:0859337 combined oxidative phosphorylation deficiency 57 0.002156507775912319 0.23742\n",
      "MONDO:0014506 hypomyelinating leukodystrophy 9 0.002156507775912319 0.23742\n",
      "MONDO:0014503 autosomal recessive spinocerebellar ataxia 17 0.002156507775912319 0.23742\n",
      "MONDO:0009567 Marinesco-Sjogren syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0014981 immunodeficiency 49 0.002156507775912319 0.23742\n",
      "MONDO:0014698 microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0032702 Coffin-Siris syndrome 8 0.002156507775912319 0.23742\n",
      "MONDO:0010613 inborn glycerol kinase deficiency 0.002156507775912319 0.23742\n",
      "MONDO:0013905 autosomal recessive spinocerebellar ataxia 13 0.002156507775912319 0.23742\n",
      "MONDO:0100348 neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities 0.002156507775912319 0.23742\n",
      "MONDO:0011897 leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome 0.002156507775912319 0.23742\n",
      "MONDO:0009653 mucolipidosis type IV 0.002156507775912319 0.23742\n",
      "MONDO:0100186 GTP cyclohydrolase I deficiency with hyperphenylalaninemia 0.002156507775912319 0.23742\n",
      "MONDO:0010848 spinocerebellar ataxia type 5 0.002156507775912319 0.23742\n",
      "MONDO:0100095 neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures 0.002156507775912319 0.23742\n",
      "MONDO:0014663 Silver-Russell syndrome 3 0.002156507775912319 0.23742\n",
      "MONDO:0032787 holoprosencephaly 12 with or without pancreatic agenesis 0.0022642110049530696 0.235509\n",
      "MONDO:0008822 arthrogryposis, renal dysfunction, and cholestasis 1 0.0022642110049530696 0.235509\n",
      "MONDO:0033864 infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0020632 epileptic encephalopathy, infantile or early childhood, 3 0.0022642110049530696 0.235509\n",
      "MONDO:0010027 free sialic acid storage disease, infantile form 0.0022642110049530696 0.235509\n",
      "MONDO:0100478 brain malformations with or without urinary tract defects 0.0022642110049530696 0.235509\n",
      "MONDO:0014617 intellectual disability, autosomal dominant 38 0.0022642110049530696 0.235509\n",
      "MONDO:0014941 arthrogryposis, distal, with impaired proprioception and touch 0.0022642110049530696 0.235509\n",
      "MONDO:0014144 autosomal recessive limb-girdle muscular dystrophy type R18 0.0022642110049530696 0.235509\n",
      "MONDO:0009590 metachromatic leukodystrophy due to saposin B deficiency 0.0022642110049530696 0.235509\n",
      "MONDO:0032611 mitochondrial complex 1 deficiency, nuclear type 6 0.0022642110049530696 0.235509\n",
      "MONDO:0018820 recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0054782 leukodystrophy, hypomyelinating, 15 0.0022642110049530696 0.235509\n",
      "MONDO:0014553 Tenorio syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0859188 neurodevelopmental disorder with seizures and brain abnormalities 0.0022642110049530696 0.235509\n",
      "MONDO:0032774 cerebellar, ocular, craniofacial, and genital syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0013801 developmental and epileptic encephalopathy, 13 0.0022642110049530696 0.235509\n",
      "MONDO:0007298 spinocerebellar ataxia type 29 0.0022642110049530696 0.235509\n",
      "MONDO:0060763 intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities 0.0022642110049530696 0.235509\n",
      "MONDO:0033364 developmental and epileptic encephalopathy, 55 0.0022642110049530696 0.235509\n",
      "MONDO:0013672 chromosome 15q25 deletion syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0054636 Skraban-Deardorff syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0010543 Barth syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0054591 Stankiewicz-Isidor syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0010714 Pelizeaus-Merzbacher spectrum disorder 0.0022642110049530696 0.235509\n",
      "MONDO:0012125 hypomyelinating leukodystrophy 2 0.0022642110049530696 0.235509\n",
      "MONDO:0013937 peroxisome biogenesis disorder 6B 0.0022642110049530696 0.235509\n",
      "MONDO:0012516 mandibulofacial dysostosis-microcephaly syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0859304 neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction 0.0022642110049530696 0.235509\n",
      "MONDO:0014946 Sifrim-Hitz-Weiss syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0012611 polyhydramnios, megalencephaly, and symptomatic epilepsy 0.0022642110049530696 0.235509\n",
      "MONDO:0013987 combined oxidative phosphorylation defect type 15 0.0022642110049530696 0.235509\n",
      "MONDO:0014725 spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0014811 cerebellar atrophy, visual impairment, and psychomotor retardation; 0.0022642110049530696 0.235509\n",
      "MONDO:0012563 holoprosencephaly 9 0.0022642110049530696 0.235509\n",
      "MONDO:0013675 multiple mitochondrial dysfunctions syndrome 2 0.0022642110049530696 0.235509\n",
      "MONDO:0009266 Gaucher disease type II 0.0022642110049530696 0.235509\n",
      "MONDO:0859164 osteootohepatoenteric syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0014016 hereditary spastic paraplegia 49 0.0022642110049530696 0.235509\n",
      "MONDO:0957397 intellectual developmental disorder, autosomal dominant 72 0.0022642110049530696 0.235509\n",
      "MONDO:0859218 developmental delay with variable neurologic and brain abnormalities 0.0022642110049530696 0.235509\n",
      "MONDO:0013053 microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type 0.0022642110049530696 0.235509\n",
      "MONDO:0010509 intellectual disability, X-linked 104 0.0022642110049530696 0.235509\n",
      "MONDO:0013048 hereditary spastic paraplegia 50 0.0022642110049530696 0.235509\n",
      "MONDO:0024554 D-2-hydroxyglutaric aciduria 1 0.0022642110049530696 0.235509\n",
      "MONDO:0013635 Adams-Oliver syndrome 2 0.0022642110049530696 0.235509\n",
      "MONDO:0014035 severe intellectual disability-progressive spastic diplegia syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0014320 Bosch-Boonstra-Schaaf optic atrophy syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0014567 glutamate pyruvate transaminase 2 deficiency 0.0022642110049530696 0.235509\n",
      "MONDO:0014708 ring chromosome 14 0.0022642110049530696 0.235509\n",
      "MONDO:0011629 MOGS-congenital disorder of glycosylation 0.0022642110049530696 0.235509\n",
      "MONDO:0014636 combined oxidative phosphorylation defect type 25 0.0022642110049530696 0.235509\n",
      "MONDO:0012143 hereditary cryohydrocytosis with reduced stomatin 0.0022642110049530696 0.235509\n",
      "MONDO:0032758 neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia 0.0022642110049530696 0.235509\n",
      "MONDO:0014219 alacrima, achalasia, and intellectual disability syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0030423 congenital disorder of glycosylation, type 2v 0.0022642110049530696 0.235509\n",
      "MONDO:0009965 Perlman syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0060491 neurodevelopmental disorder with involuntary movements 0.0022642110049530696 0.235509\n",
      "MONDO:0032775 neurodevelopmental disorder with seizures and speech and walking impairment 0.0022642110049530696 0.235509\n",
      "MONDO:0008267 orofaciodigital syndrome V 0.002371902608938751 0.233698\n",
      "MONDO:0032779 neurodevelopmental disorder with microcephaly and structural brain anomalies 0.002371902608938751 0.233698\n",
      "MONDO:0014318 hyperphosphatasia with intellectual disability syndrome 4 0.002371902608938751 0.233698\n",
      "MONDO:0013432 Meier-Gorlin syndrome 5 0.002371902608938751 0.233698\n",
      "MONDO:0032934 genitourinary and/or brain malformation syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0034145 oculocerebrodental syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0012718 hypotonia with lactic acidemia and hyperammonemia 0.002371902608938751 0.233698\n",
      "MONDO:0030473 developmental and epileptic encephalopathy 99 0.002371902608938751 0.233698\n",
      "MONDO:0024542 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 0.002371902608938751 0.233698\n",
      "MONDO:0010281 Danon disease 0.002371902608938751 0.233698\n",
      "MONDO:0012371 Noonan syndrome 3 0.002371902608938751 0.233698\n",
      "MONDO:0009070 D-glyceric aciduria 0.002371902608938751 0.233698\n",
      "MONDO:0859332 cortical dysplasia, complex, with other brain malformations 11 0.002371902608938751 0.233698\n",
      "MONDO:0014017 intellectual developmental disorder with autism and macrocephaly 0.002371902608938751 0.233698\n",
      "MONDO:0013805 intellectual disability, autosomal dominant 13 0.002371902608938751 0.233698\n",
      "MONDO:0010499 Ritscher-Schinzel syndrome 2 0.002371902608938751 0.233698\n",
      "MONDO:0032795 intellectual developmental disorder 59 0.002371902608938751 0.233698\n",
      "MONDO:0044303 congenital heart defects and ectodermal dysplasia 0.002371902608938751 0.233698\n",
      "MONDO:0030969 intellectual developmental disorder, autosomal dominant 68 0.002371902608938751 0.233698\n",
      "MONDO:0032793 O'Donnell-Luria-Rodan syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0014609 cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0008214 Pelger-Huet anomaly 0.002371902608938751 0.233698\n",
      "MONDO:0012519 Rubinstein-Taybi syndrome due to 16p13.3 microdeletion 0.002371902608938751 0.233698\n",
      "MONDO:0030933 Joubert syndrome 37 0.002371902608938751 0.233698\n",
      "MONDO:0013546 mitochondrial complex V (ATP synthase) deficiency nuclear type 2 0.002371902608938751 0.233698\n",
      "MONDO:0859293 neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment 0.002371902608938751 0.233698\n",
      "MONDO:0011833 spinocerebellar ataxia type 21 0.002371902608938751 0.233698\n",
      "MONDO:0013761 childhood encephalopathy due to thiamine pyrophosphokinase deficiency 0.002371902608938751 0.233698\n",
      "MONDO:0009033 temtamy syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0015022 intellectual developmental disorder with dysmorphic facies and ptosis 0.002371902608938751 0.233698\n",
      "MONDO:0013552 hereditary spastic paraplegia 52 0.002371902608938751 0.233698\n",
      "MONDO:0859197 intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies 0.002371902608938751 0.233698\n",
      "MONDO:0060640 neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy 0.002371902608938751 0.233698\n",
      "MONDO:0009744 neuronal ceroid lipofuscinosis 1 0.002371902608938751 0.233698\n",
      "MONDO:0859198 short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies 0.002371902608938751 0.233698\n",
      "MONDO:0009470 Baraitser-Winter syndrome 1 0.002371902608938751 0.233698\n",
      "MONDO:0054669 pontocerebellar hypoplasia, type 11 0.002371902608938751 0.233698\n",
      "MONDO:0014573 Cole-Carpenter syndrome 2 0.002371902608938751 0.233698\n",
      "MONDO:0012055 Larsen-like osseous dysplasia-short stature syndrome 0.002371902608938751 0.233698\n",
      "MONDO:0859155 chromosome 1p36 deletion syndrome, proximal 0.002371902608938751 0.233698\n",
      "MONDO:0010183 methylmalonic aciduria and homocystinuria type cblF 0.002371902608938751 0.233698\n",
      "MONDO:0859350 neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies 0.002371902608938751 0.233698\n",
      "MONDO:0032636 mitochondrial complex 1 deficiency, nuclear type 33 0.002371902608938751 0.233698\n",
      "MONDO:0009863 BH4-deficient hyperphenylalaninemia A 0.002371902608938751 0.233698\n",
      "MONDO:0032650 neurodegeneration, childhood-onset, with cerebellar atrophy 0.0024795825891241294 0.231976\n",
      "MONDO:0060578 neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures 0.0024795825891241294 0.231976\n",
      "MONDO:0957531 neurodevelopmental disorder with microcephaly and movement abnormalities 0.0024795825891241294 0.231976\n",
      "MONDO:0015010 atypical glycine encephalopathy 0.0024795825891241294 0.231976\n",
      "MONDO:0012084 aromatic L-amino acid decarboxylase deficiency 0.0024795825891241294 0.231976\n",
      "MONDO:0011778 multiple epiphyseal dysplasia, Al-Gazali type 0.0024795825891241294 0.231976\n",
      "MONDO:0030669 gastrointestinal defects and immunodeficiency syndrome 2 0.0024795825891241294 0.231976\n",
      "MONDO:0009598 metaphyseal chondrodysplasia-retinitis pigmentosa syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0014931 Alazami-Yuan syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0859230 Kury-Isidor syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0014838 Coffin-Siris syndrome 5 0.0024795825891241294 0.231976\n",
      "MONDO:0026723 intellectual developmental disorder, X-linked 108 0.0024795825891241294 0.231976\n",
      "MONDO:0014289 macrocephaly-developmental delay syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0010083 succinic semialdehyde dehydrogenase deficiency 0.0024795825891241294 0.231976\n",
      "MONDO:0012735 Temple-Baraitser syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0030491 immunodeficiency 91 and hyperinflammation 0.0024795825891241294 0.231976\n",
      "MONDO:0011537 macrocephaly-autism syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0859375 developmental delay with hypotonia, myopathy, and brain abnormalities 0.0024795825891241294 0.231976\n",
      "MONDO:0011274 Muenke syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0015005 epilepsy, early-onset, vitamin B6-dependent 0.0024795825891241294 0.231976\n",
      "MONDO:0012999 guanidinoacetate methyltransferase deficiency 0.0024795825891241294 0.231976\n",
      "MONDO:0032742 encephalopathy, acute, infection-induced, susceptibility to, 9 0.0024795825891241294 0.231976\n",
      "MONDO:0013882 hyperphosphatasia with intellectual disability syndrome 2 0.0024795825891241294 0.231976\n",
      "MONDO:0032571 spondyloepimetaphyseal dysplasia, Krakow type 0.0024795825891241294 0.231976\n",
      "MONDO:0030886 holoprosencephaly 14 0.0024795825891241294 0.231976\n",
      "MONDO:0014773 cardiac anomalies - developmental delay - facial dysmorphism syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0011049 Fine-Lubinsky syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0033372 developmental and epileptic encephalopathy, 63 0.0024795825891241294 0.231976\n",
      "MONDO:0014693 Noonan syndrome 10 0.0024795825891241294 0.231976\n",
      "MONDO:0859518 leukodystrophy, hypomyelinating, 26, with chondrodysplasia 0.0024795825891241294 0.231976\n",
      "MONDO:0030061 periventricular nodular heterotopia 9 0.0024795825891241294 0.231976\n",
      "MONDO:0010319 syndromic X-linked intellectual disability Hedera type 0.0024795825891241294 0.231976\n",
      "MONDO:0012076 midface hypoplasia, obesity, developmental delay, and neonatal hypotonia 0.0024795825891241294 0.231976\n",
      "MONDO:0013925 methylmalonic acidemia with homocystinuria, type cblJ 0.0024795825891241294 0.231976\n",
      "MONDO:0009495 Keutel syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0015007 spastic paraplegia, intellectual disability, nystagmus, and obesity 0.0024795825891241294 0.231976\n",
      "MONDO:0012184 Pierson syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0014534 lissencephaly 6 with microcephaly 0.0024795825891241294 0.231976\n",
      "MONDO:0859531 neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures 0.0024795825891241294 0.231976\n",
      "MONDO:0054573 Lopes-Maciel-Rodan syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0859214 Marbach-Schaaf neurodevelopmental syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0009821 lethal osteosclerotic bone dysplasia 0.0024795825891241294 0.231976\n",
      "MONDO:0859136 Alzahrani-Kuwahara syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0009871 pili torti-developmental delay-neurological abnormalities syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0014791 Luscan-Lumish syndrome 0.0024795825891241294 0.231976\n",
      "MONDO:0014114 cardiofaciocutaneous syndrome 4 0.0024795825891241294 0.231976\n",
      "MONDO:0032578 cortical dysplasia, complex, with other brain malformations 9 0.0024795825891241294 0.231976\n",
      "MONDO:0030953 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 0.002587250946763825 0.230335\n",
      "MONDO:0030852 neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities 0.002587250946763825 0.230335\n",
      "MONDO:0031481 microcephaly, epilepsy, and diabetes syndrome 1 0.002587250946763825 0.230335\n",
      "MONDO:0024567 hypotonia, infantile, with psychomotor retardation and characteristic facies 1 0.002587250946763825 0.230335\n",
      "MONDO:0859333 intellectual developmental disorder, autosomal dominant 70 0.002587250946763825 0.230335\n",
      "MONDO:0010626 hyper-IgM syndrome type 1 0.002587250946763825 0.230335\n",
      "MONDO:0032780 hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities 0.002587250946763825 0.230335\n",
      "MONDO:0014918 tall stature-intellectual disability-renal anomalies syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0014911 growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy 0.002587250946763825 0.230335\n",
      "MONDO:0033642 neurodevelopmental disorder with alopecia and brain abnormalities 0.002587250946763825 0.230335\n",
      "MONDO:0014353 immunodeficiency 23 0.002587250946763825 0.230335\n",
      "MONDO:0032939 intellectual developmental disorder, autosomal dominant 63, with macrocephaly 0.002587250946763825 0.230335\n",
      "MONDO:0032854 zimmermann-laband syndrome 3 0.002587250946763825 0.230335\n",
      "MONDO:0014743 rhizomelic chondrodysplasia punctata type 5 0.002587250946763825 0.230335\n",
      "MONDO:0009216 glycogen storage disease due to GLUT2 deficiency 0.002587250946763825 0.230335\n",
      "MONDO:0014006 Schuurs-Hoeijmakers syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0033630 neurodevelopmental disorder with speech impairment and dysmorphic facies 0.002587250946763825 0.230335\n",
      "MONDO:0013551 hereditary spastic paraplegia 47 0.002587250946763825 0.230335\n",
      "MONDO:0008221 prolidase deficiency 0.002587250946763825 0.230335\n",
      "MONDO:0009927 3MC syndrome 2 0.002587250946763825 0.230335\n",
      "MONDO:0014706 cutis laxa, autosomal dominant 3 0.002587250946763825 0.230335\n",
      "MONDO:0009613 methylmalonic aciduria, cblA type 0.002587250946763825 0.230335\n",
      "MONDO:0032922 Beck-Fahrner syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0010088 mucosulfatidosis 0.002587250946763825 0.230335\n",
      "MONDO:0009109 lysinuric protein intolerance 0.002587250946763825 0.230335\n",
      "MONDO:0009974 familial hemophagocytic lymphohistiocytosis type 1 0.002587250946763825 0.230335\n",
      "MONDO:0014741 DeSanto-Shinawi syndrome due to WAC point mutation 0.002587250946763825 0.230335\n",
      "MONDO:0030025 neurodevelopmental disorder with hypotonia, microcephaly, and seizures 0.002587250946763825 0.230335\n",
      "MONDO:0020850 intellectual disability, autosomal recessive 65 0.002587250946763825 0.230335\n",
      "MONDO:0100294 mitochondrial complex II deficiency, nuclear type 1 0.002587250946763825 0.230335\n",
      "MONDO:0010089 isolated sulfite oxidase deficiency 0.002587250946763825 0.230335\n",
      "MONDO:0032790 neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities 0.002587250946763825 0.230335\n",
      "MONDO:0013784 neonatal-onset encephalopathy with rigidity and seizures 0.002587250946763825 0.230335\n",
      "MONDO:0013352 intellectual disability-severe speech delay-mild dysmorphism syndrome 0.002587250946763825 0.230335\n",
      "MONDO:0024457 neurodegeneration with brain iron accumulation 2A 0.002587250946763825 0.230335\n",
      "MONDO:0012929 Compton-North congenital myopathy 0.002587250946763825 0.230335\n",
      "MONDO:0060549 congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay 0.002587250946763825 0.230335\n",
      "MONDO:0010396 developmental and epileptic encephalopathy, 2 0.002587250946763825 0.230335\n",
      "MONDO:0020789 pseudo-TORCH syndrome 1 0.002694907683112334 0.22877\n",
      "MONDO:0010632 developmental and epileptic encephalopathy, 1 0.002694907683112334 0.22877\n",
      "MONDO:0032698 neurodevelopmental disorder with central and peripheral motor dysfunction 0.002694907683112334 0.22877\n",
      "MONDO:0060596 neurodevelopmental disorder with dysmorphic facies and distal limb anomalies 0.002694907683112334 0.22877\n",
      "MONDO:0859331 Rabin-Pappas syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0044726 psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0957210 neurooculorenal syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0012593 brain-lung-thyroid syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0007800 chromosome 18p deletion syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0014382 Tatton-Brown-Rahman overgrowth syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0010970 cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies 0.002694907683112334 0.22877\n",
      "MONDO:0013745 Joubert syndrome 14 0.002694907683112334 0.22877\n",
      "MONDO:0007804 Pallister-Hall syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0011035 neurofibromatosis-Noonan syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0014529 cerebellar-facial-dental syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0044634 retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0010217 de Sanctis-Cacchione syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0859161 onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0009657 mucopolysaccharidosis type 3C 0.002694907683112334 0.22877\n",
      "MONDO:0014370 pontocerebellar hypoplasia type 2E 0.002694907683112334 0.22877\n",
      "MONDO:0032679 combined oxidative phosphorylation deficiency 37 0.002694907683112334 0.22877\n",
      "MONDO:0859186 Chopra-Amiel-Gordon syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0012690 Noonan syndrome 5 0.002694907683112334 0.22877\n",
      "MONDO:0032752 developmental and epileptic encephalopathy, 75 0.002694907683112334 0.22877\n",
      "MONDO:0859137 neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia 0.002694907683112334 0.22877\n",
      "MONDO:0011669 hypotonia-cystinuria syndrome 0.002694907683112334 0.22877\n",
      "MONDO:0011582 multiple mitochondrial dysfunctions syndrome 1 0.002694907683112334 0.22877\n",
      "MONDO:0015025 developmental and epileptic encephalopathy, 51 0.002694907683112334 0.22877\n",
      "MONDO:0030893 leukoencephalopathy, progressive, infantile-onset, with or without deafness 0.002694907683112334 0.22877\n",
      "MONDO:0011948 pontocerebellar hypoplasia type 3 0.002694907683112334 0.22877\n",
      "MONDO:0060496 neurodevelopmental disorder with hypotonia, neuropathy, and deafness 0.0028025527994240108 0.227272\n",
      "MONDO:0013357 chromosome 17q11.2 deletion syndrome, 1.4Mb 0.0028025527994240108 0.227272\n",
      "MONDO:0020841 neurodevelopmental disorder with cerebellar atrophy and with or without seizures 0.0028025527994240108 0.227272\n",
      "MONDO:0060677 chromosome 1p35 deletion syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0014605 microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0012574 Potocki-Lupski syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0013971 leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0013320 chromosome 16p12.2-p11.2 deletion syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0012117 ALG9-congenital disorder of glycosylation 0.0028025527994240108 0.227272\n",
      "MONDO:0010441 CK syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0014995 neurodevelopmental disorder with hypotonia, seizures, and absent language 0.0028025527994240108 0.227272\n",
      "MONDO:0013726 encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 0.0028025527994240108 0.227272\n",
      "MONDO:0014357 intellectual disability, autosomal dominant 24 0.0028025527994240108 0.227272\n",
      "MONDO:0014686 short stature, microcephaly, and endocrine dysfunction 0.0028025527994240108 0.227272\n",
      "MONDO:0009480 Joubert syndrome with oculorenal defect 0.0028025527994240108 0.227272\n",
      "MONDO:0035133 PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0007838 Jacobsen syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0011841 biotin-responsive basal ganglia disease 0.0028025527994240108 0.227272\n",
      "MONDO:0014263 8q24.3 microdeletion syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0013641 Warburg micro syndrome 2 0.0028025527994240108 0.227272\n",
      "MONDO:0010881 mesomelia-synostoses syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0013319 chromosome 4Q32.1-q32.2 triplication syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0032846 osteogenesis imperfecta, type 20 0.0028025527994240108 0.227272\n",
      "MONDO:0010504 immunodeficiency 47 0.0028025527994240108 0.227272\n",
      "MONDO:0032726 combined oxidative phosphorylation deficiency 39 0.0028025527994240108 0.227272\n",
      "MONDO:0014894 Meier-Gorlin syndrome 7 0.0028025527994240108 0.227272\n",
      "MONDO:0013951 peroxisome biogenesis disorder 12A (Zellweger) 0.0028025527994240108 0.227272\n",
      "MONDO:0014994 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 0.0028025527994240108 0.227272\n",
      "MONDO:0010222 X-linked Opitz G/BBB syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0008919 systemic primary carnitine deficiency disease 0.0028025527994240108 0.227272\n",
      "MONDO:0859325 developmental and epileptic encephalopathy 109 0.0028025527994240108 0.227272\n",
      "MONDO:0859232 neurodevelopmental disorder with central hypotonia and dysmorphic facies 0.0028025527994240108 0.227272\n",
      "MONDO:0010717 pyruvate dehydrogenase E1-alpha deficiency 0.0028025527994240108 0.227272\n",
      "MONDO:0032714 facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome 0.0028025527994240108 0.227272\n",
      "MONDO:0009398 hyperphosphatasia with intellectual disability syndrome 1 0.0028025527994240108 0.227272\n",
      "MONDO:0013810 COG6-ongenital disorder of glycosylation 0.0028025527994240108 0.227272\n",
      "MONDO:0044724 3-methylglutaconic aciduria type 9 0.0028025527994240108 0.227272\n",
      "MONDO:0032610 mitochondrial complex 1 deficiency, nuclear type 5 0.0028025527994240108 0.227272\n",
      "MONDO:0014336 intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency 0.0028025527994240108 0.227272\n",
      "MONDO:0009068 cytochrome-c oxidase deficiency disease 0.0028025527994240108 0.227272\n",
      "MONDO:0009841 PEHO syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0008854 Bardet-Biedl syndrome 1 0.0029101862969530736 0.225838\n",
      "MONDO:0013821 intellectual disability, autosomal dominant 16 0.0029101862969530736 0.225838\n",
      "MONDO:8000012 neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1 0.0029101862969530736 0.225838\n",
      "MONDO:0014371 developmental and epileptic encephalopathy, 23 0.0029101862969530736 0.225838\n",
      "MONDO:0014914 Dias-Logan syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0032800 robinow syndrome, autosomal recessive 2 0.0029101862969530736 0.225838\n",
      "MONDO:0011531 Noonan syndrome 2 0.0029101862969530736 0.225838\n",
      "MONDO:0010865 pseudoaminopterin syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0014464 progressive encephalopathy with leukodystrophy due to DECR deficiency 0.0029101862969530736 0.225838\n",
      "MONDO:0007113 Angelman syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0010711 TARP syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0013572 Keppen-Lubinsky syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0011157 Gomez-Lopez-Hernandez syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0015601 X-linked intellectual disability, van Esch type 0.0029101862969530736 0.225838\n",
      "MONDO:0011730 fumaric aciduria 0.0029101862969530736 0.225838\n",
      "MONDO:0014547 combined oxidative phosphorylation defect type 24 0.0029101862969530736 0.225838\n",
      "MONDO:0008872 microcephalic osteodysplastic primordial dwarfism type II 0.0029101862969530736 0.225838\n",
      "MONDO:0020630 epileptic encephalopathy, infantile or early childhood, 1 0.0029101862969530736 0.225838\n",
      "MONDO:0012427 Loeys-Dietz syndrome 2 0.0029101862969530736 0.225838\n",
      "MONDO:0009269 geleophysic dysplasia 1 0.0029101862969530736 0.225838\n",
      "MONDO:0012512 fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 0.0029101862969530736 0.225838\n",
      "MONDO:0013968 PGM1-congenital disorder of glycosylation 0.0029101862969530736 0.225838\n",
      "MONDO:0032942 neurodevelopmental disorder with microcephaly and dysmorphic facies 0.0029101862969530736 0.225838\n",
      "MONDO:0011217 desmosterolosis 0.0029101862969530736 0.225838\n",
      "MONDO:0013722 hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism 0.0029101862969530736 0.225838\n",
      "MONDO:0020781 encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 0.0029101862969530736 0.225838\n",
      "MONDO:0032890 neuromuscular disease and ocular or auditory anomalies with or without seizures 0.0029101862969530736 0.225838\n",
      "MONDO:0014948 short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay 0.0029101862969530736 0.225838\n",
      "MONDO:0054560 anauxetic dysplasia 1 0.0029101862969530736 0.225838\n",
      "MONDO:0012430 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 0.0029101862969530736 0.225838\n",
      "MONDO:0010998 ALG3-congenital disorder of glycosylation 0.0029101862969530736 0.225838\n",
      "MONDO:0032705 neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination 0.0029101862969530736 0.225838\n",
      "MONDO:0030607 Bryant-Li-Bhoj neurodevelopmental syndrome 2 0.0029101862969530736 0.225838\n",
      "MONDO:0014728 combined oxidative phosphorylation defect type 27 0.0029101862969530736 0.225838\n",
      "MONDO:0014922 myofibrillar myopathy 7 0.0029101862969530736 0.225838\n",
      "MONDO:0030917 intellectual disability, autosomal dominant 51 0.0029101862969530736 0.225838\n",
      "MONDO:0010478 SLC35A2-congenital disorder of glycosylation 0.0029101862969530736 0.225838\n",
      "MONDO:0014643 congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0009192 Wolcott-Rallison syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0033007 Galloway-Mowat syndrome 3 0.003017808176953609 0.224463\n",
      "MONDO:0859179 neurodevelopmental disorder with dysmorphic facies and thin corpus callosum 0.003017808176953609 0.224463\n",
      "MONDO:0859241 neurodegeneration, childhood-onset, with progressive microcephaly 0.003017808176953609 0.224463\n",
      "MONDO:0011337 familial hemophagocytic lymphohistiocytosis 2 0.003017808176953609 0.224463\n",
      "MONDO:0014298 chromosome 5q12 deletion syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0034121 NAD(P)HX dehydratase deficiency 0.003017808176953609 0.224463\n",
      "MONDO:0009756 Niemann-Pick disease type A 0.003017808176953609 0.224463\n",
      "MONDO:0030533 intellectual developmental disorder, autosomal recessive 73 0.003017808176953609 0.224463\n",
      "MONDO:0009504 mitochondrial DNA depletion syndrome 9 0.003017808176953609 0.224463\n",
      "MONDO:0013299 chromosome 6q11-q14 deletion syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0031000 Tessadori-Van Haaften neurodevelopmental syndrome 4 0.003017808176953609 0.224463\n",
      "MONDO:0010337 X-linked intellectual disability-cerebellar hypoplasia syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0032864 intellectual developmental disorder with speech delay, autism, and dysmorphic facies 0.003017808176953609 0.224463\n",
      "MONDO:0033544 Tolchin-Le Caignec syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0054845 developmental and epileptic encephalopathy, 66 0.003017808176953609 0.224463\n",
      "MONDO:0014198 mitochondrial DNA depletion syndrome 13 0.003017808176953609 0.224463\n",
      "MONDO:0100344 Bartter disease type 1 0.003017808176953609 0.224463\n",
      "MONDO:0859370 respiratory infections, recurrent, and failure to thrive with or without diarrhea 0.003017808176953609 0.224463\n",
      "MONDO:0019407 microcephalic osteodysplastic dysplasia, Saul-Wilson type 0.003017808176953609 0.224463\n",
      "MONDO:0010879 CODAS syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0013659 microcephaly-capillary malformation syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0014916 developmental and epileptic encephalopathy, 41 0.003017808176953609 0.224463\n",
      "MONDO:0859347 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities 0.003017808176953609 0.224463\n",
      "MONDO:0014139 Ehlers-Danlos syndrome, spondylodysplastic type, 2 0.003017808176953609 0.224463\n",
      "MONDO:0032817 neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies 0.003017808176953609 0.224463\n",
      "MONDO:0012554 cerebrooculofacioskeletal syndrome 4 0.003017808176953609 0.224463\n",
      "MONDO:0859226 craniotubular dysplasia, Ikegawa type 0.003017808176953609 0.224463\n",
      "MONDO:0012280 Goldberg-Shprintzen megacolon syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0012342 7q11.23 microduplication syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0013820 intellectual disability, autosomal dominant 15 0.003017808176953609 0.224463\n",
      "MONDO:0013169 chromosome 5p13 duplication syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0030543 combined oxidative phosphorylation deficiency 54 0.003017808176953609 0.224463\n",
      "MONDO:0014556 congenital contractures of the limbs and face, hypotonia, and developmental delay 0.003017808176953609 0.224463\n",
      "MONDO:0013401 hereditary spastic paraplegia 51 0.003017808176953609 0.224463\n",
      "MONDO:0032677 lissencephaly 9 with complex brainstem malformation 0.003017808176953609 0.224463\n",
      "MONDO:0800025 Teebi hypertelorism syndrome 1 0.003017808176953609 0.224463\n",
      "MONDO:0859208 Hengel-Maroofian-Schols syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0032764 Khan-Khan-Katsanis syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0014413 orofaciodigital syndrome type 14 0.0031254184406795693 0.223141\n",
      "MONDO:0007068 adenylosuccinate lyase deficiency 0.0031254184406795693 0.223141\n",
      "MONDO:0013628 hyperphosphatasia with intellectual disability syndrome 3 0.0031254184406795693 0.223141\n",
      "MONDO:0030043 congenital disorder of glycosylation, type iit 0.0031254184406795693 0.223141\n",
      "MONDO:0011652 Phelan-McDermid syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0054791 leukodystrophy, hypomyelinating, 16 0.0031254184406795693 0.223141\n",
      "MONDO:0859275 neurodevelopmental disorder with spasticity, seizures, and brain abnormalities 0.0031254184406795693 0.223141\n",
      "MONDO:0013579 methylmalonate semialdehyde dehydrogenase deficiency 0.0031254184406795693 0.223141\n",
      "MONDO:0011963 Joubert syndrome 2 0.0031254184406795693 0.223141\n",
      "MONDO:0026730 Basilicata-Akhtar syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0859283 neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 0.0031254184406795693 0.223141\n",
      "MONDO:0008365 recombinant 8 syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0010176 orofaciodigital syndrome type 6 0.0031254184406795693 0.223141\n",
      "MONDO:0012892 bone fragility with contractures, arterial rupture, and deafness 0.0031254184406795693 0.223141\n",
      "MONDO:0013798 chromosome 16q22 deletion syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0012927 chromosome 1q41-q42 deletion syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0009364 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 0.0031254184406795693 0.223141\n",
      "MONDO:0014723 PMP22-RAI1 contiguous gene duplication syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0014751 palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0014364 mitochondrial complex III deficiency nuclear type 8 0.0031254184406795693 0.223141\n",
      "MONDO:0014658 severe achondroplasia-developmental delay-acanthosis nigricans syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0859199 developmental delay with or without intellectual impairment or behavioral abnormalities 0.0031254184406795693 0.223141\n",
      "MONDO:0012613 intellectual disability, autosomal recessive 5 0.0031254184406795693 0.223141\n",
      "MONDO:0014671 neuropathy, hereditary motor and sensory, type 6B 0.0031254184406795693 0.223141\n",
      "MONDO:0014507 Catel-Manzke syndrome 0.0031254184406795693 0.223141\n",
      "MONDO:0032781 congenital hypotonia, epilepsy, developmental delay, and digital anomalies 0.0032330170893847643 0.22187\n",
      "MONDO:0013364 Rubinstein-Taybi syndrome due to EP300 haploinsufficiency 0.0032330170893847643 0.22187\n",
      "MONDO:0030914 Clark-Baraitser syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0030019 anauxetic dysplasia 3 0.0032330170893847643 0.22187\n",
      "MONDO:0032600 Snijders Blok-Campeau syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0010184 methylmalonic aciduria and homocystinuria type cblC 0.0032330170893847643 0.22187\n",
      "MONDO:0011451 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 0.0032330170893847643 0.22187\n",
      "MONDO:0010028 sialuria 0.0032330170893847643 0.22187\n",
      "MONDO:0030065 agenesis of corpus callosum, cardiac, ocular, and genital syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0014863 macrocephaly, dysmorphic facies, and psychomotor retardation 0.0032330170893847643 0.22187\n",
      "MONDO:0010370 Cornelia de Lange syndrome 2 0.0032330170893847643 0.22187\n",
      "MONDO:0014632 hypomyelinating leukodystrophy 10 0.0032330170893847643 0.22187\n",
      "MONDO:0013051 autosomal recessive cutis laxa type 2B 0.0032330170893847643 0.22187\n",
      "MONDO:0030837 neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities 0.0032330170893847643 0.22187\n",
      "MONDO:0030934 intellectual developmental disorder, autosomal dominant 64 0.0032330170893847643 0.22187\n",
      "MONDO:0010465 Kabuki syndrome 2 0.0032330170893847643 0.22187\n",
      "MONDO:0054581 Townes-Brocks syndrome 1 0.0032330170893847643 0.22187\n",
      "MONDO:0957215 congenital myopathy 20 0.0032330170893847643 0.22187\n",
      "MONDO:0010886 2q37 microdeletion syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0012869 intellectual disability, autosomal dominant 22 0.0032330170893847643 0.22187\n",
      "MONDO:0060532 congenital heart defects and skeletal malformations syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0014963 Shashi-Pena syndrome 0.0032330170893847643 0.22187\n",
      "MONDO:0010472 developmental and epileptic encephalopathy, 36 0.003340604124322876 0.220645\n",
      "MONDO:0060621 neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy 0.003340604124322876 0.220645\n",
      "MONDO:0009667 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 0.003340604124322876 0.220645\n",
      "MONDO:0013270 Rett syndrome, congenital variant 0.003340604124322876 0.220645\n",
      "MONDO:0033373 developmental and epileptic encephalopathy, 64 0.003340604124322876 0.220645\n",
      "MONDO:0014243 Schaaf-Yang syndrome 0.003340604124322876 0.220645\n",
      "MONDO:0014833 heart and brain malformation syndrome 0.003340604124322876 0.220645\n",
      "MONDO:0030928 microcephaly 26, primary, autosomal dominant 0.003340604124322876 0.220645\n",
      "MONDO:0032697 neurodevelopmental disorder and language delay with or without structural brain abnormalities 0.003340604124322876 0.220645\n",
      "MONDO:0009520 3-hydroxy-3-methylglutaric aciduria 0.003340604124322876 0.220645\n",
      "MONDO:0014722 Roifman syndrome 0.003340604124322876 0.220645\n",
      "MONDO:0054837 intellectual disability, autosomal dominant 57 0.003340604124322876 0.220645\n",
      "MONDO:0859297 neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities 0.003340604124322876 0.220645\n",
      "MONDO:0013894 short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome 0.003340604124322876 0.220645\n",
      "MONDO:0009079 DOORS syndrome 0.003340604124322876 0.220645\n",
      "MONDO:0060760 intellectual developmental disorder with dysmorphic facies and behavioral abnormalities 0.003340604124322876 0.220645\n",
      "MONDO:0011866 pontocerebellar hypoplasia type 1A 0.003340604124322876 0.220645\n",
      "MONDO:0032772 brain abnormalities, neurodegeneration, and dysosteosclerosis 0.003340604124322876 0.220645\n",
      "MONDO:0032651 fibrosis, neurodegeneration, and cerebral angiomatosis 0.003340604124322876 0.220645\n",
      "MONDO:0859200 cerebellar ataxia, brain abnormalities, and cardiac conduction defects 0.003340604124322876 0.220645\n",
      "MONDO:0010574 syndromic X-linked intellectual disability 5 0.003340604124322876 0.220645\n",
      "MONDO:0100111 focal segmental glomerulosclerosis and neurodevelopmental syndrome 0.003340604124322876 0.220645\n",
      "MONDO:0013943 peroxisome biogenesis disorder 8B 0.003448179546747442 0.219464\n",
      "MONDO:0014699 intellectual disability, autosomal dominant 40 0.003448179546747442 0.219464\n",
      "MONDO:0031007 spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosis 0.003448179546747442 0.219464\n",
      "MONDO:0030919 intellectual disability, autosomal dominant 53 0.003448179546747442 0.219464\n",
      "MONDO:0060624 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter 0.003448179546747442 0.219464\n",
      "MONDO:0008758 mitochondrial DNA depletion syndrome 4a 0.003448179546747442 0.219464\n",
      "MONDO:0014684 combined oxidative phosphorylation defect type 26 0.003448179546747442 0.219464\n",
      "MONDO:0014561 3-methylglutaconic aciduria, type VIIB 0.003448179546747442 0.219464\n",
      "MONDO:0014367 Aicardi-Goutieres syndrome 7 0.003448179546747442 0.219464\n",
      "MONDO:0009934 alveolar capillary dysplasia with misalignment of pulmonary veins 0.003448179546747442 0.219464\n",
      "MONDO:0013864 Cornelia de Lange syndrome 4 0.003448179546747442 0.219464\n",
      "MONDO:0030922 intellectual disability, autosomal dominant 56 0.003448179546747442 0.219464\n",
      "MONDO:0032838 neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies 0.003448179546747442 0.219464\n",
      "MONDO:0011783 ALG12-congenital disorder of glycosylation 0.003448179546747442 0.219464\n",
      "MONDO:0011575 cerebrooculonasal syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0007110 Diamond-Blackfan anemia 1 0.003448179546747442 0.219464\n",
      "MONDO:0007412 Beare-Stevenson cutis gyrata syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0010653 Renpenning syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0010361 intellectual disability, X-linked 30 0.003448179546747442 0.219464\n",
      "MONDO:0014887 bone marrow failure syndrome 3 0.003448179546747442 0.219464\n",
      "MONDO:0011939 Spondyloenchondrodysplasia with immune dysregulation 0.003448179546747442 0.219464\n",
      "MONDO:0011435 microcephaly 2, primary, autosomal recessive, with or without cortical malformations 0.003448179546747442 0.219464\n",
      "MONDO:0800167 Knobloch syndrome 1 0.003448179546747442 0.219464\n",
      "MONDO:0009393 ornithine translocase deficiency 0.003448179546747442 0.219464\n",
      "MONDO:0008893 C syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0015011 optic atrophy 11 0.003448179546747442 0.219464\n",
      "MONDO:0014294 chromosome 15q11.2 deletion syndrome 0.003448179546747442 0.219464\n",
      "MONDO:0009319 pantothenate kinase-associated neurodegeneration 0.003448179546747442 0.219464\n",
      "MONDO:0032851 intellectual developmental disorder with impaired language and dysmorphic facies 0.003555743357911879 0.218323\n",
      "MONDO:0859219 Rauch-Steindl syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0010498 MEND syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0010572 occipital horn syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0009165 Aicardi-Goutieres syndrome 1 0.003555743357911879 0.218323\n",
      "MONDO:0007415 mitochondrial complex III deficiency nuclear type 1 0.003555743357911879 0.218323\n",
      "MONDO:0010502 intellectual disability, X-linked 99, syndromic, female-restricted 0.003555743357911879 0.218323\n",
      "MONDO:0015002 developmental and epileptic encephalopathy, 49 0.003555743357911879 0.218323\n",
      "MONDO:0012634 craniofacial dysplasia - osteopenia syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0013624 Rafiq syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0060642 neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features 0.003555743357911879 0.218323\n",
      "MONDO:0014165 multiple congenital anomalies-hypotonia-seizures syndrome 3 0.003555743357911879 0.218323\n",
      "MONDO:0010512 intellectual disability, X-linked, syndromic, Bain type 0.003555743357911879 0.218323\n",
      "MONDO:0014780 hyperphosphatasia with intellectual disability syndrome 6 0.003555743357911879 0.218323\n",
      "MONDO:0009458 Schimke immuno-osseous dysplasia 0.003555743357911879 0.218323\n",
      "MONDO:0009998 Richieri Costa-Pereira syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0060631 Alkuraya-Kucinskas syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0009644 sulfite oxidase deficiency due to molybdenum cofactor deficiency type B 0.003555743357911879 0.218323\n",
      "MONDO:0010235 X-linked intellectual disability-psychosis-macroorchidism syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0013245 syndromic multisystem autoimmune disease due to ITCH deficiency 0.003555743357911879 0.218323\n",
      "MONDO:0032745 developmental delay with variable intellectual impairment and behavioral abnormalities 0.003555743357911879 0.218323\n",
      "MONDO:0013990 pontocerebellar hypoplasia type 8 0.003555743357911879 0.218323\n",
      "MONDO:0026722 Mullegama-Klein-Martinez syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0007537 lateral meningocele syndrome 0.003555743357911879 0.218323\n",
      "MONDO:0030856 developmental and epileptic encephalopathy 89 0.003555743357911879 0.218323\n",
      "MONDO:0013563 multiple congenital anomalies-hypotonia-seizures syndrome 1 0.0036632955590694496 0.217221\n",
      "MONDO:0012481 mevalonic aciduria 0.0036632955590694496 0.217221\n",
      "MONDO:0044324 Al Kaissi syndrome 0.0036632955590694496 0.217221\n",
      "MONDO:0010156 Troyer syndrome 0.0036632955590694496 0.217221\n",
      "MONDO:0011640 genitopatellar syndrome 0.0036632955590694496 0.217221\n",
      "MONDO:0014864 hypermanganesemia with dystonia 2 0.0036632955590694496 0.217221\n",
      "MONDO:0859228 combined oxidative phosphorylation deficiency 55 0.0036632955590694496 0.217221\n",
      "MONDO:0014823 hypotonia, infantile, with psychomotor retardation and characteristic facies 3 0.0036632955590694496 0.217221\n",
      "MONDO:0859516 neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum 0.0036632955590694496 0.217221\n",
      "MONDO:0859286 neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures 0.0036632955590694496 0.217221\n",
      "MONDO:0014349 pontocerebellar hypoplasia type 10 0.0036632955590694496 0.217221\n",
      "MONDO:0020847 intellectual disability, autosomal dominant 58 0.0036632955590694496 0.217221\n",
      "MONDO:0013268 frontonasal dysplasia with alopecia and genital anomaly 0.0036632955590694496 0.217221\n",
      "MONDO:0013819 intellectual disability, autosomal dominant 14 0.0036632955590694496 0.217221\n",
      "MONDO:0023657 intellectual developmental disorder, autosomal dominant 65 0.0036632955590694496 0.217221\n",
      "MONDO:0014893 Okur-Chung neurodevelopmental syndrome 0.0036632955590694496 0.217221\n",
      "MONDO:0014361 autism spectrum disorder due to AUTS2 deficiency 0.0036632955590694496 0.217221\n",
      "MONDO:0012198 PCWH syndrome 0.0036632955590694496 0.217221\n",
      "MONDO:0054831 Coffin-Siris syndrome 7 0.0036632955590694496 0.217221\n",
      "MONDO:0010305 creatine transporter deficiency 0.0036632955590694496 0.217221\n",
      "MONDO:0008546 thanatophoric dysplasia type 1 0.0037708361514733027 0.216154\n",
      "MONDO:0014757 macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0060510 Cohen-Gibson syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0025351 multiple congenital anomalies-neurodevelopmental syndrome, X-linked 0.0037708361514733027 0.216154\n",
      "MONDO:0008564 DiGeorge syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0013223 autosomal recessive spondylometaphyseal dysplasia, Megarbane type 0.0037708361514733027 0.216154\n",
      "MONDO:0013993 pontocerebellar hypoplasia type 7 0.0037708361514733027 0.216154\n",
      "MONDO:0859295 neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties 0.0037708361514733027 0.216154\n",
      "MONDO:0859365 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures 0.0037708361514733027 0.216154\n",
      "MONDO:0010758 Wieacker-Wolff syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0700107 chromosome 19q13.11 deletion syndrome, distal 0.0037708361514733027 0.216154\n",
      "MONDO:0024541 trichohepatoenteric syndrome 1 0.0037708361514733027 0.216154\n",
      "MONDO:0010570 craniofrontonasal syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0010506 intellectual disability, X-linked 61 0.0038783651363764366 0.215122\n",
      "MONDO:0012948 chromosome 6pter-p24 deletion syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0044319 intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies 0.0038783651363764366 0.215122\n",
      "MONDO:0008955 cerebrooculofacioskeletal syndrome 1 0.0038783651363764366 0.215122\n",
      "MONDO:0013308 CBL-related disorder 0.0038783651363764366 0.215122\n",
      "MONDO:0054844 pontocerebellar hypoplasia, type 1D 0.0038783651363764366 0.215122\n",
      "MONDO:0100215 Rajab interstitial lung disease with brain calcifications 1 0.0038783651363764366 0.215122\n",
      "MONDO:0054637 Noonan syndrome-like disorder with loose anagen hair 1 0.0038783651363764366 0.215122\n",
      "MONDO:0030679 Noonan syndrome 14 0.0038783651363764366 0.215122\n",
      "MONDO:0044738 Gabriele de Vries syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0030362 Aicardi-Goutieres syndrome 9 0.0038783651363764366 0.215122\n",
      "MONDO:0014300 proximal myopathy with extrapyramidal signs 0.0038783651363764366 0.215122\n",
      "MONDO:0014858 intellectual disability, autosomal dominant 43 0.0038783651363764366 0.215122\n",
      "MONDO:0009424 Bartter disease type 2 0.0038783651363764366 0.215122\n",
      "MONDO:0012562 holoprosencephaly 7 0.003985882515031713 0.214121\n",
      "MONDO:0014966 periventricular nodular heterotopia 7 0.003985882515031713 0.214121\n",
      "MONDO:0010589 Aarskog-Scott syndrome, X-linked 0.003985882515031713 0.214121\n",
      "MONDO:0012176 Emanuel syndrome 0.003985882515031713 0.214121\n",
      "MONDO:0011070 van Maldergem syndrome 1 0.003985882515031713 0.214121\n",
      "MONDO:0033532 Suleiman-El-Hattab syndrome 0.003985882515031713 0.214121\n",
      "MONDO:0013638 Warburg micro syndrome 3 0.003985882515031713 0.214121\n",
      "MONDO:0060711 Jaberi-Elahi syndrome 0.003985882515031713 0.214121\n",
      "MONDO:0008944 Joubert syndrome 1 0.003985882515031713 0.214121\n",
      "MONDO:0033005 Galloway-Mowat syndrome 1 0.003985882515031713 0.214121\n",
      "MONDO:0009053 ALDH18A1-related de Barsy syndrome 0.003985882515031713 0.214121\n",
      "MONDO:0014857 neurodevelopmental disorder with or without anomalies of the brain, eye, or heart 0.003985882515031713 0.214121\n",
      "MONDO:0859306 developmental delay with variable intellectual disability and dysmorphic facies 0.003985882515031713 0.214121\n",
      "MONDO:0032822 developmental and epileptic encephalopathy, 80 0.003985882515031713 0.214121\n",
      "MONDO:0032855 neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies 0.003985882515031713 0.214121\n",
      "MONDO:0008800 microphthalmia with limb anomalies 0.003985882515031713 0.214121\n",
      "MONDO:0010471 Cornelia de Lange syndrome 5 0.003985882515031713 0.214121\n",
      "MONDO:0013025 chromosome 6q24-q25 deletion syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0060592 Sweeney-Cox syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0010038 growth delay due to insulin-like growth factor I resistance 0.004093388288691872 0.21315\n",
      "MONDO:0000902 agenesis of the corpus callosum with peripheral neuropathy 0.004093388288691872 0.21315\n",
      "MONDO:0044646 early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0018346 ferro-cerebro-cutaneous syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0007943 Nager acrofacial dysostosis 0.004093388288691872 0.21315\n",
      "MONDO:0014482 intellectual disability, autosomal dominant 29 0.004093388288691872 0.21315\n",
      "MONDO:0010519 alpha thalassemia-X-linked intellectual disability syndrome 0.004093388288691872 0.21315\n",
      "MONDO:0859236 neurodevelopmental disorder with neuromuscular and skeletal abnormalities 0.004093388288691872 0.21315\n",
      "MONDO:0014343 Desbuquois dysplasia 2 0.004093388288691872 0.21315\n",
      "MONDO:0026762 Wieacker-Wolff syndrome, female-restricted 0.004093388288691872 0.21315\n",
      "MONDO:0100151 nephropathic cystinosis 0.004093388288691872 0.21315\n",
      "MONDO:0032672 intellectual developmental disorder with cardiac defects and dysmorphic facies 0.004093388288691872 0.21315\n",
      "MONDO:0032687 intellectual developmental disorder with abnormal behavior, microcephaly, and short stature 0.004093388288691872 0.21315\n",
      "MONDO:0013056 developmental and epileptic encephalopathy, 39 0.004093388288691872 0.21315\n",
      "MONDO:0007846 KBG syndrome 0.004200882458609504 0.212207\n",
      "MONDO:0008780 amyotrophic lateral sclerosis type 2, juvenile 0.004200882458609504 0.212207\n",
      "MONDO:0859201 neurodevelopmental disorder with impaired language and ataxia and with or without seizures 0.004200882458609504 0.212207\n",
      "MONDO:0010417 syndromic X-linked intellectual disability Najm type 0.004200882458609504 0.212207\n",
      "MONDO:0030915 intellectual disability, autosomal recessive 61 0.004200882458609504 0.212207\n",
      "MONDO:0011946 diaphanospondylodysostosis 0.004200882458609504 0.212207\n",
      "MONDO:0859080 intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies 0.004200882458609504 0.212207\n",
      "MONDO:0013424 3p- syndrome 0.004200882458609504 0.212207\n",
      "MONDO:0010664 syndromic X-linked intellectual disability Snyder type 0.004200882458609504 0.212207\n",
      "MONDO:0032572 cardiac, facial, and digital anomalies with developmental delay 0.004200882458609504 0.212207\n",
      "MONDO:0008426 Shprintzen-Goldberg syndrome 0.004200882458609504 0.212207\n",
      "MONDO:0010477 blepharophimosis - intellectual disability syndrome, MKB type 0.004200882458609504 0.212207\n",
      "MONDO:0859209 Zaki syndrome 0.004200882458609504 0.212207\n",
      "MONDO:0012095 intellectual disability-brachydactyly-Pierre Robin syndrome 0.004308365026037072 0.211292\n",
      "MONDO:0009337 Hennekam lymphangiectasia-lymphedema syndrome 1 0.004308365026037072 0.211292\n",
      "MONDO:0011936 microphthalmia with brain and digit anomalies 0.004308365026037072 0.211292\n",
      "MONDO:0020681 Ehlers-Danlos syndrome, musculocontractural type 1 0.004308365026037072 0.211292\n",
      "MONDO:0008885 Elsahy-Waters syndrome 0.004308365026037072 0.211292\n",
      "MONDO:0012496 Koolen-de Vries syndrome 0.004308365026037072 0.211292\n",
      "MONDO:0100218 arthrogryposis multiplex congenita 5 0.004308365026037072 0.211292\n",
      "MONDO:0009124 Dubowitz syndrome 0.004308365026037072 0.211292\n",
      "MONDO:0851095 KINSSHIP syndrome 0.004415835992226909 0.210402\n",
      "MONDO:0012916 chromosome 2p16.1-p15 deletion syndrome 0.004415835992226909 0.210402\n",
      "MONDO:0859301 neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects 0.004415835992226909 0.210402\n",
      "MONDO:0009768 oculodentodigital dysplasia, autosomal recessive 0.004415835992226909 0.210402\n",
      "MONDO:0009026 Costello syndrome 0.004415835992226909 0.210402\n",
      "MONDO:0008907 PMM2-congenital disorder of glycosylation 0.004415835992226909 0.210402\n",
      "MONDO:0060502 neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 0.004415835992226909 0.210402\n",
      "MONDO:0011213 Pierpont syndrome 0.004415835992226909 0.210402\n",
      "MONDO:0030918 intellectual disability, autosomal dominant 52 0.004415835992226909 0.210402\n",
      "MONDO:0009561 alpha-mannosidosis 0.0045232953584311885 0.209536\n",
      "MONDO:0012555 Cornelia de Lange syndrome 3 0.0045232953584311885 0.209536\n",
      "MONDO:0009855 d-bifunctional protein deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0009452 Vici syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0030908 intellectual disability, X-linked, syndromic, 35 0.004630743125901984 0.208692\n",
      "MONDO:0030920 intellectual disability, autosomal dominant 54 0.004630743125901984 0.208692\n",
      "MONDO:0007057 Acroosteolysis dominant type 0.004630743125901984 0.208692\n",
      "MONDO:0044302 congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 0.004630743125901984 0.208692\n",
      "MONDO:0009747 mitochondrial DNA depletion syndrome 6 (hepatocerebral type) 0.004630743125901984 0.208692\n",
      "MONDO:0008013 chromosome 9p deletion syndrome 0.004630743125901984 0.208692\n",
      "MONDO:0014348 intellectual disability, autosomal recessive 42 0.004630743125901984 0.208692\n",
      "MONDO:0014455 cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome 0.004630743125901984 0.208692\n",
      "MONDO:0007843 Kabuki syndrome 1 0.004630743125901984 0.208692\n",
      "MONDO:0859190 neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities 0.004630743125901984 0.208692\n",
      "MONDO:0030966 neurofacioskeletal syndrome with or without renal agenesis 0.004738179295891211 0.207871\n",
      "MONDO:0012864 chromosome 2q32-q33 deletion syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0010355 syndromic X-linked intellectual disability Claes-Jensen type 0.004738179295891211 0.207871\n",
      "MONDO:0011977 8q22.1 microdeletion syndrome 0.004738179295891211 0.207871\n",
      "MONDO:0060622 neurodevelopmental disorder with severe motor impairment and absent language 0.004738179295891211 0.207871\n",
      "MONDO:0859193 neuroocular syndrome 0.004845603869650658 0.207071\n",
      "MONDO:0015012 mucopolysaccharidosis-plus syndrome 0.004845603869650658 0.207071\n",
      "MONDO:0010590 FG syndrome 1 0.004845603869650658 0.207071\n",
      "MONDO:0008965 CHARGE syndrome 0.004845603869650658 0.207071\n",
      "MONDO:0014700 Au-Kline syndrome 0.004845603869650658 0.207071\n",
      "MONDO:0014242 van Maldergem syndrome 2 0.004845603869650658 0.207071\n",
      "MONDO:0014944 short stature-brachydactyly-obesity-global developmental delay syndrome 0.004845603869650658 0.207071\n",
      "MONDO:0100224 mitochondrial complex I deficiency, nuclear type 1 0.00495301684843197 0.20629\n",
      "MONDO:0032755 neurodevelopmental disorder with or without variable brain abnormalities; NEDBA 0.00495301684843197 0.20629\n",
      "MONDO:0014258 congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome 0.00495301684843197 0.20629\n",
      "MONDO:0010561 Coffin-Lowry syndrome 0.00495301684843197 0.20629\n",
      "MONDO:0029140 glycosylphosphatidylinositol biosynthesis defect 18 0.00495301684843197 0.20629\n",
      "MONDO:0010501 syndromic X-linked intellectual disability 34 0.00495301684843197 0.20629\n",
      "MONDO:0013998 MEGF8-related Carpenter syndrome 0.005060418233486664 0.205528\n",
      "MONDO:0013272 chromosome 14q11-q22 deletion syndrome 0.005060418233486664 0.205528\n",
      "MONDO:0011150 acroosteolysis-keloid-like lesions-premature aging syndrome 0.005060418233486664 0.205528\n",
      "MONDO:0859139 blepharophimosis-impaired intellectual development syndrome 0.005167808026066122 0.204785\n",
      "MONDO:0013886 cerebellar dysfunction with variable cognitive and behavioral abnormalities 0.005167808026066122 0.204785\n",
      "MONDO:0012315 distal 10q deletion syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0010483 X-linked intellectual disability, Cantagrel type 0.005275186227421581 0.204059\n",
      "MONDO:0009254 fucosidosis 0.005275186227421581 0.204059\n",
      "MONDO:0033669 Noonan syndrome 13 0.005382552838804166 0.203349\n",
      "MONDO:0060752 neurodevelopmental disorder with spasticity and poor growth 0.005382552838804166 0.203349\n",
      "MONDO:0015021 hypotonia, ataxia, and delayed development syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0010500 intellectual disability, X-linked, syndromic 33 0.005382552838804166 0.203349\n",
      "MONDO:0032760 developmental delay with or without dysmorphic facies and autism 0.005382552838804166 0.203349\n",
      "MONDO:0009571 Meckel syndrome, type 1 0.005382552838804166 0.203349\n",
      "MONDO:0011510 Bohring-Opitz syndrome 0.005382552838804166 0.203349\n",
      "MONDO:0009069 congenital lactic acidosis, Saguenay-Lac-Saint-Jean type 0.005489907861464847 0.202655\n",
      "MONDO:0019569 Cockayne syndrome type 1 0.005489907861464847 0.202655\n",
      "MONDO:0010283 syndromic X-linked intellectual disability Lubs type 0.005489907861464847 0.202655\n",
      "MONDO:0010407 intellectual disability, X-linked syndromic, Turner type 0.005489907861464847 0.202655\n",
      "MONDO:8000008 Martsolf syndrome 1 0.005489907861464847 0.202655\n",
      "MONDO:0030695 developmental and epileptic encephalopathy 100 0.005489907861464847 0.202655\n",
      "MONDO:0026771 developmental and epileptic encephalopathy, 85, with or without midline brain defects 0.005597251296654461 0.201976\n",
      "MONDO:0012374 brachyphalangy, polydactyly, and tibial aplasia/hypoplasia 0.005597251296654461 0.201976\n",
      "MONDO:0013273 chromosome 16p13.3 duplication syndrome 0.005597251296654461 0.201976\n",
      "MONDO:0859165 neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities 0.005597251296654461 0.201976\n",
      "MONDO:0009658 mucopolysaccharidosis type 3D 0.005597251296654461 0.201976\n",
      "MONDO:0030606 Bryant-Li-Bhoj neurodevelopmental syndrome 1 0.005704583145623714 0.201312\n",
      "MONDO:0010077 spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome 0.005704583145623714 0.201312\n",
      "MONDO:0013415 chromosome 17p13.1 deletion syndrome 0.005704583145623714 0.201312\n",
      "MONDO:0012637 COG1-congenital disorder of glycosylation 0.005811903409623178 0.200662\n",
      "MONDO:0013932 peroxisome biogenesis disorder 5A (Zellweger) 0.005811903409623178 0.200662\n",
      "MONDO:0014606 intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome 0.005919212089903282 0.200026\n",
      "MONDO:0054588 Noonan syndrome-like disorder with loose anagen hair 2 0.005919212089903282 0.200026\n",
      "MONDO:0859143 Radio-Tartaglia syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0007874 trichorhinophalangeal syndrome type II 0.006026509187714335 0.199403\n",
      "MONDO:0014936 ZTTK syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0024455 autosomal dominant Robinow syndrome 1 0.006026509187714335 0.199403\n",
      "MONDO:0014855 intellectual disability, autosomal dominant 42 0.006026509187714335 0.199403\n",
      "MONDO:0019349 Sotos syndrome 0.006133794704306496 0.198792\n",
      "MONDO:0011518 Wiedemann-Steiner syndrome 0.006133794704306496 0.198792\n",
      "MONDO:0859187 neurodevelopmental disorder with hypotonia and brain abnormalities 0.006133794704306496 0.198792\n",
      "MONDO:0007974 intellectual disability, autosomal dominant 1 0.006133794704306496 0.198792\n",
      "MONDO:0800044 congenital disorder of deglycosylation 1 0.006348330998834137 0.197605\n",
      "MONDO:0010466 multiple congenital anomalies-hypotonia-seizures syndrome 2 0.006348330998834137 0.197605\n",
      "MONDO:0032707 turnpenny-fry syndrome 0.006455581779269274 0.197029\n",
      "MONDO:0011929 chromosome 1p36 deletion syndrome 0.006455581779269274 0.197029\n",
      "MONDO:0008953 peroxisome biogenesis disorder 1A (Zellweger) 0.006455581779269274 0.197029\n",
      "MONDO:0859273 liver disease, severe congenital 0.006455581779269274 0.197029\n",
      "MONDO:0025699 Coffin-Siris syndrome 12 0.006562820983484835 0.196464\n",
      "MONDO:0010221 CHIME syndrome 0.006562820983484835 0.196464\n",
      "MONDO:0009798 Primrose syndrome 0.006562820983484835 0.196464\n",
      "MONDO:0014205 severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome 0.006670048612730302 0.195909\n",
      "MONDO:0011053 intellectual disability-sparse hair-brachydactyly syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0010193 Weaver syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0012914 chromosome 1q21.1 deletion syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0859191 biliary, renal, neurologic, and skeletal syndrome 0.006884469151308279 0.194829\n",
      "MONDO:0010035 Smith-Lemli-Opitz syndrome 0.006991662063139083 0.194303\n",
      "MONDO:0009999 autosomal recessive Robinow syndrome 0.00709884340499642 0.193786\n",
      "MONDO:0009856 Peters plus syndrome 0.00709884340499642 0.193786\n",
      "MONDO:0030990 Kohlschutter-Tonz syndrome-like 0.00709884340499642 0.193786\n",
      "MONDO:0009964 short-rib thoracic dysplasia 9 with or without polydactyly 0.007206013178129101 0.193278\n",
      "MONDO:0859239 Chilton-Okur-Chung neurodevelopmental syndrome 0.007206013178129101 0.193278\n",
      "MONDO:0859181 DEGCAGS syndrome 0.007313171383785802 0.192779\n",
      "MONDO:0009650 mucolipidosis type II 0.007420318023215083 0.192288\n",
      "MONDO:0007251 campomelic dysplasia 0.007527453097665351 0.191805\n",
      "MONDO:0859177 VISS syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0007617 Coffin-Siris syndrome 1 0.007527453097665351 0.191805\n",
      "MONDO:0014558 autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome 0.007741688556621809 0.190862\n",
      "MONDO:0014379 ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 0.007955877770639786 0.189949\n",
      "MONDO:0009910 Wiedemann-Rautenstrauch syndrome 0.00859816804287656 0.187368\n",
      "MONDO:0011244 Marshall-Smith syndrome 0.00859816804287656 0.187368\n",
      "MONDO:0008995 Yunis-Varon syndrome 0.009026130515962775 0.185767\n",
      "MONDO:0030993 Tessadori-Van Haaften neurodevelopmental syndrome 3 0.009240042469905887 0.184999\n",
      "MONDO:0008393 Rubinstein-Taybi syndrome due to CREBBP mutations 0.00945390824874241 0.184251\n",
      "MONDO:0011146 tetrasomy 12p 0.009560823825610605 0.183885\n",
      "MONDO:0013256 chromosome 15q24 deletion syndrome 0.009667727862439744 0.183522\n",
      "MONDO:0010457 Ogden syndrome 0.010308909812337962 0.181442\n",
      "MONDO:0859185 neurodevelopmental disorder with hypotonia and dysmorphic facies 0.011163173371231022 0.178889\n",
      "MONDO:0859178 developmental delay, impaired speech, and behavioral abnormalities 0.013082571347708405 0.173884\n"
     ]
    }
   ],
   "execution_count": 66
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:04.265053Z",
     "start_time": "2024-10-28T18:04:04.263649Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# response = phenotypes_to_gene(wdyf_phenotypes)\n",
    "# print_results(response)\n",
    "\n",
    "# No enrichment in the Database"
   ],
   "id": "c4b9e68e1ff6c182",
   "outputs": [],
   "execution_count": 67
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:04.268147Z",
     "start_time": "2024-10-28T18:04:04.265887Z"
    }
   },
   "cell_type": "code",
   "source": [
    "twogene_phenotypes = [\n",
    "    #Recurrent fever \n",
    "    \"HP:0001954\",\n",
    "    #hip dysplasia        \n",
    "    \"HP:0001385\",\n",
    "    #joint hypermobility        \n",
    "    \"HP:0001382\",\n",
    "    #optic disc pallor        \n",
    "    \"HP:0000543\",        \n",
    "    #recurrent infections        \n",
    "    \"HP:0002719\",        \n",
    "    #thin corpus callosum        \n",
    "    \"HP:0002079\",\n",
    "    #Global developmental delay \n",
    "    \"HP:0001263\",\n",
    "    #Abnormality of vision \n",
    "    \"HP:0000504\",\n",
    "    #Nystagmus \n",
    "    \"HP:0000639\",\n",
    "    #Drooling \n",
    "    \"HP:0002307\",\n",
    "    #Dysphagia \n",
    "    \"HP:0002015\",\n",
    "    #Hypotonia \n",
    "    \"HP:0001252\"\n",
    "    #Eczema \n",
    "    \"HP:0000964\",\n",
    "    #Inability to walk \n",
    "    \"HP:0002540\",\n",
    "    #Septo-optic dysplasia \n",
    "    \"HP:0100842\"\n",
    "    #Postural instability \n",
    "    \"HP:0002172\"\n",
    "]"
   ],
   "id": "209ab46281342a2c",
   "outputs": [],
   "execution_count": 68
  },
  {
   "cell_type": "code",
   "id": "37c6c855-cc09-4a2b-bfc0-4be30633c970",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:10.716833Z",
     "start_time": "2024-10-28T18:04:04.268913Z"
    }
   },
   "source": [
    "response = phenotypes_to_disease(twogene_phenotypes)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "MONDO:0030990 Kohlschutter-Tonz syndrome-like 3.267366897642553e-13 0.976863\n",
      "MONDO:0032781 congenital hypotonia, epilepsy, developmental delay, and digital anomalies 1.5438766550103143e-12 0.967882\n",
      "MONDO:0010533 Arts syndrome 1.7537587683174986e-11 0.946749\n",
      "MONDO:0010283 syndromic X-linked intellectual disability Lubs type 2.177644306855737e-11 0.944329\n",
      "MONDO:0014746 SLC39A8-CDG 2.4148326614321293e-11 0.943136\n",
      "MONDO:0033371 developmental and epileptic encephalopathy, 62 2.4148326614321293e-11 0.943136\n",
      "MONDO:0014905 encephalopathy due to defective mitochondrial and peroxisomal fission 2 4.2777578280153676e-11 0.936099\n",
      "MONDO:0032710 developmental and epileptic encephalopathy, 72 5.536048099918041e-11 0.932667\n",
      "MONDO:0014979 myoclonus, intractable, neonatal 7.053170414013553e-11 0.929288\n",
      "MONDO:0044701 childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder 8.862321093680521e-11 0.92596\n",
      "MONDO:0011897 leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome 1.3499416171165125e-10 0.919446\n",
      "MONDO:0033364 developmental and epileptic encephalopathy, 55 1.6403667462469785e-10 0.916256\n",
      "MONDO:0013048 hereditary spastic paraplegia 50 1.6403667462469785e-10 0.916256\n",
      "MONDO:0014725 spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome 1.6403667462469785e-10 0.916256\n",
      "MONDO:0060761 neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum 1.6403667462469785e-10 0.916256\n",
      "MONDO:0054669 pontocerebellar hypoplasia, type 11 1.975255485888261e-10 0.913108\n",
      "MONDO:0015010 atypical glycine encephalopathy 2.3589170788195903e-10 0.910001\n",
      "MONDO:0013551 hereditary spastic paraplegia 47 2.7958577837951537e-10 0.906932\n",
      "MONDO:0014605 microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome 3.848584836836519e-10 0.900908\n",
      "MONDO:0032705 neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination 4.4743660713842435e-10 0.897948\n",
      "MONDO:0060621 neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy 7.76601784497135e-10 0.886442\n",
      "MONDO:0060711 Jaberi-Elahi syndrome 1.5731541606885146e-09 0.870074\n",
      "MONDO:0859178 developmental delay, impaired speech, and behavioral abnormalities 1.6681497267715376e-09 0.868628\n",
      "MONDO:0026762 Wieacker-Wolff syndrome, female-restricted 1.7497160500640761e-09 0.867441\n",
      "MONDO:0859301 neurodevelopmental disorder with craniofacial dysmorphism and skeletal defects 2.3690543945727385e-09 0.859689\n",
      "MONDO:0014606 intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome 7.639304785848405e-09 0.826134\n",
      "MONDO:0014855 intellectual disability, autosomal dominant 42 8.207748104694424e-09 0.823884\n",
      "MONDO:0032900 neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements 8.961725532596226e-09 0.821098\n",
      "MONDO:0032707 turnpenny-fry syndrome 1.080319605330921e-08 0.815059\n",
      "MONDO:0011929 chromosome 1p36 deletion syndrome 1.080319605330921e-08 0.815059\n",
      "MONDO:0014205 severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome 1.2309819824613698e-08 0.810747\n",
      "MONDO:0014199 developmental and epileptic encephalopathy, 17 1.547709027607439e-08 0.803001\n",
      "MONDO:0009862 dihydropteridine reductase deficiency 1.967218534246531e-08 0.794632\n",
      "MONDO:0014928 Joubert syndrome 28 1.967218534246531e-08 0.794632\n",
      "MONDO:0859313 neurodevelopmental disorder with speech impairment and with or without seizures 1.967218534246531e-08 0.794632\n",
      "MONDO:0013007 combined immunodeficiency due to ORAI1 deficiency 2.4563125819977305e-08 0.786651\n",
      "MONDO:0030929 microcephaly 27, primary, autosomal dominant 2.4563125819977305e-08 0.786651\n",
      "MONDO:0859361 neurodevelopmental disorder with dysmorphic facies and ischiopubic hypoplasia 2.4563125819977305e-08 0.786651\n",
      "MONDO:0013159 muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 2.4563125819977305e-08 0.786651\n",
      "MONDO:0012399 complex cortical dysplasia with other brain malformations 7 2.4563125819977305e-08 0.786651\n",
      "MONDO:0030312 spinocerebellar ataxia, autosomal recessive 29 3.0203013760951864e-08 0.779022\n",
      "MONDO:0032880 developmental and epileptic encephalopathy, 82 3.0203013760951864e-08 0.779022\n",
      "MONDO:0014288 Joubert syndrome 21 3.0203013760951864e-08 0.779022\n",
      "MONDO:0032830 snijders blok-fisher syndrome 3.0203013760951864e-08 0.779022\n",
      "MONDO:0014947 developmental and epileptic encephalopathy, 46 3.0203013760951864e-08 0.779022\n",
      "MONDO:0014648 Al-Raqad syndrome 3.664489074574276e-08 0.77171\n",
      "MONDO:0013875 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome 3.664489074574276e-08 0.77171\n",
      "MONDO:0014660 microcephaly 15, primary, autosomal recessive 3.664489074574276e-08 0.77171\n",
      "MONDO:0030993 Tessadori-Van Haaften neurodevelopmental syndrome 3 4.524092213462664e-08 0.763549\n",
      "MONDO:0060641 neurodevelopmental disorder with or without seizures and gait abnormalities 5.214647608277274e-08 0.757934\n",
      "MONDO:0060704 neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures 5.214647608277274e-08 0.757934\n",
      "MONDO:0060629 neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive 5.214647608277274e-08 0.757934\n",
      "MONDO:0014018 hereditary spastic paraplegia 54 5.214647608277274e-08 0.757934\n",
      "MONDO:0015000 developmental and epileptic encephalopathy, 48 6.131196564746397e-08 0.751425\n",
      "MONDO:0859221 Yoon-Bellen neurodevelopmental syndrome 6.131196564746397e-08 0.751425\n",
      "MONDO:0054654 combined oxidative phosphorylation deficiency 32 6.131196564746397e-08 0.751425\n",
      "MONDO:0100186 GTP cyclohydrolase I deficiency with hyperphenylalaninemia 7.149100677224917e-08 0.745143\n",
      "MONDO:0030063 neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities 7.149100677224917e-08 0.745143\n",
      "MONDO:0014698 microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome 7.149100677224917e-08 0.745143\n",
      "MONDO:0032878 neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia 7.149100677224917e-08 0.745143\n",
      "MONDO:0009849 hyperimmunoglobulinemia D with periodic fever 8.273633936334651e-08 0.739072\n",
      "MONDO:0033864 infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome 8.273633936334651e-08 0.739072\n",
      "MONDO:0020632 epileptic encephalopathy, infantile or early childhood, 3 8.273633936334651e-08 0.739072\n",
      "MONDO:0014035 severe intellectual disability-progressive spastic diplegia syndrome 8.273633936334651e-08 0.739072\n",
      "MONDO:0054782 leukodystrophy, hypomyelinating, 15 8.273633936334651e-08 0.739072\n",
      "MONDO:0060491 neurodevelopmental disorder with involuntary movements 8.273633936334651e-08 0.739072\n",
      "MONDO:0014567 glutamate pyruvate transaminase 2 deficiency 8.273633936334651e-08 0.739072\n",
      "MONDO:0010714 Pelizeaus-Merzbacher spectrum disorder 8.273633936334651e-08 0.739072\n",
      "MONDO:0009863 BH4-deficient hyperphenylalaninemia A 9.510064312910607e-08 0.733198\n",
      "MONDO:0030933 Joubert syndrome 37 9.510064312910607e-08 0.733198\n",
      "MONDO:0859293 neurodevelopmental disorder with microcephaly, cerebral atrophy, and visual impairment 9.510064312910607e-08 0.733198\n",
      "MONDO:0032779 neurodevelopmental disorder with microcephaly and structural brain anomalies 9.510064312910607e-08 0.733198\n",
      "MONDO:0060640 neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy 9.510064312910607e-08 0.733198\n",
      "MONDO:0010258 MEHMO syndrome 9.510064312910607e-08 0.733198\n",
      "MONDO:0009871 pili torti-developmental delay-neurological abnormalities syndrome 1.086365376255958e-07 0.727507\n",
      "MONDO:0859518 leukodystrophy, hypomyelinating, 26, with chondrodysplasia 1.086365376255958e-07 0.727507\n",
      "MONDO:0014838 Coffin-Siris syndrome 5 1.086365376255958e-07 0.727507\n",
      "MONDO:0033372 developmental and epileptic encephalopathy, 63 1.086365376255958e-07 0.727507\n",
      "MONDO:0010319 syndromic X-linked intellectual disability Hedera type 1.086365376255958e-07 0.727507\n",
      "MONDO:0033630 neurodevelopmental disorder with speech impairment and dysmorphic facies 1.2339658230215838e-07 0.721989\n",
      "MONDO:0014351 pontocerebellar hypoplasia type 9 1.2339658230215838e-07 0.721989\n",
      "MONDO:0859186 Chopra-Amiel-Gordon syndrome 1.3943327654694047e-07 0.716632\n",
      "MONDO:0011948 pontocerebellar hypoplasia type 3 1.3943327654694047e-07 0.716632\n",
      "MONDO:0032752 developmental and epileptic encephalopathy, 75 1.3943327654694047e-07 0.716632\n",
      "MONDO:0010504 immunodeficiency 47 1.5679905973239255e-07 0.711428\n",
      "MONDO:0014357 intellectual disability, autosomal dominant 24 1.5679905973239255e-07 0.711428\n",
      "MONDO:0013726 encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 1.5679905973239255e-07 0.711428\n",
      "MONDO:0013810 COG6-ongenital disorder of glycosylation 1.5679905973239255e-07 0.711428\n",
      "MONDO:0011841 biotin-responsive basal ganglia disease 1.5679905973239255e-07 0.711428\n",
      "MONDO:0010478 SLC35A2-congenital disorder of glycosylation 1.7554631126073812e-07 0.706367\n",
      "MONDO:0013722 hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism 1.7554631126073812e-07 0.706367\n",
      "MONDO:0034121 NAD(P)HX dehydratase deficiency 1.9572735060941756e-07 0.701442\n",
      "MONDO:0013820 intellectual disability, autosomal dominant 15 1.9572735060941756e-07 0.701442\n",
      "MONDO:0014916 developmental and epileptic encephalopathy, 41 1.9572735060941756e-07 0.701442\n",
      "MONDO:0014198 mitochondrial DNA depletion syndrome 13 1.9572735060941756e-07 0.701442\n",
      "MONDO:0032677 lissencephaly 9 with complex brainstem malformation 1.9572735060941756e-07 0.701442\n",
      "MONDO:0013401 hereditary spastic paraplegia 51 1.9572735060941756e-07 0.701442\n",
      "MONDO:0014751 palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome 2.1739443737650444e-07 0.696646\n",
      "MONDO:0011652 Phelan-McDermid syndrome 2.1739443737650444e-07 0.696646\n",
      "MONDO:0054791 leukodystrophy, hypomyelinating, 16 2.1739443737650444e-07 0.696646\n",
      "MONDO:0013628 hyperphosphatasia with intellectual disability syndrome 3 2.1739443737650444e-07 0.696646\n",
      "MONDO:0014632 hypomyelinating leukodystrophy 10 2.405997713260831e-07 0.691971\n",
      "MONDO:0032651 fibrosis, neurodegeneration, and cerebral angiomatosis 2.6539549243361505e-07 0.687413\n",
      "MONDO:0033373 developmental and epileptic encephalopathy, 64 2.6539549243361505e-07 0.687413\n",
      "MONDO:0013270 Rett syndrome, congenital variant 2.6539549243361505e-07 0.687413\n",
      "MONDO:0859200 cerebellar ataxia, brain abnormalities, and cardiac conduction defects 2.6539549243361505e-07 0.687413\n",
      "MONDO:0014699 intellectual disability, autosomal dominant 40 2.918336809312581e-07 0.682965\n",
      "MONDO:0014887 bone marrow failure syndrome 3 2.918336809312581e-07 0.682965\n",
      "MONDO:0800167 Knobloch syndrome 1 2.918336809312581e-07 0.682965\n",
      "MONDO:0031007 spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosis 2.918336809312581e-07 0.682965\n",
      "MONDO:0010512 intellectual disability, X-linked, syndromic, Bain type 3.1996635735317244e-07 0.678622\n",
      "MONDO:0010502 intellectual disability, X-linked 99, syndromic, female-restricted 3.1996635735317244e-07 0.678622\n",
      "MONDO:0032851 intellectual developmental disorder with impaired language and dysmorphic facies 3.1996635735317244e-07 0.678622\n",
      "MONDO:0013990 pontocerebellar hypoplasia type 8 3.1996635735317244e-07 0.678622\n",
      "MONDO:0010305 creatine transporter deficiency 3.498454825807857e-07 0.67438\n",
      "MONDO:0032824 glycosylphosphatidylinositol biosynthesis defect 21 3.498454825807857e-07 0.67438\n",
      "MONDO:0012481 mevalonic aciduria 3.498454825807857e-07 0.67438\n",
      "MONDO:0010156 Troyer syndrome 3.498454825807857e-07 0.67438\n",
      "MONDO:0014757 macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome 3.815229578880403e-07 0.670233\n",
      "MONDO:0008564 DiGeorge syndrome 3.815229578880403e-07 0.670233\n",
      "MONDO:0010570 craniofrontonasal syndrome 4.1505062498660284e-07 0.666178\n",
      "MONDO:0044319 intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies 4.1505062498660284e-07 0.666178\n",
      "MONDO:0014858 intellectual disability, autosomal dominant 43 4.1505062498660284e-07 0.666178\n",
      "MONDO:0032855 neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies 4.5048026607105146e-07 0.662211\n",
      "MONDO:0011070 van Maldergem syndrome 1 4.5048026607105146e-07 0.662211\n",
      "MONDO:0033532 Suleiman-El-Hattab syndrome 4.5048026607105146e-07 0.662211\n",
      "MONDO:0032822 developmental and epileptic encephalopathy, 80 4.5048026607105146e-07 0.662211\n",
      "MONDO:0014966 periventricular nodular heterotopia 7 4.5048026607105146e-07 0.662211\n",
      "MONDO:0013638 Warburg micro syndrome 3 4.5048026607105146e-07 0.662211\n",
      "MONDO:0012176 Emanuel syndrome 4.5048026607105146e-07 0.662211\n",
      "MONDO:0044646 early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome 4.878636038640332e-07 0.658328\n",
      "MONDO:0032572 cardiac, facial, and digital anomalies with developmental delay 5.272523016613894e-07 0.654525\n",
      "MONDO:0008780 amyotrophic lateral sclerosis type 2, juvenile 5.272523016613894e-07 0.654525\n",
      "MONDO:0859201 neurodevelopmental disorder with impaired language and ataxia and with or without seizures 5.272523016613894e-07 0.654525\n",
      "MONDO:0060502 neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 6.122521335891393e-07 0.64715\n",
      "MONDO:0032694 microcephaly 25, primary, autosomal recessive 6.418003297075121e-07 0.644809\n",
      "MONDO:0044302 congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 7.058918813980357e-07 0.640061\n",
      "MONDO:0859190 neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities 7.058918813980357e-07 0.640061\n",
      "MONDO:0007843 Kabuki syndrome 1 7.058918813980357e-07 0.640061\n",
      "MONDO:0060622 neurodevelopmental disorder with severe motor impairment and absent language 7.560802518721325e-07 0.636618\n",
      "MONDO:0014242 van Maldergem syndrome 2 8.085827166863621e-07 0.633239\n",
      "MONDO:0010501 syndromic X-linked intellectual disability 34 8.634505244101324e-07 0.629922\n",
      "MONDO:0029140 glycosylphosphatidylinositol biosynthesis defect 18 8.634505244101324e-07 0.629922\n",
      "MONDO:0032755 neurodevelopmental disorder with or without variable brain abnormalities; NEDBA 8.634505244101324e-07 0.629922\n",
      "MONDO:0009485 oculocerebrofacial syndrome, Kaufman type 9.207348645460531e-07 0.626664\n",
      "MONDO:0013272 chromosome 14q11-q22 deletion syndrome 9.207348645460531e-07 0.626664\n",
      "MONDO:0859139 blepharophimosis-impaired intellectual development syndrome 9.80486867574802e-07 0.623464\n",
      "MONDO:0010500 intellectual disability, X-linked, syndromic 33 1.1075980893928883e-06 0.61723\n",
      "MONDO:0032760 developmental delay with or without dysmorphic facies and autism 1.1075980893928883e-06 0.61723\n",
      "MONDO:0011510 Bohring-Opitz syndrome 1.1075980893928883e-06 0.61723\n",
      "MONDO:0859170 retinal dystrophy and microvillus inclusion disease 1.140691060116855e-06 0.615719\n",
      "MONDO:0030695 developmental and epileptic encephalopathy 100 1.1750592744373875e-06 0.614193\n",
      "MONDO:0859165 neurodevelopmental disorder with hypotonia, facial dysmorphism, and brain abnormalities 1.245192054974586e-06 0.611205\n",
      "MONDO:0009658 mucopolysaccharidosis type 3D 1.245192054974586e-06 0.611205\n",
      "MONDO:0014936 ZTTK syndrome 1.5534549718815231e-06 0.599733\n",
      "MONDO:0859143 Radio-Tartaglia syndrome 1.5534549718815231e-06 0.599733\n",
      "MONDO:0010474 linear skin defects with multiple congenital anomalies 2 1.781880996403615e-06 0.592561\n",
      "MONDO:0008953 peroxisome biogenesis disorder 1A (Zellweger) 1.908519735245404e-06 0.588956\n",
      "MONDO:0009798 Primrose syndrome 2.0049774561372306e-06 0.586362\n",
      "MONDO:0800043 Stve-Wiedemann syndrome 1 2.2074751005808307e-06 0.581285\n",
      "MONDO:0012413 syndromic microphthalmia type 5 2.5652625674495586e-06 0.573326\n",
      "MONDO:0033543 cone-rod synaptic disorder syndrome, congenital nonprogressive 2.5652625674495586e-06 0.573326\n",
      "MONDO:0033310 Joubert syndrome 31 2.5652625674495586e-06 0.573326\n",
      "MONDO:0014942 developmental and epileptic encephalopathy, 45 2.5652625674495586e-06 0.573326\n",
      "MONDO:0030033 seizures, early-onset, with neurodegeneration and brain calcifications 2.5652625674495586e-06 0.573326\n",
      "MONDO:0010460 syndromic X-linked intellectual disability 17 2.5652625674495586e-06 0.573326\n",
      "MONDO:0012120 pyruvate dehydrogenase phosphatase deficiency 2.5652625674495586e-06 0.573326\n",
      "MONDO:0007617 Coffin-Siris syndrome 1 3.0220940549090252e-06 0.564598\n",
      "MONDO:0859177 VISS syndrome 3.0220940549090252e-06 0.564598\n",
      "MONDO:0034054 severe combined immunodeficiency due to CD70 deficiency 3.490728263098343e-06 0.556888\n",
      "MONDO:0031031 intellectual developmental disorder, autosomal recessive 77 3.490728263098343e-06 0.556888\n",
      "MONDO:0014398 combined oxidative phosphorylation defect type 21 3.490728263098343e-06 0.556888\n",
      "MONDO:0014170 complex cortical dysplasia with other brain malformations 3 3.490728263098343e-06 0.556888\n",
      "MONDO:0011627 autism, susceptibility to, 5 3.490728263098343e-06 0.556888\n",
      "MONDO:0014379 ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 3.566296620324282e-06 0.55574\n",
      "MONDO:0011244 Marshall-Smith syndrome 4.498368230892341e-06 0.54326\n",
      "MONDO:0007883 periodic fever, immunodeficiency, and thrombocytopenia syndrome 4.5581706341248245e-06 0.542548\n",
      "MONDO:0030518 trichothiodystrophy 9, nonphotosensitive 4.5581706341248245e-06 0.542548\n",
      "MONDO:0014086 osteogenesis imperfecta type 15 4.5581706341248245e-06 0.542548\n",
      "MONDO:0030045 Liberfarb syndrome 4.5581706341248245e-06 0.542548\n",
      "MONDO:0014186 retinitis pigmentosa with or without situs inversus 4.5581706341248245e-06 0.542548\n",
      "MONDO:0014118 congenital neutropenia-myelofibrosis-nephromegaly syndrome 4.5581706341248245e-06 0.542548\n",
      "MONDO:0010912 fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement 4.5581706341248245e-06 0.542548\n",
      "MONDO:0014714 progressive microcephaly-seizures-cortical blindness-developmental delay syndrome 4.5581706341248245e-06 0.542548\n",
      "MONDO:0859287 neurodevelopmental disorder with microcephaly, hypotonia, and absent language 4.5581706341248245e-06 0.542548\n",
      "MONDO:0032812 developmental and epileptic encephalopathy, 78 4.5581706341248245e-06 0.542548\n",
      "MONDO:0054861 intellectual disability, autosomal recessive 63 4.5581706341248245e-06 0.542548\n",
      "MONDO:0859152 neurodevelopmental disorder with cerebellar atrophy and motor dysfunction 4.5581706341248245e-06 0.542548\n",
      "MONDO:0033369 developmental and epileptic encephalopathy, 60 4.5581706341248245e-06 0.542548\n",
      "MONDO:0859292 developmental delay, behavioral abnormalities, and neuropsychiatric disorders 5.767482292204356e-06 0.529841\n",
      "MONDO:0013394 porencephaly-microcephaly-bilateral congenital cataract syndrome 5.767482292204356e-06 0.529841\n",
      "MONDO:0013254 microcephaly, seizures, and developmental delay 5.767482292204356e-06 0.529841\n",
      "MONDO:0014666 hypomyelinating leukodystrophy 11 5.767482292204356e-06 0.529841\n",
      "MONDO:0013074 encephalocraniocutaneous lipomatosis 5.767482292204356e-06 0.529841\n",
      "MONDO:0013994 Joubert syndrome 20 5.767482292204356e-06 0.529841\n",
      "MONDO:0032818 neurodevelopmental disorder with cerebellar hypoplasia and spasticity 5.767482292204356e-06 0.529841\n",
      "MONDO:0957534 megalencephalic leukoencephalopathy with subcortical cysts 4, remitting 5.767482292204356e-06 0.529841\n",
      "MONDO:0011146 tetrasomy 12p 6.178020277338167e-06 0.52612\n",
      "MONDO:0013256 chromosome 15q24 deletion syndrome 6.386809906567006e-06 0.52432\n",
      "MONDO:0010385 X-linked lymphoproliferative disease due to XIAP deficiency 7.118555909882093e-06 0.518443\n",
      "MONDO:0013008 combined immunodeficiency due to STIM1 deficiency 7.118555909882093e-06 0.518443\n",
      "MONDO:0030044 pseudo-TORCH syndrome 3 7.118555909882093e-06 0.518443\n",
      "MONDO:0010487 intellectual disability, X-linked 99 7.118555909882093e-06 0.518443\n",
      "MONDO:0013353 intellectual disability, anterior maxillary protrusion, and strabismus 7.118555909882093e-06 0.518443\n",
      "MONDO:0032605 intellectual disability, autosomal recessive 66 7.118555909882093e-06 0.518443\n",
      "MONDO:0014904 congenital disorder of glycosylation, type IAA 7.118555909882093e-06 0.518443\n",
      "MONDO:0010569 X-linked complicated corpus callosum dysgenesis 7.118555909882093e-06 0.518443\n",
      "MONDO:0014832 intellectual disability, autosomal recessive 53 7.118555909882093e-06 0.518443\n",
      "MONDO:0014116 complex cortical dysplasia with other brain malformations 2 7.118555909882093e-06 0.518443\n",
      "MONDO:0033546 neurodegeneration, infantile-onset, biotin-responsive 7.118555909882093e-06 0.518443\n",
      "MONDO:0014447 Bardet-Biedl syndrome 19 7.118555909882093e-06 0.518443\n",
      "MONDO:0054559 congenital disorder of glycosylation, type IIq 7.118555909882093e-06 0.518443\n",
      "MONDO:0014297 Joubert syndrome 22 7.118555909882093e-06 0.518443\n",
      "MONDO:0033667 Delpire-McNeill syndrome 7.118555909882093e-06 0.518443\n",
      "MONDO:0007496 dystonia 12 7.118555909882093e-06 0.518443\n",
      "MONDO:0010457 Ogden syndrome 7.738078389733436e-06 0.513917\n",
      "MONDO:0033365 developmental and epileptic encephalopathy, 56 8.611284220542381e-06 0.508116\n",
      "MONDO:0032613 mitochondrial complex 1 deficiency, nuclear type 8 8.611284220542381e-06 0.508116\n",
      "MONDO:0014828 immunodeficiency-centromeric instability-facial anomalies syndrome 3 8.611284220542381e-06 0.508116\n",
      "MONDO:0009781 Onychotrichodysplasia and neutropenia 8.611284220542381e-06 0.508116\n",
      "MONDO:0014784 severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome 8.611284220542381e-06 0.508116\n",
      "MONDO:0013541 complex cortical dysplasia with other brain malformations 1 8.611284220542381e-06 0.508116\n",
      "MONDO:0060745 intellectual developmental disorder with or without epilepsy or cerebellar ataxia 8.611284220542381e-06 0.508116\n",
      "MONDO:0011966 periventricular heterotopia with microcephaly, autosomal recessive 8.611284220542381e-06 0.508116\n",
      "MONDO:0032887 neurodevelopmental disorder with microcephaly, cortical malformations, and spasticity 8.611284220542381e-06 0.508116\n",
      "MONDO:0014718 developmental and epileptic encephalopathy, 34 8.611284220542381e-06 0.508116\n",
      "MONDO:0859253 osteoporosis, childhood- or juvenile-onset, with developmental delay 8.611284220542381e-06 0.508116\n",
      "MONDO:0014962 intellectual disability, autosomal recessive 57 8.611284220542381e-06 0.508116\n",
      "MONDO:0014862 cerebral palsy, spastic quadriplegic, 3 8.611284220542381e-06 0.508116\n",
      "MONDO:0032729 intellectual developmental disorder, autosomal recessive 70 8.611284220542381e-06 0.508116\n",
      "MONDO:0859185 neurodevelopmental disorder with hypotonia and dysmorphic facies 9.81605221651724e-06 0.501008\n",
      "MONDO:0054699 proteasome-associated autoinflammatory syndrome 3 1.0245560018378075e-05 0.498683\n",
      "MONDO:0013081 lymphoproliferative syndrome 1 1.0245560018378075e-05 0.498683\n",
      "MONDO:0011336 familial hemophagocytic lymphohistiocytosis 4 1.0245560018378075e-05 0.498683\n",
      "MONDO:0030912 intellectual disability, autosomal dominant 47 1.0245560018378075e-05 0.498683\n",
      "MONDO:0012855 Joubert syndrome 8 1.0245560018378075e-05 0.498683\n",
      "MONDO:0033366 developmental and epileptic encephalopathy, 57 1.0245560018378075e-05 0.498683\n",
      "MONDO:0014273 microcephaly-thin corpus callosum-intellectual disability syndrome 1.0245560018378075e-05 0.498683\n",
      "MONDO:0033367 developmental and epileptic encephalopathy, 58 1.0245560018378075e-05 0.498683\n",
      "MONDO:0060666 hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome 1.0245560018378075e-05 0.498683\n",
      "MONDO:0014140 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 1.0245560018378075e-05 0.498683\n",
      "MONDO:0014065 mitochondrial complex III deficiency nuclear type 4 1.0245560018378075e-05 0.498683\n",
      "MONDO:0011449 Salla disease 1.0245560018378075e-05 0.498683\n",
      "MONDO:0033570 combined oxidative phosphorylation deficiency 50 1.0245560018378075e-05 0.498683\n",
      "MONDO:0014952 intellectual disability-epilepsy-extrapyramidal syndrome 1.0245560018378075e-05 0.498683\n",
      "MONDO:0032715 intellectual developmental disorder, autosomal recessive 69 1.0245560018378075e-05 0.498683\n",
      "MONDO:0012960 intellectual disability, autosomal dominant 5 1.0245560018378075e-05 0.498683\n",
      "MONDO:0014730 microcephaly 16, primary, autosomal recessive 1.0245560018378075e-05 0.498683\n",
      "MONDO:0013931 peroxisome biogenesis disorder 4B 1.2021276158359883e-05 0.490008\n",
      "MONDO:0030378 combined oxidative phosphorylation deficiency 53 1.2021276158359883e-05 0.490008\n",
      "MONDO:0013962 hereditary spastic paraplegia 53 1.2021276158359883e-05 0.490008\n",
      "MONDO:0032623 mitochondrial complex 1 deficiency, nuclear type 18 1.2021276158359883e-05 0.490008\n",
      "MONDO:0009624 microcephaly and chorioretinopathy 1 1.2021276158359883e-05 0.490008\n",
      "MONDO:0030902 mitochondrial complex 1 deficiency, nuclear type 36 1.2021276158359883e-05 0.490008\n",
      "MONDO:0014115 hypomyelination with brain stem and spinal cord involvement and leg spasticity 1.2021276158359883e-05 0.490008\n",
      "MONDO:0031057 dyskeratosis congenita, digenic 1.2021276158359883e-05 0.490008\n",
      "MONDO:0030696 mitochondrial DNA depletion syndrome 20 (mngie type) 1.2021276158359883e-05 0.490008\n",
      "MONDO:0009238 hereditary folate malabsorption 1.2021276158359883e-05 0.490008\n",
      "MONDO:0014077 cobblestone lissencephaly without muscular or ocular involvement 1.2021276158359883e-05 0.490008\n",
      "MONDO:0030376 Martsolf syndrome 2 1.2021276158359883e-05 0.490008\n",
      "MONDO:0033658 neurodevelopmental disorder with seizures and brain atrophy 1.2021276158359883e-05 0.490008\n",
      "MONDO:0024506 Adams-Oliver syndrome 1 1.2021276158359883e-05 0.490008\n",
      "MONDO:0032768 developmental and epileptic encephalopathy, 76 1.2021276158359883e-05 0.490008\n",
      "MONDO:0030673 spastic paraplegia 86, autosomal recessive 1.2021276158359883e-05 0.490008\n",
      "MONDO:0032648 mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations 1.2021276158359883e-05 0.490008\n",
      "MONDO:0014807 spinal muscular atrophy with congenital bone fractures 2 1.2021276158359883e-05 0.490008\n",
      "MONDO:0014889 striatonigral degeneration, childhood-onset 1.2021276158359883e-05 0.490008\n",
      "MONDO:0030995 global developmental delay with speech and behavioral abnormalities 1.3938325556205777e-05 0.481981\n",
      "MONDO:0011867 microphthalmia with cyst, bilateral facial clefts, and limb anomalies 1.3938325556205777e-05 0.481981\n",
      "MONDO:0100220 Rajab interstitial lung disease with brain calcifications 2 1.3938325556205777e-05 0.481981\n",
      "MONDO:0859196 Usmani-Riazuddin syndrome, autosomal recessive 1.3938325556205777e-05 0.481981\n",
      "MONDO:0012297 SPOAN syndrome 1.3938325556205777e-05 0.481981\n",
      "MONDO:0030930 neurodevelopmental disorder with or without early-onset generalized epilepsy 1.3938325556205777e-05 0.481981\n",
      "MONDO:0010250 intellectual disability, X-linked 49 1.3938325556205777e-05 0.481981\n",
      "MONDO:0014683 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9 1.3938325556205777e-05 0.481981\n",
      "MONDO:0032813 developmental and epileptic encephalopathy, 79 1.3938325556205777e-05 0.481981\n",
      "MONDO:0013438 pontocerebellar hypoplasia type 2D 1.3938325556205777e-05 0.481981\n",
      "MONDO:0030060 neurodevelopmental disorder with language impairment and behavioral abnormalities 1.3938325556205777e-05 0.481981\n",
      "MONDO:0014559 progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome 1.3938325556205777e-05 0.481981\n",
      "MONDO:0014647 developmental and epileptic encephalopathy, 50 1.3938325556205777e-05 0.481981\n",
      "MONDO:0013351 infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly 1.3938325556205777e-05 0.481981\n",
      "MONDO:0030537 central hypoventilation syndrome, congenital, 2, and autonomic dysfunction 1.3938325556205777e-05 0.481981\n",
      "MONDO:0032616 mitochondrial complex 1 deficiency, nuclear type 10 1.3938325556205777e-05 0.481981\n",
      "MONDO:0957254 mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A 1.3938325556205777e-05 0.481981\n",
      "MONDO:0007492 early-onset generalized limb-onset dystonia 1.3938325556205777e-05 0.481981\n",
      "MONDO:0000208 microcephaly, short stature, and impaired glucose metabolism 1 1.599660118835042e-05 0.474519\n",
      "MONDO:0013933 peroxisome biogenesis disorder 5B 1.599660118835042e-05 0.474519\n",
      "MONDO:0010263 Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome 1.599660118835042e-05 0.474519\n",
      "MONDO:0030937 mitochondrial complex 2 deficiency, nuclear type 3 1.599660118835042e-05 0.474519\n",
      "MONDO:0014530 autosomal recessive spinocerebellar ataxia 18 1.599660118835042e-05 0.474519\n",
      "MONDO:0010979 Timothy syndrome 1.599660118835042e-05 0.474519\n",
      "MONDO:0014044 dysmorphism-conductive hearing loss-heart defect syndrome 1.599660118835042e-05 0.474519\n",
      "MONDO:0014485 pontocerebellar hypoplasia, type 1C 1.599660118835042e-05 0.474519\n",
      "MONDO:0030878 Kaya-Barakat-Masson syndrome 1.599660118835042e-05 0.474519\n",
      "MONDO:0020777 congenital disorder of glycosylation with defective fucosylation 2 1.599660118835042e-05 0.474519\n",
      "MONDO:0012856 Birk-Barel syndrome 1.599660118835042e-05 0.474519\n",
      "MONDO:0014399 ataxia-telangiectasia-like disorder 2 1.599660118835042e-05 0.474519\n",
      "MONDO:0033368 developmental and epileptic encephalopathy, 59 1.599660118835042e-05 0.474519\n",
      "MONDO:0025701 leukodystrophy, hypomyelinating, 22 1.599660118835042e-05 0.474519\n",
      "MONDO:0009746 hereditary sensory and autonomic neuropathy type 4 1.819599609191449e-05 0.467549\n",
      "MONDO:0012581 osteogenesis imperfecta type 8 1.819599609191449e-05 0.467549\n",
      "MONDO:0008082 multiple endocrine neoplasia type 2B 1.819599609191449e-05 0.467549\n",
      "MONDO:0033662 neurodevelopmental disorder with microcephaly, seizures, and brain atrophy 1.819599609191449e-05 0.467549\n",
      "MONDO:0859250 neurodevelopmental disorder with microcephaly, hypotonia, nystagmus, and seizures 1.819599609191449e-05 0.467549\n",
      "MONDO:0012772 Stevenson-Carey syndrome 1.819599609191449e-05 0.467549\n",
      "MONDO:0014992 lissencephaly 8 1.819599609191449e-05 0.467549\n",
      "MONDO:0012703 lissencephaly due to TUBA1A mutation 1.819599609191449e-05 0.467549\n",
      "MONDO:0011313 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 1.819599609191449e-05 0.467549\n",
      "MONDO:0030881 developmental and epileptic encephalopathy 102 1.819599609191449e-05 0.467549\n",
      "MONDO:0054785 multiple mitochondrial dysfunctions syndrome 6 1.819599609191449e-05 0.467549\n",
      "MONDO:0014874 pontocerebellar hypoplasia, type 2F 1.819599609191449e-05 0.467549\n",
      "MONDO:0011902 Charcot-Marie-Tooth disease type 1F 1.819599609191449e-05 0.467549\n",
      "MONDO:0012885 SRD5A3-congenital disorder of glycosylation 1.819599609191449e-05 0.467549\n",
      "MONDO:0008695 chorea-acanthocytosis 1.819599609191449e-05 0.467549\n",
      "MONDO:0011651 intellectual disability, short stature, facial anomalies, and joint dislocations 2.0536403364674227e-05 0.461014\n",
      "MONDO:0032632 mitochondrial complex 1 deficiency, nuclear type 28 2.0536403364674227e-05 0.461014\n",
      "MONDO:0957495 hemolytic uremic syndrome, atypical, 8, with rhizomelic short stature 2.0536403364674227e-05 0.461014\n",
      "MONDO:0014619 trichothiodystrophy 3, photosensitive 2.0536403364674227e-05 0.461014\n",
      "MONDO:0010431 Joubert syndrome 10 2.0536403364674227e-05 0.461014\n",
      "MONDO:0044205 Shwachman-Diamond syndrome 2 2.0536403364674227e-05 0.461014\n",
      "MONDO:0030261 pontocerebellar hypoplasia, type 1F 2.0536403364674227e-05 0.461014\n",
      "MONDO:0013173 intellectual disability, autosomal recessive 13 2.0536403364674227e-05 0.461014\n",
      "MONDO:0033547 Li-Ghorbani-Weisz-Hubshman syndrome 2.0536403364674227e-05 0.461014\n",
      "MONDO:0013969 combined oxidative phosphorylation defect type 11 2.0536403364674227e-05 0.461014\n",
      "MONDO:0013342 hereditary spastic paraplegia 48 2.0536403364674227e-05 0.461014\n",
      "MONDO:0032770 intellectual developmental disorder with severe speech and ambulation defects 2.0536403364674227e-05 0.461014\n",
      "MONDO:0054763 neurodegeneration with brain iron accumulation 7 2.0536403364674227e-05 0.461014\n",
      "MONDO:0032624 mitochondrial complex 1 deficiency, nuclear type 19 2.0536403364674227e-05 0.461014\n",
      "MONDO:0033045 orofaciodigital syndrome 16 2.0536403364674227e-05 0.461014\n",
      "MONDO:0014598 developmental and epileptic encephalopathy, 31 2.0536403364674227e-05 0.461014\n",
      "MONDO:0014512 PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation 2.0536403364674227e-05 0.461014\n",
      "MONDO:0060759 neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures 2.0536403364674227e-05 0.461014\n",
      "MONDO:0013858 pontine tegmental cap dysplasia 2.0536403364674227e-05 0.461014\n",
      "MONDO:0026727 Shukla-Vernon syndrome 2.0536403364674227e-05 0.461014\n",
      "MONDO:0011240 megalencephaly-capillary malformation-polymicrogyria syndrome 2.3017716165030653e-05 0.454865\n",
      "MONDO:0013870 TMEM165-congenital disorder of glycosylation 2.3017716165030653e-05 0.454865\n",
      "MONDO:0044718 alkaline ceramidase 3 deficiency 2.3017716165030653e-05 0.454865\n",
      "MONDO:0044204 Shwachman-Diamond syndrome 1 2.3017716165030653e-05 0.454865\n",
      "MONDO:0044318 intellectual developmental disorder with gastrointestinal difficulties and high pain threshold 2.3017716165030653e-05 0.454865\n",
      "MONDO:0859575 Atelis syndrome 1 2.3017716165030653e-05 0.454865\n",
      "MONDO:0014290 neurodegeneration with brain iron accumulation 6 2.3017716165030653e-05 0.454865\n",
      "MONDO:0032866 cortical dysplasia, complex, with other brain malformations 10 2.3017716165030653e-05 0.454865\n",
      "MONDO:0014933 developmental and epileptic encephalopathy, 44 2.3017716165030653e-05 0.454865\n",
      "MONDO:0008799 anophthalmia/microphthalmia-esophageal atresia syndrome 2.3017716165030653e-05 0.454865\n",
      "MONDO:0014358 AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome 2.3017716165030653e-05 0.454865\n",
      "MONDO:0032601 inflammatory bowel disease, immunodeficiency, and encephalopathy 2.3017716165030653e-05 0.454865\n",
      "MONDO:0013160 muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2 2.3017716165030653e-05 0.454865\n",
      "MONDO:0054817 leukodystrophy, hypomyelinating, 17 2.3017716165030653e-05 0.454865\n",
      "MONDO:0011829 coenzyme Q10 deficiency, primary, 1 2.3017716165030653e-05 0.454865\n",
      "MONDO:0030890 pontocerebellar hypoplasia, IIA 17 2.3017716165030653e-05 0.454865\n",
      "MONDO:0013306 combined oxidative phosphorylation defect type 7 2.3017716165030653e-05 0.454865\n",
      "MONDO:0010298 Lesch-Nyhan syndrome 2.3017716165030653e-05 0.454865\n",
      "MONDO:0009502 pyruvate dehydrogenase E2 deficiency 2.3017716165030653e-05 0.454865\n",
      "MONDO:0014896 congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome 2.5639827711979356e-05 0.449063\n",
      "MONDO:0032675 myasthenic syndrome, congenital, 25, presynaptic 2.5639827711979356e-05 0.449063\n",
      "MONDO:0013553 immunodeficiency-centromeric instability-facial anomalies syndrome 2 2.5639827711979356e-05 0.449063\n",
      "MONDO:0010395 phosphoribosylpyrophosphate synthetase superactivity 2.5639827711979356e-05 0.449063\n",
      "MONDO:0014213 intellectual disability-feeding difficulties-developmental delay-microcephaly syndrome 2.5639827711979356e-05 0.449063\n",
      "MONDO:0014347 short stature with microcephaly and distinctive facies 2.5639827711979356e-05 0.449063\n",
      "MONDO:0032618 mitochondrial complex 1 deficiency, nuclear type 13 2.5639827711979356e-05 0.449063\n",
      "MONDO:0014732 hypomyelinating leukodystrophy 12 2.5639827711979356e-05 0.449063\n",
      "MONDO:0859206 neurodevelopmental disorder with hearing loss and spasticity 2.5639827711979356e-05 0.449063\n",
      "MONDO:0032807 neurodevelopmental disorder with visual defects and brain anomalies 2.5639827711979356e-05 0.449063\n",
      "MONDO:0060490 neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies 2.5639827711979356e-05 0.449063\n",
      "MONDO:0060627 glycosylphosphatidylinositol biosynthesis defect 15 2.5639827711979356e-05 0.449063\n",
      "MONDO:0011873 Niemann-Pick disease, type C2 2.5639827711979356e-05 0.449063\n",
      "MONDO:0014806 spinal muscular atrophy with congenital bone fractures 1 2.5639827711979356e-05 0.449063\n",
      "MONDO:0012212 Loeys-Dietz syndrome 1 2.8402631285079628e-05 0.443572\n",
      "MONDO:0800103 COACH syndrome 1 2.8402631285079628e-05 0.443572\n",
      "MONDO:0859247 neurocardiofaciodigital syndrome 2.8402631285079628e-05 0.443572\n",
      "MONDO:0014908 microcephaly 17, primary, autosomal recessive 2.8402631285079628e-05 0.443572\n",
      "MONDO:0014533 developmental and epileptic encephalopathy, 28 2.8402631285079628e-05 0.443572\n",
      "MONDO:0100348 neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities 2.8402631285079628e-05 0.443572\n",
      "MONDO:0032820 neurodevelopmental disorder with structural brain anomalies and dysmorphic facies 2.8402631285079628e-05 0.443572\n",
      "MONDO:0014506 hypomyelinating leukodystrophy 9 2.8402631285079628e-05 0.443572\n",
      "MONDO:0014958 Harel-Yoon syndrome 2.8402631285079628e-05 0.443572\n",
      "MONDO:0957218 neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities 2.8402631285079628e-05 0.443572\n",
      "MONDO:0859212 neurodevelopmental disorder, nonprogressive, with spasticity and transient opisthotonus 2.8402631285079628e-05 0.443572\n",
      "MONDO:0032784 neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements 2.8402631285079628e-05 0.443572\n",
      "MONDO:0013905 autosomal recessive spinocerebellar ataxia 13 2.8402631285079628e-05 0.443572\n",
      "MONDO:0009757 Niemann-Pick disease, type C1 2.8402631285079628e-05 0.443572\n",
      "MONDO:0014599 intellectual disability, autosomal dominant 34 2.8402631285079628e-05 0.443572\n",
      "MONDO:0957229 hatipoglu immunodeficiency syndrome 3.130602022442422e-05 0.438362\n",
      "MONDO:0014553 Tenorio syndrome 3.130602022442422e-05 0.438362\n",
      "MONDO:0013987 combined oxidative phosphorylation defect type 15 3.130602022442422e-05 0.438362\n",
      "MONDO:0032611 mitochondrial complex 1 deficiency, nuclear type 6 3.130602022442422e-05 0.438362\n",
      "MONDO:0014320 Bosch-Boonstra-Schaaf optic atrophy syndrome 3.130602022442422e-05 0.438362\n",
      "MONDO:0060763 intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities 3.130602022442422e-05 0.438362\n",
      "MONDO:0100478 brain malformations with or without urinary tract defects 3.130602022442422e-05 0.438362\n",
      "MONDO:0014811 cerebellar atrophy, visual impairment, and psychomotor retardation; 3.130602022442422e-05 0.438362\n",
      "MONDO:0011629 MOGS-congenital disorder of glycosylation 3.130602022442422e-05 0.438362\n",
      "MONDO:0013672 chromosome 15q25 deletion syndrome 3.130602022442422e-05 0.438362\n",
      "MONDO:0032787 holoprosencephaly 12 with or without pancreatic agenesis 3.130602022442422e-05 0.438362\n",
      "MONDO:0054636 Skraban-Deardorff syndrome 3.130602022442422e-05 0.438362\n",
      "MONDO:0010509 intellectual disability, X-linked 104 3.130602022442422e-05 0.438362\n",
      "MONDO:0014016 hereditary spastic paraplegia 49 3.130602022442422e-05 0.438362\n",
      "MONDO:0014941 arthrogryposis, distal, with impaired proprioception and touch 3.130602022442422e-05 0.438362\n",
      "MONDO:0014144 autosomal recessive limb-girdle muscular dystrophy type R18 3.130602022442422e-05 0.438362\n",
      "MONDO:0012611 polyhydramnios, megalencephaly, and symptomatic epilepsy 3.130602022442422e-05 0.438362\n",
      "MONDO:0012143 hereditary cryohydrocytosis with reduced stomatin 3.130602022442422e-05 0.438362\n",
      "MONDO:0009590 metachromatic leukodystrophy due to saposin B deficiency 3.130602022442422e-05 0.438362\n",
      "MONDO:0009266 Gaucher disease type II 3.130602022442422e-05 0.438362\n",
      "MONDO:0014219 alacrima, achalasia, and intellectual disability syndrome 3.130602022442422e-05 0.438362\n",
      "MONDO:0018820 recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome 3.130602022442422e-05 0.438362\n",
      "MONDO:0012055 Larsen-like osseous dysplasia-short stature syndrome 3.4349887930608576e-05 0.433407\n",
      "MONDO:0015022 intellectual developmental disorder with dysmorphic facies and ptosis 3.4349887930608576e-05 0.433407\n",
      "MONDO:0010183 methylmalonic aciduria and homocystinuria type cblF 3.4349887930608576e-05 0.433407\n",
      "MONDO:0030969 intellectual developmental disorder, autosomal dominant 68 3.4349887930608576e-05 0.433407\n",
      "MONDO:0012519 Rubinstein-Taybi syndrome due to 16p13.3 microdeletion 3.4349887930608576e-05 0.433407\n",
      "MONDO:0013805 intellectual disability, autosomal dominant 13 3.4349887930608576e-05 0.433407\n",
      "MONDO:0012718 hypotonia with lactic acidemia and hyperammonemia 3.4349887930608576e-05 0.433407\n",
      "MONDO:0859332 cortical dysplasia, complex, with other brain malformations 11 3.4349887930608576e-05 0.433407\n",
      "MONDO:0030035 leukoencephalopathy, developmental delay, and episodic neurologic regression syndrome 3.4349887930608576e-05 0.433407\n",
      "MONDO:0013655 intellectual disability, autosomal dominant 8 3.4349887930608576e-05 0.433407\n",
      "MONDO:0014318 hyperphosphatasia with intellectual disability syndrome 4 3.4349887930608576e-05 0.433407\n",
      "MONDO:0060758 spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits 3.4349887930608576e-05 0.433407\n",
      "MONDO:0859197 intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies 3.4349887930608576e-05 0.433407\n",
      "MONDO:0032636 mitochondrial complex 1 deficiency, nuclear type 33 3.4349887930608576e-05 0.433407\n",
      "MONDO:0030473 developmental and epileptic encephalopathy 99 3.4349887930608576e-05 0.433407\n",
      "MONDO:0013552 hereditary spastic paraplegia 52 3.4349887930608576e-05 0.433407\n",
      "MONDO:0014132 multiple mitochondrial dysfunctions syndrome 3 3.753412786470064e-05 0.428686\n",
      "MONDO:0030491 immunodeficiency 91 and hyperinflammation 3.753412786470064e-05 0.428686\n",
      "MONDO:0011537 macrocephaly-autism syndrome 3.753412786470064e-05 0.428686\n",
      "MONDO:0014114 cardiofaciocutaneous syndrome 4 3.753412786470064e-05 0.428686\n",
      "MONDO:0859136 Alzahrani-Kuwahara syndrome 3.753412786470064e-05 0.428686\n",
      "MONDO:0014949 developmental and epileptic encephalopathy, 47 3.753412786470064e-05 0.428686\n",
      "MONDO:0014773 cardiac anomalies - developmental delay - facial dysmorphism syndrome 3.753412786470064e-05 0.428686\n",
      "MONDO:0014534 lissencephaly 6 with microcephaly 3.753412786470064e-05 0.428686\n",
      "MONDO:0011778 multiple epiphyseal dysplasia, Al-Gazali type 3.753412786470064e-05 0.428686\n",
      "MONDO:0030061 periventricular nodular heterotopia 9 3.753412786470064e-05 0.428686\n",
      "MONDO:0032578 cortical dysplasia, complex, with other brain malformations 9 3.753412786470064e-05 0.428686\n",
      "MONDO:0012890 pontocerebellar hypoplasia type 2B 3.753412786470064e-05 0.428686\n",
      "MONDO:0032650 neurodegeneration, childhood-onset, with cerebellar atrophy 3.753412786470064e-05 0.428686\n",
      "MONDO:0030669 gastrointestinal defects and immunodeficiency syndrome 2 3.753412786470064e-05 0.428686\n",
      "MONDO:0054573 Lopes-Maciel-Rodan syndrome 3.753412786470064e-05 0.428686\n",
      "MONDO:0957531 neurodevelopmental disorder with microcephaly and movement abnormalities 3.753412786470064e-05 0.428686\n",
      "MONDO:0026723 intellectual developmental disorder, X-linked 108 3.753412786470064e-05 0.428686\n",
      "MONDO:0060664 neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities 3.753412786470064e-05 0.428686\n",
      "MONDO:0030953 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 4.0858633548209975e-05 0.424179\n",
      "MONDO:0032922 Beck-Fahrner syndrome 4.0858633548209975e-05 0.424179\n",
      "MONDO:0014353 immunodeficiency 23 4.0858633548209975e-05 0.424179\n",
      "MONDO:0032790 neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities 4.0858633548209975e-05 0.424179\n",
      "MONDO:0014911 growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy 4.0858633548209975e-05 0.424179\n",
      "MONDO:0014706 cutis laxa, autosomal dominant 3 4.0858633548209975e-05 0.424179\n",
      "MONDO:0009927 3MC syndrome 2 4.0858633548209975e-05 0.424179\n",
      "MONDO:0008221 prolidase deficiency 4.0858633548209975e-05 0.424179\n",
      "MONDO:0020850 intellectual disability, autosomal recessive 65 4.0858633548209975e-05 0.424179\n",
      "MONDO:0031481 microcephaly, epilepsy, and diabetes syndrome 1 4.0858633548209975e-05 0.424179\n",
      "MONDO:0859333 intellectual developmental disorder, autosomal dominant 70 4.0858633548209975e-05 0.424179\n",
      "MONDO:0030025 neurodevelopmental disorder with hypotonia, microcephaly, and seizures 4.0858633548209975e-05 0.424179\n",
      "MONDO:0044723 3-methylglutaconic aciduria type 8 4.0858633548209975e-05 0.424179\n",
      "MONDO:0032780 hypotonia, hypoventilation, impaired intellectual development, dysautonomia, epilepsy, and eye abnormalities 4.0858633548209975e-05 0.424179\n",
      "MONDO:0010396 developmental and epileptic encephalopathy, 2 4.0858633548209975e-05 0.424179\n",
      "MONDO:0013352 intellectual disability-severe speech delay-mild dysmorphism syndrome 4.0858633548209975e-05 0.424179\n",
      "MONDO:8000024 autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD 4.432329856305778e-05 0.419868\n",
      "MONDO:0014405 STING-associated vasculopathy with onset in infancy 4.432329856305778e-05 0.419868\n",
      "MONDO:0015003 dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 4.432329856305778e-05 0.419868\n",
      "MONDO:0013225 congenital generalized lipodystrophy type 4 4.432329856305778e-05 0.419868\n",
      "MONDO:0014370 pontocerebellar hypoplasia type 2E 4.432329856305778e-05 0.419868\n",
      "MONDO:0859331 Rabin-Pappas syndrome 4.432329856305778e-05 0.419868\n",
      "MONDO:0013745 Joubert syndrome 14 4.432329856305778e-05 0.419868\n",
      "MONDO:0015025 developmental and epileptic encephalopathy, 51 4.432329856305778e-05 0.419868\n",
      "MONDO:0010632 developmental and epileptic encephalopathy, 1 4.432329856305778e-05 0.419868\n",
      "MONDO:0009657 mucopolysaccharidosis type 3C 4.432329856305778e-05 0.419868\n",
      "MONDO:0859137 neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia 4.432329856305778e-05 0.419868\n",
      "MONDO:0014263 8q24.3 microdeletion syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0014894 Meier-Gorlin syndrome 7 4.7928016551546164e-05 0.415738\n",
      "MONDO:0035133 PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0013357 chromosome 17q11.2 deletion syndrome, 1.4Mb 4.7928016551546164e-05 0.415738\n",
      "MONDO:0060677 chromosome 1p35 deletion syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0010441 CK syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0859163 Faundes-Banka syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0020841 neurodevelopmental disorder with cerebellar atrophy and with or without seizures 4.7928016551546164e-05 0.415738\n",
      "MONDO:0012574 Potocki-Lupski syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0013971 leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0032714 facial dysmorphism, hypertrichosis, epilepsy, intellectual/developmental delay, and gingival overgrowth syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0013641 Warburg micro syndrome 2 4.7928016551546164e-05 0.415738\n",
      "MONDO:0014994 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 4.7928016551546164e-05 0.415738\n",
      "MONDO:0011445 hereditary spastic paraplegia 11 4.7928016551546164e-05 0.415738\n",
      "MONDO:0060496 neurodevelopmental disorder with hypotonia, neuropathy, and deafness 4.7928016551546164e-05 0.415738\n",
      "MONDO:0010222 X-linked Opitz G/BBB syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0032610 mitochondrial complex 1 deficiency, nuclear type 5 4.7928016551546164e-05 0.415738\n",
      "MONDO:0032726 combined oxidative phosphorylation deficiency 39 4.7928016551546164e-05 0.415738\n",
      "MONDO:0859232 neurodevelopmental disorder with central hypotonia and dysmorphic facies 4.7928016551546164e-05 0.415738\n",
      "MONDO:0014336 intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency 4.7928016551546164e-05 0.415738\n",
      "MONDO:0010354 Allan-Herndon-Dudley syndrome 4.7928016551546164e-05 0.415738\n",
      "MONDO:0054560 anauxetic dysplasia 1 5.167268121632775e-05 0.411775\n",
      "MONDO:0012427 Loeys-Dietz syndrome 2 5.167268121632775e-05 0.411775\n",
      "MONDO:0014914 Dias-Logan syndrome 5.167268121632775e-05 0.411775\n",
      "MONDO:0030607 Bryant-Li-Bhoj neurodevelopmental syndrome 2 5.167268121632775e-05 0.411775\n",
      "MONDO:0014948 short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay 5.167268121632775e-05 0.411775\n",
      "MONDO:0009595 cartilage-hair hypoplasia 5.167268121632775e-05 0.411775\n",
      "MONDO:0957266 RECON progeroid syndrome 5.167268121632775e-05 0.411775\n",
      "MONDO:0030913 intellectual disability, autosomal dominant 48 5.167268121632775e-05 0.411775\n",
      "MONDO:0030992 short stature, oligodontia, dysmorphic facies, and motor delay 5.167268121632775e-05 0.411775\n",
      "MONDO:0015601 X-linked intellectual disability, van Esch type 5.167268121632775e-05 0.411775\n",
      "MONDO:0013821 intellectual disability, autosomal dominant 16 5.167268121632775e-05 0.411775\n",
      "MONDO:0009841 PEHO syndrome 5.167268121632775e-05 0.411775\n",
      "MONDO:0014643 congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome 5.167268121632775e-05 0.411775\n",
      "MONDO:0014371 developmental and epileptic encephalopathy, 23 5.167268121632775e-05 0.411775\n",
      "MONDO:0014464 progressive encephalopathy with leukodystrophy due to DECR deficiency 5.167268121632775e-05 0.411775\n",
      "MONDO:0012430 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 2 5.167268121632775e-05 0.411775\n",
      "MONDO:0014728 combined oxidative phosphorylation defect type 27 5.167268121632775e-05 0.411775\n",
      "MONDO:0014547 combined oxidative phosphorylation defect type 24 5.167268121632775e-05 0.411775\n",
      "MONDO:0014922 myofibrillar myopathy 7 5.167268121632775e-05 0.411775\n",
      "MONDO:0007113 Angelman syndrome 5.167268121632775e-05 0.411775\n",
      "MONDO:0014306 vasculitis due to ADA2 deficiency 5.555718632037505e-05 0.407968\n",
      "MONDO:0011337 familial hemophagocytic lymphohistiocytosis 2 5.555718632037505e-05 0.407968\n",
      "MONDO:0859347 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities 5.555718632037505e-05 0.407968\n",
      "MONDO:0014139 Ehlers-Danlos syndrome, spondylodysplastic type, 2 5.555718632037505e-05 0.407968\n",
      "MONDO:0031000 Tessadori-Van Haaften neurodevelopmental syndrome 4 5.555718632037505e-05 0.407968\n",
      "MONDO:0013299 chromosome 6q11-q14 deletion syndrome 5.555718632037505e-05 0.407968\n",
      "MONDO:0030543 combined oxidative phosphorylation deficiency 54 5.555718632037505e-05 0.407968\n",
      "MONDO:0010879 CODAS syndrome 5.555718632037505e-05 0.407968\n",
      "MONDO:0012280 Goldberg-Shprintzen megacolon syndrome 5.555718632037505e-05 0.407968\n",
      "MONDO:0013659 microcephaly-capillary malformation syndrome 5.555718632037505e-05 0.407968\n",
      "MONDO:0033007 Galloway-Mowat syndrome 3 5.555718632037505e-05 0.407968\n",
      "MONDO:0032864 intellectual developmental disorder with speech delay, autism, and dysmorphic facies 5.555718632037505e-05 0.407968\n",
      "MONDO:0012342 7q11.23 microduplication syndrome 5.555718632037505e-05 0.407968\n",
      "MONDO:0033613 neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities 5.555718632037505e-05 0.407968\n",
      "MONDO:0009756 Niemann-Pick disease type A 5.555718632037505e-05 0.407968\n",
      "MONDO:0032817 neurodevelopmental disorder with cataracts, poor growth, and dysmorphic facies 5.555718632037505e-05 0.407968\n",
      "MONDO:0859241 neurodegeneration, childhood-onset, with progressive microcephaly 5.555718632037505e-05 0.407968\n",
      "MONDO:0030533 intellectual developmental disorder, autosomal recessive 73 5.555718632037505e-05 0.407968\n",
      "MONDO:0014556 congenital contractures of the limbs and face, hypotonia, and developmental delay 5.555718632037505e-05 0.407968\n",
      "MONDO:0859199 developmental delay with or without intellectual impairment or behavioral abnormalities 5.958142568695085e-05 0.404306\n",
      "MONDO:0014507 Catel-Manzke syndrome 5.958142568695085e-05 0.404306\n",
      "MONDO:0014723 PMP22-RAI1 contiguous gene duplication syndrome 5.958142568695085e-05 0.404306\n",
      "MONDO:0014364 mitochondrial complex III deficiency nuclear type 8 5.958142568695085e-05 0.404306\n",
      "MONDO:0014413 orofaciodigital syndrome type 14 5.958142568695085e-05 0.404306\n",
      "MONDO:0013579 methylmalonate semialdehyde dehydrogenase deficiency 5.958142568695085e-05 0.404306\n",
      "MONDO:0014658 severe achondroplasia-developmental delay-acanthosis nigricans syndrome 5.958142568695085e-05 0.404306\n",
      "MONDO:0859283 neurodevelopmental disorder with seizures, microcephaly, and brain abnormalities 5.958142568695085e-05 0.404306\n",
      "MONDO:0009364 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 5.958142568695085e-05 0.404306\n",
      "MONDO:0014296 Warburg micro syndrome 4 5.958142568695085e-05 0.404306\n",
      "MONDO:0859208 Hengel-Maroofian-Schols syndrome 5.958142568695085e-05 0.404306\n",
      "MONDO:0007068 adenylosuccinate lyase deficiency 5.958142568695085e-05 0.404306\n",
      "MONDO:0032764 Khan-Khan-Katsanis syndrome 5.958142568695085e-05 0.404306\n",
      "MONDO:0859275 neurodevelopmental disorder with spasticity, seizures, and brain abnormalities 5.958142568695085e-05 0.404306\n",
      "MONDO:0010278 Christianson syndrome 5.958142568695085e-05 0.404306\n",
      "MONDO:0030308 immunodeficiency 82 with systemic inflammation 6.374529319957652e-05 0.400778\n",
      "MONDO:0010465 Kabuki syndrome 2 6.374529319957652e-05 0.400778\n",
      "MONDO:0060532 congenital heart defects and skeletal malformations syndrome 6.374529319957652e-05 0.400778\n",
      "MONDO:0032600 Snijders Blok-Campeau syndrome 6.374529319957652e-05 0.400778\n",
      "MONDO:0013051 autosomal recessive cutis laxa type 2B 6.374529319957652e-05 0.400778\n",
      "MONDO:0014863 macrocephaly, dysmorphic facies, and psychomotor retardation 6.374529319957652e-05 0.400778\n",
      "MONDO:0030019 anauxetic dysplasia 3 6.374529319957652e-05 0.400778\n",
      "MONDO:0030866 neurodevelopmental disorder with cardiomyopathy, spasticity, and brain abnormalities 6.374529319957652e-05 0.400778\n",
      "MONDO:0100111 focal segmental glomerulosclerosis and neurodevelopmental syndrome 6.8048682802003e-05 0.397376\n",
      "MONDO:0054837 intellectual disability, autosomal dominant 57 6.8048682802003e-05 0.397376\n",
      "MONDO:0060760 intellectual developmental disorder with dysmorphic facies and behavioral abnormalities 6.8048682802003e-05 0.397376\n",
      "MONDO:0010472 developmental and epileptic encephalopathy, 36 6.8048682802003e-05 0.397376\n",
      "MONDO:0859297 neurodevelopmental disorder with dysmorphic facies and skeletal and brain abnormalities 6.8048682802003e-05 0.397376\n",
      "MONDO:0030928 microcephaly 26, primary, autosomal dominant 6.8048682802003e-05 0.397376\n",
      "MONDO:0032697 neurodevelopmental disorder and language delay with or without structural brain abnormalities 6.8048682802003e-05 0.397376\n",
      "MONDO:0014833 heart and brain malformation syndrome 6.8048682802003e-05 0.397376\n",
      "MONDO:0014243 Schaaf-Yang syndrome 6.8048682802003e-05 0.397376\n",
      "MONDO:0011866 pontocerebellar hypoplasia type 1A 6.8048682802003e-05 0.397376\n",
      "MONDO:0030919 intellectual disability, autosomal dominant 53 7.249148849817927e-05 0.394092\n",
      "MONDO:0014561 3-methylglutaconic aciduria, type VIIB 7.249148849817927e-05 0.394092\n",
      "MONDO:0011435 microcephaly 2, primary, autosomal recessive, with or without cortical malformations 7.249148849817927e-05 0.394092\n",
      "MONDO:0011575 cerebrooculonasal syndrome 7.249148849817927e-05 0.394092\n",
      "MONDO:0032831 pontocerebellar hypoplasia, type 13 7.249148849817927e-05 0.394092\n",
      "MONDO:0030922 intellectual disability, autosomal dominant 56 7.249148849817927e-05 0.394092\n",
      "MONDO:0014601 autosomal recessive spinocerebellar ataxia 20 7.249148849817927e-05 0.394092\n",
      "MONDO:0013943 peroxisome biogenesis disorder 8B 7.249148849817927e-05 0.394092\n",
      "MONDO:0009319 pantothenate kinase-associated neurodegeneration 7.249148849817927e-05 0.394092\n",
      "MONDO:0060624 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter 7.249148849817927e-05 0.394092\n",
      "MONDO:0010361 intellectual disability, X-linked 30 7.249148849817927e-05 0.394092\n",
      "MONDO:0010572 occipital horn syndrome 7.707360435222308e-05 0.390919\n",
      "MONDO:0013624 Rafiq syndrome 7.707360435222308e-05 0.390919\n",
      "MONDO:0007537 lateral meningocele syndrome 7.707360435222308e-05 0.390919\n",
      "MONDO:0009458 Schimke immuno-osseous dysplasia 7.707360435222308e-05 0.390919\n",
      "MONDO:0030856 developmental and epileptic encephalopathy 89 7.707360435222308e-05 0.390919\n",
      "MONDO:0009644 sulfite oxidase deficiency due to molybdenum cofactor deficiency type B 7.707360435222308e-05 0.390919\n",
      "MONDO:0009165 Aicardi-Goutieres syndrome 1 7.707360435222308e-05 0.390919\n",
      "MONDO:0010235 X-linked intellectual disability-psychosis-macroorchidism syndrome 7.707360435222308e-05 0.390919\n",
      "MONDO:0020847 intellectual disability, autosomal dominant 58 8.179492448838974e-05 0.387849\n",
      "MONDO:0014893 Okur-Chung neurodevelopmental syndrome 8.179492448838974e-05 0.387849\n",
      "MONDO:0030331 Ritscher-Schinzel syndrome 4 8.179492448838974e-05 0.387849\n",
      "MONDO:0014993 myofibrillar myopathy 8 8.179492448838974e-05 0.387849\n",
      "MONDO:0013819 intellectual disability, autosomal dominant 14 8.179492448838974e-05 0.387849\n",
      "MONDO:0014349 pontocerebellar hypoplasia type 10 8.179492448838974e-05 0.387849\n",
      "MONDO:0013268 frontonasal dysplasia with alopecia and genital anomaly 8.179492448838974e-05 0.387849\n",
      "MONDO:0014823 hypotonia, infantile, with psychomotor retardation and characteristic facies 3 8.179492448838974e-05 0.387849\n",
      "MONDO:0014864 hypermanganesemia with dystonia 2 8.179492448838974e-05 0.387849\n",
      "MONDO:0011640 genitopatellar syndrome 8.179492448838974e-05 0.387849\n",
      "MONDO:0859286 neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures 8.179492448838974e-05 0.387849\n",
      "MONDO:0060510 Cohen-Gibson syndrome 8.665534309104237e-05 0.384877\n",
      "MONDO:0700107 chromosome 19q13.11 deletion syndrome, distal 8.665534309104237e-05 0.384877\n",
      "MONDO:0025351 multiple congenital anomalies-neurodevelopmental syndrome, X-linked 8.665534309104237e-05 0.384877\n",
      "MONDO:0013993 pontocerebellar hypoplasia type 7 8.665534309104237e-05 0.384877\n",
      "MONDO:0010758 Wieacker-Wolff syndrome 8.665534309104237e-05 0.384877\n",
      "MONDO:0100215 Rajab interstitial lung disease with brain calcifications 1 9.165475440462125e-05 0.381998\n",
      "MONDO:0013308 CBL-related disorder 9.165475440462125e-05 0.381998\n",
      "MONDO:0014300 proximal myopathy with extrapyramidal signs 9.165475440462125e-05 0.381998\n",
      "MONDO:0054637 Noonan syndrome-like disorder with loose anagen hair 1 9.165475440462125e-05 0.381998\n",
      "MONDO:0012948 chromosome 6pter-p24 deletion syndrome 9.165475440462125e-05 0.381998\n",
      "MONDO:0013379 Noonan syndrome 7 9.165475440462125e-05 0.381998\n",
      "MONDO:0044738 Gabriele de Vries syndrome 9.165475440462125e-05 0.381998\n",
      "MONDO:0010506 intellectual disability, X-linked 61 9.165475440462125e-05 0.381998\n",
      "MONDO:0010589 Aarskog-Scott syndrome, X-linked 9.679305273361345e-05 0.379205\n",
      "MONDO:0859306 developmental delay with variable intellectual disability and dysmorphic facies 9.679305273361345e-05 0.379205\n",
      "MONDO:0009053 ALDH18A1-related de Barsy syndrome 9.679305273361345e-05 0.379205\n",
      "MONDO:0030375 neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 2 9.679305273361345e-05 0.379205\n",
      "MONDO:0008944 Joubert syndrome 1 9.679305273361345e-05 0.379205\n",
      "MONDO:0033005 Galloway-Mowat syndrome 1 9.679305273361345e-05 0.379205\n",
      "MONDO:0014857 neurodevelopmental disorder with or without anomalies of the brain, eye, or heart 9.679305273361345e-05 0.379205\n",
      "MONDO:0014777 hypotonia, infantile, with psychomotor retardation and characteristic facies 2 9.679305273361345e-05 0.379205\n",
      "MONDO:0014343 Desbuquois dysplasia 2 0.00010207013244252334 0.376496\n",
      "MONDO:0010038 growth delay due to insulin-like growth factor I resistance 0.00010207013244252334 0.376496\n",
      "MONDO:0000902 agenesis of the corpus callosum with peripheral neuropathy 0.00010207013244252334 0.376496\n",
      "MONDO:0100151 nephropathic cystinosis 0.00010207013244252334 0.376496\n",
      "MONDO:0013056 developmental and epileptic encephalopathy, 39 0.00010207013244252334 0.376496\n",
      "MONDO:0008426 Shprintzen-Goldberg syndrome 0.00010748588795584114 0.373864\n",
      "MONDO:0030915 intellectual disability, autosomal recessive 61 0.00010748588795584114 0.373864\n",
      "MONDO:0010477 blepharophimosis - intellectual disability syndrome, MKB type 0.00010748588795584114 0.373864\n",
      "MONDO:0010417 syndromic X-linked intellectual disability Najm type 0.00010748588795584114 0.373864\n",
      "MONDO:0020681 Ehlers-Danlos syndrome, musculocontractural type 1 0.0001130402137580136 0.371306\n",
      "MONDO:0100218 arthrogryposis multiplex congenita 5 0.0001130402137580136 0.371306\n",
      "MONDO:0010275 spondyloepimetaphyseal dysplasia, Bieganski type 0.0001130402137580136 0.371306\n",
      "MONDO:0008119 spinocerebellar ataxia type 1 0.0001130402137580136 0.371306\n",
      "MONDO:0009124 Dubowitz syndrome 0.0001130402137580136 0.371306\n",
      "MONDO:0012496 Koolen-de Vries syndrome 0.0001130402137580136 0.371306\n",
      "MONDO:0010200 Wilson disease 0.00011873300439341353 0.368819\n",
      "MONDO:0012916 chromosome 2p16.1-p15 deletion syndrome 0.00011873300439341353 0.368819\n",
      "MONDO:0009341 Mowat-Wilson syndrome 0.00011873300439341353 0.368819\n",
      "MONDO:0012118 COG7-congenital disorder of glycosylation 0.00012456415446630953 0.366399\n",
      "MONDO:0009855 d-bifunctional protein deficiency 0.00012456415446630953 0.366399\n",
      "MONDO:0009452 Vici syndrome 0.00012456415446630953 0.366399\n",
      "MONDO:0007057 Acroosteolysis dominant type 0.00013053355864083536 0.364043\n",
      "MONDO:0014455 cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome 0.00013053355864083536 0.364043\n",
      "MONDO:0030908 intellectual disability, X-linked, syndromic, 35 0.00013053355864083536 0.364043\n",
      "MONDO:0014348 intellectual disability, autosomal recessive 42 0.00013053355864083536 0.364043\n",
      "MONDO:0030920 intellectual disability, autosomal dominant 54 0.00013053355864083536 0.364043\n",
      "MONDO:0030966 neurofacioskeletal syndrome with or without renal agenesis 0.00013664111164096067 0.361747\n",
      "MONDO:0015012 mucopolysaccharidosis-plus syndrome 0.00014288670825046015 0.359509\n",
      "MONDO:0008965 CHARGE syndrome 0.00014288670825046015 0.359509\n",
      "MONDO:0100224 mitochondrial complex I deficiency, nuclear type 1 0.00014927024331288344 0.357327\n",
      "MONDO:0014258 congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome 0.00014927024331288344 0.357327\n",
      "MONDO:0013886 cerebellar dysfunction with variable cognitive and behavioral abnormalities 0.00016245070846939444 0.353118\n",
      "MONDO:0009725 nemaline myopathy 2 0.00016245070846939444 0.353118\n",
      "MONDO:0010483 X-linked intellectual disability, Cantagrel type 0.00016924742854918575 0.351088\n",
      "MONDO:0033669 Noonan syndrome 13 0.00017618166705324754 0.349104\n",
      "MONDO:0015021 hypotonia, ataxia, and delayed development syndrome 0.00017618166705324754 0.349104\n",
      "MONDO:8000008 Martsolf syndrome 1 0.00018325331912355275 0.347165\n",
      "MONDO:0014892 micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome 0.00018325331912355275 0.347165\n",
      "MONDO:0010407 intellectual disability, X-linked syndromic, Turner type 0.00018325331912355275 0.347165\n",
      "MONDO:0009069 congenital lactic acidosis, Saguenay-Lac-Saint-Jean type 0.00018325331912355275 0.347165\n",
      "MONDO:0032645 trichohepatoneurodevelopmental syndrome 0.00019046227996166924 0.345268\n",
      "MONDO:0026771 developmental and epileptic encephalopathy, 85, with or without midline brain defects 0.00019046227996166924 0.345268\n",
      "MONDO:0013415 chromosome 17p13.1 deletion syndrome 0.00019780844482872838 0.343413\n",
      "MONDO:0030606 Bryant-Li-Bhoj neurodevelopmental syndrome 1 0.00019780844482872838 0.343413\n",
      "MONDO:0012637 COG1-congenital disorder of glycosylation 0.00020529170904539658 0.341597\n",
      "MONDO:0054588 Noonan syndrome-like disorder with loose anagen hair 2 0.00021291196799184386 0.339819\n",
      "MONDO:0007874 trichorhinophalangeal syndrome type II 0.0002206691171077153 0.338078\n",
      "MONDO:0019349 Sotos syndrome 0.0002285630518920994 0.336372\n",
      "MONDO:0011518 Wiedemann-Steiner syndrome 0.0002285630518920994 0.336372\n",
      "MONDO:0007974 intellectual disability, autosomal dominant 1 0.0002285630518920994 0.336372\n",
      "MONDO:0010466 multiple congenital anomalies-hypotonia-seizures syndrome 2 0.00024476086075980247 0.333061\n",
      "MONDO:0859273 liver disease, severe congenital 0.0002530645261382504 0.331454\n",
      "MONDO:0025699 Coffin-Siris syndrome 12 0.00026150455977540905 0.329877\n",
      "MONDO:0010221 CHIME syndrome 0.00026150455977540905 0.329877\n",
      "MONDO:0012914 chromosome 1q21.1 deletion syndrome 0.00027879331506856575 0.326812\n",
      "MONDO:0011053 intellectual disability-sparse hair-brachydactyly syndrome 0.00027879331506856575 0.326812\n",
      "MONDO:0859191 biliary, renal, neurologic, and skeletal syndrome 0.0002876418284940483 0.325321\n",
      "MONDO:0010035 Smith-Lemli-Opitz syndrome 0.00029662629371715105 0.323856\n",
      "MONDO:0009856 Peters plus syndrome 0.0003057466067706132 0.322418\n",
      "MONDO:0009999 autosomal recessive Robinow syndrome 0.0003057466067706132 0.322418\n",
      "MONDO:0859239 Chilton-Okur-Chung neurodevelopmental syndrome 0.0003150026637463191 0.321005\n",
      "MONDO:0009964 short-rib thoracic dysplasia 9 with or without polydactyly 0.0003150026637463191 0.321005\n",
      "MONDO:0859181 DEGCAGS syndrome 0.00032439436079526783 0.319616\n",
      "MONDO:0008871 microcephalic osteodysplastic primordial dwarfism type I 0.00034358426001228793 0.316908\n",
      "MONDO:0007251 campomelic dysplasia 0.00034358426001228793 0.316908\n",
      "MONDO:0014558 autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome 0.0003633154748108375 0.314289\n",
      "MONDO:0007814 immune deficiency, familial variable 0.0003777250116963364 0.312472\n",
      "MONDO:0013076 attention deficit-hyperactivity disorder, susceptibility to, 7 0.0003777250116963364 0.312472\n",
      "MONDO:0033670 hearing loss, autosomal recessive 116 0.0003777250116963364 0.312472\n",
      "MONDO:0008563 thumb stiffness-brachydactyly-intellectual disability syndrome 0.0003777250116963364 0.312472\n",
      "MONDO:0014442 Bardet-Biedl syndrome 14 0.0003777250116963364 0.312472\n",
      "MONDO:0010454 intellectual disability, X-linked 88 0.0003777250116963364 0.312472\n",
      "MONDO:0030480 hearing loss, autosomal recessive 119 0.0003777250116963364 0.312472\n",
      "MONDO:0030958 dystonia 35, childhood-onset 0.0003777250116963364 0.312472\n",
      "MONDO:0003649 esophageal neuroendocrine tumor 0.0003777250116963364 0.312472\n",
      "MONDO:0007577 esophageal ring, lower 0.0003777250116963364 0.312472\n",
      "MONDO:0004405 Barrett adenocarcinoma 0.0003777250116963364 0.312472\n",
      "MONDO:0009910 Wiedemann-Rautenstrauch syndrome 0.0004476369306213091 0.304605\n",
      "MONDO:0008995 Yunis-Varon syndrome 0.0004930240514231976 0.300181\n",
      "MONDO:0008393 Rubinstein-Taybi syndrome due to CREBBP mutations 0.0005405533118925838 0.296\n",
      "MONDO:0008208 patella, familial recurrent dislocation of 0.0007553073472082117 0.28109\n",
      "MONDO:0013780 retinitis pigmentosa 63 0.0007553073472082117 0.28109\n",
      "MONDO:0008984 ciliary discoordination due to random ciliary orientation 0.0007553073472082117 0.28109\n",
      "MONDO:0014865 autosomal recessive severe congenital neutropenia due to CSF3R deficiency 0.0007553073472082117 0.28109\n",
      "MONDO:0958182 C1Q deficiency 1 0.0007553073472082117 0.28109\n",
      "MONDO:0009060 cystic disease of lung 0.0007553073472082117 0.28109\n",
      "MONDO:0013955 Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency 0.0007553073472082117 0.28109\n",
      "MONDO:0008613 Tuftsin deficiency 0.0007553073472082117 0.28109\n",
      "MONDO:0013576 recurrent infections associated with rare immunoglobulin isotypes deficiency 0.0007553073472082117 0.28109\n",
      "MONDO:0032659 mucocutaneous ulceration, chronic 0.0007553073472082117 0.28109\n",
      "MONDO:0014491 immunodeficiency 37 0.0007553073472082117 0.28109\n",
      "MONDO:0014438 Bardet-Biedl syndrome 10 0.0007553073472082117 0.28109\n",
      "MONDO:0009099 nephrogenic diabetes insipidus-intracranial calcification syndrome 0.0007553073472082117 0.28109\n",
      "MONDO:0014825 chromosome 11p13 deletion syndrome, distal 0.0007553073472082117 0.28109\n",
      "MONDO:0030005 epilepsy, early-onset, with or without developmental delay 0.0007553073472082117 0.28109\n",
      "MONDO:0014436 Bardet-Biedl syndrome 8 0.0007553073472082117 0.28109\n",
      "MONDO:0007366 seizures, benign familial neonatal, 2 0.0007553073472082117 0.28109\n",
      "MONDO:0030004 autism, susceptibility to, 20 0.0007553073472082117 0.28109\n",
      "MONDO:0033665 hearing loss, autosomal dominant 78 0.0007553073472082117 0.28109\n",
      "MONDO:0013917 nephronophthisis 15 0.0007553073472082117 0.28109\n",
      "MONDO:0010450 intellectual disability, X-linked 89 0.0007553073472082117 0.28109\n",
      "MONDO:0030105 galactosemia 4 0.0007553073472082117 0.28109\n",
      "MONDO:0012060 autosomal recessive nonsyndromic hearing loss 35 0.0007553073472082117 0.28109\n",
      "MONDO:0009791 oral sensibility, disturbance of 0.0007553073472082117 0.28109\n",
      "UMLS:C1708656 Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant 0.0007553073472082117 0.28109\n",
      "MONDO:0027694 amyotrophic lateral sclerosis type 23 0.0007553073472082117 0.28109\n",
      "MONDO:0009122 Dohle bodies and leukemia 0.0011327470604279887 0.263653\n",
      "MONDO:0013417 complement component 3 deficiency 0.0011327470604279887 0.263653\n",
      "MONDO:0013999 retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome 0.0011327470604279887 0.263653\n",
      "MONDO:0014422 vesicoureteral reflux 8 0.0011327470604279887 0.263653\n",
      "MONDO:0009814 osteopenia-intellectual disability-sparse hair syndrome 0.0011327470604279887 0.263653\n",
      "MONDO:0032841 Usher syndrome, type 1M 0.0011327470604279887 0.263653\n",
      "MONDO:0032940 retinitis pigmentosa 88 0.0011327470604279887 0.263653\n",
      "MONDO:0014614 congenital stationary night blindness 1G 0.0011327470604279887 0.263653\n",
      "MONDO:0032794 leber congenital amaurosis 19 0.0011327470604279887 0.263653\n",
      "MONDO:0008444 spastic paraplegia, optic atrophy, and dementia 0.0011327470604279887 0.263653\n",
      "MONDO:0014618 retinitis pigmentosa 71 0.0011327470604279887 0.263653\n",
      "MONDO:0011630 retinitis pigmentosa 28 0.0011327470604279887 0.263653\n",
      "MONDO:0007644 IgAD1 0.0011327470604279887 0.263653\n",
      "MONDO:0014840 agammaglobulinemia 8, autosomal dominant 0.0011327470604279887 0.263653\n",
      "MONDO:0012626 Meckel syndrome, type 4 0.0011327470604279887 0.263653\n",
      "MONDO:0013734 microphthalmia, syndromic 11 0.0011327470604279887 0.263653\n",
      "MONDO:0014432 Bardet-Biedl syndrome 2 0.0011327470604279887 0.263653\n",
      "MONDO:0013116 congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome 0.0011327470604279887 0.263653\n",
      "MONDO:0014815 intellectual disability, autosomal recessive 52 0.0011327470604279887 0.263653\n",
      "MONDO:0009042 craniotelencephalic dysplasia 0.0011327470604279887 0.263653\n",
      "MONDO:0010252 intellectual disability, X-linked, with panhypopituitarism 0.0011327470604279887 0.263653\n",
      "MONDO:0012717 renal hypomagnesemia 4 0.0011327470604279887 0.263653\n",
      "MONDO:0010125 upper limb defect-eye and ear abnormalities syndrome 0.0011327470604279887 0.263653\n",
      "MONDO:0026729 congenital disorder of glycosylation, type ICC 0.0011327470604279887 0.263653\n",
      "MONDO:0859278 keratoderma-ichthyosis-deafness syndrome, autosomal recessive 0.0011327470604279887 0.263653\n",
      "MONDO:0014712 Senior-Loken syndrome 9 0.0011327470604279887 0.263653\n",
      "MONDO:0010451 intellectual disability, X-linked 41 0.0011327470604279887 0.263653\n",
      "MONDO:0014184 specific language impairment 5 0.0011327470604279887 0.263653\n",
      "MONDO:0032899 neutropenia, severe congenital, 8, autosomal dominant 0.0011327470604279887 0.263653\n",
      "MONDO:0012615 intellectual disability, autosomal recessive 7 0.0011327470604279887 0.263653\n",
      "MONDO:0013345 d-2-hydroxyglutaric aciduria 2 0.0011327470604279887 0.263653\n",
      "MONDO:0014441 Bardet-Biedl syndrome 13 0.0011327470604279887 0.263653\n",
      "MONDO:0012286 myopathy, autophagic vacuolar, infantile-onset 0.0011327470604279887 0.263653\n",
      "MONDO:0029465 intellectual developmental disorder, autosomal dominant 69 0.0011327470604279887 0.263653\n",
      "MONDO:0030726 neutropenia, severe congenital, 9, autosomal dominant 0.0011327470604279887 0.263653\n",
      "MONDO:0044638 hypopharynx squamous cell carcinoma 0.0011327470604279887 0.263653\n",
      "MONDO:0009141 torsion dystonia 2 0.0011327470604279887 0.263653\n",
      "MONDO:0003219 gastroesophageal junction adenocarcinoma 0.0011327470604279887 0.263653\n",
      "MONDO:0026733 intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type 0.0015100442052276759 0.251713\n",
      "MONDO:0009363 hydrocephaly-tall stature-joint laxity syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0012990 Leber congenital amaurosis 13 0.0015100442052276759 0.251713\n",
      "MONDO:0014483 retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies 0.0015100442052276759 0.251713\n",
      "MONDO:0044314 retinitis pigmentosa 78 0.0015100442052276759 0.251713\n",
      "MONDO:0008133 optic atrophy 3 0.0015100442052276759 0.251713\n",
      "MONDO:0013469 retinitis pigmentosa 38 0.0015100442052276759 0.251713\n",
      "MONDO:0014068 cone-rod dystrophy 17 0.0015100442052276759 0.251713\n",
      "MONDO:0014400 retinitis pigmentosa 70 0.0015100442052276759 0.251713\n",
      "MONDO:0012523 retinitis pigmentosa 36 0.0015100442052276759 0.251713\n",
      "MONDO:0013175 retinitis pigmentosa 50 0.0015100442052276759 0.251713\n",
      "MONDO:0013779 Wiskott-Aldrich syndrome 2 0.0015100442052276759 0.251713\n",
      "MONDO:0014697 immunodeficiency, common variable, 12 0.0015100442052276759 0.251713\n",
      "MONDO:0009347 familial lipochrome histiocytosis 0.0015100442052276759 0.251713\n",
      "MONDO:0014891 hyperuricemic nephropathy, familial juvenile type 4 0.0015100442052276759 0.251713\n",
      "MONDO:0010233 heterotopia, periventricular, X-linked dominant 0.0015100442052276759 0.251713\n",
      "MONDO:0040500 glycosylphosphatidylinositol biosynthesis defect 16 0.0015100442052276759 0.251713\n",
      "MONDO:0025690 microcephaly, epilepsy, and diabetes syndrome 2 0.0015100442052276759 0.251713\n",
      "MONDO:0013904 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 0.0015100442052276759 0.251713\n",
      "MONDO:0014524 intellectual disability, autosomal recessive 47 0.0015100442052276759 0.251713\n",
      "MONDO:0016581 conotruncal heart malformations 0.0015100442052276759 0.251713\n",
      "MONDO:0013939 peroxisome biogenesis disorder 7B 0.0015100442052276759 0.251713\n",
      "MONDO:0009366 normal pressure hydrocephalus 0.0015100442052276759 0.251713\n",
      "MONDO:0009844 pellagra-like syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0013606 Hermansky-Pudlak syndrome 9 0.0015100442052276759 0.251713\n",
      "MONDO:0012860 thrombophilia due to protein C deficiency, autosomal recessive 0.0015100442052276759 0.251713\n",
      "MONDO:0007634 intellectual disability, FRA12A type 0.0015100442052276759 0.251713\n",
      "MONDO:0008428 septooptic dysplasia 0.0015100442052276759 0.251713\n",
      "MONDO:0014759 intellectual disability, autosomal recessive 51 0.0015100442052276759 0.251713\n",
      "MONDO:0014839 chorea, childhood-onset, with psychomotor retardation 0.0015100442052276759 0.251713\n",
      "MONDO:0010832 Bardet-Biedl syndrome 3 0.0015100442052276759 0.251713\n",
      "MONDO:0013580 pyruvate dehydrogenase E1-beta deficiency 0.0015100442052276759 0.251713\n",
      "MONDO:0014675 autosomal recessive nonsyndromic hearing loss 104 0.0015100442052276759 0.251713\n",
      "MONDO:0030916 intellectual disability, autosomal dominant 50 0.0015100442052276759 0.251713\n",
      "MONDO:0008939 isolated cerebellar hypoplasia/agenesis 0.0015100442052276759 0.251713\n",
      "MONDO:0012548 Kostmann syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0012397 brachydactyly, coloboma, and anterior segment dysgenesis 0.0015100442052276759 0.251713\n",
      "MONDO:0010851 Lowry-MacLean syndrome 0.0015100442052276759 0.251713\n",
      "MONDO:0013493 acetyl-coa carboxylase deficiency 0.0015100442052276759 0.251713\n",
      "MONDO:0008859 berry aneurysm, cirrhosis, pulmonary emphysema, and cerebral calcification 0.0015100442052276759 0.251713\n",
      "MONDO:0014770 Joubert syndrome 25 0.0015100442052276759 0.251713\n",
      "UMLS:C1708957 Mediastinal Paraganglioma 0.0015100442052276759 0.251713\n",
      "UMLS:C1334054 Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma 0.0015100442052276759 0.251713\n",
      "UMLS:C1708649 Laryngeal Adenosquamous Carcinoma 0.0015100442052276759 0.251713\n",
      "MONDO:0013260 esophagitis, eosinophilic, 2 0.0015100442052276759 0.251713\n",
      "MONDO:0700089 paroxysmal nonkinesigenic dyskinesia 1 0.0015100442052276759 0.251713\n",
      "MONDO:0044768 vagus nerve paraganglioma 0.0015100442052276759 0.251713\n",
      "MONDO:0002762 esophagus verrucous carcinoma 0.0015100442052276759 0.251713\n",
      "MONDO:0002766 larynx verrucous carcinoma 0.0015100442052276759 0.251713\n",
      "MONDO:0060589 facial palsy, congenital, with ptosis and velopharyngeal dysfunction 0.0015100442052276759 0.251713\n",
      "MONDO:0012451 esophagitis, eosinophilic, 1 0.0015100442052276759 0.251713\n",
      "MONDO:0008845 atonic-astatic syndrome of Foerster 0.0015100442052276759 0.251713\n",
      "MONDO:0009842 Pelger-Huet-like anomaly and episodic fever with abdominal pain 0.0018871988354589298 0.242705\n",
      "MONDO:0013515 osteogenesis imperfecta type 6 0.0018871988354589298 0.242705\n",
      "MONDO:0007036 Achard syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0007244 Caffey disease 0.0018871988354589298 0.242705\n",
      "MONDO:0007523 Ehlers-Danlos syndrome, hypermobility type 0.0018871988354589298 0.242705\n",
      "MONDO:0011458 Leber congenital amaurosis 4 0.0018871988354589298 0.242705\n",
      "MONDO:0033549 optic atrophy 12 0.0018871988354589298 0.242705\n",
      "MONDO:0010828 retinitis pigmentosa 11 0.0018871988354589298 0.242705\n",
      "MONDO:0013069 autosomal recessive optic atrophy, OPA7 type 0.0018871988354589298 0.242705\n",
      "MONDO:0013611 retinitis pigmentosa 62 0.0018871988354589298 0.242705\n",
      "MONDO:0012543 optic atrophy 5 0.0018871988354589298 0.242705\n",
      "MONDO:0010818 retinitis pigmentosa 12 0.0018871988354589298 0.242705\n",
      "MONDO:0012024 retinitis pigmentosa 26 0.0018871988354589298 0.242705\n",
      "MONDO:0013613 Leber congenital amaurosis 16 0.0018871988354589298 0.242705\n",
      "MONDO:0036482 retinitis pigmentosa 81 0.0018871988354589298 0.242705\n",
      "MONDO:0012477 retinitis pigmentosa 33 0.0018871988354589298 0.242705\n",
      "MONDO:0013405 retinitis pigmentosa 49 0.0018871988354589298 0.242705\n",
      "MONDO:0012174 peripheral cone dystrophy 0.0018871988354589298 0.242705\n",
      "MONDO:0011672 persistent polyclonal B-cell lymphocytosis 0.0018871988354589298 0.242705\n",
      "MONDO:0013957 Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency 0.0018871988354589298 0.242705\n",
      "MONDO:0014645 BENTA disease 0.0018871988354589298 0.242705\n",
      "MONDO:0014083 agammaglobulinemia 7, autosomal recessive 0.0018871988354589298 0.242705\n",
      "MONDO:0012915 chromosome 1q21.1 duplication syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0030346 ciliary dyskinesia, primary, 47, and lissencephaly 0.0018871988354589298 0.242705\n",
      "MONDO:0014407 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 0.0018871988354589298 0.242705\n",
      "MONDO:0014623 microcephaly 14, primary, autosomal recessive 0.0018871988354589298 0.242705\n",
      "MONDO:0010900 intrauterine growth retardation with increased mitomycin c sensitivity 0.0018871988354589298 0.242705\n",
      "MONDO:0013387 developmental and epileptic encephalopathy, 7 0.0018871988354589298 0.242705\n",
      "MONDO:0032631 mitochondrial complex 1 deficiency, nuclear type 27 0.0018871988354589298 0.242705\n",
      "MONDO:0014592 microcephaly and chorioretinopathy 3 0.0018871988354589298 0.242705\n",
      "MONDO:0010162 tyrosinemia type III 0.0018871988354589298 0.242705\n",
      "MONDO:0013539 hypotonia-failure to thrive-microcephaly syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0013774 trigonocephaly 2 0.0018871988354589298 0.242705\n",
      "MONDO:0014490 ketoacidosis due to monocarboxylate transporter-1 deficiency 0.0018871988354589298 0.242705\n",
      "MONDO:0014953 gnb5-related intellectual disability-cardiac arrhythmia syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0014690 dyskeratosis congenita, autosomal dominant 6 0.0018871988354589298 0.242705\n",
      "MONDO:0012187 Fanconi anemia complementation group J 0.0018871988354589298 0.242705\n",
      "MONDO:0013548 acetyl-CoA acetyltransferase-2 deficiency 0.0018871988354589298 0.242705\n",
      "MONDO:0060577 neurodevelopmental disorder with microcephaly, ataxia, and seizures 0.0018871988354589298 0.242705\n",
      "MONDO:0010216 xeroderma pigmentosum group G 0.0018871988354589298 0.242705\n",
      "MONDO:0033044 Meckel syndrome 13 0.0018871988354589298 0.242705\n",
      "MONDO:0012996 AGAT deficiency 0.0018871988354589298 0.242705\n",
      "MONDO:0859158 ataxia, intention tremor, and hypotonia syndrome, childhood-onset 0.0018871988354589298 0.242705\n",
      "MONDO:0010794 NARP syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0012623 intellectual disability, autosomal recessive 4 0.0018871988354589298 0.242705\n",
      "MONDO:0008503 Worster-Drought syndrome 0.0018871988354589298 0.242705\n",
      "MONDO:0013891 amyotrophic lateral sclerosis type 18 0.0018871988354589298 0.242705\n",
      "MONDO:0004093 esophageal basaloid carcinoma 0.0018871988354589298 0.242705\n",
      "MONDO:0011719 gastrointestinal stromal tumor 0.0018871988354589298 0.242705\n",
      "MONDO:0010459 amyotrophic lateral sclerosis type 15 0.0018871988354589298 0.242705\n",
      "UMLS:C2033294 papillary squamous cell carcinoma of larynx 0.0018871988354589298 0.242705\n",
      "MONDO:0100428 progressive bulbar palsy of childhood 0.0018871988354589298 0.242705\n",
      "MONDO:0014331 Moyamoya disease with early-onset achalasia 0.0018871988354589298 0.242705\n",
      "MONDO:0011887 cataract, congenital, with mental impairment and dentate gyrus atrophy 0.0018871988354589298 0.242705\n",
      "MONDO:0020762 diencephalic-mesencephalic junction dysplasia syndrome 2 0.0018871988354589298 0.242705\n",
      "MONDO:0800045 autoinflammatory syndrome, familial, Behcet-like 1 0.0022642110049530696 0.235509\n",
      "MONDO:0008728 classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency 0.0022642110049530696 0.235509\n",
      "MONDO:0032919 intellectual developmental disorder 62 0.0022642110049530696 0.235509\n",
      "MONDO:0008377 retinitis pigmentosa 1 0.0022642110049530696 0.235509\n",
      "MONDO:0013328 retinitis pigmentosa 58 0.0022642110049530696 0.235509\n",
      "MONDO:0859308 retinitis pigmentosa 95 0.0022642110049530696 0.235509\n",
      "MONDO:0014692 retinitis pigmentosa 74 0.0022642110049530696 0.235509\n",
      "MONDO:0044320 retinitis pigmentosa 79 0.0022642110049530696 0.235509\n",
      "MONDO:0010827 retinitis pigmentosa 14 0.0022642110049530696 0.235509\n",
      "MONDO:0012796 retinitis pigmentosa 41 0.0022642110049530696 0.235509\n",
      "MONDO:0011272 retinitis pigmentosa 25 0.0022642110049530696 0.235509\n",
      "MONDO:0014267 severe combined immunodeficiency due to IKK2 deficiency 0.0022642110049530696 0.235509\n",
      "MONDO:0033551 immunodeficiency 72 with autoinflammation 0.0022642110049530696 0.235509\n",
      "MONDO:0013488 lipodystrophy, partial, acquired, with low complement component c3, with or without glomerulonephritis 0.0022642110049530696 0.235509\n",
      "MONDO:0957497 disabling pansclerotic morphea of childhood 0.0022642110049530696 0.235509\n",
      "MONDO:0014829 immunodeficiency-centromeric instability-facial anomalies syndrome 4 0.0022642110049530696 0.235509\n",
      "MONDO:0030009 alopecia-intellectual disability syndrome 4 0.0022642110049530696 0.235509\n",
      "MONDO:0013531 PSPH deficiency 0.0022642110049530696 0.235509\n",
      "MONDO:0030462 Joubert syndrome 40 0.0022642110049530696 0.235509\n",
      "MONDO:0060551 cerebellar atrophy, developmental delay, and seizures 0.0022642110049530696 0.235509\n",
      "MONDO:0014664 Joubert syndrome 23 0.0022642110049530696 0.235509\n",
      "MONDO:0013581 intellectual disability, autosomal dominant 2 0.0022642110049530696 0.235509\n",
      "MONDO:0014724 Joubert syndrome 24 0.0022642110049530696 0.235509\n",
      "MONDO:0011291 ALG6-congenital disorder of glycosylation 1C 0.0022642110049530696 0.235509\n",
      "MONDO:0024568 infantile liver failure syndrome 1 0.0022642110049530696 0.235509\n",
      "MONDO:0011772 B4GALT1-congenital disorder of glycosylation 0.0022642110049530696 0.235509\n",
      "MONDO:0011828 intellectual disability, autosomal recessive 2 0.0022642110049530696 0.235509\n",
      "MONDO:0013824 Joubert syndrome 17 0.0022642110049530696 0.235509\n",
      "MONDO:0032733 global developmental delay, progressive ataxia, and elevated glutamine 0.0022642110049530696 0.235509\n",
      "MONDO:0009008 heart defect - tongue hamartoma - polysyndactyly syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0013583 occipital pachygyria and polymicrogyria 0.0022642110049530696 0.235509\n",
      "MONDO:0012925 Diamond-Blackfan anemia 5 0.0022642110049530696 0.235509\n",
      "MONDO:0013058 cystic leukoencephalopathy without megalencephaly 0.0022642110049530696 0.235509\n",
      "MONDO:0014029 osteogenesis imperfecta type 14 0.0022642110049530696 0.235509\n",
      "MONDO:0011025 Cayman type cerebellar ataxia 0.0022642110049530696 0.235509\n",
      "MONDO:0014248 autism spectrum disorder - epilepsy - arthrogryposis syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0013900 alternating hemiplegia of childhood 2 0.0022642110049530696 0.235509\n",
      "MONDO:0014270 STT3A-congenital disorder of glycosylation 0.0022642110049530696 0.235509\n",
      "MONDO:0010318 FG syndrome 4 0.0022642110049530696 0.235509\n",
      "MONDO:0007210 Brachmann-de Lange-like facial changes with microcephaly, metatarsus adductus, and developmental delay 0.0022642110049530696 0.235509\n",
      "MONDO:0014190 combined oxidative phosphorylation defect type 17 0.0022642110049530696 0.235509\n",
      "MONDO:0032588 periventricular nodular heterotopia 8 0.0022642110049530696 0.235509\n",
      "MONDO:0007631 chromosome 16p12.1 deletion syndrome, 520kb 0.0022642110049530696 0.235509\n",
      "MONDO:0010289 intellectual disability, X-linked 72 0.0022642110049530696 0.235509\n",
      "MONDO:0010840 pachygyria-intellectual disability-epilepsy syndrome 0.0022642110049530696 0.235509\n",
      "MONDO:0018855 keratosis pilaris atrophicans 0.0022642110049530696 0.235509\n",
      "MONDO:0957576 parkinson disease 25, autosomal recessive early-onset, with impaired intellectual development 0.0022642110049530696 0.235509\n",
      "MONDO:0010317 intellectual disability, X-linked, with or without seizures, arx-related 0.0022642110049530696 0.235509\n",
      "MONDO:0012712 dystonia with cerebellar atrophy 0.0022642110049530696 0.235509\n",
      "MONDO:0007876 laryngeal abductor paralysis 0.0022642110049530696 0.235509\n",
      "MONDO:0030486 dystonia 32 0.0022642110049530696 0.235509\n",
      "MONDO:0014138 nemaline myopathy 8 0.0022642110049530696 0.235509\n",
      "MONDO:0011798 hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration 0.0022642110049530696 0.235509\n",
      "MONDO:0007827 inclusion body myositis 0.0022642110049530696 0.235509\n",
      "MONDO:0014460 nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome 0.0022642110049530696 0.235509\n",
      "UMLS:C1708653 Laryngeal Lymphoepithelial Carcinoma 0.0022642110049530696 0.235509\n",
      "MONDO:0859157 visceral myopathy 2 0.0022642110049530696 0.235509\n",
      "MONDO:0030455 dystonia 31 0.0022642110049530696 0.235509\n",
      "MONDO:0014104 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 4 0.0022642110049530696 0.235509\n",
      "MONDO:0007828 indifference to pain, congenital, autosomal dominant 0.0026410807675210763 0.229543\n",
      "MONDO:0009158 Ehlers-Danlos syndrome, fibronectinemic type 0.0026410807675210763 0.229543\n",
      "MONDO:0010535 Bazex-Dupre-Christol syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0030051 intellectual developmental disorder with autistic features and language delay, with or without seizures 0.0026410807675210763 0.229543\n",
      "MONDO:0012145 macular degeneration, age-related, 3 0.0026410807675210763 0.229543\n",
      "MONDO:0014093 retinitis pigmentosa 66 0.0026410807675210763 0.229543\n",
      "MONDO:0011395 cone-rod dystrophy 3 0.0026410807675210763 0.229543\n",
      "MONDO:0032910 mitochondrial complex 1 deficiency, nuclear type 34 0.0026410807675210763 0.229543\n",
      "MONDO:0011137 retinitis pigmentosa 19 0.0026410807675210763 0.229543\n",
      "MONDO:0020737 optic atrophy 10 with or without ataxia, intellectual disability, and seizures 0.0026410807675210763 0.229543\n",
      "MONDO:0008379 retinitis pigmentosa 10 0.0026410807675210763 0.229543\n",
      "MONDO:0014515 macular dystrophy with central cone involvement 0.0026410807675210763 0.229543\n",
      "MONDO:0012943 retinitis pigmentosa 46 0.0026410807675210763 0.229543\n",
      "MONDO:0013786 cone-rod dystrophy 16 0.0026410807675210763 0.229543\n",
      "MONDO:0032834 retinitis pigmentosa 86 0.0026410807675210763 0.229543\n",
      "MONDO:0012605 isolated microphthalmia 5 0.0026410807675210763 0.229543\n",
      "MONDO:0013673 Wolfram-like syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0032594 intellectual developmental disorder and retinitis pigmentosa; IDDRP 0.0026410807675210763 0.229543\n",
      "MONDO:0014427 cone-rod dystrophy 20 0.0026410807675210763 0.229543\n",
      "MONDO:0014082 cryptosporidiosis-chronic cholangitis-liver disease syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0013507 granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3 0.0026410807675210763 0.229543\n",
      "MONDO:0013408 FADD-related immunodeficiency 0.0026410807675210763 0.229543\n",
      "MONDO:0100219 growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant 0.0026410807675210763 0.229543\n",
      "MONDO:0010658 syndromic X-linked intellectual disability 12 0.0026410807675210763 0.229543\n",
      "MONDO:0009150 hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0008774 2-aminoadipic 2-oxoadipic aciduria 0.0026410807675210763 0.229543\n",
      "MONDO:0033311 Joubert syndrome 33 0.0026410807675210763 0.229543\n",
      "MONDO:0044702 X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0014766 leukodystrophy and acquired microcephaly with or without dystonia; 0.0026410807675210763 0.229543\n",
      "MONDO:0030859 COACH syndrome 2 0.0026410807675210763 0.229543\n",
      "MONDO:0032815 mitochondrial DNA depletion syndrome 17 0.0026410807675210763 0.229543\n",
      "MONDO:0012989 microcephaly 7, primary, autosomal recessive 0.0026410807675210763 0.229543\n",
      "MONDO:0013642 holoprosencephaly 11 0.0026410807675210763 0.229543\n",
      "MONDO:0032699 epilepsy, idiopathic generalized, susceptibility to, 15 0.0026410807675210763 0.229543\n",
      "MONDO:0100105 brain small vessel disease 3 0.0026410807675210763 0.229543\n",
      "MONDO:0012029 microcephaly 6, primary, autosomal recessive 0.0026410807675210763 0.229543\n",
      "MONDO:0014842 intellectual disability, autosomal dominant 41 0.0026410807675210763 0.229543\n",
      "MONDO:0014071 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11 0.0026410807675210763 0.229543\n",
      "MONDO:0013763 Joubert syndrome 15 0.0026410807675210763 0.229543\n",
      "MONDO:0014881 transketolase deficiency 0.0026410807675210763 0.229543\n",
      "MONDO:0012614 intellectual disability, autosomal recessive 6 0.0026410807675210763 0.229543\n",
      "MONDO:0032629 mitochondrial complex 1 deficiency, nuclear type 25 0.0026410807675210763 0.229543\n",
      "MONDO:0014168 severe combined immunodeficiency due to CORO1A deficiency 0.0026410807675210763 0.229543\n",
      "MONDO:0014444 Bardet-Biedl syndrome 16 0.0026410807675210763 0.229543\n",
      "MONDO:0010473 X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0014408 megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 0.0026410807675210763 0.229543\n",
      "MONDO:0014517 generalized epilepsy with febrile seizures plus, type 9 0.0026410807675210763 0.229543\n",
      "MONDO:0030849 intellectual developmental disorder with speech delay and axonal peripheral neuropathy 0.0026410807675210763 0.229543\n",
      "MONDO:0009952 radioulnar synostosis-developmental delay-hypotonia syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0013773 porencephaly 2 0.0026410807675210763 0.229543\n",
      "MONDO:0014595 developmental and epileptic encephalopathy, 30 0.0026410807675210763 0.229543\n",
      "MONDO:0012992 pancreatic insufficiency-anemia-hyperostosis syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0032827 epilepsy, idiopathic generalized, susceptibility to, 16 0.0026410807675210763 0.229543\n",
      "MONDO:0014600 dyskeratosis congenita, autosomal recessive 6 0.0026410807675210763 0.229543\n",
      "MONDO:0014171 complex cortical dysplasia with other brain malformations 4 0.0026410807675210763 0.229543\n",
      "MONDO:0030862 COACH syndrome 3 0.0026410807675210763 0.229543\n",
      "MONDO:0014080 osteosclerotic metaphyseal dysplasia 0.0026410807675210763 0.229543\n",
      "MONDO:0013661 combined malonic and methylmalonic acidemia 0.0026410807675210763 0.229543\n",
      "MONDO:0009475 isovaleric acidemia 0.0026410807675210763 0.229543\n",
      "MONDO:0014449 congenital analbuminemia 0.0026410807675210763 0.229543\n",
      "MONDO:0032894 neurodevelopmental disorder with epilepsy, spasticity, and brain atrophy 0.0026410807675210763 0.229543\n",
      "MONDO:0012324 Frias syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0020787 hypomagnesemia, seizures, and intellectual disability 1 0.0026410807675210763 0.229543\n",
      "MONDO:0013877 mitochondrial pyruvate carrier deficiency 0.0026410807675210763 0.229543\n",
      "MONDO:0012276 generalized epilepsy-paroxysmal dyskinesia syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0009742 neuroectodermal melanolysosomal disease 0.0026410807675210763 0.229543\n",
      "MONDO:0957255 mitochondrial complex V (ATP synthase) deficiency, nuclear type 7 0.0026410807675210763 0.229543\n",
      "MONDO:0009760 Norman-Roberts syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0032789 intellectual developmental disorder, autosomal recessive 71 0.0026410807675210763 0.229543\n",
      "MONDO:0030454 Joubert syndrome 39 0.0026410807675210763 0.229543\n",
      "MONDO:0029135 muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 8 0.0026410807675210763 0.229543\n",
      "MONDO:0030756 Stuve-Wiedemann syndrome 2 0.0026410807675210763 0.229543\n",
      "MONDO:0033614 spastic paraplegia 83, autosomal recessive 0.0026410807675210763 0.229543\n",
      "MONDO:0014562 neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome 0.0026410807675210763 0.229543\n",
      "MONDO:0010080 familial infantile bilateral striatal necrosis 0.0026410807675210763 0.229543\n",
      "MONDO:0006468 thyroid gland undifferentiated (anaplastic) carcinoma 0.0026410807675210763 0.229543\n",
      "MONDO:0012708 primary lateral sclerosis, adult, 1 0.0026410807675210763 0.229543\n",
      "MONDO:0007493 torsion dystonia 4 0.0026410807675210763 0.229543\n",
      "MONDO:0030018 autoinflammation with episodic fever and lymphadenopathy 0.003017808176953609 0.224463\n",
      "MONDO:0030692 immunodeficiency 95 0.003017808176953609 0.224463\n",
      "MONDO:0014654 Ullrich congenital muscular dystrophy 2 0.003017808176953609 0.224463\n",
      "MONDO:0011203 Pierre Robin sequence with pectus excavatum and rib and scapular anomalies 0.003017808176953609 0.224463\n",
      "MONDO:0030534 hypogonadotropic hypogonadism 26 with or without anosmia 0.003017808176953609 0.224463\n",
      "MONDO:0009159 Ehlers-Danlos syndrome, cardiac valvular type 0.003017808176953609 0.224463\n",
      "MONDO:0013437 retinitis pigmentosa 43 0.003017808176953609 0.224463\n",
      "MONDO:0012363 retinitis pigmentosa 32 0.003017808176953609 0.224463\n",
      "MONDO:0009954 Ramon syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0013314 retinitis pigmentosa 56 0.003017808176953609 0.224463\n",
      "MONDO:0013231 Leber congenital amaurosis 14 0.003017808176953609 0.224463\n",
      "MONDO:0013788 Usher syndrome type 3B 0.003017808176953609 0.224463\n",
      "MONDO:0100476 lipodystrophy, partial, acquired, susceptibility to 0.003017808176953609 0.224463\n",
      "MONDO:0009732 congenital nephrotic syndrome, Finnish type 0.003017808176953609 0.224463\n",
      "MONDO:0009562 beta-mannosidosis 0.003017808176953609 0.224463\n",
      "MONDO:0012938 Diamond-Blackfan anemia 7 0.003017808176953609 0.224463\n",
      "MONDO:0014968 encephalopathy, progressive, with amyotrophy and optic atrophy 0.003017808176953609 0.224463\n",
      "MONDO:0010558 choroideremia-deafness-obesity syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0030513 dystonia 33 0.003017808176953609 0.224463\n",
      "MONDO:0032619 mitochondrial complex 1 deficiency, nuclear type 14 0.003017808176953609 0.224463\n",
      "MONDO:0014607 developmental and epileptic encephalopathy, 32 0.003017808176953609 0.224463\n",
      "MONDO:0010334 severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0032883 intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures 0.003017808176953609 0.224463\n",
      "MONDO:0010489 intellectual disability, X-linked 101 0.003017808176953609 0.224463\n",
      "MONDO:0859303 intellectual developmental disorder with ocular anomalies and distinctive facial features 0.003017808176953609 0.224463\n",
      "MONDO:0009353 homocystinuria due to methylene tetrahydrofolate reductase deficiency 0.003017808176953609 0.224463\n",
      "MONDO:0030535 epidermolysis bullosa simplex 2d, generalized, intermediate or severe, autosomal recessive 0.003017808176953609 0.224463\n",
      "MONDO:0044313 intellectual disability, autosomal recessive 60 0.003017808176953609 0.224463\n",
      "MONDO:0009949 pyruvate carboxylase deficiency disease 0.003017808176953609 0.224463\n",
      "MONDO:0010485 X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0032626 mitochondrial complex 1 deficiency, nuclear type 22 0.003017808176953609 0.224463\n",
      "MONDO:0014696 cerebrooculofacioskeletal syndrome 3 0.003017808176953609 0.224463\n",
      "MONDO:0014633 myoclonic-atonic epilepsy 0.003017808176953609 0.224463\n",
      "MONDO:0013388 developmental and epileptic encephalopathy, 11 0.003017808176953609 0.224463\n",
      "MONDO:0012849 Joubert syndrome 9 0.003017808176953609 0.224463\n",
      "MONDO:0013302 nephronophthisis 11 0.003017808176953609 0.224463\n",
      "MONDO:0033649 mitochondrial complex 4 deficiency, nuclear type 14 0.003017808176953609 0.224463\n",
      "MONDO:0020788 hypomagnesemia, seizures, and intellectual disability 2 0.003017808176953609 0.224463\n",
      "MONDO:0011676 PHACE syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0023670 Bardet-Biedl syndrome 20 0.003017808176953609 0.224463\n",
      "MONDO:0014350 Seckel syndrome 8 0.003017808176953609 0.224463\n",
      "MONDO:0010452 intellectual disability, X-linked 90 0.003017808176953609 0.224463\n",
      "MONDO:0033115 spinocerebellar ataxia, autosomal recessive 25 0.003017808176953609 0.224463\n",
      "MONDO:0014972 chromosome 19q13.11 deletion syndrome, proximal 0.003017808176953609 0.224463\n",
      "MONDO:0014271 STT3B-congenital disorder of glycosylation 0.003017808176953609 0.224463\n",
      "MONDO:0008962 Griscelli syndrome type 1 0.003017808176953609 0.224463\n",
      "MONDO:0009324 Hartnup disease 0.003017808176953609 0.224463\n",
      "MONDO:0010555 X-linked chondrodysplasia punctata 1 0.003017808176953609 0.224463\n",
      "MONDO:0859265 neurodevelopmental disorder with epilepsy and brain atrophy 0.003017808176953609 0.224463\n",
      "MONDO:0012037 intellectual disability, autosomal recessive 3 0.003017808176953609 0.224463\n",
      "MONDO:0012740 chromosome 22q11.2 deletion syndrome, distal 0.003017808176953609 0.224463\n",
      "MONDO:0013645 autosomal recessive spinocerebellar ataxia 11 0.003017808176953609 0.224463\n",
      "MONDO:0013690 Pitt-Hopkins-like syndrome 2 0.003017808176953609 0.224463\n",
      "MONDO:0011540 spinocerebellar ataxia type 14 0.003017808176953609 0.224463\n",
      "MONDO:0011823 developmental malformations-deafness-dystonia syndrome 0.003017808176953609 0.224463\n",
      "MONDO:0013117 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 0.003017808176953609 0.224463\n",
      "MONDO:0032843 oculopharyngeal myopathy with leukoencephalopathy 1 0.003017808176953609 0.224463\n",
      "MONDO:0008407 neurogenic scapuloperoneal syndrome, Kaeser type 0.003017808176953609 0.224463\n",
      "MONDO:0020754 visceral myopathy 1 0.003017808176953609 0.224463\n",
      "UMLS:C1708650 Laryngeal Basaloid Carcinoma 0.003017808176953609 0.224463\n",
      "MONDO:0013264 amyotrophic lateral sclerosis type 12 0.003017808176953609 0.224463\n",
      "MONDO:0957264 cerebroretinal microangiopathy with calcifications and cysts 3 0.003017808176953609 0.224463\n",
      "MONDO:0859207 neurodevelopmental disorder with hypotonia and gross motor and speech delay 0.003017808176953609 0.224463\n",
      "MONDO:0859302 hypermetabolism due to uncoupled mitochondrial oxidative phosphorylation 2 0.0033943932870210093 0.220049\n",
      "MONDO:0011959 sweet syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0859175 nephronophthisis-like nephropathy 2 0.0033943932870210093 0.220049\n",
      "MONDO:0060556 joint laxity, short stature, and myopia 0.0033943932870210093 0.220049\n",
      "MONDO:0013516 retinitis pigmentosa 60 0.0033943932870210093 0.220049\n",
      "MONDO:0009007 Jalili syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0010000 rod-cone dystrophy, sensorineural deafness, and Fanconi-type renal dysfunction 0.0033943932870210093 0.220049\n",
      "MONDO:0014653 retinitis pigmentosa 72 0.0033943932870210093 0.220049\n",
      "MONDO:0012676 autosomal recessive osteopetrosis 4 0.0033943932870210093 0.220049\n",
      "MONDO:0044725 combined immunodeficiency due to GINS1 deficiency 0.0033943932870210093 0.220049\n",
      "MONDO:0009620 Say-Barber-Miller syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0020628 microcephaly, growth restriction, and increased sister chromatid exchange 2 0.0033943932870210093 0.220049\n",
      "MONDO:0026765 congenital disorder of glycosylation, type IIr 0.0033943932870210093 0.220049\n",
      "MONDO:0030693 immunodeficiency 96 0.0033943932870210093 0.220049\n",
      "MONDO:0014845 spinocerebellar ataxia, autosomal recessive 22 0.0033943932870210093 0.220049\n",
      "MONDO:0008108 oculocerebrocutaneous syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0011411 Chudley-McCullough syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0013165 hereditary spastic paraplegia 45 0.0033943932870210093 0.220049\n",
      "MONDO:0859346 mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition 0.0033943932870210093 0.220049\n",
      "MONDO:0014771 Joubert syndrome 26 0.0033943932870210093 0.220049\n",
      "MONDO:0009560 oculotrichoanal syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0030034 epilepsy, progressive myoclonic, 11 0.0033943932870210093 0.220049\n",
      "MONDO:0020741 pyridoxine-dependent epilepsy caused by ALDH7A1 mutant 0.0033943932870210093 0.220049\n",
      "MONDO:0010494 linear skin defects with multiple congenital anomalies 3 0.0033943932870210093 0.220049\n",
      "MONDO:0014437 Bardet-Biedl syndrome 9 0.0033943932870210093 0.220049\n",
      "MONDO:0014957 language delay and attention deficit-hyperactivity disorder/cognitive impairment with or without cardiac arrhythmia 0.0033943932870210093 0.220049\n",
      "MONDO:0859280 developmental delay, hypotonia, and impaired language 0.0033943932870210093 0.220049\n",
      "MONDO:0010665 Wilson-Turner syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0009285 gamma-glutamyl transpeptidase deficiency 0.0033943932870210093 0.220049\n",
      "MONDO:0032902 Joubert syndrome 36 0.0033943932870210093 0.220049\n",
      "MONDO:0012588 neuronal ceroid lipofuscinosis 7 0.0033943932870210093 0.220049\n",
      "MONDO:0032741 neurodevelopmental disorder with impaired speech and hyperkinetic movements 0.0033943932870210093 0.220049\n",
      "MONDO:0013687 autosomal recessive spinocerebellar ataxia 12 0.0033943932870210093 0.220049\n",
      "MONDO:0958185 mitochondrial trifunctional protein deficiency 2 0.0033943932870210093 0.220049\n",
      "MONDO:0014590 congenital myasthenic syndrome 18 0.0033943932870210093 0.220049\n",
      "MONDO:0013509 intellectual disability, autosomal dominant 6 0.0033943932870210093 0.220049\n",
      "MONDO:0032642 arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development 0.0033943932870210093 0.220049\n",
      "MONDO:0012756 proximal 16p11.2 microdeletion syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0032573 bone marrow failure syndrome 5 0.0033943932870210093 0.220049\n",
      "MONDO:0009611 3-methylglutaconic aciduria type 4 0.0033943932870210093 0.220049\n",
      "MONDO:0010508 intellectual disability, X-linked 103 0.0033943932870210093 0.220049\n",
      "MONDO:0012251 MEDNIK syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0859281 intellectual developmental disorder with autism and dysmorphic facies 0.0033943932870210093 0.220049\n",
      "MONDO:0009400 hyperprolinemia type 1 0.0033943932870210093 0.220049\n",
      "MONDO:0013440 autosomal recessive limb-girdle muscular dystrophy type 2P 0.0033943932870210093 0.220049\n",
      "MONDO:0030909 intellectual disability, X-linked, syndromic, Houge type 0.0033943932870210093 0.220049\n",
      "MONDO:0054736 mosaic variegated aneuploidy syndrome 3 0.0033943932870210093 0.220049\n",
      "MONDO:0014328 developmental and epileptic encephalopathy, 19 0.0033943932870210093 0.220049\n",
      "MONDO:0008721 medium chain acyl-CoA dehydrogenase deficiency 0.0033943932870210093 0.220049\n",
      "MONDO:0859256 neurodevelopmental disorder with language delay and seizures 0.0033943932870210093 0.220049\n",
      "MONDO:0014525 combined oxidative phosphorylation defect type 23 0.0033943932870210093 0.220049\n",
      "MONDO:0032598 developmental and epileptic encephalopathy, 68 0.0033943932870210093 0.220049\n",
      "MONDO:0013789 DDOST-congenital disorder of glycosylation 0.0033943932870210093 0.220049\n",
      "MONDO:0957543 auriculocondylar syndrome 4 0.0033943932870210093 0.220049\n",
      "MONDO:0011506 familial infantile myoclonic epilepsy 0.0033943932870210093 0.220049\n",
      "MONDO:0012392 2-methylbutyryl-CoA dehydrogenase deficiency 0.0033943932870210093 0.220049\n",
      "MONDO:0060554 vertebral, cardiac, renal, and limb defects syndrome 1 0.0033943932870210093 0.220049\n",
      "MONDO:0009622 Jawad syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0014764 spastic paraplegia-severe developmental delay-epilepsy syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0033203 nephrotic syndrome 14 0.0033943932870210093 0.220049\n",
      "MONDO:0010192 Waardenburg syndrome type 4A 0.0033943932870210093 0.220049\n",
      "MONDO:0859220 Ferguson-Bonni neurodevelopmental syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0032927 triokinase and FMN cyclase deficiency syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0010890 acrocardiofacial syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0013338 Charcot-Marie-Tooth disease recessive intermediate B 0.0033943932870210093 0.220049\n",
      "MONDO:0032842 Siddiqi syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0012504 camptodactyly-tall stature-scoliosis-hearing loss syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0044637 infantile-onset generalized dyskinesia with orofacial involvement 0.0033943932870210093 0.220049\n",
      "MONDO:0054750 amyotrophic lateral sclerosis, susceptibility to, 24 0.0033943932870210093 0.220049\n",
      "MONDO:0007103 amyotrophic lateral sclerosis type 1 0.0033943932870210093 0.220049\n",
      "MONDO:0008724 adducted thumbs-arthrogryposis syndrome, Christian type 0.0033943932870210093 0.220049\n",
      "MONDO:0014583 congenital myasthenic syndrome 3A 0.0033943932870210093 0.220049\n",
      "MONDO:0009688 myasthenia gravis 0.0033943932870210093 0.220049\n",
      "MONDO:0859363 spastic paraplegia 79A, autosomal dominant, with ataxia 0.0033943932870210093 0.220049\n",
      "MONDO:0013772 Huppke-Brendel syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0032681 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 0.0033943932870210093 0.220049\n",
      "MONDO:0011776 CINCA syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0014912 infantile-onset periodic fever-panniculitis-dermatosis syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0007349 familial cold autoinflammatory syndrome 1 0.0037708361514733027 0.216154\n",
      "MONDO:0015019 Yao syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0008633 Muckle-Wells syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0008751 corticosterone methyloxidase type 1 deficiency 0.0037708361514733027 0.216154\n",
      "MONDO:0010296 immunodeficiency 61 0.0037708361514733027 0.216154\n",
      "MONDO:0013896 Joubert syndrome 18 0.0037708361514733027 0.216154\n",
      "MONDO:0009806 Bruck syndrome 1 0.0037708361514733027 0.216154\n",
      "MONDO:0014950 aortic aneurysm, familial thoracic 10 0.0037708361514733027 0.216154\n",
      "MONDO:0049223 osteogenesis imperfecta, type 19 0.0037708361514733027 0.216154\n",
      "MONDO:0014850 retinitis pigmentosa and erythrocytic microcytosis 0.0037708361514733027 0.216154\n",
      "MONDO:0008765 Leber congenital amaurosis 2 0.0037708361514733027 0.216154\n",
      "MONDO:0030397 portal hypertension, noncirrhotic, 2 0.0037708361514733027 0.216154\n",
      "MONDO:0007293 leukocyte adhesion deficiency 1 0.0037708361514733027 0.216154\n",
      "MONDO:0009229 hyaline fibromatosis syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0060611 combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia 0.0037708361514733027 0.216154\n",
      "MONDO:0012721 progressive myoclonic epilepsy type 3 0.0037708361514733027 0.216154\n",
      "MONDO:0013274 retinitis pigmentosa 51 0.0037708361514733027 0.216154\n",
      "MONDO:0013644 Charcot-Marie-Tooth disease axonal type 2O 0.0037708361514733027 0.216154\n",
      "MONDO:0014112 cardiofaciocutaneous syndrome 2 0.0037708361514733027 0.216154\n",
      "MONDO:0010802 pancreatic hypoplasia-diabetes-congenital heart disease syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0032635 mitochondrial complex 1 deficiency, nuclear type 32 0.0037708361514733027 0.216154\n",
      "MONDO:0033282 multiple mitochondrial dysfunctions syndrome 5 0.0037708361514733027 0.216154\n",
      "MONDO:0014996 intellectual disability, autosomal recessive 58 0.0037708361514733027 0.216154\n",
      "MONDO:0014235 chromosome 22q13 duplication syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0013702 intellectual disability, autosomal recessive 27 0.0037708361514733027 0.216154\n",
      "MONDO:0957225 neurodegeneration with developmental delay, early respiratory failure, myoclonic seizures, and brain abnormalities 0.0037708361514733027 0.216154\n",
      "MONDO:0100119 Knobloch syndrome 2 0.0037708361514733027 0.216154\n",
      "MONDO:0014210 intellectual disability-hypotonia-spasticity-sleep disorder syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0010580 immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0011101 peroxisome biogenesis disorder 1B 0.0037708361514733027 0.216154\n",
      "MONDO:0009168 Fowler syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0054776 epilepsy, familial focal, with variable foci 4 0.0037708361514733027 0.216154\n",
      "MONDO:0009488 keratoconus posticus circumscriptus 0.0037708361514733027 0.216154\n",
      "MONDO:0032877 neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures 0.0037708361514733027 0.216154\n",
      "MONDO:0010815 spondyloepiphyseal dysplasia tarda with characteristic facies 0.0037708361514733027 0.216154\n",
      "MONDO:0054549 peroxisome biogenesis disorder 10B 0.0037708361514733027 0.216154\n",
      "MONDO:0032882 Heyn-Sproul-Jackson syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0010375 developmental and epileptic encephalopathy, 8 0.0037708361514733027 0.216154\n",
      "MONDO:0009606 methemoglobinemia due to deficiency of methemoglobin reductase 0.0037708361514733027 0.216154\n",
      "MONDO:0014886 severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0044304 hyperphenylalaninemia due to DNAJC12 deficiency 0.0037708361514733027 0.216154\n",
      "MONDO:0032621 mitochondrial complex 1 deficiency, nuclear type 16 0.0037708361514733027 0.216154\n",
      "MONDO:0014719 developmental and epileptic encephalopathy, 35 0.0037708361514733027 0.216154\n",
      "MONDO:0012964 chromosome 15q26-qter deletion syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0015015 congenital bile acid synthesis defect 6 0.0037708361514733027 0.216154\n",
      "MONDO:0013803 leukoencephalopathy with calcifications and cysts 0.0037708361514733027 0.216154\n",
      "MONDO:0014159 autosomal recessive spinocerebellar ataxia 14 0.0037708361514733027 0.216154\n",
      "MONDO:0010392 glycogen storage disease due to phosphoglycerate kinase 1 deficiency 0.0037708361514733027 0.216154\n",
      "MONDO:0013527 lissencephaly 4 0.0037708361514733027 0.216154\n",
      "MONDO:0859305 neurodevelopmental disorder with eye movement abnormalities and ataxia 0.0037708361514733027 0.216154\n",
      "MONDO:0013827 hyperekplexia 3 0.0037708361514733027 0.216154\n",
      "MONDO:0014200 aldosterone-producing adenoma with seizures and neurological abnormalities 0.0037708361514733027 0.216154\n",
      "MONDO:0013321 forsythe-wakeling syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0014260 immunodeficiency, common variable, 10 0.0037708361514733027 0.216154\n",
      "MONDO:0021013 trichothiodystrophy 4, nonphotosensitive 0.0037708361514733027 0.216154\n",
      "MONDO:0014793 microcephaly-congenital cataract-psoriasiform dermatitis syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0859263 developmental delay, impaired speech, and behavioral abnormalities, with or without seizures 0.0037708361514733027 0.216154\n",
      "MONDO:0030073 Mitchell syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0859530 myopathy, sarcoplasmic body 0.0037708361514733027 0.216154\n",
      "MONDO:0014585 congenital myasthenic syndrome 3C 0.0037708361514733027 0.216154\n",
      "MONDO:0010772 Leber optic atrophy and dystonia 0.0037708361514733027 0.216154\n",
      "MONDO:0012790 amyotrophic lateral sclerosis type 10 0.0037708361514733027 0.216154\n",
      "MONDO:0010735 Kennedy disease 0.0037708361514733027 0.216154\n",
      "MONDO:0008016 trismus-pseudocamptodactyly syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0014890 PERCHING syndrome 0.0037708361514733027 0.216154\n",
      "MONDO:0009703 myopathy with abnormal lipid metabolism 0.0037708361514733027 0.216154\n",
      "MONDO:0014395 frontotemporal dementia and/or amyotrophic lateral sclerosis 2 0.0037708361514733027 0.216154\n",
      "MONDO:0014898 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3 0.0037708361514733027 0.216154\n",
      "MONDO:0007164 spastic ataxia 1 0.0037708361514733027 0.216154\n",
      "MONDO:0014959 mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant 0.0037708361514733027 0.216154\n",
      "MONDO:0013135 familial hemophagocytic lymphohistiocytosis 5 0.004147136824040217 0.212675\n",
      "MONDO:0030498 immunodeficiency 92 0.004147136824040217 0.212675\n",
      "MONDO:0030931 proteasome-associated autoinflammatory syndrome 4 0.004147136824040217 0.212675\n",
      "MONDO:0859083 systemic lupus erythematosus 17 0.004147136824040217 0.212675\n",
      "MONDO:0030855 combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2 0.004147136824040217 0.212675\n",
      "MONDO:0011670 Ehlers-Danlos syndrome due to tenascin-X deficiency 0.004147136824040217 0.212675\n",
      "MONDO:0008146 osteogenesis imperfecta type 1 0.004147136824040217 0.212675\n",
      "MONDO:0013605 brittle cornea syndrome 2 0.004147136824040217 0.212675\n",
      "MONDO:0032792 neuropathy, hereditary motor and sensory, type VIc, with optic atrophy 0.004147136824040217 0.212675\n",
      "MONDO:0030302 immunodeficiency 81 0.004147136824040217 0.212675\n",
      "MONDO:0025708 megacystis-microcolon-intestinal hypoperistalsis syndrome 2 0.004147136824040217 0.212675\n",
      "MONDO:0024536 glucocorticoid deficiency 1 0.004147136824040217 0.212675\n",
      "MONDO:0014803 spasticity-ataxia-gait anomalies syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0054716 microcephaly 19, primary, autosomal recessive 0.004147136824040217 0.212675\n",
      "MONDO:0014569 lethal congenital contracture syndrome 7 0.004147136824040217 0.212675\n",
      "MONDO:0030046 neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity 0.004147136824040217 0.212675\n",
      "MONDO:0024507 aniridia 1 0.004147136824040217 0.212675\n",
      "MONDO:0859357 congenital disorder of glycosylation, type IIz 0.004147136824040217 0.212675\n",
      "MONDO:0012308 Joubert syndrome with renal defect 0.004147136824040217 0.212675\n",
      "MONDO:0031052 developmental and epileptic encephalopathy 106 0.004147136824040217 0.212675\n",
      "MONDO:0030988 developmental delay with dysmorphic facies and dental anomalies 0.004147136824040217 0.212675\n",
      "MONDO:0032870 intellectual developmental disorder with short stature and behavioral abnormalities 0.004147136824040217 0.212675\n",
      "MONDO:0010660 intellectual disability, X-linked 9 0.004147136824040217 0.212675\n",
      "MONDO:0044330 hyperekplexia 4 0.004147136824040217 0.212675\n",
      "MONDO:0044323 Rahman syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0009257 galactose epimerase deficiency 0.004147136824040217 0.212675\n",
      "MONDO:0013164 beta-ureidopropionase deficiency 0.004147136824040217 0.212675\n",
      "MONDO:0011830 lissencephaly due to LIS1 mutation 0.004147136824040217 0.212675\n",
      "MONDO:0030087 diabetes mellitus, permanent neonatal 2 0.004147136824040217 0.212675\n",
      "MONDO:0030971 immunodeficiency 78 with autoimmunity and developmental delay 0.004147136824040217 0.212675\n",
      "MONDO:0012221 alpha-N-acetylgalactosaminidase deficiency type 1 0.004147136824040217 0.212675\n",
      "MONDO:0011215 osteocraniostenosis 0.004147136824040217 0.212675\n",
      "MONDO:0014113 cardiofaciocutaneous syndrome 3 0.004147136824040217 0.212675\n",
      "MONDO:0030528 immunodeficiency 93 and hypertrophic cardiomyopathy 0.004147136824040217 0.212675\n",
      "MONDO:0012830 chromosome 10q23 deletion syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0012805 childhood onset GLUT1 deficiency syndrome 2 0.004147136824040217 0.212675\n",
      "MONDO:0014341 complex cortical dysplasia with other brain malformations 6 0.004147136824040217 0.212675\n",
      "MONDO:0033308 Joubert syndrome 30 0.004147136824040217 0.212675\n",
      "MONDO:0031060 microcephaly 29, primary, autosomal recessive 0.004147136824040217 0.212675\n",
      "MONDO:0014477 developmental and epileptic encephalopathy, 26 0.004147136824040217 0.212675\n",
      "MONDO:0013656 intellectual disability, autosomal dominant 9 0.004147136824040217 0.212675\n",
      "MONDO:0032634 mitochondrial complex 1 deficiency, nuclear type 31 0.004147136824040217 0.212675\n",
      "MONDO:0033009 Galloway-Mowat syndrome 5 0.004147136824040217 0.212675\n",
      "MONDO:0859362 hyperinsulinemic hypoglycemia, familial, 8 0.004147136824040217 0.212675\n",
      "MONDO:0011995 cataract - congenital heart disease - neural tube defect syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0014927 Joubert syndrome 27 0.004147136824040217 0.212675\n",
      "MONDO:0012553 cerebrooculofacioskeletal syndrome 2 0.004147136824040217 0.212675\n",
      "MONDO:0030911 intellectual disability, autosomal dominant 46 0.004147136824040217 0.212675\n",
      "MONDO:0032685 infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development 0.004147136824040217 0.212675\n",
      "MONDO:0014685 progressive myoclonic epilepsy type 9 0.004147136824040217 0.212675\n",
      "MONDO:0013166 GABA aminotransaminase deficiency 0.004147136824040217 0.212675\n",
      "MONDO:0032617 mitochondrial complex 1 deficiency, nuclear type 11 0.004147136824040217 0.212675\n",
      "MONDO:0014691 Noonan syndrome 9 0.004147136824040217 0.212675\n",
      "MONDO:0033566 combined oxidative phosphorylation deficiency 48 0.004147136824040217 0.212675\n",
      "MONDO:0016368 Rothmund-Thomson syndrome type 1 0.004147136824040217 0.212675\n",
      "MONDO:0030921 intellectual disability, autosomal dominant 55, with seizures 0.004147136824040217 0.212675\n",
      "MONDO:0014445 Bardet-Biedl syndrome 17 0.004147136824040217 0.212675\n",
      "MONDO:0033361 developmental and epileptic encephalopathy, 52 0.004147136824040217 0.212675\n",
      "MONDO:0014775 combined oxidative phosphorylation deficiency 28 0.004147136824040217 0.212675\n",
      "MONDO:0013680 cognitive impairment with or without cerebellar ataxia 0.004147136824040217 0.212675\n",
      "MONDO:0014059 microphthalmia, isolated, with coloboma 9 0.004147136824040217 0.212675\n",
      "MONDO:0010336 orofaciodigital syndrome VIII 0.004147136824040217 0.212675\n",
      "MONDO:0054701 Kleefstra syndrome 2 0.004147136824040217 0.212675\n",
      "MONDO:0020846 intellectual disability, autosomal recessive 64 0.004147136824040217 0.212675\n",
      "MONDO:0014409 intellectual disability, autosomal recessive 44 0.004147136824040217 0.212675\n",
      "MONDO:0014495 retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome 0.004147136824040217 0.212675\n",
      "MONDO:0013811 combined oxidative phosphorylation defect type 9 0.004147136824040217 0.212675\n",
      "MONDO:0014254 otofaciocervical syndrome 2 0.004147136824040217 0.212675\n",
      "MONDO:0014641 frontotemporal dementia and/or amyotrophic lateral sclerosis 4 0.004147136824040217 0.212675\n",
      "MONDO:0020845 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5 0.004147136824040217 0.212675\n",
      "MONDO:0009715 myotonia congenita, autosomal recessive 0.004147136824040217 0.212675\n",
      "MONDO:0009101 Wolfram syndrome 1 0.004147136824040217 0.212675\n",
      "MONDO:0012116 spinocerebellar ataxia type 8 0.004147136824040217 0.212675\n",
      "MONDO:0014587 congenital myasthenic syndrome 9 0.004147136824040217 0.212675\n",
      "MONDO:0010547 X-linked progressive cerebellar ataxia 0.004147136824040217 0.212675\n",
      "MONDO:0014640 frontotemporal dementia and/or amyotrophic lateral sclerosis 3 0.004147136824040217 0.212675\n",
      "MONDO:0010808 fatal familial insomnia 0.004147136824040217 0.212675\n",
      "MONDO:0011155 vacuolar Neuromyopathy 0.004147136824040217 0.212675\n",
      "MONDO:0012724 familial cold autoinflammatory syndrome 2 0.0045232953584311885 0.209536\n",
      "MONDO:0013934 combined immunodeficiency due to STK4 deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0007051 acromegaloid facial appearance syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0009123 orthostatic hypotension 1 0.0045232953584311885 0.209536\n",
      "MONDO:0800131 hyper-IgE recurrent infection syndrome 4A, autosomal dominant 0.0045232953584311885 0.209536\n",
      "MONDO:0011493 Stickler syndrome type 2 0.0045232953584311885 0.209536\n",
      "MONDO:0859335 congenital myopathy 15 0.0045232953584311885 0.209536\n",
      "MONDO:0030066 granulomatous disease, chronic, autosomal recessive, 5 0.0045232953584311885 0.209536\n",
      "MONDO:0013862 immunodeficiency, common variable, 7 0.0045232953584311885 0.209536\n",
      "MONDO:0024777 immunodeficiency 98 with autoinflammation, X-linked 0.0045232953584311885 0.209536\n",
      "MONDO:0044721 severe combined immunodeficiency due to LAT deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0014015 hereditary spastic paraplegia 56 0.0045232953584311885 0.209536\n",
      "MONDO:0014305 hereditary spastic paraplegia 63 0.0045232953584311885 0.209536\n",
      "MONDO:0054761 microcephaly 20, primary, autosomal recessive 0.0045232953584311885 0.209536\n",
      "MONDO:0012643 hereditary spastic paraplegia 32 0.0045232953584311885 0.209536\n",
      "MONDO:0012106 microcephaly 5, primary, autosomal recessive 0.0045232953584311885 0.209536\n",
      "MONDO:0007342 clubfoot 0.0045232953584311885 0.209536\n",
      "MONDO:0032662 intellectual developmental disorder, autosomal recessive 67 0.0045232953584311885 0.209536\n",
      "MONDO:0010462 syndromic X-linked intellectual disability Chudley-Schwartz type 0.0045232953584311885 0.209536\n",
      "MONDO:0009625 diencephalic-mesencephalic junction dysplasia syndrome 1 0.0045232953584311885 0.209536\n",
      "MONDO:0013658 intellectual disability, autosomal dominant 11 0.0045232953584311885 0.209536\n",
      "MONDO:0031055 developmental and epileptic encephalopathy 107 0.0045232953584311885 0.209536\n",
      "MONDO:0015004 dystonia 28, childhood-onset 0.0045232953584311885 0.209536\n",
      "MONDO:0014496 mitochondrial complex III deficiency nuclear type 9 0.0045232953584311885 0.209536\n",
      "MONDO:0020631 epileptic encephalopathy, infantile or early childhood, 2 0.0045232953584311885 0.209536\n",
      "MONDO:0013634 neuropathy, hereditary sensory, type 2C 0.0045232953584311885 0.209536\n",
      "MONDO:0009556 malonic aciduria 0.0045232953584311885 0.209536\n",
      "MONDO:0009349 holoprosencephaly 1 0.0045232953584311885 0.209536\n",
      "MONDO:0054602 gaze palsy, familial horizontal, with progressive scoliosis, 2 0.0045232953584311885 0.209536\n",
      "MONDO:0012407 pyridoxal phosphate-responsive seizures 0.0045232953584311885 0.209536\n",
      "MONDO:0010907 familial hypertryptophanemia 0.0045232953584311885 0.209536\n",
      "MONDO:0026763 holoprosencephaly 13, X-linked 0.0045232953584311885 0.209536\n",
      "MONDO:0014593 developmental and epileptic encephalopathy, 29 0.0045232953584311885 0.209536\n",
      "MONDO:0044322 intellectual developmental disorder with neuropsychiatric features 0.0045232953584311885 0.209536\n",
      "MONDO:0030318 spinocerebellar ataxia, autosomal recessive 30 0.0045232953584311885 0.209536\n",
      "MONDO:0012539 Joubert syndrome 6 0.0045232953584311885 0.209536\n",
      "MONDO:0030963 Li-Campeau syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0014487 congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0011530 mesomelic dysplasia, Savarirayan type 0.0045232953584311885 0.209536\n",
      "MONDO:0013918 distal tetrasomy 15q 0.0045232953584311885 0.209536\n",
      "MONDO:0014951 intellectual developmental disorder, autosomal recessive 74 0.0045232953584311885 0.209536\n",
      "MONDO:0012994 dopa-responsive dystonia due to sepiapterin reductase deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0010657 methylmalonic acidemia with homocystinuria, type cblX 0.0045232953584311885 0.209536\n",
      "MONDO:0030037 neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures 0.0045232953584311885 0.209536\n",
      "MONDO:0030907 intellectual disability, X-linked 106 0.0045232953584311885 0.209536\n",
      "MONDO:0033618 Vissers-Bodmer syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0011488 microcephaly 3, primary, autosomal recessive 0.0045232953584311885 0.209536\n",
      "MONDO:0030891 intellectual developmental disorder, autosomal dominant 66 0.0045232953584311885 0.209536\n",
      "MONDO:0859242 leukodystrophy, hypomyelinating, 24 0.0045232953584311885 0.209536\n",
      "MONDO:0012761 chromosome 3q29 microduplication syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0012694 Joubert syndrome 7 0.0045232953584311885 0.209536\n",
      "MONDO:0009543 prominent glabella-microcephaly-hypogenitalism syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0014311 autosomal recessive spinocerebellar ataxia 15 0.0045232953584311885 0.209536\n",
      "MONDO:0012596 PSAT deficiency 0.0045232953584311885 0.209536\n",
      "MONDO:0032759 intellectual developmental disorder with short stature and variable skeletal anomalies 0.0045232953584311885 0.209536\n",
      "MONDO:0014789 CCDC115-CDG 0.0045232953584311885 0.209536\n",
      "MONDO:0009376 carbamoyl phosphate synthetase I deficiency disease 0.0045232953584311885 0.209536\n",
      "MONDO:0859266 neurodevelopmental disorder with severe motor impairment, absent language, cerebral hypomyelination, and brain atrophy 0.0045232953584311885 0.209536\n",
      "MONDO:0859237 3-methylglutaconic aciduria, type VIIA 0.0045232953584311885 0.209536\n",
      "MONDO:0020790 gaze palsy, familial horizontal, with progressive scoliosis 1 0.0045232953584311885 0.209536\n",
      "MONDO:0010873 band heterotopia of brain 0.0045232953584311885 0.209536\n",
      "MONDO:0013362 THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome 0.0045232953584311885 0.209536\n",
      "MONDO:0009440 ichthyosiform erythroderma, corneal involvement, and hearing loss 0.0045232953584311885 0.209536\n",
      "MONDO:0011913 Alzheimer disease 3 0.0045232953584311885 0.209536\n",
      "MONDO:0032597 myasthenic syndrome, congenital, 24, presynaptic 0.0045232953584311885 0.209536\n",
      "MONDO:0009166 pontocerebellar hypoplasia type 4 0.0045232953584311885 0.209536\n",
      "MONDO:0008816 Chiari malformation type II 0.0045232953584311885 0.209536\n",
      "MONDO:0957533 megalencephalic leukoencephalopathy with subcortical cysts 3 0.0045232953584311885 0.209536\n",
      "MONDO:0021018 autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) 0.0045232953584311885 0.209536\n",
      "MONDO:0033479 spinocerebellar ataxia 44 0.0045232953584311885 0.209536\n",
      "MONDO:0011577 myopathy, proximal, and ophthalmoplegia 0.0045232953584311885 0.209536\n",
      "MONDO:0014899 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 0.0045232953584311885 0.209536\n",
      "MONDO:0032526 spinocerebellar ataxia 48 0.0045232953584311885 0.209536\n",
      "MONDO:0032788 cerebellar atrophy with seizures and variable developmental delay 0.0045232953584311885 0.209536\n",
      "MONDO:0012316 Majeed syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0009601 metaphyseal dysplasia without hypotrichosis 0.004899311808335354 0.206678\n",
      "MONDO:0012592 osteogenesis imperfecta type 11 0.004899311808335354 0.206678\n",
      "MONDO:0030861 osteogenesis imperfecta, type 21 0.004899311808335354 0.206678\n",
      "MONDO:0014954 Ehlers-Danlos syndrome, periodontal type 2 0.004899311808335354 0.206678\n",
      "MONDO:0030854 combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1 0.004899311808335354 0.206678\n",
      "MONDO:0012056 Leber congenital amaurosis 9 0.004899311808335354 0.206678\n",
      "MONDO:0014906 Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; 0.004899311808335354 0.206678\n",
      "MONDO:0014687 retinitis pigmentosa 73 0.004899311808335354 0.206678\n",
      "MONDO:0060583 platelet abnormalities with eosinophilia and immune-mediated inflammatory disease 0.004899311808335354 0.206678\n",
      "MONDO:0012471 Aicardi-Goutieres syndrome 3 0.004899311808335354 0.206678\n",
      "MONDO:0013802 infantile cerebellar-retinal degeneration 0.004899311808335354 0.206678\n",
      "MONDO:0010351 Fanconi anemia complementation group B 0.004899311808335354 0.206678\n",
      "MONDO:0014397 combined oxidative phosphorylation defect type 20 0.004899311808335354 0.206678\n",
      "MONDO:0100213 IFAP syndrome 1, with or without BRESHECK syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0033545 mitochondrial DNA depletion syndrome 19 0.004899311808335354 0.206678\n",
      "MONDO:0024607 congenital muscular dystrophy with cataracts and intellectual disability 0.004899311808335354 0.206678\n",
      "MONDO:0859231 macrocephaly, neurodevelopmental delay, lymphoid hyperplasia, and persistent fetal hemoglobin 0.004899311808335354 0.206678\n",
      "MONDO:0009279 triple-A syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0014921 developmental and epileptic encephalopathy, 43 0.004899311808335354 0.206678\n",
      "MONDO:0013281 COG4-congenital disorder of glycosylation 0.004899311808335354 0.206678\n",
      "MONDO:0014066 mitochondrial complex III deficiency nuclear type 5 0.004899311808335354 0.206678\n",
      "MONDO:0859260 Dworschak-Punetha neurodevelopmental syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0008287 Greig cephalopolysyndactyly syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0859285 neurodevelopmental disorder with microcephaly, short stature, and speech delay 0.004899311808335354 0.206678\n",
      "MONDO:0009866 phosphoenolpyruvate carboxykinase deficiency, cytosolic 0.004899311808335354 0.206678\n",
      "MONDO:0032875 short stature and microcephaly with genital anomalies 0.004899311808335354 0.206678\n",
      "MONDO:0013865 mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency 0.004899311808335354 0.206678\n",
      "MONDO:0010467 Xq27.3q28 duplication syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0011736 Cree intellectual disability syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0014705 craniosynostosis 6 0.004899311808335354 0.206678\n",
      "MONDO:0030730 Tessadori-van Haaften neurodevelopmental syndrome 2 0.004899311808335354 0.206678\n",
      "MONDO:0024552 linear skin defects with multiple congenital anomalies 1 0.004899311808335354 0.206678\n",
      "MONDO:0007733 holoprosencephaly 3 0.004899311808335354 0.206678\n",
      "MONDO:0014678 intellectual disability, autosomal dominant 39 0.004899311808335354 0.206678\n",
      "MONDO:0009509 Landau-Kleffner syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0033641 cleft palate, proliferative retinopathy, and developmental delay 0.004899311808335354 0.206678\n",
      "MONDO:0011437 microcephaly 4, primary, autosomal recessive 0.004899311808335354 0.206678\n",
      "MONDO:0011964 DPAGT1-congenital disorder of glycosylation 0.004899311808335354 0.206678\n",
      "MONDO:0032596 myasthenic syndrome, congenital, 23, presynaptic 0.004899311808335354 0.206678\n",
      "MONDO:0013549 N-acetylaspartate deficiency 0.004899311808335354 0.206678\n",
      "MONDO:0049222 intellectual disability, X-linked 107 0.004899311808335354 0.206678\n",
      "MONDO:0859085 neurodevelopmental disorder with gait disturbance, dysmorphic facies, and behavioral abnormalities, X-linked 0.004899311808335354 0.206678\n",
      "MONDO:0014976 lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0014150 developmental and epileptic encephalopathy 94 0.004899311808335354 0.206678\n",
      "MONDO:0032665 intellectual developmental disorder, autosomal recessive 68 0.004899311808335354 0.206678\n",
      "MONDO:0010185 methylmalonic aciduria and homocystinuria type cblD 0.004899311808335354 0.206678\n",
      "MONDO:0859277 intellectual developmental disorder with muscle tone abnormalities and distal skeletal defects 0.004899311808335354 0.206678\n",
      "MONDO:0014096 microcephaly-intellectual disability-phalangeal and neurological anomalies syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0009874 Rabson-Mendenhall syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0014486 intellectual disability, autosomal dominant 30 0.004899311808335354 0.206678\n",
      "MONDO:0011639 Diamond-Blackfan anemia 15 with mandibulofacial dysostosis 0.004899311808335354 0.206678\n",
      "MONDO:0010265 Simpson-Golabi-Behmel syndrome type 2 0.004899311808335354 0.206678\n",
      "MONDO:0030964 intellectual developmental disorder, autosomal dominant 67 0.004899311808335354 0.206678\n",
      "MONDO:0013292 chromosome 4q21 deletion syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0031021 developmental and epileptic encephalopathy 104 0.004899311808335354 0.206678\n",
      "MONDO:0009609 methylcobalamin deficiency type cblG 0.004899311808335354 0.206678\n",
      "MONDO:0033006 Galloway-Mowat syndrome 2, X-linked 0.004899311808335354 0.206678\n",
      "MONDO:0008722 short chain acyl-CoA dehydrogenase deficiency 0.004899311808335354 0.206678\n",
      "MONDO:0010490 SSR4-congenital disorder of glycosylation 0.004899311808335354 0.206678\n",
      "MONDO:0014072 D,L-2-hydroxyglutaric aciduria 0.004899311808335354 0.206678\n",
      "MONDO:0032693 Galloway-Mowat syndrome 8 0.004899311808335354 0.206678\n",
      "MONDO:0100217 developmental delay with short stature, dysmorphic facial features, and sparse hair 2 0.004899311808335354 0.206678\n",
      "MONDO:0014822 15q14 microdeletion syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0014625 developmental and epileptic encephalopathy, 33 0.004899311808335354 0.206678\n",
      "MONDO:0011903 Charcot-Marie-Tooth disease type 2J 0.004899311808335354 0.206678\n",
      "MONDO:0010641 X-linked diffuse leiomyomatosis-Alport syndrome 0.004899311808335354 0.206678\n",
      "MONDO:0009179 recessive dystrophic epidermolysis bullosa 0.004899311808335354 0.206678\n",
      "MONDO:0014776 spinocerebellar ataxia type 42 0.004899311808335354 0.206678\n",
      "MONDO:0013776 spastic ataxia 5 0.004899311808335354 0.206678\n",
      "MONDO:0008056 myotonic dystrophy type 1 0.004899311808335354 0.206678\n",
      "MONDO:0016163 autosomal dominant cerebellar ataxia type II 0.004899311808335354 0.206678\n",
      "MONDO:0011819 spinocerebellar ataxia type 19/22 0.004899311808335354 0.206678\n",
      "MONDO:0032657 developmental and epileptic encephalopathy, 69 0.004899311808335354 0.206678\n",
      "MONDO:0030453 developmental and epileptic encephalopathy 97 0.004899311808335354 0.206678\n",
      "MONDO:0800132 autoinflammatory-pancytopenia syndrome due to DNASE2 deficiency 0.005275186227421581 0.204059\n",
      "MONDO:0007818 hyper-IgE recurrent infection syndrome 1, autosomal dominant 0.005275186227421581 0.204059\n",
      "MONDO:0859300 neuronopathy, distal hereditary motor, autosomal dominant 10 0.005275186227421581 0.204059\n",
      "MONDO:0009052 cutis laxa, autosomal recessive, type 1A 0.005275186227421581 0.204059\n",
      "MONDO:0012558 epiphyseal dysplasia, Baumann type 0.005275186227421581 0.204059\n",
      "MONDO:0010256 intellectual disability, X-linked 21 0.005275186227421581 0.204059\n",
      "MONDO:0007352 renal coloboma syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0030012 Diets-Jongmans syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0024543 brittle cornea syndrome 1 0.005275186227421581 0.204059\n",
      "MONDO:0013457 Leber congenital amaurosis 15 0.005275186227421581 0.204059\n",
      "MONDO:0014054 lymphoproliferative syndrome 2 0.005275186227421581 0.204059\n",
      "MONDO:0009174 protein-losing enteropathy 0.005275186227421581 0.204059\n",
      "MONDO:0009194 immunodeficiency 32B 0.005275186227421581 0.204059\n",
      "MONDO:0012719 combined PSAP deficiency 0.005275186227421581 0.204059\n",
      "MONDO:0012866 hereditary spastic paraplegia 35 0.005275186227421581 0.204059\n",
      "MONDO:0014337 complex cortical dysplasia with other brain malformations 5 0.005275186227421581 0.204059\n",
      "MONDO:0008335 short stature-craniofacial anomalies-genital hypoplasia syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0014404 Webb-Dattani syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0033657 leukodystrophy, hypomyelinating, 20 0.005275186227421581 0.204059\n",
      "MONDO:0007045 acrofacial dysostosis, Catania type 0.005275186227421581 0.204059\n",
      "MONDO:0013404 hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase 0.005275186227421581 0.204059\n",
      "MONDO:0014752 nephrotic syndrome, type 11 0.005275186227421581 0.204059\n",
      "MONDO:0014917 developmental and epileptic encephalopathy, 42 0.005275186227421581 0.204059\n",
      "MONDO:0020770 spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3 0.005275186227421581 0.204059\n",
      "MONDO:0013840 encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0859519 neurodevelopmental disorder with absent speech and movement and behavioral abnormalities 0.005275186227421581 0.204059\n",
      "MONDO:0009544 macrocephaly/megalencephaly syndrome, autosomal recessive 0.005275186227421581 0.204059\n",
      "MONDO:0030674 Teebi hypertelorism syndrome 2 0.005275186227421581 0.204059\n",
      "MONDO:0030471 Galloway-Mowat syndrome 9 0.005275186227421581 0.204059\n",
      "MONDO:0011533 temtamy preaxial brachydactyly syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0007247 basal ganglia calcification, idiopathic, childhood-onset 0.005275186227421581 0.204059\n",
      "MONDO:0014101 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12 0.005275186227421581 0.204059\n",
      "MONDO:0014392 developmental and epileptic encephalopathy, 25 0.005275186227421581 0.204059\n",
      "MONDO:0014473 microcephaly 13, primary, autosomal recessive 0.005275186227421581 0.204059\n",
      "MONDO:0054742 combined oxidative phosphorylation deficiency 35 0.005275186227421581 0.204059\n",
      "MONDO:0013762 lipoic acid synthetase deficiency 0.005275186227421581 0.204059\n",
      "MONDO:0007204 Cole-Carpenter syndrome 1 0.005275186227421581 0.204059\n",
      "MONDO:0030353 Joubert syndrome 38 0.005275186227421581 0.204059\n",
      "MONDO:0010854 Toriello-Lacassie-Droste syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0010507 Xq25 microduplication syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0032901 Catifa syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0033362 developmental and epileptic encephalopathy, 53 0.005275186227421581 0.204059\n",
      "MONDO:0013349 ALG11-congenital disorder of glycosylation 0.005275186227421581 0.204059\n",
      "MONDO:0013336 chromosome 19p13.13 deletion syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0010364 X-linked intellectual disability-retinitis pigmentosa syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0014805 Hao-Fountain syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0012052 ALG1-congenital disorder of glycosylation 0.005275186227421581 0.204059\n",
      "MONDO:0011229 ethylmalonic encephalopathy 0.005275186227421581 0.204059\n",
      "MONDO:0020858 mitochondrial complex 5 (ATP synthase) deficiency nuclear type 5 0.005275186227421581 0.204059\n",
      "MONDO:0008305 Currarino triad 0.005275186227421581 0.204059\n",
      "MONDO:0032622 mitochondrial complex 1 deficiency, nuclear type 17 0.005275186227421581 0.204059\n",
      "MONDO:0013521 dyskeratosis congenita, autosomal dominant 2 0.005275186227421581 0.204059\n",
      "MONDO:0859258 neurodevelopmental disorder with dystonia and seizures 0.005275186227421581 0.204059\n",
      "MONDO:0012178 intellectual disability with optic atrophy, facial dysmorphism, microcephaly, and short stature 0.005275186227421581 0.204059\n",
      "MONDO:0012186 Fanconi anemia complementation group I 0.005275186227421581 0.204059\n",
      "MONDO:0014781 combined oxidative phosphorylation deficiency 29 0.005275186227421581 0.204059\n",
      "MONDO:0010397 severe neonatal-onset encephalopathy with microcephaly 0.005275186227421581 0.204059\n",
      "MONDO:0007938 46,XY sex reversal 4 0.005275186227421581 0.204059\n",
      "MONDO:0859378 leukodystrophy, hypomyelinating, 25 0.005275186227421581 0.204059\n",
      "MONDO:0012436 neonatal diabetes mellitus with congenital hypothyroidism 0.005275186227421581 0.204059\n",
      "MONDO:0014034 severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0012432 Joubert syndrome 5 0.005275186227421581 0.204059\n",
      "MONDO:0008988 citrullinemia type I 0.005275186227421581 0.204059\n",
      "MONDO:0009404 hypertelorism, microtia, facial clefting syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0010325 X-linked intellectual disability, Stocco dos Santos type 0.005275186227421581 0.204059\n",
      "MONDO:0036189 oculogastrointestinal-neurodevelopmental syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0014545 progressive myoclonic epilepsy type 8 0.005275186227421581 0.204059\n",
      "MONDO:0008209 Char syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0033615 coenzyme q10 deficiency, primary, 9 0.005275186227421581 0.204059\n",
      "MONDO:0033309 Joubert syndrome 32 0.005275186227421581 0.204059\n",
      "MONDO:0009735 Netherton syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0030028 neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline 0.005275186227421581 0.204059\n",
      "MONDO:0032630 mitochondrial complex 1 deficiency, nuclear type 26 0.005275186227421581 0.204059\n",
      "MONDO:0030676 parkinsonism-dystonia 3, childhood-onset 0.005275186227421581 0.204059\n",
      "MONDO:0859245 spinocerebellar ataxia, autosomal recessive 32 0.005275186227421581 0.204059\n",
      "MONDO:0008260 Kindler syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0009689 congenital myasthenic syndrome 6 0.005275186227421581 0.204059\n",
      "MONDO:0008045 spinal muscular atrophy-progressive myoclonic epilepsy syndrome 0.005275186227421581 0.204059\n",
      "MONDO:0008199 late-onset Parkinson disease 0.005275186227421581 0.204059\n",
      "MONDO:0013490 megalencephalic leukoencephalopathy with subcortical cysts 2A 0.005275186227421581 0.204059\n",
      "MONDO:0014003 developmental and epileptic encephalopathy, 15 0.005275186227421581 0.204059\n",
      "MONDO:0024770 autoinflammatory syndrome, familial, X-linked, Behcet-like 2 0.005650918669338471 0.201643\n",
      "MONDO:0060457 autoinflammation with arthritis and dyskeratosis 0.005650918669338471 0.201643\n",
      "MONDO:0014637 DOCK2 deficiency 0.005650918669338471 0.201643\n",
      "MONDO:0044329 osteogenesis imperfecta, type 18 0.005650918669338471 0.201643\n",
      "MONDO:0013618 craniofacial anomalies and anterior segment dysgenesis syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0032684 intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency 0.005650918669338471 0.201643\n",
      "MONDO:0010421 Bruton-type agammaglobulinemia 0.005650918669338471 0.201643\n",
      "MONDO:0859216 neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis 0.005650918669338471 0.201643\n",
      "MONDO:0009034 craniofacial dyssynostosis 0.005650918669338471 0.201643\n",
      "MONDO:0013277 developmental and epileptic encephalopathy, 5 0.005650918669338471 0.201643\n",
      "MONDO:0014778 Lamb-Shaffer syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0859240 intellectual developmental disorder with or without peripheral neuropathy 0.005650918669338471 0.201643\n",
      "MONDO:0859262 ACCES syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0859257 intellectual developmental disorder with language impairment and early-onset DOPA-responsive dystonia-parkinsonism 0.005650918669338471 0.201643\n",
      "MONDO:0012368 aminoacylase 1 deficiency 0.005650918669338471 0.201643\n",
      "MONDO:0013760 congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0009503 pyruvate dehydrogenase E3-binding protein deficiency 0.005650918669338471 0.201643\n",
      "MONDO:0014457 hyperphosphatasia with intellectual disability syndrome 5 0.005650918669338471 0.201643\n",
      "MONDO:0012290 CEDNIK syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0859229 cerebellar dysfunction, impaired intellectual development, and hypogonadotropic hypogonadism 0.005650918669338471 0.201643\n",
      "MONDO:0030472 developmental and epileptic encephalopathy 98 0.005650918669338471 0.201643\n",
      "MONDO:0009990 Revesz syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0032570 Joubert syndrome 35 0.005650918669338471 0.201643\n",
      "MONDO:0032858 developmental and epileptic encephalopathy, 81 0.005650918669338471 0.201643\n",
      "MONDO:0030677 Charcot-Marie-Tooth disease, demyelinating, IIA 1I 0.005650918669338471 0.201643\n",
      "MONDO:0011686 DNA ligase IV deficiency 0.005650918669338471 0.201643\n",
      "MONDO:0060568 Pilarowski-Bjornsson syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0030059 developmental and epileptic encephalopathy, 87 0.005650918669338471 0.201643\n",
      "MONDO:0009354 methylcobalamin deficiency type cblE 0.005650918669338471 0.201643\n",
      "MONDO:0029138 developmental and epileptic encephalopathy, 67 0.005650918669338471 0.201643\n",
      "MONDO:0011738 bilateral frontoparietal polymicrogyria 0.005650918669338471 0.201643\n",
      "MONDO:0014133 developmental and epileptic encephalopathy, 16 0.005650918669338471 0.201643\n",
      "MONDO:0012859 autosomal recessive osteopetrosis 7 0.005650918669338471 0.201643\n",
      "MONDO:0014031 microcephalic primordial dwarfism, Alazami type 0.005650918669338471 0.201643\n",
      "MONDO:0014516 microcephaly and chorioretinopathy 2 0.005650918669338471 0.201643\n",
      "MONDO:0010363 intellectual disability, X-linked 91 0.005650918669338471 0.201643\n",
      "MONDO:0032912 Coffin-Siris syndrome 11 0.005650918669338471 0.201643\n",
      "MONDO:0032850 neurooculocardiogenitourinary syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0030072 developmental and epileptic encephalopathy, 88 0.005650918669338471 0.201643\n",
      "MONDO:0014848 TELO2-related intellectual disability-neurodevelopmental disorder 0.005650918669338471 0.201643\n",
      "MONDO:0859272 neurodevelopmental disorder with speech delay and variable ocular anomalies 0.005650918669338471 0.201643\n",
      "MONDO:0032625 mitochondrial complex 1 deficiency, nuclear type 21 0.005650918669338471 0.201643\n",
      "MONDO:0032931 pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal 0.005650918669338471 0.201643\n",
      "MONDO:0010709 early-onset parkinsonism-intellectual disability syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0014224 developmental delay with autism spectrum disorder and gait instability 0.005650918669338471 0.201643\n",
      "MONDO:0033363 developmental and epileptic encephalopathy, 54 0.005650918669338471 0.201643\n",
      "MONDO:0013059 Aicardi-Goutieres syndrome 5 0.005650918669338471 0.201643\n",
      "MONDO:0009603 3-hydroxyisobutyryl-CoA hydrolase deficiency 0.005650918669338471 0.201643\n",
      "MONDO:0957203 intellectual developmental disorder, X-linked 111 0.005650918669338471 0.201643\n",
      "MONDO:0014120 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A13 0.005650918669338471 0.201643\n",
      "MONDO:0014141 muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14 0.005650918669338471 0.201643\n",
      "MONDO:0013949 peroxisome biogenesis disorder 11A (Zellweger) 0.005650918669338471 0.201643\n",
      "MONDO:0009104 Donnai-Barrow syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0009666 holocarboxylase synthetase deficiency 0.005650918669338471 0.201643\n",
      "MONDO:0859517 congenital myopathy 2b, severe infantile, autosomal recessive 0.005650918669338471 0.201643\n",
      "MONDO:0009699 action myoclonus-renal failure syndrome 0.005650918669338471 0.201643\n",
      "MONDO:0010190 pontocerebellar hypoplasia type 2A 0.005650918669338471 0.201643\n",
      "MONDO:0008200 autosomal dominant Parkinson disease 1 0.005650918669338471 0.201643\n",
      "MONDO:0008457 spinocerebellar ataxia type 6 0.005650918669338471 0.201643\n",
      "MONDO:0030438 pontocerebellar hypoplasia, type 16 0.005650918669338471 0.201643\n",
      "MONDO:0032673 basal ganglia calcification, idiopathic, 7, autosomal recessive 0.005650918669338471 0.201643\n",
      "MONDO:0859296 neurodevelopmental disorder with poor growth, spastic tetraplegia, and hearing loss 0.005650918669338471 0.201643\n",
      "MONDO:0014208 Charcot-Marie-Tooth disease type 2R 0.005650918669338471 0.201643\n",
      "MONDO:0024551 X-linked lymphoproliferative disease due to SH2D1A deficiency 0.006026509187714335 0.199403\n",
      "MONDO:0026777 VEXAS syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0014472 periodic fever-infantile enterocolitis-autoinflammatory syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0014389 polyglucosan body myopathy 1 with or without immunodeficiency 0.006026509187714335 0.199403\n",
      "MONDO:0019568 Ehlers-Danlos syndrome, classic type, 2 0.006026509187714335 0.199403\n",
      "MONDO:0859194 Boudin-Mortier syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0032654 hyper-IgE recurrent infection syndrome 3, autosomal recessive 0.006026509187714335 0.199403\n",
      "MONDO:0859234 agammaglobulinemia 8b, autosomal recessive 0.006026509187714335 0.199403\n",
      "MONDO:0859571 diaphragmatic hernia 4, with cardiovascular defects 0.006026509187714335 0.199403\n",
      "MONDO:0020750 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2 0.006026509187714335 0.199403\n",
      "MONDO:0013179 hereditary spastic paraplegia 44 0.006026509187714335 0.199403\n",
      "MONDO:0013989 developmental and epileptic encephalopathy, 14 0.006026509187714335 0.199403\n",
      "MONDO:0030024 neurodevelopmental disorder with or without autistic features and/or structural brain abnormalities 0.006026509187714335 0.199403\n",
      "MONDO:0060533 microcephaly, short stature, and limb abnormalities 0.006026509187714335 0.199403\n",
      "MONDO:0013255 arthrogryposis, renal dysfunction, and cholestasis 2 0.006026509187714335 0.199403\n",
      "MONDO:0014596 lissencephaly 7 with cerebellar hypoplasia 0.006026509187714335 0.199403\n",
      "MONDO:0012400 cortical dysplasia-focal epilepsy syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0030900 intellectual developmental disorder with paroxysmal dyskinesia or seizures 0.006026509187714335 0.199403\n",
      "MONDO:0032609 mitochondrial complex 1 deficiency, nuclear type 4 0.006026509187714335 0.199403\n",
      "MONDO:0054781 combined oxidative phosphorylation deficiency 36 0.006026509187714335 0.199403\n",
      "MONDO:0012824 hypomyelinating leukodystrophy 4 0.006026509187714335 0.199403\n",
      "MONDO:0010437 severe X-linked mitochondrial encephalomyopathy 0.006026509187714335 0.199403\n",
      "MONDO:0859176 neurodevelopmental disorder with motor and speech delay and behavioral abnormalities 0.006026509187714335 0.199403\n",
      "MONDO:0010327 HSD10 mitochondrial disease 0.006026509187714335 0.199403\n",
      "MONDO:0031011 neurodevelopmental disorder with dysmorphic facies and variable seizures 0.006026509187714335 0.199403\n",
      "MONDO:0032903 arthrogryposis multiplex congenita 4, neurogenic, with agenesis of the corpus callosum 0.006026509187714335 0.199403\n",
      "MONDO:0014196 Hartsfield-Bixler-Demyer syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0014505 developmental and epileptic encephalopathy, 27 0.006026509187714335 0.199403\n",
      "MONDO:0033533 combined oxidative phosphorylation deficiency 45 0.006026509187714335 0.199403\n",
      "MONDO:0008021 Cowden syndrome 1 0.006026509187714335 0.199403\n",
      "MONDO:0014801 even-plus syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0013238 chromosome 17q23.1-q23.2 deletion syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0009953 leukocyte adhesion deficiency type II 0.006026509187714335 0.199403\n",
      "MONDO:0032568 intellectual developmental disorder with macrocephaly, seizures, and speech delay 0.006026509187714335 0.199403\n",
      "MONDO:0033559 intellectual developmental disorder with seizures and language delay 0.006026509187714335 0.199403\n",
      "MONDO:0013536 heme oxygenase 1 deficiency 0.006026509187714335 0.199403\n",
      "MONDO:0009554 3MC syndrome 3 0.006026509187714335 0.199403\n",
      "MONDO:0013458 hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0010099 Tay-Sachs disease AB variant 0.006026509187714335 0.199403\n",
      "MONDO:0014218 severe dermatitis-multiple allergies-metabolic wasting syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0054835 classic dopamine transporter deficiency syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0009610 3-methylglutaconic aciduria type 1 0.006026509187714335 0.199403\n",
      "MONDO:0030987 vertebral, cardiac, tracheoesophageal, renal, and limb defects 0.006026509187714335 0.199403\n",
      "MONDO:0859211 neurodevelopmental disorder with hyperkinetic movements and dyskinesia 0.006026509187714335 0.199403\n",
      "MONDO:0011538 frontoocular syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0859225 neurodevelopmental disorder with or without variable movement or behavioral abnormalities 0.006026509187714335 0.199403\n",
      "MONDO:0012020 chromosome 22q11.2 microduplication syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0100079 developmental and epileptic encephalopathy, 6 0.006026509187714335 0.199403\n",
      "MONDO:0032730 leukodystrophy, hypomyelinating, 18 0.006026509187714335 0.199403\n",
      "MONDO:0013226 combined immunodeficiency with faciooculoskeletal anomalies 0.006026509187714335 0.199403\n",
      "MONDO:0014754 primary coenzyme Q10 deficiency 8 0.006026509187714335 0.199403\n",
      "MONDO:0030873 cardiofacioneurodevelopmental syndrome 0.006026509187714335 0.199403\n",
      "MONDO:0011342 SLC35A1-congenital disorder of glycosylation 0.006026509187714335 0.199403\n",
      "MONDO:0033008 Galloway-Mowat syndrome 4 0.006026509187714335 0.199403\n",
      "MONDO:0011339 hereditary spastic paraplegia 8 0.006026509187714335 0.199403\n",
      "MONDO:0030712 oculopharyngodistal myopathy 4 0.006026509187714335 0.199403\n",
      "MONDO:0012235 autosomal recessive spinocerebellar ataxia 7 0.006026509187714335 0.199403\n",
      "MONDO:0030512 spastic paraplegia 85, autosomal recessive 0.006026509187714335 0.199403\n",
      "MONDO:0033537 combined oxidative phosphorylation deficiency 47 0.006026509187714335 0.199403\n",
      "MONDO:0014939 congenital myasthenic syndrome 20 0.006026509187714335 0.199403\n",
      "MONDO:0012639 hereditary spastic paraplegia 18 0.006026509187714335 0.199403\n",
      "MONDO:0032905 spastic paraplegia 81, autosomal recessive 0.006026509187714335 0.199403\n",
      "MONDO:0007727 autosomal dominant familial periodic fever 0.006401957836157258 0.197316\n",
      "MONDO:0010651 Menkes disease 0.006401957836157258 0.197316\n",
      "MONDO:0030871 vertebral hypersegmentation and orofacial anomalies 0.006401957836157258 0.197316\n",
      "MONDO:0054695 myopathy, centronuclear, 6, with fiber-type disproportion 0.006401957836157258 0.197316\n",
      "MONDO:0010383 fragile X syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0010902 spondyloepiphyseal dysplasia, Reardon type 0.006401957836157258 0.197316\n",
      "MONDO:0009720 Keipert syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0032724 spondyloepimetaphyseal dysplasia with joint laxity, type 3 0.006401957836157258 0.197316\n",
      "MONDO:0013863 combined immunodeficiency due to LRBA deficiency 0.006401957836157258 0.197316\n",
      "MONDO:0014354 intellectual disability, autosomal recessive 43 0.006401957836157258 0.197316\n",
      "MONDO:0010584 dyskeratosis congenita, X-linked 0.006401957836157258 0.197316\n",
      "MONDO:0008763 Alstrom syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0011134 Curry-Jones syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0014602 intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0014702 autosomal recessive complex spastic paraplegia type 9B 0.006401957836157258 0.197316\n",
      "MONDO:0859307 cleidocranial dysplasia 2 0.006401957836157258 0.197316\n",
      "MONDO:0859279 spinal muscular atrophy, distal, autosomal recessive, 6 0.006401957836157258 0.197316\n",
      "MONDO:0032884 ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies 0.006401957836157258 0.197316\n",
      "MONDO:0026720 mitochondrial complex 1 deficiency, nuclear type 12 0.006401957836157258 0.197316\n",
      "MONDO:0010953 Fanconi anemia complementation group E 0.006401957836157258 0.197316\n",
      "MONDO:0010476 neurodegeneration with brain iron accumulation 5 0.006401957836157258 0.197316\n",
      "MONDO:0012759 camptodactyly syndrome, Guadalajara type 3 0.006401957836157258 0.197316\n",
      "MONDO:0032680 global developmental delay with or without impaired intellectual development 0.006401957836157258 0.197316\n",
      "MONDO:0859174 Usmani-Riazuddin syndrome, autosomal dominant 0.006401957836157258 0.197316\n",
      "MONDO:0018445 global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0010749 trigonocephaly-short stature-developmental delay syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0010703 ornithine carbamoyltransferase deficiency 0.006401957836157258 0.197316\n",
      "MONDO:0030785 intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly 0.006401957836157258 0.197316\n",
      "MONDO:0032712 combined oxidative phosphorylation deficiency 38 0.006401957836157258 0.197316\n",
      "MONDO:0014510 fatty acyl-CoA reductase 1 deficiency 0.006401957836157258 0.197316\n",
      "MONDO:0008814 hyperargininemia 0.006401957836157258 0.197316\n",
      "MONDO:0014563 mitochondrial short-chain Enoyl-Coa hydratase 1 deficiency 0.006401957836157258 0.197316\n",
      "MONDO:0014859 developmental and epileptic encephalopathy, 37 0.006401957836157258 0.197316\n",
      "MONDO:0014729 hereditary spastic paraplegia 75 0.006401957836157258 0.197316\n",
      "MONDO:0033482 spinocerebellar ataxia 47 0.006401957836157258 0.197316\n",
      "MONDO:0859213 congenital heart defects, multiple types, 8, with or without heterotaxy 0.006401957836157258 0.197316\n",
      "MONDO:0030517 trichothiodystrophy 8, nonphotosensitive 0.006401957836157258 0.197316\n",
      "MONDO:0008861 3-methylcrotonyl-CoA carboxylase 1 deficiency 0.006401957836157258 0.197316\n",
      "MONDO:0013456 constitutional megaloblastic anemia with severe neurologic disease 0.006401957836157258 0.197316\n",
      "MONDO:0014576 lipoyl transferase 1 deficiency 0.006401957836157258 0.197316\n",
      "MONDO:0800438 developmental delay with short stature, dysmorphic facial features, and sparse hair 1 0.006401957836157258 0.197316\n",
      "MONDO:0014646 Zimmermann-Laband syndrome 2 0.006401957836157258 0.197316\n",
      "MONDO:0014787 severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0013252 Warsaw breakage syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0009665 biotinidase deficiency 0.006401957836157258 0.197316\n",
      "MONDO:0012077 amyotrophic lateral sclerosis type 8 0.006401957836157258 0.197316\n",
      "MONDO:0029134 severe combined immunodeficiency due to CARMIL2 deficiency 0.006401957836157258 0.197316\n",
      "MONDO:0012239 congenital myopathy 4B, autosomal recessive 0.006401957836157258 0.197316\n",
      "MONDO:0011600 congenital myasthenic syndrome 4A 0.006401957836157258 0.197316\n",
      "MONDO:0011663 juvenile primary lateral sclerosis 0.006401957836157258 0.197316\n",
      "MONDO:0030927 myofibrillar myopathy 11 0.006401957836157258 0.197316\n",
      "MONDO:0012789 dystonia 16 0.006401957836157258 0.197316\n",
      "MONDO:0044696 early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome 0.006401957836157258 0.197316\n",
      "MONDO:0032849 neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and structural brain anomalies 0.006401957836157258 0.197316\n",
      "MONDO:0030979 endove syndrome, limb-brain type 0.006777264668255051 0.195364\n",
      "MONDO:0010271 X-linked myotubular myopathy-abnormal genitalia syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0013560 Hermansky-Pudlak syndrome 8 0.006777264668255051 0.195364\n",
      "MONDO:0013599 autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0032803 immunodeficiency 64 0.006777264668255051 0.195364\n",
      "MONDO:0032799 mitochondrial DNA depletion syndrome 16 (hepatic type) 0.006777264668255051 0.195364\n",
      "MONDO:0012393 congenital brain dysgenesis due to glutamine synthetase deficiency 0.006777264668255051 0.195364\n",
      "MONDO:0010044 hereditary spastic paraplegia 15 0.006777264668255051 0.195364\n",
      "MONDO:0957217 cortical dysplasia, complex, with other brain malformations 12 0.006777264668255051 0.195364\n",
      "MONDO:0015350 17q11.2 microduplication syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0011287 craniosynostosis-anal anomalies-porokeratosis syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0032691 Galloway-Mowat syndrome 6 0.006777264668255051 0.195364\n",
      "MONDO:0859569 braddock-carey syndrome 1 0.006777264668255051 0.195364\n",
      "MONDO:0014813 hypomyelinating leukodystrophy 13 0.006777264668255051 0.195364\n",
      "MONDO:0014238 severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0012698 Waardenburg syndrome type 2E 0.006777264668255051 0.195364\n",
      "MONDO:0014767 Seckel syndrome 9 0.006777264668255051 0.195364\n",
      "MONDO:0013005 EAST syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0007999 holoprosencephaly 2 0.006777264668255051 0.195364\n",
      "MONDO:0014356 mitochondrial complex III deficiency nuclear type 7 0.006777264668255051 0.195364\n",
      "MONDO:0012241 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3 0.006777264668255051 0.195364\n",
      "MONDO:0009073 Ritscher-Schinzel syndrome 1 0.006777264668255051 0.195364\n",
      "MONDO:0009723 Leigh syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0032786 Noonan syndrome 11 0.006777264668255051 0.195364\n",
      "MONDO:0009612 methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency 0.006777264668255051 0.195364\n",
      "MONDO:0011724 encephalopathy due to GLUT1 deficiency 0.006777264668255051 0.195364\n",
      "MONDO:0032916 Imagawa-Matsumoto syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0008862 3-methylcrotonyl-CoA carboxylase 2 deficiency 0.006777264668255051 0.195364\n",
      "MONDO:0013566 Fanconi anemia complementation group L 0.006777264668255051 0.195364\n",
      "MONDO:0013158 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6 0.006777264668255051 0.195364\n",
      "MONDO:0009655 mucopolysaccharidosis type 3A 0.006777264668255051 0.195364\n",
      "MONDO:0012322 holoprosencephaly 5 0.006777264668255051 0.195364\n",
      "MONDO:0859142 Hiatt-Neu-Cooper neurodevelopmental syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0010079 Canavan disease 0.006777264668255051 0.195364\n",
      "MONDO:0014499 intellectual disability, autosomal recessive 46 0.006777264668255051 0.195364\n",
      "MONDO:0013822 acrodysostosis 2 with or without hormone resistance 0.006777264668255051 0.195364\n",
      "MONDO:0009191 Lowry-Wood syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0032791 Coffin-Siris syndrome 10 0.006777264668255051 0.195364\n",
      "MONDO:0009795 orofaciodigital syndrome IX 0.006777264668255051 0.195364\n",
      "MONDO:0014023 congenital muscular dystrophy with intellectual disability and severe epilepsy 0.006777264668255051 0.195364\n",
      "MONDO:0957221 spastic paraplegia 70, autosomal recessive 0.006777264668255051 0.195364\n",
      "MONDO:0030910 intellectual disability, autosomal dominant 45 0.006777264668255051 0.195364\n",
      "MONDO:0010523 X-linked reticulate pigmentary disorder 0.006777264668255051 0.195364\n",
      "MONDO:0044208 specific granule deficiency 2 0.006777264668255051 0.195364\n",
      "MONDO:0020796 Silver-Russell syndrome 1 0.006777264668255051 0.195364\n",
      "MONDO:0958181 mitochondrial trifunctional protein deficiency 1 0.006777264668255051 0.195364\n",
      "MONDO:0014888 MIRAGE syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0008434 Smith-Magenis syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0014797 lymphatic malformation 6 0.006777264668255051 0.195364\n",
      "MONDO:0012034 autosomal dominant limb-girdle muscular dystrophy type 1F 0.006777264668255051 0.195364\n",
      "MONDO:0011638 neuroferritinopathy 0.006777264668255051 0.195364\n",
      "MONDO:0011088 congenital myasthenic syndrome 1A 0.006777264668255051 0.195364\n",
      "MONDO:0013307 myopathy, lactic acidosis, and sideroblastic anemia 2 0.006777264668255051 0.195364\n",
      "MONDO:0009568 mast syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0014233 early-onset Parkinson disease 20 0.006777264668255051 0.195364\n",
      "MONDO:0007316 Chiari malformation type I 0.006777264668255051 0.195364\n",
      "MONDO:0011632 amyotrophic lateral sclerosis type 21 0.006777264668255051 0.195364\n",
      "MONDO:0032706 spinocerebellar ataxia, autosomal recessive 27 0.006777264668255051 0.195364\n",
      "MONDO:0031002 Baralle-Macken syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0009572 autosomal recessive familial Mediterranean fever 0.0071524297375753 0.193531\n",
      "MONDO:0009218 Farber lipogranulomatosis 0.0071524297375753 0.193531\n",
      "MONDO:0007160 Stickler syndrome type 1 0.0071524297375753 0.193531\n",
      "MONDO:0859202 developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities 0.0071524297375753 0.193531\n",
      "MONDO:0013014 spondyloepimetaphyseal dysplasia, aggrecan type 0.0071524297375753 0.193531\n",
      "MONDO:0013428 Meier-Gorlin syndrome 2 0.0071524297375753 0.193531\n",
      "MONDO:0013590 Stickler syndrome, type 4 0.0071524297375753 0.193531\n",
      "MONDO:0014544 osteogenesis imperfecta type 16 0.0071524297375753 0.193531\n",
      "MONDO:0014672 osteogenesis imperfecta type 17 0.0071524297375753 0.193531\n",
      "MONDO:0056797 neurodevelopmental disorder with midbrain and hindbrain malformations 0.0071524297375753 0.193531\n",
      "MONDO:0009914 pseudodiastrophic dysplasia 0.0071524297375753 0.193531\n",
      "MONDO:0014039 mitochondrial DNA depletion syndrome 11 0.0071524297375753 0.193531\n",
      "MONDO:0014335 diffuse cerebral and cerebellar atrophy - intractable seizures - progressive microcephaly syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0013835 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7 0.0071524297375753 0.193531\n",
      "MONDO:0032893 pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures 0.0071524297375753 0.193531\n",
      "MONDO:0034106 developmental and epileptic encephalopathy, 73 0.0071524297375753 0.193531\n",
      "MONDO:0013787 psychomotor retardation, epilepsy, and craniofacial dysmorphism 0.0071524297375753 0.193531\n",
      "MONDO:0032661 neurodevelopmental disorder with impaired intellectual development, hypotonia, and ataxia 0.0071524297375753 0.193531\n",
      "MONDO:0018130 brain dopamine-serotonin vesicular transport disease 0.0071524297375753 0.193531\n",
      "MONDO:0032692 Galloway-Mowat syndrome 7 0.0071524297375753 0.193531\n",
      "MONDO:0024538 basal ganglia calcification, idiopathic, 1 0.0071524297375753 0.193531\n",
      "MONDO:0009959 peroxisome biogenesis disorder type 3B 0.0071524297375753 0.193531\n",
      "MONDO:0008943 autosomal recessive spinocerebellar ataxia 2 0.0071524297375753 0.193531\n",
      "MONDO:0009614 methylmalonic aciduria, cblB type 0.0071524297375753 0.193531\n",
      "MONDO:0014731 seizures-scoliosis-macrocephaly syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0957288 intellectual developmental disorder, autosomal recessive 79 0.0071524297375753 0.193531\n",
      "MONDO:0012073 ribose-5-P isomerase deficiency 0.0071524297375753 0.193531\n",
      "MONDO:0859356 congenital disorder of glycosylation, type IIy 0.0071524297375753 0.193531\n",
      "MONDO:0012783 RFT1-congenital disorder of glycosylation 0.0071524297375753 0.193531\n",
      "MONDO:0013853 pontocerebellar hypoplasia type 1B 0.0071524297375753 0.193531\n",
      "MONDO:0010774 striatonigral degeneration, infantile, mitochondrial 0.0071524297375753 0.193531\n",
      "MONDO:0009281 glutaryl-CoA dehydrogenase deficiency 0.0071524297375753 0.193531\n",
      "MONDO:0030031 lissencephaly 10 0.0071524297375753 0.193531\n",
      "MONDO:0018274 GM3 synthase deficiency 0.0071524297375753 0.193531\n",
      "MONDO:0010412 X-linked intellectual disability-craniofacioskeletal syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0009352 classic homocystinuria 0.0071524297375753 0.193531\n",
      "MONDO:0044306 neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination 0.0071524297375753 0.193531\n",
      "MONDO:0012514 hypomyelinating leukodystrophy 5 0.0071524297375753 0.193531\n",
      "MONDO:0009843 hypomyelinating leukodystrophy 3 0.0071524297375753 0.193531\n",
      "MONDO:0030947 neurodegeneration, childhood-onset, with hypotonia, respiratory insufficiency, and brain imaging abnormalities 0.0071524297375753 0.193531\n",
      "MONDO:0859564 epilepsy, X-linked 2, with or without impaired intellectual development and dysmorphic features 0.0071524297375753 0.193531\n",
      "MONDO:0024465 surfactant metabolism dysfunction, pulmonary, 2 0.0071524297375753 0.193531\n",
      "MONDO:0014185 chromosome 3q13.31 deletion syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0859243 neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities 0.0071524297375753 0.193531\n",
      "MONDO:0032888 neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies 0.0071524297375753 0.193531\n",
      "MONDO:0013594 spinocerebellar ataxia type 36 0.0071524297375753 0.193531\n",
      "MONDO:0023671 oculopharyngodistal myopathy 3 0.0071524297375753 0.193531\n",
      "MONDO:0010578 deafness dystonia syndrome 0.0071524297375753 0.193531\n",
      "MONDO:0008152 multicentric carpo-tarsal osteolysis with or without nephropathy 0.0071524297375753 0.193531\n",
      "MONDO:0007064 severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency 0.007527453097665351 0.191805\n",
      "MONDO:0009499 Krabbe disease 0.007527453097665351 0.191805\n",
      "MONDO:0013627 3M syndrome 3 0.007527453097665351 0.191805\n",
      "MONDO:0009712 congenital multicore myopathy with external ophthalmoplegia 0.007527453097665351 0.191805\n",
      "MONDO:0013719 cranioectodermal dysplasia 4 0.007527453097665351 0.191805\n",
      "MONDO:0013573 cranioectodermal dysplasia 3 0.007527453097665351 0.191805\n",
      "MONDO:0032798 ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features 0.007527453097665351 0.191805\n",
      "MONDO:0008948 cerebrotendinous xanthomatosis 0.007527453097665351 0.191805\n",
      "MONDO:0010797 Pearson syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0010495 trichothiodystrophy 5, nonphotosensitive 0.007527453097665351 0.191805\n",
      "MONDO:0012812 developmental and epileptic encephalopathy, 4 0.007527453097665351 0.191805\n",
      "MONDO:0014726 Charcot-Marie-Tooth disease axonal type 2X 0.007527453097665351 0.191805\n",
      "MONDO:0026724 Paganini-Miozzo syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0011504 NDE1-related microhydranencephaly 0.007527453097665351 0.191805\n",
      "MONDO:0009260 GM1 gangliosidosis type 1 0.007527453097665351 0.191805\n",
      "MONDO:0054748 Fanconi anemia, complementation group S 0.007527453097665351 0.191805\n",
      "MONDO:0011628 propionic acidemia 0.007527453097665351 0.191805\n",
      "MONDO:0011402 congenital cataracts-facial dysmorphism-neuropathy syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0014067 short ulna-dysmorphism-hypotonia-intellectual disability syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0014221 triosephosphate isomerase deficiency 0.007527453097665351 0.191805\n",
      "MONDO:0010224 corpus callosum agenesis-abnormal genitalia syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0008815 argininosuccinic aciduria 0.007527453097665351 0.191805\n",
      "MONDO:0859337 combined oxidative phosphorylation deficiency 57 0.007527453097665351 0.191805\n",
      "MONDO:0014503 autosomal recessive spinocerebellar ataxia 17 0.007527453097665351 0.191805\n",
      "MONDO:0009567 Marinesco-Sjogren syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0014981 immunodeficiency 49 0.007527453097665351 0.191805\n",
      "MONDO:0032702 Coffin-Siris syndrome 8 0.007527453097665351 0.191805\n",
      "MONDO:0010613 inborn glycerol kinase deficiency 0.007527453097665351 0.191805\n",
      "MONDO:0009653 mucolipidosis type IV 0.007527453097665351 0.191805\n",
      "MONDO:0010848 spinocerebellar ataxia type 5 0.007527453097665351 0.191805\n",
      "MONDO:0100095 neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures 0.007527453097665351 0.191805\n",
      "MONDO:0014663 Silver-Russell syndrome 3 0.007527453097665351 0.191805\n",
      "MONDO:0013501 frontotemporal dementia and/or amyotrophic lateral sclerosis 6 0.007527453097665351 0.191805\n",
      "MONDO:0011330 spinocerebellar ataxia type 10 0.007527453097665351 0.191805\n",
      "MONDO:0800341 congenital myopathy 4A, autosomal dominant 0.007527453097665351 0.191805\n",
      "MONDO:0020765 neuropathy, congenital hypomyelinating, 2 0.007527453097665351 0.191805\n",
      "MONDO:0012301 mitochondrial DNA depletion syndrome, myopathic form 0.007527453097665351 0.191805\n",
      "MONDO:0859251 Dentici-Novelli neurodevelopmental syndrome 0.007527453097665351 0.191805\n",
      "MONDO:0032876 neurodevelopmental disorder with absent language and variable seizures 0.007902334802052331 0.190174\n",
      "MONDO:0013754 cutis laxa, autosomal recessive, type 1B 0.007902334802052331 0.190174\n",
      "MONDO:0010516 midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis 0.007902334802052331 0.190174\n",
      "MONDO:0020684 Ehlers-Danlos syndrome, periodontal type 1 0.007902334802052331 0.190174\n",
      "MONDO:0011125 trichothiodystrophy 1, photosensitive 0.007902334802052331 0.190174\n",
      "MONDO:0013737 hereditary spastic paraplegia 46 0.007902334802052331 0.190174\n",
      "MONDO:0012191 hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 0.007902334802052331 0.190174\n",
      "MONDO:0859327 developmental and epileptic encephalopathy 110 0.007902334802052331 0.190174\n",
      "MONDO:0014688 short-rib thoracic dysplasia 14 with polydactyly 0.007902334802052331 0.190174\n",
      "MONDO:0030057 neurodevelopmental, jaw, eye, and digital syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0020647 microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0008822 arthrogryposis, renal dysfunction, and cholestasis 1 0.007902334802052331 0.190174\n",
      "MONDO:0010027 free sialic acid storage disease, infantile form 0.007902334802052331 0.190174\n",
      "MONDO:0014617 intellectual disability, autosomal dominant 38 0.007902334802052331 0.190174\n",
      "MONDO:0859188 neurodevelopmental disorder with seizures and brain abnormalities 0.007902334802052331 0.190174\n",
      "MONDO:0032774 cerebellar, ocular, craniofacial, and genital syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0013801 developmental and epileptic encephalopathy, 13 0.007902334802052331 0.190174\n",
      "MONDO:0007298 spinocerebellar ataxia type 29 0.007902334802052331 0.190174\n",
      "MONDO:0010543 Barth syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0054591 Stankiewicz-Isidor syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0012125 hypomyelinating leukodystrophy 2 0.007902334802052331 0.190174\n",
      "MONDO:0013937 peroxisome biogenesis disorder 6B 0.007902334802052331 0.190174\n",
      "MONDO:0012516 mandibulofacial dysostosis-microcephaly syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0859304 neurodegeneration, childhood-onset, with multisystem involvement due to mitochondrial dysfunction 0.007902334802052331 0.190174\n",
      "MONDO:0014946 Sifrim-Hitz-Weiss syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0012563 holoprosencephaly 9 0.007902334802052331 0.190174\n",
      "MONDO:0013675 multiple mitochondrial dysfunctions syndrome 2 0.007902334802052331 0.190174\n",
      "MONDO:0859164 osteootohepatoenteric syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0957397 intellectual developmental disorder, autosomal dominant 72 0.007902334802052331 0.190174\n",
      "MONDO:0859218 developmental delay with variable neurologic and brain abnormalities 0.007902334802052331 0.190174\n",
      "MONDO:0013053 microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type 0.007902334802052331 0.190174\n",
      "MONDO:0024554 D-2-hydroxyglutaric aciduria 1 0.007902334802052331 0.190174\n",
      "MONDO:0013635 Adams-Oliver syndrome 2 0.007902334802052331 0.190174\n",
      "MONDO:0014708 ring chromosome 14 0.007902334802052331 0.190174\n",
      "MONDO:0014636 combined oxidative phosphorylation defect type 25 0.007902334802052331 0.190174\n",
      "MONDO:0032758 neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia 0.007902334802052331 0.190174\n",
      "MONDO:0030423 congenital disorder of glycosylation, type 2v 0.007902334802052331 0.190174\n",
      "MONDO:0009965 Perlman syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0032775 neurodevelopmental disorder with seizures and speech and walking impairment 0.007902334802052331 0.190174\n",
      "MONDO:0850514 inclusion body myopathy and brain white matter abnormalities 0.007902334802052331 0.190174\n",
      "MONDO:0011281 congenital myasthenic syndrome 5 0.007902334802052331 0.190174\n",
      "MONDO:0012157 congenital myasthenic syndrome 4C 0.007902334802052331 0.190174\n",
      "MONDO:0012444 neurodegeneration with brain iron accumulation 2B 0.007902334802052331 0.190174\n",
      "MONDO:0030341 myasthenic syndrome, congenital, 7B, presynaptic, autosomal recessive 0.007902334802052331 0.190174\n",
      "MONDO:0011038 cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome 0.007902334802052331 0.190174\n",
      "MONDO:0013731 MEGF10-related myopathy 0.007902334802052331 0.190174\n",
      "MONDO:0012130 myofibrillar myopathy 2 0.007902334802052331 0.190174\n",
      "MONDO:0859282 neurodevelopmental disorder with microcephaly, movement abnormalities, and seizures 0.007902334802052331 0.190174\n",
      "MONDO:0009131 Riley-Day syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0009904 Gitelman syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0009599 metaphyseal dysostosis-intellectual disability-conductive deafness syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0007525 Ehlers-Danlos syndrome, arthrochalasis type 0.008277074904243129 0.18863\n",
      "MONDO:0009820 osteoporosis-pseudoglioma syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0020769 Menke-Hennekam syndrome 2 0.008277074904243129 0.18863\n",
      "MONDO:0011002 neuropathy, hereditary motor and sensory, type 6A 0.008277074904243129 0.18863\n",
      "MONDO:0035819 cerebellar hypoplasia-intellectual disability-congenital microcephaly-dystonia-anemia-growth retardation syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0044312 immunoskeletal dysplasia with neurodevelopmental abnormalities 0.008277074904243129 0.18863\n",
      "MONDO:0032566 squalene synthase deficiency 0.008277074904243129 0.18863\n",
      "MONDO:0013885 Malan overgrowth syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0008267 orofaciodigital syndrome V 0.008277074904243129 0.18863\n",
      "MONDO:0013432 Meier-Gorlin syndrome 5 0.008277074904243129 0.18863\n",
      "MONDO:0032934 genitourinary and/or brain malformation syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0034145 oculocerebrodental syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0024542 cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 0.008277074904243129 0.18863\n",
      "MONDO:0010281 Danon disease 0.008277074904243129 0.18863\n",
      "MONDO:0012371 Noonan syndrome 3 0.008277074904243129 0.18863\n",
      "MONDO:0009070 D-glyceric aciduria 0.008277074904243129 0.18863\n",
      "MONDO:0014017 intellectual developmental disorder with autism and macrocephaly 0.008277074904243129 0.18863\n",
      "MONDO:0010499 Ritscher-Schinzel syndrome 2 0.008277074904243129 0.18863\n",
      "MONDO:0032795 intellectual developmental disorder 59 0.008277074904243129 0.18863\n",
      "MONDO:0044303 congenital heart defects and ectodermal dysplasia 0.008277074904243129 0.18863\n",
      "MONDO:0032793 O'Donnell-Luria-Rodan syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0014609 cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0008214 Pelger-Huet anomaly 0.008277074904243129 0.18863\n",
      "MONDO:0013546 mitochondrial complex V (ATP synthase) deficiency nuclear type 2 0.008277074904243129 0.18863\n",
      "MONDO:0011833 spinocerebellar ataxia type 21 0.008277074904243129 0.18863\n",
      "MONDO:0013761 childhood encephalopathy due to thiamine pyrophosphokinase deficiency 0.008277074904243129 0.18863\n",
      "MONDO:0009033 temtamy syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0009744 neuronal ceroid lipofuscinosis 1 0.008277074904243129 0.18863\n",
      "MONDO:0859198 short stature, impaired intellectual development, microcephaly, hypotonia, and ocular anomalies 0.008277074904243129 0.18863\n",
      "MONDO:0009470 Baraitser-Winter syndrome 1 0.008277074904243129 0.18863\n",
      "MONDO:0014573 Cole-Carpenter syndrome 2 0.008277074904243129 0.18863\n",
      "MONDO:0859155 chromosome 1p36 deletion syndrome, proximal 0.008277074904243129 0.18863\n",
      "MONDO:0859350 neurodevelopmental disorder with poor growth, large ears, and dysmorphic facies 0.008277074904243129 0.18863\n",
      "MONDO:0013880 facial paresis, hereditary congenital, 3 0.008277074904243129 0.18863\n",
      "MONDO:0008858 Behr syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0032821 myopathy, congenital, progressive, with scoliosis 0.008277074904243129 0.18863\n",
      "MONDO:0012156 myasthenic syndrome, congenital, 1B, fast-channel 0.008277074904243129 0.18863\n",
      "MONDO:0012750 lethal arthrogryposis-anterior horn cell disease syndrome 0.008277074904243129 0.18863\n",
      "MONDO:0009583 blepharophimosis - intellectual disability syndrome, Ohdo type 0.008651673457724452 0.187163\n",
      "MONDO:0010496 X-linked intellectual disability-short stature-overweight syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0011252 spondyloepimetaphyseal dysplasia, Shohat type 0.008651673457724452 0.187163\n",
      "MONDO:0859151 fibromuscular dysplasia, multifocal 0.008651673457724452 0.187163\n",
      "MONDO:0032703 short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis 0.008651673457724452 0.187163\n",
      "MONDO:0020738 multiple benign circumferential skin creases on limbs 1 0.008651673457724452 0.187163\n",
      "MONDO:0032829 neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities 0.008651673457724452 0.187163\n",
      "MONDO:0060578 neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures 0.008651673457724452 0.187163\n",
      "MONDO:0012084 aromatic L-amino acid decarboxylase deficiency 0.008651673457724452 0.187163\n",
      "MONDO:0009598 metaphyseal chondrodysplasia-retinitis pigmentosa syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0014931 Alazami-Yuan syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0859230 Kury-Isidor syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0014289 macrocephaly-developmental delay syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0010083 succinic semialdehyde dehydrogenase deficiency 0.008651673457724452 0.187163\n",
      "MONDO:0012735 Temple-Baraitser syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0029143 intellectual developmental disorder with hypertelorism and distinctive facies 0.008651673457724452 0.187163\n",
      "MONDO:0859375 developmental delay with hypotonia, myopathy, and brain abnormalities 0.008651673457724452 0.187163\n",
      "MONDO:0011274 Muenke syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0015005 epilepsy, early-onset, vitamin B6-dependent 0.008651673457724452 0.187163\n",
      "MONDO:0012999 guanidinoacetate methyltransferase deficiency 0.008651673457724452 0.187163\n",
      "MONDO:0032742 encephalopathy, acute, infection-induced, susceptibility to, 9 0.008651673457724452 0.187163\n",
      "MONDO:0013882 hyperphosphatasia with intellectual disability syndrome 2 0.008651673457724452 0.187163\n",
      "MONDO:0032571 spondyloepimetaphyseal dysplasia, Krakow type 0.008651673457724452 0.187163\n",
      "MONDO:0030886 holoprosencephaly 14 0.008651673457724452 0.187163\n",
      "MONDO:0011049 Fine-Lubinsky syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0014693 Noonan syndrome 10 0.008651673457724452 0.187163\n",
      "MONDO:0012076 midface hypoplasia, obesity, developmental delay, and neonatal hypotonia 0.008651673457724452 0.187163\n",
      "MONDO:0013925 methylmalonic acidemia with homocystinuria, type cblJ 0.008651673457724452 0.187163\n",
      "MONDO:0009495 Keutel syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0015007 spastic paraplegia, intellectual disability, nystagmus, and obesity 0.008651673457724452 0.187163\n",
      "MONDO:0012184 Pierson syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0859531 neurodevelopmental disorder with language delay and behavioral abnormalities, with or without seizures 0.008651673457724452 0.187163\n",
      "MONDO:0859214 Marbach-Schaaf neurodevelopmental syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0009821 lethal osteosclerotic bone dysplasia 0.008651673457724452 0.187163\n",
      "MONDO:0014791 Luscan-Lumish syndrome 0.008651673457724452 0.187163\n",
      "MONDO:0030957 developmental and epileptic encephalopathy 103 0.008651673457724452 0.187163\n",
      "MONDO:0010060 mitochondrial DNA depletion syndrome 7 (hepatocerebral type) 0.008651673457724452 0.187163\n",
      "MONDO:0013897 Loeys-Dietz syndrome 4 0.009026130515962775 0.185767\n",
      "MONDO:0014236 Ehlers-Danlos syndrome, musculocontractural type 2 0.009026130515962775 0.185767\n",
      "MONDO:0008608 Down syndrome 0.009026130515962775 0.185767\n",
      "MONDO:0010515 Meester-Loeys syndrome 0.009026130515962775 0.185767\n",
      "MONDO:0030337 cutis laxa, autosomal recessive, type 2E 0.009026130515962775 0.185767\n",
      "MONDO:0008644 velocardiofacial syndrome 0.009026130515962775 0.185767\n",
      "MONDO:0009517 Donohue syndrome 0.009026130515962775 0.185767\n",
      "MONDO:0010822 Warburg micro syndrome 1 0.009026130515962775 0.185767\n",
      "MONDO:0032816 neurodevelopmental disorder with ataxia, hypotonia, and microcephaly 0.009026130515962775 0.185767\n",
      "MONDO:0032921 neurodevelopmental disorder with hypotonia, neonatal respiratory insufficiency, and thermodysregulation 0.009026130515962775 0.185767\n",
      "MONDO:0020495 PEHO-like syndrome 0.009026130515962775 0.185767\n",
      "MONDO:0030852 neurodevelopmental disorder with dysmorphic facies, sleep disturbance, and brain abnormalities 0.009026130515962775 0.185767\n",
      "MONDO:0024567 hypotonia, infantile, with psychomotor retardation and characteristic facies 1 0.009026130515962775 0.185767\n",
      "MONDO:0010626 hyper-IgM syndrome type 1 0.009026130515962775 0.185767\n",
      "MONDO:0014918 tall stature-intellectual disability-renal anomalies syndrome 0.009026130515962775 0.185767\n",
      "MONDO:0033642 neurodevelopmental disorder with alopecia and brain abnormalities 0.009026130515962775 0.185767\n",
      "MONDO:0032939 intellectual developmental disorder, autosomal dominant 63, with macrocephaly 0.009026130515962775 0.185767\n",
      "MONDO:0032854 zimmermann-laband syndrome 3 0.009026130515962775 0.185767\n",
      "MONDO:0014743 rhizomelic chondrodysplasia punctata type 5 0.009026130515962775 0.185767\n",
      "MONDO:0009216 glycogen storage disease due to GLUT2 deficiency 0.009026130515962775 0.185767\n",
      "MONDO:0014006 Schuurs-Hoeijmakers syndrome 0.009026130515962775 0.185767\n",
      "MONDO:0009613 methylmalonic aciduria, cblA type 0.009026130515962775 0.185767\n",
      "MONDO:0010088 mucosulfatidosis 0.009026130515962775 0.185767\n",
      "MONDO:0009109 lysinuric protein intolerance 0.009026130515962775 0.185767\n",
      "MONDO:0009974 familial hemophagocytic lymphohistiocytosis type 1 0.009026130515962775 0.185767\n",
      "MONDO:0014741 DeSanto-Shinawi syndrome due to WAC point mutation 0.009026130515962775 0.185767\n",
      "MONDO:0100294 mitochondrial complex II deficiency, nuclear type 1 0.009026130515962775 0.185767\n",
      "MONDO:0010089 isolated sulfite oxidase deficiency 0.009026130515962775 0.185767\n",
      "MONDO:0013784 neonatal-onset encephalopathy with rigidity and seizures 0.009026130515962775 0.185767\n",
      "MONDO:0024457 neurodegeneration with brain iron accumulation 2A 0.009026130515962775 0.185767\n",
      "MONDO:0012929 Compton-North congenital myopathy 0.009026130515962775 0.185767\n",
      "MONDO:0060549 congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay 0.009026130515962775 0.185767\n",
      "MONDO:0030458 Charcot-Marie-Tooth disease, axonal, Type 2HH 0.009026130515962775 0.185767\n",
      "MONDO:0800027 leukoencephalopathy, diffuse hereditary, with spheroids 1 0.009026130515962775 0.185767\n",
      "MONDO:0018996 spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 0.009026130515962775 0.185767\n",
      "MONDO:0009261 GM1 gangliosidosis type 2 0.009026130515962775 0.185767\n",
      "MONDO:0012278 supranuclear palsy, progressive, 2 0.009026130515962775 0.185767\n",
      "MONDO:0011781 spinocerebellar ataxia type 17 0.009026130515962775 0.185767\n",
      "MONDO:0010091 Cold-induced sweating syndrome 1 0.009400446132404395 0.184436\n",
      "MONDO:0011405 poikiloderma with neutropenia 0.009400446132404395 0.184436\n",
      "MONDO:0014541 motor developmental delay due to 14q32.2 paternally expressed gene defect 0.009400446132404395 0.184436\n",
      "MONDO:0032926 sandestig-stefanova syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0011359 acromelic frontonasal dysostosis 0.009400446132404395 0.184436\n",
      "MONDO:0020789 pseudo-TORCH syndrome 1 0.009400446132404395 0.184436\n",
      "MONDO:0032698 neurodevelopmental disorder with central and peripheral motor dysfunction 0.009400446132404395 0.184436\n",
      "MONDO:0060596 neurodevelopmental disorder with dysmorphic facies and distal limb anomalies 0.009400446132404395 0.184436\n",
      "MONDO:0044726 psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0957210 neurooculorenal syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0012593 brain-lung-thyroid syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0007800 chromosome 18p deletion syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0014382 Tatton-Brown-Rahman overgrowth syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0010970 cardiac malformation, cleft lip/palate, microcephaly, and digital anomalies 0.009400446132404395 0.184436\n",
      "MONDO:0007804 Pallister-Hall syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0011035 neurofibromatosis-Noonan syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0014529 cerebellar-facial-dental syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0044634 retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0010217 de Sanctis-Cacchione syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0859161 onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0032679 combined oxidative phosphorylation deficiency 37 0.009400446132404395 0.184436\n",
      "MONDO:0012690 Noonan syndrome 5 0.009400446132404395 0.184436\n",
      "MONDO:0011669 hypotonia-cystinuria syndrome 0.009400446132404395 0.184436\n",
      "MONDO:0011582 multiple mitochondrial dysfunctions syndrome 1 0.009400446132404395 0.184436\n",
      "MONDO:0030893 leukoencephalopathy, progressive, infantile-onset, with or without deafness 0.009400446132404395 0.184436\n",
      "MONDO:0009919 peroxisomal acyl-CoA oxidase deficiency 0.009400446132404395 0.184436\n",
      "MONDO:0030323 spinocerebellar ataxia, autosomal recessive 31 0.009400446132404395 0.184436\n",
      "MONDO:0030268 developmental and epileptic encephalopathy 6B 0.009400446132404395 0.184436\n",
      "MONDO:0011106 facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome 0.00977462036047542 0.183165\n",
      "MONDO:0010645 oculocerebrorenal syndrome 0.00977462036047542 0.183165\n",
      "MONDO:0013646 chromosome 8q21.11 deletion syndrome 0.00977462036047542 0.183165\n",
      "MONDO:0032895 developmental and epileptic encephalopathy, 83 0.00977462036047542 0.183165\n",
      "MONDO:0014915 short-rib thoracic dysplasia 16 with or without polydactyly 0.00977462036047542 0.183165\n",
      "MONDO:0032836 weiss-kruszka syndrome 0.00977462036047542 0.183165\n",
      "MONDO:0009214 Fanconi anemia complementation group D2 0.00977462036047542 0.183165\n",
      "MONDO:0013320 chromosome 16p12.2-p11.2 deletion syndrome 0.00977462036047542 0.183165\n",
      "MONDO:0012117 ALG9-congenital disorder of glycosylation 0.00977462036047542 0.183165\n",
      "MONDO:0014995 neurodevelopmental disorder with hypotonia, seizures, and absent language 0.00977462036047542 0.183165\n",
      "MONDO:0014686 short stature, microcephaly, and endocrine dysfunction 0.00977462036047542 0.183165\n",
      "MONDO:0009480 Joubert syndrome with oculorenal defect 0.00977462036047542 0.183165\n",
      "MONDO:0007838 Jacobsen syndrome 0.00977462036047542 0.183165\n",
      "MONDO:0010881 mesomelia-synostoses syndrome 0.00977462036047542 0.183165\n",
      "MONDO:0013319 chromosome 4Q32.1-q32.2 triplication syndrome 0.00977462036047542 0.183165\n",
      "MONDO:0032846 osteogenesis imperfecta, type 20 0.00977462036047542 0.183165\n",
      "MONDO:0013951 peroxisome biogenesis disorder 12A (Zellweger) 0.00977462036047542 0.183165\n",
      "MONDO:0008919 systemic primary carnitine deficiency disease 0.00977462036047542 0.183165\n",
      "MONDO:0859325 developmental and epileptic encephalopathy 109 0.00977462036047542 0.183165\n",
      "MONDO:0010717 pyruvate dehydrogenase E1-alpha deficiency 0.00977462036047542 0.183165\n",
      "MONDO:0009398 hyperphosphatasia with intellectual disability syndrome 1 0.00977462036047542 0.183165\n",
      "MONDO:0044724 3-methylglutaconic aciduria type 9 0.00977462036047542 0.183165\n",
      "MONDO:0009068 cytochrome-c oxidase deficiency disease 0.00977462036047542 0.183165\n",
      "MONDO:0013924 osteogenesis imperfecta type 13 0.01014865325358177 0.181948\n",
      "MONDO:0007875 Larsen syndrome 0.01014865325358177 0.181948\n",
      "MONDO:0032688 polymicrogyria with or without vascular-type Ehlers-Danlos syndrome 0.01014865325358177 0.181948\n",
      "MONDO:0024553 myopathy, lactic acidosis, and sideroblastic anemia 1 0.01014865325358177 0.181948\n",
      "MONDO:0008963 Chediak-Higashi syndrome 0.01014865325358177 0.181948\n",
      "MONDO:0030356 short-rib thoracic dysplasia 21 without polydactyly 0.01014865325358177 0.181948\n",
      "MONDO:0859141 neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia 0.01014865325358177 0.181948\n",
      "MONDO:0027451 autosomal recessive cutis laxa type 2D 0.01014865325358177 0.181948\n",
      "MONDO:0008854 Bardet-Biedl syndrome 1 0.01014865325358177 0.181948\n",
      "MONDO:8000012 neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1 0.01014865325358177 0.181948\n",
      "MONDO:0032800 robinow syndrome, autosomal recessive 2 0.01014865325358177 0.181948\n",
      "MONDO:0011531 Noonan syndrome 2 0.01014865325358177 0.181948\n",
      "MONDO:0010865 pseudoaminopterin syndrome 0.01014865325358177 0.181948\n",
      "MONDO:0010711 TARP syndrome 0.01014865325358177 0.181948\n",
      "MONDO:0013572 Keppen-Lubinsky syndrome 0.01014865325358177 0.181948\n",
      "MONDO:0011157 Gomez-Lopez-Hernandez syndrome 0.01014865325358177 0.181948\n",
      "MONDO:0011730 fumaric aciduria 0.01014865325358177 0.181948\n",
      "MONDO:0008872 microcephalic osteodysplastic primordial dwarfism type II 0.01014865325358177 0.181948\n",
      "MONDO:0020630 epileptic encephalopathy, infantile or early childhood, 1 0.01014865325358177 0.181948\n",
      "MONDO:0009269 geleophysic dysplasia 1 0.01014865325358177 0.181948\n",
      "MONDO:0012512 fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 0.01014865325358177 0.181948\n",
      "MONDO:0013968 PGM1-congenital disorder of glycosylation 0.01014865325358177 0.181948\n",
      "MONDO:0032942 neurodevelopmental disorder with microcephaly and dysmorphic facies 0.01014865325358177 0.181948\n",
      "MONDO:0011217 desmosterolosis 0.01014865325358177 0.181948\n",
      "MONDO:0020781 encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1 0.01014865325358177 0.181948\n",
      "MONDO:0032890 neuromuscular disease and ocular or auditory anomalies with or without seizures 0.01014865325358177 0.181948\n",
      "MONDO:0010998 ALG3-congenital disorder of glycosylation 0.01014865325358177 0.181948\n",
      "MONDO:0030917 intellectual disability, autosomal dominant 51 0.01014865325358177 0.181948\n",
      "MONDO:0009192 Wolcott-Rallison syndrome 0.01014865325358177 0.181948\n",
      "MONDO:0011803 hereditary spastic paraplegia 7 0.01014865325358177 0.181948\n",
      "MONDO:0030770 congenital disorder of deglycosylation 2 0.01014865325358177 0.181948\n",
      "MONDO:0010549 Charcot-Marie-Tooth disease X-linked dominant 1 0.01014865325358177 0.181948\n",
      "MONDO:0019567 Ehlers-Danlos syndrome, classic type, 1 0.01052254486510919 0.180782\n",
      "MONDO:0013115 RIN2 syndrome 0.01052254486510919 0.180782\n",
      "MONDO:0018163 autosomal recessive cutis laxa type 2A 0.01052254486510919 0.180782\n",
      "MONDO:0010117 3M syndrome 1 0.01052254486510919 0.180782\n",
      "MONDO:0011911 craniolenticulosutural dysplasia 0.01052254486510919 0.180782\n",
      "MONDO:0013735 microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome 0.01052254486510919 0.180782\n",
      "MONDO:0009426 hypoparathyroidism-retardation-dysmorphism syndrome 0.01052254486510919 0.180782\n",
      "MONDO:0030030 Nizon-Isidor syndrome 0.01052254486510919 0.180782\n",
      "MONDO:0020766 neuropathy, congenital hypomyelinating, 3 0.01052254486510919 0.180782\n",
      "MONDO:0020749 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 0.01052254486510919 0.180782\n",
      "MONDO:0859179 neurodevelopmental disorder with dysmorphic facies and thin corpus callosum 0.01052254486510919 0.180782\n",
      "MONDO:0014298 chromosome 5q12 deletion syndrome 0.01052254486510919 0.180782\n",
      "MONDO:0033492 Coffin-Siris syndrome 6 0.01052254486510919 0.180782\n",
      "MONDO:0009504 mitochondrial DNA depletion syndrome 9 0.01052254486510919 0.180782\n",
      "MONDO:0010337 X-linked intellectual disability-cerebellar hypoplasia syndrome 0.01052254486510919 0.180782\n",
      "MONDO:0033544 Tolchin-Le Caignec syndrome 0.01052254486510919 0.180782\n",
      "MONDO:0054845 developmental and epileptic encephalopathy, 66 0.01052254486510919 0.180782\n",
      "MONDO:0100344 Bartter disease type 1 0.01052254486510919 0.180782\n",
      "MONDO:0859370 respiratory infections, recurrent, and failure to thrive with or without diarrhea 0.01052254486510919 0.180782\n",
      "MONDO:0019407 microcephalic osteodysplastic dysplasia, Saul-Wilson type 0.01052254486510919 0.180782\n",
      "MONDO:0012554 cerebrooculofacioskeletal syndrome 4 0.01052254486510919 0.180782\n",
      "MONDO:0859226 craniotubular dysplasia, Ikegawa type 0.01052254486510919 0.180782\n",
      "MONDO:0013169 chromosome 5p13 duplication syndrome 0.01052254486510919 0.180782\n",
      "MONDO:0800025 Teebi hypertelorism syndrome 1 0.01052254486510919 0.180782\n",
      "MONDO:0859515 congenital myopathy 10b, mild variant 0.01052254486510919 0.180782\n",
      "MONDO:0859336 muscular dystrophy, congenital, with or without seizures 0.01052254486510919 0.180782\n",
      "MONDO:0007182 Machado-Joseph disease 0.01052254486510919 0.180782\n",
      "MONDO:0008070 nemaline myopathy 3 0.01052254486510919 0.180782\n",
      "MONDO:0859523 congenital myopathy 2c, severe infantile, autosomal dominant 0.01052254486510919 0.180782\n",
      "MONDO:0013266 intellectual disability, autosomal dominant 20 0.01052254486510919 0.180782\n",
      "MONDO:0008840 ataxia telangiectasia 0.01052254486510919 0.180782\n",
      "MONDO:0011933 ALG2-congenital disorder of glycosylation 0.010896295248423277 0.179662\n",
      "MONDO:0010408 syndactyly-telecanthus-anogenital and renal malformations syndrome 0.010896295248423277 0.179662\n",
      "MONDO:0030029 skeletal dysplasia, mild, with joint laxity and advanced bone age 0.010896295248423277 0.179662\n",
      "MONDO:0100325 odontochondrodysplasia 1 0.010896295248423277 0.179662\n",
      "MONDO:0010306 X-linked intellectual disability, Cabezas type 0.010896295248423277 0.179662\n",
      "MONDO:0011275 acromesomelic dysplasia 1, Maroteaux type 0.010896295248423277 0.179662\n",
      "MONDO:0013578 DYRK1A-related intellectual disability syndrome 0.010896295248423277 0.179662\n",
      "MONDO:0032660 spinal muscular atrophy, lower extremity-predominant, 2b, prenatal onset, autosomal dominant 0.010896295248423277 0.179662\n",
      "MONDO:0859377 neurodevelopmental disorder with poor growth and behavioral abnormalities 0.010896295248423277 0.179662\n",
      "MONDO:0030043 congenital disorder of glycosylation, type iit 0.010896295248423277 0.179662\n",
      "MONDO:0011963 Joubert syndrome 2 0.010896295248423277 0.179662\n",
      "MONDO:0026730 Basilicata-Akhtar syndrome 0.010896295248423277 0.179662\n",
      "MONDO:0008365 recombinant 8 syndrome 0.010896295248423277 0.179662\n",
      "MONDO:0010176 orofaciodigital syndrome type 6 0.010896295248423277 0.179662\n",
      "MONDO:0012892 bone fragility with contractures, arterial rupture, and deafness 0.010896295248423277 0.179662\n",
      "MONDO:0013798 chromosome 16q22 deletion syndrome 0.010896295248423277 0.179662\n",
      "MONDO:0012927 chromosome 1q41-q42 deletion syndrome 0.010896295248423277 0.179662\n",
      "MONDO:0012613 intellectual disability, autosomal recessive 5 0.010896295248423277 0.179662\n",
      "MONDO:0014671 neuropathy, hereditary motor and sensory, type 6B 0.010896295248423277 0.179662\n",
      "MONDO:0009577 megalocornea-intellectual disability syndrome 0.010896295248423277 0.179662\n",
      "MONDO:0024537 Brown-Vialetto-van Laere syndrome 1 0.010896295248423277 0.179662\n",
      "MONDO:0011688 muscular dystrophy-dystroglycanopathy type B5 0.010896295248423277 0.179662\n",
      "MONDO:0044714 mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome 0.010896295248423277 0.179662\n",
      "MONDO:0012791 mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria 0.010896295248423277 0.179662\n",
      "MONDO:0008830 aspartylglucosaminuria 0.011269904456869458 0.178586\n",
      "MONDO:0009681 Ullrich congenital muscular dystrophy 1 0.011269904456869458 0.178586\n",
      "MONDO:0014716 macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome 0.011269904456869458 0.178586\n",
      "MONDO:0013364 Rubinstein-Taybi syndrome due to EP300 haploinsufficiency 0.011269904456869458 0.178586\n",
      "MONDO:0030914 Clark-Baraitser syndrome 0.011269904456869458 0.178586\n",
      "MONDO:0010184 methylmalonic aciduria and homocystinuria type cblC 0.011269904456869458 0.178586\n",
      "MONDO:0011451 cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 0.011269904456869458 0.178586\n",
      "MONDO:0010028 sialuria 0.011269904456869458 0.178586\n",
      "MONDO:0030065 agenesis of corpus callosum, cardiac, ocular, and genital syndrome 0.011269904456869458 0.178586\n",
      "MONDO:0010370 Cornelia de Lange syndrome 2 0.011269904456869458 0.178586\n",
      "MONDO:0030837 neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities 0.011269904456869458 0.178586\n",
      "MONDO:0030934 intellectual developmental disorder, autosomal dominant 64 0.011269904456869458 0.178586\n",
      "MONDO:0054581 Townes-Brocks syndrome 1 0.011269904456869458 0.178586\n",
      "MONDO:0957215 congenital myopathy 20 0.011269904456869458 0.178586\n",
      "MONDO:0010886 2q37 microdeletion syndrome 0.011269904456869458 0.178586\n",
      "MONDO:0012869 intellectual disability, autosomal dominant 22 0.011269904456869458 0.178586\n",
      "MONDO:0014963 Shashi-Pena syndrome 0.011269904456869458 0.178586\n",
      "MONDO:0011706 Kufor-Rakeb syndrome 0.011269904456869458 0.178586\n",
      "MONDO:0008458 spinocerebellar ataxia type 2 0.011269904456869458 0.178586\n",
      "MONDO:0010997 supranuclear palsy, progressive, 1 0.011269904456869458 0.178586\n",
      "MONDO:0030457 immunodeficiency 87 and autoimmunity 0.011643372543773012 0.177549\n",
      "MONDO:0013426 aneurysm-osteoarthritis syndrome 0.011643372543773012 0.177549\n",
      "MONDO:0859169 White-Kernohan syndrome 0.011643372543773012 0.177549\n",
      "MONDO:0054813 Ehlers-Danlos syndrome, classic-like, 2 0.011643372543773012 0.177549\n",
      "MONDO:0008818 arterial tortuosity syndrome 0.011643372543773012 0.177549\n",
      "MONDO:0009660 mucopolysaccharidosis type 4B 0.011643372543773012 0.177549\n",
      "MONDO:0027462 autosomal recessive cutis laxa type 2C 0.011643372543773012 0.177549\n",
      "MONDO:0020485 King-Denborough syndrome 0.011643372543773012 0.177549\n",
      "MONDO:0009667 muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 0.011643372543773012 0.177549\n",
      "MONDO:0009520 3-hydroxy-3-methylglutaric aciduria 0.011643372543773012 0.177549\n",
      "MONDO:0014722 Roifman syndrome 0.011643372543773012 0.177549\n",
      "MONDO:0013894 short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome 0.011643372543773012 0.177549\n",
      "MONDO:0009079 DOORS syndrome 0.011643372543773012 0.177549\n",
      "MONDO:0032772 brain abnormalities, neurodegeneration, and dysosteosclerosis 0.011643372543773012 0.177549\n",
      "MONDO:0010574 syndromic X-linked intellectual disability 5 0.011643372543773012 0.177549\n",
      "MONDO:0024528 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1 0.011643372543773012 0.177549\n",
      "MONDO:0020793 oculopharyngodistal myopathy 1 0.011643372543773012 0.177549\n",
      "MONDO:0014063 mitochondrial complex III deficiency nuclear type 2 0.011643372543773012 0.177549\n",
      "MONDO:0010026 SHORT syndrome 0.012016699562439063 0.176551\n",
      "MONDO:0008322 pseudoachondroplasia 0.012016699562439063 0.176551\n",
      "MONDO:0008758 mitochondrial DNA depletion syndrome 4a 0.012016699562439063 0.176551\n",
      "MONDO:0014684 combined oxidative phosphorylation defect type 26 0.012016699562439063 0.176551\n",
      "MONDO:0014367 Aicardi-Goutieres syndrome 7 0.012016699562439063 0.176551\n",
      "MONDO:0009934 alveolar capillary dysplasia with misalignment of pulmonary veins 0.012016699562439063 0.176551\n",
      "MONDO:0013864 Cornelia de Lange syndrome 4 0.012016699562439063 0.176551\n",
      "MONDO:0032838 neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies 0.012016699562439063 0.176551\n",
      "MONDO:0011783 ALG12-congenital disorder of glycosylation 0.012016699562439063 0.176551\n",
      "MONDO:0007110 Diamond-Blackfan anemia 1 0.012016699562439063 0.176551\n",
      "MONDO:0007412 Beare-Stevenson cutis gyrata syndrome 0.012016699562439063 0.176551\n",
      "MONDO:0010653 Renpenning syndrome 0.012016699562439063 0.176551\n",
      "MONDO:0011939 Spondyloenchondrodysplasia with immune dysregulation 0.012016699562439063 0.176551\n",
      "MONDO:0009393 ornithine translocase deficiency 0.012016699562439063 0.176551\n",
      "MONDO:0008893 C syndrome 0.012016699562439063 0.176551\n",
      "MONDO:0015011 optic atrophy 11 0.012016699562439063 0.176551\n",
      "MONDO:0014294 chromosome 15q11.2 deletion syndrome 0.012016699562439063 0.176551\n",
      "MONDO:0011283 mitochondrial DNA depletion syndrome 1 0.012016699562439063 0.176551\n",
      "MONDO:0011945 Gaucher disease perinatal lethal 0.012016699562439063 0.176551\n",
      "MONDO:0957284 nemaline myopathy 5C, autosomal dominant 0.012016699562439063 0.176551\n",
      "MONDO:0013170 cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies 0.01238988556615262 0.175587\n",
      "MONDO:0008005 cardiospondylocarpofacial syndrome 0.01238988556615262 0.175587\n",
      "MONDO:0011335 spondyloepimetaphyseal dysplasia with multiple dislocations 0.01238988556615262 0.175587\n",
      "MONDO:0859276 primordial dwarfism-immunodeficiency-lipodystrophy syndrome 0.01238988556615262 0.175587\n",
      "MONDO:0009643 sulfite oxidase deficiency due to molybdenum cofactor deficiency type A 0.01238988556615262 0.175587\n",
      "MONDO:0859219 Rauch-Steindl syndrome 0.01238988556615262 0.175587\n",
      "MONDO:0010498 MEND syndrome 0.01238988556615262 0.175587\n",
      "MONDO:0007415 mitochondrial complex III deficiency nuclear type 1 0.01238988556615262 0.175587\n",
      "MONDO:0015002 developmental and epileptic encephalopathy, 49 0.01238988556615262 0.175587\n",
      "MONDO:0012634 craniofacial dysplasia - osteopenia syndrome 0.01238988556615262 0.175587\n",
      "MONDO:0060642 neurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features 0.01238988556615262 0.175587\n",
      "MONDO:0014165 multiple congenital anomalies-hypotonia-seizures syndrome 3 0.01238988556615262 0.175587\n",
      "MONDO:0014780 hyperphosphatasia with intellectual disability syndrome 6 0.01238988556615262 0.175587\n",
      "MONDO:0009998 Richieri Costa-Pereira syndrome 0.01238988556615262 0.175587\n",
      "MONDO:0060631 Alkuraya-Kucinskas syndrome 0.01238988556615262 0.175587\n",
      "MONDO:0013245 syndromic multisystem autoimmune disease due to ITCH deficiency 0.01238988556615262 0.175587\n",
      "MONDO:0032745 developmental delay with variable intellectual impairment and behavioral abnormalities 0.01238988556615262 0.175587\n",
      "MONDO:0026722 Mullegama-Klein-Martinez syndrome 0.01238988556615262 0.175587\n",
      "MONDO:0012873 Ehlers-Danlos syndrome, spondylocheirodysplastic type 0.012762930608178564 0.174657\n",
      "MONDO:0009659 mucopolysaccharidosis type 4A 0.012762930608178564 0.174657\n",
      "MONDO:0009161 Ehlers-Danlos syndrome, dermatosparaxis type 0.012762930608178564 0.174657\n",
      "MONDO:0009263 GAPO syndrome 0.012762930608178564 0.174657\n",
      "MONDO:0016002 Ehlers-Danlos syndrome, kyphoscoliotic type 1 0.012762930608178564 0.174657\n",
      "MONDO:0009817 autosomal recessive osteopetrosis 5 0.012762930608178564 0.174657\n",
      "MONDO:0009532 Miller-Dieker lissencephaly syndrome 0.012762930608178564 0.174657\n",
      "MONDO:0030047 microcephaly, developmental delay, and brittle hair syndrome 0.012762930608178564 0.174657\n",
      "MONDO:0013563 multiple congenital anomalies-hypotonia-seizures syndrome 1 0.012762930608178564 0.174657\n",
      "MONDO:0044324 Al Kaissi syndrome 0.012762930608178564 0.174657\n",
      "MONDO:0859228 combined oxidative phosphorylation deficiency 55 0.012762930608178564 0.174657\n",
      "MONDO:0859516 neurodevelopmental disorder with seizures, spasticity, and complete or partial agenesis of the corpus callosum 0.012762930608178564 0.174657\n",
      "MONDO:0023657 intellectual developmental disorder, autosomal dominant 65 0.012762930608178564 0.174657\n",
      "MONDO:0014361 autism spectrum disorder due to AUTS2 deficiency 0.012762930608178564 0.174657\n",
      "MONDO:0012198 PCWH syndrome 0.012762930608178564 0.174657\n",
      "MONDO:0054831 Coffin-Siris syndrome 7 0.012762930608178564 0.174657\n",
      "MONDO:0010655 X-linked intellectual disability with marfanoid habitus 0.01313583474176165 0.173757\n",
      "MONDO:0013459 osteogenesis imperfecta type 10 0.01313583474176165 0.173757\n",
      "MONDO:0008999 Cohen syndrome 0.01313583474176165 0.173757\n",
      "MONDO:0008546 thanatophoric dysplasia type 1 0.01313583474176165 0.173757\n",
      "MONDO:0013223 autosomal recessive spondylometaphyseal dysplasia, Megarbane type 0.01313583474176165 0.173757\n",
      "MONDO:0859295 neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties 0.01313583474176165 0.173757\n",
      "MONDO:0859365 neurodevelopmental disorder with hypotonia, dysmorphic facies, and skeletal anomalies, with or without seizures 0.01313583474176165 0.173757\n",
      "MONDO:0800437 Carey-Fineman-Ziter syndrome 1 0.01313583474176165 0.173757\n",
      "MONDO:0008006 Mobius syndrome 0.01313583474176165 0.173757\n",
      "MONDO:0014656 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2 0.01313583474176165 0.173757\n",
      "MONDO:0859312 neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalities 0.013508598020126513 0.172887\n",
      "MONDO:0010261 microphthalmia, syndromic 2 0.013508598020126513 0.172887\n",
      "MONDO:0014755 skin creases, congenital symmetric circumferential, 2 0.013508598020126513 0.172887\n",
      "MONDO:0008955 cerebrooculofacioskeletal syndrome 1 0.013508598020126513 0.172887\n",
      "MONDO:0054844 pontocerebellar hypoplasia, type 1D 0.013508598020126513 0.172887\n",
      "MONDO:0030679 Noonan syndrome 14 0.013508598020126513 0.172887\n",
      "MONDO:0030362 Aicardi-Goutieres syndrome 9 0.013508598020126513 0.172887\n",
      "MONDO:0009424 Bartter disease type 2 0.013508598020126513 0.172887\n",
      "MONDO:0012562 holoprosencephaly 7 0.01388122049647769 0.172043\n",
      "MONDO:0008800 microphthalmia with limb anomalies 0.01388122049647769 0.172043\n",
      "MONDO:0010471 Cornelia de Lange syndrome 5 0.01388122049647769 0.172043\n",
      "MONDO:0007524 autosomal dominant Ehlers-Danlos syndrome, vascular type 0.014253702223999637 0.171226\n",
      "MONDO:0020682 Ehlers-Danlos syndrome, spondylodysplastic type, 1 0.014253702223999637 0.171226\n",
      "MONDO:0013025 chromosome 6q24-q25 deletion syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0060592 Sweeney-Cox syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0018346 ferro-cerebro-cutaneous syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0007943 Nager acrofacial dysostosis 0.014253702223999637 0.171226\n",
      "MONDO:0014482 intellectual disability, autosomal dominant 29 0.014253702223999637 0.171226\n",
      "MONDO:0010519 alpha thalassemia-X-linked intellectual disability syndrome 0.014253702223999637 0.171226\n",
      "MONDO:0859236 neurodevelopmental disorder with neuromuscular and skeletal abnormalities 0.014253702223999637 0.171226\n",
      "MONDO:0032672 intellectual developmental disorder with cardiac defects and dysmorphic facies 0.014253702223999637 0.171226\n",
      "MONDO:0032687 intellectual developmental disorder with abnormal behavior, microcephaly, and short stature 0.014253702223999637 0.171226\n",
      "MONDO:0010248 X-linked spondyloepimetaphyseal dysplasia 0.014626043255856702 0.170433\n",
      "MONDO:0018663 regressive spondylometaphyseal dysplasia 0.014626043255856702 0.170433\n",
      "MONDO:0859209 Zaki syndrome 0.014626043255856702 0.170433\n",
      "MONDO:0007846 KBG syndrome 0.014626043255856702 0.170433\n",
      "MONDO:0011946 diaphanospondylodysostosis 0.014626043255856702 0.170433\n",
      "MONDO:0859080 intellectual developmental disorder, X-linked, syndromic, with pigmentary mosaicism and coarse facies 0.014626043255856702 0.170433\n",
      "MONDO:0013424 3p- syndrome 0.014626043255856702 0.170433\n",
      "MONDO:0010664 syndromic X-linked intellectual disability Snyder type 0.014626043255856702 0.170433\n",
      "MONDO:0007892 Lenz-Majewski hyperostotic dwarfism 0.014998243645193143 0.169663\n",
      "MONDO:0007621 Floating-Harbor syndrome 0.014998243645193143 0.169663\n",
      "MONDO:0012095 intellectual disability-brachydactyly-Pierre Robin syndrome 0.014998243645193143 0.169663\n",
      "MONDO:0009337 Hennekam lymphangiectasia-lymphedema syndrome 1 0.014998243645193143 0.169663\n",
      "MONDO:0011936 microphthalmia with brain and digit anomalies 0.014998243645193143 0.169663\n",
      "MONDO:0008885 Elsahy-Waters syndrome 0.014998243645193143 0.169663\n",
      "MONDO:0014262 Rienhoff syndrome 0.015370303445133167 0.168914\n",
      "MONDO:0007947 Marfan syndrome 0.015370303445133167 0.168914\n",
      "MONDO:0851095 KINSSHIP syndrome 0.015370303445133167 0.168914\n",
      "MONDO:0009768 oculodentodigital dysplasia, autosomal recessive 0.015370303445133167 0.168914\n",
      "MONDO:0009026 Costello syndrome 0.015370303445133167 0.168914\n",
      "MONDO:0008907 PMM2-congenital disorder of glycosylation 0.015370303445133167 0.168914\n",
      "MONDO:0011213 Pierpont syndrome 0.015370303445133167 0.168914\n",
      "MONDO:0030918 intellectual disability, autosomal dominant 52 0.015370303445133167 0.168914\n",
      "MONDO:0009783 progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1 0.015370303445133167 0.168914\n",
      "MONDO:0033561 deeah syndrome 0.015370303445133167 0.168914\n",
      "MONDO:0008222 Andersen-Tawil syndrome 0.01574222270878092 0.168187\n",
      "MONDO:0011147 chromosome 18q deletion syndrome 0.01574222270878092 0.168187\n",
      "MONDO:0009561 alpha-mannosidosis 0.01574222270878092 0.168187\n",
      "MONDO:0012555 Cornelia de Lange syndrome 3 0.01574222270878092 0.168187\n",
      "MONDO:0011714 partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome 0.01574222270878092 0.168187\n",
      "MONDO:0009629 Desbuquois dysplasia 1 0.016114001489220466 0.167479\n",
      "MONDO:0010208 wrinkly skin syndrome 0.016114001489220466 0.167479\n",
      "MONDO:0009318 Hallermann-Streiff syndrome 0.016114001489220466 0.167479\n",
      "MONDO:0013323 cranioectodermal dysplasia 2 0.016114001489220466 0.167479\n",
      "MONDO:0009579 Frank-Ter Haar syndrome 0.016114001489220466 0.167479\n",
      "MONDO:0009747 mitochondrial DNA depletion syndrome 6 (hepatocerebral type) 0.016114001489220466 0.167479\n",
      "MONDO:0008013 chromosome 9p deletion syndrome 0.016114001489220466 0.167479\n",
      "MONDO:0020763 Menke-Hennekam syndrome 1 0.016485639839515814 0.16679\n",
      "MONDO:0012864 chromosome 2q32-q33 deletion syndrome 0.016485639839515814 0.16679\n",
      "MONDO:0010355 syndromic X-linked intellectual disability Claes-Jensen type 0.016485639839515814 0.16679\n",
      "MONDO:0011977 8q22.1 microdeletion syndrome 0.016485639839515814 0.16679\n",
      "MONDO:0012589 Pitt-Hopkins syndrome 0.016857137812710955 0.166118\n",
      "MONDO:0859193 neuroocular syndrome 0.016857137812710955 0.166118\n",
      "MONDO:0010590 FG syndrome 1 0.016857137812710955 0.166118\n",
      "MONDO:0014700 Au-Kline syndrome 0.016857137812710955 0.166118\n",
      "MONDO:0014944 short stature-brachydactyly-obesity-global developmental delay syndrome 0.016857137812710955 0.166118\n",
      "MONDO:0021093 cranioectodermal dysplasia 1 0.017228495461829828 0.165464\n",
      "MONDO:0009511 Larsen-like syndrome, B3GAT3 type 0.017228495461829828 0.165464\n",
      "MONDO:0010010 Schinzel-Giedion syndrome 0.017228495461829828 0.165464\n",
      "MONDO:0010561 Coffin-Lowry syndrome 0.017228495461829828 0.165464\n",
      "MONDO:0009479 Johanson-Blizzard syndrome 0.017599712839876318 0.164826\n",
      "MONDO:0013998 MEGF8-related Carpenter syndrome 0.017599712839876318 0.164826\n",
      "MONDO:0011150 acroosteolysis-keloid-like lesions-premature aging syndrome 0.017599712839876318 0.164826\n",
      "MONDO:0010663 intellectual disability-hypotonic facies syndrome, X-linked, 1 0.017599712839876318 0.164826\n",
      "MONDO:0800436 craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1 0.01834172699466782 0.163595\n",
      "MONDO:0012315 distal 10q deletion syndrome 0.01834172699466782 0.163595\n",
      "MONDO:0009254 fucosidosis 0.01834172699466782 0.163595\n",
      "MONDO:0010592 focal dermal hypoplasia 0.01871252387732056 0.163001\n",
      "MONDO:0060752 neurodevelopmental disorder with spasticity and poor growth 0.01871252387732056 0.163001\n",
      "MONDO:0009571 Meckel syndrome, type 1 0.01871252387732056 0.163001\n",
      "MONDO:0054698 proteasome-associated autoinflammatory syndrome 1 0.019083180700716462 0.162421\n",
      "MONDO:0019569 Cockayne syndrome type 1 0.019083180700716462 0.162421\n",
      "MONDO:0009143 Meier-Gorlin syndrome 1 0.019453697517759418 0.161854\n",
      "MONDO:0010075 spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures 0.019453697517759418 0.161854\n",
      "MONDO:0012374 brachyphalangy, polydactyly, and tibial aplasia/hypoplasia 0.019453697517759418 0.161854\n",
      "MONDO:0013273 chromosome 16p13.3 duplication syndrome 0.019453697517759418 0.161854\n",
      "MONDO:0011835 sensory ataxic neuropathy, dysarthria, and ophthalmoparesis 0.019453697517759418 0.161854\n",
      "MONDO:0010077 spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome 0.019824074381333323 0.161299\n",
      "MONDO:0957228 intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities 0.020194311344302104 0.160756\n",
      "MONDO:0013932 peroxisome biogenesis disorder 5A (Zellweger) 0.020194311344302104 0.160756\n",
      "MONDO:0024455 autosomal dominant Robinow syndrome 1 0.020934365779780147 0.159704\n",
      "MONDO:0859187 neurodevelopmental disorder with hypotonia and brain abnormalities 0.02130418335791746 0.159195\n",
      "MONDO:0012853 Fontaine progeroid syndrome 0.022043399498909166 0.158206\n",
      "MONDO:0800044 congenital disorder of deglycosylation 1 0.022043399498909166 0.158206\n",
      "MONDO:0010193 Weaver syndrome 0.023520157196459984 0.15634\n",
      "MONDO:0009650 mucolipidosis type II 0.025731113602650624 0.153784\n"
     ]
    }
   ],
   "execution_count": 69
  },
  {
   "cell_type": "code",
   "id": "b28ce8d5-177f-4678-9e05-6bb4a39e6ac9",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:10.856373Z",
     "start_time": "2024-10-28T18:04:10.717821Z"
    }
   },
   "source": [
    "response = phenotypes_to_gene(twogene_phenotypes)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "NCBIGene:84466 MEGF10 0.0011327470604279887 0.263653\n",
      "NCBIGene:79042 TSEN34 0.0037708361514733027 0.216154\n",
      "NCBIGene:283989 TSEN54 0.004147136824040217 0.212675\n",
      "NCBIGene:80746 TSEN2 0.0045232953584311885 0.209536\n",
      "NCBIGene:6863 TAC1 0.012016699562439063 0.176551\n"
     ]
    }
   ],
   "execution_count": 70
  },
  {
   "cell_type": "code",
   "id": "5c2afb66-c318-40aa-97a2-2e8b0a773c22",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:10.858818Z",
     "start_time": "2024-10-28T18:04:10.857131Z"
    }
   },
   "source": [
    "autism_phenotypes=[\n",
    "    #Autistic behavior \n",
    "    \"HP:0000729\",\n",
    "    #Neurodevelopmental delay \n",
    "    \"HP:0012758\",\n",
    "    #Intellectual disability \n",
    "    \"HP:0001249\",\n",
    "    #Ventricular septal defect \n",
    "    \"HP:0001629\",\n",
    "    #Abnormal facial shape \n",
    "    \"HP:0001999\",\n",
    "    #high arched palate        \n",
    "    \"HP:0002705\",\n",
    "    #high nasal bridge        \n",
    "    \"HP:0000426\",\n",
    "    #shallow orbits        \n",
    "    \"HP:0000586\",\n",
    "    #Abnormality of the palmar creases \n",
    "    \"HP:0010490\"\n",
    "]"
   ],
   "outputs": [],
   "execution_count": 71
  },
  {
   "cell_type": "code",
   "id": "a1bbb8ea-2771-4163-a8f7-5f2b768b8768",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:11.722120Z",
     "start_time": "2024-10-28T18:04:10.859444Z"
    }
   },
   "source": [
    "response = phenotypes_to_disease(autism_phenotypes)\n",
    "print_results(response)"
   ],
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "200\n",
      "MONDO:0033492 Coffin-Siris syndrome 6 5.214647608277274e-08 0.757934\n",
      "MONDO:0013256 chromosome 15q24 deletion syndrome 1.7122897278399835e-06 0.594647\n",
      "MONDO:0008736 peroxisome biogenesis disorder 2B 4.23870594654196e-06 0.546461\n",
      "MONDO:0032850 neurooculocardiogenitourinary syndrome 6.61976266806481e-06 0.52238\n",
      "MONDO:0859252 neurodevelopmental disorder with poor growth and skeletal anomalies 1.422372092350377e-05 0.480883\n",
      "MONDO:0030030 Nizon-Isidor syndrome 2.3017716165030653e-05 0.454865\n",
      "MONDO:0008999 Cohen syndrome 3.592446802548804e-05 0.431019\n",
      "MONDO:0030679 Noonan syndrome 14 3.800047203182352e-05 0.42803\n",
      "MONDO:0014831 progeroid and marfanoid aspect-lipodystrophy syndrome 3.800047203182352e-05 0.42803\n",
      "MONDO:0010664 syndromic X-linked intellectual disability Snyder type 4.457613506478945e-05 0.419567\n",
      "MONDO:0009318 Hallermann-Streiff syndrome 5.415381663330505e-05 0.409311\n",
      "MONDO:0014700 Au-Kline syndrome 5.928934823615599e-05 0.404563\n",
      "MONDO:0011150 acroosteolysis-keloid-like lesions-premature aging syndrome 6.465570624499397e-05 0.400039\n",
      "MONDO:0013415 chromosome 17p13.1 deletion syndrome 8.213748553928864e-05 0.387633\n",
      "MONDO:0859143 Radio-Tartaglia syndrome 9.165475440462125e-05 0.381998\n",
      "MONDO:0859181 DEGCAGS syndrome 0.00013488200581530637 0.362397\n",
      "MONDO:0859177 VISS syndrome 0.00014288670825046015 0.359509\n",
      "MONDO:0007662 anterior segment dysgenesis 4 0.0002428396032477459 0.333442\n",
      "MONDO:0859178 developmental delay, impaired speech, and behavioral abnormalities 0.0004303937960394657 0.306415\n",
      "MONDO:0032862 hydrocephalus, congenital communicating, 1 0.0004856202354225857 0.300872\n",
      "MONDO:0044315 craniosynostosis 7 0.0004856202354225857 0.300872\n",
      "MONDO:0010488 intellectual disability, X-linked 100 0.0004856202354225857 0.300872\n",
      "MONDO:0032911 hearing loss, autosomal dominant 75 0.0004856202354225857 0.300872\n",
      "MONDO:0007693 hypertrichosis cubiti-short stature syndrome 0.0004856202354225857 0.300872\n",
      "MONDO:0014394 Diamond-Blackfan anemia 13 0.0004856202354225857 0.300872\n",
      "MONDO:0009900 polysyndactyly-cardiac malformation syndrome 0.0007283419108450321 0.282688\n",
      "MONDO:0009344 Hirschsprung disease-nail hypoplasia-dysmorphism syndrome 0.0007283419108450321 0.282688\n",
      "MONDO:0013703 intellectual disability, autosomal recessive 33 0.0007283419108450321 0.282688\n",
      "MONDO:0007143 aortic arch anomaly-facial dysmorphism-intellectual disability syndrome 0.0007283419108450321 0.282688\n",
      "MONDO:0009188 epilepsy-telangiectasia syndrome 0.0009710046438321194 0.270199\n",
      "MONDO:0010236 intellectual disability, X-linked 14 0.0009710046438321194 0.270199\n",
      "MONDO:0010841 Waardenburg syndrome type 2B 0.0009710046438321194 0.270199\n",
      "MONDO:0011160 autosomal recessive nonsyndromic hearing loss 15 0.0009710046438321194 0.270199\n",
      "MONDO:0009573 megaepiphyseal dwarfism 0.001213608448697405 0.260757\n",
      "MONDO:0012764 RIDDLE syndrome 0.001213608448697405 0.260757\n",
      "MONDO:0012924 Diamond-Blackfan anemia 4 0.001213608448697405 0.260757\n",
      "MONDO:0054794 hydrocephalus, congenital, 3, with brain anomalies 0.001213608448697405 0.260757\n",
      "MONDO:0009368 urofacial syndrome type 1 0.001213608448697405 0.260757\n",
      "MONDO:0010900 intrauterine growth retardation with increased mitomycin c sensitivity 0.001213608448697405 0.260757\n",
      "MONDO:0024529 MVP1 0.001213608448697405 0.260757\n",
      "MONDO:0009585 encephalopathy due to beta-mercaptolactate-cysteine disulfiduria 0.001213608448697405 0.260757\n",
      "MONDO:0010344 intellectual disability, X-linked 45 0.001213608448697405 0.260757\n",
      "MONDO:0009371 3-hydroxyisobutyric aciduria 0.0016986393312994233 0.246931\n",
      "MONDO:0007230 Brachymorphism-onychodysplasia-dysphalangism syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0010109 tetraamelia with ectodermal dysplasia and lacrimal duct abnormalities 0.0016986393312994233 0.246931\n",
      "MONDO:0009760 Norman-Roberts syndrome 0.0016986393312994233 0.246931\n",
      "MONDO:0010332 X-linked intellectual disability-cubitus valgus-dysmorphism syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0032883 intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures 0.0019410664376458965 0.241583\n",
      "MONDO:0010334 severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0010001 ectodermal dysplasia-blindness syndrome 0.0019410664376458965 0.241583\n",
      "MONDO:0030518 trichothiodystrophy 9, nonphotosensitive 0.0019410664376458965 0.241583\n",
      "MONDO:0010539 X-linked mandibulofacial dysostosis 0.0019410664376458965 0.241583\n",
      "MONDO:0044725 combined immunodeficiency due to GINS1 deficiency 0.002183434673090045 0.236933\n",
      "MONDO:0032897 intellectual developmental disorder with hypotonia and behavioral abnormalities 0.002183434673090045 0.236933\n",
      "MONDO:0008724 adducted thumbs-arthrogryposis syndrome, Christian type 0.002183434673090045 0.236933\n",
      "MONDO:0014820 mitochondrial DNA depletion syndrome 14 (cardioencephalomyopathic type) 0.002425744051928062 0.232826\n",
      "MONDO:0014297 Joubert syndrome 22 0.002425744051928062 0.232826\n",
      "MONDO:0032877 neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizures 0.002425744051928062 0.232826\n",
      "MONDO:0032605 intellectual disability, autosomal recessive 66 0.002425744051928062 0.232826\n",
      "MONDO:0010232 intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked 0.002425744051928062 0.232826\n",
      "MONDO:0011654 intellectual disability, microcephaly, growth retardation, joint contractures, and facial dysmorphism 0.002425744051928062 0.232826\n",
      "MONDO:0013473 Hirschsprung disease, cardiac defects, and autonomic dysfunction 0.002425744051928062 0.232826\n",
      "MONDO:0013321 forsythe-wakeling syndrome 0.002425744051928062 0.232826\n",
      "MONDO:0009477 Stromme syndrome 0.002425744051928062 0.232826\n",
      "MONDO:0012830 chromosome 10q23 deletion syndrome 0.0026679945884526563 0.229154\n",
      "MONDO:0044321 structural heart defects and renal anomalies syndrome 0.0026679945884526563 0.229154\n",
      "MONDO:0014454 Hennekam lymphangiectasia-lymphedema syndrome 2 0.0026679945884526563 0.229154\n",
      "MONDO:0011995 cataract - congenital heart disease - neural tube defect syndrome 0.0026679945884526563 0.229154\n",
      "MONDO:0054701 Kleefstra syndrome 2 0.0026679945884526563 0.229154\n",
      "MONDO:0007134 Cooks syndrome 0.0026679945884526563 0.229154\n",
      "MONDO:0033618 Vissers-Bodmer syndrome 0.0029101862969530736 0.225838\n",
      "MONDO:0032788 cerebellar atrophy with seizures and variable developmental delay 0.0029101862969530736 0.225838\n",
      "MONDO:0011493 Stickler syndrome type 2 0.0029101862969530736 0.225838\n",
      "MONDO:0030912 intellectual disability, autosomal dominant 47 0.0029101862969530736 0.225838\n",
      "MONDO:0009601 metaphyseal dysplasia without hypotrichosis 0.0031523191917150915 0.222819\n",
      "MONDO:0008603 trigonocephaly 1 0.0031523191917150915 0.222819\n",
      "MONDO:0014043 microcephalic primordial dwarfism due to ZNF335 deficiency 0.0031523191917150915 0.222819\n",
      "MONDO:0014527 progeroid features-hepatocellular carcinoma predisposition syndrome 0.0031523191917150915 0.222819\n",
      "MONDO:0032485 intellectual developmental disorder 61 0.0031523191917150915 0.222819\n",
      "MONDO:0013404 hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase 0.0033943932870210093 0.220049\n",
      "MONDO:0032622 mitochondrial complex 1 deficiency, nuclear type 17 0.0033943932870210093 0.220049\n",
      "MONDO:0011867 microphthalmia with cyst, bilateral facial clefts, and limb anomalies 0.0033943932870210093 0.220049\n",
      "MONDO:0007405 Crouzon syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0015014 coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness 0.0033943932870210093 0.220049\n",
      "MONDO:0007204 Cole-Carpenter syndrome 1 0.0033943932870210093 0.220049\n",
      "MONDO:0008391 Robinow-Sorauf syndrome 0.0033943932870210093 0.220049\n",
      "MONDO:0014085 hydrocephalus, nonsyndromic, autosomal recessive 2 0.0036364085971496707 0.217493\n",
      "MONDO:0011738 bilateral frontoparietal polymicrogyria 0.0036364085971496707 0.217493\n",
      "MONDO:0010363 intellectual disability, X-linked 91 0.0036364085971496707 0.217493\n",
      "MONDO:0008333 pseudoxanthoma elasticum, forme fruste 0.0036364085971496707 0.217493\n",
      "MONDO:0014044 dysmorphism-conductive hearing loss-heart defect syndrome 0.0036364085971496707 0.217493\n",
      "MONDO:0010659 FRAXE intellectual disability 0.0036364085971496707 0.217493\n",
      "MONDO:0010545 Nance-Horan syndrome 0.0036364085971496707 0.217493\n",
      "MONDO:0013226 combined immunodeficiency with faciooculoskeletal anomalies 0.0038783651363764366 0.215122\n",
      "MONDO:0008082 multiple endocrine neoplasia type 2B 0.0038783651363764366 0.215122\n",
      "MONDO:0012373 ectodermal dysplasia, sensorineural hearing loss, and distinctive facial features 0.0038783651363764366 0.215122\n",
      "MONDO:0011421 mitochondrial complex V (ATP synthase) deficiency, nuclear type 1 0.0038783651363764366 0.215122\n",
      "MONDO:0011538 frontoocular syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0007862 Waardenburg syndrome type 3 0.0038783651363764366 0.215122\n",
      "MONDO:0031010 odontochondrodysplasia 2 with hearing loss and diabetes 0.0038783651363764366 0.215122\n",
      "MONDO:0012064 choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome 0.0038783651363764366 0.215122\n",
      "MONDO:0030835 developmental delay, impaired growth, dysmorphic facies, and axonal neuropathy 0.004120262918973215 0.212912\n",
      "MONDO:0008425 omphalocele syndrome, Shprintzen-Goldberg type 0.004120262918973215 0.212912\n",
      "MONDO:0010716 X-linked lethal multiple pterygium syndrome 0.004120262918973215 0.212912\n",
      "MONDO:0033482 spinocerebellar ataxia 47 0.004120262918973215 0.212912\n",
      "MONDO:0014702 autosomal recessive complex spastic paraplegia type 9B 0.004120262918973215 0.212912\n",
      "MONDO:0013036 Zechi-Ceide syndrome 0.004120262918973215 0.212912\n",
      "MONDO:0012669 Legius syndrome 0.004120262918973215 0.212912\n",
      "MONDO:0033547 Li-Ghorbani-Weisz-Hubshman syndrome 0.004120262918973215 0.212912\n",
      "MONDO:0859249 parenti-mignot neurodevelopmental syndrome 0.004120262918973215 0.212912\n",
      "MONDO:0012099 AICA-ribosiduria 0.004120262918973215 0.212912\n",
      "MONDO:0013856 hypertelorism and other facial dysmorphism, brachydactyly, genital abnormalities, intellectual disability, and recurrent inflammatory episodes 0.004362101959208437 0.210844\n",
      "MONDO:0011131 tricho-oculo-dermo-vertebral syndrome 0.004362101959208437 0.210844\n",
      "MONDO:0012322 holoprosencephaly 5 0.004362101959208437 0.210844\n",
      "MONDO:0009668 lethal multiple pterygium syndrome 0.004362101959208437 0.210844\n",
      "MONDO:0031002 Baralle-Macken syndrome 0.004362101959208437 0.210844\n",
      "MONDO:0029131 peripheral neuropathy, autosomal recessive, with or without impaired intellectual development 0.004362101959208437 0.210844\n",
      "MONDO:0009955 rapadilino syndrome 0.004362101959208437 0.210844\n",
      "MONDO:0054770 orofaciodigital syndrome 18 0.004362101959208437 0.210844\n",
      "MONDO:0012269 chromosome 3q29 microdeletion syndrome 0.004362101959208437 0.210844\n",
      "MONDO:0010398 syndromic X-linked intellectual disability 14 0.004362101959208437 0.210844\n",
      "MONDO:0010333 corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome 0.004362101959208437 0.210844\n",
      "MONDO:0007043 Pfeiffer syndrome 0.004362101959208437 0.210844\n",
      "MONDO:0012160 spondylometaphyseal dysplasia-cone-rod dystrophy syndrome 0.0046038822713470855 0.208901\n",
      "MONDO:0009959 peroxisome biogenesis disorder type 3B 0.0046038822713470855 0.208901\n",
      "MONDO:0019073 hypotrichosis-lymphedema-telangiectasia-renal defect syndrome 0.0046038822713470855 0.208901\n",
      "MONDO:0011402 congenital cataracts-facial dysmorphism-neuropathy syndrome 0.004845603869650658 0.207071\n",
      "MONDO:0011504 NDE1-related microhydranencephaly 0.004845603869650658 0.207071\n",
      "MONDO:0033651 mitochondrial complex 4 deficiency, nuclear type 16 0.004845603869650658 0.207071\n",
      "MONDO:0013443 Seckel syndrome 5 0.004845603869650658 0.207071\n",
      "MONDO:0859251 Dentici-Novelli neurodevelopmental syndrome 0.004845603869650658 0.207071\n",
      "MONDO:0054748 Fanconi anemia, complementation group S 0.004845603869650658 0.207071\n",
      "MONDO:0957218 neurodevelopmental disorder with microcephaly and speech delay, with or without brain abnormalities 0.004845603869650658 0.207071\n",
      "MONDO:0009965 Perlman syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0008421 flat face-microstomia-ear anomaly syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0014320 Bosch-Boonstra-Schaaf optic atrophy syndrome 0.005087266768377201 0.205341\n",
      "MONDO:0010268 X-linked lissencephaly with abnormal genitalia 0.005087266768377201 0.205341\n",
      "MONDO:0032775 neurodevelopmental disorder with seizures and speech and walking impairment 0.005087266768377201 0.205341\n",
      "MONDO:0013053 microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type 0.005087266768377201 0.205341\n",
      "MONDO:0010197 whistling face syndrome, recessive form 0.005087266768377201 0.205341\n",
      "MONDO:0032793 O'Donnell-Luria-Rodan syndrome 0.005328870981781299 0.203702\n",
      "MONDO:0012519 Rubinstein-Taybi syndrome due to 16p13.3 microdeletion 0.005328870981781299 0.203702\n",
      "MONDO:0014609 cognitive impairment - coarse facies - heart defects - obesity - pulmonary involvement - short stature - skeletal dysplasia syndrome 0.005328870981781299 0.203702\n",
      "MONDO:0859332 cortical dysplasia, complex, with other brain malformations 11 0.005328870981781299 0.203702\n",
      "MONDO:0859197 intellectual developmental disorder with hypotonia, impaired speech, and dysmorphic facies 0.005328870981781299 0.203702\n",
      "MONDO:0044303 congenital heart defects and ectodermal dysplasia 0.005328870981781299 0.203702\n",
      "MONDO:0011778 multiple epiphyseal dysplasia, Al-Gazali type 0.005570416524114067 0.202145\n",
      "MONDO:0100292 Carey-Fineman-Ziter syndrome 2 0.005570416524114067 0.202145\n",
      "MONDO:0014931 Alazami-Yuan syndrome 0.005570416524114067 0.202145\n",
      "MONDO:0011049 Fine-Lubinsky syndrome 0.005570416524114067 0.202145\n",
      "MONDO:0009139 dyssegmental dysplasia, Rolland-Desbuquois type 0.005570416524114067 0.202145\n",
      "MONDO:0060549 congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay 0.005811903409623178 0.200662\n",
      "MONDO:0013897 Loeys-Dietz syndrome 4 0.005811903409623178 0.200662\n",
      "MONDO:0012929 Compton-North congenital myopathy 0.005811903409623178 0.200662\n",
      "MONDO:0030953 short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 2 0.005811903409623178 0.200662\n",
      "MONDO:0020850 intellectual disability, autosomal recessive 65 0.005811903409623178 0.200662\n",
      "MONDO:0009927 3MC syndrome 2 0.005811903409623178 0.200662\n",
      "MONDO:0032939 intellectual developmental disorder, autosomal dominant 63, with macrocephaly 0.005811903409623178 0.200662\n",
      "MONDO:0032790 neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities 0.005811903409623178 0.200662\n",
      "MONDO:0010194 Weill-Marchesani syndrome 1 0.005811903409623178 0.200662\n",
      "MONDO:0012690 Noonan syndrome 5 0.0060533316525528125 0.199249\n",
      "MONDO:0009738 sialidosis type 2 0.0060533316525528125 0.199249\n",
      "MONDO:0011948 pontocerebellar hypoplasia type 3 0.0060533316525528125 0.199249\n",
      "MONDO:0013745 Joubert syndrome 14 0.0060533316525528125 0.199249\n",
      "MONDO:0009209 autosomal recessive faciodigitogenital syndrome 0.0060533316525528125 0.199249\n",
      "MONDO:0032698 neurodevelopmental disorder with central and peripheral motor dysfunction 0.0060533316525528125 0.199249\n",
      "MONDO:0010728 SCARF syndrome 0.0060533316525528125 0.199249\n",
      "MONDO:0009282 multiple acyl-CoA dehydrogenase deficiency 0.006294701267143732 0.197897\n",
      "MONDO:0010717 pyruvate dehydrogenase E1-alpha deficiency 0.006294701267143732 0.197897\n",
      "MONDO:0014995 neurodevelopmental disorder with hypotonia, seizures, and absent language 0.006294701267143732 0.197897\n",
      "MONDO:0009564 Marden-Walker syndrome 0.006294701267143732 0.197897\n",
      "MONDO:0010101 Teebi-Shaltout syndrome 0.006294701267143732 0.197897\n",
      "MONDO:0011106 facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome 0.006294701267143732 0.197897\n",
      "MONDO:0014686 short stature, microcephaly, and endocrine dysfunction 0.006294701267143732 0.197897\n",
      "MONDO:0010441 CK syndrome 0.006294701267143732 0.197897\n",
      "MONDO:0032943 neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies 0.006294701267143732 0.197897\n",
      "MONDO:0013641 Warburg micro syndrome 2 0.006294701267143732 0.197897\n",
      "MONDO:0010865 pseudoaminopterin syndrome 0.006536012267633194 0.196604\n",
      "MONDO:0008854 Bardet-Biedl syndrome 1 0.006536012267633194 0.196604\n",
      "MONDO:0030913 intellectual disability, autosomal dominant 48 0.006536012267633194 0.196604\n",
      "MONDO:0008872 microcephalic osteodysplastic primordial dwarfism type II 0.006536012267633194 0.196604\n",
      "MONDO:0032942 neurodevelopmental disorder with microcephaly and dysmorphic facies 0.006536012267633194 0.196604\n",
      "MONDO:0010428 chromosome Xp11.23-p11.22 duplication syndrome 0.006536012267633194 0.196604\n",
      "MONDO:0957266 RECON progeroid syndrome 0.006536012267633194 0.196604\n",
      "MONDO:0014371 developmental and epileptic encephalopathy, 23 0.006536012267633194 0.196604\n",
      "MONDO:0013572 Keppen-Lubinsky syndrome 0.006536012267633194 0.196604\n",
      "MONDO:0859147 Marbach-Rustad progeroid syndrome 0.006536012267633194 0.196604\n",
      "MONDO:0015601 X-linked intellectual disability, van Esch type 0.006536012267633194 0.196604\n",
      "MONDO:0007875 Larsen syndrome 0.006536012267633194 0.196604\n",
      "MONDO:0031000 Tessadori-Van Haaften neurodevelopmental syndrome 4 0.006777264668255051 0.195364\n",
      "MONDO:0012280 Goldberg-Shprintzen megacolon syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0011911 craniolenticulosutural dysplasia 0.006777264668255051 0.195364\n",
      "MONDO:0013299 chromosome 6q11-q14 deletion syndrome 0.006777264668255051 0.195364\n",
      "MONDO:0012554 cerebrooculofacioskeletal syndrome 4 0.006777264668255051 0.195364\n",
      "MONDO:0007604 femoral-facial syndrome 0.007018458483239651 0.194173\n",
      "MONDO:0859199 developmental delay with or without intellectual impairment or behavioral abnormalities 0.007018458483239651 0.194173\n",
      "MONDO:0030043 congenital disorder of glycosylation, type iit 0.007018458483239651 0.194173\n",
      "MONDO:0014296 Warburg micro syndrome 4 0.007018458483239651 0.194173\n",
      "MONDO:0012892 bone fragility with contractures, arterial rupture, and deafness 0.007018458483239651 0.194173\n",
      "MONDO:0012123 congenital disorder of glycosylation type 1E 0.007259593726813918 0.193028\n",
      "MONDO:0032781 congenital hypotonia, epilepsy, developmental delay, and digital anomalies 0.007259593726813918 0.193028\n",
      "MONDO:0010671 microphthalmia, syndromic 1 0.007259593726813918 0.193028\n",
      "MONDO:0010370 Cornelia de Lange syndrome 2 0.007259593726813918 0.193028\n",
      "MONDO:0014863 macrocephaly, dysmorphic facies, and psychomotor retardation 0.007259593726813918 0.193028\n",
      "MONDO:0060760 intellectual developmental disorder with dysmorphic facies and behavioral abnormalities 0.007500670413201299 0.191925\n",
      "MONDO:0100101 fetal akinesia deformation sequence 1 0.007500670413201299 0.191925\n",
      "MONDO:0014833 heart and brain malformation syndrome 0.007500670413201299 0.191925\n",
      "MONDO:0054837 intellectual disability, autosomal dominant 57 0.007500670413201299 0.191925\n",
      "MONDO:0013430 Meier-Gorlin syndrome 3 0.007500670413201299 0.191925\n",
      "MONDO:0859200 cerebellar ataxia, brain abnormalities, and cardiac conduction defects 0.007500670413201299 0.191925\n",
      "MONDO:0030928 microcephaly 26, primary, autosomal dominant 0.007500670413201299 0.191925\n",
      "MONDO:0008104 Noonan syndrome 1 0.007741688556621809 0.190862\n",
      "MONDO:0010361 intellectual disability, X-linked 30 0.007741688556621809 0.190862\n",
      "MONDO:0007412 Beare-Stevenson cutis gyrata syndrome 0.007741688556621809 0.190862\n",
      "MONDO:0011575 cerebrooculonasal syndrome 0.007741688556621809 0.190862\n",
      "MONDO:0013245 syndromic multisystem autoimmune disease due to ITCH deficiency 0.007982648171292002 0.189836\n",
      "MONDO:0010498 MEND syndrome 0.007982648171292002 0.189836\n",
      "MONDO:0012683 pontocerebellar hypoplasia type 6 0.007982648171292002 0.189836\n",
      "MONDO:0044324 Al Kaissi syndrome 0.008223549271424959 0.188845\n",
      "MONDO:0009263 GAPO syndrome 0.008223549271424959 0.188845\n",
      "MONDO:0011640 genitopatellar syndrome 0.008223549271424959 0.188845\n",
      "MONDO:0014823 hypotonia, infantile, with psychomotor retardation and characteristic facies 3 0.008223549271424959 0.188845\n",
      "MONDO:0007042 Saethre-Chotzen syndrome 0.008223549271424959 0.188845\n",
      "MONDO:0859286 neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures 0.008223549271424959 0.188845\n",
      "MONDO:0024541 trichohepatoenteric syndrome 1 0.008464391871230346 0.187887\n",
      "MONDO:0014757 macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome 0.008464391871230346 0.187887\n",
      "MONDO:0008564 DiGeorge syndrome 0.008464391871230346 0.187887\n",
      "MONDO:0010655 X-linked intellectual disability with marfanoid habitus 0.008464391871230346 0.187887\n",
      "MONDO:0013459 osteogenesis imperfecta type 10 0.008464391871230346 0.187887\n",
      "MONDO:0054844 pontocerebellar hypoplasia, type 1D 0.008705175984914347 0.18696\n",
      "MONDO:0010506 intellectual disability, X-linked 61 0.008705175984914347 0.18696\n",
      "MONDO:0014858 intellectual disability, autosomal dominant 43 0.008705175984914347 0.18696\n",
      "MONDO:0044319 intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies 0.008705175984914347 0.18696\n",
      "MONDO:0008955 cerebrooculofacioskeletal syndrome 1 0.008705175984914347 0.18696\n",
      "MONDO:0010261 microphthalmia, syndromic 2 0.008705175984914347 0.18696\n",
      "MONDO:0007688 Myhre syndrome 0.008945901626679721 0.186061\n",
      "MONDO:0032855 neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies 0.008945901626679721 0.186061\n",
      "MONDO:0014777 hypotonia, infantile, with psychomotor retardation and characteristic facies 2 0.008945901626679721 0.186061\n",
      "MONDO:0010471 Cornelia de Lange syndrome 5 0.008945901626679721 0.186061\n",
      "MONDO:0012562 holoprosencephaly 7 0.008945901626679721 0.186061\n",
      "MONDO:0010038 growth delay due to insulin-like growth factor I resistance 0.009186568810725743 0.185189\n",
      "MONDO:0013056 developmental and epileptic encephalopathy, 39 0.009186568810725743 0.185189\n",
      "MONDO:0013025 chromosome 6q24-q25 deletion syndrome 0.009186568810725743 0.185189\n",
      "MONDO:0007943 Nager acrofacial dysostosis 0.009186568810725743 0.185189\n",
      "MONDO:0007846 KBG syndrome 0.00942717755124829 0.184344\n",
      "MONDO:0010417 syndromic X-linked intellectual disability Najm type 0.00942717755124829 0.184344\n",
      "MONDO:0008426 Shprintzen-Goldberg syndrome 0.00942717755124829 0.184344\n",
      "MONDO:0030880 mandibuloacral dysplasia progeroid syndrome 0.00942717755124829 0.184344\n",
      "MONDO:0020681 Ehlers-Danlos syndrome, musculocontractural type 1 0.009667727862439744 0.183522\n",
      "MONDO:0007340 cleidocranial dysplasia 1 0.009667727862439744 0.183522\n",
      "MONDO:0009124 Dubowitz syndrome 0.009667727862439744 0.183522\n",
      "MONDO:0012496 Koolen-de Vries syndrome 0.009667727862439744 0.183522\n",
      "MONDO:0012095 intellectual disability-brachydactyly-Pierre Robin syndrome 0.009667727862439744 0.183522\n",
      "MONDO:0007621 Floating-Harbor syndrome 0.009667727862439744 0.183522\n",
      "MONDO:0012013 Weill-Marchesani syndrome 2, dominant 0.009667727862439744 0.183522\n",
      "MONDO:0012916 chromosome 2p16.1-p15 deletion syndrome 0.009908219758489068 0.182724\n",
      "MONDO:0030918 intellectual disability, autosomal dominant 52 0.009908219758489068 0.182724\n",
      "MONDO:0014262 Rienhoff syndrome 0.009908219758489068 0.182724\n",
      "MONDO:0008908 MGAT2-congenital disorder of glycosylation 0.009908219758489068 0.182724\n",
      "MONDO:0007041 Apert syndrome 0.009908219758489068 0.182724\n",
      "MONDO:0008013 chromosome 9p deletion syndrome 0.010389028361899914 0.181193\n",
      "MONDO:0044302 congenital heart defects, dysmorphic facial features, and intellectual developmental disorder 0.010389028361899914 0.181193\n",
      "MONDO:0009785 opsismodysplasia 0.010389028361899914 0.181193\n",
      "MONDO:0859190 neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities 0.010389028361899914 0.181193\n",
      "MONDO:0012864 chromosome 2q32-q33 deletion syndrome 0.010629345097622128 0.180457\n",
      "MONDO:0010355 syndromic X-linked intellectual disability Claes-Jensen type 0.010629345097622128 0.180457\n",
      "MONDO:0100253 Roberts-SC phocomelia syndrome 0.010629345097622128 0.180457\n",
      "MONDO:0008150 osteoglophonic dwarfism 0.010869603474923576 0.17974\n",
      "MONDO:0010501 syndromic X-linked intellectual disability 34 0.01110980350797602 0.179042\n",
      "MONDO:0021093 cranioectodermal dysplasia 1 0.01110980350797602 0.179042\n",
      "MONDO:0032755 neurodevelopmental disorder with or without variable brain abnormalities; NEDBA 0.01110980350797602 0.179042\n",
      "MONDO:0010010 Schinzel-Giedion syndrome 0.01110980350797602 0.179042\n",
      "MONDO:0010959 van den Ende-Gupta syndrome 0.01134994521094772 0.17836\n",
      "MONDO:0013998 MEGF8-related Carpenter syndrome 0.01134994521094772 0.17836\n",
      "MONDO:0010483 X-linked intellectual disability, Cantagrel type 0.01183005368330494 0.177046\n",
      "MONDO:0019570 Cockayne syndrome type 2 0.01183005368330494 0.177046\n",
      "MONDO:0010500 intellectual disability, X-linked, syndromic 33 0.012070020481009839 0.176411\n",
      "MONDO:0060752 neurodevelopmental disorder with spasticity and poor growth 0.012070020481009839 0.176411\n",
      "MONDO:0015021 hypotonia, ataxia, and delayed development syndrome 0.012070020481009839 0.176411\n",
      "MONDO:0032760 developmental delay with or without dysmorphic facies and autism 0.012070020481009839 0.176411\n",
      "MONDO:0010283 syndromic X-linked intellectual disability Lubs type 0.012309929005272778 0.175791\n",
      "MONDO:0007387 Cornelia de Lange syndrome 1 0.01278957129007379 0.174592\n",
      "MONDO:0009039 Baller-Gerold syndrome 0.013508598020126513 0.172887\n",
      "MONDO:0019349 Sotos syndrome 0.013748157200790626 0.172342\n",
      "MONDO:0012853 Fontaine progeroid syndrome 0.01422710105287674 0.171283\n",
      "MONDO:0859273 liver disease, severe congenital 0.014466485752549425 0.17077\n",
      "MONDO:0008953 peroxisome biogenesis disorder 1A (Zellweger) 0.014466485752549425 0.17077\n",
      "MONDO:0025699 Coffin-Siris syndrome 12 0.01470581232013664 0.170266\n",
      "MONDO:0014205 severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome 0.01494508076975512 0.169771\n",
      "MONDO:0011053 intellectual disability-sparse hair-brachydactyly syndrome 0.015184291115518226 0.169286\n",
      "MONDO:0012914 chromosome 1q21.1 deletion syndrome 0.015184291115518226 0.169286\n",
      "MONDO:0859239 Chilton-Okur-Chung neurodevelopmental syndrome 0.016140551742163896 0.167429\n",
      "MONDO:0014558 autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome 0.017334571880900356 0.16528\n",
      "MONDO:0014379 ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder 0.0178117740974452 0.164468\n",
      "MONDO:0011244 Marshall-Smith syndrome 0.019241990762857288 0.162176\n",
      "MONDO:0030993 Tessadori-Van Haaften neurodevelopmental syndrome 3 0.020670124813495463 0.160075\n",
      "MONDO:0008393 Rubinstein-Taybi syndrome due to CREBBP mutations 0.0211457072180399 0.159412\n"
     ]
    }
   ],
   "execution_count": 72
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-10-28T18:04:11.725668Z",
     "start_time": "2024-10-28T18:04:11.723424Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# response = phenotypes_to_gene(autism_phenotypes)\n",
    "# print_results(response)\n",
    "\n",
    "# No enrichment in the database"
   ],
   "id": "8b95e32f11ce5ca2",
   "outputs": [],
   "execution_count": 73
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
